PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Schabort, DTWP; Letebele, PK; Steyn, L; Kilian, SG; du Preez, JC				Schabort, Du Toit W. P.; Letebele, Precious K.; Steyn, Laurinda; Kilian, Stephanus G.; du Preez, James C.			Differential RNA-seq, Multi-Network Analysis and Metabolic Regulation Analysis of Kluyveromyces marxianus Reveals a Compartmentalised Response to Xylose	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; SEQUENCE; PATHWAY; ETHANOL	We investigated the transcriptomic response of a new strain of the yeast Kluyveromyces marxianus, in glucose and xylose media using RNA-seq. The data were explored in a number of innovative ways using a variety of networks types, pathway maps, enrichment statistics, reporter metabolites and a flux simulation model, revealing different aspects of the genome-scale response in an integrative systems biology manner. The importance of the subcellular localisation in the transcriptomic response is emphasised here, revealing new insights. As was previously reported by others using a rich medium, we show that peroxisomal fatty acid catabolism was dramatically up-regulated in a defined xylose mineral medium without fatty acids, along with mechanisms to activate fatty acids and transfer products of beta-oxidation to the mitochondria. Notably, we observed a strong up-regulation of the 2-methylcitrate pathway, supporting capacity for odd-chain fatty acid catabolism. Next we asked which pathways would respond to the additional requirement for NADPH for xylose utilisation, and rationalised the unexpected results using simulations with Flux Balance Analysis. On a fundamental level, we investigated the contribution of the hierarchical and metabolic regulation levels to the regulation of metabolic fluxes. Metabolic regulation analysis suggested that genetic level regulation plays a major role in regulating metabolic fluxes in adaptation to xylose, even for the high capacity reactions, which is unexpected. In addition, isozyme switching may play an important role in re-routing of metabolic fluxes in subcellular compartments in K. marxianus.	[Schabort, Du Toit W. P.; Letebele, Precious K.; Steyn, Laurinda; Kilian, Stephanus G.; du Preez, James C.] Univ Free State, Dept Microbial Biochem & Food Biotechnol, Bloemfontein, South Africa	University of the Free State	Schabort, DTWP (corresponding author), Univ Free State, Dept Microbial Biochem & Food Biotechnol, Bloemfontein, South Africa.	SchabortDWP@ufs.ac.za	Steyn, Laurinda/AAC-7834-2019		National Research Foundation of South Africa (ZA), CSPG - Thuthuka (PhD Track) [TTK20110831000026600, 80657]	National Research Foundation of South Africa (ZA), CSPG - Thuthuka (PhD Track)	This work was supported by the National Research Foundation of South Africa (ZA), CSPG - Thuthuka (PhD Track) (http://www.nrf.ac.za/), Reference: TTK20110831000026600, UID: 80657, awarded to Mr. WPD Schabort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alff-Tuomala S, 2016, APPL MICROBIOL BIOT, V100, P969, DOI 10.1007/s00253-015-7038-7; Barupal DK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-99; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015; Canelas AB, 2011, METAB ENG, V13, P294, DOI 10.1016/j.ymben.2011.02.005; Chi ZM, 2009, APPL MICROBIOL BIOT, V82, P211, DOI 10.1007/s00253-008-1827-1; Covert MW, 2001, TRENDS BIOCHEM SCI, V26, P179, DOI 10.1016/S0968-0004(00)01754-0; Dias O, 2014, BIOTECHNOL J, V9, P776, DOI 10.1002/biot.201300242; DUPREEZ JC, 1983, BIOTECHNOL LETT, V5, P357, DOI 10.1007/BF01141138; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Gao JQ, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0295-y; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Groeneveld P, 2009, FEBS J, V276, P254, DOI 10.1111/j.1742-4658.2008.06778.x; Guaragnella N, 2003, J BIOL CHEM, V278, P45882, DOI 10.1074/jbc.M309301200; Gurvitz A, 1997, J BIOL CHEM, V272, P22140, DOI 10.1074/jbc.272.35.22140; Harcus D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080733; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kim WH, 2003, J BIOCHEM MOL BIOL, V36, P442; Lertwattanasakul N, 2007, BIOSCI BIOTECH BIOCH, V71, P1170, DOI 10.1271/bbb.60622; Lertwattanasakul N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0227-x; Lertwattanasakul N, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-20; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lucau-Danila A, 2003, J BIOL CHEM, V278, P52641, DOI 10.1074/jbc.M309580200; Luttik MAH, 2000, J BACTERIOL, V182, P7007, DOI 10.1128/JB.182.24.7007-7013.2000; Maciejewski H, 2014, BRIEF BIOINFORM, V15, P504, DOI 10.1093/bib/bbt002; Oliveira AP, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-17; Orencio-Trejo M, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-8; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; PRONK JT, 1994, MICROBIOL-UK, V140, P717, DOI 10.1099/00221287-140-4-717; Rocha SN, 2011, ANTON LEEUW INT J G, V100, P619, DOI 10.1007/s10482-011-9617-7; Runquist D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-49; Schilling CH, 1999, BIOTECHNOL PROGR, V15, P288, DOI 10.1021/bp9900357; Tang J, 2011, CURR GENOMICS, V12, P391, DOI 10.2174/138920211797248619; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001	42	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0156242	10.1371/journal.pone.0156242	http://dx.doi.org/10.1371/journal.pone.0156242			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315089	Green Published, gold			2022-12-27	WOS:000378030000002
J	Zhao, LQ; Winklhofer, S; Jiang, R; Wang, XL; He, W				Zhao, Liqin; Winklhofer, Sebastian; Jiang, Rong; Wang, Xinlian; He, Wen			Dual Energy CT (DECT) Monochromatic Imaging: Added Value of Adaptive Statistical Iterative Reconstructions (ASIR) in Portal Venography	PLOS ONE			English	Article							SPECTRAL CT; DOSE REDUCTION; QUALITY; ENHANCEMENT; ALGORITHM	Objective To investigate the effect of the adaptive statistical iterative reconstructions (ASIR) on image quality in portal venography by dual energy CT (DECT) imaging. Materials and Methods DECT scans of 45 cirrhotic patients obtained in the portal venous phase were analyzed. Monochromatic images at 70keV were reconstructed with the following 4 ASIR percentages: 0%, 30%, 50%, and 70%. The image noise (IN) (standard deviation, SD) of portal vein (PV), the contrast-to-noise-ratio (CNR), and the subjective score for the sharpness of PV boundaries, and the diagnostic acceptability (DA) were obtained. The IN, CNR, and the subjective scores were compared among the four ASIR groups. Results The IN (in HU) of PV (10.05 +/- 3.14, 9.23 +/- 3.05, 8.44 +/- 2.95 and 7.83 +/- 2.90) decreased and CNR values of PV (8.04 +/- 3.32, 8.95 +/- 3.63, 9.80 +/- 4.12 and 10.74 +/- 4.73) increased with the increase in ASIR percentage (0%, 30%, 50%, and 70%, respectively), and were statistically different for the 4 ASIR groups (p<0.05). The subjective scores showed that the sharpness of portal vein boundaries (3.13 +/- 0.59, 2.82 +/- 0.44, 2.73 +/- 0.54 and 2.07 +/- 0.54) decreased with higher ASIR percentages (p<0.05). The subjective diagnostic acceptability was highest at 30% ASIR (p<0.05). Conclusions 30% ASIR addition in DECT portal venography could improve the 70 keV monochromatic image quality.	[Zhao, Liqin; Jiang, Rong; Wang, Xinlian; He, Wen] Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China; [Winklhofer, Sebastian] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland	Capital Medical University; University of Zurich; University Zurich Hospital	Zhao, LQ (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China.	zhaolq0129@163.com	Winklhofer, Sebastian/AAB-8987-2022	Zhao, Li-qin/0000-0002-1274-5179	National Natural Science Foundation of China [81201092]; Beijing Health System High Level Health Technical Personnel Training Plan [2013-3-068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Health System High Level Health Technical Personnel Training Plan	This article is supported by a grant from the National Natural Science Foundation of China (No. 81201092) (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list) and the Beijing Health System High Level Health Technical Personnel Training Plan (No. 2013-3-068) (http://www.bjwsrc.org/hhrnew/index.php?a=show&c=index&catid=30&id=1094&m=content). Both of the roles of the two funders were in data collection and analysis.	Botsikas D, 2014, EUR J RADIOL, V83, P1746, DOI 10.1016/j.ejrad.2014.06.017; Brook OR, 2012, RADIOLOGY, V263, P696, DOI 10.1148/radiol.12111170; Chen TW, 2010, ABDOM IMAGING, V35, P1, DOI 10.1007/s00261-009-9506-y; Fleischmann D, 2009, RADIOL CLIN N AM, V47, P13, DOI 10.1016/j.rcl.2008.10.009; Flicek KT, 2010, AM J ROENTGENOL, V195, P126, DOI 10.2214/AJR.09.3855; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; He JZ, 2014, ACAD RADIOL, V21, P364, DOI 10.1016/j.acra.2013.11.004; Kim DH, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/434609; Kiyosue H, 2013, RADIOGRAPHICS, V33, P87, DOI 10.1148/rg.331125037; Li JH, 2010, J COMPUT ASSIST TOMO, V34, P874, DOI 10.1097/RCT.0b013e3181ed2f72; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Morgan DE, 2014, ABDOM IMAGING, V39, P108, DOI 10.1007/s00261-013-0033-5; Pinho DF, 2013, EUR RADIOL, V23, P351, DOI 10.1007/s00330-012-2624-x; Prakash P, 2010, J COMPUT ASSIST TOMO, V34, P40, DOI 10.1097/RCT.0b013e3181b26c67; Rampado O, 2012, EUR J RADIOL, V81, P3172, DOI 10.1016/j.ejrad.2012.06.017; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Scheske JA, 2013, RADIOLOGY, V268, P702, DOI 10.1148/radiol.13121901; Silva AC, 2010, AM J ROENTGENOL, V194, P191, DOI 10.2214/AJR.09.2953; Simons D, 2014, EUR RADIOL, V24, P930, DOI 10.1007/s00330-013-3087-4; Vohra Sandeep, 2014, Indian J Radiol Imaging, V24, P350, DOI 10.4103/0971-3026.143897; Zhao LQ, 2012, EUR J RADIOL, V81, P1677, DOI 10.1016/j.ejrad.2011.02.063; Zheng SW, 2014, EUR J RADIOL, V83, P1216, DOI 10.1016/j.ejrad.2014.02.003	22	3	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0156830	10.1371/journal.pone.0156830	http://dx.doi.org/10.1371/journal.pone.0156830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315158	Green Accepted, gold, Green Published			2022-12-27	WOS:000378030000004
J	Hu, LF; Chen, GS; Kong, QX; Gao, LP; Chen, X; Ye, Y; Li, JB				Hu, Li-Fen; Chen, Guo-Sheng; Kong, Qin-Xiang; Gao, Li-Ping; Chen, Xi; Ye, Ying; Li, Jia-Bin			Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China	PLOS ONE			English	Article							CLASS-1 INTEGRONS; PCR	Aims This study was carried to reveal the genetic mechanisms of trimethoprim/sulfamethoxazole (SXT) resistance. Methods Among 300 clinical Stenotrophomonas maltophilia isolates from China, resistance determinants such as sul and dfrA genes, integrons and transposase were examined using PCR, DNA sequencing and thermal asymmetric interlaced PCR (TAIL-PCR). Data were analyzed using SPSS 20.0. Results Of the 300 isolates, 116 (38.7%) were resistant to SXT. An alarming trend of increased resistance to SXT were found over the 10-year period. The positive rates of sul and class 1 integrase (intl1) increased gradually with the development of SXT resistance over the 10-year period. Multiple logistic regression analyses indicated that the genes of qacE Delta 1-sul1 (81% vs 46.2%, p = 0.000), sul2 (50.9% vs 9.8%, p = 0.000), intl1 (83.6% vs 65.8%, p = 0.000), dfrA12 (25% vs 3.3%, p = 0.000), dfrA17 (15.5% vs 3.8%, p = 0.000) and dfrA27 (4.3% vs 1.6%, p = 0.01) were more prevalent in SXT-resistant isolates than SXT-susceptible isolates except dfrA1(p = 0.83) and dfrA5(p = 0.18). Sequencing data revealed 12 types of resistance gene cassettes (aar-3-dfrA27, dfrA12-aadA2, dfrA17-aadA5, cmlA1, aacA4, aadA5, arr-3-aacA4, aadA1, aadB-aadA4, aacA4-catB8-aadA1, aadB-aac(60)-II-bla(CARB-8) and aac(60)-II-bla(CARB-8)) located in the class 1 integron in 163 isolates (87% SXT-resistant vs 33.7% SXT-susceptible isolates, p = 0.000). A novel finding was the aar-3-dfrA27 (KC748137) gene cassette. The gene of sul2 linked to transposase in 50 SXT-resistant and 7 SXT-susceptible isolates was detected by TAIL-PCR. Conclusions The findings demonstrated a higher prevalence of sul, dfrA, intl1 and resistance gene cassettes in class 1 integron in SXT-resistant clinical S. maltophilia isolates in China. The sul1 and dfrA genes located in integrons and the sul2 linked to transposase may imply wide and rapid dissemination of resistance gene in bacteria.	[Hu, Li-Fen; Chen, Guo-Sheng; Kong, Qin-Xiang; Gao, Li-Ping; Chen, Xi; Ye, Ying; Li, Jia-Bin] Anhui Med Univ, Affiliated Hosp 1, Dept Infect Dis, Hefei, Anhui, Peoples R China; [Hu, Li-Fen; Ye, Ying; Li, Jia-Bin] Anhui Ctr Surveillance Bacterial Resistance, Hefei, Anhui, Peoples R China; [Li, Jia-Bin] Anhui Med Univ, Chaohu Affiliated Hosp, Dept Infect Dis, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Ye, Y; Li, JB (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Infect Dis, Hefei, Anhui, Peoples R China.; Ye, Y; Li, JB (corresponding author), Anhui Ctr Surveillance Bacterial Resistance, Hefei, Anhui, Peoples R China.; Li, JB (corresponding author), Anhui Med Univ, Chaohu Affiliated Hosp, Dept Infect Dis, Hefei, Anhui, Peoples R China.	yeying2@139.com; lijiabin948@vip.sohu.com	li, jiabin/AHD-4645-2022		Natural Science Foundation of China [81101313, 81172737]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (No. 81101313, Li-Fen Hu, https://isis.nsfc.gov.cn), and by Natural Science Foundation of China (No. 81172737, Jia-Bin Li, https://isis.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbolla R, 2004, ANTIMICROB AGENTS CH, V48, P666, DOI 10.1128/AAC.48.2.666-669.2004; Brooke JS, 2014, EXPERT REV ANTI-INFE, V12, P1, DOI 10.1586/14787210.2014.864553; Chang JS, 2013, CLIN OPHTHALMOL, V7, P771, DOI 10.2147/OPTH.S39608; Chang LL, 2007, J ANTIMICROB CHEMOTH, V59, P1038, DOI 10.1093/jac/dkm034; Cho SY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0801-7; Church D, 2013, SCAND J INFECT DIS, V45, P265, DOI 10.3109/00365548.2012.732240; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA, V33, P68; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Farrell DJ, 2010, ANTIMICROB AGENTS CH, V54, P2735, DOI 10.1128/AAC.01774-09; Gaze WH, 2005, ANTIMICROB AGENTS CH, V49, P1802, DOI 10.1128/AAC.49.5.1802-1807.2005; Goldstein C, 2001, ANTIMICROB AGENTS CH, V45, P723, DOI 10.1128/AAC.45.3.723-726.2001; Hu LF, 2011, INT J ANTIMICROB AG, V37, P230, DOI 10.1016/j.ijantimicag.2010.10.025; Kaur P, 2015, MICROB DRUG RESIST, V21, P380, DOI 10.1089/mdr.2014.0176; Lee MF, 2011, ANTIMICROB AGENTS CH, V55, P943, DOI 10.1128/AAC.00988-10; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Trinh Q, 2014, ANAL BIOCHEM, V466, P24, DOI 10.1016/j.ab.2014.07.022; Toleman MA, 2007, EMERG INFECT DIS, V13, P559, DOI 10.3201/eid1304.061378; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; Wu H, 2012, J MICROBIOL IMMUNOL, V45, P120, DOI 10.1016/j.jmii.2011.09.028	20	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157693	10.1371/journal.pone.0157693	http://dx.doi.org/10.1371/journal.pone.0157693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310255	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800124
J	Mutt, E; Sowdhamini, R				Mutt, Eshita; Sowdhamini, Ramanathan			Molecular Dynamics Simulations and Structural Analysis to Decipher Functional Impact of a Twenty Residue Insert in the Ternary Complex of Mus musculus TdT Isoform	PLOS ONE			English	Article							DNA-POLYMERASE MU; TRANSFER-RNA SYNTHETASE; HUMAN POL-MU; TERMINAL DEOXYNUCLEOTIDYLTRANSFERASE; STRUCTURE NETWORK; HIGH-THROUGHPUT; DOMAIN; PROTEINS; CONSEQUENCES; TRANSITIONS	Insertions/deletions are common evolutionary tools employed to alter the structural and functional repertoire of protein domains. An insert situated proximal to the active site or ligand binding site frequently impacts protein function; however, the effect of distal indels on protein activity and/or stability are often not studied. In this paper, we have investigated a distal insert, which influences the function and stability of a unique DNA polymerase, called terminal deoxynucleotidyl transferase (TdT). TdT (EC: 2.7.7.31) is a monomeric 58 kDa protein belonging to family X of eukaryotic DNA polymerases and known for its role in V(D)J recombination as well as in non-homologous end-joining (NHEJ) pathways. Two murine isoforms of TdT, with a length difference of twenty residues and having different biochemical properties, have been studied. All-atom molecular dynamics simulations at different temperatures and interaction network analyses were performed on the short and long-length isoforms. We observed conformational changes in the regions distal to the insert position (thumb subdomain) in the longer isoform, which indirectly affects the activity and stability of the enzyme through a mediating loop (Loop1). A structural rationale could be provided to explain the reduced polymerization rate as well as increased thermosensitivity of the longer isoform caused by peripherally located length variations within a DNA polymerase. These observations increase our understanding of the roles of length variants in introducing functional diversity in protein families in general.	[Mutt, Eshita; Sowdhamini, Ramanathan] Natl Ctr Biol Sci TIFR, GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India; [Mutt, Eshita] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Sowdhamini, R (corresponding author), Natl Ctr Biol Sci TIFR, GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India.	mini@ncbs.res.in		Mutt, Eshita/0000-0003-3225-4761	Department of Biotechnology Grant, India	Department of Biotechnology Grant, India	Department of Biotechnology Grant, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; [Anonymous], PYMOL MOL GRAPH SYST; Barkho S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003188; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; Boule JB, 2000, J BIOL CHEM, V275, P28984, DOI 10.1074/jbc.M005544200; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Delarue M, 2002, EMBO J, V21, P427, DOI 10.1093/emboj/21.3.427; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; DOYEN N, 1993, NUCLEIC ACIDS RES, V21, P1187, DOI 10.1093/nar/21.5.1187; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Esteban V, 2013, DNA REPAIR, V12, P824, DOI 10.1016/j.dnarep.2013.07.007; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Ghosh A, 2007, BIOPHYS J, V92, P2523, DOI 10.1529/biophysj.106.099903; Gouge J, 2013, J MOL BIOL, V425, P4334, DOI 10.1016/j.jmb.2013.07.009; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Martin MJ, 2014, NUCLEIC ACIDS RES, V42, P7923, DOI 10.1093/nar/gku475; Juarez R, 2006, NUCLEIC ACIDS RES, V34, P4572, DOI 10.1093/nar/gkl457; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Li YL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003074; Li YL, 2010, BIOPHYS J, V99, P3463, DOI 10.1016/j.bpj.2010.09.056; Liberles DA, 2012, PROTEIN SCI, V21, P769, DOI 10.1002/pro.2071; Liu RJ, 2011, BIOCHEM J, V440, P217, DOI 10.1042/BJ20111177; Mejia E, DNA REPAIR AMST, V18, P1; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Moon AF, 2014, NAT STRUCT MOL BIOL, V21, P253, DOI 10.1038/nsmb.2766; Mutt E, 2014, NUCLEIC ACIDS RES, V42, pD246, DOI 10.1093/nar/gkt1014; Pandya C, 2013, P NATL ACAD SCI USA, V110, pE3381, DOI 10.1073/pnas.1305519110; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pellegrini-Calace M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000440; Pugalenthi G, 2006, NUCLEIC ACIDS RES, V34, pW231, DOI 10.1093/nar/gkl314; Repasky JAE, 2004, J IMMUNOL, V172, P5478, DOI 10.4049/jimmunol.172.9.5478; Romain F, 2009, NUCLEIC ACIDS RES, V37, P4642, DOI 10.1093/nar/gkp460; Sandhya S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004981; Schlick T, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1287-7; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Vijayabaskar MS, 2011, OPEN BIOINFORMA J, P5; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yamtich J, 2010, BBA-PROTEINS PROTEOM, V1804, P1136, DOI 10.1016/j.bbapap.2009.07.008; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	53	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157286	10.1371/journal.pone.0157286	http://dx.doi.org/10.1371/journal.pone.0157286			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311013	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800051
J	Anaissi, A; Goyal, M; Catchpoole, DR; Braytee, A; Kennedy, PJ				Anaissi, Ali; Goyal, Madhu; Catchpoole, Daniel R.; Braytee, Ali; Kennedy, Paul J.			Ensemble Feature Learning of Genomic Data Using Support Vector Machine	PLOS ONE			English	Article							GENE SELECTION; CLUSTERING ANALYSIS; MICROARRAY DATA; RANDOM FOREST; CLASSIFICATION; PATTERNS; TUMOR; BIAS	The identification of a subset of genes having the ability to capture the necessary information to distinguish classes of patients is crucial in bioinformatics applications. Ensemble and bagging methods have been shown to work effectively in the process of gene selection and classification. Testament to that is random forest which combines random decision trees with bagging to improve overall feature selection and classification accuracy. Surprisingly, the adoption of these methods in support vector machines has only recently received attention but mostly on classification not gene selection. This paper introduces an ensemble SVM-Recursive Feature Elimination (ESVM-RFE) for gene selection that follows the concepts of ensemble and bagging used in random forest but adopts the backward elimination strategy which is the rationale of RFE algorithm. The rationale behind this is, building ensemble SVM models using randomly drawn bootstrap samples from the training set, will produce different feature rankings which will be subsequently aggregated as one feature ranking. As a result, the decision for elimination of features is based upon the ranking of multiple SVM models instead of choosing one particular model. Moreover, this approach will address the problem of imbalanced datasets by constructing a nearly balanced bootstrap sample. Our experiments show that ESVM-RFE for gene selection substantially increased the classification performance on five microarray datasets compared to state-of-the-art methods. Experiments on the childhood leukaemia dataset show that an average 9% better accuracy is achieved by ESVM-RFE over SVM-RFE, and 5% over random forest based approach. The selected genes by the ESVM-RFE algorithm were further explored with Singular Value Decomposition (SVD) which reveals significant clusters with the selected data.	[Anaissi, Ali; Goyal, Madhu; Braytee, Ali; Kennedy, Paul J.] Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst QCIS, Fac Engn & Informat Technol, Broadway, NSW 2007, Australia; [Catchpoole, Daniel R.] Childrens Hosp Westmead, Childrens Canc Res Unit, Tumour Bank, Locked Bag 4001, Westmead, NSW 2145, Australia	University of Technology Sydney; University of Sydney	Anaissi, A (corresponding author), Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst QCIS, Fac Engn & Informat Technol, Broadway, NSW 2007, Australia.	Ali.Anaissi@uts.edu.au	Kennedy, Paul/GPC-6789-2022; Goyal, Madhu/Z-2860-2019	Kennedy, Paul/0000-0001-7837-3171; Goyal, Madhu/0000-0003-2853-9393; Braytee, Ali/0000-0003-2561-6496				Abeel T, 2009, BIOINFORMATICS, V25, pI313, DOI 10.1093/bioinformatics/btp191; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Anaissi A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-261; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brazma A, 2000, FEBS LETT, V480, P17, DOI 10.1016/S0014-5793(00)01772-5; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Ding JD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-511-S11; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Han H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S7; Kressel UHG, 1999, ADVANCES IN KERNEL METHODS, P255; Lee YK, 2004, J AM STAT ASSOC, V99, P67, DOI 10.1198/016214504000000098; Nie F., 2010, ADV NEURAL INFORM PR, V23, DOI DOI 10.1007/978-3-319-10690-8_12; Rish I., 2001, IJCAI 2001 WORKSH EM, V3, P41, DOI DOI 10.1039/B104835J; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sathishkumar E, 2013, ARXIV 13062118 2013; Tong MCX, 2013, COMPUT BIOL MED, V43, P729, DOI 10.1016/j.compbiomed.2013.03.010; Valentini G, 2004, J MACH LEARN RES, V5, P725; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197; Zhou X, 2007, BIOINFORMATICS, V23, P1106, DOI 10.1093/bioinformatics/btm036; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123; Zou Q, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/686090, 10.1155/2013/608430]	31	22	22	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157330	10.1371/journal.pone.0157330	http://dx.doi.org/10.1371/journal.pone.0157330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304923	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800048
J	Chowdhury, S; Wang, SY; Dunai, J; Kilpatrick, R; Oestricker, LZ; Wallendorf, MJ; Patterson, BW; Reeds, DN; Wice, BM				Chowdhury, Sara; Wang, Songyan; Dunai, Judit; Kilpatrick, Rachel; Oestricker, Lauren Z.; Wallendorf, Michael J.; Patterson, Bruce W.; Reeds, Dominic N.; Wice, Burton M.			Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus	PLOS ONE			English	Article							PERFUSED HUMAN-PANCREAS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; SPLANCHNIC NEURAL REGULATION; INSULIN-SECRETION; POLYPEPTIDE RELEASE; C-PEPTIDE; GLUCOSE-HOMEOSTASIS; ENDOCRINE PANCREAS; XENIN; GIP	Peripheral muscarinic acetylcholine receptors regulate insulin and glucagon release in rodents but their importance for similar roles in humans is unclear. Bethanechol, an acetylcholine analogue that does not cross the blood-brain barrier, was used to examine the role of peripheral muscarinic signaling on glucose homeostasis in humans with normal glucose tolerance (NGT; n = 10), impaired glucose tolerance (IGT; n = 11), and type 2 diabetes mellitus (T2DM; n = 9). Subjects received four liquid meal tolerance tests, each with a different dose of oral bethanechol (0, 50, 100, or 150 mg) given 60 min before a meal containing acetaminophen. Plasma pancreatic polypeptide (PP), glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), glucose, glucagon, C-peptide, and acetaminophen concentrations were measured. Insulin secretion rates (ISRs) were calculated from C-peptide levels. Acetaminophen and PP concentrations were surrogate markers for gastric emptying and cholinergic input to islets. The 150 mg dose of bethanechol increased the PP response 2-fold only in the IGT group, amplified GLP-1 release in the IGT and T2DM groups, and augmented the GIP response only in the NGT group. However, bethanechol did not alter ISRs or plasma glucose, glucagon, or acetaminophen concentrations in any group. Prior studies showed infusion of xenin-25, an intestinal peptide, delays gastric emptying and reduces GLP-1 release but not ISRs when normalized to plasma glucose levels. Analysis of archived plasma samples from this study showed xenin-25 amplified postprandial PP responses similar to 4-fold in subjects with NGT, IGT, and T2DM. Thus, increasing postprandial cholinergic input to islets augments insulin secretion in mice but not humans.	[Chowdhury, Sara; Wang, Songyan; Dunai, Judit; Kilpatrick, Rachel; Oestricker, Lauren Z.; Wice, Burton M.] Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Wallendorf, Michael J.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Patterson, Bruce W.; Reeds, Dominic N.] Washington Univ, Sch Med, Dept Internal Med, Div Nutr Sci Metab & Lipid Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wice, BM (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA.	bwice@dom.wustl.edu		Patterson, Bruce W/0000-0001-9261-0233	American Diabetes Association (BMW) [1-10-CT-58, 1-13-CE-46]; Blum Kovler Foundation BMW; National Institutes of Health (BMW) [5RC1DK086163, 1R01DK088126]; Washington University Diabetes Research Center Immunoassay Core [P60 DK020579]; Washington University Nutrition Obesity Research Center Grant from the National Institute of Diabetes and Digestive and Kidney Diseases [P30DK056341]; Washington University Digestive Disease Research Core Center [P30 DK52574-16]; Washington University Clinical and Translational Science Award from the National Center for Advancing Translational Sciences (NCATS) [UL1 TR000448]; Biologic Therapy Core Facility of the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Mo. (NCI Cancer Center) [P30 CA91842]; NIH National Center for Research Resources [P41 RR00954, UL1 RR024992]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, P30DK020579, P30DK056341] Funding Source: NIH RePORTER	American Diabetes Association (BMW); Blum Kovler Foundation BMW; National Institutes of Health (BMW); Washington University Diabetes Research Center Immunoassay Core; Washington University Nutrition Obesity Research Center Grant from the National Institute of Diabetes and Digestive and Kidney Diseases; Washington University Digestive Disease Research Core Center; Washington University Clinical and Translational Science Award from the National Center for Advancing Translational Sciences (NCATS); Biologic Therapy Core Facility of the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Mo. (NCI Cancer Center); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Portions of this research were supported by funds from the American Diabetes Association (BMW; Grants #1-10-CT-58 and #1-13-CE-46); the Blum Kovler Foundation BMW; National Institutes of Health (BMW; Grant numbers 5RC1DK086163 and 1R01DK088126); the Washington University Diabetes Research Center Immunoassay Core (P60 DK020579); the Washington University Nutrition Obesity Research Center Grant (P30DK056341) from the National Institute of Diabetes and Digestive and Kidney Diseases; the Washington University Digestive Disease Research Core Center (P30 DK52574-16); the Washington University Clinical and Translational Science Award (UL1 TR000448) from the National Center for Advancing Translational Sciences (NCATS); the Biologic Therapy Core Facility of the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Mo. (NCI Cancer Center Support Grant P30 CA91842); the NIH National Center for Research Resources (P41 RR00954 and UL1 RR024992). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH or any other funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GF, 1951, GASTROENTEROLOGY, V17, P63; Adrian T E, 1978, J Clin Pathol Suppl (Assoc Clin Pathol), V8, P43, DOI 10.1136/jcp.s1-8.1.43; ADRIAN TE, 1977, LANCET, V1, P161; Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Ahren B, 2012, DIABETOLOGIA, V55, P3152, DOI 10.1007/s00125-012-2727-6; Ahren B, 2001, DIABETES, V50, P1030, DOI 10.2337/diabetes.50.5.1030; Ahren B, 2004, INT TXB DIABETES MEL, P153; Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; AMLAND PF, 1985, SCAND J GASTROENTERO, V20, P315, DOI 10.3109/00365528509091657; AMLAND PF, 1985, SCAND J GASTROENTERO, V20, P321, DOI 10.3109/00365528509091658; Anlauf M, 2000, J HISTOCHEM CYTOCHEM, V48, P1617, DOI 10.1177/002215540004801205; BAETENS D, 1977, CELL TISSUE RES, V185, P239, DOI 10.1007/BF00220668; BERGSTROM BH, 1977, J CLIN ENDOCR METAB, V44, P795, DOI 10.1210/jcem-44-4-795; BROOKS DC, 1989, JPEN-PARENTER ENTER, V13, P102, DOI 10.1177/0148607189013001102; BRUNICARDI FC, 1987, AM J SURG, V153, P34, DOI 10.1016/0002-9610(87)90198-X; BRUNICARDI FC, 1988, AM J SURG, V155, P63, DOI 10.1016/S0002-9610(88)80259-9; Brunicardi FC, 1995, INT J PANCREATOL, V18, P177; BRUNICARDI FC, 1990, J SURG RES, V48, P273, DOI 10.1016/0022-4804(90)90058-A; BRUNICARDI FC, 1984, SURG FORUM, V35, P214; BRUNICARDI FC, 1989, AM J SURG, V157, P50, DOI 10.1016/0002-9610(89)90419-4; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Chia CW, 2014, J CLIN ENDOCR METAB, V99, P2477, DOI 10.1210/jc.2013-3994; Chowdhury S, 2014, AM J PHYSIOL-GASTR L, V306, pG301, DOI 10.1152/ajpgi.00383.2013; Chowdhury S, 2013, REGUL PEPTIDES, V187, P42, DOI 10.1016/j.regpep.2013.10.003; Cline MA, 2007, BEHAV BRAIN RES, V179, P28, DOI 10.1016/j.bbr.2007.01.008; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; Damholt MB, 1997, SCAND J CLIN LAB INV, V57, P695, DOI 10.3109/00365519709105231; de Courten BV, 2004, DIABETES, V53, P663, DOI 10.2337/diabetes.53.3.663; DIOKNO A C, 1977, Urology, V10, P23, DOI 10.1016/0090-4295(77)90031-0; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; DUMOULIN V, 1995, ENDOCRINOLOGY, V136, P5182, DOI 10.1210/en.136.11.5182; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; EVERETT HC, 1975, AM J PSYCHIAT, V132, P1202; Feurle GE, 1998, PEPTIDES, V19, P609, DOI 10.1016/S0196-9781(97)00378-1; FEURLE GE, 1992, J BIOL CHEM, V267, P22305; FLETCHER DR, 1983, REGUL PEPTIDES, V7, P31, DOI 10.1016/0167-0115(83)90279-3; FLETCHER DR, 1983, LIFE SCI, V33, P863, DOI 10.1016/0024-3205(83)90625-2; Gautam D, 2007, DIABETES OBES METAB, V9, P158, DOI 10.1111/j.1463-1326.2007.00781.x; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gorsky M, 2004, ORAL SURG ORAL MED O, V97, P190, DOI 10.1016/j.tripleo.2003.08.031; HAMSCHER G, 1995, PEPTIDES, V16, P791, DOI 10.1016/0196-9781(95)00053-M; Jham BC, 2007, ORAL ONCOL, V43, P137, DOI 10.1016/j.oraloncology.2006.01.013; Kamiyama Y, 2007, NEUROGASTROENT MOTIL, V19, P233, DOI 10.1111/j.1365-2982.2006.00881.x; KESTERSON JE, 1951, GASTROENTEROLOGY, V18, P230; Kim ER, 2010, NEUROSCI LETT, V468, P64, DOI 10.1016/j.neulet.2009.10.064; LAPIDES JACK, 1963, INVEST UROL, V1, P94; LARSSON LI, 1976, DIABETOLOGIA, V12, P211, DOI 10.1007/BF00422088; LARSSON LI, 1975, CELL TISSUE RES, V156, P167; LAYER P, 1993, PANCREAS, V8, P181, DOI 10.1097/00006676-199303000-00008; Leckstrom A, 2009, DIABETES, V58, P87, DOI 10.2337/db08-0260; LONOVICS J, 1981, ARCH SURG-CHICAGO, V116, P1256; MCGUIRE EAH, 1976, J APPL PHYSIOL, V41, P565, DOI 10.1152/jappl.1976.41.4.565; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Plamboeck A, 2013, EUR J ENDOCRINOL, V169, P187, DOI 10.1530/EJE-13-0264; Renuka TR, 2006, NEUROCHEM RES, V31, P313, DOI 10.1007/s11064-005-9022-6; Rodriguez-Diaz R, 2011, CELL METAB, V14, P45, DOI 10.1016/j.cmet.2011.05.008; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; SCHWARTZ TW, 1978, J CLIN INVEST, V61, P781, DOI 10.1172/JCI108992; SCHWARTZ TW, 1976, LANCET, V1, P1102; Silvestre JS, 2005, METHOD FIND EXP CLIN, V27, P289, DOI 10.1358/mf.2005.27.5.908643; Sparacino G, 1996, IEEE T BIO-MED ENG, V43, P512, DOI 10.1109/10.488799; Sparacino G, 2002, COMPUT METH PROG BIO, V67, P67, DOI 10.1016/S0169-2607(00)00151-6; STERN AI, 1980, DIGEST DIS SCI, V25, P485, DOI 10.1007/BF01315209; Teff KL, 2004, J CLIN ENDOCR METAB, V89, P5606, DOI 10.1210/jc.2003-032094; TSUDA K, 1983, HORM METAB RES, V15, P581, DOI 10.1055/s-2007-1018798; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Veedfald S, 2015, PEPTIDES, V71, P229, DOI 10.1016/j.peptides.2015.07.020; Wice BM, 2012, DIABETES, V61, P1793, DOI 10.2337/db11-1451; Wice BM, 2010, J BIOL CHEM, V285, P19842, DOI 10.1074/jbc.M110.129304; Zawalich WS, 2004, BIOCHEM BIOPH RES CO, V315, P872, DOI 10.1016/j.bbrc.2004.01.139; Zhang S, 2012, AM J PHYSIOL-GASTR L, V303, pG1347, DOI 10.1152/ajpgi.00116.2012	73	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156852	10.1371/journal.pone.0156852	http://dx.doi.org/10.1371/journal.pone.0156852			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304975	Green Submitted, Green Published, gold			2022-12-27	WOS:000377824800027
J	Dangles, O; Loirat, J; Freour, C; Serre, S; Vacher, J; Le Roux, X				Dangles, Olivier; Loirat, Jean; Freour, Claire; Serre, Sandrine; Vacher, Jean; Le Roux, Xavier			Research on Biodiversity and Climate Change at a Distance: Collaboration Networks between Europe and Latin America and the Caribbean	PLOS ONE			English	Article								Biodiversity loss and climate change are both globally significant issues that must be addressed through collaboration across countries and disciplines. With the December 2015 COP21 climate conference in Paris and the recent creation of the Intergovernmental Platform on Biodiversity and Ecosystem Services (IPBES), it has become critical to evaluate the capacity for global research networks to develop at the interface between biodiversity and climate change. In the context of the European Union (EU) strategy to stand as a world leader in tackling global challenges, the European Commission has promoted ties between the EU and Latin America and the Caribbean (LAC) in science, technology and innovation. However, it is not clear how these significant interactions impact scientific cooperation at the interface of biodiversity and climate change. We looked at research collaborations between two major regions-the European Research Area (ERA) and LAC-that addressed both biodiversity and climate change. We analysed the temporal evolution of these collaborations, whether they were led by ERA or LAC teams, and which research domains they covered. We surveyed publications listed on the Web of Science that were authored by researchers from both the ERA and LAC and that were published between 2003 and 2013. We also run similar analyses on other topics and other continents to provide baseline comparisons. Our results revealed a steady increase in scientific co-authorships between ERA and LAC countries as a result of the increasingly complex web of relationships that has been weaved among scientists from the two regions. The ERA-LAC co-authorship increase for biodiversity and climate change was higher than those reported for other topics and for collaboration with other continents. We also found strong differences in international collaboration patterns within the LAC: co-publications were fewest from researchers in low- and lower-middle-income countries and most prevalent from researchers in emerging countries like Mexico and Brazil. Overall, interdisciplinary publications represented 25.8% of all publications at the interface of biodiversity and climate change in the ERA-LAC network. Further scientific collaborations should be promoted 1) to prevent less developed countries from being isolated from the global cooperation network, 2) to ensure that scientists from these countries are trained to lead visible and recognized biodiversity and climate change research, and 3) to develop common study models that better integrate multiple scientific disciplines and better support decision-making.	[Dangles, Olivier] CNRS, EGCE, IRD, UPR 9034,UR 072, F-91198 Gif Sur Yvette, France; [Dangles, Olivier] Univ Paris Sud 11, F-91405 Orsay, France; [Dangles, Olivier] Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Av 12 Octubre & Roca, Quito, Ecuador; [Loirat, Jean; Freour, Claire; Serre, Sandrine] IRD, 44 Bld Dunkerque, F-13572 Marseille, France; [Vacher, Jean] MNHN, UMR PALOC, IRD, F-75005 Paris, France; [Le Roux, Xavier] Univ Lyon 1, CNRS, INRA, Ctr Microbial Ecol,UMR 1418,UMR 5557, 43 Bd 11 Nov 1918, F-69622 Villeurbanne, France; [Le Roux, Xavier] FRB, BiodivERsA, 195 Rue St Jacques, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Pontificia Universidad Catolica del Ecuador; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Dangles, O (corresponding author), CNRS, EGCE, IRD, UPR 9034,UR 072, F-91198 Gif Sur Yvette, France.; Dangles, O (corresponding author), Univ Paris Sud 11, F-91405 Orsay, France.; Dangles, O (corresponding author), Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Av 12 Octubre & Roca, Quito, Ecuador.	olivier.dangles@ird.fr	Dangles, Olivier/C-4924-2009; Serre, Sandrine/ABE-5086-2020	Dangles, Olivier/0000-0002-1987-8433; Serre, Sandrine/0000-0003-3609-3432; LE ROUX, Xavier/0000-0001-9695-0825	ALCUE-Net project (FP7 funded project; Latin America, Caribbean); ALCUE-Net project (European Union Network on Research and Innovation); ERA-NET BiodivERsA (Horizon funded project)	ALCUE-Net project (FP7 funded project; Latin America, Caribbean); ALCUE-Net project (European Union Network on Research and Innovation); ERA-NET BiodivERsA (Horizon funded project)	This research was funded by the ALCUE-Net project (FP7 funded project; Latin America, Caribbean and European Union Network on Research and Innovation; see www.alcuenet.eu), in collaboration with the ERA-NET BiodivERsA (Horizon2020 funded project; see www.biodiversa.org).	Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; CEPAL NU, 2015, EUR UN LAT AM CAR NE; Eggermont H, 2015, GAIA, V24, P243, DOI 10.14512/gaia.24.4.9; European Commission, 2006, STRONG PARTN EUR UN; European Commission, 2010, EU LAC KNOWL AR SCI; European Union, 2015, EUR RES INN ROADM CL EUR RES INN ROADM CL; Frodeman Robert, 2010, OXFORD HDB INTERDISC; Garcia RL, 2014, NUEVA AGENDA, V8, P7; Groombridge B, 2002, WORLD ATLAS BIODIVER; Hannah L, 2011, CLIMATE CHANGE BIOLOGY, P1; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Martinez R., 2011, CLIMATE CHANGE BIODI; Melin G, 1996, SCIENTOMETRICS, V36, P363, DOI 10.1007/BF02129600; Mooney H, 2009, CURR OPIN ENV SUST, V1, P46, DOI 10.1016/j.cosust.2009.07.006; Munang R, 2013, CURR OPIN ENV SUST, V5, P67, DOI 10.1016/j.cosust.2012.12.001; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Perez C, 2010, INT J ENV CULTURAL E, V6, P78; Russell JM, 2014, RES COLLABORATION EU, P49; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Swanson T, 2013, GLOBAL ACTION BIODIV; Tassara Cario, 2013, Investig. desarro., V21, P2; UNEP, 2010, STAT BIOD LAT AM CAR; Valdez Andre Calero, 2012, Active Media Technology. 8th International Conference, AMT 2012. Proceedings, P606, DOI 10.1007/978-3-642-35236-2_61; Wagner C. S., 2005, INT J TECHNOLOGY GLO, V1, P185, DOI [DOI 10.1504/IJTG.2005.007050, 10/c4jn8k]; Weingart P., 2010, OXFORD HDB INTERDISC, P3	27	18	19	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157441	10.1371/journal.pone.0157441	http://dx.doi.org/10.1371/journal.pone.0157441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304924	Green Published, gold			2022-12-27	WOS:000377824800059
J	Matsuhashi, S; Doi, H; Fujiwara, A; Watanabe, S; Minamoto, T				Matsuhashi, Saeko; Doi, Hideyuki; Fujiwara, Ayaka; Watanabe, Sonoko; Minamoto, Toshifumi			Evaluation of the Environmental DNA Method for Estimating Distribution and Biomass of Submerged Aquatic Plants	PLOS ONE			English	Article							FRESH-WATER BIODIVERSITY; HYDRILLA-VERTICILLATA; EDNA; SAMPLES; HYDROCHARITACEAE; PERSISTENCE; CHALLENGES; REVISION; JAPAN; PCR	The environmental DNA (eDNA) method has increasingly been recognized as a powerful tool for monitoring aquatic animal species; however, its application for monitoring aquatic plants is limited. To evaluate eDNA analysis for estimating the distribution of aquatic plants, we compared its estimated distributions with eDNA analysis, visual observation, and past distribution records for the submerged species Hydrilla verticillata. Moreover, we conducted aquarium experiments using H. verticillata and Egeria densa and analyzed the relationships between eDNA concentrations and plant biomass to investigate the potential for biomass estimation. The occurrences estimated by eDNA analysis closely corresponded to past distribution records, and eDNA detections were more frequent than visual observations, indicating that the method is potentially more sensitive. The results of the aquarium experiments showed a positive relationship between plant biomass and eDNA concentration; however, the relationship was not always significant. The eDNA concentration peaked within three days of the start of the experiment in most cases, suggesting that plants do not release constant amounts of DNA. These results showed that eDNA analysis can be used for distribution surveys, and has the potential to estimate the biomass of aquatic plants.	[Matsuhashi, Saeko; Doi, Hideyuki] Univ Hyogo, Grad Sch Simulat Studies, Chuo Ku, Kobe, Hyogo 6500044, Japan; [Fujiwara, Ayaka; Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, Kobe, Hyogo 657, Japan; [Watanabe, Sonoko] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima 724, Japan	University of Hyogo; Kobe University; Hiroshima University	Matsuhashi, S (corresponding author), Univ Hyogo, Grad Sch Simulat Studies, Chuo Ku, Kobe, Hyogo 6500044, Japan.	sae.matsuhashi@gmail.com	WATANABE, Sonoko/N-8102-2013; Minamoto, Toshifumi/C-6453-2009	WATANABE, Sonoko/0000-0002-4696-3588; Minamoto, Toshifumi/0000-0002-5379-1622	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [4RF-1302]; Water Resources Environment Center [2014-04]; Water Resources Environment Center	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); Water Resources Environment Center; Water Resources Environment Center	This study was supported by the Environment Research and Technology Development Fund of the Ministry of the Environment, Japan (4RF-1302, http://www.env.go.jp/policy/kenkyu/suishin/english/gaiyou/index.html) to HD and TM, and by a Research Grant from the Water Resources Environment Center (2014-04, http://www.wec.or.jp/support/season/index.html) to SM.; We thank the Natural Science Center for Basic Research and Development, Hiroshima University, for technical support for genetic experiments, and T. Takahara and K. Uchii for help with experiments and their useful comments on this study. This study was supported by the Environment Research and Technology Development Fund of the Ministry of the Environment, Japan (4RF-1302), and by a Research Grant from the Water Resources Environment Center to S. Matsuhashi.	[Anonymous], 2014, R LANG ENV STAT COMP; Barnes MA, 2014, ECOL EVOL, V4, P2584, DOI 10.1002/ece3.1120; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Buckingham GR, 1996, FLA ENTOMOL, V79, P353, DOI 10.2307/3495584; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Collen B, 2014, GLOBAL ECOL BIOGEOGR, V23, P40, DOI 10.1111/geb.12096; COOK CDK, 1982, AQUAT BOT, V13, P485, DOI 10.1016/0304-3770(82)90074-2; COOK CDK, 1984, AQUAT BOT, V19, P73, DOI 10.1016/0304-3770(84)90009-3; Davy CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130965; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Doi H, 2015, ENVIRON SCI TECHNOL, V49, P5601, DOI 10.1021/acs.est.5b00253; Doi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122763; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Fujiwara A, 2016, FRESHW SCI, V35, P748, DOI 10.1086/685882; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; HARAMOTO T, 1988, AQUAT BOT, V30, P389, DOI 10.1016/0304-3770(88)90070-8; Higashi-Hiroshima City Board of Education, 2011, AQ PLANTS HIG HIR, P108; Kadono Y., 2004, GLOB ENV STUD, V8, P163; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Langeland Kenneth A., 1996, Castanea, V61, P293; Madeira PT, 1997, AQUAT BOT, V59, P217, DOI 10.1016/S0304-3770(97)00075-2; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scriver M, 2015, AQUAT BOT, V122, P27, DOI 10.1016/j.aquabot.2015.01.003; Shimoda M, 1995, VEGETATION SCI, V11, P23; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Uchii K, 2016, MOL ECOL RESOUR, V16, P415, DOI 10.1111/1755-0998.12460; Wilcox TM, 2015, CONSERV GENET RESOUR, V7, P639, DOI 10.1007/s12686-015-0465-z; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520	45	25	28	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156217	10.1371/journal.pone.0156217	http://dx.doi.org/10.1371/journal.pone.0156217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304876	gold, Green Submitted, Green Published			2022-12-27	WOS:000377824800014
J	McCall, MK; Chutz, N; Skutsch, M				McCall, Michael K.; Chutz, Noah; Skutsch, Margaret			Moving from Measuring, Reporting, Verification (MRV) of Forest Carbon to Community Mapping, Measuring, Monitoring (MMM): Perspectives from Mexico	PLOS ONE			English	Review							LOCAL PEOPLE; MANAGEMENT; KNOWLEDGE; REDD; PARTICIPATION; CONSERVATION; TROPICS; SIERRA; RIGHTS	There have been many calls for community participation in MRV (measuring, reporting, verification) for REDD+. This paper examines whether community involvement in MRV is a requirement, why it appears desirable to REDD+ agencies and external actors, and under what conditions communities might be interested in participating. It asks What's in it for communities? What might communities gain from such an involvement? What could they lose? It embraces a broader approach which we call community MMM which involves mapping, measuring and monitoring of forest and other natural resources for issues which are of interest to the community itself. We focus on cases in Mexico because the country has an unusually high proportion of forests under community communal ownership. In particular, we refer to a recent REDD+ initiative-CONAFOR-LAIF, in which local communities select and approve local people to participate in community-based monitoring activities. From these local initiatives we identify the specific and the general drivers for communities to be involved in mapping, measuring and monitoring of their own territories and their natural resources. We present evidence that communities are more interested in this wider approach than in a narrow focus on carbon monitoring. Finally we review what the challenges to reconciling MMM with MRV requirements are likely to be.	[McCall, Michael K.; Skutsch, Margaret] UNAM, CIGA, Morelia, Michoacan, Mexico	Universidad Nacional Autonoma de Mexico	McCall, MK (corresponding author), UNAM, CIGA, Morelia, Michoacan, Mexico.	mccall@ciga.unam.mx	McCall, Michael Keith/A-9050-2012; Michael, Keith/GPK-2534-2022	McCall, Michael Keith/0000-0002-6405-3369; 	Latin American Investment Facility (LAIF); US Forest Service International Programs	Latin American Investment Facility (LAIF); US Forest Service International Programs	The work of one author, Noah Chutz, was financially supported by Latin American Investment Facility (LAIF) http://www.conafor.gob.mx/web/temas-forestales/bycc/acciones-de-preparacion-para-redd/gobernanza-local-para-implementacion-de-atreddlaif/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The second author's position was with the US Peace Corps at the time of the study, and was supported by the US Forest Service International Programs.	Alianza MREDD, 2014, PROYECT FORT REDD CO; Almeida F, 2014, STATUS FOREST CARBON; [Anonymous], 2008, PARTICIPATORY MONITO; Balderas Torres A., 2013, WHITE PAPER OPPORTUN; Barker T, 2007, CLIMATE CHANGE MITIG; Bee B, 2013, ACME, V12, P131; Boas H, 2011, NO REDD PAPERS, Vone; Browder JO, 2002, ENVIRON MANAGE, V29, P750, DOI 10.1007/s00267-001-2613-3; Cabello J., 2012, Ephemera, V12, P162; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; CMPCC, 2010, AC C MUND PUEBL CAMB; Coleman EA, 2009, J POLICY ANAL MANAG, V28, P122, DOI 10.1002/pam.20405; CONAFOR, 2014, PROP NIV REF EM FOR; Coordinadora De Las Organizaciones Indigenas De La Cuenca Amazonica (COICA), 2010, POS POL COICA REDD; Corbera E, 2011, FORESTS, V2, P301, DOI 10.3390/f2010301; Costedoat S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119881; Cronkleton P, 2007, NEGOTIATED LEARNING; Danielsen F, 2009, CONSERV BIOL, V23, P31, DOI 10.1111/j.1523-1739.2008.01063.x; Danielsen F, 2007, AMBIO, V36, P566, DOI 10.1579/0044-7447(2007)36[566:ICMABI]2.0.CO;2; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; Emery AR, 2000, INTEGRATION INDIGENO; Feiring B, 2013, INDIGENOUS PEOPLES R; Garcia CA, 2008, BIODIVERS CONSERV, V17, P1303, DOI 10.1007/s10531-008-9347-y; Gibson CC, 2005, WORLD DEV, V33, P273, DOI 10.1016/j.worlddev.2004.07.013; Guijt Irene, 2007, NEGOTIATED LEARNING; Herold M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014002; Hersch-Martinez P, 2004, AGR HUM VALUES, V21, P127, DOI 10.1023/B:AHUM.0000029404.34942.d1; Hockley NJ, 2005, BIODIVERS CONSERV, V14, P2795, DOI 10.1007/s10531-005-8416-8; Klooster DJ, 2002, ECON GEOGR, V78, P43, DOI 10.2307/4140823; Knowles T, 2010, PATHWAYS IMPLEMENTIN, P141; LaRochelle S, 2003, INT J SUST DEV WORLD, V10, P361, DOI 10.1080/13504500309470112; Larrazabal A, 2012, CURR OPIN ENV SUST, V4, P707, DOI 10.1016/j.cosust.2012.10.008; LARSON A.M., 2015, INT FORESTRY REV, V17; Locke C, 1999, DEV CHANGE, V30, P265, DOI 10.1111/1467-7660.00117; Lopez C., 2005, RIQUEZA BOSQUES MEXI; Lopez-Feldman AJ, 2006, RURAL HOUSEHOLDS NAT; Lund JF, 2014, BIODIVERS CONSERV, V23, P237, DOI 10.1007/s10531-013-0596-z; Luzar JB, 2011, BIOSCIENCE, V61, P771, DOI 10.1525/bio.2011.61.10.7; Madrid L., 2009, INVESTIGACION AMBIEN, V1, P179; Marshall E, 2003, ECON BOT, V57, P262, DOI 10.1663/0013-0001(2003)057[0262:NFPITC]2.0.CO;2; McCall M.K., 2014, SOURCEBOOK METHODS P, P216; McCall MK., 2011, COMMUNITY FOREST MON; McCall MK, 2014, REV DEP GEOGRAFIA U, VEspecial Cartogeo, P94, DOI [10.7154/RDG.2014.0114.0004, DOI 10.7154/RDG.2014.0114.0004]; Nightingale A., 2003, ACME, V2, P77, DOI DOI 10.1016/S0016-7185(99)00025-1; Pacha MJ, 2015, COMMUNITY BASED MONI; Paneque-Galvez J, 2014, FORESTS, V5, P1481, DOI 10.3390/f5061481; Peters-Guarin G, 2011, COMMUNITY FOREST MON; Raymond CM, 2010, J ENVIRON MANAGE, V91, P1766, DOI 10.1016/j.jenvman.2010.03.023; REDD Indigena, 2011, REDD IND; Reed MS, 2008, BIOL CONSERV, V141, P2417, DOI 10.1016/j.biocon.2008.07.014; SEMARNAT, 2014, EM RED PROGR ID NOT; Shiva Vandana, 1997, BIOPIRACY PLUNDER NA; Skutsch M, 2011, COMMUNITY FOREST MON; Skutsch M, 2013, GLOBAL ENVIRON CHANG, V23, P813, DOI 10.1016/j.gloenvcha.2013.02.015; Sletto Bjørn, 2013, Cuad. Geogr. Rev. Colomb. Geogr., V22, P193; TOLEDO VM, 1995, INTERCIENCIA, V20, P177; Toledo VM, 2001, ETNOECOLOGIA, V6, P7; Torres AB, 2015, FORESTS, V6, P244, DOI 10.3390/f6010244; United Nations, 2009, C PART 15 SESS COP 7; van Dam C, 2011, FORESTS, V2, P394, DOI 10.3390/f2010394	60	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0146038	10.1371/journal.pone.0146038	http://dx.doi.org/10.1371/journal.pone.0146038			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300439	Green Submitted, Green Published, gold			2022-12-27	WOS:000377822200001
J	Enewold, L; Thomas, A				Enewold, Lindsey; Thomas, Anish			Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; 1ST-LINE TREATMENT; OPEN-LABEL; AMERICAN SOCIETY; MUTATIONS; CHEMOTHERAPY; GEFITINIB; MULTICENTER; SMOKING; KRAS	Despite being the basis of one of the most effective interventions in lung cancer, little is known about the patterns of epidermal growth factor receptor (EGFR) mutation testing in the general population. We assessed the frequencies and determinants of EGFR testing and erlotinib treatment among a population-based sample. A random sample (n = 1,358) of patients diagnosed in 2010 with histologically-confirmed NSCLC, as reported to the Surveillance Epidemiology and End Results (SEER) program, had their medical records abstracted and treating physicians queried. Logistic regression was used to identify factors associated with EGFR testing and erlotinib treatment. Survival was examined using Cox proportional hazards regression. The frequency of EGFR testing was 16.8% overall and 22.6% for stage IV adenocarcinoma patients. Given an EGFR mutation, 33.6% of all patients and 48.3% of stage IV patients received erlotinib. Among stage IV patients, increased age, Medicaid/no/unknown insurance status, death within 2 months of diagnosis and comorbidity were inversely associated with EGFR testing; erlotinib treatment was less likely among smokers and patients with non-adenocarcinomas. EGFR-mutation was associated with improved survival, albeit only among stage IV adenocarcinomas. Less than a quarter of NSCLC patients diagnosed in 2010 received EGFR testing and less than half of the patients with EGFR-mutant stage IV tumors received erlotinib. Significant disparities were observed in EGFR mutation testing by health insurance status, comorbidity and age. A national strategy is imperative to ensure that resources and processes are in place to efficiently implement molecular testing of cancer.	[Enewold, Lindsey] NCI, Healthcare Assessment Res Branch, Healthcare Delivery Res Program, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Thomas, Anish] NCI, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Enewold, L (corresponding author), NCI, Healthcare Assessment Res Branch, Healthcare Delivery Res Program, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA.	lindsey.enewold@nih.gov			National Cancer Institute [HHSN261201000024C, HHSN261201000025C, HHSN261201000032C, HHSN261201000027C, HHSN261201000026C, HHSN261201000140C, HHSN261201000037C, HHSN261201000033C, HHSN261201000034C, HHSN261201000035C, HHSN261201000029C, HHSN261201000031C, HHSN261201000028C, HHSN261201000030C]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute and National Cancer Institute contracts: HHSN261201000024C; HHSN261201000025C, HHSN261201000032C, HHSN261201000027C, HHSN261201000026C, HHSN261201000140C, HHSN261201000037C, HHSN261201000033C, HHSN261201000034C, HHSN261201000035C, HHSN261201000029C, HHSN261201000031C, HHSN261201000028C, and HHSN261201000030C.	American Cancer Society, 2015, CANC FACTS FIG 2015; Araujo LH, 2015, J CLIN ONCOL, V33, P1966, DOI 10.1200/JCO.2014.59.2444; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Ellis PM, 2013, J THORAC ONCOL, V8, P1136, DOI 10.1097/JTO.0b013e31829f6a43; Ettinger DS, 2014, J NATL COMPR CANC NE, V12, P1738, DOI 10.6004/jnccn.2014.0176; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P1236, DOI 10.6004/jnccn.2012.0130; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; Harlan LC, 2005, J CLIN ONCOL, V23, P9079, DOI 10.1200/JCO.2004.00.1297; Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; Lindeman NI, 2013, J THORAC ONCOL, V8, P1343, DOI 10.1097/JTO.0000000000000003; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McQuitty E, 2014, ARCH PATHOL LAB MED, V138, P390, DOI 10.5858/arpa.2013-0225-OA; Miller FA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-131; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Moreira AL, 2012, CLIN LUNG CANCER, V13, P334, DOI 10.1016/j.cllc.2012.01.004; National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan IW, 2013, LUNG CANCER, V82, P469, DOI 10.1016/j.lungcan.2013.09.018; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Reinersman JM, 2011, J THORAC ONCOL, V6, P28, DOI 10.1097/JTO.0b013e3181fb4fe2; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sasaki H, 2006, INT J CANCER, V118, P180, DOI 10.1002/ijc.21301; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist LV, 2007, ONCOLOGIST, V12, P90, DOI 10.1634/theoncologist.12-1-90; Wheatley-Price P, 2008, J CLIN ONCOL, V26, P2350, DOI 10.1200/JCO.2007.15.2280; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang SH, 2005, CLIN CANCER RES, V11, P2106, DOI 10.1158/1078-0432.CCR-04-1853; Zhang W, 2014, ARCH PATHOL LAB MED, V138, P543, DOI 10.5858/arpa.2013-0311-OA; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	33	48	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156728	10.1371/journal.pone.0156728	http://dx.doi.org/10.1371/journal.pone.0156728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294665	Green Published, Green Submitted, gold			2022-12-27	WOS:000377821300011
J	Willeboordse, M; van de Kant, KDG; Tan, FES; Mulkens, S; Schellings, J; Crijns, Y; van der Ploeg, L; van Schayck, CP; Dompeling, E				Willeboordse, Maartje; van de Kant, Kim D. G.; Tan, Frans E. S.; Mulkens, Sandra; Schellings, Julia; Crijns, Yvonne; van der Ploeg, Liesbeth; van Schayck, Constant P.; Dompeling, Edward			A Multifactorial Weight Reduction Programme for Children with Overweight and Asthma: A Randomized Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; CHILDHOOD OVERWEIGHT; INCIDENT ASTHMA; DUTCH CHILDREN; OBESE CHILDREN; LUNG-FUNCTION; RISK; INTERVENTION; METAANALYSIS; ADOLESCENTS	Background There is increasing evidence that obesity is related to asthma development and severity. However, it is largely unknown whether weight reduction can influence asthma management, especially in children. Objective To determine the effects of a multifactorial weight reduction intervention on asthma management in overweight/obese children with (a high risk of developing) asthma. Methods An 18-month weight-reduction randomized controlled trial was conducted in 87 children with overweight/obesity and asthma. Every six months, measurements of anthropometry, lung function, lifestyle parameters and inflammatory markers were assessed. Analyses were performed with linear mixed models for longitudinal analyses. Results After 18 months, the body mass index-standard deviation score decreased by -0.14 +/- 0.29 points (p<0.01) in the intervention group and -0.12 +/- 0.34 points (p<0.01) in the control group. This change over time did not differ between groups (p>0.05). Asthma features (including asthma control and asthma-related quality of life) and lung function indices (static and dynamic) improved significantly over time in both groups. The FVC% predicted improved over time by 10.1 +/- 8.7% in the intervention group (p<0.001), which was significantly greater than the 6.1 +/- 8.4% in the control group (p<0.05). Conclusions & clinical relevance Clinically relevant improvements in body weight, lung function and asthma features were found in both the intervention and control group, although some effects were more pronounced in the intervention group (FVC, asthma control, and quality of life). This implies that a weight reduction intervention could be clinically beneficial for children with asthma.	[Willeboordse, Maartje; van de Kant, Kim D. G.; Dompeling, Edward] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Paediat Pulm, Maastricht, Netherlands; [Tan, Frans E. S.] MUMC, CAPHRI, Dept Methodol & Stat, Maastricht, Netherlands; [Mulkens, Sandra] Maastricht Univ, Fac Psychol & Neurosci, Sch Expt Psychopathol EPP, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands; [Schellings, Julia; Crijns, Yvonne] MUMC, Dept Physiotherapy, Maastricht, Netherlands; [van der Ploeg, Liesbeth] MUMC, Dept Dietet, Maastricht, Netherlands; [van Schayck, Constant P.] MUMC, CAPHRI, Dept Family Med, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Dompeling, E (corresponding author), MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Paediat Pulm, Maastricht, Netherlands.	Edward.dompeling@mumc.nl	Mulkens, Sandra/ABH-2102-2020	Mulkens, Alexandra/0000-0002-0237-1628; Willeboordse, Maartje/0000-0002-9695-9755	Dutch Lung Foundation [NAF 3.4.09.002]; TEVA Pharmaceuticals BV [TC 13.119]	Dutch Lung Foundation; TEVA Pharmaceuticals BV(Teva Pharmaceutical Industries)	This study was supported by unrestricted grants from the Dutch Lung Foundation (NAF 3.4.09.002) and TEVA Pharmaceuticals BV (TC 13.119). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Kader MS, 2013, AFR HEALTH SCI, V13, P682, DOI 10.4314/ahs.v13i3.23; Adeniyi FB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009339.pub2; Luna-Pech JA, 2014, INT ARCH ALLERGY IMM, V163, P252, DOI 10.1159/000360398; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Bindels PJ, 2014, HUISARTS WET, V57, P70; Bongers BC., 2012, PEDIAT NORMS CARDIOP, V1st edn; Boulet LP, 2012, RESP MED, V106, P651, DOI 10.1016/j.rmed.2011.12.012; Chen YC, 2013, OBES REV, V14, P222, DOI 10.1111/j.1467-789X.2012.01055.x; Cole TJ, 1999, ANN HUM BIOL, V26, P303, DOI 10.1080/030144699282633; da Silva PL, 2012, PEDIATR PULM, V47, P8, DOI 10.1002/ppul.21502; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Gezondheidsraad, 2006, RICHTL GOED VOED 200; Hutchinson SG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-177; Jansen E, 2011, INT J OBESITY, V35, P501, DOI 10.1038/ijo.2011.16; Jensen ME, 2013, CLIN EXP ALLERGY, V43, P775, DOI 10.1111/cea.12115; Jensen ME, 2011, PAEDIATR RESPIR REV, V12, P152, DOI 10.1016/j.prrv.2011.01.009; Juel CTB, 2013, RESP CARE, V58, P867, DOI 10.4187/respcare.02202; Juniper EF, 1996, QUAL LIFE RES, V5, P35, DOI 10.1007/BF00435967; Koolen BB, 2011, EUR RESPIR J, V38, P561, DOI 10.1183/09031936.00173710; Lang JE, 2012, J ASTHMA, V49, P456, DOI 10.3109/02770903.2012.677895; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moreira A, 2013, ALLERGY, V68, P425, DOI 10.1111/all.12106; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Raat H, 2005, QUAL LIFE RES, V14, P265, DOI 10.1007/s11136-004-0798-7; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; van Leeuwen JC, 2013, PEDIAT PULMONOL; Wang YF, 2012, INT REV PSYCHIATR, V24, P176, DOI 10.3109/09540261.2012.688195; Waters E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001871.pub3; Willeboordse M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-494; Zapletal A., 1977, Z ERKR ATMUNGSORGANE, V149, P343	32	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157158	10.1371/journal.pone.0157158	http://dx.doi.org/10.1371/journal.pone.0157158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294869	Green Published, gold, Green Submitted			2022-12-27	WOS:000377821300025
J	Kristensen, HK; Tistad, M; von Koch, L; Ytterberg, C				Kristensen, Hanne Kaae; Tistad, Malin; von Koch, Lena; Ytterberg, Charlotte			The Importance of Patient Involvement in Stroke Rehabilitation	PLOS ONE			English	Article							LONG-TERM NEEDS; SURVIVORS EXPERIENCES; IMPACT; SELF; CARE; PEOPLE; VIEWS	Objective To investigate the perceived needs for health services by persons with stroke within the first year after rehabilitation, and associations between perceived impact of stroke, involvement in decisions regarding care/treatment, and having health services needs met. Method Data was collected, through a mail survey, from patients with stroke who were admitted to a university hospital in 2012 and had received rehabilitation after discharge from the stroke unit. The rehabilitation lasted an average of 2 to 4.6 months. The Stroke Survivor Needs Survey Questionnaire was used to assess the participants' perceptions of involvement in decisions on care or treatment and needs for health services in 11 problem areas: mobility, falls, incontinence, pain, fatigue, emotion, concentration, memory, speaking, reading, and sight. The perceived impact of stroke in eight areas was assessed using the Stroke Impact Scale (SIS) 3.0. Eleven logistic regression models were created to explore associations between having health services needs met in each problem area respectively (dependent variable) and the independent variables. In all models the independent variables were: age, sex, SIS domain corresponding to the dependent variable, or stroke severity in cases when no corresponding SIS domain was identified, and involvement in decisions on care and treatment. Results The 63 participants who returned the questionnaires had a mean age of 72 years, 33 were male and 30 were female. Eighty percent had suffered a mild stroke. The number of participants who reported problems varied between 51 (80%, mobility) and 24 (38%, sight). Involvement in decisions on care and treatment was found to be associated with having health services needs met in six problem areas: falls, fatigue, emotion, memory, speaking, and reading. Conclusions The results highlight the importance of involving patients in making decisions on stroke rehabilitation, as it appears to be associated with meeting their health services needs.	[Kristensen, Hanne Kaae] Univ Coll Lillebaelt, Hlth Sci Res Ctr, Odense, Denmark; [Kristensen, Hanne Kaae; Ytterberg, Charlotte] Univ Southern Denmark, Res Unit Rehabil, Inst Clin Res, Odense, Denmark; [Tistad, Malin; von Koch, Lena; Ytterberg, Charlotte] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Tistad, Malin] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [von Koch, Lena] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden	University of Southern Denmark; Karolinska Institutet; Dalarna University; Karolinska Institutet; Karolinska University Hospital	Kristensen, HK (corresponding author), Univ Coll Lillebaelt, Hlth Sci Res Ctr, Odense, Denmark.; Kristensen, HK (corresponding author), Univ Southern Denmark, Res Unit Rehabil, Inst Clin Res, Odense, Denmark.	hkkr@ucl.dk	von Koch, Lena/P-2310-2018	von Koch, Lena/0000-0002-8560-3016; Kristensen, Hanne Kaae/0000-0002-9596-5571; Ytterberg, Charlotte/0000-0003-3704-8887	Danish Regions; Danish Health Cartel	Danish Regions; Danish Health Cartel	The authors acknowledge Danish Regions and the Danish Health Cartel for funding the study. The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank The UK Stroke Association for providing the Stroke Survivor Needs Survey Questionnaire. Moreover, we thank Danish Regions and the Danish Health Cartel for funding the study.	Brown M, 2014, DISABIL REHABIL, V36, P1020, DOI 10.3109/09638288.2013.825653; Constand MK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-271; Danish Board of Health, 2011, BRAIN INJURY REHABIL; Danish Health and Medicines Authority, 2014, DISEASE MANAGEMENT P; de Port IGLV, 2007, DISABIL REHABIL, V29, P1841, DOI 10.1080/09638280601129157; Docteur E., 2012, PATIENT CENTREDNESS; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Duxbury S, 2012, OCCUP THER HEALTH CA, V26, P16, DOI 10.3109/07380577.2011.621514; Dworzynski K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3615; Flink M, 2015, CLIN REHABIL; Godolphin William, 2009, Healthc Q, V12 Spec No Patient, pe186; Govan L, 2009, STROKE, V40, P3396, DOI 10.1161/STROKEAHA.109.557645; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Jones F, 2011, DISABIL REHABIL, V33, P797, DOI 10.3109/09638288.2010.511415; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Kersten P, 2002, DISABIL REHABIL, V24, P860, DOI 10.1080/09638280210142167; Kristensen HK, 2015, INT J THER REHABIL, V22, P460, DOI 10.12968/ijtr.2015.22.10.460; Kristensen HK, 2015, DISABIL REHABIL IN P; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Levack William M M, 2015, Cochrane Database Syst Rev, pCD009727, DOI 10.1002/14651858.CD009727.pub2; Lindsay MP, 2010, CANADIAN BEST PRACTI; Luker J, 2015, ARCH PHYS MED REHAB, V96, P1698, DOI 10.1016/j.apmr.2015.03.017; McKevitt C, 2011, STROKE, V42, P1398, DOI 10.1161/STROKEAHA.110.598839; Momsen AM, 2012, J REHABIL MED, V44, P901, DOI 10.2340/16501977-1040; National Institute For Health And Care Excellence [NICE], 2013, STROKE REHABILITATIO; Nordin NAM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-118; Peoples H, 2011, SCAND J OCCUP THER, V18, P163, DOI 10.3109/11038128.2010.509887; Robison J, 2009, DISABIL REHABIL, V31, P1555, DOI 10.1080/09638280802639327; Rosewilliam S, 2015, CLIN REHABIL; Rosewilliam S, 2015, REHABILITATION GOAL, P345; Salter K, 2008, J REHABIL MED, V40, P595, DOI 10.2340/16501977-0238; Satink T, 2013, ARCH PHYS MED REHAB, V94, P1171, DOI 10.1016/j.apmr.2013.01.011; Singam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144344; Sugavanam T, 2013, DISABIL REHABIL, V35, P177, DOI 10.3109/09638288.2012.690501; Sumathipala K, 2012, CHRONIC ILLN, V8, P31, DOI 10.1177/1742395311423848; Sumsion Thelma, 2006, Can J Occup Ther, V73, P153; Talbot Lise R, 2004, Health Qual Life Outcomes, V2, P53, DOI 10.1186/1477-7525-2-53; Tang WK, 2015, TOP STROKE REHABIL, V22, P194, DOI 10.1179/1074935714Z.0000000024; Tistad M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-40; Tistad M, 2012, J NEUROL SCI, V313, P160, DOI 10.1016/j.jns.2011.08.038; Turner-Stokes L, 2015, INT J THER REHABIL, V22, P210, DOI 10.12968/ijtr.2015.22.5.210; Vincent Claude, 2007, BMC Geriatr, V7, P20; Walsh ME, 2015, DISABIL REHABIL, V37, P1599, DOI 10.3109/09638288.2014.974834; Wressle E, 2002, J REHABIL MED, V34, P5, DOI 10.1080/165019702317242640; Zimmermann L, 2014, PATIENT EDUC COUNS, V96, P98, DOI 10.1016/j.pec.2014.04.015	46	37	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157149	10.1371/journal.pone.0157149	http://dx.doi.org/10.1371/journal.pone.0157149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1UG	27285997	Green Published, Green Submitted, gold			2022-12-27	WOS:000377564000041
J	Ota, M; Gonja, H; Koike, R; Fukuchi, S				Ota, Motonori; Gonja, Hideki; Koike, Ryotaro; Fukuchi, Satoshi			Multiple-Localization and Hub Proteins	PLOS ONE			English	Article							INTRINSICALLY DISORDERED PROTEINS; INTERACTION NETWORK; BINDING; PHOSPHORYLATION; RESOURCE; REGIONS; IDEAL; SRC	Protein-protein interactions are fundamental for all biological phenomena, and protein-protein interaction networks provide a global view of the interactions. The hub proteins, with many interaction partners, play vital roles in the networks. We investigated the subcellular localizations of proteins in the human network, and found that the ones localized inmultiple subcellular compartments, especially the nucleus/cytoplasm proteins (NCP), the cytoplasm/cell membrane proteins (CMP), and the nucleus/cytoplasm/cell membrane proteins (NCMP), tend to be hubs. Examinations of keywords suggested that among NCP, those related to post-translational modifications and transcription functions are the major contributors to the large number of interactions. These types of proteins are characterized by a multi-domain architecture and intrinsic disorder. A survey of the typical hub proteins with prominent numbers of interaction partners in the type revealed that most are either transcription factors or co-regulators involved in signaling pathways. They translocate from the cytoplasm to the nucleus, triggered by the phosphorylation and/or ubiquitination of intrinsically disordered regions. Among CMP and NCMP, the contributors to the numerous interactions are related to either kinase or ubiquitin ligase activity. Many of them reside on the cytoplasmic side of the cell membrane, and act as the upstream regulators of signaling pathways. Overall, these hub proteins function to transfer external signals to the nucleus, through the cell membrane and the cytoplasm. Our analysis suggests that multiple-localization is a crucial concept to characterize groups of hub proteins and their biological functions in cellular information processing.	[Ota, Motonori; Gonja, Hideki; Koike, Ryotaro] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Fukuchi, Satoshi] Maebashi Inst Technol, Fac Engn, Maebashi, Gunma, Japan	Nagoya University	Ota, M (corresponding author), Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan.	mota@is.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by the "Platform for Drug Discovery, Informatics, and Structural Life Science" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Japan Agency for Medical Research and Development (AMED).	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Alberts B., 2014, MOL BIOL CELL; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Durbin R, 1988, BIOL SEQUENCE ANAL P; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Fukuchi S, 2014, NUCLEIC ACIDS RES, V42, pD320, DOI 10.1093/nar/gkt1010; Fukuchi S, 2012, NUCLEIC ACIDS RES, V40, pD507, DOI 10.1093/nar/gkr884; Fukuchi S, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-29; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hsing M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-80; Huang QL, 2014, J PROTEOME RES, V13, P2735, DOI 10.1021/pr401019d; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; Nakai Kenta, 2007, V390, P429; Patil A, 2010, PROTEIN SCI, V19, P1461, DOI 10.1002/pro.425; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qin BY, 2002, GENE DEV, V16, P1950, DOI 10.1101/gad.1002002; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Veres DV, 2015, NUCLEIC ACIDS RES, V43, pD485, DOI 10.1093/nar/gku1007; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yang L, 2014, J THEOR BIOL, V358, P61, DOI 10.1016/j.jtbi.2014.05.008; Zhang S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-127	50	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156455	10.1371/journal.pone.0156455	http://dx.doi.org/10.1371/journal.pone.0156455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285823	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000013
J	de Jong, K; Ariti, C; van der Kam, S; Mooren, T; Shanks, L; Pintaldi, G; Kleber, R				de Jong, Kaz; Ariti, Cono; van der Kam, Saskia; Mooren, Trudy; Shanks, Leslie; Pintaldi, Giovanni; Kleber, Rolf			Monitoring and Evaluating Psychosocial Intervention Outcomes in Humanitarian Aid	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; MENTAL-HEALTH; PSYCHOTHERAPY; DISORDERS; FEEDBACK; SUPPORT	Existing tools for evaluating psychosocial interventions (un-validated self-reporting questionnaires) are not ideal for use in non-Western conflict settings. We implement a generic method of treatment evaluation, using client and counsellor feedback, in 18 projects in non-Western humanitarian settings. We discuss our findings from the perspective of validity and suggestions for future research. A retrospective analysis is executed using data gathered from psychosocial projects. Clients (n = 7,058) complete two (complaints and functioning) rating scales each session and counsellors rate the client's status at exit. The client-completed pre-and post-intervention rating scales show substantial changes. Counsellor evaluation of the clients' status shows a similar trend in improvement. All three multivariable models for each separate scale have similar associations between the scales and the investigated variables despite different cultural settings. The validity is good. Limitations are: ratings give only a general impression and clinical risk factors are not measured. Potential ceiling effects may influence change of scales. The intra and inter-rater reliability of the counsellors' rating is not assessed. The focus on client and counsellor perspectives to evaluate treatment outcome seems a strong alternative for evaluation instruments frequently used in psychosocial programming. The session client rated scales helps client and counsellor to set mutual treatment objectives and reduce drop-out risk. Further research should test the scales against a cross-cultural valid gold standard to obtain insight into their clinical relevance.	[de Jong, Kaz; van der Kam, Saskia; Shanks, Leslie; Pintaldi, Giovanni] Med Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands; [Ariti, Cono] London Sch Hyg & Trop Med, Med Stat, London WC1, England; [Mooren, Trudy; Kleber, Rolf] Arq Psychotrauma Expert Grp, Res Dept, Diemen, Netherlands; [Kleber, Rolf] Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands	Doctors Without Borders; University of London; London School of Hygiene & Tropical Medicine; Arq Psychotrauma Expert Group; Utrecht University	de Jong, K (corresponding author), Med Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands.	kaz.de.jong@amsterdam.msf.org						Ahearn EP, 1997, J PSYCHIATR RES, V31, P569, DOI 10.1016/S0022-3956(97)00029-0; Bannink FP, 2007, J CONTEMP PSYCHOTHER, V37, P87, DOI 10.1007/s10879-006-9040-y; Bannink FP., 2008, BR TREAT CRIS INTERV, V8, P215, DOI [10.1093/brief-treatment/mhn013, DOI 10.1093/BRIEF-TREATMENT/MHN013]; Barlow DH, 2004, AM PSYCHOL, V59, P869, DOI 10.1037/0003-066X.59.9.869; Benish SG, 2011, J COUNS PSYCHOL, V58, P279, DOI 10.1037/a0023626; Boss MW, 1991, PSYCHOL ASSESSMENT J, V3, P433, DOI [10.1037/1040-3590.3.3.433, DOI 10.1037/1040-3590.3.3.433]; Brown J, 1999, HEART AND SOUL OF CHANGE, P389, DOI 10.1037/11132-012; de Jong JTVM, 2014, INTERVENTION, V12, P129, DOI 10.1097/WTF.0000000000000062; de Jong K, 2005, PSYCHOSOCIAL MENTAL; de Jong K, 2003, RECONSTRUCTING EARLY, P184; de Jong Kaz, 2014, HEALTH, V6, P504, DOI DOI 10.4236/HEALTH.2014.66070; Duncan B.L., 2010, BECOMING BETTER THER, V1st ed.; Duncan B. L., 2004, HEROIC CLIENT REVOLU; FARAVELLI C, 1986, J AFFECT DISORDERS, V11, P245, DOI 10.1016/0165-0327(86)90076-5; Haas E, 2002, J CLIN PSYCHOL, V58, P1157, DOI 10.1002/jclp.10044; Hafkenscheid A, 2010, J BR THER, V7, P2; HAWLEY DR, 1995, FAM RELAT, V44, P278, DOI 10.2307/585526; Holcomb WR, 1998, PSYCHIATR SERV, V49, P929, DOI 10.1176/ps.49.7.929; Hollifield M, 2002, JAMA-J AM MED ASSOC, V288, P611, DOI 10.1001/jama.288.5.611; Horvath AO, 2002, PSYCHOTHERAPY RELATI, P37; HOWARD KI, 1986, AM PSYCHOL, V41, P159, DOI 10.1037/0003-066X.41.2.159; Jacob KS, 2014, LANCET, V383, P1433, DOI 10.1016/S0140-6736(13)62382-X; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1988, BEHAV ASSESS, V10, P133; Lambert M.J., 2013, BERGIN GARFIELDS HDB, V6th ed., P169; Lambert M.J., 2004, BERGIN GARFIELDS HDB, P139; Lambert MJ, 2001, PSYCHOTHER RES, V11, P49, DOI 10.1080/713663852; Miller S., 2006, J BRIEF THER, V5, P5; Miller S. D., 2003, J BRIEF THERAPY, V2, P91; Mooren GTM, 2003, INTERVENTION, V1, P57; Patel V, 2011, BEHAV RES THER, V49, P523, DOI 10.1016/j.brat.2011.06.012; Reese RJ, 2009, PSYCHOTHERAPY, V46, P418, DOI 10.1037/a0017901; Schoemaker M, 2006, INTERVENTION, V1, P36; Shanks Leslie, 2013, Confl Health, V7, P19, DOI 10.1186/1752-1505-7-19; SPEER DC, 1995, J CONSULT CLIN PSYCH, V63, P1044, DOI 10.1037/0022-006X.63.6.1044; Tol WA, 2011, LANCET, V378, P1581, DOI 10.1016/S0140-6736(11)61094-5; Van der Veer G., 1998, COUNSELLING THERAPY; van der Veer G., 2004, INTERVENTION AMSTELV, V2, P118; van der Veer G, 2008, INTERVENTION, V6, P132, DOI 10.1097/WTF.0b013e328307c9ba; Van Ommeren M, 2003, BRIT J PSYCHIAT, V182, P376, DOI 10.1192/bjp.182.5.376; Veerman JW, 2007, EVAL PROGRAM PLANN, V30, P212, DOI 10.1016/j.evalprogplan.2007.01.011; Williams ME, 2011, J IMMIGR MINOR HEALT, V13, P780, DOI 10.1007/s10903-010-9417-6	42	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157474	10.1371/journal.pone.0157474	http://dx.doi.org/10.1371/journal.pone.0157474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JQ	27315263	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000378030000029
J	He, Y; Schmidt, MA; Erwin, C; Guo, J; Sun, R; Pendarvis, K; Warner, BW; Herman, EM				He, Yonghua; Schmidt, Monica A.; Erwin, Christopher; Guo, Jun; Sun, Raphael; Pendarvis, Ken; Warner, Brad W.; Herman, Eliot M.			Transgenic Soybean Production of Bioactive Human Epidermal Growth Factor (EGF)	PLOS ONE			English	Article							SMALL-BOWEL RESECTION; NEONATAL NECROTIZING ENTEROCOLITIS; BIRTH-WEIGHT INFANTS; HUMAN-MILK; FACTOR RECEPTOR; PHARMACEUTICAL PROTEINS; INTESTINAL ADAPTATION; PROTEASE INHIBITOR; TYROSINE KINASE; ENHANCED LEVELS	Necrotizing enterocolitis (NEC) is a devastating condition of premature infants that results from the gut microbiome invading immature intestinal tissues. This results in a life-threatening disease that is frequently treated with the surgical removal of diseased and dead tissues. Epidermal growth factor (EGF), typically found in bodily fluids, such as amniotic fluid, salvia and mother's breast milk, is an intestinotrophic growth factor and may reduce the onset of NEC in premature infants. We have produced human EGF in soybean seeds to levels biologically relevant and demonstrated its comparable activity to commercially available EGF. Transgenic soybean seeds expressing a seed-specific codon optimized gene encoding of the human EGF protein with an added ER signal tag at the N' terminal were produced. Seven independent lines were grown to homozygous and found to accumulate a range of 6.7 +/- 3.1 to 129.0 +/- 36.7 mu g EGF/g of dry soybean seed. Proteomic and immunoblot analysis indicates that the inserted EGF is the same as the human EGF protein. Phosphorylation and immunohistochemical assays on the EGF receptor in HeLa cells indicate the EGF protein produced in soybean seed is bioactive and comparable to commercially available human EGF. This work demonstrates the feasibility of using soybean seeds as a biofactory to produce therapeutic agents in a soymilk delivery platform.	[He, Yonghua; Schmidt, Monica A.; Herman, Eliot M.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Erwin, Christopher; Guo, Jun; Sun, Raphael; Warner, Brad W.] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Erwin, Christopher; Guo, Jun; Sun, Raphael; Warner, Brad W.] Washington Univ, Sch Med, St Louis, MO 63178 USA; [Pendarvis, Ken] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ USA	University of Arizona; St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); University of Arizona	Herman, EM (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ USA.	emherman@email.arizona.edu		Herman, Eliot/0000-0001-9398-0316; Guo, Jun/0000-0003-4255-7715	NIH, University Research Strategic Alliance Program [R21 DK094065]; Washington University in St. Louis; Children's Surgical Sciences Research Institute - St. Louis Children's Hospital Foundation	NIH, University Research Strategic Alliance Program; Washington University in St. Louis; Children's Surgical Sciences Research Institute - St. Louis Children's Hospital Foundation	This research was supported by NIH# R21 DK094065 (BWW, PI; EMH and MAS coPIs), University Research Strategic Alliance Program; Washington University in St. Louis, and the Children's Surgical Sciences Research Institute - St. Louis Children's Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderberth I, 2009, ACTA PAEDIATR, V98, P229, DOI [10.1111/j.1651-2227.2008.01060.x, DOI 10.1111/J.1651-2227.2008.01060.X]; Arakawa T, 1998, NAT BIOTECHNOL, V16, P292, DOI 10.1038/4381; Arntzen C, 2015, PLANT BIOTECHNOL J, V13, P1013, DOI 10.1111/pbi.12460; Avraham T, 2005, PLANT BIOTECHNOL J, V3, P71, DOI 10.1111/j.1467-7652.2004.00102.x; Bost K, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpenter G, 1980, Birth Defects Orig Artic Ser, V16, P61; CHAET MS, 1994, J PEDIATR SURG, V29, P1035, DOI 10.1016/0022-3468(94)90274-7; Cilieborg MS, 2012, EARLY HUM DEV, V88, pS41, DOI 10.1016/j.earlhumdev.2011.12.027; CLARE JJ, 1991, GENE, V105, P205, DOI 10.1016/0378-1119(91)90152-2; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; COHEN S, 1975, P NATL ACAD SCI USA, V72, P1317, DOI 10.1073/pnas.72.4.1317; Collins J B, 1995, Semin Pediatr Surg, V4, P60; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; CroisyDelcey M, 1997, BIOMED PHARMACOTHER, V51, P286, DOI 10.1016/S0753-3322(97)83545-7; Cunha NB, 2010, GENET MOL RES, V9, P1163, DOI 10.4238/vol9-2gmr849; Cunha NB, 2011, TRANSGENIC RES, V20, P811, DOI 10.1007/s11248-010-9460-z; Ding SH, 2006, BIOTECHNOL LETT, V28, P869, DOI 10.1007/s10529-006-9018-6; Dinkins RD, 2001, IN VITRO CELL DEV-PL, V37, P742; Dvorak B, 2003, PEDIATR RES, V54, P15, DOI 10.1203/01.PDR.0000065729.74325.71; Dvorak B, 2002, AM J PHYSIOL-GASTR L, V282, pG156, DOI 10.1152/ajpgi.00196.2001; Erwin CR, 1999, AM J PHYSIOL-GASTR L, V277, pG533, DOI 10.1152/ajpgi.1999.277.3.G533; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; GEORGENASCIMENTO C, 1988, BIOCHEMISTRY-US, V27, P797, DOI 10.1021/bi00402a046; Guo J, 2009, J BIOL CHEM, V284, P134, DOI 10.1074/jbc.M806133200; Herman E.M., 2015, RECENT ADV GENE EXPR, P193, DOI [10.1007/978-1-4939-2202-4_5, DOI 10.1007/978-1-4939-2202-4_5]; Hofmann GE, 1990, ACTA OBSTET GYN SCAN, V69, P217, DOI 10.3109/00016349009028683; Howard JA, 2005, CROP SCI, V45, P468, DOI 10.2135/cropsci2005.0468; Karunanandaa B, 2005, METAB ENG, V7, P384, DOI 10.1016/j.ymben.2005.05.005; KASSELBERG AG, 1985, J HISTOCHEM CYTOCHEM, V33, P315, DOI 10.1177/33.4.3884705; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kim WS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00633; Kim WS, 2012, PLANTA, V235, P13, DOI 10.1007/s00425-011-1487-8; Kinney AJ, 2001, PLANT CELL, V13, P1165, DOI 10.1105/tpc.13.5.1165; KLIEGMAN RM, 1981, AM J DIS CHILD, V135, P608, DOI 10.1001/archpedi.1981.02130310014006; Kong QX, 2001, P NATL ACAD SCI USA, V98, P11539, DOI 10.1073/pnas.191617598; KONTUREK SJ, 1992, SCAND J GASTROENTERO, V27, P649, DOI 10.3109/00365529209000134; Leite A, 2000, MOL BREEDING, V6, P47, DOI 10.1023/A:1009648532210; Lin AHY, 2011, PHARMACOL RES, V63, P181, DOI 10.1016/j.phrs.2010.11.007; Livingstone D, 2007, PLANT MOL BIOL, V64, P397, DOI 10.1007/s11103-007-9163-x; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Madkour, 2009, ARAB J BIOTECH, V12, P291; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Martin JA, 2010, NATL VITAL STAT REP, V61, P1; Meinzen-Derr J, 2009, J PERINATOL, V29, P57, DOI 10.1038/jp.2008.117; Messing B, 1999, GASTROENTEROLOGY, V117, P1043, DOI 10.1016/S0016-5085(99)70388-4; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Moravec T, 2007, VACCINE, V25, P1647, DOI 10.1016/j.vaccine.2006.11.010; Nakamura H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020034; Neu J, 1996, PEDIATR CLIN N AM, V43, P409, DOI 10.1016/S0031-3955(05)70413-2; O'Brien DP, 2002, J SURG RES, V105, P25, DOI 10.1006/jsre.2002.6440; Philip R, 2001, PLANT SCI, V161, P323, DOI 10.1016/S0168-9452(01)00420-4; Piller KJ, 2005, PLANTA, V222, P6, DOI 10.1007/s00425-004-1445-9; Pogrebnyak N, 2005, P NATL ACAD SCI USA, V102, P9062, DOI 10.1073/pnas.0503760102; Schmidt MA, 2005, PLANT CELL REP, V24, P383, DOI 10.1007/s00299-005-0950-z; Schmidt MA, 2008, PLANT BIOTECHNOL J, V6, P832, DOI 10.1111/j.1467-7652.2008.00364.x; Schmidt MA, 2015, PLANT BIOTECHNOL J, V13, P590, DOI 10.1111/pbi.12286; Schmidt MA, 2011, PLANT PHYSIOL, V156, P330, DOI 10.1104/pp.111.173807; Schmidt MA, 2008, MOL PLANT, V1, P910, DOI 10.1093/mp/ssn049; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; Shin CE, 1998, J SURG RES, V77, P11, DOI 10.1006/jsre.1998.5336; Sisk PM, 2007, J PERINATOL, V27, P428, DOI 10.1038/sj.jp.7211758; Spencer AU, 2008, AM J CLIN NUTR, V88, P1552, DOI 10.3945/ajcn.2008.26007; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Tacket CO, 2004, VACCINE, V22, P4385, DOI 10.1016/j.vaccine.2004.01.073; Underwood MA, 2013, PEDIATR CLIN N AM, V60, P189, DOI 10.1016/j.pcl.2012.09.008; Venegas-Caleron M, 2010, PROG LIPID RES, V49, P108, DOI 10.1016/j.plipres.2009.10.001; Vitale A, 2005, MOL INTERV, V5, P216, DOI 10.1124/mi.5.4.5; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang J, 2004, MOL CELL ENDOCRINOL, V219, P171, DOI 10.1016/j.mce.2003.12.018; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; WARNER BW, 1993, PEDIATR CLIN N AM, V40, P1335; Yang EB, 1996, BIOCHEM BIOPH RES CO, V224, P309, DOI 10.1006/bbrc.1996.1026	74	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157034	10.1371/journal.pone.0157034	http://dx.doi.org/10.1371/journal.pone.0157034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314851	Green Published, gold, Green Submitted			2022-12-27	WOS:000378030000009
J	Liew, KJ; Ramli, A; Majid, AA				Liew, Khang Jie; Ramli, Ahmad; Majid, Ahmad Abd.			Point Set Denoising Using Bootstrap-Based Radial Basis Function	PLOS ONE			English	Article								This paper examines the application of a bootstrap test error estimation of radial basis functions, specifically thin-plate spline fitting, in surface smoothing. The presence of noisy data is a common issue of the point set model that is generated from 3D scanning devices, and hence, point set denoising is one of the main concerns in point set modelling. Bootstrap test error estimation, which is applied when searching for the smoothing parameters of radial basis functions, is revisited. The main contribution of this paper is a smoothing algorithm that relies on a bootstrap-based radial basis function. The proposed method incorporates a k-nearest neighbour search and then projects the point set to the approximated thin-plate spline surface. Therefore, the denoising process is achieved, and the features are well preserved. A comparison of the proposed method with other smoothing methods is also carried out in this study.	[Liew, Khang Jie; Ramli, Ahmad; Majid, Ahmad Abd.] Univ Sains Malaysia, Sch Math Sci, Minden 11800, Penang, Malaysia	Universiti Sains Malaysia	Liew, KJ (corresponding author), Univ Sains Malaysia, Sch Math Sci, Minden 11800, Penang, Malaysia.	kenji_liewkj@yahoo.com.my	Liew, Khang Jie/AAC-9581-2020; Ramli, Ahmad Lutfi Amri/X-8854-2018; Liew, PhD, Khang Jie/GXW-1829-2022	Liew, Khang Jie/0000-0002-3993-4359; Ramli, Ahmad Lutfi Amri/0000-0003-0853-3920; 	USM [304/PMATHS/6312136]; FRGS [203/PMATHS/6711433]	USM; FRGS	This research is supported by the USM short term grant no. 304/PMATHS/6312136 and FRGS grant no. 203/PMATHS/6711433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa M, 2003, IEEE T VIS COMPUT GR, V9, P3, DOI 10.1109/TVCG.2003.1175093; Amenta N, 2004, ACM T GRAPHIC, V23, P264, DOI 10.1145/1015706.1015713; [Anonymous], 2008, P 5 EUR IEEE VGTC C; Bennink HE, 2007, IFMBE PROC, V15, P28; Bremer P.-T., 2005, Point-Based Graphics 2005 (IEEE Cat. No. 05EX1159), P47, DOI 10.1109/PBG.2005.194063; Carr JC, 2001, COMP GRAPH, P67, DOI 10.1145/383259.383266; Duchon J., 1977, LECT NOTES MATH; Fleishman S, 2003, ACM T GRAPHIC, V22, P950, DOI 10.1145/882262.882368; FRANKE R, 1982, MATH COMPUT, V38, P181, DOI 10.2307/2007474; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Guennebaud G, 2008, COMPUT GRAPH FORUM, V27, P653, DOI 10.1111/j.1467-8659.2008.01163.x; Guennebaud G, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239474; HARDY RL, 1971, J GEOPHYS RES, V76, P1905, DOI 10.1029/JB076i008p01905; LANCASTER P, 1981, MATH COMPUT, V37, P141, DOI 10.1090/S0025-5718-1981-0616367-1; Levin D, 1998, MATH COMPUT, V67, P1517, DOI 10.1090/S0025-5718-98-00974-0; Liew KJ, 2016, COMPUTATION IN PRESS, DOI [10.1007/s40314-016-0332-x, DOI 10.1007/S40314-016-0332-X]; Lipman Y, 2007, ACM T GRAPHIC, V26, DOI [10.1145/1276377.1276405, 10.1145/1239451.1239473]; Pauly M, 2001, COMP GRAPH, P379, DOI 10.1145/383259.383301; Qin H., 2014, LECT NOTES COMPUTER; Qin HX, 2008, VISUAL COMPUT, V24, P1067, DOI 10.1007/s00371-007-0206-8; Ramli A, 2012, BOOTSTRAP BASED SURF; Ramli A., 2009, VMV, P101; Schall O., 2005, Point-Based Graphics 2005 (IEEE Cat. No. 05EX1159), P71, DOI 10.1109/PBG.2005.194067; Schall O., 2007, P 2007 ACM S SOL PHY, P217; Scheidegger CE, 2005, EUR S GEOM PROC; Wahba G., 1990, SPLINE MODELS OBSERV	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0156724	10.1371/journal.pone.0156724	http://dx.doi.org/10.1371/journal.pone.0156724			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315105	Green Published, gold, Green Submitted			2022-12-27	WOS:000378030000003
J	Richard, V; Lamberto, G; Lu, TW; Cappozzo, A; Dumas, R				Richard, Vincent; Lamberto, Giuliano; Lu, Tung-Wu; Cappozzo, Aurelio; Dumas, Raphael			Knee Kinematics Estimation Using Multi-Body Optimisation Embedding a Knee Joint Stiffness Matrix: A Feasibility Study	PLOS ONE			English	Article							TISSUE ARTIFACT ASSESSMENT; BONE-POSE ESTIMATION; TIBIO-FEMORAL JOINT; GLOBAL OPTIMIZATION; ROBOTIC TECHNOLOGY; CRUCIATE LIGAMENT; COORDINATE SYSTEM; MODEL; CONSTRAINTS; MOVEMENT	The use of multi-body optimisation (MBO) to estimate joint kinematics from stereophoto-grammetric data while compensating for soft tissue artefact is still open to debate. Presently used joint models embedded in MBO, such as mechanical linkages, constitute a considerable simplification of joint function, preventing a detailed understanding of it. The present study proposes a knee joint model where femur and tibia are represented as rigid bodies connected through an elastic element the behaviour of which is described by a single stiffness matrix. The deformation energy, computed from the stiffness matrix and joint angles and displacements, is minimised within the MBO. Implemented as a "soft" constraint using a penalty-based method, this elastic joint description challenges the strictness of "hard" constraints. In this study, estimates of knee kinematics obtained using MBO embedding four different knee joint models (i.e., no constraints, spherical joint, parallel mechanism, and elastic joint) were compared against reference kinematics measured using bi-planar fluoroscopy on two healthy subjects ascending stairs. Bland-Altman analysis and sensitivity analysis investigating the influence of variations in the stiffness matrix terms on the estimated kinematics substantiate the conclusions. The difference between the reference knee joint angles and displacements and the corresponding estimates obtained using MBO embedding the stiffness matrix showed an average bias and standard deviation for kinematics of 0.9 +/- 3.2 degrees and 1.6 +/- 2.3 mm. These values were lower than when no joint constraints (1.1 +/- 3.8 degrees, 2.4 +/- 4.1 mm) or a parallel mechanism (7.7 +/- 3.6 degrees, 1.6 +/- 1.7 mm) were used and were comparable to the values obtained with a spherical joint (1.0 +/- 3.2 degrees, 1.3 +/- 1.9 mm). The study demonstrated the feasibility of substituting an elastic joint for more classic joint constraints in MBO.	[Richard, Vincent; Dumas, Raphael] Univ Lyon 1, IFSTTAR, UMR T9406, LBMC, F-69622 Lyon, France; [Richard, Vincent; Cappozzo, Aurelio] Univ Roma Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Lamberto, Giuliano] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Lamberto, Giuliano] INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England; [Lu, Tung-Wu] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Lu, Tung-Wu] Natl Taiwan Univ, Dept Orthopaed Surg, Taipei 10764, Taiwan	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Universite Gustave-Eiffel; Foro Italico University of Rome; University of Sheffield; National Taiwan University; National Taiwan University	Dumas, R (corresponding author), Univ Lyon 1, IFSTTAR, UMR T9406, LBMC, F-69622 Lyon, France.	raphael.dumas@ifsttar.fr	Dumas, Raphael/H-2281-2018	Dumas, Raphael/0000-0002-0368-8248; Lamberto, Giuliano/0000-0001-7038-2655; Richard, Vincent/0000-0002-5907-6160	Mediterranean Office for Youth [2011/026/01]	Mediterranean Office for Youth	The travel fund granted (grant no 2011/026/01) to VR by the Mediterranean Office for Youth (organisation no longer active) is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MS, 2010, COMPUT METHOD BIOMEC, V13, P171, DOI 10.1080/10255840903067080; Andersen MS, 2009, COMPUT METHOD BIOMEC, V12, P371, DOI 10.1080/10255840802459412; Andersen MS, 2010, J BIOMECH, V43, P268, DOI 10.1016/j.jbiomech.2009.08.034; Bergamini E, 2011, GAIT POSTURE, V33, P706, DOI 10.1016/j.gaitpost.2011.03.006; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bolsterlee B, 2014, MED BIOL ENG COMPUT, V52, P283, DOI 10.1007/s11517-013-1065-2; Bonci T, 2015, J BIOMECH, V48, P4166, DOI 10.1016/j.jbiomech.2015.10.031; Caplan N, 2014, THE JOURNAL OF BONE, V58, P137, DOI [10.1007/978-1-4471-5451-8_33, DOI 10.1007/978-1-4471-5451-8_33]; Charbonnier C, 2014, ORTHOP TRAUMATOL-SUR, V100, P715, DOI 10.1016/j.otsr.2014.06.015; Clement J, 2014, COMPUT METHOD BIOMEC, V17, P76, DOI 10.1080/10255842.2014.931141; Clement J, 2015, J BIOMECH, V48, P3796, DOI 10.1016/j.jbiomech.2015.09.040; DEJALON JG, 1994, NATO ADV SCI INST SE, V268, P285; Dumas R, 2007, MED BIOL ENG COMPUT, V45, P315, DOI 10.1007/s11517-006-0156-8; Dumas R, 2012, Comput Methods Biomech Biomed Engin, V15 Suppl 1, P183; Duprey S, 2010, J BIOMECH, V43, P2858, DOI 10.1016/j.jbiomech.2010.06.010; El Habachi A, 2015, MED BIOL ENG COMPUT, V53, P655, DOI 10.1007/s11517-015-1269-8; Fox RJ, 1998, AM J SPORT MED, V26, P395, DOI 10.1177/03635465980260030901; Freeman MAR, 2005, J BIOMECH, V38, P197, DOI 10.1016/j.jbiomech.2004.02.006; Fujie H, 2004, J BIOMECH ENG-T ASME, V126, P54, DOI 10.1115/1.1644567; Garling EH, 2007, J BIOMECH, V40, pS18, DOI 10.1016/j.jbiomech.2007.03.003; Gasparutto X, 2015, J BIOMECH, V48, P1141, DOI 10.1016/j.jbiomech.2015.01.010; Hagemeister N, 2011, COMPUT METHOD BIOMEC, V14, P755, DOI 10.1080/10255842.2010.493887; Hsieh HJ, 2015, BIOMED ENG IN PRESS; Kanamori A, 2000, ARTHROSCOPY, V16, P633, DOI 10.1053/jars.2000.7682; Koell P, 2010, COMPUT METHOD BIOMEC, V13, P79, DOI 10.1080/10255842.2010.493731; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; Lamberto G, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4033480; LATASH ML, 1993, HUM MOVEMENT SCI, V12, P653, DOI 10.1016/0167-9457(93)90010-M; Lenhart RL, 2015, ANN BIOMED ENG, V43, P2675, DOI 10.1007/s10439-015-1326-3; Li K, 2012, J BIOMECH, V45, P2719, DOI 10.1016/j.jbiomech.2012.08.007; LOCH DA, 1992, J BIOMECH, V25, P81, DOI 10.1016/0021-9290(92)90247-X; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Marin F, 2010, CLIN BIOMECH, V25, P389, DOI 10.1016/j.clinbiomech.2010.02.004; Marouane H, 2015, COMPUT METHOD BIOMEC, V18, P339, DOI 10.1080/10255842.2013.795555; Martelli S, 2015, COMPUT METHOD BIOMEC, V18, P1555, DOI 10.1080/10255842.2014.930134; McLaughlin P, 2013, J BIOMECH, V46, P2757, DOI 10.1016/j.jbiomech.2013.08.015; Moniz-Pereira V, 2014, J APPL BIOMECH, V30, P446, DOI 10.1123/jab.2013-0105; Sandholm A, 2011, VISUAL COMPUT, V27, P161, DOI 10.1007/s00371-010-0538-7; Scheys L, 2011, GAIT POSTURE, V33, P158, DOI 10.1016/j.gaitpost.2010.11.003; Sholukha V, 2006, J BIOMECH, V39, P2087, DOI 10.1016/j.jbiomech.2005.06.014; Stagni R, 2009, GAIT POSTURE, V29, P119, DOI 10.1016/j.gaitpost.2008.07.008; Tsai TY, 2011, J BIOMECH, V44, P1182, DOI 10.1016/j.jbiomech.2011.01.009; Valente G, 2015, J BIOMECH, V48, P4198, DOI 10.1016/j.jbiomech.2015.09.042; Valente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112625; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	47	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157010	10.1371/journal.pone.0157010	http://dx.doi.org/10.1371/journal.pone.0157010			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314586	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000378030000007
J	Basa, RCB; Davies, V; Li, XX; Murali, B; Shah, J; Yang, B; Li, S; Khan, MW; Tian, MX; Tejada, R; Hassan, A; Washington, A; Mukherjee, B; Carethers, JM; McGuire, KL				Basa, Ranor C. B.; Davies, Vince; Li, Xiaoxiao; Murali, Bhavya; Shah, Jinel; Yang, Bing; Li, Shi; Khan, Mohammad W.; Tian, Mengxi; Tejada, Ruth; Hassan, Avan; Washington, Allen, Jr.; Mukherjee, Bhramar; Carethers, John M.; McGuire, Kathleen L.			Decreased Anti-Tumor Cytotoxic Immunity among Microsatellite-Stable Colon Cancers from African Americans	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; ADAPTIVE IMMUNITY; PROGNOSTIC-FACTOR; DIETARY PATTERNS; PROSTATE-CANCER; T-CELLS; INSTABILITY; EXPRESSION; IMMUNOSURVEILLANCE; SUPPRESSION	Colorectal cancer is a leading cause of cancer related deaths in the U.S., with African-Americans having higher incidence and mortality rates than Caucasian-Americans. Recent studies have demonstrated that anti-tumor cytotoxic T lymphocytes provide protection to patients with colon cancer while patients deficient in these responses have significantly worse prognosis. To determine if differences in cytotoxic immunity might play a role in racial disparities in colorectal cancer 258 microsatellite-stable colon tumors were examined for infiltrating immune biomarkers via immunohistochemistry. Descriptive summary statistics were calculated using two-sample Wilcoxon rank sum tests, while linear regression models with log-transformed data were used to assess differences in race and Pearson and Spearman correlations were used to correlate different biomarkers. The association between different biomarkers was also assessed using linear regression after adjusting for covariates. No significant differences were observed in CD8(+) (p = 0.83), CD57(+) (p = 0.55), and IL-17-expressing (p = 0.63) cell numbers within the tumor samples tested. When infiltration of granzyme B+ cells was analyzed, however, a significant difference was observed, with African Americans having lower infiltration of cells expressing this cytotoxic marker than Caucasians (p<0.01). Analysis of infiltrating granzyme B+ cells at the invasive borders of the tumor revealed an even greater difference by race (p<0.001). Taken together, the data presented suggest differences in anti-tumor immune cytotoxicity may be a contributing factor in the racial disparities observed in colorectal cancer.	[Basa, Ranor C. B.; Davies, Vince; Li, Xiaoxiao; Murali, Bhavya; Shah, Jinel; Yang, Bing; Khan, Mohammad W.; Tian, Mengxi; Tejada, Ruth; Hassan, Avan; Washington, Allen, Jr.; McGuire, Kathleen L.] San Diego State Univ, Dept Biol, Inst Mol Biol, San Diego, CA 92182 USA; [Li, Shi; Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Carethers, John M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	California State University System; San Diego State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	McGuire, KL (corresponding author), San Diego State Univ, Dept Biol, Inst Mol Biol, San Diego, CA 92182 USA.	kmcguire@mail.sdsu.edu		Basa, Ranor/0000-0001-8412-8770; Washington, Allen/0000-0002-5382-6899	National Cancer Institute [U54CA132384, U54CA132379, U01CA162147, CA156608]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK067287]; National Science Foundation; CSU LSAMP Senior Alliance [HRD-0802628]; National Institute of General Medical Sciences; Minority Access to Research Career [T34GM08303]; NATIONAL CANCER INSTITUTE [U54CA132379, R01CA206010, U01CA162147, U54CA132384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008303] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); CSU LSAMP Senior Alliance; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Minority Access to Research Career; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Cancer Institute, www.cancer.gov, U54CA132384, U54CA132379, U01CA162147 (JMC KLM), CA156608 (BM); National Institute of Diabetes and Digestive and Kidney Diseases R01DK067287 (JMC); National Science Foundation, http://www.nsf.gov/, CSU LSAMP Senior Alliance (RT AH) funded by Grant HRD-0802628; and National Institute of General Medical Sciences, https://www.nigms.nih.gov/Pages/default.aspx, Minority Access to Research Career funding (AW) grant T34GM08303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2005, AM J GASTROENTEROL, V100, P515, DOI 10.1111/j.1572-0241.2005.41829.x; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Carethers JM, 2005, NAT CLIN PRACT GASTR, V2, P352, DOI 10.1038/ncpgasthep0241; Carethers JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100461; Chaput N, 2013, BRIT J CANCER, V109, P1013, DOI 10.1038/bjc.2013.362; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Chiba T, 2004, BRIT J CANCER, V91, P1711, DOI 10.1038/sj.bjc.6602201; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; de la Cruz-Merino L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/174149; Diaz LA, 2015, NEW ENGL J MED, V373, P1979, DOI 10.1056/NEJMc1510353; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Fridman WH, 2011, CURR TOP MICROBIOL, V344, P1, DOI 10.1007/82_2010_46; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Grizzi F, 2013, WORLD J GASTROENTERO, V19, P174, DOI 10.3748/wjg.v19.i2.174; Jovov B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030168; Kinseth MA, 2014, INT J CANCER, V134, P81, DOI 10.1002/ijc.28326; LANIER LL, 1983, J IMMUNOL, V131, P1789; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Maniati E, 2010, ONCOGENE, V29, P5653, DOI 10.1038/onc.2010.367; Menon AG, 2004, LAB INVEST, V84, P493, DOI 10.1038/labinvest.3700055; Michael-Robinson JM, 2001, GUT, V48, P360, DOI 10.1136/gut.48.3.360; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Naito Y, 1998, CANCER RES, V58, P3491; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2008, J LEUKOCYTE BIOL, V84, P981, DOI 10.1189/jlb.1107773; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Satia JA, 2009, NUTR CANCER, V61, P179, DOI 10.1080/01635580802419806; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Susanto O, 2012, TISSUE ANTIGENS, V80, P477, DOI 10.1111/tan.12014; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Williams CD, 2009, CANCER EPIDEM BIOMAR, V18, P1552, DOI 10.1158/1055-9965.EPI-08-1146; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	37	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156660	10.1371/journal.pone.0156660	http://dx.doi.org/10.1371/journal.pone.0156660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310868	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800011
J	Hinojosa, IA; Green, BS; Gardner, C; Hesse, J; Stanley, JA; Jeffs, AG				Hinojosa, Ivan A.; Green, Bridget S.; Gardner, Caleb; Hesse, Jan; Stanley, Jenni A.; Jeffs, Andrew G.			Reef Sound as an Orientation Cue for Shoreward Migration by Pueruli of the Rock Lobster, Jasus edwardsii	PLOS ONE			English	Article							SPINY LOBSTER; NEW-ZEALAND; UNDERWATER SOUND; PANULIRUS-ARGUS; POPULATION CONNECTIVITY; ANTENNAL RECEPTORS; SWIMMING BEHAVIOR; FISH LARVAE; IN-SITU; SETTLEMENT	The post-larval or puerulus stage of spiny, or rock, lobsters (Palinuridae) swim many kilometres from open oceans into coastal waters where they subsequently settle. The orientation cues used by the puerulus for this migration are unclear, but are presumed to be critical to finding a place to settle. Understanding this process may help explain the biological processes of dispersal and settlement, and be useful for developing realistic dispersal models. In this study, we examined the use of reef sound as an orientation cue by the puerulus stage of the southern rock lobster, Jasus edwardsii. Experiments were conducted using in situ binary choice chambers together with replayed recording of underwater reef sound. The experiment was conducted in a sandy lagoon under varying wind conditions. A significant proportion of puerulus (69%) swam towards the reef sound in calm wind conditions. However, in windy conditions (> 25 m s(-1)) the orientation behaviour appeared to be less consistent with the inclusion of these results, reducing the overall proportion of pueruli that swam towards the reef sound (59.3%). These results resolve previous speculation that underwater reef sound is used as an orientation cue in the shoreward migration of the puerulus of spiny lobsters, and suggest that sea surface winds may moderate the ability of migrating pueruli to use this cue to locate coastal reef habitat to settle. Underwater sound may increase the chance of successful settlement and survival of this valuable species.	[Hinojosa, Ivan A.; Green, Bridget S.; Gardner, Caleb] Univ Tasmania, Inst Marine & Antarct Studies, Taroona, Tasmania 7053, Australia; [Hinojosa, Ivan A.] Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Coquimbo, Chile; [Hinojosa, Ivan A.] Millennium Nucl Ecol & Sustainable Management Oce, Coquimbo, Chile; [Hesse, Jan; Stanley, Jenni A.; Jeffs, Andrew G.] Univ Auckland, Inst Marine Sci, Leigh Marine Lab, POB 349, Warkworth, New Zealand	University of Tasmania; Universidad Catolica del Norte; University of Auckland	Hinojosa, IA (corresponding author), Univ Tasmania, Inst Marine & Antarct Studies, Taroona, Tasmania 7053, Australia.; Hinojosa, IA (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Coquimbo, Chile.; Hinojosa, IA (corresponding author), Millennium Nucl Ecol & Sustainable Management Oce, Coquimbo, Chile.	Ivan.Hinojosa@utas.edu.au	Hinojosa, Ivan/P-1572-2016; Hinojosa, Ivan A./AAQ-7445-2020; Hinojosa, Ivan/ABC-8915-2021; Jeffs, Andrew G/D-9474-2012; Gardner, Caleb/I-7086-2013	Hinojosa, Ivan/0000-0002-9752-4374; Hinojosa, Ivan/0000-0002-9752-4374; Jeffs, Andrew/0000-0002-8504-1949; Gardner, Caleb/0000-0003-0324-4337	PhD scholarship BECAS-Chile programme; Australian Research Council [LP120200164]; ANZ Trustees programme "Holsworth Wildlife Research Endowment"; Australian Research Council's Industrial Transformation Research Hub funding scheme [IH 120100032]; Chilean Millennium Initiative grant [NC120030]	PhD scholarship BECAS-Chile programme; Australian Research Council(Australian Research Council); ANZ Trustees programme "Holsworth Wildlife Research Endowment"; Australian Research Council's Industrial Transformation Research Hub funding scheme(Australian Research Council); Chilean Millennium Initiative grant	Funding for this research has been provided by the PhD scholarship BECAS-Chile programme to I.A.H., the Australian Research Council Linkage project (project no. LP120200164) from B.S.G. and C.G., the ANZ Trustees programme "Holsworth Wildlife Research Endowment", the Australian Research Council's Industrial Transformation Research Hub funding scheme (project number IH 120100032) to A.J., and the Chilean Millennium Initiative grant (NC120030) to I.A.H.	Bates AE, 2014, NAT CLIM CHANGE, V4, P62, DOI 10.1038/NCLIMATE2062; Booth JD, 2000, MAR ECOL PROG SER, V200, P241, DOI 10.3354/meps200241; BOOTH JD, 1986, NEW ZEAL J MAR FRESH, V20, P291, DOI 10.1080/00288330.1986.9516150; Booth JD, 2001, MAR FRESHWATER RES, V52, P1055, DOI 10.1071/MF01089; BOOTH JD, 1989, NEW ZEAL J MAR FRESH, V23, P43, DOI 10.1080/00288330.1989.9516339; BOOTH JD, 1994, CRUSTACEANA, V66, P271, DOI 10.1163/156854094X00035; Booth JD, 2009, FISH RES, V95, P161, DOI 10.1016/j.fishres.2008.08.009; Bradford RW, 2015, MAR FRESHWATER RES, V66, P213, DOI 10.1071/MF14065; Cato DH, 2002, ACOUST AUST, V30, P1; Chiswell SM, 1999, MAR ECOL PROG SER, V183, P227, DOI 10.3354/meps183227; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Fitzgibbon QP, 2014, FISH FISH, V15, P312, DOI 10.1111/faf.12018; Gardner C, 2001, MAR FRESHWATER RES, V52, P1271, DOI 10.1071/MF01032; Goldstein JS, 2009, LIMNOL OCEANOGR, V54, P1669, DOI 10.4319/lo.2009.54.5.1669; Green BS, 2009, MAR BIOL, V156, P1941, DOI 10.1007/s00227-009-1226-x; Harrell F, RMS REGRESSION MODEL; HAYAKAWA Y, 1990, NIPPON SUISAN GAKK, V56, P1703; Hayakawa Y, 2002, FISHERIES SCI, V68, P393, DOI 10.2331/fishsci.68.sup1_393; Hinojosa IA, 2015, ICES J MAR SCI, V72, P59, DOI 10.1093/icesjms/fsu199; Hobday AJ, 2014, REV FISH BIOL FISHER, V24, P415, DOI 10.1007/s11160-013-9326-6; Igulu MM, 2013, MAR ECOL PROG SER, V493, P243, DOI 10.3354/meps10542; Jeffs A, 2003, MAR FRESHWATER RES, V54, P841, DOI 10.1071/MF03007; Jeffs A, 1997, MAR FRESHWATER RES, V48, P681, DOI 10.1071/MF97047; Jeffs AG, 2005, NEW ZEAL J MAR FRESH, V39, P605, DOI 10.1080/00288330.2005.9517339; Jeffs AG, 2001, MAR FRESHWATER RES, V52, P1211, DOI 10.1071/MF01182; Jeffs AG, 2000, CRUSTACEANA, V73, P847, DOI 10.1163/156854000504859; Jeffs AG, 1999, COMP BIOCHEM PHYS A, V123, P351, DOI 10.1016/S1095-6433(99)00073-2; Jeffs AG, 2013, LOBSTERS: BIOLOGY, MANAGEMENT, AQUACULTURE AND FISHERIES, 2ND EDITION, P259; Kingsford MJ, 2002, B MAR SCI, V70, P309; KNUDSEN VO, 1948, J MAR RES, V7, P410; Kough AS, 2014, MAR ECOL PROG SER, V504, P207, DOI 10.3354/meps10748; Kough AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064970; Kroodsma DE, 2001, ANIM BEHAV, V61, P1029, DOI 10.1006/anbe.2000.1676; Leis JM, 2002, MAR ECOL PROG SER, V232, P259, DOI 10.3354/meps232259; Linnane A, 2010, FISH OCEANOGR, V19, P290, DOI 10.1111/j.1365-2419.2010.00544.x; MACMILLAN DL, 1992, MAR BEHAV PHYSIOL, V19, P211, DOI 10.1080/10236249209378809; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Nedelec SL, 2015, MAR ECOL PROG SER, V524, P125, DOI 10.3354/meps11175; PHILLIPS BF, 1978, MAR BIOL, V45, P347, DOI 10.1007/BF00391821; PHILLIPS BF, 1987, J CRUSTACEAN BIOL, V7, P122, DOI 10.2307/1548631; Phillips BF, 2009, REV FISH BIOL FISHER, V19, P193, DOI 10.1007/s11160-008-9099-5; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Quinn GP, 2002, EXPERIMENTAL DESIGN; R Development Core Team, 2008, R A LANGUAGE AND ENV; Radford CA, 2014, MAR ECOL PROG SER, V505, P19, DOI 10.3354/meps10782; Radford CA, 2011, CORAL REEFS, V30, P295, DOI 10.1007/s00338-010-0710-6; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford C.A., 2008, BIOACOUSTICS, V17, P87, DOI [10.1080/09524622.2008.9753776, DOI 10.1080/09524622.2008.9753776]; Radford C, 2008, MAR ECOL PROG SER, V362, P37, DOI 10.3354/meps07444; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Radford CA, 2007, B MAR SCI, V80, P369; Radford CA, 2011, MAR ECOL PROG SER, V438, P167, DOI 10.3354/meps09312; Shears NT, 2008, ECOL APPL, V18, P1860, DOI 10.1890/07-1776.1; Simpson SD, 2008, ANIM BEHAV, V75, P1861, DOI 10.1016/j.anbehav.2007.11.004; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Staaterman E, 2014, ICES J MAR SCI, V71, P918, DOI 10.1093/icesjms/fst103; Staaterman E, 2012, J THEOR BIOL, V304, P188, DOI 10.1016/j.jtbi.2012.03.016; Stanley JA, 2015, OECOLOGIA, V178, P685, DOI 10.1007/s00442-015-3251-4; Stanley JA, 2012, P ROY SOC B-BIOL SCI, V279, P3622, DOI 10.1098/rspb.2012.0697; Stanley JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028572; Stanley JA, 2010, BEHAV ECOL, V21, P113, DOI 10.1093/beheco/arp159; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010660; Weiss HM, 2006, MAR TECHNOL SOC J, V40, P86, DOI 10.4031/002533206787353213; Wilkin JL., 2011, LIMNOLOGY OCEANOGRAP, V1, P163, DOI [10.1215/21573698-1504363, DOI 10.1215/21573698-1504363]	68	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157862	10.1371/journal.pone.0157862	http://dx.doi.org/10.1371/journal.pone.0157862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310676	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800140
J	Lamadrid-Figueroa, H; Montoya, A; Fritz, J; Olvera, M; Torres, LM; Lozano, R				Lamadrid-Figueroa, Hector; Montoya, Alejandra; Fritz, Jimena; Olvera, Marisela; Torres, Luis M.; Lozano, Rafael			Towards an Inclusive and Evidence-Based Definition of the Maternal Mortality Ratio: An Analysis of the Distribution of Time after Delivery of Maternal Deaths in Mexico, 2010-2013	PLOS ONE			English	Article								Progress towards the Millennium Development Goal No. 5 was measured by an indicator that excluded women who died due to pregnancy and childbirth after 42 days from the date of delivery. These women suffered from what are defined as late deaths and sequelae-related deaths (O96 and O97 respectively, according to the International Classification of Diseases, 10th revision). Such deaths end up not being part of the numerator in the calculation of the Maternal Mortality Ratio (MMR), the indicator that governments and international agencies use for reporting. The issue is not trivial since these deaths account for a sizeable fraction of all maternal deaths in the world and show an upward trend over time in many countries. The aim of this study was to analyze empirical data on maternal deaths that occurred between 2010 and 2013 in Mexico, linking databases of the Deliberate Search and Reclassification of Maternal Deaths (BIRMM) and the Birth Information Subsystem (SINAC) of the Ministry of Health. Data were analyzed by negative binomial regression, survival analysis and multiple cause analysis. While the reported MMR decreased by 5% per year between 2010 and 2013, the MMR due to late and sequelae-related deaths doubled from 3.5 to 7 per 100,000 live-births in 2013 (p < 0.01). A survival analysis of all maternal deaths revealed nothing particular around the 42 day threshold, other than the exclusion of 18% of women who died due to childbirth in 2013. The multiple cause analysis showed a strong association between the excluded deaths and obstetric causes. It is suggested to review the construction of the MMR to make it a more inclusive and dignified measurement of maternal mortality by including all deaths due to pregnancy and childbirth into the Maternal Death definition.	[Lamadrid-Figueroa, Hector; Montoya, Alejandra; Fritz, Jimena; Olvera, Marisela; Lozano, Rafael] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Lozano, Rafael] Inst Hlth Metr & Evaluat, Seattle, WA USA	Instituto Nacional de Salud Publica; Institute for Health Metrics & Evaluation	Lozano, R (corresponding author), Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.; Lozano, R (corresponding author), Inst Hlth Metr & Evaluat, Seattle, WA USA.	rafael.lozano@insp.mx	Lamadrid-Figueroa, Hector/ABD-5416-2021; Lozano, Rafael/T-5352-2018	Lamadrid-Figueroa, Hector/0000-0001-8775-8399; Lozano, Rafael/0000-0002-7356-8823; Fritz, Jimena/0000-0002-4157-5981				Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Belotti F, 2010, STATA J, V10, P458, DOI 10.1177/1536867X1001000310; Center for Disease Control and Prevention, REPR HLTH PREGN REL; Direccion General de Informacion In Salud Subsecretaria de Integracion y Desarrollo del Sector Salud Secretaria de Salud/Centro Mexicano para la Clasificacion de Enfermedades y Centro Colaborador para la Familia de Clasificaciones Internacionales de la OMS In Mexico (CEMECE), 2010, SUBS INT DES SECT SA; Fukuda-Parr S, 2010, SHOULD MDG IMPLEMENT, P63; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hogan MC, 2016, B WORLD HEALTH ORGAN, V94, P362, DOI 10.2471/BLT.15.163360; Hoj L, 2003, BJOG-INT J OBSTET GY, V110, P995, DOI 10.1016/S1470-0328(03)03907-7; Horon IL, 2011, PUBLIC HEALTH REP, V126, P195, DOI 10.1177/003335491112600210; ISRAEL RA, 1986, AM J EPIDEMIOL, V124, P161, DOI 10.1093/oxfordjournals.aje.a114375; Johnson S, 2014, MATERNAL DEATHS SERI, V4; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Lewis G, 2011, BJOG S1, V118; Lu MC, 2015, MATERN CHILD HLTH J, V19, P1435, DOI 10.1007/s10995-015-1665-6; Torres LM, 2014, SALUD PUBLICA MEXICO, V56, P333; National Collaborating Centre for Women's and Children's Health (UK), 2010, HYP PREGN MAN HYP DI, P4; Pattinson R., 2011, 10 CEP HLTH NAT COMM; Redelings MD, 2007, AM J EPIDEMIOL, V166, P104, DOI 10.1093/aje/kwm037; Saucedo M, 2013, OBSTET GYNECOL, V122, P752, DOI 10.1097/AOG.0b013e31829fc38c; Secretaria de Salud, 2012, SUBS INT DES SECT SA; Sharma BR, 2009, J FORENSIC LEG MED, V16, P233, DOI 10.1016/j.jflm.2008.12.005; Storeng KT, 2012, B WORLD HEALTH ORGAN, V90, P418, DOI 10.2471/BLT.11.094011; UN, 2015, MILLENNIUM DEV GOALS; United Nations, 2003, DEV GROUP IND MON MI; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2004, INT STAT CLASS DIS R, V2; Yamin AE, 2014, J HUMAN DEV CAPABILI, V15	28	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157495	10.1371/journal.pone.0157495	http://dx.doi.org/10.1371/journal.pone.0157495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310260	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800085
J	Mameli, G; Arru, G; Caggiu, E; Niegowska, M; Leoni, S; Madeddu, G; Babudieri, S; Sechi, GP; Sechi, LA				Mameli, Giuseppe; Arru, Giannina; Caggiu, Elisa; Niegowska, Magdalena; Leoni, Stefania; Madeddu, Giordano; Babudieri, Sergio; Sechi, Gian Pietro; Sechi, Leonardo A.			Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS PATIENTS; EPSTEIN-BARR-VIRUS; MESSENGER-RNAS; UP-REGULATION; MICRORNA; DIFFERENTIATION; MIRNA; PATHOGENESIS; MIR-326	MicroRNAs fine-tune the regulation of Th1/Th17 lymphocyte subsets in multiple sclerosis. We investigated the expression of miRNAs (previously associated with mycobacterial and viral infections) in MS patients and healthy donors (HD) following 6 months natalizumab therapy. In addition, Th1/Th17 cytokines and the presence of anti-EBNA1/VCA IgG in MS patients with different pattern of miRNA expression have been evaluated. MiR-155, miR-26a, miR-132, miR-146a and Th1/Th17 cytokines expression was detected by RT-real time PCR; moreover anti-EBNA1 and VCA IgG titres were measured by ELISA. We observed an up-regulation of miR-155 (p value = 0.009) and miR-132 (p value = 0.04) in MS patients compared to HD. In MS patients, IL-17a (p = 0.037), IFN gamma (p = 0.012) and TNF alpha (p = 0.015) but not IL-6 were over-expressed compared to HD. Two different miRNAs patterns associated to the expression of different cytokines were observed in the MS cohort. Moreover, a down-regulation of miR-155 and miR-26a was seen in MS patients during and after natalizumab therapy. MS patients that over-expressed miR-155 showed a higher EBNA1 IgG titer than MS patients with high levels of miR-26a. In conclusions the expression of particular miRNAs modulates the pro-inflammatory cytokine expression and the humoral response against EBV and this expression is natalizumab regulated.	[Mameli, Giuseppe; Caggiu, Elisa; Niegowska, Magdalena; Sechi, Leonardo A.] Univ Sassari, Dept Med Sci, I-07100 Sassari, Italy; [Arru, Giannina; Leoni, Stefania; Madeddu, Giordano; Babudieri, Sergio; Sechi, Gian Pietro] Univ Sassari, Dept Expt Med, I-07100 Sassari, Italy	University of Sassari; University of Sassari	Sechi, LA (corresponding author), Univ Sassari, Dept Med Sci, I-07100 Sassari, Italy.	sechila@uniss.it	MADEDDU, Giordano/AAP-4342-2020; Sechi, Leonardo Antonio/Y-3109-2018	MADEDDU, Giordano/0000-0001-6099-2273; BABUDIERI, SERGIO/0000-0001-7291-8687; mameli, giuseppe/0000-0002-0286-5433	Sardinian Region [LR7 2010 CRP 25160]; FISM [2013/R/15]	Sardinian Region(Regione Sardegna); FISM(Fondazione Italiana Sclerosi Multipla (FISM))	This work was supported by the Sardinian Region Grant LR7 2010 CRP 25160, FISM (grant number Cod. 2013/R/15).	Arru G, 2015, J NEUROL SCI, V357, P106, DOI 10.1016/j.jns.2015.07.007; Castellazzi M, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/901312; Cossu D, 2015, MULT SCLER J, V21, P984, DOI 10.1177/1352458514557304; Devier DJ, 2015, FRONT MOL NEUROSCI, V8, DOI [10.3389/fnmol.2015.00005, 10.3389/fnmo1.2015.00005]; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Figueredo DD, 2015, BLOOD CELL MOL DIS, V54, P364, DOI 10.1016/j.bcmd.2015.01.004; Gandhi R, 2015, MULT SCLER J, V21, P1095, DOI 10.1177/1352458515578771; Ha JS, 2015, ANN CLIN LAB SCI, V45, P308; Honardoost MA, 2015, GENE, V572, P153, DOI 10.1016/j.gene.2015.08.043; Honardoost MA, 2014, GENE, V544, P128, DOI 10.1016/j.gene.2014.04.069; Ingwersen J, 2015, ANN CLIN TRANSL NEUR, V2, P43, DOI 10.1002/acn3.152; Khan D, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00236; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Ma XT, 2014, INT J MED SCI, V11, P810, DOI 10.7150/ijms.8647; Mameli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044991; Martinez NE, 2015, BRAIN BEHAV IMMUN, V43, P86, DOI 10.1016/j.bbi.2014.07.008; Meira M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/897249; Miyazaki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105421; Moore CS, 2013, ANN NEUROL, V74, P709, DOI 10.1002/ana.23967; Motawi TMK, 2016, GENE, V590, P210, DOI 10.1016/j.gene.2016.01.042; Munoz-Culla M, 2014, MULT SCLER J, V20, P1851, DOI 10.1177/1352458514534513; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Otenio CCM, 2012, GENET MOL RES, V11, P4468, DOI 10.4238/2012.September.20.3; Oussaief L, 2015, J VIROL, V89, P12178, DOI 10.1128/JVI.01757-15; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ransohoff RM, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.14; Rice J, 2015, SURGERY, V158, P1345, DOI 10.1016/j.surg.2015.04.025; Shi Y, 2010, SCAND J IMMUNOL, V72, P250, DOI 10.1111/j.1365-3083.2010.02425.x; Waschbisch A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024604; Yoon C, 2015, TUMOUR BIOL; Zhang J, MICRORNA 155 MODULAT; Zhang J, 2014, J NEUROIMMUNOL, V266, P56, DOI 10.1016/j.jneuroim.2013.09.019; Zhou X, 2009, GENETICA, V137, P159, DOI 10.1007/s10709-009-9378-7; Zhu XW, 2014, EUR ARCH OTO-RHINO-L, V271, P1939, DOI 10.1007/s00405-013-2818-0	36	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157153	10.1371/journal.pone.0157153	http://dx.doi.org/10.1371/journal.pone.0157153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310932	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800037
J	Muneer, S; Ko, CH; Wei, H; Chen, YZ; Jeong, BR				Muneer, Sowbiya; Ko, Chung Ho; Wei, Hao; Chen, Yuze; Jeong, Byoung Ryong			Physiological and Proteomic Investigations to Study the Response of Tomato Graft Unions under Temperature Stress	PLOS ONE			English	Article							HEAT-STRESS; ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; SALT STRESS; TOLERANCE; PROTEINS; ROOTSTOCKS; PLANTS; CELLS; ACCUMULATION	Background Grafting is an established practice for asexual propagation in horticultural and agricultural crops. The study on graft unions has become of interest for horticulturists using proteomic and genomic techniques to observe transfer of genetic material and signal transduction pathways from root to shoot and shoot to root. Another reason to study the graft unions was potentially to observe resistance against abiotic stresses. Using physiological and proteomic analyses, we investigated graft unions (rootstock and scions) of tomato genotypes exposed to standard-normal (23/23 and 25/18 degrees C day/night) and high-low temperatures (30/15 degrees C day/night). Results Graft unions had varied responses to the diverse temperatures. High-low temperature, but not standard-normal temperature, induced the production of reactive oxygen species (ROS) in the form of H2O2 and O-2(-1) in rootstock and scions. However, the expression of many cell protection molecules was also induced, including antioxidant enzymes and their immunoblots, which also show an increase in their activities such as superoxide dismutase (SOD), catalase (CAT), and ascorbate peroxidase (APX). The graft interfaces thus actively defend against stress by modifying their physiological and proteomic responses to establish a new cellular homeostasis. As a result, many proteins for cellular defense were regulated in graft unions under diverse temperature, in addition to the regulation of photosynthetic proteins, ion binding/transport proteins, and protein synthesis. Moreover, biomass, hardness, and vascular transport activity were evaluated to investigate the basic connectivity between rootstock and scions. Conclusions Our study provides physiological evidence of the grafted plants' response to diverse temperature. Most notably, our study provides novel insight into the mechanisms used to adapt the diverse temperature in graft unions (rootstock/scion).	[Muneer, Sowbiya; Ko, Chung Ho; Wei, Hao; Chen, Yuze; Jeong, Byoung Ryong] Gyeongsang Natl Univ, Div Appl Life Sci Plus BK21, Jinju 660701, South Korea; [Jeong, Byoung Ryong] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea; [Jeong, Byoung Ryong] Gyeongsang Natl Univ, Life Sci Res Inst, Jinju 660701, South Korea; [Ko, Chung Ho] Korea Natl Arboretum, Useful Plant Resource Ctr, 21-4 Dudam Gil, Yangpyeong Gun 12519, Gyeonggi Do, South Korea; [Chen, Yuze] Solar Energy Base, Qingdao 266234, Shandong, Peoples R China	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Korea National Arboretum	Jeong, BR (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci Plus BK21, Jinju 660701, South Korea.; Jeong, BR (corresponding author), Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea.; Jeong, BR (corresponding author), Gyeongsang Natl Univ, Life Sci Res Inst, Jinju 660701, South Korea.	brjeong@gnu.ac.kr	Muneer, Sowbiya/S-5382-2019; Jeong, Byoung Ryong/D-7667-2014; Wei, Hao/AAD-4222-2019	Jeong, Byoung Ryong/0000-0002-4146-7278; Muneer, Sowbiya/0000-0003-0230-772X	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture Forestry and Fisheries [312034-04]; BK21 program, Ministry of Education, Korea	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture Forestry and Fisheries(Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea); BK21 program, Ministry of Education, Korea(Ministry of Education (MOE), Republic of Korea)	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture Forestry and Fisheries (Project No. 312034-04). SM, CHK, HW and YC were supported by a scholarship from BK21 program, Ministry of Education, Korea.	Aebi H, 1984, Methods Enzymol, V105, P121; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bai XG, 2011, J PROTEOME RES, V10, P4349, DOI 10.1021/pr200333f; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Beltran-Pena E, 2002, PHYSIOL PLANTARUM, V115, P291, DOI 10.1034/j.1399-3054.2002.1150216.x; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Cookson SJ, 2014, J EXP BOT, V65, P2473, DOI 10.1093/jxb/eru145; Cookson SJ, 2013, J EXP BOT, V64, P2997, DOI 10.1093/jxb/ert144; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Ercolano MR, 2012, PLANT CELL REP, V31, P973, DOI 10.1007/s00299-012-1234-z; Estan MT, 2005, J EXP BOT, V56, P703, DOI 10.1093/jxb/eri027; Fernandez-Garcia N, 2004, ANN BOT-LONDON, V93, P53, DOI 10.1093/aob/mch014; Flaishman MA, 2008, J PLANT GROWTH REGUL, V27, P231, DOI 10.1007/s00344-008-9050-y; Flanagan LB, 2005, AGR FOREST METEOROL, V130, P237, DOI 10.1016/j.agrformet.2005.04.002; Fuentes I, 2014, NATURE, V511, P232, DOI 10.1038/nature13291; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Herald VL, 2003, FEBS LETT, V537, P96, DOI 10.1016/S0014-5793(03)00101-7; Howarth CJ., 2005, ABIOTIC STRESSES PLA, P277, DOI DOI 10.1201/9781482293609-18; Irisarri P, 2015, J PLANT PHYSIOL, V176, P25, DOI 10.1016/j.jplph.2014.10.015; Kim KY, 2004, J EXP BOT, V55, P1153, DOI 10.1093/jxb/erh125; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; KOLLMANN R, 1985, PROTOPLASMA, V124, P224, DOI 10.1007/BF01290774; Kumari A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124438; Lee DG, 2007, PROTEOMICS, V7, P3369, DOI 10.1002/pmic.200700266; Li W, 2011, J PLANT PHYSIOL, V168, P1743, DOI 10.1016/j.jplph.2011.03.018; Li WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082725; Li X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107605; Liu TX, 2013, ACTA PHYSIOL PLANT, V35, P501, DOI 10.1007/s11738-012-1092-x; Liu YW, 2014, IJC HEART VASC, V5, P1, DOI 10.1016/j.ijcha.2014.10.016; Majoul T, 2004, PROTEOMICS, V4, P505, DOI 10.1002/pmic.200300570; Milien M, 2012, SCI HORTIC-AMSTERDAM, V144, P130, DOI 10.1016/j.scienta.2012.06.045; Molassiotis AN, 2005, PLANT GROWTH REGUL, V46, P69, DOI 10.1007/s10725-005-6396-z; Muneer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120899; Muneer S, 2012, PLANT GROWTH REGUL, V68, P421, DOI 10.1007/s10725-012-9731-1; Muneer S, 2012, PLANT OMICS, V5, P167; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Neilson KA, 2010, PROTEOMICS, V10, P828, DOI 10.1002/pmic.200900538; Olmstead MA, 2006, J AM SOC HORTIC SCI, V131, P577, DOI 10.21273/JASHS.131.5.577; Prassinos C, 2009, TREE PHYSIOL, V29, P927, DOI 10.1093/treephys/tpp027; Rivard CL, 2008, HORTSCIENCE, V43, P2104, DOI 10.21273/HORTSCI.43.7.2104; Rivero RM, 2001, PLANT SCI, V160, P315, DOI 10.1016/S0168-9452(00)00395-2; Rocco M, 2006, PROTEOMICS, V6, P3781, DOI 10.1002/pmic.200600128; Rodriguez M., 2005, BIOTECNOL APL, V22, P1, DOI DOI 10.1007/S00284-005-4515-8; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Shabala S, 2010, PLANT J, V61, P839, DOI 10.1111/j.1365-313X.2009.04110.x; Siguenza C, 2005, J NEMATOL, V37, P276; SOUMELIDOU K, 1994, ANN BOT-LONDON, V74, P605, DOI 10.1006/anbo.1994.1161; Stegemann S, 2009, SCIENCE, V324, P649, DOI 10.1126/science.1170397; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Vitale A, 2014, PLANT PHYSIOL BIOCH, V83, P207, DOI 10.1016/j.plaphy.2014.08.006; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang H, 2006, J EXP BOT, V57, P827, DOI 10.1093/jxb/erj066; Xing WW, 2015, PLANT PHYSIOL BIOCH, V87, P124, DOI 10.1016/j.plaphy.2014.12.011; Yin H, 2012, J EXP BOT, V63, P4219, DOI 10.1093/jxb/ers109; Yuan K, 2011, AFR J BIOTECHNOL, V10, P14816, DOI 10.5897/AJB11.1844; Zhao FG, 2007, PLANT PHYSIOL, V145, P1061, DOI 10.1104/pp.107.105882; Zheng BS, 2010, TREE PHYSIOL, V30, P297, DOI 10.1093/treephys/tpp102; Zhou YH, 2009, J PLANT RES, V122, P529, DOI 10.1007/s10265-009-0247-3; Zhu YH, 2013, INT J MOL SCI, V14, P20614, DOI 10.3390/ijms141020614	60	24	26	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157439	10.1371/journal.pone.0157439	http://dx.doi.org/10.1371/journal.pone.0157439			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310261	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800072
J	Peralta, DR; Adler, C; Corbalan, NS; Garcia, ECP; Pomares, MF; Vincent, PA				Peralta, Daiana R.; Adler, Conrado; Corbalan, Natalia S.; Paz Garcia, Enrique Carlos; Fernanda Pomares, Maria; Vincent, Paula A.			Enterobactin as Part of the Oxidative Stress Response Repertoire	PLOS ONE			English	Article							ESCHERICHIA-COLI; SMALL RNA; IRON-METABOLISM; CATECHOLATE SIDEROPHORES; BACTERIAL SIDEROPHORES; AZOTOBACTER-VINELANDII; PEROXIDE STRESS; E. COLI; PROMOTER; GENES	Microorganisms produce siderophores to facilitate iron uptake and even though this trait has been extensively studied, there is growing evidence suggesting that siderophores may have other physiological roles aside from iron acquisition. In support of this notion, we previously linked the archetypal siderophore enterobactin with oxidative stress alleviation. To further characterize this association, we studied the sensitivity of Escherichia coli strains lacking different components of the enterobactin system to the classical oxidative stressors hydrogen peroxide and paraquat. We observed that strains impaired in enterobactin production, uptake and hydrolysis were more susceptible to the oxidative damage caused by both compounds than the wild-type strain. In addition, meanwhile iron supplementation had little impact on the sensitivity, the reducing agent ascorbic acid alleviated the oxidative stress and therefore significantly decreased the sensitivity to the stressors. This indicated that the enterobactin-mediated protection is independent of its ability to scavenge iron. Furthermore, enterobactin supplementation conferred resistance to the entE mutant but did not have any protective effect on the fepG and fes mutants. Thus, we inferred that only after enterobactin is hydrolysed by Fes in the cell cytoplasm and iron is released, the free hydroxyl groups are available for radical stabilization. This hypothesis was validated testing the ability of enterobactin to scavenge radicals in vitro. Given the strong connection between enterobactin and oxidative stress, we studied the transcription of the entE gene and the concomitant production of the siderophore in response to such kind of stress. Interestingly, we observed that meanwhile iron represses the expression and production of the siderophore, hydrogen peroxide and paraquat favour these events even if iron is present. Our results support the involvement of enterobactin as part of the oxidative stress response and highlight the existence of a novel regulation mechanism for enterobactin biosynthesis.	[Fernanda Pomares, Maria; Vincent, Paula A.] CONICET UNT, Inst Super Invest Biol INSIBIO, UNT Chacabuco 461,T4000ILI San Miguel Tucuman, San Miguel De Tucuman, Argentina; Inst Quim Biol Dr Bernabe Bloj, Fac Bioquim quim & Farmacia, UNT Chacabuco 461,T4000ILI San Miguel Tucuman, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Pomares, MF; Vincent, PA (corresponding author), CONICET UNT, Inst Super Invest Biol INSIBIO, UNT Chacabuco 461,T4000ILI San Miguel Tucuman, San Miguel De Tucuman, Argentina.	fpomares@fbqf.unt.edu.ar; pvincent@fbqf.unt.edu.ar		Corbalan, Natalia/0000-0002-3588-3099	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1939, 2222, 2991]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 0972]; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was funded by grants PICT 1939, 2222 and 2991 from the Agencia Nacional de Promocion Cientifica y Tecnologica, PIP 0972 from the Consejo Nacional de Investigaciones Cientificas y Tecnicas. DRP was recipient of a fellowship from CONICET. ECPG is CONICET CPA. CA, NSC, MFP and PAV are Career Investigators from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard MES, 2013, BIOCHEM J, V454, P543, DOI 10.1042/BJ20121771; Adler C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084734; Adler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046754; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arnow LE, 1937, J BIOL CHEM, V118, P531; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; BRICKMAN TJ, 1992, J BIOL CHEM, V267, P12350; BRICKMAN TJ, 1990, J MOL BIOL, V212, P669, DOI 10.1016/0022-2836(90)90229-F; Christoffersen CA, 2001, J BACTERIOL, V183, P2059, DOI 10.1128/JB.183.6.2059-2070.2001; COFFMAN TJ, 1990, J CLIN INVEST, V86, P1030, DOI 10.1172/JCI114805; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Cornish AS, 1998, MICROBIOL-UK, V144, P1747, DOI 10.1099/00221287-144-7-1747; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Furrer JL, 2002, MOL MICROBIOL, V44, P1225, DOI 10.1046/j.1365-2958.2002.02885.x; Gerstle K, 2012, RNA BIOL, V9, P458, DOI 10.4161/rna.19065; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; HUNT MD, 1994, J BACTERIOL, V176, P3944, DOI 10.1128/JB.176.13.3944-3955.1994; Johnstone TC, 2015, DALTON T, V44, P6320, DOI 10.1039/c4dt03559c; Kim J, 2015, APPL MICROBIOL BIOT, V99, P10611, DOI 10.1007/s00253-015-6914-5; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020777; Ma L, 2012, J BACTERIOL, V194, P6748, DOI 10.1128/JB.01574-12; Manchado M, 2000, J BACTERIOL, V182, P6842, DOI 10.1128/JB.182.23.6842-6844.2000; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Miller J.H., 1992, SHORT COURSE BACTERI, P150; OBRIEN IG, 1971, BIOCHIM BIOPHYS ACTA, V237, P537, DOI 10.1016/0304-4165(71)90274-1; Paauw A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008240; Povie G, 2010, CHEM COMMUN, V46, P803, DOI 10.1039/b917004a; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Reeder BJ, 2005, CHEM RES TOXICOL, V18, P1004, DOI 10.1021/tx049660y; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; Salvail H, 2013, EMBO J, V32, P2764, DOI 10.1038/emboj.2013.205; Salvail H, 2010, P NATL ACAD SCI USA, V107, P15223, DOI 10.1073/pnas.1007805107; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Singh V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8113; Soballe B, 2000, MICROBIOL-SGM, V146, P787, DOI 10.1099/00221287-146-4-787; Tindale AE, 2000, MICROBIOL-SGM, V146, P1617, DOI 10.1099/00221287-146-7-1617; Troxell B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00059; WINKELMANN G, 1994, BIOMETALS, V7, P149; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998	47	56	56	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157799	10.1371/journal.pone.0157799	http://dx.doi.org/10.1371/journal.pone.0157799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310257	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800137
J	Santos, V; Hirshfield, I				Santos, Victor; Hirshfield, Irvin			The Physiological and Molecular Characterization of a Small Colony Variant of Escherichia coli and Its Phenotypic Rescue	PLOS ONE			English	Article							CYCLOPROPANE FATTY-ACIDS; STAPHYLOCOCCUS-AUREUS; RESISTANCE; PERSISTENT; RECOVERY; O-2	Small colony variants (SCVs) can be defined as a naturally occurring sub-population of bacteria characterized by their reduced colony size and distinct biochemical properties. SCVs of Staphylococcus aureus have been studied extensively over the past two decades due to their role in recurrent human infections. However, little work has been done on SCVs of Escherichia coli, and this work has focused on the physiology and morphology that define these colonies of E. coli, such as small size and slow growth. E. coli strain JW0623, has a null lipA mutation in the lipoic acid synthase gene (lipA), and is a lipoic acid auxotroph. When the mutant was grown in LB medium to log phase, it showed remarkable resistance to acid (pH 3), hydrogen peroxide, heat and osmotic stress compared to its parent BW25113. Using RT-PCR and real time RT-PCR, the expression of certain genes was compared in the two strains in an attempt to create a molecular profile of Escherichia coli SCVs. These include genes involved in glycolysis, TCA cycle, electron transport, iron acquisition, biofilm formation and cyclopropane fatty acid synthesis. It was also demonstrated that the addition of 5 mu g/ml of lipoic acid to LB medium allows for the phenotypic rescue of the mutant; reversing its slow growth, its resistance characteristics, and elevated gene expression. These results indicate that the mutation in lipA leads to an E. coli SCV that resembles an electron transport defective SCV of S. aureus These strains are typically auxotrophs, and are phenotypically rescued by adding the missing metabolite to rich medium. There are global shifts in gene expression which are reversible and depend on whether the auxotrophic molecule is absent or present. Looking at the E. coli SCV from an evolutionary point of view, it becomes evident that its path to survival is to express genes that confer stress resistance.	[Santos, Victor; Hirshfield, Irvin] St Johns Univ, Dept Biol Sci, Queens, NY USA	Saint John's University	Santos, V (corresponding author), St Johns Univ, Dept Biol Sci, Queens, NY USA.	santosv@stjohns.edu	Santos, Victor Santana/B-8738-2014	Santos, Victor Santana/0000-0003-0194-7397	St. John's University	St. John's University	The authors received no specific funding for this work. Some funds supplied by St. John's University.; We wish to thank Paramita Basu, Anthony Paratore, David Matatov, Raymond Ochs, and Adam Constantine for their assistance. Finally, we thank St. John's University for financial support of this research.	Abdallah M, 2014, ARCH MICROBIOL, V196, P453, DOI 10.1007/s00203-014-0983-1; ACAR JF, 1978, J CLIN MICROBIOL, V8, P142; Becker S, 1996, J BACTERIOL, V178, P4515, DOI 10.1128/jb.178.15.4515-4521.1996; Brown JL, 1997, INT J FOOD MICROBIOL, V37, P163, DOI 10.1016/S0168-1605(97)00068-8; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Chatterjee I, 2005, J BACTERIOL, V187, P4488, DOI 10.1128/JB.187.13.4488-4496.2005; Chatterjee I, 2007, J BACTERIOL, V189, P2936, DOI 10.1128/JB.01444-06; Chen YY, 2016, INT J FOOD MICROBIOL, V222, P16, DOI 10.1016/j.ijfoodmicro.2016.01.017; CLOWES RC, 1955, J GEN MICROBIOL, V13, P461, DOI 10.1099/00221287-13-3-461; COLWELL CA, 1946, J BACTERIOL, V52, P417, DOI 10.1128/JB.52.4.417-422.1946; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; HIRSCH HM, 1961, J BACTERIOL, V81, P448, DOI 10.1128/JB.81.3.448-458.1961; Kipp F, 2003, J NEUROL NEUROSUR PS, V74, P1000, DOI 10.1136/jnnp.74.7.1000; Kohler C, 2003, J BACTERIOL, V185, P6928, DOI 10.1128/JB.185.23.6928-6937.2003; Kohler C, 2008, J BACTERIOL, V190, P6351, DOI 10.1128/JB.00505-08; Kriegeskorte A, FRONT CELL INFECT MI, DOI [10.3389/fclimb2014.00141, DOI 10.3389/FCLIMB2014.00141]; PROCTOR RA, 1995, CLIN INFECT DIS, V20, P95, DOI 10.1093/clinids/20.1.95; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Proctor RA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00099; Roggenkamp A, 1998, J CLIN MICROBIOL, V36, P2530, DOI 10.1128/JCM.36.9.2530-2534.1998; Sendi P, 2010, J CLIN MICROBIOL, V48, P1720, DOI 10.1128/JCM.01562-09; Spalding MD, 2010, MICROBIOL MOL BIOL R, V74, P200, DOI 10.1128/MMBR.00008-10; Unden G, 2002, J MOL MICROB BIOTECH, V4, P263; von Eiff C, 2008, INT J ANTIMICROB AG, V31, P507, DOI 10.1016/j.ijantimicag.2007.10.026; WEED LL, 1954, J BACTERIOL, V67, P27, DOI 10.1128/JB.67.1.27-33.1954; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	26	10	10	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157578	10.1371/journal.pone.0157578	http://dx.doi.org/10.1371/journal.pone.0157578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310825	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800102
J	Bilgin, R; Ebeoglu, N; Inak, S; Kirpik, MA; Horns, JJ; Sekercioglu, CH				Bilgin, Rasit; Ebeoglu, Nadin; Inak, Sedat; Kirpik, Mehmet Ali; Horns, Joshua J.; Sekercioglu, Cagan H.			DNA Barcoding of Birds at a Migratory Hotspot in Eastern Turkey Highlights Continental Phylogeographic Relationships	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; CLIMATE-CHANGE; HISTORY; INTROGRESSION; SPECIATION; PATTERNS	The combination of habitat loss, climate change, direct persecution, introduced species and other components of the global environmental crisis has resulted in a rapid loss of biodiversity, including species, population and genetic diversity. Birds, which inhabit a wide spectrum of different habitat types, are particularly sensitive to and indicative of environmental changes. The Caucasus endemic bird area, part of which covers northeastern Turkey, is one of the world's key regions harboring a unique bird community threatened with habitat loss. More than 75% of all bird species native to Turkey have been recorded in this region, in particular along the Kars-Igdir migratory corridor, stopover, wintering and breeding sites along the Aras River, whose wetlands harbor at least 264 bird species. In this study, DNA barcoding technique was used for evaluating the genetic diversity of land bird species of Aras River Bird Paradise at the confluence of Aras River and Igdir Plains key biodiversity areas. Seventy three COI sequences from 33 common species and 26 different genera were newly generated and used along with 301 sequences that were retrieved from the Barcoding of Life Database (BOLD). Using the sequences obtained in this study, we made global phylogeographic comparisons to define four categories of species, based on barcoding suitability, intraspecific divergence and taxonomy. Our findings indicate that the landbird community of northeastern Turkey has a genetical signature mostly typical of northern Palearctic bird communities while harboring some unique variations. The study also provides a good example of how DNA barcoding can build upon its primary mission of species identification and use available data to integrate genetic variation investigated at the local scale into a global framework. However, the rich bird community of the Aras River wetlands is highly threatened with the imminent construction of the Tuzluca Dam by the government.	[Bilgin, Rasit; Ebeoglu, Nadin] Bogazici Univ, Inst Environm Sci, TR-34342 Istanbul, Turkey; [Inak, Sedat; Kirpik, Mehmet Ali] Kafkas Univ, Fac Sci, Dept Biol, TR-36100 Kars, Turkey; [Horns, Joshua J.; Sekercioglu, Cagan H.] Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA; [Sekercioglu, Cagan H.] Koc Univ, Coll Sci, TR-34450 Istanbul, Turkey; [Sekercioglu, Cagan H.] KuzeyDoga Dernegi, Ortakapi Mah Sehit Yusuf Cad 93-1, TR-36100 Kars, Turkey	Bogazici University; Kafkas University; Utah System of Higher Education; University of Utah; Koc University	Bilgin, R (corresponding author), Bogazici Univ, Inst Environm Sci, TR-34342 Istanbul, Turkey.	rasit.bilgin@boun.edu.tr	Sekercioglu, Cagan H/A-2331-2013; Bilgin, Rasit/A-3129-2016	Sekercioglu, Cagan H/0000-0001-9639-294X; Sekercioglu, Cagan H./0000-0003-3193-0377	Christensen Fund; Whitley Fund; National Geographic Society; Kafkas University; University of Utah; Research Fund of Bogazici University in Istanbul [09S101, 15Y00R4]	Christensen Fund; Whitley Fund; National Geographic Society(National Geographic Society); Kafkas University(Kafkas University); University of Utah; Research Fund of Bogazici University in Istanbul(Bogazici University)	The authors thank the Christensen Fund, the Whitley Fund, National Geographic Society, Kafkas University, and the University of Utah for funding our fieldwork. This study was supported by two grants (Nos: 09S101 and 15Y00R4) from the Research Fund of Bogazici University in Istanbul to RB. The authors are also grateful to our donors, in particular Arkadaslar, Bilge Bahar, Seha Ismen, Lin Lougheed, Batubay Ozkan, and Burak Over for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barilani M, 2005, BIOL CONSERV, V126, P445, DOI 10.1016/j.biocon.2005.06.027; Illera JC, 2008, MOL PHYLOGENET EVOL, V48, P1145, DOI 10.1016/j.ympev.2008.05.016; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drovetski SV, 2004, J AVIAN BIOL, V35, P105; Gibbs HL, 2000, NATURE, V407, P183, DOI 10.1038/35025058; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Irwin DE, 2009, BIOL J LINN SOC, V98, P422, DOI 10.1111/j.1095-8312.2009.01282.x; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; Kvist L, 1999, HEREDITY, V82, P495, DOI 10.1038/sj.hdy.6885130; Moyle RG, 2007, J AVIAN BIOL, V38, P317, DOI 10.1111/j.2007.0908-8857.03921.x; Nyari AS, 2007, MOL PHYLOGENET EVOL, V44, P154, DOI 10.1016/j.ympev.2007.02.020; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Schrey AW, 2011, MOL ECOL, V20, P1133, DOI 10.1111/j.1365-294X.2011.05001.x; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Sekercioglu CH, 2011, BIOL CONSERV, V144, P2752, DOI 10.1016/j.biocon.2011.06.025; Sekercioglu CH, 2011, SCIENCE, V334, P1637, DOI 10.1126/science.334.6063.1637-b; Svensson L, 1992, BIRDS OF EUROPE; Svensson L, 2010, BIRDS OF EUROPE; Svensson L., 1992, IDENTIFICATION GUIDE; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wormworth J, 2011, WINGED SENTINELS: BIRDS AND CLIMATE CHANGE, P1, DOI 10.1017/CBO9781139150026; Yoo HS, 2006, MOL CELLS, V22, P323; Zink RM, 2008, J ORNITHOL, V149, P399, DOI 10.1007/s10336-008-0276-z; Zink RM, 2009, MOL PHYLOGENET EVOL, V52, P769, DOI 10.1016/j.ympev.2009.05.016	29	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0154454	10.1371/journal.pone.0154454	http://dx.doi.org/10.1371/journal.pone.0154454			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304877	Green Submitted, Green Published, gold			2022-12-27	WOS:000377824800003
J	Burroughs, AL; Durr, PA; Boyd, V; Graham, K; White, JR; Todd, S; Barr, J; Smith, I; Baverstock, G; Meers, J; Crameri, G; Wang, LF				Burroughs, A. L.; Durr, P. A.; Boyd, V.; Graham, K.; White, J. R.; Todd, S.; Barr, J.; Smith, I.; Baverstock, G.; Meers, J.; Crameri, G.; Wang, L-F			Hendra Virus Infection Dynamics in the Grey-Headed Flying Fox (Pteropus poliocephalus) at the Southern-Most Extent of Its Range: Further Evidence This Species Does Not Readily Transmit the Virus to Horses	PLOS ONE			English	Article							BATS; HENIPAVIRUS; PARAMYXOVIRUS; ANTIBODIES; ASSAYS; SPP.	Hendra virus (HeV) is an important emergent virus in Australia known to infect horses and humans in certain regions of the east coast. Whilst pteropid bats ("flying foxes") are considered the natural reservoir of HeV, which of the four mainland species is the principal reservoir has been a source of ongoing debate, particularly as shared roosting is common. To help resolve this, we sampled a colony consisting of just one of these species, the grey-headed flying fox, (Pteropus poliocephalus), at the southernmost extent of its range. Using the pooled urine sampling technique at approximately weekly intervals over a two year period, we determined the prevalence of HeV and related paramyxoviruses using a novel multiplex (Luminex) platform. Whilst all the pooled urine samples were negative for HeV nucleic acid, we successfully identified four other paramyxoviruses, including Cedar virus; a henipavirus closely related to HeV. Collection of serum from individually caught bats from the colony showed that antibodies to HeV, as estimated by a serological Luminex assay, were present in between 14.6% and 44.5% of animals. The wide range of the estimate reflects uncertainties in interpreting intermediate results. Interpreting the study in the context of HeV studies from states to the north, we add support for an arising consensus that it is the black flying fox and not the grey-headed flying fox that is the principal source of HeV in spillover events to horses.	[Burroughs, A. L.; Durr, P. A.; Boyd, V.; Graham, K.; White, J. R.; Todd, S.; Barr, J.; Smith, I.; Crameri, G.; Wang, L-F] Commonwealth Sci & Ind Res Org, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Baverstock, G.] City Greater Geelong, Geelong, Vic, Australia; [Burroughs, A. L.; Meers, J.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Wang, L-F] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; National University of Singapore	Durr, PA (corresponding author), Commonwealth Sci & Ind Res Org, Australian Anim Hlth Lab, Geelong, Vic, Australia.	peter.durr@csiro.au	wang, lin/HHM-2225-2022; wang, lili/HDL-7210-2022; Smith, Ina/H-7225-2013; WHITE, JOHN REGINALD/G-8800-2013; wang, lin/GSE-3040-2022; Durr, Peter/O-2948-2014	Smith, Ina/0000-0001-5807-3737; WHITE, JOHN REGINALD/0000-0003-2112-7185; Durr, Peter/0000-0003-0851-5300; Barr, Jennifer/0000-0001-5266-9142	Commonwealth Scientific and Industrial Research Organisation OCE Science Leader Award; Australian Post-Graduate Award	Commonwealth Scientific and Industrial Research Organisation OCE Science Leader Award; Australian Post-Graduate Award(Australian Government)	This work was supported by the Commonwealth Scientific and Industrial Research Organisation OCE Science Leader Award: L-FW. Australian Post-Graduate Award: ALB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2014, MOL PHYLOGENET EVOL, V77, P83, DOI 10.1016/j.ympev.2014.03.009; Barr J, 2015, J GEN VIROL, V96, P24, DOI 10.1099/vir.0.068106-0; Barr JA, 2012, J GEN VIROL, V93, P2590, DOI 10.1099/vir.0.045385-0; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Boyd V, 2015, J VIROL METHODS, V223, P5, DOI 10.1016/j.jviromet.2015.07.004; Breed AC, 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0028816; Breed AC, 2010, EMERG INFECT DIS, V16, P1997, DOI 10.3201/eid1612.100879; Burroughs AL, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00177-15; Clayton BA, 2013, ZOONOSES PUBLIC HLTH, V60, P69, DOI 10.1111/j.1863-2378.2012.01501.x; Edson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140670; Edson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125881; Field H., 2004, THESIS; Field H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144055; Field H, 2012, CURR TOP MICROBIOL, V359, P11, DOI 10.1007/82_2012_214; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Foord AJ, 2014, J VIROL METHODS, V203, P65, DOI 10.1016/j.jviromet.2014.03.018; Foord AJ, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/, DOI 10.1155/2013/]; Goldspink LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128835; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Mahalingam S, 2012, LANCET INFECT DIS, V12, P799, DOI 10.1016/S1473-3099(12)70158-5; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; McNabb L, 2014, J VIROL METHODS, V200, P22, DOI 10.1016/j.jviromet.2014.01.010; Middleton D, 2014, VET CLIN N AM-EQUINE, V30, P579, DOI 10.1016/j.cveq.2014.08.004; Ng JHJ, 2013, AUST J ZOOL, V61, P48, DOI 10.1071/ZO12126; Nowak RM, 1994, WALKERS BATS WORLD; Peel AJ, 2013, J VIROL METHODS, V193, P295, DOI 10.1016/j.jviromet.2013.06.030; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Sendow Indrawati, 2013, PLoS ONE, V8, P1; Smith C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099965; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Thomas D.W., 1988, P77; Victoria State Government, 2011, ASS HENDR VIR SIT VI; Westcott DA, 2004, WILDLIFE RES, V31, P551, DOI 10.1071/WR03091; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	40	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155252	10.1371/journal.pone.0155252	http://dx.doi.org/10.1371/journal.pone.0155252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304985	Green Submitted, gold, Green Published			2022-12-27	WOS:000377824800006
J	Hayashi, M; Watanabe, M; Yukuhiro, F; Nomura, M; Kageyama, D				Hayashi, Masayuki; Watanabe, Masaya; Yukuhiro, Fumiko; Nomura, Masashi; Kageyama, Daisuke			A Nightmare for Males? A Maternally Transmitted Male-Killing Bacterium and Strong Female Bias in a Green Lacewing Population	PLOS ONE			English	Article							SEX-RATIO; TRANSOVARIAL TRANSMISSION; SP-NOV; WOLBACHIA; DROSOPHILA; INFECTION; NEUROPTERA; ARTHROPODS; MECHANISMS; APHIDS	For maternally transmitted microbes, a female-biased host sex ratio is of reproductive advantage. Here we found a strong female bias in a field population of the green lacewing, Mallada desjardinsi (Insecta; Neuroptera). This bias was attributed to the predominance of individuals harboring a maternally inherited male-killing bacterium that was phylogenetically closely related to the plant-pathogenic Spiroplasma phoeniceum and Spiroplasma kunkelii. Among 35 laboratory-reared broods produced by wild-caught females, 21 broods (60%)-all infected with Spiroplasma-consisted of only females (940 individuals). Among 14 broods consisting of both males and females (516 and 635 individuals, respectively), 4 broods were doubly infected with Spiroplasma and Rickettsia, 6 broods were singly infected with Rickettsia, and 3 broods were uninfected (remaining one brood was unknown). Mortality during embryonic and larval development was prominent in all-female broods but not in normal sex ratio broods. Following antibiotic treatment on all-female broods, mortality was significantly reduced and the sex ratio was restored to 1:1. Strong expression and high prevalence of this male-killer is remarkable considering its low density (similar to 10(-5)-10(-4) cells per host mitochondrial gene copy based on quantitative PCR). In addition, a bacterium closely related to Rickettsia bellii was present in 25 of 34 broods (73.5%), irrespective of the sex ratio, with the infection density comparable to other cases of endosymbiosis (similar to 10(-2)-10(-1) cells per mitochondrial gene copy). Higher density of Rickettsia than Spiroplasma was also demonstrated by electron microscopy which visualized both Spiroplasma-like cells and Rickettsia-like cells inside and outside the ovarian cells.	[Hayashi, Masayuki; Nomura, Masashi] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan; [Watanabe, Masaya; Yukuhiro, Fumiko; Kageyama, Daisuke] Natl Inst Agrobiol Sci, Insect Microbe Res Unit, 1-2 Owashi, Tsukuba, Ibaraki, Japan; [Watanabe, Masaya] DOT Int Co Ltd, Clin Operat Div, Chuo Ku, 3-22-13 Hatchobori, Tokyo, Japan	Chiba University; National Institute of Agrobiological Sciences - Japan	Kageyama, D (corresponding author), Natl Inst Agrobiol Sci, Insect Microbe Res Unit, 1-2 Owashi, Tsukuba, Ibaraki, Japan.	kagymad@affrc.go.jp	Kageyama, Daisuke/B-4460-2010	Kageyama, Daisuke/0000-0002-9026-9825; Hayashi, Masayuki/0000-0002-7461-1723	KAKENHI [25450492]; National Institute of Agrobiological Sciences; Chiba University	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institute of Agrobiological Sciences; Chiba University	This work was financially supported by KAKENHI, a Grant-in-Aid for Scientific Research (https://www.jsps.go.jp/english/e-grants/), grant No. 25450492 for DK, and by internal grants from the National Institute of Agrobiological Sciences and Chiba University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; Brumin M, 2012, APPL ENVIRON MICROB, V78, P5565, DOI 10.1128/AEM.01184-12; Dunn AK, 2005, APPL ENVIRON MICROB, V71, P8784, DOI 10.1128/AEM.71.12.8784-8794.2005; Dunn AM, 2001, ADV PARASIT, V48, P57, DOI 10.1016/S0065-308X(01)48005-5; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Dyson EA, 2004, P NATL ACAD SCI USA, V101, P6520, DOI 10.1073/pnas.0304068101; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayashi M, 2011, APPL ENTOMOL ZOOL, V46, P407, DOI 10.1007/s13355-011-0053-y; Herren JK, 2013, MBIO, V4, DOI 10.1128/mBio.00532-12; Hornett EA, 2006, PLOS BIOL, V4, P1643, DOI 10.1371/journal.pbio.0040283; HURST GDD, 1993, HEREDITY, V71, P81, DOI 10.1038/hdy.1993.110; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Jacob C, 1997, J BACTERIOL, V179, P4802, DOI 10.1128/jb.179.15.4802-4810.1997; Jiggins FM, 2000, P ROY SOC B-BIOL SCI, V267, P69, DOI 10.1098/rspb.2000.0968; Jiggins FM, 2000, PARASITOLOGY, V120, P439, DOI 10.1017/S0031182099005867; Kageyama D, 2004, P ROY SOC B-BIOL SCI, V271, P251, DOI 10.1098/rspb.2003.2604; Kageyama D, 2007, NATURWISSENSCHAFTEN, V94, P333, DOI 10.1007/s00114-006-0195-x; Kageyama Daisuke, 2012, Insects, V3, P161, DOI 10.3390/insects3010161; Kern P, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0095; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; McEwen PK., 2007, LACEWINGS CROP ENV; Montenegro H, 2005, INSECT MOL BIOL, V14, P281, DOI 10.1111/j.1365-2583.2005.00558.x; Nakanishi K, 2008, P ROY SOC B-BIOL SCI, V275, P1249, DOI 10.1098/rspb.2008.0013; Narita S, 2007, FEMS MICROBIOL ECOL, V61, P235, DOI 10.1111/j.1574-6941.2007.00333.x; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; R Development Core Team, 2005, R LANG ENV STAT COMP; Resh V. H., 2009, ENCY INSECTS; Reuter M, 2008, EVOLUTION, V62, P401, DOI 10.1111/j.1558-5646.2007.00300.x; Ryder JJ, 2014, AM NAT, V183, pE89, DOI 10.1086/674827; SAILLARD C, 1987, INT J SYST BACTERIOL, V37, P106, DOI 10.1099/00207713-37-2-106; Sakamoto H, 2007, GENOME, V50, P645, DOI 10.1139/G07-041; SCHALL R, 1991, BIOMETRIKA, V78, P719; Tabata J, 2011, MICROB ECOL, V61, P254, DOI 10.1007/s00248-010-9799-y; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tinsley MC, 2006, PARASITOLOGY, V132, P757, DOI 10.1017/S0031182005009789; Watanabe K, 2014, P NATL ACAD SCI USA, V111, P7433, DOI 10.1073/pnas.1402476111; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; WHITCOMB RF, 1986, INT J SYST BACTERIOL, V36, P170, DOI 10.1099/00207713-36-2-170; Whitcomb RF, 1989, MYCOPLASMAS, VV; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149	41	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155794	10.1371/journal.pone.0155794	http://dx.doi.org/10.1371/journal.pone.0155794			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304213	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800010
J	Hurtig, A; Sorqvist, P; Ljung, R; Hygge, S; Ronnberg, J				Hurtig, Anders; Sorqvist, Patrik; Ljung, Robert; Hygge, Staffan; Ronnberg, Jerker			Student's Second-Language Grade May Depend on Classroom Listening Position	PLOS ONE			English	Article							SPEECH-PERCEPTION; REVERBERATION; NOISE; COMPREHENSION; ADULTS	The purpose of this experiment was to explore whether listening positions (close or distant location from the sound source) in the classroom, and classroom reverberation, influence students' score on a test for second-language (L2) listening comprehension (i.e., comprehension of English in Swedish speaking participants). The listening comprehension test administered was part of a standardized national test of English used in the Swedish school system. A total of 125 high school pupils, 15 years old, participated. Listening position was manipulated within subjects, classroom reverberation between subjects. The results showed that L2 listening comprehension decreased as distance from the sound source increased. The effect of reverberation was qualified by the participants' baseline L2 proficiency. A shorter reverberation was beneficial to participants with high L2 proficiency, while the opposite pattern was found among the participants with low L2 proficiency. The results indicate that listening comprehension scores-and hence students' grade in English-may depend on students' classroom listening position.	[Hurtig, Anders; Sorqvist, Patrik; Ljung, Robert; Hygge, Staffan] Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden; [Hurtig, Anders; Sorqvist, Patrik; Ronnberg, Jerker] Linkoping Univ, Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden; [Hurtig, Anders] Univ Dalarna, Dept Educ Hlth & Social Sci, Falun, Sweden; [Ronnberg, Jerker] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden	University of Gavle; Linkoping University; Dalarna University; Linkoping University	Hurtig, A (corresponding author), Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden.; Hurtig, A (corresponding author), Linkoping Univ, Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden.; Hurtig, A (corresponding author), Univ Dalarna, Dept Educ Hlth & Social Sci, Falun, Sweden.	anders.hurtig@hig.se	Hurtig, Anders/GWD-0238-2022; Ronnberg, Jerker/AAW-5049-2021	Sorqvist, Patrik/0000-0002-7584-2275; Hygge, Staffan/0000-0003-4298-7459; Hurtig, Anders/0000-0002-2730-7200	Swedish Research Council [A0204201]; Swedish Research Council Formas [242-2010-1006]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Both the Swedish Research Council (PI: S Hygge - A0204201) and the Swedish Research Council Formas (PI: S Hygge - 242-2010-1006) contributed to the funding of this study.	[Anonymous], 2012, THEORY PRACTICE LANG, DOI [DOI 10.4304/TPLS.2.4.657-663, 10.4304/tpls.2.4.657-663]; Crandell C. C., 1996, ED AUDIOLOGY MONOGRA, V4; Crandell CC, 2000, LANG SPEECH HEAR SER, V31, P362, DOI 10.1044/0161-1461.3104.362; De Martino S, 2001, BRAIN COGNITION, V46, P104; DUKER S, 1965, ELEM SCHOOL J, V65, P321, DOI 10.1086/460227; Everest A. L., 2015, MASTER HDB ACOUSTICS; Hodgson M, 2002, J ACOUST SOC AM, V111, P931, DOI 10.1121/1.1428264; Hurtig A, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02029; Hygge S., 2015, FRONTIERS PSYC UNPUB; Kidd GR, 2007, J ACOUST SOC AM, V122, P418, DOI 10.1121/1.2743154; Kilman L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00651; Klatte M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00578; Klatte M, 2010, NOISE HEALTH, V12, P270, DOI 10.4103/1463-1741.70506; Ljung R., 2009, POOR LISTENING CONDI, DOI [10.1260/135101009789877031, DOI 10.1260/135101009789877031]; Ljung R, 2009, BUILD ACOUST, V16, P301, DOI 10.1260/135101009790291273; Mayo LH, 1997, J SPEECH LANG HEAR R, V40, P686, DOI 10.1044/jslhr.4003.686; NABELEK AK, 1974, J SPEECH HEAR RES, V17, P724, DOI 10.1044/jshr.1704.724; PICHORAFULLER MK, 1995, J ACOUST SOC AM, V97, P593, DOI 10.1121/1.412282; Sorqvist P, 2014, SCAND J PSYCHOL, V55, P91, DOI 10.1111/sjop.12115; Tabri D, 2011, INT J LANG COMM DIS, V46, P411, DOI 10.3109/13682822.2010.519372; Townsend D. J., 1987, COMPREHENDING ORAL W; Villarreal C., 1991, TEX SPEECH; WEBB WB, 1956, J APPL PSYCHOL, V40, P237, DOI 10.1037/h0047579	23	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156533	10.1371/journal.pone.0156533	http://dx.doi.org/10.1371/journal.pone.0156533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5LO	27304980	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800016
J	Kilany, WH; Safwat, M; Mohammed, SM; Salim, A; Fasina, FO; Fasanmi, OG; Shalaby, AG; Dauphin, G; Hassan, MK; Lubroth, J; Jobre, YM				Kilany, Walid H.; Safwat, Marwa; Mohammed, Samy M.; Salim, Abdullah; Fasina, Folorunso Oludayo; Fasanmi, Olubunmi G.; Shalaby, Azhar G.; Dauphin, Gwenaelle; Hassan, Mohammed K.; Lubroth, Juan; Jobre, Yilma M.			Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus	PLOS ONE			English	Article							EXPERIMENTAL-INFECTION; DISEASE VIRUS; MUSCOVY DUCKS; PEKIN DUCKS; VACCINATION; CHICKENS; CHALLENGE; IMMUNITY; POULTRY; VIETNAM	In Egypt, ducks kept for commercial purposes constitute the second highest poultry population, at 150 million ducks/year. Hence, ducks play an important role in the introduction and transmission of avian influenza (AI) in the Egyptian poultry population. Attempts to control outbreaks include the use of vaccines, which have varying levels of efficacy and failure. To date, the effects of vaccine efficacy has rarely been determined in ducks. In this study, we evaluated the protective efficacy of a live recombinant vector vaccine based on a turkey Herpes Virus (HVT) expressing the H5 gene from a clade 2.2 H5N1 HPAIV strain (A/Swan/Hungary/499/2006) (rHVT-H5) and a bivalent inactivated H5N1 vaccine prepared from clade 2.2.1 and 2.2.1.1 H5N1 seeds in Mulard ducks. A 0.3ml/dose subcutaneous injection of rHVT-H5 vaccine was administered to one-day-old ducklings (D1) and another 0.5ml/dose subcutaneous injection of the inactivated MEFLUVAC was administered at 7 days (D7). Four separate challenge experiments were conducted at Days 21, 28, 35 and 42, in which all the vaccinated ducks were challenged with 106EID50/duck of H5N1 HPAI virus (A/chicken/Egypt/128s/2012(H5N1) (clade 2.2.1) via intranasal inoculation. Maternal-derived antibody regression and post-vaccination antibody immune responses were monitored weekly. Ducks vaccinated at 21, 28, 35 and 42 days with the rHVT-H5 and MEFLUVAC vaccines were protected against mortality (80%, 80%, 90% and 90%) and (50%, 70%, 80% and 90%) respectively, against challenges with the H5N1 HPAI virus. The amount of viral shedding and shedding rates were lower in the rHVT-H5 vaccine groups than in the MEFLUVAC groups only in the first two challenge experiments. However, the non-vaccinated groups shed significantly more of the virus than the vaccinated groups. Both rHVT-H5 and MEFLUVAC provide early protection, and rHVT-H5 vaccine in particular provides protection against HPAI challenge.	[Kilany, Walid H.; Safwat, Marwa; Mohammed, Samy M.; Salim, Abdullah; Shalaby, Azhar G.; Hassan, Mohammed K.] Anim Hlth Res Inst, Reference Lab Vet Qual Control Poultry Prod NLQP, POB 264, Giza, Egypt; [Mohammed, Samy M.; Jobre, Yilma M.] ECTAD, Food & Agr Org United Nations FAO, POB 2223, Giza, Egypt; [Fasina, Folorunso Oludayo] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Private Bag X04, Onderstepoort, South Africa; [Fasanmi, Olubunmi G.] Univ Pretoria, Fac Vet Sci, Dept Prod Anim Studies, Ibadan, Nigeria; [Fasanmi, Olubunmi G.] Fed Coll Anim Hlth & Prod Technol, Dept Anim Hlth, Ibadan, Nigeria; [Dauphin, Gwenaelle; Lubroth, Juan] FAO, Viale Terme di Caracalla, I-00153 Rome, Italy	Animal Health Research Institute (AHRI); Food & Agriculture Organization of the United Nations (FAO); University of Pretoria; Food & Agriculture Organization of the United Nations (FAO)	Kilany, WH (corresponding author), Anim Hlth Res Inst, Reference Lab Vet Qual Control Poultry Prod NLQP, POB 264, Giza, Egypt.; Fasina, FO (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Private Bag X04, Onderstepoort, South Africa.	WalidHamdy78@yahoo.com; daydupe2003@yahoo.co.uk	Fasina, Folorunso/B-6360-2015	Fasina, Folorunso/0000-0003-3088-8752; Kilany, Walid/0000-0002-4242-507X; Shalaby, azhar/0000-0003-4126-4734	United States Agency for International Development (USAID) [AID-263-IO-11-00001]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This work was supported by the United States Agency for International Development (USAID) under a grant (AID-263-IO-11-00001, Mod. #3) and within the framework of OSRO/EGY/101/USA, which applies to projects jointly implemented by the FAO, GOVS and NLQP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab EM, 2011, VACCINE, V29, P6219, DOI 10.1016/j.vaccine.2011.06.090; Abdelwhab EM, 2011, EPIDEMIOL INFECT, V139, P647, DOI 10.1017/S0950268810003122; Aly MM, 2008, AVIAN DIS, V52, P269, DOI 10.1637/8166-103007-Reg.1; Arafa AS, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.13.21085; Boltz DA, 2009, ARCH VIROL, V154, P939, DOI 10.1007/s00705-009-0385-x; Cagle C, 2011, VACCINE, V29, P6549, DOI 10.1016/j.vaccine.2011.07.004; Cha RM, 2013, VACCINE, V31, P4953, DOI 10.1016/j.vaccine.2013.08.046; Chua Tze-Hoong, 2010, Influenza Res Treat, V2010, P489213, DOI 10.1155/2010/489213; De Vriese J, 2010, AVIAN DIS, V54, P246, DOI 10.1637/8908-043009-Reg.1; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; ElMasry I, 2017, TRANSBOUND EMERG DIS, V64, P805, DOI 10.1111/tbed.12440; Esaki M, 2010, P 59 W POULTR DIS C, P124; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Food and Agriculture Organisation of the United Nations (FAO), 2012, 5 FAO UN; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Guionie O, 2010, AVIAN DIS, V54, P538, DOI 10.1637/8790-040109-Reg.1; Handberg KJ, 2001, AVIAN PATHOL, V30, P243, DOI 10.1080/03079450120054659; Hassan MK, 2013, ARCH VIROL, V158, P1361, DOI 10.1007/s00705-012-1599-x; Hawkins P, 2011, LAB ANIM-UK, V45, P1, DOI 10.1258/la.2010.010031; Henning J, 2010, EMERG INFECT DIS, V16, P1244, DOI 10.3201/eid1608.091540; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Kilany W.H., 2015, AVIAN PATHOL, P1; Kilany W, 2014, AVIAN PATHOL, V43, P514, DOI 10.1080/03079457.2014.966302; Kim JK, 2008, J VIROL, V82, P11374, DOI 10.1128/JVI.01176-08; Kim JK, 2010, P NATL ACAD SCI USA, V107, P11044, DOI 10.1073/pnas.1006419107; Liu QF, 2015, J VIROL, V89, P7401, DOI 10.1128/JVI.00031-15; Palya V, 2015, AVIAN DIS, DOI [10.1637/11129-050715, DOI 10.1637/11129-050715]; Pantin-Jackwood MJ, 2013, VIRUS RES, V178, P21, DOI 10.1016/j.virusres.2013.07.012; Peyre Marisa, 2009, J Mol Genet Med, V3, P198; Pfeiffer J, 2010, AVIAN DIS, V54, P262, DOI 10.1637/8715-031909-Reg.1; Rauw F, 2012, AVIAN DIS, V56, P913, DOI 10.1637/10172-041012-Reg.1; Rauw F, 2011, VACCINE, V29, P2590, DOI 10.1016/j.vaccine.2011.01.048; Sims LD, 2013, INFLUENZA OTHER RESP, V7, P15, DOI 10.1111/irv.12076; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Steensels M, 2009, VACCINE, V27, P646, DOI 10.1016/j.vaccine.2008.11.044; Swayne DE, 2008, AVIAN INFLUENZA, P407; Szeredi L, 2010, ACTA VET HUNG, V58, P341, DOI 10.1556/AVet.58.2010.3.7; van der Goot JA, 2008, VIROLOGY, V382, P91, DOI 10.1016/j.virol.2008.08.037; Wibawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083417; World Organisation for Animal Health (OIE), 2015, MANUAL OF DIAGNOSTIC	40	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156747	10.1371/journal.pone.0156747	http://dx.doi.org/10.1371/journal.pone.0156747			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304069	Green Submitted, Green Published, gold			2022-12-27	WOS:000377824800020
J	Shi, LH; Kim, AJ; Chang, RCA; Chang, JYA; Ying, W; Ko, ML; Zhou, BY; Ko, GYP				Shi, Liheng; Kim, Andy Jeesu; Chang, Richard Cheng-An; Chang, Janet Ya-An; Ying, Wei; Ko, Michael L.; Zhou, Beiyan; Ko, Gladys Yi-Ping			Deletion of miR-150 Exacerbates Retinal Vascular Overgrowth in High-Fat-Diet Induced Diabetic Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; INDUCED INSULIN-RESISTANCE; ADIPOSE-TISSUE; C-MYB; OCULAR NEOVASCULARIZATION; CARDIOVASCULAR-DISEASE; CIRCULATING MICRORNAS; CELL DIFFERENTIATION; MACULAR DEGENERATION	Diabetic retinopathy (DR) is the leading cause of blindness among American adults above 40 years old. The vascular complication in DR is a major cause of visual impairment, making finding therapeutic targets to block pathological angiogenesis a primary goal for developing DR treatments. MicroRNAs (miRs) have been proposed as diagnostic biomarkers and potential therapeutic targets for various ocular diseases including DR. In diabetic animals, the expression levels of several miRs, including miR-150, are altered. The expression of miR-150 is significantly suppressed in pathological neovascularization in mice with hyperoxia-induced retinopathy. The purpose of this study was to investigate the functional role of miR-150 in the development of retinal microvasculature complications in high-fat-diet (HFD) induced type 2 diabetic mice. Wild type (WT) and miR-150 null mutant (miR-150(-/-)) male mice were given a HFD (59% fat calories) or normal chow diet. Chronic HFD caused a decrease of serum miR-150 in WT mice. Mice on HFD for 7 months (both WT and miR-150-/-) had significant decreases in retinal light responses measured by electroretinograms (ERGs). The retinal neovascularization in miR-150(-/-)-HFD mice was significantly higher compared to their age matched WT-HFD mice, which indicates that miR-150 null mutation exacerbates chronic HFD-induced neovascularization in the retina. Overexpression of miR-150 in cultured endothelial cells caused a significant reduction of vascular endothelial growth factor receptor 2 (VEGFR2) protein levels. Hence, deletion of miR-150 significantly increased the retinal pathological angiogenesis in HFD induced type 2 diabetic mice, which was in part through VEGFR2.	[Shi, Liheng; Kim, Andy Jeesu; Chang, Janet Ya-An; Ko, Michael L.; Ko, Gladys Yi-Ping] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Chang, Richard Cheng-An; Ying, Wei; Zhou, Beiyan] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Zhou, Beiyan] Univ Connecticut, Ctr Hlth, Sch Med, Dept Immunol, Farmington, CT USA; [Ko, Gladys Yi-Ping] Texas A&M Univ, Texas A&M Inst Neurosci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Connecticut; Texas A&M University System; Texas A&M University College Station	Ko, GYP (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.; Ko, GYP (corresponding author), Texas A&M Univ, Texas A&M Inst Neurosci, College Stn, TX 77843 USA.	gko@cvm.tamu.edu	Ying, Wei/N-5157-2016; Kim, Andy Jeesu/AAQ-4448-2021	Kim, Andy Jeesu/0000-0003-1124-0213; Zhou, Beiyan/0000-0003-0638-2428	American Diabetes Association [1-13-JF-59]; National Institute of Diabetes and Digestive and Kidney Diseases of National Institutes of Health (NIH) [NIHR01DK098662]; National Eye Institute of NIH [NIHR01EY017452, NIHR21EY023339, NIH-R21EY023339]; NATIONAL EYE INSTITUTE [R21EY023339, R01EY017452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098662] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institute of Diabetes and Digestive and Kidney Diseases of National Institutes of Health (NIH); National Eye Institute of NIH; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by 1-13-JF-59 from the American Diabetes Association and NIHR01DK098662 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) to BZ, and NIHR01EY017452 and NIHR21EY023339 from the National Eye Institute of NIH to GK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by 1-13-JF-59 from the American Diabetes Association and NIHR01DK098662 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) to B. Zhou, and NIHR01EY017452 and NIH-R21EY023339 from the National Eye Institute of the NIH to G. Ko.	Ahren B, 1997, METABOLISM, V46, P97, DOI 10.1016/S0026-0495(97)90175-X; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Alvarez Y, 2010, DIS MODEL MECH, V3, P236, DOI 10.1242/dmm.003772; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker PM, 2005, CIRC RES, V96, P1257, DOI 10.1161/01.RES.0000171756.13554.49; Binder S, 2012, BRIT J OPHTHALMOL, V96, P1, DOI 10.1136/bjophthalmol-2011-301236; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Bousquet M, 2013, MOL CANCER RES, V11, P912, DOI 10.1158/1541-7786.MCR-13-0002-T; Chang RCA, 2015, INVEST OPHTH VIS SCI, V56, P2367, DOI 10.1167/iovs.14-16143; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chen GQ, 2012, MOL MED REP, V5, P1362, DOI 10.3892/mmr.2012.824; Cheung AT, 2000, DIABETES, V49, P810, DOI 10.2337/diabetes.49.5.810; Chou JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50489; Conte I, 2015, P NATL ACAD SCI USA, V112, pE3236, DOI 10.1073/pnas.1401464112; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Dai G, 2006, GENES CELLS, V11, P859, DOI 10.1111/j.1365-2443.2006.00985.x; Das A, 2015, OPHTHALMOLOGY, V122, P1375, DOI 10.1016/j.ophtha.2015.03.024; Eghoj MS, 2012, BRIT J OPHTHALMOL, V96, P21, DOI 10.1136/bjo.2011.203893; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Freund KB, 2013, EXPERT OPIN PHARMACO, V14, P1017, DOI 10.1517/14656566.2013.787410; Gallemore R.P., 2008, REV OPHTHALMOLOGY; Good TJ, 2011, BRIT J OPHTHALMOL, V95, P1111, DOI 10.1136/bjo.2010.180729; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ishida M, 2012, CIRC RES, V110, P253, DOI 10.1161/CIRCRESAHA.111.259499; Ito M, 2014, BLOOD, V123, P1499, DOI 10.1182/blood-2013-09-527739; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172; Liu CH, 2015, P NATL ACAD SCI USA, V112, P12163, DOI 10.1073/pnas.1508426112; Liu YC, 2013, PROTEIN CELL, V4, P932, DOI 10.1007/s13238-013-3092-z; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Luo ZL, 2013, STEM CELLS, V31, P1749, DOI 10.1002/stem.1448; Lux A, 2007, BRIT J OPHTHALMOL, V91, P1318, DOI 10.1136/bjo.2006.113902; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Narasaraju T, 2015, AM J RESP CELL MOL, V52, P253, DOI 10.1165/rcmb.2013-0021OC; NEWMAN EA, 1984, J NEUROPHYSIOL, V51, P164, DOI 10.1152/jn.1984.51.1.164; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Palejwala NV, 2014, DRUG TODAY, V50, P779, DOI 10.1358/dot.2014.50.12.2245587; Park JH, 2011, MOL CELLS, V31, P33, DOI 10.1007/s10059-011-0009-7; Pinto LH, 2007, DOC OPHTHALMOL, V115, P127, DOI 10.1007/s10633-007-9064-y; Prakhar P, 2015, J BIOL CHEM, V290, P26576, DOI 10.1074/jbc.M115.662817; Rajagopal R, 2016, DIABETES; Rodriguez-Lebron E, 2013, NEUROBIOL DIS, V54, P456, DOI 10.1016/j.nbd.2013.01.019; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Schulte C, 2015, CARDIOVASC DIAGN THE, V5, P17, DOI 10.3978/j.issn.2223-3652.2014.12.03; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Stahlhut C, 2013, GENOME MED, V5, DOI 10.1186/gm516; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tang YP, 2015, CARDIOVASC RES, V106, P387, DOI 10.1093/cvr/cvv121; Tolentino M, 2011, SURV OPHTHALMOL, V56, P95, DOI 10.1016/j.survophthal.2010.08.006; VINORES SA, 1988, EXP EYE RES, V46, P545, DOI 10.1016/S0014-4835(88)80011-3; WACHTMEISTER L, 1987, DOC OPHTHALMOL, V66, P187, DOI 10.1007/BF00145232; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Witkin AJ, 2011, CURR OPIN OPHTHALMOL, V22, P185, DOI 10.1097/ICU.0b013e3283459724; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie HM, 2009, EXPERT OPIN THER TAR, V13, P1227, DOI 10.1517/14728220903190707; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Ying W, 2016, SCI REP-UK, V6, DOI 10.1038/srep20176; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	73	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157543	10.1371/journal.pone.0157543	http://dx.doi.org/10.1371/journal.pone.0157543			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304911	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800070
J	Wilson, PK; Moore, JR				Wilson, Paige K.; Moore, Jason R.			Assessing the Control of Preservational Environment on Taphonomic and Ecological Patterns in an Oligocene Mammal Fauna from Badlands National Park, South Dakota	PLOS ONE			English	Article							BONE ASSEMBLAGE; FOSSIL; BIODIVERSITY; ABUNDANCES	Comparisons of paleofaunas from different facies are often hampered by the uncertainty in the variation of taphonomic processes biasing the paleoecological parameters of interest. By examining the taphonomic patterns exhibited by different facies in the same stratigraphic interval and area, it is possible to quantify this variation, and assess inter-facies comparability. The fossil assemblages preserved in Badlands National Park (BNP), South Dakota, have long been a rich source for mammalian faunas of the White River Group. To investigate the influence of the variation of taphonomic bias with lithology whilst controlling for the influence of changes in patterns of taphonomic modification with time, taphonomic and paleoecological data were collected from four mammal-dominated fossil assemblages (two siltstone hosted and two sandstone hosted) from a narrow stratigraphic interval within the Oligocene Poleslide Member of the Brule Formation, in the Palmer Creek Unit of BNP. Previous work in the region confirmed that the two major lithologies represent primarily aeolian- and primarily fluvial-dominated depositional environments, respectively. A suite of quantifiable taphonomic and ecological variables was recorded for each of the more than 800 vertebrate specimens studied here (857 specimens were studied in the field, 9 specimens were collected and are reposited at BNP). Distinctly different patterns of taphonomic biasing were observed between the aeolian and fluvial samples, albeit with some variability between all four sites. Fluvial samples were more heavily weathered and abraded, but also contained fewer large taxa and fewer tooth-bearing elements. No quantifiable paleofaunal differences in generic richness or evenness were observed between the respective facies. This suggests that while large vertebrate taxonomic composition in the region did vary with paleodepositional environment, there is no evidence of confounding variation in faunal structure, and therefore differences between the assemblages are attributed to differing preservational environments producing a taphonomic overprint on the assemblages. The lack of apparent taphonomic bias on paleofaunal structure suggests that such paleoecological data can be compared throughout the Poleslide Member, irrespective of lithology.	[Wilson, Paige K.; Moore, Jason R.] Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA; [Wilson, Paige K.] Univ New Mexico, Honors Coll, Albuquerque, NM 87131 USA	Dartmouth College; University of New Mexico	Wilson, PK (corresponding author), Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA.; Wilson, PK (corresponding author), Univ New Mexico, Honors Coll, Albuquerque, NM 87131 USA.	Paige.K.Wilson.14@dartmouth.edu			John Lindsley Fund	John Lindsley Fund	Supporting funding for the fieldwork and data collection in this research was provided through the John Lindsley Fund, distributed by the Dartmouth College Office of Undergraduate Advising and Research, in 2011. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P., 2003, B NATURAL HIST MUSEU, V58, P59, DOI DOI 10.1017/5096804620300010X; BADGLEY C, 1986, Palaios, V1, P328, DOI 10.2307/3514695; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Behrensmeyer Anna K., 2012, P69; Best MMR, 2000, PALEOBIOLOGY, V26, P80, DOI 10.1666/0094-8373(2000)026<0080:BTITMS>2.0.CO;2; Binford L. R., 1977, THEORY BUILDING ARCH; Binford LR., 1984, FAUNAL REMAINS KLASI; Blob RW, 1996, PALEOBIOLOGY, V22, P422, DOI 10.1017/S0094837300016377; Boaz NT., 2000, ACTA ANTHR SINICA, V19, P224; BRETT C E, 1986, Palaios, V1, P207, DOI 10.2307/3514686; Buckland W, 1823, RELIQUIAE DILUVIANAE; BUMP JD, 1956, AM J SCI, V254, P429, DOI 10.2475/ajs.254.7.429; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carlson KJ, 2003, J HUM EVOL, V44, P431, DOI 10.1016/S0047-2484(03)00025-3; Clark J, 1967, OLIGOCENE SEDIMENTAT; Connolly J. P., 1947, National Geographic Magazine Washington, V91, P589; COOK E, 1995, PALAEOGEOGR PALAEOCL, V116, P263, DOI 10.1016/0031-0182(94)00101-D; Dewar EW, 2008, DIETARY ECOLOGY COMM; Efremov IA, 1940, PAN AM GEOLOGIST, V74, P81; Evanoff E, 2010, FIELD GUIDE GEOLOGY, P1; Faith JT, 2006, J ARCHAEOL SCI, V33, P1718, DOI 10.1016/j.jas.2006.03.004; Fiorillo A.R., 1988, ROCKY MT GEOL, V26, P57; GILINSKY NL, 1994, PALEOBIOLOGY, V20, P245, DOI 10.1017/S0094837300012719; Gislason SR, 2011, P NATL ACAD SCI USA, V108, P7307, DOI 10.1073/pnas.1015053108; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Interior USDot, 2008, BADL NAT PARK GEOL R; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kidwell SM, 2001, SCIENCE, V294, P1091, DOI 10.1126/science.1064539; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; LYMAN RL, 1989, J ARCHAEOL SCI, V16, P293, DOI 10.1016/0305-4403(89)90007-1; Margalef R., 1958, GEN SYST, V3, P36, DOI DOI 10.1016/S0097-8485(01)00073-0; Moore JR, 2007, PALAEOGEOGR PALAEOCL, V253, P317, DOI 10.1016/j.palaeo.2007.06.004; Moore JR, 2009, PALAIOS, V24, P591, DOI 10.2110/palo.2008.p08-135r; Moore JR, 2012, PALAIOS, V27, P220, DOI 10.2110/palo.2011.p11-096r; Oksanen J, 2022, R PACKAGE VERSION; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Prothero D.R., 1994, EOCENE OLIGOCENE TRA; Prothero Donald R., 2004, P156; R Core Team, 2013, R LANG ENV STAT COMP; Scherer R, 2013, BIOMETRICAL J, V55, P246, DOI 10.1002/bimj.201200157; Scherer Ralph, 2014, SIMBOOT SIMULTANEOUS; Scott WB, 1937, MAMMALIAN FAUNA WHIT; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shipman P., 1988, SCANNING ELECT MICRO, ppp. 303; Sokal RR, 1995, BIOMETRY; SPEYER S E, 1986, Palaios, V1, P312, DOI 10.2307/3514694; TERRY DO, 1994, PALAEOGEOGR PALAEOCL, V110, P197, DOI 10.1016/0031-0182(94)90084-1; Voorhies MR, 1969, TAPHONOMY POPULATION; Yesares-Garcia J, 2004, PALAEOGEOGR PALAEOCL, V207, P83, DOI 10.1016/j.palaeo.2004.02.002	51	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157585	10.1371/journal.pone.0157585	http://dx.doi.org/10.1371/journal.pone.0157585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303807	Green Submitted, gold, Green Published			2022-12-27	WOS:000377824800074
J	Kuai, J; Sun, YY; Liu, TT; Zhang, PP; Zhou, M; Wu, JS; Zhou, GS				Kuai, Jie; Sun, Yingying; Liu, Tingting; Zhang, Peipei; Zhou, Min; Wu, Jiangsheng; Zhou, Guangsheng			Physiological Mechanisms behind Differences in Pod Shattering Resistance in Rapeseed (Brassica napus L.) Varieties	PLOS ONE			English	Article							WALL-DEGRADING ENZYMES; OILSEED RAPE; LODGING RESISTANCE; BIOSYNTHESIS; ALUMINUM; PROLINE; STRESS; GROWTH; LINES; YIELD	Pod shattering resistance index (SRI) is a key factor affecting the mechanical harvesting of rapeseed. Research on the differences in pod shattering resistance levels of various rapeseed varieties can provide a theoretical basis for varietal breeding and application in mechanical harvesting. The indicators on pod shattering resistance including pod morphology and wall components were evaluated on eight hybrids and open pollinators, respectively, during 2012-2014. The results showed the following: (1) From the current study, SRI varied greatly with variety, and conventional varieties had stronger resistance than hybrid according to the physiological indexes. and (2) Under the experimental conditions, the SRI was linearly related to pod wall weight and the water content in pod walls, and the goodness-of-fit measurements for the regression model of the SRI based on pod wall weight and water content were 0.584** and 0.377*, respectively, reaching the significant level. This illustrated that pod wall weight and the water content in pod walls determined the SRI. (3) Compared with the relative contents of biochemical components in pod walls, the contents of particular biochemical components in pod walls had closer correlations with SRI. Among the biochemical components, the hemicellulose content was the decisive factor for the SRI.	[Kuai, Jie; Sun, Yingying; Liu, Tingting; Zhang, Peipei; Zhou, Min; Wu, Jiangsheng; Zhou, Guangsheng] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei Province, Peoples R China	Huazhong Agricultural University	Zhou, GS (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei Province, Peoples R China.	zhougs@mail.hzau.edu.cn			National Key Technology Research and Development Program [2014BAD11B03]; Industry Technology Research Institute [CARS-13]; Special Funds for Public Welfare Industry (Agriculture) Study of China [201203096]; Fundamental Research Funds for the Central Universities [2013PY001, 2015BQ001]	National Key Technology Research and Development Program(National Key Technology R&D Program); Industry Technology Research Institute; Special Funds for Public Welfare Industry (Agriculture) Study of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was funded by the National Key Technology Research and Development Program (2014BAD11B03), the Industry Technology Research Institute (CARS-13), the Special Funds for Public Welfare Industry (Agriculture) Study of China (201203096) and the Fundamental Research Funds for the Central Universities (2013PY001; 2015BQ001).	Agrawal AP, 2002, CURR SCI INDIA, V82, P58; Baucher M, 1998, CRIT REV PLANT SCI, V17, P125, DOI 10.1016/S0735-2689(98)00360-8; Bennett EJ, 2011, NEW PHYTOL, V190, P838, DOI 10.1111/j.1469-8137.2011.03714.x; Berry PM, 2003, J AGRON CROP SCI, V189, P390, DOI 10.1046/j.0931-2250.2003.00062.x; Cavalieri A, 2014, CROP SCI, V54, P1184, DOI 10.2135/cropsci2013.09.0624; CHHABRA K S, 1990, Indian Journal of Entomology, V52, P423; Child RD, 1998, J EXP BOT, V49, P829, DOI 10.1093/jexbot/49.322.829; Child RD, 2003, J EXP BOT, V54, P1919, DOI 10.1093/jxb/erg209; Dickson TJ, 2014, GROWING SEASON WEATH; Gan Y, 2008, CAN J PLANT SCI, V88, P267, DOI 10.4141/CJPS07028; Giannakoula A, 2008, J PLANT PHYSIOL, V165, P385, DOI 10.1016/j.jplph.2007.01.014; Grant WF, 1996, CAN J PLANT SCI, V76, P447, DOI 10.4141/cjps96-079; JOSEFSSON E, 1968, Z PFLANZENZUCHTUNG, V59, P384; Khan AA, 2000, J PLANT NUTR, V23, P1303, DOI 10.1080/01904160009382101; Kuai J, 2015, FIELD CROP RES, V180, P10, DOI 10.1016/j.fcr.2015.05.004; Liu YH, 2012, ANN BOT-LONDON, V109, P1277, DOI 10.1093/aob/mcs060; MEAKIN PJ, 1990, J EXP BOT, V41, P1003, DOI 10.1093/jxb/41.8.1003; METCALFE D. S., 1957, AGRON JOUR, V49, P130; Mongkolporn O, 2003, PLANT BREEDING, V122, P479, DOI 10.1046/j.0179-9541.2003.00910.x; Morgan CL, 1998, FIELD CROP RES, V58, P153, DOI 10.1016/S0378-4290(98)00099-9; Morgan CL, 2000, J AGR SCI, V135, P347, DOI 10.1017/S0021859699008424; OOKAWA T, 1993, JPN J CROP SCI, V62, P378, DOI 10.1626/jcs.62.378; Pan LG, 2012, BIOMASS BIOENERG, V46, P453, DOI 10.1016/j.biombioe.2012.07.014; Summers JE, 2003, J AGR SCI, V140, P43, DOI 10.1017/S002185960200285X; Tripathi SC, 2003, FIELD CROP RES, V84, P271, DOI 10.1016/S0378-4290(03)00095-9; [王汉中 WANG Hanzhong], 2007, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V29, P101; Wang R, 2007, PLANT BREEDING, V126, P588, DOI 10.1111/j.1439-0523.2007.01382.x; Wu ZL, 2014, BIOMASS BIOENERG, V70, P347, DOI 10.1016/j.biombioe.2014.08.025; Yin Y, 2010, J AGR SCI TECH, V12, P16, DOI DOI 10.3969/J.ISSN.1008-0864.2010.03.03; Zuo QingSong, 2014, Acta Agronomica Sinica, V40, P650	30	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157341	10.1371/journal.pone.0157341	http://dx.doi.org/10.1371/journal.pone.0157341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299997	gold, Green Submitted, Green Published			2022-12-27	WOS:000377822200038
J	Li, YF; Wu, Q; Li, C; Liu, L; Du, K; Shen, J; Wu, YQ; Zhao, XF; Zhao, M; Bao, LY; Gao, J; Keep, RF; Xiang, JM				Li, Yangfang; Wu, Qian; Li, Chen; Liu, Ling; Du, Kun; Shen, Jin; Wu, Yuqin; Zhao, Xiaofen; Zhao, Mei; Bao, Lingyun; Gao, Jin; Keep, Richard F.; Xiang, Jianming			Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; RESISTANCE PROTEIN; ABC TRANSPORTERS; MULTIDRUG TRANSPORTER; INHIBITORS; MODEL; CNS; ACCUMULATION; MECHANISM; TARGETS	While the blood-brain barrier (BBB) protects the brain by controlling the access of solutes and toxic substances to brain, it also limits drug entry to treat central nervous system disorders. Many drugs are substrates for ATP-binding cassette (ABC) transporters at the BBB that limit their entry into the brain. The role of those transporters in limiting the entry of the widely prescribed therapeutic, benzylpenicillin, has produced conflicting results. This study investigated the possible potential involvement of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP), two ABC transporters, in benzylpenicillin transport at BBB in human using MDCKII cells overexpressing those transporters as well as pharmacological inhibition. MDCKII cells overexpressing human BCRP (MDCKII-BCRP) but not those overexpressing human P-gp (MDCKII-MDR cells) had reduced [H-3]benzylpenicillin uptake. Similarly, inhibiting BCRP increased [H-3]benzylpenicillin uptake in MDCKII-BCRP cells, while inhibiting P-gp in MDCKII-MDR cells had no effect on uptake although there was evidence that benzylpenicillin is a substrate for canine P-gp. While inhibiting BCRP affected [H-3]benzylpenicillin cell concentrations it did not affect transepithelial flux in MDCKII-BCRP cells. In summary, the results indicate that human BCRP and not human P-gp is involved in benzylpenicillin transport. However, targeting BCRP alone was not sufficient to alter transepithelial flux in MDCKII cells. Whether it would be sufficient to alter blood-to-brain flux at the human BBB remains to be investigated.	[Li, Yangfang; Wu, Qian; Liu, Ling; Du, Kun; Shen, Jin; Wu, Yuqin; Zhao, Xiaofen; Zhao, Mei; Bao, Lingyun; Gao, Jin] Kunming Childrens Hosp, Dept Neonate, Kunming, Peoples R China; [Li, Chen; Keep, Richard F.; Xiang, Jianming] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Xiang, JM (corresponding author), Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI USA.	jmxxdrnx@umich.edu		Keep, Richard/0000-0001-6441-5334	Key Projects of Kunming Science and Technology Bureau [2013-04-01-A-S-0204018]; Department of Neurosurgery, University of Michigan Medical School	Key Projects of Kunming Science and Technology Bureau; Department of Neurosurgery, University of Michigan Medical School	Key Projects of Kunming Science and Technology Bureau grant 2013-04-01-A-S-0204018, YL, by Motor City Golf Classic grant from the Department of Neurosurgery, University of Michigan Medical School, JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Agarwal S, 2011, CURR PHARM DESIGN, V17, P2793, DOI 10.2174/138161211797440186; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Baltes S, 2007, NEUROPHARMACOLOGY, V52, P333, DOI 10.1016/j.neuropharm.2006.07.038; Banks WA, 2016, NAT REV DRUG DISCOV, V22, P21; Banks WA, 2012, ENDOCRINOLOGY, V153, P4111, DOI 10.1210/en.2012-1435; Borst P, 2013, J CLIN INVEST, V123, P4131, DOI 10.1172/JCI70430; Chang C, 2006, DRUG METAB DISPOS, V34, P1976, DOI 10.1124/dmd.106.012351; Choi MK, 2009, XENOBIOTICA, V39, P171, DOI 10.1080/00498250802642256; Durmus S, 2013, PHARMACOL RES, V76, P9, DOI 10.1016/j.phrs.2013.06.009; Hartz AMS, 2011, CURR PHARM BIOTECHNO, V12, P656; Hartz AMS, 2010, MOL INTERV, V10, P293, DOI 10.1124/mi.10.5.6; Iorio AL, 2015, ANTICANCER AGENTS ME, DOI [10.2174/, DOI 10.2174/]; Kikuchi R, 2003, J PHARMACOL EXP THER, V306, P51, DOI 10.1124/jpet.103.049197; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Kuteykin-Teplyakov K, 2010, BRIT J PHARMACOL, V160, P1453, DOI 10.1111/j.1476-5381.2010.00801.x; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Miller DS, 2015, ADV CANCER RES, V125, P43, DOI 10.1016/bs.acr.2014.10.002; Montenegro L, 2012, J NANOSCI NANOTECHNO, V12, P330, DOI 10.1166/jnn.2012.5174; NORRBY SR, 1986, REV INFECT DIS, V8, pS358; Pardridge WM, 2015, EXPERT OPIN THER TAR, V19, P1059, DOI 10.1517/14728222.2015.1042364; Poelarends GJ, 2000, DRUG RESIST UPDATE, V3, P330, DOI 10.1054/drup.2000.0173; Ramos S R, 1992, Arq Neuropsiquiatr, V50, P289; Roberts JA, 2009, CRIT CARE MED, V37, P2071, DOI 10.1097/CCM.0b013e3181a0054d; Rousselle C, 2002, J DRUG TARGET, V10, P309, DOI 10.1080/10611860290031886; SCHLIAMSER SE, 1991, J ANTIMICROB CHEMOTH, V27, P405, DOI 10.1093/jac/27.4.405; Seelig A, 1998, INT J CLIN PHARM TH, V36, P50; Shen SS, 2010, REV NEUROSCIENCE, V21, P29; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Sindac JA, 2013, J MED CHEM, V56, P9222, DOI 10.1021/jm401330r; Syvanen S, 2009, DRUG METAB DISPOS, V37, P635, DOI 10.1124/dmd.108.024745; Tajes M, 2014, MOL MEMBR BIOL, V31, P152, DOI 10.3109/09687688.2014.937468; TOMASZ A, 1979, ANNU REV MICROBIOL, V33, P113, DOI 10.1146/annurev.mi.33.100179.000553; Westover D, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0275-x; Xiang JM, 2012, AM J PHYSIOL-REG I, V303, pR1, DOI 10.1152/ajpregu.00518.2011; Xiang JM, 2006, NEUROSCI LETT, V396, P225, DOI 10.1016/j.neulet.2005.11.037; Zhu Min-Li, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P910; Zolnerciks JK, 2011, J PHARM SCI-US, V100, P3055, DOI 10.1002/jps.22566	38	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157576	10.1371/journal.pone.0157576	http://dx.doi.org/10.1371/journal.pone.0157576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300692	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200062
J	Zhong, BL; Liu, TB; Huang, JX; Fung, HH; Chan, SSM; Conwell, Y; Chiu, HFK				Zhong, Bao-Liang; Liu, Tie-Bang; Huang, Jian-Xing; Fung, Helene H.; Chan, Sandra S. M.; Conwell, Yeates; Chiu, Helen F. K.			Acculturative Stress of Chinese Rural-To-Urban Migrant Workers: A Qualitative Study	PLOS ONE			English	Article							FACTORY-WORKERS; MENTAL-HEALTH; MIGRATION; DEPRESSION; PREVALENCE; ANXIETY; METAANALYSIS; POPULATION; PREDICTORS; SYMPTOMS	Background Global literature has suggested a negative impact of acculturative stress on both physical and mental health among international migrants. In China, approximately 20 percent of its population is rural-to-urban migrant workers and there are significant cultural differences between rural and urban societies, but no data are available regarding the acculturative stress of Chinese migrant workers. This study aimed to explore the forms and contexts of acculturative stress among Chinese migrant workers. Methods Qualitative data were collected from four focus group discussions with 17 Chinese rural-to-urban migrant workers and three individual interviews with three medical professionals who provided mental health services for factory-workers in Shenzhen, China. Results The data in the current study showed that rural-to-urban migrant workers in China had experienced various forms of acculturative stress including difficulties in adapting to the environment, work-related stress, family-related stress, financial hardship, and lack of sense of belonging to cities. Conclusion Rural-to-urban migration in China is a challenging transition with significant acculturative stress and demands for major adjustments among migrant workers. The assessment and management of acculturative stress is a necessary first step in providing mental health services to migrant workers.	[Zhong, Bao-Liang; Chan, Sandra S. M.; Chiu, Helen F. K.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Zhong, Bao-Liang] Huazhong Univ Sci & Technol, Tongji Med Coll, Affiliated Mental Hlth Ctr, Wuhan 430074, Peoples R China; [Liu, Tie-Bang] Shenzhen Kangning Hosp, Shenzhen Mental Hlth Ctr, Shenzhen Inst Mental Hlth, Shenzhen Key Lab Psychol Healthcare, Shenzhen, Peoples R China; [Huang, Jian-Xing] Chinese Univ Hong Kong, Ctr Study Relig & Chinese Soc, Hong Kong, Hong Kong, Peoples R China; [Huang, Jian-Xing] Fujian Normal Univ, Coll Social Dev, Fuzhou, Peoples R China; [Fung, Helene H.] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Conwell, Yeates] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA	Chinese University of Hong Kong; Huazhong University of Science & Technology; Chinese University of Hong Kong; Fujian Normal University; Chinese University of Hong Kong; University of Rochester	Chiu, HFK (corresponding author), Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	helenchiu@cuhk.edu.hk	Zhong, Baoliang/AEN-1897-2022; Conwell, Yeates/C-9347-2011; Chan, Sandra/AAT-1836-2021	Zhong, Baoliang/0000-0002-7229-1519; Conwell, Yeates/0000-0001-8517-2132; Chan, Sau Man Sandra/0000-0002-5916-139X; Fung, Helene Hoi-lam/0000-0003-1310-8750	Chinese University of Hong Kong. [2041727, 2041728]	Chinese University of Hong Kong.(Chinese University of Hong Kong)	This study was supported by Direct Grant 2041727 (SSMC, PI) and 2041728 (HFKC, PI) from The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoob M, 2011, INDIAN J SOC SCI RES, V8, P128; Berry J.W., 1992, CROSS CULTURAL PSYCH; Bhugra D, 2004, BRIT MED BULL, V69, P129, DOI 10.1093/bmb/ldh007; Bhugra D, 2004, ACTA PSYCHIAT SCAND, V109, P243, DOI 10.1046/j.0001-690X.2003.00246.x; Bhugra D., 2001, ADV PSYCHIAT TREATME, V7, P216, DOI [10.1192/apt.7.3.216, DOI 10.1192/APT.7.3.216]; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Carta Mauro Giovanni, 2005, Clin Pract Epidemiol Ment Health, V1, P13, DOI 10.1186/1745-0179-1-13; Carta MG, 2006, SOC PSYCH PSYCH EPID, V41, P452, DOI 10.1007/s00127-006-0052-4; Chan J, 2013, NEW TECH WORK EMPLOY, V28, P84, DOI 10.1111/ntwe.12007; Chan KW, 1999, CHINA QUART, P818, DOI 10.1017/S0305741000001351; Crockett LJ, 2007, CULT DIVERS ETHN MIN, V13, P347, DOI 10.1037/1099-9809.13.4.347; Ehlers CL, 2009, J ADDICT MED, V3, P227, DOI 10.1097/ADM.0b013e3181ab6db7; Fu L, 2009, J HENAN NORMAL U, V36, P63; Green EGT, 2005, J CROSS CULT PSYCHOL, V36, P321, DOI 10.1177/0022022104273654; Haviland W. A., 2013, ANTHR HUMAN CHALLENG; Hovey J D, 2000, Cultur Divers Ethnic Minor Psychol, V6, P134, DOI 10.1037/1099-9809.6.2.134; Hovey J D, 2000, J Immigr Health, V2, P119, DOI 10.1023/A:1009556802759; Hovey JD, 2002, COMMUNITY MENT HLT J, V38, P223, DOI 10.1023/A:1015215723786; Huang Z, 2011, J GUANGXI TCH ED U S, V32, P117; Hwang WC, 2008, CULT DIVERS ETHN MIN, V14, P147, DOI 10.1037/1099-9809.14.2.147; Jiang Y, 2011, JIAO YU WEN HUA LUN, P27; Jibeen T, 2010, INT J INTERCULT REL, V34, P233, DOI 10.1016/j.ijintrel.2009.09.006; Kim HS, 2013, ARCH PSYCHIAT NURS, V27, P148, DOI 10.1016/j.apnu.2013.02.005; Kroeber A. L., 1952, CULTURE CRITICAL REV; Levecque K, 2007, J AFFECT DISORDERS, V97, P229, DOI 10.1016/j.jad.2006.06.022; Li J, 2010, CROSS CULTURAL RES R; Lincoln Y.S., 2011, SAGE HDB QUALITATIVE, V4th; Liu Q, 2008, J QINGDAO AGR U SOC, V20, P78; Lu J, 2007, J XUCHANG U, V26, P126; Lu Y, 2013, SOC SCI RES, V42, P1443, DOI 10.1016/j.ssresearch.2013.06.006; Mou J, 2011, J COMMUNITY PSYCHOL, V39, P212, DOI 10.1002/jcop.20428; National Bureau of Statistics of China, 2015, 2014 CHIN STAT YB; National Bureau of Statistics of China, 2015, 2014 REP SURV CHIN R; National Bureau of Statistics of China, 2010, 2009 REP SURV CHIN R; Ngai P, 2012, MOD CHINA, V38, P383, DOI 10.1177/0097700412447164; OpenStax-College, 2012, INTRO SOCIOLOGY; PADILLA AM, 1985, J SOC PSYCHOL, V125, P295, DOI 10.1080/00224545.1985.9922890; Research Group of the State Council of China, 2006, INV REP CHIN RUR TO; Salgado H, 2012, J IMMIGR MINOR HEALT, V14, P379, DOI 10.1007/s10903-011-9568-0; Sam D, 2009, CAMBRIDGE HDB ACCULT; Statistics Bureau of Shenzhen, 2013, 2012 SHENZH STAT YB; Sznajder KK, 2014, INT J OCCUP ENV HEAL, V20, P33, DOI 10.1179/2049396713Y.0000000053; Teng Y, 2012, GUAN WEEKLY, V610, P31; Tomas-Sabado J, 2007, PSYCHOL REP, V100, P1013, DOI 10.2466/PR0.100.3.1013-1023; Torres L, 2010, CULT DIVERS ETHN MIN, V16, P256, DOI 10.1037/a0017357; Walker RL, 2008, CULT DIVERS ETHN MIN, V14, P75, DOI 10.1037/1099-9809.14.1.75; Wang B, 2010, SOC SCI MED, V71, P84, DOI 10.1016/j.socscimed.2010.03.021; Wang X., 2009, CULT WKLY, V19, P53; Wong DFK, 2008, SOC PSYCH PSYCH EPID, V43, P483, DOI 10.1007/s00127-008-0341-1; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; Wu C., 2004, J FOLK STUD, V4, P31; Xu L, 2013, ASIAN AM J PSYCHOL, V4, P217, DOI 10.1037/a0030167; Xu TX, 2013, SMALL SCALE PEASANT; Zhang H., 2009, SCI SOC PSYCHOL, V24, P45; Zhao Y, 2009, SHI JI QIAO, P147; Zhong BL, 2015, J AFFECT DISORDERS, V183, P1, DOI 10.1016/j.jad.2015.04.031; Zhong BL, 2013, SOC PSYCH PSYCH EPID, V48, P1569, DOI 10.1007/s00127-013-0672-4	57	46	47	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157530	10.1371/journal.pone.0157530	http://dx.doi.org/10.1371/journal.pone.0157530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KO	27300005	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200058
J	Nath, K; Nelson, DS; Putt, ME; Leeper, DB; Garman, B; Nathanson, KL; Glickson, JD				Nath, Kavindra; Nelson, David S.; Putt, Mary E.; Leeper, Dennis B.; Garman, Bradley; Nathanson, Katherine L.; Glickson, Jerry D.			Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice	PLOS ONE			English	Article							INTRACELLULAR PH; INDUCED ACIDIFICATION; TUMOR; BRAF; CYTOTOXICITY; INHIBITION; METABOLISM; BREAST; MELANOGENESIS; ENHANCEMENT	Previous NMR studies demonstrated that lonidamine (LND) selectively diminishes the intracellular pH (pHi) of DB-1 melanoma and mouse xenografts of a variety of other prevalent human cancers while decreasing their bioenergetic status (tumor beta NTP/Pi ratio) and enhancing the activities of melphalan and doxorubicin in these cancer models. Since melphalan and doxorubicin are highly toxic agents, we have examined three other nitrogen (N)-mustards, chlorambucil, cyclophosphamide and bendamustine, to determine if they exhibit similar potentiation by LND. As single agents LND, melphalan and these N-mustards exhibited the following activities in DB-1 melanoma xenografts; LND: 100% tumor surviving fraction (SF); chlorambucil: 100% SF; cyclophosphamide: 100% SF; bendamustine: 79% SF; melphalan: 41% SF. When combined with LND administered 40 min prior to administration of the N-mustard (to maximize intracellular acidification) the following responses were obtained; chlorambucil: 62% SF; cyclophosphamide: 42% SF; bendamustine: 36% SF; melphalan: 10% SF. The effect of LND on the activities of these N-mustards is generally attributed to acid stabilization of the aziridinium active intermediate, acid inhibition of glutathione-S-transferase, which acts as a scavenger of aziridinium, and acid inhibition of DNA repair by O-6-alkyltransferase. Depletion of ATP by LND may also decrease multidrug resistance and increase tumor response. At similar maximum tolerated doses, our data indicate that melphalan is the most effective N-mustard in combination with LND when treating DB-1 melanoma in mice, but the choice of N-mustard for coadministration with LND will also depend on the relative toxicities of these agents, and remains to be determined.	[Nath, Kavindra; Nelson, David S.; Glickson, Jerry D.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Putt, Mary E.] Univ Penn, Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Garman, Bradley; Nathanson, Katherine L.] Univ Penn, Div Translat Med & Human Genet, Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nathanson, Katherine L.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Leeper, Dennis B.] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Jefferson University	Nath, K (corresponding author), Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	kavindra.nath@uphs.upenn.edu	Glickson, Jerry/AAR-7116-2021		NIH [R01-CA129544, R01-CA172820]; NATIONAL CANCER INSTITUTE [R01CA129544, R01CA172820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants R01-CA129544 and R01-CA172820.; Jeff Roman and Kevin Muriuki are acknowledged for their help to perform this study. Support for this project was provided in part by NIH grants R01-CA129544 and R01-CA172820.	ATEMA A, 1993, INT J CANCER, V54, P166, DOI 10.1002/ijc.2910540126; Barnouin K, 1998, BRIT J CANCER, V77, P201, DOI 10.1038/bjc.1998.34; Ben-Yoseph O, 1998, J NEURO-ONCOL, V36, P149, DOI 10.1023/A:1005819604858; BENHORIN H, 1995, CANCER RES, V55, P2814; BERD D, 1989, CANCER RES, V49, P6840; Bro AYAA, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7528; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; de Andrade LF, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.998119; Demidenko E, 2010, INT J RADIAT BIOL, V86, P164, DOI 10.3109/09553000903419304; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gerweck LE, 1996, CANCER RES, V56, P1194; Guo LL, 2016, J BIOL CHEM, V291, P42, DOI 10.1074/jbc.M115.697516; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; HILL LL, 1991, CANCER RES, V51, P4937; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; JAHDE E, 1989, CANCER RES, V49, P2965; JAHDE E, 1991, CANCER CHEMOTH PHARM, V27, P440, DOI 10.1007/BF00685157; JAHDE E, 1993, EUR J CANCER, V29A, P116, DOI 10.1016/0959-8049(93)90587-6; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jiang YC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1363; Kuin A, 1999, BRIT J CANCER, V79, P793, DOI 10.1038/sj.bjc.6690127; Leoni LM, 2008, CLIN CANCER RES, V14, P309, DOI 10.1158/1078-0432.CCR-07-1061; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu S, 2006, J IMMUNOTHER, V29, P284, DOI 10.1097/01.cji.0000190168.53793.6b; Lutzky J, 2014, CHIN CLIN ONCOL, V3, DOI 10.3978/j.issn.2304-3865.2014.05.13; Mardor Y, 2000, CANCER RES, V60, P5179; Martinez-Zaguilan R, 1999, BIOCHEM PHARMACOL, V57, P1037, DOI 10.1016/S0006-2952(99)00022-2; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Nancolas B, 2016, BIOCHEM J, V473, P929, DOI 10.1042/BJ20151120; Nath K, 2015, NMR BIOMED, V28, P395, DOI 10.1002/nbm.3260; Nath K, 2015, NMR BIOMED, V28, P281, DOI 10.1002/nbm.3240; Nath K, 2013, NMR BIOMED, V26, P98, DOI 10.1002/nbm.2824; Parmenter TJ, 2014, CANCER DISCOV, V4, P423, DOI 10.1158/2159-8290.CD-13-0440; Raghunand N, 1999, BRIT J CANCER, V80, P1005, DOI 10.1038/sj.bjc.6690455; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P309, DOI 10.1016/S0006-2952(98)00306-2; Raghunand N, 2003, BIOCHEM PHARMACOL, V66, P1219, DOI 10.1016/S0006-2952(03)00468-4; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Shestov AA, 2013, ADV EXP MED BIOL, V765, P265, DOI 10.1007/978-1-4614-4989-8_37; Shestov AA, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00135; Shestov AA, 2016, J BIOL CHEM, V291, P5157, DOI 10.1074/jbc.M115.701862; Silva AS, 2009, CANCER RES, V69, P2677, DOI 10.1158/0008-5472.CAN-08-2394; SKARSGARD LD, 1995, ANTICANCER RES, V15, P219; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; TANNOCK IF, 1989, CANCER RES, V49, P4373; Thompson JA, 2012, J IMMUNOTHER, V35, P73, DOI 10.1097/CJI.0b013e31823735d6; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Wahl ML, 2002, MOL CANCER THER, V1, P617; Wang AX, 2013, IUBMB LIFE, V65, P748, DOI 10.1002/iub.1193; Warburg, 1930, METABOLISM TUMORS; Wong P, 2005, CLIN CANCER RES, V11, P3553, DOI 10.1158/1078-0432.CCR-04-2472; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Zhou R, 2001, ACAD RADIOL, V8, P571, DOI 10.1016/S1076-6332(03)80681-5	63	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157125	10.1371/journal.pone.0157125	http://dx.doi.org/10.1371/journal.pone.0157125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285585	Green Published, Green Submitted, gold			2022-12-27	WOS:000377564000039
J	Ware, C; Trites, AW; Rosen, DAS; Potvin, J				Ware, Colin; Trites, Andrew W.; Rosen, David A. S.; Potvin, Jean			Averaged Propulsive Body Acceleration (APBA) Can Be Calculated from Biologging Tags That Incorporate Gyroscopes and Accelerometers to Estimate Swimming Speed, Hydrodynamic Drag and Energy Expenditure for Steller Sea Lions	PLOS ONE			English	Article							MARINE MAMMALS; DIVING METABOLISM; KINEMATICS; BUOYANCY; MOVEMENTS; ANIMALS; DIVES	Forces due to propulsion should approximate forces due to hydrodynamic drag for animals horizontally swimming at a constant speed with negligible buoyancy forces. Propulsive forces should also correlate with energy expenditures associated with locomotion-an important cost of foraging. As such, biologging tags containing accelerometers are being used to generate proxies for animal energy expenditures despite being unable to distinguish rotational movements from linear movements. However, recent miniaturizations of gyroscopes offer the possibility of resolving this shortcoming and obtaining better estimates of body accelerations of swimming animals. We derived accelerations using gyroscope data for swimming Steller sea lions (Eumetopias jubatus), and determined how well the measured accelerations correlated with actual swimming speeds and with theoretical drag. We also compared dive averaged dynamic body acceleration estimates that incorporate gyroscope data, with the widely used Overall Dynamic Body Acceleration (ODBA) metric, which does not use gyroscope data. Four Steller sea lions equipped with biologging tags were trained to swim alongside a boat cruising at steady speeds in the range of 4 to 10 kph. At each speed, and for each dive, we computed a measure called Gyro-Informed Dynamic Acceleration (GIDA) using a method incorporating gyroscope data with accelerometer data. We derived a new metric-Averaged Propulsive Body Acceleration (APBA), which is the average gain in speed per flipper stroke divided by mean stroke cycle duration. Our results show that the gyro-based measure (APBA) is a better predictor of speed than ODBA. We also found that APBA can estimate average thrust production during a single stroke-glide cycle, and can be used to estimate energy expended during swimming. The gyroscope-derived methods we describe should be generally applicable in swimming animals where propulsive accelerations can be clearly identified in the signal-and they should also prove useful for dead-reckoning and improving estimates of energy expenditures from locomotion.	[Ware, Colin] Univ New Hampshire, Ctr Coastal & Ocean Mapping, Durham, NH 03824 USA; [Trites, Andrew W.; Rosen, David A. S.] Univ British Columbia, Marine Mammal Res Unit, Inst Oceans & Fisheries, Vancouver, BC V5Z 1M9, Canada; [Potvin, Jean] St Louis Univ, Dept Phys, St Louis, MO 63103 USA	University System Of New Hampshire; University of New Hampshire; University of British Columbia; Saint Louis University	Ware, C (corresponding author), Univ New Hampshire, Ctr Coastal & Ocean Mapping, Durham, NH 03824 USA.	cware@ccom.unh.edu		Trites, Andrew/0000-0003-0342-5322; Ware, Colin/0000-0002-4616-5017	Vancouver Aquarium through the North Pacific Marine Science Foundation; National Oceanic and Atmospheric Administration through the North Pacific Marine Science Foundation; North Pacific Universities Marine Mammal Research Consortium; NOAA [NA05NOS4001153]; ONR [N000141410395]; US Office of Naval Research	Vancouver Aquarium through the North Pacific Marine Science Foundation; National Oceanic and Atmospheric Administration through the North Pacific Marine Science Foundation; North Pacific Universities Marine Mammal Research Consortium; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); ONR(Office of Naval Research); US Office of Naval Research(Office of Naval Research)	Financial support was provided by the Vancouver Aquarium and The National Oceanic and Atmospheric Administration through the North Pacific Marine Science Foundation and the North Pacific Universities Marine Mammal Research Consortium. Funding for the UNH effort was provided by NOAA grant NA05NOS4001153 and ONR grant N000141410395.; We wish to acknowledge the essential role played by the UBC Open Water Research Station, including the technicians and Vancouver Aquarium trainers. This study was supported in part by The National Oceanic and Atmospheric Administration through the North Pacific Marine Science Foundation and the North Pacific Universities Marine Mammal Research Consortium. Additional funding was provided by the US Office of Naval Research. All research protocols were approved by the UBC Animal Care Committee.	CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cheneval O, 2007, MAR MAMMAL SCI, V23, P94, DOI 10.1111/j.1748-7692.2006.00094.x; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Dole C. E., 1981, FLIGHT THEORY AERODY; ENGLISH AW, 1976, J ZOOL, V178, P341; Euston M, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P340, DOI 10.1109/IROS.2008.4650766; Fahlman A, 2008, AQUAT BIOL, V3, P147, DOI 10.3354/ab00074; Fahlman A, 2008, AQUAT BIOL, V2, P75, DOI 10.3354/ab00039; FELDKAMP SD, 1987, J ZOOL, V212, P43, DOI 10.1111/j.1469-7998.1987.tb05113.x; FELDKAMP SD, 1987, J EXP BIOL, V131, P117; Fish FE, 2003, J EXP BIOL, V206, P667, DOI 10.1242/jeb.00144; Fish FE, 1998, J EXP BIOL, V201, P2867; FISH FE, 1993, J EXP BIOL, V185, P179; FISH FE, 1988, J EXP BIOL, V137, P157; Fourati H, 2013, NOVEL MICROELECTRONI, P324; Fourati H, 2011, BIOMED SIGNAL PROCES, V6, P94, DOI 10.1016/j.bspc.2010.06.004; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Gleiss AC, 2010, J EXP MAR BIOL ECOL, V385, P85, DOI 10.1016/j.jembe.2010.01.012; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Hertel H., 1966, STRUCTURE FORM MOVEM; Hindle AG, 2010, AQUAT BIOL, V10, P139, DOI 10.3354/ab00279; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; KOOYMAN GL, 1989, ZOOPHYSIOLOGY SERIES, V23; Luinge HJ, 2005, MED BIOL ENG COMPUT, V43, P273, DOI 10.1007/BF02345966; Lopez LMM, 2015, J EXP BIOL, V218, P1325, DOI 10.1242/jeb.106013; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; Mitani Y, 2003, POLAR BIOL, V26, P311, DOI 10.1007/s00300-003-0487-y; Noda T, 2014, J EXP MAR BIOL ECOL, V451, P55, DOI 10.1016/j.jembe.2013.10.031; Noda T, 2012, AQUAT BIOL, V16, P265, DOI 10.3354/ab00448; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Shoemake K., 1985, ACM SIGGRAPH COMPUTE, V19, P245, DOI DOI 10.1145/325165.325242; Stelle LL, 2000, J EXP BIOL, V203, P1915; Tanaka H, 2001, J EXP BIOL, V204, P3895; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; Webb PW, 2010, INTEGR COMP BIOL, V50, P1155, DOI 10.1093/icb/icq020; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; Williams TM., 1987, APPROACHES MARINE MA, P127; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; WILSON RP, 1988, MEERESFORSCHUNG, V32, P155	44	17	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157326	10.1371/journal.pone.0157326	http://dx.doi.org/10.1371/journal.pone.0157326			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285467	Green Published, Green Submitted, gold			2022-12-27	WOS:000377564000057
J	Ahn, JH; Yang, JH; Yu, CW; Kim, JS; Lee, HJ; Choi, RK; Kim, TH; Jang, HJ; Choi, YJ; Roh, YM; Shim, WH; Bin Song, Y; Hahn, JY; Choi, JH; Lee, SH; Gwon, HC; Choi, SH				Ahn, Jong-Hwa; Yang, Jeong Hoon; Yu, Cheol Woong; Kim, Je Sang; Lee, Hyun Jong; Choi, Rak Kyeong; Kim, Tae Hoon; Jang, Ho Joon; Choi, Young Jin; Roh, Young Moo; Shim, Won-Heum; Bin Song, Young; Hahn, Joo-Yong; Choi, Jin-Ho; Lee, Sang Hoon; Gwon, Hyeon-Cheol; Choi, Seung-Hyuk			First-Generation Versus Second-Generation Drug-Eluting Stents in Coronary Chronic Total Occlusions: Two-Year Results of a Multicenter Registry	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CONSENSUS DOCUMENT; FOLLOW-UP; PERCUTANEOUS RECANALIZATION; BALLOON ANGIOPLASTY; SIROLIMUS; EVEROLIMUS; ARTERIES; OUTCOMES; INTERVENTION	Background Limited data are available regarding the long-term clinical outcomes of second-generation drug-eluting stents (DES) versus first-generation DES in patients with coronary chronic total occlusion (CTO) who undergo percutaneous coronary intervention (PCI). The aim of this study was to compare the clinical outcomes of second-generation DES with those of first-generation DES for the treatment of CTO. Methods and Results Between March 2003 and February 2012, 1,006 consecutive patients with CTO who underwent successful PCI using either first-generation DES (n = 557) or second-generation DES (n = 449) were enrolled in a multicenter, observational registry. Propensity-score matching was also performed. The primary outcome was cardiac death over a 2-year follow-up period. No significant differences were observed between the two groups regarding the incidence of cardiac death (first-generation DES versus second-generation DES; 2.5% vs 2.0%; hazard ratio [HR]: 0.86; 95% confidence interval [CI]: 0.37 to 1.98; p = 0.72) or major adverse cardiac events (MACE, 11.8% vs 11.4%; HR: 1.00; 95% CI: 0.67 to 1.50; p = 0.99). After propensity score matching, the incidences of cardiac death (HR: 0.86; 95% CI: 0.35 to 2.06; p = 0.86) and MACE (HR: 0.93; 95% CI: 0.63 to 1.37; p = 0.71) were still similar in both groups. Furthermore, no significant differences were observed between sirolimus-eluting, paclitaxel-eluting, zotarolimus-eluting, and everolimus-eluting stents regarding the incidence of cardiac death or MACE. Conclusion This study shows that the efficacy of second-generation DES is comparable to that of first-generation DES for treatment of CTO over 2 years of follow-up.	[Ahn, Jong-Hwa] Gyeongsang Natl Univ, Sch Med, Dept Med, Div Cardiol, Chang Won, South Korea; [Ahn, Jong-Hwa] Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea; [Ahn, Jong-Hwa; Yang, Jeong Hoon; Bin Song, Young; Hahn, Joo-Yong; Choi, Jin-Ho; Lee, Sang Hoon; Gwon, Hyeon-Cheol; Choi, Seung-Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Cardiac & Vasc Ctr, Seoul, South Korea; [Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Yu, Cheol Woong] Korea Univ, Med Ctr, Anam Hosp, Div Cardiol,Dept Med,Cardiovasc Ctr, Seoul, South Korea; [Kim, Je Sang; Lee, Hyun Jong; Choi, Rak Kyeong; Kim, Tae Hoon; Jang, Ho Joon; Choi, Young Jin; Roh, Young Moo; Shim, Won-Heum] Sejong Gen Hosp, Dept Internal Med, Div Cardiol, Bucheon, South Korea	Gyeongsang National University; Gyeongsang National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine); Sejong General Hospital	Choi, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Cardiac & Vasc Ctr, Seoul, South Korea.	sh1214.choi@samsung.com	Kim, Tae-Hoon/AAG-3292-2021; Hahn, Joo-Yong/AAU-7250-2020	Hahn, Joo-Yong/0000-0002-4412-377X; Kim, Tae-Hoon/0000-0002-4032-1285				Agostoni P, 2006, AM HEART J, V151, P682, DOI 10.1016/j.ahj.2005.05.001; Alazzoni Ashraf, 2012, Thrombosis, V2012, P126369, DOI 10.1155/2012/126369; Almalla M, 2012, INT J CARDIOL, V157, P451, DOI 10.1016/j.ijcard.2012.04.020; Applegate RJ, 2011, AM J CARDIOL, V107, P833, DOI 10.1016/j.amjcard.2010.10.069; Buller CE, 1999, CIRCULATION, V100, P236, DOI 10.1161/01.CIR.100.3.236; Burzotta F, 2011, JACC-CARDIOVASC INTE, V4, P327, DOI 10.1016/j.jcin.2010.12.005; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; de Waha A, 2011, CIRC-CARDIOVASC INTE, V4, P371, DOI 10.1161/CIRCINTERVENTIONS.111.963256; Eisenstein EL, 2009, JACC-CARDIOVASC INTE, V2, P1199, DOI 10.1016/j.jcin.2009.10.009; Ge L, 2005, EUR HEART J, V26, P1056, DOI 10.1093/eurheartj/ehi191; Godino C, 2013, INT J CARDIOL, V168, P1402, DOI 10.1016/j.ijcard.2012.12.044; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Kimura T, 2012, CIRCULATION, V126, P1225, DOI 10.1161/CIRCULATIONAHA.112.104059; KINOSHITA I, 1995, J AM COLL CARDIOL, V26, P409, DOI 10.1016/0735-1097(95)80015-9; Kirtane AJ, 2013, JACC-CARDIOVASC INTE, V6, P325, DOI 10.1016/j.jcin.2012.12.123; Lanka V, 2014, J INVASIVE CARDIOL, V26, P304; Lansky AJ, 2002, J AM COLL CARDIOL, V39, P274, DOI 10.1016/S0735-1097(01)01745-4; Machado C, 2014, CORONARY ARTERY DIS, V25, P208, DOI 10.1097/MCA.0000000000000078; Maeng M, 2014, LANCET, V383, P2047, DOI 10.1016/S0140-6736(14)60405-0; Moreno R, 2013, CIRC-CARDIOVASC INTE, V6, P21, DOI 10.1161/CIRCINTERVENTIONS.112.000076; Nakamura S, 2005, AM J CARDIOL, V95, P161, DOI 10.1016/j.amjcard.2004.08.088; Olivari Z, 2003, J AM COLL CARDIOL, V41, P1672, DOI 10.1016/S0735-1097(03)00312-7; Park DW, 2010, J AM COLL CARDIOL, V56, P1187, DOI 10.1016/j.jacc.2010.03.086; Park HJ, 2012, CIRC J, V76, P868, DOI 10.1253/circj.CJ-11-1021; Raber L, 2012, CIRCULATION, V125, P1110, DOI 10.1161/CIRCULATIONAHA.111.058560; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Sianos G, 2012, EUROINTERVENTION, V8, P139, DOI 10.4244/EIJV8I1A21; Smits PC, 2011, J AM COLL CARDIOL, V58, P11, DOI 10.1016/j.jacc.2011.02.023; Stone GW, 2011, J AM COLL CARDIOL, V58, P19, DOI 10.1016/j.jacc.2011.02.022; Stone GW, 2005, CIRCULATION, V112, P2364, DOI 10.1161/CIRCULATIONAHA.104.481283; Stone GW, 2005, CIRCULATION, V112, P2530, DOI 10.1161/CIRCULATIONAHA.105.583716; Suttorp MJ, 2006, CIRCULATION, V114, P921, DOI 10.1161/CIRCULATIONAHA.106.613588; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Valenti R, 2013, J AM COLL CARDIOL, V61, P545, DOI 10.1016/j.jacc.2012.10.036; Werner GS, 2004, J AM COLL CARDIOL, V44, P2301, DOI 10.1016/j.jacc.2004.09.040	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157549	10.1371/journal.pone.0157549	http://dx.doi.org/10.1371/journal.pone.0157549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314589	gold, Green Published, Green Submitted			2022-12-27	WOS:000378030000033
J	Schinkel, SCB; Carrasco-Medina, L; Cooper, CL; Crawley, AM				Schinkel, Stephanie C. Burke; Carrasco-Medina, Lorna; Cooper, Curtis L.; Crawley, Angela M.			Generalized Liver- and Blood-Derived CD8(+) T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INTERLEUKIN-7 RECEPTOR EXPRESSION; PERIPHERAL-BLOOD; CD127 EXPRESSION; ANTIRETROVIRAL THERAPY; IMMUNE DYSFUNCTION; HCV INFECTION; HIV-INFECTION; VIRAL PERSISTENCE; MONONUCLEAR-CELLS	Generalized CD8(+) T-cell impairment in chronic hepatitis C virus (HCV) infection and the contribution of liver-infiltrating CD8(+) T-cells to the immunopathogenesis of this infection remain poorly understood. It is hypothesized that this impairment is partially due to reduced CD8(+) T-cell activity in response to cytokines such as IL-7, particularly within the liver. To investigate this, the phenotype and cytokine responsiveness of blood-and liver-derived CD8(+) T-cells from healthy controls and individuals with HCV infection were compared. In blood, IL-7 receptor alpha (CD127) expression on bulk CD8(+) T-cells in HCV infection was no different than controls yet was lower on central memory T-cells, and there were fewer naive cells. IL-7-induced signalling through phosphorylated STAT5 was lower in HCV infection than in controls, and differed between CD8(+) T-cell subsets. Production of Bcl-2 following IL7 stimulation was also lower in HCV infection and inversely related to the degree of liver fibrosis. In liver-derived CD8(+) T-cells, STAT5 activation could not be increased with cytokine stimulation and basal Bcl-2 levels of liver-derived CD8(+) T-cells were lower than bloodderived counterparts in HCV infection. Therefore, generalized CD8(+) T-cell impairment in HCV infection is characterized, in part, by impaired IL-7-mediated signalling and survival, independent of CD127 expression. This impairment is more pronounced in the liver and may be associated with an increased potential for apoptosis. This generalized CD8(+) T-cell impairment represents an important immune dysfunction in chronic HCV infection that may alter patient health.	[Schinkel, Stephanie C. Burke; Crawley, Angela M.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Schinkel, Stephanie C. Burke; Carrasco-Medina, Lorna; Cooper, Curtis L.; Crawley, Angela M.] Ottawa Hosp, Res Inst, Chron Dis Program, Ottawa, ON, Canada; [Cooper, Curtis L.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Cooper, Curtis L.] Ottawa Hosp Gen Campus, Div Infect Dis, Ottawa, ON, Canada; [Crawley, Angela M.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Carleton University	Crawley, AM (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Crawley, AM (corresponding author), Ottawa Hosp, Res Inst, Chron Dis Program, Ottawa, ON, Canada.; Crawley, AM (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	acrawley@ohri.ca	Cooper, Curtis/M-9320-2019	Crawley, Angela/0000-0002-7453-7922	Ontario Graduate Scholarship; Queen Elizabeth II Graduate Scholarship in Science and Technology; Canadian Institutes of Health Research; Ontario HIV Treatment Network (OHTN); OHTN; Canadian Foundation for AIDS Research; J.P. Bickell Foundation	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Queen Elizabeth II Graduate Scholarship in Science and Technology; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network (OHTN); OHTN; Canadian Foundation for AIDS Research; J.P. Bickell Foundation	S.B.S. was the recipient of the Ontario Graduate Scholarship and the Queen Elizabeth II Graduate Scholarship in Science and Technology. A.M.C. is the recipient of a New Investigator salary award from the Canadian Institutes of Health Research, and a Junior Investigator Development Award from the Ontario HIV Treatment Network (OHTN). This research was funded by the OHTN, Canadian Foundation for AIDS Research and the J.P. Bickell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hakeem MS, 2014, GASTROENTEROLOGY, V147, P870, DOI 10.1053/j.gastro.2014.07.005; Abel M, 2006, HEPATOLOGY, V44, P1607, DOI 10.1002/hep.21438; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barrett L, 2011, J VIRAL HEPATITIS, V18, P170, DOI 10.1111/j.1365-2893.2010.01293.x; Barrett L, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-28; Bazdar DA, 2009, J INFECT DIS, V199, P1019, DOI 10.1086/597210; Bengsch B, 2007, J VIROL, V81, P945, DOI 10.1128/JVI.01354-06; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bertolino P, 2002, IMMUNOL CELL BIOL, V80, P84, DOI 10.1046/j.0818-9641.2001.01048.x; Bonnel AR, 2011, CLIN GASTROENTEROL H, V9, P727, DOI 10.1016/j.cgh.2011.02.031; Borzio M, 2001, DIGEST LIVER DIS, V33, P41, DOI 10.1016/S1590-8658(01)80134-1; Boutboul F, 2005, AIDS, V19, P1981, DOI 10.1097/01.aids.0000191919.24185.46; Chen M, 2005, J IMMUNOL, V175, P1047, DOI 10.4049/jimmunol.175.2.1047; Colle JH, 2006, JAIDS-J ACQ IMM DEF, V42, P277, DOI 10.1097/01.qai.0000214823.11034.4e; Colle JH, 2006, CLIN EXP IMMUNOL, V143, P398, DOI 10.1111/j.1365-2249.2006.03022.x; Collins AS, 2014, J LEUKOCYTE BIOL, V96, P255, DOI 10.1189/jlb.2A1211-608RRRR; Colombat M, 2002, HUM PATHOL, V33, P1170, DOI 10.1053/hupa.2002.129414; Crawley AM, 2014, J LEUKOCYTE BIOL, V95, P117, DOI 10.1189/jlb.0313122; Crawley AM, 2010, J IMMUNOL, V184, P4679, DOI 10.4049/jimmunol.0903758; Faller EM, 2006, JAIDS-J ACQ IMM DEF, V43, P257, DOI 10.1097/01.qai.0000230319.78288.f4; Solari NEF, 2012, J CLIN IMMUNOL, V32, P611, DOI 10.1007/s10875-011-9635-2; Feuth T, 2014, EUR J CLIN MICROBIOL, V33, P1113, DOI 10.1007/s10096-014-2053-7; Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Graham CS, 2005, AIDS, V19, P767, DOI 10.1097/01.aids.0000168970.80551.3d; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Hartling HJ, 2013, SCAND J IMMUNOL, V78, P378, DOI 10.1111/sji.12096; Hofmeister R, 1999, CYTOKINE GROWTH F R, V10, P41, DOI 10.1016/S1359-6101(98)00025-2; Holz LE, 2012, J HEPATOL, V57, P830, DOI 10.1016/j.jhep.2012.05.015; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jin X, 2000, J INFECT DIS, V181, P165, DOI 10.1086/315201; Jo J, 2009, GASTROENTEROLOGY, V136, P1391, DOI 10.1053/j.gastro.2008.12.034; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Kimura MY, 2013, NAT IMMUNOL, V14, P143, DOI 10.1038/ni.2494; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Kroy DC, 2014, GASTROENTEROLOGY, V146, P550, DOI 10.1053/j.gastro.2013.10.022; Larrea E, 2014, GUT, V63, P665, DOI 10.1136/gutjnl-2012-304377; Larrubia JR, 2013, J VIRAL HEPATITIS, V20, P85, DOI 10.1111/j.1365-2893.2012.01618.x; Li Y, 2005, J INFECT DIS, V192, P1093, DOI 10.1086/432957; Looney RJ, 1999, CLIN IMMUNOL, V90, P213, DOI 10.1006/clim.1998.4638; Lucas M, 2004, J IMMUNOL, V172, P1744, DOI 10.4049/jimmunol.172.3.1744; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Marquez M, 2009, CLIN EXP IMMUNOL, V158, P219, DOI 10.1111/j.1365-2249.2009.04005.x; Martinez-Sierra C, 2003, CLIN INFECT DIS, V36, P491, DOI 10.1086/367643; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Meyer-Olson D, 2004, J EXP MED, V200, P307, DOI 10.1084/jem.20040638; Mohsen AH, 2003, GUT, V52, P1035, DOI 10.1136/gut.52.7.1035; Moss P, 2004, HUM IMMUNOL, V65, P456, DOI 10.1016/j.humimm.2004.02.014; Nascimbeni Michelina, 2004, Methods Mol Med, V96, P65; NOURIARIA KT, 1986, J HEPATOL, V2, P195, DOI 10.1016/S0168-8278(86)80078-2; O'Connor AM, 2010, IMMUNOLOGY, V131, P525, DOI 10.1111/j.1365-2567.2010.03325.x; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Sheahan TP, 2013, GASTROENTEROLOGY, V145, P1199, DOI 10.1053/j.gastro.2013.10.035; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Singhal S, 2000, TRANSPLANTATION, V69, P2251, DOI 10.1097/00007890-200006150-00006; Sipeki N, 2014, WORLD J GASTROENTERO, V20, P2564, DOI 10.3748/wjg.v20.i10.2564; SMYTH MJ, 1991, CELL IMMUNOL, V138, P390, DOI 10.1016/0008-8749(91)90163-6; Sommershof A, 2009, BRAIN BEHAV IMMUN, V23, P1117, DOI 10.1016/j.bbi.2009.07.003; Spangenberg HC, 2005, HEPATOLOGY, V42, P828, DOI 10.1002/hep.20856; Swainson L, 2007, BLOOD, V109, P1034, DOI 10.1182/blood-2006-06-027912; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Tokita D, 2008, J HEPATOL, V49, P1008, DOI 10.1016/j.jhep.2008.07.028; Tripathi P, 2010, J IMMUNOL, V185, P2116, DOI 10.4049/jimmunol.1000842; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Vali B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003454; Valiante NM, 2000, IMMUNOL REV, V174, P77, DOI 10.1034/j.1600-0528.2002.017417.x; Valva P, 2014, CLIN MICROBIOL INFEC, V20, pO998, DOI 10.1111/1469-0691.12728; Vranjkovic A, 2012, AIDS RES HUM RETROV, V28, P295, DOI 10.1089/aid.2011.0003; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Yao ZQ, 2008, IMMUNOLOGY, V125, P197, DOI 10.1111/j.1365-2567.2008.02829.x; Zhao BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077008	79	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157055	10.1371/journal.pone.0157055	http://dx.doi.org/10.1371/journal.pone.0157055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315061	gold, Green Submitted, Green Published			2022-12-27	WOS:000378030000011
J	DiDiodato, G; McArthur, L				DiDiodato, Giulio; McArthur, Leslie			Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, SingleSite, Observational Study	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; EPIDEMIOLOGY; HOSPITALS; PRESSURE; DISEASE; IMPACT; COSTS; NHS	Background The incidence rate of healthcare-associated Clostridium difficile infection (HA-CDI) is estimated at 1 in 100 patients. Antibiotic exposure is the most consistently reported risk factor for HA-CDI. Strategies to reduce the risk of HA-CDI have focused on reducing antibiotic utilization. Prospective audit and feedback is a commonly used antimicrobial stewardship intervention (ASi). The impact of this ASi on risk of HA-CDI is equivocal. This study examines the effectiveness of a prospective audit and feedback ASi on reducing the risk of HA-CDI. Methods Single-site, 339 bed community-hospital in Barrie, Ontario, Canada. Primary outcome is HA-CDI incidence rate. Daily prospective and audit ASi is the exposure variable. ASi implemented across 6 wards in a non-randomized, stepped wedge design. Criteria for ASi; any intravenous antibiotic use for >= 48 hrs, any oral fluoroquinolone or oral second generation cephalosporin use for >= 48 hrs, or any antimicrobial use for >= 5 days. HA-CDI cases and model covariates were aggregated by ward, year and month starting September 2008 and ending February 2016. Multi-level mixed effect negative binomial regression analysis was used to model the primary outcome, with intercept and slope coefficients for ward-level random effects estimated. Other covariates tested for inclusion in the final model were derived from previously published risk factors. Deviance residuals were used to assess the model's goodness-of-fit. Findings The dataset included 486 observation periods, of which 350 were control periods and 136 were intervention periods. After accounting for all other model covariates, the estimated overall ASi incidence rate ratio (IRR) was 0.48 (95% 0.30, 0.79). The ASi effect was independent of antimicrobial utilization. The ASi did not seem to reduce the risk of Clostridium difficile infection on the surgery wards (IRR 0.87, 95% CI 0.45, 1.69) compared to the medicine wards (IRR 0.42, 95% CI 0.28, 0.63). The ward-level burden of Clostridium difficile as measured by the ward's previous month's total CDI cases (CDI Lag) and the ward's current month's community-associated CDI cases (CA-CDI) was significantly associated with an increased risk of HA-CDI, with the estimated CDI Lag IRR of 1.21 (95% 1.15, 1.28) and the estimated CA-CDI IRR of 1.10 (95% CI 1.01, 1.20). The ward-level random intercept and slope coefficients were not significant. The final model demonstrated good fit. Conclusions In this study, a daily prospective audit and feedback ASi resulted in a significant reduction in the risk of HA-CDI on the medicine wards, however, this effect was independent of an overall reduction in antibiotic utilization. In addition, the ward-level burden of Clostridium difficile was shown to significantly increase the risk of HA-CDI, reinforcing the importance of the environment as a source of HA-CDI.	[DiDiodato, Giulio; McArthur, Leslie] Royal Victoria Reg Hlth Ctr, Dept Pharm, Barrie, ON, Canada		DiDiodato, G (corresponding author), Royal Victoria Reg Hlth Ctr, Dept Pharm, Barrie, ON, Canada.	gdidiodato@gmail.com		DiDiodato, Giulio/0000-0003-2836-8037				Accreditation Canada, 2015, REQ ORG PRACT; Ajao AO, 2011, INFECT CONT HOSP EP, V32, P481, DOI 10.1086/659403; [Anonymous], IMPACT TYPE DIAGNOST; Ashiru-Oredope D, 2012, J ANTIMICROB CHEMOTH, V67, pI51, DOI 10.1093/jac/dks202; Beaulac K., ANTIMICROBIAL STEWAR; Becerra MB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0925-9; Biswas JS, 2015, INFECT CONT HOSP EP, V36, P975, DOI 10.1017/ice.2015.79; Borde JP, 2015, INFECTION, V43, P45, DOI 10.1007/s15010-014-0693-2; Brown K, 2015, JAMA INTERN MED; Canada Public Health Agency of, 2013, CLOSTR DIFF INF INF; Cook PP, 2015, INT J ANTIMICROB AG, V45, P262, DOI 10.1016/j.ijantimicag.2014.11.006; Cooke J, 2014, PUBLIC HEALTH, V128, P693, DOI 10.1016/j.puhe.2014.06.023; Daneman N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001268; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; DiDiodato G., HAS IMPROVED HAND HY; Dubberke ER, 2007, CLIN INFECT DIS, V45, P1543, DOI 10.1086/523582; Dubberke ER, 2007, ARCH INTERN MED, V167, P1092, DOI 10.1001/archinte.167.10.1092; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Feazel LM, 2014, J ANTIMICROB CHEMOTH, V69, P1748, DOI 10.1093/jac/dku046; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Fridkin S, 2014, MMWR-MORBID MORTAL W, V63, P194; Gerding DN, 2015, INFECT DIS CLIN N AM, V29, P37, DOI 10.1016/j.idc.2014.11.004; Health Quality Ontario, 2015, PUBL REP; Kaier K, 2009, INFECT CONT HOSP EP, V30, P346, DOI 10.1086/596605; Lawrence SJ, 2007, INFECT CONT HOSP EP, V28, P123, DOI 10.1086/511793; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Levy AR, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv076; Longtin Y, 2016, JAMA INT MED; Magill SS, 2014, JAMA-J AM MED ASSOC, V312, P1438, DOI 10.1001/jama.2014.12923; Mdege ND, 2011, J CLIN EPIDEMIOL, V64, P936, DOI 10.1016/j.jclinepi.2010.12.003; Miller AC, 2016, AM J INFECT CONTROL; Moehring RW, 2013, INFECT CONT HOSP EP, V34, P1055, DOI 10.1086/673144; Ontario Agency for Health Protection and Promotion (Public Health Ontario) Provincial Infectious Diseases Advisory Committee, 2014, APP B PROV CAS DEF R; Ostrowsky B, 2014, INFECT CONT HOSP EP, V35, pS86, DOI 10.1086/677828; Pakyz AL, 2015, INFECT CONT HOSP EP, V36, P838, DOI 10.1017/ice.2015.63; Pakyz AL, 2015, J ANTIMICROB CHEMOTH, V70, P1588, DOI 10.1093/jac/dku555; Palmay L, 2014, CLIN INFECT DIS; Passaretti CL, 2011, INFECT CONT HOSP EP, V32, P768, DOI 10.1086/660873; Polk RE, 2011, CLIN INFECT DIS, V53, P1100, DOI 10.1093/cid/cir672; Sarma JB, 2015, J HOSP INFECT, V91, P74, DOI 10.1016/j.jhin.2015.05.013; Shaughnessy MK, 2011, INFECT CONT HOSP EP, V32, P201, DOI 10.1086/658669; Slayton RB, 2015, INFECT CONT HOSP EP, V36, P681, DOI 10.1017/ice.2015.43; SOCIETY FOR, 2012, INFECT CONT HOSP EP, V33, P322, DOI DOI 10.1086/665010; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; Tartof SY, 2015, INFECT CONT HOSP EP, P1; Vonberg RP, 2008, J HOSP INFECT, V70, P15, DOI 10.1016/j.jhin.2008.05.004	46	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157671	10.1371/journal.pone.0157671	http://dx.doi.org/10.1371/journal.pone.0157671			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309536	Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800119
J	Hiebert, CW; Kolmer, JA; McCartney, CA; Briggs, J; Fetch, T; Bariana, H; Choulet, F; Rouse, MN; Spielmeyer, W				Hiebert, Colin W.; Kolmer, James A.; McCartney, Curt A.; Briggs, Jordan; Fetch, Tom; Bariana, Harbans; Choulet, Frederic; Rouse, Matthew N.; Spielmeyer, Wolfgang			Major Gene for Field Stem Rust Resistance Co-Locates with Resistance Gene Sr12 in 'Thatcher' Wheat	PLOS ONE			English	Article							ADULT-PLANT RESISTANCE; RAPID METHOD; RACE TTKS; MARKERS; LEAF; ASSOCIATION; CANTHATCH; VIRULENCE; LR34; ARM	Stem rust, caused by Puccinia graminis (Pgt), is a damaging disease of wheat that can be controlled by utilizing effective stem rust resistance genes. ` Thatcher' wheat carries complex resistance to stem rust that is enhanced in the presence of the resistance gene Lr34. The purpose of this study was to examine APR in ` Thatcher' and look for genetic interactions with Lr34. A RIL population was tested for stem rust resistance in field nurseries in Canada, USA, and Kenya. BSA was used to find SNP markers associated with reduced stem rust severity. A major QTL was identified on chromosome 3BL near the centromere in all environments. Seedling testing showed that Sr12 mapped to the same region as the QTL for APR. The SNP markers were physically mapped and the region carrying the resistance was searched for sequences with homology to members of the NB-LRR resistance gene family. SNP marker from one NB-LRR-like sequence, NB-LRR3 co-segregated with Sr12. Two additional populations, including one that lacked Lr34, were tested in field nurseries. NB-LRR3 mapped near the maximum LOD for reduction in stem rust severity in both populations. Lines from a population that segregated for Sr12 and Lr34 were tested for seedling Pgt biomass and infection type, as well as APR to field stem rust which showed an interaction between the genes. We concluded that Sr12, or a gene closely linked to Sr12, was responsible for ` Thatcher'-derived APR in several environments and this resistance was enhanced in the presence of Lr34.	[Hiebert, Colin W.; McCartney, Curt A.] Agr & Agri Food Canada, Cereal Res Ctr, Morden, MB, Canada; [Kolmer, James A.; Briggs, Jordan; Rouse, Matthew N.] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA; [Kolmer, James A.; Rouse, Matthew N.] USDA ARS, Cereal Dis Lab, St Paul, MN USA; [Fetch, Tom] Agr & Agri Food Canada, Brandon Res Ctr, Brandon, MB, Canada; [Bariana, Harbans] Univ Sydney, Plant Breeding Inst, Cobbitty, NSW, Australia; [Choulet, Frederic] INRA UMR1095 Genet Divers & Ecophysiol Cereals, Clermont Ferrand, France; [Spielmeyer, Wolfgang] CSIRO, Agr & Food, Canberra, ACT, Australia	Agriculture & Agri Food Canada; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); Agriculture & Agri Food Canada; University of Sydney; INRAE; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Spielmeyer, W (corresponding author), CSIRO, Agr & Food, Canberra, ACT, Australia.	Wolfgang.Spielmeyer@csiro.au	Rouse, Matthew N/G-5474-2011; Spielmeyer, Wolfgang/M-3254-2018	Spielmeyer, Wolfgang/0000-0002-5115-7820; Choulet, Frederic/0000-0003-1788-7288	USDA-ARS Appropriated Project [5062-21220-021-00]; USDA-ARS National Plant Disease Recovery System; Durable Rust Resistance in Wheat project; Saskatchewan Agriculture Development Fund [20080009]; Agriculture and Agri-Food Canada Growing Forward; Genome Canada; Saskatchewan Ministry of Agriculture,; Western Grain Research Foundation; ARS [ARS-0423040] Funding Source: Federal RePORTER	USDA-ARS Appropriated Project; USDA-ARS National Plant Disease Recovery System; Durable Rust Resistance in Wheat project; Saskatchewan Agriculture Development Fund; Agriculture and Agri-Food Canada Growing Forward(Agriculture & Agri Food Canada); Genome Canada(Genome Canada); Saskatchewan Ministry of Agriculture,; Western Grain Research Foundation; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors thank USDA-ARS Appropriated Project 5062-21220-021-00, USDA-ARS National Plant Disease Recovery System, the Durable Rust Resistance in Wheat project (MNR), Saskatchewan Agriculture Development Fund project #20080009 (CAM), Agriculture and Agri-Food Canada Growing Forward (CWH, TF, CAM), and as part of CTAG, a Genome Prairie project funded by Genome Canada, Saskatchewan Ministry of Agriculture, and Western Grain Research Foundation (CAM) for financial support. This project was also supported through a grant CIM/2007/084 provided by Australian Centre of International Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Mira Popovic, Ghassan Mardli, Tobi Malasiuk, Elaine Martineau, Taye Zegeye, Alison Morgan, Jessica Hyles, and Shideh Mojerlou for excellent technical assistance. The authors thank USDA-ARS Appropriated Project 5062-21220-021-00, USDA-ARS National Plant Disease Recovery System, the Durable Rust Resistance in Wheat project (MNR), Saskatchewan Agriculture Development Fund project #20080009 (CAM), Agriculture and Agri-Food Canada Growing Forward (CWH, TF, CAM), and as part of CTAG, a Genome Prairie project funded by Genome Canada, Saskatchewan Ministry of Agriculture, and Western Grain Research Foundation (CAM) for financial support. This project was also supported through a grant CIM/2007/084 provided by Australian Centre of International Agricultural Research. We also thank Dr Sridhar Bhavani for providing access to stem rust nursery at Njoro, Kenya.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Ayliffe M, 2013, MOL PLANT MICROBE IN, V26, P658, DOI 10.1094/MPMI-12-12-0291-R; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; DYCK PL, 1991, CROP SCI, V31, P309, DOI 10.2135/cropsci1991.0011183X003100020016x; DYCK PL, 1993, GENOME, V36, P289, DOI 10.1139/g93-040; DYCK PL, 1987, GENOME, V29, P467, DOI 10.1139/g87-081; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Green G. J., 1975, Canadian Plant Disease Survey, V55, P85; Hayes HK, 1936, MINN AGR EXP STN TEC, P325; Hiebert CW, 2011, THEOR APPL GENET, V122, P143, DOI 10.1007/s00122-010-1430-6; HUGHES GR, 1991, CAN J PLANT SCI, V71, P1165, DOI 10.4141/cjps91-162; Jin Y, 2008, PLANT DIS, V92, P923, DOI 10.1094/PDIS-92-6-0923; Jin Y, 2007, PLANT DIS, V91, P1096, DOI 10.1094/PDIS-91-9-1096; Jin Y, 2009, PLANT DIS, V93, P367, DOI 10.1094/PDIS-93-4-0367; Kerber ER, 1999, PHYTOPATHOLOGY, V89, P518, DOI 10.1094/PHYTO.1999.89.6.518; KERBER ER, 1991, GENOME, V34, P935, DOI 10.1139/g91-144; KERBER ER, 1980, CAN J BOT, V58, P1347, DOI 10.1139/b80-166; Knott DR, 2000, CAN J PLANT SCI, V80, P53, DOI 10.4141/P99-016; Kolmer JA, 2011, CROP SCI, V51, P526, DOI 10.2135/cropsci2010.06.0381; Lagudah ES, 2009, THEOR APPL GENET, V119, P889, DOI 10.1007/s00122-009-1097-z; Liu JQ, 1998, PHYTOPATHOLOGY, V88, P171, DOI 10.1094/PHYTO.1998.88.2.171; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Luig NH., 1983, ADV PLANT BREEDING, V11; McCallum BD, 2008, CAN J PLANT SCI, V88, P649, DOI 10.4141/CJPS07159; MCINTOSH R A, 1980, Cereal Research Communications, V8, P321; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; NAZARENO NRX, 1981, PHYTOPATHOLOGY, V71, P181, DOI 10.1094/Phyto-71-181; Pallotta M.A., 2003, P 10 INT WHEAT GEN S, P789; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; PETURSON BJORN, 1958, CANADIAN JOUR PLANT SCI, V38, P16; Pretorius Z. A., 2000, Plant Disease, V84, P203, DOI 10.1094/PDIS.2000.84.2.203B; Roder MS, 1998, GENETICS, V149, P2007; Rouse MN, 2014, THEOR APPL GENET, V127, P1549, DOI 10.1007/s00122-014-2319-6; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; SINGH RP, 1992, PHYTOPATHOLOGY, V82, P835, DOI 10.1094/Phyto-82-835; SINGH RP, 1993, PLANT DIS, V77, P1103, DOI 10.1094/PD-77-1103; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; Spielmeyer W, 2005, THEOR APPL GENET, V111, P731, DOI 10.1007/s00122-005-2058-9; STAKMAN E. C., 1962, Identification of physiologic races of Puccinia graminis var. tritici.; Thomas J, 1997, GENOME, V40, P552, DOI 10.1139/g97-072; TOWNLEYSMITH TF, 1993, CAN J PLANT SCI, V73, P1095, DOI 10.4141/cjps93-146; Tsilo TJ, 2007, CROP SCI, V47, P2013, DOI 10.2135/cropsci2007.02.0087; Vanegas CDG, 2008, EUPHYTICA, V159, P391, DOI 10.1007/s10681-007-9541-0	48	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157029	10.1371/journal.pone.0157029	http://dx.doi.org/10.1371/journal.pone.0157029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309724	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800029
J	Sabido, R; Hernandez-Davo, JL; Botella, J; Moya, M				Sabido, Rafael; Luis Hernandez-Davo, Jose; Botella, Javier; Moya, Manuel			Effects of 4-Week Training Intervention with Unknown Loads on Power Output Performance and Throwing Velocity in Junior Team Handball Players	PLOS ONE			English	Article							FORCE DEVELOPMENT; STRENGTH; ELITE; KNOWLEDGE; ADAPTATIONS; SEASON	Purpose To compare the effect of 4-week unknown vs known loads strength training intervention on power output performance and throwing velocity in junior team handball players. Methods Twenty-eight junior team-handball players (17.2 +/- 0.6 years, 1.79 +/- 0.07 m, 75.6 +/- 9.4 kg) were divided into two groups (unknown loads: UL; known loads: KL). Both groups performed two sessions weekly consisting of four sets of six repetitions of the bench press throw exercise, using the 30%, 50% and 70% of subjects' individual 1 repetition maximum (1RM). In each set, two repetitions with each load were performed, but the order of the loads was randomised. In the KL group, researchers told the subjects the load to mobilise prior each repetition, while in the UL group, researchers did not provide any information. Maximal dynamic strength (1RM bench press), power output (with 30, 50 and 70% of 1RM) and throwing velocity (7 m standing throw and 9 m jumping throw) were assessed pre- and post-training intervention. Results Both UL and KL group improved similarly their 1RM bench press as well as mean and peak power with all loads. There were significant improvements in power developed in all the early time intervals measured (150 ms) with the three loads (30, 50, 70% 1RM) in the UL group, while KL only improved with 30% 1RM (all the time intervals) and with 70% 1RM (at certain time intervals). Only the UL group improved throwing velocity in both standing (4.7%) and jumping (5.3%) throw (p > 0.05). Conclusions The use of unknown loads has led to greater gains in power output in the early time intervals as well as to increases in throwing velocity compared with known loads. Therefore unknown loads are of significant practical use to increase both strength and in-field performance in a short period of training.	[Sabido, Rafael; Luis Hernandez-Davo, Jose; Botella, Javier; Moya, Manuel] Miguel Hernandez Univ, Sports Res Ctr, Elche, Spain	Universidad Miguel Hernandez de Elche	Hernandez-Davo, JL (corresponding author), Miguel Hernandez Univ, Sports Res Ctr, Elche, Spain.	jlhdez43@gmail.com	Hernandez, Jose/AAS-6643-2021; Sabido, Rafael/AAO-5763-2021; MOYA, MANUEL/F-7172-2016	Sabido, Rafael/0000-0003-0158-9075; MOYA, MANUEL/0000-0002-2291-5899; Hernandez-Davo, Jose Luis/0000-0001-5785-4697; Botella Ruiz, Javier/0000-0001-9722-8519				Behrens M, 2014, INT J SPORTS MED, V35, P101, DOI 10.1055/s-0033-1343401; Chelly MS, 2011, J STRENGTH COND RES, V25, P2410, DOI 10.1519/JSC.0b013e3182030e43; Commissaris DACM, 1997, ERGONOMICS, V40, P559, DOI 10.1080/001401397188035; Cormie P, 2007, MED SCI SPORT EXER, V39, P340, DOI 10.1249/01.mss.0000246993.71599.bf; Cormie P, 2011, SPORTS MED, V41, P125, DOI 10.2165/11538500-000000000-00000; Cormie P, 2011, SPORTS MED, V41, P17, DOI 10.2165/11537690-000000000-00000; Cormie P, 2010, MED SCI SPORT EXER, V42, P1731, DOI 10.1249/MSS.0b013e3181d392e8; Cronin J, 2001, J SCI MED SPORT, V4, P59, DOI 10.1016/S1440-2440(01)80008-6; de Looze MP, 2000, ERGONOMICS, V43, P333, DOI 10.1080/001401300184440; De Ruiter CJ, 2006, MED SCI SPORT EXER, V38, P1843, DOI 10.1249/01.mss.0000227644.14102.50; Duchateau J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00234; Duchateau J, 2011, BRAIN RES, V1409, P42, DOI 10.1016/j.brainres.2011.06.011; Earle R., 2004, NSCAS ESSENTIALS PER; Gonzalez-Badillo JJ, 2010, INT J SPORTS MED, V31, P347, DOI 10.1055/s-0030-1248333; Granados C, 2008, MED SCI SPORT EXER, V40, P351, DOI 10.1249/mss.0b013e31815b4905; Hermassi S, 2011, J STRENGTH COND RES, V25, P2424, DOI 10.1519/JSC.0b013e3182030edb; Hermassi S, 2010, J STRENGTH COND RES, V24, P2408, DOI 10.1519/JSC.0b013e3181e58d7c; Davo JLH, 2015, J SPORT MED PHYS FIT, V55, P1122; Hernandez-Davo JL, 2015, EUR J APPL PHYSIOL, V115, P2571, DOI 10.1007/s00421-015-3276-8; Holtermann A, 2007, EUR J APPL PHYSIOL, V99, P605, DOI 10.1007/s00421-006-0380-9; Rojas FJ, 2012, J HUM KINET, V34, P41, DOI 10.2478/v10078-012-0062-0; MARRAS WS, 1987, ERGONOMICS, V30, P551, DOI 10.1080/00140138708969744; McBride JM, 2002, J STRENGTH COND RES, V16, P75, DOI 10.1519/00124278-200202000-00011; Meyers BM, 2003, CLIN BIOMECH, V18, P712, DOI 10.1016/S0268-0033(03)00121-9; Newton RU, 1996, J APPL BIOMECH, V12, P31, DOI 10.1123/jab.12.1.31; Rhea MR, 2004, J STRENGTH COND RES, V18, P918, DOI 10.1519/00124278-200411000-00040; Tillin NA, 2014, EUR J APPL PHYSIOL, V114, P365, DOI 10.1007/s00421-013-2781-x; Tillin NA, 2012, EXP PHYSIOL, V97, P630, DOI 10.1113/expphysiol.2011.063040; Tillin NA, 2013, J SPORT SCI, V31, P66, DOI 10.1080/02640414.2012.720704; Toii H, 2004, J STRENGTH COND RES, V18, P792; WILSON GJ, 1993, MED SCI SPORT EXER, V25, P1279; Winchester JB, 2008, J STRENGTH COND RES, V22, P1728, DOI 10.1519/JSC.0b013e3181821abb	32	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157648	10.1371/journal.pone.0157648	http://dx.doi.org/10.1371/journal.pone.0157648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310598	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000378029800113
J	Vernaz, N; Girardin, F; Goossens, N; Brugger, U; Riguzzi, M; Perrier, A; Negro, F				Vernaz, Nathalie; Girardin, Francois; Goossens, Nicolas; Brugger, Urs; Riguzzi, Marco; Perrier, Arnaud; Negro, Francesco			Drug Pricing Evolution in Hepatitis C	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-NAIVE PATIENTS; INTERFERON-ALPHA 2A; COST-EFFECTIVENESS; PLUS RIBAVIRIN; DOUBLE-BLIND; CHRONIC HCV; INITIAL TREATMENT; VIRUS TREATMENT	Objective We aimed to determine the association between the stepwise increase in the sustained viral response (SVR) and Swiss and United States (US) market prices of drug regimens for treatment-naive, genotype 1 chronic hepatitis C virus (HCV) infection in the last 25 years. We identified the following five steps in the development of HCV treatment regimens: 1) interferon (IFN)-alpha monotherapy in the early '90s, 2) IFN-alpha in combination with ribavirin (RBV), 3) pegylated (peg) IFN-alpha in combination with RBV, 4) the first direct acting antivirals (DAAs) (telaprevir and boceprevir) in combination with pegIFN-alpha and RBV, and 5) newer DAA-based regimens, such as sofosbuvir (which is or is not combined with ledipasvir) and fixed-dose combination of ritonavir-boosted paritaprevir and ombitasvir in combination with dasabuvir. Design We performed a linear regression and mean cost analysis to test for an association between SVRs and HCV regimen prices. We conducted a sensitivity analysis using US prices at the time of US drug licensing. We selected randomized clinical trials of drugs approved for use in Switzerland from 1997 to July 2015 including treatment-naive patients with HCV genotype 1 infection. Results We identified a statistically significant positive relationship between the proportion of patients achieving SVRs and the costs of HCV regimens in Switzerland ( with a bivariate ordinary least square regression yielding an R2 measure of 0.96) and the US ( R2 = 0.95). The incremental cost per additional percentage of SVR was 597.14 USD in Switzerland and 1,063.81 USD in the US. Conclusion The pricing of drugs for HCV regimens follows a value-based model, which has a stable ratio of costs per achieved SVR over 25 years. Health care systems are struggling with the high resource use of these new agents despite their obvious long-term advantages for the overall health of the population. Therefore, the pharmaceutical industry, health care payers and other stakeholders are challenged with finding new drug pricing schemes to treat the entire population infected with HCV.	[Vernaz, Nathalie; Girardin, Francois; Perrier, Arnaud] Univ Geneva, Univ Hosp Geneva, Med Direct, Geneva, Switzerland; [Vernaz, Nathalie] Univ Hosp Geneva, Finance Direct, Geneva, Switzerland; [Girardin, Francois] Univ Geneva, Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, Geneva, Switzerland; [Goossens, Nicolas] Univ Geneva, Univ Hosp Geneva, Div Gastroenterol, Geneva, Switzerland; [Goossens, Nicolas] Univ Geneva, Univ Hosp Geneva, Div Hepatol, Geneva, Switzerland; [Brugger, Urs; Riguzzi, Marco] Zurich Univ Appl Sci, Winterthur Inst Hlth Econ, Winterthur, Switzerland; [Perrier, Arnaud] Univ Geneva, Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Negro, Francesco] Univ Hosp Geneva, Div Gastroenterol, Geneva, Switzerland; [Negro, Francesco] Univ Hosp Geneva, Div Hepatol & Clin Pathol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; Zurich University of Applied Sciences; University of Geneva; University of Geneva; University of Geneva	Vernaz, N (corresponding author), Univ Geneva, Univ Hosp Geneva, Med Direct, Geneva, Switzerland.; Vernaz, N (corresponding author), Univ Hosp Geneva, Finance Direct, Geneva, Switzerland.	nathalie.vernaz@hcuge.ch	Girardin, Francois/F-5443-2017; Negro, Francesco/E-2183-2012	Girardin, Francois/0000-0002-0842-927X; Vernaz, Nathalie/0000-0002-1371-5510				Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Andrieux-Meyer I, 2015, LANCET GLOB HEALTH, V3, pE676, DOI 10.1016/S2214-109X(15)00156-4; [Anonymous], 2015, REUTERS         0630; [Anonymous], 2014, 25 YEARS PROGR HEP C; Bach PB, 2015, NEW ENGL J MED, V373, P1797, DOI 10.1056/NEJMp1512750; Bichoupan K, 2014, HEPATOLOGY, V60, P1187, DOI 10.1002/hep.27340; Brunetto MR, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3363; Buti M, 2014, GASTROENTEROLOGY, V146, P744, DOI 10.1053/j.gastro.2013.11.047; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Ezekiel J., 2015, NY TIMES; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Girardin F, 2015, Rev Med Suisse, V11, P1610; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kamal-Yanni M, 2015, LANCET GLOB HEALTH, V3, pE73, DOI 10.1016/S2214-109X(14)70365-1; Kmietowicz Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3222; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Mailankody S, 2015, JAMA ONCOL, V1, P539, DOI 10.1001/jamaoncol.2015.0373; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; Manns MP, 2007, NAT REV DRUG DISCOV, V6, P991, DOI 10.1038/nrd2411; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marinho RT, 2013, WORLD J GASTROENTERO, V19, P6703, DOI 10.3748/wjg.v19.i40.6703; McCarthy M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5989; McCarthy M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2055; Messori A, 2014, ALIMENT PHARM THER, V40, P217, DOI 10.1111/apt.12823; Morisco F, 2013, WORLD J GASTROENTERO, V19, P2793, DOI 10.3748/wjg.v19.i18.2793; Mullhaupt B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125214; Muller KR, 2011, ISPOR GLOBAL HLTH CA; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; Neumann PJ, 2011, HEALTH AFFAIR, V30, P2329, DOI 10.1377/hlthaff.2010.1147; Paris V, 2007, PHARM PRICING REIMBU, P27; Pfeil AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126984; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2686; Silva MO, 2013, J HEPATOL, V59, P31, DOI 10.1016/j.jhep.2013.02.018; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; van de Ven N, 2015, HEPATOLOGY, V61, P1174, DOI 10.1002/hep.27641; van de Vooren K, 2015, EUR J HEALTH ECON, V16, P341, DOI 10.1007/s10198-014-0653-x; van de Vooren KV, 2014, APPL HEALTH ECON HEA, V12, P33, DOI 10.1007/s40258-013-0064-7; Vernaz N, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001460; Zoulim F, 2015, GUT, V64, P1824, DOI 10.1136/gutjnl-2015-310421	46	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157098	10.1371/journal.pone.0157098	http://dx.doi.org/10.1371/journal.pone.0157098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310294	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800033
J	Guler, N; Eroglu, C; Yilmaz, H; Karadag, A; Alacam, H; Sunbul, M; Fletcher, TE; Leblebicioglu, H				Guler, Nil; Eroglu, Cafer; Yilmaz, Hava; Karadag, Adil; Alacam, Hasan; Sunbul, Mustafa; Fletcher, Tom E.; Leblebicioglu, Hakan			Apoptosis-Related Gene Expression in an Adult Cohort with Crimean-Congo Hemorrhagic Fever	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATION; PATHOGENESIS; CASPASE-2; INHIBITOR; PROTEINS; PATHWAY; FLIP	Crimean-Congo Hemorrhagic Fever (CCHF) is a life threatening acute viral infection characterized by fever, bleeding, leukopenia and thrombocytopenia. It is a major emerging infectious diseases threat, but its pathogenesis remains poorly understood and few data exist for the role of apoptosis in acute infection. We aimed to assess apoptotic gene expression in leukocytes in a cross-sectional cohort study of adults with CCHF. Twenty participants with CCHF and 10 healthy controls were recruited at a tertiary CCHF unit in Turkey; at admission baseline blood tests were collected and total RNA was isolated. The RealTime ready Human Apoptosis Panel was used for real-time PCR, detecting differences in gene expression. Participants had CCHF severity grading scores (SGS) with low risk score (10 out of 20) and intermediate or high risk scores (10 out of 20) for mortality. Five of 20 participants had a fatal outcome. Gene expression analysis showed modulation of pro-apoptotic and anti-apoptotic genes that facilitate apoptosis in the CCHF patient group. Dominant extrinsic pathway activation, mostly related with TNF family members was observed. Severe and fatal cases suggest additional intrinsic pathway activation. The clinical significance of relative gene expression is not clear, and larger longitudinal studies with simultaneous measurement of host and viral factors are recommended.	[Guler, Nil] Ondokuz Mayis Univ, Sch Med, Dept Hematol, Samsun, Turkey; [Eroglu, Cafer; Yilmaz, Hava; Sunbul, Mustafa; Fletcher, Tom E.; Leblebicioglu, Hakan] Ondokuz Mayis Univ, Sch Med, Dept Clin Microbiol & Infect Dis, Samsun, Turkey; [Karadag, Adil] Ondokuz Mayis Univ, Sch Med, Dept Med Microbiol, Samsun, Turkey; [Alacam, Hasan] Ondokuz Mayis Univ, Sch Med, Dept Med Biochem, Samsun, Turkey; [Fletcher, Tom E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Ondokuz Mayis University; Ondokuz Mayis University; Ondokuz Mayis University; Ondokuz Mayis University; Liverpool School of Tropical Medicine; University of Liverpool	Guler, N (corresponding author), Ondokuz Mayis Univ, Sch Med, Dept Hematol, Samsun, Turkey.	nilvecay@yahoo.com	Guler, Nil/ABE-4485-2021; Leblebicioglu, Hakan/A-3960-2016	Guler, Nil/0000-0003-0604-6475; Leblebicioglu, Hakan/0000-0002-6033-8543; Fletcher, Tom/0000-0002-3712-415X	Ondokuz Mayis University (Turkey) [PYO.TIP.1901.11.020]; Wellcome Trust [104480/Z/14/Z]; UK Ministry of Defence	Ondokuz Mayis University (Turkey)(Ondokuz Mayis University); Wellcome Trust(Wellcome TrustEuropean Commission); UK Ministry of Defence	This study was supported by Ondokuz Mayis University (Turkey) with project number of PYO.TIP.1901.11.020. TF is funded by Wellcome Trust (104480/Z/14/Z) and the UK Ministry of Defence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci E, 2013, VECTOR-BORNE ZOONOT, V13, P429, DOI 10.1089/vbz.2012.1061; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bakir M, 2015, EUR J CLIN MICROBIOL, V34, P325, DOI 10.1007/s10096-014-2238-0; Baptiste-Okoh N, 2008, CELL CYCLE, V7, P1133, DOI 10.4161/cc.7.9.5805; Barnwal B, 2016, J BIOL CHEM, V291, P582, DOI 10.1074/jbc.M115.667436; Bray M, 2005, CURR OPIN IMMUNOL, V17, P399, DOI 10.1016/j.coi.2005.05.001; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Fisgin NT, 2009, TROP DOCT, V39, P158, DOI 10.1258/td.2008.080092; Ghobrial IM, CA CANC J CLIN, V55, P178; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Guven AS, 2015, PEDIATR INFECT DIS J, V34, P208, DOI 10.1097/INF.0000000000000530; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; Hui D, 2006, MODERN PATHOL, V19, P1192, DOI 10.1038/modpathol.3800632; Jordan MB, 2011, BLOOD, V118, P4041, DOI 10.1182/blood-2011-03-278127; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Lamers F, 2011, ENDOCR-RELAT CANCER, V18, P657, DOI 10.1530/ERC-11-0207; Leblebicioglu H, 2016, ANTIVIR RES, V126, P21, DOI 10.1016/j.antiviral.2015.12.003; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Mao ZG, 2010, APOPTOSIS, V15, P1211, DOI 10.1007/s10495-010-0513-9; Martins SD, 2012, VIRUSES-BASEL, V4, P2736, DOI 10.3390/v4112736; Ozturk B, 2012, INT J INFECT DIS, V16, pE89, DOI 10.1016/j.ijid.2011.06.005; Papa A, 2007, EMERG INFECT DIS, V13, P805, DOI 10.3201/eid1305.061588; Papa A, 2016, J MED VIROL, V88, P21, DOI 10.1002/jmv.24312; Rodrigues R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029712; Rojas-Cartagena C, 2005, BIOL REPROD, V73, P1211, DOI 10.1095/biolreprod.105.044131; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Subramaniam K, 2013, CANCER LETT, V332, P151, DOI 10.1016/j.canlet.2012.07.005; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157247	10.1371/journal.pone.0157247	http://dx.doi.org/10.1371/journal.pone.0157247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304063	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000377824800042
J	Jensen, R; Stanojevic, S; Klingel, M; Pizarro, ME; Hall, GL; Ramsey, K; Foong, R; Saunders, C; Robinson, PD; Webster, H; Hardaker, K; Kane, M; Ratjen, F				Jensen, Renee; Stanojevic, Sanja; Klingel, Michelle; Pizarro, Maria Ester; Hall, Graham L.; Ramsey, Kathryn; Foong, Rachel; Saunders, Clare; Robinson, Paul D.; Webster, Hailey; Hardaker, Kate; Kane, Mica; Ratjen, Felix			A Systematic Approach to Multiple Breath Nitrogen Washout Test Quality	PLOS ONE			English	Article							LUNG CLEARANCE INDEX; CYSTIC-FIBROSIS; VENTILATION; CHILDREN	Background Accurate estimates of multiple breath washout (MBW) outcomes require correct operation of the device, appropriate distraction of the subject to ensure they breathe in a manner representative of their relaxed tidal breathing pattern, and appropriate interpretation of the acquired data. Based on available recommendations for an acceptable MBW test, we aimed to develop a protocol to systematically evaluate MBW measurements based on these criteria. Methods 50 MBW test occasions were systematically reviewed for technical elements and whether the breathing pattern was representative of relaxed tidal breathing by an experienced MBW operator. The impact of qualitative and quantitative criteria on inter-observer agreement was assessed across eight MBW operators (n = 20 test occasions, compared using a Kappa statistic). Results Using qualitative criteria, 46/168 trials were rejected: 16.6% were technically unacceptable and 10.7% were excluded due to inappropriate breathing pattern. Reviewer agreement was good using qualitative criteria and further improved with quantitative criteria from (K = 0.53-0.83%) to (K 0.73-0.97%), but at the cost of exclusion of further test occasions in this retrospective data analysis. Conclusions The application of the systematic review improved inter-observer agreement but did not affect reported MBW outcomes.	[Jensen, Renee; Stanojevic, Sanja; Klingel, Michelle; Pizarro, Maria Ester; Webster, Hailey; Kane, Mica; Ratjen, Felix] Hosp Sick Children, Div Resp Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Stanojevic, Sanja; Ratjen, Felix] Univ Toronto, Toronto, ON, Canada; [Pizarro, Maria Ester] Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile; [Hall, Graham L.; Ramsey, Kathryn; Foong, Rachel] Telethon Kids Inst, Perth, WA, Australia; [Hall, Graham L.; Ramsey, Kathryn; Foong, Rachel] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Hall, Graham L.] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA 6845, Australia; [Ramsey, Kathryn] Univ N Carolina, Chapel Hill, NC USA; [Saunders, Clare] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Saunders, Clare] Univ London Imperial Coll Sci Technol & Med, Dept Gene Therapy, London, England; [Robinson, Paul D.; Hardaker, Kate] Childrens Hosp Westmead, Dept Resp Med, Sydney, NSW, Australia; [Robinson, Paul D.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Pontificia Universidad Catolica de Chile; Telethon Kids Institute; University of Western Australia; Curtin University; University of North Carolina; University of North Carolina Chapel Hill; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; University of Sydney; University of Sydney	Stanojevic, S (corresponding author), Hosp Sick Children, Div Resp Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Stanojevic, S (corresponding author), Univ Toronto, Toronto, ON, Canada.	sanja.stanojevic@sickkids.ca	Ramsey, Kathryn A/M-7607-2014; Hall, Graham/C-4775-2008; Robinson, Paul D/AAT-8318-2020; Hall, Graham/AAB-6418-2019; Stanojevic, Sanja/A-4243-2010; Ramsey, Kathryn/AAA-9850-2022; Foong, Rachel/A-4678-2019	Ramsey, Kathryn A/0000-0003-4574-6917; Hall, Graham/0000-0002-6217-9494; Jensen, Renee/0000-0002-0877-9579; Shaw, Michelle/0000-0002-0966-6779; Robinson, Paul/0000-0001-7397-105X; Foong, Rachel/0000-0002-1201-6785; Stanojevic, Sanja/0000-0001-7931-8051; Ratjen, Felix/0000-0003-4057-6592	NHLBI NIH HHS [R01 HL116232] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116232] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aurora P, 2011, AM J RESP CRIT CARE, V183, P752, DOI 10.1164/rccm.200911-1646OC; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; Jensen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056868; Kent L, 2014, J CYST FIBROS, V13, P123, DOI 10.1016/j.jcf.2013.09.005; Kuczmarski R.J., 2000, CDC GROWTH CHARTS; LARSSON A, 1988, J APPL PHYSIOL, V65, P2030, DOI 10.1152/jappl.1988.65.5.2030; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Schmalisch G, 2006, BMC Pulm Med, V6, P20, DOI 10.1186/1471-2466-6-20; Stahl M, 2014, RESPIRATION, V87, P357, DOI 10.1159/000357075; Summermatter S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132250; Verbanck S, 1997, J APPL PHYSIOL, V83, P1907, DOI 10.1152/jappl.1997.83.6.1907; Yammine S, 2014, J CYST FIBROS, V13, P190, DOI 10.1016/j.jcf.2013.08.010	13	45	45	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157523	10.1371/journal.pone.0157523	http://dx.doi.org/10.1371/journal.pone.0157523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304432	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800066
J	Li, ES; Cheung, PY; Lee, TF; Lu, M; O'Reilly, M; Schmolzer, GM				Li, Elliott S.; Cheung, Po-Yin; Lee, Tze-Fun; Lu, Min; O'Reilly, Megan; Schmolzer, Georg M.			Return of spontaneous Circulation Is Not Affected by Different Chest Compression Rates Superimposed with Sustained Inflations during Cardiopulmonary Resuscitation in Newborn Piglets	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; HIGH AIRWAY PRESSURE; NEONATAL RESUSCITATION; CARDIAC-ARREST; DELIVERY-ROOM; BLOOD-FLOW; VENTILATION RATIO; PORCINE MODEL; AUGMENTATION; IMPROVES	Objective Recently, sustained inflations (SI) during chest compression (CC) have been suggested as an alternative to the current approach during neonatal resuscitation. However, the optimal rate of CC during SI has not yet been established. Our aim was to determine whether different CC rates during SI reduce time to return of spontaneous circulation (ROSC) and improve hemodynamic recovery in newborn piglets with asphyxia-induced bradycardia. Intervention and measurements Term newborn piglets were anesthetized, intubated, instrumented and exposed to 45-min normocapnic hypoxia followed by asphyxia. Resuscitation was initiated when heart rate decreased to 25% of baseline. Piglets were randomized into three groups: CC superimposed by SI at a rate of 90 CC per minute (SI+CC 90, n = 8), CC superimposed by SI at a rate of 120 CC per minute (SI+CC 120, n = 8), or a sham group (n = 6). Cardiac function, carotid blood flow, cerebral oxygenation and respiratory parameters were continuously recorded throughout the experiment. Main results Both treatment groups had similar time of ROSC, survival rates, hemodynamic and respiratory parameters during cardiopulmonary resuscitation. The hemodynamic recovery in the subsequent 4h was similar in both groups and was only slightly lower than sham-operated piglets at the end of experiment. Conclusion Newborn piglets resuscitated by SI+CC 120 did not show a significant advantage in ROSC, survival, and hemodynamic recovery as compared to those piglets resuscitated by SI+CC 90.	[Li, Elliott S.] McGill Univ, Fac Sci, Montreal, PQ, Canada; [Li, Elliott S.; Cheung, Po-Yin; Lee, Tze-Fun; Lu, Min; O'Reilly, Megan; Schmolzer, Georg M.] Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada; [Cheung, Po-Yin; Lee, Tze-Fun; Lu, Min; O'Reilly, Megan; Schmolzer, Georg M.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	McGill University; Royal Alexandra Hospital; University of Alberta	Schmolzer, GM (corresponding author), Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada.; Schmolzer, GM (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	georg.schmoelzer@me.com	Schmölzer, Georg M/E-7883-2010; Cheung, Po-Yin/C-2804-2013	Schmölzer, Georg M/0000-0001-9798-2415; Cheung, Po-Yin/0000-0002-7141-1523	Alberta Innovates - Health Solutions Summer-Studentship; Fellowship of the Molly Towell Perinatal Foundation; Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation; Heart and Stroke Scholarship; Neonatal Resuscitation Program, Canadian Pediatric Society	Alberta Innovates - Health Solutions Summer-Studentship; Fellowship of the Molly Towell Perinatal Foundation; Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation; Heart and Stroke Scholarship; Neonatal Resuscitation Program, Canadian Pediatric Society	The authors would like to that the public for donation money to our funding agencies: Scholarships to support individual authors (salary support) was available for the study: ESL was supported by as Alberta Innovates - Health Solutions Summer-Studentship. MOR is supported by a Fellowship of the Molly Towell Perinatal Foundation. GMS is a recipient of the Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation and a Heart and Stroke Scholarship. The authors would like to thank the Neonatal Resuscitation Program, Canadian Pediatric Society (http://www.cps.ca/en/grants-bourses/details/nrp-research-grant) for supporting the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, CARDIOPULMONARY RESU, V342, P1546; Babbs CF, 2009, RESUSCITATION, V80, P1280, DOI 10.1016/j.resuscitation.2009.07.014; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Berg RA, 2000, CIRCULATION, V101, P1743; BERKOWITZ ID, 1989, PEDIATR RES, V26, P558, DOI 10.1203/00006450-198912000-00006; Chalak LF, 2011, PEDIATR RES, V69, P401, DOI 10.1203/PDR.0b013e3182125f7f; CHANDRA N, 1980, LANCET, V1, P175; CHANDRA N, 1981, AM J CARDIOL, V48, P1053, DOI 10.1016/0002-9149(81)90320-9; Chandra N, 1980, LANCET, V315, P175; Cheung P-Y, 2011, J VIS EXP; HALPERIN HR, 1986, CIRCULATION, V73, P539, DOI 10.1161/01.CIR.73.3.539; Kapadia V, 2012, CLIN PERINATOL, V39, P833, DOI 10.1016/j.clp.2012.09.011; Keszler M, 2015, CURR OPIN PEDIATR, V27, P145, DOI 10.1097/MOP.0000000000000204; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klingenberg C, 2013, ARCH DIS CHILD-FETAL, V98, pF222, DOI 10.1136/archdischild-2012-301787; KOEHLER RC, 1983, CIRCULATION, V67, P266, DOI 10.1161/01.CIR.67.2.266; Li ES-S, 2015, ARCH DIS CHILD FETAL; McGowan JE, 2014, RESUSCITATION, V85, P161, DOI 10.1016/j.resuscitation.2013.12.004; Perlman JM, 2015, CIRCULATION, V132, pS204, DOI 10.1161/CIR.0000000000000276; Pichler G, 2015, NEPHROLOGY, V20, P107, DOI 10.1111/nep.12357; RUDIKOFF MT, 1980, CIRCULATION, V61, P345, DOI 10.1161/01.CIR.61.2.345; Schmolzer GM, 2014, RESUSCITATION, V85, P270, DOI 10.1016/j.resuscitation.2013.10.011; Schmolzer GM, 2013, CIRCULATION, V128, P2495, DOI 10.1161/CIRCULATIONAHA.113.002289; Schmolzer GM, 2014, ARCH DIS CHILD FETAL; Sobotka KS, 2011, PEDIATR RES, V70, P56, DOI 10.1203/PDR.0b013e31821d06a1; Solevag AL, 2015, ARCH DIS CHILD FETAL; Solevag AL, 2011, ARCH DIS CHILD-FETAL, V96, pF417, DOI 10.1136/adc.2010.200386; Solevag AL, 2010, RESUSCITATION, V81, P1571, DOI 10.1016/j.resuscitation.2010.06.007; Solevag AL, 2015, RESUSCITATION, V96, P151, DOI 10.1016/j.resuscitation.2015.08.001; van Os S, 2014, ACTA PAEDIATR, V103, P796, DOI 10.1111/apa.12650; Wyckoff M, 2000, PEDIATRICS, V106, P618, DOI 10.1542/peds.106.3.618; Wyckoff MH, 2008, SEMIN FETAL NEONAT M, V13, P410, DOI 10.1016/j.siny.2008.04.012; Wyckoff MH, 2013, CIRCULATION, V128, P2468, DOI 10.1161/CIRCULATIONAHA.113.006093; Wyckoff MH, 2012, J PEDIATR-US, V160, P239, DOI 10.1016/j.jpeds.2011.07.041	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157249	10.1371/journal.pone.0157249	http://dx.doi.org/10.1371/journal.pone.0157249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304210	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800043
J	Holman, DB; Hao, XY; Topp, E; Yang, HE; Alexander, TW				Holman, Devin B.; Hao, Xiying; Topp, Edward; Yang, Hee Eun; Alexander, Trevor W.			Effect of Co-Composting Cattle Manure with Construction and Demolition Waste on the Archaeal, Bacterial, and Fungal Microbiota, and on Antimicrobial Resistance Determinants	PLOS ONE			English	Article							FEEDLOT MANURE; ANTIBIOTIC-RESISTANCE; COMMUNITY DYNAMICS; ESCHERICHIA-COLI; SP-NOV; 16S; PREVALENCE; SUCCESSION; IDENTIFICATION; SEQUENCES	Agricultural operations generate large quantities of manure which must be eliminated in a manner that is consistent with public health guidelines. Meanwhile, construction and demolition waste makes up about 25% of total solid municipal waste. Co-composting of manure with construction and demolition waste offers a potential means to make manure safe for soil amendment and also divert construction and demolition waste from municipal landfills. Therefore, the archaeal, bacterial, and fungal microbiota of two different types of composted cattle manure and one co-composted with construction and demolition waste, were assessed over a 99-day composting period. The microbiota of the three compost mixtures did not differ, but significant changes over time and by sampling depth were observed. Bacillus and Halocella, however, were more relatively abundant in composted manure from cattle fed dried distillers' grains and solubles. Proteobacteria and Bacteroidetes were enriched at day 0 and Firmicutes at day 99. The fungal genus Kernia was the most relatively abundant overall and was enriched at day 0. The concentration of 12 antimicrobial resistance determinants in the compost mixtures was also determined, and 10 of these determinants decreased significantly from days 0 to 99. The addition of construction and demolition waste did not affect the persistence of antimicrobial resistance genes or community structure of the compost microbiota and therefore co-composting construction and demolition waste with cattle manure offers a safe, viable way to divert this waste from landfills.	[Holman, Devin B.; Hao, Xiying; Yang, Hee Eun; Alexander, Trevor W.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Topp, Edward] Agr & Agri Food Canada, Southern Crop Protect & Food Res Ctr, London, ON, Canada	Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Alexander, TW (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	trevor.alexander@agr.gc.ca	Holman, Devin/H-8693-2019	Holman, Devin/0000-0001-5306-3732; Hao, Xiying/0000-0001-6410-9652; Topp, Ed/0000-0002-8273-9372	Agriculture and Agri-Food Canada Growing Forward 2 program; Natural Sciences and Engineering Research Council of Canada	Agriculture and Agri-Food Canada Growing Forward 2 program(Agriculture & Agri Food Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Agriculture and Agri-Food Canada Growing Forward 2 program. DBH was supported by a Natural Sciences and Engineering Research Council of Canada visiting postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Alexander TW, 2008, APPL ENVIRON MICROB, V74, P4405, DOI 10.1128/AEM.00489-08; Alexander TW, 2009, APPL ENVIRON MICROB, V75, P7125, DOI 10.1128/AEM.00944-09; Alexander TW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-19; Arikan OA, 2007, BIORESOURCE TECHNOL, V98, P169, DOI 10.1016/j.biortech.2005.10.041; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Bouanane-Darenfed A, 2014, PROKARYOTES, P13, DOI DOI 10.1007/978-3-642-30120-9_395; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1984, SCAND J STAT, V11, P265; Chee-Sanford J., 2011, Antimicrobial resistance in the environment, P203; Danon M, 2008, FEMS MICROBIOL ECOL, V65, P133, DOI 10.1111/j.1574-6941.2008.00506.x; De Gannes V, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00164; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hansgate AM, 2005, FEMS MICROBIOL ECOL, V51, P209, DOI 10.1016/j.femsec.2004.08.009; Hao XY, 2014, J ENVIRON QUAL, V43, P1799, DOI 10.2134/jeq2014.02.0087; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Holman DB, 2013, FEMS MICROBIOL ECOL, V85, P1, DOI 10.1111/1574-6941.12093; Insam H, 2007, WASTE MANAG SER, V8, P25; Khachatryan AR, 2006, APPL ENVIRON MICROB, V72, P4583, DOI 10.1128/AEM.02584-05; Langarica-Fuentes A, 2014, FEMS MICROBIOL ECOL, V88, P296, DOI 10.1111/1574-6941.12293; Larney FJ, 2000, BIORESOURCE TECHNOL, V75, P139, DOI 10.1016/S0960-8524(00)00040-7; Larney FJ, 2007, BIORESOURCE TECHNOL, V98, P3221, DOI 10.1016/j.biortech.2006.07.005; Larney FJ, 2006, CAN J SOIL SCI, V86, P597, DOI 10.4141/S05-116; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lv BY, 2015, APPL MICROBIOL BIOT, V99, P10703, DOI 10.1007/s00253-015-6884-7; Maeda K, 2010, BIORESOURCE TECHNOL, V101, P9631, DOI 10.1016/j.biortech.2010.07.057; Mathew AG, 2007, FOODBORNE PATHOG DIS, V4, P115, DOI 10.1089/fpd.2006.0066; Mayende L, 2006, SOIL BIOL BIOCHEM, V38, P2963, DOI 10.1016/j.soilbio.2006.03.019; Mehta CM, 2014, WASTE MANAGE, V34, P607, DOI 10.1016/j.wasman.2013.11.012; Morgenstern I, 2012, FUNGAL BIOL-UK, V116, P489, DOI 10.1016/j.funbio.2012.01.010; Neher DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079512; PARKER AD, 1979, MYCOLOGIA, V71, P1206, DOI 10.2307/3759107; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ryckeboer J, 2003, J APPL MICROBIOL, V94, P127, DOI 10.1046/j.1365-2672.2003.01800.x; Saludes RB, 2008, BIORESOURCE TECHNOL, V99, P7285, DOI 10.1016/j.biortech.2007.12.080; Schloss PD, 2005, APPL MICROBIOL BIOT, V66, P457, DOI 10.1007/s00253-004-1727-y; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sharma R, 2009, J ENVIRON QUAL, V38, P567, DOI 10.2134/jeq2007.0638; SIMANKOVA MV, 1993, SYST APPL MICROBIOL, V16, P385, DOI 10.1016/S0723-2020(11)80270-5; Sorokin DY, 2008, EXTREMOPHILES, V12, P431, DOI 10.1007/s00792-008-0148-8; Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017; Tian W, 2013, INT BIODETER BIODEGR, V78, P58, DOI 10.1016/j.ibiod.2012.12.008; Tiquia SM, 2005, ENVIRON TECHNOL, V26, P1101, DOI 10.1080/09593332608618482; Tuomela M, 2000, BIORESOURCE TECHNOL, V72, P169, DOI 10.1016/S0960-8524(99)00104-2; Vahjen W, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0071-3; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Westerholm M, 2011, SYST APPL MICROBIOL, V34, P260, DOI 10.1016/j.syapm.2010.11.018; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Xu S, 2015, J ENV QUAL; Zaheer R, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00133	58	38	39	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157539	10.1371/journal.pone.0157539	http://dx.doi.org/10.1371/journal.pone.0157539			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300323	Green Submitted, Green Published, gold			2022-12-27	WOS:000377822200060
J	Kinsella, E; Dora, N; Mellis, D; Lettice, L; Deveney, P; Hill, R; Ditzel, M				Kinsella, Elaine; Dora, Natalie; Mellis, David; Lettice, Laura; Deveney, Paul; Hill, Robert; Ditzel, Mark			Use of a Conditional Ubr5 Mutant Allele to Investigate the Role of an N-End Rule Ubiquitin-Protein Ligase in Hedgehog Signalling and Embryonic Limb Development	PLOS ONE			English	Article							STEM-CELLS; INDIAN-HEDGEHOG; SONIC-HEDGEHOG; RETINOIC-ACID; IN-VITRO; CHONDROCYTE MATURATION; RECOMBINASE ACTIVITY; CUBITUS INTERRUPTUS; POLARIZING ACTIVITY; STRUCTURAL BASIS	Hedgehog (Hh) signalling is a potent regulator of cell fate and function. While much is known about the events within a Hh-stimulated cell, far less is known about the regulation of Hh-ligand production. Drosophila Hyperplastic Discs (Hyd), a ubiquitin-protein ligase, represents one of the few non-transcription factors that independently regulates both hh mRNA expression and pathway activity. Using a murine embryonic stem cell system, we revealed that shRNAi of the mammalian homologue of hyd, Ubr5, effectively prevented retinoic-acid-induced Sonic hedgehog (Shh) expression. We next investigated the UBR5: Hh signalling relationship in vivo by generating and validating a mouse bearing a conditional Ubr5 loss-of-function allele. Conditionally deleting Ubr5 in the early embryonic limb-bud mesenchyme resulted in a transient decrease in Indian hedgehog ligand expression and decreased Hh pathway activity, around E13.5. Although Ubr5-deficient limbs and digits were, on average, shorter than control limbs, the effects were not statistically significant. Hence, while loss of UBR5 perturbed Hedgehog signalling in the developing limb, there were no obvious morphological defects. In summary, we report the first conditional Ubr5 mutant mouse and provide evidence for a role for UBR5 in influencing Hh signalling, but are uncertain to whether the effects on Hedgehog signaling were direct (cell autonomous) or indirect (non-cell-autonomous). Elaboration of the cellular/molecular mechanism (s) involved may help our understanding on diseases and developmental disorders associated with aberrant Hh signalling.	[Kinsella, Elaine; Mellis, David; Ditzel, Mark] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, Edinburgh CRUK Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Dora, Natalie; Lettice, Laura; Deveney, Paul; Hill, Robert] Univ Edinburgh, Western Gen Hosp, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Ditzel, M (corresponding author), Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, Edinburgh CRUK Canc Res Ctr, Edinburgh, Midlothian, Scotland.	mark.ditzel@ed.ac.uk			Biotechnology and Biological Sciences Research Council [BB/H012869/1]; Edinburgh University; Medical Research Council as part of an IGMM core grant award; BBSRC [BB/H012869/1] Funding Source: UKRI; MRC [MC_U127584494, MC_PC_U127584494] Funding Source: UKRI; Medical Research Council [MC_U127584494, MC_PC_U127584494] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Edinburgh University; Medical Research Council as part of an IGMM core grant award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk) as part of a New Investigator Award BB/H012869/1 and by Edinburgh University as part of a Chancellor's Fellowship (both awarded to MD) and the Medical Research Council (http://www.mrc.ac.uk) as part of an IGMM core grant award (RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2008, J BIOL CHEM, V283, P29513, DOI 10.1074/jbc.M803681200; Anderson E, 2014, CURR OPIN GENET DEV, V27, P54, DOI 10.1016/j.gde.2014.03.011; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Benavides M, 2013, BBA-MOL CELL RES, V1833, P21, DOI 10.1016/j.bbamcr.2012.10.007; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Byrd N, 2002, DEVELOPMENT, V129, P361; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Charite J, 2000, DEVELOPMENT, V127, P2461; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CLARKE CL, 1990, J BIOL CHEM, V265, P12694; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Frisdal A, 2014, WIRES DEV BIOL, V3, P403, DOI 10.1002/wdev.147; Gao B, 2009, NATURE, V458, P1196, DOI 10.1038/nature07862; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Hay-Koren A, 2011, MOL BIOL CELL, V22, P399, DOI 10.1091/mbc.E10-05-0440; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hill RE, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0357; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kozlov G, 2007, J BIOL CHEM, V282, P35787, DOI 10.1074/jbc.M705655200; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lee JD, 2002, DEVELOPMENT, V129, P5697, DOI 10.1242/dev.00159; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2014, DEVELOPMENT, V141, P1715, DOI 10.1242/dev.095430; Lettice LA, 2012, DEV CELL, V22, P459, DOI 10.1016/j.devcel.2011.12.010; Lim NS, 2006, J BIOL CHEM, V281, P14376, DOI 10.1074/jbc.M600307200; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; Matta-Camacho E, 2012, ACTA CRYSTALLOGR F, V68, P1158, DOI 10.1107/S1744309112036937; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Moncrieff S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136760; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Niedermaier M, 2005, J CLIN INVEST, V115, P900, DOI 10.1172/JCI200523675; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Reid MA, 2013, MOL CELL, V50, P200, DOI 10.1016/j.molcel.2013.02.008; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Scialpi F, 2015, J BIOL CHEM, V290, P12585, DOI 10.1074/jbc.M114.625673; Sears KE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005398; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Smits VA, 2012, CELL CYCLE, V11; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Su H, 2011, MOL CELL, V43, P97, DOI 10.1016/j.molcel.2011.06.013; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takamoto N, 2002, MOL ENDOCRINOL, V16, P2338, DOI 10.1210/me.2001-0154; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Towers M, 2012, CURR OPIN CELL BIOL, V24, P181, DOI 10.1016/j.ceb.2011.11.005; Towers M, 2009, DEVELOPMENT, V136, P179, DOI 10.1242/dev.024158; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang GL, 2014, MECH DEVELOP, V133, P117, DOI 10.1016/j.mod.2014.05.002; Wang WG, 2009, DEVELOPMENT, V136, P4143, DOI 10.1242/dev.043281; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang TY, 2014, P NATL ACAD SCI USA, V111, P12091, DOI 10.1073/pnas.1400230111; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhang Z, 2010, DEVELOPMENT, V137, P3417, DOI 10.1242/dev.051789	77	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157079	10.1371/journal.pone.0157079	http://dx.doi.org/10.1371/journal.pone.0157079			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299863	gold, Green Published, Green Submitted			2022-12-27	WOS:000377822200027
J	Almeida, JB; Kian, KO; Lima, RC; de Souza, MCC				Almeida, Juliana Barros; Kian, Kauhana Oliveira; Lima, Rosangela Costa; Correa de Souza, Maria Cristina			Total and Abdominal Adiposity and Hypertension in Indigenous Women in Midwest Brazil	PLOS ONE			English	Article							RISK-FACTORS; WAIST CIRCUMFERENCE; OBESITY; PREVALENCE; HEALTH; INDIANS; ADULTS	Background Obesity is a major risk factor for hypertension, and abdominal fat in particular has been more strongly associated with cardiovascular diseases and its prevalence has increased in Brazilian indigenous populations. Objective The objective of this study was to estimate the prevalence of hypertension among indigenous women and its association with total and abdominal obesity after adjustment for confounding factors. Methods This cross-sectional study evaluated indigenous non-pregnant women aged 20-59 years living in two villages of the indigenous reserve of Dourados, state of Mato Grosso do Sul, Brazil. Data were collected by trained interviewers. Households were visited and were selected by simple random sampling using SPSS software version 21. The casting of lots was performed from a list of households located on a map of villages. To locate the selected households, a Global Positioning System device was used. A questionnaire was used to obtain data on socio-demographic, lifestyle and health-related variables and to obtain anthropometric data on weight, height, and waist circumference (WC). Blood pressure was measured twice during home visits. Results Data were collected between June and October 2013 with 362 women. Most of them were aged <40 years (66.3%) and had low educational level (<= 4 years of schooling, 82.0%), had overweight/obesity (74.0%), WC >= 80 cm(83.7%), and family history of hypertension (60.5%). The prevalence of hypertension was 42.0% (CI 95%: 37.0-47.2). In the multivariable analysis, respondents with WC 80-87 cm and >= 88 cm showed approximately 2 times higher prevalence rates of hypertension compared with those with WC <80 cm after adjusting for confounding factors. There was no association between body mass index (BMI) and hypertension in this study. Conclusions The overall prevalence of hypertension was high and associated only with abdominal adiposity but not with BMI.	[Almeida, Juliana Barros; Kian, Kauhana Oliveira; Lima, Rosangela Costa; Correa de Souza, Maria Cristina] Fed Univ Grande Dourados, Coll Hlth Sci, Dourados, MS, Brazil	Universidade Federal da Grande Dourados	de Souza, MCC (corresponding author), Fed Univ Grande Dourados, Coll Hlth Sci, Dourados, MS, Brazil.	mariasouza@ufgd.edu.br			Foundation for the Advancement of Education, Science, and Technology of the state of Mato Grosso do Sul (Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul - FUNDECT) [TERMO DE OUTORGA: 0063/13]	Foundation for the Advancement of Education, Science, and Technology of the state of Mato Grosso do Sul (Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul - FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	This work was supported by Foundation for the Advancement of Education, Science, and Technology of the state of Mato Grosso do Sul (Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul - FUNDECT) (http://fundect.ledes.net/) (TERMO DE OUTORGA: 0063/13, R$ 19.600,00, MCCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, PHYS STAT US INT ANT; [Anonymous], 2010, CENS DEM 2010 CAR GE; Black HR, 1997, ARCH INTERN MED, V157, P2413; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2014, VIG BRAS 2013 VIG FA; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Barros MBD, 2011, CIENC SAUDE COLETIVA, V16, P3755, DOI 10.1590/S1413-81232011001000012; de Oliveira GF, 2011, REV PANAM SALUD PUBL, V29, P315, DOI 10.1590/S1020-49892011000500003; Favaro T, 2007, CAD SAUDE PUBLICA, V23, P785, DOI 10.1590/S0102-311X2007000400006; Florindo AA, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-794, 10.1186/1471-2458-13-1066, 10.1186/1471-2458-13-52]; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P483, DOI 10.1001/jama.269.4.483; GARRISON RJ, 1987, PREV MED, V16, P235, DOI 10.1016/0091-7435(87)90087-9; Gimeno SGA, 2009, J EPIDEMIOL COMMUN H, V63, P299, DOI 10.1136/jech.2008.077966; Guerrero-Romero F, 2000, J HUM HYPERTENS, V14, P555, DOI 10.1038/sj.jhh.1001067; Instituto Brasileiro de Geografia e Estatistica, 2010, PROJECAO GEOGRAFICA; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Mancilha-Carvalho Jairo de Jesus, 2003, Arq. Bras. Cardiol., V80, P295, DOI 10.1590/S0066-782X2003000300005; Manimunda SP, 2011, INDIAN J MED RES, V133, P287; Oliveira GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086278; Organization WH, 2009, GLOB HLTH RISKS MORT; Pavan L, 1999, J HYPERTENS, V17, P749, DOI 10.1097/00004872-199917060-00005; Lourenco AE, 2008, AM J HUM BIOL, V20, P564, DOI 10.1002/ajhb.20781; Rhoades DA, 2007, J AM GERIATR SOC, V55, P87, DOI 10.1111/j.1532-5415.2006.01018.x; Roriz-Cruz M, 2010, HYPERTENSION, V56, pE43, DOI 10.1161/HYPERTENSIONAHA.110.158956; Salvo Vera Lúcia Morais Antonio de, 2009, Rev. bras. epidemiol., V12, P458, DOI 10.1590/S1415-790X2009000300014; Santana Junior JR, 2010, CAMPO TERRITORIO REV, V5, P203; Santos RV, 2003, EPIDEMIOLOGIA SAUDE, P1; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Stoddard P, 2011, SOC SCI MED, V73, P1635, DOI 10.1016/j.socscimed.2011.09.006; Tavares FG, 2013, CIENC SAUDE COLETIVA, V18, P1399, DOI 10.1590/S1413-81232013000500025; WHO, 2013, WHODCOWHD20132; Wofford MR, 2004, CURR PHARM DESIGN, V10, P3621, DOI 10.2174/1381612043382855; World Health Organization, 2011, NONCOMMUNICABLE DIS; World Health Organization, 2000, WHO TECHN REP SER, V894; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743	36	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0155528	10.1371/journal.pone.0155528	http://dx.doi.org/10.1371/journal.pone.0155528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KF	27294870	Green Published, Green Submitted, gold			2022-12-27	WOS:000377821300001
J	Kan, SL; Li, Y; Ning, GZ; Yuan, ZF; Chen, LX; Bi, MC; Sun, JC; Feng, SQ				Kan, Shun-Li; Li, Yan; Ning, Guang-Zhi; Yuan, Zhi-Fang; Chen, Ling-Xiao; Bi, Ming-Chao; Sun, Jing-Cheng; Feng, Shi-Qing			Tanezumab for Patients with Osteoarthritis of the Knee: A Meta-Analysis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; DOUBLE-BLIND; PHASE-III; PAIN; EFFICACY; SAFETY; NGF; HIP; RECOMMENDATIONS; INTERVENTIONS	Objective Tanezumab is a new therapeutic intervention for patients with osteoarthritis (OA) of the knee. We performed the present meta-analysis to appraise the efficacy and safety of tanezumab for patients with knee OA. Methods We systematically searched randomized controlled trials from PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL). The primary outcomes were mean change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain, the WOMAC physical function and patient's global assessment (PGA). Outcomes were reported as the standard mean difference (SMD) or relative risk (RR) with 95% confidence interval (CI). We assessed the pooled data using a random-effects model. Results Of the identified studies, four were eligible and were included in this meta-analysis (N = 1839 participants). Compared with the placebo groups, tanezumab yielded a significant reduction in mean change in the WOMAC pain (SMD = 0.51, 95% CI 0.34 to 0.69, P<0.00001), the WOMAC physical function (SMD = 0.56, 95% CI 0.38 to 0.74, P<0.00001) and PGA (SMD = 0.34, 95% CI 0.22 to 0.47, P<0.00001). There was no significant difference in serious adverse events (RR = 1.06, 95% CI 0.59 to 1.92, P = 0.84) between the tanezumab and placebo groups. Tanezumab significantly increased discontinuations due to adverse events (RR = 2.89, 95% CI 1.59 to 5.26, P = 0.0005), abnormal peripheral sensations (RR = 3.14, 95% CI 2.12 to 4.66, P<0.00001), and peripheral neuropathy (RR = 6.05, 95% CI 2.32 to 15.81, P = 0.0002). Conclusion Tanezumab can alleviate pain and improve function for patients with OA of the knee. However, considering the limited number of studies, this conclusion should be interpreted cautiously and more clinical randomized controlled trials are needed to verify the efficacy and safety of tanezumab for OA of the knee.	[Kan, Shun-Li; Li, Yan; Ning, Guang-Zhi; Chen, Ling-Xiao; Sun, Jing-Cheng; Feng, Shi-Qing] Tianjin Med Univ Gen Hosp, Dept Orthopaed, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Yuan, Zhi-Fang] Tianjin Med Univ, Sch Nursing, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Bi, Ming-Chao] Jilin Univ, Hosp 1, Dept Ophthalmol, 71 Xinmin St, Changchun 130021, Peoples R China	Tianjin Medical University; Tianjin Medical University; Jilin University	Feng, SQ (corresponding author), Tianjin Med Univ Gen Hosp, Dept Orthopaed, 154 Anshan Rd, Tianjin 300052, Peoples R China.	sqfeng@tmu.edu.cn	Chen, Lingxiao/M-7806-2019	Chen, Lingxiao/0000-0001-7721-0493; Kan, Shun-Li/0000-0002-7162-7420	State Key Program of National Natural Science Foundation of China [81330042]; Special Program for Sino-Russian Joint Research - Ministry of Science and Technology, China [2014DFR31210]; Key Program - Tianjin Science and Technology Committee, China [13RCGFSY19000, 14ZCZDSY00044]	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Sino-Russian Joint Research - Ministry of Science and Technology, China; Key Program - Tianjin Science and Technology Committee, China	This study was supported by State Key Program of National Natural Science Foundation of China (81330042), Special Program for Sino-Russian Joint Research Sponsored by the Ministry of Science and Technology, China (2014DFR31210) and Key Program Sponsored by the Tianjin Science and Technology Committee, China (13RCGFSY19000, 14ZCZDSY00044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche YN, 2008, PROTEIN SCI, V17, P1326, DOI 10.1110/ps.035402.108; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Altman Roy Davis, 2009, Am J Manag Care, V15, pS236; American Academy of Orthopaedic Surgeons (AAOS), 2013, AM AC ORTH SURG CLIN; Apfel SC, 2002, INT REV NEUROBIOL, V50, P393; Araki, 2010, INT J RHEUM DIS, V13, P161, DOI DOI 10.1111/j.1756-185X.2010.01506.x; Arya RK, 2013, CLIN MED, V14, P154; Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Bannwarth B, 2014, DRUGS, V74, P619, DOI 10.1007/s40265-014-0208-6; Bennell KL, 2012, BMJ, V345, P4934; Bjordal JM, 2007, EUR J PAIN, V11, P125, DOI 10.1016/j.ejpain.2006.02.013; Bjordal JM, 2004, BMJ-BRIT MED J, V329, P1317, DOI 10.1136/bmj.38273.626655.63; Brown MT, 2012, J PAIN, V13, P790, DOI 10.1016/j.jpain.2012.05.006; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekman EF, 2014, J RHEUMATOL, V41, P2249, DOI 10.3899/jrheum.131294; Evans RJ, 2011, J UROLOGY, V185, P1716, DOI 10.1016/j.juro.2010.12.088; Food and Drug Administration Center for Drug Evaluation and Research, 2012, BACKGROUND MATERIALS; Food and Drug Administration Center for Drug Evaluation and Research, 2012, ARTHR ADV COMM M MAR; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hefti FF, 2006, TRENDS PHARMACOL SCI, V27, P85, DOI 10.1016/j.tips.2005.12.001; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Isola M, 2011, VET COMP ORTHOPAED, V24, P279, DOI 10.3415/VCOT-10-04-0051; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kon E, 2012, KNEE SURG SPORT TR A, V20, P436, DOI 10.1007/s00167-011-1713-8; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Lane NE, 2009, ARTHRITIS RHEUMATISM, V60, P836; Lane NE, 2009, OSTEOARTHR CARTILAGE, V17, pS172; Losina E, 2015, OSTEOARTHR CARTILAGE, V23, pA394, DOI 10.1016/j.joca.2015.02.727; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nagashima H, 2011, OSTEOARTHR CARTILAGE, V19, P1405, DOI 10.1016/j.joca.2011.09.006; Panzram B, 2014, PAIN, V155, P2432, DOI 10.1016/j.pain.2014.08.006; Sarchielli Paola, 2004, Expert Rev Neurother, V4, P115, DOI 10.1586/14737175.4.1.115; Schnitzer TJ, 2015, OSTEOARTHR CARTILAGE, V23, pS8, DOI 10.1016/j.joca.2014.10.003; Schnitzer TJ, 2011, OSTEOARTHR CARTILAGE, V19, P639, DOI 10.1016/j.joca.2011.01.009; Seidel MF, 2013, OSTEOARTHR CARTILAGE, V21, P1223, DOI 10.1016/j.joca.2013.06.004; Seidel MF, 2010, SEMIN ARTHRITIS RHEU, V40, P109, DOI 10.1016/j.semarthrit.2009.03.002; Tive L, 2015, OSTEOARTHR CARTILAGE, V23, pA355, DOI 10.1016/j.joca.2015.02.654; Tive L, 2010, PAIN MED, V11, P303; Watson JJ, 2008, BIODRUGS, V22, P349, DOI 10.2165/0063030-200822060-00002; Whelton A, 2000, Am J Ther, V7, P63, DOI 10.1097/00045391-200007020-00004; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang ZH, 2013, CRIT CARE, V17, DOI 10.1186/cc11919	47	33	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157105	10.1371/journal.pone.0157105	http://dx.doi.org/10.1371/journal.pone.0157105			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294371	Green Published, gold, Green Submitted			2022-12-27	WOS:000377821300020
J	Roux, P; Castro, DR; Ndiaye, K; Debrus, M; Protopopescu, C; Le Gall, JM; Haas, A; Mora, M; Spire, B; Suzan-Monti, M; Carrieri, P				Roux, Perrine; Castro, Daniela Rojas; Ndiaye, Khadim; Debrus, Marie; Protopopescu, Camelia; Le Gall, Jean-Marie; Haas, Aurelie; Mora, Marion; Spire, Bruno; Suzan-Monti, Marie; Carrieri, Patrizia			Increased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI Study	PLOS ONE			English	Article							HEPATITIS-C VIRUS; PRIMARY-CARE; USERS; COHORT; INFECTION; FRANCE; EPIDEMIOLOGY; PARTICIPANTS; POPULATION; PREVALENCE	Aims The community-based AERLI intervention provided training and education to people who inject drugs (PWID) about HIV and HCV transmission risk reduction, with a focus on drug injecting practices, other injection-related complications, and access to HIV and HCV testing and care. We hypothesized that in such a population where HCV prevalence is very high and where few know their HCV serostatus, AERLI would lead to increased HCV testing. Methods The national multisite intervention study ANRS-AERLI consisted in assessing the impact of an injection-centered face-to-face educational session offered in volunteer harm reduction (HR) centers ("with intervention") compared with standard HR centers ("without intervention"). The study included 271 PWID interviewed on three occasions: enrolment, 6 and 12 months. Participants in the intervention group received at least one face-to-face educational session during the first 6 months. Measurements The primary outcome of this analysis was reporting to have been tested for HCV during the previous 6 months. Statistical analyses used a two-step Heckman approach to account for bias arising from the non-randomized clustering design. This approach identified factors associated with HCV testing during the previous 6 months. Findings Of the 271 participants, 127 and 144 were enrolled in the control and intervention groups, respectively. Of the latter, 113 received at least one educational session. For the presentanalysis, we selected 114 and 88 participants eligible for HCV testing in the control and intervention groups, respectively. In the intervention group, 44% of participants reported having being tested for HCV during the previous 6 months at enrolment and 85% at 6 months or 12 months. In the control group, these percentages were 51% at enrolment and 78% at 12 months. Multivariable analyses showed that participants who received at least one educational session during follow-up were more likely to report HCV testing, compared with those who did not receive any intervention (95%[CI] = 4.13[1.03; 16.60]). Conclusion The educational intervention AERLI had already shown efficiency in reducing HCV at-risk practices and associated cutaneous complications and also seems to have a positive impact in increasing HCV testing in PWID.	[Roux, Perrine; Ndiaye, Khadim; Protopopescu, Camelia; Mora, Marion; Spire, Bruno; Suzan-Monti, Marie; Carrieri, Patrizia] INSERM U912 SESSTIM, Marseille, France; [Roux, Perrine; Ndiaye, Khadim; Protopopescu, Camelia; Mora, Marion; Spire, Bruno; Suzan-Monti, Marie; Carrieri, Patrizia] Aix Marseille Univ, IRD, UMR S912, Marseille, France; [Roux, Perrine; Ndiaye, Khadim; Protopopescu, Camelia; Mora, Marion; Spire, Bruno; Suzan-Monti, Marie; Carrieri, Patrizia] ORS PACA, Marseille, France; [Castro, Daniela Rojas; Le Gall, Jean-Marie; Haas, Aurelie; Spire, Bruno; Suzan-Monti, Marie] AIDES, Pantin, France; [Castro, Daniela Rojas; Debrus, Marie] Med Monde, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Roux, P (corresponding author), INSERM U912 SESSTIM, Marseille, France.; Roux, P (corresponding author), Aix Marseille Univ, IRD, UMR S912, Marseille, France.; Roux, P (corresponding author), ORS PACA, Marseille, France.	perrine.roux@inserm.fr	Roux, Perrine/P-1306-2016; Spire, Bruno/F-5546-2013; Rojas, Daniela/AAF-1591-2019	Roux, Perrine/0000-0002-5069-4982; Spire, Bruno/0000-0002-3546-8020; ROJAS CASTRO, Daniela/0000-0002-5379-1438; Carrieri, Patrizia/0000-0002-6794-4837	ANRS	ANRS(ANRSFrench National Research Agency (ANR))	This work was supported by ANRS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi M, 2014, LIVER INT, V34, P1198, DOI 10.1111/liv.12370; Benyamina A, 2014, INT J GEN MED, V7, P449, DOI 10.2147/IJGM.S61014; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bruneau J, 2014, CLIN INFECT DIS, V58, P755, DOI 10.1093/cid/cit938; Charlebois A, 2012, J VIRAL HEPATITIS, V19, P836, DOI 10.1111/j.1365-2893.2012.01648.x; Currie LB, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-404; Daiski Isolde, 2005, Policy Polit Nurs Pract, V6, P30, DOI 10.1177/1527154404272610; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; DARKE S, 1992, BRIT J ADDICT, V87, P733; Degenhardt L, 2014, INT J DRUG POLICY, V25, P53, DOI 10.1016/j.drugpo.2013.08.004; [EMCDDA European Monitoring Centre for Drugs and Drug Addiction], 2013, DRUG TREATM OV FRANC; Emmanuelli J, 2005, ADDICTION, V100, P1690, DOI 10.1111/j.1360-0443.2005.01271.x; Fischer B, 2006, ADDICTION, V101, P1760, DOI 10.1111/j.1360-0443.2006.01614.x; Fry CL, 2003, ADDICTION, V98, P171, DOI 10.1046/j.1360-0443.2003.00207.x; Gibson A, 2011, ADDICTION, V106, P2186, DOI 10.1111/j.1360-0443.2011.03575.x; Grebely J, 2008, DRUG ALCOHOL DEPEN, V93, P141, DOI 10.1016/j.drugalcdep.2007.09.008; Hastings J, 2007, J HEALTH CARE POOR U, V18, P744; Jauffret-Roustide M, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-113; McDonald SA, 2014, EPIDEMIOL INFECT, V142, P200, DOI 10.1017/S0950268813000617; McDonald SA, 2010, EPIDEMIOL INFECT, V138, P393, DOI 10.1017/S0950268809990616; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Page K, 2013, CLIN INFECT DIS, V57, pS32, DOI 10.1093/cid/cit300; Rotily M, 2002, GASTROEN CLIN BIOL, V26, P261; Roux P, 2015, ADDICTION; Salmon-Ceron D, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-59; Seidenberg A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-9; Vallejo F, 2015, J EPIDEMIOL COMMUN H, V69, P599, DOI 10.1136/jech-2014-205070; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x; Whelan C, 2010, J PRIM CARE COMMUNIT, V1, P78, DOI 10.1177/2150131910372233; Wiessing L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103345	30	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157062	10.1371/journal.pone.0157062	http://dx.doi.org/10.1371/journal.pone.0157062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KF	27294271	Green Published, gold, Green Submitted			2022-12-27	WOS:000377821300019
J	Liyanage, KA; Steward, C; Moffat, BA; Opie, NL; Rind, GS; John, SE; Ronayne, S; May, CN; O'Brien, TJ; Milne, ME; Oxley, TJ				Liyanage, Kishan Andre; Steward, Christopher; Moffat, Bradford Armstrong; Opie, Nicholas Lachlan; Rind, Gil Simon; John, Sam Emmanuel; Ronayne, Stephen; May, Clive Newton; O'Brien, Terence John; Milne, Marjorie Eileen; Oxley, Thomas James			Development and Implementation of a Corriedale Ovine Brain Atlas for Use in Atlas-Based Segmentation	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; SHEEP; MODEL; REGISTRATION; DISEASE; CORTEX	Segmentation is the process of partitioning an image into subdivisions and can be applied to medical images to isolate anatomical or pathological areas for further analysis. This process can be done manually or automated by the use of image processing computer packages. Atlas-based segmentation automates this process by the use of a pre-labelled template and a registration algorithm. We developed an ovine brain atlas that can be used as a model for neurological conditions such as Parkinson's disease and focal epilepsy. 17 female Corriedale ovine brains were imaged in-vivo in a 1.5T (low-resolution) MRI scanner. 13 of the low-resolution images were combined using a template construction algorithm to form a low-resolution template. The template was labelled to form an atlas and tested by comparing manual with atlas-based segmentations against the remaining four low-resolution images. The comparisons were in the form of similarity metrics used in previous segmentation research. Dice Similarity Coefficients were utilised to determine the degree of overlap between eight independent, manual and atlas-based segmentations, with values ranging from 0 (no overlap) to 1 (complete overlap). For 7 of these 8 segmented areas, we achieved a Dice Similarity Coefficient of 0.5-0.8. The amygdala was difficult to segment due to its variable location and similar intensity to surrounding tissues resulting in Dice Coefficients of 0.0-0.2. We developed a low resolution ovine brain atlas with eight clinically relevant areas labelled. This brain atlas performed comparably to prior human atlases described in the literature and to intra-observer error providing an atlas that can be used to guide further research using ovine brains as a model and is hosted online for public access.	[Liyanage, Kishan Andre; Opie, Nicholas Lachlan; Rind, Gil Simon; John, Sam Emmanuel; Ronayne, Stephen; May, Clive Newton; Oxley, Thomas James] Univ Melbourne, Royal Melbourne Hosp, Vasc Bion Lab, Dept Med, Parkville, Vic, Australia; [Liyanage, Kishan Andre; Steward, Christopher; Moffat, Bradford Armstrong] Univ Melbourne, Royal Melbourne Hosp, Dept Radiol, Parkville, Vic, Australia; [Moffat, Bradford Armstrong] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia; [Opie, Nicholas Lachlan; Rind, Gil Simon; John, Sam Emmanuel; Ronayne, Stephen; May, Clive Newton; Oxley, Thomas James] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [John, Sam Emmanuel] Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Parkville, Vic 3052, Australia; [John, Sam Emmanuel] Ctr Neural Engn, Parkville, Vic, Australia; [O'Brien, Terence John] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Milne, Marjorie Eileen] Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic, Australia	Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Melbourne	Liyanage, KA (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Vasc Bion Lab, Dept Med, Parkville, Vic, Australia.; Liyanage, KA (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Radiol, Parkville, Vic, Australia.	kishan.liyanage@gmail.com	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013; Moffat, Bradford/L-3777-2019; John, Sam/E-6904-2012; Opie, Nicholas/M-3831-2017	O'Brien, Terence/0000-0002-7198-8621; Moffat, Bradford/0000-0002-0278-4801; John, Sam/0000-0003-3780-2210; MILNE, MARJORIE/0000-0001-9327-0357; Opie, Nicholas/0000-0002-0342-9457	Defense Advanced Research Projects Agency (DARPA) [N66001-12-1-4045]; Office of Naval Research (ONR) [N62909-14-1-N020]; National Health and Medical Research Council of Australia (NHMRC) [APP1062532, APP1075117]; Defence Health Foundation, Australia; Defence Science Institute, Australia; Brain Foundation, Australia; Victorian Government's Operational Infrastructure Support Program	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research (ONR)(Office of Naval Research); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Defence Health Foundation, Australia; Defence Science Institute, Australia; Brain Foundation, Australia; Victorian Government's Operational Infrastructure Support Program	The research was supported by Defense Advanced Research Projects Agency (DARPA) MTO Contract No. N66001-12-1-4045 (TJO); Office of Naval Research (ONR) Global No. N62909-14-1-N020 (TJO); National Health and Medical Research Council of Australia (NHMRC) Project Grant APP1062532 (TJO) and Development Grant APP1075117 (TJO); Defence Health Foundation, Australia (Booster Grant) (TJO); Defence Science Institute, Australia, grant (TJO); Brain Foundation, Australia, research gift (TJO), and the Victorian Government's Operational Infrastructure Support Program (TJO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEKANI BA, 1995, J COMPUT ASSIST TOMO, V19, P615, DOI 10.1097/00004728-199507000-00022; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bagley C, 1922, ARCH NEURO PSYCHIATR, V7, P417, DOI 10.1001/archneurpsyc.1922.02190100002001; BASKIN DS, 1994, LIFE SCI, V54, P471, DOI 10.1016/0024-3205(94)00406-4; Brus M, 2013, J COMP NEUROL, V521, P169, DOI 10.1002/cne.23169; Cabezas M, 2011, COMPUT METH PROG BIO, V104, pE158, DOI 10.1016/j.cmpb.2011.07.015; Datta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052140; Erickson BJ, 1998, J DIGIT IMAGING, V11, P74, DOI 10.1007/BF03168729; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Gierthmuehlen M, 2014, J COMP NEUROL, V522, P3590, DOI 10.1002/cne.23631; Grovum WL, 1999, BRAIN RES, V851, P252, DOI 10.1016/S0006-8993(99)02083-1; JOHNSON JI, 1974, J COMP NEUROL, V158, P81, DOI 10.1002/cne.901580106; Klein A, 2010, NEUROIMAGE, V51, P214, DOI 10.1016/j.neuroimage.2010.01.091; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lentz L, 2015, EXP NEUROL, V273, P69, DOI 10.1016/j.expneurol.2015.07.022; Li XJ, 2015, CURR TOP BEHAV NEURO, V22, P149, DOI 10.1007/7854_2013_246; Liyanage KA, 2015, OVINE BRAIN ATLAS; Milne ME, 2015, AM J VET RES; Opdam HI, 2002, EPILEPSIA, V43, P779, DOI 10.1046/j.1528-1157.2002.04202.x; Oxley TJ, 2015, NATURE BIOT IN PRESS; Peperkamp NH, 2015, VET PATHOL, V52, P1057, DOI 10.1177/0300985814560231; Perentos N, 2015, BRAIN, V138, P862, DOI 10.1093/brain/awv026; Salouci M, 2012, ANAT HISTOL EMBRYOL, V41, P227, DOI 10.1111/j.1439-0264.2011.01127.x; Sawiak SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132331; Simpson S, 1911, Q J EXP PHYSIOL, V4, P53, DOI 10.1113/expphysiol.1911.sp000083; Stypulkowski PH, 2011, STEREOT FUNCT NEUROS, V89, P111, DOI 10.1159/000323343; Talairach J., 1988, COPLANAR STEREOTAXIC; Wells AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042157; Woods RP, 1999, HUM BRAIN MAPP, V8, P73, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<73::AID-HBM1>3.0.CO;2-7; Yousefi S, 2012, IEEE T BIO-MED ENG, V59, P1808, DOI 10.1109/TBME.2011.2122306; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	32	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0155974	10.1371/journal.pone.0155974	http://dx.doi.org/10.1371/journal.pone.0155974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285947	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000005
J	Suhr, M; Lederer, FL; Gunther, TJ; Raff, J; Pollmann, K				Suhr, Matthias; Lederer, Franziska L.; Guenther, Tobias J.; Raff, Johannes; Pollmann, Katrin			Characterization of Three Different Unusual S-Layer Proteins from Viridibacillus arvi JG-B58 That Exhibits Two Super-Imposed S-Layer Proteins	PLOS ONE			English	Article							BACILLUS-STEAROTHERMOPHILUS PV72; LYSINIBACILLUS-SPHAERICUS JG-B53; SURFACE-LAYER; LACTOBACILLUS-ACIDOPHILUS; CELL-WALL; MOLECULAR CHARACTERIZATION; CLOSTRIDIUM-DIFFICILE; POLYACRYLAMIDE GELS; WASTE PILE; GENES	Genomic analyses of Viridibacillus arvi JG-B58 that was previously isolated from heavy metal contaminated environment identified three different putative surface layer (S-layer) protein genes namely slp1, slp2, and slp3. All three genes are expressed during cultivation. At least two of the V. arvi JG-B58 S-layer proteins were visualized on the surface of living cells via atomic force microscopy (AFM). These S-layer proteins form a double layer with p4 symmetry. The S-layer proteins were isolated from the cells using two different methods. Purified S-layer proteins were recrystallized on SiO2 substrates in order to study the structure of the arrays and self-assembling properties. The primary structure of all examined Slayer proteins lack some features that are typical for Bacillus or Lysinibacillus S-layers. For example, they possess no SLH domains that are usually responsible for the anchoring of the proteins to the cell wall. Further, the pI values are relatively high ranging from 7.84 to 9.25 for the matured proteins. Such features are typical for S-layer proteins of Lactobacillus species although sequence comparisons indicate a close relationship to S-layer proteins of Lysinibacillus and Bacillus strains. In comparison to the numerous descriptions of S-layers, there are only a few studies reporting the concomitant existence of two different S-layer proteins on cell surfaces. Together with the genomic data, this is the first description of a novel type of S-layer proteins showing features of Lactobacillus as well as of Bacillus-type S-layer proteins and the first study of the cell envelope of Viridibacillus arvi.	[Suhr, Matthias; Lederer, Franziska L.; Guenther, Tobias J.; Raff, Johannes; Pollmann, Katrin] Helmholtz Zentrum Dresden Rossendorf, Helmholtz Inst Freiberg Resource Technol, Freiberg, Germany; [Raff, Johannes] Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Freiberg, Germany; [Suhr, Matthias] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Sect Microbial Biotechnol, D-06108 Halle, Germany	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Martin Luther University Halle Wittenberg	Pollmann, K (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Helmholtz Inst Freiberg Resource Technol, Freiberg, Germany.	k.pollmann@hzdr.de	Raff, Johannes/GNM-5459-2022	Raff, Johannes/0000-0002-0520-3611; Lederer, Franziska/0000-0002-0452-3242; Suhr, Matthias/0000-0003-3101-0925	German Federal Ministry of Education and Research (BMBF) grant AptaSens [BMBF/DLR01RB0805A]	German Federal Ministry of Education and Research (BMBF) grant AptaSens	The study was partly supported by the German Federal Ministry of Education and Research (BMBF) grant AptaSens (BMBF/DLR01RB0805A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was partly supported by the German Federal Ministry of Education and Research (BMBF) grant AptaSens (BMBF/DLR01RB0805A). We thank Chris Christesen for grammar and spell check of this article as native speaker.	Albert RA, 2007, INT J SYST EVOL MICR, V57, P2729, DOI 10.1099/ijs.0.65256-0; Avall-Jaaskelainen S, 2005, FEMS MICROBIOL REV, V29, P511, DOI 10.1016/j.femsre.2005.04.003; Baranova E, 2012, NATURE, V487, P119, DOI 10.1038/nature11155; BLASER MJ, 1994, MOL MICROBIOL, V14, P453, DOI 10.1111/j.1365-2958.1994.tb02180.x; Boot HJ, 1996, MICROBIOL-SGM, V142, P2375, DOI 10.1099/00221287-142-9-2375; Boot HJ, 1996, MOL MICROBIOL, V21, P799, DOI 10.1046/j.1365-2958.1996.401406.x; Boot HJ, 1996, J BACTERIOL, V178, P5388, DOI 10.1128/jb.178.18.5388-5394.1996; Boot HJ, 1996, MOL MICROBIOL, V21, P1117, DOI 10.1046/j.1365-2958.1996.711442.x; Cerquetti M, 2000, MICROB PATHOGENESIS, V28, P363, DOI 10.1006/mpat.2000.0356; Claus H, 2005, CAN J MICROBIOL, V51, P731, DOI 10.1139/W05-093; DECHER G, 1992, PROG COLL POL SCI S, V89, P160; DECHER G, 1994, BIOSENS BIOELECTRON, V9, P677, DOI 10.1016/0956-5663(94)80065-0; Dworkin J, 1996, MOL MICROBIOL, V19, P1241, DOI 10.1111/j.1365-2958.1996.tb02469.x; Fagan RP, 2014, NAT REV MICROBIOL, V12, P211, DOI 10.1038/nrmicro3213; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; Goh YJ, 2009, APPL ENVIRON MICROB, V75, P3093, DOI 10.1128/AEM.02502-08; Gunther TJ, 2014, RSC ADV, V4, P51156, DOI 10.1039/c4ra03874f; Heyrman J, 2005, INT J SYST EVOL MICR, V55, P111, DOI 10.1099/ijs.0.63240-0; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jakava-Viljanen M, 2002, J BACTERIOL, V184, P6786, DOI 10.1128/JB.184.24.6786-6795.2002; Kern VJ, 2012, J BACTERIOL, V194, P3833, DOI 10.1128/JB.00402-12; KERN W, 1970, RCA REV, V31, P187; KOVAL SF, 1984, CAN J BIOCHEM CELL B, V62, P1181, DOI 10.1139/o84-152; Kuen B, 1997, J BACTERIOL, V179, P1664, DOI 10.1128/jb.179.5.1664-1670.1997; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lederer FL, 2013, MICROBIOL-SGM, V159, P1097, DOI 10.1099/mic.0.065763-0; LORTAL S, 1992, J GEN MICROBIOL, V138, P611, DOI 10.1099/00221287-138-3-611; LUPAS A, 1994, J BACTERIOL, V176, P1224, DOI 10.1128/jb.176.5.1224-1233.1994; Mesnage S, 2001, MICROBIOL-SGM, V147, P1343, DOI 10.1099/00221287-147-5-1343; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Mignot T, 2003, MOL MICROBIOL, V47, P917, DOI 10.1046/j.1365-2958.2003.03345.x; Mignot T, 2002, MOL MICROBIOL, V43, P1615, DOI 10.1046/j.1365-2958.2002.02852.x; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Panak P, 1998, J ALLOY COMPD, V271, P262, DOI 10.1016/S0925-8388(98)00067-X; Pink T, 1996, J BIOTECHNOL, V50, P189, DOI 10.1016/0168-1656(96)01564-7; Pollmann K, 2005, MICROBIOL-SGM, V151, P2961, DOI 10.1099/mic.0.28201-0; PUM D, 1994, THIN SOLID FILMS, V244, P882, DOI 10.1016/0040-6090(94)90592-4; Pum D, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/31/312001; Pum D, 2013, INT J MOL SCI, V14, P2484, DOI 10.3390/ijms14022484; Rad B, 2015, ACS NANO, V9, P180, DOI 10.1021/nn502992x; Raff J, 2017, PROTEIN BAS IN PRESS; RENART J, 1979, P NATL ACAD SCI USA, V76, P3116, DOI 10.1073/pnas.76.7.3116; Rothfuss H, 2006, MICROBIOL-SGM, V152, P2779, DOI 10.1099/mic.0.28971-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; SARA M, 1990, ARCH MICROBIOL, V153, P209, DOI 10.1007/BF00249069; Schar-Zammaretti P, 2003, BIOPHYS J, V85, P4076, DOI 10.1016/S0006-3495(03)74820-6; Sekot G, 2012, ARCH MICROBIOL, V194, P525, DOI 10.1007/s00203-012-0792-3; Selenska-Pobell S, 1999, FEMS MICROBIOL ECOL, V29, P59, DOI 10.1111/j.1574-6941.1999.tb00598.x; Selenska-Pobell S, 2001, ANTON LEEUW INT J G, V79, P149, DOI 10.1023/A:1010237711077; Sleytr U B, 1978, Int Rev Cytol, V53, P1, DOI 10.1016/S0074-7696(08)62240-8; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; SLEYTR UB, 1988, METHOD MICROBIOL, V20, P29, DOI 10.1016/S0580-9517(08)70046-1; Sleytr UB, 2014, FEMS MICROBIOL REV, V38, P823, DOI 10.1111/1574-6976.12063; SMITH SH, 1990, CAN J MICROBIOL, V36, P327, DOI 10.1139/m90-057; STEWART M, 1982, J BACTERIOL, V150, P348, DOI 10.1128/JB.150.1.348-357.1982; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Suhr M, 2016, JOVE-J VIS EXP, DOI 10.3791/53572; Suhr M, 2014, BIOMETALS, V27, P1337, DOI 10.1007/s10534-014-9794-8; Teixeira LM, 2010, MACROMOL BIOSCI, V10, P147, DOI 10.1002/mabi.200900175; Thompson Stuart A, 2002, Ann Periodontol, V7, P43, DOI 10.1902/annals.2002.7.1.43; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YAMADA H, 1981, J BACTERIOL, V148, P322, DOI 10.1128/JB.148.1.322-332.1981; Zwick ME, 2012, GENOME RES, V22, P1512, DOI 10.1101/gr.134437.111	64	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156785	10.1371/journal.pone.0156785	http://dx.doi.org/10.1371/journal.pone.0156785			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285458	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000021
J	Durnas, B; Wnorowska, U; Pogoda, K; Deptula, P; Watek, M; Piktel, E; Gluszek, S; Gu, XB; Savage, PB; Niemirowicz, K; Bucki, R				Durnas, Bonita; Wnorowska, Urszula; Pogoda, Katarzyna; Deptula, Piotr; Watek, Marzena; Piktel, Ewelina; Gluszek, Stanislaw; Gu, Xiaobo; Savage, Paul B.; Niemirowicz, Katarzyna; Bucki, Robert			Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites	PLOS ONE			English	Article							RESISTANT ACINETOBACTER-BAUMANNII; CATIONIC STEROID ANTIBIOTICS; PSEUDOMONAS-AERUGINOSA; EXTRACELLULAR DNA; ANTIFUNGAL SUSCEPTIBILITY; ANTIBACTERIAL ACTIVITY; OMIGANAN PENTAHYDROCHLORIDE; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; BACTERICIDAL ACTIVITY	Fungal infections, especially those caused by antibiotic resistant pathogens, have become a serious public health problem due to the growing number of immunocompromised patients, including those subjected to anticancer treatment or suffering from HIV infection. In this study we assessed fungicidal activity of the ceragenins CSA-13, CSA-131 and CSA-192 against four fluconazole resistant Candida strains. We found that ceragenins activity against planktonic Candida cells was higher than activity of human LL-37 peptide and synthetic cationic peptide omiganan. Compared to LL-37 peptide, ceragenins in the presence of DNase I demonstrated an increased ability to kill DNA-induced Candida biofilm. Microscopy studies show that treatment with LL-37 or ceragenins causes Candida cells to undergo extensive surface changes indicating surface membrane damage. This conclusion was substantiated by observation of rapid incorporation of FITC-labeled CSA-13, CSA-131 or LL-37 peptide into the more lipophilic environment of the Candida membrane. In addition to activity against Candida spp., ceragenins CSA-131 and CSA-192 display strong fungicidal activity against sixteen clinical isolates including Cryptococcus neoformans and Aspergillus fumigatus. These results indicate the potential of ceragenins for future development as new fungicidal agents.	[Durnas, Bonita; Bucki, Robert] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Dept Physiol Pathophysiol & Immunol Infect, Kielce, Poland; [Durnas, Bonita; Watek, Marzena] Holy Cross Oncol Ctr Kielce, Artwinskiego 3, Kielce, Poland; [Wnorowska, Urszula; Deptula, Piotr; Piktel, Ewelina; Niemirowicz, Katarzyna; Bucki, Robert] Med Univ Bialystok, Dept Microbiol & Nanobiomed Engn, Mickiewicza 2C, Bialystok, Poland; [Pogoda, Katarzyna] Polish Acad Sci, Inst Nucl Phys, Radzikowskiego 152, Krakow, Poland; [Gluszek, Stanislaw] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Kielce, Poland; [Gu, Xiaobo; Savage, Paul B.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Jan Kochanowski University; Medical University of Bialystok; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; Jan Kochanowski University; Brigham Young University	Bucki, R (corresponding author), Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Dept Physiol Pathophysiol & Immunol Infect, Kielce, Poland.; Bucki, R (corresponding author), Med Univ Bialystok, Dept Microbiol & Nanobiomed Engn, Mickiewicza 2C, Bialystok, Poland.	buckirobert@gmail.com	Niemirowicz, Katarzyna/T-5011-2018; Piktel, Ewelina/S-8311-2018; Deptuła, Piotr/T-1176-2018; Savage, Paul B/HGB-3414-2022; Wnorowska, Urszula/S-8312-2018; Durnaś, Bonita/AAU-1826-2021; Stanisław, Gluszek/S-3303-2019; Savage, Paul B/E-1448-2011; Pogoda, Katarzyna/AAD-2057-2020; Wątek, Marzena/AAA-8789-2020	Niemirowicz, Katarzyna/0000-0002-3311-7147; Piktel, Ewelina/0000-0002-4531-7277; Deptuła, Piotr/0000-0003-3553-3774; Savage, Paul B/0000-0002-4642-6109; Wnorowska, Urszula/0000-0002-0410-3475; Durnaś, Bonita/0000-0003-1940-5799; Stanisław, Gluszek/0000-0001-7752-0459; Savage, Paul B/0000-0002-4642-6109; Pogoda, Katarzyna/0000-0001-6994-3435; Wątek, Marzena/0000-0002-3996-200X; Bucki, Robert/0000-0001-7664-9226	RPOWP [UDA-RPPD.01.01.00-20-001/15-00]; National Science Centre, Poland [UMO-2012/07/B/NZ6/03504, UMO-2014/15/D/NZ6/02665]; National Institutes of Health, United States of America [NHHSN2722011000181]	RPOWP; National Science Centre, Poland(National Science Centre, Poland); National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was conducted with the use of equipment purchased by Medical University of Bialystok as part of the RPOWP 2007-2013 funding, Priority I, Axis 1.1, contract No. UDA-RPPD.01.01.00-20-001/15-00 dated 26.06.2015 [http://www.nauka.gov.pl/]) and financially supported by grants from: the National Science Centre, Poland (UMO-2012/07/B/NZ6/03504 to R. Bucki and UMO-2014/15/D/NZ6/02665 to K. Niemirowicz [https://www.ncn.gov.pl/]), and National Institutes of Health, United States of America (NHHSN2722011000181 to P. B. Savage [http://www.nih.gov/]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki W, 2013, PHARMACEUTICALS-BASE, V6, P1055, DOI 10.3390/ph6081055; Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; Bassetti M, 2013, J CLIN MICROBIOL, V51, P4167, DOI 10.1128/JCM.01998-13; Benincasa M, 2006, J ANTIMICROB CHEMOTH, V58, P950, DOI 10.1093/jac/dkl382; Bitar D, 2014, EMERG INFECT DIS, V20, P1149, DOI 10.3201/eid2007.140087; Bucki R, 2008, J ANTIMICROB CHEMOTH, V62, P329, DOI 10.1093/jac/dkn176; Bucki R, 2006, ANTIMICROB AGENTS CH, V50, P2932, DOI 10.1128/AAC.00134-06; Bucki R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0457-x; Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Chen L, 2011, INT J ORAL SCI, V3, P66, DOI 10.4248/IJOS11022; Chin JN, 2008, J ANTIMICROB CHEMOTH, V61, P365, DOI 10.1093/jac/dkm457; Chin JN, 2007, ANTIMICROB AGENTS CH, V51, P1268, DOI 10.1128/AAC.01325-06; Choi JH, 2013, J BIOMED NANOTECHNOL, V9, P291, DOI 10.1166/jbn.2013.1542; CLSI, 2008, M27A3 CLSI; Dawson MJ, 2012, CURR OPIN PHARMACOL, V12, P545, DOI 10.1016/j.coph.2012.06.006; den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099; Ding B, 2002, J MED CHEM, V45, P663, DOI 10.1021/jm0105070; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Epand RF, 2010, ANTIMICROB AGENTS CH, V54, P3708, DOI 10.1128/AAC.00380-10; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fritsche TR, 2008, ANTIMICROB AGENTS CH, V52, P1187, DOI 10.1128/AAC.01475-07; Ganguly S, 2011, CURR OPIN MICROBIOL, V14, P380, DOI 10.1016/j.mib.2011.06.001; Garcia-Quintanilla M, 2014, ANTIMICROB AGENTS CH, V58, P2972, DOI 10.1128/AAC.02642-13; Guembe M, 2014, ANTIMICROB AGENTS CH, V58, P5581, DOI 10.1128/AAC.02738-14; Haisma EM, 2014, ANTIMICROB AGENTS CH, V58, P4411, DOI 10.1128/AAC.02554-14; Herriott MM, 2011, TRENDS MICROBIOL, V19, P557, DOI 10.1016/j.tim.2011.07.004; Howell MD, 2009, J INVEST DERMATOL, V129, P2668, DOI 10.1038/jid.2009.120; Isaacson Richard E, 2003, Curr Opin Investig Drugs, V4, P999; Jones EA, 2013, J INNATE IMMUN, V5, P24, DOI 10.1159/000339961; Kim KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028176; Lara D, 2010, J PARASITOL, V96, P638, DOI 10.1645/GE-2329.1; Leszczynska K, 2011, J APPL MICROBIOL, V110, P229, DOI 10.1111/j.1365-2672.2010.04874.x; Leszczynska K, 2013, J ANTIMICROB CHEMOTH, V68, P610, DOI 10.1093/jac/dks434; Lv YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115448, 10.1371/journal.pone.0086364]; Lyon GM, 2010, J CLIN MICROBIOL, V48, P1270, DOI 10.1128/JCM.02363-09; Martins M, 2010, MYCOPATHOLOGIA, V169, P323, DOI 10.1007/s11046-009-9264-y; Mathe L, 2013, CURR GENET, V59, P251, DOI 10.1007/s00294-013-0400-3; Moncla Bernard J, 2011, Adv Biosci Biotechnol, V2, P404; Montagna MT, 2014, J MED MICROBIOL, V63, P1638, DOI 10.1099/jmm.0.075507-0; Niemirowicz K, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0093-5; Orasch C, 2014, CLIN MICROBIOL INFEC, V20, P698, DOI 10.1111/1469-0691.12440; Ordonez SR, 2014, ANTIMICROB AGENTS CH, V58, P2240, DOI 10.1128/AAC.01670-13; Parks QM, 2009, J MED MICROBIOL, V58, P492, DOI 10.1099/jmm.0.005728-0; Polke M, 2015, ADV APPL MICROBIOL, V91, P139, DOI 10.1016/bs.aambs.2014.12.002; Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163; Rapala-Kozik M, 2015, INFECT IMMUN, V83, P2518, DOI 10.1128/IAI.00023-15; Sader HS, 2004, ANTIMICROB AGENTS CH, V48, P3112, DOI 10.1128/AAC.48.8.3112-3118.2004; Sapaar B, 2014, J APPL MICROBIOL, V116, P1531, DOI 10.1111/jam.12483; Savage PB, 2002, FEMS MICROBIOL LETT, V217, P1; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Singh Shweta, 2015, Infez Med, V23, P211; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Taff HT, 2013, FUTURE MICROBIOL, V8, P1325, DOI 10.2217/fmb.13.101; Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08; Tetz VV, 2010, DNA CELL BIOL, V29, P399, DOI 10.1089/dna.2009.1011; Tsai PW, 2014, J MICROBIOL, V52, P581, DOI 10.1007/s12275-014-3630-2; Vila-Farres X, 2015, INT J ANTIMICROB AG, V46, P568, DOI 10.1016/j.ijantimicag.2015.08.003; Wnorowska U, 2015, ANTIMICROB AGENTS CH, V59, P3808, DOI 10.1128/AAC.00421-15; Wong CS, 2013, SENSORS-BASEL, V13, P12943, DOI 10.3390/s131012943; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	63	52	52	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157242	10.1371/journal.pone.0157242	http://dx.doi.org/10.1371/journal.pone.0157242			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315208	Green Submitted, Green Published, gold			2022-12-27	WOS:000378030000014
J	Rijks, JM; Saucedo, B; Spitzen-van der Sluijs, A; Wilkie, GS; van Asten, AJAM; van den Broek, J; Boonyarittichaikij, R; Stege, M; van der Sterren, F; Martel, A; Pasmans, F; Hughes, J; Grone, A; van Beurden, SJ; Kik, MJL				Rijks, Jolianne M.; Saucedo, Bernardo; Spitzen-van der Sluijs, Annemarieke; Wilkie, Gavin S.; van Asten, Alphons J. A. M.; van den Broek, Jan; Boonyarittichaikij, Roschong; Stege, Marisca; van der Sterren, Fleur; Martel, An; Pasmans, Frank; Hughes, Joseph; Grone, Andrea; van Beurden, Steven J.; Kik, Marja J. L.			Investigation of Amphibian Mortality Events in Wildlife Reveals an On-Going Ranavirus Epidemic in the North of the Netherlands	PLOS ONE			English	Article							PELOPHYLAX KL. ESCULENTUS; MAJOR CAPSID PROTEIN; MOLECULAR CHARACTERIZATION; DISEASE; IRIDOVIRUS; MODELS; FISH	In the four years following the first detection of ranavirus (genus Ranavirus, family Iridoviridae) infection in Dutch wildlife in 2010, amphibian mortality events were investigated nationwide to detect, characterize and map ranaviruses in amphibians over time, and to establish the affected host species and the clinico-pathological presentation of the disease in these hosts. The ultimate goal was to obtain more insight into ranavirus disease emergence and ecological risk. In total 155 dead amphibians from 52 sites were submitted between 2011 and 2014, and examined using histopathology, immunohistochemistry, virus isolation and molecular genetic characterization. Ranavirus-associated amphibian mortality events occurred at 18 sites (35%), initially only in proximity of the 2010 index site. Specimens belonging to approximately half of the native amphibian species were infected, including the threatened Pelobates fuscus (spadefoot toad). Clustered massive outbreaks involving dead adult specimens and ranavirus genomic identity indicated that one common midwife toad virus (CMTV)-like ranavirus strain is emerging in provinces in the north of the Netherlands. Modelling based on the spatiotemporal pattern of spread showed a high probability that this emerging virus will continue to be detected at new sites (the discrete reproductive power of this outbreak is 0.35). Phylogenetically distinct CMTV-like ranaviruses were found in the south of the Netherlands more recently. In addition to showing that CMTV-like ranaviruses threaten wild amphibian populations not only in Spain but also in the Netherlands, the current spread and risk of establishment reiterate that understanding the underlying causes of CMTV-like ranavirus emergence requires international attention.	[Rijks, Jolianne M.; Saucedo, Bernardo; van Asten, Alphons J. A. M.; Grone, Andrea; Kik, Marja J. L.] Univ Utrecht, Dutch Wildlife Hlth Ctr, Utrecht, Netherlands; [Saucedo, Bernardo; van Asten, Alphons J. A. M.; Stege, Marisca; Grone, Andrea; van Beurden, Steven J.; Kik, Marja J. L.] Univ Utrecht, Dept Pathobiol, Utrecht, Netherlands; [Spitzen-van der Sluijs, Annemarieke; van der Sterren, Fleur] Reptile Amphibian & Fish Conservat Netherlands, Nijmegen, Netherlands; [Wilkie, Gavin S.; Hughes, Joseph] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland; [van den Broek, Jan] Univ Utrecht, Dept Farm Anim Hlth, Utrecht, Netherlands; [Boonyarittichaikij, Roschong; Martel, An; Pasmans, Frank] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium	Utrecht University; Utrecht University; University of Glasgow; Utrecht University; Ghent University	Rijks, JM (corresponding author), Univ Utrecht, Dutch Wildlife Hlth Ctr, Utrecht, Netherlands.	j.m.rijks@uu.nl	Spitzen, Annemarieke/AAV-3970-2021; Pasmans, Frank/D-3667-2014; Hughes, Joseph/B-7711-2009; Spitzen, Annemarieke/B-3453-2012	Hughes, Joseph/0000-0003-2556-2563; Spitzen, Annemarieke/0000-0003-2008-9375	Dutch Ministry of Economic Affairs [140008149/2011, 1400006202/2010, 1400008946/2011, 1300011172/2012, 1300014843/2013, 1300017645/2014]; Netherlands Food and Consumer Safety Authority [60000784/2012]; Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT) [245756/359573]; United Kingdom Medical Research Council [MC_UU_12014/3]; Medical Research Council [MC_UU_12014/12, G0801822] Funding Source: researchfish; MRC [MC_UU_12014/12, G0801822] Funding Source: UKRI	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Food and Consumer Safety Authority; Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding provided by Grants 140008149/2011, and 1400006202/2010, 1400008946/2011, 1300011172/2012, 1300014843/2013, 1300017645/2014 from the Dutch Ministry of Economic Affairs: JMR, ASvdS, AJAMvA, MS, FvdS, AG, SJvB, MJLK. Grant 60000784/2012 from the Netherlands Food and Consumer Safety Authority: JMR, ASvdS, AG, MJLK. Grant 245756/359573 from the Mexican Consejo Nacional de Ciencia y Tecnologia (CONACyT): BS. Grant MC_UU_12014/3 from the United Kingdom Medical Research Council: GSW, JH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel E, 2009, DIS AQUAT ORGAN, V85, P7, DOI 10.3354/dao02060; Balseiro A, 2009, DIS AQUAT ORGAN, V84, P95, DOI 10.3354/dao02032; Bayley AE, 2013, DIS AQUAT ORGAN, V103, P171, DOI 10.3354/dao02574; Bollinger TK, 1999, J WILDLIFE DIS, V35, P413, DOI 10.7589/0090-3558-35.3.413; Chen ZY, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-101; Creemers R. C. M., 2009, AMFIBIEEN REPTIELEN; FIJAN N, 1991, Veterinarski Arhiv, V61, P151; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Grayfer L, 2012, VIRUSES-BASEL, V4, P1075, DOI 10.3390/v4071075; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Holopainen R, 2009, DIS AQUAT ORGAN, V85, P81, DOI 10.3354/dao02074; Jancovich JK, 2005, MOL ECOL, V14, P213, DOI 10.1111/j.1365-294X.2004.02387.x; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keawcharoen J, 2011, EMERG INFECT DIS, V17, P1016, DOI [10.3201/eid1705.100880, 10.3201/eid/1706.100880]; Kik M, 2011, VET J, V190, P284, DOI 10.1016/j.tvjl.2011.08.031; Kock RA, 2010, REV SCI TECH OIE, V29, P329, DOI 10.20506/rst.29.2.1980; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Li W, 2014, VET MICROBIOL, V172, P129, DOI 10.1016/j.vetmic.2014.05.009; Maniero GD, 2006, DEV COMP IMMUNOL, V30, P649, DOI 10.1016/j.dci.2005.09.007; Mao JH, 1997, VIROLOGY, V229, P212, DOI 10.1006/viro.1996.8435; Mavian C, 2012, J VIROL, V86, P3617, DOI 10.1128/JVI.07108-11; North AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127037; Price SJ, 2014, CURR BIOL, V24, P2586, DOI 10.1016/j.cub.2014.09.028; R Core Team, 2021, R LANGUAGE ENV STAT; Rijks JM, 600007842013 NVWA DU; Schloegel LM, 2010, DIS AQUAT ORGAN, V92, P101, DOI 10.3354/dao02140; Sharifian-Fard M, 2011, EMERG INFECT DIS, V17, P2371, DOI 10.3201/eid1712.110236; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Spitzen-van der Sluijs A, J WILDL DIS IN PRESS; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stohr AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118633; Stohr AC, 2013, VET J, V197, P238, DOI 10.1016/j.tvjl.2013.02.014; Storfer A, 2007, ECOL LETT, V10, P1075, DOI 10.1111/j.1461-0248.2007.01102.x; Tompkins DM, 2015, TRENDS PARASITOL, V31, P149, DOI 10.1016/j.pt.2015.01.007; van Beurden SJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01293-14; van den Broek J, 2007, BIOSTATISTICS, V8, P453, DOI 10.1093/biostatistics/kxl023; van den Broek J, 2009, ANN APPL STAT, V3, P1505, DOI 10.1214/09-AOAS270; Wang N, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01032-13	38	20	20	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157473	10.1371/journal.pone.0157473	http://dx.doi.org/10.1371/journal.pone.0157473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315226	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000378030000028
J	Chen, ZW; Feng, K; Grover, CE; Li, PB; Liu, F; Wang, YM; Xu, Q; Shang, MZ; Zhou, ZL; Cai, XY; Wang, XX; Wendel, JF; Wang, KB; Hua, JP				Chen, Zhiwen; Feng, Kun; Grover, Corrinne E.; Li, Pengbo; Liu, Fang; Wang, Yumei; Xu, Qin; Shang, Mingzhao; Zhou, Zhongli; Cai, Xiaoyan; Wang, Xingxing; Wendel, Jonathan F.; Wang, Kunbo; Hua, Jinping			Chloroplast DNA Structural Variation, Phylogeny, and Age of Divergence among Diploid Cotton Species	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENOME SEQUENCE; EVOLUTIONARY HISTORY; MAXIMUM-LIKELIHOOD; GOSSYPIUM-HIRSUTUM; PROVIDES INSIGHTS; GENUS GOSSYPIUM; NUCLEOTIDE; CHARACTERS; ORGANIZATION	The cotton genus (Gossypium spp.) contains 8 monophyletic diploid genome groups (A, B, C, D, E, F, G, K) and a single allotetraploid clade (AD). To gain insight into the phylogeny of Gossypium and molecular evolution of the chloroplast genome in this group, we performed a comparative analysis of 19 Gossypium chloroplast genomes, six reported here for the first time. Nucleotide distance in non-coding regions was about three times that of coding regions. As expected, distances were smaller within than among genome groups. Phylogenetic topologies based on nucleotide and indel data support for the resolution of the 8 genome groups into 6 clades. Phylogenetic analysis of indel distribution among the 19 genomes demonstrates contrasting evolutionary dynamics in different clades, with a parallel genome downsizing in two genome groups and a biased accumulation of insertions in the clade containing the cultivated cottons leading to large (for Gossypium) chloroplast genomes. Divergence time estimates derived from the cpDNA sequence suggest that the major diploid clades had diverged approximately 10 to 11 million years ago. The complete nucleotide sequences of 6 cpDNA genomes are provided, offering a resource for cytonuclear studies in Gossypium.	[Chen, Zhiwen; Li, Pengbo; Wang, Yumei; Xu, Qin; Hua, Jinping] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Minist Educ, Key Lab Crop Heterosis & Utilizat,Dept Plant Gene, Beijing 100193, Peoples R China; [Feng, Kun; Liu, Fang; Shang, Mingzhao; Zhou, Zhongli; Cai, Xiaoyan; Wang, Xingxing; Wang, Kunbo] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China; [Grover, Corrinne E.; Wendel, Jonathan F.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Iowa State University	Hua, JP (corresponding author), China Agr Univ, Beijing Key Lab Crop Genet Improvement, Minist Educ, Key Lab Crop Heterosis & Utilizat,Dept Plant Gene, Beijing 100193, Peoples R China.; Wang, KB (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.; Wendel, JF (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	jfw@iastate.edu; wkbcri@163.com; jinping_hua@cau.edu.cn	Grover, Corrinne E/K-3194-2019; Hua, Jinping/L-3221-2019	Grover, Corrinne E/0000-0003-3878-5459; Chen, Zhiwen/0000-0002-0268-5942	National Natural Science Foundation of China [31171591]; central level, scientific research institutes for basic R & D special fund business [SJA0901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); central level, scientific research institutes for basic R & D special fund business	This work was supported by grants in part from the National Natural Science Foundation of China (31171591) to J. Hua and from the central level, scientific research institutes for basic R & D special fund business (SJA0901) to K. Wang.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Brouard JS, 2010, GENOME BIOL EVOL, V2, P240, DOI 10.1093/gbe/evq014; Carbonell-Caballero J, 2015, MOL BIOL EVOL, V32, P2015, DOI 10.1093/molbev/msv082; Carvalho MR, 2011, AM J BOT, V98, P1337, DOI 10.3732/ajb.1000539; Civan P, 2014, GENOME BIOL EVOL, V6, P897, DOI 10.1093/gbe/evu061; Cong J, 2015, SCI REP-UK, V5, DOI [10.1038/srep10007, 10.1038/srep14139]; Cronn R, 2004, NEW PHYTOL, V161, P133, DOI [10.1111/j.1469-8137.2004.00947.x, 10.1046/j.1469-8137.2003.00947.x]; Cronn RC, 2002, AM J BOT, V89, P707, DOI 10.3732/ajb.89.4.707; Earl D, 2014, GENOME RES, V24, P2077, DOI 10.1101/gr.174920.114; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fu YB, 2010, GENET RESOUR CROP EV, V57, P667, DOI 10.1007/s10722-009-9502-7; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; GONG XS, 1991, CHINESE SCI BULL, V36, P1633; Grover CE, 2015, GENET RESOUR CROP EV, V62, P103, DOI 10.1007/s10722-014-0138-x; Grover CE, 2008, MOL BIOL EVOL, V25, P1415, DOI 10.1093/molbev/msn085; Grover CE, 2007, PLANT J, V50, P995, DOI 10.1111/j.1365-313X.2007.03102.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamilton MB, 2003, MOL BIOL EVOL, V20, P1710, DOI 10.1093/molbev/msg190; Handy SM, 2011, J AGR FOOD CHEM, V59, P10995, DOI 10.1021/jf203215v; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Ibrahim RIH, 2006, GENES GENET SYST, V81, P311, DOI 10.1266/ggs.81.311; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li PB, 2014, GENET RESOUR CROP EV, V61, P107, DOI 10.1007/s10722-013-0018-9; Liu GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069476; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luan PT, 2013, MOL PHYLOGENET EVOL, V66, P748, DOI 10.1016/j.ympev.2012.10.023; Machado Moara, 2011, Investig Genet, V2, P3, DOI 10.1186/2041-2223-2-3; Santorum JM, 2014, BIOINFORMATICS, V30, P1310, DOI 10.1093/bioinformatics/btu032; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Martin G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067350; Muller K, 2006, MOL PHYLOGENET EVOL, V38, P667, DOI 10.1016/j.ympev.2005.07.011; Muller K, 2005, PLANT SYST EVOL, V250, P39, DOI 10.1007/s00606-004-0224-1; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Muloko-Ntoutoume N, 2000, MOL ECOL, V9, P359, DOI 10.1046/j.1365-294X.2000.00859.x; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; Oddou-Muratorio S, 2001, EVOLUTION, V55, P1123, DOI 10.1111/j.0014-3820.2001.tb00632.x; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Nguyen PAT, 2015, PLANTA, V242, P223, DOI 10.1007/s00425-015-2303-7; Randle CP, 2005, AM J BOT, V92, P1575, DOI 10.3732/ajb.92.9.1575; Rodman James E., 1994, Australian Systematic Botany, V7, P57, DOI 10.1071/SB9940057; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Simmons MP, 2001, SYST BIOL, V50, P454, DOI 10.1080/106351501300318049; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Walker JF, 2014, AM J BOT, V101, P722, DOI 10.3732/ajb.1400049; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang Z, 2015, BMC GENOMICS, V16, DOI [10.1186/s12864-015-1988-0, 10.1186/s12864-015-1216-y]; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1991, EVOLUTION, V45, P694, DOI 10.1111/j.1558-5646.1991.tb04339.x; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Wendel JF, 2015, MONOGRAPH A IN PRESS; Wendel JF, 2010, PHYSIOLOGY OF COTTON, P1, DOI 10.1007/978-90-481-3195-2_1; Wu ZH, 2014, BIG DATA RES, V1, P1, DOI 10.1016/j.bdr.2014.08.0022214; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037128; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Yuan DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17662; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207	73	29	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157183	10.1371/journal.pone.0157183	http://dx.doi.org/10.1371/journal.pone.0157183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309527	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800041
J	Farshadpour, F; Taherkhani, R; Tajbakhsh, S; Tangestani, MG; Hajiani, G; Sharifi, N; Taherkhani, S; Nejadbolkheyr, A				Farshadpour, Fatemeh; Taherkhani, Reza; Tajbakhsh, Saeed; Tangestani, Marziyeh Gholizadeh; Hajiani, Gholamreza; Sharifi, Nasrin; Taherkhani, Sakineh; Nejadbolkheyr, Abdolreza			Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; B-VIRUS; SYPHILIS INFECTIONS; RISK; SEROPREVALENCE; EPIDEMIOLOGY; HIV; METAANALYSIS; EXPERIENCE	Background Blood transfusion is considered a potential risk factor for transmission of life-threatening viral infections, including HIV, HCV and HBV infections. This study was performed to find out the prevalence and trends of these infections among blood donors in Southern Iran. Methods The blood donor data recorded in twelve regional blood transfusion centers from 2004 to 2014 were analyzed in an anonymous way with respect to the results of serological screening for HBV, HCV, and HIV infections. Overall, 293454 donors were screened for viral infections. Results Most of the donors were male, married, aged between 20-40 years, educated, and regular donors. The overall seroprevalence rates of HBV, HCV and HIV were 0.15%, 0.1% and 0.004%, respectively. The highest seroprevalence was found for HBV, followed by HCV and HIV. These infections were more prevalent in male, low educated and first time donors. The highest HCV seroprevalence was observed among donors aged 20 to 40 years, while HBV seroprevalence increased with age. The seroprevalence rates of HBV and HCV from 2004 to 2014 showed significant decreasing trends from 0.460% to 0.060% (P < 0.001) and 0.329% to 0.045% (P < 0.001), respectively. Whereas HIV infection had a slight but not significant decline from 0.0173% in 2004 to 0.0028% in 2014 (P = 0.087). Conclusions The decreasing trends of transfusion-transmissible viral infections in blood donations indicate that the attempts of IBTO were successful in improving the safety of the blood supply, since the prevalence rates of viral infections have been reduced to very low levels in blood donations over the years. However, still more effective techniques such as polymerase chain reaction (PCR) are needed to guarantee blood safety.	[Farshadpour, Fatemeh; Taherkhani, Reza; Tajbakhsh, Saeed; Tangestani, Marziyeh Gholizadeh] Bushehr Univ Med Sci, Sch Med, Dept Microbiol & Parasitol, Bushehr, Iran; [Farshadpour, Fatemeh; Taherkhani, Reza; Tajbakhsh, Saeed] Bushehr Univ Med Sci, Persian Gulf Trop Med Res Ctr, Bushehr, Iran; [Hajiani, Gholamreza; Nejadbolkheyr, Abdolreza] Bushehr Blood Transfus Org, Bushehr, Iran; [Sharifi, Nasrin] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran; [Taherkhani, Sakineh] Shahroud Univ Med Sci, Sch Nursing & Midwifery, Reprod Hlth & Midwifery Dept, Shahroud, Iran	Shahroud University Medical Sciences	Taherkhani, R (corresponding author), Bushehr Univ Med Sci, Sch Med, Dept Microbiol & Parasitol, Bushehr, Iran.; Taherkhani, R (corresponding author), Bushehr Univ Med Sci, Persian Gulf Trop Med Res Ctr, Bushehr, Iran.	taherkhanireza2005@yahoo.com	Sharifi, Nasrin/AAW-2843-2021; farshadpour, fatemeh/B-3392-2018; Taherkhani, Reza/B-3384-2018; Tajbakhsh, Saeed/B-2859-2018; Sharifi, Nasrin/G-7661-2017; Taherkhani, Sakineh/P-3990-2018	Sharifi, Nasrin/0000-0002-2879-5883; farshadpour, fatemeh/0000-0002-8317-9573; Taherkhani, Reza/0000-0001-6499-0531; Sharifi, Nasrin/0000-0002-2879-5883; Taherkhani, Sakineh/0000-0003-3161-0963; Tajbakhsh, Saeed/0000-0001-6023-3939	Deputy Research and Affairs of Bushehr University of Medical Sciences, Bushehr, Iran [5919]	Deputy Research and Affairs of Bushehr University of Medical Sciences, Bushehr, Iran	This study was supported by the Deputy Research and Affairs of Bushehr University of Medical Sciences, Bushehr, Iran (grant no. 5919). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekeye AM, 2013, ASIAN J MED SCI, V5, P101, DOI 10.19026/ajms.5.5362; Al-Gani F.A., 2011, INT J BIOL MED RES, V2, P912; Alizadeh S., 2014, Asian Journal of Biological Sciences, V7, P35; Amiri FB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151946; Bozorgi SH, 2012, TRANSFUS APHER SCI, V47, P145, DOI 10.1016/j.transci.2012.06.023; Dhruva GA, 2012, ONLINE J HLTH ALLIED, V11, P5; Elbjeirami W, 2015, J BLOOD DISORD TRANS, V6; Farshadpour F, 2010, INDIAN J MED MICROBI, V28, P54, DOI 10.4103/0255-0857.58731; FARZADEGAN H, 1979, VOX SANG, V37, P182, DOI 10.1111/j.1423-0410.1979.tb02289.x; Fessehaye N, 2011, PAN AFR MED J, V9; Flichman DM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-218; Gonzalez M, 2005, TRANSFUSION, V45, P1670, DOI 10.1111/j.1537-2995.2005.00576.x; Irani-Hakime N, 2006, AM J INFECT CONTROL, V34, P241, DOI 10.1016/j.ajic.2005.06.009; Kafi-Abad SA, 2009, TRANSFUSION MED, V19, P189, DOI 10.1111/j.1365-3148.2009.00935.x; Kafi-Abad SA, 2009, TRANSFUSION, V49, P2214, DOI 10.1111/j.1537-2995.2009.02245.x; Khan AJ, 2000, B WORLD HEALTH ORGAN, V78, P956; Khedmat H, 2009, HEPAT MON, V9, P24; Khodabandehloo M, 2013, J RES MED SCI, V18, P674; Lama JR, 2010, AM J TROP MED HYG, V83, P194, DOI 10.4269/ajtmh.2010.10-0003; Li CQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-176; Mohammadali F, 2014, ARCH IRAN MED, V17, P613, DOI 0141709/AIM.006; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Mudholkar VG, 2014, INT J MED APPL SCI, V3, P82; Nwankwo E, 2012, TURK J MED SCI, V42, P337, DOI 10.3906/sag-1009-1176; Nwokeukwu HI., 2014, HEMATOL LEUKEMIA, V2, P4, DOI [10.7243/2052-434X-2-4, DOI 10.7243/2052-434X-2-4]; O'Brien SF, 2008, TRANSFUSION, V48, P2323, DOI 10.1111/j.1537-2995.2008.01845.x; Pallavi P, 2011, INDIAN J HEMATOL BLO, V27, P1, DOI 10.1007/s12288-010-0047-x; Polizzotto MN, 2008, TRANSFUSION, V48, P55, DOI 10.1111/j.1537-2995.2007.01482.x; Poorolajal J, 2009, J RES MED SCI, V14, P249; Sethi B, 2014, INTERNET J MED UPDAT, V9, P10; Shrestha AC, 2009, J INFECT DEV COUNTR, V3, P794, DOI 10.3855/jidc.311; Song Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094528; Sube K. L. L., 2014, South Sudan Medical Journal, V7, P76; Sultan F, 2007, INT J INFECT DIS, V11, P407, DOI 10.1016/j.ijid.2006.10.004; Taherkhani R, 2015, WORLD J GASTROENTERO, V21, P10790, DOI 10.3748/wjg.v21.i38.10790; Tessema B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-111; Tserenpuntsag B, 2008, J INFECT DEV COUNTR, V2, P73, DOI 10.3855/jidc.326; WHO, BLOOD SAF AV WHO FAC; Ymele FF, 2012, J BLOOD TRANSFUS, V2012, DOI DOI 10.1155/2012/458372; Zulfikar Ahmed, 2012, Medica Innovatica, V1, P24	40	44	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157615	10.1371/journal.pone.0157615	http://dx.doi.org/10.1371/journal.pone.0157615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309959	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800108
J	Fukunaga, G; Takayasu, H; Takayasu, M				Fukunaga, Gaku; Takayasu, Hideki; Takayasu, Misako			Property of Fluctuations of Sales Quantities by Product Category in Convenience Stores	PLOS ONE			English	Article							PURCHASE BEHAVIOR; MODEL; LAW; MARKET	The ability to ascertain the extent of product sale fluctuations for each store and locality is indispensable to inventory management. This study analyzed POS data from 158 convenience stores in Kawasaki City, Kanagawa Prefecture, Japan and found a power scaling law between the mean and standard deviation of product sales quantities for several product categories. For the statistical domains of low sales quantities, the power index was 1/2; for large sales quantities, the power index was 1, so called Taylor's law holds. The value of sales quantities with changing power indixes differed according to product category. We derived a Poissonian compound distribution model taking into account fluctuations in customer numbers to show that the scaling law could be explained theoretically for most of items. We also examined why the scaling law did not hold in some exceptional cases.	[Fukunaga, Gaku; Takayasu, Misako] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 227, Japan; [Takayasu, Hideki; Takayasu, Misako] Tokyo Inst Technol, Inst Innovat Res, Adv Data Anal & Modeling Unit, Midori Ku, Yokohama, Kanagawa 227, Japan; [Takayasu, Hideki] Sony Comp Sci Labs, Shinagawa Ku, Tokyo, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Takayasu, M (corresponding author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 227, Japan.; Takayasu, M (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Adv Data Anal & Modeling Unit, Midori Ku, Yokohama, Kanagawa 227, Japan.	takayasu.m.aa@m.titech.ac.jp	Takayasu, Misako/H-9890-2014	Takayasu, Misako/0000-0002-2467-614X	JSPS KAKENHI Grant [26310207]; Sony Computer Science Laboratories	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sony Computer Science Laboratories	This work was partly supported by JSPS KAKENHI Grant Number 26310207 (MT) (https://kaken.nii.ac.jp/d/p/26310207.en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Coauthor Hideki Takayasu is employed by Sony Computer Science Laboratories. Sony Computer Science Laboratories provided support in the form of salaries for author HT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of manuscript. The specific role of this author is articulated in the "author contributions" section.; The POS data used in this research were provided by Seven-Eleven Japan Co., Ltd. This work was supported by a Grant-in-Aid for Scientific Research (B) 26310207.	Azevedo RBR, 2001, P NATL ACAD SCI USA, V98, P5699, DOI 10.1073/pnas.091485998; Bass FM, 2007, MARKET SCI, V26, P179, DOI 10.1287/mksc.1060.0208; Bruce NI, 2008, MARKET SCI, V27, P659, DOI 10.1287/mksc.1070.0317; Danaher P.J., 1988, AUSTR J STATISTICS, V30, P263, DOI [10.1111/j.1467-842X.1988.tb00621.x, DOI 10.1111/J.1467-842X.1988.TB00621.X]; Danaher P.J., 1990, AUSTR J STAT, V32, P163, DOI [10.1111/j.1467-842X.1990.tb01010.x, DOI 10.1111/J.1467-842X.1990.TB01010.X]; de Menezes MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.068701; de Menezes MA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028701; Ehrenberg A.S.C, 1988, J ROYAL STAT SOC C, V8, P26, DOI [10.2307/2985810, DOI 10.2307/2985810]; Eisler Z, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046109; Eisler Z, 2008, ADV PHYS, V57, P89, DOI 10.1080/00018730801893043; GOODHARDT GJ, 1967, J MARKETING RES, V4, P155, DOI 10.2307/3149360; Groot RD, 2006, PHYSICA A, V363, P446, DOI 10.1016/j.physa.2005.08.023; Groot RD, 2005, PHYSICA A, V353, P501, DOI 10.1016/j.physa.2004.12.064; Higuchi T, 2000, IEICE T INF SYST, VE83D, P36; Jiang ZQ, 2007, EUR PHYS J B, V57, P347, DOI 10.1140/epjb/e2007-00174-7; Kendal WS, 2002, J THEOR BIOL, V217, P203, DOI 10.1006/jtbi.2002.3021; Lachaab M, 2006, QME-QUANT MARK ECON, V4, P57, DOI 10.1007/s11129-006-6559-x; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Ma QG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123129; Mizuno T, 2008, PHYSICA A, V387, P3931, DOI 10.1016/j.physa.2008.01.059; MORRISON DG, 1979, J MARKETING, V43, P65, DOI 10.2307/1250742; MORRISON DG, 1988, J BUS ECON STAT, V6, P145, DOI 10.2307/1391551; Reed DH, 2004, ANIM CONSERV, V7, P1, DOI 10.1017/S1367943004003476; Sano Y., 2009, P 9 AS PAC COMPL SYS, P195; Sano Y, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012805; Sato AH, 2012, J ECON INTERACT COOR, V7, P167, DOI 10.1007/s11403-012-0089-2; Sato AH, 2009, PROG THEOR PHYS SUPP, P38, DOI 10.1143/PTPS.179.38; Seki Y, 2012, J JAPAN IND MANAGEME, V63, P161; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Ueno Hiromichi, 2010, Journal of Physics: Conference Series, V221, DOI 10.1088/1742-6596/221/1/012018; Ueno H, 2011, PHYSICA A, V390, P499, DOI 10.1016/j.physa.2010.09.032; Wadsworth R.N, 1952, J ROYAL STAT SOC C, V1, P169, DOI [10.2307/2985620, DOI 10.2307/2985620]; Winkelmann R, 2008, ECONOMETRIC ANAL COU	33	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157653	10.1371/journal.pone.0157653	http://dx.doi.org/10.1371/journal.pone.0157653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310915	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800115
J	Lehmann, BD; Jovanovic, B; Chen, X; Estrada, MV; Johnson, KN; Shyr, Y; Moses, HL; Sanders, ME; Pietenpol, JA				Lehmann, Brian D.; Jovanovic, Bojana; Chen, Xi; Estrada, Monica V.; Johnson, Kimberly N.; Shyr, Yu; Moses, Harold L.; Sanders, Melinda E.; Pietenpol, Jennifer A.			Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; PATHOLOGICAL COMPLETE RESPONSE; PROGNOSTIC VALUE; SURVIVAL; IDENTIFICATION; IXABEPILONE; EXPRESSION; PACLITAXEL; WOMEN; RATES	Triple-negative breast cancer (TNBC) is a heterogeneous disease that can be classified into distinct molecular subtypes by gene expression profiling. Considered a difficult-to-treat cancer, a fraction of TNBC patients benefit significantly from neoadjuvant chemotherapy and have far better overall survival. Outside of BRCA1/2 mutation status, biomarkers do not exist to identify patients most likely to respond to current chemotherapy; and, to date, no FDA-approved targeted therapies are available for TNBC patients. Previously, we developed an approach to identify six molecular subtypes TNBC (TNBCtype), with each subtype displaying unique ontologies and differential response to standard-of-care chemotherapy. Given the complexity of the varying histological landscape of tumor specimens, we used histopathological quantification and laser-capture microdissection to determine that transcripts in the previously described immunomodulatory (IM) and mesenchymal stem-like (MSL) subtypes were contributed from infiltrating lymphocytes and tumor-associated stromal cells, respectively. Therefore, we refined TNBC molecular subtypes from six (TNBCtype) into four (TNBCtype-4) tumor-specific subtypes (BL1, BL2, M and LAR) and demonstrate differences in diagnosis age, grade, local and distant disease progression and histopathology. Using five publicly available, neoadjuvant chemotherapy breast cancer gene expression datasets, we retrospectively evaluated chemotherapy response of over 300 TNBC patients from pretreatment biopsies subtyped using either the intrinsic (PAM50) or TNBCtype approaches. Combined analysis of TNBC patients demonstrated that TNBC subtypes significantly differ in response to similar neoadjuvant chemotherapy with 41% of BL1 patients achieving a pathological complete response compared to 18% for BL2 and 29% for LAR with 95% confidence intervals (CIs; [33, 51], [9, 28], [17, 41], respectively). Collectively, we provide pre-clinical data that could inform clinical trials designed to test the hypothesis that improved outcomes can be achieved for TNBC patients, if selection and combination of existing chemotherapies is directed by knowledge of molecular TNBC subtypes.	[Lehmann, Brian D.; Johnson, Kimberly N.; Pietenpol, Jennifer A.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Jovanovic, Bojana] Harvard Univ, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Chen, Xi] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Div Biostat, Miami, FL 33136 USA; [Chen, Xi] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Estrada, Monica V.] Vanderbilt Univ, Breast Canc Res Program, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Shyr, Yu] Vanderbilt Univ, Dept Biostat, Div Canc Biostat, Ctr Quantitat Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Moses, Harold L.; Pietenpol, Jennifer A.] Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Sanders, Melinda E.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Harvard University; Dana-Farber Cancer Institute; University of Miami; University of Miami; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Lehmann, BD; Pietenpol, JA (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.; Pietenpol, JA (corresponding author), Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	brian.d.lehmann@vanderbilt.edu; j.pietenpol@vanderbilt.edu	Lehmann, Brian D./H-8464-2019	Lehmann, Brian D./0000-0003-0407-5248; Estrada, Monica Valeria/0000-0001-9846-8223	NCI/NCI grants [CA105436, CA068485, CA085492, CA102162]; Komen for the Cure Foundation grants [SAC110030, CCR13262005]; Vanderbilt-Ingram Cancer Center [P30 CA068485]; Vanderbilt Vision Center [P30 EY08126]; NIH/NCRR [G20 RR030956]; Specialized Program of Research Excellence in Breast Cancer [CA098131]; NATIONAL CANCER INSTITUTE [R01CA085492, R01CA105436, P30CA068485, P50CA098131, R01CA102162] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR030956] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER	NCI/NCI grants; Komen for the Cure Foundation grants; Vanderbilt-Ingram Cancer Center; Vanderbilt Vision Center; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Specialized Program of Research Excellence in Breast Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by: NCI/NCI grants CA105436 (JAP), CA068485 (JAP), CA085492 (HLM) and CA102162 (HLM); and Komen for the Cure Foundation grants SAC110030 (JAP) and CCR13262005 (BDL). The authors would like to thank Vanderbilt Technologies for Advanced Genomics (VANTAGE) and the Translational Pathology Shared Resources supported by the Vanderbilt-Ingram Cancer Center (P30 CA068485), the Vanderbilt Vision Center (P30 EY08126) and NIH/NCRR (G20 RR030956). Grant support for the histopathological analyses was provided by CA098131 (Specialized Program of Research Excellence in Breast Cancer).; We thank members of the Pietenpol lab and Robert Seitz for critical review of the manuscript. This research was supported by: NCI/NCI grants CA105436 (JAP), CA068485 (JAP), CA085492 (HLM) and CA102162 (HLM); and Komen for the Cure Foundation grants SAC110030 (JAP) and CCR13262005 (BDL). We would like to thank Vanderbilt Technologies for Advanced Genomics (VANTAGE) and the Translational Pathology Shared Resources supported by the Vanderbilt-Ingram Cancer Center (P30 CA068485), the Vanderbilt Vision Center (P30 EY08126) and NIH/NCRR (G20 RR030956). Grant support for the histopathological analyses was provided by CA098131 (Specialized Program of Research Excellence in Breast Cancer).	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Allred DC, 1998, MODERN PATHOL, V11, P155; Amirikia KC, 2011, CANCER-AM CANCER SOC, V117, P2747, DOI 10.1002/cncr.25862; [Anonymous], 2015, CANCER DISCOV, V5, P570, DOI 10.1158/2159-8290.CD-NB2015-059; [Anonymous], 2015, CANCER DISCOV, V5, P100, DOI 10.1158/2159-8290.CD-NB2014-184; Asano Y, 2016, BRIT J CANCER, V114, P14, DOI 10.1038/bjc.2015.434; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Byrski T, 2010, J CLIN ONCOL, V28, P375, DOI 10.1200/JCO.2008.20.7019; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen X, 2012, CANCER INFORM, V11, P147, DOI 10.4137/CIN.S9983; Denkert C, 2015, J CLIN ONCOL, V33, P983, DOI 10.1200/JCO.2014.58.1967; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Esserman LJ, 2012, BREAST CANCER RES TR, V132, P1049, DOI 10.1007/s10549-011-1895-2; Gluck S, 2012, BREAST CANCER RES TR, V132, P781, DOI 10.1007/s10549-011-1412-7; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Horak CE, 2013, CLIN CANCER RES, V19, P1587, DOI 10.1158/1078-0432.CCR-12-1359; Ibrahim EM, 2014, BREAST CANCER RES TR, V148, P467, DOI 10.1007/s10549-014-3185-2; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lehmann BD, 2014, J PATHOL, V232, P142, DOI 10.1002/path.4280; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Miyake T, 2012, CANCER SCI, V103, P913, DOI 10.1111/j.1349-7006.2012.02231.x; Rahim F, 2014, BONE MARROW RES, DOI 10.1155/2014/405920; Ring BZ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2198-0; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Saura C, 2013, ONCOLOGIST, V18, P787, DOI 10.1634/theoncologist.2013-0075; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Timms KM, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0475-x; Tutt A, 2014, SAN ANTONIO BREAST C, V2014, pS3	35	617	642	9	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157368	10.1371/journal.pone.0157368	http://dx.doi.org/10.1371/journal.pone.0157368			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310713	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800062
J	Mascret, N; Ibanez-Gijon, J; Brejard, V; Buekers, M; Casanova, R; Marqueste, T; Montagne, G; Rao, G; Roux, Y; Cury, F				Mascret, Nicolas; Ibanez-Gijon, Jorge; Brejard, Vincent; Buekers, Martinus; Casanova, Remy; Marqueste, Tanguy; Montagne, Gilles; Rao, Guillaume; Roux, Yannick; Cury, Francois			The Influence of the 'Trier Social Stress Test' on Free Throw Performance in Basketball: An Interdisciplinary Study	PLOS ONE			English	Article							PSYCHOLOGICAL RESPONSES; PSYCHOSOCIAL STRESS; SALIVARY CORTISOL; MOVEMENT VARIABILITY; SPORT PERFORMANCE; TESTOSTERONE; ANXIETY; COMPETITION; KINEMATICS; LEVEL	The aim of the present study was to explore the relationship between stress and sport performance in a controlled setting. The experimental protocol used to induce stress in a basketball free throw was the Trier Social Stress Test (TSST) and its control condition (Placebo-TSST). Participants (n = 19), novice basketball players but trained sportspersons, were exposed to two counterbalanced conditions in a crossover design. They were equipped with sensors to measure movement execution, while salivary cortisol and psychological state were also measured. The task consisted of two sequences of 40 free throws, one before either the TSST or Placebo-TSST and one after. Physiological and psychological measures evidenced that the TSST induced significant stress responses, whereas the Placebo-TSST did not. Shooting performance remained stable after the TSST but decreased after the Placebo-TSST. We found no effect of the TSST or Placebo-TSST on movement execution. A multivariate model of free throw performance demonstrated that timing, smoothness and explosiveness of the movements are more relevant to account for beginner's behavior than stress-related physiological and psychological states. We conclude that the TSST is a suitable protocol to induce stress responses in sport context, even though the effects on beginners' free throw performance and execution are small and complex.	[Mascret, Nicolas; Ibanez-Gijon, Jorge; Buekers, Martinus; Casanova, Remy; Marqueste, Tanguy; Montagne, Gilles; Rao, Guillaume; Roux, Yannick; Cury, Francois] Aix Marseille Univ, CNRS, ISM, Inst Movement Sci, Marseille, France; [Brejard, Vincent] Aix Marseille Univ, LPCLS EA 3278, F-13621 Aix En Provence, France; [Buekers, Martinus] Katholieke Univ Leuven, Dept Kinesiol, Tervuursevest 101, B-3001 Heverlee, Belgium; [Cury, Francois] Univ Toulon & Var, Toulon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; KU Leuven; Universite de Toulon	Mascret, N (corresponding author), Aix Marseille Univ, CNRS, ISM, Inst Movement Sci, Marseille, France.	nicolas.mascret@univ-amu.fr	Marqueste, Tanguy/AAM-9751-2021; Casanova, Remy/GSO-3393-2022; casanova, remy/U-3603-2017; Bréjard, Vincent/ABB-7970-2021; Ibáñez-Gijón, Jorge/D-6882-2019; Montagne, Gilles/T-6322-2017; casanova, rémy/AGK-6933-2022	Marqueste, Tanguy/0000-0002-2620-1551; casanova, remy/0000-0002-7101-8043; Bréjard, Vincent/0000-0003-1344-0489; Ibáñez-Gijón, Jorge/0000-0001-6897-6980; Montagne, Gilles/0000-0003-2184-2736; casanova, rémy/0000-0002-7101-8043	A*MIDEX project [ANR-11-IDEX-0001-02]; "Investissements d'avenir" French Government Program	A*MIDEX project(French National Research Agency (ANR)); "Investissements d'avenir" French Government Program(French National Research Agency (ANR))	This work has been carried out thanks to the support of the A*MIDEX project (no ANR-11-IDEX-0001-02), funded by the "Investissements d'avenir" French Government Program, managed by the French National Research Agency. NM JIG MB RC TM GM GR YR and FC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2014, NEUROSCI BIOBEHAV R, V38, P94, DOI 10.1016/j.neubiorev.2013.11.005; [Anonymous], 2014, R LANG ENV STAT COMP; Bartlett R, 2008, ROUTLEDGE HDB BIOMEC, P285; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Buchanan TW, 2014, BIOL PSYCHOL, V97, P60, DOI 10.1016/j.biopsycho.2014.02.005; Buekers M, 2016, QUEST; Button C, 2003, RES Q EXERCISE SPORT, V74, P257, DOI 10.1080/02701367.2003.10609090; Crewther BT, 2010, J SPORT MED PHYS FIT, V50, P85; Diamond David M, 2005, Nonlinearity Biol Toxicol Med, V3, P1, DOI 10.2201/nonlin.003.01.001; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Doan BK, 2007, INT J SPORTS MED, V28, P470, DOI 10.1055/s-2006-924557; Filaire E, 2009, PSYCHONEUROENDOCRINO, V34, P150, DOI 10.1016/j.psyneuen.2008.08.022; Giles GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113618; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Gooding A, 2009, J CLIN SPORT PSYCHOL, V3, P303, DOI 10.1123/jcsp.3.4.303; HARDY L, 1991, BRIT J PSYCHOL, V82, P163, DOI 10.1111/j.2044-8295.1991.tb02391.x; Het S, 2009, PSYCHONEUROENDOCRINO, V34, P1075, DOI 10.1016/j.psyneuen.2009.02.008; Higuchi T, 2002, HUM MOVEMENT SCI, V21, P831, DOI 10.1016/S0167-9457(02)00174-4; Hill D., 2010, INT REV SPORT EXER P, V3, P24, DOI [DOI 10.1080/17509840903301199, 10.1080/17509840903301199]; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; JONES G, 1991, PSYCHOLOGIST, V4, P152; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Klaperski S, 2013, PSYCHOL SPORT EXERC, V14, P266, DOI 10.1016/j.psychsport.2012.11.003; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Kudielka B. M., 2007, SOC NEUROSCI-UK, P56, DOI DOI 10.1007/978-1-4614-6852-3; Laborde S, 2014, PERS INDIV DIFFER, V57, P43, DOI 10.1016/j.paid.2013.09.013; Lautenbach F., 2016, PERFORMANCE PSYCHOL, P315, DOI [10.1016/B978-0-12-803377-7.00019-3, DOI 10.1016/B978-0-12-803377-7.00019-3, DOI 10.1016/B978-0-12-803377-7.00019]; Lautenbach F, 2014, PSYCHONEUROENDOCRINO, V42, P218, DOI 10.1016/j.psyneuen.2014.01.011; Lesage FX, 2012, INT J OCCUP MED ENV, V25, P178, DOI 10.2478/S13382-012-0024-8; Luethi M, 2008, FRONT BEHAV NEUROSCI, V2, P1; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; McEwen BS, 2005, J PSYCHIATR NEUROSCI, V30, P315; Mellalieu SD, 2009, J SPORT SCI, V27, P729, DOI 10.1080/02640410902889834; Mullineaux DR, 2010, J SPORT SCI, V28, P1017, DOI 10.1080/02640414.2010.487872; Otten M, 2009, J SPORT EXERCISE PSY, V31, P583, DOI 10.1123/jsep.31.5.583; PASSELERGUE P, 1995, INT J SPORTS MED, V16, P298, DOI 10.1055/s-2007-973009; Quesada AA, 2012, PSYCHONEUROENDOCRINO, V37, P125, DOI 10.1016/j.psyneuen.2011.05.013; Rimmele U, 2007, PSYCHONEUROENDOCRINO, V32, P627, DOI 10.1016/j.psyneuen.2007.04.005; Rimmele U, 2009, PSYCHONEUROENDOCRINO, V34, P190, DOI 10.1016/j.psyneuen.2008.08.023; Rohleder N, 2007, PERS SOC PSYCHOL B, V33, P69, DOI 10.1177/0146167206293986; Salama-Younes M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-22; Salvador A, 2003, PSYCHONEUROENDOCRINO, V28, P364, DOI 10.1016/S0306-4530(02)00028-8; Salvador A, 2009, NEUROSCI BIOBEHAV R, V33, P160, DOI 10.1016/j.neubiorev.2008.09.005; Selye H., 1974, STRESS DISTRESS; Selye H, 1956, J BONE JOINT SURG; Smith D., 2012, SPORT EXERCISE PSYCH, V8, P3; Spielberger C.D., 1993, INVENTAIRE ANXIETE E; Strahler K, 2010, PSYCHOL SPORT EXERC, V11, P148, DOI 10.1016/j.psychsport.2009.10.003; Suay F, 2012, ROUT RES SPORT EXERC, P43; Szabo S, 2012, STRESS, V15, P472, DOI 10.3109/10253890.2012.710919; Tanaka Y, 2010, RES Q EXERCISE SPORT, V81, P416; Wada M, 2001, NEUROSCI LETT, V302, P157, DOI 10.1016/S0304-3940(01)01662-7; Wagner H, 2012, HUM MOVEMENT SCI, V31, P78, DOI 10.1016/j.humov.2011.05.005; Whitehead R, 1996, J SPORT SCI, V14, P393, DOI 10.1080/02640419608727726; Williams AM, 2002, J SPORT EXERCISE PSY, V24, P438, DOI 10.1123/jsep.24.4.438; Woodman T, 2003, J SPORT SCI, V21, P443, DOI 10.1080/0264041031000101809	56	13	16	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157215	10.1371/journal.pone.0157215	http://dx.doi.org/10.1371/journal.pone.0157215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309715	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800042
J	Tan, RYY; Markus, HS				Tan, Rhea Yan Ying; Markus, Hugh Stephen			CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships	PLOS ONE			English	Article							PREVALENCE; ACETAZOLAMIDE; SPECTRUM; AURA	Background Migraine is common in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) but its treatment responses are not well described, and its relationship to stroke risk unknown. Encephalopathy is a less common presentation; it has been suggested it is related to migraine. We characterised migraine patterns and treatment responses in CADASIL, and examined associations between migraine and both stroke risk and encephalopathy. Methods 300 symptomatic CADASIL patients were prospectively recruited from a national referral clinic over a nineteen year period, from 1996 to 2015. Data was collected using a standardised questionnaire. Migraine was classified according to the International Classification of Headache Disorders, 3rd edition (beta version). A cross-sectional analysis was carried out on the data collected. Results Migraine was present in 226 (75.3%), and the presenting feature in 203 (67.7%). It was usually accompanied by aura (89.8%). Patients showed variable responses to a variety of drugs for migraine. Of 24 given triptans, 45.5% had consistent or partial responses. None had complications following triptans. Thirty-three (11.0%) patients experienced encephalopathy lasting on average 8.1 +/- 3.4 days. Patients with migraine with aura had higher odds of encephalopathy (OR = 5.4; 95% CI 1.6-28.4; p = 0.002). Patients with confusional aura had higher odds of encephalopathy than those with other aura types (OR = 2.5, 95% CI = 1.0-5.8, p = 0.04). There was also no increase in risk of encephalopathy with sex or age at onset of migraine. Migraineurs had a lower stroke risk than non-migraineurs (HR = 0.46, 95% CI 0.3-0.6, p = 2.1x10(-6)). Conclusions Migraine with aura is a prominent feature of CADASIL. Treatment responses are similar to those seen in the general migraine population and no complications were observed with triptans. Migraine with aura was associated with increased risk of encephalopathy suggesting they may share pathophysiological mechanisms. There was no increased stroke risk associated with migraine, but risk appeared to be reduced although this finding needs confirming.	[Tan, Rhea Yan Ying; Markus, Hugh Stephen] Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England	University of Cambridge	Tan, RYY (corresponding author), Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England.	yyrt2@medschl.cam.ac.uk			Agency for Science, Technology and Research Singapore (MBBS-PhD scholarship); NIHR Senior Investigator award; Cambridge Universities Trust NIHR Comprehensive Biomedical Research Centre; National Institute for Health Research [NF-SI-0512-10019] Funding Source: researchfish	Agency for Science, Technology and Research Singapore (MBBS-PhD scholarship); NIHR Senior Investigator award; Cambridge Universities Trust NIHR Comprehensive Biomedical Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	RYYT is supported by the Agency for Science, Technology and Research Singapore (MBBS-PhD scholarship, https://www.a-star.edu.sg/Awards-Scholarship/Scholarships-Attachments/For-Undergraduate-Studies/National-Science-Scholarship-MBBS-PhD.aspx). HSM is supported by an NIHR Senior Investigator award (http://www.nihr.ac.uk/our-faculty/senior-investigators.htm). His work is supported by the Cambridge Universities Trust NIHR Comprehensive Biomedical Research Centre (http://www.cambridge-brc.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Samii P, 2010, STROKE, V41, P630, DOI 10.1161/STROKEAHA.109.568402; Becker C, 2008, CEPHALALGIA, V28, P57, DOI 10.1111/j.1468-2982.2007.01469.x; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bousser MG, 2005, LANCET NEUROL, V4, P533, DOI 10.1016/S1474-4422(05)70164-2; Brennan KC, 2007, J NEUROPHYSIOL, V97, P4143, DOI 10.1152/jn.00028.2007; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Choi JC, 2014, CEPHALALGIA, V34, P22, DOI 10.1177/0333102413497598; Desmond DW, 1999, STROKE, V30, P1230, DOI 10.1161/01.STR.30.6.1230; Dichgans M, 1998, ANN NEUROL, V44, P731, DOI 10.1002/ana.410440506; Donnini I, 2012, J HEADACHE PAIN, V13, P299, DOI 10.1007/s10194-012-0426-9; Eikermann-Haerter K, 2014, HEADACHE, V54, P1146, DOI 10.1111/head.12386; Etminan M, 2005, BMJ-BRIT MED J, V330, P63, DOI 10.1136/bmj.38302.504063.8F; Fan Yuan, 2012, Neurol Clin Pract, V2, P359; Forteza AM, 2001, NEUROLOGY, V57, P2144, DOI 10.1212/WNL.57.11.2144; Guey S, 2016, CEPHALALGIA, V36, P1038, DOI 10.1177/0333102415620909; Gunda B, 2012, STROKE, V43, P137, DOI 10.1161/STROKEAHA.111.631028; Hall GC, 2004, NEUROLOGY, V62, P563, DOI 10.1212/01.WNL.0000110312.36809.7F; Kruit MC, 2010, CEPHALALGIA, V30, P129, DOI 10.1111/j.1468-2982.2009.01904.x; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Liem MK, 2010, CEPHALALGIA, V30, P1284, DOI 10.1177/0333102410370870; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Martikainen MH, 2012, J HEADACHE PAIN, V13, P95, DOI 10.1007/s10194-011-0400-y; MHRA, 2013, MED INF PROD DET; Roine S, 2005, NEUROLOGY, V64, P1441, DOI 10.1212/01.WNL.0000158655.71323.8A; Sathe S, 2009, HEADACHE, V49, P590, DOI 10.1111/j.1526-4610.2009.01363.x; Schon F, 2003, J NEUROL NEUROSUR PS, V74, P249, DOI 10.1136/jnnp.74.2.249; Spector JT, 2010, AM J MED, V123, P612, DOI 10.1016/j.amjmed.2009.12.021; Stewart WF, 2008, CEPHALALGIA, V28, P1170, DOI 10.1111/j.1468-2982.2008.01666.x; Tfelt-Hansen P, 2006, CEPHALALGIA, V26, P1265, DOI 10.1111/j.1468-2982.2006.01194.x; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; Vahedi K, 2004, ARCH NEUROL-CHICAGO, V61, P1237, DOI 10.1001/archneur.61.8.1237; Weller M, 1998, NEUROLOGY, V50, P1505, DOI 10.1212/WNL.50.5.1505; Wenzel RG, 2003, PHARMACOTHERAPY, V23, P494, DOI 10.1592/phco.23.4.494.32124; Zivadinov R, 2001, HEADACHE, V41, P805, DOI 10.1046/j.1526-4610.2001.01147.x	35	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157613	10.1371/journal.pone.0157613	http://dx.doi.org/10.1371/journal.pone.0157613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309730	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800107
J	Burghardt, EL; Flenker, KS; Clark, KC; Miguel, J; Ince, D; Winokur, P; Ford, B; McNamara, JO				Burghardt, Elliot L.; Flenker, Katie S.; Clark, Karen C.; Miguel, Jeff; Ince, Dilek; Winokur, Patricia; Ford, Bradley; McNamara, James O., II			Rapid, Culture-Free Detection of Staphylococcus aureus Bacteremia	PLOS ONE			English	Article							BLOOD; NUCLEASE; IDENTIFICATION; THERMONUCLEASE; INFECTIONS; COAGULASE; FREQUENCY; TESTS; DNASE	S. aureus bacteremia (SAB) is a common condition with high rates of morbidity and mortality. Current methods used to diagnose SAB take at least a day, and often longer. Patients with suspected bacteremia must therefore be empirically treated, often unnecessarily, while assay results are pending. In this proof-of-concept study, we describe an inexpensive assay that detects SAB via the detection of micrococcal nuclease (an enzyme secreted by S. aureus) in patient plasma samples in less than three hours. In total, 17 patient plasma samples from culture-confirmed S. aureus bacteremic individuals were tested. 16 of these yielded greater nuclease assay signals than samples from uninfected controls or individuals with non-S. aureus bacteremia. These results suggest that a nuclease-detecting assay may enable the rapid and inexpensive diagnosis of SAB, which is expected to substantially reduce the mortality and morbidity that result from this condition.	[Burghardt, Elliot L.; Flenker, Katie S.; Clark, Karen C.; Miguel, Jeff; Ince, Dilek; Winokur, Patricia; McNamara, James O., II] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Ford, Bradley] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	McNamara, JO (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	james-mcnamara@uiowa.edu	Ince, Dilek/AAW-4724-2021	Ince, Dilek/0000-0001-5446-3789; Winokur, Patricia/0000-0002-4826-1790; McNamara, James/0000-0003-4091-618X; Ford, Bradley/0000-0002-7871-7955	National Institutes of Health [AI101391, AI106738, P30CA086862]; Carver College of Medicine of the University of Iowa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106738, R21AI101391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver College of Medicine of the University of Iowa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [AI101391 and AI106738 to J.O.M.]. The TPC is supported by the Carver College of Medicine of the University of Iowa and the National Institutes of Health [P30CA086862]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagramyan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002041; BRAKSTAD OG, 1995, APMIS, V103, P219, DOI 10.1111/j.1699-0463.1995.tb01098.x; CUATRECA.P, 1967, J BIOL CHEM, V242, P1541; Cuatrecasas P, 1968, Brookhaven Symp Biol, V21, P172; Dark P, 2015, INTENS CARE MED, V41, P21, DOI 10.1007/s00134-014-3553-8; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Diekema DJ, 2002, INT J ANTIMICROB AG, V20, P412, DOI 10.1016/S0924-8579(02)00204-2; DISALVO J W, 1958, Med Techn Bull, V9, P191; Engemann JJ, 2005, INFECT CONT HOSP EP, V26, P534, DOI 10.1086/502580; Hernandez FJ, 2014, NAT MED, V20, P301, DOI 10.1038/nm.3460; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; Kellogg JA, 2000, J CLIN MICROBIOL, V38, P2181; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; LACHICA RVF, 1972, APPL MICROBIOL, V23, P994, DOI 10.1128/AEM.23.5.994-997.1972; Lagae-Wiens PRS, 2007, J CLIN MICROBIOL, V45, P3478, DOI 10.1128/JCM.01477-07; Lesens O, 2004, J INFECTION, V48, P245, DOI 10.1016/j.jinf.2003.10.010; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; MADISON BM, 1983, J CLIN MICROBIOL, V18, P722, DOI 10.1128/JCM.18.3.722-724.1983; MENZIES RE, 1977, J CLIN PATHOL, V30, P606, DOI 10.1136/jcp.30.7.606; Ringberg H, 2000, INFECTION, V28, P132, DOI 10.1007/s150100050065; Schilcher K, 2014, J INFECT DIS, V210, P473, DOI 10.1093/infdis/jiu091; Valencia-Shelton F, 2014, FUTURE MICROBIOL, V9, P543, DOI 10.2217/fmb.14.8; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	24	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157234	10.1371/journal.pone.0157234	http://dx.doi.org/10.1371/journal.pone.0157234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305148	Green Submitted, Green Published, gold			2022-12-27	WOS:000377824800040
J	Garin, N; Felix, G; Chuard, C; Genne, D; Carballo, S; Hugli, O; Lamy, O; Marti, C; Nendaz, M; Rutschmann, O; Harbarth, S; Perrier, A				Garin, Nicolas; Felix, Garance; Chuard, Christian; Genne, Daniel; Carballo, Sebastian; Hugli, Olivier; Lamy, Olivier; Marti, Christophe; Nendaz, Mathieu; Rutschmann, Olivier; Harbarth, Stephan; Perrier, Arnaud			Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired Pneumonia	PLOS ONE			English	Article							TREATMENT FAILURE; THROMBOCYTOSIS; EUROPE; TIME; PROCALCITONIN; INFECTIONS; MANAGEMENT; MORTALITY; CHILDREN; ETIOLOGY	Background Assessment of early response to treatment is crucial for the management of community-acquired pneumonia (CAP). Objective To describe the predictors and the outcomes of early clinical stability Methods We did a secondary analysis of a multicentre randomized controlled trial on CAP treatment in which 580 patients hospitalized for moderately severe CAP were included. The association between demographic, clinical and biological variables available at inclusion and early clinical stability (stabilization of vital signs within 72 hours with predetermined cut-offs) was assessed by multivariate logistic regression. The association between early clinical stability and mortality, severe adverse events, and length of stay was also tested. Results Younger age (OR 0.98, 95% CI 0.96-0.99), lower platelet count (OR per 10 G/L increment 0.96, 95% CI 0.94-0.98), lower respiratory rate (OR 0.94, 95% CI 0.90-0.97), absence of hypoxemia (OR 0.58, 95% CI 0.40-0.85), lower numbers of co-morbid conditions (OR 0.82, 95% CI 0.69-0.98) and signs or symptoms (OR 0.78, 95% CI 0.68-0.90) were significantly associated with early clinical stability. Patients with early clinical stability had lower 90-days mortality (3.4% vs. 11.9%, p<0.001), fewer admissions to the intensive care unit (2.7% vs. 8.0%, p = 0.005) and a shorter length of stay (6.0 days, IQR 4.0-10.0 vs. 10.0 days, IQR 7.0-15.0, p<0.001). Conclusions Patients with younger age, less co-morbidity, fewer signs or symptoms, less respiratory compromise, and a lower platelet count are more likely to reach early clinical stability. Patients without early clinical stability have a worse prognosis and warrant close scrutiny.	[Garin, Nicolas; Felix, Garance; Carballo, Sebastian; Marti, Christophe; Nendaz, Mathieu; Perrier, Arnaud] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Garin, Nicolas; Felix, Garance; Carballo, Sebastian; Marti, Christophe; Nendaz, Mathieu; Rutschmann, Olivier; Harbarth, Stephan; Perrier, Arnaud] Fac Med, Geneva, Switzerland; [Garin, Nicolas] Reg Hosp Riviera Chablais, Div Internal Med, Monthey, Switzerland; [Chuard, Christian] Hop Cantonal Fribourg, Div Internal Med, Fribourg, Switzerland; [Genne, Daniel] Ctr Hosp Bienne, Div Internal Med, Biel, Switzerland; [Hugli, Olivier] CHU Vaudois, Dept Emergency Med, CH-1011 Lausanne, Switzerland; [Lamy, Olivier] CHU Vaudois, Div Internal Med, CH-1011 Lausanne, Switzerland; [Rutschmann, Olivier] Univ Hosp Geneva, Emergency Dept, Geneva, Switzerland; [Harbarth, Stephan] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland	University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Geneva	Garin, N (corresponding author), Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland.; Garin, N (corresponding author), Fac Med, Geneva, Switzerland.; Garin, N (corresponding author), Reg Hosp Riviera Chablais, Div Internal Med, Monthey, Switzerland.	Nicolas.Garin@hopitalrivierachablais.ch	Hugli, Olivier/AAA-7057-2020; Genne, Daniel/O-2305-2014; Nendaz, Mathieu R/X-6786-2019	Nendaz, Mathieu R/0000-0003-3795-3254; Hugli, Olivier/0000-0003-2312-1625	Swiss National Science Foundation [3200BO-120074]; Clinical Trial Unit; Department of Internal Medicine of Geneva University Hospitals	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Clinical Trial Unit; Department of Internal Medicine of Geneva University Hospitals	The original study (BICAP trial) was supported by grant 3200BO-120074 from the Swiss National Science Foundation (AP) and grants from the Clinical Trial Unit and the Department of Internal Medicine of Geneva University Hospitals (AP, NG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram AR, 2013, CLIN MICROBIOL INFEC, V19, P1174, DOI 10.1111/1469-0691.12173; Aliberti S, 2008, CHEST, V134, P955, DOI 10.1378/chest.08-0334; Aliberti S, 2013, EUR RESPIR J, V42, P742, DOI 10.1183/09031936.00100812; Arancibia F, 2000, AM J RESP CRIT CARE, V162, P154, DOI 10.1164/ajrccm.162.1.9907023; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; Blasi F, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-6; Blasi F, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-44; Brogly N, 2007, J INFECTION, V55, P136, DOI 10.1016/j.jinf.2007.01.011; Chalmers JD, 2008, AM J MED, V121, P219, DOI 10.1016/j.amjmed.2007.10.033; Cretikos MA, 2008, MED J AUSTRALIA, V188, P657; Dodig S, 2005, ARCH MED RES, V36, P124, DOI 10.1016/j.arcmed.2004.12.011; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Garin N, 2014, JAMA INTERN MED, V174, P1894, DOI 10.1001/jamainternmed.2014.4887; Genne D, 2006, EUR J CLIN MICROBIOL, V25, P159, DOI 10.1007/s10096-006-0113-3; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; Harrison MT, 2014, THORAX, V69, P609, DOI 10.1136/thoraxjnl-2013-203996; Hillman K, 2005, LANCET, V365, P2091; Hoogewerf M, 2006, CLIN MICROBIOL INFEC, V12, P1097, DOI 10.1111/j.1469-0691.2006.01535.x; Huang DT, 2008, ANN EMERG MED, V52, P48, DOI 10.1016/j.annemergmed.2008.01.003; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lodise TP, 2015, ANTIMICROB AGENTS CH, V59, P1119, DOI 10.1128/AAC.03643-14; Marti C, 2012, CRIT CARE, V16, DOI 10.1186/cc11447; Menendez R, 2004, CLIN INFECT DIS, V39, P1783, DOI 10.1086/426028; Menendez R, 2009, THORAX, V64, P987, DOI 10.1136/thx.2009.118612; Menendez R, 2007, CHEST, V132, P1348, DOI 10.1378/chest.06-1995; Mirsaeidi M, 2010, CHEST, V137, P416, DOI 10.1378/chest.09-0998; Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059; Ott SR, 2012, EUR RESPIR J, V39, P611, DOI 10.1183/09031936.00098411; Prina E, 2013, CHEST, V143, P767, DOI 10.1378/chest.12-1235; Ramirez JA, 2011, J ANTIMICROB CHEMOTH, V66, pIII3, DOI 10.1093/jac/dkr094; Roson B, 2004, ARCH INTERN MED, V164, P502, DOI 10.1001/archinte.164.5.502; Schuetz P, 2011, EUR RESPIR J, V37, P384, DOI 10.1183/09031936.00035610; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Talbot GH, 2012, CLIN INFECT DIS, V55, P1114, DOI 10.1093/cid/cis566; Torres A, 2014, EUR J CLIN MICROBIOL, V33, P1065, DOI 10.1007/s10096-014-2067-1; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; WOLACH B, 1990, PEDIATR INFECT DIS J, V9, P718, DOI 10.1097/00006454-199010000-00007	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157350	10.1371/journal.pone.0157350	http://dx.doi.org/10.1371/journal.pone.0157350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305046	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800050
J	Kesavan, K; Frank, P; Cordero, DM; Benharash, P; Harper, RM				Kesavan, Kalpashri; Frank, Paul; Cordero, Daniella M.; Benharash, Peyman; Harper, Ronald M.			Neuromodulation of Limb Proprioceptive Afferents Decreases Apnea of Prematurity and Accompanying Intermittent Hypoxia and Bradycardia	PLOS ONE			English	Article							CENTRAL HYPOVENTILATION SYNDROME; OBSTRUCTIVE SLEEP-APNEA; BIRTH-WEIGHT INFANTS; RANDOMIZED CLINICAL-TRIAL; EARLY CAFFEINE THERAPY; PRETERM INFANTS; BRONCHOPULMONARY DYSPLASIA; NEURAL ALTERATIONS; OXIDATIVE STRESS; RISK-FACTORS	Background Apnea of Prematurity (AOP) is common, affecting the majority of infants born at <34 weeks gestational age. Apnea and periodic breathing are accompanied by intermittent hypoxia (IH). Animal and human studies demonstrate that IH exposure contributes to multiple pathologies, including retinopathy of prematurity (ROP), injury to sympathetic ganglia regulating cardiovascular action, impaired pancreatic islet cell and bone development, cerebellar injury, and neurodevelopmental disabilities. Current standard of care for AOP/IH includes prone positioning, positive pressure ventilation, and methylxanthine therapy; these interventions are inadequate, and not optimal for early development. Objective The objective is to support breathing in premature infants by using a simple, non-invasive vibratory device placed over limb proprioceptor fibers, an intervention using the principle that limb movements trigger reflexive facilitation of breathing. Methods Premature infants (23-34 wks gestational age), with clinical evidence of AOP/IH episodes were enrolled 1 week after birth. Caffeine treatment was not a reason for exclusion. Small vibration devices were placed on one hand and one foot and activated in 6 hour ON/OFF sequences for a total of 24 hours. Heart rate, respiratory rate, oxygen saturation (SpO(2)), and breathing pauses were continuously collected. Results Fewer respiratory pauses occurred during vibration periods, relative to baseline (p<0.005). Significantly fewer SpO(2) declines occurred with vibration (p<0.05), relative to control periods. Significantly fewer bradycardic events occurred during vibration periods, relative to no vibration periods (p<0.05). Conclusions In premature neonates, limb proprioceptive stimulation, simulating limb movement, reduces breathing pauses and IH episodes, and lowers the number of bradycardic events that accompany aberrant breathing episodes. This low-cost neuromodulatory procedure has the potential to provide a non-invasive intervention to reduce apnea, bradycardia and intermittent hypoxia in premature neonates.	[Kesavan, Kalpashri; Cordero, Daniella M.] Univ Calif Los Angeles, Pediat, Los Angeles, CA USA; [Frank, Paul] Univ Calif Los Angeles, Cardiothorac Surg, Los Angeles, CA USA; [Benharash, Peyman] Harbor UCLA, Surg, Los Angeles, CA USA; [Harper, Ronald M.] Univ Calif Los Angeles, Neurobiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles	Kesavan, K (corresponding author), Univ Calif Los Angeles, Pediat, Los Angeles, CA USA.	KKesavan@mednet.ucla.edu			UCLA Children's Discovery and Innovation Institute's Seed Grant award	UCLA Children's Discovery and Innovation Institute's Seed Grant award	This work was supported by grants from the UCLA Children's Discovery and Innovation Institute's Seed Grant award (KK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the UCLA Children's Discovery and Innovation Institute's Seed Grant award.	Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Bland JM, 1996, BRIT MED J, V312, P770; Bloch-Salisbury E, 2009, J APPL PHYSIOL, V107, P1017, DOI 10.1152/japplphysiol.00058.2009; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; BUCHER HU, 1988, EUR J PEDIATR, V147, P288, DOI 10.1007/BF00442697; Cohen G, 2007, PEDIATR RES, V61, P329, DOI 10.1203/pdr.0b013e318030d0ef; Cross RL, 2008, SLEEP, V31, P1103; Curzi-Dascalova L, 2002, J PEDIATR-US, V140, P766, DOI 10.1067/mpd.2002.124383; Darnall RA, 1997, PEDIATRICS, V100, P795, DOI 10.1542/peds.100.5.795; Darnall RA, 2010, RESP PHYSIOL NEUROBI, V173, P201, DOI 10.1016/j.resp.2010.04.009; Di Fiore JM, 2010, J PEDIATR-US, V157, P69, DOI 10.1016/j.jpeds.2010.01.046; Dobson NR, 2014, J PEDIATR-US, V164, P992, DOI 10.1016/j.jpeds.2013.12.025; Eichenwald EC, 1997, PEDIATRICS, V100, P354, DOI 10.1542/peds.100.3.354; ELDRIDGE FL, 1985, RESP PHYSIOL, V59, P313, DOI 10.1016/0034-5687(85)90136-7; Fadda P, 1997, PHARMACOL RES, V35, P443, DOI 10.1006/phrs.1997.0155; Fink GR, 1995, J PHYSIOL-LONDON, V489, P663, DOI 10.1113/jphysiol.1995.sp021081; Forster HV, 2014, J PHYSIOL-LONDON, V592, P429, DOI 10.1113/jphysiol.2013.262162; FRANTZ ID, 1976, J APPL PHYSIOL, V41, P41, DOI 10.1152/jappl.1976.41.1.41; Gizzi C, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/301818; Gozal D, 1996, AM J RESP CRIT CARE, V153, P761, DOI 10.1164/ajrccm.153.2.8564130; Gozal D, 2000, AM J RESP CRIT CARE, V162, P1747, DOI 10.1164/ajrccm.162.5.2005012; Grimaldi D, 2014, DIABETES CARE, V37, P355, DOI 10.2337/dc13-0933; GUTHRIE RD, 1980, J APPL PHYSIOL, V48, P347, DOI 10.1152/jappl.1980.48.2.347; Hayes MJ, 2007, J PERINATOL, V27, P782, DOI 10.1038/sj.jp.7211820; Henderson-Smart DJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000432.pub2; Henderson-Smart DJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000140.pub2; HENDERSONSMART DJ, 1986, ARCH DIS CHILD, V61, P227, DOI 10.1136/adc.61.3.227; Hibbs AM, 2008, J PEDIATR-US, V153, P176, DOI 10.1016/j.jpeds.2008.01.040; ISCOE S, 1976, J APPL PHYSIOL, V40, P138, DOI 10.1152/jappl.1976.40.2.138; ISHIDA K, 1993, EUR J APPL PHYSIOL, V66, P507, DOI 10.1007/BF00634300; Iwamoto E, 2010, RESP PHYSIOL NEUROBI, V173, P23, DOI 10.1016/j.resp.2010.06.002; Janvier Annie, 2004, J Perinatol, V24, P763, DOI 10.1038/sj.jp.7211182; JONES RAK, 1981, ARCH DIS CHILD, V56, P889, DOI 10.1136/adc.56.11.889; KEENS TG, 1978, J APPL PHYSIOL, V44, P909, DOI 10.1152/jappl.1978.44.6.909; Kim G, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00015; Koroglu OA, 2014, NEONATOLOGY, V106, P235, DOI 10.1159/000363217; KORNER AF, 1975, PEDIATRICS, V56, P361; Kumar R, 2009, DEPRESS ANXIETY, V26, P480, DOI 10.1002/da.20531; Lehtonen Liisa, 2004, Semin Neonatol, V9, P229, DOI 10.1016/j.siny.2003.09.002; Lin M, 2008, J COMP NEUROL, V509, P103, DOI 10.1002/cne.21732; Lodha A, 2015, JAMA PEDIATR, V169, P33, DOI 10.1001/jamapediatrics.2014.2223; Malcolm WF, 2009, J PERINATOL, V29, P372, DOI 10.1038/jp.2008.234; Marcus CL, 2014, AM J RESP CRIT CARE, V190, P791, DOI 10.1164/rccm.201406-1092OC; Martin Richard J, 2004, Paediatr Respir Rev, V5 Suppl A, pS377, DOI 10.1016/S1526-0542(04)90067-X; Martin RJ, 2015, CLIN PERINATOL, V42, P825, DOI 10.1016/j.clp.2015.08.009; Martin RJ, 2011, NEONATOLOGY, V100, P303, DOI 10.1159/000329922; Moriette G, 2010, ARCH PEDIATRIE, V17, P186, DOI 10.1016/j.arcped.2009.09.016; Nanduri J, 2009, P NATL ACAD SCI USA, V106, P1199, DOI 10.1073/pnas.0811018106; Olini N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072539; Osborn DA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000502, DOI 10.1002/14651858.CD000502, 10.1002/14651858.cd000502]; Paavonen EJ, 2007, PEDIATRICS, V120, P778, DOI 10.1542/peds.2007-0540; Pae EK, 2005, NEUROSCI LETT, V375, P123, DOI 10.1016/j.neulet.2004.10.091; Pae EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090192; Pae EK, 2013, BIOCHEM BIOPH RES CO, V441, P637, DOI 10.1016/j.bbrc.2013.10.102; Pae EK, 2011, INT J DEV NEUROSCI, V29, P819, DOI 10.1016/j.ijdevneu.2011.09.003; PAN LG, 1986, J APPL PHYSIOL, V60, P1016, DOI 10.1152/jappl.1986.60.3.1016; Pantalitschka T, 2009, ARCH DIS CHILD-FETAL, V94, pF245, DOI 10.1136/adc.2008.148981; PAPE KE, 1976, PEDIATRICS, V58, P473; Patel RM, 2013, J PERINATOL, V33, P134, DOI 10.1038/jp.2012.52; PATON JY, 1993, AM REV RESPIR DIS, V147, P1185, DOI 10.1164/ajrccm/147.5.1185; Pillekamp F, 2007, NEONATOLOGY, V91, P155, DOI 10.1159/000097446; POETS CF, 1993, PEDIATR RES, V34, P144, DOI 10.1203/00006450-199308000-00007; POETS CF, 1991, EARLY HUM DEV, V26, P1, DOI 10.1016/0378-3782(91)90038-5; Potts JT, 2005, J NEUROSCI, V25, P1965, DOI 10.1523/JNEUROSCI.3881-04.2005; Pozo ME, 2012, NEONATOLOGY, V102, P107, DOI 10.1159/000338096; Ratner V, 2009, NEONATOLOGY, V95, P299, DOI 10.1159/000178798; Rhein LM, 2014, JAMA PEDIATR, V168, P250, DOI 10.1001/jamapediatrics.2013.4371; Robertson CMT, 2009, PEDIATR NEUROL, V40, P189, DOI 10.1016/j.pediatrneurol.2008.09.017; Rosen CL, 2003, J PEDIATR-US, V142, P383, DOI 10.1067/mpd.2003.28; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; SAIGAL S, 1986, J PEDIATR-US, V109, P857, DOI 10.1016/S0022-3476(86)80714-4; Schmidt B, 2012, JAMA-J AM MED ASSOC, V307, P275, DOI 10.1001/jama.2011.2024; Schmolzer GM, 2008, J PEDIATR-US, V153, P741, DOI 10.1016/j.jpeds.2008.08.016; Schussler P, 2006, PSYCHONEUROENDOCRINO, V31, P915, DOI 10.1016/j.psyneuen.2006.05.002; Sunderram J., 2012, Critical Reviews in Biomedical Engineering, V40, P265; Taha D, 2014, J MATERN-FETAL NEO M, V27, P1698, DOI 10.3109/14767058.2014.885941; Tibballs J, 2003, PEDIATR PULM, V36, P544, DOI 10.1002/ppul.10392; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Xie HG, 2011, J CLIN PHARMACOL, V51, P502, DOI 10.1177/0091270010370587; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055	80	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157349	10.1371/journal.pone.0157349	http://dx.doi.org/10.1371/journal.pone.0157349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304988	gold, Green Published, Green Submitted			2022-12-27	WOS:000377824800049
J	Wongprikorn, A; Sukasem, C; Puangpetch, A; Numthavej, P; Thakkinstian, A; Kiertiburanakul, S				Wongprikorn, Asita; Sukasem, Chonlaphat; Puangpetch, Apichaya; Numthavej, Pawin; Thakkinstian, Ammarin; Kiertiburanakul, Sasisopin			Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study	PLOS ONE			English	Article							HMG-COA REDUCTASE; PROTEASE INHIBITOR; INDIVIDUALS; THERAPY; COHORT	Background Dyslipidemia as a risk factor of cardiovascular disease is common especially in HIV-infected patients who are using protease inhibitors (PIs) including atazanavir. Pitavastatin has less drug-drug interactions and demonstrable efficacy in decreasing lipid levels in non HIV-infected individuals. Materials and Methods This study was a randomized, double-blind, crossover study comparing the safety and efficacy of pitavastatin vs placebo in HIV-infected patients with dyslipidemia and receiving atazanavir/ritonavir (ATV/r). Patients were randomized to receive either placebo or pitavastatin for 12 weeks. The follow-up visits were every 4 weeks until the end of the study. Results A total of 12 HIV-infected patients were enrolled to each study group. Of all, 14 (58%) patients were men and mean (standard deviation, SD) age was 48.1 (1.8) years. At 12 weeks of treatment with pitavastatin compared to placebo; mean [ 95% confidence interval (CI)] total cholesterol (TC) was 207 (187.3, 226.8) mg/dL vs 246.3 (226.5, 266) mg/dL (p<0.001); mean (95% CI) triglyceride (TG) was 351.3 (193.2, 509.4) mg/dL vs 279.1 (121, 437.2) mg/dL (p = 0.269); mean (95% CI) high density lipoprotein (HDL) was 45.3 (40.4, 50.2) mg/dL vs 44.2 (39.3, 49.1) mg/dL (p = 0.354); and mean (95% CI) low density lipoprotein (LDL) was 113.2 (100.4, 126) mg/dL vs 145.6 (132.8, 158.4) mg/dL (p<0.001). Mean liver enzyme and median creatine phosphokinase levels were not statistically significant between patients receiving placebo and pitavastatin. Conclusions Pitavastatin decreases TC and LDL level at 12 weeks significantly and shows indifferent in hepatotoxicity and creatine phosphokinase levels compared to those of placebo. Thus, pitavastatin can be a good option of lipid-lowering agent in HIV-infected patients who are receiving ATV/r.	[Wongprikorn, Asita; Kiertiburanakul, Sasisopin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med,Div Infect Dis, Bangkok 10700, Thailand; [Sukasem, Chonlaphat; Puangpetch, Apichaya] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol,Div Pharmacogen & Personalized Med, Bangkok 10700, Thailand; [Sukasem, Chonlaphat; Puangpetch, Apichaya] Mahidol Univ, Ramathibodi Hosp, Fac Med, Lab Pharmacogen,Somdech Phra Debaratana Med Ctr, Bangkok 10700, Thailand; [Numthavej, Pawin; Thakkinstian, Ammarin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Clin Epidemiol & Biostat, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Kiertiburanakul, S (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med,Div Infect Dis, Bangkok 10700, Thailand.	sasisopin.kie@mahidol.ac.th	Thakkinstian, Ammarin/J-4788-2019		Faculty of Medicine Ramathibodi Hospital [IO-R1 1058032]; Kowa Company Limited (Japan)	Faculty of Medicine Ramathibodi Hospital; Kowa Company Limited (Japan)	Grant support was received from Faculty of Medicine Ramathibodi Hospital (Grant IO-R1 1058032). Pitavastatin and placebo are supported by Kowa Company Limited (Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LIV PACK INS; Arora P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000305; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Bunupuradah T, 2014, PEDIATR INFECT DIS J, V33, pE316, DOI 10.1097/INF.0000000000000469; Calza L, 2005, AIDS, V19, P1051, DOI 10.1097/01.aids.0000174451.78497.8f; Dube MP, 2003, CLIN INFECT DIS, V37, P613, DOI 10.1086/378131; Estrada V, 2011, AIDS REV, V13, P49; Farmer JA, 2000, DRUG SAFETY, V23, P197, DOI 10.2165/00002018-200023030-00003; Fisher SD, 2006, ATHEROSCLEROSIS, V185, P1, DOI 10.1016/j.atherosclerosis.2005.09.025; Fujino H, 2003, XENOBIOTICA, V33, P27, DOI 10.1080/0049825021000017957; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guardiola M, 2006, CLIN CHEM, V52, P1914, DOI 10.1373/clinchem.2006.069583; Haugaard SB, 2006, METABOLISM, V55, P175, DOI 10.1016/j.metabol.2005.08.018; Lundgren JD, 2008, HIV MED, V9, P72, DOI 10.1111/j.1468-1293.2007.00534.x; Luz AJ, 2013, BRAZ J INFECT DIS, V17, P657, DOI 10.1016/j.bjid.2013.04.002; Mahley RWBT, 2001, GOODMAN GILMANS PHAR; Neuvonen PJ, 2006, CLIN PHARMACOL THER, V80, P565, DOI 10.1016/j.clpt.2006.09.003; Sasaki J, 2010, VASC HEALTH RISK MAN, V6, P997, DOI 10.2147/VHRM.S7802; Sponseller CA, 2013, J CLIN LIPIDOL, V7, P260; TOBERT JA, 1988, AM J CARDIOL, V62, pJ28, DOI 10.1016/0002-9149(88)90004-5; Winston A, 2005, J ANTIMICROB CHEMOTH, V56, P380, DOI 10.1093/jac/dki235	21	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157531	10.1371/journal.pone.0157531	http://dx.doi.org/10.1371/journal.pone.0157531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304841	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800068
J	Workneh, BD; Gebrehiwot, MG; Bayo, TA; Gidey, MT; Belay, YB; Tesfaye, DM; Kassa, TT				Workneh, Birhanu Demeke; Gebrehiwot, Mehari Gebregergis; Bayo, Tigist Assefa; Gidey, Meles Tekie; Belay, Yared Belete; Tesfaye, Desalegn Mergiaw; Kassa, Terefe Teshome			Influence of Medical Representatives on Prescribing Practices in Mekelle, Northern Ethiopia	PLOS ONE			English	Article							PHYSICIANS; IMPACT; VISITS	Background Drug promotion by medical representatives is one of the factors that influence physicians' prescribing decisions and choice of drugs. Objective To assess the influence of medical representatives on prescribing practice of physicians in health facilities, Mekelle, Northern Ethiopia. Materials and Methods Facility-based cross-sectional study was conducted enrolling all physicians working in public and private health facilities. All public and private health facilities were included and similarly, all physicians rendering services in these facilities were sampled in the study. The data were collected from February to March, 2015. Data were then entered into Epidata Version 3.1 and transferred to STATA version 12 for analysis. Both bivariable and multivariable logistic regressions were used to determine predictors. Results Of the ninety physicians approached in this study, 40 (48.2%) of the physicians believed that their prescribing decisions were influenced by visits of medical representatives (MRs). The odds of physicians who received gifts from MRs being influenced to prescribe their respective products was six times higher than those who reported not accepting any gifts [AOR = 6.56, 95% CI: 2.25, 19.13]. Stationery materials 23(35.4%) and drug samples 20 (54.2%) were the commonest kinds of gifts given to physicians and face to face talking 45 (54.2%) was the most frequent promotional methods. The finding of this study showed that around thirty-nine percent of MRs have had negative attitude toward competitors' product. Moreover, working in private health facility was also another predictor of influence of prescribing decision in the study area [AOR = 12.78, 95% CI: 1.31, 124.56]. Conclusion Nearly half of the physicians working in Mekelle reported that their prescribing decisions were influenced by MRs in the last 12 months. Accepting gifts and working in private health facilities were predictors of influencing prescribing decisions. However, most MRs fails to provide adequate and accurate information regarding their products and they had a negative attitude towards the competitors' product(s).	[Workneh, Birhanu Demeke; Gebrehiwot, Mehari Gebregergis; Bayo, Tigist Assefa; Gidey, Meles Tekie; Belay, Yared Belete; Kassa, Terefe Teshome] Mekelle Univ, Pharmacoepidemiol & Social Pharm Course, Mekelle, Ethiopia; [Workneh, Birhanu Demeke; Gebrehiwot, Mehari Gebregergis; Bayo, Tigist Assefa; Gidey, Meles Tekie; Belay, Yared Belete; Kassa, Terefe Teshome] Mekelle Univ, Coll Hlth Sci, Dept Pharm, Res Unit, Mekelle, Ethiopia; [Tesfaye, Desalegn Mergiaw] Ayder Referral Hosp, Dept Lab Med, Mekelle, Ethiopia	Mekelle University; Mekelle University	Workneh, BD (corresponding author), Mekelle Univ, Pharmacoepidemiol & Social Pharm Course, Mekelle, Ethiopia.; Workneh, BD (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Pharm, Res Unit, Mekelle, Ethiopia.	birdpharma@gmail.com						Al Zahrani H, 2014, INT J MED SCI PUBLIC, V3, P358; Al-Areefi MA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-331; Albersheim SG, 2011, IMAJ, V13; Alosaimi FD, 2014, E MEDITERR HEALTH J, V20, P812, DOI 10.26719/2014.20.12.812; Alssageer MA, 2012, LIBYAN J MED, V7, DOI 10.3402/ljm.v7i0.18556; Bansal R.K, 2005, JIAFM, V27; DACA, 2008, GUID REG PROM ADV DR; De Ferrari A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100114; Fugh-Berman A, 2007, PLOS MED, V4, P621, DOI 10.1371/journal.pmed.0040150; Goyal R., 2013, IOSR JBM, V8, P56, DOI [10.9790/487X-0815660, DOI 10.9790/487X-0815660]; Ijoma U., 2010, Turk Silahli Kuvvetleri,  Koruyucu Hekimlik Bulteni, V9, P1; Lieb K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110130; Lieb K, 2010, DTSCH ARZTEBL INT, V107, P392, DOI 10.3238/arztebl.2010.0392; Mikehael ME, 2014, INT J PHARM PHARM SC, V6, P627; Mikhael E., 2014, PHARM PHARMACOL-RUSS, V5, P705, DOI [10.4236/pp.2014.57080, DOI 10.4236/PP.2014.57080]; Othman N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-743; Siddiqi A, 2011, AFR J PHARM PHARMACO, V5, P1623, DOI 10.5897/AJPP11.243; Sondergaard J, 2009, FAM PRACT, V26, P204, DOI 10.1093/fampra/cmp010; Transitional Government of Ethiopia, 1993, NAT DRUG POL TRANST; Vancelik S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-122; WHO, 1988, ETH CRIT MED DRUG PR	21	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156795	10.1371/journal.pone.0156795	http://dx.doi.org/10.1371/journal.pone.0156795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304215	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800021
J	Wu, HT; Wu, HK; Wang, CL; Yang, YL; Wu, WH; Tsai, TH; Chang, HH				Wu, Hau-Tieng; Wu, Han-Kuei; Wang, Chun-Li; Yang, Yueh-Lung; Wu, Wen-Hsiang; Tsai, Tung-Hu; Chang, Hen-Hong			Modeling the Pulse Signal by Wave-Shape Function and Analyzing by Synchrosqueezing Transform	PLOS ONE			English	Article							TIME-FREQUENCY; SPECTRAL-ANALYSIS; COMPLEX NETWORK; PHOTOPLETHYSMOGRAPHY; DECOMPOSITION; EXTRACTION; SERIES	We apply the recently developed adaptive non-harmonic model based on the wave-shape function, as well as the time-frequency analysis tool called synchrosqueezing transform (SST) to model and analyze oscillatory physiological signals. To demonstrate how the model and algorithm work, we apply them to study the pulse wave signal. By extracting features called the spectral pulse signature, and based on functional regression, we characterize the hemodynamics from the radial pulse wave signals recorded by the sphygmomanometer. Analysis results suggest the potential of the proposed signal processing approach to extract health-related hemodynamics features.	[Wu, Hau-Tieng] Univ Toronto, Dept Math, Toronto, ON M5S 1A1, Canada; [Wu, Han-Kuei; Tsai, Tung-Hu] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Wu, Han-Kuei] Taiwan Landseed Hosp, Dept Chinese Med, Taoyuan, Taiwan; [Wang, Chun-Li] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiovasc, Taoyuan, Taiwan; [Wang, Chun-Li] Chang Gung Univ, Coll Med, Taiyuan, Taiwan; [Yang, Yueh-Lung] Keelung Chang Gung Mem Hosp, Ctr Tradit Chinese Med, Keelung, Taiwan; [Wu, Wen-Hsiang] Yuanpei Univ Med Technol, Dept Healthcare Management, Hsinchu, Taiwan; [Chang, Hen-Hong] China Med Univ, Sch Postbaccalaureate Tradit Chinese Med, Taichung, Taiwan; [Chang, Hen-Hong] China Med Univ, Res Ctr Chinese Med & Acupuncture, Taichung, Taiwan; [Chang, Hen-Hong] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan	University of Toronto; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, HH (corresponding author), China Med Univ, Sch Postbaccalaureate Tradit Chinese Med, Taichung, Taiwan.; Chang, HH (corresponding author), China Med Univ, Res Ctr Chinese Med & Acupuncture, Taichung, Taiwan.; Chang, HH (corresponding author), China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan.	tcmchh55@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020; Tsai, Tung-Hu/AAG-4558-2021	Stefanadis, Christodoulos/0000-0001-5974-6454; Tsai, Tung-Hu/0000-0002-9007-2547; Wu, Hau-Tieng/0000-0002-0253-3156	Committee on Chinese Medicine and Pharmacy of the Department of Health, Taiwan [CCMP93-RD-010]; China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan	Committee on Chinese Medicine and Pharmacy of the Department of Health, Taiwan; China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan	The authors are grateful for the support from the Committee on Chinese Medicine and Pharmacy of the Department of Health, Taiwan (CCMP93-RD-010) and China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan.	Ahrabian A, 2015, SIGNAL PROCESS, V106, P331, DOI 10.1016/j.sigpro.2014.08.010; Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; AUGER F, 1995, IEEE T SIGNAL PROCES, V43, P1068, DOI 10.1109/78.382394; Baudin F, 2014, FRONTIERS PEDIAT SEC, P2; Braunwald E., 2014, BRAUNWALDS HEART DIS, V10th, P95; Caro C.G., 2011, MECH CIRCULATION, V2nd; Chen CH, 1996, HYPERTENSION, V27, P168, DOI 10.1161/01.HYP.27.2.168; Chen YC, 2014, J R STAT SOC B, V76, P651, DOI 10.1111/rssb.12039; Chui CK, 2016, ANAL APPL, V14, P537, DOI 10.1142/S0219530515500165; Chui CK, 2016, APPL COMPUT HARMON A, V40, P97, DOI 10.1016/j.acha.2015.01.003; Cicone A, 2016, APPL COMPUT HARMON A, V41, P384, DOI 10.1016/j.acha.2016.03.001; Daubechies I, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0193; Daubechies I, 2011, APPL COMPUT HARMON A, V30, P243, DOI 10.1016/j.acha.2010.08.002; Davila MI, 2012, NONCONTACT EXTRACTIO; Flandrin P., 1999, WAVELET ANAL ITS APP, V10; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gil E, 2010, PHYSIOL MEAS, V31, P1271, DOI 10.1088/0967-3334/31/9/015; Hou TY, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0194; Hsu TL, 2006, EXP PHYSIOL, V91, P163, DOI 10.1113/expphysiol.2005.031575; HUANG CM, 2011, EVID-BASED COMPL ALT; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huang ZH, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/698630; Jeon YJ, 2011, EVID-BASED COMPL ALT, V2011; Kowalski M, 2018, APPL COMPUT HARMON A, V44, P89, DOI 10.1016/j.acha.2016.03.008; Leung L, 2011, INNOVAIT, V4, P49; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lin YT, 2014, ACTA ANAESTH SCAND, V58, P157, DOI 10.1111/aas.12251; Luo CH, 2012, J ALTERN COMPLEM MED, V18, P924, DOI 10.1089/acm.2012.0047; Malik M., 1995, HEART RATE VARIABILI; McEniery CM, 2014, EUR HEART J, V35, P1719, DOI 10.1093/eurheartj/eht565; Melenovsky V, 2007, J HYPERTENS, V25, P1403, DOI 10.1097/HJH.0b013e32811d69df; Milnor W.R., 1989, HEMODYNAMICS, V2nd Edn; Morris D. C., 1990, CLIN METHODS HIST PH; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; Oparil S, 2006, CIRCULATION, V113, P1162, DOI 10.1161/CIRCULATIONAHA.105.609313; Ramsay JO., 1997, FUNCTIONAL DATA ANAL, DOI 10.1007/978-1-4757-7107-7; Ricaud B, 2014, ADV COMPUT MATH, V40, P683, DOI 10.1007/s10444-013-9337-9; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Salvi P., 2012, PULSE WAVES VASCULAR, V154, P196, DOI [10.1007/978-3-319-40501-8, DOI 10.1007/978-3-319-40501-8, 10.1007/978-88-470-2439-7]; Scuteri A, 2001, HYPERTENSION, V38, P1471, DOI 10.1161/hy1201.099291; Tavallali P, 2014, MULTISCALE MODEL SIM, V12, P1458, DOI 10.1137/140957767; TAYLOR MG, 1966, CIRC RES, V18, P585, DOI 10.1161/01.RES.18.5.585; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Wang Yuh-Ying Lin, 2012, J Tradit Complement Med, V2, P164; Wang YYL, 2010, J MED BIOL ENG, V30, P125; Wang YYL, 2004, IEEE T BIO-MED ENG, V51, P193, DOI 10.1109/TBME.2003.820378; WANG YYL, 1991, CIRC RES, V69, P246, DOI 10.1161/01.RES.69.1.246; WEI LY, 1984, AM J ACUPUNCTURE, V12, P205; WEI LY, 1985, IEEE T BIO-MED ENG, V32, P245, DOI 10.1109/TBME.1985.325537; Westerhof BE, 2008, HYPERTENSION, V52, P478, DOI 10.1161/HYPERTENSIONAHA.108.116525; Wiseman N, 2014, PRACTICAL DICT CHINE; Wu HT, 2015, IEEE T BIO-MED ENG, V62, P1159, DOI 10.1109/TBME.2014.2375292; Wu HT, 2013, APPL COMPUT HARMON A, V35, P181, DOI 10.1016/j.acha.2012.08.008; Wu HT, 2015, OPTIMIZING EST UNPUB; Yang H, 2014, APPL COMPUTATIONAL H, V39, P33, DOI DOI 10.1016/J.ACHA.2014.08.004; Zhang JT, 2014, SCAND J STAT, V41, P51, DOI 10.1111/sjos.12025	61	11	12	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157135	10.1371/journal.pone.0157135	http://dx.doi.org/10.1371/journal.pone.0157135			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304979	gold, Green Published, Green Submitted			2022-12-27	WOS:000377824800037
J	Jansen, AML; Geilenkirchen, MA; van Wezel, T; Jagmohan-Changur, SC; Ruano, D; van der Klift, HM; van den Akker, BEWM; Laros, JFJ; van Galen, M; Wagner, A; Letteboer, TGW; Gomez-Garcia, EB; Tops, CMJ; Vasen, HF; Devilee, P; Hes, FJ; Morreau, H; Wijnen, JT				Jansen, Anne M. L.; Geilenkirchen, Marije A.; van Wezel, Tom; Jagmohan-Changur, Shantie C.; Ruano, Dina; van der Klift, Heleen M.; van den Akker, Brendy E. W. M.; Laros, Jeroen F. J.; van Galen, Michiel; Wagner, Anja; Letteboer, Tom G. W.; Gomez-Garcia, Encarna B.; Tops, Carli M. J.; Vasen, Hans F.; Devilee, Peter; Hes, Frederik J.; Morreau, Hans; Wijnen, Juul T.			Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH-REPAIR DEFICIENCY; REVISED BETHESDA GUIDELINES; MLH1 PROMOTER METHYLATION; MICROSATELLITE INSTABILITY; MUTATION CARRIERS; SOMATIC METHYLATION; GERMLINE MUTATION; PROSTATE-CANCER; FREQUENT CAUSE	Background and Aims Lynch Syndrome (LS) is caused by pathogenic germline variants in one of the mismatch repair (MMR) genes. However, up to 60% of MMR-deficient colorectal cancer cases are categorized as suspected Lynch Syndrome (sLS) because no pathogenic MMR germline variant can be identified, which leads to difficulties in clinical management. We therefore analyzed the genomic regions of 15 CRC susceptibility genes in leukocyte DNA of 34 unrelated sLS patients and 11 patients with MLH1 hypermethylated tumors with a clear family history. Methods Using targeted next-generation sequencing, we analyzed the entire non-repetitive genomic sequence, including intronic and regulatory sequences, of 15 CRC susceptibility genes. In addition, tumor DNA from 28 sLS patients was analyzed for somatic MMR variants. Results Of 1979 germline variants found in the leukocyte DNA of 34 sLS patients, one was a pathogenic variant (MLH1 c. 1667+1delG). Leukocyte DNA of 11 patients with MLH1 hypermethylated tumors was negative for pathogenic germline variants in the tested CRC susceptibility genes and for germline MLH1 hypermethylation. Somatic DNA analysis of 28 sLS tumors identified eight (29%) cases with two pathogenic somatic variants, one with a VUS predicted to pathogenic and LOH, and nine cases (32%) with one pathogenic somatic variant (n = 8) or one VUS predicted to be pathogenic (n = 1). Conclusions This is the first study in sLS patients to include the entire genomic sequence of CRC susceptibility genes. An underlying somatic or germline MMR gene defect was identified in ten of 34 sLS patients (29%). In the remaining sLS patients, the underlying genetic defect explaining the MMR deficiency in their tumors might be found outside the genomic regions harboring the MMR and other known CRC susceptibility genes.	[Jansen, Anne M. L.; Geilenkirchen, Marije A.; Jagmohan-Changur, Shantie C.; van der Klift, Heleen M.; Laros, Jeroen F. J.; van Galen, Michiel; Devilee, Peter; Wijnen, Juul T.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Jansen, Anne M. L.; van Wezel, Tom; Ruano, Dina; van den Akker, Brendy E. W. M.; Morreau, Hans] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Wagner, Anja] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Letteboer, Tom G. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Gomez-Garcia, Encarna B.] Univ Hosp Maastricht, Dept Clin Genet, Maastricht, Netherlands; [Tops, Carli M. J.; Hes, Frederik J.; Wijnen, Juul T.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Vasen, Hans F.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Wijnen, JT (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.; Wijnen, JT (corresponding author), Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands.	j.wijnen@lumc.nl	DEVILEE, PETER/ABR-2140-2022; van Wezel, Tom/AAL-5626-2021; Gomez, Encarna B/E-6022-2018; van Wezel, Tom/Z-3092-2019; Devilee, Peter/GXV-8005-2022	van Wezel, Tom/0000-0001-5773-7730; Gomez-Garcia, Encarna/0000-0003-4999-8847; tops, funnel/0000-0003-3116-4203; Laros, Jeroen F.J./0000-0002-8715-7371; Vasen, Hans/0000-0003-2682-2603; Hes, Frederik/0000-0002-3025-0882; Devilee, Peter/0000-0002-8023-2009	Dutch Cancer Society [UL2012-5542]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society under study number UL2012-5542 (www.kwf.nl). JTW received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1994, CANCER RES, V54, P1645; Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Bauer CM, 2011, FAM CANCER, V10, P37, DOI 10.1007/s10689-010-9388-8; Buchanan DD, 2014, APPL CLIN GENET, V7, P183, DOI 10.2147/TACG.S48625; Castillejo A, 2015, J MED GENET, V52, P498, DOI 10.1136/jmedgenet-2015-103076; Castillejo A, 2014, EUR J CANCER, V50, P2241, DOI 10.1016/j.ejca.2014.05.022; Colas C, 2012, ADV CANCER RES, V113, P121, DOI 10.1016/B978-0-12-394280-7.00004-X; Crepin M, 2012, HUM MUTAT, V33, P180, DOI 10.1002/humu.21617; Crucianelli F, 2014, EPIGENETICS-US, V9, P1431, DOI 10.4161/15592294.2014.970080; de la Chapelle A, 2005, FAM CANCER, V4, P233, DOI 10.1007/s10689-004-5811-3; Deng G, 2002, BRIT J CANCER, V86, P574, DOI 10.1038/sj.bjc.6600148; Dowty JG, 2013, HUM MUTAT, V34, P490, DOI 10.1002/humu.22262; Elsayed FA, 2015, EUR J HUM GENET, V23, P1080, DOI 10.1038/ejhg.2014.242; Geurts-Giele WRR, 2014, J PATHOL, V234, P548, DOI 10.1002/path.4419; Goel A, 2011, INT J CANCER, V128, P869, DOI 10.1002/ijc.25422; Haraldsdottir S, 2014, GASTROENTEROLOGY, V147, P1308, DOI 10.1053/j.gastro.2014.08.041; Haraldsdottir S, 2014, GENET MED, V16, P553, DOI 10.1038/gim.2013.193; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Hitchins MP, 2016, FAM CANCER, V15, P413, DOI 10.1007/s10689-016-9887-3; Jansen AML, 2015, EUROPEAN J HUMAN GEN; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Khalaf R, 2013, J GASTROINTEST SURG, V17, P1500, DOI 10.1007/s11605-013-2206-5; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Ligtenberg MJL, 2013, FAM CANCER, V12, P169, DOI 10.1007/s10689-012-9591-x; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Lindor NM, 2006, JAMA-J AM MED ASSOC, V296, P1507, DOI 10.1001/jama.296.12.1507; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Mensenkamp AR, 2014, GASTROENTEROLOGY, V146, P643, DOI 10.1053/j.gastro.2013.12.002; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; Morak M, 2008, EUR J HUM GENET, V16, P804, DOI 10.1038/ejhg.2008.25; Niessen RC, 2009, GENE CHROMOSOME CANC, V48, P737, DOI 10.1002/gcc.20678; Overbeek LIH, 2007, BRIT J CANCER, V96, P1605, DOI 10.1038/sj.bjc.6603754; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; Rahner N, 2008, J PATHOL, V214, P10, DOI 10.1002/path.2263; Raymond VM, 2015, FAM CANCER, V14, P77, DOI 10.1007/s10689-014-9753-0; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rodriguez-Soler M, 2013, GASTROENTEROLOGY, V144, P926, DOI 10.1053/j.gastro.2013.01.044; Senter L, 2008, GASTROENTEROLOGY, V135, P419, DOI 10.1053/j.gastro.2008.04.026; Shinbrot E, 2014, GENOME RES, V24, P1740, DOI 10.1101/gr.174789.114; Stoffel E, 2009, GASTROENTEROLOGY, V137, P1621, DOI 10.1053/j.gastro.2009.07.039; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tenesa A, 2006, BRIT J CANCER, V95, P239, DOI 10.1038/sj.bjc.6603239; Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Valle L, 2007, CLIN GENET, V71, P232, DOI 10.1111/j.1399-0004.2007.00751.x; van der Klift HM, 2015, MOL GENET GENOM MED, V3, P327, DOI 10.1002/mgg3.145; van Roon EHJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-180; Vasen HFA, 2010, GASTROENTEROLOGY, V138, P2300, DOI 10.1053/j.gastro.2010.02.053; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Vreeswijk MPG, 2009, HUM MUTAT, V30, P107, DOI 10.1002/humu.20811; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward RL, 2013, GENET MED, V15, P25, DOI 10.1038/gim.2012.91; Win AK, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3405; Win AK, 2011, INT J CANCER, V129, P2256, DOI 10.1002/ijc.25870; Young J, 2001, AM J PATHOL, V159, P2107, DOI 10.1016/S0002-9440(10)63062-3; Yurgelun MB, 2015, GASTROENTEROLOGY, V149, P604, DOI 10.1053/j.gastro.2015.05.006	60	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157381	10.1371/journal.pone.0157381	http://dx.doi.org/10.1371/journal.pone.0157381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300758	Green Published, gold			2022-12-27	WOS:000377822200043
J	Cui, Y; Zhao, JZ; Yi, L; Jiang, YG				Cui, Yan; Zhao, Jizong; Yi, Lei; Jiang, Yugang			microRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma Cells	PLOS ONE			English	Article							CANCER STATISTICS; EXPRESSION; APOPTOSIS; THERAPY; GROWTH	Rictor upregulation and mTORC complex 2 (mTORC2) over-activation participate in glioma cell progression, yet the underling mechanisms are not known. We here identified microRNA-153 (miR-153) as a potential anti-Rictor miRNA, which was downregulated in multiple human glioma tissues and glioma cell lines (U87MG, T98G, U373MG and U251MG). miR-153 downregulation was correlated with Rictor (mRNA and protein) upregulation and p-Akt Ser473 (the mTORC2 indicator) over-activation in the glioma tissues and cells. Our in vitro evidences suggested that Rictor could be one primary target of miR-153 in glioma cells. Exogenous overexpression of miR-153 downregulated Rictor (mRNA and protein) and decreased p-Akt Ser473 in U87MG cells, leading to significant growth inhibition and apoptosis activation. Notably, U87MG cells with Rictor shRNA knockdown showed similar phenotypes of cells with miR-153 overexpression. More importantly, in Rictor-silenced U87MG cells, miR-153 expression failed to further affect cell growth nor apoptosis. In vivo, we showed that miR-153 overexpression dramatically inhibited U87MG tumor growth in nude mice. Together, these results suggest that miR-153 downregulation could be one important reason of Rictor upregulation and mTORC2 over-activation in glioma cells. Further, miR153-induced anti-glioma cell activity is possibly via downregulating Rictor.	[Cui, Yan; Zhao, Jizong; Yi, Lei; Jiang, Yugang] Cent South Univ, Xiangya Hosp 2, Dept Neurosurg, Changsha 410011, Hunan, Peoples R China; [Zhao, Jizong] Capital Med Univ, Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China	Central South University; Capital Medical University	Jiang, YG (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Neurosurg, Changsha 410011, Hunan, Peoples R China.	jiangyuguang27@sina.com			Second Xiangya Hospital of Central South University [2013-029]	Second Xiangya Hospital of Central South University	This study was supported by the research fund of the Second Xiangya Hospital of Central South University (2013-029, to YJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047741; Chen MB, 2016, ONCOTARGET; Chen MB, 2015, BIOCHEM BIOPH RES CO, V463, P954, DOI 10.1016/j.bbrc.2015.06.041; Chen W, 2015, CA CANC J CLIN; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Duzgun Z, 2016, GENE, V575, P187, DOI 10.1016/j.gene.2015.08.060; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; HUANG AL, 1981, CELL, V27, P245, DOI 10.1016/0092-8674(81)90408-6; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Khasraw M, 2009, NAT REV NEUROL, V5, P646, DOI 10.1038/nrneurol.2009.194; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lefranc F, 2009, ADV TECH STAND NEURO, V34, P3, DOI 10.1007/978-3-211-78741-0_1; Li JZ, 2015, KIDNEY INT, V88, P515, DOI 10.1038/ki.2015.119; Li X, 2016, ONCOTARGET; Liang CL, 2012, BRAIN RES, V1455, P103, DOI 10.1016/j.brainres.2011.10.051; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Moller HG, 2013, MOL NEUROBIOL, V47, P131, DOI 10.1007/s12035-012-8349-7; Pollack IF, 2010, NAT REV NEUROL, V6, P533, DOI 10.1038/nrneurol.2010.144; Qin LS, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0174-1; Qin LS, 2013, MOL BIOL REP, V40, P5645, DOI 10.1007/s11033-013-2666-4; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Sun SY, 2013, CANCER LETT, V340, P1, DOI 10.1016/j.canlet.2013.06.017; Wang YZ, 2013, CANCER LETT, V331, P139, DOI 10.1016/j.canlet.2012.12.024; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Xu JZ, 2010, INT J CANCER, V126, P1029, DOI 10.1002/ijc.24823; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005	32	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156915	10.1371/journal.pone.0156915	http://dx.doi.org/10.1371/journal.pone.0156915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295037	Green Submitted, gold, Green Published			2022-12-27	WOS:000377821300014
J	Kim, JA; Cho, JH; Park, IH; Shin, JM; Lee, SA; Lee, HM				Kim, Jin Ah; Cho, Jae Hoon; Park, Il-Ho; Shin, Jae-Min; Lee, Seoung-Ae; Lee, Heung-Man			Diesel Exhaust Particles Upregulate Interleukins IL-6 and IL-8 in Nasal Fibroblasts	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; POLYP-DERIVED FIBROBLASTS; ALLERGIC RHINITIS; AIR-QUALITY; IN-VITRO; KAPPA-B; ACTIVATION; RHINOSINUSITIS; EXPRESSION; SINUSITIS	Background Diesel exhaust particles (DEP) are a major source of air pollution. Nasal fibroblasts are known to produce various cytokines and chemokines. The aim of this study was to evaluate DEP-induced cytokines and chemokines in nasal fibroblasts and to identify the signaling pathway involved. Methods A cytokine and chemokine array performed after stimulation of nasal fibroblasts with DEP revealed that levels of IL-6 and IL-8 were increased most significantly among various cytokines and chemokines. RT-PCR and ELISA were used to determine the mRNA and protein expression levels of IL-6 and IL-8. Signaling pathways of p-38, Akt, and NF-kappa B were analyzed by western blotting, luciferase assay, and ELISA. Organ cultures of nasal interior turbinate were also developed to demonstrate the ex vivo effect of DEP on the expression of IL-6 and IL-8 and the associated signaling pathway. Results DEP increased the expressions of IL-6 and IL-8 in nasal fibroblasts at mRNA and protein levels. DEP induced phosphorylation of p-38, Akt, and NF-kappa B, whereas inhibitors of p-38, Akt, and NF-kappa B blocked these phophorylations and the expressions of IL-6 and IL-8. These findings were also observed in ex vivo organ culture of nasal inferior turbinate. Conclusions DEP induces expression of IL-6 and IL-8 via p-38, Akt, and NF-kappa B signaling pathways in nasal fibroblasts. This finding suggests that air pollution might induce or aggravate allergic rhinitis or chronic rhinosinusitis.	[Kim, Jin Ah; Lee, Heung-Man] Korea Univ, Coll Med, Biomed Sci, Seoul 136705, South Korea; [Cho, Jae Hoon] Konkuk Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Park, Il-Ho; Shin, Jae-Min; Lee, Heung-Man] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 136705, South Korea; [Lee, Seoung-Ae; Lee, Heung-Man] Guro Hosp, Inst Med Devices Clin Trial Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Konkuk University; Konkuk University Medical Center; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, HM (corresponding author), Korea Univ, Coll Med, Biomed Sci, Seoul 136705, South Korea.; Lee, HM (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 136705, South Korea.; Lee, HM (corresponding author), Guro Hosp, Inst Med Devices Clin Trial Ctr, Seoul, South Korea.	lhman@korea.ac.kr		PARK, IL-HO/0000-0002-7011-6071	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI15C1512]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI15C1512).	Bhattacharyya N, 2009, LARYNGOSCOPE, V119, P429, DOI 10.1002/lary.20097; Cho JS, 2013, CLIN EXP ALLERGY, V43, P1038, DOI 10.1111/cea.12165; Cho JS, 2014, ALLERGY ASTHMA IMMUN, V6, P449, DOI 10.4168/aair.2014.6.5.449; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Hartupee J, J MOL CELL IN PRESS; Hashimoto S, 2000, AM J RESP CRIT CARE, V161, P280, DOI 10.1164/ajrccm.161.1.9904110; Hox V, 2015, THORAX, V70, P353, DOI 10.1136/thoraxjnl-2014-205520; Jang AS, 2016, CURR OPIN ALLERGY CL, V16, P13, DOI 10.1097/ACI.0000000000000235; Kafoury Ramzi M, 2005, Int J Environ Res Public Health, V2, P403, DOI 10.3390/ijerph2005030004; Kouzaki H, 2009, AM J RHINOL ALLERGY, V23, P273, DOI 10.2500/ajra.2009.23.3310; Lennard CM, 2000, AM J RHINOL, V14, P367, DOI 10.2500/105065800779954329; Lindgren A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-25; Ma CL, 2004, BIOCHEM PHARMACOL, V67, P1975, DOI 10.1016/j.bcp.2004.01.023; Marino E, 2015, THER ADV CHRONIC DIS, V6, P286, DOI 10.1177/2040622315587256; Mazzarella G, 2007, RESP MED, V101, P1155, DOI 10.1016/j.rmed.2006.11.011; Park IH, 2014, OTOLARYNG HEAD NECK, V150, P148, DOI 10.1177/0194599813513880; Park SJ, 2013, AM J RHINOL ALLERGY, V27, P372, DOI 10.2500/ajra.2013.27.3941; Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047; Shi JB, 2010, ORL-J OTO-RHIN-LARYN, V72, P256, DOI 10.1159/000312687; Simoni M, 2015, J THORAC DIS, V7, P34, DOI 10.3978/j.issn.2072-1439.2014.12.10; Song JJ, 2013, INT J PEDIATR OTORHI, V77, P1659, DOI 10.1016/j.ijporl.2013.07.021; Song JJ, 2012, INT J PEDIATR OTORHI, V76, P334, DOI 10.1016/j.ijporl.2011.12.003; Steerenberg PA, 1998, EXP LUNG RES, V24, P85, DOI 10.3109/01902149809046056; Tau J, 2013, INVEST OPHTH VIS SCI, V54, P4759, DOI 10.1167/iovs.12-10541; Thaw CA, 2011, AM J RESP CELL MOL B, V44, P840, DOI [10. 1165/ rcmb. 2010-0011OC, DOI 10.1165/RCMB.2010-0011OC]; Wolf C, 2002, HEALTH PLACE, V8, P129, DOI 10.1016/S1353-8292(01)00040-5; Zhang N, ALLERGY IN PRESS	27	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157058	10.1371/journal.pone.0157058	http://dx.doi.org/10.1371/journal.pone.0157058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295300	Green Published, gold, Green Submitted			2022-12-27	WOS:000377821300018
J	Robinski, M; Strich, F; Mau, W; Girndt, M				Robinski, Maxi; Strich, Franz; Mau, Wilfried; Girndt, Matthias			Validating a Patient-Reported Comorbidity Measure with Respect to Quality of Life in End-Stage Renal Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; DIALYSIS PATIENTS; INTERRATER RELIABILITY; MODALITY SELECTION; HIGH AGREEMENT; LOW KAPPA; QUESTIONNAIRE; RISK; HEMODIALYSIS; ADJUSTMENT	Purpose Medical record-derived comorbidity measures such as the Charlson Comorbidity Index (CCI) do not predict functional limitations or quality of life (QoL) in the chronically ill. Although these shortcomings are known since the 1980s, they have been largely ignored by the international literature. Recently, QoL has received growing interest as an end-point of interventional trials in Nephrology. The aim of this study is to compare a patient-reported comorbidity measure and the CCI with respect to its validity regarding QoL. Methods The German Self-Administered Comorbidity Questionnaire (SCQ-G) was completed by 780 adult end-stage renal disease-patients recruited from 55 dialysis units throughout Germany. Acceptance was evaluated via response rates. Content validity was examined by comparing the typical comorbidity pattern in dialysis patients and the pattern retrieved from our data. Convergent validity was assessed via kappa statistics. Data was compared to the CCI. Linear associations with QoL were examined (criterion validity). Results The SCQ-G was very well accepted by dialysis patients of all ages (response rate: 99%). Content validity can be interpreted as high (corresponding comorbidity items: 73.7%). Convergent validity was rather weak (.27 <=rho <=.29) but increased when comparing only concordant items (.39 <=rho <=.43). With respect to criterion validity, the SCQ-G performed better than the CCI regarding the correlation with QoL (e.g., SF-12-physical: SCQ-G total score: rho= -.49 vs. CCI:rho = -.36). Conclusions The patient-reported measure proved to be more valid than the external assessment when aiming at insights on QoL. Due to the inclusion of subjective limitations, the SCQ-G is more substantial with respect to patient-centered outcomes and might be used as additional measure in clinical trials.	[Robinski, Maxi; Strich, Franz; Mau, Wilfried] Univ Halle Wittenberg, Inst Rehabil Med, Fac Med, D-06108 Halle, Saale, Germany; [Girndt, Matthias] Univ Halle Wittenberg, Fac Med, Dept Internal Med 2, D-06108 Halle, Saale, Germany; [Robinski, Maxi; Strich, Franz; Mau, Wilfried; Girndt, Matthias] Univ Halle Wittenberg, Ctr Hlth Sci, D-06108 Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Robinski, M (corresponding author), Univ Halle Wittenberg, Inst Rehabil Med, Fac Med, D-06108 Halle, Saale, Germany.; Robinski, M (corresponding author), Univ Halle Wittenberg, Ctr Hlth Sci, D-06108 Halle, Saale, Germany.	maxi.robinski@uk-halle.de	Strich, Franz/T-8925-2019; Girndt, Matthias/M-1436-2019	Girndt, Matthias/0000-0003-2823-0847	"Bundesministerium fur Bildung und Forschung" (BMBF) in Germany [Federal Ministry of Education and Research] [01GY1324]	"Bundesministerium fur Bildung und Forschung" (BMBF) in Germany [Federal Ministry of Education and Research](Federal Ministry of Education & Research (BMBF))	The study received funding from the "Bundesministerium fur Bildung und Forschung" (BMBF) in Germany [Federal Ministry of Education and Research]; grant #01GY1324; https://www. bmbf. de/; authors who received funding: MG WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister SE, 2010, AM J NEPHROL, V31, P222, DOI 10.1159/000272937; Bullinger M., 2011, SF 36 FRAGEBOGEN ZUM; Bunn F, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0192-4; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chui HC, 2000, ARCH NEUROL-CHICAGO, V57, P191, DOI 10.1001/archneur.57.2.191; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Floege J, 2015, KIDNEY INT, V87, P996, DOI 10.1038/ki.2014.419; Glattacker M, 2007, PHYS MED REHAB KUROR, V17, P260, DOI 10.1055/s-2007-970405; GREENFIELD S, 1994, AM J KIDNEY DIS, V24, P298, DOI 10.1016/S0272-6386(12)80195-8; Hemmelgarn BR, 2003, AM J KIDNEY DIS, V42, P125, DOI 10.1016/S0272-6386(03)00415-3; Huang KW, 2014, DIGEST DIS SCI, V59, P807, DOI 10.1007/s10620-013-2973-6; Jassal SV, 2002, NEPHROL DIAL TRANSPL, V17, P474, DOI 10.1093/ndt/17.3.474; KAPLAN MH, 1974, J CHRON DIS, V27, P387, DOI 10.1016/0021-9681(74)90017-4; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Kho ME, 2007, AM J CRIT CARE, V16, P378; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lazarus RS, 1996, STRESS APPRAISAL COP; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Madero M, 2008, SEMIN DIALYSIS, V21, P29, DOI 10.1111/j.1525-139X.2007.00384.x; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Miskulin D, 2005, PERITON DIALYSIS INT, V25, P320; Murphy SW, 2000, KIDNEY INT, V57, P1720, DOI 10.1046/j.1523-1755.2000.00017.x; Murray AM, 2008, ADV CHRONIC KIDNEY D, V15, P123, DOI 10.1053/j.ackd.2008.01.010; Robinski M, 2017, NEPHROL DIAL TRANSPL, V32, P315, DOI 10.1093/ndt/gfv464; Robinski M, 2016, PATIENT EDUC COUNS, V99, P562, DOI 10.1016/j.pec.2015.10.014; Robinski M, 2014, CLIN KIDNEY J, V7, DOI 10.1093/ckj/sfu111; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Sirois FM, 2014, J HEALTH PSYCHOL, V7, P1; Stack AG, 2002, J AM SOC NEPHROL, V13, P1279, DOI 10.1681/ASN.V1351279; Stolwijk C, 2014, RHEUMATOLOGY, V53, P1054, DOI 10.1093/rheumatology/ket354; Streibelt M, 2012, ORTHOPADE, V41, P303, DOI 10.1007/s00132-012-1901-3; Tonelli M, 2015, KIDNEY INT, V88, P859, DOI 10.1038/ki.2015.228; van Manen JG, 2002, AM J KIDNEY DIS, V40, P82, DOI 10.1053/ajkd.2002.33916	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157506	10.1371/journal.pone.0157506	http://dx.doi.org/10.1371/journal.pone.0157506			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294867	gold, Green Published, Green Submitted			2022-12-27	WOS:000377821300049
J	Yoshimasu, K; Barbaresi, WJ; Colligan, RC; Voigt, RG; Weaver, AL; Katusic, SK				Yoshimasu, Kouichi; Barbaresi, William J.; Colligan, Robert C.; Voigt, Robert G.; Weaver, Amy L.; Katusic, Slavica K.			Mediating and Moderating Role of Depression, Conduct Disorder or Attention-Deficit/Hyperactivity Disorder in Developing Adolescent Substance Use Disorders: A Population-Based Study	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; LEARNING-DISABILITIES; CHILDREN; ASSOCIATION; CHILDHOOD; SYMPTOMS; ABUSE; ADHD; DEPENDENCE; ALCOHOL	Objective To evaluate the mediating/moderating effects of common internalizing/externalizing disorders on the association between ADHD and adolescent substance use disorders (SUD) in a population-based birth cohort. Methods Among 5718 children in the birth cohort, 343 ADHD incident cases and 712 matched controls were identified. Psychiatric diagnoses prior to age 19 were classified into DSM-IV categories. The association between ADHD and SUD was summarized (hazard ratios (HR), 95% CI). The effect of depression, CD/ODD, anxiety was evaluated separately. Results Assessment of the joint effects of ADHD and each psychiatric disorder did not support a moderating effect of these disorders on SUD on additive scale. However, the association between ADHD and SUD was partially explained by a mediating role of these psychiatric disorders. Conclusion For clinicians our results emphasize that depression (or CD/ODD) confers greater risk for SUD than ADHD alone. Early detection/treatment of SUD among adolescents with depression (or CD/ODD) is crucial regardless of ADHD.	[Yoshimasu, Kouichi; Katusic, Slavica K.] Mayo Clin, Div Epidemiol, Dept Hlth Sci Res, Rochester, MI USA; [Barbaresi, William J.] Boston Childrens Hosp, Dept Med, Div Dev Med, Boston, MA USA; [Colligan, Robert C.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Voigt, Robert G.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Weaver, Amy L.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Yoshimasu, Kouichi] Wakayama Med Univ, Sch Med, Dept Hyg, Wakayama, Japan	Mayo Clinic; Harvard University; Boston Children's Hospital; Mayo Clinic; Baylor College of Medicine; Mayo Clinic; Wakayama Medical University	Katusic, SK (corresponding author), Mayo Clin, Div Epidemiol, Dept Hlth Sci Res, Rochester, MI USA.	katusic.slavica@mayo.edu	Voigt, Robert/AAO-6336-2021		National Institutes of Health [HD29745, AG034676]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by Public Health Service research grants HD29745 and AG034676 from the National Institutes of Health.	American Psychiatric Association, 2013, DESK REFERENCE TO TH; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1111/1469-7610.00424; Arcos-Burgos M, 2012, HUM GENET, V131, P917, DOI 10.1007/s00439-012-1164-4; Barkley R, 2006, ATTENTION DEFICIT HY, P184; Brook DW, 2010, ARCH PEDIAT ADOL MED, V164, P930, DOI 10.1001/archpediatrics.2010.180; Burke JD, 2012, J ABNORM CHILD PSYCH, V40, P35, DOI 10.1007/s10802-011-9558-7; Deas D, 2006, J CLIN PSYCHIAT, V67, P18, DOI 10.4088/JCP.0706e02; Falck RS, 2008, DRUG ALCOHOL DEPEN, V98, P24, DOI 10.1016/j.drugalcdep.2008.04.004; Fergusson DM, 2007, DRUG ALCOHOL DEPEN, V88, pS14, DOI 10.1016/j.drugalcdep.2006.12.011; Goldstein BI, 2009, J AM ACAD CHILD PSY, V48, P1182, DOI 10.1097/CHI.0b013e3181bef6e8; Griswold KS, 2008, AM FAM PHYSICIAN, V77, P331; Haavik J, 2010, EXPERT REV NEUROTHER, V10, P1569, DOI [10.1586/ern.10.149, 10.1586/ERN.10.149]; HAMMILL DD, 1993, J LEARN DISABIL, V26, P295, DOI 10.1177/002221949302600502; Hawton K, 2013, J AFFECT DISORDERS, V151, P821, DOI 10.1016/j.jad.2013.08.020; Katusic SK, 2005, J CHILD ADOL PSYCHOP, V15, P764, DOI 10.1089/cap.2005.15.764; Katusic SK, 2005, ANN EPIDEMIOL, V15, P430, DOI 10.1016/j.annepidem.2004.12.004; Katusic SK, 1998, MAYO CLIN PROC, V73, P1053, DOI 10.4065/73.11.1053; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Kotov R, 2011, ARCH GEN PSYCHIAT, V68, P1003, DOI 10.1001/archgenpsychiatry.2011.107; KURLAND LT, 1981, SCI AM, V245, P54, DOI 10.1038/scientificamerican1081-54; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Levy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105640; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; March JS, 2000, J ABNORM CHILD PSYCH, V28, P527, DOI 10.1023/A:1005179014321; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MOATS LC, 1993, J LEARN DISABIL, V26, P282, DOI 10.1177/002221949302600501; Molina BSG, 2003, J ABNORM PSYCHOL, V112, P497, DOI 10.1037/0021-843X.112.3.497; Nemoda Z, 2011, NEUROSCI BIOBEHAV R, V35, P1665, DOI 10.1016/j.neubiorev.2011.04.002; Pennington BF, 2005, ADV CHILD DEV BEHAV, V33, P263, DOI 10.1016/S0065-2407(05)80010-2; Rose BM, 2004, J DEV BEHAV PEDIATR, V25, P58, DOI 10.1097/00004703-200402000-00013; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P320; Serra-Pinheiro MA, 2013, J ATTEN DISORD, V17, P459, DOI 10.1177/1087054711435362; Shrier LA, 2003, PEDIATRICS, V111, pE699, DOI 10.1542/peds.111.6.e699; Sousa NO, 2011, J PSYCHIATR RES, V45, P829, DOI 10.1016/j.jpsychires.2010.10.012; Thapar A, 2013, J CHILD PSYCHOL PSYC, V54, P3, DOI 10.1111/j.1469-7610.2012.02611.x; Therneau T.M., 2000, MODELING SURVIVAL DA; Tuithof M, 2012, DRUG ALCOHOL DEPEN, V123, P115, DOI 10.1016/j.drugalcdep.2011.10.030; Vidal SI, 2012, EUR ADDICT RES, V18, P253, DOI 10.1159/000337328; Wermter AK, 2010, EUR CHILD ADOLES PSY, V19, P199, DOI 10.1007/s00787-009-0082-z; Wilens TE, 2002, J AM ACAD CHILD PSY, V41, P262, DOI 10.1097/00004583-200203000-00005; Williams PL, 2010, AIDS BEHAV, V14, P1072, DOI 10.1007/s10461-010-9782-0; Wright AGC, 2013, J ABNORM PSYCHOL, V122, P281, DOI 10.1037/a0030133; Yoshimasu Kouichi, 2012, Curr Drug Abuse Rev, V5, P291; Yoshimasu K, 2012, J CHILD PSYCHOL PSYC, V53, P1036, DOI 10.1111/j.1469-7610.2012.02567.x; Young Joel, 2008, Adolesc Med State Art Rev, V19, P216	45	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157488	10.1371/journal.pone.0157488	http://dx.doi.org/10.1371/journal.pone.0157488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KF	27294778	gold, Green Published, Green Submitted			2022-12-27	WOS:000377821300048
J	Pajo, J				Pajo, Judi			Two Paradigmatic Waves of Public Discourse on Nuclear Waste in the United States, 1945-2009: Understanding a Magnitudinal and Longitudinal Phenomenon in Anthropological Terms	PLOS ONE			English	Article							RISK PERCEPTION; CONTROVERSY; ACCEPTANCE; ATTITUDES; DISPOSAL	This project set out to illuminate the discursive existence of nuclear waste in American culture. Given the significant temporal dimension of the phenomenon as well as the challenging size of the United States setting, the project adapted key methodological elements of the sociocultural anthropology tradition and produced proxies for ethnographic fieldnotes and key informant interviews through sampling the digital archives of the New York Times over a 64-year period that starts with the first recorded occurrence of the notion of nuclear waste and ends with the conclusion of the presidency of George W. Bush. Two paradigmatic waves of American public discourse on nuclear waste come to light when subjecting this empirical data to quantitative inventorying and interpretive analysis: between 1945 and 1969 nuclear waste was generally framed in light of the beneficial utilizations of nuclear reactions and with optimistic expectations for a scientific/technological solution; by contrast, between 1969 and 2009 nuclear waste was conceptualized as inherited harm that could not be undone and contestation that required political/legal management. Besides this key finding and the empirical timing of the two paradigms, the study's value lies also with its detailed empirical documentation of nuclear waste in its sociocultural existence.	[Pajo, Judi] Pace Univ, Dyson Coll, Dept Sociol Anthropol, New York, NY 10038 USA	Pace University	Pajo, J (corresponding author), Pace Univ, Dyson Coll, Dept Sociol Anthropol, New York, NY 10038 USA.	jpajo@pace.edu			Pace University; New York University Center for European and Mediterranean Studies	Pace University; New York University Center for European and Mediterranean Studies	This project was supported from a Summer 2013 Faculty Research Grant from Pace University and a Visiting Scholarship at the New York University Center for European and Mediterranean Studies. The Bobst Library at New York University and the Birnbaum Library at Pace University also supported by providing access to various digital resources as well as printed materials. These supporters had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren M, 2012, EUR LEG, V17, P71, DOI 10.1080/10848770.2011.640193; Anshelm Jonas, 2009, European Environment, V19, P269, DOI 10.1002/eet.512; Appadurai A., 2010, THEOR CULT SOC, V7, P295, DOI [10.1177/026327690007002017, DOI 10.1177/026327690007002017]; Beck Ulrich., 1992, RISK SOC NEW MODERNI; Benedict R., 1934, PATTERNS CULTURE; Bickerstaff K, 2012, ENVIRON PLANN A, V44, P2611, DOI 10.1068/a44583; Burton M. L., 2002, FIELD METHOD, V14, P65; CAMPBELL JL, 1987, SOC PROBL, V34, P18, DOI 10.1525/sp.1987.34.1.03a00020; Chilvers J, 2008, ENVIRON PLANN A, V40, P1881, DOI 10.1068/a40334; Durant D, 2009, TECHNOL SOC, V31, P150, DOI 10.1016/j.techsoc.2009.03.002; Elam M, 2011, ENVIRON POLIT, V20, P246, DOI 10.1080/09644016.2011.551030; Flynn J., 1995, 100 YEARS SOLITUDE R; Gawande K, 2013, J ENVIRON ECON MANAG, V65, P56, DOI 10.1016/j.jeem.2012.07.003; Geertz Clifford, 1973, INTERPRETATION CULTU; Hamdan LK, 2010, ENERG POLICY, V38, P5733, DOI 10.1016/j.enpol.2010.05.022; HUNOLD C., 2001, GERMAN POLITICS SOC, V19, P43; Hunold C., 2001, ENVIRON POLIT, V10, P127; Jenkins-Smith HC, 2011, RISK ANAL, V31, P629, DOI 10.1111/j.1539-6924.2010.01543.x; Kempton W., 1995, ENV VALUES AM CULTUR; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Lakoff George, 2003, METAPHOR WE LIVE BY; LAPORTE TR, 1978, SCIENCE, V201, P22, DOI 10.1126/science.663637; Levi-Strauss Claude, 1992, TRISTES TROPIQUES; LEVI-STRAUSS Claude, 1983, RAW COOKED; Lidskog R, 2004, J RISK RES, V7, P251, DOI 10.1080/1366987042000171924; Malinowski B., 1961, ARGONAUTS W PACIFIC; MARCUS GE, 1995, ANNU REV ANTHROPOL, V24, P95, DOI 10.1146/annurev.an.24.100195.000523; MAZUR A, 1978, SOC STUD SCI, V8, P235, DOI 10.1177/030631277800800204; MEAD MARGARET, 1935, SEX TEMPERAMENT 3 PR; Moser C, 2012, J RISK RES, V15, P459, DOI 10.1080/13669877.2011.636836; Moser C, 2012, RISK ANAL, V32, P138, DOI 10.1111/j.1539-6924.2011.01639.x; Nero KL, 2000, CONTEMP PACIFIC, V12, P319, DOI 10.1353/cp.2000.0062; Newman A, 2012, J POLICY HIST, V24, P432, DOI 10.1017/S0898030612000139; North DW, 2013, RISK ANAL, V33, P2, DOI 10.1111/risa.12003; Ortner BS., 2003, NEW JERSEY DREAMING, DOI [10.2307/j.ctv1198tvs, DOI 10.2307/J.CTV1198TVS]; Pajo E., 2008, INT MIGRATION SOCIAL; Rabinow P., 1977, REFLECTIONS FIELDWOR; Renn O., 2008, RISK GOVERNANCE; Renn O., 2000, CROSS CULTURAL RISK; Riddel M, 2009, SOUTH ECON J, V75, P781; Schaffer MB, 2011, ENERG POLICY, V39, P1382, DOI 10.1016/j.enpol.2010.12.010; Short JF, 2004, J RISK RES, V7, P135, DOI 10.1080/1366987042000171276; Sjoberg L, 2003, RISK ANAL, V23, P739, DOI 10.1111/1539-6924.00352; Sjoberg L, 2009, SAFETY SCI, V47, P542, DOI 10.1016/j.ssci.2008.07.035; Skarlatidou A, 2012, RISK ANAL, V32, P1496, DOI 10.1111/j.1539-6924.2011.01773.x; Stanley A, 2008, CAN GEOGR-GEOGR CAN, V52, P64, DOI 10.1111/j.1541-0064.2008.00201.x; Stauffacher M, 2010, CATAL J COMMU CUL ST, V2, P197, DOI 10.1386/cjcs.2.2.197_1; Strauss Claudia., 1997, COGNITIVE THEORY CUL, V9; Taebi B, 2012, ETHICS POLICY ENV, V15, P57, DOI 10.1080/21550085.2012.672688; Vander Beken T, 2010, J ENVIRON MANAGE, V91, P940, DOI 10.1016/j.jenvman.2009.11.012; Walker JS, 2009, ROAD YUCCA MOUNTAIN; Weart Spencer R., 2012, RISE NUCL FEAR	52	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157652	10.1371/journal.pone.0157652	http://dx.doi.org/10.1371/journal.pone.0157652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310719	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800114
J	Phani, NM; Adhikari, P; Nagri, SK; D'Souza, SC; Satyamoorthy, K; Rai, PS				Phani, Nagaraja M.; Adhikari, Prabha; Nagri, Shivashankara K.; D'Souza, Sydney C.; Satyamoorthy, Kapaettu; Rai, Padmalatha S.			Replication and Relevance of Multiple Susceptibility Loci Discovered from Genome Wide Association Studies for Type 2 Diabetes in an Indian Population	PLOS ONE			English	Article							LARGE-SCALE ASSOCIATION; MULTIFACTOR DIMENSIONALITY REDUCTION; GENE-GENE INTERACTIONS; COMMON VARIANTS; ASIAN-INDIANS; TCF7L2; RISK; IGF2BP2; CDKAL1; POLYMORPHISMS	Aim Several genetic variants for type 2 diabetes (T2D) have been identified through genome wide association studies (GWAS) from Caucasian population; however replication studies were not consistent across various ethnicities. Objective of the current study is to examine the possible correlation of 9 most significant GWAS single nucleotide polymorphisms (SNPs) for T2D susceptibility as well as the interactive effect of these variants on the risk of T2D in an Indian population. Methods Case-control cohorts of 1156 individuals were genotyped for 9 SNPs from an Indian population. Association analyses were performed using logistic regression after adjusting for covariates. Multifactor dimensionality reduction (MDR) analysis was adopted to determine gene-gene interactions and discriminatory power of combined SNP effect was assessed by grouping individuals based on the number of risk alleles and by calculating area under the receiver-operator characteristic curve (AUC). Results We confirm the association of TCF7L2 (rs7903146) and SLC30A8 (rs13266634) with T2D. MDR analysis showed statistically significant interactions among four SNPs of SLC30A8 (rs13266634), IGF2BP2 (rs4402960), HHEX (rs1111875) and CDKN2A (rs10811661) genes. Cumulative analysis showed an increase in odds ratio against the baseline group of individuals carrying 5 to 6 risk alleles and discriminatory power of genetic test based on 9 variants showed higher AUC value when analyzed along with body mass index (BMI). Conclusion These results provide a strong evidence for independent association between T2D and SNPs for in TCF7L2 and SLC30A8. MDR analysis demonstrates that independently nonsignificant variants may interact with one another resulting in increased disease susceptibility in the population tested.	[Phani, Nagaraja M.; Satyamoorthy, Kapaettu; Rai, Padmalatha S.] Manipal Univ, Sch Life Sci, Dept Biotechnol, Manipal 576104, Karnataka, India; [Adhikari, Prabha; D'Souza, Sydney C.] Manipal Univ, Kasturba Med Coll, Dept Med, Mangalore 575001, Karnataka, India; [Nagri, Shivashankara K.] Manipal Univ, Kasturba Med Coll, Dept Med, Manipal 576104, Karnataka, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Rai, PS (corresponding author), Manipal Univ, Sch Life Sci, Dept Biotechnol, Manipal 576104, Karnataka, India.	padmalatha.rai@manipal.edu		Satyamoorthy, Kapaettu/0000-0002-2368-5490	Indian Council of Medical Research (ICMR); Technology Information Forecasting and Assessment Council-Centre of Relevance and Excellence (TIFAC-CORE) in Pharmacogenomics at the School of Life Sciences, Government of India; Dr. TMA Pai Endowment Chair in Pharmacogenomics and Public Health Genomics, Manipal University	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Technology Information Forecasting and Assessment Council-Centre of Relevance and Excellence (TIFAC-CORE) in Pharmacogenomics at the School of Life Sciences, Government of India; Dr. TMA Pai Endowment Chair in Pharmacogenomics and Public Health Genomics, Manipal University	The authors would like to thank the Indian Council of Medical Research (ICMR), Technology Information Forecasting and Assessment Council-Centre of Relevance and Excellence (TIFAC-CORE) in Pharmacogenomics at the School of Life Sciences, Government of India, Dr. TMA Pai Endowment Chair in Pharmacogenomics and Public Health Genomics, Manipal University for financial and technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Indian Council of Medical Research (ICMR), Technology Information Forecasting and Assessment Council-Centre of Relevance and Excellence (TIFAC-CORE) in Pharmacogenomics at the School of Life Sciences, Government of India, Dr. TMA Pai Endowment Chair in Pharmacogenomics and Public Health Genomics, Manipal University for financial and technical support.	Bai HH, 2014, GENOME BIOL EVOL, V6, P3122, DOI 10.1093/gbe/evu242; Bodhini D, 2007, METABOLISM, V56, P1174, DOI 10.1016/j.metabol.2007.04.012; Brahmachari SK, 2008, J GENET, V87, P3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Gupta V, 2010, ANN HUM GENET, V74, P361, DOI 10.1111/j.1469-1809.2010.00580.x; Keaton JM, 2014, HUM GENET, V133, P1487, DOI 10.1007/s00439-014-1486-5; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Motsinger Alison A., 2006, Human Genomics, V2, P318; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Ramachandran A, 1997, DIABETES RES CLIN PR, V36, P121, DOI 10.1016/S0168-8227(97)00040-5; Sainz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032273; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Sanghera DK, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000198; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tabassum Rubina, 2008, Genomic Med, V2, P93, DOI 10.1007/s11568-009-9031-7; Vimaleswaran KS, 2010, METABOLISM, V59, P457, DOI 10.1016/j.metabol.2009.07.034; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	36	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157364	10.1371/journal.pone.0157364	http://dx.doi.org/10.1371/journal.pone.0157364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310578	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800061
J	Sanchez-Montalva, A; Salvador, F; Rodriguez-Palomares, J; Sulleiro, E; Sao-Aviles, A; Roure, S; Valerio, L; Evangelista, A; Molina, I				Sanchez-Montalva, Adrian; Salvador, Fernando; Rodriguez-Palomares, Jose; Sulleiro, Elena; Sao-Aviles, Augusto; Roure, Silvia; Valerio, Lluis; Evangelista, Arturo; Molina, Israel			Chagas Cardiomyopathy: Usefulness of EKG and Echocardiogram in a Non-Endemic Country	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; RANDOMIZED-TRIAL; DISEASE; BENZNIDAZOLE; ABNORMALITIES; ASSOCIATION; PREDICTORS; PARAMETERS; MORTALITY; DIAGNOSIS	Background Chagas disease (CD) is a major cause of cardiomyopathy in Latin America, and migration movements have now spread the disease worldwide. However, data regarding Chagas cardiomyopathy (CC) and the usefulness of echocardiography in non endemic countries are still scarce. Methods and results We selected 485 patients in the chronic phase of CD from two Spanish settings. Data from physical examination, electrocardiogram (EKG), x-ray, and two dimensional transthoracic echocardiogram were recorded. Trypanosoma cruzi DNA was assessed by PCR in peripheral blood. Patients were stratified according to the Kuschnir classification and a combination of echocardiogram and electrocardiogram findings. Patients mainly came from Bolivia (459; 94.6%). One hundred and forty three patients (31.5%) had at least one electrocardiogram abnormality. Twenty seven patients (5.3%) had an abnormal echocardiography. Patients with abnormal echocardiography were older (47 (IQR 38-57) years vs 41 (IQR 3857) years); p = 0.019) and there was a greater proportion of males (66.7% vs 29.7%); p<0.001). Among echocardiographic variables, diastolic dysfunction was associated with poor cardiac status. In the multivariate analysis, abnormal EKG and gender were associated with abnormal echocardiography. Echocardiography may be spared for males under 30 and females under 45 years old with normal EKG as the likelihood of having an abnormal echocardiography is minimal. Association between T. cruzi DNA in the peripheral blood and cardiac involvement was not observed. Conclusion CC rates in the studied population are low. Age and sex are important determinants for the development of CC, and with the EKG should guide echocardiogram performance.	[Sanchez-Montalva, Adrian; Salvador, Fernando; Sao-Aviles, Augusto; Molina, Israel] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Trop Med Unit,PROSICS, Dept Infect Dis,Int Hlth Program,Catalan Hlth Ins, E-08193 Barcelona, Spain; [Rodriguez-Palomares, Jose; Evangelista, Arturo] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Cardiol, Cardiac Imaging Dept, E-08193 Barcelona, Spain; [Sulleiro, Elena] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Microbiol, E-08193 Barcelona, Spain; [Roure, Silvia; Valerio, Lluis] Univ Autonoma Barcelona, North Metropolitan Int Hlth Unit, PROSICS, Int Hlth Program,Catalan Hlth Inst, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Sanchez-Montalva, A (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Trop Med Unit,PROSICS, Dept Infect Dis,Int Hlth Program,Catalan Hlth Ins, E-08193 Barcelona, Spain.	adsanche@vhebron.net	Sao Aviles, Augusto/GOH-0884-2022; Rodriguez-Palomares, Jose/AAX-9837-2020	Sulleiro, Elena/0000-0002-9783-6060; Rodriguez Palomares, Jose F/0000-0002-7229-9780; Salvador, Fernando/0000-0002-0546-1354; Molina Romero, Israel/0000-0001-6642-7515; Sao Aviles, Augusto/0000-0001-8497-0909				Abuhab A, 2013, INT J CARDIOL; Acquatella H, 2007, CIRCULATION, V115, P1124, DOI 10.1161/CIRCULATIONAHA.106.627323; Basquiera AL, 2003, HEART, V89, P1186, DOI 10.1136/heart.89.10.1186; CARRASCO HA, 1994, INT J CARDIOL, V43, P27, DOI 10.1016/0167-5273(94)90087-6; CARRASCO HA, 1982, AM HEART J, V104, P595, DOI 10.1016/0002-8703(82)90232-0; Cianciulli Tomas F, 2006, Cardiovasc Ultrasound, V4, P18, DOI 10.1186/1476-7120-4-18; COURA J R, 1984, Memorias do Instituto Oswaldo Cruz, V79, P101, DOI 10.1590/S0074-02761984000100012; de Andrade JP, 2011, ARQ BRAS CARDIOL, V96, DOI 10.1590/S0066-782X2011000600002; Borras SG, 2009, IMMUNOL INVEST, V38, P268, DOI 10.1080/08820130902766589; Garcia S, 2005, ANTIMICROB AGENTS CH, V49, P1521, DOI 10.1128/AAC.49.4.1521-1528.2005; Garcia-Alvarez A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000826; Garzon S A, 1995, Sao Paulo Med J, V113, P802; Hidron AI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000688; HIGUCHI MD, 1993, CARDIOVASC PATHOL, V2, P101, DOI 10.1016/1054-8807(93)90021-S; Kierszenbaum F, 1999, CLIN MICROBIOL REV, V12, P210, DOI 10.1128/CMR.12.2.210; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lee BY, 2013, LANCET INFECT DIS, V13, P342, DOI 10.1016/S1473-3099(13)70002-1; Maguire J H, 1982, Bull Pan Am Health Organ, V16, P47; Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122; Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574; Munoz J, 2009, ACTA TROP, V111, P51, DOI 10.1016/j.actatropica.2009.02.005; Navarro M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001962; Norman FF, 2011, ANN TROP MED PARASIT, V105, P425, DOI 10.1179/1364859411Y.0000000033; Pazin A, 2006, BRAZ J MED BIOL RES, V39, P483, DOI 10.1590/S0100-879X2006000400008; Perez-Ayala A, 2011, CLIN MICROBIOL INFEC, V17, P1108, DOI 10.1111/j.1469-0691.2010.03423.x; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Ramirez JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000899; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Ribeiro AL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002078; Riera C, 2012, AM J TROP MED HYG, V86, P412, DOI 10.4269/ajtmh.2012.11-0111; Salles G, 2003, CIRCULATION, V108, P305, DOI 10.1161/01.CIR.0000079174.13444.9C; Salles GF, 2003, PACE, V26, P1326, DOI 10.1046/j.1460-9592.2003.t01-1-00190.x; Salvador F, 2013, CLIN MICROBIOL INFEC; Silva SDA, 2007, MEM I OSWALDO CRUZ, V102, P845, DOI 10.1590/S0074-02762007000700010; Viotti RJ, 2004, HEART, V90, P655, DOI 10.1136/hrt.2003.018960; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; World Health Organization, 2002, WHO TECH REP SER, V905, P1	40	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157597	10.1371/journal.pone.0157597	http://dx.doi.org/10.1371/journal.pone.0157597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308824	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800104
J	Castronovo, M; Ernst, D; Couetoux, A; Fonteneau, R				Castronovo, Michael; Ernst, Damien; Couetoux, Adrien; Fonteneau, Raphael			Benchmarking for Bayesian Reinforcement Learning	PLOS ONE			English	Article							ALGORITHM	In the Bayesian Reinforcement Learning (BRL) setting, agents try to maximise the collected rewards while interacting with their environment while using some prior knowledge that is accessed beforehand. Many BRL algorithms have already been proposed, but the benchmarks used to compare them are only relevant for specific cases. The paper addresses this problem, and provides a new BRL comparison methodology along with the corresponding open source library. In this methodology, a comparison criterion that measures the performance of algorithms on large sets of Markov Decision Processes (MDPs) drawn from some probability distributions is defined. In order to enable the comparison of non-anytime algorithms, our methodology also includes a detailed analysis of the computation time requirement of each algorithm. Our library is released with all source code and documentation: it includes three test problems, each of which has two different prior distributions, and seven state-of-the-art RL algorithms. Finally, our library is illustrated by comparing all the available algorithms and the results are discussed.	[Castronovo, Michael; Ernst, Damien; Couetoux, Adrien; Fonteneau, Raphael] Univ Liege, Inst Montefiore, Syst & Modeling, B-4000 Liege, Belgium	University of Liege	Castronovo, M (corresponding author), Univ Liege, Inst Montefiore, Syst & Modeling, B-4000 Liege, Belgium.	m.castronovo@ulg.ac.be						Asmuth J., 2009, P 25 C UNC ART INT, P19; Asmuth J, 2011, P 21 INT C AUT PLANN; Audibert JY, 2007, LECT NOTES ARTIF INT, V4754, P150; Auer P, 2002, MACH LEARN, V47, P235, DOI 10.1023/A:1013689704352; Castelli M, 2014, WOR CONG NAT BIOL, P1, DOI 10.1109/NaBIC.2014.6921849; Castro PS, 2010, LECT NOTES ARTIF INT, V6321, P200, DOI 10.1007/978-3-642-15880-3_19; Castronovo M., 2013, EUR WORKSHOP REINF L, V24, P1; Dearden R, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P150; Dearden R, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P761; Guez A., 2012, NEURAL INFORM PROCES; Kearns M, 2002, MACH LEARN, V49, P193, DOI 10.1023/A:1017932429737; Kocsis L, 2006, LECT NOTES COMPUT SC, V4212, P282, DOI 10.1007/11871842_29; Kolter J. Z., 2009, P 26 ANN INT C MACH; Strens, 2000, P 17 INT C MACH LEAR, P943	15	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157088	10.1371/journal.pone.0157088	http://dx.doi.org/10.1371/journal.pone.0157088			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304891	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800036
J	Chan, W; Ismail, H; Mayaki, D; Sanchez, V; Tiedemann, K; Davis, EC; Hussain, SNA				Chan, Wilson; Ismail, Hodan; Mayaki, Dominique; Sanchez, Veronica; Tiedemann, Kerstin; Davis, Elaine C.; Hussain, Sabah N. A.			Fibulin-5 Regulates Angiopoietin-1/Tie-2 Receptor Signaling in Endothelial Cells	PLOS ONE			English	Article							EXPRESSION; TIE2; ALPHA-5-BETA-1; ROLES	Background Fibulin-5 is an extracellular matrix glycoprotein that plays critical roles in vasculogenesis and embryonic development. Deletion of Fibulin-5 in mice results in enhanced skin vascularization and upregulation of the angiogenesis factor angiopoietin-1 (Ang-1), suggesting that Fibulin-5 functions as an angiogenesis inhibitor. In this study, we investigate the inhibitory effects of Fibulin-5 on Ang-1/TIE-2 receptor pathway signaling and cell survival in human endothelial cells. Methodology/Principal Findings Recombinant wild-type and RGE-mutant Fibulin-5 proteins were generated through stable transfection of HEK293 and CHO cells, respectively. In vitro solid phase binding assays using pure proteins revealed that wild-type Fibulin-5 does not bind to Ang-1 or TIE-2 proteins but strongly binds to heparin. Binding assays using human umbilical vein endothelial cells (HUVECs) indicated that wild-type Fibulin-5 strongly binds to cells but RGE-mutant Fibulin-5, which is incapable of binding to integrins, does not. Pre-incubation of HUVECs for 1 hr with Fibulin-5 significantly increased caspase 3/7 activity, ERK1/2 phosphorylation, and expressions of the transcription factor early growth response 1 (EGR1) and the dual-specificity phosphatase 5 (DUSP5). Fibulin-5 also strongly attenuated Ang-1-induced TIE-2 and AKT phosphorylation, decreased Ang-1-induced expressions of the transcription factors Inhibitor of DNA Binding 1 (ID1) and Kruppel-like Factor 2 (KLF2), and reversed the inhibitory effect of Ang-1 on serum deprivation-induced cytotoxicity and caspase 3/7 activity. Conclusion/Significance We conclude that Fibulin-5 strongly binds to the endothelial cell surface through heparinsulfate proteoglycans and possibly integrins and that it exerts strong anti-angiogenic effects by reducing endothelial cell viability and interfering with the signaling pathways of the Ang1/TIE-2 receptor axis.	[Chan, Wilson; Davis, Elaine C.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Ismail, Hodan; Mayaki, Dominique; Sanchez, Veronica; Hussain, Sabah N. A.] McGill Univ, Translat Res Resp Dis, Ctr Hlth, Montreal, PQ, Canada; [Ismail, Hodan; Mayaki, Dominique; Sanchez, Veronica; Hussain, Sabah N. A.] McGill Univ, Dept Med, Meakins Christie Labs, Montreal, PQ, Canada; [Tiedemann, Kerstin] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Tiedemann, Kerstin] Shriners Hosp Children, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Hussain, SNA (corresponding author), McGill Univ, Translat Res Resp Dis, Ctr Hlth, Montreal, PQ, Canada.; Hussain, SNA (corresponding author), McGill Univ, Dept Med, Meakins Christie Labs, Montreal, PQ, Canada.	sabah.hussain@muhc.mcgill.ca	Tiedemann, one/A-9739-2016; Hussain, Sabah/ABC-5315-2021		Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by operating grants from the Canadian Institutes of Health Research.	Abdel-Malak NA, 2007, ENDOTHELIUM-J ENDOTH, V14, P285, DOI 10.1080/10623320701678268; Abdel-Malak NA, 2008, BLOOD, V111, P4145, DOI 10.1182/blood-2007-08-110338; Abdel-Malak NA, 2009, ARTERIOSCL THROM VAS, V29, P209, DOI 10.1161/ATVBAHA.108.181073; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Bellou S, 2009, AM J PHYSIOL-CELL PH, V297, pC1477, DOI 10.1152/ajpcell.00058.2009; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Echavarria R, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000571; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Guadall A, 2011, J BIOL CHEM, V286, P7093, DOI 10.1074/jbc.M110.162917; Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje; Harfouche R, 2003, FASEB J, V17, P1523, DOI 10.1096/fj.02-0698fje; Harfouche R, 2002, MICROVASC RES, V64, P135, DOI 10.1006/mvre.2002.2421; Khan Zia A., 2005, Angiogenesis, V8, P183, DOI 10.1007/s10456-005-9017-6; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Olsson AK, 2004, CANCER RES, V64, P9012, DOI 10.1158/0008-5472.CAN-04-2172; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Sako K, 2009, J BIOL CHEM, V284, P5592, DOI 10.1074/jbc.M806928200; Sullivan KM, 2007, LAB INVEST, V87, P818, DOI 10.1038/labinvest.3700594; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yanagisawa H, 2009, J CELL COMMUN SIGNAL, V3, P337, DOI 10.1007/s12079-009-0065-3; Yanagisawa H, 2010, INT J BIOCHEM CELL B, V42, P1084, DOI 10.1016/j.biocel.2010.03.009	33	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156994	10.1371/journal.pone.0156994	http://dx.doi.org/10.1371/journal.pone.0156994			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304216	gold, Green Published, Green Submitted			2022-12-27	WOS:000377824800032
J	Dedefo, M; Zelalem, D; Eskinder, B; Assefa, N; Ashenafi, W; Baraki, N; Tesfatsion, MD; Oljira, L; Haile, A				Dedefo, Melkamu; Zelalem, Desalew; Eskinder, Biniyam; Assefa, Nega; Ashenafi, Wondimye; Baraki, Negga; Tesfatsion, Melake Damena; Oljira, Lemessa; Haile, Ashenafi			Causes of Death among Children Aged 5 to 14 Years Old from 2008 to 2013 in Kersa Health and Demographic Surveillance System (Kersa HDSS), Ethiopia	PLOS ONE			English	Article							VERBAL AUTOPSY METHODS; MORTALITY; AFRICA; AREA	Background The global burden of mortality among children is still very huge though its trend has started declining following the improvements in the living standard. It presents serious challenges to the well-being of children in many African countries. Today, Sub-Saharan Africa alone accounts for about 50% of global child mortality. The overall objective of this study was to determine the magnitude and distribution of causes of death among children aged 5 to 14 year olds in the population of Kersa HDSS using verbal autopsy method for the period 2008 to 2013. Methods Kersa Health and Demographic Surveillance System(Kersa HDSS) was established in September 2007. The center consists of 10 rural and 2 urban kebeles which were selected randomly from 38 kebeles in the district. Thus this study was conducted in Kersa HDSS and data was taken from Kersa HDSS database. The study population included all children aged 5 to 14 years registered during the period of 2008 to 2013 in Kersa HDSS using age specific VA questionnaires. Data were extracted from SPSS database and analyzed using STATA. Results A total of 229 deaths were recorded over the period of six years with a crude death rate of 219.6 per 100,000 population of this age group over the study period. This death rate was 217.5 and 221.5 per 100,000 populations for females and males, respectively. 75% of deaths took place at home. The study identified severe malnutrition(33.9%), intestinal infectious diseases(13.8%) and acute lower respiratory infections(9.2%) to be the three most leading causes of death. In broad causes of death classification, injuries have been found to be the second most cause of death next to communicable diseases(56.3%) attributing to 13.1% of the total deaths. Conclusion and Recommendation In specific causes of death classification severe malnutrition, intestinal infectious diseases and acute lower respiratory infections were the three leading causes of death where, in broad causes of death communicable diseases and injuries were among the leading causes of death. Hence, concerned bodies should take measures to avert the situation of mortality from these causes of death and further inferential analysis into the prevention and management of infectious diseases should also be taken.	[Dedefo, Melkamu; Zelalem, Desalew; Assefa, Nega; Ashenafi, Wondimye; Baraki, Negga; Tesfatsion, Melake Damena; Oljira, Lemessa] Kersa Hlth & Demog Surveillance Syst Kersa HDSS, Harar, Ethiopia; [Dedefo, Melkamu] Haramaya Univ, Coll Comp & Informat, Dept Stat, Dire Dawa, Ethiopia; [Zelalem, Desalew; Assefa, Nega; Ashenafi, Wondimye; Baraki, Negga; Tesfatsion, Melake Damena; Oljira, Lemessa] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia; [Eskinder, Biniyam; Haile, Ashenafi] Ctr Dis Control & Prevent CDC Eth, Addis Ababa, Ethiopia	Haramaya University; Haramaya University	Dedefo, M (corresponding author), Kersa Hlth & Demog Surveillance Syst Kersa HDSS, Harar, Ethiopia.	melkyed@gmail.com	Gebeye, Ashenafi Haile/ABZ-3124-2022; Gishu, Melkamu Dedefo/C-3747-2017; Oljira, Lemessa/AAJ-1285-2020	Gebeye, Ashenafi Haile/0000-0003-3303-4031; Gishu, Melkamu Dedefo/0000-0002-3466-1232; Oljira, Lemessa/0000-0003-4542-2509; Assefa, Nega/0000-0003-0341-2329				Abbas SM, 2011, J PAK MED ASSOC, V61, P235; Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; [Anonymous], [No title captured]; Assefa N, 2016, INT J EPIDEMIOL, V45, P94, DOI 10.1093/ije/dyv284; Awoke Misganaw, 2012, BMC PUBLIC HEALTH, P12; Becher H, 2008, AM J TROP MED HYG, V78, P106, DOI 10.4269/ajtmh.2008.78.106; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Dedefo M, 2016, SPAT SPATIO-TEMPORAL, V16, P43, DOI 10.1016/j.sste.2015.11.003; Defo BK, 1996, SOC SCI MED, V42, P399, DOI 10.1016/0277-9536(95)00107-7; Dongre AR, 2009, ONLINE J HLTH ALLIED, V7; EMA, 2013, CART MAP KERS HAR; EMet, 2011, MONTHL CLIM REC TEMP; Fantahun M, 2008, MORTALITY AAND SURVI; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Janne Pearson, 2009, PATTERN INJURY MORTA; Lozano R, 2011, POPUL HEALTH METR, V9, P2; Lulu K, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-58; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583; Oti SO, 2010, RES VERBAL AUTOPSY I; Population Census Commission (pcc), 2008, SUMM STAT REP 2007 P; Ronsmans C, 1998, INT J EPIDEMIOL, V27, P660, DOI 10.1093/ije/27.4.660; Sacarlal J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-67; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Singh GK, 2010, CHILD MORTALITY US 1; Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25363; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0151929	10.1371/journal.pone.0151929	http://dx.doi.org/10.1371/journal.pone.0151929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304832	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800002
J	Rex, TS; Kasmala, L; Bond, WS; Cerrillo, AMD; Wynn, K; Lewin, AS				Rex, Tonia S.; Kasmala, Lorraine; Bond, Wesley S.; Cerrillo, Ana M. de Lucas; Wynn, Kristi; Lewin, Alfred S.			Erythropoietin Slows Photoreceptor Cell Death in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; P23H RHODOPSIN PHOTORECEPTORS; GENE DELIVERY; RAT MODEL; DEGENERATION; MUTATIONS; ACTIVATION; GLAUCOMA; MICE; DEGRADATION	Purpose To test the efficacy of systemic gene delivery of a mutant form of erythropoietin (EPO-R76E) that has attenuated erythropoietic activity, in a mouse model of autosomal dominant retinitis pigmentosa. Methods Ten-day old mice carrying one copy of human rhodopsin with the P23H mutation and both copies of wild-type mouse rhodopsin (hP23H RHO+/-, mRHO(+/+)) were injected into the quadriceps with recombinant adeno-associated virus (rAAV) carrying either enhanced green fluorescent protein (eGFP) or EpoR76E. Visual function (electroretinogram) and retina structure (optical coherence tomography, histology, and immunohistochemistry) were assessed at 7 and 12 months of age. Results The outer nuclear layer thickness decreased over time at a slower rate in rAAV. EpoR76E treated as compared to the rAAV. eGFP injected mice. There was a statistically significant preservation of the electroretinogram at 7, but not 12 months of age. Conclusions Systemic EPO-R76E slows death of the photoreceptors and vision loss in hP23H RHO+/-, mRHO(+/+) mice. Treatment with EPO-R76E may widen the therapeutic window for retinal degeneration patients by increasing the number of viable cells. Future studies might investigate if co-treatment with EPO-R76E and gene replacement therapy is more effective than gene replacement therapy alone.	[Rex, Tonia S.; Kasmala, Lorraine; Bond, Wesley S.; Cerrillo, Ana M. de Lucas; Wynn, Kristi] Vanderbilt Univ, Vanderbilt Brain Inst, Vanderbilt Eye Inst, Nashville, TN 37232 USA; [Lewin, Alfred S.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32608 USA	Vanderbilt University; State University System of Florida; University of Florida	Rex, TS (corresponding author), Vanderbilt Univ, Vanderbilt Brain Inst, Vanderbilt Eye Inst, Nashville, TN 37232 USA.	tonia.rex@vanderbilt.edu		Lewin, Alfred/0000-0002-4192-9727	NEI [R01EY022349, 1R24EY022012, T32 EY021453, P30-EY008126]; Department of Defense [W81XWH-10-1-0528, W81XWH-13-1-0048, W81XWH-15-1-0096]; Research to Prevent Blindness Career Development Award; Foundation Fighting Blindness; Research to Prevent Blindness Unrestricted Funds	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Department of Defense(United States Department of Defense); Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness Unrestricted Funds(Research to Prevent Blindness (RPB))	NEI R01EY022349 (TSR); Department of Defense W81XWH-10-1-0528 (TSR), W81XWH-13-1-0048, and W81XWH-15-1-0096; Research to Prevent Blindness Career Development Award (TSR); NEI 1R24EY022012 (AL); Foundation Fighting Blindness (AL); NEI T32 EY021453 (WSB); Research to Prevent Blindness Unrestricted Funds; NEI P30-EY008126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekeye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083871; Bond WS, 2016, MOL THER, V24, P230, DOI 10.1038/mt.2015.198; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; Bricker-Anthony C., 2016, OPTOMETRY VISUAL SCI; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Cerrillo AMD, 2015, GENE THER, V22, P365, DOI 10.1038/gt.2015.12; Chiang WC, 2016, ADV EXP MED BIOL, V854, P185, DOI 10.1007/978-3-319-17121-0_25; Chiang WC, 2015, MOL NEUROBIOL, V52, P679, DOI 10.1007/s12035-014-8881-8; Comitato A, 2014, INVEST OPHTH VIS SCI, V55, P3555, DOI 10.1167/iovs.14-13917; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; Fernandez-Sanchez L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00484; Gorbatyuk MS, 2012, ADV EXP MED BIOL, V723, P191, DOI 10.1007/978-1-4614-0631-0_26; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; Hempel C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00291; Hines-Beard J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0499-5; Hines-Beard J, 2013, CURR GENE THER, V13, P275; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jantzie LL, 2016, DEV NEUROSCI-BASEL, V38, P15, DOI 10.1159/000441024; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; Marrero MB, 1998, KIDNEY INT, V53, P1259, DOI 10.1046/j.1523-1755.1998.00887.x; McGill TJ, 2012, INVEST OPHTH VIS SCI, V53, P6232, DOI 10.1167/iovs.12-9569; Nguyen ATH, 2014, ADV EXP MED BIOL, V801, P471, DOI 10.1007/978-1-4614-3209-8_60; Noorwez SM, 2008, INVEST OPHTH VIS SCI, V49, P3224, DOI 10.1167/iovs.07-1539; Ozaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071650; Price BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049889; Rex TS, 2009, EXP EYE RES, V89, P735, DOI 10.1016/j.exer.2009.06.017; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Sizova OS, 2014, CELL SIGNAL, V26, P665, DOI 10.1016/j.cellsig.2013.12.008; Sullivan T, 2011, NEUROCHEM RES, V36, P613, DOI 10.1007/s11064-010-0272-6; Sullivan TA, 2012, EXP EYE RES, V96, P36, DOI 10.1016/j.exer.2012.01.006; Sullivan TA, 2011, HUM GENE THER, V22, P1191, DOI 10.1089/hum.2011.052; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Tsai JC, 2005, CURR EYE RES, V30, P1025, DOI 10.1080/02713680500320729; Weishaupt JH, 2004, INVEST OPHTH VIS SCI, V45, P1514, DOI 10.1167/iovs.03-1039; Zhao HP, 2015, J NEUROIMMUNE PHARM, V10, P153, DOI 10.1007/s11481-014-9571-z; Zhong LC, 2007, INVEST OPHTH VIS SCI, V48, P1212, DOI 10.1167/iovs.06-0757	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157411	10.1371/journal.pone.0157411	http://dx.doi.org/10.1371/journal.pone.0157411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299810	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200047
J	Shah, FA; Johansson, ML; Omar, O; Simonsson, H; Palmquist, A; Thomsen, P				Shah, Furqan A.; Johansson, Martin L.; Omar, Omar; Simonsson, Hanna; Palmquist, Anders; Thomsen, Peter			Laser-Modified Surface Enhances Osseointegration and Biomechanical Anchorage of Commercially Pure Titanium Implants for Bone-Anchored Hearing Systems	PLOS ONE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; DIFFERENT OXIDE THICKNESSES; DENTAL IMPLANTS; ELECTROPOLISHED IMPLANTS; STABILITY MEASUREMENTS; CONDUCTION DEVICES; TISSUE REDUCTION; GENE-EXPRESSION; FOLLOW-UP; IN-VIVO	Osseointegrated implants inserted in the temporal bone are a vital component of bone-anchored hearing systems (BAHS). Despite low implant failure levels, early loading protocols and simplified procedures necessitate the application of implants which promote bone formation, bone bonding and biomechanical stability. Here, screw-shaped, commercially pure titanium implants were selectively laser ablated within the thread valley using an Nd: YAG laser to produce a microtopography with a superimposed nanotexture and a thickened surface oxide layer. State-of-the-art machined implants served as controls. After eight weeks' implantation in rabbit tibiae, resonance frequency analysis (RFA) values increased from insertion to retrieval for both implant types, while removal torque (RTQ) measurements showed 153% higher biomechanical anchorage of the laser-modified implants. Comparably high bone area (BA) and bone-implant contact (BIC) were recorded for both implant types but with distinctly different failure patterns following biomechanical testing. Fracture lines appeared within the bone similar to 30-50 mu m from the laser-modified surface, while separation occurred at the bone-implant interface for the machined surface. Strong correlations were found between RTQ and BIC and between RFA at retrieval and BA. In the endosteal threads, where all the bone had formed de novo, the extracellular matrix composition, the mineralised bone area and osteocyte densities were comparable for the two types of implant. Using resin cast etching, osteocyte canaliculi were observed directly approaching the laser-modified implant surface. Transmission electron microscopy showed canaliculi in close proximity to the laser-modified surface, in addition to a highly ordered arrangement of collagen fibrils aligned parallel to the implant surface contour. It is concluded that the physico-chemical surface properties of laser-modified surfaces (thicker oxide, micro- and nanoscale texture) promote bone bonding which may be of benefit in situations where large demands are imposed on biomechanically stable interfaces, such as in early loading and in compromised conditions.	[Shah, Furqan A.; Johansson, Martin L.; Omar, Omar; Palmquist, Anders; Thomsen, Peter] Univ Gothenburg, Inst Clin Sci, Dept Biomat, Sahlgrenska Acad, Gothenburg, Sweden; [Shah, Furqan A.; Johansson, Martin L.; Omar, Omar; Simonsson, Hanna; Palmquist, Anders; Thomsen, Peter] BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden; [Johansson, Martin L.; Simonsson, Hanna] Oticon Med AB, Askim, Sweden	University of Gothenburg; Oticon	Thomsen, P (corresponding author), Univ Gothenburg, Inst Clin Sci, Dept Biomat, Sahlgrenska Acad, Gothenburg, Sweden.; Thomsen, P (corresponding author), BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden.	peter.thomsen@biomaterials.gu.se	Palmquist, Anders/D-2171-2014; Johansson, Martin L/R-2307-2017; Shah, Furqan/Y-9485-2019; Omar, Omar/C-9264-2019; Omar, Omar/I-2126-2017	Palmquist, Anders/0000-0002-6974-2577; Johansson, Martin L/0000-0002-7269-0288; Shah, Furqan/0000-0002-9876-0467; Omar, Omar/0000-0002-2610-1294; Omar, Omar/0000-0002-2610-1294; Thomsen, Peter/0000-0003-3910-6665	Oticon Medical AB; BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; Vastra Gotaland Region; Swedish Research Council [K2015-52X-09495-28-4]; ALF/LUA Research Grant "Optimization of osseointegration for treatment of transfemoral amputees" [ALFGBG-448851]; IngaBritt and Arne Lundberg Foundation; Hjalmar Svensson Foundation; Vilhelm and Martina Lundgren Vetenskapsfond; Swedish Government Strategic Funding of Materials Science Area of Advance; Department of Biomaterials, University of Gothenburg	Oticon Medical AB; BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; Vastra Gotaland Region; Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF/LUA Research Grant "Optimization of osseointegration for treatment of transfemoral amputees"; IngaBritt and Arne Lundberg Foundation; Hjalmar Svensson Foundation; Vilhelm and Martina Lundgren Vetenskapsfond; Swedish Government Strategic Funding of Materials Science Area of Advance; Department of Biomaterials, University of Gothenburg	This study was supported by grants from Oticon Medical AB, the BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy, the Vastra Gotaland Region, the Swedish Research Council (grant K2015-52X-09495-28-4), the ALF/LUA Research Grant "Optimization of osseointegration for treatment of transfemoral amputees" (ALFGBG-448851), the IngaBritt and Arne Lundberg Foundation, the Hjalmar Svensson Foundation, and the Vilhelm and Martina Lundgren Vetenskapsfond. FAS holds a PhD position financed by the Swedish Government Strategic Funding of Materials Science Area of Advance, provided to Chalmers and Department of Biomaterials, University of Gothenburg. MLJ holds an industrial PhD position financed by Oticon Medical AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Oticon Medical AB) provided support in the form of salaries for MLJ and HS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdel-Haq J, 2011, CLIN ORAL IMPLAN RES, V22, P265, DOI 10.1111/j.1600-0501.2010.01990.x; Ballo A, 2011, INT J NANOMED, V6, P3415, DOI 10.2147/IJN.S25867; Branemark R, 2011, NANOMED-NANOTECHNOL, V7, P220, DOI 10.1016/j.nano.2010.10.006; Brunette DM, 2001, ENG MAT SER, V7, P171, DOI 10.1007/978- 3-642-56486-4_7; Calvo Bodnia N, 2014, OTOL NEUROTOL, V35, pe301, DOI DOI 10.1097/MA0.0000000000000543; Coutinho MB, 2015, J LARYNGOL OTOL, V129, P1133, DOI 10.1017/S0022215115002510; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Davies JE, 2013, BIOMATERIALS, V34, P3535, DOI 10.1016/j.biomaterials.2013.01.024; Degidi M, 2012, CLIN IMPLANT DENT R, V14, P501, DOI 10.1111/j.1708-8208.2010.00302.x; den Besten CA, 2015, INT J PEDIATR OTORHI, V79, P2050, DOI 10.1016/j.ijporl.2015.09.010; DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x; Donos N, 2014, BRIT DENT J, V217, P425, DOI 10.1038/sj.bdj.2014.911; Dooley KA, 2011, RAMAN SPECTROSCOPIC; Drinias V, 2007, CLIN IMPLANT DENT R, V9, P94, DOI 10.1111/j.1708-8208.2007.00047.x; Dun CAJ, 2012, OTOL NEUROTOL, V33, P192, DOI 10.1097/MAO.0b013e318241c0bf; Engqvist H, 2006, J BIOMED MATER RES A, V78A, P20, DOI 10.1002/jbm.a.30696; Foghsgaard S, 2014, OTOL NEUROTOL, V35, P1238, DOI 10.1097/MAO.0000000000000345; Gamsjaeger S, 2010, BONE, V47, P392, DOI 10.1016/j.bone.2010.04.608; Grandfield K, 2013, NANOSCALE, V5, P4302, DOI 10.1039/c3nr00826f; Hogsbro M, 2015, OTOL NEUROTOL, V36, pe51, DOI 10.1097/MAO.0000000000000647; Horstink L, 2012, OTOL NEUROTOL, V33, P1013, DOI 10.1097/MAO.0b013e318259b36c; Hultcrantz M, 2014, OTOL NEUROTOL, V35, P1480, DOI 10.1097/MAO.0000000000000352; JACOBSSON M, 1992, INT J PEDIATR OTORHI, V24, P235, DOI 10.1016/0165-5876(92)90021-G; Jarmar T, 2008, J BIOMED MATER RES A, V87A, P1003, DOI 10.1002/jbm.a.31856; KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057; Kazanci M, 2007, BONE, V41, P456, DOI 10.1016/j.bone.2007.04.200; Kiringoda R, 2013, OTOL NEUROTOL, V34, P790, DOI 10.1097/MAO.0b013e318291c651; Kozielski M, 2011, J MATER SCI-MATER M, V22, P1653, DOI 10.1007/s10856-011-4353-0; Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974; Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4; LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Lenneras M, 2015, CLIN IMPLANT DENT R, V17, pE486, DOI 10.1111/cid.12276; Mazet V, 2005, CHEMOMETR INTELL LAB, V76, P121, DOI 10.1016/j.chemolab.2004.10.003; McDermott AL, 2008, INT J PEDIATR OTORHI, V72, P751, DOI 10.1016/j.ijporl.2008.01.035; Mohammadi Shams, 2003, Clin Implant Dent Relat Res, V5, P241, DOI 10.1111/j.1708-8208.2003.tb00207.x; Morris MD, 2011, CLIN ORTHOP RELAT R, V469, P2160, DOI 10.1007/s11999-010-1692-y; Nader ME, 2015, LARYNGOSCOPE; Nelissen RC, 2015, EUR ARCH OTORHINOLAR; Nelissen RC, 2016, EUR ARCH OTO-RHINO-L, V273, P105, DOI 10.1007/s00405-015-3593-x; Nelissen RC, 2014, OTOL NEUROTOL, V35, P1486, DOI 10.1097/MAO.0000000000000533; Omar O, 2010, J BIOMED MATER RES A, V92A, P1552, DOI 10.1002/jbm.a.32475; Omar OM, 2011, BIOMATERIALS, V32, P374, DOI 10.1016/j.biomaterials.2010.09.011; Palmquist A, 2012, J R SOC INTERFACE, V9, P396, DOI 10.1098/rsif.2011.0420; Palmquist A, 2011, J BIOMED MATER RES B, V97B, P289, DOI 10.1002/jbm.b.31814; Palmquist A, 2010, J BIOMED MATER RES A, V92A, P1476, DOI 10.1002/jbm.a.32439; Palmquist A, 2009, J BIOMED MATER RES B, V91B, P309, DOI 10.1002/jbm.b.31404; Papsin BC, 1997, LARYNGOSCOPE, V107, P801, DOI 10.1097/00005537-199706000-00015; Roschger A, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.6.065002; Scarano A, 2006, CLIN IMPLANT DENT R, V8, P218, DOI 10.1111/j.1708-8208.2006.00022.x; Sennerby L, 2008, PERIODONTOL 2000, V47, P51, DOI 10.1111/j.1600-0757.2008.00267.x; Shah FA, 2016, ACTA BIOMATER, V36, P296, DOI 10.1016/j.actbio.2016.03.033; Shah FA, 2015, ACS BIOMATER SCI ENG, V1, P305, DOI 10.1021/ab500127y; Shah FA, 2016, ACTA BIOMATER, V30, P357, DOI 10.1016/j.actbio.2015.11.013; Shah FA, 2015, J BIOMED MATER RES A, V103, P1565, DOI 10.1002/jbm.a.35287; Shah FA, 2014, NANOMED-NANOTECHNOL, V10, P1729, DOI 10.1016/j.nano.2014.05.015; Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603; Singam S, 2014, OTOL NEUROTOL, V35, P1596, DOI 10.1097/MAO.0000000000000522; Soares Priscilla Barbosa Ferreira, 2015, Braz. Dent. J., V26, P451, DOI 10.1590/0103-6440201300411; Soo G, 2009, OTOL NEUROTOL, V30, P496, DOI 10.1097/MAO.0b013e31819d34ab; Trtica M, 2006, APPL SURF SCI, V253, P2551, DOI 10.1016/j.apsusc.2006.05.024; Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x	63	67	69	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157504	10.1371/journal.pone.0157504	http://dx.doi.org/10.1371/journal.pone.0157504			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299883	gold, Green Submitted, Green Published			2022-12-27	WOS:000377822200057
J	Baratz-Goldstein, R; Deselms, H; Heim, LR; Khomski, L; Hoffer, BJ; Atlas, D; Pick, CG				Baratz-Goldstein, Renana; Deselms, Hanna; Heim, Leore Raphael; Khomski, Lena; Hoffer, Barry J.; Atlas, Daphne; Pick, Chaim G.			Thioredoxin-Mimetic-Peptides Protect Cognitive Function after Mild Traumatic Brain Injury (mTBI)	PLOS ONE			English	Article							N-ACETYLCYSTEINE AMIDE; NECROSIS-FACTOR-ALPHA; FOCAL CEREBRAL-ISCHEMIA; ALLERGIC AIRWAY DISEASE; NEURONAL CELL-DEATH; OXIDATIVE STRESS; RAT-BRAIN; MITOCHONDRIAL BIOENERGETICS; NEURODEGENERATIVE DISEASES; DOPAMINERGIC-NEURONS	Mild traumatic brain injury (mTBI) is recognized as a common injury among children, sportsmen, and elderly population. mTBI lacks visible objective structural brain damage but patients frequently suffer from long-lasting cognitive, behavioral and emotional difficulties associated with biochemical and cellular changes. Currently there is no effective treatment for patients with mTBI. The thioredoxin reductase/thioredoxin pathway (TrxR/Trx1) has both anti-inflammatory and anti-oxidative properties. If the system is compromised, Trx1 remains oxidized and triggers cell death via an ASK1-Trx1 signal transduction mechanism. We previously showed tri and tetra peptides which were derived from the canonical -CxxC- motif of the Trx1-active site, called thioredoxin mimetic (TXM) peptides, reversed inflammatory and oxidative stress damage mimicking Trx1 activity. Here, TXM-peptides were examined for protecting cognitive function following weight drop closed-head injury in a mouse model of mTBI. TXM-CB3 (AcCys-Pro-CysNH(2)), TXM-CB13 (DY-70; AcCys-Met-Lys-CysNH(2)) or AD4 (ACysNH(2)) were administered at 50 mg/kg, 60 min after injury and cognitive performance was monitored by the novel-object-recognition and Y-maze tests. Behavioral deficits subsequent to mTBI injury were reversed by a single dose of TXM-CB3, TXM-CB13 and, to a lesser extent, by AD4. TXM-CB13 similar to TXM-CB3 and AD4 reversed oxidative stress-induced phosphorylation of mitogen-activated kinases, p38(MAPK) and c-Jun N-terminal kinase, (JNK) in human neuronal SH-SY5Y cells. We conclude that significantly improved cognitive behavior post mTBI by the TXM-peptides could result from anti-apoptotic, and/or anti-inflammatory activities. Future preclinical studies are required to establish the TXM-peptides as potential therapeutic drugs for brain injuries.	[Baratz-Goldstein, Renana; Deselms, Hanna; Heim, Leore Raphael] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Khomski, Lena; Atlas, Daphne] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Case Western Reserve University; Tel Aviv University	Baratz-Goldstein, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.; Atlas, D (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	renanaba@post.tau.ac.il; daphne.atlas@mail.huji.ac.il	Meijer, Anna/K-5118-2016		Ari and Regine Aprijaskis Fund at Tel-Aviv University; H.L Lauterbach Fund (Hebrew University)	Ari and Regine Aprijaskis Fund at Tel-Aviv University; H.L Lauterbach Fund (Hebrew University)	This research was supported by the Ari and Regine Aprijaskis Fund at Tel-Aviv University, and by The H.L Lauterbach Fund (Hebrew University) to DA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Ari and Regine Aprijaskis Fund at Tel-Aviv University, and by The H.L Lauterbach Fund (Hebrew University).	Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; Amer J, 2008, BBA-GEN SUBJECTS, V1780, P249, DOI 10.1016/j.bbagen.2007.11.009; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Bachnoff N, 2011, FREE RADICAL BIO MED, V50, P1355, DOI 10.1016/j.freeradbiomed.2011.02.026; Bahat-Stroomza M, 2005, EUR J NEUROSCI, V21, P637, DOI 10.1111/j.1460-9568.2005.03889.x; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bartov O, 2006, BRAIN RES, V1069, P198, DOI 10.1016/j.brainres.2005.10.079; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cohen-Kutner M, 2014, REDOX BIOL, V2, P447, DOI 10.1016/j.redox.2013.12.018; Cohen-Kutner M, 2013, BIOCHEM PHARMACOL, V85, P977, DOI 10.1016/j.bcp.2013.01.003; Cuzzocrea S, 2000, BRIT J PHARMACOL, V130, P1219, DOI 10.1038/sj.bjp.0703421; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FAN PY, 1995, CLIN IMMUNOL IMMUNOP, V75, P125, DOI 10.1006/clin.1995.1061; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Finme JW, 2008, VET PATHOL, V45, P307, DOI 10.1354/vp.45-3-307; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Grinberg L, 2005, FREE RADICAL BIO MED, V38, P136, DOI 10.1016/j.freeradbiomed.2004.09.025; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kim SR, 2011, AM J RESP CRIT CARE, V183, P1015, DOI 10.1164/rccm.200906-0902OC; Kronenfeld G, 2015, FREE RADICAL BIO MED, V79, P138, DOI 10.1016/j.freeradbiomed.2014.11.021; Lee KS, 2007, EXP MOL MED, V39, P756, DOI 10.1038/emm.2007.82; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nakamura T, 2016, TRENDS PHARMACOL SCI, V37, P73, DOI 10.1016/j.tips.2015.10.002; Offen D, 2004, J NEUROCHEM, V89, P1241, DOI 10.1111/j.1471-4159.2004.02428.x; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Shenk JC, 2009, J NEUROL SCI, V283, P199, DOI 10.1016/j.jns.2009.03.002; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Stelmasiak Z, 2000, Med Sci Monit, V6, P426; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Yan MS, 2008, NEOPLASIA, V10, P160, DOI 10.1593/neo.07935; Zaitone SA, 2012, PHARMACOL BIOCHEM BE, V100, P347, DOI 10.1016/j.pbb.2011.09.002; Zhang XS, 2009, BRAIN RES, V1275, P87, DOI 10.1016/j.brainres.2009.04.008; Zohar J, 2003, CNS SPECTR, V8, P634, DOI 10.1017/S1092852900008798	59	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157064	10.1371/journal.pone.0157064	http://dx.doi.org/10.1371/journal.pone.0157064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285176	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000037
J	Bailly, S; Destors, M; Grillet, Y; Richard, P; Stach, B; Vivodtzev, I; Timsit, JF; Levy, P; Tamisier, R; Pepin, JL				Bailly, Sebastien; Destors, Marie; Grillet, Yves; Richard, Philippe; Stach, Bruno; Vivodtzev, Isabelle; Timsit, Jean-Francois; Levy, Patrick; Tamisier, Renaud; Pepin, Jean-Louis		Sci Council & Investigators French	Obstructive Sleep Apnea: A Cluster Analysis at Time of Diagnosis	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; WEIGHT-LOSS; CPAP; HYPERTENSION; NOCTURIA; BRAIN; HEART	Background The classification of obstructive sleep apnea is on the basis of sleep study criteria that may not adequately capture disease heterogeneity. Improved phenotyping may improve prognosis prediction and help select therapeutic strategies. Objectives: This study used cluster analysis to investigate the clinical clusters of obstructive sleep apnea. Methods An ascending hierarchical cluster analysis was performed on baseline symptoms, physical examination, risk factor exposure and co-morbidities from 18,263 participants in the OSFP (French national registry of sleep apnea). The probability for criteria to be associated with a given cluster was assessed using odds ratios, determined by univariate logistic regression. Results: Six clusters were identified, in which patients varied considerably in age, sex, symptoms, obesity, co-morbidities and environmental risk factors. The main significant differences between clusters were minimally symptomatic versus sleepy obstructive sleep apnea patients, lean versus obese, and among obese patients different combinations of co-morbidities and environmental risk factors. Conclusions Our cluster analysis identified six distinct clusters of obstructive sleep apnea. Our findings underscore the high degree of heterogeneity that exists within obstructive sleep apnea patients regarding clinical presentation, risk factors and consequences. This may help in both research and clinical practice for validating new prevention programs, in diagnosis and in decisions regarding therapeutic strategies.	[Bailly, Sebastien; Destors, Marie; Vivodtzev, Isabelle; Levy, Patrick; Tamisier, Renaud; Pepin, Jean-Louis] Univ Grenoble Alpes, INSERM, HP2, U1042, Grenoble, France; [Bailly, Sebastien; Timsit, Jean-Francois] Univ Paris Diderot, INSERM, IAME, UMR 1137, F-75018 Paris, France; [Destors, Marie; Levy, Patrick; Tamisier, Renaud; Pepin, Jean-Louis] Grenoble Alpes Univ Hosp, Lab EFCR, Pole THORAX & VAISSEAUX, Grenoble, France; [Grillet, Yves] Private Clin, Valence, France; [Richard, Philippe] Private Clin, St Omer, France; [Stach, Bruno] St Michel Private Clin, Valenciennes, France; [Timsit, Jean-Francois] Paris Diderot Univ, Bichat Hosp, Med & Infect Dis ICU, Paris, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Pepin, JL (corresponding author), Univ Grenoble Alpes, INSERM, HP2, U1042, Grenoble, France.; Pepin, JL (corresponding author), Grenoble Alpes Univ Hosp, Lab EFCR, Pole THORAX & VAISSEAUX, Grenoble, France.	jpepin@chu-grenoble.fr	LEVY, Patrick/AAX-2802-2020; Tamisier, Renaud/M-6858-2014; BAILLY, Sébastien SB/H-4648-2013; Destors, Marie/AAC-8151-2019	LEVY, Patrick/0000-0003-3174-7935; Tamisier, Renaud/0000-0003-1128-6529; BAILLY, Sébastien SB/0000-0002-2179-4650; Destors, Marie/0000-0001-5114-4395; Pepin, Jean Louis/0000-0003-3832-2358; Vivodtzev, Isabelle/0000-0002-5201-8603	Fond de dotation "Agir pour les maladies chroniques"	Fond de dotation "Agir pour les maladies chroniques"	This study received unrestricted GRANT from Fond de dotation "Agir pour les maladies chroniques". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzt M, 2006, ARCH INTERN MED, V166, P1716, DOI 10.1001/archinte.166.16.1716; Baguet JP, 2012, NAT REV CARDIOL, V9, P679, DOI 10.1038/nrcardio.2012.141; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Chirinos JA, 2014, NEW ENGL J MED, V370, P2265, DOI 10.1056/NEJMoa1306187; Destors M, 2015, SLEEP MED, V16, P652, DOI 10.1016/j.sleep.2014.10.019; Dixon JB, 2012, JAMA-J AM MED ASSOC, V308, P1142, DOI 10.1001/2012.jama.11580; Garrigue S, 2007, CIRCULATION, V115, P1703, DOI 10.1161/CIRCULATIONAHA.106.659706; Gasa M, 2013, J SLEEP RES, V22, P389, DOI 10.1111/jsr.12039; Jackson CL, 2015, ANNU REV PUBL HEALTH, V36, P417, DOI 10.1146/annurev-publhealth-031914-122838; Kendzerska T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001599; Lavie L, 2015, SLEEP MED REV, V20, P27, DOI 10.1016/j.smrv.2014.07.003; Lavie P, 2009, J SLEEP RES, V18, P397, DOI 10.1111/j.1365-2869.2009.00754.x; Mokhlesi B, 2016, EUR RESPIR J, V47, P1162, DOI 10.1183/13993003.01618-2015; Pathak RK, 2014, J AM COLL CARDIOL, V64, P2222, DOI 10.1016/j.jacc.2014.09.028; Pepin JL, 2012, THORAX, V67, P1025, DOI 10.1136/thoraxjnl-2012-202807; Pepin JL, 2010, AM J RESP CRIT CARE, V182, P954, DOI 10.1164/rccm.200912-1803OC; Randerath WJ, 2011, EUR RESPIR J, V37, P1000, DOI 10.1183/09031936.00099710; Rennard SI, 2015, ANN AM THORAC SOC, V12, P303, DOI 10.1513/AnnalsATS.201403-125OC; Sanchez-de-la-Torre M, 2015, J AM COLL CARDIOL, V66, P1023, DOI 10.1016/j.jacc.2015.06.1315; Sourial N, 2010, J CLIN EPIDEMIOL, V63, P638, DOI 10.1016/j.jclinepi.2009.08.008; Steiner S, 2010, CHEST, V137, P516, DOI 10.1378/chest.09-1136; Tonon C, 2007, SLEEP, V30, P305, DOI 10.1093/sleep/30.3.305; TSUCHIYA M, 1992, AM J ORTHOD DENTOFAC, V101, P533, DOI 10.1016/0889-5406(92)70128-W; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Umlauf MG, 2003, SLEEP MED REV, V7, P403, DOI 10.1053/smrv.2002.0273; Wheelock CE, 2013, EUR RESPIR J, V42, P802, DOI 10.1183/09031936.00078812; Wozniak DR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007736.pub2; Ye LC, 2014, EUR RESPIR J, V44, P1600, DOI 10.1183/09031936.00032314	28	109	111	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157318	10.1371/journal.pone.0157318	http://dx.doi.org/10.1371/journal.pone.0157318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314230	gold, Green Submitted, Green Published			2022-12-27	WOS:000378030000018
J	Chinniah, R; Vijayan, M; Thirunavukkarasu, M; Mani, D; Raju, K; Ravi, PM; Sivanadham, R; Kandeepan, C; Mahalakshmi, N; Karuppiah, B				Chinniah, Rathika; Vijayan, Murali; Thirunavukkarasu, Manikandan; Mani, Dhivakar; Raju, Kamaraj; Ravi, Padma Malini; Sivanadham, Ramgopal; Kandeepan, C.; Mahalakshmi, N.; Karuppiah, Balakrishnan			Polymorphic Alu Insertion/Deletion in Different Caste and Tribal Populations from South India	PLOS ONE			English	Article							TAMIL-NADU; AFFINITIES; ELEMENTS; DIVERSITY	Seven human-specific Alu markers were studied in 574 unrelated individuals from 10 endogamous groups and 2 hill tribes of Tamil Nadu and Kerala states. DNA was isolated, amplified by PCR-SSP, and subjected to agarose gel electrophoresis, and genotypes were assigned for various Alu loci. Average heterozygosity among caste populations was in the range of 0.292-0.468. Among tribes, the average heterozygosity was higher for Paliyan (0.3759) than for Kani (0.2915). Frequency differences were prominent in all loci studied except Alu CD4. For Alu CD4, the frequency was 0.0363 in Yadavas, a traditional pastoral and herd maintaining population, and 0.2439 in Narikuravars, a nomadic gypsy population. The overall genetic difference (Gst) of 12 populations (castes and tribes) studied was 3.6%, which corresponds to the Gst values of 3.6% recorded earlier for Western Asian populations. Thus, our study confirms the genetic similarities between West Asian populations and South Indian castes and tribes and supported the large scale coastal migrations from Africa into India through West Asia. However, the average genetic difference (Gst) of Kani and Paliyan tribes with other South Indian tribes studied earlier was 8.3%. The average Gst of combined South and North Indian Tribes (CSNIT) was 9.5%. Neighbor joining tree constructed showed close proximity of Kani and Paliyan tribal groups to the other two South Indian tribes, Toda and Irula of Nilgiri hills studied earlier. Further, the analysis revealed the affinities among populations and confirmed the presence of North and South India specific lineages. Our findings have documented the highly diverse (micro differentiated) nature of South Indian tribes, predominantly due to isolation, than the endogamous population groups of South India. Thus, our study firmly established the genetic relationship of South Indian castes and tribes and supported the proposed large scale ancestral migrations from Africa, particularly into South India through West Asian corridor.	[Chinniah, Rathika; Mani, Dhivakar; Raju, Kamaraj; Ravi, Padma Malini; Sivanadham, Ramgopal; Karuppiah, Balakrishnan] Madurai Kamaraj Univ, Sch Biol Sci, Dept Immunol, Madurai 625021, Tamil Nadu, India; [Vijayan, Murali; Thirunavukkarasu, Manikandan] Bharathidasan Univ, Sch Biotechnol, Dept Biotechnol & Genet Engn, Tiruchirappalli 620024, Tamil Nadu, India; [Kandeepan, C.] APA Coll Arts & Culture, Dept Zool, Palani 624601, Tamil Nadu, India; [Mahalakshmi, N.] Reg Forens Sci Lab, Madurai 625020, Tamil Nadu, India	Madurai Kamaraj University; Bharathidasan University	Karuppiah, B (corresponding author), Madurai Kamaraj Univ, Sch Biol Sci, Dept Immunol, Madurai 625021, Tamil Nadu, India.	immunobala@mkuniversity.org	Sivanadham, Ramgopal/AAE-2160-2019; RAVI, PADMA MALINI/AAZ-9584-2021; Raju, Kamaraj/ABA-3018-2020; KANDEEPAN, CHITHAN/U-2428-2019; Raju, Kamaraj/AAZ-6655-2020	Sivanadham, Ramgopal/0000-0002-3977-8632; Raju, Kamaraj/0000-0002-5724-0780; RAVI, PADMA MALINI/0000-0001-5485-3058; Karuppiah, Balakrishnan/0000-0002-7494-5010				Balakrishnan K, 2012, INT J HUM GENET, V12, P45, DOI 10.1080/09723757.2012.11886162; Balakrishnan K, 1996, HUM BIOL, V68, P523; Balakrishnan V., 1981, BIOL PEOPLE TAMIL NA; Balakrishnan V, 1981, BIOL PEOPLE TAMIL NA, P103; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; BATZER MA, 1990, NUCLEIC ACIDS RES, V18, P6793, DOI 10.1093/nar/18.23.6793; BATZER MA, 1995, J MOL BIOL, V247, P418, DOI 10.1006/jmbi.1994.0150; BATZER MA, 1991, GENOMICS, V9, P481, DOI 10.1016/0888-7543(91)90414-A; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; Bhasin MK., 2001, GENETICS CASTES TRIB; Cann RL, 2001, SCIENCE, V291, P1742, DOI 10.1126/science.1058948; CAVALLISTORZA LL, 1994, HIST GEOGRAPHY HUMAN; Das K, 1996, HUM BIOL, V68, P679; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; HOUCK CM, 1979, J MOL BIOL, V132, P289, DOI 10.1016/0022-2836(79)90261-4; Kanthimathi S, 2008, J GENET, V87, P2; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Majumder PP, 1999, EUR J HUM GENET, V7, P435, DOI 10.1038/sj.ejhg.5200317; Malhotra KC, 1981, BIOL PEOPLE TAMIL NA, P50; Mukherjee N, 2000, J GENET, V79, P41, DOI 10.1007/BF02728944; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Novick GE, 1996, BIOSCIENCE, V46, P32, DOI 10.2307/1312653; Ray DA, 2005, MOL PHYLOGENET EVOL, V35, P117, DOI 10.1016/j.ympev.2004.10.023; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; ROGERS J, 1983, NATURE, V301, P460, DOI 10.1038/301460e0; Rowold DJ, 2000, GENETICA, V108, P57, DOI 10.1023/A:1004099605261; Salem AH, 2003, MOL BIOL EVOL, V20, P1349, DOI 10.1093/molbev/msg150; Shanmugalakshmi S, 2003, TISSUE ANTIGENS, V61, P451, DOI 10.1034/j.1399-0039.2003.00061.x; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; ULLU E, 1982, CELL, V29, P195, DOI 10.1016/0092-8674(82)90103-9; Veerraju P., 2001, International Journal of Human Genetics, V1, P129; Vishwanathan H, 2004, ANN HUM GENET, V68, P128, DOI 10.1046/j.1529-8817.2003.00083.x; Vishwnathan H, 2003, HUM BIOL, V75, P873, DOI 10.1353/hub.2004.0013; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; Watkins WS, 2001, AM J HUM GENET, V68, P738, DOI 10.1086/318793; Welsh K, 1999, Rev Immunogenet, V1, P157; Xing J, 2005, MOL PHYLOGENET EVOL, V37, P872, DOI 10.1016/j.ympev.2005.04.015	37	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157468	10.1371/journal.pone.0157468	http://dx.doi.org/10.1371/journal.pone.0157468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315142	gold, Green Published, Green Submitted			2022-12-27	WOS:000378030000027
J	Pinaya, WHD; Lobon-Cervia, FJ; Pita, P; de Souza, RB; Freire, J; Isaac, VJ				Diaz Pinaya, Walter Hugo; Lobon-Cervia, Francisco Javier; Pita, Pablo; de Souza, Ronald Buss; Freire, Juan; Isaac, Victoria Judith			Multispecies Fisheries in the Lower Amazon River and Its Relationship with the Regional and Global Climate Variability	PLOS ONE			English	Article							FISH; FLOODPLAIN; REGRESSION; MODEL; WATER; REPRODUCTION; UNIVARIATE; DYNAMICS; HISTORY; CATCHES	This paper aims to describe the spatial-temporal variability in catch of the main fishery resources of the Amazon River and floodplain lakes of the Lower Amazon, as well as relating the Catch per Unit of Effort with anomalies of some of the Amazon River, atmosphere and Atlantic Ocean system variables, determining the influence of the environment on the Amazonian fishery resources. Finfish landings data from the towns and villages of the Lower Amazon for the fisheries of three sites (Obidos, Santarem and Monte Alegre), were obtained for the period between January 1993 and December 2004. Analysis of variance, detrended correspondence analysis, redundancy analysis and multiple regression techniques were used for the statistical analysis of the distinct time series. Fisheries production in the Lower Amazon presents differences between the Amazon River and the floodplain lakes. Production in the Amazon River is approximately half of the one of the floodplain lakes. This variability occurs both along the Lower Amazon River region (longitudinal gradient) and laterally (latitudinal gradient) for every fishing ground studied here. The distinct environmental variables alone or in association act differently on the fishery stocks and the success of catches in each fishery group studied here. Important variables are the flooding events; the soil the sea surface temperatures; the humidity; the wind and the occurence of El Nino-Southern Oscillation events. Fishery productivity presents a large difference in quantity and distribution patterns between the river and floodplain lakes. This variability occurs in the region of the Lower Amazon as well as laterally for each fishery group studied, being dependent on the ecological characteristics and life strategies of each fish group considered here.	[Diaz Pinaya, Walter Hugo; Isaac, Victoria Judith] Fed Univ Para, Lab Fisheries Biol & Management Aquat Resources, BR-66059 Belem, Para, Brazil; [Diaz Pinaya, Walter Hugo; de Souza, Ronald Buss] Southern Reg Ctr Space Res, Natl Inst Space Res, Lab Meteorol & Satellite Oceanog, Santa Maria, RS, Brazil; [Lobon-Cervia, Francisco Javier] Natl Museum Nat Sci, Dept Evolutionary Ecol, Madrid, Spain; [Pita, Pablo] Univ Santiago de Compostela, Fac Econ & Business Adm, Dept Appl Econ, Santiago De Compostela, Galicia, Spain; [Freire, Juan] Univ A Coruna, Grp Recursos Marinos & Pesquerias, La Coruna, Galicia, Spain	Universidade Federal do Para; Instituto Nacional de Pesquisas Espaciais (INPE); Universidade de Santiago de Compostela; Universidade da Coruna	Pinaya, WHD (corresponding author), Fed Univ Para, Lab Fisheries Biol & Management Aquat Resources, BR-66059 Belem, Para, Brazil.; Pinaya, WHD (corresponding author), Southern Reg Ctr Space Res, Natl Inst Space Res, Lab Meteorol & Satellite Oceanog, Santa Maria, RS, Brazil.	wpinaya@ig.com.br	de Souza, Ronald Buss/AAP-7586-2021; PITA, PABLO/I-1694-2015; Pita, Pablo/AAA-5228-2019; Souza, Ronald Buss de/R-5867-2016; Isaac, Victoria J/I-2220-2013	de Souza, Ronald Buss/0000-0003-3346-3370; PITA, PABLO/0000-0001-9273-1481; Pita, Pablo/0000-0001-9273-1481; Souza, Ronald Buss de/0000-0003-3346-3370; Freire, Juan/0000-0003-4323-4918	Universidade Federal do Para; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior of Brazil; Brazilian National Council for Scientific and Technological Development [308646/2013-4]	Universidade Federal do Para; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for translation and publishing was provided by the Pro-Reitoria de Pesquisa e Pos-Graduacao (www.propesp.ufpa.br) and Fundacao de Amparo e Desenvolvimento da Pesquisa (www.portalfadesp.org.br) from Universidade Federal do Para (www.portal.ufpa.br). WHDP was supported by Brazilian Ph.D. Scholarships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior of Brazil (www.capes.gov.br). RBS was supported by Scholarship in Research Productivity PQ CNPq 308646/2013-4 from the Brazilian National Council for Scientific and Technological Development (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ACEITUNO P, 1988, MON WEATHER REV, V116, P505, DOI 10.1175/1520-0493(1988)116<0505:OTFOTS>2.0.CO;2; Alonso JC, 2003, P 2 LARG RIV S 2003; Alonso JC, 2005, MANEJO PESCA GRANDES, P19; [Anonymous], 1998, FRUTOS TAMBAQUI ECOL; Araujo-Lima CARM, 1998, J FISH BIOL, V53, P297, DOI 10.1006/jfbi.1998.0815; Araujo-Lima CARM, 1990, THESIS; ARAUJOLIMA CARM, 1986, SCIENCE, V234, P1256, DOI 10.1126/science.234.4781.1256; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bailly D, 2008, RIVER RES APPL, V24, P1218, DOI 10.1002/rra.1147; Baran E, 2001, 2 AS WETL S PEN MAL, p[920, 1116]; Barthem R., 1997, CATFISH CONNECTION E; Barthem RB, 2004, PESCA OS RECURSOS PE, P11; Batista VS., 2007, Braz. J. Biol., V67, P651, DOI 10.1590/S1519-69842007000400009; Batista VS, 2012, PEIXES PESCA SOLIMOE; BAYLEY PB, 1988, ENVIRON BIOL FISH, V21, P127, DOI 10.1007/BF00004848; Bittencourt Maria Mercedes, 2007, Acta Amaz., V37, P303, DOI 10.1590/S0044-59672007000200019; BOHLKE J E, 1978, Acta Amazonica, V8, P657; Castello L, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150299; Castello L, 2011, FISH RES, V110, P356, DOI 10.1016/j.fishres.2011.05.002; CAUSTON D. R, 1988, INTRO VEGETATION ANA; Chiang JCH, 2013, J CLIMATE, V26, P8628, DOI 10.1175/JCLI-D-12-00487.1; Chuenpagdee R, 2008, RECONCILING FISHERIE, P575; Claro-Jr Luiz, 2004, Acta Amaz., V34, P133, DOI 10.1590/S0044-59672004000100018; Coe MT, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000740; Craig JF, 2004, FISH RES, V66, P271, DOI 10.1016/S0165-7836(03)00196-6; Cunico Almir Manoel, 2002, Acta Scientiarum Universidade Estadual de Maringa, V24, P383; da Rocha F.C., 2009, Acta Limnologica Brasiliensia, V21, P123; de Merona B, 1993, AQUAT LIVING RESOUR, V6, P97, DOI 10.1051/alr:1993010; de Ribeiro MCL., 1990, REGUL RIVER, V5, P195, DOI [10.1002/rrr.3450050302, DOI 10.1002/RRR.3450050302]; Ebisuzaki W, 1998, P 23 CLIM DIAGN PRED, P119; Espinoza JC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047862; Fabre NN, 1997, P C BRAS LIMN UFSCAR, P154; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Fisch Gilberto, 1998, Acta Amazonica, V28, P101; Freitas C.E.C., 2006, CIENCIA CULTURA, V58, P30; Freitas CEC, 2013, HYDROBIOLOGIA, V705, P159, DOI 10.1007/s10750-012-1394-4; Gafny S, 1999, AQUAT BOT, V62, P249, DOI 10.1016/S0304-3770(98)00097-7; Gilmore R.M., 1986, SUMA ETNOLOGICA BRAS, P189; Goulding M., 1980, P1; Goulding M., 1988, RIO NEGRO RICH LIFE; Isaac VJ, 2008, FISHERIES MANAG ECOL, V15, P179, DOI 10.1111/j.1365-2400.2008.00599.x; Isaac V. J., 1996, Acta Amazonica, V26, P185; Isaac VJ, 2015, PEIXES PESCA AMAZONA, P201; Isaac VJ, 1998, CROSSING BOUNDARIES; Janac M, 2010, ECOL FRESHW FISH, V19, P644, DOI 10.1111/j.1600-0633.2010.00449.x; Jongman R. H. G., 1995, DATA ANAL COMMUNITY; Junk W.J., 1997, CENTRAL AMAZON FLOOD, P3, DOI DOI 10.1007/978-3-662-03416-3_1; Junk WJ, 2004, P 2 INT S MAN LARG R, V2, P117; Junk WJ, 1984, AMAZON LIMNOLOGY LAN, P215; Junk WJ, 1989, CANADIAN SPECIAL PUB, V106, P110, DOI DOI 10.1016/J.MATCHEMPHYS.2012.10.032; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Knoppel HA, 1970, AMAZONIANA, V2; Koutroumanidis T, 2006, ENVIRON MODELL SOFTW, V21, P1711, DOI 10.1016/j.envsoft.2005.09.001; KRAMER DL, 1978, CAN J ZOOL, V56, P717, DOI 10.1139/z78-101; Lennon JJ, 2000, ECOGRAPHY, V23, P101, DOI 10.1034/j.1600-0587.2000.230111.x; Lorenzen K, 2006, CAN J FISH AQUAT SCI, V63, P1334, DOI 10.1139/F06-038; Loubens G., 1997, ICHTHYOL EXPLOR FRES, V8, P1; Lowe-McConnell R. H., 1987, ECOLOGICAL STUDIES T; Luz-Agostinho KDG, 2008, HYDROBIOLOGIA, V607, P187, DOI 10.1007/s10750-008-9390-4; Marchetti MP, 2001, ECOL APPL, V11, P530, DOI 10.2307/3060907; Marengo J, 1981, THESIS; MARENGO JA, 1992, INT J CLIMATOL, V12, P853, DOI 10.1002/joc.3370120808; Marengo JA, 2004, THEOR APPL CLIMATOL, V78, P79, DOI 10.1007/S00704-004-0045-8; MARQUES J, 1980, Acta Amazonica, V10, P357; Martelo J, 2008, FRESHWATER BIOL, V53, P2455, DOI 10.1111/j.1365-2427.2008.02065.x; MOURA AD, 1981, J ATMOS SCI, V38, P2653, DOI 10.1175/1520-0469(1981)038<2653:OTDODI>2.0.CO;2; Murchie KJ, 2008, RIVER RES APPL, V24, P197, DOI 10.1002/rra.1058; Nunes de Mello Jose Alberto, 2001, Acta Amazonica, V31, P331; Parsons D.G., 2000, Journal of Northwest Atlantic Fishery Science, V27, P11, DOI 10.2960/J.v27.a2; Peterman RM, 2003, CAN J FISH AQUAT SCI, V60, P809, DOI 10.1139/F03-069; Petrere M, 2010, BRAZ J BIOL, V70, P483, DOI 10.1590/S1519-69842010005000010; Petrere Jr M, 1992, PESCA AMAZONIA PARA, P72; Pinaya WHD, 2013, THESIS; Raffles H, 2003, LAT AM RES REV, V38, P165, DOI 10.1353/lar.2003.0041; RICHEY JE, 1989, SCIENCE, V246, P101, DOI 10.1126/science.246.4926.101; ROUBACH R, 1994, J APPL ICHTHYOL, V10, P134, DOI 10.1111/j.1439-0426.1994.tb00152.x; Ruffino M. L., 1998, Ecotropica, V4, P99; Ruffino M. L., 1995, NAGA ICLARM Q, V18, P41; RUFFINO ML, 1999, ACTA AMAZONICA, V29, P463, DOI DOI 10.1590/1809-43921999293476; Saint-Paul U, 2000, ENVIRON BIOL FISH, V57, P235, DOI 10.1023/A:1007699130333; Saint-Paul U, 1994, 0339366A BMFT; SALATI E, 1979, WATER RESOUR RES, V15, P1250, DOI 10.1029/WR015i005p01250; Sanchez-Botero Jorge Ivan, 2001, Acta Amazonica, V31, P437; Silva CO., 2004, PESCA RECURSOS PESQU, P185; Souza E.B., 2000, ACTA AMAZONICA, V30, P305, DOI DOI 10.1590/1809-43922000302318; Souza E. B., 2005, THEOR APPL CLIMATOL, V81, P177, DOI DOI 10.1007/S00704-004-0081-4; Souza JRS, 2004, ISSUES LOCAL GLOBAL, p[3756, 37]; Stergiou KI, 1997, FISH RES, V29, P55, DOI 10.1016/S0165-7836(96)00482-1; STERGIOU KI, 1989, J CONSEIL, V46, P16; Stergiou KI, 1996, FISH RES, V25, P105, DOI 10.1016/0165-7836(95)00389-4; Suzuki HI, 2009, BRAZ J BIOL, V69, P649, DOI 10.1590/S1519-69842009000300019; Tan XC, 2010, ENVIRON BIOL FISH, V88, P217, DOI 10.1007/s10641-010-9632-y; ter Braak C.J.F., 1995, DATA ANAL COMMUNITY, P69, DOI DOI 10.1017/CBO9780511525575.007; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Vallejos RO, 2013, ENVIRON MODELL SOFTW, V48, P202, DOI 10.1016/j.envsoft.2013.07.004; Vari Richard P., 1998, P1; Vieira EF, 1999, ACTA AMAZONICA, V29, P1; Wagner HH, 2013, ECOLOGY, V94, P2381, DOI 10.1890/12-1899.1; WALDHOFF D, 1996, ECOTROPICA, V2, P143; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; Welcomme, 2008, INLAND FISHERIES ECO; Welcomme RL, 2006, RIVER RES APPL, V22, P377, DOI 10.1002/rra.914; Welcomme RL, 1999, FISHERIES MANAG ECOL, V6, P1, DOI 10.1046/j.1365-2400.1999.00137.x; Welcomme RL, 1985, 262 FAO FISH RES ENV; Welcomme RL, 2010, PHILOS T R SOC B, V365, P2881, DOI 10.1098/rstb.2010.0168; Welsch R. E, 2004, REGRESSION DIAGNOSTI; WINEMILLER KO, 1989, OECOLOGIA, V81, P225, DOI 10.1007/BF00379810; Wootton R.J., 1984, P1; Yoon JH, 2010, CLIM DYNAM, V34, P249, DOI 10.1007/s00382-009-0551-6; Zeug SC, 2008, RIVER RES APPL, V24, P90, DOI 10.1002/rra.1061	110	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157050	10.1371/journal.pone.0157050	http://dx.doi.org/10.1371/journal.pone.0157050			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314951	gold, Green Published, Green Submitted			2022-12-27	WOS:000378030000010
J	Chai, BL; Tsoi, TV; Iwai, S; Liu, C; Fish, JA; Gu, C; Johnson, TA; Zylstra, G; Teppen, BJ; Li, H; Hashsham, SA; Boyd, SA; Cole, JR; Tiedje, JM				Chai, Benli; Tsoi, Tamara V.; Iwai, Shoko; Liu, Cun; Fish, Jordan A.; Gu, Cheng; Johnson, Timothy A.; Zylstra, Gerben; Teppen, Brian J.; Li, Hui; Hashsham, Syed A.; Boyd, Stephen A.; Cole, James R.; Tiedje, James M.			Sphingomonas wittichii Strain RW1 Genome-Wide Gene Expression Shifts in Response to Dioxins and Clay	PLOS ONE			English	Article							DIBENZO-P-DIOXIN; DEPENDENT TRANSPORT; DIOXYGENASE; SYSTEM; BIODEGRADATION; DEGRADATION; METABOLISM; MECHANISMS; MEMBRANE; SEQUENCE	Sphingomonas wittichii strain RW1 (RW1) is one of the few strains that can grow on dibenzo-p-dioxin (DD). We conducted a transcriptomic study of RW1 using RNA-Seq to outline transcriptional responses to DD, dibenzofuran (DF), and the smectite clay mineral saponite with succinate as carbon source. The ability to grow on DD is rare compared to growth on the chemically similar DF even though the same initial dioxygenase may be involved in oxidation of both substrates. Therefore, we hypothesized the reason for this lies beyond catabolic pathways and may concern genes involved in processes for cell-substrate interactions such as substrate recognition, transport, and detoxification. Compared to succinate (SUC) as control carbon source, DF caused over 240 protein-coding genes to be differentially expressed, whereas more than 300 were differentially expressed with DD. Stress response genes were up-regulated in response to both DD and DF. This effect was stronger with DD than DF, suggesting a higher toxicity of DD compared to DF. Both DD and DF caused changes in expression of genes involved in active cross-membrane transport such as TonB-dependent receptor proteins, but the patterns of change differed between the two substrates. Multiple transcription factor genes also displayed expression patterns distinct to DD and DF growth. DD and DF induced the catechol ortho-and the salicylate/gentisate pathways, respectively. Both DD and DF induced the shared down-stream aliphatic intermediate compound pathway. Clay caused category-wide down-regulation of genes for cell motility and chemotaxis, particularly those involved in the synthesis, assembly and functioning of flagella. This is an environmentally important finding because clay is a major component of soil microbes' microenvironment influencing local chemistry and may serve as a geosorbent for toxic pollutants. Similar to clay, DD and DF also affected expression of genes involved in motility and chemotaxis.	[Chai, Benli; Tsoi, Tamara V.; Iwai, Shoko; Fish, Jordan A.; Johnson, Timothy A.; Cole, James R.; Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Liu, Cun; Johnson, Timothy A.; Teppen, Brian J.; Li, Hui; Boyd, Stephen A.] Michigan State Univ, Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Hashsham, Syed A.] Michigan State Univ, Civil & Environm Engn, E Lansing, MI 48824 USA; [Gu, Cheng] Nanjing Univ, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China; [Zylstra, Gerben] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA; [Iwai, Shoko] Second Genome Inc, San Francisco, CA 94080 USA; [Johnson, Timothy A.] USDA ARS, Natl Anim Dis Ctr, Food Safety & Enter Pathogens Res Unit, POB 70, Ames, IA 50010 USA	Michigan State University; Michigan State University; Michigan State University; Nanjing University; Rutgers State University New Brunswick; United States Department of Agriculture (USDA)	Tiedje, JM (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.	tiedjej@msu.edu	Boyd, Stephen A/G-5819-2010; Li, Hui/G-4055-2010; Gu, Cheng/I-2084-2012	Li, Hui/0000-0003-3298-5265; Hashsham, Syed/0000-0003-2398-7453; Chai, Benli/0000-0003-4140-4530; Zylstra, Gerben/0000-0003-0419-1353	National Institute of Environmental Health Sciences grant [5P42 ES004911-18/19]	National Institute of Environmental Health Sciences grant	This study was supported by the National Institute of Environmental Health Sciences grant 5P42 ES004911-18/19.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Armengaud J, 1999, J BACTERIOL, V181, P3452, DOI 10.1128/JB.181.11.3452-3461.1999; Armengaud J, 1998, J BACTERIOL, V180, P3954, DOI 10.1128/JB.180.15.3954-3966.1998; Armengaud J, 1998, EUR J BIOCHEM, V253, P437, DOI 10.1046/j.1432-1327.1998.2530437.x; Armengaud J, 2000, J BACTERIOL, V182, P2238, DOI 10.1128/JB.182.8.2238-2244.2000; Arroyo LJ, 2005, CLAY CLAY MINER, V53, P511, DOI 10.1346/CCMN.2005.0530507; BERTAZZI PA, 1993, EPIDEMIOLOGY, V4, P398, DOI 10.1097/00001648-199309000-00004; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; BUNZ PV, 1993, J BACTERIOL, V175, P6467; Chang YS, 2008, J MOL MICROB BIOTECH, V15, P152, DOI 10.1159/000121327; Codoy P, 2001, J BACTERIOL, V183, P5285, DOI [10.1128/JB.183.18.5285-5292.2001, DOI 10.1128/JB.183.18.5285-5292.2001]; Colquhoun DR, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/408690; Cornelissen G, 2005, ENVIRON SCI TECHNOL, V39, P6881, DOI 10.1021/es050191b; Coronado E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00300; Field JA, 2008, CHEMOSPHERE, V71, P1005, DOI 10.1016/j.chemosphere.2007.10.039; Haines-Menges B, 2014, INFECT IMMUN, V82, P3667, DOI 10.1128/IAI.01854-14; HAPPE B, 1993, J BACTERIOL, V175, P7313, DOI 10.1128/JB.175.22.7313-7320.1993; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hartmann EM, 2014, ENVIRON MICROBIOL, V16, P162, DOI 10.1111/1462-2920.12264; Hiraishi A., 2003, MICROBES ENVIRON, V18, P105, DOI [10.1264/jsme2.18.105, DOI 10.1264/JSME2.18.105]; Hong HB, 2004, BIODEGRADATION, V15, P303, DOI 10.1023/B:BIOD.0000042185.04905.0d; Johnson DR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-250; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAUFFENBURGER DA, 1982, CELL BIOPHYS, V4, P177, DOI 10.1007/BF02918312; Liu C, 2009, ENVIRON SCI TECHNOL, V43, P2777, DOI 10.1021/es802381z; Merino S, 2006, FEMS MICROBIOL LETT, V263, P127, DOI 10.1111/j.1574-6968.2006.00403.x; Miller TR, 2010, J BACTERIOL, V192, P6101, DOI 10.1128/JB.01030-10; Min J, 2003, ENVIRON TOXICOL CHEM, V22, P2238, DOI 10.1897/02-465; Min J, 2003, ENVIRON TOXICOL CHEM, V22, P233, DOI 10.1002/etc.5620220201; Moreau PL, 2014, FEMS MICROBIOL LETT, V357, P151, DOI 10.1111/1574-6968.12534; Moreno-Forero SK, 2015, ISME J, V9, P150, DOI 10.1038/ismej.2014.101; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Palonen E, 2013, APPL ENVIRON MICROB, V79, P5970, DOI 10.1128/AEM.01891-13; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; R Core Team, 2012, R LANG ENV STAT COMP; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Seah SYK, 2007, J BACTERIOL, V189, P4038, DOI 10.1128/JB.01950-06; Skopelitou K, 2012, FUNCT INTEGR GENOMIC, V12, P157, DOI 10.1007/s10142-011-0248-x; Spohn G, 2001, HELICOBACTER PYLORI; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Wilkes H, 1996, APPL ENVIRON MICROB, V62, P367, DOI 10.1128/AEM.62.2.367-371.1996; WITTICH RM, 1992, APPL ENVIRON MICROB, V58, P1005, DOI 10.1128/AEM.58.3.1005-1010.1992	46	17	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157008	10.1371/journal.pone.0157008	http://dx.doi.org/10.1371/journal.pone.0157008			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309357	Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800027
J	Houdayer, E; Cursi, M; Nuara, A; Zanini, S; Gatti, R; Comi, G; Leocani, L				Houdayer, Elise; Cursi, Marco; Nuara, Arturo; Zanini, Sonia; Gatti, Roberto; Comi, Giancarlo; Leocani, Letizia			Cortical Motor Circuits after Piano Training in Adulthood: Neurophysiologic Evidence	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; VENTRAL PREMOTOR; INTERHEMISPHERIC INHIBITION; NEURAL REORGANIZATION; CORTEX; BRAIN; PRECISION; STROKE; AREAS; MODULATION	The neuronal mechanisms involved in brain plasticity after skilled motor learning are not completely understood. We aimed to study the short-term effects of keyboard training in music-naive subjects on the motor/premotor cortex activity and interhemispheric interactions, using electroencephalography and transcranial magnetic stimulation (TMS). Twelve subjects (experimental group) underwent, before and after a two week-piano training: (1) hand-motor function tests: Jamar, grip and nine-hole peg tests; (2) electroencephalography, evaluating the mu rhythm task-related desynchronization (TRD) during keyboard performance; and (3) TMS, targeting bilateral abductor pollicis brevis (APB) and abductor digiti minimi (ADM), to obtain duration and area of ipsilateral silent period (ISP) during simultaneous tonic contraction of APB and ADM. Data were compared with 13 controls who underwent twice these measurements, in a two-week interval, without undergoing piano training. Every subject in the experimental group improved keyboard performance and left-hand nine-hole peg test scores. Pre-training, ISP durations were asymmetrical, left being longer than right. Post-training, right ISPAPB increased, leading to symmetrical ISPAPB. Mu TRD during motor performance became more focal and had a lesser amplitude than in pre-training, due to decreased activity over ventral premotor cortices. No such changes were evidenced in controls. We demonstrated that a 10-day piano-training was associated with balanced interhemispheric interactions both at rest and during motor activation. Piano training, in a short timeframe, may reshape local and inter-hemispheric motor cortical circuits.	[Houdayer, Elise; Cursi, Marco; Nuara, Arturo; Zanini, Sonia; Comi, Giancarlo; Leocani, Letizia] Ist Sci San Raffaele, Expt Neurophysiol Unit, Inst Expt Neurol INSPE, I-20132 Milan, Italy; [Zanini, Sonia; Gatti, Roberto] Ist Sci San Raffaele, Lab Movement Anal, I-20132 Milan, Italy; [Nuara, Arturo; Comi, Giancarlo; Leocani, Letizia] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Houdayer, E (corresponding author), Ist Sci San Raffaele, Expt Neurophysiol Unit, Inst Expt Neurol INSPE, I-20132 Milan, Italy.	houdayer.elise@hsr.it	Leocani, Letizia/ABH-4703-2020; Gatti, Roberto/J-6452-2018; Houdayer, Elise/K-1494-2016	Gatti, Roberto/0000-0002-4669-1287; CURSI, Marco/0000-0002-7928-0417; Leocani, Letizia/0000-0001-9326-6753; Houdayer, Elise/0000-0003-3153-0365	Joint Italian-Israeli laboratory San Raffaele-Weizmann (Italian Ministry of Foreign Affairs); Institute of Experimental Neurology (INSPE, San Raffaele); INSPE; San Raffaele International Postdoctoral Program	Joint Italian-Israeli laboratory San Raffaele-Weizmann (Italian Ministry of Foreign Affairs); Institute of Experimental Neurology (INSPE, San Raffaele); INSPE; San Raffaele International Postdoctoral Program	This study was supported by the Joint Italian-Israeli laboratory San Raffaele-Weizmann (Italian Ministry of Foreign Affairs) and the Institute of Experimental Neurology (INSPE, San Raffaele). Elise Houdayer was supported by the INSPE and by the San Raffaele International Postdoctoral Program.	Alemanno F, 2012, BRAIN RES, V1484, P39, DOI 10.1016/j.brainres.2012.09.030; Altenmuller E, 2009, ANN NY ACAD SCI, V1169, P395, DOI 10.1111/j.1749-6632.2009.04580.x; Andres FG, 1999, BRAIN, V122, P855, DOI 10.1093/brain/122.5.855; Arya KN, 2011, J BODYW MOV THER, V15, P528, DOI 10.1016/j.jbmt.2011.01.023; Avanzino L, 2007, J PHYSIOL-LONDON, V583, P99, DOI 10.1113/jphysiol.2007.134510; Baumer T, 2009, CLIN NEUROPHYSIOL, V120, P1724, DOI 10.1016/j.clinph.2009.07.035; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Chen JL, 2012, NEUROIMAGE, V59, P1200, DOI 10.1016/j.neuroimage.2011.08.012; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; Coppi E, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00209; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Davare M, 2008, J PHYSIOL-LONDON, V586, P2735, DOI 10.1113/jphysiol.2008.152603; Davare M, 2009, CORTEX, V45, P1050, DOI 10.1016/j.cortex.2009.02.011; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Doyon J, 1997, BRAIN COGNITION, V34, P218, DOI 10.1006/brcg.1997.0899; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Elbert T, 1995, SCI NEW YORK THEN WA, P305; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Filippi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010198; Gallea C, 2005, NEUROREPORT, V16, P1271, DOI 10.1097/01.wnr.0000176514.17561.94; Giovannelli F, 2009, J PHYSIOL-LONDON, V587, P5393, DOI 10.1113/jphysiol.2009.175885; Grice KO, 2003, AM J OCCUP THER, V57, P570; Gryga M, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00037; GUIEU JD, 1999, HANDB EL CL, V6, P279; Hallett M, 1996, ACQUISITION OF MOTOR BEHAVIOR IN VERTEBRATES, P289; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; Hosp JA, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/871296; Houdayer E, 2012, EUR J NEUROSCI, V35, P478, DOI 10.1111/j.1460-9568.2011.07960.x; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Iriarte J, 2003, J CLIN NEUROPHYSIOL, V20, P249, DOI 10.1097/00004691-200307000-00004; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; Kuhtz-Buschbeck JP, 2001, EUR J NEUROSCI, V14, P382, DOI 10.1046/j.0953-816x.2001.01639.x; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nieuwboer A, 2009, PARKINSONISM RELAT D, V15, pS53, DOI 10.1016/S1353-8020(09)70781-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; PFURTSCHELLER G, 1981, ELECTROEN CLIN NEURO, V51, P253, DOI 10.1016/0013-4694(81)90139-5; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rojo N, 2011, BRAIN INJURY, V25, P787, DOI 10.3109/02699052.2011.576305; Sadato N, 1997, J NEUROSCI, V17, P9667; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Schneider S, 2007, J NEUROL, V254, P1339, DOI 10.1007/s00415-006-0523-2; Schneider S, 2010, MUSIC PERCEPT, V27, P271, DOI 10.1525/MP.2010.27.4.271; Spagnolo F, 2013, BRAIN STIMUL, V6, P892, DOI 10.1016/j.brs.2013.05.004; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Trompetto C, 2004, EXP BRAIN RES, V158, P133, DOI 10.1007/s00221-004-1881-6; Tyc F, 2005, EUR J NEUROSCI, V21, P259, DOI 10.1111/j.1460-9568.2004.03835.x; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x; Zhuang P, 1997, ELECTROEN CLIN NEURO, V102, P374, DOI 10.1016/S0013-4694(96)96030-7	64	9	9	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157526	10.1371/journal.pone.0157526	http://dx.doi.org/10.1371/journal.pone.0157526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309353	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800092
J	Ayana, BA; Negash, S; Yusuf, L; Tigeneh, W; Haile, D				Ayana, Birhanu Abera; Negash, Shiferaw; Yusuf, Lukman; Tigeneh, Wendemagegnhu; Haile, Demewoz			Reliability and Validity of Amharic Version of EORTC QLQ-C 30 Questionnaire among Gynecological Cancer Patients in Ethiopia	PLOS ONE			English	Article							QUALITY-OF-LIFE; EUROPEAN ORGANIZATION; VALIDATION; QLQ-C30; TRANSLATION; TURKISH	Background Cancer is a growing public health problem worldwide. The focus of cancer treatment, in addition to curation, is improving the quality of life (QOL). This study aimed to assess the reliability and validity of Amharic version of European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30) among gynecological cancer patients in Ethiopia. Methods A facility-based cross-sectional study was conducted using the Amharic version of EORTC QLQ-C30 on 153 gynecological cancer patients in Tikur Anbassa Specialized Hospital (TASH), Addis Ababa, Ethiopia. Descriptive statistics, correlation analysis and multivariable linear regression were employed in statistical analysis. Results The Amharic version of EORTC QLQ-C30 had a Cronbach's a value of 0.81. The internal consistency for each domain of EORTC QLQ-C30 was also acceptable (Cronbach's a >0.7) except for cognitive function domain (Cronbach's alpha = 0.29). Stepwise multivariable linear regression analysis showed that emotional functioning (p<0.001), fatigue (p<0.001) and social functioning (p = 0.004) were the determinative scales of EORTC QLQ-C30 on global health status (GHS). The clinical validity test (Known group validity) showed that there were significant differences in score for twelve out of 15 domains, between surgery and radiation scheduled patients. All items of emotional function, role function, fatigue, and GHS meet the discriminate validity criterion. Conclusion The Amharic version of EORTC QLQ-C30 found to be reliable and had an acceptable validity to assess the QOL for gynecological cancer patients. We recommend further work on the validity and responsiveness of the EORTC QLQ-C30 with stronger design.	[Ayana, Birhanu Abera] Univ Gondar, Dept Gynecol & Obstet, Gondar, Ethiopia; [Negash, Shiferaw; Yusuf, Lukman] Univ Addis Ababa, Dept Gynecol & Obstet, Addis Ababa, Ethiopia; [Tigeneh, Wendemagegnhu] Univ Addis Ababa, Dept Clin Oncol, Addis Ababa, Ethiopia; [Haile, Demewoz] Bahir Dar Univ, Sch Publ Hlth, Bahir Dar, Ethiopia	University of Gondar; Addis Ababa University; Addis Ababa University; Bahir Dar University	Haile, D (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Bahir Dar, Ethiopia.	demewozhaile@yahoo.com		Haile, Demewoz/0000-0003-0047-4276	school of Medicine, Addis Ababa University, Ethiopia; Addis Ababa University	school of Medicine, Addis Ababa University, Ethiopia; Addis Ababa University	This study was funded by school of Medicine, Addis Ababa University, Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Addis Ababa University for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also thank the study subjects to be participated in this study. We forward our greatest gratitude to EORTC who allowed us to use the questionnaire. Moreover Dr. Dereje H who gave us his advice and comments throughout of the study also deserve our heartfelt thanks.	[Anonymous], 2009, ECONOMIST; Cramer DW, 2012, HEMATOL ONCOL CLIN N, V26, P1, DOI 10.1016/j.hoc.2011.10.009; Davies N, 2009, STRUCTURED REV PATIE; Demirci S, 2011, ASIAN PAC J CANCER P, V12, P1283; Fayers P, 1998, EORTC QLQ C30 REFERE; Fayers P, 2001, EORTC QLQ C30 SCORIN; Goker A, 2011, ASIAN PAC J CANCER P, V12, P3121; Hoopman R, 2006, EUR J CANCER, V42, P1839, DOI 10.1016/j.ejca.2005.08.047; International Agency for Research on Cancer, 2008, GLOBO CAN 2008 FAST; Iyoke CA, 2013, WORLD J OBSTET GYNEC, V2, P1, DOI [10.5317/wjog.v2.i1.1, DOI 10.5317/wjog.v2.i1.1]; Kontodimopoulos N, 2012, SCI WORLD J, DOI 10.1100/2012/842867; Luo N, 2005, QUAL LIFE RES, V14, P1181, DOI 10.1007/s11136-004-4782-z; Masmoudi A, 2009, East Mediterr Health J, V15, P362; Michels Fernanda Alessandra Silva, 2013, Rev. bras. epidemiol., V16, P352, DOI 10.1590/S1415-790X2013000200011; Nejjari Chakib, 2014, BMC Res Notes, V7, P228, DOI 10.1186/1756-0500-7-228; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Scott NW FP, 2008, BEHALF EORTC QUALITY; Sharp LK, 1999, QUAL LIFE RES, V8, P461, DOI 10.1023/A:1008940015696; Shuleta-Qehaja S, 2015, PATIENT PREFER ADHER, V9, P459, DOI 10.2147/PPA.S78334; Silpakit C, 2006, QUAL LIFE RES, V15, P167, DOI 10.1007/s11136-005-0449-7; Tabano Maggi, 2002, Semin Oncol Nurs, V18, P223, DOI 10.1053/sonu.2002.34084; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Wan C, 2008, ANN ONCOL, V19, P2053, DOI 10.1093/annonc/mdn417; Wendemagegnhu T, 2013, PATTERNS CANC UNPUB; Wenzel L, 2003, INT J GYNECOL OBSTET, V83, P211, DOI 10.1016/S0020-7292(03)90123-8	25	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157359	10.1371/journal.pone.0157359	http://dx.doi.org/10.1371/journal.pone.0157359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5LO	27304066	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800053
J	Evans, KL; Millsteed, J; Richmond, JE; Falkmer, M; Falkmer, T; Girdler, SJ				Evans, Kiah L.; Millsteed, Jeannine; Richmond, Janet E.; Falkmer, Marita; Falkmer, Torbjorn; Girdler, Sonya J.			Working Sandwich Generation Women Utilize Strategies within and between Roles to Achieve Role Balance	PLOS ONE			English	Article							LIFE BALANCE; OCCUPATIONAL BALANCE; FAMILY CONFLICT; MODEL; CAREGIVERS; SUPPORT; ARRANGEMENTS; METAANALYSIS; PREDICTORS; THERAPY	Increasingly, women simultaneously balance the roles of mother, parental carer and worker. However, individual role balance strategies among these working 'sandwich' generation women have not been thoroughly explored. Eighteen women combining these three roles were interviewed about their individual role balance strategies. Findings were identified through the framework analysis technique, underpinned by the Model of Juggling Occupations. Achieving and maintaining role balance was explained as a complex process accomplished through a range of strategies. Findings revealed the women used six within-role balance strategies: living with integrity, being the best you can, doing what you love, loving what you do, remembering why and searching for signs of success. The women also described six between-role balance strategies: maintaining health and wellbeing, repressing perfectionism, managing time and energy, releasing responsibility, nurturing social connection and reciprocating. These findings provide a basis for health care providers to understand and potentially support working 'sandwich' generation women.	[Evans, Kiah L.; Millsteed, Jeannine; Richmond, Janet E.; Girdler, Sonya J.] Edith Cowan Univ, Sch Med & Hlth Sci, Occupat Therapy Program, Perth, WA, Australia; [Evans, Kiah L.; Falkmer, Marita; Falkmer, Torbjorn; Girdler, Sonya J.] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia	Edith Cowan University; Curtin University	Evans, KL (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, Occupat Therapy Program, Perth, WA, Australia.; Evans, KL (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia.	kiah.evans@curtin.edu.au	Girdler, Sonya/ABC-9629-2021; Richmond, Janet Elaine/H-7089-2019	Richmond, Janet Elaine/0000-0002-9582-2597; Evans, Kiah/0000-0003-2850-7674; Girdler, Sonya/0000-0001-7992-0800	Edith Cowan University	Edith Cowan University	This study was undertaken as the first author's partial fulfilment of the requirements for the degree of Doctorate of Philosophy at Edith Cowan University, for which financial support in the form of a scholarship was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon GM, 2011, J VOCAT BEHAV, V79, P549, DOI 10.1016/j.jvb.2011.03.007; Allen TD, 2012, J VOCAT BEHAV, V80, P17, DOI 10.1016/j.jvb.2011.04.004; American Occupational Therapy Association, 2014, AM J OCCUPATIONAL S1, V68, pS1, DOI [10.5014/ajot.2014.682006, DOI 10.5014/AJOT.2014.682006]; Amstad FT, 2011, J OCCUP HEALTH PSYCH, V16, P151, DOI 10.1037/a0022170; Australian Bureau of Statistics, 2013, SOCIO ECONOMIC INDEX; Australian Bureau of Statistics, 2013, AVERAGE WEEKLY EARNI; Australian Bureau of Statistics, 2013, 2011 CENS QUICKSTATS; Australian Institute of Health and Welfare, 2014, AUSTRALIAS HEALTH 20; Baxter P, 2008, QUAL REP, V13, P544; *Brockwood K.J., 2002, J FEMINIST FAMILY TH, V13, P41, DOI [DOI 10.1300/J086V13N02_04, 10.1300/J086v13n02_04]; Brown B., 2012, DARING GREATLY COURA; Buffardi L C, 1999, J Occup Health Psychol, V4, P356, DOI 10.1037/1076-8998.4.4.356; Butts MM, 2013, J APPL PSYCHOL, V98, P1, DOI 10.1037/a0030389; Byron K, 2005, J VOCAT BEHAV, V67, P169, DOI 10.1016/j.jvb.2004.08.009; Chandra V, 2012, INT J HUM RESOUR MAN, V23, P1040, DOI 10.1080/09585192.2012.651339; Chassin L, 2010, J APPL DEV PSYCHOL, V31, P38, DOI 10.1016/j.appdev.2009.06.001; Chrisakis A, 2014, THESIS; Covey S, 2004, THE 7 HABITS OF HIGH; Crosno JL, 2009, J SERV RES-US, V11, P295, DOI 10.1177/1094670508328985; Department of Education and Training, 2015, EARLY CHILDHOOD AND; DePasquale N, 2016, J GERONTOL B-PSYCHOL, V71, P201, DOI 10.1093/geronb/gbu139; DePoy E., 2020, INTRO RES UNDERSTAND, V6th; DeRigne L., 2012, Florida Public Health Review, V9, P95; Dur M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-45; Duxbury L., 2012, REVISITING WORK LIFE; Duxbury L, 2011, WORK, V40, P29, DOI 10.3233/WOR-2011-1204; Eklund M, 2010, J OCCUP SCI, V17, P231, DOI 10.1080/14427591.2010.9686700; Erlandsson LK, 2013, OCCUP THER MENT HEAL, V29, P85, DOI 10.1080/0164212X.2013.761451; Evandrou M, 2004, AGEING SOC, V24, P771, DOI 10.1017/S0144686X04002545; Evans KL, 2014, SCAND J OCCUP THER, V21, P334, DOI 10.3109/11038128.2014.902988; Forhan M, 2010, OTJR-OCCUP PART HEAL, V30, P133, DOI 10.3928/15394492-20090625-01; Funk LM, 2009, QUAL HEALTH RES, V19, P859, DOI 10.1177/1049732309334105; Goward P, 2005, STRIKING THE BALANCE; Greenhaus JH, 2006, ACAD MANAGE REV, V31, P72, DOI 10.5465/amr.2006.19379625; GREENHAUS JH, 1985, ACAD MANAGE REV, V10, P76, DOI 10.5465/AMR.1985.4277352; Hakansson C, 2010, J OCCUP SCI, V17, P112, DOI 10.1080/14427591.2010.9686682; Hakansson C, 2006, J OCCUP SCI, V13, P74, DOI 10.1080/14427591.2006.9686572; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Higgins C, 2014, WORK, V48, P69, DOI 10.3233/WOR-141859; Hilbrecht M, 2008, GENDER WORK ORGAN, V15, P454, DOI 10.1111/j.1468-0432.2008.00413.x; Ingersoll-Dayton B, 2003, J MARRIAGE FAM, V65, P201, DOI 10.1111/j.1741-3737.2003.00201.x; Ingersoll-Dayton B., 2003, J GERONTOL SOC WORK, V40, P51, DOI [10.1300/j083v40n03_05, DOI 10.1300/J083V40N03_05]; Johansson G, 2012, SCAND J OCCUP THER, V19, P239, DOI 10.3109/11038128.2011.569942; Kielhofner G., 2008, MODEL HUMAN OCCUPATI, V4th; Kim Y, 2008, J AGING HEALTH, V20, P483, DOI 10.1177/0898264308317533; Kossek EE, 2011, PERS PSYCHOL, V64, P289, DOI 10.1111/j.1744-6570.2011.01211.x; KREFTING L, 1991, AM J OCCUP THER, V45, P214, DOI 10.5014/ajot.45.3.214; Kulik L, 2013, J CAREER DEV, V40, DOI 10.1177/0894845312467500; Lau KM, 2011, CLIN GERONTOLOGIST, V34, P117, DOI 10.1080/07317115.2011.539521; Lou Q, 2015, J CLIN NURS, V24, P2668, DOI 10.1111/jocn.12870; Luchman JN, 2013, J OCCUP HEALTH PSYCH, V18, P37, DOI 10.1037/a0030541; MacDougall C, 2001, QUAL HEALTH RES, V11, P117, DOI 10.1177/104973201129118975; Malach-Pines A, 2009, PRAT PSYCHOL, V15, P225, DOI 10.1016/j.prps.2008.09.010; Marrs L, 2011, THESIS; Matuska K, 2013, OTJR-OCCUP PART HEAL, V33, P146, DOI 10.3928/15394492-20130614-03; Matuska K, 2012, OTJR-OCCUP PART HEAL, V32, P229, DOI 10.3928/15394492-20110610-02; Matuska KM, 2008, J OCCUP SCI, V15, P9, DOI 10.1080/14427591.2008.9686602; Michel JS, 2011, J ORGAN BEHAV, V32, P689, DOI 10.1002/job.695; Mihelic K.K., 2014, INT J MANAGEMENT INF, V18, P15, DOI [DOI 10.19030/IJMIS.V18I1.8335, https://doi.org/10.19030/ijmis.v18i1.8335]; MILLER DA, 1981, SOC WORK, V26, P419; Neal MB, 2007, WORKING COUPLES CARI; Northfield S, 2010, CLIN J ONCOL NURS, V14, P567, DOI 10.1188/10.CJON.567-577; Portney L.G., 2009, FDN CLIN RES APPL PR, V892; Prodinger B, 2012, J OCCUP SCI, V19, P127, DOI 10.1080/14427591.2011.582833; Purvanova RK, 2010, J VOCAT BEHAV, V77, P168, DOI 10.1016/j.jvb.2010.04.006; Reichl C, 2014, HUM RELAT, V67, P979, DOI 10.1177/0018726713509857; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Russell H, 2009, GENDER WORK ORGAN, V16, P73, DOI 10.1111/j.1468-0432.2008.00431.x; Schumacher L, 2010, THESIS; Seidler A, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-10; Seligman MEP, 2009, OXFORD REV EDUC, V35, P293, DOI 10.1080/03054980902934563; Sirgy M, 2002, THE PSYCHOLOGY OF QU; Smith-Osborne A, 2014, J GERONTOL SOC WORK, V57, P556, DOI 10.1080/01634372.2014.880101; Squire S, 2007, ITS ABOUT TIME WOMEN; van den Heuvel ETP, 2001, CLIN REHABIL, V15, P669, DOI 10.1191/0269215501cr446oa; Wada M, 2014, J OCCUP SCI, V21, P259, DOI 10.1080/14427591.2014.913331; Wagman P, 2014, SCAND J OCCUP THER, V21, P227, DOI 10.3109/11038128.2014.900571; Wagman P, 2012, J OCCUP SCI, V19, P106, DOI 10.1080/14427591.2011.575760; Wagman P, 2012, SCAND J OCCUP THER, V19, P322, DOI 10.3109/11038128.2011.596219; Wagman P, 2012, SCAND J OCCUP THER, V19, P377, DOI 10.3109/11038128.2011.645552; Wagman P, 2011, QUAL HEALTH RES, V21, P410, DOI 10.1177/1049732310379240	81	17	17	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157469	10.1371/journal.pone.0157469	http://dx.doi.org/10.1371/journal.pone.0157469			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5LO	27305074	gold, Green Published, Green Submitted			2022-12-27	WOS:000377824800061
J	Tansirichaiya, S; Rahman, MA; Antepowicz, A; Mullany, P; Roberts, AP				Tansirichaiya, Supathep; Rahman, Md. Ajijur; Antepowicz, Agata; Mullany, Peter; Roberts, Adam P.			Detection of Novel Integrons in the Metagenome of Human Saliva	PLOS ONE			English	Article							MOBILE GENE CASSETTES; TOXIN-ANTITOXIN LOCI; ANTIBIOTIC-RESISTANCE; BACTERIAL EVOLUTION; ENVIRONMENTAL DNA; RNA; RECOMBINATION; RECOVERY; SEARCH; MICROBIOTA	Integrons are genetic elements capable of capturing and expressing open reading frames (ORFs) embedded within gene cassettes. They are involved in the dissemination of antibiotic resistance genes (ARGs) in clinically important pathogens. Although the ARGs are common in the oral cavity the association of integrons and antibiotic resistance has not been reported there. In this work, a PCR-based approach was used to investigate the presence of integrons and associated gene cassettes in human oral metagenomic DNA obtained from both the UK and Bangladesh. We identified a diverse array of gene cassettes containing ORFs predicted to confer antimicrobial resistance and other adaptive traits. The predicted proteins include a putative streptogramin A O-acetyltransferase, a bleomycin binding protein, cof-like hydrolase, competence and motility related proteins. This is the first study detecting integron gene cassettes directly from oral metagenomic DNA samples. The predicted proteins are likely to carry out a multitude of functions; however, the function of the majority is yet unknown.	[Tansirichaiya, Supathep; Rahman, Md. Ajijur; Antepowicz, Agata; Mullany, Peter; Roberts, Adam P.] UCL, UCL Eastman Dent Inst, Dept Microbial Dis, 256 Grays Inn Rd, London WC1X 8LD, England; [Rahman, Md. Ajijur] Rajshahi Univ, Dept Pharm, Rajshahi 6205, Bangladesh; [Antepowicz, Agata] Univ Oxford, John Radcliffe Hosp, Gene Med Res Grp, Nuffield Div Clin Lab Sci,Radcliffe Dept Med, Oxford OX3 9DU, England	University of London; University College London; University of Rajshahi; University of Oxford	Roberts, AP (corresponding author), UCL, UCL Eastman Dent Inst, Dept Microbial Dis, 256 Grays Inn Rd, London WC1X 8LD, England.	adam.roberts@ucl.ac.uk	Rahman, Ajijur/ABG-7836-2020; Tansirichaiya, Supathep/AAC-1450-2022; Roberts, Adam/AAU-5493-2021; Roberts, Adam P/C-1787-2008	Rahman, Ajijur/0000-0003-3783-7835; Roberts, Adam/0000-0002-0760-3088; Roberts, Adam P/0000-0002-0760-3088; Antepowicz, Agata/0000-0001-5812-9446; Tansirichaiya, Supathep/0000-0002-4445-8529	Commonwealth Scholarship Commission in the UK [BDCA2013-4, BDCA 2013-4]	Commonwealth Scholarship Commission in the UK	MAR; Commonwealth Scholarship Commission in the UK. Ref number: BDCA2013-4.; We are grateful to Professor Md. Anwar Ul Islam of University of Rajshahi, Bangladesh for helping us to collect and send the saliva sample from Bangladeshi volunteers. Md. Ajijur Rahman is supported by the Commonwealth Scholarship Commission in the UK (Ref: BDCA 2013-4). We thank Prof Pal Johnsen of UiT The Arctic University of Norway for helpful comments and suggestions on the initial version of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Boucher Y, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-3; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Chen XL, 2011, RNA BIOL, V8, P947, DOI 10.4161/rna.8.6.16690; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Coleman N, 2004, MICROBIOL-SGM, V150, P3524, DOI 10.1099/mic.0.27569-0; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; COLLIS CM, 1992, MOL MICROBIOL, V6, P2875, DOI 10.1111/j.1365-2958.1992.tb01467.x; Collis CM, 2001, J BACTERIOL, V183, P2535, DOI 10.1128/JB.183.8.2535-2542.2001; DEMEESTER C, 1976, J ANTIBIOT, V29, P1297, DOI 10.7164/antibiotics.29.1297; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Diaz-Torres ML, 2006, FEMS MICROBIOL LETT, V258, P257, DOI 10.1111/j.1574-6968.2006.00221.x; ELSAIED H, 2011, THE ISME JOURNAL, V5, P1162, DOI DOI 10.1038/ISMEJ.2010.208; Elsaied H, 2007, ENVIRON MICROBIOL, V9, P2298, DOI 10.1111/j.1462-2920.2007.01344.x; Escudero JA, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0019-2014; Gillings MR, 2014, MICROBIOL MOL BIOL R, V78, P257, DOI 10.1128/MMBR.00056-13; Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914; Hall RM, 1998, DRUG RESIST UPDATE, V1, P109, DOI 10.1016/S1368-7646(98)80026-5; Han XY, 2008, J BACTERIOL, V190, P3323, DOI 10.1128/JB.01807-07; HARDMAN DJ, 1991, CRIT REV BIOTECHNOL, V11, P1, DOI 10.3109/07388559109069182; Holmes AJ, 2003, ENVIRON MICROBIOL, V5, P383, DOI 10.1046/j.1462-2920.2003.00429.x; HUANG XQ, 1992, GENOMICS, V14, P18, DOI 10.1016/S0888-7543(05)80277-0; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kahne D, 2005, CHEM REV, V105, P425, DOI 10.1021/cr030103a; Koenig JE, 2008, ENVIRON MICROBIOL, V10, P1024, DOI 10.1111/j.1462-2920.2007.01524.x; Koenig JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005276; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Michael CA, 2004, AM NAT, V164, P1, DOI 10.1086/421733; Nield BS, 2001, FEMS MICROBIOL LETT, V195, P59, DOI 10.1016/S0378-1097(00)00546-2; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Partridge SR, 2000, MICROBIOL-UK, V146, P2855, DOI 10.1099/00221287-146-11-2855; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Roberts AP, 2010, EXPERT REV ANTI-INFE, V8, P1441, DOI 10.1586/ERI.10.106; Seville LA, 2009, MICROB DRUG RESIST, V15, P159, DOI 10.1089/mdr.2009.0916; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Stokes HW, 2001, APPL ENVIRON MICROB, V67, P5240, DOI 10.1128/AEM.67.11.5240-5246.2001; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Wu YW, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-16; Wu YW, 2012, APPL ENVIRON MICROB, V78, P5288, DOI 10.1128/AEM.00564-12; Xie G, 2010, MOL ORAL MICROBIOL, V25, P391, DOI 10.1111/j.2041-1014.2010.00587.x	50	14	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157605	10.1371/journal.pone.0157605	http://dx.doi.org/10.1371/journal.pone.0157605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304457	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800077
J	Himpe, E; Cunha, DA; Song, I; Bugliani, M; Marchetti, P; Cnop, M; Bouwens, L				Himpe, Eddy; Cunha, Daniel A.; Song, Imane; Bugliani, Marco; Marchetti, Piero; Cnop, Miriam; Bouwens, Luc			Phenylpropenoic Acid Glucoside from Rooibos Protects Pancreatic Beta Cells against Cell Death Induced by Acute Injury	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ENZYME GENE-EXPRESSION; B-CELLS; Z-2-(BETA-D-GLUCOPYRANOSYLOXY)-3-PHENYLPROPENOIC ACID; ER STRESS; STREPTOZOTOCIN; APOPTOSIS; MECHANISMS; MASS; INITIATION	Objective Previous studies demonstrated that a phenylpropenoic acid glucoside (PPAG) from rooibos (Aspalathus linearis) extract had anti-hyperglycemic activity and significant protective effects on the pancreatic beta cell mass in a chronic diet-induced diabetes model. The present study evaluated the cytoprotective effect of the phytochemical on beta cells exposed to acute cell stress. Methods Synthetically prepared PPAG was administered orally in mice treated with a single dose of streptozotocin to acutely induce beta cell death and hyperglycemia. Its effect was assessed on beta cell mass, proliferation and apoptotic cell death. Its cytoprotective effect was also studied in vitro on INS-1E beta cells and on human pancreatic islet cells. Results Treatment with the phytochemical PPAG protected beta cells during the first days after the insult against apoptotic cell death, as evidenced by TUNEL staining, and prevented loss of expression of anti-apoptotic protein BCL2 in vivo. In vitro, PPAG protected INS-1E beta cells from streptozotocin-induced apoptosis and necrosis in a BCL2-dependent and independent way, respectively, depending on glucose concentration. PPAG also protected human pancreatic islet cells against the cytotoxic action of the fatty acid palmitate. Conclusions These findings show the potential use of PPAG as phytomedicine which protects the beta cell mass exposed to acute diabetogenic stress.	[Himpe, Eddy; Song, Imane; Bouwens, Luc] Vrije Univ Brussel, Diabet Res Ctr, Cell Differentiat Lab, Brussels, Belgium; [Cunha, Daniel A.; Cnop, Miriam] Univ Libre Bruxelles, Ctr Diabet Res, Brussels, Belgium; [Cnop, Miriam] Erasmus Hosp, Div Endocrinol, Brussels, Belgium; [Bugliani, Marco; Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy	Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Pisa	Himpe, E (corresponding author), Vrije Univ Brussel, Diabet Res Ctr, Cell Differentiat Lab, Brussels, Belgium.	Ehimpe@gmail.com	Bugliani, Marco/I-3168-2019	Bugliani, Marco/0000-0002-1744-1561; Cnop, Miriam/0000-0002-5112-1692; Himpe, Eddy/0000-0001-6624-5877; Bouwens, Luc/0000-0001-5767-7002	Wetenschappelijk Fonds Willy Gepts of the UZ Brussel; Actions de Recherche Concertees de la Communaute Francaise (ARC Consolidator 37C); Fonds National de la Recherche Scientifique [FNRS MIS F.4523.14]	Wetenschappelijk Fonds Willy Gepts of the UZ Brussel; Actions de Recherche Concertees de la Communaute Francaise (ARC Consolidator 37C); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from "Wetenschappelijk Fonds Willy Gepts of the UZ Brussel", "Actions de Recherche Concertees de la Communaute Francaise (ARC Consolidator 37C)", and the "Fonds National de la Recherche Scientifique (FNRS MIS F.4523.14)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrin R, 2015, FREE RADICAL RES, V49, P279, DOI 10.3109/10715762.2014.999674; Ahn C, 2015, MOL CELL ENDOCRINOL, V412, P302, DOI 10.1016/j.mce.2015.05.017; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cunha DA, 2012, DIABETES, V61, P2763, DOI 10.2337/db12-0123; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; Hayashi K, 2006, BIOL PHARM BULL, V29, P1110, DOI 10.1248/bpb.29.1110; Joubert E, 2013, FOOD CHEM, V136, P1078, DOI 10.1016/j.foodchem.2012.09.014; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Marais C, 1996, J CHEM SOC PERK T 1, P2915, DOI 10.1039/p19960002915; Mathijs I, 2014, MOL NUTR FOOD RES, V58, P1980, DOI 10.1002/mnfr.201400211; McCarty MF, 2005, MED HYPOTHESES, V64, P151, DOI 10.1016/j.mehy.2004.03.036; Meier JJ, 2013, DIABETES CARE, V36, pS113, DOI 10.2337/dcS13-2008; MORGAN NG, 1994, BIOSCIENCE REP, V14, P243, DOI 10.1007/BF01209729; Muller CJF, 2013, MOL NUTR FOOD RES, V57, P2216, DOI 10.1002/mnfr.201300294; PIPELEERS D, 1986, P NATL ACAD SCI USA, V83, P5267, DOI 10.1073/pnas.83.14.5267; Rooman I, 2004, DIABETOLOGIA, V47, P259, DOI 10.1007/s00125-003-1287-1; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Song I, 2015, CURR DRUG TARGETS, V16, P516, DOI 10.2174/1389450116666150204113928; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Uetake R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087667; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Watanabe A, 2012, J NUCL MED, V53, P1585, DOI 10.2967/jnumed.111.102459; Wu JZ, 2015, DIABET METAB SYND OB, V8, P181, DOI 10.2147/DMSO.S82272; Zhu M, 2014, ENDOCRINE, V47, P129, DOI 10.1007/s12020-013-0132-7; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	33	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157604	10.1371/journal.pone.0157604	http://dx.doi.org/10.1371/journal.pone.0157604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299564	Green Published, gold			2022-12-27	WOS:000377822200065
J	Luo, T; Shi, CR; Zhao, X; Zhao, YS; Xu, JQ				Luo, Ting; Shi, Changrong; Zhao, Xing; Zhao, Yunsong; Xu, Jinqiu			Automatic Synthesis of Panoramic Radiographs from Dental Cone Beam Computed Tomography Data	PLOS ONE			English	Article							X-RAY; CT	In this paper, we propose an automatic method of synthesizing panoramic radiographs from dental cone beam computed tomography (CBCT) data for directly observing the whole dentition without the superimposition of other structures. This method consists of three major steps. First, the dental arch curve is generated from the maximum intensity projection (MIP) of 3D CBCT data. Then, based on this curve, the long axial curves of the upper and lower teeth are extracted to create a 3D panoramic curved surface describing the whole dentition. Finally, the panoramic radiograph is synthesized by developing this 3D surface. Both open-bite shaped and closed-bite shaped dental CBCT datasets were applied in this study, and the resulting images were analyzed to evaluate the effectiveness of this method. With the proposed method, a single-slice panoramic radiograph can clearly and completely show the whole dentition without the blur and superimposition of other dental structures. Moreover, thickened panoramic radiographs can also be synthesized with increased slice thickness to show more features, such as the mandibular nerve canal. One feature of the proposed method is that it is automatically performed without human intervention. Another feature of the proposed method is that it requires thinner panoramic radiographs to show the whole dentition than those produced by other existing methods, which contributes to the clarity of the anatomical structures, including the enamel, dentine and pulp. In addition, this method can rapidly process common dental CBCT data. The speed and image quality of this method make it an attractive option for observing the whole dentition in a clinical setting.	[Luo, Ting; Shi, Changrong; Zhao, Xing; Zhao, Yunsong; Xu, Jinqiu] Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China; [Luo, Ting; Shi, Changrong; Zhao, Xing; Zhao, Yunsong; Xu, Jinqiu] Beijing Higher Inst Engn Res Ctr Testing & Imagin, Beijing, Peoples R China	Capital Normal University	Zhao, X (corresponding author), Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China.; Zhao, X (corresponding author), Beijing Higher Inst Engn Res Ctr Testing & Imagin, Beijing, Peoples R China.	zhaoxing_1999@126.com	Luo, Tingjin/R-6320-2019	Luo, Tingjin/0000-0002-4328-4627; Luo, Ting/0000-0001-7564-102X	National Natural Science Foundation of China [61371195, 61401289]; Shenzhen ZhongKe TianYue Technology Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen ZhongKe TianYue Technology Co., Ltd.	This work was supported in part by the National Natural Science Foundation of China under Grant 61371195 and Grant 61401289. Shenzhen ZhongKe TianYue Technology Co., Ltd., provided support in the form of a salary for author YSZ, and had a role in the data collection. The specific roles of this author are articulated in the 'author contributions' section.	Akhoondali H., 2009, Journal of Applied Sciences, V9, P2106, DOI 10.3923/jas.2009.2106.2114; AlHarbi S, 2008, ANGLE ORTHOD, V78, P281, DOI 10.2319/121806-516.1; Arthur D., 2007, P 18 ANN ACMS S, P1027, DOI DOI 10.1145/1283383.1283494; Barone S, 2015, ASME 2015 INT DES EN; BEGOLE EA, 1980, J DENT RES, V59, P1549, DOI 10.1177/00220345800590092901; Braun S, 1998, ANGLE ORTHOD, V68, P29; Correa LR, 2014, CLIN ORAL IMPLAN RES, V25, P690, DOI 10.1111/clr.12126; Diggs DB, 1962, THESIS; Flores-Mir Carlos, 2014, Dental Press J. Orthod., V19, P45, DOI 10.1590/2176-9451.19.5.045-053.oar; Han Bing, 2011, Proceedings 2011 International Conference on Mechatronic Science, Electric Engineering and Computer (MEC 2011), P1094; Hartigan J., 1975, CLUSTERING ALGORITHM; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hosntalab M, 2008, INT J COMPUT ASS RAD, V3, P257, DOI 10.1007/s11548-008-0230-9; Huang DY, 2011, INT J INNOV COMPUT I, V7, P5631; Jain AK, 2003, LECT NOTES COMPUT SC, V2688, P429; Momeni M, 2008, INT J COMPUTER ASSIS, V3, P339; Paris S, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964963; Sa-ing V, 2013, IEEE ENG MED BIO, P6099, DOI 10.1109/EMBC.2013.6610944; SANIN C, 1970, J DENT RES, V49, P885, DOI 10.1177/00220345700490042801; Scarfe WC, 2006, J CAN DENT ASSOC, V72, P75; Scarfe William C, 2008, Dent Clin North Am, V52, P707, DOI 10.1016/j.cden.2008.05.005; Shahbazian M, 2014, CLIN ORAL INVEST, V18, P293, DOI 10.1007/s00784-013-0963-x; Steder B, 2011, IEEE INT CONF ROBOT, P2601, DOI 10.1109/ICRA.2011.5980187; Tal H, 1991, Dentomaxillofac Radiol, V20, P40; Tohnak Sirilawan, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3329; Vandenberghe B, 2010, EUR RADIOL, V20, P2637, DOI 10.1007/s00330-010-1836-1; Vannier MW, 1997, ORAL SURG ORAL MED O, V84, P561, DOI 10.1016/S1079-2104(97)90274-2; WHITE LW, 1977, AM J ORTHOD DENTOFAC, V72, P303, DOI 10.1016/0002-9416(77)90216-0; Yang M, 2014, ENERGY, V68, P385, DOI 10.1016/j.energy.2014.02.076; Yang M, 2014, NDT&E INT, V64, P13, DOI 10.1016/j.ndteint.2014.02.004; Zhou JD, 2004, PROC SPIE, V5404, P373, DOI 10.1117/12.542689	31	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156976	10.1371/journal.pone.0156976	http://dx.doi.org/10.1371/journal.pone.0156976			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300554	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200022
J	Mao, LL; Zhang, EM; Wang, ZJ; Li, Y; Zhou, H; Liu, XS; Zhang, HJ; Cai, H; Liang, XD; Sun, YW; Zhang, ZK; Li, W; Yao, WQ; Wei, JC				Mao, Lingling; Zhang, Enmin; Wang, Zijiang; Li, Yan; Zhou, Hang; Liu, Xuesheng; Zhang, Huijuan; Cai, Hong; Liang, Xudong; Sun, Yingwei; Zhang, Zhikai; Li, Wei; Yao, Wenqing; Wei, Jianchun			Phylogenetic Characteristics of Anthrax Outbreaks in Liaoning Province, China, 2001-2015	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; POPULATION-STRUCTURE; REPEAT ANALYSIS; GENOME ANALYSIS; DIVERSITY	Anthrax is a continuous threat in China, especially in rural regions. In July 2015, an anthrax outbreak occurred in Xifeng County, Liaoning Province. A total of 10 cutaneous anthrax cases were reported, with 210 people under medical observation. In this study, the general characteristics of human anthrax outbreak occurred in Liaoning Province were described, and all cases were caused by butchering and contacting sick animal. Meanwhile, the phylogenetic relationship between outbreak-related isolates/samples of the year 2015 and previous Bacillus anthracis strains was analyzed by means of canonical single nucleotide polymorphisms (canSNP), multiple-locus variable-number tandem repeat analysis (MLVA) with 15 markers and single-nucleotide repeats (SNR) analysis. There are two canSNP subgroups found in Liaoning, A. Br. 001/002 and A. Br. Ames, and a total of six MLVA 15 genotypes and five SNR genotypes were observed. The strain collected from anthrax outbreak in Xifeng County in 2015 was classified as A. Br. 001/002 subgroup and identified as MLVA15-29 genotype, with same SNR profile (CL10: 17, CL12: 15, CL33: 29, and CL35: 13). So we conclude that the same clone of B. anthracis caused the anthrax outbreak in Xifeng County in 2015, and this clone is different to previous isolates. Strengthening public health education in China is one of the most important measures to prevent and control anthrax.	[Mao, Lingling; Wang, Zijiang; Liu, Xuesheng; Sun, Yingwei; Yao, Wenqing] Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Enmin; Zhang, Huijuan; Cai, Hong; Liang, Xudong; Zhang, Zhikai; Li, Wei; Wei, Jianchun] China CDC, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Enmin; Zhang, Huijuan; Cai, Hong; Liang, Xudong; Zhang, Zhikai; Li, Wei; Wei, Jianchun] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhang, Enmin; Zhang, Huijuan; Cai, Hong; Liang, Xudong; Zhang, Zhikai; Li, Wei; Wei, Jianchun] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Li, Yan] Tieling Prefecture Ctr Dis Control & Prevent, Tieling, Liaoning Provin, Peoples R China; [Zhou, Hang] China CDC, Div Infect Dis Prevent & Control, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Chinese Center for Disease Control & Prevention	Yao, WQ (corresponding author), Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China.; Wei, JC (corresponding author), China CDC, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.; Wei, JC (corresponding author), State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.; Wei, JC (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.	wenqingyao@sina.com; weijianchun@icdc.cn			National Priority Development Project on Key Science Instrument [2012YQ09019706]; National Science and Technology Mega-Projects of China [2012ZX10004215, 2013ZX 10004-101]	National Priority Development Project on Key Science Instrument; National Science and Technology Mega-Projects of China	This work was supported by National Priority Development Project on Key Science Instrument (2012YQ09019706, www.caiq.org.cn/) and the National Science and Technology Mega-Projects of China (no. 2012ZX10004215 and no.2013ZX 10004-101, www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001534; Fasanella A, 2005, J CLIN MICROBIOL, V43, P3398, DOI 10.1128/JCM.43.7.3398-3401.2005; Garofolo G, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-11; Girault G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-288; Grunow R, 2013, EUROSURVEILLANCE, V18, P2; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1111, DOI 10.3201/eid0810.020394; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2001, J CLIN MICROBIOL, V39, P4566, DOI 10.1128/JCM.39.12.4566-4567.2001; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Kenefic LJ, 2008, J MICROBIOL METH, V73, P269, DOI 10.1016/j.mimet.2007.11.014; Kenefic LJ, 2008, EMERG INFECT DIS, V14, P1494, DOI 10.3201/eid1409.080076; Le Fleche P, 2001, BMC Microbiol, V1, P2; Li S, 2015, EUR J CLIN MICROBIOL, V34, P89, DOI 10.1007/s10096-014-2195-7; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Rasko DA, 2011, P NATL ACAD SCI USA, V108, P5027, DOI 10.1073/pnas.1016657108; Simonson TS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-71; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Stratilo CW, 2006, J CLIN MICROBIOL, V44, P777, DOI 10.1128/JCM.44.3.777-782.2006; Thierry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095131; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; WHO, 2008, ANTHRAX HUMANS ANIMA; Zhou W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135777	24	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157496	10.1371/journal.pone.0157496	http://dx.doi.org/10.1371/journal.pone.0157496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299730	Green Submitted, Green Published, gold			2022-12-27	WOS:000377822200056
J	Shi, C; Zheng, Z; Wang, Q; Wang, CD; Zhang, DB; Zhang, M; Chan, P; Wang, XM				Shi, Chen; Zheng, Zheng; Wang, Qi; Wang, Chaodong; Zhang, Dabao; Zhang, Min; Chan, Piu; Wang, Xiaomin			Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; RISK-FACTOR; TAU-SYNUCLEIN; LRRK2 R1628P; ASSOCIATION; MAPT; SNCA; SUSCEPTIBILITY; PROGRESSION; LOCI	Many genetic variants have been linked to familial or sporadic Parkinson's disease (PD), among which those identified in PARK16, BST1, SNCA, LRRK2, GBA and MAPT genes have been demonstrated to be the most common risk factors worldwide. Moreover, complex gene-gene and gene-environment interactions have been highlighted in PD pathogenesis. Compared to studies focusing on the predisposing effects of genes, there is a relative lack of research investigating how these genes and their interactions influence the clinical profiles of PD. In a cohort consisting of 2,011 Chinese Han PD patients, we selected 9 representative variants from the 6 above-mentioned common PD genes to analyze their main and epistatic effects on the Unified Parkinson's Disease Rating Scale (UPDRS) and the Hoehn and Yahr (H-Y) stage of PD. With multiple linear regression models adjusting for medication status, disease duration, gender and age at onset, none of the variants displayed significant main effects on UPDRS or the H-Y scores. However, for gene-gene interaction analyses, 7 out of 37 pairs of variants showed significant or marginally significant associations with these scores. Among these, the GBA rs421016 (L444P)xLRRK2 rs33949390 (R1628P) interaction was consistently significant in relation to UPDRS III and UPDRS total (I+II+III), even after controlling for the family-wise error rate using False Discovery Rate (FDR-corrected p values are 0.0481 and 0.0070, respectively). Although the effects of the remaining pairs of variants did not survive the FDR correction, they showed marginally significant associations with either UPDRS or the H-Y stage (raw p<0.05). Our results highlight the importance of epistatic effects of multiple genes on the determination of PD clinical profiles and may have implications for molecular classification and personalized intervention of the disease.	[Shi, Chen; Wang, Xiaomin] Capital Med Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China; [Shi, Chen; Zhang, Dabao; Zhang, Min] Capital Med Univ, Sch Biomed Engn, Bioinformat Ctr, Beijing, Peoples R China; [Zheng, Zheng; Wang, Chaodong; Chan, Piu] Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Dept Neurobiol, Beijing, Peoples R China; [Wang, Qi; Zhang, Dabao; Zhang, Min] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Wang, Chaodong; Chan, Piu] Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Dept Neurol, Beijing, Peoples R China; [Chan, Piu] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China; [Chan, Piu] Key Lab Parkinsons Dis Beijing, Beijing, Peoples R China; [Wang, Chaodong] Fujian Med Univ, Affiliated Sanming Hosp 1, Dept Neurol, Sanming, Fujian, Peoples R China; [Chan, Piu; Wang, Xiaomin] Capital Med Univ, Parkinson Dis Ctr, Beijing Inst Brain Disorders, Beijing, Peoples R China; [Zhang, Min] Capital Med Univ, Beijing Inst Brain Disorders, Alzheimer Dis Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Capital Medical University; Fujian Medical University; Capital Medical University; Capital Medical University	Wang, XM (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China.; Zhang, M (corresponding author), Capital Med Univ, Sch Biomed Engn, Bioinformat Ctr, Beijing, Peoples R China.; Chan, P (corresponding author), Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Dept Neurobiol, Beijing, Peoples R China.; Zhang, M (corresponding author), Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA.; Chan, P (corresponding author), Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Dept Neurol, Beijing, Peoples R China.; Chan, P (corresponding author), Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China.; Chan, P (corresponding author), Key Lab Parkinsons Dis Beijing, Beijing, Peoples R China.; Chan, P; Wang, XM (corresponding author), Capital Med Univ, Parkinson Dis Ctr, Beijing Inst Brain Disorders, Beijing, Peoples R China.; Zhang, M (corresponding author), Capital Med Univ, Beijing Inst Brain Disorders, Alzheimer Dis Ctr, Beijing, Peoples R China.	zhangmin@ccmu.edu.cn; pbchan90@gmail.com; xmwang@ccmu.edu.cn	Chan, Piu/I-4580-2016	Chan, Piu/0000-0003-1346-881X	National Basic Research Program of China [2014CB744600, 2011CB504101]; Ministry of Science and Technology of China [2012AA02A514]; Beijing Municipal Commission of Education [KM201410025013]; Beijing Institute for Brain Disorders [BIBDPXM2014_014226_000016, BIBDPXM 2014_014226_000016]; China Scholarship Council; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Beijing Institute for Brain Disorders; China Scholarship Council(China Scholarship Council); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors gratefully acknowledge the support from the National Basic Research Program of China (2014CB744600 to DZ, 2011CB504101 to PC), the Ministry of Science and Technology of China (2012AA02A514 to PC), Beijing Municipal Commission of Education (KM201410025013 to MZ) and Beijing Institute for Brain Disorders (BIBDPXM2014_014226_000016 to MZ). The China Scholarship Council is also gratefully acknowledged by CS for funding her Visiting Student fellowship.; The National Basic Research Program of China (2014CB744600, 2011CB504101), the Ministry of Science and Technology of China (2012AA02A514), the Beijing Municipal Commission of Education (KM201410025013), the Beijing Institute for Brain Disorders (BIBDPXM 2014_014226_000016), and the China Scholarship Council.	Alcalay RN, 2013, MOVEMENT DISORD, V28, P1966, DOI 10.1002/mds.25647; Biernacka JM, 2011, PARKINSONISM RELAT D, V17, P730, DOI 10.1016/j.parkreldis.2011.07.001; Cheon SM, 2012, J MOV DISORD, V5, P33, DOI 10.14802/jmd.12009; Chung SJ, 2013, PARKINSONISM RELAT D, V19, P595, DOI 10.1016/j.parkreldis.2013.02.008; Devine MJ, 2008, FEBS J, V275, P5748, DOI 10.1111/j.1742-4658.2008.06707.x; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Evans W, 2004, NEUROSCI LETT, V369, P183, DOI 10.1016/j.neulet.2004.05.119; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Farrer MJ, 2007, PARKINSONISM RELAT D, V13, P89, DOI 10.1016/j.parkreldis.2006.12.001; Fidani L, 2006, MOVEMENT DISORD, V21, P1036, DOI 10.1002/mds.20864; Funayama M, 2007, NEUROREPORT, V18, P273, DOI 10.1097/WNR.0b013e32801254b6; Gan-Or Z, 2008, NEUROLOGY, V70, P2277, DOI 10.1212/01.wnl.0000304039.11891.29; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Goris A, 2007, ANN NEUROL, V62, P145, DOI 10.1002/ana.21192; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Huang CL, 2011, EUR J NEUROL, V18, P1227, DOI 10.1111/j.1468-1331.2011.03362.x; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jankovic J, 2005, ARCH NEUROL-CHICAGO, V62, P351, DOI 10.1001/archneur.62.3.351; Kooperberg C, 2009, STAT SCI, V24, P472, DOI 10.1214/09-STS287; Kumaran R, 2015, HUM MOL GENET, V24, pR32, DOI 10.1093/hmg/ddv236; Kumari U, 2009, FEBS J, V276, P6455, DOI 10.1111/j.1742-4658.2009.07344.x; Lang AE, 2007, NEUROLOGY, V68, P948, DOI 10.1212/01.wnl.0000257110.91041.5d; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Li NN, 2013, AM J MED GENET B, V162B, P452, DOI 10.1002/ajmg.b.32143; Lu CS, 2008, NEUROGENETICS, V9, P271, DOI 10.1007/s10048-008-0140-6; Mamah CE, 2005, ANN NEUROL, V57, P439, DOI 10.1002/ana.20387; Manzoni C, 2015, PEERJ, V3, DOI 10.7717/peerj.778; Mao XY, 2010, NEUROSCI LETT, V469, P256, DOI 10.1016/j.neulet.2009.12.007; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; Miller DB, 2015, METABOLISM, V64, pS40, DOI 10.1016/j.metabol.2014.10.030; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Paisan-Ruiz C, 2008, HUM MUTAT, V29, P485, DOI 10.1002/humu.20668; Pihlstrom L, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.019; Post B, 2007, MOVEMENT DISORD, V22, P1839, DOI 10.1002/mds.21537; Pulkes T, 2014, PARKINSONISM RELAT D, V20, P1018, DOI 10.1016/j.parkreldis.2014.06.013; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rana HQ, 2013, GENET MED, V15, P146, DOI 10.1038/gim.2012.107; Ross OA, 2008, ANN NEUROL, V64, P88, DOI 10.1002/ana.21405; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sharma S, 2013, NEUROCHEM INT, V63, P201, DOI 10.1016/j.neuint.2013.06.005; Shulman JM, 2014, JAMA NEUROL, V71, P429, DOI 10.1001/jamaneurol.2013.6222; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Skipper L, 2004, AM J HUM GENET, V75, P669, DOI 10.1086/424492; Trotta L, 2012, PARKINSONISM RELAT D, V18, P257, DOI 10.1016/j.parkreldis.2011.10.014; Wang C, 2014, NEUROBIOL AGING, V35, pel, DOI DOI 10.1016/J.NEUR0BI0LAGING.2013.08.012; Wang CD, 2012, PARKINSONISM RELAT D, V18, P958, DOI 10.1016/j.parkreldis.2012.05.003; Wider C, 2011, EUR J NEUROL, V18, P876, DOI 10.1111/j.1468-1331.2010.03297.x; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Yu L, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-54	55	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0155758	10.1371/journal.pone.0155758	http://dx.doi.org/10.1371/journal.pone.0155758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299523	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200005
J	Ou, SH; Chen, MY; Huang, CW; Chen, NC; Wu, CH; Hsu, CY; Chou, KJ; Lee, PT; Fang, HC; Chen, CL				Ou, Shih-Hsiang; Chen, Mei-Yin; Huang, Chien-Wei; Chen, Nai-Ching; Wu, Chien-Hsing; Hsu, Chih-Yang; Chou, Kang-Ju; Lee, Po-Tsang; Fang, Hua-Chang; Chen, Chien-Liang			Potential Role of Vegetarianism on Nutritional and Cardiovascular Status in Taiwanese Dialysis Patients: A Case-Control Study	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; NONTRADITIONAL RISK-FACTORS; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; ARTERIAL STIFFNESS; MAINTENANCE HEMODIALYSIS; OXIDATIVE STRESS; INFLAMMATION; METAANALYSIS	Background & Objectives Cardiovascular disease remains the most common cause of death for patients on chronic dialysis. End stage renal disease patients undergoing dialysis imposed to reduce phosphorus intake, which likely contributes to development of vegetarian diet behaviors. Vegetarian diets are often lower in protein content, in contradiction to the recommendation that a high protein diet is followed by patients undergoing dialysis. The purpose of the study was to investigate the effects of a vegetarian diet on the nutritional and cardiovascular status of dialysis patients. Design, Setting, Participants, Measurements A study of 21 vegetarian dialysis patients and 42 age-and sex-matched non-vegetarian dialysis patients selected as controls was conducted in the Kaohsiung Veterans General Hospital. Brachial-ankle pulse wave velocity and biochemistry data including total homocysteine levels, serum lipid profiles, high-sensitivity C-reactive protein, vitamin D levels, albumin, and normalized protein catabolic rate were measured. Results Compared with the non-vegetarian control group, vegetarian subjects had lower body weight, body mass index, serum phosphate, blood urea nitrogen, serum creatinine, vitamin D, uric acid, albumin, and normalized protein catabolic rate (p < 0.05). The vegetarian group showed higher brachial-ankle pulse wave velocity than the non-vegetarian group (1926.95 +/- 456.45 and 1684.82 +/- 309.55 cm/sec, respectively, p < 0.05). After adjustment for age, albumin, pre-dialysis systolic blood pressure, and duration of dialysis, vegetarian diet remained an independent risk factor for brachial-ankle pulse wave velocity. Conclusions The present study revealed that patients on dialysis who follow vegetarian diets may experience subclinical protein malnutrition and vitamin D deficiency that could offset the beneficial cardiovascular effects of vegetarianism.	[Ou, Shih-Hsiang; Huang, Chien-Wei; Hsu, Chih-Yang; Chou, Kang-Ju; Lee, Po-Tsang; Fang, Hua-Chang; Chen, Chien-Liang] Kaohsiung Vet Gen Hosp, Div Nephrol, Kaohsiung, Taiwan; [Chen, Mei-Yin] Kaohsiung Vet Gen Hosp, Div Nutr, Kaohsiung, Taiwan; [Ou, Shih-Hsiang; Huang, Chien-Wei; Hsu, Chih-Yang; Chou, Kang-Ju; Lee, Po-Tsang; Fang, Hua-Chang; Chen, Chien-Liang] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Chen, Nai-Ching] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, CL (corresponding author), Kaohsiung Vet Gen Hosp, Div Nephrol, Kaohsiung, Taiwan.; Chen, CL (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan.	cclchen@seed.net.tw	chen, chien-liang/I-6192-2015; Wu, Chien-Hsing/ABI-4006-2020; Huang, Chien-Wei/AAN-9838-2020	chen, chien-liang/0000-0002-9508-8396; Huang, Chien-Wei/0000-0001-5753-9654; Ou, Shih-Fu/0000-0001-5294-3113				Andrukhova O, 2014, MOL ENDOCRINOL, V28, P53, DOI 10.1210/me.2013-1252; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Danielski M, 2003, AM J KIDNEY DIS, V42, P286, DOI 10.1016/S0272-6386(03)00653-X; Davis BC, 2003, AM J CLIN NUTR, V78, p640S, DOI 10.1093/ajcn/78.3.640S; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hung CJ, 2002, J NUTR, V132, P152, DOI 10.1093/jn/132.2.152; Ingenbleek Y, 2012, NUTRITION, V28, P148, DOI 10.1016/j.nut.2011.04.009; Kahleova H, 2011, DIABETIC MED, V28, P549, DOI 10.1111/j.1464-5491.2010.03209.x; Kalantar-Zadeh K, 2005, CURR OPIN CLIN NUTR, V8, P388, DOI 10.1097/01.mco.0000172578.56396.9e; Kim Eun-Young, 2008, Electrolyte Blood Press, V6, P61, DOI 10.5049/EBP.2008.6.2.61; Kitahara T, 2005, AM J KIDNEY DIS, V46, P688, DOI 10.1053/j.ajkd.2005.06.016; Kuang DW, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-143; LAMBERG-ALLARDT C, 1993, AM J CLIN NUTR, V58, P684, DOI 10.1093/ajcn/58.5.684; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; London GM, 2001, J AM SO NEPHROL, V18, P613; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Muntner P, 2004, ANN INTERN MED, V140, P9, DOI 10.7326/0003-4819-140-1-200401060-00006; Noori N, 2011, AM J KIDNEY DIS, V58, P248, DOI 10.1053/j.ajkd.2011.03.017; Noori N, 2010, AM J CLIN NUTR, V92, P1060, DOI 10.3945/ajcn.2010.29188; Obersby D, 2013, BRIT J NUTR, V109, P785, DOI 10.1017/S000711451200520X; Pase MP, 2011, BRIT J NUTR, V106, P974, DOI 10.1017/S0007114511002819; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; US Renal Data System, 2010, USRDS 2010 ANN DAT R; Wang AYM, 2008, AM J CLIN NUTR, V87, P1631, DOI 10.1093/ajcn/87.6.1631; Wu TT, 2011, NEPHROLOGY, V16, P582, DOI 10.1111/j.1440-1797.2011.01464.x; Yamada S, 2015, AM J PHYSIOL-RENAL, V309, pF744, DOI 10.1152/ajprenal.00017.2015; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359	28	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156297	10.1371/journal.pone.0156297	http://dx.doi.org/10.1371/journal.pone.0156297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295214	Green Published, gold, Green Submitted			2022-12-27	WOS:000377821300005
J	Kovacs-Hostyanszki, A; Foldesi, R; Mozes, E; Szirak, A; Fischer, J; Hanspach, J; Baldi, A				Kovacs-Hostyanszki, Aniko; Foldesi, Rita; Mozes, Edina; Szirak, Adam; Fischer, Joern; Hanspach, Jan; Baldi, Andras			Conservation of Pollinators in Traditional Agricultural Landscapes - New Challenges in Transylvania (Romania) Posed by EU Accession and Recommendations for Future Research	PLOS ONE			English	Article							FLOWER-VISITING INSECTS; LONG-TERM CHANGES; FARMLAND BIRDS; LAND-USE; SEMINATURAL GRASSLANDS; DEPENDENT RESPONSES; NATURAL ENEMIES; BEE ABUNDANCE; BODY-SIZE; WILD BEES	Farmland biodiversity is strongly declining in most of Western Europe, but still survives in traditional low intensity agricultural landscapes in Central and Eastern Europe. Accession to the EU however intensifies agriculture, which leads to the vanishing of traditional farming. Our aim was to describe the pollinator assemblages of the last remnants of these landscapes, thus set the baseline of sustainable farming for pollination, and to highlight potential measures of conservation. In these traditional farmlands in the Transylvanian Basin, Romania (EU accession in 2007), we studied the major pollinator groups-wild bees, hoverflies and butterflies. Landscape scale effects of semi-natural habitats, land cover diversity, the effects of heterogeneity and woody vegetation cover and on-site flower resources were tested on pollinator communities in traditionally managed arable fields and grasslands. Our results showed: (i) semi-natural habitats at the landscape scale have a positive effect on most pollinators, especially in the case of low heterogeneity of the direct vicinity of the studied sites; (ii) both arable fields and grasslands hold abundant flower resources, thus both land use types are important in sustaining pollinator communities; (iii) thus, pollinator conservation can rely even on arable fields under traditional management regime. This has an indirect message that the tiny flower margins around large intensive fields in west Europe can be insufficient conservation measures to restore pollinator communities at the landscape scale, as this is still far the baseline of necessary flower resources. This hypothesis needs further study, which includes more traditional landscapes providing baseline, and exploration of other factors behind the lower than baseline level biodiversity values of fields under agri-environmental schemes (AES).	[Kovacs-Hostyanszki, Aniko; Foldesi, Rita; Mozes, Edina; Szirak, Adam; Baldi, Andras] MTA Ctr Ecol Res, Inst Ecol & Bot, Lendulet Ecosyst Serv Res Grp, Vacratot, Hungary; [Fischer, Joern; Hanspach, Jan] Leuphana Univ, Fac Sustainabil, Luneburg, Germany	Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Leuphana University Luneburg	Kovacs-Hostyanszki, A (corresponding author), MTA Ctr Ecol Res, Inst Ecol & Bot, Lendulet Ecosyst Serv Res Grp, Vacratot, Hungary.	kovacs.aniko@okologia.mta.hu	Fischer, Joern/W-5380-2019; Foldesi, Rita/AAU-7609-2020; Fischer, Joern/C-6625-2012; Baldi, Andras/A-7501-2008	Foldesi, Rita/0000-0002-3500-981X; Fischer, Joern/0000-0003-3187-8978; Baldi, Andras/0000-0001-6063-3721; Hanspach, Jan/0000-0002-6638-8699	'Lendulet' program of the Hungarian Academy of Sciences	'Lendulet' program of the Hungarian Academy of Sciences	A. Kovacs-Hostyanszki was a Bolyai and a MTA Postdoc Fellow (http://mta.hu/english/). The study was supported by the 'Lendulet' program of the Hungarian Academy of Sciences (http://mta.hu/english/).	Alignier A, 2014, BIOL CONTROL, V77, P76, DOI 10.1016/j.biocontrol.2014.06.006; [Anonymous], 2009, BUTTERFLIES EUROPE, DOI DOI 10.1111/j.1365-3113.2006.00333.x; Archer CR, 2014, OIKOS, V123, P401, DOI 10.1111/j.1600-0706.2013.00949.x; Baldi A, 2007, AGR ECOSYST ENVIRON, V118, P307, DOI 10.1016/j.agee.2006.05.021; Baldi A, 2011, BIRD STUDY, V58, P365, DOI 10.1080/00063657.2011.588685; Batary P, 2010, AGR ECOSYST ENVIRON, V136, P35, DOI 10.1016/j.agee.2009.11.004; Benelli G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093153; Benjamin FE, 2014, J APPL ECOL, V51, P440, DOI 10.1111/1365-2664.12198; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Bommarco R, 2010, P ROY SOC B-BIOL SCI, V277, P2075, DOI 10.1098/rspb.2009.2221; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; de Snoo GR, 2013, CONSERV LETT, V6, P66, DOI 10.1111/j.1755-263X.2012.00296.x; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; Delibes-Mateos M, 2009, ENVIRON MANAGE, V43, P1256, DOI 10.1007/s00267-009-9297-5; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Donald PF, 2002, AGR ECOSYST ENVIRON, V89, P167, DOI 10.1016/S0167-8809(01)00244-4; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Ekroos J, 2013, LANDSCAPE ECOL, V28, P1283, DOI 10.1007/s10980-013-9864-2; European Environment Agency (EEA), 2013, EUR TOP CTR SPAT INF; Fischer J, 2012, CONSERV LETT, V5, P167, DOI 10.1111/j.1755-263X.2012.00227.x; Fox R, 2013, INSECT CONSERV DIVER, V6, P5, DOI 10.1111/j.1752-4598.2012.00186.x; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gellrich M, 2007, AGR ECOSYST ENVIRON, V118, P93, DOI 10.1016/j.agee.2006.05.001; Genz A., 2013, MVTNORM MULTIVARIATE; Gilbert N, 2014, NATURE, V510, P455, DOI 10.1038/510455a; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Hanspach J, 2014, ECOL SOC, V19, DOI 10.5751/ES-06915-190432; Hartel T, 2010, BIOL CONSERV, V143, P1118, DOI 10.1016/j.biocon.2010.02.006; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jauker F, 2009, LANDSCAPE ECOL, V24, P547, DOI 10.1007/s10980-009-9331-2; Kleijn D, 2006, BASIC APPL ECOL, V7, P201, DOI 10.1016/j.baae.2005.07.011; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Kovacs-Hostyanszki A, 2011, AGR FOREST ENTOMOL, V13, P59, DOI 10.1111/j.1461-9563.2010.00498.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Loos J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103256; Mand M, 2002, AGR ECOSYST ENVIRON, V89, P69, DOI 10.1016/S0167-8809(01)00319-X; Meyer B, 2009, BASIC APPL ECOL, V10, P178, DOI 10.1016/j.baae.2008.01.001; Michener C.D., 2007, BEES WORLD, Vsecond; Michez D, 2013, ATLAS HYMENOPTERA; Moczar M, 1967, FAUNA HUNGARIAE; Moczar M, 1957, FAUNA HUNGARIAE, V19; Moczar M, 1958, FAUNA HUNGARIAE, V35; Moczar M, 1960, FAUNA HUNGARIAE, V51; Muller A, 2008, BIOL J LINN SOC, V95, P719, DOI 10.1111/j.1095-8312.2008.01113.x; Muller D, 2013, AGR SYST, V117, P66, DOI 10.1016/j.agsy.2012.12.010; Nicholls CI, 2013, AGRON SUSTAIN DEV, V33, P257, DOI 10.1007/s13593-012-0092-y; Nieto A., 2014, EUROPEAN RED LIST BE; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; Oksanen J., 2008, VEGAN PACKAGE COMMUN; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Pe'er G, 2014, SCIENCE, V344, P1090, DOI 10.1126/science.1253425; Pinheiro J, 2013, NLME LINEAR NONLINEA; Plieninger T, 2006, ENVIRON SCI POLICY, V9, P317, DOI 10.1016/j.envsci.2006.03.001; Poyry J, 2009, GLOBAL CHANGE BIOL, V15, P732, DOI 10.1111/j.1365-2486.2008.01789.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raymond L, 2014, AGR ECOSYST ENVIRON, V185, P99, DOI 10.1016/j.agee.2013.12.019; Rogerson P.A., 2001, STAT METHODS GEOGRAP; Rundlof M, 2014, BIOL CONSERV, V172, P138, DOI 10.1016/j.biocon.2014.02.027; Sanderson FJ, 2013, AGR ECOSYST ENVIRON, V168, P16, DOI 10.1016/j.agee.2013.01.015; Schmid-Egger C., 1997, ILLUSTRIERTE BESTIMM; Schmidt MH, 2003, P ROY SOC B-BIOL SCI, V270, P1905, DOI 10.1098/rspb.2003.2469; SSYMANK A, 1993, DEUT ENTOMOL Z, V40, P245; Stanescu Carmen, 2005, Travaux du Museum National d'Histoire Naturelle Grigore Antipa, V48, P177; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Storkey J, 2012, P ROY SOC B-BIOL SCI, V279, P1421, DOI 10.1098/rspb.2011.1686; Stubbs A., 2002, BRIT HOVERFLIES ILLU, V2nd; Sutcliffe LME, 2015, DIVERS DISTRIB, V21, P722, DOI 10.1111/ddi.12288; Tomanovic Z, 2008, EUR J ENTOMOL, V105, P495, DOI 10.14411/eje.2008.064; Tryjanowski P, 2011, ACTA ORNITHOL, V46, P1, DOI 10.3161/000164511X589857; Van Veen M. P., 2004, HOVERFLIES NW EUROPE; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Westphal C, 2006, OECOLOGIA, V149, P289, DOI 10.1007/s00442-006-0448-6	80	26	27	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0151650	10.1371/journal.pone.0151650	http://dx.doi.org/10.1371/journal.pone.0151650			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285118	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000377564000001
J	Ghaffarzadegan, T; Marungruang, N; Fak, F; Nyman, M				Ghaffarzadegan, Tannaz; Marungruang, Nittaya; Fak, Frida; Nyman, Margareta			Molecular Properties of Guar Gum and Pectin Modify Cecal Bile Acids, Microbiota, and Plasma Lipopolysaccharide-Binding Protein in Rats	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; URSODEOXYCHOLIC ACID; DIETARY FIBER; CHENODEOXYCHOLIC ACID; GAS-CHROMATOGRAPHY; DISEASE; MICE; FERMENTATION; MODULATION; EXCRETION	Bile acids (BAs) act as signaling molecules in various physiological processes, and are related to colonic microbiota composition as well as to different types of dietary fat and fiber. This study investigated whether guar gum and pectin-two fibers with distinct functional characteristics-affect BA profiles, microbiota composition, and gut metabolites in rats. Low-(LM) or high-methoxylated (HM) pectin, and low-, medium-, or high-molecular-weight (MW) guar gum were administered to rats that were fed either low-or high-fat diets. Cecal BAs, short-chain fatty acids (SCFA) and microbiota composition, and plasma lipopolysaccharide- binding protein (LBP) levels were analyzed, by using novel methodologies based on gas chromatography (BAs and SCFAs) and 16S rRNA gene sequencing on the Illumina MiSeq platform. Strong correlations were observed between cecal BA and SCFA levels, microbiota composition, and portal plasma LBP levels in rats on a high-fat diet. Notably, guar gum consumption with medium-MW increased the cecal amounts of cholic-, cheno-deoxycholic-, and ursodeoxycholic acids as well as alpha-, beta-, and omega-muricholic acids to a greater extent than other types of guar gum or the fiber-free control diet. In contrast, the amounts of cecal deoxycholic-and hyodeoxycholic acid were reduced with all types of guar gum independent of chain length. Differences in BA composition between pectin groups were less obvious, but cecal levels of alpha- and omega-muricholic acids were higher in rats fed LM as compared to HM pectin or the control diet. The inflammatory marker LBP was down-regulated in rats fed medium-MW guar gum and HM pectin; these two fibers decreased the cecal abundance of Oscillospira and an unclassified genus in Ruminococcaceae, and increased that of an unclassified family in RF32. These results indicate that the molecular properties of guar gum and pectin are important for their ability to modulate cecal BA formation, gut microbiota composition, and high-fat diet induced inflammation.	[Ghaffarzadegan, Tannaz; Marungruang, Nittaya; Fak, Frida; Nyman, Margareta] Lund Univ, Food Hlth Sci Ctr, Lund, Sweden	Lund University	Ghaffarzadegan, T (corresponding author), Lund Univ, Food Hlth Sci Ctr, Lund, Sweden.	tannaz.ghaffarzadegan@food-health-science.lu.se	Ghaffarzadegan, Tannaz/ABC-4411-2020; Nyman, Margareta/AAY-9466-2020	Nyman, Margareta/0000-0003-3660-2364; Ghaffarzadegan, Tannaz/0000-0001-6170-1474; Marungruang, Nittaya/0000-0001-9769-7980	Antidiabetic Food Centre; Per Hakansson Foundation; VINNOVA VINN Excellence Center at Lund University	Antidiabetic Food Centre; Per Hakansson Foundation; VINNOVA VINN Excellence Center at Lund University	The study was supported by the Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University (http://www.ffsc.lu.se/afc), and Per Hakansson Foundation.	Araki Y, 2000, DIGEST LIVER DIS, V32, P691, DOI 10.1016/S1590-8658(00)80332-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGGREN AM, 1993, J SCI FOOD AGR, V63, P397, DOI 10.1002/jsfa.2740630405; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carubbi F, 2002, BBA-MOL CELL BIOL L, V1580, P31, DOI 10.1016/S1388-1981(01)00184-6; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Espina-Ruiz M, 2014, J AGR FOOD CHEM, V62, P12620, DOI 10.1021/jf504829h; Fak F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127252; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; Fukiya S, 2009, FEMS MICROBIOL LETT, V293, P263, DOI 10.1111/j.1574-6968.2009.01531.x; Fuller S, 2016, PLANT FOOD HUM NUTR, V71, P1, DOI 10.1007/s11130-016-0529-6; Gaby AR, 2009, ALTERN MED REV, V14, P258; Ghaffarzadegan T, 2014, J CHROMATOGR B, V944, P69, DOI 10.1016/j.jchromb.2013.11.012; Hughes SA, 2007, J AGR FOOD CHEM, V55, P4589, DOI 10.1021/jf070293g; Im E, 2004, J NUTR, V134, P483, DOI 10.1093/jn/134.2.483; Jakobsdottir G, 2014, NUTRITION, V30, P497, DOI 10.1016/j.nut.2013.08.013; Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476; Jakobsdottir G, 2013, BRIT J NUTR, V110, P1565, DOI 10.1017/S0007114513000809; Jakobsdottir G, 2013, SCAND J GASTROENTERO, V48, P696, DOI 10.3109/00365521.2013.786128; Jones RD, 2015, STEROIDS, V93, P87, DOI 10.1016/j.steroids.2014.11.002; Joyce SA, 2016, ANNU REV FOOD SCI T, V7, P313, DOI 10.1146/annurev-food-041715-033159; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Martinez-Moya P, 2013, INT IMMUNOPHARMACOL, V15, P372, DOI 10.1016/j.intimp.2012.11.017; McDonald JH, 2014, HDB BIOL STAT, P254; Nilsson U, 2005, BRIT J NUTR, V94, P705, DOI 10.1079/BJN20051531; NYMAN M, 1990, J NUTR, V120, P459, DOI 10.1093/jn/120.5.459; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Rodriguez VA, 2016, ARCH BIOCHEM BIOPHYS, V591, P28, DOI 10.1016/j.abb.2015.12.006; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Shih DM, 2013, FASEB J, V27, P3805, DOI 10.1096/fj.12-223008; Stenman LK, 2012, WORLD J GASTROENTERO, V18, P923, DOI 10.3748/wjg.v18.i9.923; Tsuchida T, 2012, METABOLISM, V61, P944, DOI 10.1016/j.metabol.2011.10.023; Vuksan V, 2011, BRIT J NUTR, V106, P1349, DOI 10.1017/S0007114511001711; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woting A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040202; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zhong YD, 2015, MOL NUTR FOOD RES, V59, P2066, DOI 10.1002/mnfr.201500187; Zhou HP, 2014, STEROIDS, V86, P62, DOI 10.1016/j.steroids.2014.04.016	43	25	28	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157427	10.1371/journal.pone.0157427	http://dx.doi.org/10.1371/journal.pone.0157427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315087	Green Published, gold, Green Submitted			2022-12-27	WOS:000378030000025
J	Law, EC; Wilman, HR; Kelm, S; Shi, JY; Deane, CM				Law, Eleanor C.; Wilman, Henry R.; Kelm, Sebastian; Shi, Jiye; Deane, Charlotte M.			Examining the Conservation of Kinks in Alpha Helices	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSMEMBRANE HELICES; STRUCTURE ALIGNMENT; MEMBRANE-PROTEINS; DATA-BANK; PROLINE; DISTORTIONS; ACTIVATION; ALGORITHM; FEATURES	Kinks are a structural feature of alpha-helices and many are known to have functional roles. Kinks have previously tended to be defined in a binary fashion. In this paper we have deliberately moved towards defining them on a continuum, which given the unimodal distribution of kink angles is a better description. From this perspective, we examine the conservation of kinks in proteins. We find that kink angles are not generally a conserved property of homologs, pointing either to their not being functionally critical or to their function being related to conformational flexibility. In the latter case, the different structures of homologs are providing snapshots of different conformations. Sequence identity between homologous helices is informative in terms of kink conservation, but almost equally so is the sequence identity of residues in spatial proximity to the kink. In the specific case of proline, which is known to be prevalent in kinked helices, loss of a proline from a kinked helix often also results in the loss of a kink or reduction in its kink angle. We carried out a study of the seven transmembrane helices in the GPCR family and found that changes in kinks could be related both to subfamilies of GPCRs and also, in a particular subfamily, to the binding of agonists or antagonists. These results suggest conformational change upon receptor activation within the GPCR family. We also found correlation between kink angles in different helices, and the possibility of concerted motion could be investigated further by applying our method to molecular dynamics simulations. These observations reinforce the belief that helix kinks are key, functional, flexible points in structures.	[Law, Eleanor C.; Wilman, Henry R.; Deane, Charlotte M.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Kelm, Sebastian; Shi, Jiye] UCB Pharma, Informat, Slough, Berks, England; [Shi, Jiye] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai, Peoples R China	University of Oxford; UCB Pharma SA; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Deane, CM (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	deane@stats.ox.ac.uk		Kelm, Sebastian/0000-0001-7146-9322; Wilman, Henry/0000-0002-3362-1204; Deane, Charlotte/0000-0003-1388-2252; Law, Eleanor/0000-0001-5591-7316	Engineering and Physical Sciences Research Council [EP/G037280/1]; UCB Pharma; EPSRC [EP/G037280/1]; Engineering and Physical Sciences Research Council [1367765] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UCB Pharma(UCB Pharma SA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council (https://www.epsrc.ac.uk/) grant EP/G037280/1 to ECL, and UCB Pharma (http://www.ucbpharma.co.uk/home) funding to ECL and HRW. SK and JS of UCB provided ideas for the design of the study and contributed to the editing of the manuscript. The funder provided support in the form of salaries for authors SK and JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; The authors would like to thank the EPSRC (grant number EP/G037280/1) and UCB Pharma for funding, and the Oxford Protein Informatics Group for discussion.	Bansal M, 2000, J BIOMOL STRUCT DYN, V17, P811, DOI 10.1080/07391102.2000.10506570; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bettinelli I, 2011, CHEMMEDCHEM, V6, P1217, DOI 10.1002/cmdc.201100037; Choe S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3138906; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Deupi Xavier, 2012, Methods Mol Biol, V914, P219, DOI 10.1007/978-1-62703-023-6_13; Hall SE, 2009, J MOL GRAPH MODEL, V27, P944, DOI 10.1016/j.jmgm.2009.02.004; Isberg V, 2014, NUCLEIC ACIDS RES, V42, pD422, DOI 10.1093/nar/gkt1255; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kauko A, 2008, J MOL BIOL, V380, P170, DOI 10.1016/j.jmb.2008.04.052; Kelm S, 2009, BIOINFORMATICS, V25, P1086, DOI 10.1093/bioinformatics/btp102; Kneissl B, 2011, J CHEM INF MODEL, V51, P3017, DOI 10.1021/ci200278w; Kozma D, 2013, NUCLEIC ACIDS RES, V41, pD524, DOI 10.1093/nar/gks1169; Langelaan DN, 2013, BBA-BIOMEMBRANES, V1828, P1471, DOI 10.1016/j.bbamem.2013.02.005; Langelaan DN, 2010, J CHEM INF MODEL, V50, P2213, DOI 10.1021/ci100324n; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; Meruelo AD, 2011, PROTEIN SCI, V20, P1256, DOI 10.1002/pro.653; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Pedretti A, 2015, MOL INFORM, V34, P216, DOI 10.1002/minf.201400159; Tehan BG, 2014, PHARMACOL THERAPEUT, V143, P51, DOI 10.1016/j.pharmthera.2014.02.004; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Traag VA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016114; van der Kant R, 2014, INT J MOL SCI, V15, P7841, DOI 10.3390/ijms15057841; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Werner T, 2013, J CHEM INF MODEL, V53, P2926, DOI 10.1021/ci400236s; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wilman HR, 2014, J CHEM INF MODEL, V54, P2585, DOI 10.1021/ci500403a; Wilman HR, 2014, PROTEINS, V82, P1960, DOI 10.1002/prot.24550; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	36	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157553	10.1371/journal.pone.0157553	http://dx.doi.org/10.1371/journal.pone.0157553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314675	Green Published, gold, Green Submitted			2022-12-27	WOS:000378030000034
J	D'Orazio, V; Kenwick, M; Lane, M; Palmer, G; Reitter, D				D'Orazio, Vito; Kenwick, Michael; Lane, Matthew; Palmer, Glenn; Reitter, David			Crowdsourcing the Measurement of Interstate Conflict	PLOS ONE			English	Article							MECHANICAL TURK; EVENT DATA; CODING RULES; DATA SET; AGREEMENT; KAPPA	Much of the data used to measure conflict is extracted from news reports. This is typically accomplished using either expert coders to quantify the relevant information or machine coders to automatically extract data from documents. Although expert coding is costly, it produces quality data. Machine coding is fast and inexpensive, but the data are noisy. To diminish the severity of this tradeoff, we introduce a method for analyzing news documents that uses crowdsourcing, supplemented with computational approaches. The new method is tested on documents about Militarized Interstate Disputes, and its accuracy ranges between about 68 and 76 percent. This is shown to be a considerable improvement over automated coding, and to cost less and be much faster than expert coding.	[D'Orazio, Vito] Univ Texas Dallas, Sch Econ Polit & Policy Sci, Richardson, TX 75083 USA; [Kenwick, Michael; Lane, Matthew; Palmer, Glenn] Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA; [Reitter, David] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA	University of Texas System; University of Texas Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	D'Orazio, V (corresponding author), Univ Texas Dallas, Sch Econ Polit & Policy Sci, Richardson, TX 75083 USA.	dorazio@utdallas.edu			Penn State's Social Science Research Institute; NSF Grants [SBE-SES-1528624, SBE-SES-1528409]; Social Science Research Institute at Penn State	Penn State's Social Science Research Institute; NSF Grants(National Science Foundation (NSF)); Social Science Research Institute at Penn State	This works has been funded by Penn State's Social Science Research Institute (http://www.ssri.psu.edu). Award recipients are VJD, GP, and DR. This work has been funded in part by NSF Grants SBE-SES-1528624 and SBE-SES-1528409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Scott Bennett, Doug Gibler, Tracy Lin, Zeev Maoz, Alex Ororbia, Michael Schmierbach, Phil Schrodt, Aaron Shreve, and Yang Xu for their contributions to this project. The authors gratefully acknowledge Doug Teti and the Social Science Research Institute at Penn State for their assistance and financial support.	[Anonymous], 2009, RUSSIA CIS GEN  0305; [Anonymous], 2000, CORRELATES WAR MID I; Banerjee M, 1999, CAN J STAT, V27, P3, DOI 10.2307/3315487; Benoit K, 2016, AM POLITICA IN PRESS; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bond D, 1997, J CONFLICT RESOLUT, V41, P553, DOI 10.1177/0022002797041004004; Byun TM, 2015, J COMMUN DISORD, V53, P70, DOI 10.1016/j.jcomdis.2014.11.003; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Carmel D., 2014, ACM SIGIR FORUM, V48, P63, DOI DOI 10.1145/2701583.2701591; Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; D'Orazio V, 2014, POLIT ANAL, V22, P224, DOI 10.1093/pan/mpt030; Demartini G., 2012, P 21 INT C WORLD WID, P469; Felstiner A, 2011, BERKELEY J EMPLOY LA, V32, P143, DOI DOI 10.15779/Z38Z92X; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Ghosn F, 2004, CONFLICT MANAG PEACE, V21, P133, DOI 10.1080/07388940490463861; Goertz G, 2006, SOCIAL SCIENCE CONCEPTS: A USER'S GUIDE, P1; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Heckerman D, 1998, TUTORIAL LEARNING BA; Honaker J, 2013, SORTING ALGORITHMS Q; Howe J, 2006, CROWDSOURCING DEFINI; Jones DM, 1996, CONFLICT MANAG PEACE, V15, P163, DOI 10.1177/073889429601500203; Karger David R., 2013, Performance Evaluation Review, V41, P81; King G, 2003, INT ORGAN, V57, P617, DOI 10.1017/S0020818303573064; Kittur A, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P453; Krippendorff K. H., 2013, CONTENT ANAL INTRO I; Lofi C, 2012, DATENBANK SPEKTRUM, V12, P109, DOI DOI 10.1007/S13222-012-0092-8; Lombard M, 2002, HUM COMMUN RES, V28, P587, DOI 10.1111/j.1468-2958.2002.tb00826.x; Nielsen T.D., 2009, BAYESIAN NETWORKS DE; O'Brien SP, 2010, INT STUD REV, V12, P87, DOI 10.1111/j.1468-2486.2009.00914.x; OConnor B., 2013, ACL, V1, P1094; Ororbia Alexander G.  II, 2015, Social Computing, Behavioral-Cultural Modeling and Prediction. 8th International Conference, SBP 2015. Proceedings: LNCS 9021, P381, DOI 10.1007/978-3-319-16268-3_47; Palmer G, 2015, CONFLICT MANAG PEACE, V32, P222, DOI 10.1177/0738894214559680; Paolacci G, 2010, JUDGM DECIS MAK, V5, P5, DOI DOI 10.1111/NTWE.12038; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Raykar VC, 2010, J MACH LEARN RES, V11, P1297; Ross J., 2010, HUMAN FACTORS COMPUT, DOI [10.1145/1753846.1753873, DOI 10.1145/1753846.1753873]; Sabou M., 2012, P 12 INT C KNOWL MAN, P17; Sartori G., 1984, SOCIAL SCI CONCEPTS; Schrodt P. A., 2012, ANAL INT EVENT DATA; Schrodt P.A., 2010, AUTOMATED PRODUCTION; SCHRODT PA, 1994, INT INTERACT, V20, P35, DOI 10.1080/03050629408434839; SCHRODT PA, 1994, AM J POLIT SCI, V38, P825, DOI 10.2307/2111609; Schrodt PA, 2014, TABARI TEXTUAL ANAL; Schrodt PA., 2012, CONFLICT MEDIATION E; Snow R., 2008, P C EMP METH NAT LAN, P254, DOI DOI 10.3115/1613715.1613751; Surowiecki J., 2005, WISDOM CROWDS; Tingley D, 2014, COMP POLIT STUD, V47, P344, DOI 10.1177/0010414013509571; Wolfson S. M., 2011, ASIST P, V48, P1, DOI [DOI 10.1002/MEET.2011.14504801135, DOI 10.1002/MEET.2011]; Zeller R. A., 1980, MEASUREMENT SOCIAL S; Zhai HJ, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2426	53	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156527	10.1371/journal.pone.0156527	http://dx.doi.org/10.1371/journal.pone.0156527			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310427	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800008
J	Elbel, B; Corcoran, SP; Schwartz, AE				Elbel, Brian; Corcoran, Sean P.; Schwartz, Amy Ellen			Neighborhoods, Schools and Obesity: The Potential for Place-Based Approaches to Reduce Childhood Obesity	PLOS ONE			English	Article							NEW-YORK-CITY; BODY-MASS INDEX; HEALTH; ENVIRONMENTS; OVERWEIGHT; BEHAVIORS; QUALITY; ACCESS	A common policy approach to reducing childhood obesity aims to shape the environment in which children spend most of their time: neighborhoods and schools. This paper uses richly detailed data on the body mass index (BMI) of all New York City public school students in grades K-8 to assess the potential for place-based approaches to reduce child obesity. We document variation in the prevalence of obesity across NYC public schools and census tracts, and then estimate the extent to which this variation can be explained by differences in individual-level predictors (such as race and household income). Both unadjusted and adjusted variability across neighborhoods and schools suggest place-based policies have the potential to meaningfully reduce child obesity, but under most realistic scenarios the improvement would be modest.	[Elbel, Brian] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Elbel, Brian; Schwartz, Amy Ellen] NYU, Robert F Wagner Grad Sch Publ Serv, New York, NY 10003 USA; [Corcoran, Sean P.; Schwartz, Amy Ellen] NYU, Steinhardt Sch Culture Educ & Human Dev, New York, NY USA; [Schwartz, Amy Ellen] Syracuse Univ, Maxwell Sch, Syracuse, NY USA	New York University; New York University; New York University; Syracuse University	Elbel, B (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY USA.; Elbel, B (corresponding author), NYU, Robert F Wagner Grad Sch Publ Serv, New York, NY 10003 USA.	brian.elbel@nyumc.org		Corcoran, Sean/0000-0002-0640-2751; Elbel, Brian/0000-0003-1615-9430	National Institutes of Health [R01HD070739, R01DK097347]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health, Award Numbers R01HD070739 (AS) and R01DK097347 (BE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black JL, 2010, HEALTH PLACE, V16, P489, DOI 10.1016/j.healthplace.2009.12.007; Black JL, 2010, AM J EPIDEMIOL, V171, P765, DOI 10.1093/aje/kwp458; Borders TF, 2006, J COMMUN HEALTH, V31, P57, DOI 10.1007/s10900-005-8189-8; Briefel RR, 2009, J AM DIET ASSOC, V109, pS91, DOI 10.1016/j.jada.2008.10.059; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Centers for Disease Control and Prevention, CUT OFFS DEF OUTL 20; Centers for Disease Control and Prevention, 2015, CHILDR HLTH BUILT EN; Cradock AL, 2014, HDB HLTH BEHAV CHANG; Drewnowski A., 2012, AM J PUBLIC HEALTH, V102, P74, DOI DOI 10.2105/AJPH.2012.300660; Economic Research Service (ERS) U.S. Department of Agriculture (USDA), FOOD ACC RES ATL; Grow HMG, 2010, SOC SCI MED, V71, P584, DOI 10.1016/j.socscimed.2010.04.018; Hoelscher DM, 2004, AM J PUBLIC HEALTH, V94, P1002, DOI 10.2105/AJPH.94.6.1002; Janssen I, 2004, PEDIATRICS, V113, P1187, DOI 10.1542/peds.113.5.1187; Karpyn A, 2012, CHILD OBES, V8, P28, DOI 10.1089/chi.2011.0113; Morrow JR, 2010, RES Q EXERCISE SPORT, V81, pS24, DOI 10.1080/02701367.2010.10599691; Nelson JA, 2004, AM J PUBLIC HEALTH, V94, P458, DOI 10.2105/AJPH.94.3.458; O'Malley PM, 2007, AM J PREV MED, V33, pS187, DOI 10.1016/j.amepre.2007.07.001; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pearce J, 2008, J EPIDEMIOL COMMUN H, V62, P198, DOI 10.1136/jech.2006.059196; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Rundle A, 2007, AM J HEALTH PROMOT, V21, P326, DOI 10.4278/0890-1171-21.4s.326; Rundle A, 2009, ENVIRON HEALTH PERSP, V117, P442, DOI 10.1289/ehp.11590; Rundle A, 2012, AM J EPIDEMIOL, V176, P986, DOI 10.1093/aje/kws187; Schwartz AE, 2016, JAMA PEDIATR, V170, P220, DOI 10.1001/jamapediatrics.2015.3778; Singh GK, 2010, HEALTH AFFAIR, V29, P503, DOI 10.1377/hlthaff.2009.0730; Stark JH, 2014, PREV MED, V64, P63, DOI 10.1016/j.ypmed.2014.03.026; Story M, 1999, INT J OBESITY, V23, pS43, DOI 10.1038/sj.ijo.0800859; Thorpe LE, 2004, AM J PUBLIC HEALTH, V94, P1496, DOI 10.2105/AJPH.94.9.1496; US Census Bureau, US CENS BUR PART STA; Veugelers PJ, 2005, AM J PUBLIC HEALTH, V95, P432, DOI 10.2105/AJPH.2004.045898	31	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157479	10.1371/journal.pone.0157479	http://dx.doi.org/10.1371/journal.pone.0157479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309533	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800080
J	Sollberger, G; Amulic, B; Zychlinsky, A				Sollberger, Gabriel; Amulic, Borko; Zychlinsky, Arturo			Neutrophil Extracellular Trap Formation Is Independent of De Novo Gene Expression	PLOS ONE			English	Article							IMMUNITY	Neutrophils are essential innate immune cells whose responses are crucial in the clearance of invading pathogens. Neutrophils can respond to infection by releasing neutrophil extracellular traps (NETs). NETs are formed of chromatin and specific granular proteins and are released after execution of a poorly characterized cell death pathway. Here, we show that NET formation induced by PMA or Candida albicans is independent of RNA polymerase II and III-mediated transcription as well as of protein synthesis. Thus, neutrophils contain all the factors required for NET formation when they emerge from the bone marrow as differentiated cells.	[Sollberger, Gabriel; Amulic, Borko; Zychlinsky, Arturo] Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany	Max Planck Society	Sollberger, G; Amulic, B (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany.	sollberger@mpiib-berlin.mpg.de; amulic@mpiib-berlin.mpg.de		Amulic, Borko/0000-0002-8518-8393; si yun, feng/0000-0002-3546-824X	Swiss National Science Foundation; EMBO long term fellowship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO long term fellowship(European Molecular Biology Organization (EMBO))	GS is supported by an Advanced PostDoc. Mobility fellowship from the Swiss National Science Foundation. BA was supported by an EMBO long term fellowship.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00413; Ermert D, 2009, J INNATE IMMUN, V1, P181, DOI 10.1159/000205281; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Harbort CJ, 2015, BLOOD, V126, P2842, DOI 10.1182/blood-2015-05-645424; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; KASAMA T, 1993, J EXP MED, V178, P63, DOI 10.1084/jem.178.1.63; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Subrahmanyam YVBK, 2001, BLOOD, V97, P2457, DOI 10.1182/blood.V97.8.2457	15	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157454	10.1371/journal.pone.0157454	http://dx.doi.org/10.1371/journal.pone.0157454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310721	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800075
J	Victor, JM; Debret, G; Lesne, A; Pascoe, L; Carrivain, P; Wainrib, G; Hugot, JP				Victor, Jean-Marc; Debret, Gaelle; Lesne, Annick; Pascoe, Leigh; Carrivain, Pascal; Wainrib, Gilles; Hugot, Jean-Pierre			Network Modeling of Crohn's Disease Incidence	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; EPIDEMIOLOGY; VARIANT; UPDATE; SUSCEPTIBILITY; PREVALENCE; MINNESOTA; COMPLEX; BINDING	Background Numerous genetic and environmental risk factors play a role in human complex genetic disorders (CGD). However, their complex interplay remains to be modelled and explained in terms of disease mechanisms. Methods and findings Crohn's Disease (CD) was modeled as a modular network of patho-physiological functions, each summarizing multiple gene-gene and gene-environment interactions. The disease resulted from one or few specific combinations of module functional states. Network aging dynamics was able to reproduce age-specific CD incidence curves as well as their variations over the past century in Western countries. Within the model, we translated the odds ratios (OR) associated to at-risk alleles in terms of disease propensities of the functional modules. Finally, the model was successfully applied to other CGD including ulcerative colitis, ankylosing spondylitis, multiple sclerosis and schizophrenia. Conclusion Modeling disease incidence may help to understand disease causative chains, to delineate the potential of personalized medicine, and to monitor epidemiological changes in CGD.	[Victor, Jean-Marc; Debret, Gaelle; Lesne, Annick; Carrivain, Pascal] CNRS, UMR 7600, Lab Phys Theor Matiere Condensee, Paris, France; [Victor, Jean-Marc; Debret, Gaelle; Lesne, Annick; Carrivain, Pascal] Sorbonne Univ, Univ Paris 06, Paris, France; [Victor, Jean-Marc; Lesne, Annick] Univ Montpellier, CNRS, Inst Genet Mol Montpellier, UMR 5535, F-34059 Montpellier, France; [Pascoe, Leigh] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, Paris, France; [Wainrib, Gilles] Ecole Normale Super, 24 Rue Lhomond, F-75231 Paris, France; [Wainrib, Gilles; Hugot, Jean-Pierre] Univ Paris Diderot, Sorbonne Paris Cite, Labex Inflamex, Paris, France; [Hugot, Jean-Pierre] INSERM, UMR 1149, Paris, France; [Hugot, Jean-Pierre] Hop Robert Debre, AP HP, F-75019 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Foundation Jean Dausset-CEPH; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Victor, JM (corresponding author), CNRS, UMR 7600, Lab Phys Theor Matiere Condensee, Paris, France.; Victor, JM (corresponding author), Sorbonne Univ, Univ Paris 06, Paris, France.; Victor, JM (corresponding author), Univ Montpellier, CNRS, Inst Genet Mol Montpellier, UMR 5535, F-34059 Montpellier, France.; Hugot, JP (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Labex Inflamex, Paris, France.; Hugot, JP (corresponding author), INSERM, UMR 1149, Paris, France.; Hugot, JP (corresponding author), Hop Robert Debre, AP HP, F-75019 Paris, France.	victor@lptmc.jussieu.fr; jean-pierre.hugot@rdb.aphp.fr	Victor, Jean-Marc/AAB-1362-2020; Lesne, Annick/W-9444-2018	Hugot, Jean-Pierre/0000-0002-8446-6056; Lesne, Annick/0000-0002-6647-612X	ANR, Investissements d'Avenir programme [ANR-11-IDEX-0005-02]; CNRS; INSERM; Universite Paris Diderot-Sorbonne Paris-Cite; Universite Pierre et Marie Curie; Universite Paris 13; Association Francois Aupetit; Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX	ANR, Investissements d'Avenir programme(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Diderot-Sorbonne Paris-Cite; Universite Pierre et Marie Curie; Universite Paris 13; Association Francois Aupetit; Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX	This work was supported by ANR, Investissements d'Avenir programme ANR-11-IDEX-0005-02 Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX, CNRS, INSERM, Universite Paris Diderot-Sorbonne Paris-Cite, Universite Pierre et Marie Curie, Universite Paris 13 and Association Francois Aupetit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by ANR, Investissements d'Avenir programme ANR-11-IDEX-0005-02 Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX, CNRS, INSERM, Universite Paris Diderot-Sorbonne Paris-Cite, Universite Pierre et Marie Curie, Universite Paris 13 and Association Francois Aupetit.	Aguilar C, 2014, J ALLERGY CLIN IMMUN, V134, P1131, DOI 10.1016/j.jaci.2014.04.031; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; CARBONE LD, 1992, ARTHRITIS RHEUM, V35, P1476, DOI 10.1002/art.1780351211; Chouraki V, 2011, ALIMENT PHARM THER, V33, P1133, DOI 10.1111/j.1365-2036.2011.04628.x; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; CROHN BB, 1984, JAMA-J AM MED ASSOC, V251, P73, DOI 10.1001/jama.251.1.73; Debret G, 2011, HIST PHIL LIFE SCI, V33, P497; Gavrilov LA, 2001, J THEOR BIOL, V213, P527, DOI 10.1006/jtbi.2001.2430; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gordon H, 2015, INFLAMM BOWEL DIS, V21, P1428, DOI 10.1097/MIB.0000000000000393; Gunesh S, 2008, ALIMENT PHARM THER, V27, P211, DOI 10.1111/j.1365-2036.2007.03576.x; Hugot JP, 2003, LANCET, V362, P2012, DOI 10.1016/S0140-6736(03)15024-6; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Lapidus A, 1997, GUT, V41, P480, DOI 10.1136/gut.41.4.480; Li XJ, 2007, SCHIZOPHR RES, V97, P43, DOI 10.1016/j.schres.2007.09.027; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Muise AM, 2012, GUT, V61, P1028, DOI 10.1136/gutjnl-2011-300078; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; PHADKE JG, 1987, J EPIDEMIOL COMMUN H, V41, P5, DOI 10.1136/jech.41.1.5; ROSE JDR, 1988, GUT, V29, P346, DOI 10.1136/gut.29.3.346; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Thevenot R, 1978, ESSAI HIST FROID ART; Wei Z, 2013, AM J HUM GENET, V92, P1008, DOI 10.1016/j.ajhg.2013.05.002; Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310	32	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156138	10.1371/journal.pone.0156138	http://dx.doi.org/10.1371/journal.pone.0156138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309539	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800002
J	Deliano, M; Tabelow, K; Konig, R; Polzehl, J				Deliano, Matthias; Tabelow, Karsten; Koenig, Reinhard; Polzehl, Joerg			Improving Accuracy and Temporal Resolution of Learning Curve Estimation for within- and across-Session Analysis	PLOS ONE			English	Article							INTERVAL ESTIMATION; AVOIDANCE; DYNAMICS; MODEL	Estimation of learning curves is ubiquitously based on proportions of correct responses within moving trial windows. Thereby, it is tacitly assumed that learning performance is constant within the moving windows, which, however, is often not the case. In the present study we demonstrate that violations of this assumption lead to systematic errors in the analysis of learning curves, and we explored the dependency of these errors on window size, different statistical models, and learning phase. To reduce these errors in the analysis of single-subject data as well as on the population level, we propose adequate statistical methods for the estimation of learning curves and the construction of confidence intervals, trial by trial. Applied to data from an avoidance learning experiment with rodents, these methods revealed performance changes occurring at multiple time scales within and across training sessions which were otherwise obscured in the conventional analysis. Our work shows that the proper assessment of the behavioral dynamics of learning at high temporal resolution can shed new light on specific learning processes, and, thus, allows to refine existing learning concepts. It further disambiguates the interpretation of neurophysiological signal changes recorded during training in relation to learning.	[Deliano, Matthias] Leibniz Inst Neurobiol, Dept Syst Physiol Learning, AG Brain Machine Interfaces, Magdeburg, Germany; [Tabelow, Karsten; Polzehl, Joerg] Weierstrass Inst Appl Anal & Stochast, Res Grp Stochast Algorithms & Nonparametr Stat, Berlin, Germany; [Koenig, Reinhard] Leibniz Inst Neurobiol, Special Lab Noninvas Brain Imaging, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Weierstrass Institute for Applied Analysis & Stochastics; Leibniz Institut fur Neurobiologie (LIN)	Deliano, M (corresponding author), Leibniz Inst Neurobiol, Dept Syst Physiol Learning, AG Brain Machine Interfaces, Magdeburg, Germany.	matthias.deliano@lin-magdeburg.de	Tabelow, Karsten/AAI-4490-2021	Tabelow, Karsten/0000-0003-1274-9951; Polzehl, Joerg/0000-0001-7471-2658				Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bathellier B, 2013, P NATL ACAD SCI USA, V110, P19950, DOI 10.1073/pnas.1312125110; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Brown S, 2003, BEHAV RES METH INS C, V35, P11, DOI 10.3758/BF03195493; Cain CK, 2008, HBK BEHAV NEUROSCI, V17, P103, DOI 10.1016/S1569-7339(07)00007-0; Collett D., 2003, MODELLING SURVIVAL D; Fan J., 1996, MONOGRAPHS STAT APPL, V66, pxvi+341; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Heinze G., 2013, R PACKAGE VERSION 12; Hennevin E, 2007, NEUROBIOL LEARN MEM, V87, P416, DOI 10.1016/j.nlm.2006.10.006; Maia TV, 2010, LEARN BEHAV, V38, P50, DOI 10.3758/LB.38.1.50; MCSWEENEY FK, 1993, J EXP ANAL BEHAV, V60, P621, DOI 10.1901/jeab.1993.60-621; Moutoussis M, 2008, NETWORK-COMP NEURAL, V19, P137, DOI 10.1080/09548980802192784; MYERS CE, 2014, FRONT BEHAV NEUROSCI, V8, DOI DOI 10.3389/FNBEH.2014.00283; Nelder J. A., 1998, MONOGRAPHS STAT APPL; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; R Development Core Team, R LANG ENV STAT COMP; Rothe T, 2009, BRAIN RES, V1297, P143, DOI 10.1016/j.brainres.2009.08.055; Schicknick H, 2006, NEUROPHARMACOLOGY, V50, P671, DOI 10.1016/j.neuropharm.2005.11.013; Seifert B., 2013, LPRIDGE LOCAL POLYNO; Servatius RJ, 2008, BEHAV BRAIN RES, V192, P191, DOI 10.1016/j.bbr.2008.04.006; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; SPEAR NE, 1973, J COMP PHYSIOL PSYCH, V85, P601, DOI 10.1037/h0035314; Stark H, 2008, NEUROSCIENCE, V151, P467, DOI 10.1016/j.neuroscience.2007.11.005; Suzuki Wendy A, 2005, Behav Cogn Neurosci Rev, V4, P67, DOI 10.1177/1534582305280030	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157355	10.1371/journal.pone.0157355	http://dx.doi.org/10.1371/journal.pone.0157355			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303809	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800052
J	Jones, D				Jones, Doug			Socially Enforced Nepotism: How Norms and Reputation Can Amplify Kin Altruism	PLOS ONE			English	Article							INDIRECT RECIPROCITY; EVOLUTION; COOPERATION; KINSHIP	Kin selection, which can lead organisms to behave altruistically to their genetic relatives, works differently when-as is often the case in human societies-altruism can be boosted by social pressure. Here I present a model of social norms enforced by indirect reciprocity. In the model there are many alternative stable allocations of rewards ("distributional norms"); a stable norm is stable in the sense that each player is best off following the norm if other players do the same. Stable norms vary widely in how equally they reward players with unequal abilities. In a population of mixed groups (some group members follow one norm, some follow another, and some compromise) with modest within-group coefficients of relatedness, selection within groups favors those who compromise, and selection between groups favors generous generalized reciprocity rather than balanced reciprocity. Thus evolved social norms can amplify kin altruism, giving rise to a uniquely human mode of kin-based sociality distinct from spontaneous altruism among close kin, or cooperation among non-kin.	[Jones, Doug] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Jones, D (corresponding author), Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA.	dougias.jones@anthro.utah.edu						Alexander R., 2008, ESSAYS PEDAGOGY; Alvard M, 2011, HUM NATURE-INT BIOS, V22, P89, DOI 10.1007/s12110-011-9104-x; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Chapais Bernard, 2008, PRIMEVAL KINSHIP PAI, DOI DOI 10.1111/btp.12564; Chwe Michael Suk-Young, 2001, RATIONAL RITUAL CULT; Du WB, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/60004; Fiske A.P., 1991, STRUCTURES SOCIAL LI; Fortes M., 1969, KINSHIP SOCIAL ORDER; Fox Robin, 1967, KINSHIP MARRIAGE ANT; Gintis H, 2009, GAME THEORY EVOLVING: A PROBLEM-CENTERED INTRODUCTION TO MODELING STRATEGIC INTERACTION, SECOND EDITION, P1; Gintis H, 2014, BOUNDS REASON GAME T; Goffman Erving, 1959, MISE SCENE VIE QUOTI; Haidt J., 2012, RIGHTEOUS MIND WHY G; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; Hill K., 2009, QUESTION ANIMAL CULT, P269; Jones D, 2000, CURR ANTHROPOL, V41, P779, DOI 10.1086/317406; Langville Amy, 2012, GOOGLES PAGERANK SCI; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Lyle HF, 2014, P NATL ACAD SCI USA, V111, P4820, DOI 10.1073/pnas.1318372111; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nolin DA, 2011, HUM NATURE-INT BIOS, V22, P156, DOI 10.1007/s12110-011-9113-9; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Ohtsuki H, 2006, J THEOR BIOL, V239, P435, DOI 10.1016/j.jtbi.2005.08.008; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Panchanathan K, 2003, J THEOR BIOL, V224, P115, DOI 10.1016/S0022-5193(03)00154-1; Sigmund K, 2012, J THEOR BIOL, V299, P25, DOI 10.1016/j.jtbi.2011.03.024; Taylor C, 2007, EVOLUTION, V61, P2281, DOI 10.1111/j.1558-5646.2007.00196.x; Tylor EB, 1994, ANTHR INTRO STUDY MA	32	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155596	10.1371/journal.pone.0155596	http://dx.doi.org/10.1371/journal.pone.0155596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305045	Green Submitted, Green Published, gold			2022-12-27	WOS:000377824800007
J	Mucke, N; Winheim, S; Merlitz, H; Buchholz, J; Langowski, J; Herrmann, H				Muecke, Norbert; Winheim, Stefan; Merlitz, Holger; Buchholz, Jan; Langowski, Joerg; Herrmann, Harald			In Vitro Assembly Kinetics of Cytoplasmic Intermediate Filaments: A Correlative Monte Carlo Simulation Study	PLOS ONE			English	Article							X-RAY-SCATTERING; TETRAMERIC VIMENTIN; EPIDERMAL KERATIN; DYNAMICS; MECHANISM; NETWORKS; PROTEINS; DOMAINS; INVITRO; LENGTH	Intermediate filament (IF) elongation proceeds via full-width "mini-filaments", referred to as "unit-length" filaments (ULFs), which instantaneously form by lateral association of extended coiled-coil complexes after assembly is initiated. In a comparatively much slower process, ULFs longitudinally interact end-to-end with other ULFs to form short filaments, which further anneal with ULFs and with each other to increasingly longer filaments. This assembly concept was derived from time-lapse electron and atomic force microscopy data. We previously have quantitatively verified this concept through the generation of time-dependent filament length-profiles and an analytical model that describes assembly kinetics well for about the first ten minutes. In this time frame, filaments are shorter than one persistence length, i.e. similar to 1 mu m, and thus filaments were treated as stiff rods associating via their ends. However, when filaments grow several mu m in length over hours, their flexibility becomes a significant factor for the kinetics of the longitudinal annealing process. Incorporating now additional filament length distributions that we have recorded after extended assembly times by total internal reflection fluorescence microscopy (TIRFM), we developed a Monte Carlo simulation procedure that accurately describes the underlying assembly kinetics for large time scales.	[Muecke, Norbert; Winheim, Stefan; Buchholz, Jan; Langowski, Joerg] German Canc Res Ctr, Div Biophys Macromol, Heidelberg, Germany; [Merlitz, Holger] Xiamen Univ, Dept Phys, Xiamen 361005, Peoples R China; [Merlitz, Holger] Xiamen Univ, ITPA, Xiamen, Peoples R China; [Herrmann, Harald] Univ Hosp Erlangen, Inst Neuropathol, Erlangen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Xiamen University; Xiamen University; University of Erlangen Nuremberg	Mucke, N (corresponding author), German Canc Res Ctr, Div Biophys Macromol, Heidelberg, Germany.	norbert.muecke@dkfz-heidelberg.de	Langowski, Jörg/A-1843-2011	Langowski, Jörg/0000-0001-8600-0666; Mucke, Norbert/0000-0002-0683-4386	German research Foundation (DFG) [HE 1853/11-1, FOR 1228, LA 500/17-1]	German research Foundation (DFG)(German Research Foundation (DFG))	HH and JL received funding from the German research Foundation (DFG), grants HE 1853/11-1, FOR 1228 and LA 500/17-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E, 2001, J MOL BIOL, V312, P721, DOI 10.1006/jmbi.2001.5005; Aziz A, 2012, J BIOL CHEM, V287, P28349, DOI 10.1074/jbc.M111.334011; Brennich ME, 2014, SOFT MATTER, V10, P2059, DOI 10.1039/c3sm52532e; Brennich ME, 2011, LAB CHIP, V11, P708, DOI 10.1039/c0lc00319k; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; Chernyatina AA, 2015, CURR OPIN CELL BIOL, V32, P65, DOI 10.1016/j.ceb.2014.12.007; Chernyatina AA, 2012, P NATL ACAD SCI USA, V109, P13620, DOI 10.1073/pnas.1206836109; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; Herrmann H, 2003, INT REV CYTOL, V223, P83; Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3; HOFMANN I, 1991, EUR J CELL BIOL, V56, P328; Hu T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155434; HUIATT TW, 1980, J BIOL CHEM, V255, P6981; IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5; KAWAMURA M, 1970, J BIOCHEM-TOKYO, V67, P437, DOI 10.1093/oxfordjournals.jbchem.a129267; Kayser J, 2012, SOFT MATTER, V8, P8873, DOI 10.1039/c2sm26032h; Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200; Klenin K, 1998, BIOPHYS J, V74, P780, DOI 10.1016/S0006-3495(98)74003-2; Koster S, 2015, CURR OPIN CELL BIOL, V32, P82, DOI 10.1016/j.ceb.2015.01.001; Kreplak L, 2008, METHODS CELL BIOL, V88; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; Lichtenstern T, 2012, J STRUCT BIOL, V177, P54, DOI 10.1016/j.jsb.2011.11.003; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038; Mucke N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007756; Niklas KJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00008; Noding B, 2014, BIOPHYS J, V107, P2914, DOI 10.1016/j.bpj.2014.09.050; Parry DAD, 2005, ADV PROTEIN CHEM, V70, P113, DOI 10.1016/S0065-3233(04)70005-4; PARRY DAD, 1995, PROTEINS, V22, P267, DOI 10.1002/prot.340220307; Portet S, 2013, J THEOR BIOL, V332, P20, DOI 10.1016/j.jtbi.2013.04.004; Portet S, 2009, LANGMUIR, V25, P8817, DOI 10.1021/la900509r; REISLER E, 1980, J MOL BIOL, V143, P129, DOI 10.1016/0022-2836(80)90127-8; Rubinstein M, 2003, POLYM PHYS, V91; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; STEINERT PM, 1993, J BIOL CHEM, V268, P24916; Winheim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019202	42	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157451	10.1371/journal.pone.0157451	http://dx.doi.org/10.1371/journal.pone.0157451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304995	Green Submitted, Green Published, gold			2022-12-27	WOS:000377824800060
J	Yeh, CH; Stafford, AR; Leslie, BA; Fredenburgh, JC; Weitz, JI				Yeh, Calvin H.; Stafford, Alan R.; Leslie, Beverly A.; Fredenburgh, James C.; Weitz, Jeffrey I.			Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function	PLOS ONE			English	Article							HEPARIN-CATALYZED INHIBITION; HIGH-AFFINITY INTERACTION; RAY CRYSTAL-STRUCTURE; HUMAN ALPHA-THROMBIN; ACTIVE-SITE; ALLOSTERIC LINKAGE; FACTOR-V; STRUCTURAL-CHANGES; ANTITHROMBIN-III; LIGAND-BINDING	Thrombin is a highly plastic molecule whose activity and specificity are regulated by exosites 1 and 2, positively-charged domains that flank the active site. Exosite binding by substrates and cofactors regulates thrombin activity by localizing thrombin, guiding substrates, and by inducing allosteric changes at the active site. Although inter-exosite and exosite-toactive-site allostery have been demonstrated, the impact of active site ligation on exosite function has not been examined. To address this gap, we used surface plasmon resonance to determine the effects of dabigatran and argatroban, active site-directed inhibitors, on thrombin binding to immobilized gamma(A)/gamma(A)-fibrin or glycoprotein Iba peptide via exosite 1 and 2, respectively, and thrombin binding to gamma(A)/gamma'-fibrin or factor Va, which is mediated by both exosites. Whereas dabigatran attenuated binding, argatroban increased thrombin binding to gamma(A)/gamma(A)-and gamma(A)/gamma'-fibrin and to factor Va. The results with immobilized fibrin were confirmed by examining the binding of radiolabeled thrombin to fibrin clots. Thus, dabigatran modestly accelerated the dissociation of thrombin from gamma(A)/gamma(A)-fibrin clots, whereas argatroban attenuated dissociation. Dabigatran had no effect on thrombin binding to glycoprotein Iba peptide, whereas argatroban promoted binding. These findings not only highlight functional effects of thrombin allostery, but also suggest that individual active site-directed thrombin inhibitors uniquely modulate exosite function, thereby identifying potential novel mechanisms of action.	[Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	weitzj@taari.ca	Weitz, Jeffrey/AAD-1929-2019; Yeh, Calvin/AAA-1685-2019	Weitz, Jeffrey/0000-0002-1092-7550; 	Canadian Institutes of Health Research [MOP-136820, FRN-3992]; Heart and Stroke Foundation of Canada [T6357]; Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded in part by grants from the Canadian Institutes of Health Research (MOP-136820 and FRN-3992) and the Heart and Stroke Foundation of Canada (T6357). C.H.Y. is supported by a Doctoral Scholarship from the Canadian Institutes of Health Research. J.I.W. holds the Canada Research Chair (Tier I) in Thrombosis and the Heart and Stroke Foundation J. Fraser Mustard Chair in Cardiovascular Research at McMaster University. The funders had no role study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2009, J THROMB HAEMOST, V7, P1688, DOI 10.1111/j.1538-7836.2009.03563.x; Aziz MHA, 2012, J MED CHEM, V55, P6888, DOI 10.1021/jm300670q; Becker DL, 1999, J BIOL CHEM, V274, P6226, DOI 10.1074/jbc.274.10.6226; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; BODE W, 1992, PROTEIN SCI, V1, P426; BRANDSTETTER H, 1992, J MOL BIOL, V226, P1085, DOI 10.1016/0022-2836(92)91054-S; Croy CH, 2004, BIOCHEMISTRY-US, V43, P5246, DOI 10.1021/bi0499718; De Candia E, 2001, J BIOL CHEM, V276, P4692, DOI 10.1074/jbc.M008160200; De Cristofaro R, 2000, J BIOL CHEM, V275, P3887, DOI 10.1074/jbc.275.6.3887; DECRISTOFARO R, 1994, J MOL BIOL, V239, P569, DOI 10.1006/jmbi.1994.1396; DECRISTOFARO R, 1995, J MOL BIOL, V245, P447; Dharmawardana KR, 1999, J BIOL CHEM, V274, P18635, DOI 10.1074/jbc.274.26.18635; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; Figueiredo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034354; Fitzgerald D, 1996, CORONARY ARTERY DIS, V7, P455, DOI 10.1097/00019501-199606000-00008; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Fredenburgh JC, 2001, J BIOL CHEM, V276, P44828, DOI 10.1074/jbc.M108710200; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Hauel NH, 2002, J MED CHEM, V45, P1757, DOI 10.1021/jm0109513; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Kim PY, 2012, J BIOL CHEM, V287, P4652, DOI 10.1074/jbc.M111.317719; Kretz CA, 2006, J BIOL CHEM, V281, P37477, DOI 10.1074/jbc.M607359200; Krishnaswamy S, 2013, J THROMB HAEMOST, V11, P265, DOI 10.1111/jth.12217; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Lechtenberg BC, 2014, J MOL BIOL, V426, P881, DOI 10.1016/j.jmb.2013.11.027; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Li CQ, 2001, J BIOL CHEM, V276, P6161, DOI 10.1074/jbc.M004164200; Li W, 2010, J BIOL CHEM, V285, P38621, DOI 10.1074/jbc.M110.144964; LIU LW, 1991, J BIOL CHEM, V266, P16977; Malovichko MV, 2013, J BIOL CHEM, V288, P8667, DOI 10.1074/jbc.M112.410829; MATHEWS II, 1995, ACTA CRYSTALLOGR D, V51, P550, DOI 10.1107/S0907444994013132; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; NASKI MC, 1990, J BIOL CHEM, V265, P13484; NESHEIM ME, 1979, BIOCHEMISTRY-US, V18, P996, DOI 10.1021/bi00573a010; Ng NMY, 2009, ARCH BIOCHEM BIOPHYS, V489, P48, DOI 10.1016/j.abb.2009.07.012; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; PARRY MAA, 1993, BIOCHEM J, V290, P665, DOI 10.1042/bj2900665; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Pozzi N, 2013, J THROMB HAEMOST, V11, P1093, DOI 10.1111/jth.12238; Pozzi N, 2011, BIOPHYS CHEM, V159, P6, DOI 10.1016/j.bpc.2011.04.003; Sabo TM, 2006, BIOCHEMISTRY-US, V45, P7434, DOI 10.1021/bi060360k; Sabo TM, 2009, BIOCHEMISTRY-US, V48, P7110, DOI 10.1021/bi900745b; Schaefer AVL, 2006, BIOCHEMISTRY-US, V45, P4257, DOI 10.1021/bi0525730; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; Treuheit NA, 2011, BIOCHEMISTRY-US, V50, P4590, DOI 10.1021/bi2004069; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; Vu TT, 2013, J BIOL CHEM, V288, P16862, DOI 10.1074/jbc.M113.464750; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; Wienen W, 2007, THROMB HAEMOSTASIS, V98, P155, DOI 10.1160/TH07-03-0183; WOLFENSTEINTODEL C, 1981, BIOCHEMISTRY-US, V20, P6146, DOI 10.1021/bi00524a036; YE J, 1991, J BIOL CHEM, V266, P23016; Zarpellon A, 2011, P NATL ACAD SCI USA, V108, P8628, DOI 10.1073/pnas.1017042108	58	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157471	10.1371/journal.pone.0157471	http://dx.doi.org/10.1371/journal.pone.0157471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305147	gold, Green Submitted, Green Published			2022-12-27	WOS:000377824800062
J	Bedwell, JS; Potts, GF; Gooding, DC; Trachik, BJ; Chan, CC; Spencer, CC				Bedwell, Jeffrey S.; Potts, Geoffrey F.; Gooding, Diane C.; Trachik, Benjamin J.; Chan, Chi C.; Spencer, Christopher C.			Transdiagnostic Psychiatric Symptoms and Event-Related Potentials following Rewarding and Aversive Outcomes	PLOS ONE			English	Article							SCHIZOPHRENIA-PATIENTS; BEHAVIORAL ACTIVATION; MOTIVATED ATTENTION; BIPOLAR DISORDER; DEPRESSION; PLEASURE; POSITIVITY; ANHEDONIA; DEFICITS; FUTURE	There is a need for a better understanding of transdiagnostic psychiatric symptoms that relate to neurophysiological abnormalities following rewarding and aversive feedback in order to inform development of novel targeted treatments. To address this need, we examined a transdiagnostic sample of 44 adults (mean age: 35.52; 57% female), which consisted of individuals with broadly-defined schizophrenia-spectrum disorders (n = 16), bipolar disorders (n = 10), other mood and anxiety disorders (n = 5), and no history of a psychiatric disorder (n = 13). Participants completed a Pavlovian monetary reward prediction task during 32-channel electroencephalogram recording. We assessed the event-related potentials (ERPs) of feedback-related negativity (FRN), feedback-related positivity (FRP), and the late positive potential (LPP), following better and worse than expected outcomes. Examination of symptom relationships using stepwise regressions across the entire sample revealed that an increase in the clinician-rated Negative Symptoms factor score from the Positive and Negative Syndrome Scale, was related to a decreased LPP amplitude during better than expected (i.e., rewarding) outcomes. We also found that increased self-reported scores on the Schizotypal Personality Questionnaire (Brief-Revised) Disorganized factor related to an increased FRN amplitude during worse than expected (i.e., aversive) outcomes. Across the entire sample, the FRP component amplitudes did not show significant relationships to any of the symptoms examined. Analyses of the three diagnostic groups of schizophrenia-spectrum disorders, bipolar disorders, and nonpsychiatric controls did not reveal any statistically significant differences across the ERP amplitudes and conditions. These findings suggest relationships between specific neurophysiological abnormalities following rewarding and aversive outcomes and particular transdiagnostic psychiatric symptoms.	[Bedwell, Jeffrey S.; Trachik, Benjamin J.; Chan, Chi C.; Spencer, Christopher C.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA; [Potts, Geoffrey F.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Gooding, Diane C.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of South Florida; University of Wisconsin System; University of Wisconsin Madison	Bedwell, JS (corresponding author), Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA.	jeffrey.bedwell@ucf.edu		Chan, Chi/0000-0001-7861-7316; Bedwell, Jeffrey/0000-0002-1205-5792	University of Central Florida Office of Research and Commercialization; College of Sciences (Orlando, Florida, United States of America) [1053929]	University of Central Florida Office of Research and Commercialization; College of Sciences (Orlando, Florida, United States of America)	This study was funded by an internal university "SEED grant" from the University of Central Florida Office of Research and Commercialization and the College of Sciences (Orlando, Florida, United States of America; Research ID: 1053929). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen EH, 2016, CLIN EEG NEUROSCI, V47, P11, DOI 10.1177/1550059415598063; Brunia CHM, 2011, CLIN NEUROPHYSIOL, V122, P858, DOI 10.1016/j.clinph.2010.12.039; Caceda R, 2014, J NEUROPSYCH CLIN N, V26, P196, DOI 10.1176/appi.neuropsych.12110268; Callaway DA, 2014, PERSONAL DISORD, V5, P32, DOI 10.1037/per0000041; Cassidy CM, 2014, J PSYCHIATR NEUROSCI, V39, P339, DOI 10.1503/jpn.130207; Cohen AS, 2010, J PERS DISORD, V24, P516, DOI 10.1521/pedi.2010.24.4.516; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Daban C, 2002, PSYCHIAT RES, V113, P83, DOI 10.1016/S0165-1781(02)00228-7; Dichter GS, 2009, BIOL PSYCHIAT, V66, P886, DOI 10.1016/j.biopsych.2009.06.021; Gable PA, 2013, PSYCHOPHYSIOLOGY, V50, P1251, DOI 10.1111/psyp.12135; Gard DE, 2007, SCHIZOPHR RES, V93, P253, DOI 10.1016/j.schres.2007.03.008; Gooding DC, 2014, COMPR PSYCHIAT, V55, P1455, DOI 10.1016/j.comppsych.2014.04.013; Gooding DC, 2014, PSYCHIAT RES, V215, P237, DOI 10.1016/j.psychres.2013.10.012; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hilgard J, 2014, EMOTION, V14, P940, DOI 10.1037/a0036791; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; Holroyd CB, 2008, CORTEX, V44, P548, DOI 10.1016/j.cortex.2007.08.013; Horan WP, 2012, PSYCHOL MED, V42, P1637, DOI 10.1017/S0033291711002819; Horan WP, 2012, SCHIZOPHR RES, V135, P95, DOI 10.1016/j.schres.2011.11.005; Horan WP, 2010, J ABNORM PSYCHOL, V119, P18, DOI 10.1037/a0017510; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Lejuez CW, 2011, BEHAV MODIF, V35, P111, DOI 10.1177/0145445510390929; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Luo PC, 2014, NEUROSCI LETT, V578, P85, DOI 10.1016/j.neulet.2014.06.032; Martin LE, 2009, NEUROREPORT, V20, P1140, DOI 10.1097/WNR.0b013e32832f0dca; Martinez-Horta S, 2014, J NEUROSCI, V34, P5918, DOI 10.1523/JNEUROSCI.0251-14.2014; Mason L, 2016, BIOL PSYCHIAT, V79, P311, DOI 10.1016/j.biopsych.2015.03.014; Mason L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047754; Mason L, 2012, BIOL PSYCHIAT, V71, P530, DOI 10.1016/j.biopsych.2011.10.008; Mori A, 2016, J AFFECT DISORDERS, V189, P254, DOI 10.1016/j.jad.2015.09.036; Morris SE, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00123; Patrick RE, 2015, INT J PSYCHOPHYSIOL, V98, P612, DOI 10.1016/j.ijpsycho.2015.01.006; Phillips ML, 2014, AM J PSYCHIAT, V171, P829, DOI 10.1176/appi.ajp.2014.13081008; Pinheiro AP, 2013, NEUROSCI LETT, V550, P75, DOI 10.1016/j.neulet.2013.06.022; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Potts GF, 2006, J COGNITIVE NEUROSCI, V18, P1112, DOI 10.1162/jocn.2006.18.7.1112; Proudfit GH, 2015, PSYCHOPHYSIOLOGY, V52, P449, DOI 10.1111/psyp.12370; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Thomsen KR, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00049; van Dinteren R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087347; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242; Wexler BE, 2014, SCHIZOPHR RES, V158, P163, DOI 10.1016/j.schres.2014.07.012; Whitton AE, 2015, CURR OPIN PSYCHIATR, V28, P7, DOI 10.1097/YCO.0000000000000122; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME	44	9	9	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157084	10.1371/journal.pone.0157084	http://dx.doi.org/10.1371/journal.pone.0157084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KO	27299996	gold, Green Published, Green Submitted			2022-12-27	WOS:000377822200028
J	Fanget, C; Chauleur, C; Stadler, A; Presles, E; Varlet, MN; Gris, JC; Raia-Barjat, T				Fanget, Cecile; Chauleur, Celine; Stadler, Amandine; Presles, Emilie; Varlet, Marie-Noelle; Gris, Jean-Christophe; Raia-Barjat, Tiphaine			Relationship between Plasma D-Dimer Concentration and Three-Dimensional Ultrasound Placental Volume in Women at Risk for Placental Vascular Diseases: A Monocentric Prospective Study	PLOS ONE			English	Article							UTERINE ARTERY DOPPLER; FETAL-GROWTH RESTRICTION; FOR-GESTATIONAL-AGE; 1ST TRIMESTER; ENDOTHELIAL DYSFUNCTION; 2ND TRIMESTER; PREGNANCY; PREECLAMPSIA; PARAMETERS; THROMBOMODULIN	Introduction The aim of this study was to correlate placental volumes deduced from three-dimensional ultrasound and virtual organ computer-aided analysis (VOCAL) software with systemic concentrations of D-dimer and soluble endothelial protein C receptor (sEPCR). Methods This was a monocentric experimental prospective study conducted from October 2008 to July 2009. Forty consecutive patients at risk of placental vascular pathology (PVP) recurrence or occurrence were included. Placental volumes were systematically measured three times (11-14, 16-18 and 20-22 weeks of gestation (WG)) by two independent sonographers. D-dimers and sEPCR plasma concentrations were measured using ELISA kits (Enzyme Linked ImmunoSorbent Assay). Results Eleven patients had a PVP. The plasma D-dimer level was positively correlated with placental volume (r = 0.45, p < 0.001). A smaller placental volume and placental quotient was evidenced in women who developed a PVP at the three gestational ages, and the difference was more pronounced during the third exam (20 WG). No obvious correlation could be demonstrated between the development of a PVP and the levels of D-dimer and sEPCR. There was no significant difference in the values of placental volumes measured by the two sonographers. Conclusion The placenta growth could be a major determinant of the elevation of D-dimer during pregnancy. Consideration of placental volume could allow for modulation of the D-dimer concentrations for restoring their clinical interest.	[Fanget, Cecile; Chauleur, Celine; Stadler, Amandine; Varlet, Marie-Noelle; Raia-Barjat, Tiphaine] Univ Hosp, Dept Gynecol & Obstet, St Etienne, France; [Chauleur, Celine; Presles, Emilie; Raia-Barjat, Tiphaine] Univ St Etienne, Res Unit EA3065, F-42023 Saint Etienne, France; [Gris, Jean-Christophe] Univ Hosp, Haematol Lab, Nimes, France; [Gris, Jean-Christophe] Univ Montpellier, Res Unit EA2992, F-34059 Montpellier, France	CHU de St Etienne; Universite Jean Monnet; Universite de Montpellier; CHU de Nimes; Universite de Montpellier	Raia-Barjat, T (corresponding author), Univ Hosp, Dept Gynecol & Obstet, St Etienne, France.; Raia-Barjat, T (corresponding author), Univ St Etienne, Res Unit EA3065, F-42023 Saint Etienne, France.	tiphaine.barjat@chu-st-etienne.fr	GRIS, Jean-Christophe/AAA-2923-2019; BARJAT, Tiphaine/AAJ-7310-2021	GRIS, Jean-Christophe/0000-0002-9899-9910; Raia-Barjat, Tiphaine/0000-0002-4408-6075				Abramowicz JS, 2007, PLACENTA, V28, pS14, DOI 10.1016/j.placenta.2007.02.004; Baschat AA, 2004, SEMIN PERINATOL, V28, P67, DOI 10.1053/j.semperi.2003.10.014; Belo L, 2002, BJOG-INT J OBSTET GY, V109, P1250, DOI 10.1016/S1470-0328(02)01957-2; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; Bujold E, 2009, J OBSTET GYNAECOL CA, V31, P1144, DOI 10.1016/S1701-2163(16)34375-4; Burstein E, 2009, AM J PERINAT, V26, P169, DOI 10.1055/s-0028-1095188; CLAPP JF, 1995, J SOC GYNECOL INVEST, V2, P19, DOI 10.1016/1071-5576(94)00042-Y; Deurloo K, 2007, J CLIN ULTRASOUND, V35, P125, DOI 10.1002/jcu.20306; Dusse LM, 2013, CLIN CHIM ACTA, V415, P226, DOI 10.1016/j.cca.2012.10.006; Ercan S, 2014, J MATEM FETAL NEONAT, V8, P1; FRANCALANCI I, 1995, THROMB RES, V80, P89, DOI 10.1016/0049-3848(95)00153-I; Franchi F, 2001, BRIT J HAEMATOL, V114, P641, DOI 10.1046/j.1365-2141.2001.02964.x; Giavarina D, 2001, CLIN BIOCHEM, V34, P331, DOI 10.1016/S0009-9120(01)00205-3; Gu JM, 2002, J BIOL CHEM, V277, P43335, DOI 10.1074/jbc.M207538200; Hafner E, 2006, ULTRASOUND OBST GYN, V27, P652, DOI 10.1002/uog.2641; Hafner E, 2003, PLACENTA, V24, P336, DOI 10.1053/plac.2002.0918; Hafner E, 2001, PLACENTA, V22, P729, DOI 10.1053/plac.2001.0721; Hafner E, 1998, ULTRASOUND OBST GYN, V12, P97, DOI 10.1046/j.1469-0705.1998.12020097.x; Hafner F, 2001, ULTRASOUND OBST GYN, V18, P116, DOI 10.1046/j.1469-0705.2001.00489.x; Han L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114488; HO CH, 1992, THROMB HAEMOSTASIS, V67, P214; HOWE D, 1994, J CLIN ULTRASOUND, V22, P77, DOI 10.1002/jcu.1870220203; Hurtado V, 2004, BLOOD, V104, P1369, DOI 10.1182/blood-2004-03-0793; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Jeremiah ZA, 2012, INT J WOMENS HEALTH, V4, P437, DOI 10.2147/IJWH.S32655; Law LW, 2009, ULTRASOUND OBST GYN, V34, P283, DOI 10.1002/uog.6455; Metzenbauer M, 2001, PLACENTA, V22, P602, DOI 10.1053/plac.2001.0684; Nishii A, 2009, J OBSTET GYNAECOL RE, V35, P689, DOI 10.1111/j.1447-0756.2008.01007.x; NOLAN TE, 1993, OBSTET GYNECOL, V81, P235; Odeh M, 2011, PRENATAL DIAG, V31, P367, DOI 10.1002/pd.2697; Pinheiro MB, 2014, CLIN CHIM ACTA, V427, P65, DOI 10.1016/j.cca.2013.09.050; Rizzo G, 2008, EUR J OBSTET GYN R B, V138, P147, DOI 10.1016/j.ejogrb.2007.08.015; Saposnik B, 2012, THROMB RES, V129, P152, DOI 10.1016/j.thromres.2011.07.023; Schuchter K, 2001, ULTRASOUND OBST GYN, V18, P590, DOI 10.1046/j.0960-7692.2001.00596.x; Thame M, 2001, OBSTET GYNECOL, V98, P279, DOI 10.1016/S0029-7844(01)01414-4; Wang M, 2013, CLIN CHIM ACTA, V425, P176, DOI 10.1016/j.cca.2013.08.006; Wegrzyn P, 2005, ULTRASOUND OBST GYN, V26, P28, DOI 10.1002/uog.1923; WOLF H, 1989, AM J OBSTET GYNECOL, V160, P121, DOI 10.1016/0002-9378(89)90102-6; Yigiter AB, 2011, J PERINAT MED, V39, P137, DOI [10.1515/JPM.2010.136, 10.1515/jpm.2010.136]	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156593	10.1371/journal.pone.0156593	http://dx.doi.org/10.1371/journal.pone.0156593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294274	Green Published, gold, Green Submitted			2022-12-27	WOS:000377821300007
J	Geenens, R; Famaey, N; Gijbels, A; Verhelle, S; Vinckier, S; Sloten, JV; Herijgers, P				Geenens, Rachel; Famaey, Nele; Gijbels, Andy; Verhelle, Silke; Vinckier, Stefan; Sloten, Jos Vander; Herijgers, Paul			Atherosclerosis Alters Loading-Induced Arterial Damage: Implications for Robotic Surgery	PLOS ONE			English	Article							INJURY; CLAMP; SHUNT	Background Lack of intra-operative haptic information during robotic surgery increases the risk for unintended tissue overload and damage. Knowledge about the acute and chronic fundamental relationship between force load and induced damage in healthy and diseased arteries is crucial to enable intra-operative haptic feedback or shared autonomy and improve patient safety. Methods Arteries of wildtype and atherosclerotic mice were clamped in vivo for 2 minutes (0.0N, 0.6N or 1.27N). Histological analysis (Verhoeff's-Van Gieson, Osteopontin, CD45, CD105) was performed immediately, or after 6 hours, 2 weeks or 1 month. Endothelium-dependent and- independent vasodilatation was assessed immediately or 1 month after clamping. Results Endothelium dependent vasodilatation is worse after clamping of wildtype arteries, but is restored after one month. Clamping also results in flattening of the innermost elastic membrane of both genotypes, which is reversed over time for wildtype arteries but not for vessels from atherosclerotic mice. Higher osteopontin content in wildtype and LDLR-/- mice after 2 weeks suggests a phenotypic switch of the medial smooth muscle cells (SMCs), an effect that is reversed after 1 month. While inflammation in the intima diminishes, medial CD45 content rises through time in both genotypes. CD105 staining shows that even manipulation without clamping results in endothelial cell loss in both LDLR+/+ and LDLR-/- mice. Conclusions Arterial clamping induces different acute and long-term injury to the vessel wall of atherosclerotic and healthy arteries.	[Geenens, Rachel; Verhelle, Silke; Herijgers, Paul] Katholieke Univ Leuven, Dept Cardiovasc Sci, Res Unit Expt Cardiac Surg, Herestr 49 Box 7003, B-3000 Leuven, Belgium; [Famaey, Nele; Gijbels, Andy; Sloten, Jos Vander] Katholieke Univ Leuven, Dept Mech Engn, Celestijnenlaan 300 Box 2419, BE-3001 Heverlee, Belgium; [Vinckier, Stefan] KU Leuven VIB, Dept Oncol, Vesalius Res Ctr, Herestr 49 Box 912, B-3000 Leuven, Belgium	KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven	Herijgers, P (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Sci, Res Unit Expt Cardiac Surg, Herestr 49 Box 7003, B-3000 Leuven, Belgium.	paul.herijgers@uzleuven.be	Herijgers, Paul/B-8064-2013	Herijgers, Paul/0000-0003-0951-8132; Famaey, Nele/0000-0002-7374-8912	IWT Flanders and Interdisciplinary Research funding [3E100307]; Centre of Excellence Financing "Cellular Interactions and Heterogeneity in Ischemic Cardiovascular Disease" from the KU Leuven; Research Foundation Flanders [FWO - PDO/12]	IWT Flanders and Interdisciplinary Research funding; Centre of Excellence Financing "Cellular Interactions and Heterogeneity in Ischemic Cardiovascular Disease" from the KU Leuven; Research Foundation Flanders(FWO)	This research was funded by IWT Flanders and Interdisciplinary Research funding (3E100307). Additional funding was obtained from Centre of Excellence Financing "Cellular Interactions and Heterogeneity in Ischemic Cardiovascular Disease" from the KU Leuven and from a postdoctoral fellowship of the Research Foundation Flanders (FWO - PDO/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONE GW, 1989, SURGERY, V105, P465; Dobrin P B, 1992, Ann Vasc Surg, V6, P153, DOI 10.1007/BF02042737; Famaey N, 2012, J MECH BEHAV BIOMED, V12, P107, DOI 10.1016/j.jmbbm.2012.03.010; Famaey N, 2013, BIOMECH MODEL MECHAN, V12, P123, DOI 10.1007/s10237-012-0386-7; Famaey N, 2010, MED ENG PHYS, V32, P437, DOI 10.1016/j.medengphy.2010.04.002; Geenens R, 2016, ANN THORAC CARDIOVAS, V22, P38, DOI 10.5761/atcs.oa.15-00225; Hangler H, 2008, ANN THORAC SURG, V86, P1873, DOI 10.1016/j.athoracsur.2008.06.047; HARVEY JG, 1981, BRIT J SURG, V68, P267, DOI 10.1002/bjs.1800680415; Hsi Charles, 2002, Asian Cardiovasc Thorac Ann, V10, P293; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jackiewic Tanyana A., 1996, Microsurgery, V17, P674, DOI 10.1002/(SICI)1098-2752(1996)17:12<674::AID-MICR4>3.0.CO;2-N; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Margovsky AI, 1999, CARDIOVASC SURG, V7, P457, DOI 10.1016/S0967-2109(98)00154-9; Margovsky AI, 1997, AUST NZ J SURG, V67, P448, DOI 10.1111/j.1445-2197.1997.tb02012.x; Mulligan-Kehoe MJ, 2014, CIRCULATION, V129, P2557, DOI 10.1161/CIRCULATIONAHA.113.007189; Pierce DM, 2015, J MECH BEHAV BIOMED, V41, P92, DOI 10.1016/j.jmbbm.2014.10.003; Puangmali P, 2008, IEEE SENS J, V8, P371, DOI 10.1109/JSEN.2008.917481; Rinaldi B, 2006, BRIT J PHARMACOL, V147, P175, DOI 10.1038/sj.bjp.0706472; Rodriguez E, 2009, SCANDINAVIAN J SURG, P120; Sandow SL, 2009, J ANAT, V214, P258, DOI 10.1111/j.1469-7580.2008.01020.x; Shao JS, 2011, ARTERIOSCL THROM VAS, V31, P1821, DOI 10.1161/ATVBAHA.111.230011; SLAYBACK JB, 1976, AM J SURG, V132, P183, DOI 10.1016/0002-9610(76)90045-3; TANAKA H, 1993, CIRCULATION, V88, P1788, DOI 10.1161/01.CIR.88.4.1788; Vural AH, 2008, J SURG RES, V150, P261, DOI 10.1016/j.jss.2007.12.774	24	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156936	10.1371/journal.pone.0156936	http://dx.doi.org/10.1371/journal.pone.0156936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295082	Green Published, Green Submitted, gold			2022-12-27	WOS:000377821300015
J	Haeckel, A; Appler, F; de Schellenberger, AA; Schellenberger, E				Haeckel, Akvile; Appler, Franziska; de Schellenberger, Angela Ariza; Schellenberger, Eyk			XTEN as Biological Alternative to PEGylation Allows Complete Expression of a Protease-Activatable Killin-Based Cytostatic	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; BREAST-CANCER; DOXORUBICIN; PROTEINS; DNA; CARCINOMA; GERMLINE; GROWTH; LINES; KLLN	Increased effectiveness and reduced side effects are general goals in drug research, especially important in cancer therapy. The aim of this study was to design a long-circulating, activatable cytostatic drug that is completely producible in E. coli. Crucial for this goal was the novel unstructured polypeptide XTEN, which acts like polyethylene glycol (PEG) but has many important advantages. Most importantly, it can be produced in E. coli, is less immunogenic, and is biodegradable. We tested constructs containing a fragment of Killin as cytostatic/cytotoxic element, a cell-penetrating peptide, an MMP-2 cleavage site for specific activation, and XTEN for long blood circulation and deactivation of Killin. One of three sequence variants was efficiently expressed in E. coli. As typical for XTEN, it allowed efficient purification of the E. coli lysate by a heat step (10 min 75 degrees C) and subsequent anion exchange chromatography using XTEN as purification tag. After 24 h XTEN-Killin reduced the number of viable cells of HT-1080 tumor cell line to 3.8 +/- 2.0% (p<0.001) compared to untreated controls. In contrast, liver derived non-tumor cells (BRL3A) did not show significant changes in viability. Our results demonstrate the feasibility of completely producing a complex protease-activatable, potentially long-circulating cytostatic/cytotoxic prodrug in E. coli-a concept that could lead to efficient production of highly multifunctional drugs in the future.	[Haeckel, Akvile; de Schellenberger, Angela Ariza; Schellenberger, Eyk] Charite, Dept Radiol, D-13353 Berlin, Germany; [Appler, Franziska] NanoPET Pharma, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schellenberger, E (corresponding author), Charite, Dept Radiol, D-13353 Berlin, Germany.	eyk.schellenberger@charite.de		Schellenberger, Eyk/0000-0003-4096-6865; Ariza de Schellenberger, Angela/0000-0002-1005-5780	German Research Foundation, Deutsche Forschungsgemeinschaft (DFG) [KFO 213: SCHE 1416/2-2]	German Research Foundation, Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation, Deutsche Forschungsgemeinschaft (DFG) in the form of salaries for FA and AH (KFO 213: SCHE 1416/2-2). nanoPET Pharma is the current employer of FA. Her contribution for this manuscript was during her PhD program when she was employed in our group at the Charite - University Medicine Berlin. nanoPET Pharma did not support this project, was not involved, and has no rights. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bettina Herwig for language editing. The work was supported by the Deutsche Forschungsgemeinschaft DFG (KFO 213: SCHE 1416/2-2).	Albright CF, 2005, MOL CANCER THER, V4, P751, DOI 10.1158/1535-7163.MCT-05-0006; Alters SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050630; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Bennett KL, 2011, GENE CHROMOSOME CANC, V50, P654, DOI 10.1002/gcc.20887; Cho YJ, 2008, P NATL ACAD SCI USA, V105, P5396, DOI 10.1073/pnas.0705410105; Choi KY, 2012, THERANOSTICS, V2, P156, DOI 10.7150/thno.4068; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Erazo-Oliveras A, 2012, PHARMACEUTICALS-BASE, V5, P1177, DOI 10.3390/ph5111177; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Garay RP, 2012, EXPERT OPIN DRUG DEL, V9, P1319, DOI 10.1517/17425247.2012.720969; Geething NC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010175; Haeckel A, 2014, J NUCL MED, V55, P508, DOI 10.2967/jnumed.113.128108; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Lee GY, 2007, EUR J PHARM BIOPHARM, V67, P646, DOI 10.1016/j.ejpb.2007.03.023; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Mahdi H, 2015, CANCER-AM CANCER SOC, V121, P688, DOI 10.1002/cncr.29106; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Ng EK, 2014, ONCOTARGETS THER, V7, P2085, DOI 10.2147/OTT.S53597; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Qian ZQ, 2015, CHEM COMMUN, V51, P2162, DOI 10.1039/c4cc09441g; Roomi MW, 2014, INT J ONCOL, V44, P986, DOI 10.3892/ijo.2013.2235; Roomi MW, 2009, ONCOL REP, V22, P1283, DOI 10.3892/or_00000566; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Suzuki T, 2012, INT J PHARMACEUT, V436, P636, DOI 10.1016/j.ijpharm.2012.07.049; Taurin S, 2012, J CONTROL RELEASE, V164, P265, DOI 10.1016/j.jconrel.2012.07.013; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang Y, 2014, ENDOCR-RELAT CANCER, V21, P579, DOI 10.1530/ERC-14-0148; Wang Y, 2013, HUM MOL GENET, V22, P2263, DOI 10.1093/hmg/ddt077	30	14	14	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157193	10.1371/journal.pone.0157193	http://dx.doi.org/10.1371/journal.pone.0157193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295081	Green Submitted, Green Published, gold			2022-12-27	WOS:000377821300027
J	Lee, JY; Cho, K; Park, KA; Oh, SY				Lee, Ju-Yeun; Cho, Kyuyeon; Park, Kyung-Ah; Oh, Sei Yeul			Analysis of Retinal Layer Thicknesses and Their Clinical Correlation in Patients with Traumatic Optic Neuropathy	PLOS ONE			English	Article							NERVE-FIBER LAYER; GANGLION-CELL COMPLEX; VISUAL-FIELD LOSS; COHERENCE TOMOGRAPHY; FUNCTIONAL-CHANGES; EVOKED-POTENTIALS; AXONAL LOSS; SD-OCT; GLAUCOMA; DOMAIN	The aims of this study were 1) To evaluate retinal nerve fiber layer (fRNFL) thickness and ganglion cell layer plus inner plexiform layer (GCIPL) thickness at the fovea in eyes affected with traumatic optic neuropathy (TON) compared with contralateral normal eyes, 2) to further evaluate these thicknesses within 3 weeks following trauma (defined as "early TON"), and 3) to investigate the relationship between these retinal layer thicknesses and visual function in TON eyes. Twenty-nine patients with unilateral TON were included. Horizontal and vertical spectral-domain optical coherence tomography (SD-OCT) scans of the fovea were taken in patients with unilateral TON. The main outcome measure was thickness of the entire retina, fRNFL, and GCIPL in eight areas. Thickness of each retinal layer was compared between affected and unaffected eyes. The correlation between the thickness of each retinal layer and visual function parameters, including best corrected visual acuity, color vision, P100 latency, and P100 amplitude in visual evoked potential (VEP), mean deviation (MD) and visual field index (VFI) in Humphrey visual field analysis in TON eyes was analyzed. Thicknesses of the entire retina, fRNFL, and GCIPL in SD-OCT were significantly thinner (3-36%) in all measurement areas of TON eyes compared to those in healthy eyes (all p<0.05). Whereas, only GCIPL in the outer nasal, superior, and inferior areas was significantly thinner (5-10%) in the early TON eyes than that in the control eyes (all p<0.01). A significant correlation was detected between retinal layer thicknesses and visual function parameters including color vision, P100 latency and P100 amplitude in VEP, MD, and VFI (particularly P100 latency, MD, and VFI) (r = -0.70 to 0.84). Among the retinal layers analyzed in this study, GCIPL (particularly in the superior and inferior areas) was most correlated with these five visual function parameters (r = -0.70 to 0.71). Therefore, evaluation of morphological change of each retinal layer using SD-OCT can help in understanding TON pathophysiology and indirectly assessing visual function. Moreover, evaluation of the morphological change of the GCIPL in TON eyes may be useful to assess visual function in patients with early TON.	[Lee, Ju-Yeun; Cho, Kyuyeon; Park, Kyung-Ah; Oh, Sei Yeul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Oh, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	syoh@skku.edu						Alasil T, 2014, AM J OPHTHALMOL, V157, P953, DOI 10.1016/j.ajo.2014.01.014; Arintawati P, 2013, J GLAUCOMA, V22, P713, DOI 10.1097/IJG.0b013e318259b2e1; Bengtsson B, 2008, AM J OPHTHALMOL, V145, P343, DOI 10.1016/j.ajo.2007.09.038; Boone MI, 1996, OPHTHALMOLOGY, V103, P1223, DOI 10.1016/S0161-6420(96)30519-8; Cennamo G, 2015, EYE, V29, P797, DOI 10.1038/eye.2015.35; Chauhan BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040352; Chen Ting, 2015, Zhonghua Yan Ke Za Zhi, V51, P592; Cunha LP, 2009, ARQ BRAS OFTALMOL, V72, P622, DOI 10.1590/S0004-27492009000500004; Dotan G, 2015, CURR EYE RES, V40, P632, DOI 10.3109/02713683.2014.952829; Gabriele ML, 2010, PROG RETIN EYE RES, V29, P556, DOI 10.1016/j.preteyeres.2010.05.005; Gazala M, 2014, GUJARAT MED J, V69, P93; Kanamori A, 2012, ARCH OPHTHALMOL-CHIC, V130, P1067, DOI 10.1001/archophthalmol.2012.470; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Le PV, 2013, INVEST OPHTH VIS SCI, V54, P4287, DOI 10.1167/iovs.12-11388; Lennartsson F, 2014, INVEST OPHTH VIS SCI, V55, P8278, DOI 10.1167/iovs.14-14913; Levkovitch-Verbin H, 2001, INVEST OPHTH VIS SCI, V42, P975; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Miki A, 2015, JPN J OPHTHALMOL, V59, P230, DOI 10.1007/s10384-015-0386-0; Miller NR, 2005, WALSH HOYTS CLIN NEU; Munemasa Y, 2015, PROG RETIN EYE RES, V47, P1, DOI 10.1016/j.preteyeres.2015.03.002; Munguba GC, 2014, INVEST OPHTH VIS SCI, V55, P6505, DOI 10.1167/iovs.14-14525; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Parisi V, 2006, OPHTHALMOLOGY, V113, P216, DOI 10.1016/j.ophtha.2005.10.044; Park KA, 2014, ACTA OPHTHALMOL, V92, pE57, DOI 10.1111/aos.12215; Parrilla-Reverter G, 2009, VISION RES, V49, P2808, DOI 10.1016/j.visres.2009.08.020; Prager TC, 1999, J AAPOS, V3, P275, DOI 10.1016/S1091-8531(99)70023-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; Renard JP, 2013, J FR OPHTALMOL, V36, P299, DOI 10.1016/j.jfo.2013.01.005; Rosenberg R, 2015, J FR OPHTALMOL, V38, P832, DOI 10.1016/j.jfo.2015.03.015; Rovere G, 2015, INVEST OPHTH VIS SCI, V56, P4487, DOI 10.1167/iovs.15-17145; Seibold LK, 2010, AM J OPHTHALMOL, V150, P807, DOI 10.1016/j.ajo.2010.06.024; Shi W, 2013, CHINESE MED J-PEKING, V126, P1292, DOI 10.3760/cma.j.issn.0366-6999.20122854; Shin HY, 2014, OPHTHALMOLOGY, V121, P93, DOI 10.1016/j.ophtha.2013.06.041; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; TOWLE VL, 1977, INVEST OPHTH VIS SCI, V16, P1073; Valeria B, 2014, INVEST OPHTHALMOL, V55, P5633; Wheat JL, 2012, J GLAUCOMA, V21, P95, DOI 10.1097/IJG.0b013e31820bcfbe; Yaqub Moustafa, 2012, Community Eye Health, V25, P1; Yukita M, 2015, DOC OPHTHALMOL, V130, P149, DOI 10.1007/s10633-014-9478-2	40	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157388	10.1371/journal.pone.0157388	http://dx.doi.org/10.1371/journal.pone.0157388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295139	Green Published, gold, Green Submitted			2022-12-27	WOS:000377821300040
J	Smith, HM; Dickman, CR; Banks, PB				Smith, Helen M.; Dickman, Chris R.; Banks, Peter B.			Nest Predation by Commensal Rodents in Urban Bushland Remnants	PLOS ONE			English	Article							RATTUS-RATTUS; HOLLAND HONEYEATER; SMALL MAMMALS; NEW-ZEALAND; BLACK RATS; ARTIFICIAL NESTS; BIRD ASSEMBLAGES; INVASIVE RATS; SHIP RATS; COMMUNITY	Exotic predators are a major threat to native wildlife in many parts of the world. Developing and implementing effective strategies to mitigate their effects requires robust quantitative data so that management can be evidence-based, yet in many ecosystems this is missing. Birds in particular have been severely impacted by exotic mammalian predators, and a plethora of studies on islands record predation of bird eggs, fledglings and adults by exotic species such as rodents, stoats and cats. By comparison, few studies have examined nest predation around mainland urban centres which often act as dispersal hubs, especially for commensal species such as rodents. Here, we experimentally examine nest predation rates in habitat patches with varying black rat (Rattus rattus) densities in Sydney, Australia and test whether these exotic rats have the effects expected of exotic predators using effect size benchmarks. In the case where black rats have replaced native Rattus spp., we expected that black rats, being more arboreal than native Rattus spp., would be a significant source of predation on birds because they can readily access the arboreal niche where many birds nest. We tested this idea using above-ground artificial nests to represent those of typical small bird species such as the New Holland honeyeater (Phylidonyris novaehollandiae). We found that fewer eggs were depredated by rodents on sites where we removed black rats compared to unmanipulated sites, and that the effect size calculated from the total number of eggs surviving beyond the typical incubation period was similar to that expected for an exotic predator. Our results suggest that, although Australian birds have co-evolved with native Rattus species, in the case where black rats have replaced native Rattus species, exotic black rats appear to pose an additive source of predation on birds in remnant habitats, most likely due to their ability to climb more efficiently than their native counterparts. Management of these commensal rodents may be necessary to retain urban birdlife.	[Smith, Helen M.; Dickman, Chris R.; Banks, Peter B.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia	University of Sydney	Smith, HM (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.	h.smith@sydney.edu.au	Dickman, Christopher/Q-4662-2019	Dickman, Christopher/0000-0002-1067-3730; Smith, Helen/0000-0002-4302-338X; Banks, Peter/0000-0002-4340-6495	Australian Research Council [LP100100600]	Australian Research Council(Australian Research Council)	This work was funded by the Australian Research Council Grant (LP100100600) received by PBB and CRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1992, ECOLOGY, V73, P794, DOI 10.2307/1940158; ANGELSTAM P, 1986, OIKOS, V47, P365, DOI 10.2307/3565450; [Anonymous], 2001, AVIAN ECOLOGY CONSER; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2014, JMP VERS 9 0 0; Aplin K.P., 2003, ACIAR MONOGRAPH SERI, V96, P487; ARMSTRONG DP, 1991, AUK, V108, P99; Atkinson I., 1989, P54; Atkinson IAE, 1996, WILDLIFE BIOL, V2, P135, DOI 10.2981/wlb.1996.011; Banks PB, 1999, J APPL ECOL, V36, P1063, DOI 10.1046/j.1365-2664.1999.00463.x; Banks PB, 2000, AUSTRAL ECOL, V25, P283, DOI 10.1046/j.1442-9993.2000.01039.x; Banks PB, 2015, WILDLIFE RES, V42, P86, DOI 10.1071/WR15048; Banks PB, 2012, WILDLIFE RES, V39, P78, DOI 10.1071/WR11086; Banks Peter B., 2011, Australian Zoologist, V35, P1033; BEISSINGER SR, 1982, CONDOR, V84, P75, DOI 10.2307/1367825; Berry L, 2001, EMU, V101, P191, DOI 10.1071/MU00043; Blackburn TM, 2005, ECOLOGY, V86, P2916, DOI 10.1890/04-1847; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bradley JE, 2003, AUK, V120, P1180, DOI 10.1642/0004-8038(2003)120[1180:RANPIO]2.0.CO;2; BRAITHWAITE RW, 1978, AUST J ECOL, V3, P423, DOI 10.1111/j.1442-9993.1978.tb01190.x; BRAITHWAITE RW, 1978, AUST J ECOL, V3, P109, DOI 10.1111/j.1442-9993.1978.tb00857.x; Buchanan R, 1989, P LINNEAN SOC NEW S; Bytheway JP, 2013, BEHAV ECOL SOCIOBIOL, V67, P715, DOI 10.1007/s00265-013-1494-9; Cain JW, 2006, J WILDLIFE MANAGE, V70, P522, DOI 10.2193/0022-541X(2006)70[522:IOMAON]2.0.CO;2; Cain JW, 2003, J WILDLIFE MANAGE, V67, P600; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cote IM, 1997, CONSERV BIOL, V11, P395, DOI 10.1046/j.1523-1739.1997.95410.x; Craddock P, 1997, EFFECT RODENT CONTRO; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; DANIEL MJ, 1984, NEW ZEAL J ECOL, V7, P9; De Santo TL, 2001, J FIELD ORNITHOL, V72, P136, DOI 10.1648/0273-8570-72.1.136; DICKMAN CR, 1986, ECOL MONOGR, V56, P221, DOI 10.2307/2937075; EMLEN JT, 1974, CONDOR, V76, P184, DOI 10.2307/1366729; Eswaryani LP, 2005, JURNAL BIOL, VIX, P65; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; FINLAYSON H. H., 1939, TRANS ROY SOC S AUSTRALIA, V63, P88; Garden J, 2006, AUSTRAL ECOL, V31, P126, DOI 10.1111/j.1442-9993.2006.01578.x; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Haythorpe KM, 2012, EMU, V112, P129, DOI 10.1071/MU11046; HOLISOVA V, 1969, Zoologicke Listy, V18, P121; HOOKER S, 1995, NEW ZEAL J ZOOL, V22, P291, DOI 10.1080/03014223.1995.9518044; HUHTALO H, 1977, BIRD STUDY, V24, P179, DOI 10.1080/00063657709476554; Innes J., 2005, HDB NZ MAMMALS, P187; Jones HP, 2008, CONSERV BIOL, V22, P16, DOI 10.1111/j.1523-1739.2007.00859.x; Keast Allan, 1995, Australian Zoologist, V30, P3; Kinnear JE, 1998, WILDLIFE RES, V25, P81, DOI 10.1071/WR96072; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Leimgruber P, 2014, MAMM BIOL, V79, P313, DOI 10.1016/j.mambio.2014.04.002; Linster C, 1999, PHYSIOL BEHAV, V66, P701, DOI 10.1016/S0031-9384(99)00007-4; Long JL, 2003, INTRO MAMMALS WORLD; Major RE, 1996, AUST J ECOL, V21, P399, DOI 10.1111/j.1442-9993.1996.tb00626.x; MAJOR RE, 1991, AUK, V108, P190; MAJOR RE, 1994, OIKOS, V69, P364, DOI 10.2307/3545849; Major RE, 2010, EMU, V110, P92, DOI 10.1071/MU09058; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; MARTIN TE, 1993, BIOSCIENCE, V43, P523, DOI 10.2307/1311947; Martin TE, 1988, EVOL ECOL, V2, P37, DOI 10.1007/BF02071587; Marzluff John M., 2001, P19; Matthews A, 1999, ECOGRAPHY, V22, P349, DOI 10.1111/j.1600-0587.1999.tb00572.x; MCFARLAND DC, 1986, EMU, V86, P180, DOI 10.1071/MU9860180; MCFARLAND DC, 1986, EMU, V86, P161, DOI 10.1071/MU9860161; MILES MA, 1976, AM J TROP MED HYG, V25, P671, DOI 10.4269/ajtmh.1976.25.671; Moore RP, 2004, ECOLOGY, V85, P1562, DOI 10.1890/03-0088; Murray BR, 1999, WILDLIFE RES, V26, P421, DOI 10.1071/WR97046; Newsome TM, 2015, GLOBAL ECOL BIOGEOGR, V24, P1, DOI 10.1111/geb.12236; O'Donnell CFJ, 2009, NZ J ZOOLOGY, V37, P297, DOI [10.1080/03014223.2010.513395, DOI 10.1080/03014223.2010.513395]; Olsen Penny D., 1996, Bird Conservation International, V6, P63; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Parsons H, 2006, AUSTRAL ECOL, V31, P217, DOI 10.1111/j.1442-9993.2006.01584.x; Pastorelli J, 1990, URBAN WILDLIFE NEW S; Pelech SA, 2010, OIKOS, V119, P841, DOI 10.1111/j.1600-0706.2009.17786.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Piper SD, 2004, FOREST ECOL MANAG, V203, P361, DOI 10.1016/j.foreco.2004.08.005; Price CJ, 2012, P NATL ACAD SCI USA, V109, P19304, DOI 10.1073/pnas.1210981109; Rangen SA, 2000, AUK, V117, P136, DOI 10.1642/0004-8038(2000)117[0136:VAOAOA]2.0.CO;2; RECHER H F, 1971, Emu, V71, P147; Rose Tania A., 2007, P66; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Ruscoe WA, 2013, CONSERV BIOL, V27, P74, DOI 10.1111/j.1523-1739.2012.01932.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Sanders MD, 2002, BIOL CONSERV, V106, P225, DOI 10.1016/S0006-3207(01)00248-8; Schmidt KA, 2003, ECOLOGY, V84, P406, DOI 10.1890/0012-9658(2003)084[0406:SPIFEP]2.0.CO;2; Schodde R, 1988, READERS DIGEST COMPL; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Sorace A, 2002, ORNIS FENNICA, V79, P60; St Clair JJH, 2011, ANIM CONSERV, V14, P66, DOI 10.1111/j.1469-1795.2010.00391.x; St Clair JJH, 2011, BIOL CONSERV, V144, P68, DOI 10.1016/j.biocon.2010.10.006; Stapp P, 2002, J APPL ECOL, V39, P831, DOI 10.1046/j.1365-2664.2002.00754.x; Stattersfield A J, 2000, THREATENED BIRDS WOR, P205; Stokes VL, 2012, BEHAV ECOL SOCIOBIOL, V66, P329, DOI 10.1007/s00265-011-1280-5; Stokes VL, 2009, J APPL ECOL, V46, P1239, DOI 10.1111/j.1365-2664.2009.01735.x; Stokes VL, 2009, AUSTRAL ECOL, V34, P395, DOI 10.1111/j.1442-9993.2009.01941.x; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Terborgh John, 1989, HAVE ALL BIRDS GONE; Tewksbury JJ, 1998, ECOLOGY, V79, P2890, DOI 10.1890/0012-9658(1998)079[2890:BPDNDW]2.0.CO;2; Thompson FR, 2004, CONSERV BIOL, V18, P373, DOI 10.1111/j.1523-1739.2004.00167.x; Threlfall C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1144; Watts CHS, 1981, RODENTS AUSTR; WATTS CHS, 1978, WILDLIFE RES, V5, P47; White JG, 2005, LANDSCAPE URBAN PLAN, V71, P123, DOI 10.1016/j.landurbplan.2004.02.006; Zanette L, 2000, AUK, V117, P445, DOI 10.1642/0004-8038(2000)117[0445:NSANPI]2.0.CO;2	105	10	14	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156180	10.1371/journal.pone.0156180	http://dx.doi.org/10.1371/journal.pone.0156180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295091	gold, Green Published, Green Submitted			2022-12-27	WOS:000377821300003
J	Zhao, L; Jiang, XW; Zuo, YJ; Liu, XL; Chin, SW; Haberle, R; Potter, D; Chang, ZY; Wen, J				Zhao, Liang; Jiang, Xi-Wang; Zuo, Yun-Juan; Liu, Xiao-Lin; Chin, Siew-Wai; Haberle, Rosemarie; Potter, Daniel; Chang, Zhao-Yang; Wen, Jun			Multiple Events of Allopolyploidy in the Evolution of the Racemose Lineages in Prunus (Rosaceae) Based on Integrated Evidence from Nuclear and Plastid Data	PLOS ONE			English	Article							PLANT PHYLOGENETICS PROGRESS; SEQUENCE DATA; GENE DATA; SPECIATION; INFERENCE; PLUMS; CLASSIFICATION; PRUNOCERASUS; SYSTEMATICS; POLYPLOIDY	Prunus is an economically important genus well-known for cherries, plums, almonds, and peaches. The genus can be divided into three major groups based on inflorescence structure and ploidy levels: (1) the diploid solitary-flower group (subg. Prunus, Amygdalus and Emplectocladus); (2) the diploid corymbose group (subg. Cerasus); and (3) the polyploid racemose group (subg. Padus, subg. Laurocerasus, and the Maddenia group). The plastid phylogeny suggests three major clades within Prunus: Prunus-Amygdalus-Emplectocladus, Cerasus, and Laurocerasus-Padus-Maddenia, while nuclear ITS trees resolve Laurocerasus-Padus-Maddenia as a paraphyletic group. In this study, we employed sequences of the nuclear loci At103, ITS and s6pdh to explore the origins and evolution of the racemose group. Two copies of the At103 gene were identified in Prunus. One copy is found in Prunus species with solitary and corymbose inflorescences as well as those with racemose inflorescences, while the second copy (II) is present only in taxa with racemose inflorescences. The copy I sequences suggest that all racemose species form a paraphyletic group composed of four clades, each of which is definable by morphology and geography. The tree from the combined At103 and ITS sequences and the tree based on the single gene s6pdh had similar general topologies to the tree based on the copy I sequences of At103, with the combined At103-ITS tree showing stronger support in most clades. The nuclear At103, ITS and s6pdh data in conjunction with the plastid data are consistent with the hypothesis that multiple independent allopolyploidy events contributed to the origins of the racemose group. A widespread species or lineage may have served as the maternal parent for multiple hybridizations involving several paternal lineages. This hypothesis of the complex evolutionary history of the racemose group in Prunus reflects a major step forward in our understanding of diversification of the genus and has important implications for the interpretation of its phylogeny, evolution, and classification.	[Zhao, Liang; Chang, Zhao-Yang] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Jiang, Xi-Wang] Jianghan Univ, Coll Life Sci, Wuhan 430056, Hubei, Peoples R China; [Zuo, Yun-Juan] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai Chenshan Bot Garden, 3888 Chenhua Rd, Shanghai 201602, Peoples R China; [Liu, Xiao-Lin] Weifang Engn Vocat Coll, Sch Appl Chem & Biol Engn, Qingzhou 262500, Shandong, Peoples R China; [Chin, Siew-Wai; Potter, Daniel] Univ Calif Davis, Dept Plant Sci, MS2, Davis, CA 95616 USA; [Haberle, Rosemarie] Pacific Lutheran Univ, Dept Biol, Washington, DC USA; [Wen, Jun] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20013 USA	Northwest A&F University - China; Jianghan University; Chinese Academy of Sciences; University of California System; University of California Davis; Pacific Lutheran University; Smithsonian Institution; Smithsonian National Museum of Natural History	Wen, J (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20013 USA.	wenj@si.edu			Smithsonian Endowment program; National Science Foundation (NSF) [DEB 0515431]; Fundamental Research Funds for the Central Universities [QN2012020, 2452015406]; China Scholarship Council	Smithsonian Endowment program; National Science Foundation (NSF)(National Science Foundation (NSF)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Scholarship Council(China Scholarship Council)	This work was supported by the Smithsonian Endowment program, the National Science Foundation (NSF Award number DEB 0515431 to JW) and Fundamental Research Funds for the Central Universities (No. QN2012020, 2452015406 to LZ). The China Scholarship Council was gratefully acknowledged for financial support of LZ's research visit to the Smithsonian Institution.; This work was supported by the Smithsonian Endowment program, the National Science Foundation (NSF Award number DEB 0515431) and Fundamental Research Funds for the Central Universities (No. QN2012020, 2452015406). The China Scholarship Council was gratefully acknowledged for financial support of L. Zhao's research visit to the Smithsonian Institution. Peiliang Liu and Ning Zhang are acknowledged for assistance with data analyses.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Bortiri E, 2006, PLANT SYST EVOL, V259, P53, DOI 10.1007/s00606-006-0427-8; Bortiri E, 2002, AM J BOT, V89, P1697, DOI 10.3732/ajb.89.10.1697; Bortiri E, 2001, SYST BOT, V26, P797; Chin SW, 2014, MOL PHYLOGENET EVOL, V76, P34, DOI 10.1016/j.ympev.2014.02.024; Chin SW, 2013, INT J PLANT SCI, V174, P27, DOI 10.1086/668219; Chin SW, 2010, BOT J LINN SOC, V164, P236, DOI 10.1111/j.1095-8339.2010.01083.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dickinson TA, 2007, PLANT SYST EVOL, V266, P59, DOI 10.1007/s00606-007-0541-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hegarty MJ, 2005, NEW PHYTOL, V165, P411, DOI 10.1111/j.1469-8137.2004.01253.x; Hosie RC, 1969, CAN FOR SER DEP FISH; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jacobson Arthur L., 2007, Madrono, V54, P74, DOI 10.3120/0024-9637(2007)54[74:ANHCPP]2.0.CO;2; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Wen J, 2008, J SYST EVOL, V46, P322, DOI 10.3724/SP.J.1002.2008.08050; KALKMAN C., 1965, BLUMEA, V13, P1; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lee S, 2001, AM J BOT, V88, P150, DOI 10.2307/2657135; Li MG, 2008, CLADISTICS, V24, P727, DOI 10.1111/j.1096-0031.2008.00207.x; Liu XL, 2013, J PLANT RES, V126, P351, DOI 10.1007/s10265-012-0535-1; Lu L.D., 2003, FLORA CHINA, P46, DOI DOI 10.3321/J.ISSN:1000-131X.2003.09.008; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Rehder A., 1940, MANUAL CULTIVATED TR, V2nd; Rohrer Joseph R., 2008, Journal of the Botanical Research Institute of Texas, V2, P401; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; Shaw J, 2005, AM J BOT, V92, P2011, DOI 10.3732/ajb.92.12.2011; Shi S, 2013, J INTEGR PLANT BIOL, V55, P1069, DOI 10.1111/jipb.12095; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanford AM, 2000, AM J BOT, V87, P872, DOI 10.2307/2656895; Tavaud M, 2004, HEREDITY, V93, P631, DOI 10.1038/sj.hdy.6800589; Triplett JK, 2014, NEW PHYTOL, V204, P66, DOI 10.1111/nph.12988; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Watkins R., 1976, Evolution of crop plants., P242; Wen J, 2015, J SYST EVOL, V53, P369, DOI 10.1111/jse.12175; Wen J, 2012, PHYTOKEYS, V11, P39, DOI 10.3897/phytokeys.11.2825; White TL, 2007, FORSET GENETICS; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; YAMAKI S, 1986, J AM SOC HORTIC SCI, V111, P134; Yu T.T., 1986, FLORA REIPUBLICAE PO, V38, P1; Zimmer EA, 2015, J SYST EVOL, V53, P371, DOI 10.1111/jse.12174; Zimmer EA, 2012, MOL PHYLOGENET EVOL, V65, P774, DOI 10.1016/j.ympev.2012.07.015	48	21	23	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157123	10.1371/journal.pone.0157123	http://dx.doi.org/10.1371/journal.pone.0157123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294529	Green Published, gold, Green Submitted			2022-12-27	WOS:000377821300022
J	Krauss, P; Tziridis, K; Buerbank, S; Schilling, A; Schulze, H				Krauss, Patrick; Tziridis, Konstantin; Buerbank, Stefanie; Schilling, Achim; Schulze, Holger			Therapeutic Value of Ginkgo biloba Extract EGb 761 (R) in an Animal Model (Meriones unguiculatus) for Noise Trauma Induced Hearing Loss and Tinnitus	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; GAP DETECTION; ACOUSTIC TRAUMA; DOUBLE-BLIND; GUINEA-PIGS; EGB-761; PREVENTION; RESPONSES; STRESS; RATS	Noise induced hearing loss (NIHL) is a common disease in modern societies and may lead to maladaptations within the auditory system that finally result in subjective tinnitus. Available therapies may only alleviate the symptoms rather than restore normal hearing. In a previous study we demonstrated that the prophylactic application of Ginkgo biloba extract EGb 761 (R) significantly reduces NIHL and tinnitus development in our Mongolian gerbil (Meriones unguiculatus) animal model. Here, we tested whether the application of EGb 761 (R) has beneficial effects after the formation of permanent NIHL and tinnitus. To this end we monitored the therapeutic effects of EGb 761 (R) on noise trauma-induced changes in signal processing within the auditory system of our animal model by behavioral (acoustic startle response, ASR) and electrophysiological approaches (auditory brainstem responses, ABR). We found that-in contrast to vehicle-three weeks of daily oral EGb 761 (R) treatment (100 mg/kg body weight) led to a restoration of hearing thresholds back to pre-trauma conditions. In addition, all 9 animals that displayed behavioral signs of subjective tinnitus showed improvement, with 7 of them showing complete relief of tinnitus symptoms during the time of EGb 761 (R) treatment. After discontinuation of EGb 761 (R) treatment, tinnitus related behavior reappeared in all but one of these animals while auditory thresholds remained restored. A detailed analysis of ABR waves revealed that EGb 761 (R) treatment did not simply change auditory processing back to pre-trauma conditions, but led to subtle changes of ABR wave amplitude and latency at different levels of the auditory pathway, with an overall increase of response to low stimulus intensities and a decrease at high intensities. The functional relevance of these changes may be the observed improvement of hearing thresholds while at the same time suppression of responses to high stimulus intensities may point to a global inhibitory mechanism that counteracts tinnitus.	[Krauss, Patrick; Tziridis, Konstantin; Buerbank, Stefanie; Schilling, Achim; Schulze, Holger] Univ Erlangen Nurnberg, Expt Otolaryngol, Waldstr 1, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Schulze, H (corresponding author), Univ Erlangen Nurnberg, Expt Otolaryngol, Waldstr 1, D-91054 Erlangen, Germany.	holger.schulze@uk-erlangen.de		Krauss, Patrick/0000-0002-6611-7733	Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing	Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing	This work was supported by the Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany. We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing.	Abdel-Kader R, 2007, PHARMACOL RES, V56, P493, DOI 10.1016/j.phrs.2007.09.011; Ahlf S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044519; AXELSSON A, 1985, British Journal of Audiology, V19, P271, DOI 10.3109/03005368509078983; DeFeudis FV, 2004, DRUG DEVELOP RES, V62, P1, DOI 10.1002/ddr.10351; Drew S, 2001, BRIT MED J, V322, P73, DOI 10.1136/bmj.322.7278.73; Eckert A, 2005, ANN NY ACAD SCI, V1056, P474, DOI 10.1196/annals.1352.023; Eggermont JJ, 2013, HEARING RES, V295, P140, DOI 10.1016/j.heares.2012.01.005; Fehske CJ, 2009, PHARMACOL RES, V60, P68, DOI 10.1016/j.phrs.2009.02.012; Galazyuk A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00088; Guitton Matthieu J., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/80904; HALFORD JBS, 1991, J PSYCHOSOM RES, V35, P383, DOI 10.1016/0022-3999(91)90033-K; HENRY KR, 1979, J AM AUDITORY SOC, V4, P173; Jezova D, 2002, J PHYSIOL PHARMACOL, V53, P337; JONES DA, 1984, J EPIDEMIOL COMMUN H, V38, P75, DOI 10.1136/jech.38.1.75; Katzenell U, 2001, OTOL NEUROTOL, V22, P321, DOI 10.1097/00129492-200105000-00009; Kopke R, 2005, ACTA OTO-LARYNGOL, V125, P235, DOI 10.1080/00016480410023038; Langguth B, 2009, EXPERT OPIN EMERG DR, V14, P687, DOI 10.1517/14728210903206975; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Lockwood AH, 2002, NEW ENGL J MED, V347, P904, DOI 10.1056/NEJMra013395; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; Massieu L, 2004, BRAIN RES, V1002, P76, DOI 10.1016/j.brainres.2003.12.018; Muller WE, 2003, PHARMACOPSYCHIATRY, V36, pS24; Mwilambwe-Tshilobo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137749; NEGRI B, 1991, HNO, V39, P192; Oishi N, 2011, EXPERT OPIN EMERG DR, V16, P235, DOI 10.1517/14728214.2011.552427; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Passchier-Vermeer W, 2000, ENVIRON HEALTH PERSP, V108, P123, DOI 10.1289/ehp.00108s1123; Sadlier M, 2008, J LARYNGOL OTOL, V122, P31, DOI 10.1017/S0022215107007438; Schindowski K, 2001, J NEURAL TRANSM, V108, P969, DOI 10.1007/s007020170016; Sendowski I, 2006, HEARING RES, V221, P119, DOI 10.1016/j.heares.2006.08.010; STANGE G, 1975, ARCH OTO-RHINO-LARYN, V209, P203, DOI 10.1007/BF00453774; STANGE G, 1976, ARZNEIMITTEL-FORSCH, V26, P367; Suneja SK, 1998, EXP NEUROL, V151, P273, DOI 10.1006/exnr.1998.6812; Tchantchou F, 2007, FASEB J, V21, P2400, DOI 10.1096/fj.06-7649com; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Tziridis K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00022; Tziridis K, 2012, JOVE-J VIS EXP, DOI 10.3791/4433; Tziridis K, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/427298; von Boetticher A, 2011, NEUROPSYCH DIS TREAT, V7, P441, DOI 10.2147/NDT.S22793; Walter M., 2012, OPEN J ACOUSTICS, V2, P34, DOI DOI 10.4236/0JA.2012.21004; Weible AP, 2014, CURR BIOL, V24, P1447, DOI 10.1016/j.cub.2014.05.031; Woelk H, 2007, J PSYCHIATR RES, V41, P472, DOI 10.1016/j.jpsychires.2006.05.004; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Yang TH, 2011, J NUTR BIOCHEM, V22, P886, DOI 10.1016/j.jnutbio.2010.08.009; Yoshitake T, 2010, BRIT J PHARMACOL, V159, P659, DOI 10.1111/j.1476-5381.2009.00580.x; Zheng YW, 2012, NEUROPHARMACOLOGY, V62, P940, DOI 10.1016/j.neuropharm.2011.09.027	49	16	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157574	10.1371/journal.pone.0157574	http://dx.doi.org/10.1371/journal.pone.0157574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315063	Green Submitted, gold, Green Published			2022-12-27	WOS:000378030000037
J	Mei, YQ; Pan, ZF; Chen, WT; Xu, MH; Zhu, DY; Yu, YP; Lou, YJ				Mei, Yu-qin; Pan, Zong-fu; Chen, Wen-teng; Xu, Min-hua; Zhu, Dan-yan; Yu, Yong-ping; Lou, Yi-jia			A Flavonoid Compound Promotes Neuronal Differentiation of Embryonic Stem Cells via PPAR-beta Modulating Mitochondrial Energy Metabolism	PLOS ONE			English	Article							NEURAL DIFFERENTIATION; SKELETAL-MUSCLE; IN-VITRO; RECEPTORS; NEUROGENESIS; EXPRESSION; PROTECTS; ICARITIN; PATHWAY; NEURODEGENERATION	Relatively little is known regarding mitochondrial metabolism in neuronal differentiation of embryonic stem (ES) cells. By using a small molecule, present research has investigated the pattern of cellular energy metabolism in neural progenitor cells derived from mouse ES cells. Flavonoid compound 4a faithfully facilitated ES cells to differentiate into neurons morphologically and functionally. The expression and localization of peroxisome proliferator-activated receptors (PPARs) were examined in neural progenitor cells. PPAR-beta expression showed robust upregulation compared to solvent control. Treatment with PPAR-beta agonist L165041 alone or together with compound 4a significantly promoted neuronal differentiation, while antagonist GSK0660 blocked the neurogenesis-promoting effect of compound 4a. Consistently, knockdown of PPAR-beta in ES cells abolished compound 4a-induced neuronal differentiation. Interestingly, we found that mitochondrial fusion protein Mfn2 was also abolished by sh-PPAR-beta, resulting in abnormal mitochondrial Ca2+ ([Ca2+](M)) transients as well as impaired mitochondrial bioenergetics. In conclusion, we demonstrated that by modulating mitochondrial energy metabolism through Mfn2 and mitochondrial Ca2+, PPAR-beta took an important role in neuronal differentiation induced by flavonoid compound 4a.	[Mei, Yu-qin; Pan, Zong-fu; Xu, Min-hua; Zhu, Dan-yan; Lou, Yi-jia] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Wen-teng; Yu, Yong-ping] Zhejiang Univ, Coll Pharmaceut Sci, Inst Mat Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Lou, YJ (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310003, Zhejiang, Peoples R China.	yijialou@zju.edu.cn			National Natural Science Foundation of China [81573513, 81173135, 90813026]; Zhejiang Provincial Natural Science Foundation of China [LZ12H31001, Z2110655]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China (No 81573513, No 81173135, No 90813026; http://www.nsfc.gov.cn), and by Zhejiang Provincial Natural Science Foundation of China (No LZ12H31001, No Z2110655; http://www.zjnsf.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin S, 2013, NEUROCHEM INT, V63, P322, DOI 10.1016/j.neuint.2013.06.012; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Cimini A, 2005, NEUROSCIENCE, V130, P325, DOI 10.1016/j.neuroscience.2004.09.043; Coatesworth W, 2006, CELL CALCIUM, V39, P217, DOI 10.1016/j.ceca.2005.10.012; D'Angelo B, 2011, J CELL PHYSIOL, V226, P2170, DOI 10.1002/jcp.22552; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Di Loreto S, 2007, J CELL PHYSIOL, V211, P837, DOI 10.1002/jcp.20996; Ding L, 2007, CELL BIOL INT, V31, P1002, DOI 10.1016/j.cellbi.2007.03.013; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Fonteriz RI, 2010, CELL CALCIUM, V48, P61, DOI 10.1016/j.ceca.2010.07.001; Fornazari M, 2011, J BIOENERG BIOMEMBR, V43, P531, DOI 10.1007/s10863-011-9374-3; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Hall MG, 2008, PPAR RES, V2008, DOI 10.1155/2008/780452; Huang PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020655; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Li YQ, 2009, J MOL CELL CARDIOL, V46, P876, DOI 10.1016/j.yjmcc.2009.02.020; Liang XG, 2012, J CELL BIOCHEM, V113, P2884, DOI 10.1002/jcb.24164; Liu D, 2008, ANN NY ACAD SCI, V1147, P275, DOI 10.1196/annals.1427.028; Merkwirth C, 2008, CELL, V135, P1165, DOI 10.1016/j.cell.2008.12.005; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Ou LL, 2011, MOL DIVERS, V15, P665, DOI 10.1007/s11030-010-9289-7; Parekh A, 2009, CURR BIOL, V19, pR200, DOI 10.1016/j.cub.2009.01.012; QIU GT, 2000, ACAD J SUMS, V21, P100; Solanki L, 2015, ADV NUTR, V6, P64, DOI 10.3945/an.114.007500; Teslaa T, 2015, EMBO J, V34, P138, DOI 10.15252/embj.201490446; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wang DY, 2011, ACTA PHARMACOL SIN, V32, P425, DOI 10.1038/aps.2011.5; Wang Z, 2007, NEUROSCIENCE, V145, P911, DOI 10.1016/j.neuroscience.2006.12.059; Wang ZQ, 2009, CHEM-BIOL INTERACT, V179, P375, DOI 10.1016/j.cbi.2008.12.007; Williams DR, 2008, NAT PROTOC, V3, P835, DOI 10.1038/nprot.2008.47; Williams DR, 2007, J AM CHEM SOC, V129, P9258, DOI 10.1021/ja072817z; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Wu JY, 2013, NEUROCHEM INT, V62, P92, DOI 10.1016/j.neuint.2012.09.016; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yan HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4334; Yu SL, 2012, J BIOL CHEM, V287, P42195, DOI 10.1074/jbc.M112.410381; Zhu DY, 2010, J CELL BIOCHEM, V109, P498, DOI 10.1002/jcb.22426; Zhu DY, 2005, ACTA PHARMACOL SIN, V26, P477, DOI 10.1111/j.1745-7254.2005.00076.x	46	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157747	10.1371/journal.pone.0157747	http://dx.doi.org/10.1371/journal.pone.0157747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315062	gold, Green Submitted, Green Published			2022-12-27	WOS:000378030000050
J	Arbula, S; Capizzi, M; Lombardo, N; Vallesi, A				Arbula, Sandra; Capizzi, Mariagrazia; Lombardo, Nicoletta; Vallesi, Antonino			How Life Experience Shapes Cognitive Control Strategies: The Case of Air Traffic Control Training	PLOS ONE			English	Article							NEURAL MECHANISMS; DUAL MECHANISMS; AGE-DIFFERENCES; WORKING-MEMORY; TASK; INTERFERENCE; RECONFIGURATION; ACTIVATION; ATTENTION; SPAN	Although human flexible behavior relies on cognitive control, it would be implausible to assume that there is only one, general mode of cognitive control strategy adopted by all individuals. For instance, different reliance on proactive versus reactive control strategies could explain inter-individual variability. In particular, specific life experiences, like a highly demanding training for future Air Traffic Controllers (ATCs), could modulate cognitive control functions. A group of ATC trainees and a matched group of university students were tested longitudinally on task-switching and Stroop paradigms that allowed us tomeasure indices of cognitive control. The results showed that the ATCs, with respect to the control group, had substantially smaller mixing costs during long cue-target intervals (CTI) and a reduced Stroop interference effect. However, this advantage was present also prior to the training phase. Beingmore capable inmanagingmultiple task sets and less distracted by interfering events suggests a more efficient selection and maintenance of task relevant information as an inherent characteristic of the ATC group, associated with proactive control. Critically, the training that the ATCs underwent improved their accuracy in general and reduced response time switching costs during short CTIs only. These results indicate a training-induced change in reactive control, which is described as a transient process in charge of stimulus-driven task detection and resolution. This experience-based enhancement of reactive control strategy denotes how cognitive control and executive functions in general can be shaped by real-life training and underlines the importance of experience in explaining inter-individual variability in cognitive functioning.	[Arbula, Sandra; Capizzi, Mariagrazia; Vallesi, Antonino] Univ Padua, Dept Neurosci, Padua, Italy; [Lombardo, Nicoletta] Human Factor Unit ENAV SpA, Forli, Italy	University of Padua	Arbula, S (corresponding author), Univ Padua, Dept Neurosci, Padua, Italy.	sandra.arbula@gmail.com	Capizzi, Mariagrazia/ABF-8363-2020; ARBULA, SANDRA/AAL-1629-2021; Vallesi, Antonino/E-8987-2011; Arbula, Sandra/AAK-2971-2021	Capizzi, Mariagrazia/0000-0001-7880-7320; ARBULA, SANDRA/0000-0002-7915-2140; Vallesi, Antonino/0000-0002-4087-2845; 	European Research Council [313692]	European Research Council(European Research Council (ERC)European Commission)	This work was funded by the European Research Council Starting grant no 313692 (FP7/2007-2013) to AV. http://erc.europa.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini E, 2016, NEUROIMAGE, V124, P843, DOI 10.1016/j.neuroimage.2015.09.035; Babcock L., 2015, THESIS; Bajo MT, 2000, BENJAMIN TRANSL LIB, V39, P127; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Buchler NG, 2008, MEM COGNITION, V36, P735, DOI 10.3758/MC.36.4.735; Capizzi M, 2015, BIOL PSYCHOL, V110, P148, DOI 10.1016/j.biopsycho.2015.06.011; Cepeda NJ, 2000, J ABNORM CHILD PSYCH, V28, P213, DOI 10.1023/A:1005143419092; Colzato LS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00116; Di Fabio A, 2007, MATRICI PROGRESSIVE; Dittmann A, 2000, EUROPEAN AIR TRAFFIC; Friedman NP, 2000, J EXP PSYCHOL GEN, V129, P61, DOI 10.1037/0096-3445.129.1.61; Gaser C, 2003, J NEUROSCI, V23, P9240; Grandjean J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041513; Handley SJ, 2002, BRIT J PSYCHOL, V93, P501, DOI 10.1348/000712602761381376; Hilburn B, 2004, COGNITIVE COMPLEXITY; Hopkin VD, 1996, PROCEEDINGS OF THE F; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Karayanidis F., 2014, TASK SWITCHING COGNI, P200, DOI DOI 10.1093/ACPROF:OSOBL/9780199921959.003.0009; Karayanidis F, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00025; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Kopke Barbara., 2006, INTERPRETING, V8, P1, DOI DOI 10.1075/INTP.8.1.02KOP; Koros A, 2006, HUM FACTORS, P1; Kramer AF, 1999, ACTA PSYCHOL, V101, P339, DOI 10.1016/S0001-6918(99)00011-6; Kray J, 2000, PSYCHOL AGING, V15, P126, DOI 10.1037//0882-7974.15.1.126; Li P, 2014, CORTEX, V58, P301, DOI 10.1016/j.cortex.2014.05.001; LINDSAY DS, 1994, J EXP PSYCHOL HUMAN, V20, P219, DOI 10.1037/0096-1523.20.2.219; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Meiran N, 2005, EXP PSYCHOL, V52, P109, DOI 10.1027/1618-3169.52.2.109; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Muckschel M, 2014, CEREB CORTEX, V24, P2120, DOI 10.1093/cercor/bht066; Nunes A, 2009, J EXP PSYCHOL-APPL, V15, P12, DOI 10.1037/a0014947; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pawlak WS, 1996, PRESENT AIAA NATL CO; Puccioni O, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00327; Puccioni O, 2012, PSYCHOL RES-PSYCH FO, V76, P591, DOI 10.1007/s00426-011-0360-5; Rubin O, 2005, J EXP PSYCHOL LEARN, V31, P1477, DOI 10.1037/0278-7393.31.6.1477; Ruge H, 2013, HUM BRAIN MAPP, V34, P12, DOI 10.1002/hbm.21420; Schneider W., 2002, E PRIME USERS GUIDE; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tzou YZ, 2012, INT J BILINGUAL, V16, P213, DOI 10.1177/1367006911403197; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Vandierendonck A, 2010, PSYCHOL BULL, V136, P601, DOI 10.1037/a0019791; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Vijayakumar N, 2014, J COGNITIVE NEUROSCI, V26, P1118, DOI 10.1162/jocn_a_00549; West R, 2012, PSYCHOPHYSIOLOGY, V49, P1309, DOI 10.1111/j.1469-8986.2012.01464.x; Wickens CD, 1997, FLIGHT TO THE FUTURE; Yildiz A, 2014, HUM BRAIN MAPP, V35, P5040, DOI 10.1002/hbm.22530	54	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157731	10.1371/journal.pone.0157731	http://dx.doi.org/10.1371/journal.pone.0157731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27311017	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800129
J	Bal-Theoleyre, L; Lalande, A; Kober, F; Giorgi, R; Collart, F; Piquet, P; Habib, G; Avierinos, JF; Bernard, M; Guye, M; Jacquier, A				Bal-Theoleyre, Laurence; Lalande, Alain; Kober, Frank; Giorgi, Roch; Collart, Frederic; Piquet, Philippe; Habib, Gilbert; Avierinos, Jean-Francois; Bernard, Monique; Guye, Maxime; Jacquier, Alexis			Aortic Function's Adaptation in Response to Exercise-Induced Stress Assessing by 1.5T MRI: A Pilot Study in Healthy Volunteers	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; MARFAN-SYNDROME; FLOW; DISTENSIBILITY; PREDICTION; STRAIN; VALVE; REST; WALL	Aim Evaluation of the aortic "elastic reserve" might be a relevant marker to assess the risk of aortic event. Our aim was to compare regional aortic elasticity at rest and during supine bicycle exercise at 1.5 T MRI in healthy individuals. Methods Fifteen volunteers (8 men), with a mean age of 29 (23-41) years, completed the entire protocol. Images were acquired immediately following maximal exercise. Retrospective cine sequences were acquired to assess compliance, distensibility, maximum rates of systolic distension and diastolic recoil at four different locations: ascending aorta, proximal descending aorta, distal descending aorta and aorta above the coeliac trunk level. Segmental aortic pulse wave velocity (PWV) was assessed by through plane velocity-encoded MRI. Results Exercise induced a significant decrease of aortic compliance and distensibility, and a significant increase of the absolute values of maximum rates of systolic distension and diastolic recoil at all sites (p<10-3). At rest and during stress, ascending aortic compliance was statistically higher compared to the whole descending aorta (p <= 0.0007). We found a strong correlation between the rate pressure product and aortic distensibility at all sites (r = - 0.6 to - 0.75 according to the site, p<10-4). PWV measured at the proximal and distal descending aorta increased significantly during stress (p = 0.02 and p = 0.008, respectively). Conclusion Assessment of regional aortic function during exercise is feasible using MRI. During stress, aortic elasticity decreases significantly in correlation with an increase of the PWV. Further studies are required to create thresholds for ascending aorta dysfunction among patients with aneurysms, and to monitor the impact of medication on aortic remodeling.	[Bal-Theoleyre, Laurence; Kober, Frank; Bernard, Monique; Guye, Maxime; Jacquier, Alexis] Aix Marseille Univ, CRMBM CEMEREM, UMR CNRS 7339, Marseille, France; [Jacquier, Alexis] La Timone Hosp, Dept Radiol & Cardiovasc Imaging, Marseille, France; [Bal-Theoleyre, Laurence; Piquet, Philippe] La Timone Hosp, Dept Vasc Surg & Vasc Med, Marseille, France; [Lalande, Alain] Univ Burgundy, LE2I, UMR CNRS 6306, Dijon, France; [Lalande, Alain] Univ Hosp Dijon, MRI Dept, Dijon, France; [Giorgi, Roch] Aix Marseille Univ, SESSTIM, UMR S INSERM 912, Marseille, France; [Giorgi, Roch] La Timone Hosp, Dept Biostat, Marseille, France; [Giorgi, Roch] La Timone Hosp, ICT, Marseille, France; [Collart, Frederic] La Timone Hosp, Dept Cardiac Surg, Marseille, France; [Collart, Frederic; Piquet, Philippe; Habib, Gilbert; Avierinos, Jean-Francois; Jacquier, Alexis] La Timone Hosp, Aort Ctr, Marseille, France; [Habib, Gilbert; Avierinos, Jean-Francois] La Timone Hosp, Dept Cardiol, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Bourgogne; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Lalande, A (corresponding author), Univ Burgundy, LE2I, UMR CNRS 6306, Dijon, France.; Lalande, A (corresponding author), Univ Hosp Dijon, MRI Dept, Dijon, France.	alain.lalande@u-bourgogne.fr	Kober, Frank/L-8737-2013; Lalande, Alain/T-1050-2017; Bernard, Monique/Q-7254-2017; Jacquier, Alexis/ABD-6454-2020; GIORGI, Roch/A-6438-2009; Stefanadis, Christodoulos/ABH-2232-2020	Kober, Frank/0000-0002-7869-3615; Bernard, Monique/0000-0002-3179-8698; GIORGI, Roch/0000-0001-6135-3078; Stefanadis, Christodoulos/0000-0001-5974-6454; Avierinos, Jean Francois/0000-0002-3775-8371; Lalande, Alain/0000-0002-7970-366X				Ahimastos AA, 2007, JAMA-J AM MED ASSOC, V298, P1539, DOI 10.1001/jama.298.13.1539; Aquaro GD, 2011, AM J CARDIOL, V108, P81, DOI 10.1016/j.amjcard.2011.03.005; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Boutouyrie P, 2014, NEPHROL DIAL TRANSPL, V29, P232, DOI 10.1093/ndt/gft309; Cruickshank JK, 2009, HYPERTENSION, V53, P602, DOI 10.1161/HYPERTENSIONAHA.108.128033; Doonan RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026151; Elefteriades JA, 2015, J THORAC CARDIOV SUR, V149, pS10, DOI 10.1016/j.jtcvs.2014.07.066; Groenink M, 2001, RADIOLOGY, V219, P535, DOI 10.1148/radiology.219.2.r01ma01535; Groenink M, 2013, EUR HEART J, V34, P3491, DOI 10.1093/eurheartj/eht334; Herment A, 2011, MAGN RESON MED, V65, P986, DOI 10.1002/mrm.22678; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Hope MD, 2011, JACC-CARDIOVASC IMAG, V4, P781, DOI 10.1016/j.jcmg.2011.05.004; Kim EK, 2013, INT J CARDIOVAS IMAG, V29, P57, DOI 10.1007/s10554-013-0206-x; Kroner ESJ, 2013, INT J CARDIOL, V167, P2977, DOI 10.1016/j.ijcard.2012.08.057; Kumar A, 2010, CAN J CARDIOL, V26, P313, DOI 10.1016/S0828-282X(10)70396-2; Lalande A, 2008, J MAGN RESON IMAGING, V28, P1180, DOI 10.1002/jmri.21565; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Laurent S, 2014, HYPERTENSION, V64, P709, DOI 10.1161/HYPERTENSIONAHA.114.03282; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; MOHIADDIN RH, 1993, J APPL PHYSIOL, V74, P492, DOI 10.1152/jappl.1993.74.1.492; Nelson AJ, 2009, J HYPERTENS, V27, P535, DOI 10.1097/HJH.0b013e32831e4599; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; Peres P, 2010, BRAZ J MED BIOL RES, V43, P397, DOI 10.1590/S0100-879X2010000400011; Puntmann VO, 2012, HYPERTENSION, V59, P712, DOI 10.1161/HYPERTENSIONAHA.111.183335; Redheuil A, 2010, HYPERTENSION, V55, P319, DOI 10.1161/HYPERTENSIONAHA.109.141275; Rose JL, 2010, MAGN RESON IMAGING, V28, P255, DOI 10.1016/j.mri.2009.07.001; Rose JL, 2005, COMPUT CARDIOL, V32, P411; Teixido-Tura G, 2014, INT J CARDIOL, V171, P56, DOI 10.1016/j.ijcard.2013.11.044; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Voges I, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-77; Weber TF, 2011, EUR J RADIOL, V80, P103, DOI 10.1016/j.ejrad.2010.06.045; Weigang E, 2008, EUR J CARDIO-THORAC, V34, P11, DOI 10.1016/j.ejcts.2008.03.047; Westenberg JJM, 2011, J MAGN RESON IMAGING, V34, P526, DOI 10.1002/jmri.22646; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	34	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157704	10.1371/journal.pone.0157704	http://dx.doi.org/10.1371/journal.pone.0157704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310400	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800125
J	Luo, X; Huang, Y; Chen, YM; Tu, Z; Hu, JL; Tavis, JE; Huang, AL; Hu, Y				Luo, Xuan; Huang, Yao; Chen, Yanmeng; Tu, Zeng; Hu, Jieli; Tavis, John E.; Huang, Ailong; Hu, Yuan			Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							ROLLING CIRCLE AMPLIFICATION; CYTIDINE DEAMINASES; NONHEPATOTOXIC DEGRADATION; NATURAL-HISTORY; IN-VITRO; CCCDNA; REPLICATION; HYPERMUTATION; MUTAGENESIS; INHIBITION	Chronic Hepatitis B Virus (HBV) infections can progresses to liver cirrhosis and hepatocellular carcinoma (HCC). The HBV covalently-closed circular DNA cccDNA is a key to HBV persistence, and its degradation can be induced by the cellular deaminase APOBEC3. This study aimed to measure the distribution of intrahepatic cccDNA levels and evaluate the association between levels of cccDNA and APOBEC3 in HCC patients. Among 49 HCC patients, 35 matched cancerous and contiguous noncancerous liver tissues had detectable cccDNA, and the median intrahepatic cccDNA in the cancerous tissues (CT) was significantly lower than in the contiguous noncancerous tissues (CNCT) (p = 0.0033). RCA (rolling circle amplification), followed by 3D-PCR identified positive amplification in 27 matched HCC patients. Sequence analysis indicated G to A mutations accumulated to higher levels in CT samples compared to CNCT samples, and the dinucleotide context showed preferred editing in the GpA context. Among 7 APOBEC3 genes, APOBEC3B was the only one upregulated in cancerous tissues both at the transcriptional and protein levels (p < 0.05). This implies APOBEC3B may contribute to cccDNA editing and subsequent degradation in cancerous tissues.	[Luo, Xuan; Huang, Yao; Chen, Yanmeng; Hu, Jieli; Huang, Ailong; Hu, Yuan] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Affiliated Hosp 2, Minist Educ,Inst Viral Hepatitis,Dept Infect Dis, Chongqing, Peoples R China; [Tu, Zeng] Chongqing Med Univ, Dept Microbiol, Coll Basic Med Sci, Chongqing, Peoples R China; [Tavis, John E.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, Ctr Liver, St Louis, MO 63103 USA; [Huang, Ailong] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Xuan] Chongqing Med Univ, Dept Inspect, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Saint Louis University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Chongqing Medical University	Huang, AL; Hu, Y (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Affiliated Hosp 2, Minist Educ,Inst Viral Hepatitis,Dept Infect Dis, Chongqing, Peoples R China.; Huang, AL (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.	ahuang1964@163.com; biotottyhy@hotmail.com		, jieli/0000-0002-9869-659X	National Sciences Foundation of China award [81471945]; Natural Science Foundation Project of CQ CSTC [cstc2014jcyjA10075]; Major National Science and Technology program [2013ZX10002002]; Chongqing Postdoctoral Science Foundation [Xm2014006]; Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ1400205]	National Sciences Foundation of China award; Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Major National Science and Technology program; Chongqing Postdoctoral Science Foundation; Scientific and Technological Research Program of Chongqing Municipal Education Commission	This work was supported by a National Sciences Foundation of China award (http://www.nsfc.gov.cn/) (81471945) to Y. Hu. This fund provided the publication. This work was supported by a Natural Science Foundation Project of CQ CSTC (http://www.cstc.gov.cn/)(cstc2014jcyjA10075) to Y. Hu. This fund provided the data collection and analysis. This work was supported by a Major National Science and Technology program (http://www.nhfpc.gov.cn/) (2013ZX10002002) to AL.H. This fund provided study design. This work was supported by a Chongqing Postdoctoral Science Foundation (http://www.cqhrss.gov.cn/u/cqhrss/) (Xm2014006) to Z.T. This fund provided the data collection and analysis. This work was supported by the Scientific and Technological Research Program of Chongqing Municipal Education Commission (http://www.cqedu.cn/) (KJ1400205) to Z.T. This fund provided the data collection and analysis.	Bai FG, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/849290; Bonvin M, 2007, J GEN VIROL, V88, P3270, DOI 10.1099/vir.0.83149-0; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Chisari FV, 2014, SCIENCE, V344, DOI 10.1126/science.1254082; Cougot D, 2005, J CLIN VIROL, V34, pS75, DOI 10.1016/S1386-6532(05)80014-9; Dandri M, 2000, HEPATOLOGY, V32, P139, DOI 10.1053/jhep.2000.8701; Deng Y, 2014, CANCER LETT, V343, P161, DOI 10.1016/j.canlet.2013.09.041; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fujii R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh147; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; Gao YT, 2010, J VIROL METHODS, V169, P181, DOI 10.1016/j.jviromet.2010.07.031; Guo JT, 2015, ANTIVIR RES, V122, P91, DOI 10.1016/j.antiviral.2015.08.005; Hai H, 2014, WORLD J GASTROENTERO, V20, P6236, DOI 10.3748/wjg.v20.i20.6236; Hu Y, 2013, ANTIVIR RES, V99, P221, DOI 10.1016/j.antiviral.2013.06.007; Kitamura K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003361; Kock J, 2008, J GEN VIROL, V89, P1184, DOI 10.1099/vir.0.83507-0; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089046; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Margeridon S, 2008, ANTIMICROB AGENTS CH, V52, P3068, DOI 10.1128/AAC.01318-07; Moraleda G, 1997, J VIROL, V71, P9392, DOI 10.1128/JVI.71.12.9392-9399.1997; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; Ohba K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097787; Pak V, 2011, J VIROL, V85, P8538, DOI 10.1128/JVI.02645-10; Reaiche-Miller GY, 2013, VIROLOGY, V446, P357, DOI 10.1016/j.virol.2013.08.014; Seeger C., 2007, FIELDS VIROLOGY, V1, P2977; Seeger C, 2015, VIROLOGY; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Tavis JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003125; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Vieira VC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/683095; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107162; Wang Q, 2013, ANN SURG ONCOL, V20, P3761, DOI 10.1245/s10434-013-3046-y; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wong DKH, 2006, J HEPATOL, V45, P553, DOI 10.1016/j.jhep.2006.05.014; Wong DKH, 2004, HEPATOLOGY, V40, P727, DOI 10.1002/hep.20353; Xu RZ, 2007, HEPATOLOGY, V46, P1810, DOI 10.1002/hep.21893; Zhang TW, 2013, HUM MOL GENET, V22, P1262, DOI 10.1093/hmg/dds513; Zhang Xiao-Dong, 2014, Cancer Biology Medicine, V11, P182, DOI 10.7497/j.issn.2095-3941.2014.03.004	45	21	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157708	10.1371/journal.pone.0157708	http://dx.doi.org/10.1371/journal.pone.0157708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310677	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800127
J	MacDonald, J; Fagan, J; Geller, A				MacDonald, John; Fagan, Jeffrey; Geller, Amanda			The Effects of Local Police Surges on Crime and Arrests in New York City	PLOS ONE			English	Article							ROBBERY RATES; PRECINCT; IMPACT	The New York Police Department (NYPD) under Operation Impact deployed extra police officers to high crime areas designated as impact zones. Officers were encouraged to conduct investigative stops in these areas. City officials credited the program as one of the leading causes of New York City's low crime rate. We tested the effects of Operation Impact on reported crimes and arrests from 2004 to 2012 using a difference-in-differences approach. We used Poisson regression models to compare differences in crime and arrest counts before and after census block groups were designated as impact zones compared to census block groups in the same NYPD precincts but outside impact zones. Impact zones were significantly associated with reductions in total reported crimes, assaults, burglaries, drug violations, misdemeanor crimes, felony property crimes, robberies, and felony violent crimes. Impact zones were significantly associated with increases in total reported arrests, arrests for burglary, arrests for weapons, arrests for misdemeanor crimes, and arrests for property felony crimes. Impact zones were also significantly associated with increases in investigative stops for suspected crimes, but only the increase in stops made based on probable cause indicators of criminal behaviors were associated with crime reductions. The largest increase in investigative stops in impact zones was based on indicators of suspicious behavior that had no measurable effect on crime. The findings suggest that saturating high crime blocks with police helped reduce crime in New York City, but that the bulk of the investigative stops did not play an important role in the crime reductions. The findings indicate that crime reduction can be achieved with more focused investigative stops.	[MacDonald, John] Univ Penn, Dept Criminol, Philadelphia, PA 19104 USA; [Fagan, Jeffrey] Columbia Univ, Columbia Law Sch, New York, NY USA; [Geller, Amanda] NYU, Dept Sociol, New York, NY 10003 USA	University of Pennsylvania; Columbia University; New York University	MacDonald, J (corresponding author), Univ Penn, Dept Criminol, Philadelphia, PA 19104 USA.	johnmm@upenn.edu						[Anonymous], 2013, 18815 NBER; ASHENFELTER O, 1985, REV ECON STAT, V67, P648, DOI 10.2307/1924810; Berk R, 2010, CRIMINOL PUBLIC POL, V9, P813, DOI 10.1111/j.1745-9133.2010.00673.x; Braga AA, 2008, CRIMINOLOGY, V46, P577, DOI 10.1111/j.1745-9125.2008.00124.x; Bratton W., 2009, TURNAROUND AM TOP CO; Chang Y-C, 2013, EMPIRICAL LEGAL ANAL, P125; Corman H, 2005, J LAW ECON, V48, P235, DOI 10.1086/425594; Di Tella R, 2004, AM ECON REV, V94, P115, DOI 10.1257/000282804322970733; Draca M., 2011, AM ECON REV, V101, P2157; Fagan J, 2016, TERRYS ORIG IN PRESS; Fagan J, 2015, U CHICAGO LAW REV, V82, P51; Fagan J, 2012, J EMPIR LEGAL STUD, V9, P697, DOI 10.1111/j.1740-1461.2012.01272.x; Goel S, 2016, ANN APPL STAT, V10, P365, DOI 10.1214/15-AOAS897; Golden M., 2004, REDUCING GUN VIOLENC; Greenberg DF, 2014, JUSTICE Q, V31, P194, DOI 10.1080/07418825.2012.752026; Heymann Philip B., 2000, FORDHAM URB LJ, V28, P407; Karmen Andrew., 2000, NEW YORK MURDER MYST; Klick J, 2005, J LAW ECON, V48, P267, DOI 10.1086/426877; Kubrin CE, 2010, CRIMINOLOGY, V48, P57, DOI 10.1111/j.1745-9125.2010.00180.x; Levitt SD, 2004, J ECON PERSPECT, V18, P163, DOI 10.1257/089533004773563485; Livingston D, 1997, COLUMBIA LAW REV, V97, P551, DOI 10.2307/1123359; MacDonald H, 2013, WALL ST J; MacDonald JM, 2015, J ROYAL STAT SOC A; McCrary J, 2007, AM ECON REV, V97, P318, DOI 10.1257/aer.97.1.318; Meares TL, 2015, U CHICAGO LAW REV, V82, P159; Rosenfeld R, 2007, CRIMINOLOGY, V45, P355, DOI 10.1111/j.1745-9125.2007.00081.x; Rosenfeld R, 2014, JUSTICE Q, V31, P132, DOI 10.1080/07418825.2012.712152; Sherman LW., 1995, JUSTICE Q, V12, P625, DOI [10.1080/07418829500096221, DOI 10.1080/07418829500096221]; Spitzer E., 1999, NEW YORK CITY POLICE; WEISBURD D, 2003, CRIMINOLOGY PUBLIC P, V0002; Weisburd D, 2015, CRIMINOLOGY PUBLIC P; Zimring Franklin E., 2011, CITY BECAME SAFE NEW	32	61	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157223	10.1371/journal.pone.0157223	http://dx.doi.org/10.1371/journal.pone.0157223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310252	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800046
J	Rout, N				Rout, Namita			Enhanced Th1/Th17 Functions of CD161(+) CD8(+) T Cells in Mucosal Tissues of Rhesus Macaques	PLOS ONE			English	Article							HUMAN TH17 CELLS; LYMPHOCYTE RESPONSES; MAIT CELLS; EXPRESSION; SUBSETS; NK; ACCUMULATE; DEFINES; NKR-P1A; SYSTEM	Expression of the C-type lectin-like receptor CD161 by human T cells is associated with type-17 responses, which play critical regulatory roles in immunity and inflammation at mucosal sites. However, the functions of CD161-expressing T cells in macaques, the pre-clinical model of several human diseases, remain unknown. This study examined the phenotypic and functional characteristics of CD161(+) T cells in peripheral blood, mucosal tissues and lymph nodes of rhesus macaques. Majority of CD161-expressing T cells in peripheral blood and lung/intestinal mucosal tissues of rhesus macaques were found to be CD8(+)CD4(-) in phenotype. There was a significant enrichment of CD161(+) CD8(+) T cells in the lungs and colonic mucosa (16.1%+/- 6.6 and 16.8%+/- 5.7) in comparison to peripheral blood (4.2%+/- 1.2) and mesenteric lymph nodes (1.3%+/- 0.8). Regardless of the tissue compartment, CD161(+) CD8(+) T cells mainly comprised of gamma delta T cells and TCR V alpha 7.2(+) MAIT cells (up to 80%), and displayed Th1 and Th17 cytokine responses to mitogen stimulation. Mucosal CD161(+) CD8(+) T cells were characterized by very high expression of CD69, a recent activation marker that is preferentially expressed on tissue resident cells. Furthermore, lung and colonic mucosal CD161(+) CD8(+) T cells showed enhanced IFN-gamma, IL-17, and Perforin production in comparison to those in blood. Thus, macaque CD161(+) CD8(+) T cells represent mucosal tissue-homing innate-like CD8(+) T-cell populations with Th1/Th17 type cytokine and cytotoxic effector functions that can potentially enhance the recruitment of adaptive immune cells and control initial pathogen burden/dissemination in tissues. Analysis of their role in early immune responses to mucosal pathogens will be valuable in the design of vaccines and therapeutics.	[Rout, Namita] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA	Tulane University	Rout, N (corresponding author), Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA.	nrout@tulane.edu			Research Infrastructure Program of the United States National Institutes of Health; Research Infrastructure Program of the TNPRC Pilot Study Grant; Research Infrastructure Program of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI126683] Funding Source: NIH RePORTER	Research Infrastructure Program of the United States National Institutes of Health; Research Infrastructure Program of the TNPRC Pilot Study Grant; Research Infrastructure Program of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by start-up funds from Research Infrastructure Programs of the United States National Institutes of Health and the TNPRC Pilot Study Grant.; This study was supported by the Research Infrastructure Programs of the National Institutes of Health and the TNPRC Pilot Study Grant. Maury Duplantis, and all animal care staff of the department of veterinary medicine are gratefully acknowledged for coordinating the blood and tissue collections. Technical assistance of the flow cytometry core facility staff at the Tulane National Primate Research Center, for flow cytometric analysis is greatly appreciated. The NIH Tetramer Core Facility is acknowledged for provision of PBS-57-loaded CD1d tetramers, and the NIH Nonhuman Primate Reagent Resource provided the alpha 4 beta 7, CD4, and CD8 antibodies.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Chen ZW, 2011, CELL MOL LIFE SCI, V68, P2409, DOI 10.1007/s00018-011-0703-9; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eberhard JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111323; Evans DT, 2003, J VIROL, V77, P2400, DOI 10.1128/JVI.77.4.2400-2409.2003; Fergusson JR, 2016, MUCOSAL IMMUNOL, V9, P401, DOI 10.1038/mi.2015.69; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Gao YF, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00302; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; GIORDA R, 1990, SCIENCE, V249, P1298, DOI 10.1126/science.2399464; Gonzalez Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123591; Hintz M, 2001, FEBS LETT, V509, P317, DOI 10.1016/S0014-5793(01)03191-X; Iiai T, 2002, CLIN EXP IMMUNOL, V129, P92, DOI 10.1046/j.1365-2249.2002.01886.x; Ishihara S, 1999, EUR J IMMUNOL, V29, P2406, DOI 10.1002/(SICI)1521-4141(199908)29:08<2406::AID-IMMU2406>3.3.CO;2-6; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kunkel EJ, 2002, AM J PATHOL, V160, P347, DOI 10.1016/S0002-9440(10)64378-7; LANIER LL, 1994, J IMMUNOL, V153, P2417; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; O'Keeffe J, 2004, EUR J IMMUNOL, V34, P2110, DOI 10.1002/eji.200424958; Poggi A, 1998, EUR J IMMUNOL, V28, P1611, DOI 10.1002/(SICI)1521-4141(199805)28:05<1611::AID-IMMU1611>3.0.CO;2-6; Rout N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002928; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Wang ZC, 2006, J VIROL, V80, P2771, DOI 10.1128/JVI.80.6.2771-2783.2006	35	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157407	10.1371/journal.pone.0157407	http://dx.doi.org/10.1371/journal.pone.0157407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309719	Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800068
J	Spiga, R; Batton-Hubert, M; Sarazin, M				Spiga, Radia; Batton-Hubert, Mireille; Sarazin, Marianne			Predicting Fluctuating Rates of Hospitalizations in Relation to Influenza Epidemics and Meteorological Factors	PLOS ONE			English	Article							VITAMIN-D; UNITED-STATES; A VIRUS; TRANSMISSION; ILLNESS; SEASONALITY; HUMIDITY	Introduction In France, rates of hospital admissions increase at the peaks of influenza epidemics. Predicting influenza-associated hospitalizations could help to anticipate increased hospital activity. The purpose of this study is to identify predictors of influenza epidemics through the analysis of meteorological data, and medical data provided by general practitioners. Methods Historical data were collected from Meteo France, the Sentinelles network and hospitals' information systems for a period of 8 years (2007-2015). First, connections between meteorological and medical data were estimated with the Pearson correlation coefficient, Principal component analysis and classification methods (Ward and k-means). Epidemic states of tested weeks were then predicted for each week during a one-year period using linear discriminant analysis. Finally, transition probabilities between epidemic states were calculated with the Markov Chain method. Results High correlations were found between influenza-associated hospitalizations and the variables: Sentinelles and emergency department admissions, and anti-correlations were found between hospitalizations and each of meteorological factors applying a time lag of: -13, -12 and -32 days respectively for temperature, absolute humidity and solar radiation. Epidemic weeks were predicted accurately with the linear discriminant analysis method; however there were many misclassifications about intermediate and non-epidemic weeks. Transition probability to an epidemic state was 100% when meteorological variables were below: 2 degrees C, 4 g/m(3) and 32 W/m(2), respectively for temperature, absolute humidity and solar radiation. This probability was 0% when meteorological variables were above: 6 degrees C, 5.8g/m(3) and 74W/m(2). Conclusion These results confirm a good correlation between influenza-associated hospitalizations, meteorological factors and general practitioner's activity, the latter being the strongest predictor of hospital activity.	[Spiga, Radia] Ctr Hosp Univ, Serv Sante Publ & Informat Med, St Etienne, France; [Batton-Hubert, Mireille] Ecole Natl Super Mines, Inst Fayol, Unite Mixte Rech 6158, St Etienne, France; [Sarazin, Marianne] Inst Natl Sante & Rech Med, Unite Mixte Rech Sante 1136, Paris, France; [Sarazin, Marianne] Univ Paris 06, Sorbonne Univ, Paris, France; [Sarazin, Marianne] Ecole Natl Super Mines, Ctr Ingn & Sante, St Etienne, France; [Sarazin, Marianne] Ctr Hosp, Dept Med Informat, Firminy, France	CHU de St Etienne; IMT - Institut Mines-Telecom; Mines Saint-Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; IMT - Institut Mines-Telecom; Mines Saint-Etienne	Spiga, R (corresponding author), Ctr Hosp Univ, Serv Sante Publ & Informat Med, St Etienne, France.	Radia.Spiga@chu-st-etienne.fr		SPIGA, RADIA/0000-0002-3146-4129				Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Axelsen JB, 2014, P NATL ACAD SCI USA, V111, P9538, DOI 10.1073/pnas.1321656111; Beard JA, 2011, J CLIN VIROL, V50, P194, DOI 10.1016/j.jcv.2010.12.006; Borella E, 2014, ANN NY ACAD SCI, V1317, P76, DOI 10.1111/nyas.12321; Boyle JR, 2011, MED J AUSTRALIA, V194, pS28; Bresee J, 2013, NEW ENGL J MED, V368, P589, DOI 10.1056/NEJMp1300375; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Cannell JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-29; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dao CN, 2010, J INFECT DIS, V202, P881, DOI 10.1086/655904; DAVIES R, 1975, OPER RES QUART, V26, P599, DOI 10.2307/3008064; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Fleming DM, 2007, EPIDEMIOL INFECT; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garza RC, 2013, EMERG INFECT DIS, V19, P938, DOI 10.3201/eid1906.120916; Hufty A, 2001, INTRODUCTION A LA CL; Husson F, TECHNICAL REPORT AGR; Jhung MA, 2014, AM J INFECT CONTROL, V42, P7, DOI 10.1016/j.ajic.2013.06.018; Juzeniene A, 2010, INT J INFECT DIS, V14, pE1099, DOI 10.1016/j.ijid.2010.09.002; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Shaman J, 2009, PLOS CURR, V1; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Shaman J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020743; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; te Beest DE, 2013, AM J EPIDEMIOL, V178, P1469, DOI 10.1093/aje/kwt132; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; van Noort SP, 2012, J THEOR BIOL, V298, P131, DOI 10.1016/j.jtbi.2011.12.020; Yaari R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0298; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	34	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157492	10.1371/journal.pone.0157492	http://dx.doi.org/10.1371/journal.pone.0157492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310145	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800084
J	Hocine, MN; Bouziad, KA; Legeron, P; Dab, W; Saporta, G				Hocine, Mounia N.; Bouziad, Karim Ait; Legeron, Patrick; Dab, William; Saporta, Gilbert			How to Identify and Prioritize Psychosocial Factors Impacting Stress Level	PLOS ONE			English	Article							OCCUPATIONAL STRESS; WORK; VALIDITY; DISEASE; GENDER	We develop a methodological approach to identify and prioritize psychosocial factors (stressors) requiring priority action to reduce stress levels. Data analysis was carried out on a random sample of 10 000 French employees who completed, during a routine interview with the occupational physician, a 25-item questionnaire about stress levels, as well as a questionnaire about 58 stressors grouped into 5 latent variables: job control, job context, relationships at work, tasks performed and recognition. Our method combines Importance-Performance Analysis, a valuable approach for prioritizing improvements in the quality of services, with Partial Least Squares-Path modeling, a Structural Equation Modeling approach widely applied in psychosocial research. Findings on our data suggest two areas worthy of attention: one with five stressors on which decision makers should concentrate, and another with five stressors that managers should leave alone when acting to reduce stress levels. We show that IPA is robust when answers to questions are dichotomized, as opposed to the initial 6-point Likert scale. We believe that our approach will be a useful tool for experts and decision-makers in the field of stress management and prevention.	[Hocine, Mounia N.; Bouziad, Karim Ait; Dab, William] Conservatoire Natl Arts & Metiers, Lab Modelisat Epidemiol & Surveillance Risques Sa, 292 Rue St Martin, F-75003 Paris, France; [Legeron, Patrick] Stimulus, 28 Rue Mogador, F-75009 Paris, France; [Saporta, Gilbert] Conservatoire Natl Arts & Metiers, Ctr Etud & Rech Informat & Commun, 292 Rue St Martin, F-75003 Paris, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Hocine, MN (corresponding author), Conservatoire Natl Arts & Metiers, Lab Modelisat Epidemiol & Surveillance Risques Sa, 292 Rue St Martin, F-75003 Paris, France.	mounia.hocine@cnam.fr	HOCINE, Mounia N./AAA-2896-2021; HOCINE, Mounia N. N./F-7162-2019	HOCINE, Mounia N./0000-0003-0942-7441; HOCINE, Mounia N. N./0000-0003-0942-7441; Saporta, Gilbert/0000-0002-3406-5887				Aneshensel CS, 1987, STRUCTURAL CONTEXTS; Barkhuizen N, 2008, S AFR J PSYCHOL, V38, P321, DOI 10.1177/008124630803800205; BARUCH GK, 1987, AM PSYCHOL, V42, P130, DOI 10.1037/0003-066X.42.2.130; Biron C, 2008, WORK, V30, P511; Biron C, 2006, HEALTH RISK SOC, V8, P417, DOI 10.1080/13698570601008222; Buhlmann P, 2013, MATH METHOD OPER RES, V77, P357, DOI 10.1007/s00186-012-0404-7; Chin WW, 1998, QUANT METH SER, P295; Clarke SG, 2000, HEALTH RISK SOC, V2, P173, DOI 10.1080/713670158; COOPER CL, 1976, J OCCUP PSYCHOL, V49, P11, DOI 10.1111/j.2044-8325.1976.tb00325.x; Danna K, 1999, J MANAGE, V25, P357, DOI 10.1016/S0149-2063(99)00006-9; FILLION L, 1989, CAN PSYCHOL, V30, P30, DOI 10.1037/h0079852; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; Goetz O., 2010, HDB PARTIAL LEAST SQ, P411, DOI [10.1007/978-3-540-32827-8_33, DOI 10.1007/978-3-540-32827-8]; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Lee JS, 2013, STRESS HEALTH, V29, P75, DOI 10.1002/smi.2428; Lemyre L, 2003, CAN FAM PHYSICIAN, V49, P1159; MARTILLA JA, 1977, J MARKETING, V41, P77, DOI 10.2307/1250495; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; Matzler K, 2004, IND MARKET MANAG, V33, P271, DOI 10.1016/S0019-8501(03)00055-5; Niedhammer I, 2008, INT ARCH OCC ENV HEA, V82, P87, DOI 10.1007/s00420-008-0311-7; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; SIEGRIST J, 1994, WORK STRESS, V8, P130, DOI 10.1080/02678379408259985; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Tessier R, 1990, MESURE STRESS PSYCHO; Vinzi VE, 2013, WILEY INTERDISCIP RE, V5, P1, DOI 10.1002/wics.1239	25	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157078	10.1371/journal.pone.0157078	http://dx.doi.org/10.1371/journal.pone.0157078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5LO	27304854	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800035
J	Lo, AS; Mao, XM; Mukherjee, EM; Ellebrecht, CT; Yu, XC; Posner, MR; Payne, AS; Cavacini, LA				Lo, Agnes S.; Mao, Xuming; Mukherjee, Eric M.; Ellebrecht, Christoph T.; Yu, Xiaocong; Posner, Marshall R.; Payne, Aimee S.; Cavacini, Lisa A.			Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; SWAPPED MOLECULES; TARGET; INHIBITION; EXPRESSION; FOLIACEUS; DISEASE; BINDING; REGION; DOMAIN	Pemphigus vulgaris (PV) is characterized by IgG1 and IgG4 autoantibodies to desmoglein (Dsg) 3, causing suprabasal blistering of skin and mucous membranes. IgG4 is the dominant autoantibody subclass in PV and correlates with disease activity, whereas IgG1 can be associated with remittent disease. It is unknown if switching the same variable region between IgG4 and IgG1 directly impacts pathogenicity. Here, we tested whether three pathogenic PV monoclonal antibodies (mAbs) from three different patients demonstrate differences in antigen affinity, epitope specificity, or pathogenicity when expressed as IgG1 or IgG4. F706 anti-Dsg3 IgG4 and F779 anti-Dsg3 IgG1, previously isolated as heterohybridomas, and Px43, a monovalent anti-Dsg3/Dsg1 IgG antibody isolated by phage display, were subcloned to obtain paired sets of IgG1 and IgG4 mAbs. Using ELISA and cell surface staining assays, F706 and F779 demonstrated similar antigen binding affinities of IgG1 and IgG4, whereas Px43 showed 3- to 8-fold higher affinity of IgG4 versus IgG1 by ELISA, but identical binding affinities to human skin, perhaps due to targeting of a quaternary epitope best displayed in tissues. All 3 mAb pairs targeted the same extracellular cadherin (EC) domain on Dsg3, caused Dsg3 internalization in primary human keratinocytes, and caused suprabasal blisters in human skin at comparable doses. We conclude that switching IgG1 and IgG4 subclasses of pathogenic PV mAbs does not directly affect their antigen binding or pathogenic properties.	[Lo, Agnes S.; Yu, Xiaocong; Posner, Marshall R.; Cavacini, Lisa A.] Dana Farber Canc Inst, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Lo, Agnes S.; Yu, Xiaocong; Posner, Marshall R.; Cavacini, Lisa A.] Harvard Univ, Sch Med, Boston, MA USA; [Mao, Xuming; Mukherjee, Eric M.; Ellebrecht, Christoph T.; Payne, Aimee S.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Cavacini, Lisa A.] MassBiologics, 460 Walk Hill St, Boston, MA USA; [Posner, Marshall R.] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA	Harvard University; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Pennsylvania; Icahn School of Medicine at Mount Sinai	Cavacini, LA (corresponding author), Dana Farber Canc Inst, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA.; Cavacini, LA (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Cavacini, LA (corresponding author), MassBiologics, 460 Walk Hill St, Boston, MA USA.	lisa.cavacini@umassmed.edu		Mukherjee, Eric/0000-0001-8715-1378	Dana-Farber Cancer Institute Friends Head and Neck Cancer Research Award; NIAMS/NIH [AR057001, AR064220, P30-AR057217, T32-AR007465, F30-AR065870]; Dermatology Foundation; DFG [EL711/1-1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F30AR065870, T32AR007465, P30AR057217, R56AR064220, R01AR057001] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute Friends Head and Neck Cancer Research Award; NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dermatology Foundation; DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by Dana-Farber Cancer Institute Friends Head and Neck Cancer Research Award (ASL and LAC); in part by NIAMS/NIH grants AR057001, AR064220, P30-AR057217 (ASP) and T32-AR007465, F30-AR065870 (EMM); the Dermatology Foundation (XM); and DFG grant EL711/1-1 (CTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Sosthene Essono, Martin Jadus and Richard Junghans for reviewing this manuscript, and Mark Duval for his assistance with antibody purification and ELISAs. This work was funded by Dana-Farber Cancer Institute Friends Head and Neck Cancer Research Award (ASL and LAC); in part by NIAMS/NIH grants AR057001, AR064220, P30-AR057217 (ASP) and T32-AR007465, F30-AR065870 (EMM); the Dermatology Foundation (XM); and DFG grant EL711/1-1 (CTE).	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; BHOL K, 1994, DERMATOLOGY, V189, P85, DOI 10.1159/000246938; Bhol KC, 2002, AUTOIMMUNITY, V35, P87, DOI 10.1080/08916930290016655; Chen YJ, 2007, ONCOGENE, V26, P467, DOI 10.1038/sj.onc.1209802; Cho MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5167; DAVID M, 1989, ARCH DERMATOL, V125, P787, DOI 10.1001/archderm.125.6.787; Di Zenzo G, 2012, J CLIN INVEST, V122, P3781, DOI 10.1172/JCI64413; Futei Y, 2000, J INVEST DERMATOL, V115, P829, DOI 10.1046/j.1523-1747.2000.00137.x; Futei Y, 2001, J DERMATOL SCI, V26, P55, DOI 10.1016/S0923-1811(00)00158-4; Hanakawa Y, 2002, J INVEST DERMATOL, V119, P27, DOI 10.1046/j.1523-1747.2002.01780.x; Hertl M, 2006, J CLIN INVEST, V116, P1159, DOI 10.1172/JCI28547; Jeannin P, 1998, J IMMUNOL, V160, P3555; Kouno M, 2013, J INVEST DERMATOL, V133, P2212, DOI 10.1038/jid.2013.85; Kricheli D, 2000, BRIT J DERMATOL, V143, P337, DOI 10.1046/j.1365-2133.2000.03659.x; Liu FB, 2003, AIDS RES HUM RETROV, V19, P597, DOI 10.1089/088922203322230969; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Mao XM, 2014, J INVEST DERMATOL, V134, P68, DOI 10.1038/jid.2013.224; Mao XM, 2009, J INVEST DERMATOL, V129, P908, DOI 10.1038/jid.2008.339; Mascaro JM, 1997, CLIN IMMUNOL IMMUNOP, V85, P90, DOI 10.1006/clin.1997.4408; Miranda LR, 2007, J IMMUNOL, V178, P7132, DOI 10.4049/jimmunol.178.11.7132; Ohyama B, 2012, J INVEST DERMATOL, V132, P1158, DOI 10.1038/jid.2011.448; Payne AS, 2007, J INVEST DERMATOL, V127, P1681, DOI 10.1038/sj.jid.5700790; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; Payne AS, 2012, DERMATOLOGY GEN MED; Sekiguchi M, 2001, J IMMUNOL, V167, P5439, DOI 10.4049/jimmunol.167.9.5439; Sharma PM, 2009, J INVEST DERMATOL, V129, P2309, DOI 10.1038/jid.2009.41; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Takahashi H, 2007, J INVEST DERMATOL, V127, P324, DOI 10.1038/sj.jid.5700527; Tavakolpour S, 2016, INT IMMUNOPHARMACOL, V34, P139, DOI 10.1016/j.intimp.2016.02.020; Tavakolpour S, 2016, CYTOKINE, V77, P189, DOI 10.1016/j.cyto.2015.09.017; Yeh SW, 2006, CLIN IMMUNOL, V120, P68, DOI 10.1016/j.clim.2006.03.006; ZHANG K, 1994, J IMMUNOL, V152, P3427	33	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156800	10.1371/journal.pone.0156800	http://dx.doi.org/10.1371/journal.pone.0156800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304671	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800023
J	Ardhaoui, M; Ennaifer, E; Letaief, H; Salsabil, R; Lassili, T; Chahed, K; Bougatef, S; Bahrini, A; El Fehri, E; Ouerhani, K; Jimenez, AP; Guizani, I; Boubaker, MS; Ben Alaya, NBE				Ardhaoui, Monia; Ennaifer, Emna; Letaief, Hajer; Salsabil, Rejaibi; Lassili, Thalja; Chahed, Karim; Bougatef, Souha; Bahrini, Asma; El Fehri, Emna; Ouerhani, Kaouther; Jimenez, Adela Paez; Guizani, Ikram; Boubaker, Med Samir; Ben Alaya, Nissaf Bouafif Ep			Prevalence, Genotype Distribution and Risk Factors for Cervical Human Papillomavirus Infection in the Grand Tunis Region, Tunisia	PLOS ONE			English	Article							AGE-SPECIFIC PREVALENCE; WOMEN OLDER; VACCINES; DETERMINANTS; FEMALES	Implementation of Human Papillomavirus (HPV) vaccination should be considered a key cervical cancer prevention strategy in Tunisia, where Pap smear screening is not efficient. This study aims to estimate the prevalence and to identify risk factors associated with HPV infection among women from Grand Tunis, Tunisia. We conducted a cross-sectional study, between December 2012 and May 2013. Eligible women for this study were those aged 1865 years, sexually active, who sought medical attention at their primary health care centre or clinic in Grand Tunis, Tunisia and who gave written consent. A liquid-based Pap smear sample was obtained from all women using a cervical brush. Only women with betaglobin positive test were further analysed for HPV detection and typing. A nested-PCR of the L1 region was performed followed by reverse line blot hybridization to facilitate the specific detection of 31 HPV genotypes. Multiple logistic regression modeling was used for the analysis of associations between variables with some considered possible confounders after checking for interactions. A total of 391 women were enrolled in this study and 325 out of the 391 cervical samples were positive for the betaglobin test. Overall HPV prevalence was 13.2% [9.8%-17.5%], with the following most prevalent HPV genotypes: HPV6 (40%), HPV40 (14%), HPV16 (12%), HPV52 (9%), HPV31 and HPV59 (7%), followed by HPV68 (4%). Mean age of HPV positive women was 40.7 +/- 0.92 years. Independently associated risk factors of HPV infection were smoking (OR: 2.8 [0.8-9.6]), low income (OR: 9.6 [1.463.4]), bad housing type (OR: 2.5 [1-6.8]), partner with multiple sexual relationship (OR: 4.5 [0.9-22.9]) and single women (widowed, divorced, separated, never married) (OR: 6.9 [1.142.2]). This study provides the first national-based estimate of HPV prevalence in Tunisia. Our findings contribute to the evidence on the current burden of HPV infection, the critical role of sexual behaviour and socioeconomic status and call for increased support for the screening program in Tunisia to prevent cervical cancer. These results allow us to evaluate the cost-effectiveness of vaccine program implementation in Tunisia in future.	[Ardhaoui, Monia; Ennaifer, Emna; Lassili, Thalja; El Fehri, Emna; Ouerhani, Kaouther; Guizani, Ikram] Inst Pasteur Tunis, Dept Mol Epidemiol Infect Dis, Tunis, Tunisia; [Ardhaoui, Monia; Ennaifer, Emna; Lassili, Thalja; El Fehri, Emna; Ouerhani, Kaouther; Boubaker, Med Samir] Inst Pasteur Tunis, Dept Human & Expt Pathol, Tunis, Tunisia; [Letaief, Hajer; Salsabil, Rejaibi; Chahed, Karim; Bougatef, Souha; Bahrini, Asma; Ben Alaya, Nissaf Bouafif Ep] Observ Natl Malad Nouvelles & Emergentes Tunis, Dept Epidemiol, Tunis, Tunisia; [Salsabil, Rejaibi; Chahed, Karim; Jimenez, Adela Paez] European Ctr Dis Prevent & Control ECDC, Dept Dis Prevent & Control, Solna, Sweden; [Letaief, Hajer] Fac Med Tunis, Dept Prevent Med, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; European Centre for Disease Prevention & Control; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT)	Ardhaoui, M (corresponding author), Inst Pasteur Tunis, Dept Mol Epidemiol Infect Dis, Tunis, Tunisia.; Ardhaoui, M (corresponding author), Inst Pasteur Tunis, Dept Human & Expt Pathol, Tunis, Tunisia.	ardhaouimonia@gmail.com	Rejaibi, Salsabil/HGA-7850-2022	Bouafif ep Ben Alaya, Nissaf/0000-0002-3326-9861; PAEZ JIMENEZ, Adela/0000-0002-8653-610X; Guizani, Ikram/0000-0003-2763-8963	African Development bank [55001550022552]	African Development bank(CGIAR)	The project of "National HPV prevalence in Tunisia" has been granted by the "African Development bank" (http://www.afdb.org/en/) under the grant number: 55001550022552. Grant recipient is Pr. N. Bouafif, Director of the "Observatoire National des Maladies Nouvelles et Emergentes de Tunis". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER HM, 1993, SEX TRANSM DIS, V20, P274, DOI 10.1097/00007435-199309000-00007; Bethesda System, 2001, ACTA CYTOLOGICA, V45, P1077; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brismar-Wendel S, 2009, BRIT J CANCER, V101, P511, DOI 10.1038/sj.bjc.6605165; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Chan PKS, 2009, J MED VIROL, V81, P1635, DOI 10.1002/jmv.21575; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Coker AL, 2002, CANCER DETECT PREV, V26, P121, DOI 10.1016/S0361-090X(02)00039-9; De Marco F, 2006, J MED VIROL, V78, P950, DOI 10.1002/jmv.20646; De Vincenzo R, 2013, GYNECOL ONCOL, V130, P642, DOI 10.1016/j.ygyno.2013.05.033; Dillner J, 2015, SEMIN ONCOL, V42, P272, DOI 10.1053/j.seminoncol.2014.12.028; Dimassi K, 2015, INT J GYNECOL OBSTET, V128, P268, DOI 10.1016/j.ijgo.2014.09.019; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; El Mzibri M, 2010, J INFECT DEV CTRIES, V4; Ennaifer Emna, 2014, Tunis Med, V92, P253; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gasperov NM, 2008, PATHOL ONCOL RES, V14, P355, DOI 10.1007/s12253-008-9084-2; Gonzalez P, 2010, CANCER EPIDEM BIOMAR, V19, P3044, DOI 10.1158/1055-9965.EPI-10-0645; Grainge MJ, 2005, EMERG INFECT DIS, V11, P1680, DOI 10.3201/eid1111.050575; Guettiti H, 2014, ASIAN PAC J CANCER P, V15, P9361, DOI 10.7314/APJCP.2014.15.21.9361; Hammouda D, 2011, INT J CANCER, V128, P2224, DOI 10.1002/ijc.25539; Hassen E, 1999, Tunis Med, V77, P497; HAUSEN HZ, 1982, LANCET, V2, P1370; HILDESHEIM A, 1993, SEX TRANSM DIS, V20, P279, DOI 10.1097/00007435-199309000-00008; *IARC WORK GROUP, 1995, IARC MON EV CARC RIS, V64; Jumaan AO, 2013, VACCINE, V31, pG58, DOI 10.1016/j.vaccine.2012.06.097; Liu Zhi-Chang, 2015, Asian Pac J Cancer Prev, V16, P3893; Mbulawa ZZA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1181-8; Mitchell S, 2014, AM J OBSTET GYNECOL, V1, pe1; Moralejo Donna, 2009, Evid Based Nurs, V12, P122, DOI 10.1136/ebn.12.4.122; Moscicki AB, 2008, J ADOLESCENT HEALTH, V43, pS1, DOI 10.1016/j.jadohealth.2008.07.008; Ogembo RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122488; Ojiyi EC, 2013, ANN MED HEALTH SCI R, V3, P529, DOI 10.4103/2141-9248.122082; Shaltout MF, 2014, INT J INFECT DIS, V29, P226, DOI 10.1016/j.ijid.2014.07.029; Shi Runhua, 2014, BMC Res Notes, V7, P544, DOI 10.1186/1756-0500-7-544; Sudenga SL, 2013, INT J INFECT DIS, V17, pE216, DOI 10.1016/j.ijid.2012.12.027; Unger E. R, 2009, HUM PAP LAB MAN; Villa LL, 2006, VACCINE, V24, P23, DOI 10.1016/j.vaccine.2005.09.001; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; World Health Organization (WHO), 2014, HUM PAP VACC WHO POS; Xu CY, 2012, J OBSTET GYNAECOL RE, V38, P310, DOI 10.1111/j.1447-0756.2011.01624.x	42	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157432	10.1371/journal.pone.0157432	http://dx.doi.org/10.1371/journal.pone.0157432			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299955	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200048
J	Dyomin, AG; Koshel, EI; Kiselev, AM; Saifitdinova, AF; Galkina, SA; Fukagawa, T; Kostareva, AA; Gaginskaya, ER				Dyomin, Alexander G.; Koshel, Elena I.; Kiselev, Artem M.; Saifitdinova, Alsu F.; Galkina, Svetlana A.; Fukagawa, Tatsuo; Kostareva, Anna A.; Gaginskaya, Elena R.			Chicken rRNA Gene Cluster Structure	PLOS ONE			English	Article							DNA BARCODE; SEQUENCES; GENOME; MICROCHROMOSOME; EVOLUTION; NUCLEAR; REGION; ITS2; PCR	Ribosomal RNA (rRNA) genes, whose activity results in nucleolus formation, constitute an extremely important part of genome. Despite the extensive exploration into avian genomes, no complete description of avian rRNA gene primary structure has been offered so far. We publish a complete chicken rRNA gene cluster sequence here, including 5'ETS (1836 bp), 18S rRNA gene (1823 bp), ITS1 (2530 bp), 5.8S rRNA gene (157 bp), ITS2 (733 bp), 28S rRNA gene (4441 bp) and 3'ETS (343 bp). The rRNA gene cluster sequence of 11863 bp was assembled from raw reads and deposited to GenBank under KT445934 accession number. The assembly was validated through in situ fluorescent hybridization analysis on chicken metaphase chromosomes using computed and synthesized specific probes, as well as through the reference assembly against de novo assembled rRNA gene cluster sequence using sequenced fragments of BAC-clone containing chicken NOR (nucleolus organizer region). The results have confirmed the chicken rRNA gene cluster validity.	[Dyomin, Alexander G.; Koshel, Elena I.; Saifitdinova, Alsu F.; Galkina, Svetlana A.; Gaginskaya, Elena R.] St Petersburg State Univ, St Petersburg 199034, Russia; [Kiselev, Artem M.; Kostareva, Anna A.] Almazov Fed Med Res Ctr, St Petersburg 197341, Russia; [Kiselev, Artem M.; Kostareva, Anna A.] ITMO Univ, St Petersburg 197101, Russia; [Fukagawa, Tatsuo] Osaka Univ, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan	Saint Petersburg State University; Almazov National Medical Research Centre; ITMO University; Osaka University	Gaginskaya, ER (corresponding author), St Petersburg State Univ, St Petersburg 199034, Russia.	elena.gaginskaya@gmail.com	Galkina, Svetlana/AAK-7179-2021; Kostareva, Anna/AAO-5429-2020; Demin, Aleksandr G./N-6526-2015; Galkina, Svetlana A./J-2493-2013; Gaginskaya, Elena/C-9963-2013; Saifitdinova, Alsu F/C-1104-2011; Fukagawa, Tatsuo/AAK-3922-2021; Galkina, Svetlana/P-2308-2019; Koshel, Elena I/L-7493-2016; Kiselev, Artem M/H-1283-2016; Kostareva, Anna/H-2204-2016	Galkina, Svetlana A./0000-0002-7034-2466; Gaginskaya, Elena/0000-0003-4967-9053; Saifitdinova, Alsu F/0000-0002-1221-479X; Galkina, Svetlana/0000-0002-7034-2466; Koshel, Elena I/0000-0002-8957-5956; Kiselev, Artem M/0000-0002-5524-6900; Kostareva, Anna/0000-0002-9349-6257	Saint-Petersburg State University [1.50.1043.2014]; Russian Basic Research Foundation [15-04-05684]; RF Government [074-U01]	Saint-Petersburg State University; Russian Basic Research Foundation(Russian Foundation for Basic Research (RFBR)); RF Government	The research has been financed by 1. Saint-Petersburg State University Grant #1.50.1043.2014 (AD EK) http://english.spbu.ru/; 2. Russian Basic Research Foundation Grant #15-04-05684 (EG SG AD EK) http://www.rfbr.ru/rffi/eng; 3. RF Government Grant #074-U01 (AnK ArK) http://government.ru/en/. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AUER H, 1987, CYTOGENET CELL GENET, V45, P218, DOI 10.1159/000132457; AZAD AA, 1980, NUCLEIC ACIDS RES, V8, P4365, DOI 10.1093/nar/8.19.4365; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bozinovic G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-132; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chikuni K., 1995, J YAMASHINA I ORNITH, V28, P1; Coleman AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079122; Delany ME, 2007, CYTOGENET GENOME RES, V117, P54, DOI 10.1159/000103165; EVERS R, 1995, P NATL ACAD SCI USA, V92, P5827, DOI 10.1073/pnas.92.13.5827; Galkina S, 2006, GENETICA, V128, P241, DOI 10.1007/s10709-005-5776-7; HEDGES SB, 1990, MOL BIOL EVOL, V7, P607; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Koepfli KP, 2015, ANNU REV ANIM BIOSCI, V3, P57, DOI 10.1146/annurev-animal-090414-014900; Masabanda JS, 2004, GENETICS, V166, P1367, DOI 10.1534/genetics.166.3.1367; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Miller MM, 1996, P NATL ACAD SCI USA, V93, P3958, DOI 10.1073/pnas.93.9.3958; Pasko L, 2011, MOL PHYLOGENET EVOL, V61, P760, DOI 10.1016/j.ympev.2011.07.021; Shang WH, 2013, DEV CELL, V24, P635, DOI 10.1016/j.devcel.2013.02.009; Shaw P, 2012, PLANT PHYSIOL, V158, P44, DOI 10.1104/pp.111.188052; Singer M. F., 1991, GENES GENOMES CHANGI; Smirnov E, 2006, FOLIA BIOL-PRAGUE, V52, P59; Solinhac R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-616; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; van Tuinen M, 2000, MOL BIOL EVOL, V17, P451, DOI 10.1093/oxfordjournals.molbev.a026324; Wain HM, 1998, ANIM GENET, V29, P446, DOI 10.1046/j.1365-2052.1998.296374.x; Wang XC, 2015, MOL ECOL RESOUR, V15, P573, DOI 10.1111/1755-0998.12325; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zhang XW, 2003, MAGNET RESON MED, V49, P1192, DOI 10.1002/mrm.10460; Zheng Z, 2012, J BIOL CHEM, V287, P19949, DOI 10.1074/jbc.M112.355099; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157464	10.1371/journal.pone.0157464	http://dx.doi.org/10.1371/journal.pone.0157464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299357	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200054
J	Shenje, J; Millard, PS				Shenje, Justin; Millard, Peter S.			Sutureless Adult Voluntary Male Circumcision with Topical Anesthetic: A Randomized Field Trial of Unicirc, a Single-Use Surgical Instrument	PLOS ONE			English	Article								Introduction The World Health Organization has solicited rapid and minimally invasive techniques to facilitate scale-up of voluntary medical male circumcision (VMMC). Study design Non-blinded randomized controlled field trial with 2:1 allocation ratio. Participants 75 adult male volunteers. Setting Outpatient primary care clinic. Intervention Open surgical circumcision under local anesthetic with suturing vs. Unicirc disposable instrument under topical anesthetic and wound sealing with cyanoacrylate tissue adhesive. Primary Outcome Intraoperative duration. Secondary Outcomes Intraoperative and postoperative pain; adverse events; time to healing; patient satisfaction; cosmetic result. Results The intraoperative time was less with the Unicirc technique (median 12 vs. 25 min, p < 0.001). Wound healing and cosmetic results were superior in the Unicirc group. Adverse events were similar in both groups. Conclusions VMMC with Unicirc under topical anesthetic and wound sealing with cyanoacrylate tissue adhesive is rapid, heals by primary intention with superior cosmetic results, and is potentially safer and more cost-effective than open surgical VMMC.	[Shenje, Justin] Univ Cape Town, Sch Publ Hlth & Family Med, Dept Epidemiol, ZA-7925 Cape Town, South Africa; [Millard, Peter S.] Univ New England, Grad Program Publ Hlth, Dept Epidemiol, Portland, ME USA	University of Cape Town; University of New England - Maine	Millard, PS (corresponding author), Univ New England, Grad Program Publ Hlth, Dept Epidemiol, Portland, ME USA.	pmillard@me.com		Millard, Peter/0000-0002-7361-3356	Simunye Primary Health Care	Simunye Primary Health Care	This study was funded by Simunye Primary Health Care. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, WHO PROGR BRIEF VOL; [Anonymous], 2015, FAST TRACK END GLOB; Elemen L, 2011, PEDIATR SURG INT, V27, P879, DOI 10.1007/s00383-010-2741-z; Elmore JM, 2007, UROLOGY, V70, P803, DOI 10.1016/j.urology.2007.07.002; Grund JM, 2016, MMWR-MORBID MORTAL W, V65, P36, DOI 10.15585/mmwr.mm6502a5; Kaye JD, 2010, J UROLOGY, V184, P1758, DOI 10.1016/j.juro.2010.03.081; Kelly BD, 2012, PEDIATR SURG INT, V28, P305, DOI 10.1007/s00383-011-3015-0; Lane V, 2010, PEDIATR SURG INT, V26, P141, DOI 10.1007/s00383-009-2475-y; Millard PS, 2014, SAMJ S AFR MED J, V104, P52, DOI [10.7196/SAMJ.7357, 10.7196/samj.7357]; Millard PS, 2013, SAMJ S AFR MED J, V103, P736, DOI [10.7196/SAMJ.6856, 10.7196/samj.6856]; Millard PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121686; Ndagijimana A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138287; O'Sullivan J, 2002, RES B IRISH NATL I H, V1, P14; O'Sullivan J, 2002, IRISH J MED SCI, V171, P57, DOI [10.1007/BF03170099, DOI 10.1007/BF031700991]; Sharma P, 2004, INDIAN J SURG, V66, P276; Tiwari P, 2011, INDIAN J UROL, V27, P475, DOI 10.4103/0970-1591.91435; Tobian AAR, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001820; Van Haute C, 2015, J PEDIATR UROL, V11, DOI 10.1016/j.jpurol.2015.02.013; World Health Organization, 2009, MAN MAL CIRC UND LOC; World Health Organization, 2011, FRAM CLIN EV DEV AD; World Health Organization (WHO), 2010, CONS IMPL MOD OPT VO	21	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157065	10.1371/journal.pone.0157065	http://dx.doi.org/10.1371/journal.pone.0157065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299735	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200026
J	Kim, BI; Ki, H; Park, S; Cho, E; Chun, BC				Kim, Bryan Inho; Ki, Hyunok; Park, Sunhee; Cho, Eunhi; Chun, Byung Chul			Effect of Climatic Factors on Hand, Foot, and Mouth Disease in South Korea, 2010-2013	PLOS ONE			English	Article							CHINA; EPIDEMIC; PATTERNS; VACCINE	Hand, foot, and mouth disease (HFMD) causes characteristic blisters and sores mainly in infants and children, and has been monitored in South Korea through sentinel surveillance since 2009. We described the patterns of HFMD occurrence and analyzed the effect of climatic factors on national HFMD incidence. Weekly clinically diagnosed HFMD case rates (per 1,000 outpatients) in sentinel sites and weekly climatic factors, such as average temperature, relative humidity, duration of sunshine, precipitation, and wind speed from 2010 to 2013, were used in this study. A generalized additive model with smoothing splines and climatic variables with time lags of up to 2 weeks were considered in the modeling process. To account for long-term trends and seasonality, we controlled for each year and their corresponding weeks. The autocorrelation issue was also adjusted by using autocorrelation variables. At an average temperature below 18 degrees C, the HFMD rate increased by 10.3% for every 1 degrees C rise in average temperature (95% confidence interval (CI): 8.4, 12.3%). We also saw a 6.6% increase in HFMD rate (95% CI: 3.6, 9.7%) with every 1% increase in relative humidity under 65%, with a 1.5% decrease in HFMD rate observed (95% CI: 0.4, 2.7%) with each 1% humidity increase above 65%. Modeling results have shown that average temperature and relative humidity are related to HFMD rate. Additional research on the environmental risk factors of HFMD transmission is required to understand the underlying mechanism between climatic factors and HFMD incidence.	[Kim, Bryan Inho; Ki, Hyunok; Park, Sunhee; Cho, Eunhi] Korea Ctr Dis Control & Prevent, Div Infect Dis Surveillance, Chungcheongbuk Do, South Korea; [Kim, Bryan Inho; Chun, Byung Chul] Korea Univ, Sch Publ Hlth, Dept Epidemiol & Med Informat, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Infectious Disease Control; Korea University	Chun, BC (corresponding author), Korea Univ, Sch Publ Hlth, Dept Epidemiol & Med Informat, Seoul, South Korea.	chun@korea.ac.kr	Chun, Byung Chul/AGO-1458-2022; Chun, Byung Chul/AGO-1390-2022; Ibrahim, Essam Hassan/G-1960-2018	Chun, Byung Chul/0000-0001-6576-8916; Chun, Byung Chul/0000-0001-6576-8916; Ibrahim, Essam Hassan/0000-0003-0130-2257				Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Chan CB, 2009, INT J ENV RES PUB HE, V6, P2639, DOI 10.3390/ijerph6102639; Frydenberg Alexis, 2003, Aust Fam Physician, V32, P594; Goksugur Nadir, 2010, N Engl J Med, V362, pe49, DOI 10.1056/NEJMicm0910628; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Huang JX, 2014, INT J ENV RES PUB HE, V11, P3407, DOI 10.3390/ijerph110303407; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; Jiang M, 2012, NEW ENGL J MED, V367, P91, DOI 10.1056/NEJMc1110981; Li T, 2014, EPIDEMIOL INFECT, V142, P1741, DOI 10.1017/S0950268813002938; Liao YL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1446-6; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Mao QY, 2016, EXPERT REV VACCINES, V15, P599, DOI 10.1586/14760584.2016.1138862; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Sun LM, 2011, JPN J INFECT DIS, V64, P13; Suzuki Y, 2010, PEDIATR INT, V52, P203, DOI 10.1111/j.1442-200X.2009.02937.x; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JF, 2013, GEOSPATIAL HEALTH, V7, P381, DOI 10.4081/gh.2013.95; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923	25	41	45	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157500	10.1371/journal.pone.0157500	http://dx.doi.org/10.1371/journal.pone.0157500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285850	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000068
J	Osterloff, J; Nilssen, I; Eide, I; Figueiredo, MAD; Tamega, FTD; Nattkemper, TW				Osterloff, Jonas; Nilssen, Ingunn; Eide, Ingvar; de Oliveira Figueiredo, Marcia Abreu; de Souza Tamega, Frederico Tapajos; Nattkemper, Tim W.			Computational Visual Stress Level Analysis of Calcareous Algae Exposed to Sedimentation	PLOS ONE			English	Article							RHODOLITH DISTRIBUTION; DEEP; CORAL; CONSERVATION; ABUNDANCE; ISSUES	This paper presents a machine learning based approach for analyses of photos collected from laboratory experiments conducted to assess the potential impact of water-based drill cuttings on deep-water rhodolith-forming calcareous algae. This pilot study uses imaging technology to quantify and monitor the stress levels of the calcareous algae Mesophyllum engelhartii (Foslie) Adey caused by various degrees of light exposure, flow intensity and amount of sediment. A machine learning based algorithm was applied to assess the temporal variation of the calcareous algae size (similar to mass) and color automatically. Measured size and color were correlated to the photosynthetic efficiency (maximum quantum yield of charge separation in photosystem II, Phi(PSIImax)) and degree of sediment coverage using multivariate regression. The multivariate regression showed correlations between time and calcareous algae sizes, as well as correlations between fluorescence and calcareous algae colors.	[Osterloff, Jonas; Nattkemper, Tim W.] Univ Bielefeld, Biodata Min Grp, Fac Technol, D-33615 Bielefeld, Germany; [Nilssen, Ingunn; Eide, Ingvar] Statoil ASA, Res & Technol, N-7005 Trondheim, Norway; [Nilssen, Ingunn] Norwegian Univ Sci & Technol, Trondhjem Biol Stn, Dept Biol, N-7491 Trondheim, Norway; [de Oliveira Figueiredo, Marcia Abreu] Inst Pesquisa Jardim Bot Rio de Janeiro, BR-22460030 Rio De Janeiro, RJ, Brazil; [de Oliveira Figueiredo, Marcia Abreu; de Souza Tamega, Frederico Tapajos] Inst Biodiversidade Marinha, BR-22793000 Rio De Janeiro, RJ, Brazil; [de Souza Tamega, Frederico Tapajos] Inst Estudos Mar Almirante Paulo Moreira, BR-28930000 Arraial Do Cabo, RJ, Brazil	University of Bielefeld; Equinor; Norwegian University of Science & Technology (NTNU)	Osterloff, J (corresponding author), Univ Bielefeld, Biodata Min Grp, Fac Technol, D-33615 Bielefeld, Germany.	josterlo@cebitec.uni-bielefeld.de	Tamega, Frederico/ABD-8849-2021; Nattkemper, Tim W/F-3332-2017	Tamega, Frederico/0000-0003-2773-2036; Nattkemper, Tim W/0000-0002-7986-1158; Osterloff, Jonas/0000-0002-5962-5326	STATOIL Brasil Oleo e Gas Ltda (STATOIL Brazil Oil and Gas LLC)	STATOIL Brasil Oleo e Gas Ltda (STATOIL Brazil Oil and Gas LLC)	Financial support was given by STATOIL Brasil Oleo e Gas Ltda (STATOIL Brazil Oil and Gas LLC) (http://www.statoil.com/brazil/). Agencia Nacional de Petroleo, Gas Natural e Biocombustiveis - ANP (National Agency of Petroleum, Natural Gas and Biofuels - ANP) (http://www.anp.gov.br/), Rio de Janeiro, Brazil, has accepted the Project under the Federal Participation Agreement (FPE). The decision to publish was not influenced by the funders.	Amado GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035171; Basso D, 1998, PALAEOGEOGR PALAEOCL, V137, P173, DOI 10.1016/S0031-0182(97)00099-0; Beijbom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130312; Bergmann M, 2012, MAR POLLUT BULL, V64, P2734, DOI 10.1016/j.marpolbul.2012.09.018; Bergmann M, 2011, MAR BIOL RES, V7, P525, DOI 10.1080/17451000.2010.535834; Box G. E. P., 1978, Statistics for experimenters. An introduction to design, data analysis and model building.; Buhl-Mortensen P, 2015, MAR BIOL RES, V11, P725, DOI 10.1080/17451000.2014.993651; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Figueiredo MAO, 2015, MAR POLLUT BULL, V95, P81, DOI 10.1016/j.marpolbul.2015.04.040; Forina M, 2007, MULTIVARIATE CALIBRA, V1158; Foster DH., 2010, WILEY IS T SERIES IM, V51; Foster MS, 2001, J PHYCOL, V37, P659, DOI 10.1046/j.1529-8817.2001.00195.x; Gonzalez R. C., 2018, DIGITAL IMAGE PROCES, V4th, P119; Hall-Spencer J, 1998, J CONCHOL, P271; Henriques MC, 2014, PHYTOTAXA, V190, P112, DOI 10.11646/phytotaxa.190.1.9; IOCCG, 2000, REPORTS INT OCEAN CO; Johnsen G., 2009, ECOSYSTEM BARENTS SE, V9, P139; KEMPF M, 1970, MAR BIOL, V5, P213, DOI 10.1007/BF00346909; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; LITTLER MM, 1991, J EXP MAR BIOL ECOL, V150, P163, DOI 10.1016/0022-0981(91)90066-6; LITTLER MM, 1986, DEEP-SEA RES, V33, P881, DOI 10.1016/0198-0149(86)90003-8; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; Nilssen I, 2015, MAR POLLUT BULL, V96, P374, DOI 10.1016/j.marpolbul.2015.04.045; Ontrup J, 2002, ADV NEUR IN, V14, P1417; Ontrup J., 2009, OCEANS 2009 EUROPE, V17, DOI [10.1109/OCEANSE.2009.5278332, DOI 10.1109/OCEANSE.2009.5278332]; Osterloff J., 2016, METHODS OCEANOG, V15, P114, DOI DOI 10.1016/J.MIO.2016.03.002; Purser A, 2013, BIOGEOSCIENCES, V10, P5779, DOI 10.5194/bg-10-5779-2013; Purser A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134076; Purser A, 2009, MAR ECOL PROG SER, V397, P241, DOI 10.3354/meps08154; Riosmena-Rodriguez R, 2010, REEFS ROCK ROLL BIOL, P49; Schoening T., 2016, METHODS OCEANOGR, V15-16, P78, DOI DOI 10.1016/J.MI0.2016.04.002; Schoening T., 2015, 2015 MTSIEEE OCEANS, P1; Schoening T, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00059; Schoening T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038179; Shihavuddin A. S. M., 2012, Proceedings of the International Conference on Computer Vision Theory and Applications. VISAPP 2012, P161; Siebeck UE, 2006, CORAL REEFS, V25, P453, DOI 10.1007/s00338-006-0123-8; Steller DL, 2001, ECOSYSTEMS, P72; Stokes M., 1996, STANDARD DEFAULT COL; Tamega FTS, 2013, CATALOGUE BENTHIC MA, P140; Villas-Boas AB, 2014, CRYPTOGAMIE ALGOL, V35, P67, DOI 10.7872/crya.v35.iss1.2014.67; Westad F, 2002, MULTIVARIATE DATA AN; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Wold S, 2012, MATRIX PENCILS, V973, P286; YUEN HK, 1990, IMAGE VISION COMPUT, V8, P71, DOI 10.1016/0262-8856(90)90059-E	44	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157329	10.1371/journal.pone.0157329	http://dx.doi.org/10.1371/journal.pone.0157329			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285611	Green Published, Green Submitted, gold			2022-12-27	WOS:000377564000058
J	Usui, J; Tawara-Iida, T; Takada, K; Ebihara, I; Ueda, A; Iwabuchi, S; Ishizu, T; Iitsuka, T; Takemura, K; Kawamura, T; Kaneko, S; Sakai, K; Kai, H; Gomibuchi, T; Nagata, M; Kobayashi, M; Koyama, A; Suka, M; Radhakrishnan, J; Yamagata, K				Usui, Joichi; Tawara-Iida, Takashi; Takada, Kenji; Ebihara, Itaru; Ueda, Atsushi; Iwabuchi, Satoshi; Ishizu, Takashi; Iitsuka, Tadashi; Takemura, Katsumi; Kawamura, Tetsuya; Kaneko, Shuzo; Sakai, Kentaro; Kai, Hirayasu; Gomibuchi, Tomoka; Nagata, Michio; Kobayashi, Masaki; Koyama, Akio; Suka, Machi; Radhakrishnan, Jai; Yamagata, Kunihiro			Temporal Changes in Post-Infectious Glomerulonephritis in Japan (1976-2009)	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INFECTION; EXPERIENCE; SPECTRUM; ADULTS	Background The incidence of post-infectious glomerulonephritis (PIGN) in developed countries has decreased over the last 50 years. Here we identified the trends of the incidence of PIGN in Japan during the past four decades. Methods We explored the frequency, clinicopathological findings, and prognosis of PIGN based on 6,369 cases from the Renal Biopsy Database of our institute in the Kanto region of Japan, diagnosed histologically from 1976 to 2009. Results The numbers of PIGN cases were 131 (2.1%) in total, and 2.4%, 1.1%, 2.6% and 2.1% identified in the 1970s, 1980s, 1990s, and 2000s, respectively. Acute glomerulonephritis (AGN), including post-streptococcal glomerulonephritis (PSGN), accounted for almost all of the PIGN cases in the 1970s, but decreased to approx. 40%-50% since the 1990s. In the 1990s, Staphylococcus aureus infection-related nephritis (SARN) showed a rapid increase in rate, reaching 30%. The incidence of hepatitis C virus infection-associated GN (HCVGN) has increased since the 1990s. The average age at onset rose from 33 to 51 years over the study period. These transitions can be summarized as increases in SARN and HCVGN and decreases in PSGN and other types of AGN, since SARN and HCVGN have older onsets compared to PSGN and other AGN types. The clinicopathological features were marked for each PIGN. Regarding the prognosis, the renal death rates of both the SARN and HCVGN groups were significantly higher than those of other PIGN. Conclusion Based on our analysis of the Renal Biopsy Database, the incidence of PIGN in Japan reached its peak in the 1990s. The temporal changes in the incidence of PIGN reflected the trends in infectious diseases of each decade and the continual aging of the population, with a related higher susceptibility to infections.	[Usui, Joichi; Tawara-Iida, Takashi; Kawamura, Tetsuya; Kaneko, Shuzo; Kai, Hirayasu; Koyama, Akio; Yamagata, Kunihiro] Univ Tsukuba, Dept Nephrol, Tsukuba, Ibaraki, Japan; [Nagata, Michio] Univ Tsukuba, Fac Med, Pathol, Tsukuba, Ibaraki, Japan; [Takada, Kenji] Tsukuba Gakuen Hosp, Dept Nephrol, Tsukuba, Ibaraki, Japan; [Ebihara, Itaru] Mito Saiseikai Gen Hosp, Dept Nephrol, Mito, Ibaraki, Japan; [Ueda, Atsushi] Hitachi Gen Hosp, Dept Nephrol, Hitachi, Ibaraki, Japan; [Iwabuchi, Satoshi] Kensei Gen Hosp, Dept Med, Sakuragawa, Ibaraki, Japan; [Ishizu, Takashi] Tsukuba Cent Hosp, Dept Nephrol, Ushiku, Ibaraki, Japan; [Iitsuka, Tadashi; Sakai, Kentaro] Ibaraki Seinan Med Ctr Hosp, Dept Nephrol, Sakai, Ibaraki, Japan; [Takemura, Katsumi] Takemura Nephrol Clin, Kanuma, Tochigi, Japan; [Gomibuchi, Tomoka] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan; [Kobayashi, Masaki] Tokyo Med Univ, Ibaraki Med Ctr, Dept Nephrol, Ami, Ibaraki, Japan; [Koyama, Akio] Ibaraki Prefectural Univ, Ami, Ibaraki, Japan; [Suka, Machi] Jikei Univ, Sch Med, Dept Publ Hlth & Environm Med, Tokyo, Japan; [Radhakrishnan, Jai] Columbia Univ, Div Nephrol, Med Ctr, New York, NY USA	University of Tsukuba; University of Tsukuba; University of Tokyo; Tokyo Medical University; Jikei University; Columbia University	Usui, J (corresponding author), Univ Tsukuba, Dept Nephrol, Tsukuba, Ibaraki, Japan.	j-usui@md.tsukuba.ac.jp			Japan Science Technology Agency; Ministry of Education, Culture, Sport, Science, and Technology, Japan; Ministry of Health, Labour and Welfare of Japan	Japan Science Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sport, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a grant from the Japan Science Technology Agency, the Ministry of Education, Culture, Sport, Science, and Technology, Japan, and a Grant-in-Aid for Intractable Renal Diseases Research, Research on rare and intractable diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel G, 2007, CLEV CLIN J MED, V74, P353, DOI 10.3949/ccjm.74.5.353; Arase Y, 1998, INTERNAL MED, V37, P836, DOI 10.2169/internalmedicine.37.836; Azmi AN, 2015, WORLD J HEPATOL, V7, P78, DOI 10.4254/wjh.v7.i1.78; Barsoum RS, 2007, NEPHROL DIAL TRANSPL, V22, P1840, DOI 10.1093/ndt/gfm205; Churg J, 1995, RENAL DIS CLASSIFECA; El-Serag HB, 2002, HEPATOLOGY, V36, P1439, DOI 10.1053/jhep.2002.37191; Jennette JC., 2015, HEPTINSTALLS PATHOLO; KOYAMA A, 1995, KIDNEY INT, V47, P207, DOI 10.1038/ki.1995.25; McGuire BM, 2006, ANN INTERN MED, V144, P735, DOI 10.7326/0003-4819-144-10-200605160-00007; MONTSENY JJ, 1995, MEDICINE, V74, P63, DOI 10.1097/00005792-199503000-00001; Nasr SH, 2008, MEDICINE, V87, P21, DOI [10.1097/MD.0b013e318161b0fc, 10.1097/md.0b013e318161b0fc]; Nasr SH, 2013, KIDNEY INT, V83, P792, DOI 10.1038/ki.2012.407; Nasr SH, 2011, J AM SOC NEPHROL, V22, P187, DOI 10.1681/ASN.2010060611; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Rodriguez-Iturbe B., 2010, COMPR CLIN NEPHROL, P662, DOI [10.1016/b978-0-323-05876-6.00055-1, DOI 10.1016/B978-0-323-05876-6.00055-1]; Rodriguez-Iturbe B, 2008, J AM SOC NEPHROL, V19, P1855, DOI 10.1681/ASN.2008010092; ROY S, 1990, PEDIATR NEPHROL, V4, P585, DOI 10.1007/BF00858626; SIMON P, 1995, NEPHROLOGIE, V16, P191; Takeda S, 2007, SHOUNIKA RINSHO, V60, P1003; Wen YK, 2010, CLIN NEPHROL, V73, P173	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157356	10.1371/journal.pone.0157356	http://dx.doi.org/10.1371/journal.pone.0157356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286043	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000060
J	Wysocki, AD; Villa, TCS; Arakawa, T; Brunello, MEF; Vendramini, SHF; Monroe, AA; Kritski, AL				Wysocki, Anneliese Domingues; Scatena Villa, Tereza Cristina; Arakawa, Tiemi; Firmino Brunello, Maria Eugenia; Figueiredo Vendramini, Silvia Helena; Monroe, Aline Aparecida; Kritski, Afranio Lineu			Latent Tuberculosis Infection Diagnostic and Treatment Cascade among Contacts in Primary Health Care in a City of Sao Paulo State, Brazil: Cross-Sectional Study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; PREVENTIVE THERAPY; ADHERENCE; CHILDREN	Background Diagnosis and treatment of latent tuberculosis infection (LTBI) is a tool for global TB control, especially in close contacts. But data is scarce in high burden countries, under field conditions, including data on the benefits of LTBI management. Objective To analyze the LTBI diagnosis and treatment cascade among contacts in primary health care (PHC) services in Sao Jose do Rio Preto-SP, Brazil. Methods Cross-sectional design, conducted with contacts of pulmonary TB patients followed in all PHC services. Data was collected from May to September 2014 in the Reporting System for TB cases (TBWEB) and Reporting System for Chemoprophylaxis. Medical records and treatment follow-up forms were reviewed and all the nurses responsible for TB in PHC services were interviewed. Results Among 336 contacts included, 267 (79.4%) were screened for TB or LTBI, according to the presence or not of respiratory symptoms. Among those contacts screened, 140 (52.4%) were symptomatic, 9 (3.4%) had TB disease, 106/221 (48%) had positive TST result, meeting the criteria for LTBI treatment, and 64/106 (60.4%) actually started it. Overall, among 267 screened, only 64 (24%) started LTBI treatment. The completion rates of treatment among the contacts who started it, those with positive TST result and those screened were 56.3% (36/64), 16.3%(36/221) and 13.5%(36/267), respectively. Nurses claimed that asymptomatic TB contacts pay no attention to preventive health care and do not seek medical care as they do not have symptoms of the disease. In reviewing the medical records, high proportions of contacts without evaluation, incomplete assessment, incorrect records of contraindication for LTBI treatment, lack of notes regarding the identification and evaluation of contacts were identified. Conclusions There is a need for better organization of the surveillance and investigation routine for contacts in PHC, considering the reorganization of the work process and the features of the local health system.	[Wysocki, Anneliese Domingues] Univ Fed Mato Grosso do Sul, Coll Nursing, Tres Lagoas, MS, Brazil; [Scatena Villa, Tereza Cristina; Arakawa, Tiemi; Firmino Brunello, Maria Eugenia; Monroe, Aline Aparecida] Univ Sao Paulo, Sch Nursing Ribeirao Preto, Dept Publ Hlth, BR-14049 Ribeirao Preto, SP, Brazil; [Figueiredo Vendramini, Silvia Helena] Sch Med Sao Jose do Rio Preto, Dept Publ Hlth Nursing & Profess Orientat, Sao Paulo, Brazil; [Kritski, Afranio Lineu] Univ Fed Rio de Janeiro, Sch Med, TB Acad Program, Rio De Janeiro, Brazil; [Wysocki, Anneliese Domingues; Scatena Villa, Tereza Cristina; Arakawa, Tiemi; Firmino Brunello, Maria Eugenia; Figueiredo Vendramini, Silvia Helena; Monroe, Aline Aparecida; Kritski, Afranio Lineu] Brazilian TB Res Network Rede TB, Rio De Janeiro, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro	Wysocki, AD (corresponding author), Univ Fed Mato Grosso do Sul, Coll Nursing, Tres Lagoas, MS, Brazil.; Wysocki, AD (corresponding author), Brazilian TB Res Network Rede TB, Rio De Janeiro, Brazil.	lilisew@yahoo.com.br	Wysocki, Anneliese Domingues/I-3696-2014; Kritski, Afranio/I-6760-2016; Monroe, Aline Aparecida/C-9568-2017; Villa, Tereza Cristina Scatena/K-7891-2013; Villa, Teresa/GQQ-9643-2022	Wysocki, Anneliese Domingues/0000-0002-8381-9999; Monroe, Aline Aparecida/0000-0003-4073-2735; Villa, Tereza Cristina Scatena/0000-0001-8927-2624; kritski, afranio/0000-0002-5900-6007	US Agency for International Development (USAID); International Clinical, Operational, and Health Services Research and Training Award (ICOHRTA)	US Agency for International Development (USAID)(United States Agency for International Development (USAID)); International Clinical, Operational, and Health Services Research and Training Award (ICOHRTA)	The study was conducted as a part of the TREAT TB program, funded by the US Agency for International Development (USAID), in a virtual approach. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to acknowledge the unreserved assistance provided by the training team of the TREAT TB virtual Operational Research Learning Programme. The study was conducted as a part of the TREAT TB program, funded by the US Agency for International Development (USAID), in a virtual approach. This training project was implemented jointly by the SJRP TB control Programme, addressing its need to get better results in TB control. The authors also express their gratitude to the International Clinical, Operational, and Health Services Research and Training Award (ICOHRTA), to the Brazilan Tuberculosis Research Network (Rede TB) and to PHC staff whose collaboration in this study made this research possible.	AISU T, 1995, AIDS, V9, P267, DOI 10.1097/00002030-199509030-00008; Arakawa T, 2011, REV LAT-AM ENFERM, V19, P994, DOI 10.1590/S0104-11692011000400019; Brasil. Programa Nacional de Controle de Tuberculose, 2015, B EP SECR VIG SAUD M, V46, P2; Mendonca AMC, 2015, BRAZ J INFECT DIS, V19, P296, DOI 10.1016/j.bjid.2014.12.005; Caldeira ZMR, 2004, REV SAUDE PUBL, V38, P339, DOI 10.1590/S0034-89102004000300001; Chakhaia T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111773; da Silva DM, 2014, REV ESC ENFERM USP, V48, P1041, DOI 10.1590/S0080-623420140000700012; Pereira ATD, 2008, CAD SAUDE PUBLICA, V24, pS123, DOI 10.1590/S0102-311X2008001300017; Lima Lílian Moura de, 2013, Rev. Gaúcha Enferm., V34, P102; Delai MY, 2012, PUBLIC HEALTH ACTION, V2, P142, DOI 10.5588/pha.12.0064; Duarte R, 2012, INT J TUBERC LUNG D, V16, P55, DOI 10.5588/ijtld.10.0511; Durovni PBP, 2013, THESIS NATL SCH PUBL; Ekwueme OEC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1175; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Gebregergs GB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125767; Gomes VF, 2011, INT J TUBERC LUNG D, V15, P1637, DOI 10.5588/ijtld.10.0558; Hartwig Shaiana Vilella, 2008, J. bras. pneumol., V34, P298, DOI 10.1590/S1806-37132008000500009; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Machado A, 2009, INT J TUBERC LUNG D, V13, P719; Mandal P, 2012, QJM-INT J MED, V105, P741, DOI 10.1093/qjmed/hcs045; Marais BJ, 2009, CLIN CHEST MED, V30, P827, DOI 10.1016/j.ccm.2009.08.012; Mendes EV, 2012, CUIDADO CONDICOES CR; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Person AK, 2013, CURR PULMONOL REP, V2, P199, DOI 10.1007/s13665-013-0064-y; RIEDER HL, 2002, INTERVENTIONS TUBERC; Rutherford ME, 2013, B WORLD HEALTH ORGAN, V91, P932, DOI 10.2471/BLT.13.118414; Rutherford Merrin E, 2012, BMC Res Notes, V5, P7, DOI 10.1186/1756-0500-5-7; Scatena LM, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005548; Scatena Lúcia Marina, 2009, Rev. Saúde Pública, V43, P389, DOI 10.1590/S0034-89102009005000022; Villa TCS, 2013, REV LAT-AM ENFERM, V21, P190, DOI 10.1590/S0104-11692013000700024; Sharma SK, 2012, CHEST, V142, P761, DOI 10.1378/chest.12-0142; Silva DM, 2012, THE FIEP B, V82, P268; Teixeira TP, 2010, VISITA DOMICILIAR CO, V22, P75; Thanh THT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-713; Tornee Songpol, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P375; van Zyl S, 2006, INT J TUBERC LUNG D, V10, P13; Vasconcellos MM, 2008, REGISTROS SAUDE AVAL, V24, P173; Wakiyama TP, 2012, REV CIENCE SAUDE, V14, P15; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organisation, 2015, GUID MAN LAT TUB INF	40	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0155348	10.1371/journal.pone.0155348	http://dx.doi.org/10.1371/journal.pone.0155348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1UG	27285720	gold, Green Published, Green Submitted			2022-12-27	WOS:000377564000004
J	Zoso, A; Serafini, P; Lanzoni, G; Peixoto, E; Messinger, S; Mantero, A; Padilla-Tellez, ND; Baidal, DA; Alejandro, R; Ricordi, C; Inverardi, L				Zoso, Alessia; Serafini, Paolo; Lanzoni, Giacomo; Peixoto, Eduardo; Messinger, Shari; Mantero, Alejandro; Padilla-Tellez, Nathalia D.; Baidal, David A.; Alejandro, Rodolfo; Ricordi, Camillo; Inverardi, Luca			G-CSF and Exenatide Might Be Associated with Increased Long-Term Survival of Allogeneic Pancreatic Islet Grafts	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; REGULATORY T-CELLS; INSULIN INDEPENDENCE; PRIMARY NONFUNCTION; DENDRITIC CELLS; IN-VIVO; TRANSPLANTATION; ATP; IMMUNOSUPPRESSION; INDUCTION	Background Allogeneic human islet transplantation is an effective therapy for the treatment of patients with Type 1 Diabetes (T1D). The low number of islet transplants performed worldwide and the different transplantation protocols used limit the identification of the most effective therapeutic options to improve the efficacy of this approach. Methods We present a retrospective analysis on the data collected from 44 patients with T1D who underwent islet transplantation at our institute between 2000 and 2007. Several variables were included: recipient demographics and immunological characteristics, donor and transplant characteristics, induction protocols, and additional medical treatment received. Immunosuppression was induced with anti-CD25 (Daclizumab), alone or in association with antitumor necrosis factor alpha (TNF-alpha) treatments (Etanercept or Infliximab), or with anti-CD52 (Alemtuzumab) in association with anti-TNF-alpha treatments (Etanercept or Infliximab). Subsets of patients were treated with Filgrastim for moderate/severe neutropenia and/or Exenatide for post prandial hyperglycemia. Results The analysis performed indicates a negative association between graft survival (c-peptide level >= 0.3 ng/ml) and islet infusion volume, with the caveat that, the progressive reduction of infusion volumes over the years has been paralleled by improved immunosuppressive protocols. A positive association is instead suggested between graft survival and administration of Exenatide and Filgrastim, alone or in combination. Conclusion This retrospective analysis may be of assistance to further improve long-term outcomes of protocols for transplant of islets and other organs.	[Zoso, Alessia; Lanzoni, Giacomo; Peixoto, Eduardo; Padilla-Tellez, Nathalia D.; Baidal, David A.; Alejandro, Rodolfo; Ricordi, Camillo; Inverardi, Luca] Univ Miami, Diabet Res Inst, Miami, FL USA; [Serafini, Paolo] Univ Miami, Dept Microbiol Immunol, Miami, FL USA; [Messinger, Shari; Mantero, Alejandro] Univ Miami, Dept Publ Hlth Sci, Miami, FL USA; [Peixoto, Eduardo] Framingham Union Hosp, Internal Med, Framingham, MA USA	University of Miami; University of Miami; University of Miami	Inverardi, L (corresponding author), Univ Miami, Diabet Res Inst, Miami, FL USA.	linverar@med.miami.edu	Serafini, Paolo/C-8195-2012; Lanzoni, Giacomo/K-7396-2019; RICORDI, CAMILLO/AAA-4740-2019; Padilla, Nathalia/AAQ-9596-2020; Mantero, Alejandro/AAS-6415-2021; Lanzoni, Giacomo/H-1695-2015	Serafini, Paolo/0000-0002-3651-9176; Padilla, Nathalia/0000-0002-7177-1107; Lanzoni, Giacomo/0000-0003-3996-4803	National Center for Research Resources [U42-RR16603, GCRC-M01RR16587]; National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK55347, R01-DK25802]; National Center for Advancing Translational [1UL1TR000460]; Juvenile Diabetes Research Foundation [4-2000-946, 4-2004-361]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000460] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Center for Research Resources: U42-RR16603 (CR), GCRC-M01RR16587 (CR); the National Institute of Diabetes and Digestive and Kidney Diseases: R01-DK55347 (CR), R01-DK25802 (LI), R01-DK25802 (CR); National Center for Advancing Translational: 1UL1TR000460 (CR); and the Juvenile Diabetes Research Foundation: 4-2000-946 (CR), 4-2004-361 (CR).	Adeegbe D, 2011, CELL TRANSPLANT, V20, P941, DOI 10.3727/096368910X540621; Balamurugan AN, 2014, AM J TRANSPLANT, V14, P2595, DOI 10.1111/ajt.12872; Bassi R, 2011, CURR DIABETES REP, V11, P355, DOI 10.1007/s11892-011-0211-1; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Bellin MD, 2012, AM J TRANSPLANT, V12, P1576, DOI 10.1111/j.1600-6143.2011.03977.x; Bruni A, 2014, DIABETES METAB SYNDR, V7, P211, DOI 10.2147/DMSO.S50789; Bucher P, 2004, TRANSPL P, V36, P1119, DOI 10.1016/j.transproceed.2004.04.022; Buss JL, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/382518; Chaudhuri A, 2012, J CLIN ENDOCR METAB, V97, P198, DOI 10.1210/jc.2011-1508; D'Addio F, 2014, DIABETES, V63, P3041, DOI 10.2337/db14-0295; Deng S, 1997, TRANSPLANT P, V29, P2062, DOI 10.1016/S0041-1345(97)00232-7; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Faradji RN, 2008, TRANSPLANTATION, V86, P1658, DOI 10.1097/TP.0b013e31818fe448; FARNEY AC, 1993, TRANSPL P, V25, P865; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Froud T, 2005, AM J TRANSPLANT, V5, P2037, DOI 10.1111/j.1600-6143.2005.00957.x; Froud T, 2008, TRANSPLANTATION, V86, P36, DOI 10.1097/TP.0b013e31817c4ab3; Froud T, 2008, TRANSPLANTATION, V86, P1695, DOI 10.1097/TP.0b013e31819025e5; Gangemi A, 2008, AM J TRANSPLANT, V8, P1250, DOI 10.1111/j.1600-6143.2008.02234.x; Haag F, 2007, PURINERG SIGNAL, V3, P71, DOI 10.1007/s11302-006-9038-7; Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830; Huss DJ, 2015, J IMMUNOL, V194, P84, DOI 10.4049/jimmunol.1402140; Kared H, 2008, BLOOD, V112, P2575, DOI 10.1182/blood-2008-02-140681; Kawahara T, 2012, J HEPATO-BIL-PAN SCI, V19, P281, DOI 10.1007/s00534-011-0441-2; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Koh A, 2010, TRANSPLANTATION, V89, P361, DOI 10.1097/TP.0b013e3181bcdbe8; Mineo D, 2008, AM J TRANSPLANT, V8, P1262, DOI 10.1111/j.1600-6143.2008.02230.x; MITTAL VK, 1981, TRANSPLANTATION, V31, P302; Niclauss N, 2014, TRANSPLANTATION, V98, P593, DOI 10.1097/TP.0000000000000288; PATCHEN ML, 1986, J IMMUNOPHARMACOL, V8, P407; Piemonti L, 2013, DIABETES, V62, P1656, DOI 10.2337/db12-1258; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Rossetti M, 2010, EUR J IMMUNOL, V40, P3097, DOI 10.1002/eji.201040659; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Serafini P, 2013, IMMUNOL RES, V57, P172, DOI 10.1007/s12026-013-8455-2; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Steptoe RJ, 2005, DIABETES, V54, P434, DOI 10.2337/diabetes.54.2.434; Toso C, 2009, TRANSPL INT, V22, P182, DOI 10.1111/j.1432-2277.2008.00746.x; Van Belle T, 2008, J CLIN INVEST, V118, P1625, DOI 10.1172/JCI35639; Vergani A, 2013, DIABETES, V62, P1665, DOI 10.2337/db12-0242; VISTE A, 1990, TRANSPLANT P, V22, P808; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Xue S, 2008, ANN NY ACAD SCI, V1150, P152, DOI 10.1196/annals.1447.049	44	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157245	10.1371/journal.pone.0157245	http://dx.doi.org/10.1371/journal.pone.0157245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285580	gold, Green Published, Green Submitted			2022-12-27	WOS:000377564000048
J	Vallega, KA; Liu, NN; Myers, JS; Yu, KX; Sang, QXA				Vallega, Karin A.; Liu, NingNing; Myers, Jennifer S.; Yu, Kaixian; Sang, Qing-Xiang Amy			Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; OBESITY; BIOMARKER; MORTALITY	Introduction African American (AA) women diagnosed with breast cancer are more likely to have aggressive subtypes. Investigating differentially expressed genes between patient populations may help explain racial health disparities. Resistin, one such gene, is linked to inflammation, obesity, and breast cancer risk. Previous studies indicated that resistin expression is higher in serum and tissue of AA breast cancer patients compared to Caucasian American (CA) patients. However, resistin expression levels have not been compared between AA and CA patients in a stage- and subtype-specific context. Breast cancer prognosis and treatments vary by subtype. This work investigates differential resistin gene expression in human breast cancer tissues of specific stages, receptor subtypes, and menopause statuses in AA and CA women. Methods Differential gene expression analysis was performed using human breast cancer gene expression data from The Cancer Genome Atlas. We performed inter-race resistin gene expression level comparisons looking at receptor status and stage-specific data between AA and CA samples. DESeq was run to test for differentially expressed resistin values. Results Resistin RNA was higher in AA women overall, with highest values in receptor negative subtypes. Estrogen-, progesterone-, and human epidermal growth factor receptor 2-negative groups showed statistically significant elevated resistin levels in Stage I and II AA women compared to CA women. In inter-racial comparisons, AA women had significantly higher levels of resistin regardless of menopause status. In whole population comparisons, resistin expression was higher among Stage I and III estrogen receptor negative cases. In comparisons of molecular subtypes, resistin levels were significant higher in triple negative than in luminal A breast cancer. Conclusion Resistin gene expression levels were significantly higher in receptor negative subtypes, especially estrogen receptor negative cases in AA women. Resistin may serve as an early breast cancer biomarker and possible therapeutic target for AA breast cancer.	[Vallega, Karin A.; Liu, NingNing; Myers, Jennifer S.; Sang, Qing-Xiang Amy] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Yu, Kaixian] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Sang, Qing-Xiang Amy] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Sang, QXA (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.; Sang, QXA (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	qxsang@chem.fsu.edu			Florida State University	Florida State University	This work was in part supported by grants from the Florida State University and an Endowed Chair Professorship in Cancer Research from anonymous donors to QXAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Alokail MS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-54; Amend K, 2006, CANCER RES, V66, P8327, DOI 10.1158/0008-5472.CAN-06-1927; American Cancer Society, 2015, BREAST CANC FACTS FI; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Dal Maso L, 2008, INT J CANCER, V123, P2188, DOI 10.1002/ijc.23747; Dalamaga M, 2014, BIOMARK MED, V8, P107, DOI 10.2217/bmm.13.99; Dalamaga M, 2013, MENOPAUSE, V20, P845, DOI [10.1097/GME.0b013e31827f06dc, 10.1097/gme.0b013e31827f06dc]; Dalamaga M, 2013, CLIN BIOCHEM, V46, P584, DOI 10.1016/j.clinbiochem.2013.01.001; Danforth DN, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3429; Deshmukh SK, 2015, RESISTIN INTERLEUKIN; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Gapstur SM, 1996, HORMONE RECEPTOR STA; Gaudet MM, 2010, CANCER EPIDEMIOL, V34, P580, DOI 10.1016/j.canep.2010.05.014; Kang JH, 2007, J KOREAN MED SCI, V22, P117, DOI 10.3346/jkms.2007.22.1.117; Lee YC, 2012, GYNECOL ONCOL, V125, P742, DOI 10.1016/j.ygyno.2012.02.032; Lewis A., 2006, J TRANSL MED, V12, P1; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Mehrotra J, 2004, CLIN CANCER RES, V10, P2052, DOI 10.1158/1078-0432.CCR-03-0514; Montazeri A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-278; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242; Stewart PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082460; Sun CA, 2010, BREAST CANCER RES TR, V123, P869, DOI 10.1007/s10549-010-0792-4	26	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157741	10.1371/journal.pone.0157741	http://dx.doi.org/10.1371/journal.pone.0157741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314854	Green Submitted, gold, Green Published			2022-12-27	WOS:000378030000048
J	Komninou, ER; Remiao, MH; Lucas, CG; Domingues, WB; Basso, AC; Jornada, DS; Deschamps, JC; Beck, RCR; Pohlmann, AR; Bordignon, V; Seixas, FK; Campos, VF; Guterres, SS; Collares, T				Komninou, Eliza Rossi; Remiao, Mariana Harter; Lucas, Caroline Gomes; Domingues, William Borges; Basso, Andrea Cristina; Jornada, Denise Soledade; Deschamps, Joao Carlos; Ruver Beck, Ruy Carlos; Pohlmann, Adriana Raffin; Bordignon, Vilceu; Seixas, Fabiana Kommling; Campos, Vinicius Farias; Guterres, Silvia Staniscuaski; Collares, Tiago			Effects of Two Types of Melatonin-Loaded Nanocapsules with Distinct Supramolecular Structures: Polymeric (NC) and Lipid-Core Nanocapsules (LNC) on Bovine Embryo Culture Model	PLOS ONE			English	Article							IN-VITRO DEVELOPMENT; OXIDATIVE STRESS; GENE-EXPRESSION; NANOPARTICLES; PREIMPLANTATION; IMPLANTATION; MATURATION; DELIVERY; OOCYTE; MOUSE	Melatonin has been used as a supplement in culture medium to improve the efficiency of in vitro produced mammalian embryos. Through its ability to scavenge toxic oxygen derivatives and regulate cellular mRNA levels for antioxidant enzymes, this molecule has been shown to play a protective role against damage by free radicals, to which in vitro cultured embryos are exposed during early development. In vivo and in vitro studies have been performed showing that the use of nanocapsules as active substances carriers increases stability, bioavailability and biodistribution of drugs, such as melatonin, to the cells and tissues, improving their antioxidant properties. These properties can be modulated through the manipulation of formula composition, especially in relation to the supramolecular structures of the nanocapsule core and the surface area that greatly influences drug release mechanisms in biological environments. This study aimed to evaluate the effects of two types of melatonin-loaded nanocapsules with distinct supramolecular structures, polymeric (NC) and lipid-core (LNC) nanocapsules, on in vitro cultured bovine embryos. Embryonic development, apoptosis, reactive oxygen species (ROS) production, and mRNA levels of genes involved in cell apoptosis, ROS and cell pluripotency were evaluated after supplementation of culture medium with non-encapsulated melatonin (Mel), melatonin-loaded polymeric nanocapsules (Mel-NC) and melatonin-loaded lipid-core nanocapsules (Mel-LNC) at 10(-6), 10(-9), and 10(-12) M drug concentrations. The highest hatching rate was observed in embryostreated with 10(-9) M Mel-LNC. When compared to Mel and Mel-NC treatments at the same concentration (10(-9) M), Mel-LNC increased embryo cell number, decreased cell apoptosis and ROS levels, down-regulated mRNA levels of BAX, CASP3, and SHC1 genes, and upregulated mRNA levels of CAT and SOD2 genes. These findings indicate that nanoencapsulation with LNC increases the protective effects of melatonin against oxidative stress and cell apoptosis during in vitro embryo culture in bovine species.	[Komninou, Eliza Rossi; Remiao, Mariana Harter; Lucas, Caroline Gomes; Domingues, William Borges; Deschamps, Joao Carlos; Seixas, Fabiana Kommling; Campos, Vinicius Farias; Collares, Tiago] Univ Fed Pelotas, Biotecnol Ctr Dev Tecnol, Grp Pesquisa Oncol Celular & Mol, PPGB, BR-96010900 Pelotas, RS, Brazil; [Basso, Andrea Cristina] In Vitro Brasil SA, BR-13800970 Mogi Mirim, SP, Brazil; [Jornada, Denise Soledade; Ruver Beck, Ruy Carlos; Guterres, Silvia Staniscuaski] Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752, BR-90610000 Porto Alegre, RS, Brazil; [Pohlmann, Adriana Raffin] Univ Fed Rio Grande do Sul, Inst Quim, Dept Quim Organ, BR-91501970 Porto Alegre, RS, Brazil; [Bordignon, Vilceu] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Universidade Federal de Pelotas; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; McGill University	Collares, T (corresponding author), Univ Fed Pelotas, Biotecnol Ctr Dev Tecnol, Grp Pesquisa Oncol Celular & Mol, PPGB, BR-96010900 Pelotas, RS, Brazil.; Guterres, SS (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752, BR-90610000 Porto Alegre, RS, Brazil.	silvia.guterres@ufrgs.br; tiago.collares@pq.cnpq.br	Guterres, Silvia S/B-6420-2015; Collares, Tiago/K-2779-2019; Beck, Ruy C. R./D-7735-2011; Seixas, Fabiana Kommling/X-2706-2018; Pohlmann, Adriana Raffin/B-9910-2008; Domingues, William Borges/AAM-5818-2021; Cristina Basso, Andrea/AHC-5589-2022; Campos, Vinicius Farias/G-3546-2012; Komninou, Eliza Rossi/J-7031-2014; Collares, Tiago/S-2117-2016	Guterres, Silvia S/0000-0002-6085-6826; Collares, Tiago/0000-0002-1535-3795; Beck, Ruy C. R./0000-0001-6262-1097; Seixas, Fabiana Kommling/0000-0003-4204-2500; Pohlmann, Adriana Raffin/0000-0001-5222-1807; Domingues, William Borges/0000-0002-4351-2271; Campos, Vinicius Farias/0000-0003-2119-293X; Komninou, Eliza Rossi/0000-0001-6591-408X; Collares, Tiago/0000-0002-1535-3795; Bordignon, Vilceu/0000-0001-7076-7707; , Andrea Cristina Basso/0000-0002-8679-5232; Gomes Lucas, Caroline/0000-0003-3029-7987				Amarnath D, 2007, J REPROD DEVELOP, V53, P1247, DOI 10.1262/jrd.19096; Arias-Alvarez M, 2013, THERIOGENOLOGY, V79, P323, DOI 10.1016/j.theriogenology.2012.09.019; Asgari Z, 2012, CELL J, V14, P203; Barkalina N, 2015, HUM REPROD UPDATE, V21, P627, DOI 10.1093/humupd/dmv027; Barkalina N, 2014, NANOMED-NANOTECHNOL, V10, P921, DOI 10.1016/j.nano.2014.01.001; Barkalina N, 2014, NANOMED-NANOTECHNOL, V10, P859, DOI 10.1016/j.nano.2013.10.011; Campos VF, 2011, THERIOGENOLOGY, V75, P1476, DOI 10.1016/j.theriogenology.2011.01.009; Campos VF, 2011, THERIOGENOLOGY, V76, P1552, DOI 10.1016/j.theriogenology.2011.06.027; Cebrian-Serrano A, 2013, REPROD DOMEST ANIM, V48, P738, DOI 10.1111/rda.12154; Chattoraj A, 2008, COMP BIOCHEM PHYS A, V150, P301, DOI 10.1016/j.cbpa.2008.03.014; Choi J, 2008, MOL REPROD DEV, V75, P1127, DOI 10.1002/mrd.20861; Cruz MHC, 2014, ANIM REPROD SCI, V145, P150, DOI 10.1016/j.anireprosci.2014.01.011; Duarte AA, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13098-7; El-Gibaly I, 2003, INT J PHARM, V260, P5, DOI 10.1016/S0378-5173(03)00149-2; El-Raey M, 2011, MOL REPROD DEV, V78, P250, DOI 10.1002/mrd.21295; Feng RL, 2012, INT J NANOMED, V7, P4089, DOI 10.2147/IJN.S33607; Fiel LA, 2011, SOFT MATTER, V7, P7240, DOI 10.1039/c1sm05508a; Fiorentino I, 2015, EXP CELL RES, V330, P240, DOI 10.1016/j.yexcr.2014.09.017; Fischer TW, 2013, J PINEAL RES, V54, P303, DOI 10.1111/jpi.12018; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Gao C, 2012, J PINEAL RES, V52, P305, DOI 10.1111/j.1600-079X.2011.00944.x; Gou ML, 2011, CURR DRUG TARGETS, V12, P1131, DOI 10.2174/138945011795906642; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Hoffmeister CRD, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-251; Ishizuka B, 2000, J PINEAL RES, V28, P48, DOI 10.1034/j.1600-079x.2000.280107.x; Jager E, 2009, J BIOMED NANOTECHNOL, V5, P130, DOI 10.1166/jbn.2009.1004; Jornada DS, 2012, SOFT MATTER, V8, P6646, DOI 10.1039/c2sm25754h; Kang JT, 2009, J PINEAL RES, V46, P22, DOI 10.1111/j.1600-079X.2008.00602.x; Karja NWK, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-54; Kumar A, 2015, THERIOGENOLOGY, V83, P1402, DOI 10.1016/j.theriogenology.2014.12.023; Lane M, 2005, REPROD FERT DEVELOP, V17, P371, DOI 10.1071/RD04102; Lord T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106450; Lucas CG, 2015, REPROD TOXICOL, V58, P131, DOI 10.1016/j.reprotox.2015.10.004; Manjunatha BM, 2009, REPROD DOMEST ANIM, V44, P12, DOI 10.1111/j.1439-0531.2007.00982.x; Mora-Huertas CE, 2010, INT J PHARMACEUT, V385, P113, DOI 10.1016/j.ijpharm.2009.10.018; Oliveira CP, 2013, SOFT MATTER, V9, P1141, DOI 10.1039/c2sm26959g; Ourique AF, 2010, J BIOMED NANOTECHNOL, V6, P214, DOI 10.1166/jbn.2010.1120; Papis K, 2007, J PINEAL RES, V43, P321, DOI 10.1111/j.1600-079X.2007.00479.x; Pardeike J, 2009, INT J PHARMACEUT, V366, P170, DOI 10.1016/j.ijpharm.2008.10.003; Pers-Kamczyc E, 2010, THERIOGENOLOGY, V74, P581, DOI 10.1016/j.theriogenology.2010.03.011; Pohlmann AR, 2010, METHODS MOL BIOL, V610, P109, DOI 10.1007/978-1-60327-029-8_7; Pohlmann AR, 2013, EXPERT OPIN DRUG DEL, V10, P623, DOI 10.1517/17425247.2013.769956; Poletto FS, 2015, J NANOSCI NANOTECHNO, V15, P827, DOI 10.1166/jnn.2015.9182; Proietti S, 2014, EXPERT OPIN DRUG MET, V10, P1193, DOI 10.1517/17425255.2014.943183; Reis CP, 2006, NANOMED-NANOTECHNOL, V2, P8, DOI 10.1016/j.nano.2005.12.003; Rivara S, 2005, J MED CHEM, V48, P4049, DOI 10.1021/jm048956y; Rodriguez-Alvarez L, 2010, ZYGOTE, V18, P269, DOI 10.1017/S0967199409990323; Rodriguez-Osorio N, 2007, J PINEAL RES, V43, P283, DOI 10.1111/j.1600-079X.2007.00475.x; Sakatani M, 2004, MOL REPROD DEV, V67, P77, DOI 10.1002/mrd.20014; Schaffazick SR, 2007, PHARMAZIE, V62, P354, DOI 10.1691/ph.2007.5.6087; Schaffazick SR, 2006, J BRAZIL CHEM SOC, V17, P562, DOI 10.1590/S0103-50532006000300020; Schaffazick SR, 2005, INT J PHARMACEUT, V289, P209, DOI 10.1016/j.ijpharm.2004.11.003; Schultze E, 2014, EUR J PHARM BIOPHARM, V87, P55, DOI 10.1016/j.ejpb.2014.02.003; Shi JM, 2009, J PINEAL RES, V47, P318, DOI 10.1111/j.1600-079X.2009.00717.x; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4; Takada L, 2012, RES VET SCI, V92, P124, DOI 10.1016/j.rvsc.2010.11.004; Takahashi M, 2012, J REPROD DEVELOP, V58, P1, DOI 10.1262/jrd.11-138N; Tian XZ, 2014, J PINEAL RES, V57, P239, DOI 10.1111/jpi.12163; Venturini CG, 2011, COLLOID SURFACE A, V375, P200, DOI 10.1016/j.colsurfa.2010.12.011; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093641; Wang F, 2013, J PINEAL RES, V55, P267, DOI 10.1111/jpi.12069; Zhang LM, 2013, J PINEAL RES, V54, P24, DOI 10.1111/j.1600-079X.2012.01016.x; Zhao MX, 2011, BIOMATERIALS, V32, P5223, DOI 10.1016/j.biomaterials.2011.03.060; Zhao T, 2014, SCI REP-UK, V4, DOI 10.1038/srep03793	64	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157561	10.1371/journal.pone.0157561	http://dx.doi.org/10.1371/journal.pone.0157561			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310006	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800096
J	Lu, YY; Chen, M; Huang, ZY; Tang, CW				Lu, Yaoyao; Chen, Meng; Huang, Zhiyin; Tang, Chengwei			Antidepressants in the Treatment of Functional Dyspepsia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							GASTRIC SENSORIMOTOR FUNCTION; IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; DOUBLE-BLIND; GASTROINTESTINAL DISORDERS; CLINICAL-TRIAL; EFFICACY; AMITRIPTYLINE; POPULATION; SYMPTOMS	Background Antidepressants have been empirically used in the treatment of functional dyspepsia (FD). However, results from recent clinical trials investigating their efficacy are conflicting. The aim of this study is to evaluate the efficacy of antidepressants in the management of FD in adults. Methods Databases of MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials and BIOSIS Previews were searched for all randomized controlled trials (RCT) investigating efficacy of antidepressants in the management of FD in adult patients. Data of overall symptom unimproved and adverse events were compared between the antidepressants and placebo group. Results The search strategy identified 432 citations. Of those, eight RCTs met the inclusion criteria and were included in the meta-analysis. The pooled relative risk (RR) of symptom unimproved with tricyclic antidepressants (TCAs) versus placebo was 0.76 (95% CI: 0.62 to 0.94, P = 0.01; I-2 = 0%, P = 0.39). By contrast, selective serotonin reuptake inhibitors (SSRIs) did not show a benefit over placebo (RR = 1.00, 95% CI: 0.86 to 1.17, P = 0.95; I-2 = 0%, P = 0.82). Adverse events were significantly more frequent among patients receiving antidepressants than those receiving placebos (RR = 1.64, 95% CI: 1.14 to 2.35, P = 0.007). Conclusion TCAs but not SSRIs, are effective in the treatment of FD, but antidepressants were also associated with more adverse events compared with placebo.	[Lu, Yaoyao; Chen, Meng; Huang, Zhiyin; Tang, Chengwei] Sichuan Univ, Dept Gastroenterol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Tang, CW (corresponding author), Sichuan Univ, Dept Gastroenterol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	shcqcdmed@163.com						Aro P, 2009, GASTROENTEROLOGY, V137, P94, DOI 10.1053/j.gastro.2009.03.039; Bouras EP, 2008, AM J GASTROENTEROL, V103, P2043, DOI 10.1111/j.1572-0241.2008.02021.x; Braak B, 2011, ALIMENT PHARM THER, V34, P638, DOI 10.1111/j.1365-2036.2011.04775.x; Chen Y, 2014, CHINESE J GASTROENTE, V19, P340; Chial HJ, 2003, AM J PHYSIOL-GASTR L, V284, pG130, DOI 10.1152/ajpgi.00266.2002; Fischler B, 2003, GASTROENTEROLOGY, V124, P903, DOI 10.1053/gast.2003.50155; Ford AC, 2009, GUT, V58, P367, DOI 10.1136/gut.2008.163162; Gao FY, 2011, ZHONGGUO XINYAO YU L, V27, P293; Giao Ly H, 2013, GASTROENTEROLOGY, V144, pS337; Guo QX, 2015, WORLD CHINESE J DIGE, V23, P324, DOI 10.11569/wcjd.v23.i2.324; Halder SLS, 2004, ALIMENT PHARM THER, V19, P233, DOI 10.1111/j.0269-2813.2004.01807.x; Hashash JG, 2008, ALIMENT PHARM THER, V27, P1148, DOI 10.1111/j.1365-2036.2008.03677.x; Hiyama T, 2007, J GASTROEN HEPATOL, V22, P304, DOI 10.1111/j.1440-1746.2006.04493.x; Hojo M, 2005, J GASTROENTEROL, V40, P1036, DOI 10.1007/s00535-005-1687-8; Hsu YC, 2011, J GASTROENTEROL, V46, P183, DOI 10.1007/s00535-010-0334-1; Jackson JL, 2000, AM J MED, V108, P65, DOI 10.1016/S0002-9343(99)00299-5; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kaosombatwattana U, 2015, GASTROENTEROLOGY, V148, pS822; Koloski NA, 2012, GUT, V61, P1284, DOI 10.1136/gutjnl-2011-300474; Koloski NA, 2000, AM J GASTROENTEROL, V95, P67; Li Z, 2004, CHINESE J CLIN REHAB, V8, P4953; Lu CL, 2005, SCAND J GASTROENTERO, V40, P402, DOI 10.1080/00365520510012190; Mertz H, 1998, AM J GASTROENTEROL, V93, P160, DOI 10.1111/j.1572-0241.1998.00160.x; Miwa H, 2012, J GASTROEN HEPATOL, V27, P626, DOI [10.1111/j.1440-1746.2011.07037.x, 10.5056/jnm.2012.18.2.150]; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Otaka M, 2005, ALIMENT PHARM THERAP, V21, P42, DOI 10.1111/j.1365-2036.2005.02473.x; Passos Maria do Carmo Friche, 2008, Pain Physician, V11, P597; Qiu ZS, 2013, J GASTROEN HEPATOL, V28, P760; Rahimi R, 2009, WORLD J GASTROENTERO, V15, P1548, DOI 10.3748/wjg.15.1548; ROSSI F, 1995, PHARMACOL RES, V31, P81, DOI 10.1016/1043-6618(95)80052-2; Salerno SM, 2002, ARCH INTERN MED, V162, P19, DOI 10.1001/archinte.162.1.19; Shaib Y, 2004, AM J GASTROENTEROL, V99, P2210, DOI 10.1111/j.1572-0241.2004.40052.x; Song JM, 2011, WORLD CHINESE J DIGE, V19, P2895; Tack J, 2003, ALIMENT PHARM THER, V17, P603, DOI 10.1046/j.1365-2036.2003.01469.x; Tack J, 1998, GASTROENTEROLOGY, V115, P1346, DOI 10.1016/S0016-5085(98)70012-5; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Talley NJ, 2015, GASTROENTEROLOGY, V149, P340, DOI 10.1053/j.gastro.2015.04.020; Talley NJ, 2006, ALIMENT PHARM THERAP, V23, P923, DOI 10.1111/j.1365-2036.2006.02845.x; Tan VPY, 2012, WORLD J GASTROENTERO, V18, P6127, DOI 10.3748/wjg.v18.i42.6127; Tanum L, 1996, SCAND J GASTROENTERO, V31, P318, DOI 10.3109/00365529609006404; Tonini M, 2003, DIGEST LIVER DIS, V35, P244, DOI 10.1016/S1590-8658(03)00061-6; Van Kerkhoven LAS, 2008, CLIN GASTROENTEROL H, V6, P746, DOI 10.1016/j.cgh.2008.02.051; Wang WH, 2007, CLIN GASTROENTEROL H, V5, P178, DOI 10.1016/j.cgh.2006.09.012; Wang W, 2012, PAIN PHYSICIAN, V15, pE131; Wu JC, 2011, GASTROENTEROLOGY, V140, pS50; Yamawaki H, 2014, J NEUROGASTROENTEROL, V20, P104, DOI 10.5056/jnm.2014.20.1.104; Zhao W, 2013, J GASTROEN HEPATOL, V28, P302	47	21	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157798	10.1371/journal.pone.0157798	http://dx.doi.org/10.1371/journal.pone.0157798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310135	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800136
J	Yuan, SZ; Zhang, N; Xu, L; Zhou, L; Ge, XN; Guo, X; Yang, HC				Yuan, Shuaizhen; Zhang, Ning; Xu, Lei; Zhou, Lei; Ge, Xinna; Guo, Xin; Yang, Hanchun			Induction of Apoptosis by the Nonstructural Protein 4 and 10 of Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							SYNDROME PRRS VIRUS; CELL-DEATH PROGRAM; ARTERIVIRUS REPLICASE; MOLECULAR-BIOLOGY; ECONOMIC-IMPACT; UNITED-STATES; BCL-2 FAMILY; IN-VITRO; ACTIVATION; CLEAVAGE	Infection by most viruses triggers apoptosis in host cells, and viruses manipulate this cell response to promote viral replication, virus spread, and cell killing. Porcine reproductive and respiratory syndrome virus (PRRSV) has been shown to induce apoptosis both in vitro and in vivo, while the regulatory roles of PRRSV-encoded products in apoptosis are not fully understood. In the present study, we first showed a biphasic apoptosis regulation by a highly pathogenic PRRSV strain JXwn06. It was indicated that PRRSV infection delays apoptosis at early infection but activates apoptosis at late infection in MARC-145 cells. In PRRSV-infected MARC-145 cells, procaspase-8, -9 and -12 were activated at late infection, demonstrating the involvements of death receptor pathway, mitochondrial pathway and endoplasmic reticulum (ER) stress pathway in inducing apoptosis. PRRSV was also shown to induce a similar apoptosis process in pulmonary alveolar macrophages (PAMs) with an early initiation. Next, the PRRSV-encoded apoptosis inducers were screened, indicating that the nonstructural protein (Nsp) 4 and Nsp10 of PRRSV are pro-apoptotic. In the presence of Nsp4, it was confirmed that procaspase-8, -9 and -12 were cleaved, and Nsp4 facilitates the cleavage of procaspase-9 by activating B-cell lymphoma 2 interacting mediator of cell death (Bim), a pro-apoptotic protein. In addition, Nsp4 was shown to induce the degradation of an anti-apoptotic protein, B-cell lymphoma-extra large (Bcl-xL). Nsp10 was shown to activate procaspase-8 and -9 but procaspase-12 and to upregulate the expression of BH3-only pro-apoptotic protein BH3 interacting-domain death agonist (Bid) and its active form, truncated Bid (tBid). Clearly, the participation of both activated caspase-8 and Bid is required for Nsp10-induced apoptosis, indicating a crosstalk between extrinsic-and mitochondria-dependent pathways. Together, our findings suggest that PRRSV infection regulates apoptosis in a two-phase manner and activates all three apoptotic pathways; the Nsp4 and Nsp10 of PRRSV function as apoptosis inducers with different molecular basis.	[Yuan, Shuaizhen; Zhang, Ning; Xu, Lei; Zhou, Lei; Ge, Xinna; Guo, Xin; Yang, Hanchun] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China; [Yang, Hanchun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Yang, HC (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China.; Yang, HC (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	yanghanchun1@cau.edu.cn		Zhou, Lei/0000-0002-8837-3965	National Natural Science Funds from National Natural Science Foundation of China [31330077]; National Key Basic Research Plan Grant from the Chinese Ministry of Science and Technology [2014CB542700]; earmarked fund for Modern Agro-industry Technology Research System of China from the Chinese Ministry of Agriculture [CARS-36]	National Natural Science Funds from National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Plan Grant from the Chinese Ministry of Science and Technology; earmarked fund for Modern Agro-industry Technology Research System of China from the Chinese Ministry of Agriculture	This work was supported by Key project of National Natural Science Funds from National Natural Science Foundation of China (31330077), http://www.nsfc.gov.cn/nsfc/; National Key Basic Research Plan Grant (2014CB542700) from the Chinese Ministry of Science and Technology, http://program.most.gov.cn/; The earmarked fund for Modern Agro-industry Technology Research System of China (CARS-36) from the Chinese Ministry of Agriculture, http://119.253.58.231/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Key project of National Natural Science Funds from National Natural Science Foundation of China (31330077) and National Key Basic Research Plan Grant (2014CB542700) from the Chinese Ministry of Science and Technology, and the earmarked fund for Modern Agro-industry Technology Research System of China (CARS-36) from the Chinese Ministry of Agriculture.	Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chau DHW, 2007, APOPTOSIS, V12, P513, DOI 10.1007/s10495-006-0013-0; Chen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064877; Costers S, 2008, ARCH VIROL, V153, P1453, DOI 10.1007/s00705-008-0135-5; DENBOON JA, 1995, J VIROL, V69, P4500, DOI 10.1128/JVI.69.7.4500-4505.1995; Duan X, 1997, ARCH VIROL, V142, P2483, DOI 10.1007/s007050050256; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Fernandez A, 2002, VIRUS RES, V83, P103, DOI 10.1016/S0168-1702(01)00426-9; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Garner MG, 2001, REV SCI TECH OIE, V20, P671, DOI 10.20506/rst.20.3.1303; Han MY, 2014, VET MICROBIOL, V174, P279, DOI 10.1016/j.vetmic.2014.10.007; Han MY, 2014, VIRUS RES, V194, P100, DOI 10.1016/j.virusres.2014.09.007; Han MY, 2013, VIRUS RES, V172, P54, DOI 10.1016/j.virusres.2012.12.012; Hardwick J M, 1997, Adv Pharmacol, V41, P295, DOI 10.1016/S1054-3589(08)61063-7; He Q, 2015, VIRUS RES, V201, P32, DOI 10.1016/j.virusres.2015.02.014; He YL, 2012, VET MICROBIOL, V160, P455, DOI 10.1016/j.vetmic.2012.05.040; Herold S, 2012, J LEUKOCYTE BIOL, V92, P75, DOI 10.1189/jlb.1011530; Huo YZ, 2013, VIROLOGY, V444, P233, DOI 10.1016/j.virol.2013.06.015; Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim DY, 2009, VIRUS GENES, V38, P118, DOI 10.1007/s11262-008-0303-4; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; KRAMMER PH, 1994, CURR OPIN IMMUNOL, V6, P279, DOI 10.1016/0952-7915(94)90102-3; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Labarque G, 2003, VET RES, V34, P249, DOI 10.1051/vetres:2003001; Lee C, 2004, VIRUS RES, V104, P33, DOI 10.1016/j.virusres.2004.03.001; Lee SM, 2007, VIROLOGY, V365, P419, DOI 10.1016/j.virol.2007.04.001; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Li Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004216; Lin CW, 2006, FEMS IMMUNOL MED MIC, V46, P375, DOI 10.1111/j.1574-695X.2006.00045.x; Ma ZT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069387; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; MENG XJ, 1994, J GEN VIROL, V75, P1795, DOI 10.1099/0022-1317-75-7-1795; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; Mu Y, 2015, VIROLOGY, V484, P136, DOI 10.1016/j.virol.2015.05.019; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; O'Brien V, 1998, J GEN VIROL, V79, P1833, DOI 10.1099/0022-1317-79-8-1833; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Prikhod'ko EA, 2004, VIROLOGY, V329, P53, DOI 10.1016/j.virol.2004.08.012; Prikhod'ko GG, 2002, J VIROL, V76, P5701, DOI 10.1128/JVI.76.11.5701-5710.2002; Ramanathan MP, 2006, VIROLOGY, V345, P56, DOI 10.1016/j.virol.2005.08.043; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Seybert A, 2000, J VIROL, V74, P9586, DOI 10.1128/JVI.74.20.9586-9593.2000; Shafee N, 2003, J GEN VIROL, V84, P2191, DOI 10.1099/vir.0.19022-0; Sirinarumitr T, 1998, J GEN VIROL, V79, P2989, DOI 10.1099/0022-1317-79-12-2989; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Suarez P, 1996, J VIROL, V70, P2876; Sur JH, 1997, J VIROL, V71, P9170, DOI 10.1128/JVI.71.12.9170-9179.1997; Sur JH, 1998, VET PATHOL, V35, P506, DOI 10.1177/030098589803500605; Takada E, 2006, EXP CELL RES, V312, P3728, DOI 10.1016/j.yexcr.2006.06.036; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; van Aken D, 2006, J GEN VIROL, V87, P3473, DOI 10.1099/vir.0.82269-0; van Dinten LC, 2000, J VIROL, V74, P5213, DOI 10.1128/JVI.74.11.5213-5223.2000; van Dinten LC, 1999, J VIROL, V73, P2027, DOI 10.1128/JVI.73.3.2027-2037.1999; vanDinten LC, 1996, J VIROL, V70, P6625, DOI 10.1128/JVI.70.10.6625-6633.1996; Yatim N, 2011, IMMUNITY, V35, P478, DOI 10.1016/j.immuni.2011.10.010; Yin ST, 2012, VIRUS RES, V166, P103, DOI 10.1016/j.virusres.2012.03.010; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang HM, 2009, J PROTEOME RES, V8, P3091, DOI 10.1021/pr900002f; Zhang HM, 2010, ARCH VIROL, V155, P571, DOI 10.1007/s00705-010-0611-6; Zhou L, 2010, VIRUS RES, V154, P31, DOI 10.1016/j.virusres.2010.07.016; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08	71	21	23	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156518	10.1371/journal.pone.0156518	http://dx.doi.org/10.1371/journal.pone.0156518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310256	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800007
J	Zhou, XZ; Wei, YT; Qiu, S; Xu, Y; Zhang, T; Zhang, SC				Zhou, Xuezhi; Wei, Yantao; Qiu, Suo; Xu, Yue; Zhang, Ting; Zhang, Shaochong			Propofol Decreases Endoplasmic Reticulum Stress-Mediated Apoptosis in Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CEREBRAL-ISCHEMIA; ER STRESS; MITOCHONDRIAL DYSFUNCTION; MACULAR DEGENERATION; PROAPOPTOTIC BAX; UP-REGULATION; IN-VITRO; KAPPA-B; BCL-2	Age-related macular degeneration (AMD) is the major cause of loss of sight globally. There is currently no effective treatment available. Retinal pigment epithelial (RPE) cells are an important part of the outer blood-retina barrier and their death is a determinant of AMD. Propofol, a common clinically used intravenous anesthetic agent, has been shown to act as an efficacious neuroprotective agent with antioxidative and anti-inflammatory properties in vivo and in vitro. However, little is known about its effects on RPE cells. The purpose of our research was to investigate whether propofol could protect RPE cells from apoptosis through endoplasmic reticulum (ER) stress-dependent pathways. To this end, prior to stimulation with thapsigargin (TG), ARPE-19 cells were pretreated with varying concentrations of propofol. A protective effect of propofol in TG-treated ARPE-9 was apparent, TUNEL and flow cytometric assays showed decreased apoptosis. We further demonstrated that propofol pretreatment attenuated or inhibited the effects caused by TG, such as upregulation of Bax, BiP, C/EBP homologous protein (CHOP), active caspase 12, and cleaved caspase 3, and downregulation of Bcl2. It also decreased the TG-induced levels of ER stress-related molecules such as p-PERK, p-eIF2 alpha, and ATF4. Furthermore, it downregulated the expression of nuclear factor kappa B (NF-kappa B). This study elucidated novel propofol-induced cellular mechanisms for antiapoptotic activities in RPE cells undergoing ER stress and demonstrated the potential value of using propofol in the treatment of AMD.	[Zhou, Xuezhi; Wei, Yantao; Qiu, Suo; Xu, Yue; Zhang, Ting; Zhang, Shaochong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, SC (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhshaochong@sohu.com	Xu, yue/HGE-1737-2022; Qiu, Suo/HGD-2041-2022	Zhou, Xuezhi/0000-0002-4501-1817	Fund for National Natural Science Foundation [81441025, 81170866]	Fund for National Natural Science Foundation	This study was supported by the Fund for National Natural Science Foundation (81441025) and the Fund for National Natural Science Foundation (81170866).	Acquaviva R, 2004, ANESTHESIOLOGY, V101, P1363; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AKAO Y, 1994, CANCER RES, V54, P2468; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Cano M, 2014, FREE RADICAL BIO MED, V69, P1, DOI 10.1016/j.freeradbiomed.2014.01.004; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Del Priore LV, 2002, INVEST OPHTH VIS SCI, V43, P3312; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Distelhorst CW, 1996, CELL CALCIUM, V19, P473, DOI 10.1016/S0143-4160(96)90056-1; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Engelhard K, 2004, ANESTHESIOLOGY, V101, P912, DOI 10.1097/00000542-200410000-00016; Engelhard K, 2004, EUR J ANAESTH, V21, P530, DOI 10.1017/S0265021504007057; Grasshoff C, 2002, ANESTH ANALG, V95, P920, DOI 10.1213/01.ANE.0000025705.93185.09; Gui B, 2012, INFLAMMATION, V35, P1632, DOI 10.1007/s10753-012-9478-x; Ha JH, 2014, J NUTR, V144, P799, DOI 10.3945/jn.113.186957; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hardy B, 2010, J MOL MED, V88, P1157, DOI 10.1007/s00109-010-0657-7; He JG, 2013, NEUROL SCI, V34, P165, DOI 10.1007/s10072-012-0978-0; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hutchens MP, 2006, NEUROCRIT CARE, V4, P54, DOI 10.1385/NCC:4:1:054; Iijima T, 2006, BRAIN RES, V1099, P25, DOI 10.1016/j.brainres.2006.04.117; Inagi R, 2010, CURR OPIN PHARMACOL, V10, P156, DOI 10.1016/j.coph.2009.11.006; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Klee M, 2009, EMBO J, V28, P1757, DOI 10.1038/emboj.2009.90; Kubo K, 2011, BRAIN RES, V1387, P125, DOI 10.1016/j.brainres.2011.02.079; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Leitman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090803; Li J, 2016, J NEUROSURG ANESTH, V28, P51, DOI 10.1097/ANA.0000000000000181; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Lynch K, 2000, ENDOCRINOLOGY, V141, P4209, DOI 10.1210/en.141.11.4209; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Oslowski CM, 2011, CURR OPIN CELL BIOL, V23, P207, DOI 10.1016/j.ceb.2010.11.005; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Solaroglu I, 2004, BIOL NEONATE, V85, P221, DOI 10.1159/000075835; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Susuki S, 2009, J BIOL CHEM, V284, P8312, DOI 10.1074/jbc.M809354200; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Takayanagi S, 2013, CELL STRESS CHAPERON, V18, P11, DOI 10.1007/s12192-012-0351-5; Vasileiou I, 2009, EUR J PHARMACOL, V605, P1, DOI 10.1016/j.ejphar.2009.01.007; Vosler PS, 2009, STROKE, V40, P3149, DOI 10.1161/STROKEAHA.108.543769; Wang HY, 2011, J NEUROCHEM, V119, P210, DOI 10.1111/j.1471-4159.2011.07400.x; Wang P, 2013, EUR REV MED PHARMACO, V17, P1722; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xi HJ, 2011, BRAIN RES, V1410, P24, DOI 10.1016/j.brainres.2011.06.060; Yamani L, 2015, CELL SIGNAL, V27, P2555, DOI 10.1016/j.cellsig.2015.09.016; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong YL, 2014, CELL BIOCHEM FUNCT, V32, P720, DOI 10.1002/cbf.3077	54	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157590	10.1371/journal.pone.0157590	http://dx.doi.org/10.1371/journal.pone.0157590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311010	Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800103
J	Kim, YI; Kim, HS; Park, JW				Kim, Young-Il; Kim, Hyoung Sang; Park, Joong-Won			Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase	PLOS ONE			English	Article							PROGNOSIS; DIAGNOSIS; HBSAG	Background The role of serum alpha-fetoprotein (AFP) levels in the surveillance and diagnosis of hepatocellular carcinoma (HCC) is controversial. The aim of this study was to investigate the value of serially measured serum AFP levels in HCC progression or recurrence after initial treatment. Methods A total of 722 consecutive patients newly diagnosed with HCC and treated at the National Cancer Center, Korea, between January 2004 and December 2009 were enrolled. The AFP ratios between 4-8 weeks post-treatment and those at the time of HCC progression or recurrence were obtained. Multivariate logistic regression analysis was performed to correlate the post-treatment AFP ratios with the presence of HCC progression or recurrence. Results The etiology of HCC was related to chronic hepatitis B virus (HBV) infection in 562 patients (77.8%), chronic hepatitis C virus (HCV) infection in 74 (10.2%), and non-viral cause in 86 (11.9%). There was a significant decrease in serum AFP levels from the baseline to 4 to 8 weeks after treatment (median AFP, 319.6 ng/mL vs. 49.6 ng/mL; p < 0.001). Multivariate analysis showed that an AFP ratio > 1.0 was an independently associated with HCC progression or recurrence. Among the different causes of HCC analyzed, this association was significant only for HCC related to chronic hepatitis B (p < 0.001) and non-viral causes (p < 0.05), and limited only to patients who had normal alanine aminotransferase (ALT) levels. Conclusion Serial measurements of serum AFP ratios could be helpful in detecting progression or recurrence in treated patients with HBV-HCC and normal ALT.	[Kim, Young-Il; Kim, Hyoung Sang; Park, Joong-Won] Natl Canc Ctr, Ctr Liver Canc, Goyang, South Korea	National Cancer Center - Korea (NCC)	Park, JW (corresponding author), Natl Canc Ctr, Ctr Liver Canc, Goyang, South Korea.	jwpark@ncc.re.kr			National Cancer Center, Korea [1510520]	National Cancer Center, Korea	This study was supported by a grant from the National Cancer Center, Korea (#1510520).; This study was supported by a grant from the National Cancer Center, Korea (#1510520). We thank Prof. Byung-Ho Nam (Biometric Research, National Cancer Center, Korea) for a precise consult on statistical analysis.	Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Di Bisceglie AM, 2005, J HEPATOL, V43, P434, DOI 10.1016/j.jhep.2005.03.019; Hakeem AR, 2012, ALIMENT PHARM THER, V35, P987, DOI 10.1111/j.1365-2036.2012.05060.x; Korean Liver Cancer Study Group and National Cancer Center Korea, 2009, Korean J Hepatol, V15, P391, DOI 10.3350/kjhep.2009.15.3.391; Korean-Liver-Canc-Study-Grp-KLCSG, 2015, GUT LIVER, V9, P267, DOI 10.5009/gnl14460; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; LEE HS, 1991, HEPATOLOGY, V14, P68, DOI 10.1002/hep.1840140112; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; LIAW YF, 1986, LIVER, V6, P133; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Manghisi G, 1998, HEPATOLOGY, V28, P751; Peng SY, 2004, INT J CANCER, V112, P44, DOI 10.1002/ijc.20279; Riaz A, 2009, J CLIN ONCOL, V27, P5734, DOI 10.1200/JCO.2009.23.1282; Richardson P, 2012, CLIN GASTROENTEROL H, V10, P428, DOI 10.1016/j.cgh.2011.11.025; Song DS, 2012, CLIN MOL HEPATOL, V18, P258, DOI 10.3350/cmh.2012.18.3.258; Spangenberg HC, 2006, SEMIN LIVER DIS, V26, P385, DOI 10.1055/s-2006-951606; Tan CK, 2003, J CLIN ONCOL, V21, P2294, DOI 10.1200/JCO.2003.03.151; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Toro A, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-40; Toso C, 2015, HEPATOLOGY, V62, P158, DOI 10.1002/hep.27787; Trevisani F, 2001, J HEPATOL, V34, P570, DOI 10.1016/S0168-8278(00)00053-2; Ueno S, 2002, HEPATOL RES, V24, P395, DOI 10.1016/S1386-6346(02)00144-4; Wong GLH, 2014, HEPATOLOGY, V59, P986, DOI 10.1002/hep.26739	26	52	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157299	10.1371/journal.pone.0157299	http://dx.doi.org/10.1371/journal.pone.0157299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304617	gold, Green Submitted, Green Published			2022-12-27	WOS:000377824800045
J	Wang, F; Coe, RA; Karki, S; Wanchana, S; Thakur, V; Henry, A; Lin, HC; Huang, JL; Peng, SB; Quick, WP				Wang, Fei; Coe, Robert A.; Karki, Shanta; Wanchana, Samart; Thakur, Vivek; Henry, Amelia; Lin, Hsiang-Chun; Huang, Jianliang; Peng, Shaobing; Quick, William Paul			Overexpression of OsSAP16 Regulates Photosynthesis and the Expression of a Broad Range of Stress Response Genes in Rice (Oryza sativa L.)	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; INDUCED STOMATAL CLOSURE; HETEROTRIMERIC G-PROTEIN; T-DNA; ABC TRANSPORTER; ABSCISIC-ACID; DIFFERENTIAL EXPRESSION; DROUGHT-RESISTANCE; HYDROGEN-PEROXIDE; MESOPHYLL CONDUCTANCE	This study set out to identify and characterize transcription factors regulating photosynthesis in rice. Screening populations of rice T-DNA activation lines led to the identification of a T-DNA mutant with an increase in intrinsic water use efficiency (iWUE) under well-watered conditions. Flanking sequence analysis showed that the T-DNA construct was located upstream of LOC_Os07g38240 (OsSAP16) encoding for a stress-associated protein (SAP). A second mutant identified with activation in the same gene exhibited the same phenotype; expression of OsSAP16 was shown to be enhanced in both lines. There were no differences in stomatal development or morphology in either of these mutants, although overexpression of OsSAP16 reduced stomatal conductance. This phenotype limited CO2 uptake and the rate of photosynthesis, which resulted in the accumulation of less biomass in the two mutants. Whole transcriptome analysis showed that overexpression of OsSAP16 led to global changes in gene expression consistent with the function of zinc-finger transcription factors. These results show that the gene is involved in modulating the response of rice to drought stress through regulation of the expression of a set of stress-associated genes.	[Wang, Fei; Huang, Jianliang; Peng, Shaobing] Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Improvement, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Wuhan 430070, Hubei Province, Peoples R China; [Coe, Robert A.; Karki, Shanta; Wanchana, Samart; Thakur, Vivek; Lin, Hsiang-Chun; Quick, William Paul] Int Rice Res Inst, Rice Ctr C4, Los Banos, Philippines; [Henry, Amelia] Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Philippines	Huazhong Agricultural University; CGIAR; International Rice Research Institute (IRRI); CGIAR; International Rice Research Institute (IRRI)	Wang, F (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Improvement, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Wuhan 430070, Hubei Province, Peoples R China.	fwang@mail.hzau.edu.cn	Wanchana, Samart/AAF-5773-2020; Karki, Shanta/AAO-2373-2021	Henry, Amelia/0000-0001-6255-5480; Wanchana, Samart/0000-0002-5459-3425; Lin, Hsiang-Chun/0000-0003-1108-2622	Bill and Melinda Gates Foundation under C4 Rice Center at IRRI	Bill and Melinda Gates Foundation under C4 Rice Center at IRRI	This work was funded by Bill and Melinda Gates Foundation under the C4 Rice Center at IRRI.; This work was funded by Bill and Melinda Gates Foundation under the C4 Rice Center at IRRI. The authors wish to thank Irma Canicosa for the photosynthesis measurements, Julius Ver Sagun for assistance with the PCR and Abigail Mabilangan for assistance with the microscopy.	Adachi S, 2011, J EXP BOT, V62, P1927, DOI 10.1093/jxb/erq387; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Balazadeh S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00234; Blum A, 2005, AUST J AGR RES, V56, P1159, DOI 10.1071/AR05069; Brodribb TJ, 2010, FUNCT PLANT BIOL, V37, P488, DOI 10.1071/FP10010; Chae L, 2009, MOL PLANT, V2, P84, DOI 10.1093/mp/ssn083; Chen YL, 2004, PLANT PHYSIOL, V136, P4096, DOI 10.1104/pp.104.047837; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Cominelli E, 2010, TRANSCR-AUSTIN, V1, P41, DOI 10.4161/trns.1.1.12064; Dansana PK, 2014, PLANT CELL REP, V33, P1425, DOI 10.1007/s00299-014-1626-3; DESILVA DLR, 1985, NEW PHYTOL, V101, P555, DOI 10.1111/j.1469-8137.1985.tb02861.x; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Ding ZJ, 2014, PLANT J, V79, P13, DOI 10.1111/tpj.12538; Dixit AR, 2011, THESIS; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gaedeke N, 2001, EMBO J, V20, P1875, DOI 10.1093/emboj/20.8.1875; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Guillemaut P, 1992, PLANT MOL BIOL REP, V10, P60, DOI 10.1007/BF02669265; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; HAYASHI H, 1992, SCIENCE, V258, P1350, DOI 10.1126/science.1455228; Henry A, 2012, J EXP BOT, V63, P4751, DOI 10.1093/jxb/ers150; Hsing YI, 2007, PLANT MOL BIOL, V63, P351, DOI 10.1007/s11103-006-9093-z; Hsu KH, 2014, PLANT MOL BIOL, V86, P125, DOI 10.1007/s11103-014-0217-6; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Hua DP, 2012, PLANT CELL, V24, P2546, DOI 10.1105/tpc.112.100107; Huang SS, 2001, PLANT PHYSIOL, V125, P573, DOI 10.1104/pp.125.2.573; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Jeong DH, 2002, PLANT PHYSIOL, V130, P1636, DOI 10.1104/pp.014357; Jin Y, 2007, GENOMICS, V90, P265, DOI 10.1016/j.ygeno.2007.03.019; Kajala K, 2011, J EXP BOT, V62, P3001, DOI 10.1093/jxb/err022; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Klein M, 2004, PLANT J, V39, P219, DOI 10.1111/j.1365-313X.2004.02125.x; Kollist H, 2014, NEW PHYTOL, V203, P44, DOI 10.1111/nph.12832; KOORNNEEF M, 1982, MUTAT RES, V93, P109, DOI 10.1016/0027-5107(82)90129-4; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Kuromori T, 2011, PLANT J, V67, P885, DOI 10.1111/j.1365-313X.2011.04641.x; Kusumi K, 2012, J EXP BOT, V63, P5635, DOI 10.1093/jxb/ers216; LANGE OL, 1971, PLANTA, V100, P76, DOI 10.1007/BF00386887; Lee M, 2008, NAT CELL BIOL, V10, P1217, DOI 10.1038/ncb1782; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Li B, 2011, BMC BIOINFORMATICS, P12; Li J, 2001, P NATL ACAD SCI USA, V98, P5916, DOI 10.1073/pnas.091065998; Li JH, 2009, PLANT PHYSIOL, V150, P114, DOI 10.1104/pp.109.137067; Li J, 2013, NEW PHYTOL, V200, P455, DOI 10.1111/nph.12378; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093290; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Luo LJ, 2010, J EXP BOT, V61, P3509, DOI 10.1093/jxb/erq185; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Ocheltree TW, 2012, PLANT CELL ENVIRON, V35, P1040, DOI 10.1111/j.1365-3040.2011.02470.x; Ohsumi A, 2007, ANN BOT-LONDON, V99, P265, DOI 10.1093/aob/mcl253; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Skirycz A, 2011, NAT BIOTECHNOL, V29, P212, DOI 10.1038/nbt.1800; Sundaresan V, 1996, TRENDS PLANT SCI, V1, P184, DOI 10.1016/1360-1385(96)10022-4; Suzuki Y, 2001, PLANT MOL BIOL, V45, P123, DOI 10.1023/A:1006455130098; Taylaran RD, 2011, J EXP BOT, V62, P4067, DOI 10.1093/jxb/err126; Tyagi H, 2014, PLANT SCI, V225, P68, DOI 10.1016/j.plantsci.2014.05.016; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; van der Fits L, 2001, TRANSGENIC RES, V10, P513, DOI 10.1023/A:1013087011562; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; Vij S, 2006, MOL GENET GENOMICS, V276, P565, DOI 10.1007/s00438-006-0165-1; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Xiong DL, 2015, FUNCT PLANT BIOL, V42, P347, DOI 10.1071/FP14166; Xu YF, 1997, JPN J CROP SCI, V66, P616, DOI 10.1626/jcs.66.616; Yi J, 2013, J PLANT BIOL, V56, P85, DOI 10.1007/s12374-013-0905-9; Zeng WQ, 2010, CURR OPIN BIOTECH, V21, P599, DOI 10.1016/j.copbio.2010.05.006; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zubko E, 2002, PLANT J, V29, P797, DOI 10.1046/j.1365-313X.2002.01256.x	83	8	9	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157244	10.1371/journal.pone.0157244	http://dx.doi.org/10.1371/journal.pone.0157244			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303811	gold, Green Published, Green Submitted			2022-12-27	WOS:000377824800041
J	Sorman, K; Nilsonne, G; Howner, K; Tamm, S; Caman, S; Wang, HX; Ingvar, M; Edens, JF; Gustavsson, P; Lilienfeld, SO; Petrovic, P; Fischer, H; Kristiansson, M				Sorman, Karolina; Nilsonne, Gustav; Howner, Katarina; Tamm, Sandra; Caman, Shilan; Wang, Hui-Xin; Ingvar, Martin; Edens, John F.; Gustavsson, Petter; Lilienfeld, Scott O.; Petrovic, Predrag; Fischer, Hakan; Kristiansson, Marianne			Reliability and Construct Validity of the Psychopathic Personality Inventory-Revised in a Swedish Non-Criminal Sample - A Multimethod Approach including Psychophysiological Correlates of Empathy for Pain	PLOS ONE			English	Article							TORONTO-ALEXITHYMIA-SCALE; FEARLESS DOMINANCE; COMPREHENSIVE ASSESSMENT; CROSS-VALIDATION; BRAIN RESPONSE; OFFENDERS; TRAITS; INDIVIDUALS; COMMUNITY; INTEGRATION	Cross-cultural investigation of psychopathy measures is important for clarifying the nomological network surrounding the psychopathy construct. The Psychopathic Personality Inventory-Revised (PPI-R) is one of the most extensively researched self-report measures of psychopathic traits in adults. To date however, it has been examined primarily in North American criminal or student samples. To address this gap in the literature, we examined PPI-R's reliability, construct validity and factor structure in non-criminal individuals (N = 227) in Sweden, using a multimethod approach including psychophysiological correlates of empathy for pain. PPI-R construct validity was investigated in subgroups of participants by exploring its degree of overlap with (i) the Psychopathy Checklist: Screening Version (PCL:SV), (ii) self-rated empathy and behavioral and physiological responses in an experiment on empathy for pain, and (iii) additional self-report measures of alexithymia and trait anxiety. The PPI-R total score was significantly associated with PCL: SV total and factor scores. The PPI-R Coldheartedness scale demonstrated significant negative associations with all empathy subscales and with rated unpleasantness and skin conductance responses in the empathy experiment. The PPI-R higher order Self-Centered Impulsivity and Fearless Dominance dimensions were associated with trait anxiety in opposite directions (positively and negatively, respectively). Overall, the results demonstrated solid reliability (test-retest and internal consistency) and promising but somewhat mixed construct validity for the Swedish translation of the PPI-R.	[Sorman, Karolina; Nilsonne, Gustav; Howner, Katarina; Tamm, Sandra; Caman, Shilan; Ingvar, Martin; Petrovic, Predrag; Kristiansson, Marianne] Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden; [Nilsonne, Gustav; Tamm, Sandra] Stockholm Univ, Stress Res Inst, SE-10691 Stockholm, Sweden; [Wang, Hui-Xin] Karolinska Inst, Aging Res Ctr, SE-11330 Stockholm, Sweden; [Wang, Hui-Xin] Stockholm Univ, SE-11330 Stockholm, Sweden; [Edens, John F.] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA; [Gustavsson, Petter] Karolinska Inst, Dept Psychol, SE-17177 Stockholm, Sweden; [Lilienfeld, Scott O.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Fischer, Hakan] Stockholm Univ, Dept Psychol, SE-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Stockholm University; Texas A&M University System; Texas A&M University College Station; Karolinska Institutet; Emory University; Stockholm University	Sorman, K (corresponding author), Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden.	karolina.sorman@ki.se	Petrovic, Predrag/AAS-6736-2020; Edens, John/AAN-2657-2020	Petrovic, Predrag/0000-0002-5536-945X; Edens, John/0000-0002-2218-0650; Tamm, Sandra/0000-0001-5371-9631; Kristiansson, Marianne/0000-0002-9448-7643; Caman, Shilan/0000-0002-3147-2153; Ingvar, Martin/0000-0002-9041-5714; Wang, Hui-Xin/0000-0002-5051-4929; Gustavsson, Petter/0000-0001-9571-9349; Fischer, Hakan/0000-0001-6710-1744				Andershed H., 2002, PSYCHOPATHS CURRENT, P131, DOI DOI 10.1037/T07576-000; Anderson JL, 2014, J PERS DISORD, V28, P675, DOI 10.1521/pedi_2014_28_134; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Benning SD, 2005, ASSESSMENT, V12, P3, DOI 10.1177/1073191104271223; Benning SD, 2003, PSYCHOL ASSESSMENT, V15, P340, DOI 10.1037/1040-3590.15.3.340; Berg JM, 2015, PSYCHOL ASSESSMENT, V27, P1494, DOI 10.1037/pas0000129; Blair RJR, 2008, Q J EXP PSYCHOL, V61, P157, DOI 10.1080/17470210701508855; Blonigen DM, 2013, PERSONAL DISORD, V4, P87, DOI 10.1037/a0027152; Brook M, 2013, J ABNORM PSYCHOL, V122, P156, DOI 10.1037/a0030261; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Cale EM, 2002, CLIN PSYCHOL REV, V22, P1179, DOI 10.1016/S0272-7358(01)00125-8; Cleckley H., 1941, MASK SANITY; Cliffordson C, 2002, SCAND J PSYCHOL, V43, P49, DOI 10.1111/1467-9450.00268; Cooke DJ, 2012, INT J FORENSIC MENT, V11, P242, DOI 10.1080/14999013.2012.746759; Cooke DJ, 2005, BRIT J PSYCHIAT, V186, P335, DOI 10.1192/bjp.186.4.335; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety J, 2013, JAMA PSYCHIAT, V70, P638, DOI 10.1001/jamapsychiatry.2013.27; Derefinko KJ, 2015, J PERS, V83, P693, DOI 10.1111/jopy.12124; Dindo L, 2011, J PERS SOC PSYCHOL, V100, P557, DOI 10.1037/a0021848; Drislane LE, 2014, PERSONAL DISORD, V5, P154, DOI 10.1037/per0000060; Edens JF, 2010, PSYCHOL ASSESSMENT, V22, P32, DOI 10.1037/a0018220; Engen HG, 2013, CURR OPIN NEUROBIOL, V23, P275, DOI 10.1016/j.conb.2012.11.003; Fecteau S, 2008, PSYCHIAT RES, V160, P137, DOI 10.1016/j.psychres.2007.08.022; Forsman M, 2008, J ABNORM PSYCHOL, V117, P606, DOI 10.1037/0021-843X.117.3.606; Hall JR, 2014, PSYCHOL ASSESSMENT, V26, P447, DOI 10.1037/a0035665; Hare R. D., 2003, HARE PSYCHOPATHY CHE, V2nd; Hare RD., 2003, MANUAL REVISED PSYCH, V2; Hare RD, 2008, ANNU REV CLIN PSYCHO, V4, P217, DOI 10.1146/annurev.clinpsy.3.022806.091452; Hart S. D., 1995, MANUAL PSYCHOPATHY C; Haviland MG, 2004, J PERS ASSESS, V82, P306, DOI 10.1207/s15327752jpa8203_06; Hoppenbrouwers SS, 2015, PERSONAL DISORD, V6, P251, DOI 10.1037/per0000115; Hopwood CJ, 2010, PERS SOC PSYCHOL REV, V14, P332, DOI 10.1177/1088868310361240; Karpman B., 1941, J CRIMINAL PSYCHOPAT, V3, P112, DOI [10.1371/journal.pone.0069565, DOI 10.2307/1888886]; Kreis MKF, 2011, BEHAV SCI LAW, V29, P634, DOI 10.1002/bsl.1003; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Langstrom N, 2002, ACTA PSYCHIAT SCAND, V106, P86, DOI 10.1034/j.1600-0447.106.s412.19.x; Laurell J, 2010, CRIM BEHAV MENT HEAL, V20, P285, DOI 10.1002/cbm.779; Lilienfeld S. O., 2006, HDB PSYCHOPATHY, P107; Lilienfeld S.O., 2005, PSYCHOPATHIC PERSONA; Lilienfeld SO, 2012, PERSONAL DISORD, V3, P327, DOI 10.1037/a0026987; LILIENFELD SO, 1994, CLIN PSYCHOL REV, V14, P17, DOI 10.1016/0272-7358(94)90046-9; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; Lilienfeld SO, 2015, PSYCHOL ASS IN PRESS; Lopez R, 2013, PSYCHOPHYSIOLOGY, V50, P210, DOI 10.1111/j.1469-8986.2012.01493.x; LUTZ M, 1999, QUANTITATIVE MOL PHA; Malterer MB, 2010, ASSESSMENT, V17, P3, DOI 10.1177/1073191109349743; Marcus DK, 2013, PERSONAL DISORD, V4, P67, DOI 10.1037/a0025282; Marsh HW, 2014, ANNU REV CLIN PSYCHO, V10, P85, DOI 10.1146/annurev-clinpsy-032813-153700; McCord W., 1964, PSYCHOPATH ESSAY CRI; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Miller JD, 2012, PERSONAL DISORD, V3, P305, DOI 10.1037/a0024567; Miller JD, 2011, PERS INDIV DIFFER, V50, P564, DOI 10.1016/j.paid.2010.11.028; Mokros A, 2011, INT J LAW PSYCHIAT, V34, P56, DOI 10.1016/j.ijlp.2010.11.009; Muthen B, 1998, MPLUS USERS GUIDE V7; Neumann CS, 2008, PSYCHOL ASSESSMENT, V20, P169, DOI 10.1037/1040-3590.20.2.169; Neumann CS, 2015, J PERS, V83, P678, DOI 10.1111/jopy.12127; Neumann CS, 2013, PERSONAL DISORD, V4, P77, DOI 10.1037/a0027196; Neumann CS, 2013, PERSONAL DISORD, V4, P129, DOI 10.1037/a0027886; Neumann CS, 2012, BEHAV SCI LAW, V30, P557, DOI 10.1002/bsl.2038; Nilsonne G, 2015, NO EFFECT 25 MG OXAZ, DOI [10.6084/m9.figshare.1558201, DOI 10.6084/M9.FIGSHARE.1558201]; Patrick CJ, 2013, J ABNORM PSYCHOL, V122, P902, DOI 10.1037/a0032807; Patrick CJ, 2009, DEV PSYCHOPATHOL, V21, P913, DOI 10.1017/S0954579409000492; Patrick CJ, 2006, PSYCHOL ASSESSMENT, V18, P204, DOI 10.1037/1040-3590.18.2.204; Paulhus D. L., MANUAL HARE IN PRESS; Pfabigan DM, 2015, J PERS DISORD, V29, P42, DOI 10.1521/pedi_2014_28_145; Pinheiro J, 2015, NLME LINEAR NONLINEA; Poythress NG, 1998, PSYCHOL ASSESSMENT, V10, P426, DOI 10.1037/1040-3590.10.4.426; Rizopoulos D, 2006, J STAT SOFTW, V17; Schmitt WA, 1999, J ABNORM PSYCHOL, V108, P353, DOI 10.1037/0021-843X.108.2.353; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Simonsson-Sarnecki M, 2000, SCAND J PSYCHOL, V41, P25, DOI 10.1111/1467-9450.00167; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Skeem JL, 2011, PSYCHOL SCI PUBL INT, V12, P95, DOI 10.1177/1529100611426706; Skeem JL, 2010, PSYCHOL ASSESSMENT, V22, P433, DOI 10.1037/a0008512; Smith ST, 2011, J PERS ASSESS, V93, P244, DOI 10.1080/00223891.2011.558876; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sullivan EA, 2006, PSYCHOL ASSESSMENT, V18, P382, DOI 10.1037/1040-3590.18.4.382; Uzieblo K, 2010, ASSESSMENT, V17, P334, DOI 10.1177/1073191109356544; Vaidyanathan U, 2009, PSYCHOPHYSIOLOGY, V46, P75, DOI 10.1111/j.1469-8986.2008.00751.x; Veit R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00706; Venables NC, 2015, J ABNORM PSYCHOL, V124, P319, DOI 10.1037/abn0000032; Venables NC, 2014, PSYCHOPHYSIOLOGY, V51, P427, DOI 10.1111/psyp.12189; Visser BA, 2012, J PERS, V80, P725, DOI 10.1111/j.1467-6494.2011.00745.x; Wahlund K, 2010, PSYCHIAT RES, V180, P30, DOI 10.1016/j.psychres.2009.09.009	86	15	15	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156570	10.1371/journal.pone.0156570	http://dx.doi.org/10.1371/journal.pone.0156570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KO	27300292	Green Published, gold			2022-12-27	WOS:000377822200010
J	Tao, WD; Zhang, XX; Zhao, FZ; Huang, KL; Ma, HJ; Wang, Z; Ye, L; Ren, HQ				Tao, Wenda; Zhang, Xu-Xiang; Zhao, Fuzheng; Huang, Kailong; Ma, Haijun; Wang, Zhu; Ye, Lin; Ren, Hongqiang			High Levels of Antibiotic Resistance Genes and Their Correlations with Bacterial Community and Mobile Genetic Elements in Pharmaceutical Wastewater Treatment Bioreactors	PLOS ONE			English	Article							SEWAGE-TREATMENT PLANT; TETRACYCLINE RESISTANCE; METAGENOMIC APPROACH; ACTIVATED-SLUDGE; ANTIMICROBIAL RESISTANCE; SULFONAMIDE ANTIBIOTICS; RECEIVING RIVER; PLASMID; SYSTEM; DIVERSITY	To understand the diversity and abundance of antibiotic resistance genes (ARGs) in pharmaceutical wastewater treatment bioreactors, the ARGs in sludge from two full-scale pharmaceutical wastewater treatment plants (PWWTPs) were investigated and compared with sludge samples from three sewage treatment plants (STPs) using metagenomic approach. The results showed that the ARG abundances in PWWTP sludge ranged from 54.7 to 585.0 ppm, which were higher than those in STP sludge (27.2 to 86.4 ppm). Moreover, the diversity of ARGs in PWWTP aerobic sludge (153 subtypes) was higher than that in STP aerobic sludge (118 subtypes). In addition, it was found that the profiles of ARGs in PWWTP aerobic sludge were similar to those in STP aerobic sludge but different from those in PWWTP anaerobic sludge, suggesting that dissolve oxygen (DO) could be one of the important factors affecting the profiles of ARGs. In PWWTP aerobic sludge, aminoglycoside, sulfonamide and multidrug resistance genes were frequently detected. While, tetracycline, macrolide-lincosamide-streptogramin and polypeptide resistance genes were abundantly present in PWWTP anaerobic sludge. Furthermore, we investigated the microbial community and the correlation between microbial community and ARGs in PWWTP sludge. And, significant correlations between ARG types and seven bacterial genera were found. In addition, the mobile genetic elements (MGEs) were also examined and correlations between the ARGs and MGEs in PWWTP sludge were observed. Collectively, our results suggested that the microbial community and MGEs, which could be affected by DO, might be the main factors shaping the profiles of ARGs in PWWTP sludge.	[Tao, Wenda; Zhang, Xu-Xiang; Zhao, Fuzheng; Huang, Kailong; Ma, Haijun; Wang, Zhu; Ye, Lin; Ren, Hongqiang] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Environm Hlth Res Ctr, Sch Environm, Nanjing 210023, Jiangsu, Peoples R China	Nanjing University	Zhang, XX; Ye, L (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Environm Hlth Res Ctr, Sch Environm, Nanjing 210023, Jiangsu, Peoples R China.	zhangxx@nju.edu.cn; linye@nju.edu.cn	zhang, xu/GYE-3558-2022; Zhao, Fuzheng/H-1590-2015; 王, 铸/I-3824-2016; zhang, xu/GRX-9733-2022; Zhang, xiaoyu/GXA-3206-2022; Zhao, Fuzheng/J-8280-2019; zhang, xian/GYA-0290-2022; Ye, Lin/F-9709-2013; Zhu, Wang/AAT-1740-2021; hq, ren/AGA-1128-2022	Zhao, Fuzheng/0000-0002-9911-4360; 王, 铸/0000-0002-6763-8194; Ye, Lin/0000-0002-4682-8917; Ren, Hong-qiang/0000-0001-6136-800X	Excellent Youth Foundation of Jiangsu Scientific Committee [SBK2015010297]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2014BAC08B04]; Key Technology Research and Development Program of Jiangsu Province [BE2013704]	Excellent Youth Foundation of Jiangsu Scientific Committee; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Key Technology Research and Development Program of Jiangsu Province	This study was financially supported by the Excellent Youth Foundation of Jiangsu Scientific Committee (SBK2015010297), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2014BAC08B04) and Key Technology Research and Development Program of Jiangsu Province (BE2013704).; This study was financially supported by the Excellent Youth Foundation of Jiangsu Scientific Committee (SBK2015010297), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2014BAC08B04) and Key Technology Research and Development Program of Jiangsu Province (BE2013704). We also thank the High Performance Computing Center (HPCC) of Nanjing University for the help of computation.	Fernandez-Fuentes MA, 2014, INT J FOOD MICROBIOL, V172, P49, DOI 10.1016/j.ijfoodmicro.2013.11.032; Arzese AR, 2000, J ANTIMICROB CHEMOTH, V45, P577, DOI 10.1093/jac/45.5.577; Boente RF, 2010, ANAEROBE, V16, P190, DOI 10.1016/j.anaerobe.2010.02.003; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Chen BW, 2013, ENVIRON SCI TECHNOL, V47, P12753, DOI 10.1021/es403818e; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Fang H, 2015, ENVIRON SCI TECHNOL, V49, P1095, DOI 10.1021/es504157v; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Gao P, 2012, SCI TOTAL ENVIRON, V421, P173, DOI 10.1016/j.scitotenv.2012.01.061; Gutierrez IR, 2010, J SOIL SEDIMENT, V10, P537, DOI 10.1007/s11368-009-0168-8; Hamidian M, 2014, J ANTIMICROB CHEMOTH, V69, P955, DOI 10.1093/jac/dkt454; Huang MH, 2015, J HAZARD MATER, V298, P303, DOI 10.1016/j.jhazmat.2015.05.039; Huerta B, 2013, SCI TOTAL ENVIRON, V456, P161, DOI 10.1016/j.scitotenv.2013.03.071; Ibarbalz FM, 2013, WATER RES, V47, P3854, DOI 10.1016/j.watres.2013.04.010; Klein G, 2000, J APPL MICROBIOL, V89, P815, DOI 10.1046/j.1365-2672.2000.01187.x; Knapp CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027300; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Li B, 2010, ENVIRON SCI TECHNOL, V44, P3468, DOI 10.1021/es903490h; Li D, 2009, ENVIRON MICROBIOL, V11, P1506, DOI 10.1111/j.1462-2920.2009.01878.x; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Liu MM, 2014, WATER RES, V63, P33, DOI 10.1016/j.watres.2014.05.045; Liu MM, 2012, ENVIRON SCI TECHNOL, V46, P7551, DOI 10.1021/es301145m; Ma LP, 2014, APPL MICROBIOL BIOT, V98, P5195, DOI 10.1007/s00253-014-5511-3; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miao Y, 2015, WATER RES, V76, P43, DOI 10.1016/j.watres.2015.02.042; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033; Novo A, 2013, WATER RES, V47, P1875, DOI 10.1016/j.watres.2013.01.010; Ouyang WY, 2015, APPL MICROBIOL BIOT, V99, P5697, DOI 10.1007/s00253-015-6416-5; Pai MP, 2000, ANN PHARMACOTHER, V34, P495, DOI 10.1345/aph.19138; Ploy MC, 2000, CLIN CHEM LAB MED, V38, P483, DOI 10.1515/CCLM.2000.070; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quintiliani Richard Jr., 1995, P1308; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; SPEER BS, 1991, J BACTERIOL, V173, P176, DOI 10.1128/jb.173.1.176-183.1991; Szczepanowski R, 2004, MICROBIOL-SGM, V150, P3613, DOI 10.1099/mic.0.27317-0; Tang SS, 2014, ADV DRUG DELIVER REV, V78, P3, DOI 10.1016/j.addr.2014.08.003; Thomson JM, 2005, CURR OPIN MICROBIOL, V8, P518, DOI 10.1016/j.mib.2005.08.014; Tojo S, 2015, ANTIMICROB AGENTS CH, V59, P7799, DOI 10.1128/AAC.01932-15; Varela AR, 2014, WATER RES, V54, P327, DOI 10.1016/j.watres.2014.02.003; Venturini C, 2010, FASEB J, V24, P1160, DOI 10.1096/fj.09-144972; Vesth T, 2013, STAND GENOMIC SCI, V9, P431, DOI 10.4056/sigs.2981345; Vishnivetskaya TA, 2014, FEMS MICROBIOL ECOL, V87, P217, DOI 10.1111/1574-6941.12219; Wang JL, 2015, SCI TOTAL ENVIRON, V526, P366, DOI 10.1016/j.scitotenv.2015.05.046; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113603; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076079; Xiong WG, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00061; Xiong WG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00194; Xu J, 2015, CHEMOSPHERE, V119, P1379, DOI 10.1016/j.chemosphere.2014.02.040; Yang Y, 2014, WATER RES, V62, P97, DOI 10.1016/j.watres.2014.05.019; Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365; Zhang T, 2015, APPL MICROBIOL BIOT, V99, P7771, DOI 10.1007/s00253-015-6688-9; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P397, DOI 10.1007/s00253-008-1829-z; Zhou LJ, 2013, SCI TOTAL ENVIRON, V452, P365, DOI 10.1016/j.scitotenv.2013.03.010	63	49	53	9	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156854	10.1371/journal.pone.0156854	http://dx.doi.org/10.1371/journal.pone.0156854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294780	gold, Green Published, Green Submitted			2022-12-27	WOS:000377821300012
J	Sung, TY; Yoon, JH; Han, M; Lee, YH; Lee, YM; Song, DE; Chung, KW; Kim, WB; Shong, YK; Hong, SJ				Sung, Tae-Yon; Yoon, Jong Ho; Han, Minkyu; Lee, Yi Ho; Lee, Yu-mi; Song, Dong Eun; Chung, Ki-Wook; Kim, Won Bae; Shong, Young Kee; Hong, Suck Joon			Oncologic Safety of Robot Thyroid Surgery for Papillary Thyroid Carcinoma: A Comparative Study of Robot versus Open Thyroid Surgery Using Inverse Probability of Treatment Weighting	PLOS ONE			English	Article							CONVENTIONAL OPEN THYROIDECTOMY; SURGICAL OUTCOMES; REMNANT ABLATION; INCREASING INCIDENCE; RADIOACTIVE IODINE; CANCER PATIENTS; MICROCARCINOMA; METAANALYSIS; LEVEL; TIME	The aim of this study was to evaluate the oncologic safety of robot thyroid surgery compared to open thyroid surgery for papillary thyroid carcinoma (PTC). We enrolled 722 patients with PTC who underwent a total thyroidectomy with central compartment node dissection (CCND) from January 2009 to December 2010. These patients were classified into open thyroid surgery (n = 610) or robot thyroid surgery (n = 112) groups. We verified the impact of robot thyroid surgery on clinical recurrence and ablation/control-stimulated thyroglobulin (sTg) levels predictive of non-recurrence using weighted logistic regression models with inverse probability of treatment weighting (IPTW). Age, sex, thyroid weight, extent of CCND, and TNM were significantly different between the two groups (p < 0.05); however, there was no significant difference in recurrence between the open and robot groups (1.5% vs. 2.7%; p = 0.608). The proportion of patients with ablation sTg < 10.0 ng/mL and control sTg < 1.0 ng/mL was comparable between the two groups (p > 0.05). Logistic regression with IPTW using the propensity scores estimated by adjusting all of the parameters demonstrated that robot thyroid surgery did not influence the clinical recurrence (OR; 0.784, 95% CI; 0.150-3.403, p = 0.750), ablation sTg (OR; 0.950, 95% CI; 0.361-2.399, p = 0.914), and control sTg levels (OR; 0.498, 95% CI; 0.190-1.189, p = 0.130). Robot thyroid surgery is comparable to open thyroid surgery with regard to oncologic safety in PTC patients.	[Sung, Tae-Yon; Yoon, Jong Ho; Lee, Yi Ho; Lee, Yu-mi; Chung, Ki-Wook; Hong, Suck Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea; [Han, Minkyu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Song, Dong Eun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Kim, Won Bae; Shong, Young Kee] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Yoon, JH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea.	gsyoon@amc.seoul.kr		YOON, JONG HO/0000-0003-1105-3653				Choi Y, 2014, ANN DERMATOL, V26, P693, DOI 10.5021/ad.2014.26.6.693; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Curtis LH, 2007, MED CARE, V45, pS103, DOI 10.1097/MLR.0b013e31806518ac; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Dralle H, 2013, EUR THYROID J, V2, P71, DOI 10.1159/000350856; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Erbil Y, 2008, J LARYNGOL OTOL, V122, P615, DOI 10.1017/S0022215107008997; Grodski S, 2009, CURR OPIN ONCOL, V21, P1, DOI 10.1097/CCO.0b013e32831a9a82; Grodski S, 2008, SURGERY, V144, P1038, DOI 10.1016/j.surg.2008.08.023; Han JM, 2012, THYROID, V22, P784, DOI 10.1089/thy.2011.0322; Kang SW, 2009, SURG ENDOSC, V23, P2399, DOI 10.1007/s00464-009-0366-x; Kim EY, 2011, NUCL MED COMMUN, V32, P954, DOI 10.1097/MNM.0b013e32834956ec; Kim TY, 2005, J CLIN ENDOCR METAB, V90, P1440, DOI 10.1210/jc.2004-1771; Kim WW, 2011, WORLD J SURG, V35, P779, DOI 10.1007/s00268-011-0960-7; Kuppersmith RB, 2011, LARYNGOSCOPE, V121, P521, DOI 10.1002/lary.21347; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Kwon T, 2015, J CANCER RES CLIN, V141, P169, DOI 10.1007/s00432-014-1793-1; Lallemant B, 2013, EUR THYROID J, V2, P110, DOI 10.1159/000351111; Lee J, 2011, ANN SURG ONCOL, V18, P1439, DOI 10.1245/s10434-010-1486-1; Lee J, 2011, ANN SURG ONCOL, V18, P2538, DOI 10.1245/s10434-011-1628-0; Lee J, 2010, SURG ENDOSC, V24, P3186, DOI 10.1007/s00464-010-1113-z; Lee KE, 2011, SURGERY, V150, P1266, DOI 10.1016/j.surg.2011.09.015; Lee S, 2012, SURGERY, V151, P724, DOI 10.1016/j.surg.2011.12.013; Lee YM, 2014, HEAD NECK-J SCI SPEC, V36, P1413, DOI 10.1002/hed.23472; Park CS, 2001, SURG TODAY, V31, P665, DOI 10.1007/s005950170066; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Schlumberger M, 2012, NEW ENGL J MED, V366, P1663, DOI 10.1056/NEJMoa1108586; Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506; Son SK, 2015, ANN SURG ONCOL, V22, P3022, DOI 10.1245/s10434-015-4375-9; Sung TY, 2015, J VIDEO ENDOCRINOLOG, V2, DOI [10.1089/ve.2015.0042, DOI 10.1089/VE.2015.0042]; Webb RC, 2012, J CLIN ENDOCR METAB, V97, P2754, DOI 10.1210/jc.2012-1533; Yi O, 2013, ANN SURG ONCOL, V20, P1927, DOI 10.1245/s10434-012-2850-0; Yoo H, 2012, J SURG ONCOL, V105, P705, DOI 10.1002/jso.22106	33	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157345	10.1371/journal.pone.0157345	http://dx.doi.org/10.1371/journal.pone.0157345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285846	gold, Green Submitted, Green Published			2022-12-27	WOS:000377564000059
J	Chair, H; Traore, RE; Duval, MF; Rivallan, R; Mukherjee, A; Aboagye, LM; Van Rensburg, J; Andrianavalona, V; de Carvalho, MAAP; Saborio, F; Prana, MS; Komolong, B; Lawac, F; Lebot, V				Chair, H.; Traore, R. E.; Duval, M. F.; Rivallan, R.; Mukherjee, A.; Aboagye, L. M.; Van Rensburg, J.; Andrianavalona, V.; Pinheiro de Carvalho, M. A. A.; Saborio, F.; Prana, M. Sri; Komolong, B.; Lawac, F.; Lebot, V.			Genetic Diversification and Dispersal of Taro (Colocasia esculenta (L.) Schott)	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE MARKERS; PAPUA-NEW-GUINEA; SOUTHEAST-ASIA; RAPD MARKERS; SWEET-POTATO; DIVERSITY; PLANTS; ORIGIN; GENOTYPE; OCEANIA	Taro (Colocasia esculenta (L.) Schott) is widely distributed in tropical and sub-tropical areas. However, its origin, diversification and dispersal remain unclear. While taro genetic diversity has been documented at the country and regional levels in Asia and the Pacific, few reports are available from Americas and Africa where it has been introduced through human migrations. We used eleven microsatellite markers to investigate the diversity and diversification of taro accessions from nineteen countries in Asia, the Pacific, Africa and America. The highest genetic diversity and number of private alleles were observed in Asian accessions, mainly from India. While taro has been diversified in Asia and the Pacific mostly via sexual reproduction, clonal reproduction with mutation appeared predominant in African and American countries investigated. Bayesian clustering revealed a first genetic group of diploids from the Asia-Pacific region and to a second diploid-triploid group mainly from India. Admixed cultivars between the two genetic pools were also found. In West Africa, most cultivars were found to have originated from India. Only one multi-locus lineage was assigned to the Asian pool, while cultivars in Madagascar originated from India and Indonesia. The South African cultivars shared lineages with Japan. The Caribbean Islands cultivars were found to have originated from the Pacific, while in Costa Rica they were from India or admixed between Indian and Asian groups. Taro dispersal in the different areas of Africa and America is thus discussed in the light of available records of voyages and settlements.	[Chair, H.; Duval, M. F.; Rivallan, R.] CIRAD, UMR AGAP, Montpellier, France; [Traore, R. E.] Univ Ouagadougou, UFR SVT, Ouagadougou, Burkina Faso; [Mukherjee, A.] CTCRI, Thiruvananthapuram, Kerala, India; [Aboagye, L. M.] CSRI, Accra, Ghana; [Van Rensburg, J.] ARC, Pretoria, South Africa; [Andrianavalona, V.] FOFIFA, Antananarivo, Madagascar; [Pinheiro de Carvalho, M. A. A.] Univ Madeira, BG ISOPlexis, Funchal, Portugal; [Saborio, F.] Univ Costa Rica, San Jose, Costa Rica; [Prana, M. Sri] LIPI, Bogor, West Java, Indonesia; [Komolong, B.] LAE, NARI, Lae, Morobe Province, Guinea; [Lawac, F.] VARTC, Santo, Vanuatu; [Lebot, V.] CIRAD, UMR AGAP, Port Vila, Vanuatu	CIRAD; Universite de Montpellier; Indian Council of Agricultural Research (ICAR); ICAR - Central Tuber Crops Research Institute; Agricultural Research Council of South Africa; Universidade da Madeira; Universidad Costa Rica; Indonesian Institute of Sciences; CIRAD	Chair, H (corresponding author), CIRAD, UMR AGAP, Montpellier, France.	hana.chair@cirad.fr			Europe-Aid project "Adapting clonally propagated crops to climatic and commercial changes" [DCI-FOOD/2010/230-267 SPC]; French Foreign Ministry; CIRAD	Europe-Aid project "Adapting clonally propagated crops to climatic and commercial changes"; French Foreign Ministry; CIRAD	This study was funded by grant no. DCI-FOOD/2010/230-267 SPC, Europe-Aid project "Adapting clonally propagated crops to climatic and commercial changes." RET was supported by a doctoral grant from the French Foreign Ministry and grant from CIRAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud-Haond S, 2005, J HERED, V96, P434, DOI 10.1093/jhered/esi043; Attri B. L., 2013, Indian Forester, V139, P452; Beaujard P, 2011, AZANIA, V46, P169, DOI 10.1080/0067270X.2011.580142; Blench R. M., 2009, ETHNOBOTANY RES APPL, V7, P363, DOI DOI 10.17348/ERA.7.0.363-380; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Burlakova LE, 2009, RESTOR ECOL, V17, P433, DOI 10.1111/j.1526-100X.2008.00429.x; COATES DJ, 1988, CYTOLOGIA, V53, P551, DOI 10.1508/cytologia.53.551; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Duss RP, 1897, FLORE PHANEROGAMIQUE; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fullagar R, 2006, J ARCHAEOL SCI, V33, P595, DOI 10.1016/j.jas.2005.07.020; Fuller DQ, 2011, ANTIQUITY, V85, P544, DOI 10.1017/S0003598X00067934; Goncalves RF, 2013, FOOD CHEM, V141, P3480, DOI 10.1016/j.foodchem.2013.06.009; Horrocks M, 2007, J ARCHAEOL SCI, V34, P739, DOI 10.1016/j.jas.2006.07.011; Hu K, 2009, MOL ECOL RESOUR, V9, P582, DOI 10.1111/j.1755-0998.2008.02441.x; Hunt HV, 2013, GENET RESOUR CROP EV, V60, P1695, DOI 10.1007/s10722-012-9952-1; Irwin SV, 1998, EUPHYTICA, V99, P183, DOI 10.1023/A:1018309417762; Isshiki S, 1999, J JPN SOC HORTIC SCI, V68, P774, DOI 10.2503/jjshs.68.774; Ivancic Anton, 1999, Pacific Science, V53, P273; Jianchu X., 2001, BOTANY, V55, P14, DOI DOI 10.1007/BF02864543; Kreike CM, 2004, THEOR APPL GENET, V109, P761, DOI 10.1007/s00122-004-1691-z; KURUVILLA KM, 1981, EUPHYTICA, V30, P405, DOI 10.1007/BF00034004; Kusuma P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1394-7; Lakhanpaul S, 2003, GENET RESOUR CROP EV, V50, P603, DOI 10.1023/A:1024498408453; LEBOT V, 1991, EUPHYTICA, V56, P55; Lebot V, 2004, GENET RESOUR CROP EV, V51, P381, DOI 10.1023/B:GRES.0000023453.30948.4d; Lebot V., 2009, TROPICAL ROOT AND TU; LOY TH, 1992, ANTIQUITY, V66, P898, DOI 10.1017/S0003598X00044811; Mace ES, 2002, GENOME, V45, P823, DOI [10.1139/g02-045, 10.1139/G02-045]; MATTHEWS P, 1992, JPN J BREED, V42, P825; Matthews P.J., 1991, INDO PACIFIC PREHIST, V11, P69, DOI [10.7152/bippa.v11i0.11374, DOI 10.7152/BIPPA.V11I0.11374]; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Ndaeyo NU, 2003, INDIAN J AGR SCI, V73, P194; Nunes RSC, 2012, HORTIC BRAS, V30, P106, DOI 10.1590/S0102-05362012000100018; Ochiai T, 2001, EUPHYTICA, V122, P219, DOI 10.1023/A:1012967922502; Osada M., 2002, SANCTIONS AND HONORA; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrier X., 2006, DARWIN SOFTWARE; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; PORTERES ROLAND, 1960, JOUR AGRIC TROP ET BOT APPL, V7, P169; Pritchard JK, 2000, GENETICS, V155, P945; Quero-Garcia J, 2006, EUPHYTICA, V151, P187, DOI 10.1007/s10681-006-9139-y; Ramanatha RV, 2010, THE GLOBAL DIVERSITY; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; Rodriguez Manzano A., 2001, Plant Genetic Resources Newsletter, P31; Roullier C, 2013, HEREDITY, V110, P594, DOI 10.1038/hdy.2013.14; Roullier C, 2013, P NATL ACAD SCI USA, V110, P2205, DOI 10.1073/pnas.1211049110; Sampson JF, 2012, BIOL J LINN SOC, V105, P218, DOI 10.1111/j.1095-8312.2011.01787.x; Sanou H, 2015, CROP SCI, V55, P749, DOI 10.2135/cropsci2014.02.0165; Sanou J, 2012, AGROFOREST SYST, V85, P431, DOI 10.1007/s10457-011-9405-4; Santosa E, 2007, MOL ECOL NOTES, V7, P814, DOI 10.1111/j.1471-8286.2007.01713.x; Sardos J, 2012, GENET RESOUR CROP EV, V59, P805, DOI 10.1007/s10722-011-9720-7; Saur Etienne, 2003, Bois et Forets des Tropiques, P85; Scarcelli N, 2011, GENETICA, V139, P1055, DOI 10.1007/s10709-011-9607-8; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Singh D, 2008, GENET RESOUR CROP EV, V55, P811, DOI 10.1007/s10722-007-9286-6; Teixeira H, 2014, PLOS ONE, V9; Vandenbroucke H, 2015, GENET RESOUR CROP EV	60	41	42	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157712	10.1371/journal.pone.0157712	http://dx.doi.org/10.1371/journal.pone.0157712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314588	Green Published, Green Submitted, gold			2022-12-27	WOS:000378030000046
J	Singh, R				Singh, Raghvendra			Model Predicts That MKP1 and TAB1 Regulate p38 alpha Nuclear Pulse and Its Basal Activity through Positive and Negative Feedback Loops in Response to IL-1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; P38 MAP-KINASE; RECEPTOR-ASSOCIATED KINASE; NF-KAPPA-B; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; INDUCED APOPTOSIS; GENE-EXPRESSION; DOWN-REGULATION; INDEPENDENT ACTIVATION	Interleukin-1 mediates inflammation and stress response through nuclear activity of p38 alpha. Although IL-1 receptor is not degraded, p38 alpha activation is transient. IL-1 also causes cell migration and EMT by modulating cell-cell junctions. Although molecules involved in p38 activation are known, mechanism of the transient nuclear response and its basal activity remains unknown. By mathematical modeling of IL1/p38 signaling network, we show that IL-1 induces robust p38 alpha activation both in the nucleus and in the cytoplasm/membrane. While nuclear response consists of an acute phase, membrane response resembles a step change. Following stimulation, p38 alpha activity returns to a basal level in absence of receptor degradation. While nuclear pulse is controlled by MKP1 through a negative feedback to pp38, its basal activity is controlled by both TAB1 and MKP1 through a positive feedback loop. Our model provides insight into the mechanism of p38 alpha activation, reason for its transient nuclear response, and explanation of the basal activity of MKK3/6 and p38 alpha, which has been experimentally observed by other groups.	[Singh, Raghvendra] Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Singh, R (corresponding author), Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India.	raghvend@iitk.ac.in			Indian Institute of Technology Kanpur grant [IITK/CHE/20090282]	Indian Institute of Technology Kanpur grant	This work was supported by Indian Institute of Technology Kanpur grant IITK/CHE/20090282 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Indian Institute of Technology Kanpur grant IITK/CHE/20090282 to RS.	Bakin AV, 2002, J CELL SCI, V115, P3193; Bani-Hani AH, 2008, J UROLOGY, V180, P461, DOI 10.1016/j.juro.2008.04.001; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; CHARLES CH, 1993, P NATL ACAD SCI USA, V90, P5292, DOI 10.1073/pnas.90.11.5292; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; CURTIS BM, 1990, J IMMUNOL, V144, P1295; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FACCIOLI LH, 1990, AGENTS ACTIONS, V30, P344, DOI 10.1007/BF01966298; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Gallez-Hawkins G, 2002, SCAND J IMMUNOL, V55, P592, DOI 10.1046/j.1365-3083.2002.01099.x; Gang L, 2006, J BIOL CHEM, V281, P6087, DOI 10.1074/jbc.M507610200; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gong XW, 2010, J CELL BIOCHEM, V110, P1420, DOI 10.1002/jcb.22675; Gorog DA, 2004, CARDIOVASC RES, V61, P123, DOI 10.1016/j.cardiores.2003.09.034; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hu J, 2002, J IMMUNOL, V168, P3910, DOI 10.4049/jimmunol.168.8.3910; Hu JH, 2007, CELL SIGNAL, V19, P393, DOI 10.1016/j.cellsig.2006.07.010; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Inagaki M, 2008, J BIOL CHEM, V283, P33080, DOI 10.1074/jbc.M807574200; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kim SY, 2002, NEUROREPORT, V13, P2483, DOI 10.1097/00001756-200212200-00021; Kojima T, 2003, CELL COMMUN ADHES, V10, P437, DOI 10.1080/714040465; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Liao P, 2002, CIRC RES, V90, P190, DOI 10.1161/hh0202.104220; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MATSUSHIMA K, 1986, J IMMUNOL, V137, P3183; McDermott EP, 2002, J BIOL CHEM, V277, P7808, DOI 10.1074/jbc.M108133200; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Nagata Y, 1999, BLOOD, V94, P853, DOI 10.1182/blood.V94.3.853.415a12_853_863; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2012, P NATL ACAD SCI USA, V109, P3365, DOI 10.1073/pnas.1116188109; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rastogi R, 2011, AM J RESP CRIT CARE, V183, P500, DOI 10.1164/rccm.201005-0792OC; Ridley SH, 1997, J IMMUNOL, V158, P3165; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tanno M, 2003, CIRC RES, V93, P254, DOI 10.1161/01.RES.0000083490.43943.85; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tomida T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9350; Volpe F, 1997, FEBS LETT, V419, P41, DOI 10.1016/S0014-5793(97)01426-9; Waas WF, 2001, J BIOL CHEM, V276, P5676, DOI 10.1074/jbc.M008787200; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto T, 2005, J HEPATOL, V42, P707, DOI 10.1016/j.jhep.2004.12.033; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	63	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157572	10.1371/journal.pone.0157572	http://dx.doi.org/10.1371/journal.pone.0157572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314954	Green Submitted, gold, Green Published			2022-12-27	WOS:000378030000036
J	Asher, E; Abu-Much, A; Goldenberg, I; Segev, A; Sabbag, A; Mazin, I; Shlezinger, M; Atar, S; Zahger, D; Polak, A; Beigel, R; Matetzky, S				Asher, Elad; Abu-Much, Arsalan; Goldenberg, Ilan; Segev, Amit; Sabbag, Avi; Mazin, Israel; Shlezinger, Meital; Atar, Shaul; Zahger, Doron; Polak, Arthur; Beigel, Roy; Matetzky, Shlomi		Platelets Thrombosis Sheba-PLATIS	Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2)	PLOS ONE			English	Article							DUAL-ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY INTERVENTION; ZOTAROLIMUS-ELUTING STENT; CLOPIDOGREL THERAPY; PREMATURE DISCONTINUATION; INTRACORONARY ULTRASOUND; PLATELET REACTIVITY; IMPLANTATION; PREDICTORS; TRIAL	Early stent thrombosis (EST) (<= 30 days after stent implantation) is a relatively rare but deleterious complication of percutaneous coronary intervention (PCI). Administration of newer P2Y12 inhibitors (prasugrel and ticagrelor) combined with aspirin has been shown to reduce the incidence of sub-acute and late stent thrombosis, compared with clopidogrel. We investigated the "real life" incidence of EST in patients from a large acute coronary syndrome (ACS) national registry, where newer P2Y12 inhibitors are widely used. Patients were derived from the ACS Israeli Survey (ACSIS), conducted during 2006, 2008, 2010 and 2013. Major adverse cardiac events (MACE) at 30days were defined as all-cause death, recurrent ACS, EST and stroke. Of the 4717 ACS patients who underwent PCI and stenting, 83% received clopidogrel and 17% newer P2Y12 inhibitors. The rate of EST was similar in both groups (1.7% in the newer P2Y12 inhibitor group vs. 1.4% in the clopidogrel-treated patients, p = 0.42). Results were consistent after multivariate analysis (adjusted HR = 1.06 [p = 0.89]). MACE occurred in 6.4% in the newer P2Y12 inhibitor group compared with 9.2% in the clopidogrel group (P < 0.01). However, multivariate logistic regression modeling showed that treatment with newer P2Y12 inhibitors was not significantly associated with the secondary endpoint of MACE when compared with clopidogrel therapy [OR = 1.26 95%CI (0.93-1.73), P = 0.136]. The incidence of "real life" EST at 1month is relatively low, and appears to be similar in patients who receive newer P2Y12 inhibitors as well as in those who receive clopidogrel.	[Asher, Elad; Abu-Much, Arsalan; Goldenberg, Ilan; Segev, Amit; Sabbag, Avi; Mazin, Israel; Shlezinger, Meital; Beigel, Roy; Matetzky, Shlomi] Sheba Med Ctr, Leviev Heart Ctr, Tel Hashomer, Israel; [Asher, Elad; Abu-Much, Arsalan; Goldenberg, Ilan; Segev, Amit; Sabbag, Avi; Mazin, Israel; Shlezinger, Meital; Beigel, Roy; Matetzky, Shlomi] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Atar, Shaul] Galilee Med Ctr, Div Cardiol, Nahariyya, Israel; [Zahger, Doron] Soroka Med Ctr, Dept Cardiol, Beer Sheva, Israel; [Polak, Arthur] Hadassah Univ Hosp, Inst Heart, IL-91120 Jerusalem, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Western Galilee Hospital; Ben Gurion University; Soroka Medical Center; Hebrew University of Jerusalem	Asher, E (corresponding author), Sheba Med Ctr, Leviev Heart Ctr, Tel Hashomer, Israel.; Asher, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	el.asher@gmail.com	Asher, Elad/I-3544-2019; sabbag, avi/AFU-5323-2022; Sabbag, Avi/AAA-1532-2021	Asher, Elad/0000-0003-3381-605X; sabbag, avi/0000-0003-4295-6679; SEgev, Amit/0000-0002-2290-0400				[Anonymous], 2015, PROMETHEOUS TRIAL SO; Aoki J, 2009, CIRCULATION, V119, P687, DOI 10.1161/CIRCULATIONAHA.108.804203; Asher E, 2016, THROMB HAEMOSTASIS, V115, P433, DOI 10.1160/TH15-05-0384; Beinart R, 2010, AM HEART J, V159, P118, DOI 10.1016/j.ahj.2009.09.020; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; COLOMBO A, 1995, CIRCULATION, V91, P1676, DOI 10.1161/01.CIR.91.6.1676; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Costa F, 2015, EUR HEART J, V36, P1242, DOI 10.1093/eurheartj/ehv038; Dangas GD, 2011, CIRCULATION, V123, P1745, DOI 10.1161/CIRCULATIONAHA.110.981688; Feres F, 2012, AM HEART J, V164, P810, DOI 10.1016/j.ahj.2012.09.009; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Gilard M, 2015, J AM COLL CARDIOL, V65, P777, DOI 10.1016/j.jacc.2014.11.008; GOLDBERG SL, 1994, J AM COLL CARDIOL, V24, P996, DOI 10.1016/0735-1097(94)90861-3; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; James S, 2009, AM HEART J, V157, P599, DOI 10.1016/j.ahj.2009.01.003; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Kirtane AJ, 2014, AM COLL CARDIOL, V64; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Monassier JP, 1997, CATHETER CARDIO DIAG, V42, P243, DOI 10.1002/(SICI)1097-0304(199711)42:3<243::AID-CCD1>3.0.CO;2-C; Montalescot G, 2014, NEW ENGL J MED, V371, P1016, DOI 10.1056/NEJMoa1407024; NAKAMURA S, 1994, CIRCULATION, V89, P2026, DOI 10.1161/01.CIR.89.5.2026; Nakano M, 2014, J AM COLL CARDIOL, V63, P2510, DOI 10.1016/j.jacc.2014.02.607; Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Piccolo R, 2014, ANGIOLOGY, V65, P130, DOI 10.1177/0003319712467530; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Schulz-Schupke S, 2015, EUR HEART J, V36, P1252, DOI 10.1093/eurheartj/ehu523; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Steg PG, 2013, CIRCULATION, V128, P1055, DOI 10.1161/CIRCULATIONAHA.113.002589; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157437	10.1371/journal.pone.0157437	http://dx.doi.org/10.1371/journal.pone.0157437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310147	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800071
J	Gliszczynska, A; Niezgoda, N; Gladkowski, W; Czarnecka, M; Switalska, M; Wietrzyk, J				Gliszczynska, Anna; Niezgoda, Natalia; Gladkowski, Witold; Czarnecka, Marta; Switalska, Marta; Wietrzyk, Joanna			Synthesis and Biological Evaluation of Novel Phosphatidylcholine Analogues Containing Monoterpene Acids as Potent Antiproliferative Agents	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; PHOSPHOLIPASE-D; CELLS; INHIBITION; FARNESOL; LACTONE	The synthesis of novel phosphatidylcholines with geranic and citronellic acids in sn-1 and sn-2 positions is described. The structured phospholipids were obtained in high yields (59-87%) and evaluated in vitro for their cytotoxic activity against several cancer cell lines of different origin: MV4-11, A-549, MCF-7, LOVO, LOVO/DX, HepG2 and also towards non-cancer cell line BALB/3T3 (normal mice fibroblasts). The phosphatidylcholines modified with monoterpene acid showed a significantly higher antiproliferative activity than free monoterpene acids. The highest activity was observed for the terpene-phospholipids containing the isoprenoid acids in sn-1 position of phosphatidylcholine and palmitic acid in sn-2.	[Gliszczynska, Anna; Niezgoda, Natalia; Gladkowski, Witold; Czarnecka, Marta] Wroclaw Univ Environm & Life Sci, Dept Chem, Norwida 25, PL-50375 Wroclaw, Poland; [Switalska, Marta; Wietrzyk, Joanna] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Expt Oncol, Weigla 12, PL-53114 Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Gliszczynska, A (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Chem, Norwida 25, PL-50375 Wroclaw, Poland.	anna.gliszczynska@wp.pl	Gładkowski, Witold/A-5750-2017; Niezgoda, Natalia/A-2387-2017; Czarnecka, Marta/B-6787-2017; Wietrzyk, Joanna/O-4392-2018; Niezgoda, Natalia/HHN-1650-2022; Gliszczyńska, Anna/A-2601-2017	Gładkowski, Witold/0000-0002-3271-779X; Niezgoda, Natalia/0000-0002-1154-9707; Wietrzyk, Joanna/0000-0003-4980-6606; Niezgoda, Natalia/0000-0002-1154-9707; Gliszczyńska, Anna/0000-0002-0218-6369; Switalska, Marta/0000-0001-7920-2251	National Science Center of Poland [2013/09/D/NZ9/02457]; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	National Science Center of Poland(National Science Centre, Poland); Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This project was financed by National Science Center of Poland no. 2013/09/D/NZ9/02457. Publication was supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018 (http://know.wroc.pl).	ADANY I, 1994, CANCER LETT, V79, P175, DOI 10.1016/0304-3835(94)90257-7; Bezrukov SM, 2000, CURR OPIN COLLOID IN, V5, P237, DOI 10.1016/S1359-0294(00)00061-3; Biodrowska K, 2012, PRZEM CHEM, V91, P692; Burke YD, 1997, LIPIDS, V32, P151, DOI 10.1007/s11745-997-0019-y; Chrencik JE, 2015, CELL, V161, P1633, DOI 10.1016/j.cell.2015.06.002; D'Arrigo P, 2007, CHEM PHYS LIPIDS, V147, P113, DOI 10.1016/j.chemphyslip.2007.03.008; D'Arrigo P, 2010, MOLECULES, V15, P1354, DOI 10.3390/molecules15031354; Fasoli E, 2006, ORG BIOMOL CHEM, V4, P2974, DOI 10.1039/b604636c; Fujita K, 2005, BIOORGAN MED CHEM, V13, P6742, DOI 10.1016/j.bmc.2005.07.023; Gliszczynska A, 2016, CHEM BIODIVERS, V13, P477, DOI 10.1002/cbdv.201500127; GUPTA CM, 1977, P NATL ACAD SCI USA, V74, P4315, DOI 10.1073/pnas.74.10.4315; HARKER WG, 1991, BIOCHEMISTRY-US, V30, P9953, DOI 10.1021/bi00105a020; Hernandez V, 2005, EUR J PHARM SCI, V26, P162, DOI 10.1016/j.ejps.2005.05.007; Hrdaka N, 2008, J NUTR SCI VITAMINOL, V54, P255, DOI 10.3177/jnsv.54.255; Ichihara K, 2005, CHEM PHYS LIPIDS, V137, P94, DOI 10.1016/j.chemphyslip.2005.06.001; Innis SM, 2007, AM J CLIN NUTR, V85, P702, DOI 10.1093/ajcn/85.3.702; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Lambert DM, 2000, EUR J PHARM SCI, V11, pS15, DOI 10.1016/S0928-0987(00)00161-5; Lee TC, 1998, BBA-LIPID LIPID MET, V1394, P129, DOI 10.1016/S0005-2760(98)00107-6; Masuda T, 2008, J AGR FOOD CHEM, V56, P597, DOI 10.1021/jf072893l; MATTSON FH, 1962, J LIPID RES, V3, P281; MORGADO MAP, 1995, J CHEM TECHNOL BIOT, V63, P181, DOI 10.1002/jctb.280630214; Niezgoda N, 2015, AUST J CHEM, V68, P1065, DOI 10.1071/CH14606; Niezgoda N, 2013, AUST J CHEM, V66, P354, DOI 10.1071/CH12404; Peng JN, 2002, TETRAHEDRON LETT, V43, P9699, DOI 10.1016/S0040-4039(02)02369-9; Rioja A, 2000, FEBS LETT, V467, P291, DOI 10.1016/S0014-5793(00)01168-6; Schlegel RA, 2003, NUTR BIOCH PHOSPHOLI; SINGH A, 1990, J LIPID RES, V31, P1522; Singh SB, 2000, BIOORG MED CHEM LETT, V10, P235, DOI 10.1016/S0960-894X(99)00666-6; SZUHAJ BF, 2003, NUTR BIOCH PHOSPHOLI; TAKAMI M, 1994, BIOSCI BIOTECH BIOCH, V58, P1716, DOI 10.1271/bbb.58.1716; Vance DE, 2002, BIOCH LIPIDS LIPOPRO; Wang T, 2008, OILY PRESS LIPID LIB; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200; Wuryatmo E, 2003, J AGR FOOD CHEM, V51, P2637, DOI 10.1021/jf026183l; Yamamoto Y, 2008, BIOORG MED CHEM LETT, V18, P4044, DOI 10.1016/j.bmcl.2008.05.113; Yamamoto Y, 2008, J AM OIL CHEM SOC, V85, P313, DOI 10.1007/s11746-008-1206-1; Yang T, 2011, METAB ENG, V13, P414, DOI 10.1016/j.ymben.2011.01.011	38	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157278	10.1371/journal.pone.0157278	http://dx.doi.org/10.1371/journal.pone.0157278			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310666	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800049
J	Hillreiner, M; Flinspach, C; Pfaffl, MW; Kliem, H				Hillreiner, Maria; Flinspach, Claudia; Pfaffl, Michael W.; Kliem, Heike			Effect of the Ketone Body Beta-Hydroxybutyrate on the Innate Defense Capability of Primary Bovine Mammary Epithelial Cells	PLOS ONE			English	Article							DAIRY-CATTLE; ESCHERICHIA-COLI; GENE-EXPRESSION; SUBCLINICAL KETOSIS; MASTITIS PATHOGENS; LIPOTEICHOIC ACID; HOST-DEFENSE; IN-VITRO; COWS; GLAND	Negative energy balance and ketosis are thought to cause impaired immune function and to increase the risk of clinical mastitis in dairy cows. The present in vitro study aimed to investigate the effect of elevated levels of the predominant ketone body beta-hydroxybutyrate on the innate defense capability of primary bovine mammary epithelial cells (pbMEC) challenged with the mastitis pathogen Escherichia coli (E. coli). Therefore, pbMEC of healthy dairy cows in mid-lactation were isolated from milk and challenged in culture with 3 mM BHBA and E. coli. pbMEC stimulated with E. coli for 6 h or 30 h showed an up-regulation of several innate immune genes, whereas co-stimulation of pbMEC with 3 mM BHBA and E. coli resulted in the down-regulation of CCL2, SAA3, LF and C3 gene expression compared to the challenge with solely the bacterial stimulus. These results indicated that increased BHBA concentrations may be partially responsible for the higher mastitis susceptibility of dairy cows in early lactation. Elevated levels of BHBA in blood and milk during negative energy balance and ketosis are likely to impair innate immune function in the bovine mammary gland by attenuating the expression of a broad range of innate immune genes.	[Hillreiner, Maria; Flinspach, Claudia; Pfaffl, Michael W.; Kliem, Heike] Tech Univ Munich, Chair Anim Physiol & Immunol, Freising Weihenstephan, Germany	Technical University of Munich	Kliem, H (corresponding author), Tech Univ Munich, Chair Anim Physiol & Immunol, Freising Weihenstephan, Germany.	kliem@wzw.tum.de	Pfaffl, Michael/G-6622-2013	Pfaffl, Michael/0000-0002-3192-1019	German Research Foundation (DFG); Technische Universitat Munchen; "Vereinigung zur Forderung der Milchwissenschaftlichen Forschung an der Technischen Universitat Muchen e. V." (Freising, Germany)	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen; "Vereinigung zur Forderung der Milchwissenschaftlichen Forschung an der Technischen Universitat Muchen e. V." (Freising, Germany)	This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding program Open Access Publishing. Furthermore, this study was funded by the "Vereinigung zur Forderung der Milchwissenschaftlichen Forschung an der Technischen Universitat Muchen e. V." (Freising, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alluwaimi AM, 2004, RES VET SCI, V77, P211, DOI 10.1016/j.rvsc.2004.04.006; ANDERSSON L, 1988, VET CLIN N AM-FOOD A, V4, P233, DOI 10.1016/S0749-0720(15)31046-X; BAIRD GD, 1982, J DAIRY SCI, V65, P1, DOI 10.3168/jds.S0022-0302(82)82146-2; Boudjellab N, 2000, COMP BIOCHEM PHYS A, V127, P191, DOI 10.1016/S1095-6433(00)00257-9; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CARROLL EJ, 1982, AM J VET RES, V43, P1661; CORREA MT, 1993, J DAIRY SCI, V76, P1305, DOI 10.3168/jds.S0022-0302(93)77461-5; Danowski K, 2013, J ANIM PHYSIOL AN N, V97, P647, DOI 10.1111/j.1439-0396.2012.01305.x; Dirksen G, 2006, PAREY, V47, P1325; Duffield TF, 2009, J DAIRY SCI, V92, P571, DOI 10.3168/jds.2008-1507; ERB HN, 1988, J DAIRY SCI, V71, P2557, DOI 10.3168/jds.S0022-0302(88)79845-8; GRAY GD, 1982, AM J VET RES, V43, P757; Griesbeck-Zilch B, 2008, J DAIRY SCI, V91, P2215, DOI 10.3168/jds.2007-0752; Gross J, 2011, J DAIRY SCI, V94, P1820, DOI 10.3168/jds.2010-3707; Gunther J, 2009, VET RES, V40, DOI 10.1051/vetres/2009014; Hsu Kenneth, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P290; Hunziker W, 1998, J MAMMARY GLAND BIOL, V3, P287, DOI 10.1023/A:1018715511178; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kruger S, 2000, INFECT IMMUN, V68, P328, DOI 10.1128/IAI.68.1.328-334.2000; Kutila T, 2003, ACTA VET SCAND, V44, P35, DOI 10.1186/1751-0147-44-35; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutzow YCS, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-18; McArt JAA, 2012, J DAIRY SCI, V95, P5056, DOI 10.3168/jds.2012-5443; Molenaar AJ, 2009, BIOMARKERS, V14, P26, DOI 10.1080/13547500902730714; Nguyen DAD, 1998, J MAMMARY GLAND BIOL, V3, P233, DOI 10.1023/A:1018707309361; OLTENACU PA, 1994, VET RES, V25, P208; Pfaffl MW, 2003, J DAIRY SCI, V86, P538, DOI 10.3168/jds.S0022-0302(03)73632-7; PRAKASH BS, 1987, J STEROID BIOCHEM, V28, P623, DOI 10.1016/0022-4731(87)90389-X; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; SCHULTZ LH, 1968, J DAIRY SCI, V51, P1133, DOI 10.3168/jds.S0022-0302(68)87141-3; Seegers H, 2003, VET RES, V34, P475, DOI 10.1051/vetres:2003027; Sordillo LM, 1997, J DAIRY SCI, V80, P1851, DOI 10.3168/jds.S0022-0302(97)76121-6; Sorg D., 2013, Animal Genetic Resources, P91; Sorg D, 2013, ANIMAL, V7, P799, DOI 10.1017/S1751731112002315; Sorg D, 2012, IN VITRO CELL DEV-AN, V48, P550, DOI 10.1007/s11626-012-9544-6; Strandberg Y, 2005, CYTOKINE, V31, P72, DOI 10.1016/j.cyto.2005.02.010; Suriyasathaporn W, 2000, VET RES, V31, P397, DOI 10.1051/vetres:2000128; Suriyasathaporn W, 1999, VET IMMUNOL IMMUNOP, V68, P177, DOI 10.1016/S0165-2427(99)00017-3; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wellnitz O, 2006, VET MED-CZECH, V51, P125, DOI 10.17221/5531-VETMED; Wellnitz O, 2016, J DAIRY SCI, V99, P4851, DOI 10.3168/jds.2016-10927; Wheeler TT, 2012, ANIMAL, V6, P415, DOI 10.1017/S1751731111002151; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	43	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157774	10.1371/journal.pone.0157774	http://dx.doi.org/10.1371/journal.pone.0157774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310007	gold, Green Published			2022-12-27	WOS:000378029800135
J	Holdbrook, DA; Huber, RG; Piggot, TJ; Bond, PJ; Khalid, S				Holdbrook, Daniel A.; Huber, Roland G.; Piggot, Thomas J.; Bond, Peter J.; Khalid, Syma			Dynamics of Crowded Vesicles: Local and Global Responses to Membrane Composition	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; SIMULATIONS; PROTEINS; MODEL; INSERTION; GROMACS; FUSION; DETAIL; AREA	The bacterial cell envelope is composed of a mixture of different lipids and proteins, making it an inherently complex organelle. The interactions between integral membrane proteins and lipids are crucial for their respective spatial localization within bacterial cells. We have employed microsecond timescale coarse-grained molecular dynamics simulations of vesicles of varying sizes and with a range of protein and lipid compositions, and used novel approaches to measure both local and global system dynamics, the latter based on spherical harmonics analysis. Our results suggest that both hydrophobic mismatch, enhanced by embedded membrane proteins, and curvature based sorting, due to different modes of undulation, may drive assembly in vesicular systems. Interestingly, the modes of undulation of the vesicles were found to be altered by the specific protein and lipid composition of the vesicle. Strikingly, lipid dynamics were shown to be coupled to proteins up to 6 nm from their surface, a substantially larger distance than has previously been observed, resulting in multi-layered annular rings enriched with particular types of phospholipid. Such large protein- lipid complexes may provide a mechanism for long-range communication. Given the complexity of bacterial membranes, our results suggest that subtle changes in lipid composition may have major implications for lipid and protein sorting under a curvature-based membrane-sorting model.	[Holdbrook, Daniel A.; Huber, Roland G.; Bond, Peter J.] ASTAR, Bioinformat Inst, 30 Biopolis Str,07-01 Matrix, Singapore 138671, Singapore; [Piggot, Thomas J.] Def Sci & Technol Lab, Salisbury SP4 0JQ, Wilts, England; [Bond, Peter J.] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Holdbrook, Daniel A.; Piggot, Thomas J.; Khalid, Syma] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Defence Science & Technology Laboratory; National University of Singapore; University of Southampton	Bond, PJ (corresponding author), ASTAR, Bioinformat Inst, 30 Biopolis Str,07-01 Matrix, Singapore 138671, Singapore.; Bond, PJ (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.; Khalid, S (corresponding author), Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England.	peterjb@bii.a-star.edu.sg; s.khalid@soton.ac.uk	Khalid, Syma/P-6868-2019; Huber, Roland G/AAG-6353-2019; Khalid, Syma/B-8108-2009	Khalid, Syma/0000-0002-3694-5044; Huber, Roland G/0000-0001-5093-5988; Khalid, Syma/0000-0002-3694-5044; Bond, Peter/0000-0003-2900-098X; Holdbrook, Daniel Aitor/0000-0002-8116-9208	BBSRC [BB/H000658/1]; Ministry of Education in Singapore (MOE AcRF Tier 3) [MOE2012-T3-1-008]; Biotechnology and Biological Sciences Research Council [BB/H000658/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Education in Singapore (MOE AcRF Tier 3)(Ministry of Education, Singapore); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	TJP was funded by the BBSRC grant no: BB/H000658/1. PJB acknowledges support from the Ministry of Education in Singapore (MOE AcRF Tier 3 Grant Number MOE2012-T3-1-008). The authors wish to acknowledge that High performance computing was provided by the University of Southampton through the IridisIII supercomputer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBARA S, 1972, BIOCHIM BIOPHYS ACTA, V270, P301; Apajalahti T, 2010, FARADAY DISCUSS, V144, P411, DOI 10.1039/b901487j; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bond PJ, 2008, BIOCHEMISTRY-US, V47, P11321, DOI 10.1021/bi800642m; Bond PJ, 2008, BIOPHYS J, V95, P3802, DOI 10.1529/biophysj.108.128686; Bond PJ, 2007, J STRUCT BIOL, V157, P593, DOI 10.1016/j.jsb.2006.10.004; Bond PJ, 2006, J AM CHEM SOC, V128, P2697, DOI 10.1021/ja0569104; Braun AR, 2015, BIOPHYS J, V108, P1848, DOI 10.1016/j.bpj.2015.03.029; Braun AR, 2014, J CHEM THEORY COMPUT, V10, P4160, DOI 10.1021/ct500460u; Braun AR, 2011, BIOPHYS J, V100, P2112, DOI 10.1016/j.bpj.2011.03.009; Casuso I, 2012, NAT NANOTECHNOL, V7, P525, DOI [10.1038/nnano.2012.109, 10.1038/NNANO.2012.109]; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; de Vries AH, 2004, J AM CHEM SOC, V126, P4488, DOI 10.1021/ja0398417; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Goose JE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003033; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones E., SCIPY OPEN SOURCE SC; Khalid S, 2015, BIOCHEM SOC T, V43, P162, DOI 10.1042/BST20140262; Khalid Syma, 2013, Methods Mol Biol, V924, P635, DOI 10.1007/978-1-62703-017-5_25; KITO M, 1975, EUR J BIOCHEM, V54, P55, DOI 10.1111/j.1432-1033.1975.tb04113.x; Knecht V, 2007, BIOPHYS J, V92, P4254, DOI 10.1529/biophysj.106.103572; Koldso H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003911; Markvoort AJ, 2006, J PHYS CHEM B, V110, P22780, DOI 10.1021/jp064888a; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2003, J AM CHEM SOC, V125, P15233, DOI 10.1021/ja0352092; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Nielsen SO, 2004, BIOPHYS J, V87, P2107, DOI 10.1529/biophysj.104.040311; Niemela PS, 2010, J AM CHEM SOC, V132, P7574, DOI 10.1021/ja101481b; Noguchi H, 2001, J CHEM PHYS, V115, P9547, DOI 10.1063/1.1414314; Orsi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028637; Parton DL, 2011, BIOPHYS J, V101, P691, DOI 10.1016/j.bpj.2011.06.048; Periole X, 2007, J AM CHEM SOC, V129, P10126, DOI 10.1021/ja0706246; Reddy T, 2015, STRUCTURE, V23, P584, DOI 10.1016/j.str.2014.12.019; Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291	37	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156963	10.1371/journal.pone.0156963	http://dx.doi.org/10.1371/journal.pone.0156963			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310814	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000378029800023
J	Koppitz, M; Eschenburg, C; Salzmann, E; Rosewich, M; Schubert, R; Zielen, S				Koppitz, Martin; Eschenburg, Charlotte; Salzmann, Emilia; Rosewich, Martin; Schubert, Ralf; Zielen, Stefan			Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial	PLOS ONE			English	Article							CYSTIC FIBROSIS BRONCHIECTASIS; CHRONIC MUCUS HYPERSECRETION; PLACEBO-CONTROLLED TRIAL; AIR-FLOW OBSTRUCTION; HUMAN DNASE I; CHRONIC-BRONCHITIS; HYPERTONIC SALINE; N-ACETYLCYSTEINE; LUNG-FUNCTION; INHALED MANNITOL	Objective Mucoactive drugs should increase the ability to expectorate sputum and, ideally, have antiinflammatory properties. The aim of the study was to evaluate the mucolytic activity of Tyloxapol compared to saline (0.9%) in COPD. Design A randomized, placebo-controlled, double-blinded crossover, clinical trial was carried out. Patients were randomly assigned to either inhale 5 ml Tyloxapol 1% or saline 0.9% solution three times daily for 3 weeks and vice versa for another 3 weeks. 28 patients (18 male, 10 female, 47 to 73 years old, median age 63.50) were screened, 21 were treated and 19 patients completed the study per protocol. Results A comparison of the two treatment phases showed that the primary endpoint sputum weight was statistically significant higher when patients inhaled Tyloxapol (mean 4.03 g, 95% CI: 2.34-5.73 g at week 3) compared to saline (mean 2.63 g, 95% CI: 1.73-3.53 g at week 3). The p-value at three weeks of treatment was 0.041 between treatment arms. Sputum cells decreased during the Tyloxapol treatment after 3 weeks, indicating that Tyloxapol might have some anti-neutrophilic properties. Lung function parameters (FVC, FEV1, RV, and RV/TLC) remained stable during the study, and no treatment effect was shown. Interestingly, there was a mean increase in all inflammatory cytokines (IL-1 beta, IL-6, and IL-8) during the saline treatment from day 1 to week 3, whereas during the Tyloxapol treatment, all cytokines decreased. Due to the small sample size and the large individual variation in sputum cytokines, these differences were not significant. However, analyses confirmed that Tyloxapol has significant anti-inflammatory properties in vitro. Despite the high number of inhalations (more than 1000), only 27 adverse events (20 during the Tyloxapol and seven during saline) were recorded. Eleven patients experienced AEs under Tyloxapol and six under saline treatment, which indicates that inhalation of saline or Tyloxapol is a very safe procedure. Conclusion Our study demonstrated that inhalation of Tyloxapol by patients with COPD is safe and superior to saline and has some anti-inflammatory effects.	[Koppitz, Martin; Eschenburg, Charlotte; Rosewich, Martin; Schubert, Ralf; Zielen, Stefan] Goethe Univ Frankfurt, Univ Hosp, Dept Children & Adolescents, Div Allergol Pneumol & Cyst Fibrosis, D-60054 Frankfurt, Germany; [Salzmann, Emilia] Goethe Univ Frankfurt, Univ Hosp, Dept Children & Adolescents, Div Stem Cell Transplantat & Immunol, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Zielen, S (corresponding author), Goethe Univ Frankfurt, Univ Hosp, Dept Children & Adolescents, Div Allergol Pneumol & Cyst Fibrosis, D-60054 Frankfurt, Germany.	Stefan.Zielen@kgu.de	Zielen, Stefan/AAD-7243-2020		bene-Arzneimittel GmbH, Munich, Germany	bene-Arzneimittel GmbH, Munich, Germany	This study was funded by bene-Arzneimittel GmbH, Munich, Germany, http://www.bene-arzneimittel.de. The authors declare that they have no other relevant conflicts of interest. The grant number was 100.000 (sic). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra L, 1996, RESPIRATION, V63, P174; Aytemur ZA, 2015, WIEN KLIN WOCHENSCHR, V127, P256, DOI 10.1007/s00508-014-0692-4; Balsamo R, 2010, EUR RESPIR REV, V19, P127, DOI 10.1183/09059180.00003510; Bilton D, 2013, CHEST, V144, P215, DOI 10.1378/chest.12-1763; BRUMFITT W, 1957, LANCET, V2, P1306; CEGLA U H, 1988, Praxis und Klinik der Pneumologie, V42, P715; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Cerveri I, 2010, EUR RESPIR REV, V19, P109, DOI 10.1183/09059180.00002710; CONLEY JJ, 1954, JAMA-J AM MED ASSOC, V154, P829, DOI 10.1001/jama.1954.02940440027008; Criee CP, 2011, RESP MED, V105, P959, DOI 10.1016/j.rmed.2011.02.006; Daviskas E, 2005, RESPIROLOGY, V10, P46, DOI 10.1111/j.1440-1843.2005.00659.x; de Marco R, 2007, AM J RESP CRIT CARE, V175, P32, DOI 10.1164/rccm.200603-381OC; Decramer M, 2005, LANCET, V365, P1552, DOI 10.1016/S0140-6736(05)66456-2; Decramer M, 2010, EUR RESPIR REV, V19, P134, DOI 10.1183/09059180.00003610; Decramer M, GLOBAL STRATEGY DIAG; Dijkstra AE, 2014, OCCUP ENVIRON MED, V71, P346, DOI 10.1136/oemed-2013-101654; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; DUEHOLM M, 1992, RESP MED, V86, P89, DOI 10.1016/S0954-6111(06)80220-9; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; Faner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097491; FARBER S M, 1955, Calif Med, V82, P102; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gallon AM, 1996, THORAX, V51, P429, DOI 10.1136/thx.51.4.429; Ghio AJ, 1996, AM J RESP CRIT CARE, V154, P783, DOI 10.1164/ajrccm.154.3.8810619; GUYATT GH, 1987, CHEST, V92, P618, DOI 10.1378/chest.92.4.618; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Tse HN, 2013, CHEST, V144, P106, DOI 10.1378/chest.12-2357; HUTSCHENREUTER K, 1958, Z GEBIETE OPERATIVEN, V29, P252; Kellett F, 2005, RESP MED, V99, P27, DOI 10.1016/j.rmed.2004.05.006; Kellett F, 2011, RESP MED, V105, P1831, DOI 10.1016/j.rmed.2011.07.019; Khan Shahina Y, 2004, BMC Pulm Med, V4, P9, DOI 10.1186/1471-2466-4-9; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; McCoy K, 1996, CHEST, V110, P889, DOI 10.1378/chest.110.4.889; Nicolson CHH, 2012, RESP MED, V106, P661, DOI 10.1016/j.rmed.2011.12.021; O'Donnell AE, 1998, CHEST, V113, P1329, DOI 10.1378/chest.113.5.1329; OLIVIERI D, 1987, RESPIRATION, V51, P42, DOI 10.1159/000195274; PAEZ PN, 1971, CHEST, V60, P312, DOI 10.1378/chest.60.4.312; PALMER KN, 1961, LANCET, V2, P802; PETTY TL, 1990, CHEST, V97, P75, DOI 10.1378/chest.97.1.75; Poole P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001287.pub5; Poole PJ, 2001, BMJ-BRIT MED J, V322, P1271, DOI 10.1136/bmj.322.7297.1271; Poole PJ, 1998, AUST NZ J MED, V28, P322, DOI 10.1111/j.1445-5994.1998.tb01956.x; RAVENEL SF, 1953, JAMA-J AM MED ASSOC, V151, P707; Robinson M, 1999, EUR RESPIR J, V14, P678, DOI 10.1034/j.1399-3003.1999.14c30.x; Robinson M, 1997, THORAX, V52, P900, DOI 10.1136/thx.52.10.900; Rosewich M, 2015, CYTOKINE, V73, P156, DOI 10.1016/j.cyto.2014.10.026; Sathe NA, 2015, RESP CARE, V60, P1061, DOI 10.4187/respcare.04086; Schmitt-Grohe S, 2005, PEDIATR RES, V58, P903, DOI 10.1203/01.PDR.0000182598.98167.24; Schulze J, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-78; Shah PL, 1996, THORAX, V51, P119, DOI 10.1136/thx.51.2.119; SUTTON PP, 1988, THORAX, V43, P57, DOI 10.1136/thx.43.1.57; TAINTER ML, 1955, NEW ENGL J MED, V253, P764, DOI 10.1056/NEJM195511032531804; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530, DOI 10.1164/ajrccm.153.5.8630597; Vestbo J, 2006, THORAX, V61, P86, DOI 10.1136/thx.2005.046227; WAGENEDER F M, 1962, Munch Med Wochenschr, V104, P2296; Wilde A., 1978, NOTABENE MED; Woolhouse IS, 2002, THORAX, V57, P667, DOI 10.1136/thorax.57.8.667	57	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156999	10.1371/journal.pone.0156999	http://dx.doi.org/10.1371/journal.pone.0156999			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308826	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800026
J	Rosenberg, AZ; Palmer, M; Merlino, L; Troost, JP; Gasim, A; Bagnasco, S; Avila-Casado, C; Johnstone, D; Hodgin, JB; Conway, C; Gillespie, BW; Nast, CC; Barisoni, L; Hewitt, SM				Rosenberg, Avi Z.; Palmer, Matthew; Merlino, Lino; Troost, Jonathan P.; Gasim, Adil; Bagnasco, Serena; Avila-Casado, Carmen; Johnstone, Duncan; Hodgin, Jeffrey B.; Conway, Catherine; Gillespie, Brenda W.; Nast, Cynthia C.; Barisoni, Laura; Hewitt, Stephen M.			The Application of Digital Pathology to Improve Accuracy in Glomerular Enumeration in Renal Biopsies	PLOS ONE			English	Article							VIRTUAL MICROSCOPY; NEPHROTIC SYNDROME; NETWORK NEPTUNE; IGA NEPHROPATHY; CLASSIFICATION; DENSITY; REPRODUCIBILITY; MULTICENTER; NEPHRITIS; DISEASE	Background In renal biopsy reporting, quantitative measurements, such as glomerular number and percentage of globally sclerotic glomeruli, is central to diagnostic accuracy and prognosis. The aim of this study is to determine the number of glomeruli and percent globally sclerotic in renal biopsies by means of registration of serial tissue sections and manual enumeration, compared to the numbers in pathology reports from routine light microscopic assessment. Design We reviewed 277 biopsies from the Nephrotic Syndrome Study Network (NEPTUNE) digital pathology repository, enumerating 9,379 glomeruli by means of whole slide imaging. Glomerular number and the percentage of globally sclerotic glomeruli are values routinely recorded in the official renal biopsy pathology report from the 25 participating centers. Two general trends in reporting were noted: total number per biopsy or average number per level/section. Both of these approaches were assessed for their accuracy in comparison to the analogous numbers of annotated glomeruli on WSI. Results The number of glomeruli annotated was consistently higher than those reported (p<0.001); this difference was proportional to the number of glomeruli. In contrast, percent globally sclerotic were similar when calculated on total glomeruli, but greater in FSGS when calculated on average number of glomeruli (p<0.01). The difference in percent globally sclerotic between annotated and those recorded in pathology reports was significant when global sclerosis is greater than 40%. Conclusions Although glass slides were not available for direct comparison to whole slide image annotation, this study indicates that routine manual light microscopy assessment of number of glomeruli is inaccurate, and the magnitude of this error is proportional to the total number of glomeruli.	[Rosenberg, Avi Z.] Childrens Natl Med Ctr, Dept Pathol, Washington, DC 20010 USA; [Rosenberg, Avi Z.] NIDDK, NIH, Bethesda, MD 20892 USA; [Palmer, Matthew] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Merlino, Lino; Barisoni, Laura] Univ Miami, Dept Pathol, Miami, FL USA; [Troost, Jonathan P.] Univ Michigan, Dept Pediat, Div Pediat Nephrol, Ann Arbor, MI 48109 USA; [Gasim, Adil] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA; [Bagnasco, Serena] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Avila-Casado, Carmen] Toronto Gen Hosp, Dept Pathol, Toronto, ON, Canada; [Johnstone, Duncan] Temple Univ, Dept Med, Sect Nephrol Hypertens & Kidney Transplantat, Philadelphia, PA 19122 USA; [Hodgin, Jeffrey B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Conway, Catherine; Hewitt, Stephen M.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Gillespie, Brenda W.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Nast, Cynthia C.] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA	Children's National Health System; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Pennsylvania; University of Miami; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Michigan System; University of Michigan; Cedars Sinai Medical Center	Hewitt, SM (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	genejock@helix.nih.gov		Hewitt, Stephen/0000-0001-8283-1788; Troost, Jonathan/0000-0002-1183-8330; Rosenberg, Avi/0000-0003-2356-950X	Office of Rare Diseases Research, NCATS [U54-DK-083912]; National Institute of Diabetes, Digestive, and Kidney Diseases [U54-DK-083912]; University of Michigan; NephCure Kidney International; Halpin Foundation; NephCure-ASN Foundation; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research;  [K08-DK088944]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK083912] Funding Source: NIH RePORTER	Office of Rare Diseases Research, NCATS; National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Michigan(University of Michigan System); NephCure Kidney International; Halpin Foundation; NephCure-ASN Foundation; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Nephrotic Syndrome Study Network Consortium (U54-DK-083912) is a part of the National Center for Advancing Translational Sciences, Rare Disease Clinical Research Network, supported through a collaboration between the Office of Rare Diseases Research, NCATS, and the National Institute of Diabetes, Digestive, and Kidney Diseases. Additional funding and/or programmatic support for this project has also been provided by the University of Michigan, NephCure Kidney International, and the Halpin Foundation. Dr. Jeffrey Hodgin is supported by K08-DK088944 and the NephCure-ASN Foundation. Additional support in part was provided by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	AUSTIN HA, 1983, AM J KIDNEY DIS, V2, P512, DOI 10.1016/S0272-6386(83)80092-4; Barisoni L, 2013, CLIN J AM SOC NEPHRO, V8, P1449, DOI 10.2215/CJN.08370812; Barisoni L, 2012, ARCH PATHOL LAB MED, V136, P816, DOI 10.5858/arpa.2011-0350-OA; CORWIN HL, 1988, AM J NEPHROL, V8, P85, DOI 10.1159/000167563; Fine Jeffrey L, 2014, J Pathol Inform, V5, P44, DOI 10.4103/2153-3539.145733; Gadegbeku CA, 2013, KIDNEY INT, V83, P749, DOI 10.1038/ki.2012.428; GAMBARA V, 1993, J AM SOC NEPHROL, V3, P1458; Imasawa T, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-11; Jen KY, 2013, HUM PATHOL, V44, P888, DOI 10.1016/j.humpath.2012.08.015; MUEHRCKE RC, 1957, MEDICINE, V36, P1; Nast CC, 2015, SEMIN NEPHROL, V35, P266, DOI 10.1016/j.semnephrol.2015.04.006; Ozluk Y, 2012, CLIN TRANSPLANT, V26, P336, DOI 10.1111/j.1399-0012.2011.01506.x; PIRANI CL, 1964, NEPHRON, V1, P230, DOI 10.1159/000179336; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Sethi S, 2016, J AM SOC NEPHROL, V27, P1278, DOI 10.1681/ASN.2015060612; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Tsuboi N, 2012, CLIN J AM SOC NEPHRO, V7, P735, DOI 10.2215/CJN.07270711; Tsuboi N, 2011, NEPHROL DIAL TRANSPL, V26, P3555, DOI 10.1093/ndt/gfr399; Tsuboi N, 2010, CLIN J AM SOC NEPHRO, V5, P39, DOI 10.2215/CJN.04680709; Walker PD, 2004, MODERN PATHOL, V17, P1555, DOI 10.1038/modpathol.3800239; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D	22	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156441	10.1371/journal.pone.0156441	http://dx.doi.org/10.1371/journal.pone.0156441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310011	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800005
J	Thorburn, AN; Tseng, HY; Donovan, C; Hansbro, NG; Jarnicki, AG; Foster, PS; Gibson, PG; Hansbro, PM				Thorburn, Alison N.; Tseng, Hsin-Yi; Donovan, Chantal; Hansbro, Nicole G.; Jarnicki, Andrew G.; Foster, Paul S.; Gibson, Peter G.; Hansbro, Philip M.			TLR2, TLR4 AND MyD88 Mediate Allergic Airway Disease (AAD) and Streptococcus pneumoniae-Induced Suppression of AAD	PLOS ONE			English	Article							REGULATORY T-CELLS; OBSTRUCTIVE PULMONARY-DISEASE; TOLL-LIKE RECEPTOR-4; RESPIRATORY-INFECTION; IMMUNE-RESPONSE; COMPONENTS; LIPOPOLYSACCHARIDE; EXPRESSION; AGONISTS; RECOGNITION	Background Exposure to non-pathogenic Streptococcus pneumoniae and vaccination are inversely associated with asthma. Studies in animal models demonstrate that airway administration of S. pneumoniae (live or killed), or its vaccines or components, suppresses the characteristic features of asthma in mouse models of allergic airway disease (AAD). These components could be developed into immunoregulatory therapies. S. pneumoniae components are recognized by Toll-like receptors (TLR) 2 and TLR4, and both induce inflammatory cell responses through the adaptor protein myeloid differentiation primary response gene 88 (MyD88). The involvement of TLR2, TLR4 and MyD88 in the pathogenesis of AAD and asthma is incompletely understood, and has not been studied in S. pneumoniae-mediated suppression of AAD. We investigated the role of TLR2, TLR4 and MyD88 in the development of AAD and S. pneumoniae-mediated suppression of AAD. Methods and Findings OVA-induced AAD and killed S. pneumoniae-mediated suppression of AAD were assessed in wild-type, TLR2(-/-), TLR4(-/-), TLR2/4(-/-) and MyD88(-/-) BALB/c mice. During OVA-induced AAD, TLR2, TLR4 and MyD88 were variously involved in promoting eosinophil accumulation in bronchoalveolar lavage fluid and blood, and T-helper type (Th) 2 cytokine release from mediastinal lymph node T cells and splenocytes. However, all were required for the induction of airways hyperresponsiveness (AHR). In S. pneumoniae-mediated suppression of AAD, TLR2, TLR4 and MyD88 were variously involved in the suppression of eosinophilic and splenocyte Th2 responses but all were required for the reduction in AHR. Conclusions These results highlight important but complex roles for TLR2, TLR4 and MyD88 in promoting the development of OVA-induced AAD, but conversely in the S. pneumoniae-mediated suppression of AAD, with consistent and major contributions in both the induction and suppression of AHR. Thus, TLR signaling is likely required for both the development of asthma and the suppression of asthma by S. pneumoniae, and potentially other immunoregulatory therapies.	[Hansbro, Philip M.] Hunter Med Res Inst, Prior Res Ctr Hlth Lungs, Newcastle, NSW, Australia; Univ Newcastle, Newcastle, NSW 2300, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Hansbro, PM (corresponding author), Hunter Med Res Inst, Prior Res Ctr Hlth Lungs, Newcastle, NSW, Australia.	Philip.Hansbro@newcastle.edu.au	Hansbro, Phil/G-7486-2013; Foster, Paul/G-5057-2013; Tseng, Cindy Hsin-Yi/AAB-8958-2022; gibson, peter/G-6194-2014	Hansbro, Phil/0000-0002-4741-3035; Tseng, Cindy Hsin-Yi/0000-0002-7499-7515; , Paul/0000-0002-0827-8299; gibson, peter/0000-0001-5865-489X	Hill family; Asthma Foundation of NSW; Australian Research Council of Australia [DP110101107]; NHMRC [1079187]; Gladys Brawn Memorial Trust; Medical Research Council [MR/K006584/1] Funding Source: researchfish	Hill family; Asthma Foundation of NSW; Australian Research Council of Australia(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Gladys Brawn Memorial Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PMH was funded to perform these studies by The Hill family and the Asthma Foundation of NSW, and Australian Research Council (DP110101107) of Australia. PMH is supported by Research Fellowships from the NHMRC (1079187) and the Gladys Brawn Memorial Trust.	Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Aryan Z, 2014, INT ARCH ALLERGY IMM, V164, P46, DOI 10.1159/000362553; Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Beckett EL, 2013, J ALLERGY CLIN IMMUN, V131, P752, DOI 10.1016/j.jaci.2012.11.053; Beckett EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039460; Beigelman A, 2014, CURR OPIN ALLERGY CL, V14, P137, DOI 10.1097/ACI.0000000000000036; Bjornvold M, 2009, GENES IMMUN, V10, P181, DOI 10.1038/gene.2008.100; Bortolatto J, 2008, CLIN EXP ALLERGY, V38, P1668, DOI 10.1111/j.1365-2222.2008.03036.x; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Conroy H, 2008, ONCOGENE, V27, P168, DOI 10.1038/sj.onc.1210910; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Essilfie AT, 2015, THORAX, V70, P458, DOI 10.1136/thoraxjnl-2014-206067; Essilfie AT, 2012, THORAX, V67, P588, DOI 10.1136/thoraxjnl-2011-200160; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Goodridge HS, 2007, PARASITE IMMUNOL, V29, P127, DOI 10.1111/j.1365-3024.2006.00926.x; Hallstrand TS, 2014, CLIN IMMUNOL, V151, P1, DOI 10.1016/j.clim.2013.12.003; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hansbro PM, 2014, J BIOL CHEM, V289, P18214, DOI 10.1074/jbc.M114.548594; Hansbro PM, 2013, EXPERT OPIN INV DRUG, V22, P49, DOI 10.1517/13543784.2013.732997; Hardy MP, 2004, BIOCHEM J, V380, P83, DOI 10.1042/BJ20040030; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hollingsworth JW, 2006, J IMMUNOL, V176, P5856, DOI 10.4049/jimmunol.176.10.5856; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Horvat JC, 2010, J IMMUNOL, V184, P4159, DOI 10.4049/jimmunol.0902287; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; Hsu ACY, 2015, AM J RESP CRIT CARE, V191, P1012, DOI 10.1164/rccm.201501-0188OC; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Kaiko GE, 2008, J IMMUNOL, V180, P2225, DOI 10.4049/jimmunol.180.4.2225; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Koedel U, 2004, BRAIN, V127, P1437, DOI 10.1093/brain/awh171; Krishnaswamy JK, 2012, AM J RESP CELL MOL, V47, P852, DOI 10.1165/rcmb.2011-0414OC; Letiembre M, 2005, INFECT IMMUN, V73, P8397, DOI 10.1128/IAI.73.12.8397-8401.2005; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Patel PS, 2015, J IMMUNOL, V194, P5838, DOI 10.4049/jimmunol.1500251; Preston JA, 2011, EUR RESPIR J, V37, P53, DOI 10.1183/09031936.00049510; Preston JA, 2007, VACCINE, V25, P8154, DOI 10.1016/j.vaccine.2007.09.034; Puggioni F, 2005, ALLERGY, V60, P678, DOI 10.1111/j.1398-9995.2005.00762.x; Regueiro V, 2009, INFECT IMMUN, V77, P714, DOI 10.1128/IAI.00852-08; Schmeck B, 2006, RESP RES, V7, P7149; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Shalaby KH, 2012, J IMMUNOL, V189, P2793, DOI 10.4049/jimmunol.1201194; Starkey MR, 2013, MUCOSAL IMMUNOL, V6, P569, DOI 10.1038/mi.2012.99; Starkey MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042588; Starkey MR, 2013, CURR OPIN PHARMACOL, V13, P337, DOI 10.1016/j.coph.2013.03.005; Starkhammar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104114; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Tay HL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004549; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Thorburn AN, 2013, J IMMUNOL, V191, P4112, DOI 10.4049/jimmunol.1201232; Thorburn AN, 2012, J IMMUNOL, V188, P4611, DOI 10.4049/jimmunol.1101299; Thorburn AN, 2010, THORAX, V65, P1053, DOI 10.1136/thx.2009.131508; Thorburn AN, 2010, AM J RESP CELL MOL, V43, P511, DOI 10.1165/rcmb.2009-0342TR; Tomlinson G, 2014, J IMMUNOL, V193, P3736, DOI 10.4049/jimmunol.1401413; Velasco G, 2005, AM J RESP CELL MOL, V32, P218, DOI 10.1165/rcmb.2003-0435OC; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235	61	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156402	10.1371/journal.pone.0156402	http://dx.doi.org/10.1371/journal.pone.0156402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309732	gold, Green Published			2022-12-27	WOS:000378029800003
J	Boeselt, T; Spielmanns, M; Nell, C; Storre, JH; Windisch, W; Magerhans, L; Beutel, B; Kenn, K; Greulich, T; Alter, P; Vogelmeier, C; Koczulla, AR				Boeselt, Tobias; Spielmanns, Marc; Nell, Christoph; Storre, Jan Hendrik; Windisch, Wolfram; Magerhans, Lena; Beutel, Bjoern; Kenn, Klaus; Greulich, Timm; Alter, Peter; Vogelmeier, Claus; Koczulla, Andreas Rembert			Validity and Usability of Physical Activity Monitoring in Patients with Chronic Obstructive Pulmonary Disease (COPD)	PLOS ONE			English	Article								Background A large proportion of COPD patients do not achieve the recommended level of physical activity. It is suggested that feedback on the level of activity by using an activity monitoring device (PAM) increases awareness and may stimulate patients to increase their physical activity in daily life. Our objective was to assess the validity and usability of a simple and low-cost physical activity monitor (Polar A300 (TM)) when compared with the validated and established Bodymedia-SenseWear (TM) (SWA) device. Methods To assess the diagnostic equivalent, two different PAM devices were used in parallel in 20 COPD patients GOLD I to IV during 3 consecutive days of daily life. Both systems were compared in terms of steps, calories burned, daily activity time and metabolic equivalents using linear regression analysis and Bland-Altman plots. Practical usability was examined by a 16-item-questionnaire. Results High correlations of both devices were observed with regard to the sensed step count (r = 0.96; p <0.01) and calories burned (r = 0.74; p <0.01), and a lower correlation of daily activity (r = 0.25; p <0.01) was found. Data analysis over 3 days showed that 90% of the steps (95% CI -4223 to 1887), 100% of the calories (95% CI -2798 to 1887), 90% of the daily activity data (95% CI -12.32, 4065) and 95% of the MET (95% CI -3.11 to 2.75) were within the limits of agreement. A favorable usability (system-, information- and interface quality) of the A300 (TM) device was shown (p < 0.01). Conclusion The A300 (TM) device with easy practical usability was shown not to be inferior for assessment of physical activity time, step count and calorie consumption in COPD patients when compared with the SWA. It is suggested to consider widespread available devices as commonly used for monitoring recreational sporting activities also in patients for assessment of physical activity in daily life.	[Boeselt, Tobias; Nell, Christoph; Magerhans, Lena; Beutel, Bjoern; Kenn, Klaus; Greulich, Timm; Alter, Peter; Vogelmeier, Claus; Koczulla, Andreas Rembert] Univ Marburg, Dept Med Pulm & Crit Care Med, Marburg, Germany; [Storre, Jan Hendrik] Univ Hosp, Dept Pneumol, Freiburg, Germany; [Storre, Jan Hendrik; Windisch, Wolfram] Cologne Merheim Hosp, Dept Pneumol, Cologne, Germany; [Windisch, Wolfram] Univ Witten Herdecke, Fac Hlth, Dept Pneumol, Halle, Germany; [Spielmanns, Marc] Remigius Hosp, Med Clin, Leverkusen Opladen, Germany; [Spielmanns, Marc] Remigius Hosp, Pulm Rehabil Leverkusen April, Leverkusen Opladen, Germany; [Kenn, Klaus] Schoen Klin Berchtesgadener Land, Schonau, Germany	Philipps University Marburg; University of Freiburg; Witten Herdecke University	Boeselt, T (corresponding author), Univ Marburg, Dept Med Pulm & Crit Care Med, Marburg, Germany.	tobias.boeselt@uni-marburg.de	Boeselt, Tobias/HHM-5170-2022; Windisch, Wolfram/AFV-2171-2022; Windisch, Wolfram/ABI-7381-2020; Spielmanns, Marc/AAH-7894-2021; Alter, Peter/G-2673-2015; Boeselt, Tobias/AAE-8908-2021	Alter, Peter/0000-0002-2115-1743; 				Carkeet A, 2015, OPTOMETRY VISION SCI, V92, pE71, DOI 10.1097/OPX.0000000000000513; Danilack VA, 2015, J REHABIL RES DEV, V52, P333, DOI 10.1682/JRRD.2014.11.0282; Demeyer H, 2014, CHEST, V146, P318, DOI 10.1378/chest.13-1968; Donaire-Gonzalez D, 2013, EUR RESPIR J, V42, P993, DOI 10.1183/09031936.00101512; Emtner E., 2010, CHRONIC OBSTRUCTIVE, P271; Farooqi N, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.150; Fruhling A, 2005, AMCIS 2005 P; Garcia-Aymerich J, 2007, AM J RESP CRIT CARE, V175, P458, DOI 10.1164/rccm.200607-896OC; Glaab T, 2012, INT J CHRONIC OBSTR, V7, P101, DOI 10.2147/COPD.S27887; Haughney J, 2005, EUR RESPIR J, V26, P623, DOI 10.1183/09031936.05.00142704; Hill K, 2010, THORAX, V65, P486, DOI 10.1136/thx.2009.128702; Lollgen H, 2013, DEUT MED WOCHENSCHR, V138, P2253, DOI 10.1055/s-0033-1349606; O'Brien T, 2015, GERIATR NURS, V36, pS21, DOI 10.1016/j.gerinurse.2015.02.019; Puhan MA, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005305.pub4, 10.1002/14651858.CD005305.pub3]; Rabinovich RA, 2013, EUR RESPIR J, V42, P1205, DOI 10.1183/09031936.00134312; ROGERS JL, 1993, PSYCHOL BULL, V113, P553, DOI 10.1037/0033-2909.113.3.553; Sievi NA, 2015, INT J CHRONIC OBSTR, V10, P1891, DOI 10.2147/COPD.S90943; Thompson PD, 2013, CURR SPORT MED REP, V12, P215, DOI 10.1249/JSR.0b013e31829a68cf; Troosters T, 2010, RESP MED, V104, P1005, DOI 10.1016/j.rmed.2010.01.012; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; Vooijs M, 2014, INTERACT J MED RES, V3, P12, DOI 10.2196/ijmr.3056; Vorrink SNW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-33; Waschki B, 2015, AM J RESP CRIT CARE, V192, P295, DOI 10.1164/rccm.201501-0081OC; Waschki B, 2011, CHEST, V140, P331, DOI 10.1378/chest.10-2521; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608; Watz H, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-158; Welk GJ, 2005, MED SCI SPORT EXER, V37, pS501, DOI 10.1249/01.mss.0000185660.38335.de	27	23	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157229	10.1371/journal.pone.0157229	http://dx.doi.org/10.1371/journal.pone.0157229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305105	gold, Green Submitted, Green Published			2022-12-27	WOS:000377824800039
J	Cui, K; Wang, HY; Liao, SX; Tang, Q; Li, L; Cui, YZ; He, Y				Cui, Kai; Wang, Haiying; Liao, Shengxi; Tang, Qi; Li, Li; Cui, Yongzhong; He, Yuan			Transcriptome Sequencing and Analysis for Culm Elongation of the World's Largest Bamboo (Dendrocalamus sinicus)	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; RNA-SEQ; GENE-EXPRESSION; ARABIDOPSIS; PLANT; CO2; MARKERS; TOOL; IDENTIFICATION; ASSIMILATION	Dendrocalamus sinicus is the world's largest bamboo species with strong woody culms, and known for its fast-growing culms. As an economic bamboo species, it was popularized for multi-functional applications including furniture, construction, and industrial paper pulp. To comprehensively elucidate the molecular processes involved in its culm elongation, Illumina paired-end sequencing was conducted. About 65.08 million high-quality reads were produced, and assembled into 81,744 unigenes with an average length of 723 bp. A total of 64,338 (79%) unigenes were annotated for their functions, of which, 56,587 were annotated in the NCBI non-redundant protein database and 35,262 were annotated in the Swiss-Prot database. Also, 42,508 and 21,009 annotated unigenes were allocated to gene ontology (GO) categories and clusters of orthologous groups (COG), respectively. By searching against the Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG), 33,920 unigenes were assigned to 128 KEGG pathways. Meanwhile, 8,553 simple sequence repeats (SSRs) and 81,534 single-nucleotide polymorphism (SNPs) were identified, respectively. Additionally, 388 transcripts encoding lignin biosynthesis were detected, among which, 27 transcripts encoding Shikimate O-hydroxycinnamoyltransferase (HCT) specifically expressed in D. sinicus when compared to other bamboo species and rice. The phylogenetic relationship between D. sinicus and other plants was analyzed, suggesting functional diversity of HCT unigenes in D. sinicus. We conjectured that HCT might lead to the high lignin content and giant culm. Given that the leaves are not yet formed and culm is covered with sheaths during culm elongation, the existence of photosynthesis of bamboo culm is usually neglected. Surprisedly, 109 transcripts encoding photosynthesis were identified, including photosystem I and II, cytochrome b6/f complex, photosynthetic electron transport and F-type ATPase, and 24 transcripts were characterized as antenna proteins that regarded as the main tool for capturing light of plants, implying stem photosynthesis plays a key role during culm elongation due to the unavailability of its leaf. By real-time quantitative PCR, the expression level of 6 unigenes was detected. The results showed the expression level of all genes accorded with the transcriptome data, which confirm the reliability of the transcriptome data. As we know, this is the first study underline the D. sinicus transcriptome, which will deepen the understanding of the molecular mechanisms of culm development. The results may help variety improvement and resource utilization of bamboos.	[Cui, Kai; Wang, Haiying; Liao, Shengxi; Li, Li; Cui, Yongzhong; He, Yuan] Chinese Acad Forestry, Res Inst Resources Insects, Kunming 650224, Peoples R China; [Tang, Qi] Hunan Agr Univ, Hunan Coinnovat Ctr Utilizat Bot Funct Ingredient, Changsha 410128, Hunan, Peoples R China	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF; Hunan Agricultural University	Liao, SX (corresponding author), Chinese Acad Forestry, Res Inst Resources Insects, Kunming 650224, Peoples R China.	cafjone@126.com		Tang, Qi/0000-0003-2385-4263	National Natural Science Foundation of China [31300501]; Fundamental Research Funds for the Central Non-profit Research Institution of CAF [CAFYBB2014QB020, riricaf2013002M]; China Scholarship Council [201503270020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Non-profit Research Institution of CAF; China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (Grant No. 31300501), the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (Grant No. CAFYBB2014QB020 and Grant No. riricaf2013002M), and the China Scholarship Council (Grant No. 201503270020).; This work was supported by the National Natural Science Foundation of China (Grant No. 31300501), the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (Grant No. CAFYBB2014QB020 and Grant No. riricaf2013002M), and the China Scholarship Council (Grant No. 201503270020).	[Anonymous], 2011, MACROMOL RAPID COMM, V32, P1297, DOI 10.1002/marc.201100488; Ariizumi T, 2011, PLANT PHYSIOL, V155, P765, DOI 10.1104/pp.110.166272; Avila E, 2014, PHOTOSYNTHETICA, V52, P3, DOI 10.1007/s11099-014-0004-2; Banik RL, 2015, TROP FOREST, P43, DOI 10.1007/978-3-319-14133-6_3; Banik RL, 2000, SILVICULTURE FIELD G, P1; Bloemen J, 2013, J EXP BOT, V64, P2129, DOI 10.1093/jxb/ert071; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Busch FA, 2013, PLANT CELL ENVIRON, V36, P200, DOI 10.1111/j.1365-3040.2012.02567.x; Cardoso DC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-66; Carocha V, 2015, NEW PHYTOL, V206, P1297, DOI 10.1111/nph.13313; Chen CY, 2010, PHYTOCHEMISTRY, V71, P1270, DOI 10.1016/j.phytochem.2010.05.011; Chen SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089495; Chen TH, 2009, PHYTOCHEMISTRY, V70, P25, DOI 10.1016/j.phytochem.2008.10.004; Chiu WB, 2006, NEW PHYTOL, V170, P53, DOI 10.1111/j.1469-8137.2005.01638.x; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui K, 2012, J PROTEOME RES, V11, P2492, DOI 10.1021/pr2011878; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Dong YR, 2012, AM J BOT, V99, pE347, DOI 10.3732/ajb.1200029; FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gui YJ, 2010, J INTEGR PLANT BIOL, V52, P1008, DOI 10.1111/j.1744-7909.2010.00965.x; Han XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076890; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Hansen NML, 2008, BIOMACROMOLECULES, V9, P1493, DOI 10.1021/bm800053Z; He CY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-119; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hsieh CW, 2006, J AGR FOOD CHEM, V54, P3101, DOI 10.1021/jf052711s; Hui C.M., 2014, APPL MECH MAT, V522, P1084, DOI [10.4028/www.scientific.net/AMM.522-524.1084, DOI 10.4028/WWW.SCIENTIFIC.NET/AMM.522-524.1084]; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang ZH, 2012, PHOTOSYNTHETICA, V50, P129, DOI 10.1007/s11099-012-0009-7; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Lockton S, 2005, TRENDS GENET, V21, P60, DOI 10.1016/j.tig.2004.11.013; McGuire MA, 2009, J EXP BOT, V60, P3809, DOI 10.1093/jxb/erp222; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ohrnberger D, 1999, BAMBOOS WORLD ANNOTA, P12; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; Scurlock JMO, 2000, BIOMASS BIOENERG, V19, P229, DOI 10.1016/S0961-9534(00)00038-6; Shi ZJ, 2013, BIOENERG RES, V6, P1212, DOI 10.1007/s12155-013-9321-8; Sun Q, 2003, J EXP BOT, V54, P1627, DOI 10.1093/jxb/erg167; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Teskey RO, 2008, NEW PHYTOL, V177, P17, DOI 10.1111/j.1469-8137.2007.02286.x; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Ueda K., 1960, B KYOTO U FORESTRY, V30, P1; Vandegehuchte MW, 2015, NEPHROL DIAL TRANSPL, P1; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wu YJ, 2006, PROTEOMICS, V6, P5898, DOI 10.1002/pmic.200600278; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Yang L, 2015, PLANT CELL REP, V34, P2001, DOI 10.1007/s00299-015-1846-1; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yi TP., 2008, ICONOGRAPHIA BAMBUSO; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang LQ, 2003, GENOME RES, V13, P2533, DOI 10.1101/gr.1318503; Zhang X, 2011, BIOENERG RES, V4, P246, DOI 10.1007/s12155-011-9147-1; Zhou MB, 2011, PLANT MOL BIOL REP, V29, P224, DOI 10.1007/s11105-010-0222-0	70	15	22	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157362	10.1371/journal.pone.0157362	http://dx.doi.org/10.1371/journal.pone.0157362			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304219	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800054
J	Li, BM; Tang, HW; Zhang, AQ; Dong, JH				Li, Bingmin; Tang, Haowen; Zhang, Aiqun; Dong, Jiahong			Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis	PLOS ONE			English	Article							FORMING INTRAHEPATIC CHOLANGIOCARCINOMA; GENE-EXPRESSION; SURGICAL-TREATMENT; HUMAN ENDOCERVIX; CARCINOMA; TRACT; ADENOCARCINOMA; EPIDEMIOLOGY; SURVIVAL; FAMILY	Background and Objective Surgery carries the best hope for cure in the treatment of cholangiocarcinoma (CC), whereas surgical outcome is not fully satisfactory. Bio-molecularmarkers have been used to improve tumor staging and prognosis prediction. Mucin antigenMUC4 (MUC4) has been implicated as a marker for poor survival in various tumors. However, prognostic significance ofMUC4 for patients with CC remains undefined. The aim of the present meta-analysis was to investigate the association between MUC4 expression and overall survival (OS) of patients with resected CC. Methods The meta-analysis was conducted in adherence to the MOOSE guidelines. PubMed, Embase databases, Cochrane Library and the Chinese SinoMed were systematically searched to identify eligible studies from the initiation of the databases to April, 2016. OSs were pooled by using hazard ratio (HR) with corresponding 95% confidence interval (CI). Random effect models were utilized because of the between-study heterogeneities. Results Five studies reporting on 249 patients were analyzed: 94 (37.75%) were in positive or high expression group and 155 (62.25%) in negative or low expression group. The pooled HR for positive or high expression group was found to be 3.04 (95% CI 2.25-4.12) when compared with negative or low expression group with slight between-study heterogeneities (I-2 3.10%, P = 0.39). The result indicated that a positive or high expression level of MUC4 was significantly related to poor survival in patients with resected CC. A commensurate result was identified by sensitivity analysis. The main limitations of the present meta-analysis were the rather small size of the studies included and relatively narrow geographical distribution of population. Conclusion The result of this meta-analysis indicated that a positive or high expression level of MUC4 was significantly related to poor survival in patients with resected CC.	[Li, Bingmin; Tang, Haowen; Dong, Jiahong] Chinese PLA Med Sch, 28 Fuxing Rd, Beijing 100853, Peoples R China; [Tang, Haowen; Zhang, Aiqun; Dong, Jiahong] Chinese Peoples Liberat Army Gen Hosp, Chinese PLA Med Sch, Hosp & Inst Hepatobiliary Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital	Dong, JH (corresponding author), Chinese PLA Med Sch, 28 Fuxing Rd, Beijing 100853, Peoples R China.; Dong, JH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Chinese PLA Med Sch, Hosp & Inst Hepatobiliary Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China.	dongjh301@163.com			National Key Technology R&D Program of China [2012BAI06B01]; National S&T Major Project for Infectious Diseases of China [2012ZX10002-017]	National Key Technology R&D Program of China(National Key Technology R&D Program); National S&T Major Project for Infectious Diseases of China	The work is supported by the National Key Technology R&D Program of China (NO. 2012BAI06B01) and the National S&T Major Project for Infectious Diseases of China (NO. 2012ZX10002-017).; The work is supported by the National Key Technology R&D Program of China (NO. 2012BAI06B01) and the National S&T Major Project for Infectious Diseases of China (NO. 2012ZX10002-017). In addition, we gratefully acknowledge the statistical assistance of Professor Dan Feng from Department of Medical Statistics, Chinese PLA Medical School. We also thank Professor Xiansheng Lu from Department of Medical English, Academy of Military Medical Sciences for assistance in language editing.	Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; AUDIE JP, 1995, HUM REPROD, V10, P98, DOI 10.1093/humrep/10.1.98; AUDIE JP, 1993, J HISTOCHEM CYTOCHEM, V41, P1479, DOI 10.1177/41.10.8245407; Buisine MP, 1999, AM J RESP CELL MOL, V20, P209, DOI 10.1165/ajrcmb.20.2.3259; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; Carraway KL, 1999, J BIOL CHEM, V274, P5263, DOI 10.1074/jbc.274.9.5263; Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; Gipson IK, 1999, BIOL REPROD, V60, P58, DOI 10.1095/biolreprod60.1.58; Higashi M, 2012, PATHOBIOLOGY, V79, P101, DOI 10.1159/000335164; Khanh DT, 2013, CANCER SCI, V104, P958, DOI 10.1111/cas.12170; Komatsu M, 1999, CANCER RES, V59, P2229; Kwon HJ, 2014, WORLD J GASTROENTERO, V20, P6658, DOI 10.3748/wjg.v20.i21.6658; Longnecker R, 2000, ADV CANCER RES, V79, P175, DOI 10.1016/S0065-230X(00)79006-3; MARUYAMA T, 1991, DIABETES RES CLIN EX, V16, P171; Matull WR, 2008, BRIT J CANCER, V98, P1675, DOI 10.1038/sj.bjc.6604364; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; McLean L, 2006, LIVER INT, V26, P1047, DOI 10.1111/j.1478-3231.2006.01350.x; Moniaux N, 1999, BIOCHEM J, V338, P325, DOI 10.1042/0264-6021:3380325; Murakami Y, 2007, WORLD J SURG, V31, P337, DOI 10.1007/s00268-006-0224-0; Nakeeb A, 2002, SURGERY, V132, P555, DOI 10.1067/msy.2002.127555; Ohtsuka M, 2002, BRIT J SURG, V89, P1525, DOI 10.1046/j.1365-2168.2002.02268.x; Olnes MJ, 2004, ONCOLOGY-BASEL, V66, P167, DOI 10.1159/000077991; Pino V, 2006, J BIOL CHEM, V281, P29411, DOI 10.1074/jbc.M604858200; PORCHET N, 1991, BIOCHEM BIOPH RES CO, V175, P414, DOI 10.1016/0006-291X(91)91580-6; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Sasaki M, 2007, PROG HISTOCHEM CYTO, V42, P61, DOI 10.1016/j.proghi.2007.02.001; Shibahara H, 2004, HEPATOLOGY, V39, P220, DOI 10.1002/hep.20031; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suzuki S, 2002, WORLD J SURG, V26, P687, DOI 10.1007/s00268-001-0291-1; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Tamada S, 2006, CLIN CANCER RES, V12, P4257, DOI 10.1158/1078-0432.CCR-05-2814; Tsutsumida H, 2007, LUNG CANCER, V55, P195, DOI 10.1016/j.lungcan.2006.10.013; Weed DT, 2004, LARYNGOSCOPE, V114, P1, DOI 10.1097/00005537-200408001-00001; Yeh CN, 2009, ONCOL REP, V21, P49, DOI 10.3892/or_00000188; Yuyan H, 2012, THESIS	37	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157878	10.1371/journal.pone.0157878	http://dx.doi.org/10.1371/journal.pone.0157878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305093	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800084
J	Hudon, C; Sanche, S; Haggerty, JL				Hudon, Catherine; Sanche, Steven; Haggerty, Jeannie L.			Personal Characteristics and Experience of Primary Care Predicting Frequent Use of Emergency Department: A Prospective Cohort Study	PLOS ONE			English	Article							HEALTH-CARE; DISEASE; POPULATION; INSURANCE; SERVICES; INTERVENTIONS; METAANALYSIS; VALIDATION; COMMUNITY; OUTCOMES	Objective A small number of patients frequently using the emergency department (ED) account for a disproportionate amount of the total ED workload and are considered using this service inappropriately. The aim of this study was to identify prospectively personal characteristics and experience of organizational and relational dimensions of primary care that predict frequent use of ED. Methods This study was conducted among parallel cohorts of the general population and primary care patients (N = 1,769). The measures were at baseline (T-1), 12 (T-2) and 24 months (T-3): self-administered questionnaire on current health, health behaviours and primary care experience in the previous year. Use of medical services was confirmed using administrative databases. Mixed effect logistic regression modeling identified characteristics predicting frequent ED utilization. Results A higher likelihood of frequent ED utilization was predicted by lower socioeconomic status, higher disease burden, lower perceived organizational accessibility, higher number of reported healthcare coordination problems and not having a complete annual check-up, above and beyond adjustment for all independent variables. Conclusions Personal characteristics such as low socioeconomic status and high disease burden as well as experience of organizational dimensions of primary care such as low accessibility, high healthcare coordination problems and low comprehensiveness of care are prospectively associated with frequent ED utilization. Interventions developed to prevent inappropriate ED visits, such as case management for example, should tailor low socioeconomic status and patients with high disease burden and should aim to improve experience of primary care regarding accessibility, coordination and comprehensiveness.	[Hudon, Catherine] Univ Sherbrooke, Dept Family Med & Emergency Med, Sherbrooke, PQ J1K 2R1, Canada; [Sanche, Steven] St Marys Hosp, St Marys Res Ctr, Montreal, PQ, Canada; [Haggerty, Jeannie L.] McGill Univ, Dept Family Med, Montreal, PQ H3A 2T5, Canada	University of Sherbrooke; McGill University; McGill University	Hudon, C (corresponding author), Univ Sherbrooke, Dept Family Med & Emergency Med, Sherbrooke, PQ J1K 2R1, Canada.	catherine.hudon@usherbrooke.ca	Haggerty, Jeannie/GSD-7271-2022		Canadian Institutes of Health Research (CIHR); Canadian Foundation for Healthcare Improvement (CFHI); Canadian Institutes of Health Research [185860]; Canadian Foundation for Healthcare Improvement [RC2-1784-05]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Healthcare Improvement (CFHI); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Healthcare Improvement	This work was financed by grants from the Canadian Institutes of Health Research (CIHR) and the Canadian Foundation for Healthcare Improvement (CFHI). Funding institution: Canadian Institutes of Health Research, grant number: 185860, URL: http://www.cihr-irsc.gc.ca/f/193.html, authors who received the funding: JH and CH. Funding institution: Canadian Foundation for Healthcare Improvement, grant number: RC2-1784-05, URL: http://www.cfhi-fcass.ca/Home.aspx, authors who received the funding: JH and CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, MAIL TELEPHONE SURVE; Bayliss Elizabeth A, 2005, Health Qual Life Outcomes, V3, P51; Belzile E, 2011, MEASURE EMERGENCY DE; Bertakis KD, 2011, J AM BOARD FAM MED, V24, P229, DOI 10.3122/jabfm.2011.03.100170; Bieler G, 2012, ACAD EMERG MED, V19, P63, DOI 10.1111/j.1553-2712.2011.01246.x; Boulware LE, 2007, ANN INTERN MED, V146, P289, DOI 10.7326/0003-4819-146-4-200702200-00008; Brown, 2006, APPL MIXED MODELS ME; Brown AD, 2001, CAN J PUBLIC HEALTH, V92, P155, DOI 10.1007/BF03404951; Bryant Heather, 2006, Chronic Dis Can, V27, P51; Butt P., 2011, ALCOHOL HLTH CANADA; Carret ML, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-131; Centers for Disease Control and Prevention, 2007, BEH RISK FACT SURV S; Chan BT, 2002, CAN FAM PHYSICIAN, V48, P1654; Cherpitel CJ, 2008, DRUG ALCOHOL DEPEN, V97, P226, DOI 10.1016/j.drugalcdep.2008.03.033; Da Silva Roxane Borges, 2011, Healthc Policy, V6, pe106; Dillman D. A., 2000, MAIL INTERNET SURVEY, V2; Enard KR, 2013, J HEALTHC MANAG, V58, P412, DOI 10.1097/00115514-201311000-00007; Haggerty J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-258; Haggerty JL, 2012, ANN FAM MED, V10, P443, DOI 10.1370/afm.1378; Haggerty Jeannie L, 2007, Healthc Policy, V3, P72; Haggerty JL, NEW MEASURE AV UNPUB; Hansagi H, 2001, ANN EMERG MED, V37, P561, DOI 10.1067/mem.2001.111762; Harrell FE, 2001, INT J TECHNOL ASSESS, V17, P17, DOI 10.1017/S0266462301104034; Huang JA, 2003, J FORMOS MED ASSOC, V102, P222; Hunt KA, 2006, ANN EMERG MED, V48, P1, DOI 10.1016/j.annemergmed.2005.12.030; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Locker TE, 2007, EMERG MED J, V24, P398, DOI 10.1136/emj.2006.043844; Lowe RA, 2005, MED CARE, V43, P792, DOI 10.1097/01.mlr.0000170413.60054.54; Mandelberg JH, 2000, ACAD EMERG MED, V7, P637, DOI 10.1111/j.1553-2712.2000.tb02037.x; McCusker J, 2012, CAN MED ASSOC J, V184, pE307, DOI 10.1503/cmaj.111069; McCusker J, 2010, MED CARE, V48, P972, DOI 10.1097/MLR.0b013e3181eaf86d; McCusker Jane, 2009, Healthc Policy, V5, pe115; Mehl-Madrona LE, 2008, CAN J RURAL MED, V13, P22; Miller JB, 2013, AM J EMERG MED, V31, P16, DOI 10.1016/j.ajem.2012.05.001; Ofman JJ, 2004, AM J MED, V117, P182, DOI 10.1016/j.amjmed.2004.03.018; Olsson M, 2001, EMERG MED J, V18, P430, DOI 10.1136/emj.18.6.430; Poitras ME, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-35; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Stewart AL, 1999, MILBANK Q, V77, P305, DOI 10.1111/1468-0009.00138; Sun BC, 2003, ACAD EMERG MED, V10, P320, DOI 10.1111/j.1553-2712.2003.tb01344.x; Tsai AC, 2005, AM J MANAG CARE, V11, P478; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; Wong CKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095328; Zuckerman S, 2004, MED CARE, V42, P176, DOI 10.1097/01.mlr.0000108747.51198.41	45	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157489	10.1371/journal.pone.0157489	http://dx.doi.org/10.1371/journal.pone.0157489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299525	Green Submitted, Green Published, gold			2022-12-27	WOS:000377822200055
J	Jaffe, A; Giveon, S; Wulffhart, L; Oberman, B; Freedman, L; Ziv, A; Kalter-Leibovici, O				Jaffe, Anat; Giveon, Shmuel; Wulffhart, Liat; Oberman, Bernice; Freedman, Laurence; Ziv, Arnona; Kalter-Leibovici, Ofra			Diabetes among Ethiopian Immigrants to Israel: Exploring the Effects of Migration and Ethnicity on Diabetes Risk	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; BLOOD-PRESSURE; BODY-COMPOSITION; PREVALENCE; GLUCOSE; POPULATIONS; MELLITUS; INSULIN; RESIDENT; OBESITY	Objective Diabetes prevalence among ethnic minorities and immigrants often differs from the majority indigenous population. We compared diabetes prevalence, incidence and risk among Ethiopian and non-Ethiopian Jews. Within these main groups, we controlled for the effect of migration on diabetes risk by comparing the subgroups of Ethiopian and former Soviet Union (FSU) immigrants, and compared both with Israeli-born non-Ethiopian Jews. Methods The study cohort included adult Ethiopian (n = 8,398) and age-matched non-Ethiopian Jews (n = 15,977) and subgroups: Ethiopian immigrants (n = 7,994), FSU immigrants (n = 1,541) and Israeli-born non-Ethiopian Jews (n = 10,828). Diabetes prevalence, annual incidence, and hazard ratios (HRs) adjusted for sex and metabolic syndrome (MetS)-components, were determined in three age groups (<50yrs, 50-59yrs, and >= 60yrs). Comparisons of body mass index (BMI) at diabetes incidence were made. Results Younger (<50yrs) Ethiopians had higher prevalence rates, 3.6% (95% CI: 3.1-4.1) and annual incidence, 0.9% (95% CI: 0.8-1.0) than non-Ethiopians, 2.7% (95% CI: 2.3-3.0) and 0.5% (95% CI: 0.4-0.6), respectively. These differences were particularly pronounced among Ethiopian women. Diabetes risk among Ethiopians was higher and adjustment for MetS-components was important only for BMI, which further increased hazard ratio (HR) estimates associated with Ethiopian ethnicity from 1.81 (95% CI: 1.50-2.17) to 2.31 (95% CI: 1.91-2.79). The same differences were seen when comparing Ethiopian to FSU immigrants. BMI before incident diabetes was lower among younger Ethiopian immigrants than younger FSU immigrants and Israeli-born. Conclusions Ethiopian ethnicity is associated with increased diabetes risk, which is age and BMI dependent. Young Ethiopians<50yrs, particularly women, had the greatest increase in risk. Lower BMI cut-offs should be defined to reflect diabetes risk among Ethiopians.	[Jaffe, Anat] Hillel Yaffe Med Ctr, Endocrinol & Diabet Unit, Hadera, Israel; [Giveon, Shmuel] Tel Aviv Univ, Sackler Sch Med, Dept Family Practice, Clalit Hlth Serv,Dept Family Practice, IL-69978 Tel Aviv, Israel; [Wulffhart, Liat; Oberman, Bernice; Freedman, Laurence] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Unit Biostat, Ramat Gan, Israel; [Ziv, Arnona] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Unit Informat & Comp, Ramat Gan, Israel; [Jaffe, Anat; Kalter-Leibovici, Ofra] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Unit Cardiovasc Epidemiol, Ramat Gan, Israel; [Kalter-Leibovici, Ofra] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Clalit Health Services; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Jaffe, A (corresponding author), Hillel Yaffe Med Ctr, Endocrinol & Diabet Unit, Hadera, Israel.; Jaffe, A (corresponding author), Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Unit Cardiovasc Epidemiol, Ramat Gan, Israel.	anatjaffe@gmail.com		Jaffe, Anat/0000-0003-3976-0923				Abebe SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060081; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Aspray TJ, 2000, T ROY SOC TROP MED H, V94, P637, DOI 10.1016/S0035-9203(00)90216-5; Balde NM, 2007, DIABETES METAB, V33, P114, DOI 10.1016/j.diabet.2006.10.001; BURSZTYN M, 1993, J HYPERTENS, V11, P455, DOI 10.1097/00004872-199304000-00018; BURSZTYN M, 1995, J HYPERTENS, V13, P57; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Choi YJ, 2009, DIABETES CARE, V32, P2016, DOI 10.2337/dc08-2228; Cohen A M, 1993, Diabetes Res, V23, P65; COHEN AM, 1961, METABOLISM, V10, P50; COHEN MP, 1988, DIABETES, V37, P824, DOI 10.2337/diabetes.37.6.824; Cooper RS, 1997, DIABETES CARE, V20, P343, DOI 10.2337/diacare.20.3.343; Creatore MI, 2010, CAN MED ASSOC J, V182, P781, DOI 10.1503/cmaj.091551; Feldman M, 1998, THE ETHIOPIAN EXODUS; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Gill G, 2009, DIABETOLOGIA, V52, P8, DOI 10.1007/s00125-008-1167-9; GREEN MS, 1991, J EPIDEMIOL COMMUN H, V45, P281, DOI 10.1136/jech.45.4.281; Hales CN, 2013, INT J EPIDEMIOL, V42, P1215, DOI 10.1093/ije/dyt133; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Hilawe EH, 2013, B WORLD HEALTH ORGAN, V91, P671, DOI 10.2471/BLT.12.113415; Hosler AS, 2004, ETHNIC DIS, V14, P372; Kalchiem-Dekel O, 2015, J DIABETES, V7, P531, DOI 10.1111/1753-0407.12215; Kalter-Leibovici O, 2012, DIABETIC MED, V29, P748, DOI 10.1111/j.1464-5491.2011.03516.x; Langley-Evans S, 2015, NUTR HLTH DIS LIFESP; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Logue J, 2011, DIABETOLOGIA, V54, P3003, DOI 10.1007/s00125-011-2313-3; Mbanya JC, 2006, DIS MORTALITY SUBSAH; Mbanya JCN, 1999, DIABETES CARE, V22, P434, DOI 10.2337/diacare.22.3.434; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Meeks KAC, 2015, DIABETES RES CLIN PR, V110, P137, DOI 10.1016/j.diabres.2015.09.017; Murphy GAV, 2014, DIABETES CARE, V37, pE64, DOI 10.2337/dc13-2096; RAVUSSIN E, 1994, DIABETES CARE, V17, P1067, DOI 10.2337/diacare.17.9.1067; ROSENTHAL T, 1989, J HYPERTENS, V7, pS53, DOI 10.1097/00004872-198902001-00016; RUBINSTEIN A, 1993, ISRAEL J MED SCI, V29, P344; Wai WS, 2012, OBESITY, V20, P1887, DOI 10.1038/oby.2011.103; Wilf-Miron R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-729	36	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157354	10.1371/journal.pone.0157354	http://dx.doi.org/10.1371/journal.pone.0157354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300299	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200040
J	Khan, SA; Jackson, RT; Momen, B				Khan, Saira A.; Jackson, Robert T.; Momen, Bahram			The Relationship between Diet Quality and Acculturation of Immigrated South Asian American Adults and Their Association with Metabolic Syndrome	PLOS ONE			English	Article							DEPARTMENT-OF-AGRICULTURE; HEALTHY EATING INDEX; DISEASE RISK-FACTORS; UNITED-STATES; PATTERNS; ATHEROSCLEROSIS; PREVALENCE; RESIDENCE; INDIANS; OBESITY	Even though the total SA American population is increasing rapidly, there is a paucity of information on the relationship between diet quality, acculturation and health outcomes such as Metabolic Syndrome (MetS) in the low-income South Asian (SA) sub-population. Our goal was to examine diet quality, degree of acculturation and their potential influence on MetS in a diverse sample of SA Americans. A convenience sample of 401 adult SA men and women were studied using a cross-sectional study design. Volunteers from two low-income community health clinics in Maryland were interviewed by questionnaires. MetS, defined by the consensus harmonized definition by the presence of >= 3 of the 5 abnormal indicators, was studied. An interviewer obtained an automated self-administered 24-hour Recall (ASA24) and an acculturation index (using a previously validated (SL-ASIA). SA had a composite HEI2010 score of 68 suggesting an overall need for diet improvements. Males had a higher diet quality (mean HEI2010 score) than females. Males with MetS had lower diet quality (68) than males without MetS (73). The converse was true for females (68 vs. 65). Americanized (more acculturated) subjects had a higher diet quality compared to less acculturated SA. Small differences were found in diet quality scores among SA adults from different countries. Less acculturated females, had a higher percentage of MetS and lower diet quality compared to males. These results suggest that interventions are needed in males and females who were less acculturated because they may have greater MetS and lower diet quality compared to more Americanized SA.	[Khan, Saira A.; Jackson, Robert T.] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Momen, Bahram] Univ Maryland, Dept Environm Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Khan, SA (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.	skhan12@umd.edu		Khan, Saira/0000-0002-1894-7839				Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 1995, REL VAL SUIJJ LEW AS, P17; [Anonymous], COMP HEI 2005 HEI 20; Bharmal N, 2015, J IMMIGR MINOR HEALT, V17, P781, DOI 10.1007/s10903-013-9973-7; Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594; Britten P, 2012, J ACAD NUTR DIET, V112, P1648, DOI 10.1016/j.jand.2012.05.021; Chakraborty BM, 2010, COLLEGIUM ANTROPOL, V34, P1179; Dodani S, 2011, J EPIDEMIOL COMMUN H, V65, pA237, DOI 10.1136/jech.2011.142976h.100; Flowers E, 2010, METAB SYNDR RELAT D, V8, P417, DOI 10.1089/met.2009.0097; Gadgil MD, 2014, J ACAD NUTR DIET, V114, P238, DOI 10.1016/j.jand.2013.09.021; Gany F, 2012, J HEALTH CARE POOR U, V23, P615, DOI 10.1353/hpu.2012.0070; Garduno-Diaz SD, 2013, J HUM NUTR DIET, V26, P145, DOI 10.1111/j.1365-277X.2012.01284.x; Guenther P. M., 2014, J NUTR; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Gupta R, 2004, INT J CARDIOL, V97, P257, DOI 10.1016/j.ijcard.2003.11.003; Huynh QL, 2009, J CROSS CULT PSYCHOL, V40, P256, DOI 10.1177/0022022108328919; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Kawada T., 2014, INT J CARDIOLOGY; KENNEDY ET, 1995, J AM DIET ASSOC, V95, P1103, DOI 10.1016/S0002-8223(95)00300-2; Khan SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004952; Khanna R, 2013, INDIAN J MED RES, V137, P295; Koya DL, 2007, J GEN INTERN MED, V22, P841, DOI 10.1007/s11606-007-0163-y; McGuire S, 2011, ADV NUTR, V2, P293, DOI 10.3945/an.111.000430; Misra A, 2003, INDIAN J MED RES, V117, P170; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2009, METAB SYNDR RELAT D, V7, P497, DOI 10.1089/met.2009.0024; Misra R, 2010, J DIABETES COMPLICAT, V24, P145, DOI 10.1016/j.jdiacomp.2009.01.003; Narayan KMV, 2010, J AM COLL CARDIOL, V55, P966, DOI 10.1016/j.jacc.2009.07.075; Oza-Frank R, 2013, J IMMIGR MINOR HEALT, V15, P918, DOI 10.1007/s10903-012-9683-6; Perez-Escamilla R, 2011, AM J CLIN NUTR, V93, p1163S, DOI 10.3945/ajcn.110.003467; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Poudyal H, 2015, PROG LIPID RES, V59, P172, DOI 10.1016/j.plipres.2015.07.002; Ram CVS, 2012, J CLIN HYPERTENS, V14, P561, DOI 10.1111/j.1751-7176.2012.00652.x; Rehm CD, 2011, AM J CLIN NUTR, V94, P1333, DOI 10.3945/ajcn.111.015560; Roshania R, 2008, OBESITY, V16, P2669, DOI 10.1038/oby.2008.425; Sheikh AJ, 2001, GENDER LEVELS ACCULT; Singh GK, 2004, CAN J PUBLIC HEALTH, V95, pI14, DOI 10.1007/BF03403660; SUINN RM, 1987, EDUC PSYCHOL MEAS, V47, P401, DOI 10.1177/0013164487472012; SUINN RM, 1992, EDUC PSYCHOL MEAS, V52, P1041, DOI 10.1177/0013164492052004028; Wang ET, 2010, J AM COLL NUTR, V29, P130, DOI 10.1080/07315724.2010.10719826	41	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156851	10.1371/journal.pone.0156851	http://dx.doi.org/10.1371/journal.pone.0156851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KO	27299862	gold, Green Published, Green Submitted			2022-12-27	WOS:000377822200017
J	Lee, ES; Vedanthan, R; Jeemon, P; Kamano, JH; Kudesia, P; Rajan, V; Engelgau, M; Moran, AE				Lee, Edward S.; Vedanthan, Rajesh; Jeemon, Panniyammakal; Kamano, Jemima H.; Kudesia, Preeti; Rajan, Vikram; Engelgau, Michael; Moran, Andrew E.			Quality Improvement for Cardiovascular Disease Care in Low- and Middle-Income Countries: A Systematic Review	PLOS ONE			English	Review							ACUTE CORONARY SYNDROMES; TYPE-2 DIABETES-MELLITUS; CLUSTER-RANDOMIZED-TRIAL; RHEUMATIC HEART-DISEASE; SECONDARY PREVENTION; HEALTH-INSURANCE; BLOOD-PRESSURE; RISK-FACTORS; POLYPILL POLYCAP; PEER SUPPORT	Background The majority of global cardiovascular disease (CVD) burden falls on people living in low- and middle-income countries (LMICs). In order to reduce preventable CVD mortality and morbidity, LMIC health systems and health care providers need to improve the delivery and quality of CVD care. Objectives As part of the Disease Control Priorities Three (DCP3) Study efforts addressing quality improvement, we reviewed and summarized currently available evidence on interventions to improve quality of clinic-based CVD prevention and management in LMICs. Methods We conducted a narrative review of published comparative clinical trials that evaluated efficacy or effectiveness of clinic-based CVD prevention and management quality improvement interventions in LMICs. Conditions selected a priori included hypertension, diabetes, hyperlipidemia, coronary artery disease, stroke, rheumatic heart disease, and congestive heart failure. MEDLINE and EMBASE electronic databases were systematically searched. Studies were categorized as occurring at the system or patient/provider level and as treating the acute or chronic phase of CVD. Results From 847 articles identified in the electronic search, 49 met full inclusion criteria and were selected for review. Selected studies were performed in 19 different LMICs. There were 10 studies of system level quality improvement interventions, 38 studies of patient/provider interventions, and one study that fit both criteria. At the patient/provider level, regardless of the specific intervention, intensified, team-based care generally led to improved medication adherence and hypertension control. At the system level, studies provided evidence that introduction of universal health insurance coverage improved hypertension and diabetes control. Studies of system and patient/provider level acute coronary syndrome quality improvement interventions yielded inconclusive results. The duration of most studies was less than 12 months. Conclusions The results of this review suggest that CVD care quality improvement can be successfully implemented in LMICs. Most studies focused on chronic CVD conditions; more acute CVD care quality improvement studies are needed. Longer term interventions and follow-up will be needed in order to assess the sustainability of quality improvement efforts in LMICs.	[Lee, Edward S.] Univ So Calif, Keck Sch Med, Dept Med, Palliat & Gen Internal Med,Div Geriatr, Los Angeles, CA 90033 USA; [Vedanthan, Rajesh] Icahn Sch Med Mt Sinai, Div Cardiol, Dept Med, New York, NY 10029 USA; [Jeemon, Panniyammakal] Publ Hlth Fdn India, Ctr Control Chron Condit, Cochin, Kerala, India; [Kamano, Jemima H.] Moi Univ, Coll Hlth Sci, Eldoret, Kenya; [Kamano, Jemima H.] Acad Model Providing Access Healthcare, Eldoret, Kenya; [Kudesia, Preeti] World Bank, Hlth Nutr & Populat Global Practice, Kathmandu, Nepal; [Rajan, Vikram] World Bank, Jakarta, Indonesia; [Engelgau, Michael] NHLBI, Ctr Translat Res & Implementat Sci, NIH, Bldg 10, Bethesda, MD 20892 USA; [Moran, Andrew E.] Columbia Univ, Div Gen Med, Dept Med, Med Ctr, New York, NY USA	University of Southern California; Icahn School of Medicine at Mount Sinai; Public Health Foundation of India; Moi University; The World Bank; The World Bank; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Columbia University	Moran, AE (corresponding author), Columbia Univ, Div Gen Med, Dept Med, Med Ctr, New York, NY USA.	aem35@cumc.columbia.edu		Vedanthan, Rajesh/0000-0001-7138-2382; Jeemon, Panniyammakal/0000-0003-4172-4307; kamano, jemima/0000-0003-2179-8202	U.S. National Heart, Lung and Blood Institute career development award [K08 HL089675-01]; Fogarty International Center of the U.S. National Institutes of Health [K01 TW 009218-05]; Department of Biotechnology India Alliance clinical and public health intermediate career fellowship; Wellcome Trust	U.S. National Heart, Lung and Blood Institute career development award; Fogarty International Center of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Department of Biotechnology India Alliance clinical and public health intermediate career fellowship(Wellcome Trust DBT India Alliance); Wellcome Trust(Wellcome TrustEuropean Commission)	AEM was supported by a grant from the U.S. National Heart, Lung and Blood Institute career development award (K08 HL089675-01; www.nhlbi.nih.gov). RV was supported by a grant from the Fogarty International Center of the U.S. National Institutes of Health (K01 TW 009218-05; www.flc.nih.gov). PJ is supported by a Wellcome Trust, Department of Biotechnology India Alliance clinical and public health intermediate career fellowship (www.wellcome.ac.uk). The views expressed in this article are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute, National Institutes of Health, or the U.S. Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2013, J HYPERTENS, V31, P201, DOI 10.1097/HJH.0b013e32835b0842; Ahmadipour H, 2010, INT J PREVENTIVE MED, V1, P50; Alexander T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003850; Alhalaiqa F, 2012, J HUM HYPERTENS, V26, P117, DOI 10.1038/jhh.2010.133; Anchala R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001213; Andryukhin A, 2010, EUR J GEN PRACT, V16, P205, DOI 10.3109/13814788.2010.527938; Arevian Mary, 2005, J Interprof Care, V19, P444, DOI 10.1080/13561820500215095; Beaton A, 2012, CIRCULATION, V125, P3127, DOI 10.1161/CIRCULATIONAHA.112.092312; Berwanger O, 2012, JAMA-J AM MED ASSOC, V307, P2041, DOI 10.1001/jama.2012.413; Binanay CA, 2015, J AM COLL CARDIOL, V66, P2550, DOI 10.1016/j.jacc.2015.09.086; Bleich SN, 2007, BMJ-BRIT MED J, V335, P875, DOI 10.1136/bmj.39350.617616.BE; Bocchi EA, 2008, CIRC-HEART FAIL, V1, P115, DOI 10.1161/CIRCHEARTFAILURE.107.744870; Carapetis JR, 2008, NAT CLIN PRACT CARD, V5, P411, DOI 10.1038/ncpcardio1185; Chan JCN, 2014, JAMA INTERN MED, V174, P972, DOI 10.1001/jamainternmed.2014.655; de Jongh T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007459.pub2; Doval HC, 2005, BMJ-BRIT MED J, V331, P425, DOI 10.1136/bmj.38516.398067.E0; Du X, 2014, CIRC-CARDIOVASC QUAL, V7, P217, DOI 10.1161/CIRCOUTCOMES.113.000526; Erhun WO, 2005, PUBLIC HEALTH, V119, P792, DOI 10.1016/j.puhe.2004.11.009; FDA, 2014, BRIEFING DOCUMENT CA; Ferrante D, 2010, J AM COLL CARDIOL, V56, P372, DOI 10.1016/j.jacc.2010.03.049; Flather MD, 2011, AM HEART J, V162, P700, DOI 10.1016/j.ahj.2011.07.027; Gaziano TA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-240; Gaziano TA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-170; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Goodarzi M, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-10; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hendriks ME, 2014, JAMA INTERN MED, V174, P555, DOI 10.1001/jamainternmed.2013.14458; International Telecommunication Union, 2014, THE WORLD IN 2014 IC; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Kengne AP, 2009, J CLIN HYPERTENS, V11, P564, DOI 10.1111/j.1751-7176.2009.00165.x; Khonsari S, 2015, EUR J CARDIOVASC NUR, V14, P170, DOI 10.1177/1474515114521910; Labhardt ND, 2011, TROP MED INT HEALTH, V16, P1276, DOI 10.1111/j.1365-3156.2011.02827.x; Lohr KN, 1990, MEDICARE A STRATEGY; Macharia WM, 2009, AFR HEALTH SCI, V9, P118; Mendis S, 2010, B WORLD HEALTH ORGAN, V88, P412, DOI 10.2471/BLT.08.062364; Mohammadi Eesa, 2006, Int J Nurs Pract, V12, P153, DOI 10.1111/j.1440-172X.2006.00563.x; Nazzal C, 2008, REV MED CHILE, V136, P1231, DOI /S0034-98872008001000001; Nesari M, 2010, JPN J NURS SCI, V7, P121, DOI 10.1111/j.1742-7924.2010.00146.x; Obreli-Neto PR, 2011, INT J CLIN PHARM-NET, V33, P642, DOI 10.1007/s11096-011-9518-x; Ortega KC, 2010, CLINICS, V65, P857, DOI 10.1590/S1807-59322010000900008; Peng B, 2014, STROKE, V45, P515, DOI 10.1161/STROKEAHA.113.001424; Piette JD, 2012, TELEMED E-HEALTH, V18, P613, DOI 10.1089/tmj.2011.0271; Prabhakaran D, 2008, NATL MED J INDIA, V21, P107; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Qureshi NN, 2007, BMJ-BRIT MED J, V335, P1030, DOI 10.1136/bmj.39360.617986.AE; Rabkin Miriam, 2012, AIDS, V26 Suppl 1, pS77; Ramachandran A, 2013, LANCET DIABETES ENDO, V1, P191, DOI 10.1016/S2213-8587(13)70067-6; Ramanath KV, 2012, J YOUNG PHARM, V4, P95, DOI 10.4103/0975-1483.96623; Ranasinghe I, 2014, CIRC-CARDIOVASC QUAL, V7, P209, DOI 10.1161/CIRCOUTCOMES.113.000527; Reutens AT, 2012, DIABETES RES CLIN PR, V98, P38, DOI 10.1016/j.diabres.2012.06.002; Roth GA, 2015, CIRCULATION, V132, P1667, DOI 10.1161/CIRCULATIONAHA.114.008720; Rotheram-Borus MJ, 2012, DIABETES EDUCATOR, V38, P357, DOI 10.1177/0145721712444617; Sekhri N, 2011, HEALTH AFFAIR, V30, P1498, DOI 10.1377/hlthaff.2010.0461; Shetty Ananth Samith, 2011, J Assoc Physicians India, V59, P711; Sosa-Rubi SG, 2009, B WORLD HEALTH ORGAN, V87, P512, DOI 10.2471/BLT.08.053256; Steyn K, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20796; Tan MY, 2011, HEALTH EDUC RES, V26, P896, DOI 10.1093/her/cyr047; Thom S, 2013, JAMA-J AM MED ASSOC, V310, P918, DOI 10.1001/jama.2013.277064; Trujillo AJ, 2010, HEALTH AFFAIR, V29, P2180, DOI 10.1377/hlthaff.2010.0463; Vedanthan R, 2015, GLOB HEART, V10, P313, DOI 10.1016/j.gheart.2015.09.003; Walker RW, 2013, LANCET GLOB HEALTH, V1, pE282, DOI 10.1016/S2214-109X(13)70068-8; World Health Organisation, 2008, TASK SHIFTING GLOBAL; Yu BR, 2013, AM J MANAG CARE, V19, pE22; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2012, CIRC-CARDIOVASC QUAL, V5, P463, DOI 10.1161/CIRCOUTCOMES.111.963637; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zou GY, 2015, J PUBLIC HEALTH-UK, V37, P241, DOI 10.1093/pubmed/fdu013	67	34	34	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157036	10.1371/journal.pone.0157036	http://dx.doi.org/10.1371/journal.pone.0157036			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KO	27299563	Green Submitted, gold, Green Published			2022-12-27	WOS:000377822200025
J	Marzano, M; Fosso, B; Manzari, C; Grieco, F; Intranuovo, M; Cozzi, G; Mule, G; Scioscia, G; Valiente, G; Tullo, A; Sbisa, E; Pesole, G; Santamaria, M				Marzano, Marinella; Fosso, Bruno; Manzari, Caterina; Grieco, Francesco; Intranuovo, Marianna; Cozzi, Giuseppe; Mule, Giuseppina; Scioscia, Gaetano; Valiente, Gabriel; Tullo, Apollonia; Sbisa, Elisabetta; Pesole, Graziano; Santamaria, Monica			Complexity and Dynamics of the Winemaking Bacterial Communities in Berries, Musts, and Wines from Apulian Grape Cultivars through Time and Space	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; MALOLACTIC FERMENTATION; SACCHAROMYCES-CEREVISIAE; STARTER CULTURES; YEAST; STRAINS; BIODIVERSITY; KNOWLEDGE; PCR; DNA	Currently, there is very little information available regarding the microbiome associated with the wine production chain. Here, we used an amplicon sequencing approach based on high-throughput sequencing (HTS) to obtain a comprehensive assessment of the bacterial community associated with the production of three Apulian red wines, from grape to final product. The relationships among grape variety, the microbial community, and fermentation was investigated. Moreover, the winery microbiota was evaluated compared to the autochthonous species in vineyards that persist until the end of the winemaking process. The analysis highlighted the remarkable dynamics within the microbial communities during fermentation. A common microbial core shared among the examined wine varieties was observed, and the unique taxonomic signature of each wine appellation was revealed. New species belonging to the genus Halomonas were also reported. This study demonstrates the potential of this metagenomic approach, supported by optimized protocols, for identifying the biodiversity of the wine supply chain. The developed experimental pipeline offers new prospects for other research fields in which a comprehensive view of microbial community complexity and dynamics is desirable.	[Marzano, Marinella; Fosso, Bruno; Manzari, Caterina; Pesole, Graziano; Santamaria, Monica] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy; [Grieco, Francesco] CNR, Operat Unit Lecce, Inst Sci Food Prod, Lecce, Le, Italy; [Intranuovo, Marianna; Pesole, Graziano] Univ Bari A Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Cozzi, Giuseppe; Mule, Giuseppina] CNR, Inst Sci Food Prod, I-70126 Bari, Italy; [Scioscia, Gaetano] IBM Corp, GBS BAO Adv Analyt Serv, Bari, Italy; [Scioscia, Gaetano] IBM Corp, MBLab, Bari, Italy; [Valiente, Gabriel] Univ Politecn Cataluna, Algorithms Bioinformat Complex & Formal Methods R, Barcelona, Spain; [Tullo, Apollonia; Sbisa, Elisabetta] CNR, Inst Biomed Technol, Bari, Italy	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR); Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR); International Business Machines (IBM); International Business Machines (IBM); Universitat Politecnica de Catalunya; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Pesole, G; Santamaria, M (corresponding author), CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy.; Pesole, G (corresponding author), Univ Bari A Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.	g.pesole@ibbe.cnr.it; m.santamaria@ibbe.cnr.it	Sbisa', Elisabetta/AAW-9727-2020; Fosso, Bruno/P-1538-2018; Grieco, Francesco/B-6590-2015; Marzano, Marinella/T-7306-2018; Valiente, Gabriel/AAH-4424-2021; Pesole, Graziano/K-5283-2019; Mule, Giuseppina/B-6478-2015; Tullo, Apollonia/AAX-1079-2020; Santamaria, Monica/AAQ-3050-2020	Fosso, Bruno/0000-0003-2324-086X; Grieco, Francesco/0000-0002-8599-6091; Mule, Giuseppina/0000-0002-9094-1888; Tullo, Apollonia/0000-0002-5081-4745; Marzano, Marinella/0000-0002-9996-8817	"Laboratorio di Bioinformatica per la Biodiversita Molecolare'' (MBLab) [DM19410]; "Biotecnologie degli alimenti per l'innovazione e la competitivita delle principali filiere regionali: estensione della conservabilita e aspetti funzionali - BiotecA" [QCBRAJ6]	"Laboratorio di Bioinformatica per la Biodiversita Molecolare'' (MBLab); "Biotecnologie degli alimenti per l'innovazione e la competitivita delle principali filiere regionali: estensione della conservabilita e aspetti funzionali - BiotecA"	This study was partially supported by the following Projects: "Laboratorio di Bioinformatica per la Biodiversita Molecolare'' (MBLab) (Project code DM19410), "Biotecnologie degli alimenti per l'innovazione e la competitivita delle principali filiere regionali: estensione della conservabilita e aspetti funzionali - BiotecA" (Project code QCBRAJ6),	Alexandre H, 2004, INT J FOOD MICROBIOL, V93, P141, DOI 10.1016/j.ijfoodmicro.2003.10.013; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arahal DR, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P811, DOI 10.1007/0-387-30746-x_28; Baiano A, 2009, J FOOD SCI, V74, pC258, DOI 10.1111/j.1750-3841.2009.01101.x; Barata A, 2012, MICROB ECOL, V64, P416, DOI 10.1007/s00248-012-0041-y; Bauer R., 2004, South African Journal of Enology and Viticulture, V25, P74; Bergholz TM, 2014, TRENDS MICROBIOL, V22, P275, DOI 10.1016/j.tim.2014.01.006; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066437; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Capozzi V, 2010, LETT APPL MICROBIOL, V50, P327, DOI 10.1111/j.1472-765X.2010.02795.x; Capozzi V, 2015, MICROBIOL RES, V181, P75, DOI 10.1016/j.micres.2015.10.005; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Revel G, 1999, J AGR FOOD CHEM, V47, P4003, DOI 10.1021/jf981383b; du Toit M, 2011, FOOD BIOPROCESS TECH, V4, P876, DOI 10.1007/s11947-010-0448-8; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fosso B, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0595-z; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Garofalo C, 2015, J APPL MICROBIOL, V118, P1395, DOI 10.1111/jam.12789; Godalova Z, 2016, INT J FOOD MICROBIOL, V217, P110, DOI 10.1016/j.ijfoodmicro.2015.10.015; HENICKKLING T, 1994, AM J ENOL VITICULT, V45, P464; Jeong SH, 2013, ANTON LEEUW INT J G, V103, P503, DOI 10.1007/s10482-012-9832-x; Kergourlay G, 2015, INT J FOOD MICROBIOL, V213, P31, DOI 10.1016/j.ijfoodmicro.2015.09.010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lasik M, 2013, EUR FOOD RES TECHNOL, V237, P843, DOI 10.1007/s00217-013-2083-x; Lonvaud-Funel A, 1999, ANTON LEEUW INT J G, V76, P317, DOI 10.1023/A:1002088931106; Lonvaud-Funel A, 2008, BIOFUTUR, P26; LONVAUDFUNEL A, 1988, J SCI FOOD AGR, V44, P183, DOI 10.1002/jsfa.2740440209; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Manzari C, 2015, BIOL INVASIONS, V17, P923, DOI 10.1007/s10530-014-0810-2; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/NMETH.2575, 10.1038/nmeth.2575]; Nakamura S, 2007, J AGR FOOD CHEM, V55, P10388, DOI 10.1021/jf072407u; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Piao HL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00809; Pinto C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00905; Renouf V, 2006, FOOD MICROBIOL, V23, P136, DOI 10.1016/j.fm.2005.01.019; Renouf V, 2007, APPL MICROBIOL BIOT, V75, P149, DOI 10.1007/s00253-006-0798-3; Robinson Jancis, 2015, OXFORD COMPANION WIN, V4th; Ruiz P, 2010, APPL MICROBIOL BIOT, V86, P1555, DOI 10.1007/s00253-010-2492-8; Savazzini F, 2006, ANAL CHIM ACTA, V563, P274, DOI 10.1016/j.aca.2005.10.078; Setati ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052609; Singh Jagtar, 2009, Biotechnology Journal, V4, P480, DOI 10.1002/biot.200800201; Siret R, 2000, J AGR FOOD CHEM, V48, P5035, DOI 10.1021/jf991168a; Taylor MW, 2014, ENVIRON MICROBIOL, V16, P2848, DOI 10.1111/1462-2920.12456; Tessonniere H, 2009, INT J FOOD MICROBIOL, V129, P237, DOI 10.1016/j.ijfoodmicro.2008.11.027; Tristezza M, 2016, LWT-FOOD SCI TECHNOL, V66, P406, DOI 10.1016/j.lwt.2015.10.064; Tristezza M, 2013, FOOD MICROBIOL, V36, P335, DOI 10.1016/j.fm.2013.07.001; Tufariello M, 2014, LWT-FOOD SCI TECHNOL, V58, P35, DOI 10.1016/j.lwt.2014.03.016; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14; Zoecklein B. W., 2000, Small Fruits Review, V1, P63, DOI 10.1300/J301v01n01_08	54	35	35	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157383	10.1371/journal.pone.0157383	http://dx.doi.org/10.1371/journal.pone.0157383			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299312	Green Published, gold			2022-12-27	WOS:000377822200044
J	Lv, YC; Tang, YY; Zhang, P; Wan, W; Yao, F; He, PP; Xie, W; Mo, ZC; Shi, JF; Wu, JF; Peng, J; Liu, D; Cayabyab, FS; Zheng, XL; Tang, XY; Ouyang, XP; Tang, CK				Lv, Yun-Cheng; Tang, Yan-Yan; Zhang, Ping; Wan, Wei; Yao, Feng; He, Ping-Ping; Xie, Wei; Mo, Zhong-Cheng; Shi, Jin-Feng; Wu, Jian-Feng; Peng, Juan; Liu, Dan; Cayabyab, Francisco S.; Zheng, Xi-Long; Tang, Xiang-Yang; Ouyang, Xin-Ping; Tang, Chao-Ke			Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis	PLOS ONE			English	Article							CASSETTE TRANSPORTER A1; KRUPPEL-LIKE FACTOR-2; APOLIPOPROTEIN-E; DOWN-REGULATION; CHOLESTEROL; EXPRESSION; GENE; CANCER; CELLS; MICE	ATP-binding cassette transporter A1 (ABCA1) plays a critical role in maintaining cellular cholesterol homeostasis. The purpose of this study is to identify the molecular mechanism (s) underlying ABCA1 epigenetic modification and determine its potential impact on ABCA1 expression in macrophage-derived foam cell formation and atherosclerosis development. DNA methylation induced foam cell formation from macrophages and promoted atherosclerosis in apolipoprotein E-deficient (apoE(-/-)) mice. Bioinformatics analyses revealed a large CpG island (CGI) located in the promoter region of ABCA1. Histone methyltransferase enhancer of zeste homolog 2 (EZH2) downregulated ABCA1 mRNA and protein expression in THP-1 and RAW264.7 macrophage-derived foam cells. Pharmacological inhibition of DNA methyltransferase 1 (DNMT1) with 5-Aza-dC or knockdown of DNMT1 prevented the downregulation of macrophage ABCA1 expression, suggesting a role of DNA methylation in ABCA1 expression. Polycomb protein EZH2 induced DNMT1 expression and methyl-CpG-binding protein-2 (MeCP2) recruitment, and stimulated the binding of DNMT1 and MeCP2 to ABCA1 promoter, thereby promoting ABCA1 gene DNA methylation and atherosclerosis. Knockdown of DNMT1 inhibited EZH2-induced downregulation of ABCA1 in macrophages. Conversely, EZH2 overexpression stimulated DNMT1-induced ABCA1 gene promoter methylation and atherosclerosis. EZH2-induced downregulation of ABCA1 gene expression promotes foam cell formation and the development of atherosclerosis by DNA methylation of ABCA1 gene promoter.	[Lv, Yun-Cheng; Tang, Yan-Yan; Yao, Feng; He, Ping-Ping; Xie, Wei; Mo, Zhong-Cheng; Shi, Jin-Feng; Wu, Jian-Feng; Peng, Juan; Liu, Dan; Ouyang, Xin-Ping; Tang, Chao-Ke] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Key Lab Atherosclerol Hunan Prov, Inst Cardiovasc Res,Med Res Ctr, Hengyang 421001, Hunan, Peoples R China; [Lv, Yun-Cheng; Wan, Wei; Tang, Xiang-Yang] Univ South China, Lab Clin Anat, Hengyang 421001, Peoples R China; [Tang, Yan-Yan] Cent S Univ, Key Lab Carcinogenesis, Chinese Minist Hlth, Changsha 410013, Hunan, Peoples R China; [Tang, Yan-Yan] Cent S Univ, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Canc Res Inst, Changsha 410013, Hunan, Peoples R China; [Zhang, Ping] Hunan Univ Sci & Engn, Sch Elect & Informat Engn, Yongzhou 425100, Hunan, Peoples R China; [Zhang, Ping] Cent S Univ, Sch Informat Sci & Engn, Changsha 410000, Hunan, Peoples R China; [Cayabyab, Francisco S.] Univ Saskatchewan, Coll Med, Dept Surg, Saskatoon, SK S7N 5E5, Canada; [Zheng, Xi-Long] Univ Calgary, Dept Biochem & Mol Biol, Libin Cardiovasc Inst Alberta, Hlth Sci Ctr, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; [Tang, Xiang-Yang] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, WCI Suite C5018,1701 Uppergate Dr, Atlanta, GA 30322 USA	University of South China; University of South China; Central South University; Central South University; Central South University; University of Saskatchewan; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; Emory University	Ouyang, XP; Tang, CK (corresponding author), Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Key Lab Atherosclerol Hunan Prov, Inst Cardiovasc Res,Med Res Ctr, Hengyang 421001, Hunan, Peoples R China.	y1655@163.com; tangchaoke@qq.com	莫, 中成/AAY-8561-2020; Cayabyab, Francisco/HHR-8711-2022	Zheng, Xi-Long/0000-0002-0889-1827	National Natural Sciences Foundation of China [81370377, 81300158]; Hunan Provincial Natural Science Foundation of China [14JJ2091]; Aid Program for Science and Technology Department of Human Province [2015JC3083]; Scientific Research Fund of Hunan Provincial Education Department [12C0339]; start-up funds for Ph.Ds in University of South China [2014XQD37]; Zhengxiang scholar program of the University of South China; construct program of key discipline in Hunan Province	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Aid Program for Science and Technology Department of Human Province; Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); start-up funds for Ph.Ds in University of South China; Zhengxiang scholar program of the University of South China; construct program of key discipline in Hunan Province	The authors gratefully acknowledge the financial support from the National Natural Sciences Foundation of China (81370377 and 81300158), the Hunan Provincial Natural Science Foundation of China (14JJ2091), the Aid Program for Science and Technology Department of Human Province (2015JC3083), the Scientific Research Fund of Hunan Provincial Education Department (12C0339), the start-up funds for Ph.Ds in University of South China (2014XQD37), Zhengxiang scholar program (prof. Xiangyang Tang) of the University of South China and the construct program of the key discipline in Hunan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the financial support from the National Natural Sciences Foundation of China (81370377 and 81300158), the Hunan Provincial Natural Science Foundation of China (14JJ2091), the Aid Program for Science and Technology Department of Human Province (2015JC3083), the Scientific Research Fund of Hunan Provincial Education Department (12C0339), The start-up funds for Ph.Ds in University of South China (2014XQD37), Zhengxiang scholar program (prof. Xiangyang Tang) of the University of South China and the construct program of the key discipline in Hunan Province.	Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bowen NJ, 2004, CELL MOL LIFE SCI, V61, P2163, DOI 10.1007/s00018-004-4177-x; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Connelly JJ, 2013, HUM MOL GENET, V22, P5107, DOI 10.1093/hmg/ddt365; De Paoli F, 2014, CIRC J, V78, P1775, DOI 10.1253/circj.CJ-14-0621; Delaney C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056253; Dunn J, 2015, ARTERIOSCL THROM VAS, V35, P1562, DOI 10.1161/ATVBAHA.115.305042; Guay SP, 2012, EPIGENETICS-US, V7, P464, DOI 10.4161/epi.19633; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; Hu YW, 2015, ARTERIOSCL THROM VAS, V35, P87, DOI 10.1161/ATVBAHA.114.304296; Kanduri M, 2013, EPIGENETICS-US, V8, P1280, DOI 10.4161/epi.26546; Kumar A, 2013, ARTERIOSCL THROM VAS, V33, P1936, DOI 10.1161/ATVBAHA.113.301765; Li GJ, 2009, BLOOD, V114, P3422, DOI 10.1182/blood-2009-01-200170; Lu Q, 2013, CIRC J, V77, P2399, DOI 10.1253/circj.CJ-12-1616; Lund G, 2004, J BIOL CHEM, V279, P29147, DOI 10.1074/jbc.M403618200; Mo ZC, 2014, CIRC J, V78, P2760, DOI 10.1253/circj.CJ-14-0193; Newman PE, 1999, MED HYPOTHESES, V53, P421, DOI 10.1054/mehy.1998.0794; Probst MCO, 2004, ATHEROSCLEROSIS, V175, P269, DOI 10.1016/j.atherosclerosis.2004.02.019; Ramirez CM, 2013, CIRC RES, V112, P1592, DOI 10.1161/CIRCRESAHA.112.300626; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Taniguchi H, 2012, ONCOGENE, V31, P1988, DOI 10.1038/onc.2011.387; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Ye D, 2011, CURR DRUG TARGETS, V12, P647, DOI 10.2174/138945011795378522; Yeh JL, 2013, ATHEROSCLEROSIS, V226, P364, DOI 10.1016/j.atherosclerosis.2012.12.005; Yin K, 2011, J BIOL CHEM, V286, P13834, DOI 10.1074/jbc.M110.202275; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; Yu CE, 2013, HUM MOL GENET, V22, P5036, DOI 10.1093/hmg/ddt354; Zaina S, 2015, ARTERIOSCL THROM VAS, V35, P1835, DOI 10.1161/ATVBAHA.115.305630; Zhang DH, 2014, CIRC J, V78, P1915, DOI 10.1253/circj.CJ-14-0233; Zhao GJ, 2014, INT J CARDIOL, V171, pE93, DOI 10.1016/j.ijcard.2013.11.093	34	45	46	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157265	10.1371/journal.pone.0157265	http://dx.doi.org/10.1371/journal.pone.0157265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295295	Green Published, gold, Green Submitted			2022-12-27	WOS:000377821300030
J	Bafna, JA; Soni, GV				Bafna, Jayesh A.; Soni, Gautam V.			Fabrication of Low Noise Borosilicate Glass Nanopores for Single Molecule Sensing	PLOS ONE			English	Article							SOLID-STATE NANOPORES; RESISTIVE-PULSE TECHNIQUE; DNA TRANSLOCATION; NANOCAPILLARIES; TRANSPORT; MEMBRANES	We show low-cost fabrication and characterization of borosilicate glass nanopores for single molecule sensing. Nanopores with diameters of similar to 100 nm were fabricated in borosilicate glass capillaries using laser assisted glass puller. We further achieve controlled reduction and nanometer-size control in pore diameter by sculpting them under constant electron beam exposure. We successfully fabricate pore diameters down to 6 nm. We next show electrical characterization and low-noise behavior of these borosilicate nanopores and compare their taper geometries. We show, for the first time, a comprehensive characterization of glass nanopore conductance across six-orders of magnitude (1M-1 mu M) of salt conditions, highlighting the role of buffer conditions. Finally, we demonstrate single molecule sensing capabilities of these devices with real-time translocation experiments of individual lambda-DNA molecules. We observe distinct current blockage signatures of linear as well as folded DNA molecules as they undergo voltage-driven translocation through the glass nanopores. We find increased signal to noise for single molecule detection for higher trans-nanopore driving voltages. We propose these nanopores will expand the realm of applications for nanopore platform.	[Bafna, Jayesh A.; Soni, Gautam V.] Raman Res Inst, Bangalore 560080, Karnataka, India	Department of Science & Technology (India); Raman Research Institute (RRI)	Soni, GV (corresponding author), Raman Res Inst, Bangalore 560080, Karnataka, India.	gvsoni@rri.res.in	Gautam, Soni/E-6502-2017	Soni, Gautam/0000-0002-0134-5583	Raman Research Institute India; Department of Biotechnology, India	Raman Research Institute India; Department of Biotechnology, India(Department of Biotechnology (DBT) India)	GVS received startup funds from Raman Research Institute India and Ramalingaswami Fellowship from Department of Biotechnology, India. Raman Research Institute and Department of Biotechnology, India had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Balan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17775; Beamish E, 2013, JOVE-J VIS EXP, DOI 10.3791/51081; Behrens SH, 2001, J CHEM PHYS, V115, P6716, DOI 10.1063/1.1404988; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Briggs K, 2014, SMALL, V10, P2077, DOI 10.1002/smll.201303602; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Calin P, NANOTECHNOLOGY, V26; Carlsen AT, 2014, ACS NANO, V8, P4754, DOI 10.1021/nn501694n; Chen P, 2004, NANO LETT, V4, P2293, DOI 10.1021/nl048654j; DEBLOIS RW, 1977, J COLLOID INTERF SCI, V61, P323, DOI 10.1016/0021-9797(77)90395-2; DEBLOIS RW, 1977, J VIROL, V23, P227, DOI 10.1128/JVI.23.2.227-233.1977; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Farimani AB, 2014, ACS NANO, V8, P7914, DOI 10.1021/nn5029295; German SR, 2013, J PHYS CHEM C, V117, P703, DOI 10.1021/jp310513v; Gong XQ, 2014, ANAL CHEM, V86, P835, DOI 10.1021/ac403391q; Graham MD, 2003, JALA J ASS LAB AUTOM, V8, P72, DOI [DOI 10.1016/S1535-5535(03)00023-6, 10.1016/s1535-5535-03-00023-6, DOI 10.1016/S1535-5535-03-00023-6]; GRAHAME DC, 1947, CHEM REV, V41, P441, DOI 10.1021/cr60130a002; Gu Z, 2015, SOFT MATTER; Heerema SJ, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/7/074001; Kowalczyk SW, 2012, NANOPORES FOR BIOANA; Kuan AT, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4921620; Kwok H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092880; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Liu K, 2014, ACS NANO, V8, P2504, DOI 10.1021/nn406102h; Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t; Min Jun K, 2007, NANOTECHNOLOGY, V18; Schneider GF, 2010, NANO LETT, V10, P3163, DOI [10.1021/nl102069z, 10.1021/nl101046t]; Sischka A, 2015, ANALYST, V140, P4843, DOI 10.1039/c4an02319f; Smeets RMM, 2008, P NATL ACAD SCI USA, V105, P417, DOI 10.1073/pnas.0705349105; Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Soni GV, 2012, NANO LETT, V12, P3180, DOI 10.1021/nl301163m; Steinbock LJ, 2013, NANO LETT, V13, P1717, DOI 10.1021/nl400304y; Steinbock LJ, 2013, ACS NANO, V7, P11255, DOI 10.1021/nn405029j; Steinbock LJ, 2012, ELECTROPHORESIS, V33, P3480, DOI 10.1002/elps.201100663; Steinbock LJ, 2010, NANO LETT, V10, P2493, DOI 10.1021/nl100997s; Storm AJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051903; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Wanunu M, 2012, PHYS LIFE REV, V9, P125, DOI 10.1016/j.plrev.2012.05.010; Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/nnano.2010.202, 10.1038/NNANO.2010.202]; Wendell D, 2009, NAT NANOTECHNOL, V4, P765, DOI [10.1038/NNANO.2009.259, 10.1038/nnano.2009.259]; Yanagi I, 2015, SCI REP-UK, V5, DOI 10.1038/srep14656; Zhang B, 2007, ANAL CHEM, V79, P4778, DOI 10.1021/ac070609j	44	21	22	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157399	10.1371/journal.pone.0157399	http://dx.doi.org/10.1371/journal.pone.0157399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285088	Green Published, gold			2022-12-27	WOS:000377564000064
J	Duan, C; Li, CW; Zhao, L; Subramaniam, S; Yu, XM; Li, YY; Chen, DH; Li, TY; Shen, L; Shi, L; Wang, DY				Duan, Chen; Li, Chun Wei; Zhao, Li; Subramaniam, Somasundaram; Yu, Xue Min; Li, Ying Ying; Chen, De Hua; Li, Tian Ying; Shen, Liang; Shi, Li; Wang, De Yun			Differential Expression Patterns of EGF, EGFR, and ERBB4 in Nasal Polyp Epithelium	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; GENE-EXPRESSION; IN-VITRO; INTRACELLULAR DOMAIN; GOBLET CELLS; REPAIR; LIGANDS; INFLAMMATION; ASTHMA	Epidermal growth factor receptors play an important role in airway epithelial cell growth and differentiation. The current study investigates the expression profiles of EGF, EGFR and ERBB4 in patients with nasal polyps (NP), and their response to glucocorticosteroid (GC) treatment. Fifty patients with NP (40 without GC treatment and 10 with oral GC) and 20 control subjects with septal deviation were recruited into the study. Protein levels of EGF, EGFR, and ERBB4 were evaluated by immune-staining. In healthy nasal epithelium, EGF and EGFR localized within p63(+) basal cells, while ERBB4 localized within ciliated cells. GC-naive NP epithelium showed weak expression of EGF in 90% of samples versus 5% of controls. EGFR was significantly increased in the epithelium with basal cell hyperplasia from GC-naive NPs (78%, 31/40) compared to controls (23%, 4/17). EGFR was also found in some degranulating goblet cells. ERBB4 expression was significantly higher in hyperplastic epithelium from GC-naive NPs (65%, 26/40) than in controls (6%, 1/17). GC treatment restored the EGF expression and normalized the EGFR and ERBB4 expression in NPs. Differential expression patterns of EGF, EGFR, and ERBB4 are essential in epithelial restitution and remodeling in nasal epithelium.	[Duan, Chen; Zhao, Li; Shi, Li] Shandong Univ, Hosp 2, Dept Otolaryngol, Jinan 250100, Peoples R China; [Duan, Chen; Li, Chun Wei; Li, Ying Ying; Wang, De Yun] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Otolaryngol, Singapore 117548, Singapore; [Li, Chun Wei; Chen, De Hua; Li, Tian Ying] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Guangzhou 510275, Guangdong, Peoples R China; [Subramaniam, Somasundaram] Ng Teng Fong Gen Hosp, Dept Otolaryngol, Singapore, Singapore; [Yu, Xue Min] Shandong Univ, Qilu Hosp, Dept Otolaryngol, Jinan 250100, Peoples R China; [Shen, Liang] Natl Univ Singapore, Natl Univ Hlth Syst, Biostat Unit, Singapore 117548, Singapore	Shandong University; National University of Singapore; Sun Yat Sen University; Shandong University; National University of Singapore	Shi, L (corresponding author), Shandong Univ, Hosp 2, Dept Otolaryngol, Jinan 250100, Peoples R China.; Wang, DY (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Dept Otolaryngol, Singapore 117548, Singapore.	shili126@sina.com; entwdy@nus.edu.sg			National Medical Research Council (NMRC) [IRG10may086, CIRG12Nov033]; Singapore Immunology Network (SIgN) of Singapore [SIgN 10-028]; National Nature Science Foundation of China [81170897, 81441028]	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Singapore Immunology Network (SIgN) of Singapore; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Medical Research Council (NMRC, IRG10may086, CIRG12Nov033) and from Singapore Immunology Network (SIgN, SIgN 10-028) of Singapore; and the National Nature Science Foundation of China (Grant awarded number 81170897, 81441028).	Burgel PR, 2000, J ALLERGY CLIN IMMUN, V106, P705, DOI 10.1067/mai.2000.109823; Cho HY, 2000, AM J RESP CRIT CARE, V162, P629, DOI 10.1164/ajrccm.162.2.9811078; Fiaturi N, 2014, J CELL COMMUN SIGNAL, V8, P105, DOI 10.1007/s12079-014-0233-y; Frey MR, 2014, PEDIATR RES, V75, P127, DOI 10.1038/pr.2013.210; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; Holgate ST, 2000, CLIN EXP ALLERGY, V30, P37; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Johnson AC, 2000, MOL MED, V6, P17, DOI 10.1007/BF03401931; Lee HM, 2001, J ALLERGY CLIN IMMUN, V107, P1046, DOI 10.1067/mai.2001.115140; Li CW, 2009, THORAX, V64, P306, DOI 10.1136/thx.2008.106096; Li CW, 2011, J ALLERGY CLIN IMMUN, V127, P765, DOI 10.1016/j.jaci.2010.12.011; Li YY, 2014, J ALLERGY CLIN IMMUN, V134, P1282, DOI 10.1016/j.jaci.2014.07.038; Linggi B, 2006, J BIOL CHEM, V281, P25373, DOI 10.1074/jbc.M603998200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Muraoka-Cook RS, 2006, MOL BIOL CELL, V17, P4118, DOI 10.1091/mbc.E06-02-0101; Park JA, 2005, AM J PATHOL, V167, P651, DOI 10.1016/S0002-9440(10)62040-8; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Polosa R, 2002, J ALLERGY CLIN IMMUN, V109, P75, DOI 10.1067/mai.2002.120274; Polosa R, 2000, J ALLERGY CLIN IMMUN, V106, P1124; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Schneider MR, 2009, TRENDS ENDOCRIN MET, V20, P517, DOI 10.1016/j.tem.2009.06.008; Sundvall M, 2010, MOL BIOL CELL, V21, P4275, DOI 10.1091/mbc.E10-04-0332; Turner J, 2011, AM J RESP CELL MOL, V44, P276, DOI 10.1165/rcmb.2009-0304OC; Voynow JA, 2004, AM J PHYSIOL-LUNG C, V287, pL1293, DOI 10.1152/ajplung.00140.2004; Wadsworth SJ, 2006, J CLIN IMMUNOL, V26, P376, DOI 10.1007/s10875-006-9029-z; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Yu XM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04619; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zscheppang K, 2011, AM J RESP CELL MOL, V45, P761, DOI 10.1165/rcmb.2010-0179OC	30	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156949	10.1371/journal.pone.0156949	http://dx.doi.org/10.1371/journal.pone.0156949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285994	gold, Green Submitted, Green Published			2022-12-27	WOS:000377564000032
J	Huang, V; Peck, K; Mallya, S; Lupien, SJ; Fiocco, AJ				Huang, Vivian; Peck, Katlyn; Mallya, Sasha; Lupien, Sonia J.; Fiocco, Alexandra J.			Subjective Sleep Quality as a Possible Mediator in the Relationship between Personality Traits and Depressive Symptoms in Middle-Aged Adults	PLOS ONE			English	Article							STRESSFUL LIFE EVENTS; MAJOR DEPRESSION; ANXIETY DISORDERS; HIGHER-ORDER; NEUROTICISM; INSOMNIA; POPULATION; CONSCIENTIOUSNESS; DISTURBANCE; PREDICTORS	This study explored the mediating role of sleep in the relationship between personality traits and depressive symptoms in a group of community-dwelling men and women (M-age = 57.92, SD = 4.00). Participants completed the short form NEO Five Factor Inventory (NEO-FFI), Pittsburgh Sleep Quality Index (PSQI), and the Center for Epidemiologic Studies Depression Scale (CES-D). High neuroticism and low conscientiousness was associated with poor sleep, as well as greater depressive symptom severity. Partial indirect mediation effects were found between personality traits (i.e., neuroticism and conscientiousness) and depressive symptoms through self-report sleep measures. An alternative model was also explored, entering depression as the mediator; however a smaller portion of the variance was explained by this model, compared with the hypothesized model. The current study provides preliminary information regarding the mechanisms that influence the relationship between personality traits, sleep, and depression among a group of community-dwelling middle-aged adults. Implications and future directions are discussed.	[Huang, Vivian; Peck, Katlyn; Mallya, Sasha; Fiocco, Alexandra J.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Lupien, Sonia J.] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada	Toronto Metropolitan University; Universite de Montreal	Fiocco, AJ (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.	afiocco@psych.ryerson.ca		Fiocco, Alexandra/0000-0002-9353-476X				Akerstedt T, 2006, SCAND J WORK ENV HEA, V32, P493, DOI 10.5271/sjweh.1054; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Atkinson G, 2007, PHYSIOL BEHAV, V90, P229, DOI 10.1016/j.physbeh.2006.09.015; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Barbui C, 2006, EPIDEMIOL PSICHIAT S, V15, P276, DOI 10.1017/S1121189X00002165; Bartley CE, 2011, PERS INDIV DIFFER, V50, P79, DOI 10.1016/j.paid.2010.08.027; Bienvenu OJ, 2004, DEPRESS ANXIETY, V20, P92, DOI 10.1002/da.20026; BM Corp, IBM SPSS STATISTICS; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Calkins AW, 2013, BEHAV SLEEP MED, V11, P133, DOI 10.1080/15402002.2011.643968; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Cho HJ, 2008, AM J PSYCHIAT, V165, P1543, DOI 10.1176/appi.ajp.2008.07121882; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080; COSTA PT, 1991, PERS INDIV DIFFER, V12, P887, DOI 10.1016/0191-8869(91)90177-D; Costa PT, 2007, REVISED NEO PERSONAL; Danielsson NS, 2010, PERS INDIV DIFFER, V48, P463, DOI 10.1016/j.paid.2009.11.023; de Graaf R, 2002, ACTA PSYCHIAT SCAND, V106, P303, DOI 10.1034/j.1600-0447.2002.01397.x; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; Duggan KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090628; Fanous AH, 2007, PSYCHOL MED, V37, P1163, DOI 10.1017/S0033291707000244; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Friedman EM, 2007, PSYCHOSOM MED, V69, P682, DOI 10.1097/PSY.0b013e31814ceada; Gelfand LA, 2009, J GEN PSYCHOL, V136, P153, DOI 10.3200/GENP.136.2.153-178; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Gray EK, 2002, J PERS, V70, P177; Hall M, 2000, PSYCHOSOM MED, V62, P227, DOI 10.1097/00006842-200003000-00014; Harman JS, 2004, PSYCHIAT SERV, V55, P1379, DOI 10.1176/appi.ps.55.12.1379; Harvey AG, 2001, CLIN PSYCHOL REV, V21, P1037, DOI 10.1016/S0272-7358(00)00083-0; Harvey CJ, 2014, SLEEP MED REV, V18, P237, DOI 10.1016/j.smrv.2013.11.004; Hayes A. F., 2013, INTRODUCTION TO MEDI; Hayes AF, 2013, PSYCHOL SCI, V24, P1918, DOI 10.1177/0956797613480187; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hintsanen M, 2014, HEALTH PSYCHOL, V33, P1214, DOI 10.1037/hea0000105; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kern ML, 2008, HEALTH PSYCHOL, V27, P505, DOI 10.1037/0278-6133.27.5.505; Kessler R., 2010, J LIFELONG LEARNING, V8, P459, DOI DOI 10.1176/FOC.8.3.FOC459; Klein DN, 2011, ANNU REV CLIN PSYCHO, V7, P269, DOI 10.1146/annurev-clinpsy-032210-104540; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Lee E, 2013, SLEEP, V36, P1685, DOI 10.5665/sleep.3128; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Mallinckrodt B, 2006, J COUNS PSYCHOL, V53, P372, DOI 10.1037/0022-0167.53.3.372; Manber R, 2009, CURR PSYCHIAT REP, V11, P437, DOI 10.1007/s11920-009-0066-1; MCCRAE RR, 1995, EUR J PERSONALITY, V9, P231, DOI 10.1002/per.2410090402; McCrae RR, 2005, HANDBOOK OF PERSONAL, P159; McHugh JE, 2011, AGING MENT HEALTH, V15, P749, DOI 10.1080/13607863.2011.562180; Meeks TW, 2011, J AFFECT DISORDERS, V129, P126, DOI 10.1016/j.jad.2010.09.015; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 2003, PSYCHOSOM MED, V65, P259, DOI 10.1097/01.PSY.0000030391.09558.A3; Muris P, 2005, PERS INDIV DIFFER, V39, P1105, DOI 10.1016/j.paid.2005.04.005; Naragon-Gainey K, 2014, ASSESSMENT, V21, P387, DOI 10.1177/1073191114528030; Nyer M, 2013, DEPRESS ANXIETY, V30, P873, DOI 10.1002/da.22064; O'Connor DB, 2009, ANN BEHAV MED, V37, P184, DOI 10.1007/s12160-009-9087-6; Ohayon MM, 2003, J PSYCHIAT RES, V37, P9, DOI 10.1016/S0022-3956(02)00052-3; Ormel J, 2004, ARCH GEN PSYCHIAT, V61, P990, DOI 10.1001/archpsyc.61.10.990; Pandi-Perumal SR, 2009, PROG NEUROBIOL, V88, P264, DOI 10.1016/j.pneurobio.2009.04.007; Pek J, 2016, SOC PERSONAL PSYCHOL, V10, P150, DOI 10.1111/spc3.12237; Perlis Michael L, 2006, Behav Sleep Med, V4, P104, DOI 10.1207/s15402010bsm0402_3; Perlman CA, 2006, BIPOLAR DISORD, V8, P271, DOI 10.1111/j.1399-5618.2006.00330.x; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Quilty LC, 2008, J AFFECT DISORDERS, V108, P241, DOI 10.1016/j.jad.2007.10.022; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Randler C, 2008, PERS INDIV DIFFER, V45, P191, DOI 10.1016/j.paid.2008.03.007; REYNER A, 1995, SLEEP, V18, P127; Roberts BW, 2004, J PERS, V72, P325, DOI 10.1111/j.0022-3506.2004.00264.x; Roberts BW, 2003, J PERS SOC PSYCHOL, V84, P582, DOI 10.1037/0022-3514.84.3.582; Roehrs T, 2008, SLEEP MED REV, V12, P153, DOI 10.1016/j.smrv.2007.07.004; Roelofs J, 2008, BEHAV RES THER, V46, P1283, DOI 10.1016/j.brat.2008.10.002; SAKLOFSKE DH, 1995, PERS INDIV DIFFER, V18, P27, DOI 10.1016/0191-8869(94)00128-F; Sbarra DA, 2009, J ABNORM PSYCHOL, V118, P171, DOI 10.1037/a0014375; Schneider TR, 2012, STRESS HEALTH, V28, P102, DOI 10.1002/smi.1409; Staner L, 2010, SLEEP MED REV, V14, P35, DOI 10.1016/j.smrv.2009.09.003; van de Laar M, 2010, SLEEP MED REV, V14, P61, DOI 10.1016/j.smrv.2009.07.007; Vincent N, 2009, COMPR PSYCHIAT, V50, P158, DOI 10.1016/j.comppsych.2008.07.007; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Weber K, 2012, AGING MENT HEALTH, V16, P472, DOI 10.1080/13607863.2011.630375; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Williams PG, 2009, PERS INDIV DIFFER, V46, P598, DOI 10.1016/j.paid.2008.12.017; Yoon KL, 2013, ANXIETY STRESS COPIN, V26, P558, DOI 10.1080/10615806.2012.734810; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55	84	18	19	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157238	10.1371/journal.pone.0157238	http://dx.doi.org/10.1371/journal.pone.0157238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1UG	27285159	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000046
J	Ali, SM; Mehmood, CA; Khan, B; Jawad, M; Farid, U; Jadoon, JK; Ali, M; Tareen, NK; Usman, S; Majid, M; Anwar, SM				Ali, S. M.; Mehmood, C. A.; Khan, B.; Jawad, M.; Farid, U.; Jadoon, J. K.; Ali, M.; Tareen, N. K.; Usman, S.; Majid, M.; Anwar, S. M.			Stochastic and Statistical Analysis of Utility Revenues and Weather Data Analysis for Consumer Demand Estimation in Smart Grids	PLOS ONE			English	Article								In smart grid paradigm, the consumer demands are random and time-dependent, owning towards stochastic probabilities. The stochastically varying consumer demands have put the policy makers and supplying agencies in a demanding position for optimal generation management. The utility revenue functions are highly dependent on the consumer deterministic stochastic demand models. The sudden drifts in weather parameters effects the living standards of the consumers that in turn influence the power demands. Considering above, we analyzed stochastically and statistically the effect of random consumer demands on the fixed and variable revenues of the electrical utilities. Our work presented the Multi-Variate Gaussian Distribution Function (MVGDF) probabilistic model of the utility revenues with time-dependent consumer random demands. Moreover, the Gaussian probabilities outcome of the utility revenues is based on the varying consumer n demands data-pattern. Furthermore, Standard Monte Carlo (SMC) simulations are performed that validated the factor of accuracy in the aforesaid probabilistic demand-revenue model. We critically analyzed the effect of weather data parameters on consumer demands using correlation and multi-linear regression schemes. The statistical analysis of consumer demands provided a relationship between dependent (demand) and independent variables (weather data) for utility load management, generation control, and network expansion.	[Ali, S. M.; Mehmood, C. A.; Khan, B.; Farid, U.; Jadoon, J. K.; Tareen, N. K.] COMSATS Inst IT, Dept Elect Engn, Abbottabad, Kpk, Pakistan; [Jawad, M.] COMSATS Inst IT, Dept Elect Engn, Lahore, Pakistan; [Ali, M.] COMSATS Inst IT, Dept Comp Sci, Abbottabad, Kpk, Pakistan; [Usman, S.] COMSATS Inst IT, Dept Elect Engn, Sahiwal, Pakistan; [Majid, M.] Univ Engn & Technol, Dept Comp Engn, Taxila, Pakistan; [Anwar, S. M.] Univ Engn & Technol, Software Engn Dept, Taxila, Pakistan	COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); University of Engineering & Technology Taxila; University of Engineering & Technology Taxila	Farid, U (corresponding author), COMSATS Inst IT, Dept Elect Engn, Abbottabad, Kpk, Pakistan.	umarfarid@ciit.net.pk	Farid, Umar/Z-1203-2019; Mehmood, Chaudhry/ABB-5669-2021; Majid, Muhammad/Z-5667-2019; Anwar, Syed/AAN-4398-2020; Jawad, Muhammad/H-5765-2018	Mehmood, Chaudhry/0000-0003-1796-3180; Majid, Muhammad/0000-0003-3662-2525; Anwar, Syed/0000-0002-8179-3959; Jawad, Muhammad/0000-0003-3730-2128				Ali SM, 2014, INT CONF ELECTRO INF, P459, DOI 10.1109/EIT.2014.6871808; Awad A., 2012, 2012 INT C SMART GRI, P1; Bienstock D, 2013, IEEE DECIS CONTR P, P4335, DOI 10.1109/CDC.2013.6760556; Blum, 2012, 2012 46 ANN C INF SC, P1, DOI [10.1109/CISS.2012.6310731, DOI 10.1109/CISS.2012.6310731]; Deng RL, 2014, IEEE T POWER SYST, V29, P2823, DOI 10.1109/TPWRS.2014.2311127; Dickert J., 2011, 2011 IEEE PES TRONDH, P1; Goddard NH, 2012, SUST INTERNET ICT; Goude Y, 2014, IEEE T SMART GRID, V5, P440, DOI 10.1109/TSG.2013.2278425; Harsha P, 2013, IEEE T SMART GRID, V4, P2274, DOI 10.1109/TSG.2013.2278238; He Y., 2013, P IEEE PES INN SMART, P1; Hobby JD, 2012, IEEE T SMART GRID, V3, P217, DOI 10.1109/TSG.2011.2167353; Hong T, 2014, IEEE T SMART GRID, V5, P456, DOI 10.1109/TSG.2013.2274373; Hosseini SS, 2013, 2013 INTERNATIONAL CONFERENCE ON POWER, ENERGY AND CONTROL (ICPEC), P728, DOI 10.1109/ICPEC.2013.6527751; Imamura Akiyuki, 2013, 2013 IEEE Region 10 Humanitarian Technology Conference (R10-HTC), P148, DOI 10.1109/R10-HTC.2013.6669032; Kekatos V., 2013, 2013 IEEE PES INN SM, P1; Li J, 2014, 2014 INTERNATIONAL CONFERENCE ON POWER SYSTEM TECHNOLOGY (POWERCON), P852, DOI 10.1109/POWERCON.2014.6993892; Liu M, CONTROL SYSTEMS TECH, VPP, P1; Ma T, 2014, IEEE T IND APPL, V50, P2323, DOI 10.1109/TIA.2013.2296620; Niyato D, 2013, IEEE T SMART GRID, V4, P21, DOI 10.1109/TSG.2012.2224677; Sahibzada M. A, 2013, IREE, V8, P262; Samadi M., 2013, 2013 21 IR C EL ENG, P1, DOI DOI 10.1109/IRANIANCEE.2013.6599801; Shafiq M. Zubair, 2013, Performance Evaluation Review, V41, P17; Sheikhalr A., 2013, IEEE GRENOBLE POWERT, P1; Shengrong Bu, 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P307, DOI 10.1109/INFCOMW.2011.5928828; Shi D, 2014, IEEE POW ENER SOC GE; Shirzeh H, 2013, P IEEE EN MAY 2013, P1; Tigas K., 2012, P IEEE INT C REN EN, P1; Verzijlbergh RA, 2013, IEEE INT C NETW SENS, P889, DOI 10.1109/ICNSC.2013.6548855; Zhou Y., 2012, 2012 IEEE PES Innovative Smart Grid Technologies (ISGT), DOI 10.1109/ISGT.2012.6175805	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0156849	10.1371/journal.pone.0156849	http://dx.doi.org/10.1371/journal.pone.0156849			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314229	gold, Green Published, Green Submitted			2022-12-27	WOS:000378030000005
J	Hector, RD; Dando, O; Landsberger, N; Kilstrup-Nielsen, C; Kind, PC; Bailey, MES; Cobb, SR				Hector, Ralph D.; Dando, Owen; Landsberger, Nicoletta; Kilstrup-Nielsen, Charlotte; Kind, Peter C.; Bailey, Mark E. S.; Cobb, Stuart R.			Characterisation of CDKL5 Transcript Isoforms in Human and Mouse	PLOS ONE			English	Article							INTEGRATIVE GENOMICS VIEWER; MENTAL-RETARDATION; INFANTILE SPASMS; C-TERMINUS; ARRAY-CGH; GENE; MUTATIONS; ENCEPHALOPATHIES; PREDICTION; DISORDER	Mutations in the X-linked Cyclin-Dependent Kinase-Like 5 gene (CDKL5) cause early onset infantile spasms and subsequent severe developmental delay in affected children. Deleterious mutations have been reported to occur throughout the CDKL5 coding region. Several studies point to a complex CDKL5 gene structure in terms of exon usage and transcript expression. Improvements in molecular diagnosis and more extensive research into the neurobiology of CDKL5 and pathophysiology of CDKL5 disorders necessitate an updated analysis of the gene. In this study, we have analysed human and mouse CDKL5 transcript patterns both bioinformatically and experimentally. We have characterised the predominant brain isoform of CDKL5, a 9.7 kb transcript comprised of 18 exons with a large 6.6 kb 3'-untranslated region (UTR), which we name hCDKL5_1. In addition we describe new exonic regions and a range of novel splice and UTR isoforms. This has enabled the description of an updated gene model in both species and a standardised nomenclature system for CDKL5 transcripts. Profiling revealed tissue-and brain development stage-specific differences in expression between transcript isoforms. These findings provide an essential backdrop for the diagnosis of CDKL5-related disorders, for investigations into the basic biology of this gene and its protein products, and for the rational design of gene-based and molecular therapies for these disorders.	[Hector, Ralph D.; Cobb, Stuart R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Dando, Owen; Kind, Peter C.] Univ Edinburgh, Patrick Wild Ctr, Edinburgh, Midlothian, Scotland; [Dando, Owen; Kind, Peter C.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Dando, Owen; Kind, Peter C.] Inst Stem Cell Biol & Regenerat Med, Ctr Brain Dev & Repair, Bangalore, Karnataka, India; [Landsberger, Nicoletta] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Kilstrup-Nielsen, Charlotte] Univ Insubria, Dept Theoret & Appl Sci, Div Biomed Res, Busto Arsizio, Italy; [Bailey, Mark E. S.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Edinburgh; University of Edinburgh; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; University of Milan; University of Insubria; University of Glasgow	Cobb, SR (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	stuart.cobb@glasgow.ac.uk	Hector, Ralph D/AAB-5455-2019	Hector, Ralph D/0000-0002-3778-1483; Kind, Peter/0000-0002-4256-9639; Dando, Owen/0000-0002-6269-6408; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077; Landsberger, Nicoletta/0000-0003-0820-3155; Bailey, Mark E. S./0000-0002-9788-2278	Chief Scientist Office of the Scottish Government [ETM/334]; Rett Syndrome Association Scotland; Italian parents' association L'Albero di Greta; Medical Research Council [MR/K014137/1] Funding Source: researchfish; Chief Scientist Office [ETM/334] Funding Source: researchfish; MRC [MR/K014137/1] Funding Source: UKRI	Chief Scientist Office of the Scottish Government; Rett Syndrome Association Scotland; Italian parents' association L'Albero di Greta; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Chief Scientist Office of the Scottish Government (grant ETM/334) and the Rett Syndrome Association Scotland provided funding to SRC and MESB. NL and CKN are supported by the Italian parents' association L'Albero di Greta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091613; Artuso R, 2010, BRAIN DEV-JPN, V32, P17, DOI 10.1016/j.braindev.2009.02.004; Bahi-Buisson N, 2008, BRAIN, V131, P2647, DOI 10.1093/brain/awn197; Bahi-Buisson N, 2008, EPILEPSIA, V49, P1027, DOI 10.1111/j.1528-1167.2007.01520.x; Bahi-Buisson N, 2010, AM J MED GENET B, V153B, P202, DOI 10.1002/ajmg.b.30974; Bartnik M, 2011, GENET MED, V13, P447, DOI 10.1097/GIM.0b013e31820605f5; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Christodoulou J, 2003, HUM MUTAT, V21, P466, DOI 10.1002/humu.10194; Diebold B, 2014, EUR J HUM GENET, V22, P270, DOI 10.1038/ejhg.2013.133; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fehr S, 2015, J NEURODEV DISORD, V7, DOI 10.1186/1866-1955-7-2; Fehr S, 2013, EUR J HUM GENET, V21, P266, DOI 10.1038/ejhg.2012.156; Fichou Y, 2011, J HUM GENET, V56, P52, DOI 10.1038/jhg.2010.143; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Intusoma U, 2011, EUR J PAEDIATR NEURO, V15, P432, DOI 10.1016/j.ejpn.2011.01.005; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Katz Y, 2015, BIOINFORMATICS, V31, P2400, DOI 10.1093/bioinformatics/btv034; Kilstrup-Nielsen C, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/728267; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; La Montanara P, 2015, J BIOL CHEM, V290, P4512, DOI 10.1074/jbc.M114.589762; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; McMahon AC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1900; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; Montini E, 1997, HUM MOL GENET, V6, P1137, DOI 10.1093/hmg/6.7.1137; Moseley BD, 2012, PEDIATR NEUROL, V46, P101, DOI 10.1016/j.pediatrneurol.2011.11.007; Nemos C, 2009, CLIN GENET, V76, P357, DOI 10.1111/j.1399-0004.2009.01194.x; Pecorelli A, 2015, FREE RADICAL BIO MED, V86, P156, DOI 10.1016/j.freeradbiomed.2015.05.010; Rademacher N, 2011, NEUROGENETICS, V12, P165, DOI 10.1007/s10048-011-0277-6; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rusconi L, 2008, J BIOL CHEM, V283, P30101, DOI 10.1074/jbc.M804613200; Tao J, 2004, AM J HUM GENET, V75, P1149, DOI 10.1086/426460; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tzschach A, 2008, AM J MED GENET A, V146A, P197, DOI 10.1002/ajmg.a.32070; Vavouri T, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r110; Vitezic M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1177; Vorozheykin PS, 2015, MOL BIOL+, V49, P755, DOI 10.1134/S0026893315050192; Wang ITJ, 2012, P NATL ACAD SCI USA, V109, P21516, DOI 10.1073/pnas.1216988110; Weaving LS, 2004, AM J HUM GENET, V75, P1079, DOI 10.1086/426462; Williamson SL, 2012, HUM GENET, V131, P187, DOI 10.1007/s00439-011-1058-x; Yamashita R, 2012, NUCLEIC ACIDS RES, V40, pD150, DOI 10.1093/nar/gkr1005; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhu YC, 2013, P NATL ACAD SCI USA, V110, P9118, DOI 10.1073/pnas.1300003110	50	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157758	10.1371/journal.pone.0157758	http://dx.doi.org/10.1371/journal.pone.0157758			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315173	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000378030000052
J	Ali, GC; Ryan, G; De Silva, MJ				Ali, Gemma-Claire; Ryan, Grace; De Silva, Mary J.			Validated Screening Tools for Common Mental Disorders in Low and Middle Income Countries: A Systematic Review	PLOS ONE			English	Review							DEPRESSION SCALE; VALIDITY; ANXIETY; HEALTH; MORBIDITY; QUESTIONNAIRE; DIAGNOSIS; CARE	Background A wide range of screening tools are available to detect common mental disorders (CMDs), but few have been specifically developed for populations in low and middle income countries (LMIC). Cross-cultural application of a screening tool requires that its validity be assessed against a gold standard diagnostic interview. Validation studies of brief CMD screening tools have been conducted in several LMIC, but until now there has been no review of screening tools for all CMDs across all LMIC populations. Methods A systematic review with broad inclusion criteria was conducted, producing a comprehensive summary of brief CMD screening tools validated for use in LMIC populations. For each validation, the diagnostic odds ratio (DOR) was calculated as an easily comparable measure of screening tool validity. Average DOR results weighted by sample size were calculated for each screening tool, enabling us to make broad recommendations about best performing screening tools. Results 153 studies fulfilled our inclusion criteria. Because many studies validated two or more screening tools, this corresponded to 273 separate validations against gold standard diagnostic criteria. We found that the validity of every screening tool tested in multiple settings and populations varied between studies, highlighting the importance of local validation. Many of the best performing tools were purposely developed for a specific population; however, as these tools have only been validated in one study, it is not possible to draw broader conclusions about their applicability in other contexts. Conclusions Of the tools that have been validated in multiple settings, the authors broadly recommend using the SRQ-20 to screen for general CMDs, the GHQ-12 for CMDs in populations with physical illness, the HADS-D for depressive disorders, the PHQ-9 for depressive disorders in populations with good literacy levels, the EPDS for perinatal depressive disorders, and the HADS-A for anxiety disorders. We recommend that, wherever possible, a chosen screening tool should be validated against a gold standard diagnostic assessment in the specific context in which it will be employed.	[Ali, Gemma-Claire] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Ali, Gemma-Claire; Ryan, Grace; De Silva, Mary J.] Ctr Global Mental Hlth, London, England; [Ryan, Grace] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [De Silva, Mary J.] Wellcome Trust Res Labs, Dept Populat Environm & Hlth, London, England	University of Cambridge; University of London; London School of Hygiene & Tropical Medicine	Ali, GC (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.; Ali, GC (corresponding author), Ctr Global Mental Hlth, London, England.	gemmaclaire.ali@gmail.com	Ali, Gemma-Claire/O-7032-2018	Ali, Gemma-Claire/0000-0001-7510-2034	Grand Challenges Canada [EPPHZG35-10]	Grand Challenges Canada(CGIAR)	Grand Challenges Canada EPPHZG35-10 http://www.grandchallenges.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas M, 2014, TROP MED INT HEALTH, V19, P1392, DOI 10.1111/tmi.12382; ABIODUN OA, 1993, COMPR PSYCHIAT, V34, P10, DOI 10.1016/0010-440X(93)90030-8; ABIODUN OA, 1994, BRIT J PSYCHIAT, V165, P669, DOI 10.1192/bjp.165.5.669; Adewuya AO, 2006, J PSYCHOSOM OBST GYN, V27, P267, DOI 10.1080/01674820600915478; Adewuya AO, 2006, J AFFECT DISORDERS, V96, P89, DOI 10.1016/j.jad.2006.05.021; Akena D, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-187; Azah N MN, 2005, VALIDATION MALAY VER; Bass JK, 2008, TROP MED INT HEALTH, V13, P1534, DOI 10.1111/j.1365-3156.2008.02160.x; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; Bronstein I, 2011, CLIN CHILD FAM PSYCH, V14, P44, DOI 10.1007/s10567-010-0081-0; Brown LF, 2009, PSYCHOSOMATICS, V50, P440, DOI 10.1176/appi.psy.50.5.440; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Greenhalgh T, 2006, READ PAPER BASICS EV, P98; Hotopf M, 2002, PREVALENCE CASE FIND, V16, P81; Khamseh ME, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-61; Kirmayer LJ, 2001, J CLIN PSYCHIAT, V62, P22; Lindert J, 2009, SOC SCI MED, V69, P246, DOI 10.1016/j.socscimed.2009.04.032; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Missinne S, 2012, SOC PSYCH PSYCH EPID, V47, P97, DOI 10.1007/s00127-010-0321-0; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mumford DB, 2005, J AFFECT DISORDERS, V88, P175, DOI 10.1016/j.jad.2005.05.015; Patel V, 1998, CULTURE COMMON MENTA; Reuland DS, 2009, ANN FAM MED, V7, P455, DOI 10.1370/afm.981; Rumble S, 1996, PSYCHOL MED, V26, P997, DOI 10.1017/S0033291700035327; Sheng L, 2010, ASIAN J PSYCHIATR, V3, P227, DOI 10.1016/j.ajp.2010.07.011; Simon GE, 2003, BIOL PSYCHIAT, V54, P208, DOI 10.1016/S0006-3223(03)00420-7; Tsai AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082521; Uwakwe R, 2003, ACTA PSYCHIAT SCAND, V107, P251, DOI 10.1034/j.1600-0447.2003.02477.x; Vythilingum B, 2013, ARCH WOMEN MENT HLTH, V16, P371, DOI 10.1007/s00737-013-0343-1; Wang Y., 2012, J CHINESE PEOPLES LI, V37, P420; World Health Organization , 2014, PROC TRANSL AD INSTR; World Health Organization, 2010, INT CLASSIFICATION D; Wu CM, 2007, J GERONTOL NURS, V33, P12, DOI 10.3928/00989134-20070801-04; Zhang YL, 2013, ASIA-PAC PSYCHIAT, V5, P268, DOI 10.1111/appy.12103	35	150	154	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156939	10.1371/journal.pone.0156939	http://dx.doi.org/10.1371/journal.pone.0156939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310297	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000378029800020
J	Lopez, AG; Seoane, JM; Sanjuan, MAF				Lopez, Alvaro G.; Seoane, Jesus M.; Sanjuan, Miguel A. F.			Decay Dynamics of Tumors	PLOS ONE			English	Article							MODEL; HALLMARKS; GROWTH	The fractional cell kill is a mathematical expression describing the rate at which a certain population of cells is reduced to a fraction of itself. We investigate the mathematical function that governs the rate at which a solid tumor is lysed by a cell population of cytotoxic lymphocytes. We do it in the context of enzyme kinetics, using geometrical and analytical arguments. We derive the equations governing the decay of a tumor in the limit in which it is plainly surrounded by immune cells. A cellular automaton is used to test such decay, confirming its validity. Finally, we introduce a modification in the fractional cell kill so that the expected dynamics is attained in the mentioned limit. We also discuss the potential of this new function for non-solid and solid tumors which are infiltrated with lymphocytes.	[Lopez, Alvaro G.; Seoane, Jesus M.; Sanjuan, Miguel A. F.] Univ Rey Juan Carlos, Nonlinear Dynam Chaos & Complex Syst Grp, Dept Fis, Tulipan S-N, Madrid, Spain	Universidad Rey Juan Carlos	Lopez, AG (corresponding author), Univ Rey Juan Carlos, Nonlinear Dynam Chaos & Complex Syst Grp, Dept Fis, Tulipan S-N, Madrid, Spain.	alvaro.lopez@urjc.es	Sanjuán, Miguel AF/B-7709-2011; Lopez, Alvaro Garcia/Y-9898-2019; García, Alvaro/B-8422-2015	Sanjuán, Miguel AF/0000-0003-3515-0837; Lopez, Alvaro Garcia/0000-0002-2485-4639; 	Spanish Ministry of Economy and Competitiveness [FIS2013-40653-P]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness under project number FIS2013-40653-P.	de Pillis L. G., 2005, CANCER RES, V6, P235; De Pillis LG, 2003, MATH COMPUT MODEL, V37, P1221, DOI 10.1016/S0895-7177(03)00133-X; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Ferreira SC, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021907; Garcia A., 2016, FRACTIONAL CELL KILL; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Holling C. S., 1959, Canadian Entomologist, V91, P385; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; KUZNETSOV VA, 1994, B MATH BIOL, V56, P295, DOI 10.1007/BF02460644; Lopez AG, 2014, B MATH BIOL, V76, P2884, DOI 10.1007/s11538-014-0037-5; Lotka AJ, 1920, P NATL ACAD SCI USA, V6, P410, DOI 10.1073/pnas.6.7.410; Mallet DG, 2006, J THEOR BIOL, V239, P334, DOI 10.1016/j.jtbi.2005.08.002; Michaelis L, 1913, BIOCHEM Z, V49, P333; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Norton L, 2005, ONCOLOGIST, V10, P370, DOI 10.1634/theoncologist.10-6-370; Schaller G, 2006, PHILOS T R SOC A, V364, P1443, DOI 10.1098/rsta.2006.1780; Sonnenschein C, 2013, J BIOSCIENCES, V38, P651, DOI 10.1007/s12038-013-9335-6; Sonnenschein C, 2011, CANCER RES, V71, P4334, DOI 10.1158/0008-5472.CAN-11-0639; VOLTERRA VITO, 1926, MEM R ACCAD NAZ LINCEI CL FIS MAT E NAT, V2, P31; Witz IP, 2006, CANCER LETT, V242, P1, DOI 10.1016/j.canlet.2005.12.005	23	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157689	10.1371/journal.pone.0157689	http://dx.doi.org/10.1371/journal.pone.0157689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310010	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800122
J	Vartun, A; Flo, K; Widnes, C; Acharya, G				Vartun, Ase; Flo, Kari; Widnes, Christian; Acharya, Ganesh			Static and Functional Hemodynamic Profiles of Women with Abnormal Uterine Artery Doppler at 22-24 Weeks of Gestation	PLOS ONE			English	Article							THORACIC ELECTRICAL BIOIMPEDANCE; CARDIAC-OUTPUT; IMPEDANCE CARDIOGRAPHY; DIASTOLIC FUNCTION; NORMAL-PREGNANCY; BLOOD-FLOW; PREECLAMPSIA; TERM; ECHOCARDIOGRAPHY; COMPLICATIONS	Objective To compare cardiac function, systemic hemodynamics and preload reserve of women with increased (cases) and normal (controls) uterine artery (UtA) pulsatility index (PI) at 22-24 weeks of gestation. Materials and Methods A prospective cross-sectional study of 620 pregnant women. UtA blood flow velocities were measured using Doppler ultrasonography, and PI was calculated. Mean UtA PI >= 1.16 (90th percentile) was considered abnormal. Maternal hemodynamics was investigated at baseline and during passive leg raising (PLR) using impedance cardiography (ICG). Preload reserve was defined as percent increase in stroke volume (SV) 90 seconds after passive leg raising compared to baseline. Results Mean UtA PI was 1.49 among cases (n = 63) and 0.76 among controls (n = 557) (p < 0.0001). Eighteen (28.6%) cases and 53 (9.5%) controls developed pregnancy complications (p < 0.0001). The mean arterial pressure and systemic vascular resistance were 83 mmHg and 1098.89 +/- 293.87 dyne s/cm(5) among cases and 79 mmHg and 1023.95 +/- 213.83 dyne s/cm(5) among controls (p = 0.007 and p = 0.012, respectively). Heart rate, SV and cardiac output were not different between the groups. Both cases and controls responded with a small (4-5%) increase in SV in response to PLR, but the cardiac output remained unchanged. The preload reserve was not significantly different between two groups. Conclusion Pregnant women with abnormal UtA PI had higher blood pressure and systemic vascular resistance, but similar functional hemodynamic profile at 22-24 weeks compared to controls. Further studies are needed to clarify whether functional hemodynamic assessment using ICG can be useful in predicting pregnancy complications.	[Vartun, Ase; Flo, Kari; Widnes, Christian; Acharya, Ganesh] UiT Arctic Univ Norway, Womens Hlth & Perinatol Res Grp, Dept Clin Med, Fac Hlth Sci, Tromso, Norway; [Vartun, Ase; Flo, Kari; Widnes, Christian; Acharya, Ganesh] Univ Hosp Northern Norway, Dept Obstet & Gynaecol, Tromso, Norway; [Acharya, Ganesh] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Karolinska Institutet	Vartun, A (corresponding author), UiT Arctic Univ Norway, Womens Hlth & Perinatol Res Grp, Dept Clin Med, Fac Hlth Sci, Tromso, Norway.; Vartun, A (corresponding author), Univ Hosp Northern Norway, Dept Obstet & Gynaecol, Tromso, Norway.	ase.vartun@uit.no			Regional Health Authority of Northern Norway (Helse-Nord) [SFP873/ID1646]; Northern Norway Regional Health Authority	Regional Health Authority of Northern Norway (Helse-Nord); Northern Norway Regional Health Authority	This study was funded by the Regional Health Authority of Northern Norway (Helse-Nord), Grant No. SFP873/ID1646, GA.; This study was supported by a grant from the Northern Norway Regional Health Authority. We want to thank the midwives at the antenatal clinic for their help in recruiting participants for the study.	Albaiges G, 2000, OBSTET GYNECOL, V96, P559, DOI 10.1016/S0029-7844(00)00946-7; Barnett S B, 2001, J Matern Fetal Med, V10, P75, DOI 10.1080/714904312; Brun C, 2013, INTENS CARE MED, V39, P593, DOI 10.1007/s00134-012-2770-2; Burlingame J, 2013, J PERINATOL, V33, P675, DOI 10.1038/jp.2013.35; Cavallaro F, 2010, INTENS CARE MED, V36, P1475, DOI 10.1007/s00134-010-1929-y; Clapp JF, 1997, AM J CARDIOL, V80, P1469, DOI 10.1016/S0002-9149(97)00738-8; CLARK SL, 1994, OBSTET GYNECOL, V83, P669; DUVEKOT JJ, 1993, AM J OBSTET GYNECOL, V169, P1382, DOI 10.1016/0002-9378(93)90405-8; Estensen ME, 2013, ULTRASOUND OBST GYN, V41, P659, DOI 10.1002/uog.12296; Flo K, 2011, ULTRASOUND OBST GYN, V37, P538, DOI 10.1002/uog.8907; Flo K, 2010, BJOG-INT J OBSTET GY, V117, P837, DOI 10.1111/j.1471-0528.2010.02548.x; Gallo DM, 2013, FETAL DIAGN THER, V34, P241, DOI 10.1159/000356171; Gomez O, 2006, ULTRASOUND OBST GYN, V28, P802, DOI 10.1002/uog.2814; Hartgill TW, 2011, ACTA PHYSIOL, V201, P467, DOI 10.1111/j.1748-1716.2010.02228.x; HUNTER S, 1992, BRIT HEART J, V68, P540; HYTTEN FE, 1963, J OBSTET GYN BR COMM, V70, P402; Khalil A, 2014, ULTRASOUND OBST GYN, V43, P541, DOI 10.1002/uog.13257; Kingma Boris Rm, 2014, Temperature (Austin), V1, P142, DOI 10.4161/temp.29702; Li H, 2005, ULTRASOUND OBST GYN, V25, P459, DOI 10.1002/uog.1895; Liu LX, 2014, CARDIOVASC RES, V101, P545, DOI 10.1093/cvr/cvu009; MASAKI DI, 1989, AM J OBSTET GYNECOL, V161, P680, DOI 10.1016/0002-9378(89)90379-7; Melchiorre K, 2013, BJOG-INT J OBSTET GY, V120, P496, DOI 10.1111/1471-0528.12068; Melchiorre K, 2011, HYPERTENSION, V57, P85, DOI 10.1161/HYPERTENSIONAHA.110.162321; Monnet X, 2008, INTENS CARE MED, V34, P659, DOI 10.1007/s00134-008-0994-y; Paelinck B P, 2003, Eur J Echocardiogr, V4, P196, DOI 10.1016/S1525-2167(02)00167-1; Papageorghiou A T, 2002, J Matern Fetal Neonatal Med, V12, P78, DOI 10.1080/713605620; Papageorghiou AT, 2005, BJOG-INT J OBSTET GY, V112, P703, DOI 10.1111/j.1471-0528.2005.00519.x; Papageorghiou AT, 2004, BEST PRACT RES CL OB, V18, P383, DOI 10.1016/j.bpobgyn.2004.02.003; ROBSON SC, 1989, AM J PHYSIOL, V256, pH1060, DOI 10.1152/ajpheart.1989.256.4.H1060; RUBLER S, 1977, AM J CARDIOL, V40, P534, DOI 10.1016/0002-9149(77)90068-6; Scardo JA, 2000, AM J OBSTET GYNECOL, V183, P911, DOI 10.1067/mob.2000.108892; Simmons LA, 2002, AM J PHYSIOL-HEART C, V283, pH1627, DOI 10.1152/ajpheart.00966.2001; Staelens A, 2013, EXPERT REV MED DEVIC, V10, P765, DOI 10.1586/17434440.2013.853466; Tomsin K, 2012, J OBSTET GYNAECOL, V32, P630, DOI 10.3109/01443615.2012.673036; Valensise H, 2000, ULTRASOUND OBST GYN, V15, P487, DOI 10.1046/j.1469-0705.2000.00135.x; Valensise H, 2001, ULTRASOUND OBST GYN, V18, P450, DOI 10.1046/j.0960-7692.2001.00576.x; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; Vartun A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135300; Vartun A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094629; Vasapollo B, 2008, HYPERTENSION, V51, P1020, DOI 10.1161/HYPERTENSIONAHA.107.105858; Ventura W, 2015, PRENATAL DIAG, V35, P294, DOI 10.1002/pd.4542; Wang Y, 1992, J Clin Anesth, V4, P4, DOI 10.1016/0952-8180(92)90111-D; WONG DH, 1989, CRIT CARE MED, V17, P979, DOI 10.1097/00003246-198910000-00002	43	3	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157916	10.1371/journal.pone.0157916	http://dx.doi.org/10.1371/journal.pone.0157916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308858	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800143
J	Zbinden, A; Durig, R; Shah, C; Boni, J; Schupbach, J				Zbinden, Andrea; Durig, Roland; Shah, Cyril; Boni, Jurg; Schupbach, Jorg			Importance of an Early HIV Antibody Differentiation Immunoassay for Detection of Dual Infection with HIV-1 and HIV-2	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; GUINEA-BISSAU; WEST-AFRICA; VIRAL LOAD; VIRUS; INDIVIDUALS; PROTECTION; ASSAYS	Background HIV-2 is primarily endemic in West Africa and India, however, in time of global migration, a possible HIV-2 infection or co-infection with HIV-1 should be recognized right at the time of HIV diagnosis, in order to enable optimized antiretroviral treatment. Laboratory HIV testing consists of a combined HIV1/2/O antibody + antigen screening test and subsequent confirmation and type differentiation by a serological test formatted as a multi-line or multi-spot assay. CDC has proposed a revised alternative HIV diagnostic strategy which, in case of a reactive result in a combined HIV1/2/O antibody + antigen screening test, comprises an HIV-1 nucleic acid test (NAT) for HIV confirmation instead of an antibody differentiation immunoassay (ADI). Only a negative NAT must be further investigated by an ADI, thus saving expenses for ADI in most instances. We have investigated this alternative strategy with respect to its recognition of dual HIV-1 and HIV-2 infection. Methods and Results Anonymized data of HIV notifications of patients newly diagnosed with HIV in Switzerland between 2007 and 2014 were analysed retrospectively. In a total of 4'679 notifications, we found 35 HIV-2 infections, 9 (25.7%) of which were dually infected with HIV-1. In 7 of the 9 dual HIV-1 and HIV-2 infections, HIV-1 RNA testing at the time of HIV diagnosis was positive with concentrations from 102 to 94'300 copies/mL plasma. HIV-1 RNA data were not available for the other two cases. Conclusions The alternative CDC strategy would have missed the concomitant HIV-2 infection in at least 7, but probably even more, of the 9 dually infected patients, as the detectable HIV-1 RNA would have precluded a supplemental ADI. Early ADI is mandatory for diagnosis of dual HIV-1/HIV-2 infection and guidance of appropriate therapy.	[Zbinden, Andrea; Shah, Cyril; Boni, Jurg; Schupbach, Jorg] Univ Zurich, Inst Med Virol, CH-8057 Zurich, Switzerland; [Durig, Roland] Maihof Praxis, CH-6004 Luzern, Switzerland; [Shah, Cyril; Boni, Jurg; Schupbach, Jorg] Univ Zurich, Swiss Natl Ctr Retroviruses, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich	Zbinden, A (corresponding author), Univ Zurich, Inst Med Virol, CH-8057 Zurich, Switzerland.	zbinden.andrea@virology.uzh.ch	Boeni, Juerg/B-8386-2015					Andersson S, 2000, ARCH INTERN MED, V160, P3286, DOI 10.1001/archinte.160.21.3286; Boni J, 2004, J MED VIROL, V72, P1, DOI 10.1002/jmv.10535; Centers for Disease Control and Prevention Association of Public Health Laboratories, 2014, LAB TEST DIAGN HIV I; Damond F, 2011, J CLIN MICROBIOL, V49, P3491, DOI 10.1128/JCM.02389-10; de Mendoza C, 2014, AIDS REV, V16, P152; Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0; Gunthard HF, 2009, CLIN INFECT DIS, V48, pE117, DOI 10.1086/598987; Jallow S, 2009, J CLIN MICROBIOL, V47, P2200, DOI 10.1128/JCM.01654-08; Landman R, 2009, AIDS, V23, P426, DOI 10.1097/QAD.0b013e328321305a; Norrgren H, 1999, AIDS, V13, P701, DOI 10.1097/00002030-199904160-00011; Ramos EM, 2013, J CLIN VIROL, V58, pE104, DOI 10.1016/j.jcv.2013.08.018; Raugi DN, 2013, AIDS, V27, P2441, DOI 10.1097/QAD.0b013e328362e856; Schupbach J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131828; Schutten M, 2000, NEW ENGL J MED, V342, P1758, DOI 10.1056/NEJM200006083422317; Taylor N, 2014, WIEN KLIN WOCHENSCHR, V126, P212, DOI 10.1007/s00508-013-0493-1; TRAVERS K, 1995, SCIENCE, V268, P1612, DOI 10.1126/science.7539936; Westheimer E, 2014, J CLIN VIROL, V61, P623, DOI 10.1016/j.jcv.2014.10.010	17	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157690	10.1371/journal.pone.0157690	http://dx.doi.org/10.1371/journal.pone.0157690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310138	gold, Green Published, Green Accepted			2022-12-27	WOS:000378029800123
J	Cao, JF; Cui, HY; Shi, H; Jiao, LJ				Cao, Jianfang; Cui, Hongyan; Shi, Hao; Jiao, Lijuan			Big Data: A Parallel Particle Swarm Optimization-Back-Propagation Neural Network Algorithm Based on MapReduce	PLOS ONE			English	Article							GENETIC ALGORITHM; PREDICTION; MODEL	A back-propagation (BP) neural network can solve complicated random nonlinear mapping problems; therefore, it can be applied to a wide range of problems. However, as the sample size increases, the time required to train BP neural networks becomes lengthy. Moreover, the classification accuracy decreases as well. To improve the classification accuracy and runtime efficiency of the BP neural network algorithm, we proposed a parallel design and realization method for a particle swarm optimization (PSO)-optimized BP neural network based on MapReduce on the Hadoop platform using both the PSO algorithm and a parallel design. The PSO algorithm was used to optimize the BP neural network's initial weights and thresholds and improve the accuracy of the classification algorithm. The MapReduce parallel programming model was utilized to achieve parallel processing of the BP algorithm, thereby solving the problems of hardware and communication overhead when the BP neural network addresses big data. Datasets on 5 different scales were constructed using the scene image library from the SUN Database. The classification accuracy of the parallel PSO-BP neural network algorithm is approximately 92%, and the system efficiency is approximately 0.85, which presents obvious advantages when processing big data. The algorithm proposed in this study demonstrated both higher classification accuracy and improved time efficiency, which represents a significant improvement obtained from applying parallel processing to an intelligent algorithm on big data.	[Cao, Jianfang; Cui, Hongyan; Jiao, Lijuan] Xinzhou Teachers Univ, Comp Sci & Technol Dept, Xinzhou, Peoples R China; [Shi, Hao] Taiyuan Univ Sci & Technol, Coll Comp Sci & Technol, Taiyuan, Peoples R China	Xinzhou Teachers University; Taiyuan University of Science & Technology	Cui, HY (corresponding author), Xinzhou Teachers Univ, Comp Sci & Technol Dept, Xinzhou, Peoples R China.	cuihy16@yeah.net			College Students' Innovative and Entrepreneurial Training Project in universities and colleges in Shanxi Province [2014383]; Natural Science Foundation of Shanxi Province [2013011017-2]; key discipline project of Xinzhou Teachers University [XK201308, XK201404]; Youth Foundation Project of Xinzhou Teachers University [201209]	College Students' Innovative and Entrepreneurial Training Project in universities and colleges in Shanxi Province; Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); key discipline project of Xinzhou Teachers University; Youth Foundation Project of Xinzhou Teachers University	This study was supported by the College Students' Innovative and Entrepreneurial Training Project in universities and colleges in Shanxi Province (2014383), the Natural Science Foundation of Shanxi Province (2013011017-2), the key discipline project of Xinzhou Teachers University (XK201308, XK201404), and the Youth Foundation Project of Xinzhou Teachers University (201209).	Cao JW, 2016, MULTIMED TOOLS APPL, V75, P2839, DOI 10.1007/s11042-014-2424-1; Chen C, 2013, IEEE T INTELL TRANSP, V14, P22, DOI 10.1109/TITS.2012.2205144; Cheng C, 2015, COMPUT BIOL MED, V66, P103, DOI 10.1016/j.compbiomed.2015.08.018; Chiroma H, 2014, PROCEEDINGS OF THE 1; Chiroma H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136140; Chiroma H, 2015, APPL ENERG, V142, P266, DOI 10.1016/j.apenergy.2014.12.045; Chung IH, 2014, INT CONF HIGH PERFOR, P745, DOI 10.1109/SC.2014.66; Ding SF, 2011, ARTIF INTELL REV, V36, P153, DOI 10.1007/s10462-011-9208-z; Doulkeridis C, 2014, VLDB J, V23, P355, DOI 10.1007/s00778-013-0319-9; Elsebakhi E, 2015, J COMPUT SCI-NETH, V11, P69, DOI 10.1016/j.jocs.2015.09.008; Feng JQ, 2014, APPL MECH MATER, V614, P521, DOI 10.4028/www.scientific.net/AMM.614.521; Gao Yu-ming, 2014, Computer Engineering, V40, P187, DOI 10.3969/j.issn.1000-3428.2014.04.036; Guo YH, 2013, APPL MECH MATER, V239-240, P1541, DOI 10.4028/www.scientific.net/AMM.239-240.1541; Guo ZH, 2011, KNOWL-BASED SYST, V24, P1048, DOI 10.1016/j.knosys.2011.04.019; Hu Ming-xia, 2012, Computer Engineering, V38, P148, DOI 10.3969/j.issn.1000-3428.2012.06.048; Hu Y, 2003, THE PARALLELISM AND; Jia WK, 2015, APPL INTELL, V43, P176, DOI 10.1007/s10489-014-0618-x; Jing GL, 2012, DESALINATION, V291, P78, DOI 10.1016/j.desal.2012.02.002; Kim Y, 2014, INFORM SYST, V42, P15, DOI 10.1016/j.is.2013.11.002; Liu J, 2012, J GUANGDONG U PETROC, V12, P34; Liu M. L., 2012, J SYSTEMS SCI, V20, P88; Liu Y, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/297672; Mohamed H, 2013, PARALLEL COMPUT, V39, P851, DOI 10.1016/j.parco.2013.08.010; Nawi NM, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/868375; Pan RR, 2011, J TEXT I, V102, P19, DOI 10.1080/00405000903430255; Qian J, 2015, KNOWL-BASED SYST, V73, P18, DOI 10.1016/j.knosys.2014.09.001; Ren C, 2014, KNOWL-BASED SYST, V56, P226, DOI 10.1016/j.knosys.2013.11.015; Roberge V, 2013, IEEE T IND INFORM, V9, P132, DOI 10.1109/TII.2012.2198665; Rong Gu, 2013, 2013 IEEE International Conference on Big Data, P376, DOI 10.1109/BigData.2013.6691598; Saadi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144371; Scardapane S., 2015, NEURAL NETWORKS; Shen H, 2014, INT CONF CLOUD COMPU, P499, DOI 10.1109/CCIS.2014.7175787; Stateczny A, 2014, LECT NOTES COMPUT SC, V8537, P335, DOI 10.1007/978-3-319-08729-0_34; Wang GG, 2014, INFORM SCIENCES, V274, P17, DOI 10.1016/j.ins.2014.02.123; Wang GG, 2014, APPL MATH MODEL, V38, P2454, DOI 10.1016/j.apm.2013.10.052; Wang Gai-ge, 2013, Journal of Jilin University (Engineering and Technology Edition), V43, P1064, DOI 10.7964/jdxbgxb201304035; Wang GG, 2014, J COMPUT THEOR NANOS, V11, P477, DOI 10.1166/jctn.2014.3383; Wang HS, 2013, EXPERT SYST APPL, V40, P418, DOI 10.1016/j.eswa.2012.01.166; Wang YB, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/830869; [徐黎明 Xu Liming], 2013, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V43, P186; Yan J, 2014, J HENAN NORM UNIV, V42, P152; Yu F, 2014, APPL ENERG, V134, P102, DOI 10.1016/j.apenergy.2014.07.104; Zhang F, 2012, NEUROCOMPUTING, V78, P139, DOI 10.1016/j.neucom.2011.05.033; Zhang JianHua, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P161; Zheng Xiao-wei, 2014, Journal of Chinese Computer Systems, V35, P1348; Zhu Weisheng, 2014, Journal of Computer Applications, V34, P695; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	49	55	60	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157551	10.1371/journal.pone.0157551	http://dx.doi.org/10.1371/journal.pone.0157551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304987	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800071
J	Huik, K; Avi, R; Pauskar, M; Kallas, E; Jogeda, EL; Karki, T; Ruutel, K; Talu, A; Abel-Ollo, K; Uuskula, A; Carrillo, A; Ahuja, SK; He, WJ; Lutsar, I				Huik, Kristi; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Jogeda, Ene-Ly; Karki, Tonis; Ruutel, Kristi; Talu, Ave; Abel-Ollo, Katri; Uuskula, Anneli; Carrillo, Andrew; Ahuja, Sunil K.; He, Weijing; Lutsar, Irja			A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RANTES GENE VARIANTS; CD4(+) T-CELLS; CHEMOKINES; EXPRESSION; IL28B; LIVER; TRANSMISSION; POLYMORPHISM; LYMPHOCYTES	Objective The role of CC chemokine receptor 5 (CCR5) and its ligand CCL5 on the pathogenesis of HIV infection has been well studied but not for HCV infection. Here, we investigated whether CCL5 haplotypes influence HIV and HCV seropositivity among 373 Caucasian people who inject drugs (PWID) from Estonia. Methods Study included 373 PWID; 56% were HIV seropositive, 44% HCV seropositive and 47% coinfected. Four CCL5 haplotypes (A-D) were derived from three CCL5 polymorphisms (rs2107538/rs2280788/rs2280789) typed by Taqman allelic discrimination assays. The data of CCR5 haplotypes were used from our previous study. The association between CCL5 haplotypes with HIV and/or HCV seropositivity was determined using logistic regression analysis. Results Possessing CCL5 haplotype D (defined by rs2107538A/rs2280788G/rs2280789C) decreased the odds of HCV seropositivity compared to those not possessing it (OR = 0.19; 95% CI 0.09-0.40), which remained significant after adjustment to co-variates (OR = 0.08; 95% CI 0.02-0.29). An association of this haplotype with HIV seropositivity was not found. In step-wise logistic regression with backward elimination CCL5 haplotype D and CCR5 HHG*1 had reduced odds for HCV seropositivity (OR = 0.28 95% CI 0.09-0.92; OR = 0.23 95% CI 0.08-0.68, respectively) compared to those who did not possess these haplotypes, respectively. Conclusions Our results suggest that among PWID CCL5 haplotype D and CCR5 HHG*1 independently protects against HCV. Our findings highlight the importance of CCL5 genetic variability and CCL5-CCR5 axis on the susceptibility to HCV.	[Huik, Kristi; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Jogeda, Ene-Ly; Karki, Tonis; Lutsar, Irja] Univ Tartu, Inst Biomed & Translat Med, Dept Microbiol, EE-50411 Tartu, Estonia; [Ruutel, Kristi; Abel-Ollo, Katri] Natl Inst Hlth Dev, EE-11619 Tallinn, Estonia; [Talu, Ave; Uuskula, Anneli] Univ Tartu, Inst Family Med & Publ Hlth, EE-50411 Tartu, Estonia; [Carrillo, Andrew; Ahuja, Sunil K.; He, Weijing] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Carrillo, Andrew; Ahuja, Sunil K.; He, Weijing] South Texas Vet Hlth Care Syst, Vet Adm Ctr Personalized Med, San Antonio, TX 78229 USA	University of Tartu; National Institute for Health Development - Estonia; University of Tartu; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Huik, K (corresponding author), Univ Tartu, Inst Biomed & Translat Med, Dept Microbiol, EE-50411 Tartu, Estonia.	kristi.huik@ut.ee	Talu, Ave/D-7677-2014; Uusküla, Anneli/H-3303-2015; Huik, Kristi/AGY-9109-2022	Talu, Ave/0000-0003-3543-483X; Uusküla, Anneli/0000-0002-4036-3856; Huik, Kristi/0000-0002-1569-8830; Avi, Radko/0000-0002-9640-8427	European Union through the European Regional Development Fund; Basic Financing; Target Financing [SF0180004s12]; Institutional research funding of Estonian Ministry of Education and Research [IUT34-24, IUT34-17]; European Commission - project Expanding Network for Comprehensive and Coordinated Action on HIV/AIDS prevention among IDUs and Bridging Population [2005305]; Global Fund; Tuberculosis and Malaria Program "Scaling up the response to HIV in Estonia"; National HIV/AIDS Strategy; US Civilian Research Development Foundation [ESX0-2722-TA-06]; US National Institutes of Health; National Institute on Drug Abuse [R01DA03574]; Archimedes Foundation and Norwegian Financial Mechanism/EEA [EE0016]; Veterans Affairs (VA) Center for AIDS and HIV Infection and VA Center for Personalized Medicine of the South Texas Veterans Health Care System; National Institutes of Health MERIT grant [R37AI046326]; Doris Duke Distinguished Clinical Scientist Award; VA MERIT award; Elizabeth Glaser Pediatric AIDS Foundation; Burroughs Welcome Clinical Scientist Award in Translational Research; Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046326] Funding Source: NIH RePORTER	European Union through the European Regional Development Fund(European Commission); Basic Financing; Target Financing; Institutional research funding of Estonian Ministry of Education and Research; European Commission - project Expanding Network for Comprehensive and Coordinated Action on HIV/AIDS prevention among IDUs and Bridging Population; Global Fund; Tuberculosis and Malaria Program "Scaling up the response to HIV in Estonia"; National HIV/AIDS Strategy; US Civilian Research Development Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Archimedes Foundation and Norwegian Financial Mechanism/EEA; Veterans Affairs (VA) Center for AIDS and HIV Infection and VA Center for Personalized Medicine of the South Texas Veterans Health Care System; National Institutes of Health MERIT grant; Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); VA MERIT award(US Department of Veterans Affairs); Elizabeth Glaser Pediatric AIDS Foundation; Burroughs Welcome Clinical Scientist Award in Translational Research; Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Study was supported by: European Union through the European Regional Development Fund; Basic Financing and the Target Financing (SF0180004s12) and Institutional research funding (IUT34-24, IUT34-17) of Estonian Ministry of Education and Research; European Commission funded project Expanding Network for Comprehensive and Coordinated Action on HIV/AIDS prevention among IDUs and Bridging Population Nr. 2005305 (ENCAP); Global Fund to Fight HIV, Tuberculosis and Malaria Program "Scaling up the response to HIV in Estonia" for 2003-2007; National HIV/AIDS Strategy for 2006-2015; US Civilian Research Development Foundation (grant ESX0-2722-TA-06); US National Institutes of Health, National Institute on Drug Abuse (grant R01DA03574); the Archimedes Foundation and Norwegian Financial Mechanism/EEA (grant EE0016); the Veterans Affairs (VA) Center for AIDS and HIV Infection and VA Center for Personalized Medicine of the South Texas Veterans Health Care System, a National Institutes of Health MERIT grant (R37AI046326), and the Doris Duke Distinguished Clinical Scientist Award to S.K.A. S.K.A. is also supported by a VA MERIT award, the Elizabeth Glaser Pediatric AIDS Foundation, the Burroughs Welcome Clinical Scientist Award in Translational Research and the Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund.	Abad-Molina C, 2012, CLIN VACCINE IMMUNOL, V19, P223, DOI 10.1128/CVI.05305-11; An P, 2002, P NATL ACAD SCI USA, V99, P10002, DOI 10.1073/pnas.142313799; Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x; Broadhead RS, 1999, PUBLIC HEALTH REP, V114, P439, DOI 10.1093/phr/114.5.439; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Furci L, 1997, J EXP MED, V186, P455, DOI 10.1084/jem.186.3.455; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Hellier S, 2003, HEPATOLOGY, V38, P1468, DOI [10.1016/j.hep.2003.09.027, 10.1053/jhep.2003.09027]; Heydtmann M, 2009, HEPATOLOGY, V49, P676, DOI 10.1002/hep.22763; Huik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070561; Huik K, 2010, J INFECT DIS, V201, P730, DOI 10.1086/650491; Jansson M, 1996, P NATL ACAD SCI USA, V93, P15382, DOI 10.1073/pnas.93.26.15382; Kase K, 2015, 25 EUR C CLIN MICR I; Kusano F, 2000, LAB INVEST, V80, P415, DOI 10.1038/labinvest.3780046; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Liu HL, 1999, P NATL ACAD SCI USA, V96, P4581, DOI 10.1073/pnas.96.8.4581; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Nattermann J, 2004, J VIRAL HEPATITIS, V11, P519, DOI 10.1111/j.1365-2893.2004.00545.x; Pauskar M, 2015, 25 EUR C CLIN MICR I; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Rathore A, 2008, J MED VIROL, V80, P1133, DOI 10.1002/jmv.21201; Shields PL, 1999, J IMMUNOL, V163, P6236; Solari R, 1997, J BIOL CHEM, V272, P9617; Soo HM, 2002, VIROLOGY, V303, P253, DOI 10.1006/viro.2002.1617; Tallo T, 2007, J MED VIROL, V79, P374, DOI 10.1002/jmv.20828; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Team RDC, 2019, R LANG ENV STAT COMP; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Wasmuth HE, 2004, HEPATOLOGY, V40, P327, DOI 10.1002/hep.20322; Woitas RP, 1997, J IMMUNOL, V159, P1012	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156850	10.1371/journal.pone.0156850	http://dx.doi.org/10.1371/journal.pone.0156850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304910	Green Submitted, Green Published, gold			2022-12-27	WOS:000377824800026
J	Song, LP; Ding, XQ; Feng, LP; Shi, Q				Song, Li-Peng; Ding, Xiao-Qiang; Feng, Li-Ping; Shi, Qiong			Hopf Bifurcation of an Epidemic Model with Delay	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; BRUCELLOSIS MODEL; GLOBAL STABILITY; TIME-DELAY; DISEASE; POPULATION; BEHAVIOR; MEASLES; SYSTEM	A spatiotemporal epidemic model with nonlinear incidence rate and Neumann boundary conditions is investigated. On the basis of the analysis of eigenvalues of the eigenpolynomial, we derive the conditions of the existence of Hopf bifurcation in one dimension space. By utilizing the normal form theory and the center manifold theorem of partial functional differential equations (PFDs), the properties of bifurcating periodic solutions are analyzed. Moreover, according to numerical simulations, it is found that the periodic solutions can emerge in delayed epidemic model with spatial diffusion, which is consistent with our theoretical results. The obtained results may provide a new viewpoint for the recurrent outbreak of disease.	[Song, Li-Peng; Ding, Xiao-Qiang; Feng, Li-Ping; Shi, Qiong] North Univ China, Dept Comp Sci & Technol, Taiyuan 030051, Shanxi, Peoples R China	North University of China	Song, LP (corresponding author), North Univ China, Dept Comp Sci & Technol, Taiyuan 030051, Shanxi, Peoples R China.	slp880nuc@sina.com			National Natural Science foundation of China [61379125]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science foundation of China under Grant No. 61379125.	ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; [Anonymous], 2012, ELECT J DIFFER EQU; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; BERETTA E, 1995, J MATH BIOL, V33, P250, DOI 10.1007/BF00169563; BUSENBERG S, 1980, J MATH BIOL, V10, P13, DOI 10.1007/BF00276393; Capasso, 1993, LECT NOTES BIOMATHEM; CAPASSO V, 1978, MATH BIOSCI, V42, P43, DOI 10.1016/0025-5564(78)90006-8; Dye C, 2003, SCIENCE, V300, P1884, DOI 10.1126/science.1086925; FARIA T, 1995, J DIFFER EQUATIONS, V122, P181, DOI 10.1006/jdeq.1995.1144; Hale J., 1977, THEORY FUNCTIONAL DI; Hethcote H.W., 1989, APPL MATH ECOLOGY; HOPPENSTEADT F, 1971, Mathematical Biosciences, V12, P133, DOI 10.1016/0025-5564(71)90078-2; Huo X, 2016, VACCINE, V34, P1767, DOI 10.1016/j.vaccine.2016.02.046; Kadder A., 2009, ELECT JDE, V1, P1; Klinkenberg D, 2011, J THEOR BIOL, V284, P52, DOI 10.1016/j.jtbi.2011.06.015; Korobeinikov A, 2007, B MATH BIOL, V69, P1871, DOI 10.1007/s11538-007-9196-y; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; LIU WM, 1986, J MATH BIOL, V23, P187, DOI 10.1007/BF00276956; LIU WM, 1987, J MATH BIOL, V25, P359, DOI 10.1007/BF00277162; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; McCluskey CC, 2010, NONLINEAR ANAL-REAL, V11, P3106, DOI 10.1016/j.nonrwa.2009.11.005; Song LP, 2011, J BIOL PHYS, V37, P133, DOI 10.1007/s10867-010-9204-6; Soper HE, 1929, J R STAT SOC, V92, P34, DOI 10.2307/2341437; Sun CJ, 2006, CHAOS SOLITON FRACT, V30, P204, DOI 10.1016/j.chaos.2005.08.167; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Sun GQ, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/08/P08011; Sun G, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/11/P11011; White MC, 2012, PUBLIC HEALTH, V126, P752, DOI 10.1016/j.puhe.2012.04.009; Wu J, 1996, THEORY AND APPLICATI; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Xiao DM, 2007, MATH BIOSCI, V208, P419, DOI 10.1016/j.mbs.2006.09.025; Yan XP, 2007, APPL MATH COMPUT, V192, P552, DOI 10.1016/j.amc.2007.03.033; Zhang JZ, 2009, NONLINEAR ANAL-THEOR, V70, P658, DOI 10.1016/j.na.2008.01.002; Zhang J, 2012, J APPL ANAL COMPUT, V2, P111; Zhang J, 2012, B MATH BIOL, V74, P1226, DOI 10.1007/s11538-012-9720-6; Zuo WJ, 2011, NONLINEAR ANAL-REAL, V12, P1998, DOI 10.1016/j.nonrwa.2010.12.016	45	2	2	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157367	10.1371/journal.pone.0157367	http://dx.doi.org/10.1371/journal.pone.0157367			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304674	gold, Green Published, Green Submitted			2022-12-27	WOS:000377824800056
J	Wills, C; Harms, KE; Wiegand, T; Punchi-Manage, R; Gilbert, GS; Erickson, D; Kress, WJ; Hubbell, SP; Gunatilleke, CVS; Gunatilleke, IAUN				Wills, Christopher; Harms, Kyle E.; Wiegand, Thorsten; Punchi-Manage, Ruwan; Gilbert, Gregory S.; Erickson, David; Kress, W. John; Hubbell, Stephen P.; Gunatilleke, C. V. Savitri; Gunatilleke, I. A. U. Nimal			Persistence of Neighborhood Demographic Influences over Long Phylogenetic Distances May Help Drive Post-Speciation Adaptation in Tropical Forests	PLOS ONE			English	Article							DEPENDENT SEEDLING MORTALITY; NEGATIVE DENSITY-DEPENDENCE; NEOTROPICAL FOREST; RAIN-FOREST; REPRODUCTIVE ISOLATION; PLANT DIVERSITY; HABITAT ASSOCIATIONS; SPECIES COEXISTENCE; DIPTEROCARP FOREST; TREE RECRUITMENT	Studies of forest dynamics plots (FDPs) have revealed a variety of negative density-dependent (NDD) demographic interactions, especially among conspecific trees. These interactions can affect growth rate, recruitment and mortality, and they play a central role in the maintenance of species diversity in these complex ecosystems. Here we use an equal area annulus (EAA) point-pattern method to comprehensively analyze data from two tropical FDPs, Barro Colorado Island in Panama and Sinharaja in Sri Lanka. We show that these NDD interactions also influence the continued evolutionary diversification of even distantly related tree species in these FDPs. We examine the details of a wide range of these interactions between individual trees and the trees that surround them. All these interactions, and their cumulative effects, are strongest among conspecific focal and surrounding tree species in both FDPs. They diminish in magnitude with increasing phylogenetic distance between heterospecific focal and surrounding trees, but do not disappear or change the pattern of their dependence on size, density, frequency or physical distance even among the most distantly related trees. The phylogenetic persistence of all these effects provides evidence that interactions between tree species that share an ecosystem may continue to promote adaptive divergence even after the species' gene pools have become separated. Adaptive divergence among taxa would operate in stark contrast to an alternative possibility that has previously been suggested, that distantly related species with dispersal-limited distributions and confronted with unpredictable neighbors will tend to converge on common strategies of resource use. In addition, we have also uncovered a positive density-dependent effect: growth rates of large trees are boosted in the presence of a smaller basal area of surrounding trees. We also show that many of the NDD interactions switch sign rapidly as focal trees grow in size, and that their cumulative effect can strongly influence the distributions and species composition of the trees that surround the focal trees during the focal trees' lifetimes.	[Wills, Christopher] Univ Calif San Diego, Sect Ecol Behav & Evolut, Div Biol Sci, La Jolla, CA 92093 USA; [Harms, Kyle E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Wiegand, Thorsten] UFZ Helmholtz Ctr Environm Res GmbH UFZ, Dept Ecol Modeling, D-04318 Leipzig, Germany; [Wiegand, Thorsten] German Ctr Integrat Biodivers Res iDiv, Biodivers Synth, Deutsch Pl 5e, D-04103 Leipzig, Germany; [Punchi-Manage, Ruwan] Univ Gottingen, Dept Ecosyst Modelling, Busgenweg 4, D-37077 Gottingen, Germany; [Gilbert, Gregory S.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Gilbert, Gregory S.; Erickson, David; Kress, W. John; Hubbell, Stephen P.] Smithsonian Trop Res Inst, Balboa 084303092, Ancon, Panama; [Hubbell, Stephen P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Gunatilleke, C. V. Savitri; Gunatilleke, I. A. U. Nimal] Univ Peradeniya, Dept Bot, Fac Sci, Peradeniya 20400, Sri Lanka	University of California System; University of California San Diego; Louisiana State University System; Louisiana State University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Gottingen; University of California System; University of California Santa Cruz; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Los Angeles; University of Peradeniya	Wills, C (corresponding author), Univ Calif San Diego, Sect Ecol Behav & Evolut, Div Biol Sci, La Jolla, CA 92093 USA.	cwills@ucsd.edu	Wiegand, Thorsten/AAP-9709-2021; Wiegand, Thorsten/H-5877-2016	Wiegand, Thorsten/0000-0002-3721-2248; Wiegand, Thorsten/0000-0002-3721-2248; Punchi-Manage, Ruwan/0000-0002-4753-4996	ERC advanced grant [233066-SPATIODIVERSITY]; National Science Foundation; Center for Tropical Forest Science; Smithsonian Tropical Research Institute; John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund; Direct For Biological Sciences [1545761, 1354741] Funding Source: National Science Foundation	ERC advanced grant(European Research Council (ERC)); National Science Foundation(National Science Foundation (NSF)); Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Small World Institute Fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Thorsten Wiegand and Ruwan Punchi-Manage acknowledge funding from ERC advanced grant 233066-SPATIODIVERSITY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge assistance from Cam Webb in the phylogenetic analysis, for the advice of Andreas Huth, Livio Fenga and Rick Condit, and for help in data analysis from Jerry Greenberg, Ron Hawkins and Paul Rodriguez of the San Diego Supercomputer Center. The detailed and constructive comments by reviewers of earlier versions of the manuscript were of great assistance in refining both the data analysis and its presentation. The BCI forest dynamics research project is supported by the National Science Foundation, the Center for Tropical Forest Science, the Smithsonian Tropical Research Institute, the John D. and Catherine T. MacArthur Foundation, the Mellon Foundation, the Small World Institute Fund, and numerous private individuals, and through the hard work of over 100 people from 10 countries over the past three decades. We thank the University of Peradeniya, Postgraduate Institute of Science and the Forest Department of Sri Lanka for administrative support, and the field staff who contributed to the censuses of the Sinharaja plot. These plot projects are part of the Center for Tropical Forest Science, a global network of large-scale demographic tree plots. BCI plot data are available from http://ctfs.arnarb.harvard.edu/webatlas/datasets/bci/. The Sinharaja Forest Monitoring Plot data belongs to the plot PIs and is managed by the CTFS-ForestGEO network. Data are available under request at http://ctfs.si.edu/Public/plotdataaccess/SiteDescription.php?plotname=sinharaja&typedata=tree. Thorsten Wiegand and Ruwan Punchi-Manage acknowledge funding from ERC advanced grant 233066-SPATIODIVERSITY. Programs for EAA analysis are available from C. Wills, cwills@ucsd.edu	Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; [Anonymous], 2004, TROPICAL FOREST DIVE; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Bagchi R, 2010, ECOL LETT, V13, P1262, DOI 10.1111/j.1461-0248.2010.01520.x; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Canham CD, 2006, ECOL APPL, V16, P62, DOI 10.1890/04-0657; Chen YX, 2016, ECOLOGY, V97, P776, DOI 10.1890/15-0625.1; Comita LS, 2007, J VEG SCI, V18, P163, DOI 10.1658/1100-9233(2007)18[163:POWPSA]2.0.CO;2; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; CONDIT R, 1992, AM NAT, V140, P261, DOI 10.1086/285412; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Condit R, 1998, TROPICAL FOREST CENS; CONNELL J H, 1971, P298; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Danner JE, 2011, AM NAT, V178, P53, DOI 10.1086/660283; Diggle P., 2003, STAT ANAL SPATIAL PO; Ediriweera S, 2008, FOREST ECOL MANAG, V256, P1339, DOI 10.1016/j.foreco.2008.06.035; Endara MJ, 2015, J ECOL, V103, P1107, DOI 10.1111/1365-2745.12431; Fricke EC, 2014, ECOL LETT, V17, P593, DOI 10.1111/ele.12261; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gilbert GS, 2012, EVOL APPL, V5, P869, DOI 10.1111/j.1752-4571.2012.00265.x; Green PT, 2014, P NATL ACAD SCI USA, V111, P18649, DOI 10.1073/pnas.1321892112; Gunatilleke CVS, 2006, J TROP ECOL, V22, P371, DOI 10.1017/S0266467406003282; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell S.P., 1986, BIOL CHANCE HIST STR, P314; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Illian J, 2008, STAT ANAL MODELLING; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson DJ, 2014, ECOLOGY, V95, P2493, DOI 10.1890/13-2098.1; Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; Kanagaraj R, 2011, J ECOL, V99, P1441, DOI 10.1111/j.1365-2745.2011.01878.x; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Lebrija-Trejos E, 2014, ECOLOGY IN PRESS; Lebrija-Trejos E, 2014, ECOLOGY, V95, P940, DOI 10.1890/13-0623.1; Liu XB, 2012, ECOL LETT, V15, P111, DOI 10.1111/j.1461-0248.2011.01715.x; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Marhaver KL, 2013, ECOLOGY, V94, P146, DOI 10.1890/12-0985.1; Metz MR, 2010, ECOLOGY, V91, P3675, DOI 10.1890/08-2323.1; Packer A, 2004, P ROY SOC B-BIOL SCI, V271, P317, DOI 10.1098/rspb.2003.2583; Paine CET, 2007, ECOLOGY, V88, P3076, DOI 10.1890/06-1835.1; Paine CET, 2012, ECOL LETT, V15, P34, DOI 10.1111/j.1461-0248.2011.01705.x; Palma-Silva C, 2011, MOL ECOL, V20, P3185, DOI 10.1111/j.1365-294X.2011.05143.x; Parker IM, 2015, NATURE, V520, P542, DOI 10.1038/nature14372; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Punchi-Manage R, 2013, J ECOL, V101, P149, DOI 10.1111/1365-2745.12017; Rabosky DL, 2013, P NATL ACAD SCI USA, V110, P15354, DOI 10.1073/pnas.1305529110; SHELLY TE, 1985, OECOLOGIA, V67, P57, DOI 10.1007/BF00378452; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Surget-Groba Y, 2013, MOL ECOL, V22, P4931, DOI 10.1111/mec.12442; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Uriarte M, 2004, J ECOL, V92, P348, DOI 10.1111/j.0022-0477.2004.00867.x; Uriarte Maria, 2005, P89, DOI 10.1017/CBO9780511541971.005; Velho N, 2012, OECOLOGIA, V169, P995, DOI 10.1007/s00442-012-2252-9; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wendt T, 2008, PLANT SYST EVOL, V275, P31, DOI 10.1007/s00606-008-0054-7; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yamazaki M, 2009, PLANT ECOL, V201, P181, DOI 10.1007/s11258-008-9531-x; Zhu K, 2015, ECOLOGY, V96, P2319, DOI 10.1890/14-1780.1; Zhu Y, 2015, J ECOLOGY	72	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156913	10.1371/journal.pone.0156913	http://dx.doi.org/10.1371/journal.pone.0156913			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305092	Green Published, gold			2022-12-27	WOS:000377824800029
J	Byeon, B; Kovalchuk, I				Byeon, Boseon; Kovalchuk, Igor			Pattern Recognition on Read Positioning in Next Generation Sequencing	PLOS ONE			English	Article							ALIGNMENT; BIAS	The usefulness and the utility of the next generation sequencing (NGS) technology are based on the assumption that the DNA or cDNA cleavage required to generate short sequence reads is random. Several previous reports suggest the existence of sequencing bias of NGS reads. To address this question in greater detail, we analyze NGS data from four organisms with different GC content, Plasmodium falciparum (19.39%), Arabidopsis thaliana (36.03%), Homo sapiens (40.91%) and Streptomyces coelicolor (72.00%). Using machine learning techniques, we recognize the pattern that the NGS read start is positioned in the local region where the nucleotide distribution is dissimilar from the global nucleotide distribution. We also demonstrate that the mono-nucleotide distribution underestimates sequencing bias, and the recognized pattern is explained largely by the distribution of multi-nucleotides (di-, tri-, and tetra-nucleotides) rather than mono-nucleotides. This implies that the correction of sequencing bias needs to be performed on the basis of the multi-nucleotide distribution. Providing companion software to quantify the effect of the recognized pattern on read positioning, we exemplify that the bias correction based on the mono-nucleotide distribution may not be sufficient to clean sequencing bias.	[Byeon, Boseon; Kovalchuk, Igor] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Kovalchuk, I (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.	igor.kovalchuk@uleth.ca			Natural Sciences and Engineering Research Council of Canada Discovery grant; NSERC Create grant	Natural Sciences and Engineering Research Council of Canada Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Create grant	This work was funded by a Natural Sciences and Engineering Research Council of Canada Discovery grant to IK and NSERC Create grant to BB.	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Awad M., 2015, EFFICIENT LEARNING M, P67, DOI [10.1007/978-1-4302-5990-9, DOI 10.1007/978-1-4302-5990-9_4]; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bouckaert R., 2010, 1 U WAIK; Byeon B, 2010, P IASTED INT C COMP, P593; Darwiche A, 2009, MODELING AND REASONING WITH BAYESIAN NETWORKS, P1, DOI 10.1017/CBO9780511811357; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Gabadinho A, 2011, J STAT SOFTW, V40, P1; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knierim E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028240; Korpelainen E., 2014, RNA SEQ DATA ANAL PR; Kryukov K, 2012, GENOME BIOL EVOL, V4, P501, DOI 10.1093/gbe/evs026; Kubat M, 1997, P 14 INT C MACH LEAR, V97; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Mitchell T.M, 2003, MACH LEARN; Neapolitan RE, 2009, PROBABILISTIC METHODS FOR BIOINFORMATICS WITH AN INTRODUCTION TO BAYESIAN NETWORKS, P1; Pages H, BIOSTRINGS STRING OB; Poptsova MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04532; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Schwartz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016685; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Venables WN., 2002, MODERN APPL STAT S 4; Wang X., 2016, NEXT GENERATION SEQU; Witten IH, 2011, MOR KAUF D, P1; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	29	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157033	10.1371/journal.pone.0157033	http://dx.doi.org/10.1371/journal.pone.0157033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299343	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200024
J	Wei, Q; Wang, XC; Gao, J; Li, J; Li, J; Qi, CS; Li, YY; Li, ZW; Shen, L				Wei, Qing; Wang, Xicheng; Gao, Jing; Li, Jian; Li, Jie; Qi, Changsong; Li, Yanyan; Li, Zhongwu; Shen, Lin			Clinicopathologic and Molecular Features of Colorectal Adenocarcinoma with Signet-Ring Cell Component	PLOS ONE			English	Article							CARCINOMA; CANCER; COLON; SUSCEPTIBILITY; POLYPOSIS; SURVIVAL; MUTATION; CARRIERS; AGE	Background We performed a retrospective study to assess the clinicopathological characters, molecular alterations and multigene mutation profiles in colorectal cancer patients with signet-ring cell component. Methods Between November 2008 and January 2015, 61 consecutive primary colorectal carcinomas with signet-ring cell component were available for pathological confirmation. RAS/BRAF status was performed by direct sequencing. 14 genes associated with hereditary cancer syndromes were analyzed by targeted gene sequencing. Results A slight male predominance was detected in these patients (59.0%). Colorectal carcinomas with signet-ring cell component were well distributed along the large intestine. A frequently higher TNM stage at the time of diagnosis was observed, compared with the conventional adenocarcinoma. Family history of malignant tumor was remarkable with 49.2% in 61 cases. The median OS time of stage IV patients in our study was 14 months. RAS mutations were detected in 22.2% (12/54) cases with KRAS mutations in 16.7% (9/54) cases and Nras mutations in 5.4%(3/54) cases. BRAF V600E mutation was detected in 3.7% (2/54) cases. As an exploration, we analyzed 14 genes by targeted gene sequencing. These genes were selected based on their biological role in association with hereditary cancer syndromes. 79.6% cases carried at least one pathogenic mutation. Finally, the patients were classified by the percentage of signet-ring cell. 39 (63.9%) cases were composed of >= 50% signet-ring cells; 22 (36.1%) cases were composed of <50% signet-ring cells. Wecompared clinical parameters, molecular and genetic alterations between the two groups and found no significant differences. Conclusions Colorectal adenocarcinoma with signet-ring cell component is characterized by advanced stage at diagnosis with remarkable family history of malignant tumor. It is likely a negative prognostic factor and tends to affect male patients with low rates of RAS/BRAF mutation. Colorectal patients with any component of signet-ring cells, regardless of the extent, shared similar clinicopathological characteristics, molecular alterations and genetic profiles.	[Wei, Qing; Wang, Xicheng; Gao, Jing; Li, Jian; Li, Jie; Qi, Changsong; Li, Yanyan; Shen, Lin] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, Beijing 100871, Peoples R China; [Li, Zhongwu] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ, Beijing 100871, Peoples R China	Peking University; Peking University	Shen, L (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, Beijing 100871, Peoples R China.; Li, ZW (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ, Beijing 100871, Peoples R China.	zhwuli@hotmail.com; lin100@medmail.com.cn						Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Anthony T, 1996, ANN SURG ONCOL, V3, P344, DOI 10.1007/BF02305663; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; Borger ME, 2007, J PATHOL, V212, P278, DOI 10.1002/path.2181; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Burt R, 2005, GASTROENTEROLOGY, V128, P1696, DOI 10.1053/j.gastro.2005.03.036; Catalano V, 2009, BRIT J CANCER, V100, P881, DOI 10.1038/sj.bjc.6604955; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Huntsman DG, 2001, NEW ENGL J MED, V344, P1904, DOI 10.1056/NEJM200106213442504; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Kakar S, 2012, MODERN PATHOL, V25, P1040, DOI 10.1038/modpathol.2012.44; Kang HJ, 2005, DIS COLON RECTUM, V48, P1161, DOI 10.1007/s10350-004-0932-1; Lang K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-227; Lee S, 2008, PATHOL INT, V58, P104, DOI 10.1111/j.1440-1827.2007.02197.x; MALLORY SB, 1995, DERMATOL CLIN, V13, P27, DOI 10.1016/S0733-8635(18)30103-7; MESSERINI L, 1995, DIS COLON RECTUM, V38, P1189, DOI 10.1007/BF02048335; Mizushima T, 2010, SURG TODAY, V40, P234, DOI 10.1007/s00595-009-4057-y; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Ooi BS, 2001, ANZ J SURG, V71, P703, DOI 10.1046/j.1445-1433.2001.02269.x; Pande R, 2008, DIS COLON RECTUM, V51, P50, DOI 10.1007/s10350-007-9073-7; Perea J, 2011, ANN SURG ONCOL, V18, P3285, DOI 10.1245/s10434-011-1782-4; Phelan CM, 2014, BRIT J CANCER, V110, P530, DOI 10.1038/bjc.2013.741; Psathakis D, 1999, DIS COLON RECTUM, V42, P1618, DOI 10.1007/BF02236218; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Rowley PT, 2005, ANNU REV MED, V56, P539, DOI 10.1146/annurev.med.56.061704.135235; Schreibman IR, 2005, AM J GASTROENTEROL, V100, P476, DOI 10.1111/j.1572-0241.2005.40237.x; Song W, 2009, CHINESE MED J-PEKING, V122, P1486, DOI 10.3760/cma.j.issn.0366-6999.2009.13.002; Stoffel EM, 2014, CLIN GASTROENTEROL H, V12, P1059, DOI 10.1016/j.cgh.2013.08.015; Sung CO, 2008, MODERN PATHOL, V21, P1533, DOI 10.1038/modpathol.2008.170; Tan Y, 2015, CHINA PLOS ONE, V10, DOI [10. 1371/ journal. pone. 0121944, DOI 10.1371/J0URNAL.P0NE.0121944]; Tung SY, 1996, AM J GASTROENTEROL, V91, P2195; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yanyan Li, 2016, CHIN CLIN ONCOL, V21, P27	36	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156659	10.1371/journal.pone.0156659	http://dx.doi.org/10.1371/journal.pone.0156659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300552	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200012
J	Sliwoski, G; Schubert, M; Stichel, J; Weaver, D; Beck-Sickinger, AG; Meiler, J				Sliwoski, Gregory; Schubert, Mario; Stichel, Jan; Weaver, David; Beck-Sickinger, Annette G.; Meiler, Jens			Discovery of Small-Molecule Modulators of the Human Y-4 Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; PANCREATIC-POLYPEPTIDE; NEUROPEPTIDE-Y; FOOD-INTAKE; ALLOSTERIC MODULATION; BODY-WEIGHT; PEPTIDE YY; GUT HORMONES; CHALLENGES; BINDING	The human neuropeptide Y-4 receptor (Y4R) and its native ligand, pancreatic polypeptide, are critically involved in the regulation of human metabolism by signaling satiety and regulating food intake, as well as increasing energy expenditure. Thus, this receptor represents a putative target for treatment of obesity. With respect to new approaches to treat complex metabolic disorders, especially in multi-receptor systems, small molecule allosteric modulators have been in the focus of research in the last years. However, no positive allosteric modulators or agonists of the Y4R have been described so far. In this study, small molecule compounds derived from the Niclosamide scaffold were identified by high-throughput screening to increase Y4R activity. Compounds were characterized for their potency and their effects at the human Y4R and as well as their selectivity towards Y1R, Y2R and Y5R. These compounds provide a structure-activity relationship profile around this common scaffold and lay the groundwork for hit-to-lead optimization and characterization of positive allosteric modulators of the Y4R.	[Sliwoski, Gregory; Schubert, Mario; Stichel, Jan; Beck-Sickinger, Annette G.] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, D-04109 Leipzig, Germany; [Sliwoski, Gregory; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Dept Chem, Nashville, TN USA; [Weaver, David] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA	Leipzig University; Vanderbilt University; Vanderbilt University	Beck-Sickinger, AG (corresponding author), Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, D-04109 Leipzig, Germany.; Meiler, J (corresponding author), Vanderbilt Univ, Struct Biol Ctr, Dept Chem, Nashville, TN USA.	abeck-sickinger@uni-leipzig.de; jens@meilerlab.org		Schubert, Mario/0000-0002-8375-8233	National Institutes of Health [R01 DK097376]; Deutsche Forschungsgemeinschaft (DFG) [Be1264-16]; European Union; Free State of Saxony [100148835, 1423213128452]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097376] Funding Source: NIH RePORTER; Division Of Chemistry [1305874] Funding Source: National Science Foundation; Office Of The Director [1157751] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union(European Commission); Free State of Saxony; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by National Institutes of Health [R01 DK097376 to JM], by the Deutsche Forschungsgemeinschaft (DFG) [Grant Be1264-16 to ABS], and by the European Union and the Free State of Saxony [Grants 100148835 and 1423213128452 to ABS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2005, J NEUROSCI, V25, P7406, DOI 10.1523/JNEUROSCI.1008-05.2005; Asakawa A, 1999, PEPTIDES, V20, P1445, DOI 10.1016/S0196-9781(99)00155-2; Asakawa A, 2003, GASTROENTEROLOGY, V124, P1325, DOI 10.1016/S0016-5085(03)00216-6; BERNTSON GG, 1993, PEPTIDES, V14, P497, DOI 10.1016/0196-9781(93)90138-7; Brunicardi FC, 1996, J CLIN ENDOCR METAB, V81, P3566, DOI 10.1210/jc.81.10.3566; Chan WY, 2008, P NATL ACAD SCI USA, V105, P10978, DOI 10.1073/pnas.0800567105; Cho HP, 2014, ACS CHEM BIOL, V9, P2334, DOI 10.1021/cb500560h; Conn PJ, 2014, NAT REV DRUG DISCOV, V13, P692, DOI 10.1038/nrd4308; Cox HM, 2007, AUTON NEUROSCI-BASIC, V133, P76, DOI 10.1016/j.autneu.2006.10.005; Davey AE, 2012, ENDOCRINOLOGY, V153, P1232, DOI 10.1210/en.2011-1426; Ekblad E, 2002, PEPTIDES, V23, P251, DOI 10.1016/S0196-9781(01)00601-5; Ershow Abby G, 2009, J Diabetes Sci Technol, V3, P727; Field BCT, 2010, NAT REV ENDOCRINOL, V6, P444, DOI 10.1038/nrendo.2010.93; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Gregory KJ, 2011, NEUROPHARMACOLOGY, V60, P66, DOI 10.1016/j.neuropharm.2010.07.007; Heppner KM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00092; Holzer P, 2012, NEUROPEPTIDES, V46, P261, DOI 10.1016/j.npep.2012.08.005; Inui A, 2000, PHARMACOL REV, V52, P35; Jesudason DR, 2007, BRIT J NUTR, V97, P426, DOI 10.1017/S0007114507336799; Kaiser A, 2015, ANGEW CHEM INT EDIT, V54, P7446, DOI 10.1002/anie.201411688; Katsuura G, 2002, PEPTIDES, V23, P323, DOI 10.1016/S0196-9781(01)00604-0; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kissler HJ, 2013, SEMIN NEPHROL, V33, P75, DOI 10.1016/j.semnephrol.2012.12.004; Kojima S, 2007, PEPTIDES, V28, P459, DOI 10.1016/j.peptides.2006.09.024; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Made V, 2014, CHEMMEDCHEM, V9, P2463, DOI 10.1002/cmdc.201402235; Makris A, 2011, PSYCHIAT CLIN N AM, V34, P813, DOI 10.1016/j.psc.2011.08.004; Misra S, 2004, J PHARMACOL EXP THER, V311, P1154, DOI 10.1124/jpet.104.071415; Moreno-Herrera A, 2014, MINIREVIEWS MED CHEM; Pedragosa-Badia X, 2014, J BIOL CHEM, V289, P5846, DOI 10.1074/jbc.M113.502021; Pedragosa-Badia Xavier, 2013, Front Endocrinol (Lausanne), V4, P5, DOI 10.3389/fendo.2013.00005; Sato N, 2009, EXPERT OPIN THER PAT, V19, P1401, DOI 10.1517/13543770903251722; Seymour NE, 1996, J SURG RES, V65, P1, DOI 10.1006/jsre.1996.9999; Shonberg J, 2014, MED RES REV, V34, P1286, DOI 10.1002/med.21318; Smith BR, 2008, ENDOCRIN METAB CLIN, V37, P943, DOI 10.1016/j.ecl.2008.08.001; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Troke RC, 2014, THER ADV CHRONIC DIS, V5, P4, DOI 10.1177/2040622313506730; Ueno N, 1999, GASTROENTEROLOGY, V117, P1427, DOI 10.1016/S0016-5085(99)70293-3; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Yulyaningsih E, 2011, BRIT J PHARMACOL, V163, P1170, DOI 10.1111/j.1476-5381.2011.01363.x; Zhang R, 2012, ACTA PHARMACOL SIN, V33, P372, DOI 10.1038/aps.2011.173	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157146	10.1371/journal.pone.0157146	http://dx.doi.org/10.1371/journal.pone.0157146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294784	Green Submitted, gold, Green Published			2022-12-27	WOS:000377821300024
J	Asakawa-Haas, K; Schiestl, M; Bugnyar, T; Massen, JJM				Asakawa-Haas, Kenji; Schiestl, Martina; Bugnyar, Thomas; Massen, Jorg J. M.			Partner Choice in Raven (Corvus corax) Cooperation	PLOS ONE			English	Article							CHIMPANZEES; COGNITION; BEHAVIOR; FISH	Although social animals frequently make decisions about when or with whom to cooperate, little is known about the underlying mechanisms of partner choice. Most previous studies compared different dyads' performances, though did not allow an actual choice among partners. We tested eleven ravens, Corvus corax, in triads, giving them first the choice to cooperate with either a highly familiar or a rather unfamiliar partner and, second, with either a friend or a non-friend using a cooperative string-pulling task. In either test, the ravens had a second choice and could cooperate with the other partner, given that this one had not pulled the string in the meantime. We show that during the experiments, these partner ravens indeed learn to wait and inhibit pulling, respectively. Moreover, the results of these two experiments show that ravens' preferences for a specific cooperation partner are not based on familiarity. In contrast, the ravens did show a preference based on relationship quality, as they did choose to cooperate significantly more with friends than with non-friends and they were also more proficient when cooperating with a friend. In order to further identify the proximate mechanism of this preference, we designed an open-choice experiment for the whole group where all birds were free to cooperate on two separate apparatuses. This setup allowed us to distinguish between preferences for close proximity and preferences to cooperate. The results revealed that friends preferred staying close to each other, but did not necessarily cooperate with one another, suggesting that tolerance of proximity and not relationship quality as a whole may be the driving force behind partner choice in raven cooperation. Consequently, we stress the importance of experiments that allow such titrations and, suggest that these results have important implications for the interpretations of cooperation studies that did not include open partner choice.	[Asakawa-Haas, Kenji; Schiestl, Martina; Bugnyar, Thomas; Massen, Jorg J. M.] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Schiestl, Martina; Bugnyar, Thomas] Univ Vienna, Haidlhof Res Stn, Bad Voslau, Austria; [Schiestl, Martina; Bugnyar, Thomas] Univ Vet Med Vienna, Bad Voslau, Austria	University of Vienna; University of Vienna	Massen, JJM (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	jorgmassen@gmail.com	Asakawa-Haas, Kenji/GQI-1119-2022; Massen, Jorg/F-1190-2011	Massen, Jorg/0000-0002-1630-9606	Stand-Alone grant of the Austrian Science Fund (FWF) [M 1351, P 26806]; Austrian Science Fund (FWF) [P 26806] Funding Source: researchfish	Stand-Alone grant of the Austrian Science Fund (FWF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was funded by a Lise Meitner- and a Stand-Alone grant of the Austrian Science Fund (FWF, grant nos: M 1351 & P 26806) to JJMM.; We thank the whole Haidlhof personnel for their help and especially Andras Peter for the technical support, and Kerstin Polzl and Judith Schmidt for their help with coding videos. We are grateful for comments and suggestions of Angel Sanchez and two anonymous reviewers to an earlier version of this paper. This research was funded by a Lise Meitner- and a Stand-Alone grant of the Austrian Science Fund (FWF, grant nrs.: M 1351 & P 26806) to JJMM.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BEDNARZ JC, 1988, SCIENCE, V239, P1525, DOI 10.1126/science.239.4847.1525; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Boeckle M, 2012, CURR BIOL, V22, P801, DOI 10.1016/j.cub.2012.03.023; Boesch C, 2002, HUM NATURE-INT BIOS, V13, P27, DOI 10.1007/s12110-002-1013-6; Brosnan SF, 2002, HUM NATURE-INT BIOS, V13, P129, DOI 10.1007/s12110-002-1017-2; BROWN JA, 1986, BEHAV ECOL SOCIOBIOL, V19, P373, DOI 10.1007/BF00295711; Bugnyar T, 2008, CURR BIOL, V18, pR530, DOI 10.1016/j.cub.2008.04.057; Bugnyar T, 2013, COMP COGN BEHAV REV, V8, P1, DOI 10.3819/ccbr.2013.80001; Chalmeau R, 1997, INT J PRIMATOL, V18, P23, DOI 10.1023/A:1026337006136; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Cronin KA, 2005, ANIM BEHAV, V69, P133, DOI 10.1016/j.anbehav.2004.02.024; de Waal FBM, 2003, NEUROPSYCHOLOGIA, V41, P221, DOI 10.1016/S0028-3932(02)00152-5; DEVRIES H, 1993, BEHAVIOUR, V125, P157, DOI 10.1163/156853993X00218; Drea CM, 2009, ANIM BEHAV, V78, P967, DOI 10.1016/j.anbehav.2009.06.030; DUGATKIN LA, 1992, ANIM BEHAV, V44, P223, DOI 10.1016/0003-3472(92)90028-8; Engelmann JM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2803; Fraser ON, 2012, ANIM BEHAV, V83, P171, DOI 10.1016/j.anbehav.2011.10.023; Fraser ON, 2010, ANIM BEHAV, V79, P927, DOI 10.1016/j.anbehav.2010.01.008; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Hammerstein P, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0101; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; HEMELRIJK CK, 1990, J THEOR BIOL, V143, P405, DOI 10.1016/S0022-5193(05)80036-0; Hendricks P, 1998, CAN FIELD NAT, V112, P702; Hirata S., 2003, HATTATSU, V95, P103; Loretto MC, 2016, J ORNITHOL, V157, P439, DOI 10.1007/s10336-015-1289-z; MAGURRAN AE, 1994, J FISH BIOL, V45, P401, DOI 10.1111/j.1095-8649.1994.tb01322.x; Majolo B, 2006, BEHAVIOUR, V143, P1383, DOI 10.1163/156853906778987506; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; Massen JJM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15021; Massen JJM, 2014, CURR BIOL, V24, P2733, DOI 10.1016/j.cub.2014.09.073; Massen JJM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4679; Massen JJM, 2011, PRIMATES, V52, P237, DOI 10.1007/s10329-011-0244-8; Massen JJM, 2010, BEHAVIOUR, V147, P1379, DOI 10.1163/000579510X528224; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Mendres KA, 2000, ANIM BEHAV, V60, P523, DOI 10.1006/anbe.2000.1512; Molesti S, 2016, ANIM COGN, V19, P133, DOI 10.1007/s10071-015-0919-4; Ostojic L, 2014, ANIM COGN, V17, P445, DOI 10.1007/s10071-013-0676-1; Plotnik JM, 2011, P NATL ACAD SCI USA, V108, P5116, DOI 10.1073/pnas.1101765108; Schino G, GROOMING COALITIONS; Schino G, 2009, ADV STUD BEHAV, V39, P45, DOI 10.1016/S0065-3454(09)39002-6; Schmelz M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0067; Seed AM, 2008, P ROY SOC B-BIOL SCI, V275, P1421, DOI 10.1098/rspb.2008.0111; Seyfarth RM, 2012, ANNU REV PSYCHOL, V63, P153, DOI 10.1146/annurev-psych-120710-100337; Silk JB, 2002, BEHAVIOUR, V139, P421, DOI 10.1163/156853902760102735; Smuts B.B., 1985, SEX FRIENDSHIP BABOO; STANDER PE, 1992, BEHAV ECOL SOCIOBIOL, V29, P445; Suchak M, 2014, PEERJ, V2, DOI 10.7717/peerj.417; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vail AL, 2014, CURR BIOL, V24, pR791, DOI 10.1016/j.cub.2014.07.033; Wedekind C, 1996, P NATL ACAD SCI USA, V93, P2686, DOI 10.1073/pnas.93.7.2686; Werdenich D, 2002, ANIM BEHAV, V64, P771, DOI 10.1006/anbe.2002.9001	53	37	38	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156962	10.1371/journal.pone.0156962	http://dx.doi.org/10.1371/journal.pone.0156962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286247	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000033
J	Ramu, VS; Paramanantham, A; Ramegowda, V; Mohan-Raju, B; Udayakumar, M; Senthil-Kumar, M				Ramu, Vemanna S.; Paramanantham, Anjugam; Ramegowda, Venkategowda; Mohan-Raju, Basavaiah; Udayakumar, Makarla; Senthil-Kumar, Muthappa			Transcriptome Analysis of Sunflower Genotypes with Contrasting Oxidative Stress Tolerance Reveals Individual- and Combined-Biotic and Abiotic Stress Tolerance Mechanisms	PLOS ONE			English	Article							RICE ORYZA-SATIVA; GENE-EXPRESSION; HEAT-SHOCK; HIGH LIGHT; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; TRANSGENIC TOBACCO; RESPONSES; DROUGHT; IDENTIFICATION	In nature plants are often simultaneously challenged by different biotic and abiotic stresses. Although the mechanisms underlying plant responses against single stress have been studied considerably, plant tolerance mechanisms under combined stress is not understood. Also, the mechanism used to combat independently and sequentially occurring many number of biotic and abiotic stresses has also not systematically studied. From this context, in this study, we attempted to explore the shared response of sunflower plants to many independent stresses by using meta-analysis of publically available transcriptome data and transcript profiling by quantitative PCR. Further, we have also analyzed the possible role of the genes so identified in contributing to combined stress tolerance. Meta-analysis of transcriptomic data from many abiotic and biotic stresses indicated the common representation of oxidative stress responsive genes. Further, menadione-mediated oxidative stress in sunflower seedlings showed similar pattern of changes in the oxidative stress related genes. Based on this a large scale screening of 55 sunflower genotypes was performed under menadione stress and those contrasting in oxidative stress tolerance were identified. Further to confirm the role of genes identified in individual and combined stress tolerance the contrasting genotypes were individually and simultaneously challenged with few abiotic and biotic stresses. The tolerant hybrid showed reduced levels of stress damage both under combined stress and few independent stresses. Transcript profiling of the genes identified from meta-analysis in the tolerant hybrid also indicated that the selected genes were up-regulated under individual and combined stresses. Our results indicate that menadione-based screening can identify genotypes not only tolerant to multiple number of individual biotic and abiotic stresses, but also the combined stresses.	[Paramanantham, Anjugam; Senthil-Kumar, Muthappa] Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India; [Ramu, Vemanna S.; Ramegowda, Venkategowda; Mohan-Raju, Basavaiah; Udayakumar, Makarla] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India; [Ramu, Vemanna S.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK USA; [Ramegowda, Venkategowda] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); University of Agricultural Sciences Bangalore; Noble Research Institute; University of Arkansas System; University of Arkansas Fayetteville	Senthil-Kumar, M (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	skmuthappa@nipgr.ac.in	Mohan Raju, Basavaiah/HDN-8937-2022; Senthil-Kumar, Muthappa/AAF-6389-2020	Mohan Raju, Basavaiah/0000-0002-7566-7286; Vemanna, Ramu/0000-0002-9729-8768	National Institute of Plant Genome Research (NIPGR); DBT-Ramalingaswami re-entry fellowship grant [BT/RLF/re-entry/23/2012]; Indian Council of Agricultural Research niche area of excellence program [10-(6)/2005 EPD, 10 (15) 2012 EPD]	National Institute of Plant Genome Research (NIPGR)(Department of Biotechnology (DBT) India); DBT-Ramalingaswami re-entry fellowship grant; Indian Council of Agricultural Research niche area of excellence program	Combined stress tolerance projects at MSK lab are supported by National Institute of Plant Genome Research (NIPGR) core funding and DBT-Ramalingaswami re-entry fellowship grant (BT/RLF/re-entry/23/2012). MUK lab is supported by Indian Council of Agricultural Research niche area of excellence program (F. No. 10-(6)/2005 EPD & F. No. 10 (15) 2012 EPD). VSR is currently Fulbright-Nehru postdoctoral fellow under United States-India Educational Foundation (USIEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Albuquerque MCD, 2003, SEED SCI TECHNOL, V31, P465, DOI 10.15258/sst.2003.31.2.23; Alignan M, 2006, NEW PHYTOL, V170, P523, DOI 10.1111/j.1469-8137.2006.01696.x; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Babitha KC, 2013, TRANSGENIC RES, V22, P327, DOI 10.1007/s11248-012-9645-8; Balazadeh S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00234; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Borges AV, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017143; Breuer C, 2012, EMBO J, V31, P4488, DOI 10.1038/emboj.2012.294; Carrera J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r96; Chamnongpol S, 1996, PLANT J, V10, P491, DOI 10.1046/j.1365-313X.1996.10030491.x; Chang LC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-368; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; DATTA K, 1989, PLANT CELL, V1, P945, DOI 10.1105/tpc.1.9.945; Dehkhoda A., 2013, INT J FARM ALLI SCI, V2, P1319; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Fernandez P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-11; Fernandez-Ocana A, 2011, J PLANT PHYSIOL, V168, P1303, DOI 10.1016/j.jplph.2011.01.020; Fisher RA, 1960, THE DESIGN OF EXPERI; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Garg N, 2009, PLANT BIOSYST, V143, P81, DOI 10.1080/11263500802633626; Gascuel Q, 2015, MOL PLANT PATHOL, V16, P109, DOI 10.1111/mpp.12164; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hema R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099110; Hewezi T, 2008, ANN BOT-LONDON, V102, P127, DOI 10.1093/aob/mcn071; Hewezi T, 2006, J EXP BOT, V57, P3109, DOI 10.1093/jxb/erl080; Hey SJ, 2010, ANN BOT-LONDON, V105, P197, DOI 10.1093/aob/mcp285; Jajic Ivan, 2015, Plants-Basel, V4, P393, DOI 10.3390/plants4030393; Jayaprakash TL, 1998, ANN BOT-LONDON, V82, P513, DOI 10.1006/anbo.1998.0712; Jocic S., 2010, Helia, V33, P173, DOI 10.2298/HEL1053173J; KENDALL AC, 1983, PLANTA, V159, P505, DOI 10.1007/BF00409139; Kim SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063290; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Koussevitzky S, 2008, J BIOL CHEM, V283, P34197, DOI 10.1074/jbc.M806337200; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kumar B. R. P., 2000, Helia, V23, P1; Kumar D, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0122690, 10.1371/jo]; Kumar G, 1999, THEOR APPL GENET, V99, P359, DOI 10.1007/s001220051245; Lai Z, 2005, THEOR APPL GENET, V111, P1532, DOI 10.1007/s00122-005-0082-4; Landoni M, 2013, J EXP BOT, V64, P4313, DOI 10.1093/jxb/ert237; Li J, 2013, MICRO NANO LETT, V8, P8, DOI 10.1049/mnl.2012.0578; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Liu HT, 2003, PLANT PHYSIOL, V132, P1186, DOI 10.1104/pp.102.018564; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Lyngdoh IE, 2004, JOURNAL OF PLANT BIO, V31, P21; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Madgwick JW, 2011, EUR J PLANT PATHOL, V130, P117, DOI 10.1007/s10658-010-9739-1; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-99; Cecchini NM, 2011, PLANT PHYSIOL, V155, P1947, DOI 10.1104/pp.110.167163; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Narsai R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-93; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Oracz K, 2009, PLANT PHYSIOL, V150, P494, DOI 10.1104/pp.109.138107; Pastori GM, 2002, PLANT PHYSIOL, V129, P460, DOI 10.1104/pp.011021; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; PRASAD TK, 1994, PLANT PHYSIOL, V105, P619, DOI 10.1104/pp.105.2.619; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; Ramegowda V, 2015, J PLANT PHYSIOL, V176, P47, DOI 10.1016/j.jplph.2014.11.008; Ramegowda V, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-193; Ramegowda V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040397; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Reichheld JP, 1999, PLANT J, V17, P647, DOI 10.1046/j.1365-313X.1999.00413.x; Rengel D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045249; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Roche J, 2007, PLANTA, V226, P601, DOI 10.1007/s00425-007-0508-0; Rowe HC, 2008, GENETICS, V180, P2237, DOI 10.1534/genetics.108.091439; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Senthil-Kumar M, 2003, J EXP BOT, V54, P2569, DOI 10.1093/jxb/erg278; Senthil-Kumar M, 2007, J PLANT PHYSIOL, V164, P111, DOI 10.1016/j.jplph.2006.09.009; Shaik R, 2014, PLANT PHYSIOL, V164, P481, DOI 10.1104/pp.113.225862; Shaik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077261; Sharma R, 2013, MOL PLANT, V6, P250, DOI 10.1093/mp/sss147; Singh DP, 2004, MOL PLANT PATHOL, V5, P57, DOI 10.1111/j.1364-3703.2004.00203.x; Srikanthbabu V, 2002, J PLANT PHYSIOL, V159, P535, DOI 10.1078/0176-1617-00650; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Takahashi H, 1997, PLANT J, V11, P993, DOI 10.1046/j.1365-313X.1997.11050993.x; TURNER JG, 1974, PHYTOPATHOLOGY, V64, P885, DOI 10.1094/Phyto-64-885; UMA S, 1995, ANN BOT-LONDON, V76, P43, DOI 10.1006/anbo.1995.1076; Wasternack C, 2002, PROG NUCLEIC ACID RE, V72, P165, DOI 10.1016/S0079-6603(02)72070-9; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Xia JG, 2013, NUCLEIC ACIDS RES, V41, pW63, DOI 10.1093/nar/gkt338; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Yi HC, 2002, PLANT J, V32, P285, DOI 10.1046/j.1365-313X.2002.01425.x	90	43	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157522	10.1371/journal.pone.0157522	http://dx.doi.org/10.1371/journal.pone.0157522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314499	Green Published, Green Submitted, gold			2022-12-27	WOS:000378030000032
J	Song, SY; Ding, MY; Li, H; Song, XP; Fan, WL; Zhang, XM; Xu, HB				Song, Shuyan; Ding, Mingyue; Li, Hong; Song, Xiaopeng; Fan, Wenliang; Zhang, Xuming; Xu, Haibo			Frequency Specificity of fMRI in Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							HILBERT-HUANG TRANSFORM; FUNCTIONAL CONNECTIVITY; REGIONAL HOMOGENEITY; BRAIN ACTIVITY; PERFUSION CHANGES; DEFAULT MODE; HIPPOCAMPAL; NETWORK; LATERALIZATION; CORTEX	Medial temporal lobe epilepsy (mTLE) is a system-level disease characterized by aberrant neuronal synchronization and widespread alterations in function. Previous studies have focused on the amplitude analysis of the blood oxygenation level-dependent (BOLD) signals to reveal the aberrant alterations in mTLE. However, these methods did not work well in the cases where the amplitudes of two oscillations are correlated but the underlying oscillations are neither phase coherent nor frequency consistent. To address this problem, we investigated the differences of frequency specificity between patients with mTLE and healthy controls using the extreme-point symmetric mode decomposition (ESMD) method. In this method, the BOLD signals were decomposed into a set of intrinsic mode functions (IMFs) and the instantaneous frequency of each IMF was calculated using the direct interpolation strategy. The intrinsic frequency (denoted as Freq) for every voxel was obtained by the weighted sum of the instantaneous frequencies of all the IMFs. The Freq was used as an index to evaluate the altered frequency specificity of 41 patients with mTLE (17 right-side, 24 left-side) and 24 healthy control subjects. The results show that the peak of frequency distribution curve for the patients moves towards the higher frequency than that for the healthy controls. Compared with the healthy control group, the patients with left mTLE demonstrate higher Freq in the default mode network, middle frontal gyrus, insula, middle temporal gyrus and calcarine gyrus; the patients with right mTLE demonstrate higher Freq in the precuneus and occipital lobe. For the three groups, the distinct frequency distribution appears in the left and right hippocampus due to the hippocampal structural and functional asymmetries. The preliminary results imply that the frequency-specific correlated oscillations in the distributed brain regions can provide information about the nature of diseases affecting the brain and the alterations of frequency specificity are associated with the pathological characteristics of mTLE.	[Song, Shuyan; Ding, Mingyue; Zhang, Xuming] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Key Lab Image Proc & Intelligent Control, Sch Life Sci & Technol,Minist Educ, Wuhan 430074, Peoples R China; [Li, Hong] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China; [Song, Xiaopeng] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Fan, Wenliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan 430074, Peoples R China; [Xu, Haibo] Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan 430072, Peoples R China	Huazhong University of Science & Technology; Zhejiang University; Peking University; Huazhong University of Science & Technology; Wuhan University	Zhang, XM (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Key Lab Image Proc & Intelligent Control, Sch Life Sci & Technol,Minist Educ, Wuhan 430074, Peoples R China.; Xu, HB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Radiol, Wuhan 430072, Peoples R China.	zxmboshi@hust.edu.cn; xuhaibo1120@hotmail.com	Zhang, Xuming/AAS-7462-2020	Fan, Wenliang/0000-0001-8949-6775	National Nature Science Foundation of China [81171386, 81372369]; National Key Scientific Instrument and Equipment Development Project [2013YQ160551]; Fundamental Research Funds for the Central Universities [2015TS094]; Science and Technology Program of Wuhan, China [2015060101010027]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific Instrument and Equipment Development Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science and Technology Program of Wuhan, China	This work was supported by grants from the National Nature Science Foundation of China (81171386(to HX), 81372369(to HX), http://www.nsfc.gov.cn/) and by the National Key Scientific Instrument and Equipment Development Project (Grant No.: 2013YQ160551 (to MD), http://www.most.gov.cn/). This work is also supported by the Fundamental Research Funds for the Central Universities (No.: 2015TS094 (to XZ), http://www.moe.gov.cn/) and Science and Technology Program of Wuhan, China (No.: 2015060101010027 (to XZ), http://www.whst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baria AT, 2013, NEUROIMAGE, V73, P144, DOI 10.1016/j.neuroimage.2013.01.072; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Bouilleret V, 2002, ANN NEUROL, V51, P202, DOI 10.1002/ana.10087; Deng F, 2013, IEEE T BIO-MED ENG, V60, P42, DOI 10.1109/TBME.2012.2221125; Dinkelacker V, 2015, EPILEPSIA, V56, P1217, DOI 10.1111/epi.13051; He BJ, 2013, J NEUROSCI, V33, P4672, DOI 10.1523/JNEUROSCI.2922-12.2013; Huang NE, 2003, APPL STOCH MODEL BUS, V19, P245, DOI 10.1002/asmb.501; James GA, 2013, J NEUROSURG, V119, P288, DOI 10.3171/2013.3.JNS121041; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Lister JP, 2006, HIPPOCAMPUS, V16, P946, DOI 10.1002/hipo.20221; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; Morgan VL, 2008, HUM BRAIN MAPP, V29, P57, DOI 10.1002/hbm.20362; Morgan VL, 2010, EPILEPSY RES, V88, P168, DOI 10.1016/j.eplepsyres.2009.10.018; Nelissen N, 2006, NEUROIMAGE, V32, P684, DOI 10.1016/j.neuroimage.2006.04.185; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Pryor KO, 2015, BRIT J ANAESTH, V115, P104, DOI 10.1093/bja/aev038; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Song XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16376; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Tae WS, 2005, NEUROIMAGE, V24, P101, DOI 10.1016/j.neuroimage.2004.08.005; Tracy JI, 2015, CURR OPIN NEUROL, V28, P158, DOI 10.1097/WCO.0000000000000178; Vannest J, 2008, EPILEPSY BEHAV, V12, P410, DOI 10.1016/j.yebeh.2007.11.012; Wagner K, 2008, EPILEPSY BEHAV, V12, P382, DOI 10.1016/j.yebeh.2007.11.003; Wang JL, 2013, ADV DATA SCI ADAPT, V5, DOI 10.1142/S1793536913500155; Woolard AA, 2012, PSYCHIAT RES-NEUROIM, V201, P48, DOI 10.1016/j.pscychresns.2011.07.016; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Wurina, 2012, NEUROSCI BULL, V28, P449, DOI 10.1007/s12264-012-1255-1; Xie HB, 2006, COMPUT METH PROG BIO, V82, P114, DOI 10.1016/j.cmpb.2006.02.009; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeng HW, 2013, EPILEPSIA, V54, P658, DOI 10.1111/epi.12066; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	38	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157342	10.1371/journal.pone.0157342	http://dx.doi.org/10.1371/journal.pone.0157342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314671	gold, Green Published, Green Submitted			2022-12-27	WOS:000378030000021
J	Acharya, J; Kaehler, N; Marahatta, SB; Mishra, SR; Subedi, S; Adhikari, B				Acharya, Jeevan; Kaehler, Nils; Marahatta, Sujan Babu; Mishra, Shiva Raj; Subedi, Sudarshan; Adhikari, Bipin			Hidden Costs of Hospital Based Delivery from Two Tertiary Hospitals in Western Nepal	PLOS ONE			English	Article							MATERNITY CARE	Introduction Hospital based delivery has been an expensive experience for poor households because of hidden costs which are usually unaccounted in hospital costs. The main aim of this study was to estimate the hidden costs of hospital based delivery and determine the factors associated with the hidden costs. Methods A hospital based cross-sectional study was conducted among 384 post-partum mothers with their husbands/house heads during the discharge time in Manipal Teaching Hospital and Western Regional Hospital, Pokhara, Nepal. A face to face interview with each respondent was conducted using a structured questionnaire. Hidden costs were calculated based on the price rate of the market during the time of the study. Results The total hidden costs for normal delivery and C-section delivery were 243.4 USD (US Dollar) and 321.6 USD respectively. Of the total maternity care expenditures; higher mean expenditures were found for food & drinking (53.07%), clothes (9.8%) and transport (7.3%). For postpartum women with their husband or house head, the total mean opportunity cost of "days of work loss" were 84.1 USD and 81.9 USD for normal delivery and C-section respectively. Factors such as literate mother (p = 0.007), employed house head (p = 0.011), monthly family income more than 25,000 NRs (Nepalese Rupees) (p = 0.014), private hospital as a place of delivery (p = 0.0001), C-section as a mode of delivery (p = 0.0001), longer duration (>5 days) of stay in hospital (p = 0.0001), longer distance (>15 km) from house to hospital (p = 0.0001) and longer travel time (>240 minutes) from house to hospital (p = 0.007) showed a significant association with the higher hidden costs (>25000 NRs). Conclusion Experiences of hidden costs on hospital based delivery and opportunity costs of days of work loss were found high. Several socio-demographic factors, delivery related factors (place and mode of delivery, length of stay, distance from hospital and travel time) were associated with hidden costs. Hidden costs can be a critical factor for many poor and remote households who attend the hospital for delivery. Current remuneration (10-15 USD for normal delivery, 30 USD for complicated delivery and 70 USD for caesarean section delivery) for maternity incentive needs to account the hidden costs by increasing it to 250 USD for normal delivery and 350 USD for C-section. Decentralization of the obstetric care to remote and under-privileged population might reduce the economic burden of pregnant women and can facilitate their attendance at the health care centers.	[Acharya, Jeevan] Pokhara Univ, La Grandee Int Coll, Pokhara, Nepal; [Kaehler, Nils] Sandefjord Helsepk, Skiringssalveien 20, Sandefjord, Norway; [Marahatta, Sujan Babu] Manmohan Mem Med Coll & Teaching Hosp, Dept Community Med, Kathmandu, Nepal; [Mishra, Shiva Raj] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; [Subedi, Sudarshan] Pokhara Univ, Sch Hlth & Allied Sci, Kaski, Nepal; [Adhikari, Bipin] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok 10700, Thailand	University of Western Australia; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Adhikari, B (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok 10700, Thailand.	biopion@gmail.com	Mishra, Shiva Raj/C-4172-2014; Adhikari, Bipin/X-3110-2019; Subedi, Sudarshan/L-5774-2019	Mishra, Shiva Raj/0000-0002-2993-3504; Adhikari, Bipin/0000-0001-8981-3910; Subedi, Sudarshan/0000-0003-4860-579X; Acharya, Jeevan/0000-0002-2872-6343				Baral G, 2012, J Nepal Health Res Counc, V10, P118; Bhusal C L, 2011, J Nepal Health Res Counc, V9, P129; Borghi J, 2006, TROP MED INT HEALTH, V11, P228, DOI 10.1111/j.1365-3156.2005.01546.x; Department of Health Services, 2014, DEP HLTH SERV ANN RE; Douangvichit Daovieng, 2012, BMC Res Notes, V5, P30, DOI 10.1186/1756-0500-5-30; Gal MS, 2015, NEW YORK U LAW EC WO, P1; Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Isa A., 2013, J WOMENS HLTH CARE, V2, DOI [10.4172/2167-0420.1000134, DOI 10.4172/2167-0420.1000134, 10.4172/ 2167- 0420.1000134]; Kaitelidou DC, 2013, HEALTH POLICY, V109, P23, DOI 10.1016/j.healthpol.2012.10.012; Karkee Rajendra, 2013, WHO South East Asia J Public Health, V2, P135, DOI 10.4103/2224-3151.206759; Khan A, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-2; Khan Suhaila H, 2005, Cost Eff Resour Alloc, V3, P1, DOI 10.1186/1478-7547-3-1; Ministry of Health and Population (MOHP), 2012, NEP DEM HLTH SURV 20; Mohanty SK, 2013, HEALTH POLICY PLANN, V28, P247, DOI 10.1093/heapol/czs057; Nahar S, 1998, HEALTH POLICY PLANN, V13, P417, DOI 10.1093/heapol/13.4.417; Network SC, 2012, CALCULATE LOSS PAY B; Njie B, 2011, THESIS; Offei AK, 2004, HEALTHCARE QUALITY A, P1; Sabes-Figuera R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-56; Sharma G, 2012, HLTH SCI J, V6, P317; Srivastav S, 2012, NATL J MED RES, V2, P35; Subedi S, 2014, INDAN J COMMUNITY HE, V26, P273; Usher D, 1989, SEQ I SEM WASH DC, P1; Witter S, 2011, HEALTH POLICY PLANN, V26, pII84, DOI 10.1093/heapol/czr066; World Bank, 2016, MAT MORT RAT MOD EST	26	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157746	10.1371/journal.pone.0157746	http://dx.doi.org/10.1371/journal.pone.0157746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308836	Green Published, gold			2022-12-27	WOS:000378029800130
J	February, EC; Higgins, SI				February, Edmund Carl; Higgins, Steven Ian			Rapid Leaf Deployment Strategies in a Deciduous Savanna	PLOS ONE			English	Article							NUTRIENT RESORPTION; TREE; WATER; PHENOLOGY; EVERGREEN; PATTERNS; GROWTH; DECOMPOSITION; NITROGEN; TRAITS	Deciduous plants avoid the costs of maintaining leaves in the unfavourable season, but carry the costs of constructing new leaves every year. Deciduousness is therefore expected in ecological situations with pronounced seasonality and low costs of leaf construction. In our study system, a seasonally dry tropical savanna, many trees are deciduous, suggesting that leaf construction costs must be low. Previous studies have, however, shown that nitrogen is limiting in this system, suggesting that leaf construction costs are high. Here we examine this conundrum using a time series of soil moisture availability, leaf phenology and nitrogen distribution in the tree canopy to illustrate how trees resorb nitrogen before leaf abscission and use stored reserves of nitrogen and carbon to construct new leaves at the onset of the growing season. Our results show that trees deployed leaves shortly before and in anticipation of the first rains with its associated pulse of nitrogen mineralisation. Our results also show that trees rapidly constructed a full canopy of leaves within two weeks of the first rains. We detected an increase in leaf nitrogen content that corresponded with the first rains and with the movement of nitrogen to more distal branches, suggesting that stored nitrogen reserves are used to construct leaves. Furthermore the stable carbon isotope ratios (delta C-13) of these leaves suggest the use of stored carbon for leaf construction. Our findings suggest that the early deployment of leaves using stored nitrogen and carbon reserves is a strategy that is integrally linked with the onset of the first rains. This strategy may confer a competitive advantage over species that deploy leaves at or after the onset of the rains.	[February, Edmund Carl] Univ Cape Town, Dept Biol Sci, ZA-7701 Rondebosch, South Africa; [Higgins, Steven Ian] Univ Otago, Dept Bot, POB 56, Dunedin 9054, New Zealand; [Higgins, Steven Ian] Senckenberg Gesell Naturforsch, Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, D-60325 Frankfurt, Germany	University of Cape Town; University of Otago; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	February, EC (corresponding author), Univ Cape Town, Dept Biol Sci, ZA-7701 Rondebosch, South Africa.	Edmund.February@uct.ac.za	Higgins, Steven I/A-5138-2012	Higgins, Steven I/0000-0001-5695-9665; February, Edmund/0000-0001-9790-0395	Andrew W Mellon Foundation of New York; South African Nation Research Foundation; Deutsche Forschungsgemeinschaft	Andrew W Mellon Foundation of New York; South African Nation Research Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The Andrew W Mellon Foundation of New York funded both ECF and SIH. The South African Nation Research Foundation funded ECF. The Deutsche Forschungsgemeinschaft funded SIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald S, 2007, J VEG SCI, V18, P583, DOI 10.1111/j.1654-1103.2007.tb02572.x; Badeck FW, 2005, RAPID COMMUN MASS SP, V19, P1381, DOI 10.1002/rcm.1912; BARBER STANLEY A., 1962, SOIL SCI, V93, P39, DOI 10.1097/00010694-196201000-00007; Barton Jr J. H., 1986, KOEDOE, V29, P39, DOI DOI 10.4102/K0ED0E.V29I1.518; BERNHARDREVERSAT F, 1982, OIKOS, V38, P321, DOI 10.2307/3544672; BRUGNOLI E, 1988, PLANT PHYSIOL, V88, P1418, DOI 10.1104/pp.88.4.1418; BUTTROSE M. S., 1966, VTTIS BER REBENFORSCH, V5, P455; CHAPIN FS, 1983, ECOLOGY, V64, P376, DOI 10.2307/1937083; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chidumayo EN, 2001, J VEG SCI, V12, P347, DOI 10.2307/3236848; Coetsee C, 2012, ENVIRON MANAGE, V49, P387, DOI 10.1007/s00267-011-9779-0; Craine JM, 2008, NEW PHYTOL, V179, P829, DOI 10.1111/j.1469-8137.2008.02513.x; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; Damesin C, 1998, FUNCT ECOL, V12, P778, DOI 10.1046/j.1365-2435.1998.00259.x; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; Eamus D, 1999, TRENDS ECOL EVOL, V14, P11, DOI 10.1016/S0169-5347(98)01532-8; February EC, 2013, AUSTRAL ECOL, V38, P66, DOI 10.1111/j.1442-9993.2012.02376.x; February EC, 2010, S AFR J BOT, V76, P517, DOI 10.1016/j.sajb.2010.04.001; February EC, 2007, J BIOGEOGR, V34, P270, DOI 10.1111/j.1365-2699.2006.01583.x; Franco AC, 2005, TREES-STRUCT FUNCT, V19, P326, DOI 10.1007/s00468-004-0394-z; Frost PGH, 1986, RESPONSES SAVANNAS S; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; Helle G, 2004, PLANT CELL ENVIRON, V27, P367, DOI 10.1111/j.0016-8025.2003.01159.x; Higgins SI, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0572; Higgins SI, 2011, J BIOGEOGR, V38, P2165, DOI 10.1111/j.1365-2699.2011.02549.x; Higgins SI, 2010, ECOLOGY, V91, P1682, DOI 10.1890/08-1368.1; Jarvis P, 2007, TREE PHYSIOL, V27, P929, DOI 10.1093/treephys/27.7.929; Kozovits AR, 2007, FUNCT ECOL, V21, P1034, DOI 10.1111/j.1365-2435.2007.01325.x; Mucina L., 2006, VEGETATION S AFRICA; MURALI KS, 1993, OECOLOGIA, V94, P114, DOI 10.1007/BF00317311; Pallardy SG, 2008, PHYSIOLOGY OF WOODY PLANTS, 3RD EDITION, P233; Plummer M., 2003, P 3 INT WORKSHOP DIS; Ratnam J, 2008, OECOLOGIA, V157, P141, DOI 10.1007/s00442-008-1047-5; Rossatto DR, 2009, FUNCT ECOL, V23, P689, DOI 10.1111/j.1365-2435.2009.01568.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Santa-Regina I, 1997, J VEG SCI, V8, P651, DOI 10.2307/3237369; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; van der Waal C, 2009, J ECOL, V97, P430, DOI 10.1111/j.1365-2745.2009.01498.x; Williams CA, 2009, OECOLOGIA, V161, P469, DOI 10.1007/s00442-009-1405-y; Williams RJ, 1997, ECOLOGY, V78, P2542, DOI 10.1890/0012-9658(1997)078[2542:LPOWSI]2.0.CO;2	40	17	17	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157833	10.1371/journal.pone.0157833	http://dx.doi.org/10.1371/journal.pone.0157833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310398	Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800138
J	Gadd, VL; Patel, PJ; Jose, S; Horsfall, L; Powell, EE; Irvine, KM				Gadd, Victoria L.; Patel, Preya J.; Jose, Sara; Horsfall, Leigh; Powell, Elizabeth E.; Irvine, Katharine M.			Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation	PLOS ONE			English	Article							PREDICT CARDIOVASCULAR EVENTS; C-VIRUS; SINUSOIDAL ENDOTHELIUM; ANTIVIRAL RESPONSE; DUCTULAR REACTION; IN-VIVO; EXPRESSION; CIRRHOSIS; FIBROSIS; CELLS	Background and Aims Liver and systemic inflammatory factors influence monocyte phenotype and function, which has implications for hepatic recruitment and subsequent inflammatory and fibrogenic responses, as well as host defence. Methods Peripheral blood monocyte surface marker (CD14, CD16, CD163, CSF1R, CCR2, CCR4, CCR5, CXCR3, CXCR4, CX3CR1, HLA-DR, CD62L, SIGLEC-1) expression and capacity for phagocytosis, oxidative burst and LPS-stimulated TNF production were assessed in patients with hepatitis C (HCV) (n = 39) or non-alcoholic fatty liver disease (NAFLD) (n = 34) (classified as non-advanced disease, compensated cirrhosis and decompensated cirrhosis) and healthy controls (n = 11) by flow cytometry. Results The selected markers exhibited similar monocyte-subset-specific expression patterns between patients and controls. Monocyte phenotypic signatures differed between NAFLD and HCV patients, with an increased proportion of CD16(+) non-classical monocytes in NAFLD, but increased expression of CXCR3 and CXCR4 in HCV. In both cohorts, monocyte CCR2 expression was reduced and CCR4 elevated over controls. CD62L expression was specifically elevated in patients with decompensated cirrhosis and positively correlated with the model-for-end-stage-liver-disease score. Functionally, monocytes from patients with decompensated cirrhosis had equal phagocytic capacity, but displayed features of dysfunction, characterised by lower HLA-DR expression and blunted oxidative responses. Lower monocyte TNF production in response to LPS stimulation correlated with time to death in 7 (46%) of the decompensated patients who died within 8 months of recruitment. Conclusions Chronic HCV and NAFLD differentially affect circulating monocyte phenotype, suggesting specific injury-induced signals may contribute to hepatic monocyte recruitment and systemic activation state. Monocyte function, however, was similarly impaired in patients with both HCV and NAFLD, particularly in advanced disease, which likely contributes to the increased susceptibility to infection in these patients.	[Gadd, Victoria L.; Patel, Preya J.; Jose, Sara; Horsfall, Leigh; Powell, Elizabeth E.; Irvine, Katharine M.] Univ Queensland, Ctr Liver Dis Res, Sch Med, Translat Res Inst, Brisbane, Qld, Australia; [Patel, Preya J.; Horsfall, Leigh; Powell, Elizabeth E.] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia	University of Queensland	Irvine, KM (corresponding author), Univ Queensland, Ctr Liver Dis Res, Sch Med, Translat Res Inst, Brisbane, Qld, Australia.	katharine.irvine@gmail.com	Powell, Elizabeth/B-4455-2011; Irvine, Katharine M/A-5559-2011	Powell, Elizabeth/0000-0001-5008-8061; Irvine, Katharine M/0000-0002-6716-1605; Jose, Sara/0000-0002-3791-9120; Gadd, Victoria/0000-0003-1819-8660	National Health and Medical Research Foundation; Princess Alexandra Hospital Foundation, an Australian Liver Foundation Pauline Hall Fellowship; National Health and Medical Research Foundation Practitioner Fellowship [APP1044650]	National Health and Medical Research Foundation; Princess Alexandra Hospital Foundation, an Australian Liver Foundation Pauline Hall Fellowship; National Health and Medical Research Foundation Practitioner Fellowship	This study was funded by grants from the National Health and Medical Research Foundation (www.nhmrc.gov.au) and the Princess Alexandra Hospital Foundation, an Australian Liver Foundation Pauline Hall Fellowship to KMI (www.liver.org.au/pauline-hall-fellowship) and National Health and Medical Research Foundation Practitioner Fellowship to EEP (APP1044650).	Albillos A, 2004, J HEPATOL, V40, P624, DOI 10.1016/j.jhep.2003.12.010; Aspinall AI, 2010, HEPATOLOGY, V51, P2030, DOI 10.1002/hep.23591; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Bernsmeier C, 2015, GASTROENTEROLOGY, V148, P603, DOI 10.1053/j.gastro.2014.11.045; Berres ML, 2009, LIVER INT, V29, P536, DOI 10.1111/j.1478-3231.2008.01870.x; Berry PA, 2011, INTENS CARE MED, V37, P453, DOI 10.1007/s00134-010-2099-7; Bolen CR, 2013, J INTERF CYTOK RES, V33, P15, DOI 10.1089/jir.2012.0037; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Cannon JG, 2014, PHYSL REPORTS, P2; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Erhardt A, 2011, J IMMUNOL, V186, P5284, DOI 10.4049/jimmunol.1003750; Fahey S, 2014, CELL MOL IMMUNOL, V11, P25, DOI 10.1038/cmi.2013.37; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Gadd VL, 2013, LIVER INT, V33, P569, DOI 10.1111/liv.12050; Hall MW, 2013, CRIT CARE MED, V41, P224, DOI 10.1097/CCM.0b013e318267633c; Karlmark KR, 2010, HEPATOLOGY, V52, P1769, DOI 10.1002/hep.23894; Kim MS, 2006, J CELL BIOCHEM, V97, P512, DOI 10.1002/jcb.20649; Kjaergaard AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092331; Krinninger P, 2014, J CLIN ENDOCR METAB, V99, P2500, DOI 10.1210/jc.2013-2611; Leber B, 2012, SEMIN RESP CRIT CARE, V33, P80, DOI 10.1055/s-0032-1301737; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; Liaskou E, 2013, HEPATOLOGY, V57, P385, DOI 10.1002/hep.26016; Martinez Fernando O, 2009, J Biol, V8, P99, DOI 10.1186/jbiol206; Matsubara T, 2013, HEPATOLOGY, V57, P1416, DOI 10.1002/hep.25965; Melino M, 2016, AM J PATHOL; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Moore JK, 2015, CYTOTHERAPY, V17, P1604, DOI 10.1016/j.jcyt.2015.07.016; Munshaw S, 2012, HEPATOLOGY, V56, P544, DOI 10.1002/hep.25655; Nguyen N, 2014, J GASTROEN HEPATOL, V29, P860, DOI 10.1111/jgh.12462; Nieto JC, 2015, J LEUKOCYTE BIOL, V98, P819, DOI 10.1189/jlb.3AB0315-106R; Oo YH, 2012, J HEPATOL, V57, P1044, DOI 10.1016/j.jhep.2012.07.008; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Rodriguez-Munoz Y, 2011, ALIMENT PHARM THER, V34, P960, DOI 10.1111/j.1365-2036.2011.04807.x; Rogacev KS, 2014, ARTERIOSCL THROM VAS, V34, P2120, DOI 10.1161/ATVBAHA.114.304172; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Saiman Y, 2015, HEPATOL RES, V45, P794, DOI 10.1111/hepr.12411; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Shi Y, 2015, J HEPATOL, V63, P60, DOI 10.1016/j.jhep.2015.02.020; Sipeki N, 2014, WORLD J GASTROENTERO, V20, P2564, DOI 10.3748/wjg.v20.i10.2564; Stansfield BK, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0040-3; Tacke F, 2011, LIVER INT, V31, P842, DOI 10.1111/j.1478-3231.2011.02504.x; Terada R, 2003, LAB INVEST, V83, P665, DOI 10.1097/01.LAB.0000067498.89585.06; Thalheimer U, 2005, GUT, V54, P556, DOI 10.1136/gut.2004.048181; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Wald O, 2004, EUR J IMMUNOL, V34, P1164, DOI 10.1002/eji.200324441; Wang Y, 2016, HORM METAB RES, V48, P54, DOI 10.1055/s-0035-1547233; Wang YF, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-32; Wasmuth HE, 2005, J HEPATOL, V42, P195, DOI 10.1016/j.jhep.2004.10.019; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Xu HP, 2008, BLOOD, V112, P1166, DOI 10.1182/blood-2007-06-098327; Ye H, 2013, WORLD J GASTROENTERO, V19, P2818, DOI 10.3748/wjg.v19.i18.2818; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484; Zimmermann HW, 2016, HEPATOLOGY, V63, P233, DOI 10.1002/hep.28285; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	56	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157771	10.1371/journal.pone.0157771	http://dx.doi.org/10.1371/journal.pone.0157771			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309850	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800134
J	Kelch, NS; Neves, FS; Fernandes, GW; Wirth, R				Kelch, Nina-S.; Neves, Frederico S.; Fernandes, G. Wilson; Wirth, Rainer			Mechanisms Driving Galling Success in a Fragmented Landscape: Synergy of Habitat and Top-Down Factors along Temperate Forest Edges	PLOS ONE			English	Article							FAGUS-SYLVATICA L.; SPECIES RICHNESS; INSECTS; CECIDOMYIIDAE; DIVERSITY; PARADIGM; DIPTERA; FAUNA; FIELD; SIZE	Edge effects play key roles in the anthropogenic transformation of forested ecosystems and their biota, and are therefore a prime field of contemporary fragmentation research. We present the first empirical study to address edge effects on the population level of a widespread galling herbivore in a temperate deciduous forest. By analyzing edge effects on abundance and trophic interactions of beech gall midge (Mikiola fagi Htg.), we found 30% higher gall abundance in the edge habitat as well as lower mortality rates due to decreased top-down control, especially by parasitoids. Two GLM models with similar explanatory power (58%) identified habitat specific traits (such as canopy closure and altitude) and parasitism as the best predictors of gall abundance. Further analyses revealed a crucial influence of light exposure (46%) on top-down control by the parasitoid complex. Guided by a conceptual framework synthesizing the key factors driving gall density, we conclude that forest edge proliferation of M. fagi is due to a complex interplay of abiotic changes and trophic control mechanisms. Most prominently, it is caused by the microclimatic regime in forest edges, acting alone or in synergistic concert with top-down pressure by parasitoids. Contrary to the prevailing notion that specialists are edge-sensitive, this turns M. fagi into a winner species in fragmented temperate beech forests. In view of the increasing proportion of edge habitats and the documented benefits from edge microclimate, we call for investigations exploring the pest status of this galling insect and the modulators of its biological control.	[Kelch, Nina-S.; Wirth, Rainer] Univ Kaiserslautern, Plant Ecol & Systemat, D-67663 Kaiserslautern, Germany; [Neves, Frederico S.; Fernandes, G. Wilson] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Fernandes, G. Wilson] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Kaiserslautern; Universidade Federal de Minas Gerais; Stanford University	Wirth, R (corresponding author), Univ Kaiserslautern, Plant Ecol & Systemat, D-67663 Kaiserslautern, Germany.	wirth@rhrk.uni-kl.de	Wirth, Rainer/I-1552-2013; Fernandes, Geraldo/AAN-5602-2021; Neves, Frederico/E-5777-2013	Wirth, Rainer/0000-0001-8042-3123; Fernandes, Geraldo/0000-0003-1559-6049; Neves, Frederico/0000-0002-2691-3743				Allan E, 2011, ECOL LETT, V14, P1246, DOI 10.1111/j.1461-0248.2011.01694.x; Altamirano A, 2016, J INSECT CONSERV, V20, P119, DOI 10.1007/s10841-016-9845-2; [Anonymous], 2012, SCIENCE, DOI DOI 10.1126/science.1215904; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brose K., 1957, KLIMA ATLAS RHEINLAN; Brunet Jorg, 2010, Ecological Bulletins, V53, P77; Colinet H, 2015, ANNU REV ENTOMOL, V60, P123, DOI 10.1146/annurev-ento-010814-021017; COURTNEY SP, 1982, ECOL ENTOMOL, V7, P131, DOI 10.1111/j.1365-2311.1982.tb00651.x; Crawley MJ, 2013, THE R BOOK, P1076; de Almeida WR, 2008, ENTOMOL EXP APPL, V129, P251, DOI 10.1111/j.1570-7458.2008.00774.x; de Araujo WS, 2012, BIODIVERS CONSERV, V21, P2991, DOI 10.1007/s10531-012-0333-z; Dziurzynski A, 1961, ACTA ZOOL CRAC, V15, P9; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Eschrich W, 1989, TREES-STRUCT FUNCT, V3, P1, DOI 10.1007/BF00202394; Espirito-Santo MM, 2007, ANN ENTOMOL SOC AM, V100, P95, DOI 10.1603/0013-8746(2007)100[95:HMSOGI]2.0.CO;2; Evans J, 2001, FORESTS HDB OVERVIEW; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FERNANDES GW, 1988, OECOLOGIA, V76, P161, DOI 10.1007/BF00379948; FERNANDES GW, 1992, OECOLOGIA, V90, P14, DOI 10.1007/BF00317803; Fernandes GW, 2003, TREES-STRUCT FUNCT, V17, P407, DOI 10.1007/s00468-003-0252-4; Geiger M., 2010, GEOGRAPHIE PFALZ; Gripenberg S, 2007, OIKOS, V116, P181, DOI [10.1111/j.2006.0030-1299.15266.x, 10.1111/j.0030-1299.2007.15266.x]; Hagen M, 2012, ADV ECOL RES, V46, P89, DOI 10.1016/B978-0-12-396992-7.00002-2; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Holt Robert D., 1996, P313; Hulme PE, 1996, J ECOL, V84, P609, DOI 10.2307/2261482; JENSEN PB, 1948, PHYSIOL PLANTARUM, V1, P95, DOI 10.1111/j.1399-3054.1948.tb07113.x; Juliao GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114986; Juliao GR, 2004, BIODIVERS CONSERV, V13, P2055, DOI 10.1023/B:BIOC.0000040006.81958.f2; Kampichler C, 2002, EUR J ENTOMOL, V99, P79, DOI 10.14411/eje.2002.014; Kirst GO, 2006, BIOCH PHYS PFL, V165, P445; Kramer K, 2010, FOREST ECOL MANAG, V259, P2213, DOI 10.1016/j.foreco.2009.12.023; Kruess A, 2000, OECOLOGIA, V122, P129, DOI 10.1007/PL00008829; Lampe KH, 1989, NACHR DTSCH GES ALLG, V3, P64; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Lemmon PE, 1957, FOREST SCI, V2, P319; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Maldonado-Lopez Y, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00355.1; Malinga GM, 2014, OECOLOGIA, V176, P511, DOI 10.1007/s00442-014-3024-5; Martinez JJI, 2005, LANDSCAPE ECOL, V20, P1013, DOI 10.1007/s10980-005-7753-z; Martinson HM, 2014, ECOL LETT, V17, P1178, DOI 10.1111/ele.12305; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; National Committee of World Cultural and Natural Heritage, 1990, NOM FIL BAN CHIANG A; Peuke AD, 2002, NEW PHYTOL, V154, P373, DOI 10.1046/j.1469-8137.2002.00400.x; Price P.W., 1986, Ecological Research, V1, P1, DOI 10.1007/BF02361200; Raman A, 2011, FLORA, V206, P517, DOI 10.1016/j.flora.2010.08.004; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Schreiber HJ, 1998, THESIS; Skuhravy VV, 1996, ANZ SCHADLINGSKD PFL, V69, P56, DOI 10.1007/BF01906276; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Urban J., 2000, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V48, P97; Urban J., 2000, Journal of Forest Science (Prague), V46, P543; Urban J., 2000, Journal of Forest Science (Prague), V46, P114; Valladares G, 2006, CONSERV BIOL, V20, P212, DOI 10.1111/j.1523-1739.2006.00337.x; Valladares G, 2012, OIKOS, V121, P299, DOI 10.1111/j.1600-0706.2011.19671.x; Wimp GM, 2011, ECOL LETT, V14, P863, DOI 10.1111/j.1461-0248.2011.01656.x; Wirth Rainer, 2008, V69, P423, DOI 10.1007/978-3-540-72954-9_17; Yukawa J, 2000, POPUL ECOL, V42, P105, DOI 10.1007/PL00011989	60	7	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157448	10.1371/journal.pone.0157448	http://dx.doi.org/10.1371/journal.pone.0157448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310599	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800074
J	Kobayashi, T; Sasaki, S; Utsumi, Y; Fujita, N; Umeda, K; Sawada, T; Kubo, A; Abe, J; Colleoni, C; Ball, S; Nakamura, Y				Kobayashi, Taiki; Sasaki, Satoshi; Utsumi, Yoshinori; Fujita, Naoko; Umeda, Kazuhiro; Sawada, Takayuki; Kubo, Akiko; Abe, Jun-ichi; Colleoni, Christophe; Ball, Steven; Nakamura, Yasunori			Comparison of Chain-Length Preferences and Glucan Specificities of Isoamylase-Type alpha-Glucan Debranching Enzymes from Rice, Cyanobacteria, and Bacteria	PLOS ONE			English	Article							STARCH GRANULE INITIATION; AMYLOPECTIN BIOSYNTHESIS; BIOCHEMICAL-CHARACTERIZATION; ARABIDOPSIS LACKING; BRANCHING ENZYMES; SUGARY-1 MUTANTS; HOMO-OLIGOMER; R-ENZYME; GLYCOGEN; PURIFICATION	It has been believed that isoamylase (ISA)-type alpha-glucan debranching enzymes (DBEs) play crucial roles not only in a-glucan degradation but also in the biosynthesis by affecting the structure of glucans, although molecular basis on distinct roles of the individual DBEs has not fully understood. In an attempt to relate the roles of DBEs to their chain-length specificities, we analyzed the chain-length distribution of DBE enzymatic reaction products by using purified DBEs from various sources including rice, cyanobacteria, and bacteria. When DBEs were incubated with phytoglycogen, their chain-length specificities were divided into three groups. First, rice endosperm ISA3 (OsISA3) and Eschericia coli GlgX (EcoGlgX) almost exclusively debranched chains having degree of polymerization (DP) of 3 and 4. Second, OsISA1, Pseudomonas amyloderamosa ISA (PsaISA), and rice pullulanase (OsPUL) could debranch a wide range of chains of DP >= 3. Third, both cyanobacteria ISAs, Cyanothece ATCC 51142 ISA (CytISA) and Synechococcus elongatus PCC7942 ISA (ScoISA), showed the intermediate chain-length preference, because they removed chains of mainly DP3-4 and DP3-6, respectively, while they could also react to chains of DP5-10 and 7-13 to some extent, respectively. In contrast, all these ISAs were reactive to various chains when incubated with amylopectin. In addition to a great variation in chain-length preferences among various ISAs, their activities greatly differed depending on a variety of glucans. Most strikingly, cyannobacteria ISAs could attack branch points of pullulan to a lesser extent although no such activity was found in OsISA1, OsISA3, EcoGlgX, and PsaISA. Thus, the present study shows the high possibility that varied chain-length specificities of ISA-type DBEs among sources and isozymes are responsible for their distinct functions in glucan metabolism.	[Kobayashi, Taiki; Sasaki, Satoshi; Utsumi, Yoshinori; Fujita, Naoko; Umeda, Kazuhiro; Sawada, Takayuki; Kubo, Akiko; Nakamura, Yasunori] Akita Prefectural Univ, Fac Bioresource Sci, Akita, Japan; [Abe, Jun-ichi] Kagoshima Univ, Fac Agr, Kagoshima 890, Japan; [Colleoni, Christophe; Ball, Steven] Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, Villeneuve Dascq, France; [Nakamura, Yasunori] Akita Nat Sci Lab, Akita, Japan; [Utsumi, Yoshinori] RIKEN Ctr Sustainable Resource Sci, Plant Genom Network Res Team, Yokohama, Kanagawa, Japan; [Umeda, Kazuhiro] M3 Inc, Minato Ku, Tokyo, Japan; [Sawada, Takayuki] TDK Coorporat, Adv Agr Dev Grp, Akita, Japan; [Kubo, Akiko] Ezaki Glico Co Ltd, Inst Hlth Sci, Nishiyodagawa Ku, Osaka, Japan	Akita Prefectural University; Kagoshima University; Universite de Lille - ISITE; Universite de Lille; RIKEN; TDK Corporation; Ezaki Glico Co., Ltd.	Nakamura, Y (corresponding author), Akita Prefectural Univ, Fac Bioresource Sci, Akita, Japan.; Nakamura, Y (corresponding author), Akita Nat Sci Lab, Akita, Japan.	nakayn@silver.plala.or.jp	Colleoni, Christophe/AAP-2411-2021; Utsumi, Yoshinori/AAR-1844-2020	Utsumi, Yoshinori/0000-0002-9196-7123; Ball, Steven/0000-0003-1629-1650	Ministry of Education, Sports, Science and Technology [20248002]; Research Project Fund of APU President	Ministry of Education, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Project Fund of APU President	The present study was funded by the Ministry of Education, Sports, Science and Technology [Grant-in-Aid for Scientific Research (A), 20248002] and the Research Project Fund of APU President to YN and NF, respectively.; The present study was funded by the Ministry of Education, Sports, Science and Technology [Grant-in-Aid for Scientific Research (A), 20248002] and the Research Project Fund of APU President to Y.N. and N.F., respectively. The DNA sequence analysis was performed with the aid of the Biotechnology Center, APU. The DNA sequencing in this study was conducted with the aid of the Biotechnology Center, APU. We thank Drs. Hikaru Satoh and Eiji Suzuki for providing us with rice cultivars and Cyanobacteria cells, respectively. We also thank Ms. Masami Ono for growing rice plants in the experimental field of APU. The Pseudomonas amyloderamosa ISA (PsaISA) was kindly provided by Hayashibara Biochemical Laboratories Inc. (Okayama, Japan).	Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Ball S, 2011, J EXP BOT, V62, P1775, DOI 10.1093/jxb/erq411; Beatty MK, 1999, PLANT PHYSIOL, V119, P255, DOI 10.1104/pp.119.1.255; Bertoft E, 2015, STARCH METABOLISM ST, P3; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Cenci U, 2013, PLANT CELL, V25, P3961, DOI 10.1105/tpc.113.118174; Colleoni C, 1999, PLANT PHYSIOL, V120, P1005, DOI 10.1104/pp.120.4.1005; Colleoni C., 2012, ESSENTIAL REV EXPT B, V5, P217; Dauvillee D, 2005, J BACTERIOL, V187, P1465, DOI 10.1128/JB.187.4.1465-1473.2005; Dauvillee D, 2001, PLANT PHYSIOL, V125, P1710, DOI 10.1104/pp.125.4.1710; Dauvillee D, 2001, PLANT PHYSIOL, V125, P1723, DOI 10.1104/pp.125.4.1723; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Deschamps P, 2008, MOL BIOL EVOL, V25, P536, DOI 10.1093/molbev/msm280; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; FOX JD, 1991, ANAL BIOCHEM, V195, P93, DOI 10.1016/0003-2697(91)90300-I; Fujita N, 1999, PLANTA, V208, P283, DOI 10.1007/s004250050560; Fujita N, 2003, PLANT CELL PHYSIOL, V44, P607, DOI 10.1093/pcp/pcg079; Fujita N, 2009, J EXP BOT, V60, P1009, DOI 10.1093/jxb/ern349; Hennen-Bierwagen TA, 2012, ESSENTIAL REV EXPT B, V5, P179; HIZUKURI S, 1986, CARBOHYD RES, V147, P342, DOI 10.1016/S0008-6215(00)90643-8; Hizukuri S., 1996, CARBOHYDRATES FOOD, P347; Hussain H, 2003, PLANT CELL, V15, P133, DOI 10.1105/tpc.006635; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; JEANNINGROS R, 1976, BIOCHIM BIOPHYS ACTA, V438, P186, DOI 10.1016/0005-2744(76)90235-7; JENKINS JPJ, 1993, STARCH-STARKE, V45, P417; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kubo A, 1999, PLANT PHYSIOL, V121, P399, DOI 10.1104/pp.121.2.399; Kubo A, 2005, PLANT PHYSIOL, V137, P43, DOI 10.1104/pp.104.051359; Kubo A, 2010, PLANT PHYSIOL, V153, P956, DOI 10.1104/pp.110.155259; Lee E. Y. C., 1971, ENZYMES, V5, P191; Lin QH, 2013, NEW PHYTOL, V200, P1009, DOI 10.1111/nph.12446; Lin QH, 2012, PLANT PHYSIOL, V158, P679, DOI 10.1104/pp.111.189704; Mouille G, 1996, PLANT CELL, V8, P1353; Nakamura Y, 1996, PHYSIOL PLANTARUM, V97, P491, DOI [10.1111/j.1399-3054.1996.tb00508.x, 10.1034/j.1399-3054.1996.970311.x]; Nakamura Y, 1996, PLANT SCI, V121, P1, DOI 10.1016/S0168-9452(96)04504-9; Nakamura Y, 2005, PLANT CELL PHYSIOL, V46, P539, DOI 10.1093/pcp/pci045; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nakamura Y, 1996, PLANTA, V199, P209, DOI 10.1007/BF00196561; Nakamura Y, 1997, PLANT J, V12, P143, DOI 10.1046/j.1365-313X.1997.12010143.x; Nakamura Y., 2015, STARCH-STARKE, P161, DOI DOI 10.1007/978-4-431-55495-0_5; Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035; O'Shea MG, 1998, CARBOHYD RES, V307, P1, DOI 10.1016/S0008-6215(97)10085-4; Pfister B, 2014, PLANT PHYSIOL, V165, P1457, DOI 10.1104/pp.114.241455; ROMEO T, 1988, GENE, V70, P363, DOI 10.1016/0378-1119(88)90208-9; Sawada T, 2014, ARCH BIOCHEM BIOPHYS, V562, P9, DOI 10.1016/j.abb.2014.07.032; Shimonaga T, 2008, PLANT CELL PHYSIOL, V49, P103, DOI 10.1093/pcp/pcm172; Sim L, 2014, J BIOL CHEM, V289, P22991, DOI 10.1074/jbc.M114.565044; Song HN, 2010, PROTEINS, V78, P1847, DOI 10.1002/prot.22697; Streb S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092174; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Sundberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075223; Suzuki E, 2007, BBA-GEN SUBJECTS, V1770, P763, DOI 10.1016/j.bbagen.2007.01.006; Suzuki E, 2013, PLANT CELL PHYSIOL, V54, P465, DOI 10.1093/pcp/pcs190; Takashima Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2308, DOI 10.1271/bbb.70215; TAKEDA Y, 1986, CARBOHYD RES, V148, P299, DOI 10.1016/S0008-6215(00)90397-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Utsumi Y, 2009, J APPL GLYCOSCI, V56, P215, DOI [DOI 10.5458/JAG.56.215, 10.5458/jag.56.215]; Utsumi Y, 2006, PLANTA, V225, P75, DOI 10.1007/s00425-006-0331-z; Utsumi Y, 2011, PLANT PHYSIOL, V156, P61, DOI 10.1104/pp.111.173435; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Wattebled F, 2008, PLANT PHYSIOL, V148, P1309, DOI 10.1104/pp.108.129379; Wong KS, 2003, J CEREAL SCI, V37, P139, DOI 10.1006/jcrs.2002.0485; YOKOBAYA, 1970, BIOCHIM BIOPHYS ACTA, V212, P458, DOI 10.1016/0005-2744(70)90252-4; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	65	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157020	10.1371/journal.pone.0157020	http://dx.doi.org/10.1371/journal.pone.0157020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309534	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800028
J	Kriengwatana, B; Terry, J; Chladkova, K; Escudero, P				Kriengwatana, Buddhamas; Terry, Josephine; Chladkova, Katerina; Escudero, Paola			Speaker and Accent Variation Are Handled Differently: Evidence in Native and Non-Native Listeners	PLOS ONE			English	Article							SPEECH SOUND DISCRIMINATION; PERCEPTUAL ADAPTATION; VOWEL NORMALIZATION; TALKER VARIABILITY; ENGLISH; SPOKEN; PITCH; IDENTIFICATION; RECOGNITION; SEX	Listeners are able to cope with between-speaker variability in speech that stems from anatomical sources (i.e. individual and sex differences in vocal tract size) and sociolinguistic sources (i.e. accents). We hypothesized that listeners adapt to these two types of variation differently because prior work indicates that adapting to speaker/sex variability may occur pre-lexically while adapting to accent variability may require learning from attention to explicit cues (i.e. feedback). In Experiment 1, we tested our hypothesis by training native Dutch listeners and Australian-English (AusE) listeners without any experience with Dutch or Flemish to discriminate between the Dutch vowels /I/ and /epsilon/ from a single speaker. We then tested their ability to classify /I/ and /epsilon/ vowels of a novel Dutch speaker (i.e. speaker or sex change only), or vowels of a novel Flemish speaker (i.e. speaker or sex change plus accent change). We found that both Dutch and AusE listeners could successfully categorize vowels if the change involved a speaker/sex change, but not if the change involved an accent change. When AusE listeners were given feedback on their categorization responses to the novel speaker in Experiment 2, they were able to successfully categorize vowels involving an accent change. These results suggest that adapting to accents may be a two-step process, whereby the first step involves adapting to speaker differences at a pre-lexical level, and the second step involves adapting to accent differences at a contextual level, where listeners have access to word meaning or are given feedback that allows them to appropriately adjust their perceptual category boundaries.	[Kriengwatana, Buddhamas] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [Kriengwatana, Buddhamas] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Terry, Josephine; Escudero, Paola] Univ Western Sydney, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia; [Terry, Josephine; Escudero, Paola] Australian Natl Univ, ARC Ctr Excellence Dynam Language, Canberra, ACT, Australia; [Chladkova, Katerina] Univ Amsterdam, Amsterdam Ctr Language & Commun, Phonet Sci, Amsterdam, Netherlands; [Chladkova, Katerina] Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany	Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Western Sydney University; Australian National University; University of Amsterdam; Leipzig University	Kriengwatana, B (corresponding author), Leiden Univ, Inst Biol Leiden, Leiden, Netherlands.; Kriengwatana, B (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	bkrieng@alumni.uwo.ca	Chládková, Kateřina/K-2039-2015; Escudero, Paola/Q-5310-2019	Chládková, Kateřina/0000-0003-2009-1897; Escudero, Paola/0000-0002-8071-7663; Kriengwatana, Buddhamas (Pralle)/0000-0002-4258-883X	Australian Research Council [DP130102181]; Australian Research Council Centre of Excellence for the Dynamics of Language [CE140100041]	Australian Research Council(Australian Research Council); Australian Research Council Centre of Excellence for the Dynamics of Language(Australian Research Council)	This research and the work of BK, KC, and JT was conducted with support from the Australian Research Council grant DP130102181 awarded to PE. KC's work was also supported by the Australian Research Council Centre of Excellence for the Dynamics of Language, where PE is the Chief Investigator (project number CE140100041).	Adank P, 2004, J ACOUST SOC AM, V116, P3099, DOI 10.1121/1.1795335; Adank P, 2004, J ACOUST SOC AM, V116, P1729, DOI 10.1121/1.1779271; Adank P, 2012, HUM BRAIN MAPP, V33, P360, DOI 10.1002/hbm.21218; ASSMANN PF, 1982, J ACOUST SOC AM, V71, P975, DOI 10.1121/1.387579; Bachorowski J, 1993, JASA, V106, P1054; Boersma P., 1992, PRAAT DOING PHONETIC; Bradlow AR, 2008, COGNITION, V106, P707, DOI 10.1016/j.cognition.2007.04.005; BURDICK CK, 1975, J ACOUST SOC AM, V58, P415, DOI 10.1121/1.380686; Clarke CM, 2004, J ACOUST SOC AM, V116, P3647, DOI 10.1121/1.1815131; Clopper CG, 2004, LANG SPEECH, V47, P207, DOI 10.1177/00238309040470030101; Dadwani R, 2015, P 18 INT C PHON SCI, P1; Dahan D, 2008, COGNITION, V108, P710, DOI 10.1016/j.cognition.2008.06.003; Deutsch D, 2009, J ACOUST SOC AM, V125, pEL208, DOI 10.1121/1.3113892; DEWSON JH, 1964, SCIENCE, V144, P555, DOI 10.1126/science.144.3618.555; DEWSON JH, 1969, EXP NEUROL, V24, P579, DOI 10.1016/0014-4886(69)90159-9; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; DOOLING RJ, 1990, PERCEPT PSYCHOPHYS, V47, P568, DOI 10.3758/BF03203109; Escudero P, 2007, P 16 INT C PHON SCI, P1413; Escudero P, 2014, SPEECH SCI TECHN C, P80; Escudero P, 2015, P 18 INT C PHON SCI, P1; Escudero P, 2011, J ACOUST SOC AM, V129, pEL1, DOI 10.1121/1.3525042; Escudero P, 2010, LANG SPEECH, V53, P343, DOI 10.1177/0023830910371447; Evans BG, 2004, J ACOUST SOC AM, V115, P352, DOI 10.1121/1.1635413; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Fitch WTS, 1994, THESIS; Flynn N., 2011, YORK PAPERS LINGUIST, V2, P1; GERSTMAN LJ, 1968, IEEE T ACOUST SPEECH, VAU16, P78, DOI 10.1109/TAU.1968.1161953; Goldinger SD, 1998, PSYCHOL REV, V105, P251, DOI 10.1037/0033-295X.105.2.251; Goldinger SD, 1996, J EXP PSYCHOL LEARN, V22, P1166, DOI 10.1037/0278-7393.22.5.1166; Goldinger SD, 2007, 16 INT C PHON SCI, VXVI, P49; Goudbeek M, 2008, SPEECH COMMUN, V50, P109, DOI 10.1016/j.specom.2007.07.003; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Johnson Keith, 1997, TALKER VARIABILITY S, P145; Kraljic T, 2008, COGNITION, V107, P54, DOI 10.1016/j.cognition.2007.07.013; Kriengwatana B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01243; Kriengwatana B, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01543; KUHL PK, 1983, INFANT BEHAV DEV, V6, P263, DOI 10.1016/S0163-6383(83)80036-8; LADEFOGED P, 1957, J ACOUST SOC AM, V29, P98, DOI 10.1121/1.1908694; LASS NJ, 1976, J ACOUST SOC AM, V59, P675, DOI 10.1121/1.380917; LOBANOV BM, 1971, J ACOUST SOC AM, V49, P606, DOI 10.1121/1.1912396; LOVEDAY L, 1981, LANG SPEECH, V24, P71, DOI 10.1177/002383098102400105; Macmillan NA, 2005, DETECTION THEORY USE; Magnuson JS, 2007, J EXP PSYCHOL HUMAN, V33, P391, DOI 10.1037/0096-1523.33.2.391; Monahan PJ, 2010, LANG COGNITIVE PROC, V25, P808, DOI 10.1080/01690965.2010.490047; MULLENNIX JW, 1989, J ACOUST SOC AM, V85, P365, DOI 10.1121/1.397688; NEAREY TM, 1989, J ACOUST SOC AM, V85, P2088, DOI 10.1121/1.397861; Norris D, 2003, COGNITIVE PSYCHOL, V47, P204, DOI 10.1016/S0010-0285(03)00006-9; Nygaard LC, 1998, PERCEPT PSYCHOPHYS, V60, P355, DOI 10.3758/BF03206860; Ohms VR, 2012, ANIM COGN, V15, P155, DOI 10.1007/s10071-011-0441-2; Ohms VR, 2010, P ROY SOC B-BIOL SCI, V277, P1003, DOI 10.1098/rspb.2009.1788; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Pierrehumbert JB, 2006, J PHONETICS, V34, P516, DOI 10.1016/j.wocn.2006.06.003; Samuel AG, 2009, ATTEN PERCEPT PSYCHO, V71, P1207, DOI 10.3758/APP.71.6.1207; Schmale R, 2012, DEVELOPMENTAL SCI, V15, P732, DOI 10.1111/j.1467-7687.2012.01175.x; Seidl A, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00448, 10.3389/fpsyg.2012.00479]; Smith DRR, 2014, ACTA PSYCHOL, V148, P81, DOI 10.1016/j.actpsy.2014.01.010; Stroup W.W., 2012, GEN LINEAR MIXED MOD; Sumner M, 2011, COGNITION, V119, P131, DOI 10.1016/j.cognition.2010.10.018; SYRDAL AK, 1986, J ACOUST SOC AM, V79, P1086, DOI 10.1121/1.393381; Trude AM, 2013, J MEM LANG, V69, P349, DOI 10.1016/j.jml.2013.05.002; Trude AM, 2012, LANG COGNITIVE PROC, V27, P979, DOI 10.1080/01690965.2011.597153; Tuinman A, 2012, J MEM LANG, V66, P530, DOI 10.1016/j.jml.2012.02.001; Tuomainen J, 2013, BRAIN RES, V1490, P170, DOI 10.1016/j.brainres.2012.10.067; van der Zande P, 2014, J PHONETICS, V43, P38, DOI 10.1016/j.wocn.2014.01.003; van Heugten M, 2014, J EXP PSYCHOL GEN, V143, P340, DOI 10.1037/a0032192; van Leussen JW, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01000; vanBezooijen R, 1995, LANG SPEECH, V38, P253, DOI 10.1177/002383099503800303; von Kriegstein K, 2006, NEUROIMAGE, V32, P368, DOI 10.1016/j.neuroimage.2006.02.045; WEISMAN R, 1994, J COMP PSYCHOL, V108, P363, DOI 10.1037/0735-7036.108.4.363; Weisman RG, 2004, BEHAV PROCESS, V66, P289, DOI 10.1016/j.beproc.2004.03.010; White KS, 2011, DEVELOPMENTAL SCI, V14, P372, DOI 10.1111/j.1467-7687.2010.00986.x	72	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156870	10.1371/journal.pone.0156870	http://dx.doi.org/10.1371/journal.pone.0156870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309889	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000378029800017
J	Li, C; Li, XY; Deng, C; Guo, CB				Li, Chun; Li, Xiaoyu; Deng, Chun; Guo, Chunbao			Circulating Fibrocytes Are Increased in Neonates with Bronchopulmonary Dysplasia	PLOS ONE			English	Article							ATTENUATES BRONCHIOLITIS OBLITERANS; CHRONIC OBSTRUCTIVE ASTHMA; DIFFERENTIATION; INFLAMMATION; TRAFFICKING; MIGRATION; FIBROSIS; ACTIVATION; LUNGS	Background Bronchopulmonary dysplasia (BPD) is characterized by the aberrant remodeling of the lung parenchyma, resulting from accumulation of fibroblasts or myofibroblasts. Circulating fibrocytes are implied in pulmonary fibrosis, but whether these cells are associated with the development of BPD or the progressive fibrosis is unknown. The aim of the present study was to investigate the occurrence of fibrocytes in peripheral venous blood and explore whether these cells might be associated with severity of BPD. Methods We investigated circulating fibrocytes in 66 patients with BPD, 23 patients with acute respiratory distress syndrome(ARDS) and 11 normal subjects. Circulating fibrocytes were defined and quantified as cells positive for CD45 andcollagen-1 by flow cytometry. Furthermore, serum SDF-1/CXCL12 and TGF-beta 1 were evaluated using ELISA methods. We also investigated the clinical value of fibrocyte counts by comparison with standard clinical parameters. Results The patients with BPD had significantly increased numbers of fibrocytes compared to the controls (p < 0.01). Patients with ARDS were not different from healthy control subjects. There was a correlation between the number of fibrocytes and pulmonary hypertension or oxygen saturation (p < 0.05). Fibrocyte numbers were not correlated with other clinical or functional variables or radiologic severity scores. The fibrocyte attractant chemokine CXCL12 increased in plasma (p < 0.05) and was detectable in the bronchoalveolar lavage fluid of 40% of the patients but not in controls. Conclusion These findings indicate that circulating fibrocytes are increased in patients with BPD and may contribute to pulmonary fibrosis in BPD. Circulating fibrocytes, likely recruited through the CXCR4/CXCL12 axis, might contribute to the production of TGF-beta 1 for the expansion of fibroblast/myofibroblast population in BPD.	[Guo, Chunbao] Chongqing Med Univ, Childrens Hosp, Dept Pediat Gen Surg & Liver Transplantat, Chongqing 400014, Peoples R China; [Li, Chun; Li, Xiaoyu; Deng, Chun] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China; [Deng, Chun; Guo, Chunbao] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Guo, CB (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Pediat Gen Surg & Liver Transplantat, Chongqing 400014, Peoples R China.; Deng, C (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China.; Deng, C; Guo, CB (corresponding author), Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China.	dengcgcb@163.com; guochunbao@cqmu.edu.cn			National Natural Science Foundation of China [81270058, 30770950]; Chongqing Natural Science Foundation (CSTC) [2009BB6072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC)	This research was supported by the National Natural Science Foundation of China (No. 81270058, 30770950) and by the Chongqing Natural Science Foundation (CSTC, 2009BB6072).	Alhamad EH, 2015, ANN THORAC MED, V10, P279, DOI 10.4103/1817-1737.157294; Aono Y, 2014, AM J RESP CELL MOL, V51, P793, DOI 10.1165/rcmb.2013-0455OC; Borie R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053736; Negrete-Garcia MC, 2010, CHEST, V138, P100, DOI 10.1378/chest.09-2104; de Alba CG, 2015, AM J RESP CRIT CARE, V191, P427, DOI 10.1164/rccm.201407-1334OC; Dupin I, 2015, J ALLERGY CLINIMMUNO; Fu XY, 2015, CELL PHYSIOL BIOCHEM, V35, P489, DOI 10.1159/000369714; Gillen JR, 2013, ANN THORAC SURG, V95, P1768, DOI 10.1016/j.athoracsur.2013.02.021; Han WL, 2015, CELL TISSUE RES, V359, P589, DOI 10.1007/s00441-014-2035-1; Harris DA, 2013, J THORAC CARDIOV SUR, V145, P854, DOI 10.1016/j.jtcvs.2012.03.079; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Inomata M, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-16; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kitamura H, 2011, J CLIN INVEST, V121, P2863, DOI 10.1172/JCI45589; LaPar DJ, 2011, ANN THORAC SURG, V92, P470, DOI 10.1016/j.athoracsur.2011.04.065; Lo CY, 2015, J ALLERGY CLIN IMMUN, V135, P1186, DOI 10.1016/j.jaci.2014.10.031; Lohmann P, 2014, PEDIATR RES, V76, P294, DOI 10.1038/pr.2014.85; Madala SK, 2014, AM J RESP CELL MOL, V50, P777, DOI 10.1165/rcmb.2013-0042OC; Maharaj S, 2013, EUR RESPIR REV, V22, P552, DOI 10.1183/09059180.00007713; Shipe R, 2015, J ALLERGY CLINIMMUNO; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Torchin H, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2163; Trimble A, 2014, AM J RESP CRIT CARE, V190, P1395, DOI 10.1164/rccm.201407-1287OC; Velten M, 2010, J APPL PHYSIOL, V108, P1347, DOI 10.1152/japplphysiol.01392.2009; Wang CH, 2015, J ALLERGY CLIN IMMUN, V135, P1154, DOI 10.1016/j.jaci.2014.09.011; Wang CH, 2012, J ALLERGY CLIN IMMUN, V129, P1367, DOI 10.1016/j.jaci.2012.01.038; Wang JF, 2007, WOUND REPAIR REGEN, V15, P113, DOI 10.1111/j.1524-475X.2006.00192.x; Wang JF, 2007, J INTERF CYTOK RES, V27, P921, DOI 10.1089/jir.2007.0008	28	7	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157181	10.1371/journal.pone.0157181	http://dx.doi.org/10.1371/journal.pone.0157181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309347	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800040
J	Plaisted, WC; Zavala, A; Hingco, E; Tran, H; Coleman, R; Lane, TE; Loring, JF; Walsh, CM				Plaisted, Warren C.; Zavala, Angel; Hingco, Edna; Tran, Ha; Coleman, Ronald; Lane, Thomas E.; Loring, Jeanne F.; Walsh, Craig M.			Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis	PLOS ONE			English	Article							NERVOUS-SYSTEM INFLAMMATION; RAT MODEL; AUTOIMMUNE ENCEPHALOMYELITIS; DISEASE; DEMYELINATION; RECOVERY; NEUROPROTECTION; DIFFERENTIATION; CORONAVIRUS; CONVERSION	We have recently described sustained clinical recovery associated with dampened neuroinflammation and remyelination following transplantation of neural precursor cells (NPCs) derived from human embryonic stem cells (hESCs) in a viral model of the human demyelinating disease multiple sclerosis. The hNPCs used in that study were derived by a novel direct differentiation method (direct differentiation, DD-NPCs) that resulted in a unique gene expression pattern when compared to hNPCs derived by conventional methods. Since the therapeutic potential of human NPCs may differ greatly depending on the method of derivation and culture, we wanted to determine whether NPCs differentiated using conventional methods would be similarly effective in improving clinical outcome under neuroinflammatory demyelinating conditions. For the current study, we utilized hNPCs differentiated from a human induced pluripotent cell line via an embryoid body intermediate stage (EB-NPCs). Intraspinal transplantation of EB-NPCs into mice infected with the neurotropic JHM strain of mouse hepatitis virus (JHMV) resulted in decreased accumulation of CD4+ T cells in the central nervous system that was concomitant with reduced demyelination at the site of injection. Dampened neuroinflammation and remyelination was correlated with a transient increase in CD4+FOXP3+ regulatory T cells (Tregs) concentrated within the peripheral lymphatics. However, compared to our earlier study, pathological improvements were modest and did not result in significant clinical recovery. We conclude that the genetic signature of NPCs is critical to their effectiveness in this model of viral-induced neurologic disease. These comparisons will be useful for understanding what factors are critical for the sustained clinical improvement.	[Plaisted, Warren C.; Zavala, Angel; Hingco, Edna; Walsh, Craig M.] Univ Calif Irvine, Dept Mol Biol & Biochem, Sue & Bill Gross Stem Cell Ctr, Multiple Sclerosis Res Ctr,Inst Immunol, Irvine, CA 92717 USA; [Tran, Ha; Coleman, Ronald; Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Lane, Thomas E.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA	University of California System; University of California Irvine; Scripps Research Institute; Utah System of Higher Education; University of Utah	Walsh, CM (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Sue & Bill Gross Stem Cell Ctr, Multiple Sclerosis Res Ctr,Inst Immunol, Irvine, CA 92717 USA.; Loring, JF (corresponding author), Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA.; Lane, TE (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA.	tom.lane@path.utah.edu; jloring@scripps.edu; cwalsh@uci.edu		Walsh, Craig/0000-0001-7808-2817	National Institutes of Health [NS082174, R01NS092042]; National Multiple Sclerosis Society [RG4925, CA1058]; California Institute for Regenerative Medicine [TR3-05603, CL1-00502]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092042, T32NS082174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health Training Grant NS082174 to WCP; National Institutes of Health R01NS092042 to TEL, JFL; National Multiple Sclerosis Society RG4925 to TEL; California Institute for Regenerative Medicine TR3-05603 to CMW, JFL; California Institute for Regenerative Medicine CL1-00502 to JFL; National Multiple Sclerosis Society CA1058 to CMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Cao W, 2011, IMMUNITY, V35, P273, DOI 10.1016/j.immuni.2011.06.011; Carbajal KS, 2011, JOVE-J VIS EXP, DOI 10.3791/2834; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen L, 2014, STEM CELL REP, V2, P825, DOI 10.1016/j.stemcr.2014.04.005; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Emre N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012148; Fainstein N, 2013, GLIA, V61, P140, DOI 10.1002/glia.22420; Fainstein N, 2013, NEUROBIOL DIS, V49, P41, DOI 10.1016/j.nbd.2012.08.004; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gao L, 2014, INT J MOL SCI, V15, P4431, DOI 10.3390/ijms15034431; Gao W, 2009, CELL CYCLE, V8, P1444, DOI 10.4161/cc.8.9.8348; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Hatch MN, 2009, J NEUROIMMUNOL, V212, P74, DOI 10.1016/j.jneuroim.2009.05.002; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huss DJ, 2016, IMMUNOLOGY, V148, P276, DOI 10.1111/imm.12609; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Lane TE, 1997, TRENDS MICROBIOL, V5, P9, DOI 10.1016/S0966-842X(97)81768-4; Laterza C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3597; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Nazmi A, 2014, VIRAL IMMUNOL, V27, P48, DOI 10.1089/vim.2013.0090; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Park J, 2011, MOL PHARMACEUT, V8, P143, DOI 10.1021/mp100203a; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; Riley J, 2014, NEUROSURGERY, V74, P77, DOI 10.1227/NEU.0000000000000156; Sakaguchi S, 2006, CURR TOP MICROBIOL, V305, P51, DOI 10.1007/3-540-29714-6_3; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Trandem K, 2010, J IMMUNOL, V184, P4391, DOI 10.4049/jimmunol.0903918; Uchida N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004371; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Wang YC, 2011, CELL RES, V21, P1551, DOI 10.1038/cr.2011.148; Weinger JG, 2012, STEM CELLS, V30, P2584, DOI 10.1002/stem.1234; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540	42	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157620	10.1371/journal.pone.0157620	http://dx.doi.org/10.1371/journal.pone.0157620			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310015	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800109
J	Russo, F; D'Este, M; Vadala, G; Cattani, C; Papalia, R; Alini, M; Denaro, V				Russo, Fabrizio; D'Este, Matteo; Vadala, Gianluca; Cattani, Caterina; Papalia, Rocco; Alini, Mauro; Denaro, Vincenzo			Platelet Rich Plasma and Hyaluronic Acid Blend for the Treatment of Osteoarthritis: Rheological and Biological Evaluation	PLOS ONE			English	Article							INTRAARTICULAR INJECTION; KNEE OSTEOARTHRITIS; RHEUMATOID-ARTHRITIS; CLINICAL-APPLICATION; CHONDRAL DEFECTS; MOLECULAR-WEIGHT; SYNOVIAL-FLUID; CARTILAGE; JOINT; REGENERATION	Introduction Osteoarthritis (OA) is the most common musculoskeletal disease. Current treatments for OA are mainly symptomatic and inadequate since none results in restoration of fully functional cartilage. Hyaluronic Acid (HA) intra-articular injections are widely accepted for the treatment of pain associated to OA. The goal of HA viscosupplementation is to reduce pain and improve viscoelasticity of synovial fluid. Platelet-rich plasma (PRP) has been also employed to treat OA to possibly induce cartilage regeneration. The combination of HA and PRP could supply many advantages for tissue repair. Indeed, it conjugates HA viscosupplementation with PRP regenerative properties. The aim of this study was to evaluate the rheological and biological properties of different HA compositions in combination with PRP in order to identify (i) the viscoelastic features of the HA-PRP blends, (ii) their biological effect on osteoarthritic chondrocytes and (iii) HA formulations suitable for use in combination with PRP. Materials and Methods HA/PRP blends have been obtained mixing human PRP and three different HA at different concentrations: 1) Sinovial, 0.8% (SN); 2) Sinovial Forte 1.6% (SF); 3) Sinovial HL 3.2% (HL); 4) Hyalubrix 1.5% (HX). Combinations of phosphate buffered saline (PBS) and the four HA types were used as control. Rheological measurements were performed on an Anton PaarMCR-302 rheometer. Amplitude sweep, frequency sweep and rotational measurements were performed and viscoelastic properties were evaluated. The rheological data were validated performing the tests in presence of Bovine Serum Albumin (BSA) up to ultra-physiological concentration (7%). Primary osteoarthritic chondrocytes were cultured in vitro with the HA and PRP blends in the culture medium for one week. Cell viability, proliferation and glycosaminoglycan (GAG) content were assessed. Results PRP addition to HA leads to a decrease of viscoelastic shear moduli and increase of the crossover point, due to a pure dilution effect. For viscosupplements with HA concentration below 1% the viscoelasticity is mostly lost. Results were validated also in presence of proteins, which in synovial fluid are more abundant than HA. Chondrocytes proliferated overtime in all different culture conditions. The proliferation rate was higher in chondrocytes cultured in the media containing PRP compared to the cultures with different HA alone. GAG content was significantly higher in chondrocytes cultured in PRP and HL blend. Discussion We investigated the rheological and biological properties of four different HA concentrations when combined with PRP giving insights on viscoelastic and biological properties of a promising approach for future OA therapy. Our data demonstrate that PRP addition is not detrimental to the viscosupplementation effect of HA. Viscosupplements containing low HA concentration are not indicated for combination with PRP, as the viscoelastic properties are lost. Although having the same rheological behavior of SF and HX, HL was superior in stimulating extracellular matrix production in vitro.	[Russo, Fabrizio; Vadala, Gianluca; Cattani, Caterina; Papalia, Rocco; Denaro, Vincenzo] Campus Biomed Univ Rome, Dept Orthopaed & Trauma Surg, Via Alvaro Portillo 200, I-00128 Rome, Italy; [D'Este, Matteo; Alini, Mauro] AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland	University Campus Bio-Medico - Rome Italy	Vadala, G (corresponding author), Campus Biomed Univ Rome, Dept Orthopaed & Trauma Surg, Via Alvaro Portillo 200, I-00128 Rome, Italy.	g.vadala@gmail.com	Vadalà, Gianluca/B-1538-2014; Alini, Mauro/AAG-7961-2020; D'Este, Matteo/AAB-2835-2022; Russo, Fabrizio/AAE-4285-2020; Denaro, Vincenzo/K-9567-2016	Vadalà, Gianluca/0000-0001-7142-1660; D'Este, Matteo/0000-0002-0424-8172; Russo, Fabrizio/0000-0002-8566-8952; Denaro, Vincenzo/0000-0003-4739-9795; Papalia, Rocco/0000-0002-6069-4871	Young Investigator Grant of the Italian Ministry of Health [GR-2010-2318448]	Young Investigator Grant of the Italian Ministry of Health	This work was supported by the Young Investigator Grant of the Italian Ministry of Health (GR-2010-2318448) to GV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andia I, 2014, EXPERT OPIN BIOL TH, V14, P635, DOI 10.1517/14712598.2014.889677; Andia I, 2012, EXPERT OPIN BIOL TH, V12, P7, DOI 10.1517/14712598.2012.632765; [Anonymous], 2000, ARTHRITIS RHEUM, V43, P1905, DOI DOI 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P; Ayhan E, 2014, WORLD J ORTHOP, V5, P351, DOI 10.5312/wjo.v5.i3.351; Balazs EA, 2004, CHEM BIOL HYALURONAN, V1st; Baltzer AWA, 2009, OSTEOARTHR CARTILAGE, V17, P152, DOI 10.1016/j.joca.2008.06.014; Bernstein J, 2004, J BONE JOINT SURG AM, V86A, P2567, DOI 10.2106/00004623-200411000-00032; BLUMBERG BS, 1957, BIOCHEM J, V66, P342, DOI 10.1042/bj0660342; Castellacci E, 2004, DRUG EXP CLIN RES, V30, P67; Chen WH, 2014, BIOMATERIALS, V35, P9599, DOI 10.1016/j.biomaterials.2014.07.058; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; DAHL LB, 1985, ANN RHEUM DIS, V44, P817, DOI 10.1136/ard.44.12.817; Di Matteo B, 2015, Musculoskelet Surg, V99, P1, DOI 10.1007/s12306-014-0340-1; Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51; Fam H, 2007, BIORHEOLOGY, V44, P59; Flanigan DC, 2010, MED SCI SPORT EXER, V42, P1795, DOI 10.1249/MSS.0b013e3181d9eea0; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; GOTOH S, 1993, ANN RHEUM DIS, V52, P817, DOI 10.1136/ard.52.11.817; Handl M, 2007, PHYSIOL RES, V56, P243, DOI 10.33549/physiolres.930917; IWATA H, 1993, CLIN ORTHOP RELAT R, P285; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Juni P, 2007, ARTHRITIS RHEUM-US, V56, P3610, DOI 10.1002/art.23026; Kon E, 2011, ARTHROSCOPY, V27, P1490, DOI 10.1016/j.arthro.2011.05.011; Kon E, 2010, KNEE SURG SPORT TR A, V18, P472, DOI 10.1007/s00167-009-0940-8; Kruger JP, 2012, J ORTHOP RES, V30, P845, DOI 10.1002/jor.22005; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Liebman J, 2001, SJ ENNA, DOI [10.1002/0471141755.ph1202s12, DOI 10.1002/0471141755.PH1202S12]; Lippross S, 2011, ARTHRITIS RHEUM-US, V63, P3344, DOI 10.1002/art.30547; Malhotra R, 2015, Musculoskelet Surg, V99, P243, DOI 10.1007/s12306-015-0378-8; Marshall K Wayne, 2003, Foot Ankle Clin, V8, P221, DOI 10.1016/S1083-7515(03)00046-9; Marshall KW, 2003, FOOT ANKLE CLIN, V8, pviii; Marx R E, 2001, Implant Dent, V10, P225; Milano G, 2010, OSTEOARTHR CARTILAGE, V18, P971, DOI 10.1016/j.joca.2010.03.013; Milano G, 2012, ARTHROSCOPY, V28, P688, DOI 10.1016/j.arthro.2011.09.016; Moreland LW, 2003, ARTHRITIS RES THER, V5, P54, DOI 10.1186/ar623; OGSTON AG, 1953, J PHYSIOL-LONDON, V119, P244, DOI 10.1113/jphysiol.1953.sp004842; OGSTON AG, 1950, BIOCHEM J, V46, P364, DOI 10.1042/bj0460364; Paoloni J, 2011, CLIN J SPORT MED, V21, P37, DOI 10.1097/JSM.0b013e31820758c7; Patti AM, 2001, TISSUE CELL, V33, P294, DOI 10.1054/tice.2001.0178; Prasadam I, 2013, J MOL MED, V91, P369, DOI 10.1007/s00109-012-0953-5; Raeissadat SA, 2015, CLIN MED INSIGHTS-AR, V8, P1, DOI 10.4137/CMAMD.S17894; Richmond J, 2010, J BONE JOINT SURG AM, V92A, P990, DOI 10.2106/JBJS.I.00982; Saito M, 2009, CLIN EXP RHEUMATOL, V27, P201; Sheth U, 2012, J BONE JOINT SURG AM, V94A, P298, DOI 10.2106/JBJS.K.00154; Strauss EJ, 2009, AM J SPORT MED, V37, P1636, DOI 10.1177/0363546508326984; Sun Y, 2010, INT ORTHOP, V34, P589, DOI 10.1007/s00264-009-0793-2; Thompson CL, 2015, J ORTHOP RES, V33, P1552, DOI 10.1002/jor.22913; Thysen S, 2015, DIS MODEL MECH, V8, P17, DOI 10.1242/dmm.016881; Vadala G, 2015, J TISSUE ENG REGEN M, V9, P679, DOI 10.1002/term.1719; Vitanzo Peter C Jr, 2006, Am J Orthop (Belle Mead NJ), V35, P421; WEIGEL PH, 1986, J THEOR BIOL, V119, P219, DOI 10.1016/S0022-5193(86)80076-5; Wu CC, 2011, BIOMATERIALS, V32, P5847, DOI 10.1016/j.biomaterials.2011.05.002; Xie XT, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4493; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013; Zhu Y, 2013, OSTEOARTHR CARTILAGE, V21, P1627, DOI 10.1016/j.joca.2013.07.017	55	50	52	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157048	10.1371/journal.pone.0157048	http://dx.doi.org/10.1371/journal.pone.0157048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310019	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800031
J	Bashford, L; Mehring, C				Bashford, Luke; Mehring, Carsten			Ownership and Agency of an Independent Supernumerary Hand Induced by an Imitation Brain-Computer Interface	PLOS ONE			English	Article							RUBBER HAND; ILLUSION; LIMB; AMPUTEES; THREAT; CORTEX; SHIFTS; TOUCH; OWN	To study body ownership and control, illusions that elicit these feelings in non-body objects are widely used. Classically introduced with the Rubber Hand Illusion, these illusions have been replicated more recently in virtual reality and by using brain-computer interfaces. Traditionally these illusions investigate the replacement of a body part by an artificial counterpart, however as brain-computer interface research develops it offers us the possibility to explore the case where non-body objects are controlled in addition to movements of our own limbs. Therefore we propose a new illusion designed to test the feeling of ownership and control of an independent supernumerary hand. Subjects are under the impression they control a virtual reality hand via a brain-computer interface, but in reality there is no causal connection between brain activity and virtual hand movement but correct movements are observed with 80% probability. These imitation brain-computer interface trials are interspersed with movements in both the subjects' real hands, which are in view throughout the experiment. We show that subjects develop strong feelings of ownership and control over the third hand, despite only receiving visual feedback with no causal link to the actual brain signals. Our illusion is crucially different from previously reported studies as we demonstrate independent ownership and control of the third hand without loss of ownership in the real hands.	[Bashford, Luke] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Bashford, Luke; Mehring, Carsten] Univ Freiburg, Bernstein Ctr Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany	Imperial College London; University of Freiburg	Bashford, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.; Bashford, L (corresponding author), Univ Freiburg, Bernstein Ctr Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany.	luke.bashford11@imperial.ac.uk	Mehring, Carsten/R-8986-2019	Mehring, Carsten/0000-0001-8125-5205; Bashford, Luke/0000-0003-4391-2491	German Federal Ministry of Education and Research (BMBF) [01GQ0830]; German Research Foundation (DFG); University of Freiburg	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This work was supported by the German Federal Ministry of Education and Research (BMBF) grant 01GQ0830 to BFNT Freiburg and Tubingen (http://www.bmbf.de/en/), received by CM. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134501; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Di Pino G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00109; Ehrsson HH, 2009, PERCEPTION, V38, P310, DOI 10.1068/p6304; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Evans N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130019; Folegatti A, 2012, CONSCIOUS COGN, V21, P799, DOI 10.1016/j.concog.2012.02.008; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Giummarra MJ, 2011, CORTEX, V47, P998, DOI 10.1016/j.cortex.2011.02.010; Gonzalez-Franco M, 2014, EXP BRAIN RES, V232, P875, DOI 10.1007/s00221-013-3800-1; Guterstam A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017208; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kammers MPM, 2011, NEUROPSYCHOLOGIA, V49, P1316, DOI 10.1016/j.neuropsychologia.2011.02.039; Kanayama N, 2007, PSYCHOPHYSIOLOGY, V44, P392, DOI 10.1111/j.1469-8986.2007.00511.x; Limanowski J, 2014, NEUROIMAGE, V86, P514, DOI 10.1016/j.neuroimage.2013.10.035; Ma K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00604; Marasco PD, 2011, BRAIN, V134, P747, DOI 10.1093/brain/awq361; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Ninaus M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00914; Orsborn AL, 2014, NEURON, V82, P1380, DOI 10.1016/j.neuron.2014.04.048; Parietti F, 2014, IEEE INT CONF ROBOT, P141, DOI 10.1109/ICRA.2014.6906601; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Schaefer M, 2009, HUM BRAIN MAPP, V30, P1413, DOI 10.1002/hbm.20609; Shokur S, 2013, P NATL ACAD SCI USA, V110, P15121, DOI 10.1073/pnas.1308459110; Thompson SC, 2007, BASIC APPL SOC PSYCH, V29, P75, DOI 10.1080/01973530701331189; Yokosaka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06201	27	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156591	10.1371/journal.pone.0156591	http://dx.doi.org/10.1371/journal.pone.0156591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303808	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800019
J	Baylis, AMM; Kowalski, GJ; Voigt, CC; Orben, RA; Trillmich, F; Staniland, IJ; Hoffman, JI				Baylis, Alastair M. M.; Kowalski, Gabriele J.; Voigt, Christian C.; Orben, Rachael A.; Trillmich, Fritz; Staniland, Iain J.; Hoffman, Joseph I.			Pup Vibrissae Stable Isotopes Reveal Geographic Differences in Adult Female Southern Sea Lion Habitat Use during Gestation	PLOS ONE			English	Article							MARINE PREDATOR; PATTERNS; ECOLOGY; DIET	Individuals within populations often differ substantially in habitat use, the ecological consequences of which can be far reaching. Stable isotope analysis provides a convenient and often cost effective means of indirectly assessing the habitat use of individuals that can yield valuable insights into the spatiotemporal distribution of foraging specialisations within a population. Here we use the stable isotope ratios of southern sea lion (Otaria flavescens) pup vibrissae at the Falkland Islands, in the South Atlantic, as a proxy for adult female habitat use during gestation. A previous study found that adult females from one breeding colony (Big Shag Island) foraged in two discrete habitats, inshore (coastal) or offshore (outer Patagonian Shelf). However, as this species breeds at over 70 sites around the Falkland Islands, it is unclear if this pattern is representative of the Falkland Islands as a whole. In order to characterize habitat use, we therefore assayed carbon (delta C-13) and nitrogen (delta N-15) ratios from 65 southern sea lion pup vibrissae, sampled across 19 breeding colonies at the Falkland Islands. Model-based clustering of pup isotope ratios identified three distinct clusters, representing adult females that foraged inshore, offshore, and a cluster best described as intermediate. A significant difference was found in the use of inshore and offshore habitats between West and East Falkland and between the two colonies with the largest sample sizes, both of which are located in East Falkland. However, habitat use was unrelated to the proximity of breeding colonies to the Patagonian Shelf, a region associated with enhanced biological productivity. Our study thus points towards other factors, such as local oceanography and its influence on resource distribution, playing a prominent role in inshore and offshore habitat use.	[Baylis, Alastair M. M.] South Atlantic Environm Res Inst, Stanley FIQQ1ZZ, Falkland Isl, England; [Baylis, Alastair M. M.] Falklands Conservat, Stanley FIQQ1ZZ, Falkland Isl, England; [Baylis, Alastair M. M.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Kowalski, Gabriele J.; Trillmich, Fritz; Hoffman, Joseph I.] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany; [Kowalski, Gabriele J.] Univ Potsdam, Dept Anim Ecol, Potsdam, Germany; [Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Alfred Kowalke Str 17, D-10315 Berlin, Germany; [Orben, Rachael A.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Staniland, Iain J.] British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 0ET, England	Macquarie University; University of Bielefeld; University of Potsdam; Leibniz Institut fur Zoo und Wildtierforschung; Oregon State University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Hoffman, JI (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany.	joseph.hoffman@uni-bielefeld.de	Hoffman, Joseph i/K-7725-2012; Orben, Rachael A./H-9460-2019	Hoffman, Joseph i/0000-0001-5895-8949; Orben, Rachael A./0000-0002-0802-407X; Staniland, Iain/0000-0003-2736-9134	Marie Curie FP7-Reintegration Grant within the 7th European Community Framework Programme [PCIG-GA-2011-303618]; NERC [bas0100035] Funding Source: UKRI; Natural Environment Research Council [bas0100035] Funding Source: researchfish	Marie Curie FP7-Reintegration Grant within the 7th European Community Framework Programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Field work was supported by the Shackleton Scholarship Fund (Centenary Award), Rufford Small Grants, Sea World and Busch Gardens Conservation Fund, Joint Nature Conservation Council, National Geographic, Winifred Violet Scott and the Falkland Islands Government (to AMMB). Laboratory work was supported by a Marie Curie FP7-Reintegration Grant within the 7th European Community Framework Programme PCIG-GA-2011-303618 (to JIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; Arkhipkin A, 2012, J FISH BIOL, V81, P882, DOI 10.1111/j.1095-8649.2012.03359.x; Arkhipkin Alexander, 2012, Arquipelago-Life and Marine Sciences, P19; Arkhipkin A, 2010, FISH RES, V105, P156, DOI 10.1016/j.fishres.2010.03.022; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Baylis AMM, 2015, OECOLOGIA, V179, P1053, DOI 10.1007/s00442-015-3421-4; Baylis AMM, 2015, ECOLOGY, V96, P2834, DOI 10.1890/14-1948.1.sm; Baylis AMM, 2015, MAR BIOL, V162, P99, DOI 10.1007/s00227-014-2561-0; Baylis AMM, 2015, MAR MAMMAL SCI, V31, P322, DOI 10.1111/mms.12148; Baylis AMM, 2008, MAR ECOL PROG SER, V361, P279, DOI 10.3354/meps07258; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Cherel Y, 2000, OECOLOGIA, V122, P155, DOI 10.1007/PL00008843; Drago M, 2010, SCI MAR, V74, P589, DOI 10.3989/scimar.2010.74n3589; Drago M, 2010, MAR MAMMAL SCI, V26, P309, DOI 10.1111/j.1748-7692.2009.00321.x; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fraley C., 2007, MCLUST VERSION 4 R N; Hazen EL, 2013, NAT CLIM CHANGE, V3, P234, DOI 10.1038/NCLIMATE1686; Jeglinski JWE, 2015, OECOLOGIA, V179, P1041, DOI 10.1007/s00442-015-3424-1; Jeglinski JWE, 2012, MAR ECOL PROG SER, V453, P279, DOI 10.3354/meps09649; Kernaleguen L, 2016, OECOLOGIA, V180, P657, DOI 10.1007/s00442-015-3407-2; Lowther AD, 2011, MAR MAMMAL SCI, V27, P567, DOI 10.1111/j.1748-7692.2010.00425.x; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; RCore Team, 2020, R LANG ENV STAT COMP; Rea LD, 2015, MAR MAMMAL SCI, V31, P1213, DOI 10.1111/mms.12221; Robson BW, 2004, CAN J ZOOL, V82, P20, DOI 10.1139/Z03-208; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Scherer RD, 2015, MAR ECOL PROG SER, V527, P261, DOI 10.3354/meps11255; Sepulveda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134926; Stephens D.W., 1986, pi; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Thompson D, 1998, J ZOOL, V246, P135, DOI 10.1111/j.1469-7998.1998.tb00142.x; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077	34	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157394	10.1371/journal.pone.0157394	http://dx.doi.org/10.1371/journal.pone.0157394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304855	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000377824800057
J	Drymala, SM; Zanno, LE				Drymala, Susan M.; Zanno, Lindsay E.			Osteology of Carnufex carolinensis (Archosauria: Psuedosuchia) from the Pekin Formation of North Carolina and Its Implications for Early Crocodylomorph Evolution	PLOS ONE			English	Article							ORIGIN; REVISION; ANATOMY; REPTILE; SUCHIA; PSEUDOSUCHIA; POSTOSUCHUS; RADIATION; SKELETON; GERMANY	Crocodylomorphs originated in the Late Triassic and were the only crocodile-line archosaurs to survive the end-Triassic extinction. Recent phylogenetic analyses suggest that the closest relatives of these generally gracile, small-bodied taxa were a group of robust, large-bodied predators known as rauisuchids implying a problematic morphological gap between early crocodylomorphs and their closest relatives. Here we provide a detailed osteological description of the recently named early diverging crocodylomorph Carnufex carolinensis from the Upper Triassic Pekin Formation of North Carolina and assess its phylogenetic position within the Paracrocodylomorpha. Carnufex displays a mosaic of crocodylomorph, rauisuchid, and dinosaurian characters, as well as highly laminar cranial elements and vertebrae, ornamented dermal skull bones, a large, subtriangular antorbital fenestra, and a reduced forelimb. A phylogenetic analysis utilizing a comprehensive dataset of early paracrocodylomorphs and including seven new characters and numerous modifications to characters culled from the literature recovers Carnufex carolinensis as one of the most basal members of Crocodylomorpha, in a polytomy with two other large bodied taxa ( CM 73372 and Redondavenator). The analysis also resulted in increased resolution within Crocodylomorpha and a monophyletic clade containing the holotype and two referred specimens of Hesperosuchus as well as Dromicosuchus. Carnufex occupies a key transition at the origin of Crocodylomorpha, indicating that the morphology typifying early crocodylomorphs appeared before the shift to small body size.	[Drymala, Susan M.; Zanno, Lindsay E.] North Carolina Museum Nat Sci, Res & Collect, Raleigh, NC USA; [Drymala, Susan M.; Zanno, Lindsay E.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Drymala, SM (corresponding author), North Carolina Museum Nat Sci, Res & Collect, Raleigh, NC USA.; Drymala, SM (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	sdrymal@ncsu.edu		Zanno, Lindsay/0000-0002-1654-1990; Drymala, Susan/0000-0002-6736-965X	Dorris O. and Samuel P. Welles Research Fund through University of California Museum of Paleontology; Ernst Mayr Travel Grant in Animal Systematics through Harvard Museum of Comparative Zoology; Jackson School of Geosciences Student Travel Grant through Society of Vertebrate Paleontology	Dorris O. and Samuel P. Welles Research Fund through University of California Museum of Paleontology; Ernst Mayr Travel Grant in Animal Systematics through Harvard Museum of Comparative Zoology; Jackson School of Geosciences Student Travel Grant through Society of Vertebrate Paleontology	SMD received travel grants from the following sources: The Dorris O. and Samuel P. Welles Research Fund through the University of California Museum of Paleontology (http://www.ucmp.berkeley.edu/museum/wellesfund/), an Ernst Mayr Travel Grant in Animal Systematics through the Harvard Museum of Comparative Zoology (http://www.mcz.harvard.edu/grants_and_funding/ernstmayr-travel.html), and a Jackson School of Geosciences Student Travel Grant through the Society of Vertebrate Paleontology (http://vertpaleo.org/Awards/Award-%2814%29.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie JW, 2008, SYST ZOOL, V34, P326; Bambach RK, 2007, PALAEONTOLOGY, V50, P1, DOI 10.1111/j.1475-4983.2006.00611.x; Benton M.J., 1988, Systematics Association Special Volume Series, P295; Brusatte SL, 2008, BIOL LETTERS, V4, P733, DOI 10.1098/rsbl.2008.0441; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Brusatte SL, 2009, ACTA PALAEONTOL POL, V54, P221, DOI 10.4202/app.2008.0065; Butler RJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-128; Butler RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025693; Campbell MR, 1923, N CAROLINA GEOLOGICA, V33, P1; CHATTERJEE S, 1985, PHILOS T ROY SOC B, V309, P395, DOI 10.1098/rstb.1985.0092; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/ngeo1475, 10.1038/NGEO1475]; Clark JM, 2004, NATURE, V430, P1021, DOI 10.1038/nature02802; Clark JM, 2002, ZOOL J LINN SOC-LOND, V136, P77, DOI 10.1046/j.1096-3642.2002.00026.x; Clark JM, 2000, J VERTEBR PALEONTOL, V20, P683, DOI 10.1671/0272-4634(2000)020[0683:ANSOHA]2.0.CO;2; CODDINGTON J, 1994, CLADISTICS, V10, P415; COLBERT EDWIN H., 1952, BULL AMER MUS NAT HIST, V99, P561; Cope E.D., 1869, T AM PHIL SOC, V14, P1; CRUSH PJ, 1984, PALAEONTOLOGY, V27, P131; De Franca MAG, 2013, GEOL SOC SPEC PUBL, V379, P469, DOI 10.1144/SP379.8; DEBUFFRENIL V, 1982, ZOOMORPHOLOGY, V99, P155, DOI 10.1007/BF00310307; Drumheller SK, 2014, NATURWISSENSCHAFTEN, V101, P975, DOI 10.1007/s00114-014-1238-3; Drymala S., 2015, THESIS; Emmons E., 1856, GEOLOGICAL REPORT MI; Ezcurra MD, 2011, 4 C LAT PAL VERT; FAITH DP, 1991, CLADISTICS, V7, P1, DOI 10.1111/j.1096-0031.1991.tb00020.x; Furin S, 2006, GEOLOGY, V34, P1009, DOI 10.1130/G22967A.1; Galton PM, STUTTGARTER BEITRAGE, V116, P1; Gauthier J., 1985, P185; Gower DJ, 2009, J VERTEBR PALEONTOL, V29, P103, DOI 10.1080/02724634.2009.10010365; Gower David J., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V280, P1; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Irmis RB, 2013, GEOL SOC SPEC PUBL, V379, P275, DOI 10.1144/SP379.24; Jalil NE, 2007, PALAEONTOLOGY, V50, P417, DOI 10.1111/j.1475-4983.2007.00640.x; Kitching I.J., 1998, SYSTEMATICS ASS PUBL; KREBS B, 1974, NATURWISSENSCHAFTEN, V61, P17, DOI 10.1007/BF00602887; Langer MC, 2010, BIOL REV, V85, P55, DOI 10.1111/j.1469-185X.2009.00094.x; LITWIN RJ, 1993, REV PALAEOBOT PALYNO, V77, P75, DOI 10.1016/0034-6667(93)90057-2; Maddison W. P, 2014, MESQUITE MODULAR SYS; Merrem B., 1820, VERSUCH SYSTEMS AMPH; Muttoni G, 2004, GEOL SOC AM BULL, V116, P1043, DOI 10.1130/B25326.1; Nesbitt S, 2007, B AM MUS NAT HIST, P1; Nesbitt Sterling J., 2005, Palaeontologische Zeitschrift, V79, P471; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2013, GEOL SOC SPEC PUBL, V379, P241, DOI 10.1144/SP379.1; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Olsen P. E., 1978, NEWSL STRATIGR, V7, P90, DOI DOI 10.1127/NOS/7/1978/90; Olsen PE, 2010, EARTH ENV SCI T R SO, V101, P201, DOI 10.1017/S1755691011020032; OLSEN PE, 1982, AM J SCI, V282, P1, DOI 10.2475/ajs.282.1.1; Parker WG, 2013, GEOL SOC SPEC PUBL, V379, P503, DOI 10.1144/SP379.3; Parrish J.M., 1991, Journal of Vertebrate Paleontology, V11, P198; Parrish J. Michael, 1993, Journal of Vertebrate Paleontology, V13, P287; Peyer K, 2008, J VERTEBR PALEONTOL, V28, P363, DOI 10.1671/0272-4634(2008)28[363:ANSAFT]2.0.CO;2; Pol D, 2013, BIOL REV, V88, P862, DOI 10.1111/brv.12030; Reinemund JA, 1955, 246 US GEOL SURV PRO; Sereno PC, 2001, SCIENCE, V294, P1516, DOI 10.1126/science.1066521; Sues HD, 2013, ZOOL J LINN SOC-LOND, V168, P859, DOI 10.1111/zoj.12038; Sulej T, 2005, J VERTEBR PALEONTOL, V25, P78, DOI 10.1671/0272-4634(2005)025[0078:ANRRDA]2.0.CO;2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TRAVERSE A, 1987, SCIENCE, V236, P1469, DOI 10.1126/science.236.4807.1469; Traverse A, 1986, 3 ANN MID M; Turner AH, 2013, GEOL SOC SPEC PUBL, V379, P573, DOI 10.1144/SP379.15; WALKER AD, 1990, PHILOS T ROY SOC B, V330, P1, DOI 10.1098/rstb.1990.0185; WALKER AD, 1968, GEOL MAG, V105, P1, DOI 10.1017/S0016756800046434; Ward LF, 1899, US GEOLOGICAL SURVEY; Weinbaum JC, 2007, PALAEONTOL Z, V81, P131, DOI 10.1007/BF02988388; Weinbaum JC, 2013, GEOL SOC SPEC PUBL, V379, P525, DOI 10.1144/SP379.7; Weinbaum Jonathan C., 2011, Paleobios, V30, P18; Whiteside JH, 2011, P NATL ACAD SCI USA, V108, P8972, DOI 10.1073/pnas.1102473108; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Wu Xiao-Chun, 1993, Journal of Vertebrate Paleontology, V13, P58; Zanno LE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09276	74	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157528	10.1371/journal.pone.0157528	http://dx.doi.org/10.1371/journal.pone.0157528			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304665	Green Submitted, gold, Green Published			2022-12-27	WOS:000377824800067
J	Huang, YH; Lien, Y; Huang, CC; Huang, CY				Huang, Yen-Hua; Lien, Yi; Huang, Chien-Chih; Huang, Cheng-Yang			Characterization of Staphylococcus aureus Primosomal DnaD Protein: Highly Conserved C-Terminal Region Is Crucial for ssDNA and PriA Helicase Binding but Not for DnaA Protein-Binding and Self-Tetramerization	PLOS ONE			English	Article							BACILLUS-SUBTILIS DNAD; STALLED REPLICATION FORKS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MECHANISMS; INITIATION; RESTART; RECOGNITION; REVEALS; OLIGOMERIZATION	The role of DnaD in the recruitment of replicative helicase has been identified. However, knowledge of the DNA, PriA, and DnaA binding mechanism of this protein for the DnaA-and PriA-directed replication primosome assemblies is limited. We characterized the DNA-binding properties of DnaD from Staphylococcus aureus (SaDnaD) and analyzed its interactions with SaPriA and SaDnaA. The gel filtration chromatography analysis of purified SaDnaD and its deletion mutant proteins (SaDnaD1-195, SaDnaD1-200 and SaDnaD1-204) showed a stable tetramer in solution. This finding indicates that the C-terminal region aa 196-228 is not crucial for SaDnaD oligomerization. SaDnaD forms distinct complexes with ssDNA of different lengths. In fluorescence titrations, SaDnaD bound to ssDNA with a binding-site size of approximately 32 nt. A stable complex of SaDnaD1-195, SaDnaD1-200, and SaDnaD1-204 with ssDNA dT40 was undetectable, indicating that the C-terminal region of SaDnaD (particularly aa 205-228) is crucial for ssDNA binding. The SPR results revealed that SaDnaD1-195 can interact with SaDnaA but not with SaPriA, which may indicate that DnaD has different binding sites for PriA and DnaA. Both SaDnaD and SaDna-DY176A mutant proteins, but not SaDnaD1-195, can significantly stimulate the ATPase activity of SaPriA. Hence, the stimulation effect mainly resulted from direct contact within the protein-protein interaction, not via the DNA-protein interaction. Kinetic studies revealed that the SaDnaD-SaPriA interaction increases the V-max of the SaPriA ATPase fivefold without significantly affecting the K-m. These results indicate that the conserved C-terminal region is crucial for ssDNA and PriA helicase binding, but not for DnaA protein-binding and self-tetramerization.	[Huang, Yen-Hua; Lien, Yi; Huang, Chien-Chih; Huang, Cheng-Yang] Chung Shan Med Univ, Sch Biomed Sci, 110,Sec 1,Chien Kuo N Rd, Taichung 40201, Taiwan; [Huang, Cheng-Yang] Chung Shan Med Univ Hosp, Dept Med Res, 110,Sec 1,Chien Kuo N Rd, Taichung 40201, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Huang, CY (corresponding author), Chung Shan Med Univ, Sch Biomed Sci, 110,Sec 1,Chien Kuo N Rd, Taichung 40201, Taiwan.; Huang, CY (corresponding author), Chung Shan Med Univ Hosp, Dept Med Res, 110,Sec 1,Chien Kuo N Rd, Taichung 40201, Taiwan.	cyhuang@csmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 103-2320-B-040-018-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	i This research was supported by a grant from the Ministry of Science and Technology, Taiwan (MOST 103-2320-B-040-018-MY2 to C.Y. Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; Bonilla CY, 2012, J BACTERIOL, V194, P5110, DOI 10.1128/JB.00958-12; Briggs GS, 2012, J BACTERIOL, V194, P5162, DOI 10.1128/JB.00865-12; Bruand C, 2005, MOL MICROBIOL, V55, P1138, DOI 10.1111/j.1365-2958.2004.04451.x; BRUAND C, 1995, EMBO J, V14, P2642, DOI 10.1002/j.1460-2075.1995.tb07262.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Carneiro MJVM, 2006, MOL MICROBIOL, V60, P917, DOI 10.1111/j.1365-2958.2006.05152.x; Chan KW, 2009, J MOL BIOL, V388, P508, DOI 10.1016/j.jmb.2009.03.022; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Huang CY, 2008, BIOCHEM BIOPH RES CO, V375, P220, DOI 10.1016/j.bbrc.2008.07.160; Huang CY, 2006, NUCLEIC ACIDS RES, V34, P3878, DOI 10.1093/nar/gkl536; Huang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127634; Huang YH, 2015, PROTEIN J, V34, P169, DOI 10.1007/s10930-015-9609-y; Huang YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/195162; Huang YH, 2013, GENES CELLS, V18, P1007, DOI 10.1111/gtc.12095; Huang YH, 2012, GENES CELLS, V17, P837, DOI 10.1111/gtc.12001; Ishigo-oka D, 2001, J BACTERIOL, V183, P2148, DOI 10.1128/JB.183.6.2148-2150.2001; Kobayashi SD, 2009, CURR OPIN PHARMACOL, V9, P545, DOI 10.1016/j.coph.2009.07.009; Koyama N, 2013, MOLECULES, V18, P204, DOI 10.3390/molecules18010204; Leonard AC, 2011, ANNU REV MICROBIOL, V65, P19, DOI 10.1146/annurev-micro-090110-102934; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; Marston FY, 2010, NUCLEIC ACIDS RES, V38, P6930, DOI 10.1093/nar/gkq465; Masai H, 2010, BIOESSAYS, V32, P687, DOI 10.1002/bies.200900196; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Mizukoshi T, 2003, J BIOL CHEM, V278, P42234, DOI 10.1074/jbc.C300285200; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Peng WF, 2014, BIOCHIMIE, V101, P113, DOI 10.1016/j.biochi.2014.01.001; Sandler SJ, 2000, GENETICS, V155, P487; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; SCHEKMAN R, 1974, SCIENCE, V186, P987, DOI 10.1126/science.186.4168.987; Schneider S, 2008, J MOL BIOL, V376, P1237, DOI 10.1016/j.jmb.2007.12.045; Smits WK, 2010, MOL MICROBIOL, V75, P452, DOI 10.1111/j.1365-2958.2009.06999.x; Soultanas P, 2002, NUCLEIC ACIDS RES, V30, P966, DOI 10.1093/nar/30.4.966; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Szymanski MR, 2010, J MOL BIOL, V398, P8, DOI 10.1016/j.jmb.2010.02.009; Tanaka T, 2002, J BIOL CHEM, V277, P38062, DOI 10.1074/jbc.M204397200; Tanaka T, 2007, J BIOL CHEM, V282, P19917, DOI 10.1074/jbc.M701848200; Thompson AB, 2011, ACS APPL MATER INTER, V3, P2979, DOI 10.1021/am200459a; Turner IJ, 2004, FEBS LETT, V577, P460, DOI 10.1016/j.febslet.2004.10.051; Wang CC, 2010, PROTEIN J, V29, P445, DOI 10.1007/s10930-010-9272-2; Zhang W, 2008, J MOL BIOL, V377, P706, DOI 10.1016/j.jmb.2008.01.067; Zhang WK, 2006, J BACTERIOL, V188, P5487, DOI 10.1128/JB.00339-06; Zhang WK, 2005, J MOL BIOL, V351, P66, DOI 10.1016/j.jmb.2005.05.065	57	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157593	10.1371/journal.pone.0157593	http://dx.doi.org/10.1371/journal.pone.0157593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304067	Green Submitted, Green Published, gold			2022-12-27	WOS:000377824800075
J	Potocnjak, I; Degoricija, V; Trbusic, M; Teresak, SD; Radulovic, B; Pregartner, G; Berghold, A; Tiran, B; Marsche, G; Frank, S				Potocnjak, Ines; Degoricija, Vesna; Trbusic, Matias; Teresak, Sanda Dokoza; Radulovic, Bojana; Pregartner, Gudrun; Berghold, Andrea; Tiran, Beate; Marsche, Gunther; Frank, Sasa			Metrics of High-Density Lipoprotein Function and Hospital Mortality in Acute Heart Failure Patients	PLOS ONE			English	Article							CHOLESTEROL EFFLUX CAPACITY; HDL CHOLESTEROL; SERUM PARAOXONASE; TASK-FORCE; ASSOCIATION; GUIDELINES; DIAGNOSIS; DISEASE; ESC	Objective The functionality of high-density lipoprotein (HDL) is impaired in chronic ischaemic heart failure (HF). However, the relationship between HDL functionality and outcomes in acute HF (AHF) has not been studied. The present study investigates whether the metrics of HDL functionality, including HDL cholesterol efflux capacity and HDL-associated paraoxonase (PON)-1 arylesterase (AE) activity are associated with hospital mortality in AHF patients. Methods and Results The study was performed as a prospective, single-centre, observational research on 152 patients, defined and categorised according to the ESC and ACCF/AHA Guidelines for HF by time of onset, final clinical presentation and ejection fraction. The mean age of the included patients (52% female) was 75.2 years (SD 10.3) and hospital mortality was 14.5%. HDL cholesterol efflux capacity was examined by measuring the capacity of apoB depleted serum to remove tritium-labelled cholesterol from cultured macrophages. The AE activity of the HDL fraction was examined by a photometric assay. In a univariable regression analysis, low cholesterol efflux, but not AE activity, was significantly associated with hospital mortality [odds ratio (OR) 0.78, 95% confidence interval (CI) 0.64-0.96, p = 0.019]. In multivariable analysis progressively adjusting for important clinical and laboratory parameters the association obtained for cholesterol efflux capacity and hospital mortality by univariable analysis, despite a stable OR, did not stay significant (p = 0.179). Conclusion Our results suggest that HDL cholesterol efflux capacity (but not AE activity) contributes to, but is not an independent risk factor for, hospital mortality in AHF patients. Larger studies are needed to draw firm conclusions.	[Potocnjak, Ines; Degoricija, Vesna; Trbusic, Matias; Teresak, Sanda Dokoza] Univ Hosp Ctr Sisters Char, Dept Med, Zagreb, Croatia; [Degoricija, Vesna; Trbusic, Matias] Univ Zagreb, Sch Med, Zagreb 41001, Croatia; [Radulovic, Bojana] Univ Hosp Ctr Zagreb, Zagreb, Croatia; [Pregartner, Gudrun; Berghold, Andrea] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Tiran, Beate] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Marsche, Gunther] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria; [Frank, Sasa] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria	University of Zagreb; University of Zagreb; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Potocnjak, I (corresponding author), Univ Hosp Ctr Sisters Char, Dept Med, Zagreb, Croatia.; Marsche, G (corresponding author), Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria.; Frank, S (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria.	ines.potocnjak@yahoo.com; gunther.marsche@medunigraz.at; sasa.frank@medunigraz.at		Marsche, Gunther/0000-0002-2422-5381	Austrian Science Foundation [P27166-B23, P22976-B18]; Jubilee Foundation of the Austrian National Bank [15858]; Lanyar Foundation [386]; Austrian Science Fund (FWF) [P 22976] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Jubilee Foundation of the Austrian National Bank; Lanyar Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation [P27166-B23 to SF; P22976-B18 to GM]; the Jubilee Foundation of the Austrian National Bank [15858 to SF]; and the Lanyar Foundation [386 to SF], which had no roles in the study design, collection, analysis and interpretation of data, writing report or submission of the article.	Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Christ M, 2006, EUR HEART J, V27, P691, DOI 10.1093/eurheartj/ehi195; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Favari E, 2013, J LIPID RES, V54, P238, DOI 10.1194/jlr.P030452; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Freitas HFG, 2009, BRAZ J MED BIOL RES, V42, P420, DOI 10.1590/S0100-879X2009000500004; Gomaraschi Monica, 2016, Front Pharmacol, V7, P2, DOI 10.3389/fphar.2016.00002; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Holzer M, 2014, J INVEST DERMATOL, V134, P635, DOI 10.1038/jid.2013.359; Holzer M, 2013, BBA-MOL CELL BIOL L, V1831, P1442, DOI 10.1016/j.bbalip.2013.06.004; Horwich TB, 2008, AM HEART J, V156, P1170, DOI 10.1016/j.ahj.2008.07.004; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kalantar-Zadeh K, 2004, J AM COLL CARDIOL, V43, P1439, DOI 10.1016/j.jacc.2003.11.039; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; McGarrah RW, 2016, ATHEROSCLEROSIS, V246, P229, DOI 10.1016/j.atherosclerosis.2016.01.012; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mehra MR, 2009, J HEART LUNG TRANSPL, V28, P876, DOI 10.1016/j.healun.2009.04.026; O'Connor CM, 2012, EUR J HEART FAIL, V14, P605, DOI 10.1093/eurjhf/hfs029; PARTHASARATHY S, 1990, BIOCHIM BIOPHYS ACTA, V1044, P275, DOI 10.1016/0005-2760(90)90314-N; Patel PJ, 2013, EUR J HEART FAIL, V15, P1215, DOI 10.1093/eurjhf/hft084; RALPH P, 1975, NATURE, V257, P393, DOI 10.1038/257393a0; Ritsch A, 2015, NEW ENGL J MED, V372, P1870, DOI 10.1056/NEJMc1503139; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Saleheen D, 2015, LANCET DIABETES ENDO, V3, P507, DOI 10.1016/S2213-8587(15)00126-6; Santos-Gallego CG, 2015, ATHEROSCLEROSIS, V243, P121, DOI 10.1016/j.atherosclerosis.2015.08.027; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Tang WHW, 2011, CIRC-HEART FAIL, V4, P59, DOI 10.1161/CIRCHEARTFAILURE.110.958348; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Van Linthout S, 2015, HANDB EXP PHARMACOL, V224, P527, DOI 10.1007/978-3-319-09665-0_17; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986	41	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157507	10.1371/journal.pone.0157507	http://dx.doi.org/10.1371/journal.pone.0157507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304214	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800065
J	Zhang, F; Suh, KJ; Lee, KM				Zhang, Fan; Suh, Kyung-Jin; Lee, Kyung-Min			Validity of Intraoral Scans Compared with Plaster Models: An In-Vivo Comparison of Dental Measurements and 3D Surface Analysis	PLOS ONE			English	Article							CLINICAL-EVALUATION; CERAMIC CROWNS; TOOTH WIDTHS; ACCURACY; IMPRESSIONS; REPRODUCIBILITY; RELIABILITY; TECHNOLOGY; PRECISION; SCANNERS	Purpose Dental measurements have been commonly taken from plaster dental models obtained from alginate impressions can. Through the use of an intraoral scanner, digital impressions now acquire the information directly from the mouth. The purpose of this study was to determine the validity of the intraoral scans compared to plaster models. Materials and Methods Two types of dental models (intraoral scan and plaster model) of 20 subjects were included in this study. The subjects had impressions taken of their teeth and made as plaster model. In addition, their mouths were scanned with the intraoral scanner and the scans were converted into digital models. Eight transverse and 16 anteroposterior measurements, 24 tooth heights and widths were recorded on the plaster models with a digital caliper and on the intraoral scan with 3D reverse engineering software. For 3D surface analysis, the two models were superimposed by using best-fit algorithm. The average differences between the two models at all points on the surfaces were computed. Paired t-test and Bland-Altman plot were used to determine the validity of measurements from the intraoral scan compared to those from the plaster model. Results There were no significant differences between the plaster models and intraoral scans, except for one measurement of lower intermolar width. The Bland-Altman plots of all measurements showed that differences between the two models were within the limits of agreement. The average surface difference between the two models was within 0.10 mm. Conclusions The results of the present study indicate that the intraoral scans are clinically acceptable for diagnosis and treatment planning in dentistry and can be used in place of plaster models.	[Zhang, Fan; Suh, Kyung-Jin; Lee, Kyung-Min] Chonnam Natl Univ, Dent Res Inst 4D, Sch Dent, Dept Orthodont, Gwangju, South Korea	Chonnam National University	Lee, KM (corresponding author), Chonnam Natl Univ, Dent Res Inst 4D, Sch Dent, Dept Orthodont, Gwangju, South Korea.	ortholkm@chonnam.ac.kr		Lee, Kyung-Min/0000-0001-6221-3405	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2014R1A1A1003559]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (Grant number: NRF-2014R1A1A1003559, URL: www.nrf.re.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2014R1A1A1003559).	Anadioti E, 2015, J PROSTHET DENT, V113, P304, DOI 10.1016/j.prosdent.2014.09.015; Andriessen FS, 2014, J PROSTHET DENT, V111, P186, DOI 10.1016/j.prosdent.2013.07.010; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boeddinghaus M., 2015, CLIN ORAL INVESTIG; Ender A, 2013, INT J COMPUT DENT, V16, P11; Ender A, 2011, Int J Comput Dent, V14, P11; Ender A, 2015, QUINTESSENCE INT, V46, P9, DOI 10.3290/j.qi.a32244; Ender A, 2013, J PROSTHET DENT, V109, P121, DOI 10.1016/S0022-3913(13)60028-1; Fleming PS, 2011, ORTHOD CRANIOFAC RES, V14, P1, DOI 10.1111/j.1601-6343.2010.01503.x; Gimenez B, 2014, INT J ORAL MAX IMPL, V29, P853, DOI 10.11607/jomi.3343; Gimenez B, 2015, CLIN IMPLANT DENT R, V17, pE54, DOI 10.1111/cid.12124; Grunheid T, 2014, AM J ORTHOD DENTOFAC, V146, P673, DOI 10.1016/j.ajodo.2014.07.023; Guth JF, 2013, CLIN ORAL INVEST, V17, P1201, DOI 10.1007/s00784-012-0795-0; Naidu D, 2013, AM J ORTHOD DENTOFAC, V144, P304, DOI 10.1016/j.ajodo.2013.04.011; Naidu D, 2009, AUST ORTHOD J, V25, P97; Nedelcu RG, 2014, J PROSTHET DENT, V112, P1461, DOI 10.1016/j.prosdent.2014.05.027; Papaspyridakos P, 2015, CLIN ORAL IMPLANTS R; Patzelt SBM, 2014, J AM DENT ASSOC, V145, P1133, DOI 10.14219/jada.2014.87; Patzelt SBM, 2014, CLIN ORAL INVEST, V18, P1687, DOI 10.1007/s00784-013-1132-y; Patzelt SBM, 2013, J AM DENT ASSOC, V144, P914, DOI 10.14219/jada.archive.2013.0209; Peluso MJ, 2004, SEMIN ORTHOD, V10, P226; Pradies G, 2015, J DENT, V43, P201, DOI 10.1016/j.jdent.2014.12.007; Rheude B, 2005, ANGLE ORTHOD, V75, P300; Santoro M, 2003, AM J ORTHOD DENTOFAC, V124, P101, DOI 10.1016/S0889-5406(03)00152-5; Seelbach P, 2013, CLIN ORAL INVEST, V17, P1759, DOI 10.1007/s00784-012-0864-4; Tamim H, 2014, INT J PROSTHODONT, V27, P331, DOI 10.11607/ijp.3607; Ueda K, 2015, CLIN ORAL INVESTIG; van der Meer WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043312	28	38	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157713	10.1371/journal.pone.0157713	http://dx.doi.org/10.1371/journal.pone.0157713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304976	gold, Green Published, Green Submitted			2022-12-27	WOS:000377824800082
J	Kotlarek, D; Worch, R				Kotlarek, Daria; Worch, Remigiusz			New Insight into Metal Ion-Driven Catalysis of Nucleic Acids by Influenza PA-Nter	PLOS ONE			English	Article							CROSS-CORRELATION SPECTROSCOPY; A VIRUS POLYMERASE; RNA-POLYMERASE; ENDONUCLEASE DOMAIN; HOST ADAPTATION; SUBSTRATE-SPECIFICITY; VIRAL TRANSCRIPTION; CRYSTAL-STRUCTURE; SUBUNIT; MECHANISM	PA subunit of influenza RNA-dependent RNA polymerase deserves constantly increasing attention due to its essential role in influenza life cycle. N-terminal domain of PA (PA-Nter) harbors endonuclease activity, which is indispensable in viral transcription and replication. Interestingly, existing literature reports on in vitro ion preferences of the enzyme are contradictory. Some show PA-Nter activity exclusively with Mn2+, whereas others report Mg2+ as a natural cofactor. To clarify it, we performed a series of experiments with varied ion concentrations and substrate type. We observed cleavage in the presence of both ions, with a slight preference for manganese, however PA-Nter activity highly depended on the amount of residual, co-purified ions. Furthermore, to quantify cleavage reaction rate, we applied fluorescence cross-correlation spectroscopy (FCCS), providing highly sensitive and real-time monitoring of single molecules. Using nanomolar ssDNA in the regime of enzyme excess, we estimated the maximum reaction rate at 0.81 +/- 0.38 and 1.38 +/- 0.34 nM/min for Mg2+ and Mn2+, respectively. However, our calculations of PA-Nter ion occupancy, based on thermodynamic data, suggest Mg2+ to be a canonical metal in PA-Nter processing of RNA in vivo. Presented studies constitute a step toward better understanding of PA-Nter ion-dependent activity, which will possibly contribute to new successful inhibitor design in the future.	[Kotlarek, Daria; Worch, Remigiusz] Polish Acad Sci, Inst Phys, Phys Biol Lab, Warsaw, Poland; [Kotlarek, Daria] AIT Austrian Inst Technol GmbH, BioSensor Technol, Vienna, Austria	Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; Austrian Institute of Technology (AIT)	Worch, R (corresponding author), Polish Acad Sci, Inst Phys, Phys Biol Lab, Warsaw, Poland.	remiwo@ifpan.edu.pl		Worch, Remigiusz/0000-0002-3222-4821	National Science Centre [2012/07/D/NZ1/04255]; Foundation for Polish Science [123/UD/SKILLS/2013]	National Science Centre(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This work was supported by the National Science Centre, 2012/07/D/NZ1/04255 (https://www.ncn.gov.pl/?language=en) and the Foundation for Polish Science, 123/UD/SKILLS/2013 (http://www.fnp.org.pl/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alla NR, 2012, FEBS J, V279, P4492, DOI 10.1111/febs.12035; Bacia K, 2012, CHEMPHYSCHEM, V13, P1221, DOI 10.1002/cphc.201100801; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002; Crepin T, 2010, J VIROL, V84, P9096, DOI 10.1128/JVI.00995-10; Datta K, 2013, NUCLEIC ACIDS RES, V41, P8289, DOI 10.1093/nar/gkt603; De Clereq E, 2007, TRENDS PHARMACOL SCI, V28, P280, DOI 10.1016/j.tips.2007.04.005; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Doan L, 1999, BIOCHEMISTRY-US, V38, P5612, DOI 10.1021/bi9828932; DuBois RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002830; Eyers S, 2010, J ROY SOC MED, V103, P403, DOI 10.1258/jrsm.2010.090441; Fedor MJ, 2002, CURR OPIN STRUC BIOL, V12, P289, DOI 10.1016/S0959-440X(02)00324-X; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; Garman EF, 2005, PROG BIOPHYS MOL BIO, V89, P173, DOI 10.1016/j.pbiomolbio.2004.09.005; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hengrung N, 2015, NATURE, V527, P114, DOI 10.1038/nature15525; Hohlbein J, 2014, CHEM SOC REV, V43, P1156, DOI 10.1039/c3cs60233h; Hu J, 2015, MED MICROBIOL IMMUN, V204, P137, DOI 10.1007/s00430-014-0349-y; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Jefferson T, 2014, SAO PAULO MED J, V132, P256, DOI 10.1590/1516-3180.20141324T2; Kettling U, 1998, P NATL ACAD SCI USA, V95, P1416, DOI 10.1073/pnas.95.4.1416; Klumpp K, 2000, J BIOL CHEM, V275, P6181, DOI 10.1074/jbc.275.9.6181; Koppstein D, 2015, NUCLEIC ACIDS RES, V43, P5052, DOI 10.1093/nar/gkv333; Kowalinski E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002831; Liu YF, 2009, SCI CHINA SER C, V52, P450, DOI 10.1007/s11427-009-0060-1; Noble E, 2012, VIROLOGY, V433, P27, DOI 10.1016/j.virol.2012.07.008; Palermo G, 2015, ACCOUNTS CHEM RES, V48, P220, DOI 10.1021/ar500314j; Parkes KEB, 2003, J MED CHEM, V46, P1153, DOI 10.1021/jm020334u; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Preaud E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-813; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Stevaert A, 2015, MOL PHARMACOL, V87, P323, DOI 10.1124/mol.114.095588; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Thierry E, 2016, MOL CELL, V61, P125, DOI 10.1016/j.molcel.2015.11.016; Treanor JJ, 2010, VIRAL INFECT HUMANS, P2265; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xiao SY, 2014, J PHYS CHEM B, V118, P873, DOI 10.1021/jp408383g; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhao C, 2009, J VIROL, V83, P9024, DOI 10.1128/JVI.00911-09	43	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156972	10.1371/journal.pone.0156972	http://dx.doi.org/10.1371/journal.pone.0156972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300442	Green Published, gold			2022-12-27	WOS:000377822200021
J	Lu, XK; Chen, XG; Mu, M; Wang, JJ; Wang, XG; Wang, DL; Yin, ZJ; Fan, WL; Wang, S; Guo, LX; Ye, WW				Lu, Xuke; Chen, Xiugui; Mu, Min; Wang, Junjuan; Wang, Xiaoge; Wang, Delong; Yin, Zujun; Fan, Weili; Wang, Shuai; Guo, Lixue; Ye, Wuwei			Genome-Wide Analysis of Long Noncoding RNAs and Their Responses to Drought Stress in Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; FIBER DEVELOPMENT; REVEALS; PROTEIN; EXPRESSION; SEQUENCE; PROVIDES; IDENTIFICATION; EVOLUTION	Recent researches on long noncoding RNAs (lncRNAs) have expanded our horizon of gene regulation and the cellular complexity. However, the number, characteristics and expression patterns of lncRNAs remain poorly characterized and how these lncRNAs biogenesis are regulated in response to drought stress in cotton are still largely unclear. In the study, using a reproducibility-based RNA-sequencing and bioinformatics strategy to analyze the lncRNAs of 9 samples under three different environment stresses (control, drought stress and re-watering, three replications), we totally identified 10,820 lncRNAs of high-confidence through five strict steps filtration, of which 9,989 were lincRNAs, 153 were inronic lncRNAs, 678 were anti-sense lncRNAs. Coding function analysis showed 6,470 lncRNAs may have the ability to code proteins. Small RNAs precursor analysis revealed that 196 lncRNAs may be the precursors to small RNAs, most of which (35.7%, 70) were miRNAs. Expression patterns analysis showed that most of lncRNAs were expressed at a low level and most inronic lncRNAs (75.95%) had a consistent expression pattern with their adjacent protein-coding genes. Further analysis of transcriptome data uncovered that lncRNAs XLOC_063105 and XLOC_115463 probably function in regulating two adjacent coding genes CotAD_37096 and CotAD_12502, respectively. Investigations of the content of plant hormones and proteomics analysis under drought stress also complemented the prediction. We analyzed the characteristics and the expression patterns of lncRNAs under drought stress and re-watering treatment, and found lncRNAs may be likely to involve in regulating plant hormones pathway in response to drought stress.	[Chen, Xiugui; Mu, Min; Wang, Junjuan; Wang, Xiaoge; Wang, Delong; Yin, Zujun; Fan, Weili; Wang, Shuai; Guo, Lixue; Ye, Wuwei] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China; [Lu, Xuke; Ye, Wuwei] Xinjiang Agr Univ, Coll Agron, Urumqi 830052, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Xinjiang Agricultural University	Ye, WW (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.; Ye, WW (corresponding author), Xinjiang Agr Univ, Coll Agron, Urumqi 830052, Peoples R China.	yew158@163.com			Genetically modified organisms breeding [2014 ZX0800504B]	Genetically modified organisms breeding	This project was supported by grants from the Genetically modified organisms breeding (2014 ZX0800504B).	Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Bhan A, 2014, CHEMMEDCHEM, V9, P1932, DOI 10.1002/cmdc.201300534; Boerner S, 2012, PLOS ONE, P7; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Charon C, 2010, MOL PLANT, V3, P729, DOI 10.1093/mp/ssq037; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cramer GR, 2001, AUST J PLANT PHYSIOL, V28, P101, DOI 10.1071/PP00101; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Ding JH, 2012, P NATL ACAD SCI USA, V109, P2654, DOI 10.1073/pnas.1121374109; Dong YP, 2014, FUNCT INTEGR GENOMIC, V14, P479, DOI 10.1007/s10142-014-0373-4; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gong L, 2013, GENOME BIOL EVOL, V5, P2449, DOI 10.1093/gbe/evt196; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Kapusta A, 2014, TRENDS GENET, V30, P439, DOI 10.1016/j.tig.2014.08.004; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Pandey DM, 2003, BIOL PLANTARUM, V47, P535, DOI 10.1023/B:BIOP.0000041058.65442.41; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Shin H, 2006, PLANT J, V45, P712, DOI 10.1111/j.1365-313X.2005.02629.x; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang H, 2014, GENOME RES, V24, P444, DOI 10.1101/gr.165555.113; Wang MJ, 2015, NEW PHYTOL, V207, P1181, DOI 10.1111/nph.13429; Wang XJ, 2005, GENOME BIOL, P6; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Werner A, 2005, PHYSIOL GENOMICS, V23, P125, DOI 10.1152/physiolgenomics.00124.2005; Xue W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-629; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang Y, 2006, NUCLEIC ACIDS RES, V34, P3465, DOI 10.1093/nar/gkl473; Zhao L, 2012, PHYTOCHEM ANALYSIS, V23, P647, DOI 10.1002/pca.2368; Zhu YX, 2013, J INTEGR PLANT BIOL, V55, P570, DOI 10.1111/jipb.12076	51	70	76	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156723	10.1371/journal.pone.0156723	http://dx.doi.org/10.1371/journal.pone.0156723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294517	Green Published, gold			2022-12-27	WOS:000377821300010
J	Giles, EL; Becker, F; Ternent, L; Sniehotta, FF; McColl, E; Adams, J				Giles, Emma L.; Becker, Frauke; Ternent, Laura; Sniehotta, Falko F.; McColl, Elaine; Adams, Jean			Acceptability of Financial Incentives for Health Behaviours: A Discrete Choice Experiment	PLOS ONE			English	Article							SMOKING-CESSATION; EXTERNAL VALIDITY; RANDOM UTILITY; GLOBAL BURDEN; CARE; VACCINATIONS; PREGNANCY; INTERVENTIONS; PREFERENCES; COUNTRIES	Background Healthy behaviours are important determinants of health and disease, but many people find it difficult to perform these behaviours. Systematic reviews support the use of personal financial incentives to encourage healthy behaviours. There is concern that financial incentives may be unacceptable to the public, those delivering services and policymakers, but this has been poorly studied. Without widespread acceptability, financial incentives are unlikely to be widely implemented. We sought to answer two questions: what are the relative preferences of UK adults for attributes of financial incentives for healthy behaviours? Do preferences vary according to the respondents' socio-demographic characteristics? Methods We conducted an online discrete choice experiment. Participants were adult members of a market research panel living in the UK selected using quota sampling. Preferences were examined for financial incentives for: smoking cessation, regular physical activity, attendance for vaccination, and attendance for screening. Attributes of interest (and their levels) were: type of incentive (none, cash, shopping vouchers or lottery tickets); value of incentive (a continuous variable); schedule of incentive (same value each week, or value increases as behaviour change is sustained); other information provided (none, written information, face-to-face discussion, or both); and recipients (all eligible individuals, people living in low-income households, or pregnant women). Results Cash or shopping voucher incentives were preferred as much as, or more than, no incentive in all cases. Lower value incentives and those offered to all eligible individuals were preferred. Preferences for additional information provided alongside incentives varied between behaviours. Younger participants and men were more likely to prefer incentives. There were no clear differences in preference according to educational attainment. Conclusions Cash or shopping voucher-type financial incentives for healthy behaviours are not necessarily less acceptable than no incentives to UK adults.	[Giles, Emma L.; Becker, Frauke; Ternent, Laura; Sniehotta, Falko F.; McColl, Elaine; Adams, Jean] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Giles, Emma L.] Univ Teesside, Hlth & Social Care Inst, Sch Hlth & Social Care, Middlesbrough, Cleveland, England; [Adams, Jean] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England	Newcastle University - UK; University of Teesside; University of Cambridge	Adams, J (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.; Adams, J (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.	jma79@medschl.cam.ac.uk	McColl, Elaine/V-9906-2019; Becker, Frauke/Q-7738-2018; Sniehotta, Falko F/C-5481-2008; Giles, Emma/AAE-9096-2019; Sniehotta, Falko/ABF-7131-2021; Adams, Jean/G-2402-2010	McColl, Elaine/0000-0001-8300-3204; Becker, Frauke/0000-0003-1175-3932; Sniehotta, Falko F/0000-0003-1738-4269; Giles, Emma/0000-0002-2166-3300; Sniehotta, Falko/0000-0003-1738-4269; Adams, Jean/0000-0002-5733-7830; Ternent, laura/0000-0001-7056-298X	National Institute of Health Research [NIHR-CDF-2011-04-17]; Centre for Diet AMP; Activity Research (CEDAR); Fuse: the Centre for Translational Research in Public Health; British Heart Foundation [MR/K023187/1, MR/K02325X/1]; Cancer Research UK [MR/K023187/1, MR/K02325X/1]; Economic and Social Research Council [MR/K023187/1, MR/K02325X/1]; Medical Research Council [MR/K023187/1, MR/K02325X/1]; National Institute for Health Research, under the UK Clinical Research Collaboration; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K02325X/1B] Funding Source: researchfish	National Institute of Health Research(National Institute for Health Research (NIHR)); Centre for Diet AMP; Activity Research (CEDAR); Fuse: the Centre for Translational Research in Public Health; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under the UK Clinical Research Collaboration; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is produced under the terms of a Career Development Fellowship research training fellowship issued by the National Institute of Health Research to JA (grant number NIHR-CDF-2011-04-17; http://www.nihr.ac.uk/funding/fellowshipprogramme.htm). The views expressed are those of the authors and not necessarily those of the NHS, The National Institute for Health Research or the Department of Health. JA is currently funded in full by the Centre for Diet & Activity Research (CEDAR), and the FFS is funded in full by Fuse: the Centre for Translational Research in Public Health. CEDAR and Fuse are UKCRC Public Health Research Centres of Excellence (http://www.ukcrc.org/researchcoordination/joint-funding-initiatives/public-healthresearch/). Funding for CEDAR (grant number MR/K023187/1) and Fuse (grant number MR/K02325X/1) from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Adams J, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19940; Adams J, 2014, HEALTH PSYCHOL REV, V8, P286, DOI 10.1080/17437199.2013.848410; [Anonymous], 2012, NEG 1 1 1; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Boyd KA, 2016, ADDICTION, V111, P360, DOI 10.1111/add.13160; Brown KF, 2010, VACCINE, V28, P4235, DOI 10.1016/j.vaccine.2010.04.052; Cahill K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004307.pub4; Centre for Cancer Prevention, 2014, BREAST SCREEN RES NH; Coast J, 2008, SOC SCI MED, V67, P874, DOI 10.1016/j.socscimed.2008.05.015; Coast J, 2012, HEALTH ECON, V21, P730, DOI 10.1002/hec.1739; Craig R, 2014, HLTH SURV ENGL 2013; Craig R, 2013, HLTH SURV ENGL 2012; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Dwight-Johnson M, 2004, PSYCHIAT SERV, V55, P934, DOI 10.1176/appi.ps.55.8.934; Falagas ME, 2008, CURR MED RES OPIN, V24, P1719, DOI 10.1185/03007990802085692; Farooqui MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-141; Flynn Terry N, 2008, Popul Health Metr, V6, P6, DOI 10.1186/1478-7954-6-6; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Giles E, 2015, PREV MED, P10; Giles EL, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0549-5; Giles EL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1409-y; Giles EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090347; Giles EL, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00200; Hashemi A., 2015, Journal of Obesity & Weight Loss Therapy, V5, P247; Hicks RL, 2000, LAND ECON, V76, P374, DOI 10.2307/3147035; Hoddinott P, 2014, LANCET, V384, P37; Ierfino D, 2015, ADDICTION, V110, P680, DOI 10.1111/add.12817; Ipsos MORI, 2015, BRITAIN VOTED 2015; Kane RL, 2004, AM J PREV MED, V27, P327, DOI 10.1016/j.amepre.2004.07.002; Kavanagh J, 2009, INCENTIVES IMPROVE S; Krucien N, 2015, HEALTH ECON, V24, P951, DOI 10.1002/hec.3076; Lader D, 2003, SMOKING RELATED BEHA; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lancsar E, 2004, HEALTH ECON, V13, P901, DOI 10.1002/hec.870; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Lancsar E, 2014, PHARMACOECONOMICS, V32, P951, DOI 10.1007/s40273-014-0181-7; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Madison K, 2013, JAMA-J AM MED ASSOC, V310, P143, DOI 10.1001/jama.2013.7617; Mantzari E, 2015, PREV MED, V75, P75, DOI 10.1016/j.ypmed.2015.03.001; Marteau TM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1415; Mills E, 2005, J CLIN EPIDEMIOL, V58, P1081, DOI 10.1016/j.jclinepi.2005.09.002; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Office for National Statistics, 2015, MYE 1 POP EST SUMM U; Office for National Statistics, 2011, 2011 CENS HIGH LEV Q; Popay Jennie, 2008, BMJ, V337, pa594, DOI 10.1136/bmj.a594; Promberger M, 2013, HEALTH PSYCHOL, V32, P950, DOI 10.1037/a0032727; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; Public Health England, 2015, INFL IMM PROGR ENGL; Roll JM, 1996, J APPL BEHAV ANAL, V29, P495, DOI 10.1901/jaba.1996.29-495; Ryan M, 2008, ECON NON-MARK GOOD, V11, P1, DOI 10.1007/978-1-4020-5753-3; Ryan M, 2010, 6 ANN SCI M UK SOC B; Ryan M, 2006, J HEALTH ECON, V25, P927, DOI 10.1016/j.jhealeco.2006.01.001; Scott A, 2003, SOC SCI MED, V56, P803, DOI 10.1016/S0277-9536(02)00079-5; Secretary of State for Health, 2010, HLTH LIV HLTH PEOPL; Strohacker K, 2014, ANN BEHAV MED, V48, P92, DOI 10.1007/s12160-013-9577-4; Sutherland K, 2008, MED CARE RES REV, V65, p36S, DOI 10.1177/1077558708324235; Tappin D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h134; U.S. Department of Health and Human Services, 2010, HLTH PEOPL 2020; Wall J, 2006, NUTR REV, V64, P518, DOI [10.1301/nr.2006.dec.518-531, 10.1111/j.1753-4887.2006.tb00185.x]; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440; Whelan B, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-355; Wigham S, 2014, PEDIATRICS, V134, pE1117, DOI 10.1542/peds.2014-1279; Wilks-Heeg S, 2012, ELECT REGISTRATION U; Willis G.B, 2004, COGNITIVE INTERVIEWI; Willis GB, 1999 M AM STAT ASS; World Health Organization, 2008, 2008 2013 ACT PLAN G	68	29	29	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157403	10.1371/journal.pone.0157403	http://dx.doi.org/10.1371/journal.pone.0157403			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JQ	27314953	Green Submitted, Green Published, gold			2022-12-27	WOS:000378030000023
J	Zawbaa, HM; Szlek, J; Grosan, C; Jachowicz, R; Mendyk, A				Zawbaa, Hossam M.; Szlek, Jakub; Grosan, Crina; Jachowicz, Renata; Mendyk, Aleksander			Computational Intelligence Modeling of the Macromolecules Release from PLGA Microspheres-Focus on Feature Selection	PLOS ONE			English	Article							DRUG-DELIVERY	Poly-lactide-co-glycolide (PLGA) is a copolymer of lactic and glycolic acid. Drug release from PLGA microspheres depends not only on polymer properties but also on drug type, particle size, morphology of microspheres, release conditions, etc. Selecting a subset of relevant properties for PLGA is a challenging machine learning task as there are over three hundred features to consider. In this work, we formulate the selection of critical attributes for PLGA as a multiobjective optimization problem with the aim of minimizing the error of predicting the dissolution profile while reducing the number of attributes selected. Four bioinspired optimization algorithms: antlion optimization, binary version of antlion optimization, grey wolf optimization, and social spider optimization are used to select the optimal feature set for predicting the dissolution profile of PLGA. Besides these, LASSO algorithm is also used for comparisons. Selection of crucial variables is performed under the assumption that both predictability and model simplicity are of equal importance to the final result. During the feature selection process, a set of input variables is employed to find minimum generalization error across different predictive models and their settings/architectures. The methodology is evaluated using predictive modeling for which various tools are chosen, such as Cubist, random forests, artificial neural networks (monotonic MLP, deep learning MLP), multivariate adaptive regression splines, classification and regression tree, and hybrid systems of fuzzy logic and evolutionary computations (fugeR). The experimental results are compared with the results reported by Szl.k. We obtain a normalized root mean square error (NRMSE) of 15.97% versus 15.4%, and the number of selected input features is smaller, nine versus eleven.	[Zawbaa, Hossam M.; Grosan, Crina] Univ Babes Bolyai, Fac Math & Comp Sci, R-3400 Cluj Napoca, Romania; [Zawbaa, Hossam M.] Beni Suef Univ, Fac Comp & Informat, Bani Suwayf, Egypt; [Szlek, Jakub; Jachowicz, Renata; Mendyk, Aleksander] Jagiellonian Univ, Coll Med, Dept Pharmaceut Technol & Biopharmaceut, Krakow, Poland; [Grosan, Crina] Brunel Univ, Coll Engn Design & Phys Sci, London, England	Babes Bolyai University from Cluj; Egyptian Knowledge Bank (EKB); Beni Suef University; Jagiellonian University; Collegium Medicum Jagiellonian University; Brunel University	Zawbaa, HM (corresponding author), Univ Babes Bolyai, Fac Math & Comp Sci, R-3400 Cluj Napoca, Romania.; Zawbaa, HM (corresponding author), Beni Suef Univ, Fac Comp & Informat, Bani Suwayf, Egypt.	hossam.zawbaa@gmail.com	Zawbaa, Hossam M./O-6203-2014; Grosan, Crina/B-8435-2011	Zawbaa, Hossam M./0000-0001-6548-2993; Szlek, Jakub/0000-0003-1537-9650; Mendyk, Aleksander/0000-0002-4394-9115; Grosan, Crina/0000-0003-1049-2136	IPROCOM Marie Curie initial training network through the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grants [316555]; Romanian National Authority for Scientific Research, CNDI-UEFISCDI [PN-II-PT-PCCA-2011-3.2-0917]	IPROCOM Marie Curie initial training network through the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grants; Romanian National Authority for Scientific Research, CNDI-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by the IPROCOM Marie Curie initial training network, funded through the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grants agreement No. 316555, and by the Romanian National Authority for Scientific Research, CNDI-UEFISCDI, project number PN-II-PT-PCCA-2011-3.2-0917.	Aiello S, 2015, CONTRIBUTIONS H2O AI; Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004; [Anonymous], 2009, ICH Q8R2 PHARM DEV T; Barat A, 2008, J PHARMACEUT BIOMED, V48, P361, DOI 10.1016/j.jpba.2008.02.031; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2016, RANDOM FORESTS; Breiman L., 2017, CLASSIFICATION REGRE; Bujard A, 2012, FUGER FUZZY GENETIC; Cannon AJ, 2015, MONMLP MONOTONE MULT; Chung TW, 2006, J MICROENCAPSUL, V23, P15, DOI 10.1080/02652040500286110; Corrigan OI, 2009, EUR J PHARM SCI, V37, P477, DOI 10.1016/j.ejps.2009.04.004; Cuevas E, 2013, EXPERT SYST APPL, V40, P6374, DOI 10.1016/j.eswa.2013.05.041; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Davies S., 1994, IEEE AAAI FALL S REL, P37; Emary E, 2016, NEUROCOMPUTING, V172, P371, DOI 10.1016/j.neucom.2015.06.083; Emary E, 2015, ADV INTELL SYST, V334, P1, DOI 10.1007/978-3-319-13572-4_1; Fister I, 2013, ELEKTROTEH VESTN, V80, P116; Fredenberg S, 2011, INT J PHARMACEUT, V415, P34, DOI 10.1016/j.ijpharm.2011.05.049; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Hong Zhang, 1999, IJCNN'99. International Joint Conference on Neural Networks. Proceedings (Cat. No.99CH36339), P1820, DOI 10.1109/IJCNN.1999.832655; Jones TC, 2008, ANIM BEHAV, V76, P2011, DOI 10.1016/j.anbehav.2008.07.033; Kapoor DN, 2015, THER DELIV, V6, P41, DOI [10.4155/tde.14.91, 10.4155/TDE.14.91]; Karr C., 1991, AI Expert, V6, P26; Kim Y., 2004, P 21 INT C MACHINE L, P60; Kuhn M, 2014, C CODE CUBIST R QUIN; Meng XB, 2016, J EXP THEOR ARTIF IN, V28, P673, DOI 10.1080/0952813X.2015.1042530; Milborrow S., 2011, EARTH MULTIVARIATE A; Mirjalili S, 2015, ADV ENG SOFTW, V83, P80, DOI 10.1016/j.advengsoft.2015.01.010; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Ojha VK, 2015, INT J NANOMED, V10, P1119, DOI 10.2147/IJN.S71847; Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343; Rantanen J, 2015, J PHARM SCI-US, V104, P3612, DOI 10.1002/jps.24594; Sammut C, 2010, ENCY MACHINE LEARNIN, DOI [10.1007/978-0-387-30164-8_11, 10.1007/978-0-387-30164-8]; Segura C, 2015, GECCO'15: PROCEEDINGS OF THE 2015 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P489, DOI 10.1145/2739480.2754802; Szlek J, 2013, INT J NANOMED, V8, P4601, DOI 10.2147/IJN.S53364; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; US Food & Drug Administration, 2004, GUID IND PAT FRAM IN; Valdez F, 2015, SPRINGER HANDBOOK OF COMPUTATIONAL INTELLIGENCE, P1533; Versypt ANF, 2014, COMPUT CHEM ENG, V71, P241, DOI 10.1016/j.compchemeng.2014.05.022; Versypt ANF, 2013, J CONTROL RELEASE, V165, P29, DOI 10.1016/j.jconrel.2012.10.015; Yang LJ, 2016, EXPERT SYST APPL, V44, P156, DOI 10.1016/j.eswa.2015.08.034; YAO X, 1993, INT J INTELL SYST, V8, P539, DOI 10.1002/int.4550080406; Yip EC, 2008, P NATL ACAD SCI USA, V105, P11818, DOI 10.1073/pnas.0710603105; Zawbaa HM, NEUROCOMPUT IN PRESS; Zawbaa HM, 2015, 7 INT C SOFT COMP PA	46	13	14	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157610	10.1371/journal.pone.0157610	http://dx.doi.org/10.1371/journal.pone.0157610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315205	Green Published, gold			2022-12-27	WOS:000378030000041
J	Botrel, TEA; Clark, O; Pompeo, ACL; Bretas, FFH; Sadi, MV; Ferreira, U; dos Reis, RB				Ayer Botrel, Tobias Engel; Clark, Otovio; Lima Pompeo, Antonio Carlos; Horta Bretas, Francisco Flavio; Sadi, Marcus Vinicius; Ferreira, Ubirajara; dos Reis, Rodolfo Borges			Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PHASE-II TRIAL; CHEMOHORMONAL THERAPY; CHEMOTHERAPY; ESTRAMUSTINE; RADIOTHERAPY; SURVIVAL; CARE; MITOXANTRONE; PREDNISONE; GUIDELINES	Objective Prostate cancer is the most common nonskin cancer and second most common cause of cancer mortality in older men in the United States (USA) and Western Europe. Androgen-deprivation therapy alone (ADT) remains the first line of treatment in most cases, for metastatic disease. We performed a systematic review and meta-analysis of all randomized controlled trials (RCT) that compared the efficacy and adverse events profile of a chemohormonal therapy (ADT +/- docetaxel) for metastatic hormone-naive prostate cancer (mHNPC). Methods Several databases were searched, including MEDLINE, EMBASE, LILACS, and CENTRAL. The primary endpoint was overall survival. Data extracted from the studies were combined by using the hazard ratio (HR) or risk ratio (RR) with their corresponding 95% confidence intervals (95% CI). Results The final analysis included 3 trials comprising 2,264 patients (mHNPC). Patients who received the chemohormonal therapy had a longer clinical progression-free survival interval (HR = 0.64; 95% CI: 0.55 to 0.75; p<0.00001), and no heterogeneity (Chi(2) = 0.64; df = 1 [p = 0.42]; I-2 = 0%). The biochemical progression-free survival (bPFS) also was higher in patients treated with ADT plus docetaxel (HR = 0.63; 95% CI: 0.57 to 0.69; p<0.00001), also with no heterogeneity noted (Chi(2) = 0.48; df = 2 [p = 0.79]; I-2 = 0%). Finally, the combination of ADT with docetaxel showed a superior overall survival (OS) compared with ADT alone (HR = 0.73; 95% CI: 0.64 to 0.84; p<0.0001), with moderate heterogeneity (Chi(2) = 3.84; df = 2 [p = 0.15]; I-2 = 48%). A random-effects model analysis was performed, and the results remained favorable to the use of ADT plus docetaxel (HR = 0.73; 95% CI: 0.60 to 0.89; p = 0.002). In the final combined analysis of the high-volume disease patients, the use of the combination therapy also favored an increased overall survival (HR = 0.67; 95% CI: 0.54 to 0.83; p = 0.0003). Regarding adverse events and severe toxicity (grade >= 3), the group receiving the combined therapy had higher rates of neutropenia, febrile neutropenia and fatigue. Conclusion The combination of ADT with docetaxel improved the clinical progression-free survival, bPFS and OS of patients with mHNPC. A superior OS was seen especially for patients with metastatic and high-volume disease. This contemporary combination therapy may now be offered as a first-line treatment for selected patients.	[Ayer Botrel, Tobias Engel; Clark, Otovio] Evidencias A Kantar Hlth Co, Campinas, SP, Brazil; [Ayer Botrel, Tobias Engel; Clark, Otovio; Lima Pompeo, Antonio Carlos; Horta Bretas, Francisco Flavio; Sadi, Marcus Vinicius; Ferreira, Ubirajara; dos Reis, Rodolfo Borges] Comite Brasileiro Estudos Urooncol CoBEU, Sao Paulo, SP, Brazil		Botrel, TEA (corresponding author), Evidencias A Kantar Hlth Co, Campinas, SP, Brazil.; Botrel, TEA (corresponding author), Comite Brasileiro Estudos Urooncol CoBEU, Sao Paulo, SP, Brazil.	tobias.engel@evidencias.com.br	Pompeo, Antonio Carlos Lima/E-2557-2012; Reis, Rodolfo B/F-5877-2014	Pompeo, Antonio Carlos Lima/0000-0002-7462-3679; Reis, Rodolfo B/0000-0003-0328-1840				Altman Douglas G, 2002, BMC Med Res Methodol, V2, P3, DOI 10.1186/1471-2288-2-3; Amato R, 2013, CANCER CHEMOTH PHARM, V71, P1629, DOI 10.1007/s00280-013-2163-4; [Anonymous], 2011, REV MAN REVMAN COMP; Botrel TEA, 2012, INT BRAZ J UROL, V38, P717, DOI 10.1590/1677-553820133806717; Beltran H, 2011, EUR UROL, V60, P279, DOI 10.1016/j.eururo.2011.04.038; Beri N, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.1534; Castro A A, 1999, Sao Paulo Med J, V117, P138; Clarke M, 2000, COCHRANE LIB; Deeks J, 2006, COCHRANE HDB SYSTEMA; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2001, SYSTEMATIC REV HLTH; Fizazi K, 2015, ANN ONCOL, V26, P1660, DOI 10.1093/annonc/mdv245; Fizazi K, 2015, LANCET ONCOL, V16, P787, DOI 10.1016/S1470-2045(15)00011-X; Gillessen S, 2015, ANN ONCOL, V26, P1589, DOI 10.1093/annonc/mdv257; Gravis G, 2015, 2015 GENITOURINARY C; Gravis G, 2016, EUR UROL, V70, P256, DOI 10.1016/j.eururo.2015.11.005; Gravis G, 2013, LANCET ONCOL, V14, P149, DOI 10.1016/S1470-2045(12)70560-0; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; James ND, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.5001; James ND, 2015, EUR UROL, V67, P1028, DOI 10.1016/j.eururo.2014.09.032; Kellokumpu-Lehtinen PL, 2013, LANCET ONCOL, V14, P117, DOI 10.1016/S1470-2045(12)70537-5; Kellokumpu-Lehtinen PLI, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.4_suppl.23; Liaw BC, 2015, AM J HEMATOL-ONCOL, V11, P17; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Loblaw DA, 2007, J CLIN ONCOL, V25, P1596, DOI 10.1200/JCO.2006.10.1949; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; Morgan SC, 2008, RADIOTHER ONCOL, V88, P1, DOI 10.1016/j.radonc.2008.04.013; Mottet N, 2012, EUR UROL, V62, P213, DOI 10.1016/j.eururo.2012.03.053; Nakabayashi M, 2013, UROLOGY, V81, P611, DOI 10.1016/j.urology.2012.12.025; Noguchi M, 2004, INT J UROL, V11, P103, DOI 10.1111/j.1442-2042.2004.t01-1-00748.x; Parker C, 2015, ANN ONCOL, V26, pV69, DOI 10.1093/annonc/mdv222; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Rajan Prabhakar, 2015, Urol Oncol, V33, DOI 10.1016/j.urolonc.2015.05.012; Smeeth L, 1999, BMJ-BRIT MED J, V318, P1548, DOI 10.1136/bmj.318.7197.1548; Sweeney C, 2014, J CLIN ONCOL S, V32, P5; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Thalgott M, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-20; Warde P, 2011, LANCET, V378, P2104, DOI 10.1016/S0140-6736(11)61095-7; Widmark A, 2009, LANCET, V373, P301, DOI 10.1016/S0140-6736(08)61815-2; Yang K, 2010, CLIN DRUG INVEST, V30, P229, DOI 10.2165/11532260-000000000-00000	45	21	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157660	10.1371/journal.pone.0157660	http://dx.doi.org/10.1371/journal.pone.0157660			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308831	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800117
J	Dupuy, AM; Curinier, C; Kuster, N; Huet, F; Leclercq, F; Davy, JM; Cristol, JP; Roubille, F				Dupuy, Anne Marie; Curinier, Corentin; Kuster, Nils; Huet, Fabien; Leclercq, Florence; Davy, Jean Marc; Cristol, Jean Paul; Roubille, Francois			Multi-Marker Strategy in Heart Failure: Combination of ST2 and CRP Predicts Poor Outcome	PLOS ONE			English	Article							SOLUBLE ST2; ROC CURVE	Natriuretic peptides (BNP and NT-proBNP) are recognized as gold-standard predictive markers in Heart Failure (HF). However, currently ST2 (member of the interleukin 1 receptor family) has emerged as marker of inflammation, fibrosis and cardiac stress. We evaluated ST2 and CRP as prognostic markers in 178 patients with chronic heart failure in comparison with other classical markers such as clinical established parameters but also biological markers: NT-proBNP, hs-cTnT alone or in combination. In multivariate analysis, subsequent addition of ST2 led to age, CRP and ST2 as the only remaining predictors of all-cause mortality (HR 1.03, HR 1.61 and HR 2.75, respectively) as well as of cardiovascular mortality (HR 1.00, HR 2.27 and HR 3.78, respectively). The combined increase of ST2 and CRP was significant for predicting worsened outcomes leading to identify a high risk subgroup that individual assessment of either marker. The same analysis was performed with ST2 in combination with Barcelona score. Overall, our findings extend previous data demonstrating that ST2 in combination with CRP as a valuable tool for identifying patients at risk of death.	[Dupuy, Anne Marie; Kuster, Nils; Cristol, Jean Paul] Univ Hosp Montpellier, Ctr Ressources Biol Montpellier, Dept Biochem, Montpellier, France; [Curinier, Corentin; Huet, Fabien; Leclercq, Florence; Davy, Jean Marc; Roubille, Francois] Univ Hosp Montpellier, Dept Cardiol, Montpellier, France; [Cristol, Jean Paul; Roubille, Francois] Univ Montpellier, CNRS UMR 9214, INSERM, PhyMedExp,U1046, F-34059 Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Roubille, F (corresponding author), Univ Hosp Montpellier, Dept Cardiol, Montpellier, France.; Roubille, F (corresponding author), Univ Montpellier, CNRS UMR 9214, INSERM, PhyMedExp,U1046, F-34059 Montpellier, France.	francois.roubille@gmail.com		dupuy, anne marie/0000-0001-6538-3944				Araujo JP, 2009, J CARD FAIL, V15, P256, DOI 10.1016/j.cardfail.2008.10.030; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Dieplinger B, 2015, CLIN CHIM ACTA, V443, P57, DOI 10.1016/j.cca.2014.09.021; Dieplinger B, 2009, CLIN CHIM ACTA, V409, P33, DOI 10.1016/j.cca.2009.08.010; Gaggin HK, 2013, BBA-MOL BASIS DIS, V1832, P2442, DOI 10.1016/j.bbadis.2012.12.014; Heringlake M, 2013, J AM COLL CARDIOL, V61, P672, DOI 10.1016/j.jacc.2012.09.059; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Kempf Tibor, 2009, Heart Fail Clin, V5, P537, DOI 10.1016/j.hfc.2009.04.006; Lassus J, 2013, INT J CARDIOL, V168, P2186, DOI 10.1016/j.ijcard.2013.01.228; Lupon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085466; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nagarajan V, 2012, HEART, V98, P1778, DOI 10.1136/heartjnl-2012-301779; Oshikawa K, 2002, AM J RESP CRIT CARE, V165, P1005, DOI 10.1164/ajrccm.165.7.2105109; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Roubille F, 2014, EXPERT REV CARDIOVAS, V12, P111, DOI 10.1586/14779072.2013.839942; Sun RR, 2014, EUR REV MED PHARMACO, V18, P2927; Tajima S, 2007, EXP LUNG RES, V33, P81, DOI 10.1080/01902140701198583; Wu AHB, 2003, AM J CARDIOL, V92, P628, DOI 10.1016/S0002-9149(03)00741-0	23	25	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157159	10.1371/journal.pone.0157159	http://dx.doi.org/10.1371/journal.pone.0157159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311068	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800038
J	Gowanlock, Z; Sriram, S; Martin, A; Xenocostas, A; Lazo-Langner, A				Gowanlock, Zachary; Sriram, Swetha; Martin, Alison; Xenocostas, Anargyros; Lazo-Langner, Alejandro			Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology	PLOS ONE			English	Article							QUALITY-OF-LIFE; UNEXPLAINED ANEMIA; RISK; EQUATION; COHORT; IMPACT	Background In many elderly patients with anemia, a specific cause cannot be identified. This study investigates whether erythropoietin levels are inappropriately low in these cases of "anemia of unknown etiology" and whether this trend persists after accounting for confounders. Methods This study includes all anemic patients over 60 years old who had erythropoietin measured between 2005 and 2013 at a single center. Three independent reviewers used defined criteria to assign each patient's anemia to one of ten etiologies: chronic kidney disease, iron deficiency, chronic disease, confirmed myelodysplastic syndrome (MDS), suspected MDS, vitamin B-12 deficiency, folate deficiency, anemia of unknown etiology, other etiology, or multifactorial etiology. Iron deficiency anemia served as the comparison group in all analyses. We used linear regression to model the relationship between erythropoietin and the presence of each etiology, sequentially adding terms to the model to account for the hemoglobin concentration, estimated glomerular filtration rate (eGFR) and Charlson Comorbidity Index. Results A total of 570 patients met the inclusion criteria. Linear regression analysis showed that erythropoietin levels in chronic kidney disease, anemia of chronic disease and anemia of unknown etiology were lower by 48%, 46% and 27%, respectively, compared to iron deficiency anemia even after adjusting for hemoglobin, eGFR and comorbidities. Conclusions We have shown that erythropoietin levels are inappropriately low in anemia of unknown etiology, even after adjusting for confounders. This suggests that decreased erythropoietin production may play a key role in the pathogenesis of anemia of unknown etiology.	[Gowanlock, Zachary; Sriram, Swetha; Martin, Alison; Xenocostas, Anargyros; Lazo-Langner, Alejandro] Univ Western Ontario, Div Hematol, Dept Med, London, ON, Canada; [Xenocostas, Anargyros; Lazo-Langner, Alejandro] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Lazo-Langner, Alejandro] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Lazo-Langner, A (corresponding author), Univ Western Ontario, Div Hematol, Dept Med, London, ON, Canada.; Lazo-Langner, A (corresponding author), Univ Western Ontario, Dept Oncol, London, ON, Canada.; Lazo-Langner, A (corresponding author), Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada.	alejandro.lazolangner@lhsc.on.ca	Xenocostas, Anargyros/G-3358-2011; Lazo-Langner, Alejandro/E-6993-2011; Lazo-Langner, Alejandro/G-3318-2011	Lazo-Langner, Alejandro/0000-0001-6869-8431; Lazo-Langner, Alejandro/0000-0001-6869-8431	Program of Experimental Medicine, Department of Medicine, Western University; Janssen Inc.	Program of Experimental Medicine, Department of Medicine, Western University; Janssen Inc.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This study was partially funded by the Program of Experimental Medicine, Department of Medicine, Western University. AX has received funding from Janssen Inc., not related to the present work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artz AS, 2011, J GERONTOL A-BIOL, V66, P925, DOI 10.1093/gerona/glr090; Balducci L, 2006, CRIT REV ONCOL HEMAT, V58, P156, DOI 10.1016/j.critrevonc.2005.09.003; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Denny WA, 2012, J MED CHEM, V55, P2943, DOI 10.1021/jm300314a; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Ferrucci L, 2007, BRIT J HAEMATOL, V136, P849, DOI 10.1111/j.1365-2141.2007.06502.x; Ferrucci L, 2006, ARCH INTERN MED, V166, P1380, DOI 10.1001/archinte.166.13.1380; Giagounidis A, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.92.92; HIROTA Y, 1988, EUR J HAEMATOL, V40, P83; Jelkmann W, 1998, J INTERF CYTOK RES, V18, P555, DOI 10.1089/jir.1998.18.555; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Juarez-Cedillo T, 2014, ANN HEMATOL, V93, P2057, DOI 10.1007/s00277-014-2155-4; Kling PJ, 1996, BRIT J HAEMATOL, V95, P241, DOI 10.1046/j.1365-2141.1996.d01-1919.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lucca U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001920; Malgor L. A., 1998, Acta Physiologica Pharmacologica et Therapeutica Latinoamericana, V48, P99; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Mercadal L, 2012, CLIN J AM SOC NEPHRO, V7, P35, DOI 10.2215/CJN.04690511; Peterson TJ, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.273.273; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Sriram S, 2016, HEMATOLOGY; Sriram S, ERYTHROPOIETIN ANEMI; Thein M, 2009, MEDICINE, V88, P107, DOI 10.1097/MD.0b013e31819d89d5; World Health Organization, 2011, SER FERR CONC ASS IR; Xu CL, 2014, BIOL TRACE ELEM RES, V162, P142, DOI 10.1007/s12011-014-0166-6; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214	29	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157279	10.1371/journal.pone.0157279	http://dx.doi.org/10.1371/journal.pone.0157279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310832	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800050
J	Kassem, A; Lindholm, C; Lerner, UH				Kassem, Ali; Lindholm, Catharina; Lerner, Ulf H.			Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL	PLOS ONE			English	Article							NF-KAPPA-B; PORPHYROMONAS-GINGIVALIS; RHEUMATOID-ARTHRITIS; SEPTIC ARTHRITIS; OSTEOMYELITIS; DIFFERENTIATION; ACTIVATION; EXPRESSION; INDUCTION; CYTOKINES	Severe Staphylococcus aureus (S. aureus) infections pose an immense threat to population health and constitute a great burden for the health care worldwide. Inter alia, S. aureus septic arthritis is a disease with high mortality and morbidity caused by destruction of the infected joints and systemic bone loss, osteoporosis. Toll-Like receptors (TLRs) are innate immune cell receptors recognizing a variety of microbial molecules and structures. S. aureus recognition via TLR2 initiates a signaling cascade resulting in production of various cytokines, but the mechanisms by which S. aureus causes rapid and excessive bone loss are still unclear. We, therefore, investigated how S. aureus regulates periosteal/endosteal osteoclast formation and bone resorption. S. aureus stimulation of neonatal mouse parietal bone induced ex vivo bone resorption and osteoclastic gene expression. This effect was associated with increased mRNA and protein expression of receptor activator of NF-kappa B ligand (RANKL) without significant change in osteoprotegerin (OPG) expression. Bone resorption induced by S. aureus was abolished by OPG. S. aureus increased the expression of osteoclastogenic cytokines and prostaglandins in the parietal bones but the stimulatory effect of S. aureus on bone resorption and Tnfsf11 mRNA expression was independent of these cytokines and prostaglandins. Stimulation of isolated periosteal osteoblasts with S. aureus also resulted in increased expression of Tnfsf11 mRNA, an effect lost in osteoblasts from Tlr2 knockout mice. S. aureus stimulated osteoclastogenesis in isolated periosteal cells without affecting RANKL-stimulated resorption. In contrast, S. aureus inhibited RANKL-induced osteoclast formation in bone marrow macrophages. These data show that S. aureus enhances bone resorption and periosteal osteoclast formation by increasing osteoblast RANKL production through TLR2. Our study indicates the importance of using different in vitro approaches for studies of how S. aureus regulates osteoclastogenesis to obtain better understanding of the complex mechanisms of S. aureus induced bone destruction in vivo.	[Kassem, Ali; Lerner, Ulf H.] Umea Univ, Dept Mol Periodontol, Umea, Sweden; [Lindholm, Catharina; Lerner, Ulf H.] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Ctr Bone & Arthrit Res,Inst Med, Gothenburg, Sweden; [Lindholm, Catharina] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	Umea University; University of Gothenburg; University of Gothenburg	Lerner, UH (corresponding author), Umea Univ, Dept Mol Periodontol, Umea, Sweden.; Lerner, UH (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Ctr Bone & Arthrit Res,Inst Med, Gothenburg, Sweden.	ulf.lerner@umu.se		Lerner, Ulf/0000-0002-3579-1960	Swedish Research Council; County Council of Vasterbotten; Swedish National Graduate School in Odontological Sciences; Swedish Rheumatism Association; Royal 80-Year Fund of King Gustav V; Lundberg Foundation; COMBINE; ALF/LUA research grant from Sahlgrenska University Hospital in Gothenburg	Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of Vasterbotten; Swedish National Graduate School in Odontological Sciences; Swedish Rheumatism Association; Royal 80-Year Fund of King Gustav V; Lundberg Foundation(European Commission); COMBINE; ALF/LUA research grant from Sahlgrenska University Hospital in Gothenburg	This work was supported by The Swedish Research Council, the County Council of Vasterbotten, the Swedish National Graduate School in Odontological Sciences, the Swedish Rheumatism Association, the Royal 80-Year Fund of King Gustav V, COMBINE, ALF/LUA research grant from Sahlgrenska University Hospital in Gothenburg and the Lundberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Belli E, 2002, J CRANIOFAC SURG, V13, P765, DOI 10.1097/00001665-200211000-00010; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; BREMELL T, 1992, INFECT IMMUN, V60, P2976, DOI 10.1128/IAI.60.7.2976-2985.1992; Calfee DP, 2012, CURR OPIN INFECT DIS, V25, P385, DOI 10.1097/QCO.0b013e3283553441; Chen QB, 2014, CELL PHYSIOL BIOCHEM, V34, P1890, DOI 10.1159/000366387; Choo MK, 2009, BONE, V45, P579, DOI 10.1016/j.bone.2009.05.009; Claro T, 2013, MICROBIOL-SGM, V159, P147, DOI 10.1099/mic.0.063016-0; Conaway HH, 2011, J BIOL CHEM, V286, P31425, DOI 10.1074/jbc.M111.247734; Conaway HH, 2009, FASEB J, V23, P3526, DOI 10.1096/fj.09-132548; Costa AG, 2011, NAT REV RHEUMATOL, V7, P447, DOI 10.1038/nrrheum.2011.77; Dhaliwal Sandeep, 2012, Am J Orthop (Belle Mead NJ), V41, pE100; Dodwell ER, 2013, CURR OPIN PEDIATR, V25, P58, DOI 10.1097/MOP.0b013e32835c2b42; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Garcia-Arias M, 2011, BEST PRACT RES CL RH, V25, P407, DOI 10.1016/j.berh.2011.02.001; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; Granholm S, 2013, BONE, V52, P83, DOI 10.1016/j.bone.2012.09.019; Herman S, 2008, ARTHRITIS RHEUM-US, V58, P3041, DOI 10.1002/art.23943; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; Kassem A, 2015, J BIOL CHEM, V290, P20147, DOI 10.1074/jbc.M115.655787; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim J, 2013, J BONE MINER RES, V28, P2381, DOI 10.1002/jbmr.1973; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kishimoto T, 2012, J PERIODONTAL RES, V47, P446, DOI 10.1111/j.1600-0765.2011.01452.x; Koga K, 2002, NAT MED, V11, P880; Lerner UH, 1998, CLIN ORTHOP RELAT R, P244; LERNER UH, 1987, J BONE MINER RES, V2, P375; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; LJUNGGREN O, 1991, J BONE MINER RES, V6, P543; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Matsumoto C, 2012, BIOCHEM BIOPH RES CO, V428, P110, DOI 10.1016/j.bbrc.2012.10.016; Meghji S, 1998, BRIT J RHEUMATOL, V37, P1095; Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]; Nagano F, 2013, J PERIODONTAL RES, V48, P420, DOI 10.1111/jre.12021; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Pacifici R, 1996, J BONE MINER RES, V11, P1043; Peltola H, 2014, NEW ENGL J MED, V370, P352, DOI 10.1056/NEJMra1213956; Sanchez CJ, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-187; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Sims NA, 2014, CALCIFIED TISSUE INT, V94, P2, DOI 10.1007/s00223-013-9766-y; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Somayaji SN, 2008, INFECT IMMUN, V76, P5120, DOI 10.1128/IAI.00228-08; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Suzaki A, 2014, J ORTHOP RES, V32, P910, DOI 10.1002/jor.22627; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tarkowski A, 2006, BEST PRACT RES CL RH, V20, P1029, DOI 10.1016/j.berh.2006.08.001; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tong SYC, 2012, SEMIN IMMUNOPATHOL, V34, P185, DOI 10.1007/s00281-011-0300-x; Trouillet-Assant S, 2015, J INFECT DIS, V211, P571, DOI 10.1093/infdis/jiu386; Verdrengh M, 2007, J ORTHOP RES, V25, P304, DOI 10.1002/jor.20317; Verdrengh M, 2010, BONE, V46, P752, DOI 10.1016/j.bone.2009.10.028; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Widaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040586; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Wright JA, 2010, INT J MED MICROBIOL, V300, P193, DOI 10.1016/j.ijmm.2009.10.003; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang J, 2009, J LEUKOCYTE BIOL, V86, P823, DOI 10.1189/jlb.0309206; Young AB, 2011, BONE, V48, P857, DOI 10.1016/j.bone.2010.11.015; Zanotti S, 2011, J BIOL CHEM, V286, P4576, DOI 10.1074/jbc.M110.161893; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085; Zhuang LF, 2014, CLIN ORAL IMPLANTS R	65	40	44	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156708	10.1371/journal.pone.0156708	http://dx.doi.org/10.1371/journal.pone.0156708			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311019	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800012
J	Munyan, BG; Neer, SM; Beidel, DC; Jentsch, F				Munyan, Benson G., III; Neer, Sandra M.; Beidel, Deborah C.; Jentsch, Florian			Olfactory Stimuli Increase Presence in Virtual Environments	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; REALITY EXPOSURE THERAPY; ANXIETY DISORDERS; MEMORY; PREVALENCE; COMORBIDITY; EXTINCTION; ODORS; CUES; CARE	Background Exposure therapy (EXP) is the most empirically supported treatment for anxiety and trauma-related disorders. EXP consists of repeated exposure to a feared object or situation in the absence of the feared outcome in order to extinguish associated anxiety. Key to the success of EXP is the need to present the feared object/event/situation in as much detail and utilizing as many sensory modalities as possible, in order to augment the sense of presence during exposure sessions. Various technologies used to augment the exposure therapy process by presenting multi-sensory cues (e.g., sights, smells, sounds). Studies have shown that scents can elicit emotionally charged memories, but no prior research has examined the effect of olfactory stimuli upon the patient's sense of presence during simulated exposure tasks. Methods 60 adult participants navigated a mildly anxiety-producing virtual environment (VE) similar to those used in the treatment of anxiety disorders. Participants had no autobiographical memory associated with the VE. State anxiety, Presence ratings, and electrodermal (EDA) activity were collected throughout the experiment. Results Utilizing a Bonferroni corrected Linear Mixed Model, our results showed statistically significant relationships between olfactory stimuli and presence as assessed by both the Igroup Presence Questionnaire (IPQ: R-2 = 0.85, (F(3,52) = 6.625, p = 0.0007) and a single item visual-analogue scale (R-2 = 0.85, (F(3,52) = 5.382, p = 0.0027). State anxiety was unaffected by the presence or absence of olfactory cues. EDA was unaffected by experimental condition. Conclusion Olfactory stimuli increase presence in virtual environments that approximate those typical in exposure therapy, but did not increase EDA. Additionally, once administered, the removal of scents resulted in a disproportionate decrease in presence. Implications for incorporating the use of scents to increase the efficacy of exposure therapy is discussed.	[Munyan, Benson G., III; Neer, Sandra M.; Beidel, Deborah C.; Jentsch, Florian] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Munyan, BG (corresponding author), Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA.	benson.munyan@knights.ucf.edu			Sigma Xi, The Scientific Research Society	Sigma Xi, The Scientific Research Society	This research was supported by a Grant-In-Aid of Research from Sigma Xi, The Scientific Research Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a Grant-In-Aid of Research from Sigma Xi, The Scientific Research Society. We wish to thank Fallen Planet Studios for VE consulting and creation. We also wish to thank Aaron Necaise and Vincent Van Berkum who were instrumental in data collection.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Beidel DC, 2011, J ANXIETY DISORD, V25, P224, DOI 10.1016/j.janxdis.2010.09.006; Blanchard EB, 2003, BEHAV RES THER, V41, P79, DOI 10.1016/S0005-7967(01)00131-0; Bouchard Stephane, 2006, Technol Health Care, V14, P19; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Carlson N. R., 2013, PHYSL BEHAV; Chen Y, 2006, 16 INT C ART REAL TE; Chu S, 2002, MEM COGNITION, V30, P511, DOI 10.3758/BF03194952; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; Davey HM, 2007, J CLIN EPIDEMIOL, V60, P356, DOI 10.1016/j.jclinepi.2006.07.015; Delahanty DL, 1997, J CONSULT CLIN PSYCH, V65, P560, DOI 10.1037/0022-006X.65.4.560; Difede J, 2002, CYBERPSYCHOL BEHAV, V5, P529, DOI 10.1089/109493102321018169; Dinh HQ, 1999, VIRT REAL 1999 P IEE; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Emmelkamp PMG, 2001, CYBERPSYCHOL BEHAV, V4, P335, DOI 10.1089/109493101300210222; Fleurkens P, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.21359; Foa EB., 2006, PATHOLOGICAL ANXIETY, P3, DOI DOI 10.1037/0022-006X.72.5.879; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Hasson D., 2005, International Electronic Journal of Health Education, V8, P178; Herz RS, 2000, SCIENCES, V40, P34, DOI 10.1002/j.2326-1951.2000.tb03507.x; Herz RS, 1998, ANN NY ACAD SCI, V855, P670, DOI 10.1111/j.1749-6632.1998.tb10643.x; Hodges LF, 1994, GITGVU9406; Hoffman H. G., 1998, Virtual Reality, V3, P226, DOI 10.1007/BF01408703; Ijsselsteijn W, 2001, PRESENCE-TELEOP VIRT, V10, P298, DOI 10.1162/105474601300343621; Jackman AH, 2005, LARYNGOSCOPE, V115, P2209, DOI 10.1097/01.mlg.0000183194.17484.bb; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KLINE NA, 1985, J CLIN PSYCHIAT, V46, P383; Kolasinski E. M., 1995, SIMULATOR SICKNESS V; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; LEON AC, 1995, BRIT J PSYCHIAT, V166, P19, DOI 10.1192/S0007125000293355; Lepine JP, 2002, J CLIN PSYCHIAT, V63, P4; Lombard M., 1997, J COMPUT-MEDIAT COMM, V3, DOI DOI 10.1111/J.1083-6101.1997.TB00072.X; McLay RN, 2011, CYBERPSYCH BEH SOC N, V14, P223, DOI 10.1089/cyber.2011.0003; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Owens ME, 2013, DOES VIRTUAL REALITY; Pavlov I. P., 1902, WORK DIGESTIVE GLAND; Penny K. I., 1996, J R STAT SOC C-APPL, V45, P73, DOI 10.2307/2986224; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Pietrzak RH, 2011, PSYCHIAT RES, V189, P251, DOI 10.1016/j.psychres.2011.07.019; Powers MB, 2008, J ANXIETY DISORD, V22, P561, DOI 10.1016/j.janxdis.2007.04.006; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Proust M, 1925, SWANNS WAY; Reips UD, 2008, BEHAV RES METHODS, V40, P699, DOI 10.3758/BRM.40.3.699; Rescorla RA, 2006, J EXP PSYCHOL ANIM B, V32, P135, DOI 10.1037/0097-7403.32.2.135; Rescorla RA, 2000, J EXP PSYCHOL ANIM B, V26, P251, DOI 10.1037//0097-7403.26.3.251; Resick PA, 2012, J CONSULT CLIN PSYCH, V80, P201, DOI 10.1037/a0026602; Rizzo A, 2010, ANN NY ACAD SCI, V1208, P114, DOI 10.1111/j.1749-6632.2010.05755.x; Rothbaum BO, 2001, J CLIN PSYCHIAT, V62, P617, DOI 10.4088/JCP.v62n0808; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Schuemie MJ, 2001, CYBERPSYCHOL BEHAV, V4, P183, DOI 10.1089/109493101300117884; Short J., 1976, SOCIAL PSYCHOL TELEC; Slater M, 1999, IEEE COMPUT GRAPH, V19, P6, DOI 10.1109/38.749116; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; SPIELBERGER CD, 1984, J PERS ASSESS, V48, P95; Spoont MR, 2014, PSYCHIAT SERV, V65, P654, DOI 10.1176/appi.ps.201200324; Vermetten E, 2003, J CLIN PSYCHIAT, V64, P202, DOI 10.4088/JCP.v64n0214; Watson JB, 1920, J EXP PSYCHOL, V3, P1, DOI 10.1037/h0069608; Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3; Wiederhold BK, 2002, IEEE T INF TECHNOL B, V6, P218, DOI 10.1109/TITB.2002.802378; Wilson D. A., 2006, LEARNING SMELL; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686	65	27	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157568	10.1371/journal.pone.0157568	http://dx.doi.org/10.1371/journal.pone.0157568			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310253	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800098
J	Rahman, MM; Rahman, MM; Tareque, MI; Ferdos, J; Jesmin, SS				Rahman, Md. Mosfequr; Rahman, Md. Mizanur; Tareque, Md. Ismail; Ferdos, Jannatul; Jesmin, Syeda S.			Maternal Pregnancy Intention and Professional Antenatal Care Utilization in Bangladesh: A Nationwide Population-Based Survey	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; SUB-SAHARAN AFRICA; UNINTENDED PREGNANCY; PRENATAL-CARE; HEALTH-CARE; REPRODUCTIVE HEALTH; INDUCED-ABORTION; WOMEN; SERVICES; ASSOCIATION	Objective To investigate the association between maternal pregnancy intention and professional antenatal and delivery care utilization. Methods Our data were derived from the 2011 nationally representative Bangladesh Demographic Health Survey. We included antenatal and delivery care utilization data of the most recent live births for women for the previous three years (n = 4672). We used multilevel logistic regression models to assess the relationship between pregnancy intention and use of professional antenatal and delivery care, with adjustment for potential confounding variables. Results Approximately 13% and 16% of children were reported by their mothers as unwanted and mistimed at the time of conception, respectively. Among the women, 55% received at least one professional antenatal care service; 21% received four or more professional antenatal services, while 32% were attended by professionals during deliveries. Mothers of children whose pregnancies had been unwanted had a greater risk for not seeking professional antenatal and professional delivery care than those whose pregnancies had been wanted [1 >= ANC from professionals: AOR: 0.66; 95% CI: 0.51-0.93; 4 >= ANC from professionals: AOR: 0.56; 95% CI: 0.37-0.84; and delivery care from professionals: AOR: 0.70; 95% CI: 0.50-0.97]. Women who were married after age 18, had secondary or higher level of education, and were from the wealthiest households were more likely to utilize antenatal and delivery care. Conclusion Unwanted pregnancy is significantly associated with lower utilization of professional antenatal and delivery care services in Bangladesh. Reducing unwanted births and promoting access to professional antenatal and delivery care are crucial for achieving the Sustainable Development Goals (SDGs) 3 in Bangladesh.	[Rahman, Md. Mosfequr; Rahman, Md. Mizanur; Tareque, Md. Ismail; Ferdos, Jannatul] Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh; [Rahman, Md. Mizanur] Univ Tokyo, Sch Int Hlth, Dept Global Hlth Policy, Tokyo, Japan; [Jesmin, Syeda S.] Univ N Texas, Dept Sociol, Dallas, TX USA	University of Rajshahi; University of Tokyo; University of North Texas System	Rahman, MM (corresponding author), Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh.	mosfeque@gmail.com	Rahman, Md. Mosfequr/D-9107-2017; Rahman, Mosfequr/D-2973-2011	Rahman, Md. Mosfequr/0000-0002-2402-5814; Rahman, Mosfequr/0000-0002-2402-5814; Tareque, Md Ismail/0000-0002-6507-1171				Acharya DR, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-15; Alio AP, 2011, INT J GYNECOL OBSTET, V112, P83, DOI 10.1016/j.ijgo.2010.08.024; Anwar I, 2008, B WORLD HEALTH ORGAN, V86, P252, DOI 10.2471/BLT.07.042754; Anwar I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120309; Bangladesh Bureau of Statistics [BBS], 2011, REPORT OF THE HOUSEH; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Bernstein S, 2005, STUD FAMILY PLANN, V36, P127, DOI 10.1111/j.1728-4465.2005.00050.x; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Cripe SM, 2008, INT J GYNECOL OBSTET, V100, P104, DOI 10.1016/j.ijgo.2007.08.003; Dibaba Y, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-50; Eggleston E, 2000, SOC SCI MED, V51, P1011, DOI 10.1016/S0277-9536(00)00010-1; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; Erol N, 2010, EUR J CONTRACEP REPR, V15, P290, DOI 10.3109/13625187.2010.500424; Exavery A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-35; Fanslow J, 2008, AUST NZ J OBSTET GYN, V48, P391, DOI 10.1111/j.1479-828X.2008.00866.x; Furuta M, 2006, INT FAM PLAN PERSPEC, V32, P17, DOI 10.1363/3201706; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gausia K, 2009, PSYCHOL MED, V39, P999, DOI 10.1017/S0033291708004455; Gross K, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-16; Guliani H, 2014, HEALTH POLICY PLANN, V29, P589, DOI 10.1093/heapol/czt045; Hindin MJ, 2008, DHS ANALYTICAL STUDI; Jejeebhoy SJ, 1995, WOMENS EDUCATION AUT; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Koenig MA, 2007, INT FAM PLAN PERSPEC, V33, P75, DOI 10.1363/3307507; Kost K, 1998, FAM PLANN PERSPECT, V30, P79, DOI 10.2307/2991664; Magadi MA, 2007, SOC SCI MED, V64, P1311, DOI 10.1016/j.socscimed.2006.11.004; Marcus SM, 2009, PRIMARY CARE, V36, P151, DOI 10.1016/j.pop.2008.10.011; Marston C, 2003, POP STUD-J DEMOG, V57, P77, DOI 10.1080/0032472032000061749; Mayer JP, 1997, BIRTH-ISS PERINAT C, V24, P247, DOI 10.1111/j.1523-536X.1997.tb00598.x; Moore AM, 2010, SOC SCI MED, V70, P1737, DOI 10.1016/j.socscimed.2010.02.009; Nasreen HE, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-22; National Institute of Population Research and Training (NIPORT), 2015, ICF INTERNATIONAL BA; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2013, BANGLADESH DEMOGRAPH; National Institute of Population Research and Training (NIPORT); Mitra and Associates; and Macro International, 2009, BANGLADESH DEMOGRAPH; Nicolaidis C, 2007, J GEN INTERN MED, V22, P1216, DOI 10.1007/s11606-007-0262-9; Pallitto CC, 2013, INT J GYNECOL OBSTET, V120, P3, DOI 10.1016/j.ijgo.2012.07.003; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Rahman M, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0095-7; Rahman M, 2014, ASIA-PAC J PUBLIC HE, V26, P160, DOI 10.1177/1010539511423301; Rahman M, 2012, J INTERPERS VIOLENCE, V27, P2999, DOI 10.1177/0886260512441072; Rahman M, 2012, MATERN CHILD HLTH J, V16, P1206, DOI 10.1007/s10995-011-0897-3; Rahman M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-913; Rutstein S., 2004, DHS COMPARATIVE REPO; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Schmidt JO, 2010, HEALTH POLICY, V96, P98, DOI 10.1016/j.healthpol.2010.01.008; Silverman JG, 2007, BJOG-INT J OBSTET GY, V114, P1246, DOI 10.1111/j.1471-0528.2007.01481.x; Singh A, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1481, DOI 10.1177/1010539513498769; Singh A, 2012, POP STUD-J DEMOG, V66, P223, DOI 10.1080/00324728.2012.697568; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Stephenson R, 2012, PUBLIC HEALTH REP, V127, P96; Taft AJ, 2015, AUST NZ J PUBL HEAL, V39, P177, DOI 10.1111/1753-6405.12339; Twisk JWR, 2006, APPLIED MULTILEVEL A; United Nations, 2015, TRANSFORMING OUR WOR; Wado YD, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-36	55	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157760	10.1371/journal.pone.0157760	http://dx.doi.org/10.1371/journal.pone.0157760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309727	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800133
J	Shen, AL; Moran, SA; Glover, EA; Drinkwater, NR; Swearingen, RE; Teixeira, LB; Bradfield, CA				Shen, Anna L.; Moran, Susan A.; Glover, Edward A.; Drinkwater, Norman R.; Swearingen, Rebecca E.; Teixeira, Leandro B.; Bradfield, Christopher A.			Association of a Chromosomal Rearrangement Event with Mouse Posterior Polymorphous Corneal Dystrophy and Alterations in Csrp2bp, Dzank1, and Ovol2 Gene Expression	PLOS ONE			English	Article							IRIDOCORNEAL ENDOTHELIAL SYNDROME; VIII COLLAGEN; GENOME-WIDE; MUTATIONS; ATAC; MICE; GENERATION; COMPLEX; COL8A2; CELLS	We have previously described a mouse model of human posterior polymorphous corneal dystrophy (PPCD) and localized the causative mutation to a 6.2 Mbp region of chromosome 2, termed Ppcd1. We now show that the gene rearrangement linked to mouse Ppcd1 is a 3.9 Mbp chromosomal inversion flanked by 81 Kbp and 542 bp deletions. This recombination event leads to deletion of Csrp2bp Exons 8 through 11, Dzank1 Exons 20 and 21, and the pseudogene Znf133. In addition, we identified translocation of novel downstream sequences to positions adjacent to Csrp2bp Exon 7 and Dzank1 Exon 20. Twelve novel fusion transcripts involving Csrp2bp or Dzank1 linked to downstream sequences have been identified. Eight are expressed at detectable levels in PPCD1 but not wildtype eyes. Upregulation of two Csrp2bp fusion transcripts, as well as upregulation of the adjacent gene, Ovol2, was observed. Absence of the PPCD1 phenotype in animals haploinsufficient for Csrp2bp or both Csrp2bp and Dzank1 rules out haploinsufficiency of these genes as a cause of mouse PPCD1. Complementation experiments confirm that PPCD1 embryonic lethality is due to disruption of Csrp2bp expression. The ocular expression pattern of Csrp2bp is consistent with a role for this protein in corneal development and pathogenesis of PPCD1.	[Shen, Anna L.; Moran, Susan A.; Glover, Edward A.; Drinkwater, Norman R.; Swearingen, Rebecca E.; Bradfield, Christopher A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI USA; [Teixeira, Leandro B.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Bradfield, Christopher A.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI USA; [Shen, Anna L.; Teixeira, Leandro B.; Bradfield, Christopher A.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, AL; Bradfield, CA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI USA.; Bradfield, CA (corresponding author), Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI USA.; Shen, AL; Bradfield, CA (corresponding author), Univ Wisconsin, McPherson Eye Res Inst, Madison, WI USA.	alshen@wisc.edu; bradfield@oncology.wisc.edu	Teixeira, Leandro B C/H-9272-2015; Teixeira, Leandro/AAU-6094-2021	Teixeira, Leandro B C/0000-0001-9960-678X; Teixeira, Leandro/0000-0001-9960-678X	National Eye Institute, National Institutes of Health (NIH) [EY021376]; Core Grant for Vision Research - National Eye Institute, NIH [P30 EY016665]; University of Wisconsin Carbone Cancer Center - Cancer Center Support Grant from the National Cancer Institute, NIH [P30 CA014520]; Wellcome Trust; NIH [U01HG004085, U01HG004080]; Children's Hospital of Oakland Research Institute (CHORI) [U42RR024244]; NATIONAL EYE INSTITUTE [P30EY016665, R01EY021376] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Core Grant for Vision Research - National Eye Institute, NIH; University of Wisconsin Carbone Cancer Center - Cancer Center Support Grant from the National Cancer Institute, NIH; Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Oakland Research Institute (CHORI); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by Grant EY021376 from the National Eye Institute, National Institutes of Health (NIH) (nei.nih.gov) to CAB. Portions of this study utilized shared resources supported by the Core Grant for Vision Research funded by the National Eye Institute, NIH, to the University of Wisconsin-Madison (P30 EY016665) and the University of Wisconsin Carbone Cancer Center, funded by Cancer Center Support Grant P30 CA014520 from the National Cancer Institute, NIH (www.cancer.gov). The authors thank the Wellcome Trust Sanger Institute Mouse Genetics Project, supported by the Wellcome Trust (www.wellcome.ac.uk). NIH grants to Velocigene at Regeneron Inc (U01HG004085) and the CSD Consortium (U01HG004080) funded the generation of gene-targeted ES cells for 8500 genes in the KOMP Program and archived and distributed by the KOMP Repository at UC Davis and Children's Hospital of Oakland Research Institute (CHORI) (U42RR024244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiguzel E, 2006, ARTERIOSCL THROM VAS, V26, P56, DOI 10.1161/01.ATV.0000194155.96456.b7; Aldave AJ, 2013, CLIN GENET, V84, P109, DOI 10.1111/cge.12191; Aldave AJ, 2007, AM J MED GENET A, V143A, P2549, DOI 10.1002/ajmg.a.31978; Aldave AJ, 2013, JAMA OPHTHALMOL, V131, P1583, DOI 10.1001/jamaophthalmol.2013.5036; Aldave AJ, 2009, CORNEA, V28, P801, DOI 10.1097/ICO.0b013e31819672fb; Anderson NJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P624; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Brandt JD, 1999, OPHTHALMOLOGY; Brigid H, 1994, MANIPULATING MOUSE E; CIBIS GW, 1977, ARCH OPHTHALMOL-CHIC, V95, P1529; Cockerham GC, 2002, CORNEA, V21, P787, DOI 10.1097/00003226-200211000-00012; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davidson AE, 2016, AM J HUM GENET, V98, P75, DOI 10.1016/j.ajhg.2015.11.018; Evans CJ, 2015, ANN HUM GENET, V79, P1, DOI 10.1111/ahg.12090; Gheldof A, 2012, CELL MOL LIFE SCI, V69, P2527, DOI 10.1007/s00018-012-0935-3; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Harewood L, 2014, HUM MOL GENET, V23, pR76, DOI 10.1093/hmg/ddu278; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Hickner Paul V., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-358; Hopfer U, 2005, FASEB J, V19, P1232, DOI 10.1096/fj.04-3019com; Howell DN, 1997, INVEST OPHTH VIS SCI, V38, P1896; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Lai IN, 2010, MOL VIS, V16, P2829; Liskova P, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9495; Liskova P, 2013, JAMA OPHTHALMOL, V131, P1296, DOI 10.1001/jamaophthalmol.2013.405; Liskova P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045495; Liu YQ, 2008, INVEST OPHTH VIS SCI, V49, P1843, DOI 10.1167/iovs.07-0789; Luo MZ, 2003, METH MOL B, V236, P3; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Schmedt T, 2012, EXP EYE RES, V95, P24, DOI 10.1016/j.exer.2011.08.002; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Suganuma T, 2010, CELL, V142, P726, DOI 10.1016/j.cell.2010.07.045; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Williams M, 2002, ENVIRON MOL MUTAGEN, V39, P22, DOI 10.1002/em.10040; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	42	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157577	10.1371/journal.pone.0157577	http://dx.doi.org/10.1371/journal.pone.0157577			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310661	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800101
J	Shuman, SJ; Falb, KL; Cardoso, LF; Cole, H; Kpebo, D; Gupta, J				Shuman, Sara J.; Falb, Kathryn L.; Cardoso, Lauren F.; Cole, Heather; Kpebo, Denise; Gupta, Jhumka			Perceptions and Experiences of Intimate Partner Violence in Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							POLITICAL VIOLENCE; WOMEN; INTERVENTION; EXPOSURE	Background Men and women's perceptions of intimate partner violence (IPV) within crisis-affected populations are not well understood. This mixed-methods study examined the frequency of IPV against women in urban Cote d'Ivoire, and qualitatively explored how men and women perceive the impact of various forms of IPV on health, everyday activities, and feelings of shame. Methods A survey was administered to Ivorian women (N = 80) to measure the frequency of IPV, and ten focus group discussions were conducted with women (n = 46) and men (n = 45) to explore perceptions of different forms of IPV, including its impacts on disruptions to health, everyday activities, and experiences of shame. Results Half of all surveyed women (53.6%) reported past year exposure to physical, sexual, or emotional IPV. Of the multiple types of violence, emotional IPV was most common (46.4%), followed by sexual IPV (21.7%) and physical IPV (17.4%). Focus group participants identified additional forms of violence including economic IPV and community discrimination. Lack of financial resources and unemployment were common problems among crisis-affected women and were described as an underlying source of IPV. Both women and men reported that shame and stigma play a large role in how women experience the repercussions of IPV, regardless of the form of violence, with public episodes of IPV almost always seen as more detrimental than private episodes of IPV. Conclusions These results underscore the need for increased social support mechanisms for women to reduce the shame, stigma, and isolation associated with their experiences. The creation of safe and supportive spaces for women to talk about and challenge social norms may be an important first step in reducing community shaming and the secrecy that often surrounds IPV. Safe spaces along with broader societal outreach, including challenging men's social positions and creating opportunities for increasing economic resources can, in turn potentially decrease the frequency of IPV and its deleterious impacts on a woman's well-being	[Shuman, Sara J.] La Salle Univ, Sch Nursing & Hlth Sci, Philadelphia, PA 19141 USA; [Falb, Kathryn L.; Cole, Heather] Int Rescue Comm, New York, NY USA; [Cardoso, Lauren F.] Univ Penn, Sch Social Policy & Practice, Philadelphia, PA 19104 USA; [Kpebo, Denise] Innovat Poverty Act, Abidjan, Cote Ivoire; [Gupta, Jhumka] George Mason Univ, Coll Hlth & Human Serv, Dept Global & Community Hlth, Fairfax, VA 22030 USA	University of Pennsylvania; Innovations for Poverty Action (IPA); George Mason University	Shuman, SJ (corresponding author), La Salle Univ, Sch Nursing & Hlth Sci, Philadelphia, PA 19141 USA.	shumans@lasalle.edu			United States Institute for Peace	United States Institute for Peace	Project support was provided by United States Institute for Peace (http://www.usip.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; Annan J, 2010, SOC SCI MED, V70, P152, DOI 10.1016/j.socscimed.2009.09.027; Cardoso L., 2016, J LAT AM STUD, P1, DOI [10.1017/S0022216X16001978, DOI 10.1017/S0022216X16001978]; Charmaz K., 2008, HDB EMERGENT METHODS, P155, DOI DOI 10.1080/15332691.2013.779094; Clark CJ, 2010, LANCET, V375, P310, DOI 10.1016/S0140-6736(09)61827-4; Erickson A, 2015, PRIVATE VIOLENCE PUB; Falb K L, 2014, Health Educ Res, V29, P1015, DOI 10.1093/her/cyu058; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2013, PREVALENCE HLTH EFFE; Garcia-Moreno C., 2012, INTIMATE PARTNER VIO; Gupta J, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-46; Gupta J, 2009, AM J PUBLIC HEALTH, V99, P462, DOI 10.2105/AJPH.2007.120634; Horn Rebecca, 2014, Confl Health, V8, P12, DOI 10.1186/1752-1505-8-12; Hossain M, 2010, LIFE EXPERIENCES COT; Hossain M, 2010, VIOLENCE WOMEN MEN C; Hynes ME, 2015, GLOB PUBLIC HEALTH, P1; Kelly J, 2012, GLOB PUBLIC HEALTH, V7, P285, DOI 10.1080/17441692.2011.585344; Livelihoods Levron E., 2013, LIVELIHOODS GENDER I; Quinlan M., 2005, FIELD METHOD, V17, P219, DOI [10.1177/1525822X05277460, DOI 10.1177/1525822X05277460]; Stark L, 2011, TRAUMA VIOLENCE ABUS, V12, P127, DOI 10.1177/1524838011404252; Usta J, 2008, J WOMENS HEALTH, V17, P793, DOI 10.1089/jwh.2007.0602; Wells M, 2011, HUMAN RIGHTS WATCH	22	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157348	10.1371/journal.pone.0157348	http://dx.doi.org/10.1371/journal.pone.0157348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310143	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800058
J	Soderman, M; Rhedin, S; Tolfvenstam, T; Rotzen-Ostlund, M; Albert, J; Broliden, K; Lindblom, A				Soderman, Martina; Rhedin, Samuel; Tolfvenstam, Thomas; Rotzen-Ostlund, Maria; Albert, Jan; Broliden, Kristina; Lindblom, Anna			Frequent Respiratory Viral Infections in Children with Febrile Neutropenia - A Prospective Follow-Up Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CELL TRANSPLANT RECIPIENTS; RHINOVIRUS C INFECTIONS; ONCOLOGY PATIENTS; HUMAN BOCAVIRUS; US CHILDREN; VIRUSES; ILLNESS; CANCER; LEUKEMIA	Objective Febrile neutropenia is common in children undergoing chemotherapy for the treatment of malignancies. In the majority of cases, the cause of the fever is unknown. Although respiratory viruses are commonly associated with this condition, the etiologic significance of this finding remains unclear and is therefore the subject of this study. Study design Nasopharyngeal aspirates were collected during 87 episodes of febrile neutropenia in children age 0-18 years, being treated at a children's oncology unit between January 2013 and June 2014. Real-time polymerase chain reaction was used to determine the presence of 16 respiratory viruses. Follow-up samples were collected from children who tested positive for one or more respiratory viruses. Rhinoviruses were genotyped by VP4/ VP2 sequencing. Fisher's exact test and Mann-Whitney U test were used for group comparisons. Results At least one respiratory virus was detected in samples from 39 of 87 episodes of febrile neutropenia (45%), with rhinoviruses the most frequently detected. Follow-up samples were collected after a median of 28 days (range, 9-74 days) in 32 of the 39 virus-positive episodes. The respiratory viral infection had resolved in 25 episodes (78%). The same virus was detected at follow-up in one coronavirus and six rhinovirus episodes. Genotyping revealed a different rhinovirus species in two of the six rhinovirus infections. Conclusion The frequency of respiratory viral infections in this group of patients suggests an etiologic role in febrile neutropenia. However, these findings must be confirmed in larger patient cohorts.	[Soderman, Martina; Rhedin, Samuel; Tolfvenstam, Thomas; Broliden, Kristina; Lindblom, Anna] Karolinska Inst, Ctr Mol Med, Infect Dis Unit, Dept Med Solna, Stockholm, Sweden; [Soderman, Martina; Rhedin, Samuel; Tolfvenstam, Thomas; Broliden, Kristina; Lindblom, Anna] Karolinska Univ Hosp, Stockholm, Sweden; [Tolfvenstam, Thomas] Publ Hlth Agcy Sweden, Unit Highly Pathogen Viruses, Stockholm, Sweden; [Rotzen-Ostlund, Maria; Albert, Jan] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Rotzen-Ostlund, Maria; Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Lindblom, Anna] Karolinska Univ Hosp, Astrid Lindgrens Childrens Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Public Health Agency of Sweden; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Lindblom, A (corresponding author), Karolinska Inst, Ctr Mol Med, Infect Dis Unit, Dept Med Solna, Stockholm, Sweden.; Lindblom, A (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.; Lindblom, A (corresponding author), Karolinska Univ Hosp, Astrid Lindgrens Childrens Hosp, Stockholm, Sweden.	anna.lindblom@ki.se	Arthur Rhedin, Samuel/H-4653-2019	Arthur Rhedin, Samuel/0000-0001-5798-2875; Tolfvenstam, Thomas/0000-0003-3549-8083; Berggren, Anna/0000-0002-4012-699X	Swedish Children's Cancer Foundation; Swedish Society of Medicine	Swedish Children's Cancer Foundation; Swedish Society of Medicine	This study was supported financially by grants from the Swedish Children's Cancer Foundation (barncancerfonden.se) and the Swedish Society of Medicine (http://www.sls.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper CM, 2008, J CLIN VIROL, V43, P120, DOI 10.1016/j.jcv.2008.04.008; Averbuch D, 2013, HAEMATOLOGICA, V98, P1826, DOI 10.3324/haematol.2013.091025; Castagnola E, 2007, CLIN INFECT DIS, V45, P1296, DOI 10.1086/522533; Chemaly RF, 2014, CLIN INFECT DIS, V59, pS344, DOI 10.1093/cid/ciu623; Cheng S, 2011, BRIT J CANCER, V105, P606, DOI 10.1038/bjc.2011.213; Dotan A, 2014, J PEDIAT HEMATOL ONC, V36, pE271, DOI 10.1097/MPH.0000000000000043; Dyrdak R, 2015, INFECT DIS LONDON EN, P1; El-Mahallawy HA, 2011, PEDIATR BLOOD CANCER, V57, P283, DOI 10.1002/pbc.22926; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALL CB, 1986, NEW ENGL J MED, V315, P77, DOI 10.1056/NEJM198607103150201; Iwane MK, 2011, J INFECT DIS, V204, P1702, DOI 10.1093/infdis/jir634; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Johnston DL, 2013, MYCOSES, V56, P482, DOI 10.1111/myc.12063; Kobayashi R, 2008, J PEDIAT HEMATOL ONC, V30, P886, DOI 10.1097/MPH.0b013e3181864a80; Koskenvuo M, 2008, PEDIATR INFECT DIS J, V27, P974, DOI 10.1097/INF.0b013e31817b0799; Koskenvuo M, 2008, EUR J PEDIATR, V167, P1011, DOI 10.1007/s00431-007-0631-8; Lindblom A, 2010, J CLIN VIROL, V47, P234, DOI 10.1016/j.jcv.2009.11.026; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; Loeffelholz MJ, 2014, PEDIATRICS, V134, P1144, DOI 10.1542/peds.2014-2132; Loria C, 2015, PEDIATR TRANSPLANT, V19, P94, DOI 10.1111/petr.12383; Lv H, 2013, EXP THER MED, V5, P201, DOI 10.3892/etm.2012.738; Martin ET, 2013, J INFECT DIS, V207, P982, DOI 10.1093/infdis/jis934; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Paulus SC, 2005, EUR J CANCER, V41, P2132, DOI 10.1016/j.ejca.2005.04.037; Peck AJ, 2007, BLOOD, V110, P1681, DOI 10.1182/blood-2006-12-060343; Rhedin S, 2014, PEDIATRICS, V133, pE538, DOI 10.1542/peds.2013-3042; Schenk T, 2011, PEDIATR INFECT DIS J, V30, P82, DOI 10.1097/INF.0b013e3181f12fcf; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Suryadevara M, 2012, CLIN PEDIATR, V51, P1164, DOI 10.1177/0009922812456736; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; Torres JP, 2012, PEDIATR INFECT DIS J, V31, P889, DOI 10.1097/INF.0b013e31825c4b7e; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; Wisdom A, 2009, J CLIN MICROBIOL, V47, P3958, DOI 10.1128/JCM.00993-09; Xiang ZC, 2010, J CLIN VIROL, V49, P94, DOI 10.1016/j.jcv.2010.07.013	37	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157398	10.1371/journal.pone.0157398	http://dx.doi.org/10.1371/journal.pone.0157398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309354	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800066
J	Wen, Z; Zhang, J; Li, JL; Dai, JK; Lin, FC; Wu, GY				Wen, Zhi; Zhang, Jie; Li, Jielan; Dai, Jiankun; Lin, Fuchun; Wu, Guangyao			Altered Activation in Cerebellum Contralateral to Unilateral Thalamotomy May Mediate Tremor Suppression in Parkinson's Disease: A Short-Term Regional Homogeneity fMRI Study	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; THALAMIC-STIMULATION; FEATURES	Background Ventral intermediate nucleus thalamotomy is an effective treatment for Parkinson's disease tremor. However, its mechanism is still unclear. Purpose We used resting-state fMRI to investigate short-term ReHo changes after unilateral thalamotomy in tremor-dominant PD, and to speculate about its possible mechanism on tremor suppression. Methods 26 patients and 31 healthy subjects (HS) were recruited. Patients were divided into two groups according to right- (rPD) and left-side (IPD) thalamotomy. Tremor was assessed using the 7-item scale from the Unified Parkinson's disease rating scale motor score (mUPDRS). Patients were scanned using resting state fMRI after 12h withdrawal of medication, both preoperatively (PDpre) and 7-day postoperatively (PDpost), whereas healthy subjects were scanned once. The regions associated with tremor and altered ReHo due to thalamic ablation were examined. Results The impact of unilateral VIM thalamotomy was characterized in the frontal, parietal, temporal regions, basal ganglia, thalamus, and cerebellum. Compared with PDpre, significantly reduced ReHo was found in the left cerebellum in patients with rPD(post), and slightly decreased ReHo in the cerebellum vermis in patients with IPDpost, which was significantly higher than HS. We demonstrated a positive correlation between the ReHo values in the cerebellum ( in rPD, peak coordinate [-12, -54, -21], R = 0.64, P = 0.0025, and peak coordinate [-9, -54, -18], R = 0.71, P = 0.0025; in IPD, peak coordinate [ 3, -45, -15], R = 0.71, P = 0.004) in the pre-surgical condition, changes of ReHo induced by thalamotomy ( in rPD, R = 0.63, P = 0.021, R = 0.6, P = 0.009; in IPD, R = 0.58, P = 0.028) and tremor scores contralateral to the surgical side, respectively. Conclusion The specific area that may be associated with PD tremor and altered ReHo due to thalamic ablation is the cerebellum. The neural basis underlying thalamotomy is complex; cerebellum involvement is far beyond cerebello-thalamic tract breakage.	[Wen, Zhi; Li, Jielan; Wu, Guangyao] Wuhan Univ, Zhongnan Hosp, Dept Magnet Resonance Imaging, Wuhan 430072, Hubei, Peoples R China; [Zhang, Jie] Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Wuhan 430072, Hubei, Peoples R China; [Dai, Jiankun; Lin, Fuchun] Chinese Acad Sci, Wuhan Inst Phys & Math, Key State Lab Atom & Mol Phys, Natl Ctr Magnet Resonance, Wuhan, Hubei, Peoples R China; [Dai, Jiankun] Univ Chinese Acad Sci, Beijing, Peoples R China	Wuhan University; Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, GY (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Magnet Resonance Imaging, Wuhan 430072, Hubei, Peoples R China.; Zhang, J (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Wuhan 430072, Hubei, Peoples R China.	zhangjie8790@163.com; wuguangy2002@163.com	Lin, Fuchun/D-2371-2012; Lin, Fuchun/M-2789-2019	Lin, Fuchun/0000-0002-2282-6474; Lin, Fuchun/0000-0002-2282-6474; Wen, Zhi/0000-0003-2946-3650; dai, jiankun/0000-0002-2461-6737; Wu, Guangyao/0000-0002-0456-3682	National Science Fund of China [81171315]	National Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Fund of China (http://www.nsfc.gov.cn/) Grant Nos. 81171315 to GW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Science Fund of China (Grant Nos. 81171315 to Guangyao Wu).	Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; DEIBER MP, 1993, BRAIN, V116, P267, DOI 10.1093/brain/116.1.267; Duval C, 2016, NEUROBIOL DIS, V85, P49, DOI 10.1016/j.nbd.2015.10.009; Dwarakanath S, 2014, CLIN NEUROL NEUROSUR, V125, P131, DOI 10.1016/j.clineuro.2014.07.016; Fukuda M, 2004, NEUROIMAGE, V21, P608, DOI 10.1016/j.neuroimage.2003.09.068; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Hassler R., 1959, INTRO STEREOTAXIS AT, P230; Helmich RC, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0378-8; Helmich RC, 2012, BRAIN, V135, P3206, DOI 10.1093/brain/aws023; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; Herz DM, 2014, HUM BRAIN MAPP, V35, P3227, DOI 10.1002/hbm.22397; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jiang L, 2015, NEUROSCIENTIST REV J, DOI [10.1177/1073858415595004, DOI 10.1177/1073858415595004]; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Mure H, 2011, NEUROIMAGE, V54, P1244, DOI 10.1016/j.neuroimage.2010.09.028; Prodoehl J, 2013, JAMA NEUROL, V70, P100, DOI 10.1001/jamaneurol.2013.582; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tahmasian M, 2015, CORTEX, V73, P80, DOI 10.1016/j.cortex.2015.08.005; Tessitore A, 2012, NEUROLOGY, V79, P2226, DOI 10.1212/WNL.0b013e31827689d6; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DL, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00006; Zhang JQ, 2015, PARKINSONISM RELAT D, V21, P23, DOI 10.1016/j.parkreldis.2014.10.017; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	30	5	5	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157562	10.1371/journal.pone.0157562	http://dx.doi.org/10.1371/journal.pone.0157562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310133	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800097
J	Kim, J; Jones, CAR; Groves, NS; Sun, B				Kim, Jihan; Jones, Christopher A. R.; Groves, Nicholas Scott; Sun, Bo			Three-Dimensional Reflectance Traction Microscopy	PLOS ONE			English	Article							CELLS; MATRIX; MICROMECHANICS; INVASION; STRESSES; ROLES	Cells in three-dimensional (3D) environments exhibit very different biochemical and biophysical phenotypes compared to the behavior of cells in two-dimensional (2D) environments. As an important biomechanical measurement, 2D traction force microscopy can not be directly extended into 3D cases. In order to quantitatively characterize the contraction field, we have developed 3D reflectance traction microscopy which combines confocal reflection imaging and partial volume correlation postprocessing. We have measured the deformation field of collagen gel under controlled mechanical stress. We have also characterized the deformation field generated by invasive breast cancer cells of different morphologies in 3D collagen matrix. In contrast to employ dispersed tracing particles or fluorescently-tagged matrix proteins, our methods provide a label-free, computationally effective strategy to study the cell mechanics in native 3D extracellular matrix.	[Kim, Jihan; Jones, Christopher A. R.; Groves, Nicholas Scott; Sun, Bo] Oregon State Univ, Dept Phys, Corvallis, OR 97331 USA	Oregon State University	Sun, B (corresponding author), Oregon State Univ, Dept Phys, Corvallis, OR 97331 USA.	sunb@physics.oregonstate.edu	Kim, Jihan/AAE-6280-2021					Arevalo RC, 2010, BIOPHYS J, V99, pL65, DOI 10.1016/j.bpj.2010.08.008; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Bar-Kochba E, 2015, EXP MECH, V55, P261, DOI 10.1007/s11340-014-9874-2; Bashour KT, 2014, P NATL ACAD SCI USA, V111, P2241, DOI 10.1073/pnas.1315606111; Brightman AO, 2000, BIOPOLYMERS, V54, P222; Brown RA, 2013, EXP CELL RES, V319, P2460, DOI 10.1016/j.yexcr.2013.07.001; Brugues A, 2014, NAT PHYS, V10, P684, DOI [10.1038/nphys3040, 10.1038/NPHYS3040]; Delanoe-Ayari H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248103; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Elson E. L., 1999, P299; Franck C, 2007, EXP MECH, V47, P427, DOI 10.1007/s11340-007-9037-9; Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114; Garcia D, 2011, EXP FLUIDS, V50, P1247, DOI 10.1007/s00348-010-0985-y; Garcia D, 2010, COMPUT STAT DATA AN, V54, P1167, DOI 10.1016/j.csda.2009.09.020; Gjorevski N, 2012, BIOPHYS J, V103, P152, DOI 10.1016/j.bpj.2012.05.048; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; HOPWOOD D, 1995, GUT, V37, P598, DOI 10.1136/gut.37.5.598; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Huang H, 1997, MEAS SCI TECHNOL, V8, P1427, DOI 10.1088/0957-0233/8/12/007; Jannat RA, 2011, BIOPHYS J, V101, P575, DOI 10.1016/j.bpj.2011.05.040; Jawerth LM, 2010, BIOPHYS J, V98, pL1, DOI 10.1016/j.bpj.2009.09.065; Jones CAR, 2015, P NATL ACAD SCI USA, V112, pE5117, DOI 10.1073/pnas.1509663112; Jones CAR, 2014, SOFT MATTER, V10, P8855, DOI 10.1039/c4sm01772b; KEANE RD, 1992, APPL SCI RES, V49, P191, DOI 10.1007/BF00384623; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; Lang NR, 2013, BIOPHYS J, V105, P1967, DOI 10.1016/j.bpj.2013.09.038; Legant WR, 2013, P NATL ACAD SCI USA, V110, P881, DOI 10.1073/pnas.1207997110; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Li B, 2011, J TISSUE VIABILITY, V20, P108, DOI 10.1016/j.jtv.2009.11.004; Lombardi ML, 2007, J CELL SCI, V120, P1624, DOI 10.1242/jcs.002527; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; Notbohm J, 2015, INTEGR BIOL-UK, V7, P1186, DOI 10.1039/c5ib00013k; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Petrie RJ, 2013, J CELL SCI, V125, P1; Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; Rajadhyaksha M, 1999, J INVEST DERMATOL, V113, P293, DOI 10.1046/j.1523-1747.1999.00690.x; Roesgen T, 2003, EXP FLUIDS, V35, P252, DOI 10.1007/s00348-003-0627-8; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332; Steinwachs J, 2016, NAT METHODS, V13, P171, DOI [10.1038/NMETH.3685, 10.1038/nmeth.3685]; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Thielicke W., 2014, J OPEN RES STW, V2, P30, DOI [10.5334/JORS.BL, DOI 10.5334/JORS.BL]; Thievessen I, 2015, FASEB J, V14; Toyjanova J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090976; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109	50	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156797	10.1371/journal.pone.0156797	http://dx.doi.org/10.1371/journal.pone.0156797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304456	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800022
J	Thompson, GN; McArthur, J; Doupe, M				Thompson, Genevieve N.; McArthur, Jennifer; Doupe, Malcolm			Identifying Markers of Dignity-Conserving Care in Long-Term Care: A Modified Delphi Study	PLOS ONE			English	Article							QUALITY INDICATORS; HEALTH-CARE; PALLIATIVE CARE; OLDER-PEOPLE; CAREGIVERS; PERCEPTIONS; RESIDENTS; AUTONOMY; FAMILY; EXPERIENCES	Ensuring that people living in nursing homes (NHs) are afforded with dignity in their daily lives is an essential and humane concern. Promoting dignity-conserving care is fundamentally important. By nature, however, this care is all-encompassing and holistic, and from current knowledge it is challenging to create explicit strategies for measuring dignity-conserving care. In practice the majority of current NH indicators of quality care are derived from information that is routinely collected on NH residents using the RAI-Minimum Data Set (MDS). In this regard, issues that are more tangible to resident dignity such as being treated with respect, compassion, and having opportunities to engage with others are not adequately captured in current NH quality of care indicators. An initial set of markers was created by conducting an integrative literature review of existing markers and indicators of dignity in the NH setting. A modified Delphi process was used to prioritize essential dignity-conserving care markers for use by NH providers, based on factors such as the importance to fostering a culture of dignity, the impact it may have on the residents, and how achievable it is in practice. Through this consensus building technique, we were able to develop a comprehensive set of markers that capture the range and diversity of important dignity-conserving care strategies for use in NHs. The final 10 markers were judged as having high face validity by experts in the field and have explicit implications for enhancing the provision of daily dignified care to NH residents. These markers make an important addition to the traditional quality indicators used in the NH setting and as such, bridge an important gap in addressing the psychosocial and the less easily quantified needs of NH residents.	[Thompson, Genevieve N.] Univ Manitoba, Rady Fac Hlth Sci, Coll Nursing, Winnipeg, MB, Canada; [Thompson, Genevieve N.] CancerCare Manitoba, Manitoba Palliat Care Res Unit, Winnipeg, MB, Canada; [McArthur, Jennifer] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Doupe, Malcolm] Univ Manitoba, Rady Fac Hlth Sci, Coll Med, Winnipeg, MB, Canada	University of Manitoba; CancerCare Manitoba Foundation; University of Alberta; University of Manitoba	Thompson, GN (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Coll Nursing, Winnipeg, MB, Canada.; Thompson, GN (corresponding author), CancerCare Manitoba, Manitoba Palliat Care Res Unit, Winnipeg, MB, Canada.	Genevieve.thompson@umanitoba.ca		Thompson, Genevieve/0000-0003-2558-9926	Government of Manitoba	Government of Manitoba	This project was funded by the Government of Manitoba. There is no funding number allocated for this project as it was done by contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg P, 2007, J ADV NURS, V59, P635, DOI 10.1111/j.1365-2648.2007.04375.x; Asselin M, 2014, J NURSES PROF DEV, V30, P11, DOI 10.1097/01.NND.0000434028.30432.34; Boisaubin EV, 2007, J MED PHILOS, V32, P447, DOI 10.1080/03605310701626414; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Campbell SM, 1999, MED CARE, V37, P964, DOI 10.1097/00005650-199909000-00012; Carinci F, 2015, INT J QUAL HEALTH C, V27, P137, DOI 10.1093/intqhc/mzv004; Chochinov Harvey Max, 2005, J Palliat Med, V8 Suppl 1, pS103; Chochinov HM, 2002, JAMA-J AM MED ASSOC, V287, P2253, DOI 10.1001/jama.287.17.2253; Chochinov HM, 2004, J CLIN ONCOL, V22, P1336, DOI 10.1200/JCO.2004.12.095; Coventry ML, 2006, J GERONTOL NURS, V32, P42, DOI 10.3928/00989134-20060501-08; Doupe M, 2012, JAMDA, V12, P467; Dwyer LL, 2009, INT J OLDER PEOPLE N, V4, P185, DOI 10.1111/j.1748-3743.2008.00153.x; Enes SPD, 2003, PALLIATIVE MED, V17, P263, DOI 10.1191/0269216303pm699oa; Franklin LL, 2006, NURS ETHICS, V13, P130, DOI 10.1191/0969733006ne851oa; Gallagher A, 2004, NURS ETHICS, V11, P587, DOI 10.1191/0969733004ne744oa; Gallagher A, 2008, BMC NURS, V7, DOI 10.1186/1472-6955-7-11; Haddock J, 1996, J ADV NURS, V24, P924, DOI 10.1111/j.1365-2648.1996.tb02927.x; Hall S, 2009, AGE AGEING, V38, P411, DOI 10.1093/ageing/afp069; Heggestad AKT, 2013, NURS ETHICS, V20, P881, DOI 10.1177/0969733013484484; Jacelon CS, 2004, J ADV NURS, V48, P76, DOI 10.1111/j.1365-2648.2004.03170.x; Jacobson N, 2009, QUAL HEALTH RES, V19, P1536, DOI 10.1177/1049732309349809; Johnstone DE, 2012, CAN J CARDIOL, V28, P599, DOI 10.1016/j.cjca.2012.01.024; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Keeney S, 2001, INT J NURS STUD, V38, P195, DOI 10.1016/S0020-7489(00)00044-4; Lin YP, 2013, NURS ETHICS, V20, P168, DOI 10.1177/0969733012458609; Lobchuk MM, 2007, J PAIN SYMPTOM MANAG, V33, P130, DOI 10.1016/j.jpainsymman.2006.07.015; Lothian K, 2001, BRIT MED J, V322, P668, DOI 10.1136/bmj.322.7287.668; Magee H., 2008, MEASURING DIGNITY CA; McClement SE, 2006, TXB PALLIATIVE MED, P100; McClement Susan E, 2004, Int J Palliat Nurs, V10, P173; Naden D, 2013, NURS ETHICS, V20, P748, DOI 10.1177/0969733012475253; Nekolaichuk Cheryl L, 2004, Palliat Support Care, V2, P243; Oosterveld-Vlug MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073822; Oosterveld-Vlug MG, 2014, J ADV NURS, V70, P97, DOI 10.1111/jan.12171; Periyakoil VS, 2013, J AM GERIATR SOC, V61, P440, DOI 10.1111/jgs.12145; Pleschberger S, AGE AGEING, V36, P197; Proulx Kathryn, 2004, Am J Hosp Palliat Care, V21, P116, DOI 10.1177/104990910402100209; Puchalski CM, 2014, J PALLIAT MED, V17, P105, DOI [10.1089/jpm.2014.9427, 10.1089/jpm.2013.9458]; Pullman D, 2004, J PALLIAT CARE, V20, P171, DOI 10.1177/082585970402000309; Shaw KL, 2014, PALLIATIVE MED, V28, P501, DOI 10.1177/0269216314521852; Zhai X, 2007, J MED PHILOS, V32, P425, DOI 10.1080/03605310701631695	42	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156816	10.1371/journal.pone.0156816	http://dx.doi.org/10.1371/journal.pone.0156816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5LO	27304853	Green Submitted, Green Published, gold			2022-12-27	WOS:000377824800024
J	Gandley, RE; Althouse, A; Jeyabalan, A; Bregand-White, JM; McGonigal, S; Myerski, AC; Gallaher, M; Powers, RW; Hubel, CA				Gandley, Robin E.; Althouse, Andrew; Jeyabalan, Arundhathi; Bregand-White, Julia M.; McGonigal, Stacy; Myerski, Ashley C.; Gallaher, Marcia; Powers, Robert W.; Hubel, Carl A.			Low Soluble Syndecan-1 Precedes Preeclampsia	PLOS ONE			English	Article							ENDOTHELIAL GLYCOCALYX; VASCULAR-PERMEABILITY; PLACENTAL SYNDECAN-1; EXPRESSION; PREGNANCY; COMPONENTS	Introduction Syndecan-1 (Sdc1; CD138) is a major transmembrane heparan sulfate proteoglycan expressed on the extracellular, luminal surface of epithelial cells and syncytiotrophoblast, thus comprising a major component of the glycocalyx of these cells. The "soluble" (shed) form of Sdc1 has paracrine and autocrine functions and is normally produced in a regulated fashion. We compared plasma soluble Sdc1 concentrations, in relation to placental Sdc1 expression, in uncomplicated (control) and preeclamptic pregnancies. Methods We evaluated soluble Sdc1 across uncomplicated pregnancy, and between preeclamptic, gestational hypertensive and control patients at mid-pregnancy (20 weeks) and 3rd trimester by ELISA. Placental expression level of Sdc1 was compared between groups in relation to pre-delivery plasma soluble Sdc1. Participants were recruited from Magee-Womens Hospital. Results In uncomplicated pregnancy, plasma soluble Sdc1 rose significantly in the 1st trimester, and reached an approximate 50-fold increase at term compared to post pregnancy levels. Soluble Sdc1 was lower at mid-pregnancy in women who later developed preeclampsia (P<0.05), but not gestational hypertension, compared to controls, and remained lower at late pregnancy in preeclampsia (P<0.01) compared to controls. Sdc1 was prominently expressed on syncytiotrophoblast of microvilli. Syncytiotrophoblast Sdc1 immunostaining intensities, and mRNA content in villous homogenates, were lower in preeclampsia vs. controls (P<0.05). Soluble Sdc1 and Sdc1 immunostaining scores were inversely associated with systolic blood pressures, and positively correlated with infant birth weight percentile. Conclusion Soluble Sdc1 is significantly lower before the clinical onset of preeclampsia, with reduced expression of Sdc1 in the delivered placenta, suggesting a role for glycocalyx disturbance in preeclampsia pathophysiology.	[Gandley, Robin E.; Althouse, Andrew; Jeyabalan, Arundhathi; McGonigal, Stacy; Myerski, Ashley C.; Gallaher, Marcia; Powers, Robert W.] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA USA; [Gandley, Robin E.; Jeyabalan, Arundhathi; Bregand-White, Julia M.; Powers, Robert W.; Hubel, Carl A.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, Pittsburgh, PA USA; [Jeyabalan, Arundhathi] Univ Pittsburgh, Clin & Translat Res Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hubel, CA (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, Pittsburgh, PA USA.	chubel@mwri.magee.edu	Althouse, Andrew/AAF-4836-2019; Althouse, Andrew/AAF-5053-2019	Althouse, Andrew/0000-0002-8654-5014	State of Pennsylvania Health Research Formula Fund; National Institutes of Health [R21HD083659, P01HD030367, UL1RR024153, UL1TR000005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD030367, R21HD083659] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	State of Pennsylvania Health Research Formula Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by the State of Pennsylvania Health Research Formula Fund (CAH) (portal.state.pa.us), and National Institutes of Health Grants R21HD083659 (REG and CAH), P01HD030367 (CAH, REG, AJ, SM, ACM, RWP), and UL1RR024153 and UL1TR000005 (University of Pittsburgh Clinical and Translational Science Institute)(nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annecke T, 2011, BRIT J ANAESTH, V107, P679, DOI 10.1093/bja/aer269; Becker BF, 2015, BRIT J CLIN PHARMACO, V80, P389, DOI 10.1111/bcp.12629; Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; BRADBURY S, 1970, Histochemical Journal, V2, P263, DOI 10.1007/BF01004995; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Burke-Gaffney A, 2012, CRIT CARE, V16, DOI 10.1186/cc11239; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; CHESLEY LC, 1980, KIDNEY INT, V18, P234, DOI 10.1038/ki.1980.131; Chui A, 2012, GYNECOL OBSTET INVES, V73, P277, DOI 10.1159/000333262; Chui A, 2012, AM J PATHOL, V180, P693, DOI 10.1016/j.ajpath.2011.10.023; Crescimanno C, 1999, J PATHOL, V189, P600; Deng YP, 2012, HEPATOLOGY, V55, P277, DOI 10.1002/hep.24626; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gunatillake T, 2013, J GLYCOBIOL, V2, P105, DOI [10.4172/2168-958X.1000105, DOI 10.4172/2168-958X.1000105]; Heyer-Chauhan N, 2014, J PERINAT MED, V42, P329, DOI 10.1515/jpm-2013-0097; Hofmann-Kiefer KF, 2013, REPROD SCI, V20, P1237, DOI 10.1177/1933719113483011; Hofmann-Kiefer KF, 2013, REPROD SCI, V20, P318, DOI 10.1177/1933719112453508; Jansson Thomas, 2009, Curr Vasc Pharmacol, V7, P521; Jeyabalan A, 2008, AM J HYPERTENS, V21, P943, DOI 10.1038/ajh.2008.219; Jokimaa V, 1998, PLACENTA, V19, P157, DOI 10.1016/S0143-4004(98)90004-2; Jokimaa VIS, 2000, AM J OBSTET GYNECOL, V183, P1495, DOI 10.1067/mob.2000.107320; Lamorte S, 2012, LEUKEMIA, V26, P1081, DOI 10.1038/leu.2011.290; Lanoix D, 2012, PLACENTA, V33, P151, DOI 10.1016/j.placenta.2011.12.008; Lemkes BA, 2012, DIABETES TECHNOL THE, V14, pS3, DOI 10.1089/dia.2012.0011; Leonova EI, 2015, ADV EXPT MED BIOL, P241; Maksimenko AV, 2012, BIOCH RES INT, V2012, P1; Manon-Jensen T, 2013, FEBS J, V280, P2320, DOI 10.1111/febs.12174; Maynard SE, 2005, PEDIATR RES, V57, p1R, DOI 10.1203/01.PDR.0000159567.85157.B7; NELSON DM, 1976, ANAT REC, V184, P159, DOI 10.1002/ar.1091840204; Nussbaum C, 2014, J PEDIATR-US, V164, P584, DOI 10.1016/j.jpeds.2013.11.016; Redman CWG, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.003; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Sallisalmi M, 2012, ACTA ANAESTH SCAND, V56, P316, DOI 10.1111/j.1399-6576.2011.02578.x; Sela S, 2011, CIRC RES, V108, P1063, DOI 10.1161/CIRCRESAHA.110.239665; Shi SR, 2008, AM J CLIN PATHOL, V129, P358, DOI 10.1309/7CXUYXT23E5AL8KQ; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Stepp MA, 2015, ADV WOUND CARE, V4, P235, DOI 10.1089/wound.2014.0555; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Szabo S, 2013, VIRCHOWS ARCH, V463, P445, DOI 10.1007/s00428-013-1426-0; Tarbell JM, 2016, J INTERN MED, V280, P97, DOI 10.1111/joim.12465; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Weissgerber TL, 2014, J CLIN ENDOCR METAB, V99, P978, DOI 10.1210/jc.2013-3277	44	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157608	10.1371/journal.pone.0157608	http://dx.doi.org/10.1371/journal.pone.0157608			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299886	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200067
J	Zahn, D; Duchstein, P				Zahn, Dirk; Duchstein, Patrick			Multi-Scale Modelling of Deformation and Fracture in a Biomimetic Apatite-Protein Composite: Molecular-Scale Processes Lead to Resilience at the mu m-Scale	PLOS ONE			English	Article							COLLAGEN; SIMULATION	Fracture mechanisms of an enamel-like hydroxyapatite-collagen composite model are elaborated by means of molecular and coarse-grained dynamics simulation. Using fully atomistic models, we uncover molecular-scale plastic deformation and fracture processes initiated at the organic-inorganic interface. Furthermore, coarse-grained models are developed to investigate fracture patterns at the mu m-scale. At the meso-scale, micro-fractures are shown to reduce local stress and thus prevent material failure after loading beyond the elastic limit. On the basis of our multi-scale simulation approach, we provide a molecular scale rationalization of this phenomenon, which seems key to the resilience of hierarchical biominerals, including teeth and bone.	[Zahn, Dirk; Duchstein, Patrick] Univ Erlangen Nurnberg, Lehrstuhl Theoret Chem, Comp Chem Ctr, Nagelsbachstr 25, D-91052 Erlangen, Germany	University of Erlangen Nuremberg	Zahn, D (corresponding author), Univ Erlangen Nurnberg, Lehrstuhl Theoret Chem, Comp Chem Ctr, Nagelsbachstr 25, D-91052 Erlangen, Germany.	dirk.zahn@chemie.uni-erlangen.de	Duchstein, Patrick/H-3243-2017	Duchstein, Patrick/0000-0002-9925-8639; Zahn, Dirk/0000-0002-4303-3422	Deutsche Forschungsgemeinschaft [ZA 420-7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors gratefully acknowledge Deutsche Forschungsgemeinschaft for funding within the grant ZA 420-7. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almora-Barrios N, 2012, CRYST GROWTH DES, V12, P756, DOI 10.1021/cg201092s; Duchstein P, 2011, J MOL MODEL, V17, P73, DOI 10.1007/s00894-010-0707-7; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Fratzl P., 2008, COLLAGEN STRUCTURE M; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; He LH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2450649; He LH, 2007, J DENT, V35, P431, DOI 10.1016/j.jdent.2006.12.002; He LH, 2009, J BIOMED MATER RES A, V91A, P352, DOI 10.1002/jbm.a.32223; Kawska A, 2008, ANGEW CHEM, V120, P5060; Kniep R, 2008, ANGEW CHEM INT EDIT, V47, P1405, DOI 10.1002/anie.200702532; Kniep R, 2007, TOP CURR CHEM, V270, P73, DOI 10.1007/128_053; Nair AK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2720; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Zahn D, 2007, J MATER SCI, V42, P8966, DOI 10.1007/s10853-007-1586-x; Zahn D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093309; Zahn D, 2010, ANGEW CHEM INT EDIT, V49, P9405, DOI 10.1002/anie.201002663	16	2	2	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157241	10.1371/journal.pone.0157241	http://dx.doi.org/10.1371/journal.pone.0157241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300748	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200033
J	Brillante, L; Belfiore, N; Gaiotti, F; Lovat, L; Sansone, L; Poni, S; Tomasi, D				Brillante, Luca; Belfiore, Nicola; Gaiotti, Federica; Lovat, Lorenzo; Sansone, Luigi; Poni, Stefano; Tomasi, Diego			Comparing Kaolin and Pinolene to Improve Sustainable Grapevine Production during Drought	PLOS ONE			English	Article							WATER-USE EFFICIENCY; PARTICLE FILM TECHNOLOGY; LEAF; PHOTOSYNTHESIS; TEMPERATURE; STRESS; ANTITRANSPIRANT; ANTHOCYANINS; PHYSIOLOGY; RADIATION	Viticulture is widely practiced in dry regions, where the grapevine is greatly exposed to water stress. Optimizing plant water use efficiency (WUE) without affecting crop yield, grape and wine quality is crucial to limiting use of water for irrigation and to significantly improving viticulture sustainability. This study examines the use in vineyards of particle film technology (engineered kaolin) and compares it to a film-forming antitranspirant (pinolene), traditionally used to limit leaf water loss, and to an untreated control. The trial was carried out under field conditions over three growing seasons, during which moderate to very severe plant water stress (down to -1.9 MPa) was measured through stem water potential. Leaf stomatal conductance (g(s)) and photosynthesis rate (A(n)) were measured during the seasons and used to compute intrinsic WUE (WUEi, defined as A(n)/g(s) ratio). Leaf temperature was also recorded and compared between treatments. Bunch quantity, bunch and berry weight, sugar accumulation, anthocyanin and flavonoid contents were measured. Finally, microvinifications were performed and resultant wines subjected to sensory evaluation. Results showed that the use of kaolin increased grapevine intrinsic WUE (+18% on average as compared to unsprayed vines) without affecting berry and bunch weight and quantity, or sugar level. Anthocyanin content increased (+35%) in kaolin treatment, and the wine was judged more attractive (p-value < 0.05) and slightly more appreciated (p-value < 0.1) than control. Pinolene did not increase WUEi, limiting An more than gs; grapes with this treatment contained lower sugar and anthocyanin content than control, and the obtained wine was the least appreciated. This study demonstrates that particle film technology can improve vine WUEi and wine quality at the same time, while traditional antitranspirants were not as effective for these purposes. This positive effect can be used in interaction with other already-demonstrated uses of particle film technology, such as pest control and sunburn reduction, in order to achieve more sustainable vineyard management.	[Brillante, Luca; Belfiore, Nicola; Gaiotti, Federica; Lovat, Lorenzo; Sansone, Luigi; Tomasi, Diego] CREA VIT, Viticulture Res Ctr, Council Agr Res & Econ, Conegliano, Italy; [Poni, Stefano] Univ Cattolica Sacro Cuore, Dipartimento Sci Prod Vegetali Sostenibili, Piacenza, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Catholic University of the Sacred Heart	Brillante, L (corresponding author), CREA VIT, Viticulture Res Ctr, Council Agr Res & Econ, Conegliano, Italy.	brillanteluca@live.it	Brillante, Luca/T-1825-2018	Brillante, Luca/0000-0002-5747-6312; Sansone, Luigi/0000-0002-5941-7746				Bates FJ, 1942, 440 NBS; Boari F, 2015, AGR WATER MANAGE, V147, P154, DOI 10.1016/j.agwat.2014.07.014; Bodner G, 2015, AGRON SUSTAIN DEV, V35, P401, DOI 10.1007/s13593-015-0283-4; Bucchetti B, 2011, SCI HORTIC-AMSTERDAM, V128, P297, DOI 10.1016/j.scienta.2011.02.003; Cantore V, 2009, ENVIRON EXP BOT, V66, P279, DOI 10.1016/j.envexpbot.2009.03.008; Chone X, 2001, ANN BOT-LONDON, V87, P477, DOI 10.1006/anbo.2000.1361; Coniberti A, 2013, EUR J AGRON, V50, P75, DOI 10.1016/j.eja.2013.06.001; del Amor FM, 2010, J PLANT PHYSIOL, V167, P1232, DOI 10.1016/j.jplph.2010.04.010; Di Stefano R., 1991, Rivista di Viticoltura e di Enologia, V44, P37; Dinis LT, 2016, J PLANT PHYSIOL, V191, P45, DOI 10.1016/j.jplph.2015.12.005; EBELING W, 1971, ANNU REV ENTOMOL, V16, P123, DOI 10.1146/annurev.en.16.010171.001011; Evans RG, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006200; Flexas J, 2010, AUST J GRAPE WINE R, V16, P106, DOI 10.1111/j.1755-0238.2009.00057.x; Gacula M, 2006, J SENS STUD, V21, P129, DOI 10.1111/j.1745-459X.2006.00055.x; Glenn D. M., 2005, Horticultural Reviews, V31, P1, DOI 10.1002/9780470650882.ch1; Glenn DM, 2007, HORTSCIENCE, V42, P91, DOI 10.21273/HORTSCI.42.1.91; Glenn DM, 2012, HORTSCIENCE, V47, P710, DOI 10.21273/HORTSCI.47.6.710; Glenn DM, 2010, HORTSCIENCE, V45, P1178, DOI 10.21273/HORTSCI.45.8.1178; Glenn DM, 2009, J AM SOC HORTIC SCI, V134, P314, DOI 10.21273/JASHS.134.3.314; Glenn DM, 2001, J AM SOC HORTIC SCI, V126, P175, DOI 10.21273/JASHS.126.2.175; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; HARDIE WJ, 1976, AM J ENOL VITICULT, V27, P55; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Intrieri C, 2013, VITIS, V52, P117; Iriti M, 2009, ENVIRON EXP BOT, V66, P493, DOI 10.1016/j.envexpbot.2009.01.004; Jeong ST, 2004, PLANT SCI, V167, P247, DOI 10.1016/j.plantsci.2004.03.021; Jifon JL, 2003, J AM SOC HORTIC SCI, V128, P107, DOI 10.21273/JASHS.128.1.0107; Katerji N, 2008, EUR J AGRON, V28, P493, DOI 10.1016/j.eja.2007.12.003; Keller M, 2010, AUST J GRAPE WINE R, V16, P56, DOI 10.1111/j.1755-0238.2009.00077.x; Koyama K, 2008, J AM SOC HORTIC SCI, V133, P743, DOI 10.21273/JASHS.133.6.743; Lovisolo C, 2010, FUNCT PLANT BIOL, V37, P98, DOI 10.1071/FP09191; Medrano H, 2015, CROP J, V3, P220, DOI 10.1016/j.cj.2015.04.002; Medrano H, 2015, AGRON SUSTAIN DEV, V35, P499, DOI 10.1007/s13593-014-0280-z; Medrano H, 2010, METHODOLOGIES AND RESULTS IN GRAPEVINE RESEARCH, P123, DOI 10.1007/978-90-481-9283-0_9; Merli MC, 2015, FUNCT PLANT BIOL, V42, P198, DOI 10.1071/FP14112; MOFTAH AE, 2005, AGR SCI, V18, P35; Mori K, 2007, J EXP BOT, V58, P1935, DOI 10.1093/jxb/erm055; Palliotti A, 2010, AUST J GRAPE WINE R, V16, P426, DOI 10.1111/j.1755-0238.2010.00103.x; Palliotti A, 2014, SCI HORTIC-AMSTERDAM, V178, P43, DOI 10.1016/j.scienta.2014.07.039; Palliotti A, 2013, AM J ENOL VITICULT, V64, P378, DOI 10.5344/ajev.2013.13015; Pinheiro J., 2016, NLME LINEAR NONLINEA; R Core team, 2014, R LANG ENV STAT COMP; Rosati A, 2007, ANN BOT-LONDON, V99, P255, DOI 10.1093/aob/mcl252; Sekutowski D, 1998, U. S. Patent, Patent No. [5,908,708, 5908708]; Shellie K, 2015, AM J ENOL VITICULT, V66, P348, DOI 10.5344/ajev.2015.14121; Shellie KC, 2013, AM J ENOL VITICULT, V64, P214, DOI 10.5344/ajev.2013.12067; Spayd SE, 2002, AM J ENOL VITICULT, V53, P171; Steiman SR, 2007, HORTSCIENCE, V42, P1605, DOI 10.21273/HORTSCI.42.7.1605; Tomasi D, 2011, AM J ENOL VITICULT, V62, P329, DOI 10.5344/ajev.2011.10108; Tubajika KM, 2007, CROP PROT, V26, P92, DOI 10.1016/j.cropro.2006.04.006; Van Leeuwen C, 2009, J INT SCI VIGNE VIN, V43, P121; van Leeuwen C, 2010, METHODOLOGIES AND RESULTS IN GRAPEVINE RESEARCH, P87, DOI 10.1007/978-90-481-9283-0_7; Wallace JS, 2000, AGR ECOSYST ENVIRON, V82, P105, DOI 10.1016/S0167-8809(00)00220-6; Williams LE, 2012, IRRIGATION SCI, V30, P363, DOI 10.1007/s00271-012-0355-z; Williams LE, 2002, J AM SOC HORTIC SCI, V127, P448, DOI 10.21273/JASHS.127.3.448; World Water Assessment Programme, 2012, 4 WORLD WAT ASS PROG	56	69	70	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156631	10.1371/journal.pone.0156631	http://dx.doi.org/10.1371/journal.pone.0156631			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294368	Green Submitted, gold, Green Published			2022-12-27	WOS:000377821300008
J	Tan, TY; Dong, S; Huang, YW; Liu, J; Le, J; Liu, KP				Tan, Tianyuan; Dong, Shuan; Huang, Yingwei; Liu, Jian; Le, Jian; Liu, Kaipei			Improved Active Harmonic Current Elimination Based on Voltage Detection	PLOS ONE			English	Article								With the increasing penetration of power electronic equipment in modern residential distribution systems, harmonics mitigation through the distributed generation (DG) interfacing converters has received significant attention. Among recently proposed methods, the so-called active resonance damper (ARD) and harmonic voltage compensator (HVC) based on voltage detection can effectively reduce the harmonic distortions in selected areas of distribution systems. However, it is found out that when traditional ARD algorithm is used to eliminate harmonic current injected by non-linear loads, its performance is constrained by stability problems and can at most eliminate half of the load harmonic currents. Thus, inspired by the duality between ARD and HVC, this paper presents a novel improved resistive active power filter (R-APF) algorithm based on integral-decoupling control. The design guideline for its parameters is then investigated through carefully analyzing the closed-loop poles' trajectory. Computer studies demonstrate that the proposed algorithm can effectively mitigate the load harmonic currents and its performance is much better than traditional ARD based on proportional control.	[Tan, Tianyuan; Liu, Jian; Le, Jian; Liu, Kaipei] Wuhan Univ, Sch Elect Engn, Wuhan 430072, Hubei, Peoples R China; [Dong, Shuan; Huang, Yingwei] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V5Z 1M9, Canada; [Tan, Tianyuan] 3312-8 South East Lake Rd, Wuhan 430072, Peoples R China; [Dong, Shuan] 3085-2332 Main Mall, Vancouver, BC V6T 1Z4, Canada	Wuhan University; University of British Columbia	Tan, TY (corresponding author), Wuhan Univ, Sch Elect Engn, Wuhan 430072, Hubei, Peoples R China.; Tan, TY (corresponding author), 3312-8 South East Lake Rd, Wuhan 430072, Peoples R China.	tty@whu.edu.cn	Huang, Yingwei/T-7363-2019	Huang, Yingwei/0000-0002-5162-6420	National Science Foundation for Young Scientists of China; NSFC (National Science Foundation of China) [51307127]	National Science Foundation for Young Scientists of China; NSFC (National Science Foundation of China)(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Foundation for Young Scientists of China (https://isisn.nsfc.gov.cn/egrantweb/). The Grand No. is 51307127 and the receipt is TT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thanks NSFC (National Science Foundation of China) for their fund supporting to this research under Grant No. 51307127.	Akagi H, 1997, IEEE T POWER DELIVER, V12, P354, DOI 10.1109/61.568259; Bagheri P, 2014, IEEE T POWER DELIVER, V29, P215, DOI 10.1109/TPWRD.2013.2291866; Blaabjerg F, 2004, IEEE T POWER ELECTR, V19, P1184, DOI 10.1109/TPEL.2004.833453; Desmet J., 2010, ICHQP2010; El-Samahy I, 2005, IEEE POWER ENG SOC, P2969; He JW, 2012, IEEE T IND ELECTRON, V59, P444, DOI 10.1109/TIE.2011.2141098; He Jinwei, 2010, IPEC2010; Lasseter RH, 2011, P IEEE, V99, P1074, DOI 10.1109/JPROC.2011.2114630; Carrasco JM, 2006, IEEE T IND ELECTRON, V53, P1002, DOI 10.1109/TIE.2006.878356; McBee KD, 2014, IEEE T IND APPL, V50, P2142, DOI 10.1109/TIA.2013.2288606; Menniti D, 2011, ELECTR POW SYST RES, V81, P798, DOI 10.1016/j.epsr.2010.11.010; Tan Tianyuan, 2007, Automation of Electric Power Systems, V31, P81; Tan Tianyuan, 2006, POWERCON2006; Wang YF, 2013, IEEE T POWER ELECTR, V28, P2204, DOI 10.1109/TPEL.2012.2214445; Yuan ZH, 2004, PROCEEDINGS OF THE 2004 IEEE INTERNATIONAL CONFERENCE ON ELECTRIC UTILITY DEREGULATION, RESTRUCTURING AND POWER TECHNOLOGIES, VOLS 1 AND 2, P763, DOI 10.1109/DRPT.2004.1338085	15	0	0	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157057	10.1371/journal.pone.0157057	http://dx.doi.org/10.1371/journal.pone.0157057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295213	Green Published, Green Submitted, gold			2022-12-27	WOS:000377821300017
J	Yazawa, S; Takahashi, R; Yokobori, T; Sano, R; Mogi, A; Saniabadi, AR; Kuwano, H; Asao, T				Yazawa, Shin; Takahashi, Ryo; Yokobori, Takehiko; Sano, Rie; Mogi, Akira; Saniabadi, Abby R.; Kuwano, Hiroyuki; Asao, Takayuki			Fucosylated Glycans in alpha 1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients	PLOS ONE			English	Article							ALPHA(1)-ACID GLYCOPROTEIN; CARCINOEMBRYONIC ANTIGEN; MONOCLONAL-ANTIBODY; TUMOR-MARKERS; HUMAN ADENOCARCINOMA; SERUM; GLYCOSYLATION; PLASMA; LUNG; IDENTIFICATION	One standard treatment option for advanced-stage cancer is surgical resection of malignant tumors following by adjuvant chemotherapy and chemoradiotherapy. Additionally, neoadjuvant chemotherapy may be applied if required. During the time course of treatments, patients are generally followed by computed tomography (CT) surveillance, and by tumor marker diagnosis. However, currently, early evidence of recurrence and/or metastasis of tumors with a clinically relevant biomarker remains a major therapeutic challenge. In particular, there has been no validated biomarker for predicting treatment outcomes in therapeutic settings. Recently, we have looked at glycoforms of serum alpha(1)-acid glycoprotein (AGP) by using a crossed affinoimmunoelectrophoresis with two lectins and an anti-AGP antibody. The primary glycan structures of AGP were also analyzed by a mass spectrometer and a novel software in a large number of patients with various cancers. Accordingly, the relative abundance of alpha 1,3fucosylated glycans in AGP (FUCAGP) was found to be significantly high in cancer patients as compared with the healthy controls. Further, strikingly elevated levels of FUCAGP were found in patients with poor prognosis but not in patients with good prognosis. In the current study, levels of FUCAGP in serum samples from various cancer patients were analyzed and 17 patients including 13 who had undergone chemotherapy were followed for several years post operation. FUCAGP level determined diligently by using a mass spectrometer was found to change along with disease prognosis as well as with responses to treatments, in particular, to various chemotherapies. Therefore, FUCAGP levels measured during following-up of the patients after operation appeared to be clinically relevant biomarker of treatment intervention.	[Yazawa, Shin; Takahashi, Ryo; Mogi, Akira; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 371, Japan; [Yokobori, Takehiko] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol, Maebashi, Gunma 371, Japan; [Sano, Rie] Gunma Univ, Grad Sch Med, Dept Legal Med, Maebashi, Gunma 371, Japan; [Saniabadi, Abby R.] Hamamatsu Univ, Sch Med, Dept Pharmacol, Hamamatsu, Shizuoka 4312102, Japan; [Asao, Takayuki] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Maebashi, Gunma 371, Japan; [Asao, Takayuki] Gunma Univ Initiat Adv Res, Big Data Ctr Integrat Anal, Maebashi, Gunma, Japan	Gunma University; Gunma University; Gunma University; Hamamatsu University School of Medicine; Gunma University	Yazawa, S (corresponding author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 371, Japan.	syazawa@gunma-u.ac.jp						Abelev G I, 1971, Adv Cancer Res, V14, P295, DOI 10.1016/S0065-230X(08)60523-0; Ahn YH, 2014, J PROTEOMICS, V106, P221, DOI 10.1016/j.jprot.2014.04.031; Ahn YH, 2012, J PROTEOMICS, V75, P5507, DOI 10.1016/j.jprot.2012.06.027; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; ASAO T, 1989, CANCER, V64, P2541, DOI 10.1002/1097-0142(19891215)64:12<2541::AID-CNCR2820641222>3.0.CO;2-7; Asao T, 2001, CLIN EXP METASTAS, V18, P605; Asao T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/834790; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; BORIES PN, 1990, INFLAMMATION, V14, P315, DOI 10.1007/BF00915815; BrinkmanVanderLinden ECM, 1996, J BIOL CHEM, V271, P14492, DOI 10.1074/jbc.271.24.14492; BrinkmanVanderLinden ECM, 1996, GLYCOBIOLOGY, V6, P407, DOI 10.1093/glycob/6.4.407; Chavan MM, 2005, GLYCOBIOLOGY, V15, P838, DOI 10.1093/glycob/cwi067; CHIU KM, 1977, IMMUNOLOGY, V32, P997; Comunale MA, 2009, J PROTEOME RES, V8, P595, DOI 10.1021/pr800752c; Dobryszycka W, 1992, AFFINITY ELECTROPHOR, P211; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Ferens-Sieczkowska M, 2013, POSTEP HIG MED DOSW, V67, P828; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Fukuda M, 1996, CANCER RES, V56, P2237; FUKUDA MN, 1989, BLOOD, V73, P84; FUKUSHI Y, 1985, CANCER RES, V45, P3711; FUKUSHI Y, 1984, J BIOL CHEM, V259, P4681; Gaspar MJ, 2008, ANTICANCER RES, V28, P2947; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; Gu JG, 2012, GLYCOCONJUGATE J, V29, P599, DOI 10.1007/s10719-012-9386-1; HADA T, 1995, GLYCOCONJUGATE J, V12, P627, DOI 10.1007/BF00731257; Hakomori S, 1996, CANCER RES, V56, P5309; HAKOMORI S, 1983, JNCI-J NATL CANCER I, V71, P231; HAKOMORI S, 1984, J BIOL CHEM, V259, P4672; HAKOMORI SI, 1986, CHEM PHYS LIPIDS, V42, P209, DOI 10.1016/0009-3084(86)90054-X; HANSEN JES, 1984, CLIN CHIM ACTA, V138, P41, DOI 10.1016/0009-8981(84)90352-8; HANSEN JES, 1987, CANCER, V60, P1630, DOI 10.1002/1097-0142(19871001)60:7<1630::AID-CNCR2820600735>3.0.CO;2-X; Hashimoto S, 2004, CANCER, V15, P2825; Haston JL, 2003, BIOMED CHROMATOGR, V17, P361, DOI 10.1002/bmc.251; HRYCAJ P, 1993, J RHEUMATOL, V20, P2020; INOUE M, 1990, OBSTET GYNECOL, V75, P1032; ITZKOWITZ SH, 1990, CANCER-AM CANCER SOC, V66, P1960, DOI 10.1002/1097-0142(19901101)66:9<1960::AID-CNCR2820660919>3.0.CO;2-X; KANNAGI R, 1986, CANCER RES, V46, P2619; Klug TL, 1981, CANCER RES, V44, P1048; KOPROWSKI H, 1982, LANCET, V1, P1332; KOPROWSKI H, 1979, SOMAT CELL GENET, V5, P957, DOI 10.1007/BF01542654; Kratz E, 2003, CLIN CHIM ACTA, V331, P87, DOI 10.1016/S0009-8981(03)00084-6; KREMER JMH, 1988, PHARMACOL REV, V40, P1; KUBUSHIRO K, 1995, JPN J CANCER RES, V86, P361, DOI 10.1111/j.1349-7006.1995.tb03065.x; Kushner I, 1993, MOL BIOL BIOCH CLIN, P4; Lai H, 2014, TUMOR BIOL, V35, P10547, DOI 10.1007/s13277-014-2355-5; Levander L, 2009, SCAND J IMMUNOL, V69, P412, DOI 10.1111/j.1365-3083.2009.02240.x; LIBERT C, 1994, J EXP MED, V180, P1571, DOI 10.1084/jem.180.4.1571; Litvak A, 2014, J NATL COMPR CANC NE, V12, P907, DOI 10.6004/jnccn.2014.0085; Liu L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052287, 10.1371/journal.pone.0061188, 10.1371/journal.pone.0083052]; MACKIEWICZ A, 1995, GLYCOCONJUGATE J, V12, P241, DOI 10.1007/BF00731326; MADIYALAKAN R, 1986, ANAL BIOCHEM, V152, P22, DOI 10.1016/0003-2697(86)90112-0; MAGNANI JL, 1982, J BIOL CHEM, V257, P4365; MOLLICONE R, 1994, J BIOL CHEM, V269, P12662; Mondal G, 2009, GLYCOCONJUGATE J, V26, P1225, DOI 10.1007/s10719-009-9241-1; Ni XG, 2005, EJSO-EUR J SURG ONC, V31, P164, DOI 10.1016/j.ejso.2004.09.007; NICHOLS EJ, 1985, J IMMUNOL, V135, P1911; Olewicz-Gawlik A, 2007, CLIN RHEUMATOL, V26, P1679, DOI 10.1007/s10067-007-0572-7; Ongay S, 2010, ELECTROPHORESIS, V31, P3314, DOI 10.1002/elps.201000244; Poland DCW, 2005, J LEUKOCYTE BIOL, V78, P453, DOI 10.1189/jlb.1004566; Poland DCW, 2003, GLYCOCONJUGATE J, V20, P99, DOI 10.1023/B:GLYC.0000018584.66712.2c; Schutter EMJ, 2002, AM J OBSTET GYNECOL, V187, P385, DOI 10.1067/mob.2002.123768; Selvaraju S, 2013, PROTEOMICS, V13, P1701, DOI 10.1002/pmic.201200524; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; Shiyan SD, 1997, GLYCOCONJUGATE J, V14, P631, DOI 10.1023/A:1018544711767; Sobin L, 2009, TNM CLASSIFICATION M; STENMAN UH, 1981, J IMMUNOL METHODS, V46, P337, DOI 10.1016/0022-1759(81)90319-7; TACHIKAWA T, 1991, CLIN CHEM, V37, P2081; Tanaka S, 2001, EXP CLIN IMMUNOGENET, V18, P1, DOI 10.1159/000049082; Tsuboi K, 2007, ANN SURG ONCOL, V14, P1880, DOI 10.1245/s10434-007-9363-2; Van Dijk W, 1998, TRENDS GLYCOSCI GLYC, V10, P235, DOI 10.4052/tigg.10.235; VANDIJK W, 1995, GLYCOCONJUGATE J, V12, P227, DOI 10.1007/BF00731324; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; Wu J, 2012, J PROTEOME RES, V11, P4541, DOI 10.1021/pr300330z; YAMASHITA K, 1985, J BIOL CHEM, V260, P4688; Yang AP, 2014, CLIN CHIM ACTA, V437, P183, DOI 10.1016/j.cca.2014.07.034; Yazawa S, 1999, EXP CLIN IMMUNOGENET, V16, P125, DOI 10.1159/000019104; Yazawa S, 1998, GLYCOCONJUGATE J, V15, P863, DOI 10.1023/A:1006954915102; YAZAWA S, 1990, ANAL BIOCHEM, V187, P374, DOI 10.1016/0003-2697(90)90472-L; Yazawa S, 2002, GLYCOBIOLOGY, V12, P545, DOI 10.1093/glycob/cwf070; YAZAWA S, 1988, JPN J CANCER RES, V79, P538, DOI 10.1111/j.1349-7006.1988.tb01624.x; YAZAWA S, 1984, J BIOCHEM-TOKYO, V96, P1737, DOI 10.1093/oxfordjournals.jbchem.a135006; YAZAWA S, 1989, Journal of Tumor Marker Oncology, V4, P355; YAZAWA S, 1989, J CANCER RES CLIN, V115, P451, DOI 10.1007/BF00393336; YAZAWA S, 1995, CANCER RES, V55, P1473; YAZAWA S, 1990, IMMUNOL INVEST, V19, P319, DOI 10.3109/08820139009050773; YAZAWA S, 1993, JPN J CANCER RES, V84, P989, DOI 10.1111/j.1349-7006.1993.tb00190.x; YAZAWA S, 1988, CANCER, V62, P516, DOI 10.1002/1097-0142(19880801)62:3<516::AID-CNCR2820620313>3.0.CO;2-4; Zimmermann-Belsing T, 2002, AUTOIMMUNITY, V35, P441, DOI 10.1080/0891693021000038721	89	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156277	10.1371/journal.pone.0156277	http://dx.doi.org/10.1371/journal.pone.0156277			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295180	Green Submitted, Green Published, gold			2022-12-27	WOS:000377821300004
J	Deepthi, BV; Rao, KP; Chennapa, G; Naik, MK; Chandrashekara, KT; Sreenivasa, MY				Deepthi, B. V.; Rao, K. Poornachandra; Chennapa, G.; Naik, M. K.; Chandrashekara, K. T.; Sreenivasa, M. Y.			Antifungal Attributes of Lactobacillus plantarum MYS6 against Fumonisin Producing Fusarium proliferatum Associated with Poultry Feeds	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; IN-VITRO; FERMENTATIVE BACTERIA; STRAINS; CONTAMINATION; AFLATOXIN; BINDING; COMPONENTS; COMPOUND; SPOILAGE	Fumonisins, being common in occurrence in maize-based feeds, pose a great threat to animal and human health. The present study is aimed at determining the antifungal activity of Lactobacillus plantarum MYS6 against a fumonisin producing fungus, Fusarium proliferatum MYS9. The isolate was subjected to standard tests for determining its probiotic attributes and antifungal properties. L. plantarum MYS6 thrived well at pH 3.0 and 6.0, and exhibited strong resistance up to 3% bile. The isolate showed a high degree of cell surface hydrophobicity corresponding to its strong adhesion to chicken crop epithelial cells. Co-inoculation with the fungus on modified de Man Rogosa Sharpe medium revealed the inhibitory effect of L. plantarum MYS6 on fungal growth and biomass. Observation using scanning electron microscopy showed distortion of hyphal structures, swollen tips and disrupted conidia. Conidia germination inhibition assay restrained germination and showed deformed hyphae. The bioprotective feature of the isolate was evident by the inhibition of fungal development in maize-kernel treated with the cell free supernatant of L. plantarum MYS6. Both the isolate and its extracellular metabolites lowered fumonisin content in feed model up to 0.505 mg/Kg of feed and 0.3125 mg/Kg of feed respectively when compared to the level of 0.870 mg/Kg of feed in control. The major antifungal compounds produced by the isolate were 10-Octadecenoic acid, methyl ester; palmitic acid, methyl ester; heptadecanoic acid, 16-methyl ester; stearic acid and lauric acid. L. plantarum MYS6 reduced 61.7% of fumonisin possibly by a binding mechanism. These findings suggest the application of L. plantarum MYS6 as an efficient probiotic additive and biocontrol agent in feed used in poultry industry. Additionally, the antifungal metabolites pose a conspicuous inhibition of Fusarium growth and fumonisin production.	[Deepthi, B. V.; Rao, K. Poornachandra; Chennapa, G.; Sreenivasa, M. Y.] Univ Mysore, Dept Studies Microbiol, Mysuru, Karnataka, India; [Naik, M. K.] UAS, Coll Agr Sci, Dept Plant Pathol, Raichur, Karnataka, India; [Chandrashekara, K. T.] Univ Mysore, Inst Excellence, Vijnana Bhavan, Mysuru, Karnataka, India	University of Mysore; University of Mysore	Sreenivasa, MY (corresponding author), Univ Mysore, Dept Studies Microbiol, Mysuru, Karnataka, India.	sreenivasamy@gmail.com	Gurikar, Chennappa/AAF-7707-2019; Y, Sreenivasa M/F-7220-2011; K, Poornachandra Rao/AAT-3027-2021	Gurikar, Chennappa/0000-0001-5664-2393; 	University Grants Commission	University Grants Commission(University Grants Commission, India)	B V Deepthi acknowledges University Grants Commission for the award of RGNF research fellowship. The authors also thank Central Instrumentation Facility, Institute of Excellence (IOE), University with Potential for Excellence-Centre with Potential for Excellence in Particular Area (UPE-CPEPA), University of Mysore for providing timely assistance in LC/MS analysis, Fluorescent Microscopy and Scanning Electron Microscopy. We also thank Dr. Sadashiva MP, Department of Chemistry, University of Mysore, for his valuable guidance in analysis and interpretation of GCMS analysis.	Agoramoorthy G, 2007, BRAZ J MICROBIOL, V38, P739, DOI 10.1590/S1517-83822007000400028; Arasu MV, 2013, J APPL MICROBIOL, V115, P1172, DOI 10.1111/jam.12319; CHANDEL U, 2014, INDIAN J SCI RES, V4, P70; CLSI, 2012, PERF STAND ANT SUSC; Dalie D, 2012, FOOD CONTROL, V23, P405, DOI 10.1016/j.foodcont.2011.08.008; Davidson M., 2001, FOOD MICROBIOLOGY FU, P593; Ehrmann MA, 2002, J APPL MICROBIOL, V92, P966, DOI 10.1046/j.1365-2672.2002.01608.x; El-Nezami H, 2002, APPL ENVIRON MICROB, V68, P3545, DOI 10.1128/AEM.68.7.3545-3549.2002; El-Nezami HS, 2002, FOOD ADDIT CONTAM, V19, P680, DOI 10.1080/02652030210134236; Fandohan P, 2005, INT J FOOD MICROBIOL, V99, P173, DOI 10.1016/j.ijfoodmicro.2004.08.012; Gong AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116871; Haskard C, 2000, CHEM-BIOL INTERACT, V128, P39, DOI 10.1016/S0009-2797(00)00186-1; Hassan YI, 2008, INT J FOOD MICROBIOL, V121, P112, DOI 10.1016/j.ijfoodmicro.2007.11.038; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; IARC, 2002, SOM TRAD HERB MED SO, V82; Jakava-Vijanen M, 2007, VET MICROBIOL, V124, P264, DOI 10.1016/j.vetmic.2007.04.029; Jurado M, 2006, SYST APPL MICROBIOL, V29, P681, DOI 10.1016/j.syapm.2006.01.014; Kim PI, 2007, APPL MICROBIOL BIOT, V74, P1103, DOI 10.1007/s00253-006-0741-7; Koch E, 2009, J PHYTOPATHOL, V157, P235, DOI 10.1111/j.1439-0434.2008.01484.x; Lahtinen SJ, 2004, FOOD ADDIT CONTAM A, V21, P158, DOI [10.1080/02652030310001639521, 10.1080/02646830020032300]; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee H, 2011, INT J FOOD MICROBIOL, V145, P155, DOI 10.1016/j.ijfoodmicro.2010.12.003; Leslie J.F., 2006, FUSARIUM LAB MANUAL, P224; Gerez CL, 2009, FOOD CONTROL, V20, P144, DOI 10.1016/j.foodcont.2008.03.005; Magnusson J, 2003, FEMS MICROBIOL LETT, V219, P129, DOI 10.1016/S0378-1097(02)01207-7; Magnusson J, 2001, APPL ENVIRON MICROB, V67, P1, DOI 10.1128/AEM.67.1.1-5.2001; Maragkoudakis PA, 2006, INT DAIRY J, V16, P189, DOI 10.1016/j.idairyj.2005.02.009; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; MASUI H, 1989, PHYTOCHEMISTRY, V28, P2613, DOI 10.1016/S0031-9422(00)98051-8; Mauch A, 2010, INT J FOOD MICROBIOL, V141, P116, DOI 10.1016/j.ijfoodmicro.2010.05.002; Morgavi DP, 2007, ANIM FEED SCI TECH, V137, P201, DOI 10.1016/j.anifeedsci.2007.06.002; Musikasang H, 2009, WORLD J MICROB BIOT, V25, P1337, DOI 10.1007/s11274-009-0020-8; Narasimharao Bhogireddy, 2015, Advances in Biological Research, V9, P109; Niderkorn V, 2009, J APPL MICROBIOL, V106, P977, DOI 10.1111/j.1365-2672.2008.04065.x; Niderkorn V, 2007, FOOD ADDIT CONTAM A, V24, P406, DOI 10.1080/02652030601101110; Niderkorn V, 2006, J APPL MICROBIOL, V101, P849, DOI 10.1111/j.1365-2672.2006.02958.x; Park SC, 2006, WORLD J MICROB BIOT, V22, P35, DOI 10.1007/s11274-005-4856-2; Pearson TC, 2004, CEREAL CHEM, V81, P490, DOI 10.1094/CCHEM.2004.81.4.490; Pohl C. H., 2011, ANTIFUNGAL FREE FATT; Proctor RH, 2004, MYCOL RES, V108, P815, DOI 10.1017/S0953756204000577; Rao KP, 2015, PROBIOTICS ANTIMICRO, V7, P146, DOI 10.1007/s12602-015-9186-6; Rouse S, 2008, J APPL MICROBIOL, V104, P915, DOI 10.1111/j.1365-2672.2007.03619.x; Salah R.B., 2012, ANAEROBE, V18, P436, DOI DOI 10.1016/J.ANAEROBE.2012.05.001; Sangmanee P, 2014, FOOD CONTROL, V40, P224, DOI 10.1016/j.foodcont.2013.12.005; Sathe SJ, 2007, J APPL MICROBIOL, V103, P2622, DOI 10.1111/j.1365-2672.2007.03525.x; Sreenivasa MY, 2008, FOOD BIOTECHNOL, V22, P160, DOI 10.1080/08905430802043206; Strom K, 2005, FEMS MICROBIOL LETT, V246, P119, DOI 10.1016/j.femsle.2005.03.047; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Yang EJ, 2010, INT J FOOD MICROBIOL, V139, P56, DOI 10.1016/j.ijfoodmicro.2010.02.012	50	40	44	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0155122	10.1371/journal.pone.0155122	http://dx.doi.org/10.1371/journal.pone.0155122			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285317	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000377564000002
J	Jee, D; Kim, EC; Cho, E; Arroyo, JG				Jee, Donghyun; Kim, Eun Chul; Cho, Eunyoung; Arroyo, Jorge G.			Positive Association between Blood 25-Hydroxyvitamin D Levels and Pterygium after Control for Sunlight Exposure	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; VITAMIN-D STATUS; NATIONAL-HEALTH; ULTRAVIOLET-RADIATION; MACULAR DEGENERATION; RISK-FACTOR; PATHOGENESIS; METABOLISM; P450SCC; PATHWAY	Purpose To investigate the association between blood 25-hydroxyvitamin D levels and pterygium. Methods Korean National Health and Nutrition Examination Survey 2008-2011 were used for the present epidemiologic study. A total of 19,178 participants aged >= 30 years were evaluated for blood 25-hydroxyvitamin D levels and performed ophthalmic slit lamp examinations. Pterygium was considered as a growth of fibrovascular tissue over the cornea. Results The average blood 25-hydroxyvitamin D levels were 18.6 ng/mL, and prevalence of pterygium was 6.5%. The odds of pterygium significantly increased across blood 25-hydroxyvitamin D quintiles after controlling sun exposure time as well as other confounders such as sex, age, smoking, diabetes, hypertension (P < 0.001). The odds ratios (OR) for pterygium was 1.51 (95% Confidence Interval[95% CI]; 1.19-1.92) in the highest blood vitamin D quintile. Stratified analysis by sex showed a positive association between blood 25-hydroxyvitamin D levels and pterygium in both men (quintile 5 versus 1, OR; 1.68, 95% CI; 1.19-2.37) and women (quintile 5 versus 1, OR; 1.37, 95% CI; 1.00-1.88). Conclusions Even after controlling sun light exposure time, we found a positive association between blood 25-hydroxyvitamin D levels and pterygium in a representative Korean population. The mechanism underlying this association is unknown.	[Jee, Donghyun] Catholic Univ Korea, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea; [Kim, Eun Chul] Catholic Univ Korea, Coll Med, Bucheon St Marys Hosp, Dept Ophthalmol & Visual Sci, Bucheon, South Korea; [Cho, Eunyoung] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Cho, Eunyoung] Harvard Univ, Sch Med, Boston, MA USA; [Cho, Eunyoung] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, Providence, RI 02912 USA; [Arroyo, Jorge G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Ophthalmol, Boston, MA 02215 USA	Catholic University of Korea; Catholic University of Korea; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kim, EC (corresponding author), Catholic Univ Korea, Coll Med, Bucheon St Marys Hosp, Dept Ophthalmol & Visual Sci, Bucheon, South Korea.	doj087@mail.harvard.edu	Cho, Eunyoung/AAV-4469-2020	Cho, Eunyoung/0000-0001-6594-2582; Arroyo, Jorge/0000-0001-9812-296X	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1A1A1A05028023]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015R1A1A1A05028023).	Alvarez JA, 2014, CLIN ENDOCRINOL, V81, P458, DOI 10.1111/cen.12449; Chalam KV, 2011, EYE CONTACT LENS, V37, P225, DOI 10.1097/ICL.0b013e31821fbd3e; Choi HS, 2011, J CLIN ENDOCR METAB, V96, P643, DOI 10.1210/jc.2010-2133; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P2041, DOI [10.1167/iovs.13-12853, 10.1167/IOVS.13-12853]; Chui J, 2008, OCUL SURF, V6, P24, DOI 10.1016/S1542-0124(12)70103-9; Coroneo M T, 1999, Curr Opin Ophthalmol, V10, P282, DOI 10.1097/00055735-199908000-00011; CORONEO MT, 1993, BRIT J OPHTHALMOL, V77, P734, DOI 10.1136/bjo.77.11.734; Di Girolamo N, 2006, INVEST OPHTH VIS SCI, V47, P2430, DOI 10.1167/iovs.05-1130; Eum KD, 2008, SCI TOTAL ENVIRON, V407, P147, DOI 10.1016/j.scitotenv.2008.08.037; Fang CL, 2013, INVEST OPHTH VIS SCI, V54, P4563, DOI 10.1167/iovs.13-11604; Grant W B, 2003, J Cosmet Dermatol, V2, P86, DOI 10.1111/j.1473-2130.2004.00041.x; Jee D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149294; Jee D, 2015, J CATARACT REFR SURG, V41, P1705, DOI 10.1016/j.jcrs.2014.12.052; Jee DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115199; Kim EC, 2014, INVEST OPHTH VIS SCI, V55, P4823, DOI 10.1167/iovs.14-14763; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Lee MS, 2011, ENVIRON RES, V111, P171, DOI 10.1016/j.envres.2010.10.006; Lee YA, 2014, PUBLIC HEALTH NUTR, V17, P764, DOI 10.1017/S1368980013000438; Liu T, 2013, CURR EYE RES, V38, P1191, DOI 10.3109/02713683.2013.823212; Lucas RM, 2011, EYE CONTACT LENS, V37, P168, DOI 10.1097/ICL.0b013e31821cb0cf; Mangge H, 2013, CURRENT VASCULAR PHA; Parekh N, 2007, ARCH OPHTHALMOL-CHIC, V125, P661, DOI 10.1001/archopht.125.5.661; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Patrick PA, 2012, ARCH OPHTHALMOL-CHIC, V130, P756, DOI 10.1001/archophthalmol.2011.2749; Payne JF, 2012, ENDOCR PRACT, V18, P185, DOI 10.4158/EP11147.OR; Riau AK, 2009, MOL VIS, V15, P335; Rim THT, 2013, CORNEA, V32, P962, DOI 10.1097/ICO.0b013e3182801668; Roberts JE, 2011, EYE CONTACT LENS, V37, P246, DOI 10.1097/ICL.0b013e31821cbcc9; Sempos CT, 2012, SCAND J CLIN LAB INV, V72, P32, DOI 10.3109/00365513.2012.681935; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2012, INT J BIOCHEM CELL B, V44, P2003, DOI 10.1016/j.biocel.2012.07.027; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Smith M, 2010, BIOSCI HORIZ, V3, P124; Sui GY, 2013, BRIT J OPHTHALMOL, V97, P389, DOI 10.1136/bjophthalmol-2012-302281; Tan DTH, 2000, INVEST OPHTH VIS SCI, V41, P1684; Uberti F, 2014, J CLIN ENDOCR METAB, V99, P1367, DOI 10.1210/jc.2013-2103	38	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157501	10.1371/journal.pone.0157501	http://dx.doi.org/10.1371/journal.pone.0157501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286036	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000069
J	Lemley, KV; Bagnasco, SM; Nast, CC; Barisoni, L; Conway, CM; Hewitt, SM; Song, PXK				Lemley, Kevin V.; Bagnasco, Serena M.; Nast, Cynthia C.; Barisoni, Laura; Conway, Catherine M.; Hewitt, Stephen M.; Song, Peter X. K.			Morphometry Predicts Early GFR Change in Primary Proteinuric Glomerulopathies: A Longitudinal Cohort Study Using Generalized Estimating Equations	PLOS ONE			English	Article							INTERSTITIAL FIBROSIS; GLOMERULAR DENSITY; NEPHROTIC SYNDROME; PROGRESSION; NUMBER	Objective Most predictive models of kidney disease progression have not incorporated structural data. If structural variables have been used in models, they have generally been only semi-quantitative. Methods We examined the predictive utility of quantitative structural parameters measured on the digital images of baseline kidney biopsies from the NEPTUNE study of primary proteinuric glomerulopathies. These variables were included in longitudinal statistical models predicting the change in estimated glomerular filtration rate (eGFR) over up to 55 months of follow-up. Results The participants were fifty-six pediatric and adult subjects from the NEPTUNE longitudinal cohort study who had measurements made on their digital biopsy images; 25% were African-American, 70% were male and 39% were children; 25 had focal segmental glomerular sclerosis, 19 had minimal change disease, and 12 had membranous nephropathy. We considered four different sets of candidate predictors, each including four quantitative structural variables (for example, mean glomerular tuft area, cortical density of patent glomeruli and two of the principal components from the correlation matrix of six fractional cortical areas-interstitium, atrophic tubule, intact tubule, blood vessel, sclerotic glomerulus, and patent glomerulus) along with 13 potentially confounding demographic and clinical variables (such as race, age, diagnosis, and baseline eGFR, quantitative proteinuria and BMI). We used longitudinal linear models based on these 17 variables to predict the change in eGFR over up to 55 months. All 4 models had a leave-one-out cross-validated R-2 of about 62%. Conclusions Several combinations of quantitative structural variables were significantly and strongly associated with changes in eGFR. The structural variables were generally stronger than any of the confounding variables, other than baseline eGFR. Our findings suggest that quantitative assessment of diagnostic renal biopsies may play a role in estimating the baseline risk of succeeding loss of renal function in future clinical studies, and possibly in clinical practice.	[Lemley, Kevin V.] Univ So Calif, Keck Sch Med, Div Pediat Nephrol, Dept Pediat, Los Angeles, CA 90033 USA; [Bagnasco, Serena M.] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Nast, Cynthia C.] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA; [Barisoni, Laura] Univ Miami, Dept Pathol, Miami, FL USA; [Conway, Catherine M.; Hewitt, Stephen M.] NCI, NIH, Bethesda, MD 20892 USA; [Song, Peter X. K.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Conway, Catherine M.] Leica Biosyst Ltd, Dublin, Ireland	University of Southern California; Johns Hopkins University; Johns Hopkins Medicine; Cedars Sinai Medical Center; University of Miami; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Michigan System; University of Michigan	Lemley, KV (corresponding author), Univ So Calif, Keck Sch Med, Div Pediat Nephrol, Dept Pediat, Los Angeles, CA 90033 USA.	klemley@chla.usc.edu		Hewitt, Stephen/0000-0001-8283-1788	NIH/ORDR [U-54DK083912]; NephCure Kidney International; National Cancer Institute (NIH): Intramural Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK083912] Funding Source: NIH RePORTER	NIH/ORDR; NephCure Kidney International; National Cancer Institute (NIH): Intramural Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/ORDR U-54DK083912; NephCure: nephcure.org (now NephCure Kidney International); and National Cancer Institute (NIH): Intramural Research. None of the funders had any role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Barisoni L, 2016, MODERN PATHOL, V29, P671, DOI 10.1038/modpathol.2016.58; Barisoni L, 2013, CLIN J AM SOC NEPHRO, V8, P1449, DOI 10.2215/CJN.08370812; BOHLE A, 1990, PATHOL RES PRACT, V186, P135, DOI 10.1016/S0344-0338(11)81021-6; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Farris AB, 2014, AM J TRANSPLANT, V14, P897, DOI 10.1111/ajt.12641; Gadegbeku CA, 2013, KIDNEY INT, V83, P749, DOI 10.1038/ki.2012.428; Hayek SS, 2015, NEW ENGL J MED, V373, P1916, DOI 10.1056/NEJMoa1506362; Lemley KV, 2008, NEPHROL DIAL TRANSPL, V23, P213, DOI 10.1093/ndt/gfm560; Lemley KV, 2013, J AM SOC NEPHROL, V24, P1193, DOI 10.1681/ASN.2012111078; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Puelles VG, 2014, NEPHROL DIAL TRANSPL, V29, P1686, DOI 10.1093/ndt/gfu088; Rule AD, 2011, MAYO CLIN PROC, V86, P282, DOI 10.4065/mcp.2010.0821; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Servais A, 2011, AM J TRANSPLANT, V11, P1456, DOI 10.1111/j.1600-6143.2011.03594.x; Song PXK, 2009, STAT MED, V28, P3683, DOI 10.1002/sim.3719; Tangri N, 2013, ANN INTERN MED, V158, P596, DOI 10.7326/0003-4819-158-8-201304160-00004; Tsuboi N, 2011, NEPHROL DIAL TRANSPL, V26, P3555, DOI 10.1093/ndt/gfr399; Tsuboi N, 2010, CLIN J AM SOC NEPHRO, V5, P39, DOI 10.2215/CJN.04680709; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120	20	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157148	10.1371/journal.pone.0157148	http://dx.doi.org/10.1371/journal.pone.0157148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285824	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000040
J	Matamales, M; Gotz, J; Bertran-Gonzalez, J				Matamales, Miriam; Gotz, Jurgen; Bertran-Gonzalez, Jesus			Quantitative Imaging of Cholinergic Interneurons Reveals a Distinctive Spatial Organization and a Functional Gradient across the Mouse Striatum	PLOS ONE			English	Article							COMPARTMENTAL ORGANIZATION; NUCLEUS-ACCUMBENS; NEURONS; ACETYLCHOLINESTERASE; ACETYLTRANSFERASE; MODULATION; MORPHOLOGY; RECEPTORS; PATTERNS; DENSITY	Information processing in the striatum requires the postsynaptic integration of glutamatergic and dopaminergic signals, which are then relayed to the output nuclei of the basal ganglia to influence behavior. Although cellularly homogeneous in appearance, the striatum contains several rare interneuron populations which tightly modulate striatal function. Of these, cholinergic interneurons (CINs) have been recently shown to play a critical role in the control of reward-related learning; however how the striatal cholinergic network is functionally organized at the mesoscopic level and the way this organization influences striatal function remains poorly understood. Here, we systematically mapped and digitally reconstructed the entire ensemble of CINs in the mouse striatum and quantitatively assessed differences in densities, spatial arrangement and neuropil content across striatal functional territories. This approach demonstrated that the rostral portion of the striatum contained a higher concentration of CINs than the caudal striatum and that the cholinergic content in the core of the ventral striatum was significantly lower than in the rest of the regions. Additionally, statistical comparison of spatial point patterns in the striatal cholinergic ensemble revealed that only a minor portion of CINs (17%) aggregated into cluster and that they were predominantly organized in a random fashion. Furthermore, we used a fluorescence reporter to estimate the activity of over two thousand CINs in naive mice and found that there was a decreasing gradient of CIN overall function along the dorsomedial-to-ventrolateral axis, which appeared to be independent of their propensity to aggregate within the striatum. Altogether this work suggests that the regulation of striatal function by acetylcholine across the striatum is highly heterogeneous, and that signals originating in external afferent systems may be principally determining the function of CINs in the striatum.	[Matamales, Miriam; Gotz, Jurgen; Bertran-Gonzalez, Jesus] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia	University of Queensland	Matamales, M; Bertran-Gonzalez, J (corresponding author), Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia.	matamales@uq.edu.au; j.bertrangonzalez@uq.edu.au	Götz, Jürgen/C-2448-2014; Matamales, Miriam/J-5189-2014; Bertran-Gonzalez, J/L-1410-2017	Götz, Jürgen/0000-0001-8501-7896; Matamales, Miriam/0000-0001-9978-0091; Bertran-Gonzalez, J/0000-0002-3794-1782	Australian Research Council [DP13300101932]; National Health and Medical Research Council [APP1037746, APP1003150]; Estate of Dr Clem Jones AO, the State Government of Queensland	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Estate of Dr Clem Jones AO, the State Government of Queensland	The research reported in the manuscript was supported by the Estate of Dr Clem Jones AO, the State Government of Queensland, and by grants from the Australian Research Council (DP13300101932) and the National Health and Medical Research Council (APP1037746, APP1003150) to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2013, J NEUROSCI, V33, P4854, DOI 10.1523/JNEUROSCI.4791-12.2013; Aosaki T, 2010, GERIATR GERONTOL INT, V10, pS148, DOI 10.1111/j.1447-0594.2010.00588.x; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Bernacer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001174; Bertran-Gonzalez J, 2013, J NEUROSCI, V33, P16060, DOI 10.1523/JNEUROSCI.1927-13.2013; Bertran-Gonzalez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053195; BOLAM JP, 1984, NEUROSCIENCE, V12, P711, DOI 10.1016/0306-4522(84)90165-9; Bradfield LA, 2013, THALAMOSTRIATAL PATH, P1; Brauer K, 2000, BRAIN RES, V858, P151, DOI 10.1016/S0006-8993(00)01938-7; BURKE RE, 1990, NEUROSCI LETT, V108, P58, DOI 10.1016/0304-3940(90)90706-F; BUTCHER SG, 1974, BRAIN RES, V71, P167, DOI 10.1016/0006-8993(74)90202-9; Ciceri G, 2013, NAT NEUROSCI; Diggle P., 2003, STAT ANAL SPATIAL PO; Doig NM, 2014, J NEUROSCI, V34, P3101, DOI 10.1523/JNEUROSCI.4627-13.2014; Eglen SJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-68; Gangarossa G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00124; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gonzales KK, 2015, ANN N Y ACAD SCI; GRAYBIEL AM, 1986, NATURE, V323, P625, DOI 10.1038/323625a0; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hansson K, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00005; Harper CA, 2018, SEX ABUSE-J RES TR, V30, P533, DOI 10.1177/1079063216681561; HERKENHAM M, 1981, NATURE, V291, P415, DOI 10.1038/291415a0; Krosnowski K, 2012, NEUROSCIENCE, V213, P161, DOI 10.1016/j.neuroscience.2012.04.024; KUBOTA Y, 1993, J COMP NEUROL, V332, P499, DOI 10.1002/cne.903320409; Laurent V, 2014, J NEUROSCI, V34, P1358, DOI 10.1523/JNEUROSCI.4592-13.2014; Mailly P, 2013, J NEUROSCI, V33, P5718, DOI 10.1523/JNEUROSCI.5248-12.2013; Matamales M, 2016, NEURON, V90, P362, DOI 10.1016/j.neuron.2016.03.006; MCGEER PL, 1971, BRAIN RES, V35, P308, DOI 10.1016/0006-8993(71)90625-1; MEREDITH GE, 1989, NEUROSCIENCE, V31, P327, DOI 10.1016/0306-4522(89)90377-1; MESULAM MM, 1984, BRAIN RES, V311, P245, DOI 10.1016/0006-8993(84)90087-8; Owen DM, 2012, METHOD ENZYMOL, V504, P221, DOI 10.1016/B978-0-12-391857-4.00011-2; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Paxinos G., 1982, RAT BRAIN STEREOTAXI, P1, DOI [10.1016/B978-0-12-547620-1.50006-0pp, DOI 10.1016/B978-0-12-547620-1.50006-0PP]; PHELPS PE, 1986, J NEUROCYTOL, V15, P595, DOI 10.1007/BF01611860; REA MA, 1981, BRAIN RES, V219, P317, DOI 10.1016/0006-8993(81)90294-8; Ripley B.D., 1988, STAT INFERENCE SPATI; SCHWABER JS, 1987, J COMP NEUROL, V263, P309, DOI 10.1002/cne.902630302; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; WILSON CJ, 1990, J NEUROSCI, V10, P508; Wouterlood FG, 2012, J COMP NEUROL, V520, P2123, DOI 10.1002/cne.23031	45	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157682	10.1371/journal.pone.0157682	http://dx.doi.org/10.1371/journal.pone.0157682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314496	gold, Green Published, Green Submitted			2022-12-27	WOS:000378030000045
J	Cordero, RJB; de Leon-Rodriguez, CM; Alvarado-Torres, JK; Rodriguez, AR; Casadevall, A				Cordero, Radames J. B.; de Leon-Rodriguez, Carlos M.; Alvarado-Torres, John K.; Rodriguez, Ana R.; Casadevall, Arturo			Life Science's Average Publishable Unit (APU) Has Increased over the Past Two Decades	PLOS ONE			English	Article							AUTHORSHIP PATTERNS; CITATION; US; PUBLICATION; REFERENCES; JOURNALS; GROWTH; NUMBER; PAPER	Quantitative analysis of the scientific literature is important for evaluating the evolution and state of science. To study how the density of biological literature has changed over the past two decades we visually inspected 1464 research articles related only to the biological sciences from ten scholarly journals (with average Impact Factors, IF, ranging from 3.8 to 32.1). By scoring the number of data items (tables and figures), density of composite figures (labeled panels per figure or PPF), as well as the number of authors, pages and references per research publication we calculated an Average Publishable Unit or APU for 1993, 2003, and 2013. The data show an overall increase in the average +/- SD number of data items from 1993 to 2013 of approximately 7 +/- 3 to 14 +/- 11 and PPF ratio of 2 +/- 1 to 4 +/- 2 per article, suggesting that the APU has doubled in size over the past two decades. As expected, the increase in data items per article is mainly in the form of supplemental material, constituting 0 to 80% of the data items per publication in 2013, depending on the journal. The changes in the average number of pages (approx. 8 +/- 3 to 10 +/- 3), references (approx. 44 +/- 18 to 56 +/- 24) and authors (approx. 5 +/- 3 to 8 +/- 9) per article are also presented and discussed. The average number of data items, figure density and authors per publication are correlated with the journal's average IF. The increasing APU size over time is important when considering the value of research articles for life scientists and publishers, as well as, the implications of these increasing trends in the mechanisms and economics of scientific communication.	[Cordero, Radames J. B.] Univ Fed Rio de Janeiro, CCS, Inst Bioquim Med IBqM Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil; [de Leon-Rodriguez, Carlos M.; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Alvarado-Torres, John K.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Rodriguez, Ana R.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA; [Cordero, Radames J. B.; Casadevall, Arturo] Johns Hopkins Bloomberg Sch Publ Hlth, Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA	Universidade Federal do Rio de Janeiro; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cordero, RJB (corresponding author), Univ Fed Rio de Janeiro, CCS, Inst Bioquim Med IBqM Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil.; Cordero, RJB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.	rcorder4@jhu.edu	Cordero, Radamés JB/F-6912-2011	Cordero, Radamés JB/0000-0002-3026-7094	"Science without Borders"-Young Talent Attraction Scholarship from the Conselho Nacional de Desenvolvimento Tecnologico (CnPq) e Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	"Science without Borders"-Young Talent Attraction Scholarship from the Conselho Nacional de Desenvolvimento Tecnologico (CnPq) e Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	RJBC was supported by "Science without Borders"-Young Talent Attraction Scholarship from the Conselho Nacional de Desenvolvimento Tecnologico (CnPq) e Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Associates CEP, 2008, ACT COSTS FUND FLOWS; Bearinger LH, 2006, RES NURS HEALTH, V29, P71, DOI 10.1002/nur.20119; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Biglu MH, 2008, SCIENTOMETRICS, V74, P453, DOI 10.1007/s11192-007-1815-8; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Borowski C, 2011, J EXP MED, V208, P1337, DOI 10.1084/jem.20111061; BROAD WJ, 1981, SCIENCE, V211, P1137, DOI 10.1126/science.7008199; Casadevall A, 2014, FASEB J; Casadevall A, 2014, MBIO, V5, DOI [10.1128/mBio.00846-13, 10.1128/mBio.01730-14, 10.1128/mBio.01342-14, 10.1128/mBio.00064-14]; Casadevall A, 2014, INFECT IMMUN, V82, P1355, DOI 10.1128/IAI.01530-13; Casadevall A, 2012, INFECT IMMUN, V80, P891, DOI 10.1128/IAI.06183-11; Cokol M, 2008, EMBO REP, V9, DOI 10.1038/sj.embor.7401143; Committee NRCU, 2011, INT MULT DSIC LIF SC; Evans JA, 2013, SCIENCE, V342, P44, DOI 10.1126/science.1245218; Fanelli Daniele, 2009, PLoS One, V4, pe5738, DOI 10.1371/journal.pone.0005738; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Fang FC, 2012, P NATL ACAD SCI USA, V109, P17028, DOI 10.1073/pnas.1212247109; Fang FC, 2012, INFECT IMMUN, V80, P897, DOI 10.1128/IAI.06184-11; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Gordo O., 2014, REV CATALANA ORNITOL, V30, P63; Hayashi T, 1999, SCIENTOMETRICS, V46, P73, DOI 10.1007/BF02766296; Hirshleifer D., 2003, EUR FINANC MANAG, V9, P25, DOI DOI 10.1111/1468-036X.00207; Jinha AE, 2010, LEARN PUBL, V23, P258, DOI 10.1087/20100308; Larsen PO, 2010, SCIENTOMETRICS, V84, P575, DOI 10.1007/s11192-010-0202-z; Ledford H, 2014, NATURE, V515, P326, DOI 10.1038/515326a; Levsky ME, 2007, SOUTH MED J, V100, P371, DOI 10.1097/01.smj.0000257537.51929.4b; Li Z, 2008, SCIENTOMETRICS, V75, P97, DOI 10.1007/s11192-007-1838-1; Lovaglia MJ., 1991, AM SOCIOL, V22, P49, DOI [DOI 10.1007/BF02691867, 10.1007/BF02691867]; Maunsell J, 2010, J NEUROSCI, V30, P10599; Mayden Kelley D, 2012, J Adv Pract Oncol, V3, P117; Miller DR, 2011, CAN J ANESTH, V58, P777, DOI 10.1007/s12630-011-9558-7; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; Munafo MR, 2010, BRIT J PSYCHIAT, V197, P257, DOI 10.1192/bjp.bp.109.069849; Ploegh H, 2011, NATURE, V472, P391, DOI 10.1038/472391a; Price DJdS, 1975, SCI BABYLON, Vxvi; Price DJdS, 1963, LITTLE SCI BIG SCI; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Ruediger Bornmann LM, 2014, GROWTH RATES MODERN; SATYANARAYANA K, 1989, SCIENTOMETRICS, V17, P363, DOI 10.1007/BF02026418; Shaban S, 2007, SAUDI MED J, V28, P927; Shaban Sami, 2009, J Occup Med Toxicol, V4, P3, DOI 10.1186/1745-6673-4-3; Smith R, 2006, J ROY SOC MED, V99, P178, DOI 10.1258/jrsm.99.4.178; Steen RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068397; Steen RG, 2011, J MED ETHICS, V37, P249, DOI 10.1136/jme.2010.040923; Tabah AN, 1999, ANNU REV INFORM SCI, V34, P249; Trust W, 2004, COSTS BUSINESS MODEL; Ucar I, 2013, ARXIV E PRINTS, P4223; Ware M, 2013, PEER REV INTRO GUIDE; Weeks WB, 2004, SOC SCI MED, V59, P1949, DOI 10.1016/j.socscimed.2004.02.029; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; YITZHAKI M, 1991, SCIENTOMETRICS, V21, P3, DOI 10.1007/BF02019179; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	53	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156983	10.1371/journal.pone.0156983	http://dx.doi.org/10.1371/journal.pone.0156983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310929	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800024
J	Gagic, V; Petrovic-Obradovic, O; Frund, J; Kavallieratos, NG; Athanassiou, CG; Stary, P; Tomanovic, Z				Gagic, Vesna; Petrovic-Obradovic, Olivera; Fruend, Jochen; Kavallieratos, Nickolas G.; Athanassiou, Christos G.; Stary, Petr; Tomanovic, Zeljko			The Effects of Aphid Traits on Parasitoid Host Use and Specialist Advantage	PLOS ONE			English	Article							ECOLOGICAL SPECIALIZATION; COMMUNITY ECOLOGY; SPECIES RICHNESS; PATTERNS; HYMENOPTERA; ASSEMBLAGES; BRACONIDAE; DIVERSITY; HOMOPTERA; EVOLUTION	Specialization is a central concept in ecology and one of the fundamental properties of parasitoids. Highly specialized parasitoids tend to be more efficient in host-use compared to generalized parasitoids, presumably owing to the trade-off between host range and hostuse efficiency. However, it remains unknown how parasitoid host specificity and host-use depends on host traits related to susceptibility to parasitoid attack. To address this question, we used data from a 13-year survey of interactions among 142 aphid and 75 parasitoid species in nine European countries. We found that only aphid traits related to local resource characteristics seem to influence the trade-off between host-range and efficiency: more specialized parasitoids had an apparent advantage (higher abundance on shared hosts) on aphids with sparse colonies, ant-attendance and without concealment, and this was more evident when host relatedness was included in calculation of parasitoid specificity. More traits influenced average assemblage specialization, which was highest in aphids that are monophagous, monoecious, large, highly mobile (easily drop from a plant), without myrmecophily, habitat specialists, inhabit non-agricultural habitats and have sparse colonies. Differences in aphid wax production did not influence parasitoid host specificity and host-use. Our study is the first step in identifying host traits important for aphid parasitoid host specificity and host-use and improves our understanding of bottom-up effects of aphid traits on aphid-parasitoid food web structure.	[Gagic, Vesna] CSIRO, GPO Box 2583, Brisbane, Qld 4001, Australia; [Gagic, Vesna; Tomanovic, Zeljko] Univ Belgrade, Fac Biol, Inst Zool, Belgrade, Serbia; [Petrovic-Obradovic, Olivera] Univ Belgrade, Fac Agr, Belgrade, Serbia; [Fruend, Jochen] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Fruend, Jochen] Univ Gottingen, Agrarokol, D-37073 Gottingen, Germany; [Kavallieratos, Nickolas G.] Agr Univ Athens, Dept Crop Sci, Lab Agr Zool & Entomol, GR-11855 Athens, Greece; [Kavallieratos, Nickolas G.] Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Lab Agr Entomol, Attica, Greece; [Athanassiou, Christos G.] Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Lab Entomol & Agr Zool, Magnissia, Greece; [Stary, Petr] Acad Sci Czech Republic, Ctr Biol, Inst Entomol, Lab Aphidol,Dept Expt Ecol, Ceske Budejovice, Czech Republic	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Belgrade; University of Belgrade; University of Guelph; University of Gottingen; Agricultural University of Athens; University of Thessaly; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Gagic, V (corresponding author), CSIRO, GPO Box 2583, Brisbane, Qld 4001, Australia.; Gagic, V (corresponding author), Univ Belgrade, Fac Biol, Inst Zool, Belgrade, Serbia.	vesna.gagic@csiro.au	Gagic, Vesna/L-1203-2017; Athanassiou, Christos/ABE-8867-2020; Kavallieratos, Nickolas G./AAB-7500-2022; Fründ, Jochen/AAV-3105-2020	Gagic, Vesna/0000-0002-3214-7547; Kavallieratos, Nickolas G./0000-0001-5851-5013; Fründ, Jochen/0000-0002-7079-3478; Kavallieratos, Nickolas/0000-0003-4342-1289; Zeljko, Tomanovic/0000-0002-5063-5480	Multilateral European project [SEE-ERA.NET 9608]; Serbian Ministry of Education and Science [III43001]; German Research Foundation (DFG)	Multilateral European project; Serbian Ministry of Education and Science(Ministry of Education, Science & Technological Development, Serbia); German Research Foundation (DFG)(German Research Foundation (DFG))	The study was funded by the Multilateral European project SEE-ERA.NET 9608 and the Serbian Ministry of Education and Science (III43001). The research by P. S. was conducted with institutional support RVO: 60077344. J. F. was supported by a research fellowship of the German Research Foundation (DFG).	Askew R. R., 1994, P177; Blackman R.L., 2021, APHIDS WORLDS PLANTS; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Blackman R.L., 2000, J ECON ENTOMOL, V2; Bulgarella M, 2015, ECOL EVOL, V5, P3695, DOI 10.1002/ece3.1621; Cagnolo L, 2011, J ANIM ECOL, V80, P342, DOI 10.1111/j.1365-2656.2010.01778.x; CAPPUCCINO N, 1987, ECOLOGY, V68, P1634, DOI 10.2307/1939856; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Combes C, 1997, INT J PARASITOL, V27, P1, DOI 10.1016/S0020-7519(96)00168-3; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Desneux N, 2009, ANN ENTOMOL SOC AM, V102, P925, DOI 10.1603/008.102.0603; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Elias M, 2013, CURR BIOL, V23, P1355, DOI 10.1016/j.cub.2013.05.066; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; HAWKINS BA, 1990, J ANIM ECOL, V59, P57, DOI 10.2307/5158; HAWKINS BA, 1987, NATURE, V326, P788, DOI 10.1038/326788a0; HAWKINS BA, 1988, J ANIM ECOL, V57, P137, DOI 10.2307/4769; Heie O.E., 1995, FAUNA ENTOMOLOGICA S, V31; HEIE O.E., 1992, FAUNA ENTOMOLOGICA S, V25, P190; Heie OE, 1982, FAUNA ENTOMOLOGICA S, V9; Heie OE, 1994, FAUNA ENTOMOLOGICA S, V28; Heie OE, 1986, FAUNA ENTOMOLOGICA S, V17; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Henri DC, 2011, ADV ECOL RES, V45, P135, DOI 10.1016/B978-0-12-386475-8.00004-6; Henry LM, 2010, ECOL APPL, V20, P242, DOI 10.1890/08-1869.1; Hrcek J, 2013, OECOLOGIA, V173, P521, DOI 10.1007/s00442-013-2619-6; Husson F., 2017, FACTOMINER MULTIVARI, V1, P38; Husson F, 2010, CHAPMAN HALL CRC COM; Husson F, 2013, MISSMDA HANDLING MIS; Josse J, 2012, J CLASSIF, V29, P91, DOI 10.1007/s00357-012-9097-0; Kavallieratos NG, 2004, APPL ENTOMOL ZOOL, V39, P527, DOI 10.1303/aez.2004.527; Krasnov BR, 2004, INT J PARASITOL, V34, P1289, DOI 10.1016/j.ijpara.2004.08.003; LAWTON JH, 1979, J ANIM ECOL, V48, P619, DOI 10.2307/4183; Mackauer M., 1997, VERTICAL FOOD WEB IN, P191, DOI [10.1007/978-3-642-60725-7_11, DOI 10.1007/978-3-642-60725-7_11]; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; Petchey OL, 2008, AM NAT, V171, P568, DOI 10.1086/587068; Porter EE, 1998, OECOLOGIA, V116, P234, DOI 10.1007/s004420050584; Poulin R, 1998, ECOL LETT, V1, P118; Poulin R, 2004, EVOL ECOL, V18, P231, DOI 10.1023/B:EVEC.0000035029.55952.68; Poulin R, 2003, PARASITOLOGY, V126, P473, DOI 10.1017/S0031182003002993; R Development Core Team, 2014, R LANG ENV STAT COMP; Rasmann S, 2011, AM NAT, V177, P728, DOI 10.1086/659948; Raymond L, 2016, J PEST SCI, V89, P7, DOI 10.1007/s10340-015-0687-6; Rejmanek M., 1981, ENTOMOL SCAND S, V15, P341; Shaw Mark R., 1994, P111; SHEEHAN W, 1989, ECOLOGY, V70, P993, DOI 10.2307/1941367; Sloan D, 1994, AM NAT, V144, P692; Stadler B, 2002, J APPL ENTOMOL, V126, P258, DOI 10.1046/j.1439-0418.2002.00640.x; Stadler B., 1997, VERTICAL FOOD WEB IN, P241, DOI [10.1007/978-3-642-60725-7_14, DOI 10.1007/978-3-642-60725-7_14]; Stary P., 1970, BIOL APHID PARASITES; Stilmant D, 2008, OECOLOGIA, V156, P905, DOI 10.1007/s00442-008-1036-8; Stireman JO, 2003, ECOLOGY, V84, P296, DOI 10.1890/0012-9658(2003)084[0296:DOPHAI]2.0.CO;2; Stone GN, 2002, ANNU REV ENTOMOL, V47, P633, DOI 10.1146/annurev.ento.47.091201.145247; Straub CS, 2011, AM NAT, V177, P389, DOI 10.1086/658177; vanSteenis MJ, 1996, J INSECT BEHAV, V9, P283, DOI 10.1007/BF02213871; Vazquez DP, 2002, AM NAT, V159, P606, DOI 10.1086/339991; VOLKL W, 1992, J ANIM ECOL, V61, P273, DOI 10.2307/5320; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; [No title captured]	62	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157674	10.1371/journal.pone.0157674	http://dx.doi.org/10.1371/journal.pone.0157674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309729	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800120
J	Lewis, AM; Croughan, WD; Aranibar, N; Lee, AG; Warrack, B; Abu-Absi, NR; Patel, R; Drew, B; Borys, MC; Reily, MD; Li, ZJ				Lewis, Amanda M.; Croughan, William D.; Aranibar, Nelly; Lee, Alison G.; Warrack, Bethanne; Abu-Absi, Nicholas R.; Patel, Rutva; Drew, Barry; Borys, Michael C.; Reily, Michael D.; Li, Zheng Jian			Understanding and Controlling Sialylation in a CHO Fc-Fusion Process	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; GLYCOSYLATION PROFILE; INTERMITTENT HYPOXIA; ANTIOXIDANT DEFENSE; MONOCLONAL-ANTIBODY; DISSOLVED-OXYGEN; CELLS; DEHYDROGENASE; METABOLISM	A Chinese hamster ovary (CHO) bioprocess, where the product is a sialylated Fc-fusion protein, was operated at pilot and manufacturing scale and significant variation of sialylation level was observed. In order to more tightly control glycosylation profiles, we sought to identify the cause of variability. Untargeted metabolomics and transcriptomics methods were applied to select samples from the large scale runs. Lower sialylation was correlated with elevated mannose levels, a shift in glucose metabolism, and increased oxidative stress response. Using a 5-L scale model operated with a reduced dissolved oxygen set point, we were able to reproduce the phenotypic profiles observed at manufacturing scale including lower sialylation, higher lactate and lower ammonia levels. Targeted transcriptomics and metabolomics confirmed that reduced oxygen levels resulted in increased mannose levels, a shift towards glycolysis, and increased oxidative stress response similar to the manufacturing scale. Finally, we propose a biological mechanism linking large scale operation and sialylation variation. Oxidative stress results from gas transfer limitations at large scale and the presence of oxygen dead-zones inducing upregulation of glycolysis and mannose biosynthesis, and downregulation of hexosamine biosynthesis and acetyl-CoA formation. The lower flux through the hexosamine pathway and reduced intracellular pools of acetyl-CoA led to reduced formation of N-acetylglucosamine and N-acetylneuraminic acid, both key building blocks of N-glycan structures. This study reports for the first time a link between oxidative stress and mammalian protein sialyation. In this study, process, analytical, metabolomic, and transcriptomic data at manufacturing, pilot, and laboratory scales were taken together to develop a systems level understanding of the process and identify oxygen limitation as the root cause of glycosylation variability.	[Lewis, Amanda M.; Croughan, William D.; Lee, Alison G.; Abu-Absi, Nicholas R.; Patel, Rutva; Drew, Barry; Borys, Michael C.; Li, Zheng Jian] Bristol Myers Squibb Co, Global Mfg & Supply, Biol Dev, Devens, MA USA; [Aranibar, Nelly; Warrack, Bethanne; Reily, Michael D.] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ USA	Bristol-Myers Squibb; Bristol-Myers Squibb	Lewis, AM (corresponding author), Bristol Myers Squibb Co, Global Mfg & Supply, Biol Dev, Devens, MA USA.	amanda.lewis@bms.com		Lee, Alison/0000-0001-8305-3332	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	All authors declare a financial competing interest, based on paid employment by Bristol-Myers Squibb, who funded this research. This commercial affiliation does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Abu-Absi NR, 2014, PHARM BIOPROCESS, V2, DOI 10.4155/PBP.14.24; Agblevor FA, 2004, BIOTECHNOL LETT, V26, P1207, DOI 10.1023/B:BILE.0000036596.95796.42; Baker KN, 2001, BIOTECHNOL BIOENG, V73, P188, DOI 10.1002/bit.1051; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Butler M, 2006, CYTOTECHNOLOGY, V50, P57, DOI 10.1007/s10616-005-4537-x; Cartularo L, 2015, TOXICOL APPL PHARM, V288, P399, DOI 10.1016/j.taap.2015.08.011; CHOTIGEAT W, 1994, CYTOTECHNOLOGY, V15, P217, DOI 10.1007/BF00762396; Ciofani G, 2014, BBA-GEN SUBJECTS, V1840, P495, DOI 10.1016/j.bbagen.2013.10.009; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Corpas FJ, 1999, PLANT PHYSIOL, V121, P921, DOI 10.1104/pp.121.3.921; Downs CA, 2011, MICROVASC RES, V82, P311, DOI 10.1016/j.mvr.2011.09.013; Etchison JR, 1997, CLIN CHEM, V43, P533; Filosa S, 2003, BIOCHEM J, V370, P935, DOI 10.1042/BJ20021614; Funato Y, 2013, BIOCHEM BIOPH RES CO, V440, P737, DOI 10.1016/j.bbrc.2013.09.138; Go S, 2007, BIOCHEM BIOPH RES CO, V357, P537, DOI 10.1016/j.bbrc.2007.03.181; Graf A, 2013, INT J BIOCHEM CELL B, V45, P175, DOI 10.1016/j.biocel.2012.07.002; Hadziahmetovic M, 2011, AM J PATHOL, V179, P335, DOI 10.1016/j.ajpath.2011.03.033; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hnatyshyn S, 2013, BIOANALYSIS, V5, P1195, DOI [10.4155/BIO.13.86, 10.4155/bio.13.86]; Hossler P, 2009, GLYCOBIOLOGY; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kucharzewska P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116740; Kunkel JP, 1998, J BIOTECHNOL, V62, P55, DOI 10.1016/S0168-1656(98)00044-3; Lavie L, 2009, EUR RESPIR J, V33, P1467, DOI 10.1183/09031936.00086608; Lewis AM, 2015, BIOTECHNOLOGY BIOENG; Li F, 2006, BIOTECHNOL PROGR, V22, P696, DOI 10.1021/bp0504041; Liu B, 2014, J BIOTECHNOL, V170, P17, DOI 10.1016/j.jbiotec.2013.11.007; Liu X, 2015, NUCL FUNCTIONS PLANT, P81; Makarenko VV, 2014, AM J PHYSIOL-CELL PH, V306, pC745, DOI 10.1152/ajpcell.00313.2013; Markely LRA, 2010, ANAL BIOCHEM, V407, P128, DOI 10.1016/j.ab.2010.07.029; McAtee AG, 2014, PHARM BIOPROCESS, V2, P63, DOI 10.4155/PBP.13.65; McCracken NA, 2014, BIOTECHNOL PROGR, V30, P547, DOI 10.1002/btpr.1906; McLain AL, 2011, FREE RADICAL RES, V45, P29, DOI 10.3109/10715762.2010.534163; Morel Y, 1999, BIOCHEM J, V342, P481, DOI 10.1042/0264-6021:3420481; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Prabhakar NR, 2007, ANTIOXID REDOX SIGN, V9, P1397, DOI 10.1089/ars.2007.1732; Restelli V, 2006, BIOTECHNOL BIOENG, V94, P481, DOI 10.1002/bit.20875; RIGOBELLO MP, 1994, CELL BIOCHEM FUNCT, V12, P69, DOI 10.1002/cbf.290120110; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Senesi S, 2010, BIOL CHEM, V391, P1, DOI 10.1515/BC.2009.146; Sharma V, 2014, BIOCHEM BIOPH RES CO, V453, P220, DOI 10.1016/j.bbrc.2014.06.021; Shirato K, 2011, J CLIN BIOCHEM NUTR, V48, P20, DOI 10.3164/jcbn.11-015FR; Teruya R, 2013, ACTA CIR BRAS, V28, P848, DOI 10.1590/S0102-86502013001200007; Vexler ZS, 2003, BRAIN RES, V960, P90, DOI 10.1016/S0006-8993(02)03777-0; Visser WF, 2002, BIOCHEM BIOPH RES CO, V299, P494, DOI 10.1016/S0006-291X(02)02663-3; Wong DCF, 2010, BIOTECHNOL BIOENG, V107, P516, DOI 10.1002/bit.22828; Wong NSC, 2010, BIOTECHNOL BIOENG, V107, P321, DOI 10.1002/bit.22812; Xing ZZ, 2009, BIOTECHNOL BIOENG, V103, P733, DOI 10.1002/bit.22287; Zhou XF, 2009, PLANT J, V60, P79, DOI 10.1111/j.1365-313X.2009.03931.x	51	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157111	10.1371/journal.pone.0157111	http://dx.doi.org/10.1371/journal.pone.0157111			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310468	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800034
J	McNeilly, C; Cosh, S; Vu, T; Nichols, J; Henningham, A; Hofmann, A; Fane, A; Smeesters, PR; Rush, CM; Hafner, LM; Ketheesan, N; Sriprakash, KS; McMillan, DJ				McNeilly, Celia; Cosh, Samantha; Vu, Therese; Nichols, Jemma; Henningham, Anna; Hofmann, Andreas; Fane, Anne; Smeesters, Pierre R.; Rush, Catherine M.; Hafner, Louise M.; Ketheesan, Natkuman; Sriprakash, Kadaba S.; McMillan, David J.			Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; M-PROTEIN; RHEUMATIC-FEVER; ANTIBODIES; EMM; COLONIZATION; IMMUNIZATION; PERSISTENCE; PROTECTION; DIVERSITY	The C-terminal region of the M-protein of Streptococcus pyogenes is a major target for vaccine development. The major feature is the C-repeat region, consisting of 35-42 amino acid repeat units that display high but not perfect identity. SV1 is a S. pyogenes vaccine candidate that incorporates five 14mer amino acid sequences (called J14(i) variants) from differing C-repeat units in a single recombinant construct. Here we show that the J14(i) variants chosen for inclusion in SV1 are the most common variants in a dataset of 176 unique M-proteins. Murine antibodies raised against SV1 were shown to bind to each of the J14(i) variants present in SV1, as well as variants not present in the vaccine. Antibodies raised to the individual J14(i) variants were also shown to bind to multiple but different combinations of J14(i) variants, supporting the underlying rationale for the design of SV1. A Lewis Rat Model of valvulitis was then used to assess the capacity of SV1 to induce deleterious immune response associated with rheumatic heart disease. In this model, both SV1 and the M5 positive control protein were immunogenic. Neither of these antibodies were cross-reactive with cardiac myosin or collagen. Splenic T cells from SV1/CFA and SV1/alum immunized rats did not proliferate in response to cardiac myosin or collagen. Subsequent histological examination of heart tissue showed that 4 of 5 mice from the M5/CFA group had valvulitis and inflammatory cell infiltration into valvular tissue, whereas mice immunised with SV1/CFA, SV1/alum showed no sign of valvulitis. These results suggest that SV1 is a safe vaccine candidate that will elicit antibodies that recognise the vast majority of circulating GAS M-types.	[McNeilly, Celia; Cosh, Samantha; Vu, Therese; Sriprakash, Kadaba S.; McMillan, David J.] QIMR Berghofer Med Res Inst, Bacterial Pathogenesis Lab, 300 Herston Rd, Herston, Qld 4006, Australia; [Nichols, Jemma; McMillan, David J.] Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Qld 4558, Australia; [Henningham, Anna] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia; [Henningham, Anna] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Hofmann, Andreas] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Struct Chem Program, Nathan, Qld 4111, Australia; [Hofmann, Andreas] Queensland Trop Hlth Alliance, Smithfield, Qld, Australia; [Fane, Anne; Rush, Catherine M.; Ketheesan, Natkuman] James Cook Univ, Australian Inst Trop Med, Townsville, Qld 4811, Australia; [Smeesters, Pierre R.] Univ Libre Bruxelles, Fac Sci, Inst Biol & Med Mol, Lab Genet & Physiol Bacterienne, Gosselies, Belgium; [Smeesters, Pierre R.] Murdoch Children Res Inst, Melbourne, Vic 3052, Australia; [Hafner, Louise M.] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Brisbane, Qld 4001, Australia; [Hafner, Louise M.] Queensland Univ Technol, IHBI, Brisbane, Qld 4001, Australia	QIMR Berghofer Medical Research Institute; University of the Sunshine Coast; University of Queensland; University of Queensland; Griffith University; James Cook University; Universite Libre de Bruxelles; Murdoch Children's Research Institute; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	McMillan, DJ (corresponding author), QIMR Berghofer Med Res Inst, Bacterial Pathogenesis Lab, 300 Herston Rd, Herston, Qld 4006, Australia.; McMillan, DJ (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Qld 4558, Australia.	david.mcmillan@usc.edu.au	Hofmann, Andreas/M-9870-2019; Henningham, Anna/C-7355-2017; McMillan, David/P-5582-2016; Rush, Catherine M/L-4308-2013; Cosh, Samantha/M-6363-2016; Smeesters, Pierre/I-7723-2012	Hofmann, Andreas/0000-0003-4408-5467; Henningham, Anna/0000-0002-0554-6593; McMillan, David/0000-0002-9339-0639; Rush, Catherine M/0000-0002-3044-9488; Cosh, Samantha/0000-0002-0679-2067; Smeesters, Pierre/0000-0002-2642-9919; Ketheesan, Natkunam/0000-0002-4870-706X; Sriprakash, Kadaba/0000-0001-7844-323X; Vu, Therese/0000-0003-2831-2957	National Health and Medical Research Council of Australia; National Heart Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation(National Heart Foundation of Australia)	This work was funded by the National Health and Medical Research Council of Australia and National Heart Foundation. The funders had no role in the study design, data analysis, and preparation of the manuscript or decision to submit the article for publication.; This work was funded by the National Health and Medical Research Council of Australia and National Heart Foundation. The funders had no role in the study design, data analysis, and preparation of the manuscript or decision to submit the article for publication. Members of the M-protein study group provided the isolates that emm-sequences were derived from for analysis of the distribution of J14<INF>i</INF>.	Abdissa A, 2006, CLIN INFECT DIS, V42, P1362, DOI 10.1086/503422; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Batzloff MR, 2005, J INFECT DIS, V192, P1450, DOI 10.1086/466528; Batzloff MR, 2003, J INFECT DIS, V187, P1598, DOI 10.1086/374800; Bauer MJ, 2012, VACCINE, V30, P2197, DOI 10.1016/j.vaccine.2011.12.115; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; BESSEN D, 1990, J IMMUNOL, V145, P1251; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Cunningham MW, 1997, INFECT IMMUN, V65, P3913, DOI 10.1128/IAI.65.9.3913-3923.1997; Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005; Dale JB, 1999, VACCINE, V17, P193, DOI 10.1016/S0264-410X(98)00150-9; De Amicis KM, 2014, VACCINE, V32, P4104, DOI 10.1016/j.vaccine.2013.08.043; Dinkla K, 2007, MICROBES INFECT, V9, P922, DOI 10.1016/j.micinf.2007.03.011; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Good MF, 2013, HUM VACC IMMUNOTHER, V9, P2393, DOI 10.4161/hv.25506; Gorton D, 2009, INFECT IMMUN, V77, P2177, DOI 10.1128/IAI.01514-08; Gryllos L, 2001, MOL MICROBIOL, V42, P61; Guilherme L, 2013, AM J CARDIOVASC DRUG, V13, P1, DOI 10.1007/s40256-013-0005-8; Henningham A, 2013, MBIO, V4, DOI 10.1128/mBio.00509-13; Hofmann A, 2009, J APPL CRYSTALLOGR, V42, P137, DOI 10.1107/S0021889808037229; Ji YD, 1997, INFECT IMMUN, V65, P2080, DOI 10.1128/IAI.65.6.2080-2087.1997; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; LANCEFIELD RC, 1959, J EXP MED, V110, P271, DOI 10.1084/jem.110.2.271; McMillan DJ, 2013, CLIN MICROBIOL INFEC, V19, pE222, DOI 10.1111/1469-0691.12134; McMillan DJ, 2004, FEMS IMMUNOL MED MIC, V40, P249, DOI 10.1016/S0928-8244(04)00003-3; Parks T, 2012, CURR OPIN INFECT DIS, V25, P145, DOI 10.1097/QCO.0b013e3283511d27; PHILLIPS GN, 1981, P NATL ACAD SCI-BIOL, V78, P4689, DOI 10.1073/pnas.78.8.4689; Postol E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060969; Rush CM, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00116; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; SCOTT JR, 1986, J EXP MED, V164, P1641, DOI 10.1084/jem.164.5.1641; Smeesters PR, 2008, VACCINE, V26, P5835, DOI 10.1016/j.vaccine.2008.08.037; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Steer AC, 2009, J CLIN MICROBIOL, V47, P2502, DOI 10.1128/JCM.00312-09; Tamayo E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-233; van Sorge NM, 2014, CELL HOST MICROBE, V15, P729, DOI 10.1016/j.chom.2014.05.009; Veasy LG, 2004, PEDIATRICS, V113, pE168, DOI 10.1542/peds.113.3.e168; Vohra H, 2005, RES MICROBIOL, V156, P575, DOI 10.1016/j.resmic.2004.12.009; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Weeratunga S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-201	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156639	10.1371/journal.pone.0156639	http://dx.doi.org/10.1371/journal.pone.0156639			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310707	gold, Green Published, Green Accepted			2022-12-27	WOS:000378029800010
J	van den Dungen, P; van Charante, EPM; van de Ven, PM; van Marwijk, HWJ; van der Horst, HE; van Hout, HPJ				van den Dungen, Pim; van Charante, Eric P. Moll; van de Ven, Peter M.; van Marwijk, Harm W. J.; van der Horst, Henriette E.; van Hout, Hein P. J.			Case Finding of Mild Cognitive Impairment and Dementia and Subsequent Care; Results of a Cluster RCT in Primary Care	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ALZHEIMERS-DISEASE; GENERAL-PRACTITIONERS; SIGNIFICANT OTHERS; GROUP-THERAPY; DIAGNOSIS; DISCLOSURE; INTERVENTIONS; CAREGIVERS; CAMCOG	Purpose Despite a call for earlier diagnosis of dementia, the diagnostic yield of case finding and its impact on the mental health of patients and relatives are unclear. This study assessed the effect of a two-component intervention of case finding and subsequent care on these outcomes. Methods In a cluster RCT we assessed whether education of family physicians (FPs; trial stage 1) resulted in more mild cognitive impairment (MCI) and dementia diagnoses among older persons in whom FPs suspected cognitive decline and whether case finding by a practice nurse and the FP (trial stage 2) added to this number of diagnoses. In addition, we assessedmental health effects of case finding and subsequent care (trial stage 2). FPs of 15 primary care practices (PCPs = clusters) judged the cognitive status of all persons >= 65 years. The primary outcome, new MCI and dementia diagnoses by FPs after 12months as indicated on a list, was assessed among all persons in whom FPs suspected cognitive impairment but without a formal diagnosis of dementia. The secondary outcome, mental health of patients and their relatives, was assessed among persons consenting to participate in trial stage 2. Trial stage 1 consisted of either intervention component 1: training FPs to diagnoseMCI and dementia, or control: no training. Trial stage 2 consisted of either intervention component 2: case finding of MCI and dementia and care by a trained nurse and the FP, or control: care as usual. Results Seven PCPs were randomized to the intervention; eight to the control condition. MCI or dementia was diagnosed in 42.3% (138/326) of persons in the intervention, and in 30.5% 98/321) in the control group (estimated difference GEE: 10.8%, OR: 1.51, 95%-CI 0.60-3.76). Among patients and relatives who consented to stage 2 of the trial (n = 145; 25%), there were no differences in mental health between the intervention and control group. Conclusions We found a non-significant increase in the number of new MCI diagnoses. As we cannot exclude a clinically relevant effect, a larger study is warranted to replicate ours.	[van den Dungen, Pim; van Marwijk, Harm W. J.; van der Horst, Henriette E.; van Hout, Hein P. J.] Vrije Univ Amsterdam, Dept Gen Practice & Elderly Care Med, EMGO Inst Hlth & Care Res, Med Ctr Amsterdam, Amsterdam, Netherlands; [van Charante, Eric P. Moll] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van de Ven, Peter M.] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr Amsterdam, Amsterdam, Netherlands; [van Marwijk, Harm W. J.] Univ Manchester, Primary Care Res Ctr, Inst Populat Hlth, Manchester, Lancs, England	Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Manchester	van den Dungen, P (corresponding author), Vrije Univ Amsterdam, Dept Gen Practice & Elderly Care Med, EMGO Inst Hlth & Care Res, Med Ctr Amsterdam, Amsterdam, Netherlands.	p.vandendungen@vumc.nl	van Charante, Eric Moll/L-4856-2019; Van Marwijk, Harm/K-6306-2013	van Charante, Eric Moll/0000-0002-1489-5218; Van Marwijk, Harm/0000-0001-6206-485X; van Hout, Hein/0000-0002-2495-4808	National Care for the Elderly Programme (ZonMw) [60-61900-98-279]; charitable Stoffels-Hornstra Foundation	National Care for the Elderly Programme (ZonMw); charitable Stoffels-Hornstra Foundation	This study is funded by a governmental grant from the National Care for the Elderly Programme (ZonMw no. 60-61900-98-279) and by a grant from the charitable Stoffels-Hornstra Foundation, a non-profit organisation supporting research in cancer, brain diseases, cardiovascular disease and eye diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aminzadeh F, 2012, CAN GERIATR J, V15, P85, DOI 10.5770/cgj.15.42; [Anonymous], 2012, DEMENTIA GUIDELINE D; Banningh LJW, 2008, INT J GERIATR PSYCH, V23, P148, DOI 10.1002/gps.1855; Banningh LWAJW, 2013, DEMENTIA-LONDON, V12, P81, DOI 10.1177/1471301211420332; Banningh LWAJW, 2011, GERONTOLOGY, V57, P444, DOI 10.1159/000315933; Beard RL, 2013, SOCIOL HEALTH ILL, V35, P130, DOI 10.1111/j.1467-9566.2012.01481.x; Birks JS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001191.pub3; Bradford A, 2009, ALZ DIS ASSOC DIS, V23, P306, DOI 10.1097/WAD.0b013e3181a6bebc; Burgener SC, 2015, DEMENTIA-LONDON, V14, P609, DOI 10.1177/1471301213504202; Burgener SC, 2015, DEMENTIA-LONDON, V14, P589, DOI 10.1177/1471301213508399; Cahill S, 2006, INT J GERIATR PSYCH, V21, P319, DOI 10.1002/gps.1464; Carpenter B, 2004, GERONTOLOGIST, V44, P149, DOI 10.1093/geront/44.2.149; Chodosh J, 2007, J AM GERIATR SOC, V55, P1260, DOI 10.1111/j.1532-5415.2007.01249.x; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; Creavin S, 2015, BRIT J GEN PRACT, V65, pE489, DOI 10.3399/bjgp15X686053; Dean K, 2012, INT PSYCHOGERIATR, V24, P871, DOI 10.1017/S104161021100264X; Derksen E, 2006, AGING MENT HEALTH, V10, P525, DOI 10.1080/13607860600638024; Draper B, 2010, ALZHEIMERS DEMENT, V6, P75, DOI 10.1016/j.jalz.2009.04.1229; Gallagher D, 2010, INT J GERIATR PSYCH, V25, P1280, DOI 10.1002/gps.2480; Garand L, 2014, AM J GERIAT PSYCHIAT, V22, P771, DOI 10.1016/j.jagp.2013.07.007; Gove D, 2016, AGING MENT HEALTH, V20, P391, DOI 10.1080/13607863.2015.1015962; Grundmeijer Hans G L M, 2011, Ned Tijdschr Geneeskd, V155, pA3821; Guidelines & Protocols Advisory Committee of the Ministry of Health of British Columbia, 2014, COGN IMP REC DIAGN M; Hayashi S, 2013, INT PSYCHOGERIATR, V25, P1357, DOI 10.1017/S1041610213000537; Hirdes J., 2009, INTERRAI HOME CARE H; HUPPERT FA, 1995, BRIT J CLIN PSYCHOL, V34, P529, DOI 10.1111/j.2044-8260.1995.tb01487.x; Julayanont P, 2014, J AM GERIATR SOC, V62, P679, DOI 10.1111/jgs.12742; Kempen G I, 1995, Tijdschr Gerontol Geriatr, V26, P163; Klekociuk SZ, 2014, EUR J NEUROL, V21, P1330, DOI 10.1111/ene.12488; Lee SM, 2014, DEMENTIA-LONDON, V13, P289, DOI 10.1177/1471301213497080; Lindeboom J, 2002, J NEUROL NEUROSUR PS, V73, P126, DOI 10.1136/jnnp.73.2.126; Mate KE, 2012, INT PSYCHOGERIATR, V24, P1962, DOI 10.1017/S1041610212001111; Milby E, 2017, DEMENTIA-LONDON, V16, P611, DOI 10.1177/1471301215612676; Moore V, 2013, AGING MENT HEALTH, V17, P77, DOI 10.1080/13607863.2012.692763; Mormont E, 2014, J GERIATR PSYCH NEUR, V27, P231, DOI 10.1177/0891988714532021; Mukadam N, 2015, INT J GERIATR PSYCH, V30, P32, DOI 10.1002/gps.4184; Murray E, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-63; NICE, 2006, DEM SUPP PEOPL DEM T, V42; Olafsdottir M, 2001, SCAND J PRIM HEALTH, V19, P194, DOI 10.1080/028134301316982469; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; Parlevliet JL, 2016, INT J GERIATR PSYCH, V31, P1040, DOI 10.1002/gps.4417; Pentzek M, 2009, AM J GERIAT PSYCHIAT, V17, P965, DOI 10.1097/JGP.0b013e3181b2075e; Perry M, 2008, INT J GERIATR PSYCH, V23, P1312, DOI 10.1002/gps.2128; Perry M., 2011, THESIS; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610206003462; Reilly S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008345.pub2; Rickenbach EH, 2015, PSYCHOL AGING, V30, P420, DOI 10.1037/a0038973; Roberto KA, 2011, J GERONTOL B-PSYCHOL, V66, P756, DOI 10.1093/geronb/gbr107; Rondeau V., 2008, DEMENTIA, V7, P433, DOI DOI 10.1177/1471301208096628; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Ryan KA, 2010, ALZ DIS ASSOC DIS, V24, P171, DOI 10.1097/WAD.0b013e3181aba90d; Salmon DP, 2002, NEUROLOGY, V59, P1022, DOI 10.1212/WNL.59.7.1022; Schmand B, 2000, PSYCHOL MED, V30, P619, DOI 10.1017/S0033291799002068; Smith AP, 2001, CAN J NEUROL SCI, V28, pS67, DOI 10.1017/S0317167100001220; Spijker A, 2008, J AM GERIATR SOC, V56, P1116, DOI 10.1111/j.1532-5415.2008.01705.x; Stewart TV, 2014, J AM BOARD FAM MED, V27, P275, DOI 10.3122/jabfm.2014.02.120284; van den Dungen P, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0105-1; van den Dungen P, 2014, INT PSYCHOGERIATR, V26, P1603, DOI 10.1017/S1041610214000969; van den Dungen P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-609; van den Dungen P, 2012, INT J GERIATR PSYCH, V27, P342, DOI 10.1002/gps.2726; van Hout H, 2000, PATIENT EDUC COUNS, V39, P219, DOI 10.1016/S0738-3991(99)00034-8; Vernooij-Dassen M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005318.pub2; Vroomen JM, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.06.011; Waldorff FB, 2003, SCAND J PRIM HEALTH, V21, P142, DOI 10.1080/02813430310005136; Wells RE, 2013, J AM GERIATR SOC, V61, P642, DOI 10.1111/jgs.12179; Wilcock J, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-397; Wilson J JG, 1968, PUBLIC HLTH PAPERS, V34; Woods B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005562.pub2; Wray LO, 2014, AM J GERIAT PSYCHIAT, V22, P1282, DOI 10.1016/j.jagp.2013.04.018	72	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156958	10.1371/journal.pone.0156958	http://dx.doi.org/10.1371/journal.pone.0156958			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310616	gold, Green Accepted, Green Published			2022-12-27	WOS:000378029800022
J	Bawah, A; Houle, B; Alam, N; Razzaque, A; Streatfield, PK; Debpuur, C; Welaga, P; Oduro, A; Hodgson, A; Tollman, S; Collinson, M; Kahn, K; Toan, TK; Phuc, HD; Chuc, NTK; Sankoh, O; Clark, SJ				Bawah, Ayaga; Houle, Brian; Alam, Nurul; Razzaque, Abdur; Streatfield, Peter Kim; Debpuur, Cornelius; Welaga, Paul; Oduro, Abraham; Hodgson, Abraham; Tollman, Stephen; Collinson, Mark; Kahn, Kathleen; Tran Khan Toan; Ho Dang Phuc; Nguyen Thi Kim Chuc; Sankoh, Osman; Clark, Samuel J.			The Evolving Demographic and Health Transition in Four Low- and Middle-Income Countries: Evidence from Four Sites in the INDEPTH Network of Longitudinal Health and Demographic Surveillance Systems	PLOS ONE			English	Article							EPIDEMIOLOGIC TRANSITION; NONCOMMUNICABLE DISEASES; POPULATION; MORTALITY; COVERAGE; AFRICA; POOR	This paper contributes evidence documenting the continued decline in all-cause mortality and changes in the cause of death distribution over time in four developing country populations in Africa and Asia. We present levels and trends in age-specific mortality (all-cause and cause-specific) from four demographic surveillance sites: Agincourt (South Africa), Navrongo (Ghana) in Africa; Filabavi (Vietnam), Matlab (Bangladesh) in Asia. We model mortality using discrete time event history analysis. This study illustrates how data from INDEPTH Network centers can provide a comparative, longitudinal examination of mortality patterns and the epidemiological transition. Health care systems need to be reconfigured to deal simultaneously with continuing challenges of communicable disease and increasing incidence of non-communicable diseases that require long-term care. In populations with endemic HIV, long-term care of HIV patients on ART will add to the chronic care needs of the community.	[Bawah, Ayaga] Univ Ghana, RIPS, Legon, Ghana; [Houle, Brian] Australian Natl Univ, Sch Demog, Canberra, ACT, Australia; [Houle, Brian; Tollman, Stephen; Collinson, Mark; Kahn, Kathleen; Clark, Samuel J.] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, MRC Wits Rural Publ Hlth Transit Res Unit Agincou, Johannesburg, South Africa; [Houle, Brian; Clark, Samuel J.] Univ Colorado, Inst Behav Sci, CU Populat Ctr, Boulder, CO 80309 USA; [Alam, Nurul; Razzaque, Abdur; Streatfield, Peter Kim] Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh; [Debpuur, Cornelius; Welaga, Paul; Oduro, Abraham; Hodgson, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Tollman, Stephen; Collinson, Mark; Kahn, Kathleen] Umea Univ, Div Epidemiol & Global Hlth, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res, Umea, Sweden; [Bawah, Ayaga; Tollman, Stephen; Collinson, Mark; Kahn, Kathleen; Sankoh, Osman; Clark, Samuel J.] INDEPTH Network, Accra, Ghana; [Tran Khan Toan; Ho Dang Phuc; Nguyen Thi Kim Chuc] Filabavi Hlth & Demog Surveillance Site, Hanoi, Vietnam; [Clark, Samuel J.] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Clark, Samuel J.] London Sch Hyg & Trop Med, ALPHA Network, London WC1, England; [Bawah, Ayaga] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	University of Ghana; Australian National University; University of Witwatersrand; University of Colorado System; University of Colorado Boulder; International Centre for Diarrhoeal Disease Research (ICDDR); Navrongo Health Research Center; Umea University; INDEPTH Network; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine; Columbia University	Houle, B (corresponding author), Australian Natl Univ, Sch Demog, Canberra, ACT, Australia.; Houle, B (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, MRC Wits Rural Publ Hlth Transit Res Unit Agincou, Johannesburg, South Africa.; Houle, B (corresponding author), Univ Colorado, Inst Behav Sci, CU Populat Ctr, Boulder, CO 80309 USA.	brian.houle@anu.edu.au	Clark, Samuel J/A-8419-2009; Tran, Toan K/O-7671-2017; Sankoh, Osman/ABB-3755-2020	Clark, Samuel J/0000-0002-4929-6231; Tran, Toan K/0000-0002-5902-749X; Sankoh, Osman/0000-0003-4405-9808; Alam, Nurul/0000-0002-1202-4451; Kahn, Kathleen/0000-0003-3339-3931; Tollman, Stephen/0000-0003-0744-7588; Houle, Brian/0000-0003-2157-3118; Debpuur, Cornelius/0000-0003-0968-5280; ODURO, ABRAHAM/0000-0002-4191-7419	Canadian International Development Research Center [IDRC: 105727-001]	Canadian International Development Research Center	This work has been funded by a grant from the Canadian International Development Research Center (IDRC: 105727-001) made to the INDEPTH Network and administrative support from the INDEPTH Network Secretariat.	Allison P.D., 1984, EVENT HIST ANAL REGR; Byass P, 2014, GLOBAL HEALTH ACTION, V7, P158, DOI 10.3402/gha.v7.23359; CALDWELL JC, 1986, POPUL DEV REV, V12, P171, DOI 10.2307/1973108; Defo BK, 2014, GLOBAL HEALTH ACTION, V7, P17, DOI 10.3402/gha.v7.22443; Gwatkin DR, 1997, BRIT MED J, V315, P497, DOI 10.1136/bmj.315.7107.497; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; John TJ, 2011, LANCET, V377, P252, DOI 10.1016/S0140-6736(10)61265-2; Kahn K, 2006, AGING SUBSAHARAN AFR, P166; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kowal P, 2010, GLOBAL HEALTH ACTION, V3, P11, DOI 10.3402/gha.v3i0.5302; Long N, 2002, FILABAVI DEMOGRAPHIC, P305; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MCKEOWN T, 1972, POP STUD-J DEMOG, V26, P345, DOI 10.2307/2173815; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nyarko P, 2002, NAVRONGO DEMOGRAPHIC, P247; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Preston S. H., 1991, FATAL YEARS CHILD MO; Razzaque A, 2002, MATLAB DEMOGRAPHIC S, P287; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Sankoh O, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23286; Sankoh O, 2012, INT J EPIDEMIOL, V41, P579, DOI 10.1093/ije/dys081; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; The World Bank Group, 2015, WORLD BANK ANN REP 2; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; Unwin N, 2001, B WORLD HEALTH ORGAN, V79, P947; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5	28	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157281	10.1371/journal.pone.0157281	http://dx.doi.org/10.1371/journal.pone.0157281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304429	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000377824800044
J	Che, LQ; Hu, L; Liu, Y; Yan, C; Peng, X; Xu, Q; Wang, R; Cheng, YF; Chen, H; Fang, ZF; Lin, Y; Xu, SY; Feng, B; Chen, DW; Wu, D				Che, Lianqiang; Hu, Liang; Liu, Yan; Yan, Chuan; Peng, Xie; Xu, Qin; Wang, Ru; Cheng, Yuanfang; Chen, Hong; Fang, Zhengfeng; Lin, Yan; Xu, Shengyu; Feng, Bin; Chen, Daiwen; Wu, De			Dietary Nucleotides Supplementation Improves the Intestinal Development and Immune Function of Neonates with Intra-Uterine Growth Restriction in a Pig Model	PLOS ONE			English	Article							FORMULA-FED INFANTS; TOLL-LIKE RECEPTORS; NECROTIZING ENTEROCOLITIS; EXOGENOUS NUCLEOTIDES; GUT STRUCTURE; PERFORMANCE; IUGR; PROLIFERATION; RETARDATION; DIFFERENTIATION	The current study aimed to determine whether dietary nucleotides supplementation could improve growth performance, intestinal development and immune function of intra-uterine growth restricted (IUGR) neonate using pig as animal model. A total of 14 pairs of normal birth weight (NBW) and IUGR piglets (7 days old) were randomly assigned to receive a milk-based control diet (CON diet) or diet supplemented with nucleotides (NT diet) for a period of 21 days. Blood samples, intestinal tissues and digesta were collected at necropsy and analyzed for morphology, digestive enzyme activities, microbial populations, peripheral immune cells, expression of intestinal innate immunity and barrier-related genes and proteins. Compared with NBW piglets, IUGR piglets had significantly lower average daily dry matter intake and body weight gain (P<0.05). Moreover, IUGR markedly decreased the villous height and villi: crypt ratio in duodenum (P<0.05), as well as the maltase activity in jejunum (P<0.05). In addition, IUGR significantly decreased the serum concentrations of IgA, IL-1 beta and IL-10 (P<0.05), as well as the percentage of peripheral lymphocytes (P<0.05). Meanwhile, the down-regulation of innate immunity-related genes such as TOLLIP (P<0.05), TLR-9 (P = 0.08) and TLR-2 (P = 0.07) was observed in the ileum of IUGR relative to NBW piglets. Regardless of birth weight, however, feeding NT diet markedly decreased (P<0.05) feed conversion ratio, increased the villous height in duodenum(P<0.05), activities of lactase and maltase in jejunum (P<0.05), count of peripheral leukocytes (P<0.05), serum concentrations of IgA and IL-1 beta as well as gene expressions of TLR-9, TLR-4 and TOLLIP in ileum (P<0.05). In addition, expressions of tight junction proteins (Claudin-1 and ZO-1) in ileum were markedly increased by feeding NT diet relative to CON diet (P<0.05). These results indicated that IUGR impaired growth performance, intestinal and immune function, but dietary nucleotides supplementation improved nutrients utilization, intestinal function and immunity.	[Che, Lianqiang; Hu, Liang; Liu, Yan; Yan, Chuan; Peng, Xie; Xu, Qin; Wang, Ru; Cheng, Yuanfang; Fang, Zhengfeng; Lin, Yan; Xu, Shengyu; Feng, Bin; Chen, Daiwen; Wu, De] Sichuan Agr Univ, Inst Anim Nutr, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China; [Chen, Hong] Sichuan Agr Univ, Coll Food Sci, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China; [Cheng, Yuanfang] Tongwei Grp Co Ltd, Inst Livestock Nutr, 588 Tianfu Rd, Chengdu 610041, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Che, LQ (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China.	clianqiang@hotmail.com	Xu, Shengyu/AFN-8288-2022	Xu, Shengyu/0000-0002-4415-8542	National Natural Science Foundation of China [31101727]; International Cooperation in Science and Technology Project of Sichuan Province [2014HH0034]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13083]; Development Plan for Sichuan Strategically New Products [2015GZX0011]; Tongwei group Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation in Science and Technology Project of Sichuan Province; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Development Plan for Sichuan Strategically New Products; Tongwei group Co., Ltd.	The present study was supported by the National Natural Science Foundation of China (31101727), the International Cooperation in Science and Technology Project of Sichuan Province (2014HH0034), the Program for Changjiang Scholars and Innovative Research Team in University (IRT13083), and the Development Plan for Sichuan Strategically New Products (2015GZX0011). Tongwei group Co., Ltd., partly provided support in the form of salaries for YC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of Yuanfang Cheng are articulated in the 'author contributions' section.	Alexandre-Gouabau MC, 2011, J PROTEOME RES, V10, P3292, DOI 10.1021/pr2003193; Aly H, 2013, J MATERN-FETAL NEO M, V26, P388, DOI 10.3109/14767058.2012.733767; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Andres-Elias N, 2007, LIVEST SCI, V108, P280, DOI 10.1016/j.livsci.2007.01.080; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; CARVER JD, 1994, J NUTR, V124, pS144, DOI 10.1093/jn/124.suppl_1.144S; Castaneda-Gutierrez E, 2014, ACTA PHYSIOL, V210, P161, DOI 10.1111/apha.12145; Che LQ, 2010, PEDIATR RES, V67, P54, DOI 10.1203/PDR.0b013e3181c1b15e; Chen L, 2016, J DEV ORIG HLTH DIS, V7, P91, DOI 10.1017/S2040174415007242; Chen Y, 2012, BRIT J NUTR, V108, P1069, DOI 10.1017/S0007114511006350; Chiesa C, 2008, CLIN CHEM, V54, P550, DOI 10.1373/clinchem.2007.095299; Cicalese L, 2016, J GASTROINTEST SURG, V20, P34, DOI 10.1007/s11605-015-2974-1; Cortes-Barberena E, 2013, CELL PROLIFERAT, V46, P164, DOI 10.1111/cpr.12019; Cosgrove M, 1996, ARCH DIS CHILD-FETAL, V74, pF122, DOI 10.1136/fn.74.2.F122; D'Inca R, 2011, NEONATOLOGY, V99, P208, DOI 10.1159/000314919; Dancey CP, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-16; Dourmad JY, 1998, J ANIM SCI, V76, P542; Ferenc K, 2014, REPROD BIOL, V14, P51, DOI 10.1016/j.repbio.2014.01.005; Gil A, 2002, EUR J CLIN NUTR, V56, pS1, DOI 10.1038/sj.ejcn.1601475; Hackam DJ, 2013, SEMIN PEDIATR SURG, V22, P76, DOI 10.1053/j.sempedsurg.2013.01.003; Han F, 2013, BRIT J NUTR, V110, P1819, DOI 10.1017/S0007114513001232; Hawkes JS, 2006, EUR J CLIN NUTR, V60, P254, DOI 10.1038/sj.ejcn.1602310; He JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136848; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; Hu L, 2015, BRIT J NUTR, V114, P53, DOI 10.1017/S0007114515001579; Jamin A, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/545341; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Lee DN, 2007, J ANIM PHYSIOL AN N, V91, P508, DOI 10.1111/j.1439-0396.2007.00684.x; Liu JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034835; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansoori B, 2009, ANIM FEED SCI TECH, V148, P301, DOI 10.1016/j.anifeedsci.2008.04.009; Mateo CD, 2004, J ANIM SCI, V82, P1339; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Nanthakumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017776; Neumann CG, 1998, NUTR RES, V18, P201, DOI 10.1016/S0271-5317(98)00013-X; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Rosero DS, 2015, BRIT J NUTR, V114, P1985, DOI 10.1017/S000711451500392X; Rueda-Clausen CF, 2011, DIABETES, V60, P507, DOI 10.2337/db10-1239; Sangild PT, 2006, EXP BIOL MED, V231, P1695, DOI 10.1177/153537020623101106; Sanz-Cortes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080121; Sato N, 1999, J NUTR SCI VITAMINOL, V45, P107, DOI 10.3177/jnsv.45.107; Sauer N, 2012, J ANIM SCI, V90, P3126, DOI 10.2527/jas.2011-4417; Sauer N, 2011, NUTR RES REV, V24, P46, DOI 10.1017/S0954422410000326; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Singhal A, 2008, AM J CLIN NUTR, V87, P1785, DOI 10.1093/ajcn/87.6.1785; Singhal A, 2010, PEDIATRICS, V126, pE946, DOI 10.1542/peds.2009-2609; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tanaka M, 1996, J NUTR, V126, P424, DOI 10.1093/jn/126.2.424; Thureen P, 2005, PEDIATR RES, V57, p95R, DOI 10.1203/01.PDR.0000160434.69916.34; TSUJINAKA T, 1993, NUTRITION, V9, P532; Tzschoppe A, 2011, CLIN ENDOCRINOL, V74, P459, DOI 10.1111/j.1365-2265.2010.03943.x; Wang T, 2005, BIOL NEONATE, V88, P66, DOI 10.1159/000084645; Wu BangYuan, 2012, Health, V4, P32, DOI 10.4236/health.2012.41007; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Xu DX, 2005, TOXICOL SCI, V88, P525, DOI 10.1093/toxsci/kfi300; YANG SL, 1983, OBSTET GYNECOL, V62, P561; Zanardo V, 2015, J MATERN-FETAL NEO M, V28, P362, DOI 10.3109/14767058.2014.916684; Zhang BK, 2009, BRIT J NUTR, V102, P687, DOI 10.1017/S0007114509289033	60	32	40	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157314	10.1371/journal.pone.0157314	http://dx.doi.org/10.1371/journal.pone.0157314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304828	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800046
J	Choi, Y; Kim, HR; Lim, EJ; Park, M; Yoon, JA; Kim, YS; Kim, EK; Shin, JE; Kim, JH; Kwon, H; Song, H; Choi, DH				Choi, Youngsok; Kim, Hye-Ryun; Lim, Eun Jin; Park, Miseon; Yoon, Jung Ah; Kim, Yeon Sun; Kim, Eun-Kyung; Shin, Ji-Eun; Kim, Ji Hyang; Kwon, Hwang; Song, Haengseok; Choi, Dong-Hee			Integrative Analyses of Uterine Transcriptome and MicroRNAome Reveal Compromised LIF-STAT3 Signaling and Progesterone Response in the Endometrium of Patients with Recurrent/Repeated Implantation Failure (RIF)	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; CALCIUM-BINDING PROTEIN; EMBRYO IMPLANTATION; BLASTOCYST IMPLANTATION; GROWTH-FACTORS; EXPRESSION; WOMEN; RECEPTIVITY; PREGNANCY; RECEPTOR	Intimate two-way interactions between the implantation-competent blastocyst and receptive uterus are prerequisite for successful embryo implantation. In humans, recurrent/repeated implantation failure (RIF) may occur due to altered uterine receptivity with aberrant gene expression in the endometrium as well as genetic defects in embryos. Several studies have been performed to understand dynamic changes of uterine transcriptome during menstrual cycles in humans. However, uterine transcriptome of the patients with RIF has not been clearly investigated yet. Here we show that several signaling pathways as well as many genes and microRNAs are dysregulated in the endometrium of patients with RIF (RIFE). Whereas unsupervised hierarchical clustering showed that overall mRNA and microRNA profiles of RIFE were similar to those of endometria of healthy women, many genes were significantly dysregulated in RIFE (cut off at 1.5 fold change). The majority (similar to 75%) of differentially expressed genes in RIFE including S100 calcium binding protein P (S100P), Chemokine (C-X-C motif) ligand 13 (CXCL13) and SIX homeobox 1 (SIX1) were down-regulated, suggesting that reduced uterine expression of these genes is associated with RIF. Gene Set Enrichment analyses (GSEA) for mRNA microarrays revealed that various signaling pathways including Leukemia inhibitory factor (LIF) signaling and a P-4 response were dysregulated in RIFE although expression levels of Estrogen receptor alpha (ER alpha) and Progesterone receptor (PR) were not significantly altered in RIFE. Furthermore, expression and phosphorylation of Signal transducer and activator of transcription 3 (STAT3) are reduced and a gene set associated with Janus kinase (JAK)-STAT signaling pathway is systemically down-regulated in these patients. Pairwise analyses of microRNA arrays with prediction of dysregulated microRNAs based on mRNA expression datasets demonstrated that 6 microRNAs are aberrantly regulated in RIFE. Collectively, we here suggest that dysregulation of several major signaling pathways and genes critical for uterine biology and embryo implantation may lead to uterine abnormalities in patients with RIF.	[Choi, Youngsok; Kim, Hye-Ryun; Lim, Eun Jin; Kim, Yeon Sun; Song, Haengseok] CHA Univ, Dept Biomed Sci, Seongnam, South Korea; [Park, Miseon; Yoon, Jung Ah] CHA Univ, Fertil Ctr, CHA Gangnam Med Ctr, Seoul, South Korea; [Kim, Eun-Kyung; Shin, Ji-Eun; Kim, Ji Hyang; Kwon, Hwang; Song, Haengseok; Choi, Dong-Hee] CHA Univ, CHA Bundang Med Ctr, Fertil Ctr, Seongnam, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University	Song, H (corresponding author), CHA Univ, Dept Biomed Sci, Seongnam, South Korea.; Song, H; Choi, DH (corresponding author), CHA Univ, CHA Bundang Med Ctr, Fertil Ctr, Seongnam, South Korea.	hssong@cha.ac.kr; dhchoimc@cha.ac.kr		Song, Haengseok/0000-0002-5027-7310; Choi, Youngsok/0000-0002-3862-4105	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [NRF-2015R1A2A2A01006714, NRF-2014R1A1A2059980]	National Research Foundation of Korea (NRF) grant - Korea government (MEST)	This work was supported in part by the National Research Foundation of Korea (NRF) grants funded by the Korea government (MEST)(NRF-2015R1A2A2A01006714 to HS and NRF-2014R1A1A2059980 to DHC).	Aghajanova L, 2009, FERTIL STERIL, V91, P2602, DOI 10.1016/j.fertnstert.2008.04.010; Arck P, 2007, AM J REPROD IMMUNOL, V58, P268, DOI 10.1111/j.1600-0897.2007.00512.x; Bae S, 2016, BIOCHEM BIOPH RES CO, V472, P489, DOI 10.1016/j.bbrc.2016.02.116; Bhurke AS, 2016, AM J REPROD IMMUNOL, V75, P237, DOI 10.1111/aji.12473; Bissonnette L, 2016, CELL ADHES MIGR, V10, P282, DOI 10.1080/19336918.2015.1128623; Borthwick JM, 2003, MOL HUM REPROD, V9, P19, DOI 10.1093/molehr/gag004; Casper RF, 2016, FERTIL STERIL, V105, P867, DOI 10.1016/j.fertnstert.2016.01.006; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Fox C, 2016, FERTIL STERIL, V105, P873, DOI 10.1016/j.fertnstert.2016.02.018; Franasiak JM, 2015, REPROD SCI, V22, P442, DOI 10.1177/1933719114542011; Granot I, 2012, REPRODUCTION, V144, P661, DOI 10.1530/REP-12-0217; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; Horcajadas JA, 2008, J CLIN ENDOCR METAB, V93, P4500, DOI 10.1210/jc.2008-0588; JOTTI GS, 1994, J CLIN PATHOL, V47, P900; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Kim JY, 2009, J CLIN ENDOCR METAB, V94, P1416, DOI 10.1210/jc.2008-1612; Kim YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20242; Koler M, 2009, HUM REPROD, V24, P2541, DOI 10.1093/humrep/dep193; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Liu XM, 2012, J CLIN ENDOCR METAB, V97, P3672, DOI 10.1210/jc.2012-2075; Mariee N, 2012, HUM REPROD, V27, P1946, DOI 10.1093/humrep/des134; Miravet-Valenciano JA, 2015, CURR OPIN OBSTET GYN, V27, P187, DOI 10.1097/GCO.0000000000000173; Nastri CO, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009517.pub3; Polanski LT, 2014, REPROD BIOMED ONLINE, V28, P409, DOI 10.1016/j.rbmo.2013.12.006; Potdar N, 2012, REPROD BIOMED ONLINE, V25, P561, DOI 10.1016/j.rbmo.2012.08.005; Revel A, 2011, HUM REPROD, V26, P2830, DOI 10.1093/humrep/der255; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Sharkey A, 1998, REV REPROD, V3, P52, DOI 10.1530/revreprod/3.1.52; Shohayeb A, 2012, EUR J OBSTET GYN R B, V164, P176, DOI 10.1016/j.ejogrb.2012.06.029; Song H, 2007, REPRODUCTION, V133, P487, DOI 10.1530/REP-06-0330; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; Stewart CL, 1997, DEV GENET, V21, P91, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;91::AID-DVG11&gt;3.0.CO;2-D; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Subramani E, 2016, FERTIL STERIL, V105, P1076, DOI 10.1016/j.fertnstert.2015.12.015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Tan BK, 2005, BJOG-INT J OBSTET GY, V112, P773, DOI 10.1111/j.1471-0528.2005.00523.x; Tapia A, 2008, HUM REPROD, V23, P340, DOI 10.1093/humrep/dem319; Tapia-Pizarro A, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-92; Thouas GA, 2015, ENDOCR REV, V36, P92, DOI 10.1210/er.2014-1046; Tong XM, 2010, FERTIL STERIL, V94, P1510, DOI 10.1016/j.fertnstert.2009.07.1667; Vasquez YM, 2013, SEMIN CELL DEV BIOL, V24, P724, DOI 10.1016/j.semcdb.2013.08.004; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Yoshioka S, 2006, HUM REPROD, V21, P3290, DOI 10.1093/humrep/del312; Yu N, 2014, AM J REPROD IMMUNOL, V71, P24, DOI 10.1111/aji.12150; Zhang RX, 2017, REPRODUCTION, V154, pZ1, DOI 10.1530/REP-15-0381	48	53	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157696	10.1371/journal.pone.0157696	http://dx.doi.org/10.1371/journal.pone.0157696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304912	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800081
J	Li, H; Zhou, GY; Liu, JA; Xu, JP				Li, He; Zhou, Guo-Ying; Liu, Jun-Ang; Xu, Jianping			Population Genetic Analyses of the Fungal Pathogen Colletotrichum fructicola on Tea-Oil Trees in China	PLOS ONE			English	Article							1ST REPORT; CRYPTOCOCCUS-NEOFORMANS; GLOEOSPORIOIDES; RECOMBINATION; SOFTWARE; SEQUENCE; HYBRIDIZATION; DISPERSAL; PATTERNS; ORIGINS	The filamentous fungus Colletotrichum fructicola is found in all five continents and is capable of causing severe diseases in a number of economically important plants such as avocado, fig, cocoa, pear, and tea-oil trees. However, almost nothing is known about its patterns of genetic variation and epidemiology on any of its host plant species. Here we analyzed 167 isolates of C. fructicola obtained from the leaves of tea-oil tree Camellia oleifera at 15 plantations in seven Chinese provinces. Multilocus sequence typing was conducted for all isolates based on DNA sequences at fragments of four genes: the internal transcribed spacers of the nuclear ribosomal RNA gene cluster (539 bp), calmodulin (633 bp), glutamine synthetase (711 bp), and glyceraldehyde-3-phosphate dehydrogenase (190 bp), yielding 3.52%, 0.63%, 8.44%, and 7.89% of single nucleotide polymorphic sites and resulting in 15, 5, 12 and 11 alleles respectively at the four gene fragments in the total sample. The combined allelic information from all four loci identified 53 multilocus genotypes with the most frequent represented by 21 isolates distributed in eight tea-oil plantations in three provinces, consistent with long-distance clonal dispersal. However, despite evidence for clonal dispersal, statistically significant genetic differentiation among geographic populations was detected. In addition, while no evidence of recombination was found within any of the four gene fragments, signatures of recombination were found among the four gene fragments in most geographic populations, consistent with sexual mating of this species in nature. Our study provides the first insights into the population genetics and epidemiology of the important plant fungal pathogen C. fructicola.	[Li, He; Zhou, Guo-Ying; Liu, Jun-Ang; Xu, Jianping] Cent South Univ Forestry & Technol, Minist Educ, Key Lab Nonwood Forest Cultivat & Conservat, Changsha, Hunan, Peoples R China; [Li, He; Zhou, Guo-Ying; Liu, Jun-Ang; Xu, Jianping] Cent South Univ Forestry & Technol, Coll Forestry, Changsha, Hunan, Peoples R China; [Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Central South University of Forestry & Technology; Central South University of Forestry & Technology; McMaster University	Xu, JP (corresponding author), Cent South Univ Forestry & Technol, Minist Educ, Key Lab Nonwood Forest Cultivat & Conservat, Changsha, Hunan, Peoples R China.; Xu, JP (corresponding author), Cent South Univ Forestry & Technol, Coll Forestry, Changsha, Hunan, Peoples R China.; Xu, JP (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	jpxu@mcmaster.ca			National Science Foundation of China [31100479]; Natural Sciences and Engineering Research Council of Canada; Lotus Scholar Visiting Professorship program of Hunan Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Lotus Scholar Visiting Professorship program of Hunan Province	This work was supported by grants from National Science Foundation of China (grant numbers: 31100479), Natural Sciences and Engineering Research Council of Canada, and the Lotus Scholar Visiting Professorship program of Hunan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from National Science Foundation of China (grant numbers: 31100479), Natural Sciences and Engineering Research Council of Canada, and the Lotus Scholar Visiting Professorship program of Hunan Province. We thank Liao Yu for helping with sample collections.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Ali S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003903; BROWN AHD, 1980, GENETICS, V96, P523; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Cai L, 2009, FUNGAL DIVERS, V39, P183; Campbell FT, 2001, BIOSCIENCE, V51, P148, DOI 10.1641/0006-3568(2001)051[0148:TSORAF]2.0.CO;2; Cannon PF, 2008, MYCOTAXON, V104, P189; CISAR CR, 1994, CURR GENET, V25, P330, DOI 10.1007/BF00351486; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Diao YZ, 2015, EVOL APPL, V8, P108, DOI 10.1111/eva.12233; DICKENS JSW, 1989, PLANT PATHOL, V38, P75, DOI 10.1111/j.1365-3059.1989.tb01430.x; Dilmaghani A, 2012, MOL ECOL, V21, P2519, DOI 10.1111/j.1365-294X.2012.05535.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gilbert KJ, 2012, MOL ECOL, V21, P4925, DOI 10.1111/j.1365-294X.2012.05754.x; He Fang, 2002, Scientia Silvae Sinicae, V38, P64; Hiremath SS, 2008, MICROBIOL-SGM, V154, P1513, DOI 10.1099/mic.0.2007/015594-0; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hyde KD, 2009, FUNGAL DIVERS, V39, P147; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang YL, 2010, JIANGXI FORESTRY TEC, V2, P24; Liu Wei, 2012, THESIS; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Phoulivong S, 2010, FUNGAL DIVERS, V44, P33, DOI 10.1007/s13225-010-0046-0; Prihastuti H, 2009, FUNGAL DIVERS, V39, P89; Pritchard JK, 2000, GENETICS, V155, P945; Qing AX, 2009, CHINESE FOREST PATHO, V28, P27; Rojas EI, 2010, MYCOLOGIA, V102, P1318, DOI 10.3852/09-244; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanders GM, 2003, MICROBIOL RES, V158, P143, DOI 10.1078/0944-5013-00186; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Silva DN, 2012, MOL ECOL, V21, P2655, DOI 10.1111/j.1365-294X.2012.05557.x; Snowdon AL, 1991, VEGETABLES, V2; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Sun S, 2006, MICROBIOL-SGM, V152, P3245, DOI 10.1099/mic.0.29170-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TEBEEST DO, 1988, PLANT DIS, V72, P16, DOI 10.1094/PD-72-0016; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Berkum P, 2010, APPL ENVIRON MICROB, V76, P3967, DOI 10.1128/AEM.00251-10; VON ARX J. A., 1970, A revision of the fungi classified as Gloeosporium.; Wang XX, 2010, PLANT DIS, V94, P1508, DOI 10.1094/PDIS-08-10-0556; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; Weir BS, 1996, GENETICS DATA ANAL; Xie Liu, 2010, Mycology - An International Journal on Fungal Biology, V1, P242, DOI 10.1080/21501203.2010.526644; Xu J, 2010, MICROBIAL POPULATION GENETICS, P1; Xu J., 2005, EVOLUTIONARY GENETIC; Xu JP, 2009, MOL ECOL, V18, P2628, DOI 10.1111/j.1365-294X.2009.04227.x; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; XU JP, 1994, TRENDS GENET, V10, P226, DOI 10.1016/0168-9525(94)90158-9; Xu JP, 2002, MICROBIOL-SGM, V148, P203, DOI 10.1099/00221287-148-1-203; Yan J, 2011, PLANT DIS, V95, P880, DOI 10.1094/PDIS-03-11-0186; Yang SY, 2011, PLANT DIS, V95, P1314, DOI 10.1094/PDIS-04-11-0269; Zhang RQ, 2010, NONWOOD FOREST RES, V28, P146	54	44	51	7	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156841	10.1371/journal.pone.0156841	http://dx.doi.org/10.1371/journal.pone.0156841			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299731	Green Submitted, Green Published, gold			2022-12-27	WOS:000377822200016
J	Moscicki, AB; Yao, TJ; Ryder, MI; Russell, JS; Dominy, SS; Patel, K; McKenna, M; Van Dyke, RB; Seage, GR; Hazra, R; Shiboski				Moscicki, Anna-Barbara; Yao, Tzy-Jyun; Ryder, Mark I.; Russell, Jonathan S.; Dominy, Stephen S.; Patel, Kunjal; McKenna, Matt; Van Dyke, Russell B.; Seage, George R., III; Hazra, Rohan; Shiboski			The Burden of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected Youth	PLOS ONE			English	Article							EARLY ENAMEL CARIES; DENTAL-CARIES; ANTIRETROVIRAL TREATMENT; US CHILDREN; PREVALENCE; PREDICTORS; BACTERIA; THERAPY; LESIONS; HUMANS	Objective To compare oral health parameters in perinatally HIV-infected (PHIV) and perinatally HIV-exposed but uninfected youth (PHEU). Methods In a cross-sectional substudy within the Pediatric HIV/AIDS Cohort Study, participants were examined for number of decayed teeth (DT), Decayed, Missing, and Filled Teeth (DMFT), oral mucosal disease, and periodontal disease (PD). Covariates for oral health parameters were examined using zero-inflated negative binomial regression and ordinal logistic regression models. Results Eleven sites enrolled 209 PHIV and 126 PHEU. Higher DT scores were observed in participants who were PHIV [ Adjusted Mean Ratio (aMR) = 1.7 (95% CI 1.2-2.5)], female [ aMR = 1.4 (1.0-1.9)], had no source of regular dental care [aMR = 2.3 (1.5-3.4)], and had a high frequency of meals/snacks [>= 5 /day vs 0-3, aMR = 1.9 (1.1-3.1)] and juice/soda [>= 5 /day vs 0-3, aMR = 1.6 (1.1-2.4)]. Higher DMFT scores were observed in participants who were older [>= 19, aMR = 1.9 (1.2-2.9)], had biological parent as caregiver [ aMR = 1.2 (1.0-1.3)], had a high frequency of juice/soda [>= 5 /day vs 0-3, aMR = 1.4 (1.1-1.7)] and a low salivaflow rate [mL/min, aMR = 0.8 per unit higher (0.6-1.0)]. Eighty percent had PD; no differences were seen by HIV status using the patient-based classifications of health, gingivitis or mild, moderate, or severe periodontitis. No associations were observed of CD4 count and viral load with oral health outcomes after adjustment. Conclusions Oral health was poor in PHIV and PHEU youth. This was dismaying since most HIV infected children in the U.S. are carefully followed at medical health care clinics. This data underscore the need for regular dental care. As PHIV youth were at higher risk for cavities, it will be important to better understand this relationship in order to develop targeted interventions.	[Moscicki, Anna-Barbara] Univ Calif Los Angeles, Dept Pediat, Div Adolescent Med, Los Angeles, CA 90024 USA; [Yao, Tzy-Jyun; Russell, Jonathan S.; McKenna, Matt] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Ryder, Mark I.; Shiboski] Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, San Francisco, CA USA; [Dominy, Stephen S.] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; [Patel, Kunjal] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Van Dyke, Russell B.] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA; [Seage, George R., III] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hazra, Rohan] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Maternal & Pediat Infect Dis Branch, NIH, Bethesda, MD USA	University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Tulane University; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Moscicki, AB (corresponding author), Univ Calif Los Angeles, Dept Pediat, Div Adolescent Med, Los Angeles, CA 90024 USA.	amoscicki@mednet.ucla.edu	Moscicki, Anna-Barbara/AAP-3806-2021		National Institute of Dental and Craniofacial Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute of Allergy and Infectious Diseases; Office of AIDS Research; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Institute on Deafness and Other Communication Disorders; National Heart Lung and Blood Institute; National Institute on Alcohol Abuse and Alcoholism; Harvard T. H. Chan School of Public Health [HD052102, 3 U01 HD052102-05S1, 3 U01 HD052102-06S3]; Tulane University School of Medicine [HD052104, 3U01 HD052104-06S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD052102, U01HD052104] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Harvard T. H. Chan School of Public Health; Tulane University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the National Institute of Dental and Craniofacial Research and Eunice Kennedy Shriver National Institute of Child Health and Human Development with cofunding from the National Institute on Drug Abuse, the National Institute of Allergy and Infectious Diseases, the Office of AIDS Research, the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the National Institute on Deafness and Other Communication Disorders, the National Heart Lung and Blood Institute, and the National Institute on Alcohol Abuse and Alcoholism, through cooperative agreements with the Harvard T. H. Chan School of Public Health (HD052102, 3 U01 HD052102-05S1, and 3 U01 HD052102-06S3) (PI: George Seage; Project Director: Julie Alperen) and the Tulane University School of Medicine (HD052104, 3U01 HD052104-06S1) (PI: Russell Van Dyke; Co-PI: Kenneth Rich; Project Director: Patrick Davis). Data management services were provided by Frontier Science and Technology Research Foundation (PI: Suzanne Siminski), and regulatory services and logistical support were provided by Westat, Inc (PI: Julie Davidson). The funders NICHD have a significant role in study design, data collection, decision to publish and preparation of manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Westat, Inc. provided regulatory services, protocol development support and logistical support but had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperen J, 2014, J ADOLESCENT HEALTH, V54, P341, DOI 10.1016/j.jadohealth.2013.09.003; American Academy of Pediatric Dentistry, 2014, PEDIAT DENT, V36, P171; [Anonymous], 2014, PEDIATRICS, V134, P1224, DOI 10.1542/peds.2014-2984; Armitage GC, 1996, PERIODONTOL 2000, V12, P33, DOI 10.1111/j.1600-0757.1996.tb00078.x; Beil H, 2014, AM J PUBLIC HEALTH, V104, P1979, DOI 10.2105/AJPH.2013.301325; Boyce WT, 2010, SOC SCI MED, V71, P1644, DOI 10.1016/j.socscimed.2010.07.045; Centers for Disease Control and Prevention, 2009, DATA 2010 HLTH PEOPL; Sales-Peres SHD, 2012, CIENC SAUDE COLETIVA, V17, P55, DOI 10.1590/S1413-81232012000100008; Dye Bruce A, 2015, NCHS Data Brief, P1; Ebersole JL, 2003, PERIODONTOL 2000, V31, P135, DOI 10.1034/j.1600-0757.2003.03109.x; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; General Surgeon, 2000, OR HLTH AM REP SURG; Jeganathan S, 2012, SPEC CARE DENT, V32, P130, DOI 10.1111/j.1754-4505.2012.00247.x; KLEIN H., 1938, Public Health Reports, V53, P751, DOI 10.2307/4582532; Lingstrom P, 2000, J DENT RES, V79, P770, DOI 10.1177/00220345000790021101; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Masiga MA, 2013, J CLIN PEDIATR DENT, V38, P83, DOI 10.17796/jcpd.38.1.62l1q94650j5l815; Massarente DB, 2009, ORAL HLTH PREV DENT, V7, P403; Meless D, 2014, TROP MED INT HEALTH, V19, P246, DOI 10.1111/tmi.12253; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Nelson-Filho Paulo, 2013, Braz. Dent. J., V24, P415, DOI 10.1590/0103-6440201302266; Offenbacher S, 2008, J PERIODONTOL, V79, P1577, DOI 10.1902/jop.2008.080220; Okunseri C, 2003, AIDS PATIENT CARE ST, V17, P5, DOI 10.1089/108729103321042863; Oladokun Regina E, 2013, Oral Health Dent Manag, V12, P200; Pari Arul, 2014, J Clin Diagn Res, V8, pZE01, DOI 10.7860/JCDR/2014/9004.4957; Preisser JS, 2012, CARIES RES, V46, P413, DOI 10.1159/000338992; Ramos-Gomez F J, 1999, J Clin Pediatr Dent, V23, P85; Rwenyonyi Charles Mugisha, 2011, Eur J Dent, V5, P291; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Shiboski CH, 2009, J ORAL PATHOL MED, V38, P481, DOI 10.1111/j.1600-0714.2009.00749.x; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Subramaniam P, 2014, SPEC CARE DENT, V34, P127, DOI 10.1111/scd.12041; Tassiopoulos K, 2013, CLIN INFECT DIS, V56, P283, DOI 10.1093/cid/cis816; Tinanoff N, 2009, ACAD PEDIATR, V9, P396, DOI 10.1016/j.acap.2009.08.006; Tomar SL, 2009, ACAD PEDIATR, V9, P388, DOI 10.1016/j.acap.2009.09.018; Van Dyke RB, 2011, JAIDS-J ACQ IMM DEF, V57, P165, DOI 10.1097/QAI.0b013e318215c7b1; van Ruyven FOJ, 2000, J DENT RES, V79, P778, DOI 10.1177/00220345000790021201	38	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156459	10.1371/journal.pone.0156459	http://dx.doi.org/10.1371/journal.pone.0156459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299992	gold, Green Submitted, Green Published			2022-12-27	WOS:000377822200008
J	Wu, DQ; Xu, LW; Tang, SX; Guan, LL; He, ZX; Guan, YJ; Tan, ZL; Han, XF; Zhou, CS; Kang, JH; Wang, M				Wu, Duanqin; Xu, Liwei; Tang, Shaoxun; Guan, Leluo; He, Zhixiong; Guan, Yongjuan; Tan, Zhiliang; Han, Xuefeng; Zhou, Chuanshe; Kang, Jinhe; Wang, Min			Influence of Oleic Acid on Rumen Fermentation and Fatty Acid Formation In Vitro	PLOS ONE			English	Article							RUMINAL FERMENTATION; GAS-PRODUCTION; ANAEROBIC FUNGUS; LINOLEIC ACIDS; SUNFLOWER OIL; COCONUT OIL; FISH-OIL; SUPPLEMENTATION; METHANE; BIOHYDROGENATION	A series of batch cultures were conducted to investigate the effects of oleic acid (OA) on in vitro ruminal dry matter degradability (IVDMD), gas production, methane (CH4) and hydrogen (H-2) production, and proportion of fatty acids. Rumen fluid was collected from fistulated goats, diluted with incubation buffer, and then incubated with 500 mg Leymus chinensis meal supplemented with different amounts of OA (0, 20, 40, and 60 mg for the CON, OA20, OA40 and OA60 groups, respectively). Incubation was carried out anaerobically at 39 degrees C for 48 h, and the samples were taken at 12, 24 and 48 h and subjected to laboratory analysis. Supplementation of OA decreased IVDMD, the cumulative gas production, theoretical maximum of gas production and CH4 production, but increased H-2 production. However, no effect was observed on any parameters of rumen fermentation pH, ammonia, production of acetate, propionate and butyrate and total volatile fatty acid production). The concentrations of some beneficial fatty acids, such as cis monounsaturated fatty acids and conjugated linoleic acid (CLA) were higher (P < 0.05) from OA groups than those from the control group at 12 h incubation. In summary, these results suggest that the OA supplementation in diet can reduce methane production and increase the amount of some beneficial fatty acids in vitro.	[Wu, Duanqin; Xu, Liwei; Tang, Shaoxun; He, Zhixiong; Tan, Zhiliang; Han, Xuefeng; Zhou, Chuanshe; Kang, Jinhe; Wang, Min] Chinese Acad Sci, Inst Subtrop Agr, Changsha 410125, Hunan, Peoples R China; [Wu, Duanqin] Chinese Acad Agricultrial Sci, Inst Bast Fiber Crops, Changsha 410205, Hunan, Peoples R China; [Guan, Leluo] Univ Alberta, Dept Agr Food & Nutrit Sci, Edmonton, AB, Canada; [Guan, Yongjuan] Univ Western Australia, UWA Inst Agr M082, 35 Stirling Highway, Crawley, WA 6009, Australia	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS; University of Alberta; University of Western Australia	Tan, ZL (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Changsha 410125, Hunan, Peoples R China.	zltan@isa.ac.cn	Wu, Duanqin/GLR-0201-2022	He, Zhixiong/0000-0002-4802-3506	Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues [XDA05020700]; National Natural Science Foundation of China [31320103917]; CAS Visiting Professorship for Senior International Scientists [2010T2S13, 2012T1S0009]; Hunan Provincial Creation Development Project [2013TF3006]	Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Visiting Professorship for Senior International Scientists; Hunan Provincial Creation Development Project	The authors express their appreciation for "Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues" (Grant No. XDA05020700), the National Natural Science Foundation of China (Grant No. 31320103917), "CAS Visiting Professorship for Senior International Scientists" (Grant No. 2010T2S13, 2012T1S0009), and Hunan Provincial Creation Development Project (2013TF3006).; We express our appreciation to "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" (Grant No. XDA05020700), the National Natural Science Foundation of China (Grant No. 31320103917), "CAS Visiting Professorship for Senior International Scientists" (Grant No. 2010T2S13, 2012T1S0009), and Hunan Provincial Creation Development Project (2013TF3006) for suppling this work.	Alves SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058386; Armando J, 2012, REV MEX CIENC PECU, V3, P215; Beauchemin KA, 2007, CAN J ANIM SCI, V87, P431, DOI 10.4141/CJAS07011; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buccioni A, 2012, ANIM FEED SCI TECH, V174, P1, DOI 10.1016/j.anifeedsci.2012.02.009; Ding XZ, 2012, TROP ANIM HEALTH PRO, V44, P1541, DOI 10.1007/s11250-012-0103-7; Goering HK, 1970, AGR HDB, V379, P13; Harfoot C. G., 1988, The rumen microbial ecosystem., P285; Hook SE, 2010, ARCHAEA, V2010, DOI 10.1155/2010/945785; Hristov AN, 2011, J DAIRY SCI, V94, P4057, DOI 10.3168/jds.2011-4283; Hristov AN, 2009, J DAIRY SCI, V92, P5561, DOI 10.3168/jds.2009-2383; Hwang IH, 2001, ASIAN AUSTRAL J ANIM, V14, P501, DOI 10.5713/ajas.2001.501; Ichihara K, 1996, LIPIDS, V31, P535, DOI 10.1007/BF02522648; Immig I, 1996, ENVIRON MONIT ASSESS, V42, P57, DOI 10.1007/BF00394042; Jalc D, 2007, VET MED-CZECH, V52, P87, DOI 10.17221/2012-VETMED; Jalc D, 2002, FOLIA MICROBIOL, V47, P171, DOI 10.1007/BF02817677; Janssen PH, 2010, ANIM FEED SCI TECH, V160, P1, DOI 10.1016/j.anifeedsci.2010.07.002; Jenkins TC, 2008, J ANIM SCI, V86, P397, DOI 10.2527/jas.2007-0588; Jenkins TC, 2006, J NUTR, V136, P926, DOI 10.1093/jn/136.4.926; Kim CH, 2008, ANAEROBE, V14, P19, DOI 10.1016/j.anaerobe.2007.08.005; Laverroux S, 2011, LIPIDS, V46, P843, DOI 10.1007/s11745-011-3584-7; Lee SS, 2001, ASIAN AUSTRAL J ANIM, V14, P1110, DOI 10.5713/ajas.2001.1110; Maia MRG, 2007, ANTON LEEUW INT J G, V91, P303, DOI 10.1007/s10482-006-9118-2; McKain N, 2010, MICROBIOL-SGM, V156, P579, DOI 10.1099/mic.0.036442-0; Mosley EE, 2002, J LIPID RES, V43, P290; Mosley EE, 2006, LIPIDS, V41, P513, DOI 10.1007/s11745-006-5125-3; O'Brien M, 2014, ANIM PROD SCI, V54, P141, DOI 10.1071/AN12204; Pilajun R, 2011, LIVEST SCI, V141, P148, DOI 10.1016/j.livsci.2011.05.013; Shingfield KJ, 2008, ADV EXP MED BIOL, V606, P3, DOI 10.1007/978-0-387-74087-4_1; Shingfield KJ, 2006, J DAIRY SCI, V89, P714, DOI 10.3168/jds.S0022-0302(06)72134-8; Tang SX, 2008, J ANIM SCI, V86, P1164, DOI 10.2527/jas.2007-0438; Toral PG, 2010, J DAIRY SCI, V93, P1604, DOI 10.3168/jds.2009-2530; Wanapat M, 2011, LIVEST SCI, V135, P32, DOI 10.1016/j.livsci.2010.06.006; Wang M, 2011, ANIM FEED SCI TECH, V165, P137, DOI 10.1016/j.anifeedsci.2010.09.016; Wang M., 2013, ANIMAL, V1, P1; Wang M, 2008, LIVEST SCI, V117, P233, DOI 10.1016/j.livsci.2007.12.016; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Wu DQ, 2015, EUR J LIPID SCI TECH, V117, P945, DOI 10.1002/ejlt.201400370; Wu DQ, 2013, J FOOD AGRIC ENVIRON, V11, P464; Zhang CM, 2008, ANIM FEED SCI TECH, V146, P259, DOI 10.1016/j.anifeedsci.2008.01.005	40	15	17	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156835	10.1371/journal.pone.0156835	http://dx.doi.org/10.1371/journal.pone.0156835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299526	gold, Green Submitted, Green Published			2022-12-27	WOS:000377822200015
J	Hincke, AJC; Broere, T; Kurschner, WM; Donders, TH; Wagner-Cremer, F				Hincke, Alexandra J. C.; Broere, Tom; Kurschner, Wolfram M.; Donders, Timme H.; Wagner-Cremer, Friederike			Multi-Year Leaf-Level Response to Sub-Ambient and Elevated Experimental CO2 in Betula nana	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; STOMATAL FREQUENCY; CLIMATE-CHANGE; QUERCUS-ROBUR; RISING CO2; WATER-USE; CONDUCTANCE; FUTURE; LEAVES; INCREASE	The strong link between stomatal frequency and CO2 in woody plants is key for understanding past CO2 dynamics, predicting future change, and evaluating the significant role of vegetation in the hydrological cycle. Experimental validation is required to evaluate the long-term adaptive leaf response of C3 plants to CO2 conditions; however, studies to date have only focused on short-term single-season experiments and may not capture (1) the full ontogeny of leaves to experimental CO2 exposure or (2) the true adjustment of structural stomatal properties to CO2, which we postulate is likely to occur over several growing seasons. We conducted controlled growth chamber experiments at 150 ppmv, 450 ppmv and 800 ppmv CO2 with woody C3 shrub Betula nana (dwarf birch) over two successive annual growing seasons and evaluated the structural stomatal response to atmospheric CO2 conditions. We find that while some adjustment of leaf morphological and stomatal parameters occurred in the first growing season where plants are exposed to experimental CO2 conditions, amplified adjustment of non-plastic stomatal properties such as stomatal conductance occurred in the second year of experimental CO2 exposure. We postulate that the species response limit to CO2 of B. nana may occur around 400-450 ppmv. Our findings strongly support the necessity for multi-annual experiments in C3 perennials in order to evaluate the effects of environmental conditions and provide a likely explanation of the contradictory results between historical and palaeobotanical records and experimental data.	[Hincke, Alexandra J. C.; Broere, Tom; Donders, Timme H.; Wagner-Cremer, Friederike] Univ Utrecht, Fac Geosci, Dept Phys Geog, Palaeoecol, Utrecht, Netherlands; [Kurschner, Wolfram M.] Univ Oslo, Dept Geosci, Oslo, Norway	Utrecht University; University of Oslo	Hincke, AJC; Wagner-Cremer, F (corresponding author), Univ Utrecht, Fac Geosci, Dept Phys Geog, Palaeoecol, Utrecht, Netherlands.	A.J.C.Hincke@gmail.com; F.Wagner-Cremer@uu.nl	Kürschner, Wolfram Michael/B-4724-2009; Kürschner, Wolfram Michael/AAC-7769-2020; Wagner-Cremer, Friederike/B-4225-2009	Kürschner, Wolfram Michael/0000-0001-6883-6486; Kürschner, Wolfram Michael/0000-0001-6883-6486; Wagner-Cremer, Friederike/0000-0002-8119-3558; Donders, Timme/0000-0003-4698-3463	Darwin Centre for Biogeosciences; Utrecht University Botanische Tuinen	Darwin Centre for Biogeosciences; Utrecht University Botanische Tuinen	This project was funded by the Darwin Centre for Biogeosciences (http://www.darwincenter.nl/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; We greatly appreciate the support from the Utrecht University Botanische Tuinen, particularly the assistance of Gerard van Buiten. Thank you to Rob Welschen for technical assistance in the Fytotron.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Andrews T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043991; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; BEERLING DJ, 1993, ANN BOT-LONDON, V71, P231, DOI 10.1006/anbo.1993.1029; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Cao L, 2010, P NATL ACAD SCI USA, V107, P9513, DOI 10.1073/pnas.0913000107; de Boer HJ, 2011, P NATL ACAD SCI USA, V108, P4041, DOI 10.1073/pnas.1100555108; England JR, 2011, TREES-STRUCT FUNCT, V25, P987, DOI 10.1007/s00468-011-0573-7; Epron D, 1996, TREE PHYSIOL, V16, P425; Ferris R, 2001, PLANT CELL ENVIRON, V24, P305, DOI 10.1046/j.1365-3040.2001.00684.x; Finsinger W, 2009, HOLOCENE, V19, P757, DOI 10.1177/0959683609105300; Franks PJ, 2014, NEW PHYTOL, V201, P1079, DOI 10.1111/nph.12673; Franks PJ, 2012, PHILOS T R SOC B, V367, P537, DOI 10.1098/rstb.2011.0270; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Gagen M, 2011, GLOBAL CHANGE BIOL, V17, P1064, DOI 10.1111/j.1365-2486.2010.02273.x; Kurschner WM, 2008, P NATL ACAD SCI USA, V105, P449, DOI 10.1073/pnas.0708588105; Kurschner WM, 1997, GEOL RUNDSCH, V86, P512, DOI 10.1007/s005310050158; Lake JA, 2001, NATURE, V411, P154, DOI 10.1038/35075660; Lammertsma EI, 2011, P NATL ACAD SCI USA, V108, P4035, DOI 10.1073/pnas.1100371108; Li YY, 2014, J EXP BOT, V65, P3657, DOI 10.1093/jxb/eru193; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; MORISON JIL, 1984, AUST J PLANT PHYSIOL, V11, P361, DOI 10.1071/PP9840361; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pettersson R, 1992, PLANT CELL ENVIRON, V15, P1115; RADOGLOU KM, 1990, ANN BOT-LONDON, V65, P627, DOI 10.1093/oxfordjournals.aob.a087979; Reid CD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017775; Rico C, 2013, NEW PHYTOL, V199, P956, DOI 10.1111/nph.12339; Roth-Nebelsick A, 2013, PLANT CELL ENVIRON, V36, P579, DOI 10.1111/j.1365-3040.2012.02597.x; Roth-Nebelsick A, 2012, REV PALAEOBOT PALYNO, V174, P106, DOI 10.1016/j.revpalbo.2012.01.001; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; Royer DL, 2001, REV PALAEOBOT PALYNO, V114, P1, DOI 10.1016/S0034-6667(00)00074-9; Royer DL, 2001, SCIENCE, V292, P2310, DOI 10.1126/science.292.5525.2310; Salisbury EJ, 1928, PHILOS T R SOC LON B, V216, P1, DOI 10.1098/rstb.1928.0001; Temme AA, 2015, ECOL EVOL, V5, P4949, DOI 10.1002/ece3.1687; TICHA I, 1982, PHOTOSYNTHETICA, V16, P375; van Hoof TB, 2006, PLANT ECOL, V183, P237, DOI 10.1007/s11258-005-9021-3; VANDERBURGH J, 1993, SCIENCE, V260, P1788, DOI 10.1126/science.260.5115.1788; Wagner F, 2005, AM J BOT, V92, P690, DOI 10.3732/ajb.92.4.690; Wagner F, 2004, QUATERNARY SCI REV, V23, P1947, DOI 10.1016/j.quascirev.2004.04.003; Wagner F, 1996, P NATL ACAD SCI USA, V93, P11705, DOI 10.1073/pnas.93.21.11705; Wagner F, 1999, SCIENCE, V284, P1971, DOI 10.1126/science.284.5422.1971; Wagner F, 1998, EFFECTS NITROGEN DEF, P102; Wagner F, 2007, COUR FOR SEKENBG, V258, P183	43	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157400	10.1371/journal.pone.0157400	http://dx.doi.org/10.1371/journal.pone.0157400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285314	Green Published, gold			2022-12-27	WOS:000377564000065
J	Lokuge, K; Verputten, M; Ajakali, M; Tolboom, B; Joshy, G; Thurber, KA; Plana, D; Howes, S; Wakon, A; Banks, E				Lokuge, Kamalini; Verputten, Meggy; Ajakali, Maryanne; Tolboom, Bianca; Joshy, Grace; Thurber, Katherine A.; Plana, Daisy; Howes, Steven; Wakon, Anastasia; Banks, Emily			Health Services for Gender-Based Violence: Medecins Sans Frontieres Experience Caring for Survivors in Urban Papua New Guinea	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; PREVALENCE; MULTICOUNTRY; WOMEN; PERPETRATION; PACIFIC; RISK; ASIA; MEN	Background Levels of gender-based violence in Papua New Guinea (PNG) are high; health services for survivors are limited. Evidence from the few existing health services for survivors can inform improvements in care in this and similar settings. Methods Medecins Sans Frontieres supported health services for survivors in Lae, PNG from 2008-2013. Routine monitoring data from August 2010-April 2013 were used to describe patient and service characteristics. Results 5,892 individuals received care over 6,860 presentations, the majority self-referred or referred by friends and family. Presentations were attributed to intimate partner violence (62%), non-partner sexual violence(15%), other forms of violence(3%), and past (but not current) violence(21%). 97% were female; an estimated 4.9% (95% CI:4.8-5.0%) of females resident in the catchment area presented to the programme during the 2.8years analysed. Of presentations for non-partner sexual violence, 79% knew their abuser and 50% were children <16 years. 92% of presentations reporting current violence received medical treatment for injuries. The majority of patients who received multiple counselling sessions reported improved functioning and decreased severity of psycho-social complaints. Conclusions Community awareness of the availability of free, best-practice, accessible, confidential medical and counselling services for sexual and gender-based violence in Lae, PNG resulted in many survivors presenting for care. High levels of ongoing intimate partner violence and child sexual abuse by known abusers indicates that alongside comprehensive medical care, access to effective services in non-health sectors such as policing, protection and legal services are needed if survivors are to escape the cycle of violence.	[Lokuge, Kamalini; Joshy, Grace; Thurber, Katherine A.; Banks, Emily] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Acton, Australia; [Lokuge, Kamalini] Medecins Sans Frontieres MSF UK, London, England; [Lokuge, Kamalini; Plana, Daisy; Howes, Steven] Femili PNG, Lae, Papua N Guinea; [Verputten, Meggy] MSF Operat Ctr Amsterdam, Amsterdam, Netherlands; [Ajakali, Maryanne; Plana, Daisy; Wakon, Anastasia] Natl Dept Hlth, Angau Hosp, Lae, Papua N Guinea; [Tolboom, Bianca] MSF Operat Ctr Papua New Guinea Programme, Port Moresby, Papua N Guinea; [Howes, Steven] Australian Natl Univ, Dev Policy Ctr, Crawford Sch Publ Policy, Acton, Australia	Australian National University; Australian National University	Lokuge, K (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Acton, Australia.; Lokuge, K (corresponding author), Medecins Sans Frontieres MSF UK, London, England.; Lokuge, K (corresponding author), Femili PNG, Lae, Papua N Guinea.	kamalini.lokuge@anu.edu.au	DSILVA, BROOKE/HCI-4879-2022	Lokuge, Kamalini/0000-0002-6287-1296; Joshy, Grace/0000-0002-0718-6368; Banks, Emily/0000-0002-4617-1302	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	EB is supported by the National Health and Medical Research Council of Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels SA, 2012, DISASTER MED PUBLIC, V6, P393, DOI 10.1001/dmp.2012.66; Beydoun HA, 2012, SOC SCI MED, V75, P959, DOI 10.1016/j.socscimed.2012.04.025; Bradley C, 2000, FAMILY SEXUAL VIOLEN; Bureau of Statistics, 2012, PNG POP EST; De Jong K, 2011, PSYCHOSOCIAL MENTAL; Ellsberg M, 2015, LANCET, V385, P1555, DOI 10.1016/S0140-6736(14)61703-7; Fox T, 2011, Pac Health Dialog, V17, P65; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Jewkes R, 2013, LANCET GLOB HEALTH, V1, pE208, DOI 10.1016/S2214-109X(13)70069-X; Koka BE, 2014, INT J SOC PSYCHIATR, V60, P711, DOI 10.1177/0020764013513441; Lewis I, 2008, J FAM STUD, V14, P183, DOI 10.5172/jfs.327.14.2-3.183; Lewis IR, 2012, J CHILD SEX ABUS, V21, P273, DOI 10.1080/10538712.2012.668265; Medecins Sans Frontieres, 2015, MSF ETH REV BOARD ST; Medecins Sans Frontieres Ethics Review Board, 2015, MSF RES ETH FRAM GUI; Morrison A, 2007, WORLD BANK RES OBSER, V22, P25, DOI 10.1093/wbro/lkm003; MSF-Holland, 2006, PAP NEW GUIN ASS A 1; NSO, 2009, PNG DEM HLTH SURV 20; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Spratt K., 2012, ANAL SERVICES ADDRES; van Amstel H, 2004, SOC SCI MED, V59, P2087, DOI 10.1016/j.socscimed.2004.03.011; WHO, 2011, PNG COUNTR PROF	23	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156813	10.1371/journal.pone.0156813	http://dx.doi.org/10.1371/journal.pone.0156813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1UG	27285845	Green Submitted, gold, Green Published			2022-12-27	WOS:000377564000023
J	Lecube, A; Sanchez, E; Gomez-Peralta, F; Abreu, C; Valls, J; Mestre, O; Romero, O; Martinez, MD; Sampol, G; Ciudin, A; Hernandez, C; Simo, R				Lecube, Albert; Sanchez, Enric; Gomez-Peralta, Fernando; Abreu, Cristina; Valls, Joan; Mestre, Olga; Romero, Odile; Dolores Martinez, Maria; Sampol, Gabriel; Ciudin, Andreea; Hernandez, Cristina; Simo, Rafael			Global Assessment of the Impact of Type 2 Diabetes on Sleep through Specific Questionnaires. A Case-Control Study	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; GLYCEMIC CONTROL; LATENCY TEST; QUALITY; APNEA; SCALE; OBESE; DEPRESSION; DISORDERS; DURATION	Type 2 diabetes (T2D) is an independent risk factor for sleep breathing disorders. However, it is unknown whether T2D affects daily somnolence and quality of sleep independently of the impairment of polysomnographic parameters. Material and Methods A case-control study including 413 patients with T2D and 413 non-diabetic subjects, matched by age, gender, BMI, and waist and neck circumferences. A polysomnography was performed and daytime sleepiness was evaluated using the Epworth Sleepiness Scale (ESS). In addition, 135 subjects with T2D and 45 controls matched by the same previous parameters were also evaluated through the Pittsburgh Sleep Quality Index (PSQI) to calculate sleep quality. Results Daytime sleepiness was higher in T2D than in control subjects (p = 0.003), with 23.9% of subjects presenting an excessive daytime sleepiness (ESS>10). Patients with fasting plasma glucose (FPG >= 13.1 mmol/l) were identified as the group with a higher risk associated with an ESS>10 (OR 3.9, 95% CI 1.8-7.9, p = 0.0003). A stepwise regression analyses showed that the presence of T2D, baseline glucose levels and gender but not polysomnographic parameters (i.e apnea-hyoapnea index or sleeping time spent with oxigen saturation lower than 90%) independently predicted the ESS score. In addition, subjects with T2D showed higher sleep disturbances [PSQI: 7.0 (1.0-18.0) vs. 4 (0.0-12.0), p<0.001]. Conclusion The presence of T2D and high levels of FPG are independent risk factors for daytime sleepiness and adversely affect sleep quality. Prospective studies addressed to demonstrate whether glycemia optimization could improve the sleep quality in T2D patients seem warranted.	[Lecube, Albert; Sanchez, Enric; Dolores Martinez, Maria] Univ Lleida, Hosp Univ Arnau de Vilanova, Biomed Res Inst Lleida IRBLLEIDA, Endocrinol & Nutr Dept, Av Rovira Roure 80, Lleida 25198, Spain; [Lecube, Albert; Mestre, Olga; Ciudin, Andreea; Hernandez, Cristina; Simo, Rafael] Univ Autonoma Barcelona, Inst Recerca, Diabet & Metab Res Unit,Inst Salud Carlos ISCII 3, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Pg Vall Hebron 119-129, Barcelona 08035, Spain; [Lecube, Albert; Mestre, Olga; Romero, Odile; Sampol, Gabriel; Ciudin, Andreea; Hernandez, Cristina; Simo, Rafael] Univ Autonoma Barcelona, Hosp Univ Vall Hebron VHIR, Pg Vall Hebron 119-129, Barcelona 08035, Spain; [Gomez-Peralta, Fernando; Abreu, Cristina] Segovia Gen Hosp, Endocrinol & Nutr Unit, C Miguel Servet S-N, Segovia 40002, Spain; [Valls, Joan] Biomed Res Inst Lleida IRBLLEIDA, Biostat & Epidemiol Unit, Av Rovira Roure 80, Lleida 25198, Spain; [Romero, Odile] Univ Autonoma Barcelona, Inst Salud Carlos ISCIII 3, CIBER Enfermedades Respiratorias CIBERES, Sleep Unit,Neurophysiol Dept,Inst Recerca, Pg Vall Hebron 119-129, Barcelona 08035, Spain; [Sampol, Gabriel] Univ Autonoma Barcelona, Inst Salud Carlos ISCIII 3, CIBER Enfermedades Respiratorias CIBERES, Sleep Unit,Pneumol Dept,Inst Recerca, Pg Vall Hebron 119-129, Barcelona 08035, Spain	Universitat de Lleida; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Lecube, A (corresponding author), Univ Lleida, Hosp Univ Arnau de Vilanova, Biomed Res Inst Lleida IRBLLEIDA, Endocrinol & Nutr Dept, Av Rovira Roure 80, Lleida 25198, Spain.; Lecube, A (corresponding author), Univ Autonoma Barcelona, Inst Recerca, Diabet & Metab Res Unit,Inst Salud Carlos ISCII 3, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Pg Vall Hebron 119-129, Barcelona 08035, Spain.; Lecube, A (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall Hebron VHIR, Pg Vall Hebron 119-129, Barcelona 08035, Spain.	alecube@gmail.com	CIUDIN, ANDREEA/O-5250-2016; Romero, Odile/N-8109-2015; Gomez-Peralta, Fernando/J-8249-2019; Lecube, Albert/H-3813-2019; Sánchez, Enric/K-8225-2017; Valls, Joan/GXM-6532-2022	CIUDIN, ANDREEA/0000-0001-5622-0203; Romero, Odile/0000-0002-0147-596X; Gomez-Peralta, Fernando/0000-0003-0106-0091; Lecube, Albert/0000-0001-9684-0183; Sánchez, Enric/0000-0001-7345-1601; Simo Canonge, Rafael/0000-0003-0475-3096; Hernandez, Cristina/0000-0002-3109-1721; Valls, Joan/0000-0002-4806-7568; ABREU, CRISTINA/0000-0002-9238-443X	de Instituto de Salud Carlos III ISCIII (Fondo de Investigacion Sanitaria) [FI12/00803]; European Union (European Regional Development Fund); Fundacion Sociedad Espanola Endocrinologia y Nutricion (FSEEN); European Union (Fondo Europeo de Desarrollo Regional, FEDER); European Union ("Una manera de hacer Europa")	de Instituto de Salud Carlos III ISCIII (Fondo de Investigacion Sanitaria); European Union (European Regional Development Fund)(European Commission); Fundacion Sociedad Espanola Endocrinologia y Nutricion (FSEEN); European Union (Fondo Europeo de Desarrollo Regional, FEDER)(European Commission); European Union ("Una manera de hacer Europa")	This work was supported by grants from de Instituto de Salud Carlos III ISCIII (Fondo de Investigacion Sanitaria, FI12/00803), European Union (European Regional Development Fund, Fondo Europeo de Desarrollo Regional, FEDER, "Una manera de hacer Europa"), and Fundacion Sociedad Espanola Endocrinologia y Nutricion (FSEEN). CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) and CIBER de Enfermedades Respiratorias (CIBERES) are an initiative of the Instituto Carlos III.	Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Basta M, 2008, J CLIN SLEEP MED, V4, P19; Benbadis SR, 1999, ANN INTERN MED, V130, P289, DOI 10.7326/0003-4819-130-4-199902160-00014; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Buysse D J, 1989, Psychiatry Res, V28, P193; Chasens Eileen R, 2008, Issues Ment Health Nurs, V29, P1134, DOI 10.1080/01612840802319878; Cuellar NG, 2008, J CLIN SLEEP MED, V4, P50; Dixon JB, 2007, OBESITY, V15, P2504, DOI 10.1038/oby.2007.297; Foster GD, 2009, DIABETES CARE, V32, P1017, DOI 10.2337/dc08-1776; Hayashino Y, 2008, EXP CLIN ENDOCR DIAB, V116, P1, DOI 10.1055/s-2007-984442; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Kendzerska TB, 2014, SLEEP MED REV, V18, P321, DOI 10.1016/j.smrv.2013.08.002; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Lamond N, 2000, SLEEP, V23, P415; Lecube A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119073; Lecube A, 2015, J DIABETES, V7, P133, DOI 10.1111/1753-0407.12197; Lecube A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004692; Lou PA, 2015, DIABETES RES CLIN PR, V109, P178, DOI 10.1016/j.diabres.2015.04.012; Luyster FS, 2011, DIABETES EDUCATOR, V37, P347, DOI 10.1177/0145721711400663; Meng LL, 2015, J DIABETES COMPLICAT, V29, P882, DOI 10.1016/j.jdiacomp.2015.06.011; Punjabi NM, 2005, J APPL PHYSIOL, V99, P1998, DOI 10.1152/japplphysiol.00695.2005; R Core Team, 2021, R LANGUAGE ENV STAT; Ramachandran SK, 2009, ANESTHESIOLOGY, V110, P928, DOI 10.1097/ALN.0b013e31819c47b6; Sampol Gabriel, 2012, Endocrinol Nutr, V59, P95, DOI 10.1016/j.endonu.2011.12.003; Shaw JE, 2008, DIABETES RES CLIN PR, V81, P2, DOI 10.1016/j.diabres.2008.04.025; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Taub LFM, 2008, BIOL RES NURS, V9, P231, DOI 10.1177/1099800407311016; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	30	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157579	10.1371/journal.pone.0157579	http://dx.doi.org/10.1371/journal.pone.0157579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315083	Green Published, gold, Green Submitted			2022-12-27	WOS:000378030000038
J	Weel, IC; Baergen, RN; Romao-Veiga, M; Borges, VT; Ribeiro, VR; Witkin, SS; Bannwart-Castro, C; Peracoli, JC; De Oliveira, L; Peracoli, MT				Weel, Ingrid C.; Baergen, Rebecca N.; Romao-Veiga, Mariana; Borges, Vera T.; Ribeiro, Vanessa R.; Witkin, Steven S.; Bannwart-Castro, Camila; Peracoli, Jose C.; De Oliveira, Leandro; Peracoli, Maria T.			Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; EARLY-ONSET; SYNCYTIAL KNOTS; SOLUBLE ENDOGLIN; IN-VITRO; PATHOPHYSIOLOGY; PATHOGENESIS; HYPOXIA; RESTRICTION	Preeclampsia (PE) is considered the leading cause of maternal and perinatal morbidity and mortality. The placenta seems to play an essential role in this disease, probably due to factors involved in its formation and development. The present study aimed to investigate the association between placental lesions, cytokines and angiogenic factors in pregnant women with preeclampsia (PE). We evaluated 20 normotensive pregnant women, 40 with early-onset PE and 80 with late-onset PE. Placental samples were analyzed for histopathology, immunohistochemistry and determination of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-10 (IL-10), transforming growth factor-beta 1 (TGF-beta 1), tumor necrosis factor-alpha (TNF-alpha), placental growth factor (PlGF), vascular endothelial growth factor (VEGF), fms-like tyrosine-kinase-1 (Flt-1) and endoglin (Eng) levels. Higher percentages of increased syncytial knots and increased perivillous fibrin deposits, and greater levels of TNF-alpha, TGF-beta 1 and Flt-1 were detected in placentas from early-onset PE. Levels of IL-10, VEGF and PlGF were decreased in PE versus normotensive placentas. Both the TNF-alpha/IL-10 and sFlt-1/PlGF ratios were higher in placental homogenate of early-onset PE than late-onset PE and control groups. The more severe lesions and the imbalance between TNF-alpha/IL-10 and PlGF/sFlt-1 in placentas from early-onset PE allows differentiation of early and late-onset PE and suggests higher placental impairment in early-onset PE.	[Weel, Ingrid C.; Romao-Veiga, Mariana; Borges, Vera T.; Bannwart-Castro, Camila; Peracoli, Jose C.; De Oliveira, Leandro] Sao Paulo State Univ, Botucatu Med Sch, Dept Obstet & Gynaecol, BR-18618970 Botucatu, SP, Brazil; [Baergen, Rebecca N.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Witkin, Steven S.] Weill Cornell Med Coll, Dept Obstet & Gynecol, New York, NY USA; [Ribeiro, Vanessa R.; Peracoli, Maria T.] Sao Paulo State Univ, Inst Biosci, Dept Microbiol & Immunol, BR-18618970 Botucatu, SP, Brazil	Universidade Estadual Paulista; Cornell University; NewYork-Presbyterian Hospital; Cornell University; Universidade Estadual Paulista	Peracoli, MT (corresponding author), Sao Paulo State Univ, Inst Biosci, Dept Microbiol & Immunol, BR-18618970 Botucatu, SP, Brazil.	peracoli@ibb.unesp.br	CASTRO, CAMILA FERREIRA Ferreira/AAJ-8778-2020; Veiga, Mariana Romão/J-1590-2015; Witkin, Steven/AAF-3812-2019; Peracoli, Jose Carlos/GME-1756-2022; Witkin, Steven/AAW-8602-2021; Peracoli, Maria/AAD-2409-2019; Ribeiro, Vanessa Rocha/B-1460-2016; BORGES, VERA T/B-7363-2014; Ribeiro Vasques, Vanessa Rocha/AAU-7634-2021; De Oliveira, Leandro/G-3476-2012; Peracoli, Maria Terezinha/G-4034-2012; Peracoli, Jose Carlos/G-4923-2012	Veiga, Mariana Romão/0000-0002-8990-0237; Witkin, Steven/0000-0002-3502-3929; Ribeiro, Vanessa Rocha/0000-0001-7629-7689; BORGES, VERA T/0000-0002-9347-9641; Ribeiro Vasques, Vanessa Rocha/0000-0001-7629-7689; De Oliveira, Leandro/0000-0002-8422-9907; Peracoli, Maria Terezinha/0000-0002-0936-9512; Peracoli, Jose Carlos/0000-0002-3273-3001; Ferreira Bannwart Castro, Camila/0000-0002-8010-4496				[Anonymous], 2002, OBSTET GYNECOL, V99, P159; Baltajian K, 2014, HYPERTENS PREGNANCY, V33, P427, DOI 10.3109/10641955.2014.926914; Cristofalo R, 2013, FREE RADICAL RES, V47, P268, DOI 10.3109/10715762.2013.765951; De Oliveira L, 2013, PREGNANCY HYPERTENS, V3, P191, DOI 10.1016/j.preghy.2013.02.003; Devisme L, 2013, INT J GYNECOL OBSTET, V120, P165, DOI 10.1016/j.ijgo.2012.08.023; Feng C, 2011, ARCH GYNECOL OBSTET, V283, P161, DOI 10.1007/s00404-009-1303-x; George EM, 2011, CURR HYPERTENS REP, V13, P269, DOI 10.1007/s11906-011-0204-0; Gu Y, 2008, J CLIN ENDOCR METAB, V93, P260, DOI 10.1210/jc.2007-1550; Guller S, 2008, ANN NY ACAD SCI, V1127, P129, DOI 10.1196/annals.1434.015; Hayashi M, 2004, AM J OBSTET GYNECOL, V190, P456, DOI 10.1016/j.ajog.2003.07.032; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Hennessy A, 1999, J IMMUNOL, V163, P3491; Hung TH, 2004, AM J PATHOL, V164, P1049, DOI 10.1016/S0002-9440(10)63192-6; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Kane SC, 2014, AUST NZ J OBSTET GYN, V54, P101, DOI 10.1111/ajo.12151; KAPLAN C, 1991, ARCH PATHOL LAB MED, V115, P709; Kim SC, 2012, J OBSTET GYNAECOL RE, V38, P665, DOI 10.1111/j.1447-0756.2011.01773.x; Kovo M, 2012, PRENATAL DIAG, V32, P632, DOI 10.1002/pd.3872; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Loukeris K, 2010, PEDIATR DEVEL PATHOL, V13, P305, DOI 10.2350/09-08-0692-OA.1; Makris A, 2006, PLACENTA, V27, P445, DOI 10.1016/j.placenta.2005.05.003; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Nagy JA, 2003, TRENDS CARDIOVAS MED, V13, P169, DOI 10.1016/S1050-1738(03)00056-2; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Ogge G, 2011, J PERINAT MED, V39, P641, DOI [10.1515/JPM.2011.098, 10.1515/jpm.2011.098]; Peracoli JC, 2013, J REPROD IMMUNOL, V100, P129, DOI 10.1016/j.jri.2013.08.003; Pratt A, 2015, ANGIOGENESIS, V18, P115, DOI 10.1007/s10456-014-9452-3; Raghupathy R, 2013, MED PRIN PRACT, V22, P8, DOI 10.1159/000354200; Rajakumar A, 2012, HYPERTENSION, V59, P256, DOI 10.1161/HYPERTENSIONAHA.111.182170; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Redman C W G, 2011, Rev Med Interne, V32 Suppl 1, pS41, DOI 10.1016/j.revmed.2011.03.331; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Sankar KD, 2012, ANAT CELL BIOL, V45, P86, DOI 10.5115/acb.2012.45.2.86; Sikkema JM, 2002, PLACENTA, V23, P337, DOI 10.1053/plac.2001.0785; Silasi M, 2010, OBSTET GYN CLIN N AM, V37, P239, DOI 10.1016/j.ogc.2010.02.013; Souza D. A. de, 2011, Jornal Brasileiro de Patologia e Medicina Laboratorial, V47, P71, DOI 10.1590/S1676-24442011000100010; Stark MW, 2014, PEDIATR DEVEL PATHOL, V17, P181, DOI 10.2350/13-09-1378-OA.1; Tripathi R, 2008, ANN ANAT, V190, P477, DOI 10.1016/j.aanat.2008.08.002; Tsatsaris V, 2003, J CLIN ENDOCR METAB, V88, P5555, DOI 10.1210/jc.2003-030528; van der Merwe JL, 2010, HYPERTENS PREGNANCY, V29, P457, DOI 10.3109/10641950903572282; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Vinnars MT, 2011, ACTA OBSTET GYN SCAN, V90, P19, DOI 10.1111/j.1600-0412.2010.01012.x; Wang Y., 2006, Spectral Analysis of Signals. The Missing Data Case; Weed S, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.003; Zhou P, 2012, INFLAMM RES, V61, P1005, DOI 10.1007/s00011-012-0507-x	47	66	70	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157584	10.1371/journal.pone.0157584	http://dx.doi.org/10.1371/journal.pone.0157584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315098	gold, Green Published, Green Submitted			2022-12-27	WOS:000378030000039
J	Griffin, JM; Kho, D; Graham, ES; Nicholson, LFB; O'Carroll, SJ				Griffin, Jarred M.; Kho, Dan; Graham, E. Scott; Nicholson, Louise F. B.; O'Carroll, Simon J.			Statins Inhibit Fibrillary beta-Amyloid Induced Inflammation in a Model of the Human Blood Brain Barrier	PLOS ONE			English	Article							NF-KAPPA-B; COA REDUCTASE INHIBITORS; ENDOTHELIAL-CELLS; ALZHEIMERS-DISEASE; IN-VITRO; OXIDATIVE STRESS; DOWN-REGULATION; TIGHT JUNCTION; MULTIPLE-SCLEROSIS; ACTIVATION	Background Astrocytes and cerebral endothelial cells are important components of the blood-brain barrier (BBB). Disruption to this barrier through inflammation is a major contributor to Alzheimer's disease (AD) pathology. The amyloid beta (A beta) protein is known to exist in several forms and is a key modulator of AD that is known to cause inflammation and changes to BBB function. While one of these forms, fibrillary A beta (fA beta), is known to cause endothelial cell death at the BBB, no studies have looked specifically at its role on inflammation in a model of the human BBB. Aims To determine if fA beta is inflammatory to the human BBB. As statins have been shown to be anti-inflammatory and protective in AD, we also tested if these could inhibit the inflammatory effect of fA beta. Methods Using cultured cerebral endothelial cells and astrocytes we determined changes in cytokine release, cell toxicity and barrier function in response to fibrillary beta-amyloid(1-42) (fA beta(1-42)) alone and in combination with statins. Results fA beta(1-42) induced inflammatory cytokine release from endothelial cells in the absence of cell toxicity. It also induced astrocyte cytokine release and cell death and caused a loss of barrier integrity. Statin treatment inhibited all of these effects. Conclusions We conclude that fA beta(1-42) has both inflammatory and cytotoxic effects on the BBB and the protective effect of statins in AD may in part be through inhibiting these effects.	[Griffin, Jarred M.; Kho, Dan; Graham, E. Scott; Nicholson, Louise F. B.; O'Carroll, Simon J.] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Ctr Brain Res, Auckland 1, New Zealand; [Griffin, Jarred M.; Nicholson, Louise F. B.; O'Carroll, Simon J.] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Dept Anat & Med Imaging, Auckland 1, New Zealand; [Kho, Dan; Graham, E. Scott] Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	O'Carroll, SJ (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Ctr Brain Res, Auckland 1, New Zealand.; O'Carroll, SJ (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Med Sci, Dept Anat & Med Imaging, Auckland 1, New Zealand.	s.ocarroll@auckland.ac.nz		Nicholson, Louise/0000-0003-1737-7624; Graham, Scott/0000-0002-2925-9126; Kho, Dan/0000-0001-7193-2954; Griffin, Jarred/0000-0002-3013-8057	Maurice Phyllis Paykel Trust; New Zealand Lotteries Health Fund	Maurice Phyllis Paykel Trust; New Zealand Lotteries Health Fund	The authors greatly acknowledge funding from the Maurice Phyllis Paykel Trust to LFBN and SJO and New Zealand Lotteries Health Fund to SJO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors greatly acknowledge funding from the Maurice Phyllis Paykel Trust to LN and SO and New Zealand Lotteries Health Fund to SO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Aguirre-Rueda D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122843; Andras IE, 2008, MOL PHARMACOL, V73, P1424, DOI 10.1124/mol.107.042028; Brkic M, 2015, J NEUROSCI, V35, P12766, DOI 10.1523/JNEUROSCI.0006-15.2015; Burkert K, 2012, NEUROCHEM INT, V60, P573, DOI 10.1016/j.neuint.2011.09.002; Buttmann M, 2007, J NEUROCHEM, V102, P1001, DOI 10.1111/j.1471-4159.2007.04563.x; Capurro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056870; Carrano A, 2012, NEURODEGENER DIS, V10, P329, DOI 10.1159/000334916; Carrano A, 2011, ANTIOXID REDOX SIGN, V15, P1167, DOI 10.1089/ars.2011.3895; Dichtl W, 2003, ARTERIOSCL THROM VAS, V23, P58, DOI 10.1161/01.ATV.0000043456.48735.20; Eisenhauer PB, 2000, J NEUROSCI RES, V60, P804, DOI 10.1002/1097-4547(20000615)60:6<804::AID-JNR13>3.3.CO;2-T; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Frigerio S, 2006, NEUROL SCI, V27, P261, DOI 10.1007/s10072-006-0681-0; Hensley K, 2010, J ALZHEIMERS DIS, V21, P1, DOI 10.3233/JAD-2010-1414; Hofman FM, 1998, BLOOD, V92, P3064, DOI 10.1182/blood.V92.9.3064.421a10_3064_3072; Ifergan I, 2006, ANN NEUROL, V60, P45, DOI 10.1002/ana.20875; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jiang F, 2015, NEUROCHEM RES, V40, P1954, DOI 10.1007/s11064-015-1691-1; Jiang X., 2012, INT J ALZHEIMERS DIS, V2012, P109324, DOI DOI 10.1155/2012/109324; Kallmann BA, 2002, FASEB J, V16, P589, DOI 10.1096/fj.01-0594fje; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kaur U, 2015, CURR TOP MED CHEM, V15, P446, DOI 10.2174/1568026615666150114160543; Keaney J, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500472; Koizumi K, 2016, CELL MOL NEUROBIOL, V36, P155, DOI 10.1007/s10571-015-0256-9; Lamoke F, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0304-x; Li YK, 2012, NEUROPSYCHOPHARMACOL, V37, P1867, DOI 10.1038/npp.2012.34; Liang YJ, 2008, CARDIOLOGY, V110, P182, DOI 10.1159/000111928; Lim JH, 2007, BRAIN RES, V1164, P1, DOI 10.1016/j.brainres.2007.06.020; Liu WJ, 2016, EXP CELL RES, V343, P248, DOI 10.1016/j.yexcr.2016.03.026; Luscombe PRTaM, 1987, BRIT J CANCER, V56, P279, DOI [10.1038/bjc.1987.190, DOI 10.1038/BJC.1987.190]; Merlini M, 2011, ACTA NEUROPATHOL, V122, P293, DOI 10.1007/s00401-011-0834-y; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Mincheva-Tasheva S, 2013, NEUROSCIENTIST, V19, P175, DOI 10.1177/1073858412444007; Morishita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084387; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; O'Carroll SJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0346-0; Pac-Soo C, 2011, J ALZHEIMERS DIS, V27, P1, DOI [10.3233/JAD-2011-110524, 10.1097/WAD.0b013e31821f5787]; Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x; Park L, 2005, J NEUROSCI, V25, P1769, DOI 10.1523/JNEUROSCI.5207-04.2005; Park R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.258; Qosa H, 2014, BBA-MOL BASIS DIS, V1842, P1806, DOI 10.1016/j.bbadis.2014.06.029; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Ridker P M, 2000, Curr Cardiol Rep, V2, P269, DOI 10.1007/s11886-000-0080-8; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; SAHEKI A, 1994, PHARMACEUT RES, V11, P305, DOI 10.1023/A:1018975928974; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Smits HA, 2001, J IMMUNOL, V166, P6869, DOI 10.4049/jimmunol.166.11.6869; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sparks DL, 2011, NAT REV NEUROL, V7, P662, DOI 10.1038/nrneurol.2011.165; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Stuve O, 2003, CURR OPIN NEUROL, V16, P393, DOI 10.1097/01.wco.0000073942.19076.d1; Sutinen EM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-199; Tamagno E, 2006, FREE RADICAL BIO MED, V41, P202, DOI 10.1016/j.freeradbiomed.2006.01.021; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; Tong XK, 2005, J NEUROSCI, V25, P11165, DOI 10.1523/JNEUROSCI.4031-05.2005; Wan WB, 2015, J NEUROCHEM, V134, P382, DOI 10.1111/jnc.13122; Wan WB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/301575; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013; Wilhelmus MMM, 2007, AM J PATHOL, V171, P1989, DOI 10.2353/ajpath.2007.070050; Yang CH, 2015, J SURG RES, V194, P591, DOI 10.1016/j.jss.2014.11.030; Yang Dongmei, 2013, J Behav Brain Sci, V3, P100; Yang SP, 2004, NEUROBIOL AGING, V25, P283, DOI 10.1016/S0197-4580(03)00111-8; Yu HC, 2013, INT J BIOL SCI, V9, P966, DOI 10.7150/ijbs.6996	66	16	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157483	10.1371/journal.pone.0157483	http://dx.doi.org/10.1371/journal.pone.0157483			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309956	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800082
J	Kinner, SA; Forsyth, SJ				Kinner, Stuart A.; Forsyth, Simon J.			Development and Validation of a National System for Routine Monitoring of Mortality in People Recently Released from Prison	PLOS ONE			English	Article							EX-PRISONERS; DEATH INDEX; HEALTH OUTCOMES; MENTAL-DISORDER; RECORD LINKAGE; COHORT; RISK; AUSTRALIA; ACCURACY; SUICIDE	Background People released from prison are at increased risk of death. However, no country has established a system for routine monitoring of mortality in this population. The aims of this study were to (a) evaluate a system for routine monitoring of deaths after release from prison in Australia and (b) estimate the number of deaths annually within 28 and 365 days of prison release from 2000 to 2013. Methods Persons released from prison and deaths were identified in records held by Centrelink, Australia's national provider of unemployment benefits. Estimates generated in this manner were compared with those from a study that probabilistically linked correctional records with the National Death Index (NDI), for each calendar year 2000 to 2007. Using Centrelink data, national estimates of mortality within 28 and 365 days of release were produced for each calendar year 2000 to 2013. Findings Compared with estimates based on linkage with the NDI, the estimated crude mortality rate based on Centrelink records was on average 52% lower for deaths within 28 days of release and 24% lower for deaths within 365 days of release. Nationally, over the period 2000 to 2013, we identified an average of 32 deaths per year within 28 days of release and 188 deaths per year within 365 days of release. The crude mortality rate for deaths within both 28 and 365 days of release increased over this time. Conclusions Using routinely collected unemployment benefits data we detected the majority of deaths in people recently released from prison in Australia. These data may be sufficient for routine monitoring purposes and it may be possible to adopt a similar approach in other countries. Routine surveillance of mortality in ex-prisoners serves to highlight their extreme vulnerability and provides a basis for evaluating policy reforms designed to reduce preventable deaths.	[Kinner, Stuart A.] Griffith Univ, Griffith Criminol Inst, Brisbane, Qld 4111, Australia; [Kinner, Stuart A.] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld 4111, Australia; [Kinner, Stuart A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Kinner, Stuart A.] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia; [Kinner, Stuart A.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Kinner, Stuart A.] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Forsyth, Simon J.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia	Griffith University; Griffith University; Menzies Health Institute Queensland; University of Melbourne; Mater Research; University of Queensland; Monash University; Murdoch Children's Research Institute; University of Queensland	Kinner, SA (corresponding author), Griffith Univ, Griffith Criminol Inst, Brisbane, Qld 4111, Australia.; Kinner, SA (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld 4111, Australia.; Kinner, SA (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.; Kinner, SA (corresponding author), Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia.; Kinner, SA (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia.; Kinner, SA (corresponding author), Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia.	s.kinner@griffith.edu.au	Forsyth, Simon J/N-9522-2013	Forsyth, Simon J/0000-0002-3100-3584	National Health and Medical Research Council [456107]; NHMRC Senior Research Fellowship [APP1078168]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The MARC project was funded by National Health and Medical Research Council (www.nhmrc.gov.au) project grant #456107. Stuart Kinner is supported by NHMRC Senior Research Fellowship APP1078168. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2015, 451702015 ABS; Baker A, 2015, DEATHS CUSTODY AUSTR; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Brook EL, 2008, AUST NZ J PUBL HEAL, V32, P19, DOI 10.1111/j.1753-6405.2008.00160.x; Choi BCK, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/875253; Csete J, 2010, INT J PRISONER HLTH, V6, P3; Cutcher Z, 2014, AUST NZ J PUBL HEAL, V38, P424, DOI 10.1111/1753-6405.12207; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Forsyth SJ, 2014, ADDICTION, V109, P1676, DOI 10.1111/add.12646; Freudenberg N, 2005, AM J PUBLIC HEALTH, V95, P1725, DOI 10.2105/AJPH.2004.056325; Graham A, 2003, AUST NZ J CRIMINOL, V36, P94, DOI 10.1375/000486503764805365; Kariminia A, 2007, INT J EPIDEMIOL, V36, P310, DOI 10.1093/ije/dyl225; Kariminia A, 2005, AUST NZ J PUBL HEAL, V29, P572, DOI 10.1111/j.1467-842X.2005.tb00253.x; Kelman C, 2000, AUST NZ J PUBL HEAL, V24, P201, DOI 10.1111/j.1467-842X.2000.tb00143.x; Kinner SA, 2013, ADDICTION, V108, P38, DOI 10.1111/add.12010; Kinner SA, 2011, MED J AUSTRALIA, V195, P64, DOI 10.5694/j.1326-5377.2011.tb03208.x; Kinner SA, 2010, ADDICTION, V105, P1555, DOI 10.1111/j.1360-0443.2010.03030.x; Larney S, 2011, EVALUATION REV, V35, P118, DOI 10.1177/0193841X11401695; Magliano D, 2003, AUST NZ J PUBL HEAL, V27, P649, DOI 10.1111/j.1467-842X.2003.tb00615.x; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Ministry of Justice, 2013, SAF CUST STAT ENGL W; Noonan M, 2010, MORTALITY LOCAL JAIL; Pratt D, 2006, LANCET, V368, P119, DOI 10.1016/S0140-6736(06)69002-8; Rosen DL, 2008, AM J PUBLIC HEALTH, V98, P2278, DOI 10.2105/AJPH.2007.121855; SAS Institute, 2010, SAS SYST WIND VERS; Souza KA, 2010, CRIM JUSTICE BEHAV, V37, P1330, DOI 10.1177/0093854810379969; Spittal MJ, 2014, J EPIDEMIOL COMMUN H, V68, P993, DOI 10.1136/jech-2014-204295; Stewart LM, 2004, AUST NZ J PUBL HEAL, V28, P32, DOI 10.1111/j.1467-842X.2004.tb00629.x; van Dooren K, 2013, AUST NZ J PUBL HEAL, V37, P377, DOI 10.1111/1753-6405.12087; Visher CA, 2011, JUSTICE Q, V28, P698, DOI 10.1080/07418825.2010.535553	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157328	10.1371/journal.pone.0157328	http://dx.doi.org/10.1371/journal.pone.0157328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309540	Green Published, gold			2022-12-27	WOS:000378029800054
J	Bryzgunova, OE; Zaripov, MM; Skvortsova, TE; Lekchnov, EA; Grigor'eva, AE; Zaporozhchenko, IA; Morozkin, ES; Ryabchikova, EI; Yurchenko, YB; Voitsitskiy, VE; Laktionov, PP				Bryzgunova, Olga E.; Zaripov, Marat M.; Skvortsova, Tatyana E.; Lekchnov, Evgeny A.; Grigor'eva, Alina E.; Zaporozhchenko, Ivan A.; Morozkin, Evgeny S.; Ryabchikova, Elena I.; Yurchenko, Yuri B.; Voitsitskiy, Vladimir E.; Laktionov, Pavel P.			Comparative Study of Extracellular Vesicles from the Urine of Healthy Individuals and Prostate Cancer Patients	PLOS ONE			English	Article							CIRCULATING MICRORNA; BIOMARKER DISCOVERY; EXOSOMES; IDENTIFICATION; MICROVESICLES; KIDNEY; CELLS; DNA; EXOSOMES/MICROVESICLES; QUANTIFICATION	Recent studies suggest that extracellular vesicles may be the key to timely diagnosis and monitoring of genito-urological malignancies. In this study we investigated the composition and content of extracellular vesicles found in the urine of healthy donors and prostate cancer patients. Urine of 14 PCa patients and 20 healthy volunteers was clarified by low-speed centrifugation and total extracellular vesicles fraction was obtain by high-speed centrifugation. The exosome-enriched fraction was obtained by filtration of total extracellular vesicles through a 0.1 mu m pore filter. Transmission electron microscopy showed that cell-free urine in both groups contained vesicles from 20 to 230 nm. Immunogold staining after ultrafiltration demonstrated that 95% and 90% of extracellular vesicles in healthy individuals and cancer patients, respectively, were exosomes. Protein, DNA and RNA concentrations as well as size distribution of extracellular vesicles in both fractions were analyzed. Only 75% of the total protein content of extracellular vesicles was associated with exosomes which amounted to 90-95% of all vesicles. Median DNA concentrations in total extracellular vesicles and exosome-enriched fractions were 18 pg/ml and 2.6 pg/ml urine, correspondingly. Urine extracellular vesicles carried a population of RNA molecules 25 nt to 200 nt in concentration of no more than 290 pg/ml of urine. Additionally, concentrations of miR-19b, miR-25, miR-125b, and miR-205 were quantified by qRT-PCR. MiRNAs were shown to be differently distributed between different fractions of extracellular vesicles. Detection of miR-19b versus miR-16 in total vesicles and exosome-enriched fractions achieved 100%/93% and 95%/79% specificity/sensitivity in distinguishing cancer patients from healthy individuals, respectively, demonstrating the diagnostic value of urine extracellular vesicles.	[Bryzgunova, Olga E.; Skvortsova, Tatyana E.; Lekchnov, Evgeny A.; Zaporozhchenko, Ivan A.; Morozkin, Evgeny S.; Laktionov, Pavel P.] Inst Chem Biol & Fundamental Med CD RAS, Mol Med Lab, Novosibirsk, Russia; [Zaripov, Marat M.; Voitsitskiy, Vladimir E.] Novosibirsk Reg Oncol Ctr, Dispensary Dept 2, Novosibirsk, Russia; [Grigor'eva, Alina E.; Ryabchikova, Elena I.] Inst Chem Biol & Fundamental Med CD RAS, Grp Microscopy, Novosibirsk, Russia; [Morozkin, Evgeny S.; Laktionov, Pavel P.] Novosibirsk Res Inst Circulat Pathol Academician, Ctr Oncol & Radiotherapy, Novosibirsk, Russia; [Yurchenko, Yuri B.] ICBFM SB RAS, Ctr New Med Technol, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Meshalkin National Medical Research Center; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Zaporozhchenko, IA (corresponding author), Inst Chem Biol & Fundamental Med CD RAS, Mol Med Lab, Novosibirsk, Russia.	ivanzap@niboch.nsc.ru	Ryabchikova, Elena/G-3089-2013; Bryzgunova, Olga E/G-6279-2014; Grigoreva, Alina/I-3881-2014; Morozkin, Evgeny/AAJ-1779-2020; Yurchenko, Yuri A/B-8549-2009	Ryabchikova, Elena/0000-0003-4714-1524; Morozkin, Evgeny/0000-0001-8407-2623; Grigor'eva, Alina/0000-0001-9853-223X; Zaporozhchenko, Ivan/0000-0001-9101-2207	Russian Science Foundation [16-15-00124]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation (project No 16-15-00124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Bryzgunova O, 2011, ANAL BIOCHEM, V408, P354, DOI 10.1016/j.ab.2010.09.005; Bryzgunova OE, 2008, ANN NY ACAD SCI, V1137, P222, DOI 10.1196/annals.1448.039; Burden HP, 2006, HUM REPROD UPDATE, V12, P283, DOI 10.1093/humupd/dmi052; Channavajjhala SK, 2014, CLIN CHEM LAB MED, V52, P345, DOI 10.1515/cclm-2013-0562; Cheng L, 2014, KIDNEY INT, V86, P433, DOI 10.1038/ki.2013.502; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Conde-Vancells Javier, 2012, Methods Mol Biol, V909, P321, DOI 10.1007/978-1-61779-959-4_21; De Long J, 2015, AM J TRANSL RES, V7, P2500; Deras IL, 2008, J UROLOGY, V179, P1587, DOI 10.1016/j.juro.2007.11.038; Dijkstra S, 2014, CLIN BIOCHEM, V47, P889, DOI 10.1016/j.clinbiochem.2013.10.023; Dimov I, 2009, THESCIENTIFICWORLDJO, V9, P1107, DOI 10.1100/tsw.2009.128; Downes MR, 2007, BJU INT, V99, P263, DOI 10.1111/j.1464-410X.2006.06610.x; Duijvesz D, 2011, EUR UROL, V59, P823, DOI 10.1016/j.eururo.2010.12.031; Fabris L, 2016, EUR UROL, V70, P312, DOI 10.1016/j.eururo.2015.12.054; Fang DYP, 2013, NEPHROLOGY, V18, P1, DOI 10.1111/nep.12005; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Haese A, 2008, EUR UROL, V54, P1081, DOI 10.1016/j.eururo.2008.06.071; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; King JB, 2012, AM J PHYSIOL-GASTR L, V303, pG443, DOI 10.1152/ajpgi.00087.2012; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Li M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0502; Lv LL, 2013, INT J BIOL SCI, V9, P1021, DOI 10.7150/ijbs.6100; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Merchant ML, 2010, PROTEOM CLIN APPL, V4, P84, DOI 10.1002/prca.200800093; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; MIZUTA K, 1990, ARCH BIOCHEM BIOPHYS, V281, P144, DOI 10.1016/0003-9861(90)90424-W; Moon PG, 2011, MASS SPECTROM REV, V30, P1185, DOI 10.1002/mas.20319; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Murakami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109074; Musante L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037279; Naskalski JW, MAT MED POL, V23, P107; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Oosthuyzen W, 2013, J PHYSIOL-LONDON, V591, P5833, DOI 10.1113/jphysiol.2013.264069; Overbye A, 2015, ONCOTARGET, V6, P30357, DOI 10.18632/oncotarget.4851; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Raimondo F, 2013, MOL BIOSYST, V9, P1220, DOI 10.1039/c3mb25582d; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Royo F, 2016, ONCOTARGET, V7, P6835, DOI 10.18632/oncotarget.6899; Royo F, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29497; Rykova EY, 2012, EXPERT OPIN BIOL TH, V12, pS141, DOI 10.1517/14712598.2012.673577; Shen C, 2011, J INT MED RES, V39, P740, DOI 10.1177/147323001103900305; Tian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075885; van Balkom BWM, 2011, KIDNEY INT, V80, P1138, DOI 10.1038/ki.2011.292; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang DQ, 2014, PROTEOMICS, V14, P1922, DOI 10.1002/pmic.201300371; Wang G, 2010, DIS MARKERS, V28, P79, DOI [10.1155/2010/396328, 10.3233/DMA-2010-0687]; Wang Z, 2012, PROTEOMICS, V12, P329, DOI 10.1002/pmic.201100477; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Ye P, 2014, J PERIODONTAL RES, V49, P253, DOI 10.1111/jre.12102; Zaporozhchenko IA, 2015, ANAL BIOCHEM, V479, P43, DOI 10.1016/j.ab.2015.03.028; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273	60	97	101	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157566	10.1371/journal.pone.0157566	http://dx.doi.org/10.1371/journal.pone.0157566			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305142	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800073
J	Han, JC; Eo, DR; Lee, TK; Shin, JH; Kee, C				Han, Jong Chul; Eo, Doo Ri; Lee, Taek Kwan; Shin, Jong Hoon; Kee, Changwon			Does Glaucoma Share Common Pathogenesis with Branch Retinal Vein Occlusion?	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; RISK-FACTORS; INTRAOCULAR-PRESSURE; EYE; ABNORMALITIES; PREVALENCE; VASOSPASM; DAMAGE	Background To evaluate the observed prevalence and the optic nerve head (ONH) characteristics of normal tension glaucoma (NTG)-suspect eyes in branch retinal vein occulusion (BRVO) eyes in Korean population. Methods This was a retrospective observational study. We investigated 445 BRVO eyes that were diagnosed in the retina clinic of Samsung Medical Center between March 2005 and December 2011. The observed prevalence of NTG-suspect in BRVO eyes was evaluated compared to the previous population based study. In addition, NTG-suspect cases in BRVO were divided into three groups based on the characteristics of optic disc morphology. Results In 445 BRVO eyes, 30 eyes were excluded from the present study. In 415 BRVO eyes, 4.3% (18 eyes) (95% confident interval [CI], 2.4-6.3%) were diagnosed with suspect glaucoma and this is not significantly different from the result in the general Korean population (P = 0.09). We classified the NTG-suspect eyes into three groups such as disc rim notching and thinning type (Group 1; 55.6%), optic cup-sited hemorrhage type (Group 2; 16.7%) and disc rim thinning and pallor type (Group 3; 27.8%). NTG-suspect in the fellow eye were only found in group 1 (80%) and group 2 (67%), but not in group 3 (P = 0.01). Conclusions BRVO and glaucoma seem to have no common vascular pathogenesis in consideration of the prevalence of NTG-suspect in BRVO eyes compared to general Korean population.	[Han, Jong Chul; Eo, Doo Ri; Lee, Taek Kwan; Kee, Changwon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Shin, Jong Hoon] Busan Natl Univ, Sch Med, Dept Ophthalmol, Busan Natl Univ Hosp, Busan, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Pusan National University; Pusan National University Hospital	Kee, C (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	ckee@skku.edu		Kee, Changwon/0000-0002-7419-0316				Alencar Luciana M, 2007, Semin Ophthalmol, V22, P103, DOI 10.1080/08820530701420058; Beaumont PE, 2002, OPHTHALMOLOGY, V109, P282, DOI 10.1016/S0161-6420(01)00922-8; Bertelsen M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7885; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Chan EW, 2013, BRIT J OPHTHALMOL, V97, P611, DOI 10.1136/bjophthalmol-2012-302280; Danesh-Meyer HV, 2010, INVEST OPHTH VIS SCI, V51, P2003, DOI 10.1167/iovs.09-3492; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Flammer J, 2001, PROG RETIN EYE RES, V20, P319, DOI 10.1016/S1350-9462(00)00028-8; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gherghel D, 2000, AM J OPHTHALMOL, V130, P597, DOI 10.1016/S0002-9394(00)00766-2; Hayreh SS, 2015, RETINA-J RET VIT DIS, V35, P29, DOI 10.1097/IAE.0000000000000256; Hayreh SS, 2004, OPHTHALMOLOGY, V111, P133, DOI 10.1016/j.ophtha.2003.03.002; Kim CS, 2014, RETINA-J RET VIT DIS, V34, P525, DOI 10.1097/IAE.0b013e3182a2e746; Kim MJ, 2011, OPHTHALMOLOGY, V118, P706, DOI 10.1016/j.ophtha.2010.08.028; Kim Soa, 2013, Korean J Ophthalmol, V27, P440, DOI 10.3341/kjo.2013.27.6.440; Klein BEK, 2006, AM J OPHTHALMOL, V141, P859, DOI 10.1016/j.ajo.2005.12.015; Krupin T, 2005, OPHTHALMOLOGY, V112, P376, DOI 10.1016/j.ophtha.2004.10.034; Mitchell P, 1996, ARCH OPHTHALMOL-CHIC, V114, P1243, DOI 10.1001/archopht.1996.01100140443012; Nicolela MT, 2003, INVEST OPHTH VIS SCI, V44, P2565, DOI 10.1167/iovs.02-0913; Pasquale LR, 2006, OPHTHALMOLOGY, V113, P1081, DOI 10.1016/j.ophtha.2006.01.066; RATH EZ, 1992, OPHTHALMOLOGY, V99, P509; Saito H, 2006, OPHTHALMOLOGY, V113, P1340, DOI 10.1016/j.ophtha.2006.01.072; Simons BD, 1997, RETINA-J RET VIT DIS, V17, P191, DOI 10.1097/00006982-199705000-00003; Sonnsjo B, 2002, PROG RETIN EYE RES, V21, P35, DOI 10.1016/S1350-9462(01)00019-2; Sperduto RD, 1998, OPHTHALMOLOGY, V105, P765, DOI 10.1016/S0161-6420(98)95012-6; SUSANNA R, 1978, BRIT J OPHTHALMOL, V62, P327, DOI 10.1136/bjo.62.5.327; Takahashi H, 2006, AM J OPHTHALMOL, V142, P88, DOI 10.1016/j.ajo.2006.02.016	27	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156966	10.1371/journal.pone.0156966	http://dx.doi.org/10.1371/journal.pone.0156966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304065	gold, Green Published, Green Submitted			2022-12-27	WOS:000377824800031
J	Lira, RMM; Flores, AYL; Carmona, MCS; Stern, AO				Mifuji Lira, Roque M.; Limon Flores, Alberto Yairh; Salinas Carmona, Mario Cesar; Ortiz Stern, Alejandro			Experimental Granulomatous Pulmonary Nocardiosis in BALB/C Mice	PLOS ONE			English	Article							DELTA T-LYMPHOCYTES; ASTEROIDES; INFECTION; BRASILIENSIS; ACTINOMYCETOMA; MACROPHAGE; GAMMA; CLEARANCE; DIAGNOSIS; MODEL	Pulmonary nocardiosis is a granulomatous disease with high mortality that affects both immunosuppressed and immunocompetent patients. The mechanisms leading to the establishment and progression of the infection are currently unknown. An animal model to study these mechanisms is sorely needed. We report the first in vivo model of granulomatous pulmonary nocardiosis that closely resembles human pathology. BALB/c mice infected intranasally with two different doses of GFP-expressing Nocardia brasiliensis ATCC700358 (NbGFP), develop weight loss and pulmonary granulomas. Mice infected with 10(9) CFUs progressed towards death within a week while mice infected with 10(8) CFUs died after five to six months. Histological examination of the lungs revealed that both the higher and lower doses of NbGFP induced granulomas with NbGFP clearly identifiable at the center of the lesions. Mice exposed to 10(8) CFUs and subsequently to 10(9) CFUs were not protected against disease severity but had less granulomas suggesting some degree of protection. Attempts to identify a cellular target for the infection were unsuccessful but we found that bacterial microcolonies in the suspension used to infect mice were responsible for the establishment of the disease. Small microcolonies of NbGFP, incompatible with nocardial doubling times starting from unicellular organisms, were identified in the lung as early as six hours after infection. Mice infected with highly purified unicellular preparations of NbGFP did not develop granulomas despite showing weight loss. Finally, intranasal delivery of nocardial microcolonies was enough for mice to develop granulomas with minimal weight loss. Taken together these results show that Nocardia brasiliensis microcolonies are both necessary and sufficient for the development of granulomatous pulmonary nocardiosis in mice.	[Mifuji Lira, Roque M.; Limon Flores, Alberto Yairh; Salinas Carmona, Mario Cesar; Ortiz Stern, Alejandro] Univ Autonoma Nuevo Leon, Fac Med, Dept Inmunol, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon	Stern, AO (corresponding author), Univ Autonoma Nuevo Leon, Fac Med, Dept Inmunol, Monterrey, Nuevo Leon, Mexico.	alejandro.ortizst@uanl.edu.mx	Salinas-Carmona, Mario C/Y-2456-2019; Ortiz-Stern, Alejandro/C-3048-2013	Salinas-Carmona, Mario C/0000-0002-4239-7363; Ortiz-Stern, Alejandro/0000-0002-4468-4817; Limon-Flores, Alberto Yairh/0000-0003-4718-4356				Baracco Gio J., 2001, Curr Infect Dis Rep, V3, P286, DOI 10.1007/s11908-001-0032-5; BEAMAN BL, 1978, INFECT IMMUN, V22, P867, DOI 10.1128/IAI.22.3.867-877.1978; BEAMAN BL, 1977, INFECT IMMUN, V15, P925, DOI 10.1128/IAI.15.3.925-937.1977; Brown-Elliott B. A., 2015, Clinical Microbiology Newsletter, V37, P25, DOI 10.1016/j.clinmicnews.2015.01.; BYRON PR, 1986, J PHARM SCI-US, V75, P433, DOI 10.1002/jps.2600750502; Cakir E, 2013, PEDIATR PULM, V48, P1144, DOI 10.1002/ppul.22740; Dominguez DC, 1999, J NATL MED ASSOC, V91, P35; Ellis TN, 2002, J LEUKOCYTE BIOL, V72, P373; Gama JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002503; Hui CH, 2003, RESP MED, V97, P709, DOI 10.1053/rmed.2003.1505; Trevino-Villarreal JH, 2012, INFECT IMMUN, V80, P3587, DOI 10.1128/IAI.00446-12; Martinez R, 2008, CURR OPIN PULM MED, V14, P219, DOI 10.1097/MCP.0b013e3282f85dd3; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; Menendez R, 1997, EUR RESPIR J, V10, P1542, DOI 10.1183/09031936.97.10071542; Mihai MM, 2015, CURR TOP MED CHEM; MISHRA SK, 1973, INFECT IMMUN, V7, P123, DOI 10.1128/IAI.7.2.123-129.1973; Moore TA, 2000, J IMMUNOL, V164, P908, DOI 10.4049/jimmunol.164.2.908; Munoz-Hernandez B, 2009, MYCOPATHOLOGIA, V168, P37, DOI 10.1007/s11046-009-9189-5; Negi Amita, 2013, J Oral Maxillofac Pathol, V17, P363, DOI 10.4103/0973-029X.125199; Salinas-Carmona MC, 2011, PLASMID, V65, P25, DOI 10.1016/j.plasmid.2010.09.005; Salinas-Carmona MC, 1999, INFECT IMMUN, V67, P2428, DOI 10.1128/IAI.67.5.2428-2432.1999; SILVA CL, 1992, INFECT IMMUN, V60, P3566, DOI 10.1128/IAI.60.9.3566-3570.1992; Tam S, 2001, INFECT IMMUN, V69, P6165, DOI 10.1128/IAI.69.10.6165-6171.2001; Tam S, 2012, MICROBES INFECT, V14, P1133, DOI 10.1016/j.micinf.2012.05.008; Minero MV, 2009, MEDICINE, V88, P250, DOI 10.1097/MD.0b013e3181afa1c8; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Zehra Y, 2014, CASE REPORTS PULMONO, DOI [10.1155/2014/963482, DOI 10.1155/2014/963482]	27	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157475	10.1371/journal.pone.0157475	http://dx.doi.org/10.1371/journal.pone.0157475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303806	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000377824800063
J	Painting, CJ; Splinter, W; Callander, S; Maricic, T; Peso, M; Backwell, PRY				Painting, Christina J.; Splinter, William; Callander, Sophia; Maricic, Tim; Peso, Marianne; Backwell, Patricia R. Y.			Ladies First: Coerced Mating in a Fiddler Crab	PLOS ONE			English	Article							FEMALE RESISTANCE BEHAVIOR; MATE CHOICE; FORCED COPULATION; UCA; COURTSHIP; DECAPODA; CONSTRAINTS; PREFERENCE; BURROWS; SYSTEM	In some species males increase their reproductive success by forcing females to copulate with them, usually by grasping the female or pinning her to the ground to prevent her from escaping. Here we report an example of males coercing copulation by trapping a female in a confined space. During mate-searching, female Uca mjoebergi fiddler crabs visit males and choose whether or not to enter their burrow for inspection. Males typically enter the burrow first and we found that 71% of females will follow him down and 54% decide to stay and mate. However, some males use an alternative tactic where he will wait for the female to enter the burrow first, after which he traps her inside. Although a significantly lower percentage of females will enter a burrow following this behaviour (41%), upon entry 79% females that enter will become trapped and almost all of these females (90%) produce a clutch of eggs. Our observations suggest that males are able to gain fertilisations from females that may not have remained in the burrow by trapping them and coercing them to mate.	[Painting, Christina J.; Splinter, William; Callander, Sophia; Maricic, Tim; Peso, Marianne; Backwell, Patricia R. Y.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Painting, Christina J.] Univ Auckland, Sch Biol Sci, Auckland Mail Ctr, Private Bag 92019, Auckland 1, New Zealand; [Peso, Marianne] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Australian National University; University of Auckland; Macquarie University	Painting, CJ (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.; Painting, CJ (corresponding author), Univ Auckland, Sch Biol Sci, Auckland Mail Ctr, Private Bag 92019, Auckland 1, New Zealand.	chrissiepainting@gmail.com	Backwell, Patricia RY/C-8883-2009	Painting, Christina/0000-0003-0701-2648	Australian Research Council [DP 120101427]	Australian Research Council(Australian Research Council)	This study was supported by an Australian Research Council Discovery Grant (DP 120101427) to PRYB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 1996, ANIM BEHAV, V52, P737, DOI 10.1006/anbe.1996.0218; Andersson Malte, 1994; [Anonymous], 2014, R LANG ENV STAT COMP; ARNQVIST G, 1992, ANIM BEHAV, V43, P559, DOI 10.1016/S0003-3472(05)81016-4; Backwell PRY, 1996, BEHAV ECOL SOCIOBIOL, V38, P407, DOI 10.1007/s002650050258; Bates D, 2012, R PACKAGE VERSION 09; Beinlich B., 2006, Zoologische Mededelingen (Leiden), V80, P9; Bisazza A, 2001, BEHAV ECOL, V12, P59, DOI 10.1093/oxfordjournals.beheco.a000379; Callander S, 2011, BEHAV ECOL SOCIOBIOL, V65, P2071, DOI 10.1007/s00265-011-1216-0; Castro I, 1996, IBIS, V138, P765, DOI 10.1111/j.1474-919X.1996.tb08834.x; Chang ES, 2005, NATURAL HIST CRUSTAC, V4; CHRISTY JH, 1983, BEHAV ECOL SOCIOBIOL, V12, P169, DOI 10.1007/BF00343209; CHRISTY JH, 1987, B MAR SCI, V41, P177; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Conroy LP, 2014, BEHAV ECOL SOCIOBIOL, V68, P1431, DOI 10.1007/s00265-014-1750-7; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; Curran E, 2008, FEMALE MATE CHOICE F; Derivera CE, 2005, ANIM BEHAV, V70, P289, DOI 10.1016/j.anbehav.2004.10.027; Detto T, 2009, ANIM BEHAV, V78, P407, DOI 10.1016/j.anbehav.2009.05.014; Dukas R, 2012, ANIM BEHAV, V84, P1177, DOI 10.1016/j.anbehav.2012.08.021; Eberhard WG, 2002, REV BIOL TROP, V50, P485; Gowaty PA, 1998, AM ZOOL, V38, P207; HENMI Y, 1993, J CRUSTACEAN BIOL, V13, P736, DOI 10.2307/1549104; How MJ, 2008, J COMP PHYSIOL A, V194, P1053, DOI 10.1007/s00359-008-0376-5; Kasatani A, 2012, J ETHOL, V30, P69, DOI 10.1007/s10164-011-0296-7; McKinney Frank, 1998, Ornithological Monographs, V49, P163; MITANI JC, 1985, ANIM BEHAV, V33, P392, DOI 10.1016/S0003-3472(85)80063-4; Morrell LJ, 2005, ANIM BEHAV, V70, P653, DOI 10.1016/j.anbehav.2004.11.014; MURAI M, 1995, J CRUSTACEAN BIOL, V15, P655, DOI 10.2307/1548814; Murai M, 1996, J CRUSTACEAN BIOL, V16, P522, DOI 10.2307/1548742; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nakasone Y, 1998, J CRUSTACEAN BIOL, V18, P70, DOI 10.2307/1549522; OLSSON M, 1995, HERPETOLOGICA, V51, P19; Reaney LT, 2008, CURR BIOL, V18, pR62, DOI 10.1016/j.cub.2007.11.047; Reaney LT, 2007, BEHAV ECOL SOCIOBIOL, V61, P1515, DOI 10.1007/s00265-007-0383-5; Reaney LT, 2012, BEHAV ECOL SOCIOBIOL, V66, P1017, DOI 10.1007/s00265-012-1349-9; Reaney LT, 2009, ANIM BEHAV, V77, P139, DOI 10.1016/j.anbehav.2008.09.019; SAKALUK SK, 1995, P ROY SOC B-BIOL SCI, V261, P65, DOI 10.1098/rspb.1995.0118; SALMON M, 1984, Transactions of the Zoological Society of London, V37, P1; Seeley C, 2011, ANIM BEHAV, V81, P595, DOI 10.1016/j.anbehav.2010.12.003; THORNHILL R, 1980, ANIM BEHAV, V28, P52, DOI 10.1016/S0003-3472(80)80007-8; VONHAGEN HO, 1993, ETHOLOGY, V93, P3; WADA K, 1984, J ETHOL, V2, P7, DOI DOI 10.1007/BF02348201; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; ZUCKER N, 1983, MAR BEHAV PHYSIOL, V10, P57, DOI 10.1080/10236248309378606	45	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155707	10.1371/journal.pone.0155707	http://dx.doi.org/10.1371/journal.pone.0155707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303816	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800008
J	Meng, JA; Saberi, K; Hsieh, IH				Meng, Jhao-An; Saberi, Kourosh; Hsieh, I-Hui			Velocity Selective Networks in Human Cortex Reveal Two Functionally Distinct Auditory Motion Systems	PLOS ONE			English	Article							AUDIBLE MOVEMENT ANGLE; SPATIAL SEPARATION; SIGNAL FREQUENCY; HORIZONTAL PLANE; APPARENT MOTION; PARIETAL CORTEX; VISUAL-SYSTEM; EYE-MOVEMENTS; SOUND SOURCE; NO EVIDENCE	The auditory system encounters motion cues through an acoustic object's movement or rotation of the listener's head in a stationary sound field, generating a wide range of naturally occurring velocities from a few to several hundred degrees per second. The angular velocity of moving acoustic objects relative to a listener is typically slow and does not exceed tens of degrees per second, whereas head rotations in a stationary acoustic field may generate fast-changing spatial cues in the order of several hundred degrees per second. We hypothesized that these two types of systems (i.e., encoding slow movements of an object or fast head rotations) may engage functionally distinct substrates in processing spatially dynamic auditory cues, with the latter potentially involved in maintaining perceptual constancy in a stationary field during head rotations and therefore possibly involving corollary-discharge mechanisms in premotor cortex. Using fMRI, we examined cortical response patterns to sound sources moving at a wide range of velocities in 3D virtual auditory space. We found a significant categorical difference between fast and slow moving sounds, with stronger activations in response to higher velocities in the posterior superior temporal regions, the planum temporale, and notably the premotor ventral-rostral (PMVr) area implicated in planning neck and head motor functions.	[Meng, Jhao-An; Hsieh, I-Hui] Natl Cent Univ, Inst Cognit Neurosci, Jhongli 32001, Taiwan; [Saberi, Kourosh] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92697 USA	National Central University; University of California System; University of California Irvine	Saberi, K (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92697 USA.	saberi@uci.edu	Saberi, Kourosh/GXG-0944-2022	Hsieh, I-Hui/0000-0003-4001-4274	National Institutes of Health [R01 DC03681, R01 DC009659]; National Science Foundation [BCS-1329255]; National Science Council, Taiwan [NSC 98-2410-H-008-081]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health R01 DC03681 (KS); National Science Foundation BCS-1329255 (KS); National Institutes of Health R01 DC009659 (KS); and National Science Council, Taiwan NSC 98-2410-H-008-081 (IH).	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ANDERSON DC, 1964, AM J PSYCHOL, V77, P502, DOI 10.2307/1421029; Barton B, 2012, P NATL ACAD SCI USA, V109, P20738, DOI 10.1073/pnas.1213381109; BERNARDIN AC, 1957, AM J PSYCHOL, V70, P133, DOI 10.2307/1419249; Bradley DC, 2008, NAT REV NEUROSCI, V9, P686, DOI 10.1038/nrn2472; Budinger E, 2009, HEARING RES, V258, P16, DOI 10.1016/j.heares.2009.04.021; Burtt HE, 1917, J EXP PSYCHOL, V2, P63, DOI 10.1037/h0070778; DAVIDSON ML, 1973, PERCEPT PSYCHOPHYS, V14, P110, DOI 10.3758/BF03198624; DeValois RL, 1988, SPATIAL VISION; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Flight MH, 2013, NAT REV NEUROSCI, V14, P669, DOI 10.1038/nrn3590; Gibson JJ, 1950, PERCEPTION VISUAL WO; GRANTHAM DW, 1986, J ACOUST SOC AM, V79, P1939, DOI 10.1121/1.393201; GRANTHAM DW, 1984, J ACOUST SOC AM, V76, P71, DOI 10.1121/1.391009; Grantham DW, 1989, C P NATL ACAD SCI US, P35; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Graziano MSA, 2008, INTELLIGENT MOVEMENT; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; IRWIN DE, 1983, PERCEPT PSYCHOPHYS, V34, P49, DOI 10.3758/BF03205895; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; MOISEFF A, 1992, J NEUROPHYSIOL, V67, P1428, DOI 10.1152/jn.1992.67.6.1428; Nelson A, 2013, J NEUROSCI, V33, P14342, DOI 10.1523/JNEUROSCI.2275-13.2013; Ocklenburg S, 2010, BRAIN COGNITION, V72, P210, DOI 10.1016/j.bandc.2009.08.013; Pavani F, 2005, CORTEX, V41, P181, DOI 10.1016/S0010-9452(08)70892-X; PERROTT D R, 1981, Journal of Auditory Research, V21, P287; PERROTT DR, 1977, J ACOUST SOC AM, V62, P1463, DOI 10.1121/1.381675; PERROTT DR, 1990, PERCEPT PSYCHOPHYS, V48, P214, DOI 10.3758/BF03211521; PERROTT DR, 1989, J ACOUST SOC AM, V85, P1773, DOI 10.1121/1.397968; PERROTT DR, 1969, PSYCHON SCI, V17, P207; PERROTT DR, 1988, J ACOUST SOC AM, V83, P1522, DOI 10.1121/1.395908; PERROTT DR, 1990, J ACOUST SOC AM, V87, P1728, DOI 10.1121/1.399421; REEP RL, 1987, BRAIN RES BULL, V19, P203, DOI 10.1016/0361-9230(87)90086-4; Reichardt W, 1961, SENS COMMUN, P303; RUSSELL G, 1974, J EXP PSYCHOL, V103, P173, DOI 10.1037/h0036797; Saberi K, 2002, HEARING RES, V174, P149, DOI 10.1016/S0378-5955(02)00652-4; SABERI K, 1990, J ACOUST SOC AM, V88, P2639, DOI 10.1121/1.399984; Saberi K., 1997, BINAURAL SPATIAL HEA, P315; Schneider DM, 2014, NATURE, V513, P189, DOI 10.1038/nature13724; SHAW EAG, 1974, J ACOUST SOC AM, V56, P1848, DOI 10.1121/1.1903522; Smith KR, 2007, BRAIN RES, V1150, P94, DOI 10.1016/j.brainres.2007.03.003; Smith KR, 2010, J COGNITIVE NEUROSCI, V22, P632, DOI 10.1162/jocn.2009.21196; Smith KR, 2004, NEUROREPORT, V15, P1523, DOI 10.1097/01.wnr.0000130233.43788.4b; SPITZER MW, 1991, SCIENCE, V254, P721, DOI 10.1126/science.1948053; STRYBEL TZ, 1990, PERCEPT PSYCHOPHYS, V47, P439, DOI 10.3758/BF03208177; Strybel TZ, 1998, PERCEPT PSYCHOPHYS, V60, P1441, DOI 10.3758/BF03208004; Warren JE, 2005, TRENDS NEUROSCI, V28, P636, DOI 10.1016/j.tins.2005.09.010; WAUGH W, 1979, Journal of Auditory Research, V19, P103; WESTHEIMER G, 1977, VISION RES, V17, P941, DOI 10.1016/0042-6989(77)90069-4; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wolbers T, 2011, NEUROIMAGE, V56, P681, DOI 10.1016/j.neuroimage.2010.04.266; Zwicker E, 1952, ACUSTICA          S3, V2, P125	56	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157131	10.1371/journal.pone.0157131	http://dx.doi.org/10.1371/journal.pone.0157131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294673	Green Published, Green Submitted, gold			2022-12-27	WOS:000377821300023
J	Zuo, W; Sun, W; Zhao, DY; Gao, FQ; Su, YM; Li, ZR				Zuo, Wei; Sun, Wei; Zhao, Dingyan; Gao, Fuqiang; Su, Yangming; Li, Zirong			Investigating Clinical Failure of Bone Grafting through a Window at the Femoral Head Neck Junction Surgery for the Treatment of Osteonecrosis of the Femoral Head	PLOS ONE			English	Article							TERM-FOLLOW-UP; CORE DECOMPRESSION; AVASCULAR NECROSIS; SURVIVORSHIP ANALYSIS	Aims This study aimed to analyze the clinical factors related to the failure of bone grafting through a window at the femoral head-neck junction. Methods In total, 119 patients (158 hips) underwent bone grafting for treatment of avascular necrosis of the femoral head. The patients were classified by their ARCO staging and CJFH classification. All patients were clinically and radiographically followed up every three months during the first year and every six months in the following year. The clinical follow-up comprised determination of pre- and postoperative Harris hip scores, while serial AP, frog lateral radiographs, and CT scan were used for the radiographic follow-up. Results The clinical failure of bone grafting was observed in 40 patients. The clinical failure rates in patients belonging to ARCO stage II period, IIIa, and III (b + c) were 25.9%, 16.2%, and 61.5%, respectively, while those in patients belonging to (C + M + L1) type and L2, L3 type disease groups were 1.7%, 38.9%, and 39%, respectively. The clinical failure rates in patients aged below 40 and those aged 40 and over were 20.5% and 39.0%, respectively (all P < 0.05). Conclusion Disease type, disease stage, and patient age are risk factors for failure of bone graft surgery. Patients belonging to ARCO stage II and IIIa showed a good overall response rate, while patients belonging to ARCO stage IIIb and IIIc and those with necrotic lesions involving the lateral pillar (L2 and L3 type) showed high surgical failure rates.	[Zuo, Wei] Peking Univ, Hlth Sci Ctr, China Japan Friendship Med Sch, Dept Orthopaed Surg, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Sun, Wei; Zhao, Dingyan; Gao, Fuqiang; Li, Zirong] China Japan Friendship Hosp, Ctr Osteonecrosis & Joint Preserving & Reconstruc, 2 Yingdong Rd, Beijing 100029, Peoples R China; [Su, Yangming] Beijing Univ Chinese Med, 2 Yingdong Rd, Beijing 100029, Peoples R China	Peking University; China-Japan Friendship Hospital; Beijing University of Chinese Medicine	Sun, W (corresponding author), China Japan Friendship Hosp, Ctr Osteonecrosis & Joint Preserving & Reconstruc, 2 Yingdong Rd, Beijing 100029, Peoples R China.	sun887@163.com			National Natural Science Foundation of China [81372013]; China-Japan Friendship Hospital Youth Science and Technology Excellence Project [2014-QNYC-A-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China-Japan Friendship Hospital Youth Science and Technology Excellence Project	This study was supported by the National Natural Science Foundation of China (81372013), and China-Japan Friendship Hospital Youth Science and Technology Excellence Project (2014-QNYC-A-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozic KJ, 1999, J BONE JOINT SURG AM, V81A, P200, DOI 10.2106/00004623-199902000-00007; Chang Y, 2009, SURG INNOV, V16, P63, DOI 10.1177/1553350608330398; Chen CC, 2009, J BONE JOINT SURG AM, V91A, P2390, DOI 10.2106/JBJS.H.01814; Classen T, 2015, J TISSUE ENG REGEN M; Israelite C, 2005, CLIN ORTHOP RELAT R, P285, DOI 10.1097/01.blo.0000192365.58958.84; Kawate K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-78; Landgraeber S, 2015, ARCH ORTHOP TRAUM SU, V135, P1357, DOI 10.1007/s00402-015-2287-6; Lieberman JR, 2012, CLIN ORTHOP RELAT R, V470, P525, DOI 10.1007/s11999-011-2050-4; Marker DR, 2008, CLIN ORTHOP RELAT R, V466, P1093, DOI 10.1007/s11999-008-0184-9; Mont MA, 1998, J BONE JOINT SURG BR, V80B, P56, DOI 10.1302/0301-620X.80B1.7989; Mont MA, 2003, CLIN ORTHOP RELAT R, P84, DOI 10.1097/01.blo.0000096826.67494.38; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; Mont MA, 2004, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01.blo.0000150128.57777.8e; Mont MA, 2010, J BONE JOINT SURG AM, V92A, P2165, DOI 10.2106/JBJS.I.00575; ROSENWASSER MP, 1994, CLIN ORTHOP RELAT R, P17; Simank HG, 1999, INT ORTHOP, V23, P154, DOI 10.1007/s002640050335; Wang BL, 2010, INT ORTHOP, V34, P635, DOI 10.1007/s00264-009-0822-1; Yoo MC, 2008, CLIN ORTHOP RELAT R, V466, P1133, DOI 10.1007/s11999-008-0204-9; Yoon TR, 2001, INT ORTHOP, V24, P316, DOI 10.1007/s002640000186	19	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156903	10.1371/journal.pone.0156903	http://dx.doi.org/10.1371/journal.pone.0156903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285821	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000031
J	Alkhayal, KA; Awadalia, ZH; Vaali-Mohammed, MA; Al Obeed, OA; Al Wesaimer, A; Halwani, R; Zubaidi, AM; Khan, Z; Abdulla, MH				Alkhayal, Khayal A.; Awadalia, Zainab H.; Vaali-Mohammed, Mansoor-Ali; Al Obeed, Omar A.; Al Wesaimer, Alanoud; Halwani, Rabih; Zubaidi, Ahmed M.; Khan, Zahid; Abdulla, Maha-Hamadien			Association of Vitamin D Receptor Gene Polymorphisms with Colorectal Cancer in a Saudi Arabian Population	PLOS ONE			English	Article							COLON-CANCER; UNITED-STATES; BSMI POLYMORPHISM; DIETARY CALCIUM; PROSTATE-CANCER; OVARIAN-CANCER; D DEFICIENCY; RISK; MORTALITY; METAANALYSIS	Background Vitamin D, causally implicated in bone diseases and human malignancies, exerts its effects through binding to the vitamin D receptor (VDR). VDR is a transcription factor modulating the expression of several genes in different pathways. Genetic variants in the VDR gene have been associated with several cancers in different population including colorectal cancer. Objective To assess the association of VDR gene polymorphisms in relation with colorectal cancer (CRC) in a Saudi population. Methods The polymorphisms of VDR gene (BsmI, FokI, ApaI and TaqI) were analyzed by the polymerase chain reaction amplification of segments of interest followed by Sanger sequencing. One hundred diagnosed CRC patients and 100 healthy control subjects that were age and gender matched were recruited. Results We did not observe significant association of any of the four VDR polymorphisms with colorectal cancer risk in the overall analysis. Although not statistically significant, the AA genotype of BsmI conferred about two-fold protection against CRCs compared to the GG genotype. Stratification of the study subjects based on age and gender suggests statistically significant association of CRC with the 'C' allele of ApaI in patients >57 years of age at disease diagnosis and BsmI polymorphism in females. In addition, statistically significant differences were observed for the genotypic distributions of VDR-BsmI, ApaI and TaqI SNPs between Saudi Arabian population and several of the International HapMap project populations. Conclusion Despite the absence of correlation of the examined VDR polymorphisms with CRCs in the combined analysis, ApaI and BsmI loci are statistically significantly associated with CRC in elderly and female patients, respectively. These findings need further validation in larger cohorts prior to utilizing these SNPs as potential screening markers for colorectal cancers in Saudi population.	[Alkhayal, Khayal A.; Awadalia, Zainab H.; Vaali-Mohammed, Mansoor-Ali; Al Obeed, Omar A.; Zubaidi, Ahmed M.; Abdulla, Maha-Hamadien] King Saud Univ, Coll Med, King Khalid Univ Hosp, Colorectal Res Chair,Dept Surg, Riyadh 11461, Saudi Arabia; [Al Wesaimer, Alanoud] Prince Sultan Mil Med City, Dept Internal Med, Riyadh, Saudi Arabia; [Halwani, Rabih] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Riyadh 11461, Saudi Arabia; [Halwani, Rabih] King Saud Univ, Coll Med, Asthma Res Chair, Dept Pediat, Riyadh 11461, Saudi Arabia; [Khan, Zahid] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia	King Saud University; Prince Sultan Military Medical City; King Saud University; King Saud University; King Saud University	Abdulla, MH (corresponding author), King Saud Univ, Coll Med, King Khalid Univ Hosp, Colorectal Res Chair,Dept Surg, Riyadh 11461, Saudi Arabia.; Khan, Z (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia.	zkhan@ksu.edu.sa; mabdulla@ksu.edu.sa	Halwani, Rabih/AAN-1568-2021; Vaali-Mohammed, Mansoor-Ali/G-4772-2012	Halwani, Rabih/0000-0002-6516-7771; Vaali-Mohammed, Mansoor-Ali/0000-0002-6437-711X; Al-Khayal, Khayal/0000-0001-8296-808X; Zubaidi, Ahmad/0000-0003-0994-5310	King Saud University	King Saud University(King Saud University)	The study was funded by King Saud University, through Vice Deanship of Research Chairs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by King Saud University, through Vice Deanship of Research Chairs.	Alsanea N, 2015, ANN SAUDI MED, V35, P196, DOI 10.5144/0256-4947.2015.196; Atoum MF, 2014, ASIAN PAC J CANCER P, V15, P7337, DOI 10.7314/APJCP.2014.15.17.7337; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Bentley RW, 2012, NEW ZEAL MED J, V125, P47; El Mouzan MI, 2008, ANN SAUDI MED, V28, P169, DOI 10.5144/0256-4947.2008.169; ELHAZMI MAF, 1995, J MED GENET, V32, P623, DOI 10.1136/jmg.32.8.623; Flugge J, 2007, EUR J CLIN PHARMACOL, V63; Gandini Sara, 2014, Adv Exp Med Biol, V810, P69; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; GARLAND FC, 1990, PREV MED, V19, P614, DOI 10.1016/0091-7435(90)90058-R; Hamadien MA, 2015, TUMOUR BIOL; HANCHETTE CL, 1992, CANCER, V70, P2861, DOI 10.1002/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hughes David J, 2011, J Gastrointest Cancer, V42, P149, DOI 10.1007/s12029-010-9168-6; Hussain AN, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0190-3; Ingles SA, 2001, CANCER CAUSE CONTROL, V12, P607, DOI 10.1023/A:1011292002475; Kadiyska T, 2007, INT J COLORECTAL DIS, V22, P395, DOI 10.1007/s00384-006-0163-0; Kostner K, 2009, ANTICANCER RES, V29, P3511; Kupfer SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026123; Laczmanska I, 2014, TUMOR BIOL, V35, P12397, DOI 10.1007/s13277-014-2554-0; LEFKOWITZ ES, 1994, INT J EPIDEMIOL, V23, P1133, DOI 10.1093/ije/23.6.1133; Li C, 2009, DIGEST DIS SCI, V54, P634, DOI 10.1007/s10620-008-0375-y; Ma J, 1998, CANCER EPIDEM BIOMAR, V7, P385; Meeker S, 2016, WORLD J GASTROENTERO, V22, P933, DOI 10.3748/wjg.v22.i3.933; Mohapatra S, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-37; Nabi G, 2015, MED HYPOTHESES, V85, P117, DOI 10.1016/j.mehy.2015.04.006; Ochs-Balcom HM, 2008, CARCINOGENESIS, V29, P1788, DOI 10.1093/carcin/bgn166; Park K, 2006, CANCER LETT, V237, P199, DOI 10.1016/j.canlet.2005.05.048; Perna L, 2013, CANCER EPIDEMIOL, V37, P905, DOI 10.1016/j.canep.2013.09.007; Raimondi S, 2014, MUTAT RES-FUND MOL M, V769, P17, DOI 10.1016/j.mrfmmm.2014.06.001; Sarkissyan M, 2014, CANCER-AM CANCER SOC, V120, P1387, DOI 10.1002/cncr.28565; Schwartz GG, 1990, ANTICANCER RES; Serrano D, 2016, EUR J CANCER PREV, V25, P85, DOI 10.1097/CEJ.0000000000000132; SITRIN MD, 1991, CANCER RES, V51, P5608; Takeshige Nobuyuki, 2015, Asian Pac J Cancer Prev, V16, P2019; Theodoratou E, 2008, INT J CANCER, V123, P2170, DOI 10.1002/ijc.23769; Tong WM, 1998, EUR J CANCER, V34, P2119, DOI 10.1016/S0959-8049(98)00267-6; Tuffaha M, 2015, N AM J MED SCI, V7, P467, DOI 10.4103/1947-2714.168675; Uhry Z, 2013, CANCER EPIDEMIOL, V37, P270, DOI 10.1016/j.canep.2012.12.007; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Xu YQ, 2014, TUMOR BIOL, V35, P4153, DOI 10.1007/s13277-013-1544-y; Xue LX, 1999, JNCI-J NATL CANCER I, V91, P176, DOI 10.1093/jnci/91.2.176; Yaylim-Eraltan I, 2007, CELL BIOCHEM FUNCT, V25, P731, DOI 10.1002/cbf.1386; Yu K, 2014, ASIAN PAC J CANCER P, V15, P4801, DOI 10.7314/APJCP.2014.15.12.4801	44	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0155236	10.1371/journal.pone.0155236	http://dx.doi.org/10.1371/journal.pone.0155236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309378	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800001
J	Ballhausen, MB; Vandamme, P; de Boer, W				Ballhausen, Max-Bernhard; Vandamme, Peter; de Boer, Wietse			Trait Differentiation within the Fungus-Feeding (Mycophagous) Bacterial Genus Collimonas	PLOS ONE			English	Article							PHYLOGENETIC SIGNAL; SP NOV.; SOIL; COMMUNITIES; FUNGIVORANS; GROWTH; EXPRESSION; DIVERSITY; IMPACT	The genus Collimonas consists of facultative, fungus-feeding (mycophagous) bacteria. To date, 3 species (C. fungivorans, C. pratensis and C. arenae) have been described and over 100 strains have been isolated from different habitats. Functional traits of Collimonas bacteria that are potentially involved in interactions with soil fungi mostly negatively (fungal inhibition e.g.), but also positively (mineral weathering e.g.), affect fungal fitness. We hypothesized that variation in such traits between Collimonas strains leads to different mycophagous bacterial feeding patterns. We investigated a) whether phylogenetically closely related Collimonas strains possess similar traits, b) how far phylogenetic resolution influences the detection of phylogenetic signal (possession of similar traits by related strains) and c) if there is a pattern of co-occurrence among the studied traits. We measured genetically encoded (nifH genes, antifungal collimomycin gene cluster e.g.) as well as phenotypically expressed traits (chitinase-and siderophore production, fungal inhibition and others) and related those to a high-resolution phylogeny (MLSA), constructed by sequencing the housekeeping genes gyrB and rpoB and concatenating those with partial 16S rDNA sequences. Additionally, high-resolution and 16S rDNA derived phylogenies were compared. We show that MLSA is superior to 16SrDNA phylogeny when analyzing trait distribution and relating it to phylogeny at fine taxonomic resolution (a single bacterial genus). We observe that several traits involved in the interaction of collimonads and their host fungus (fungal inhibition e.g.) carry phylogenetic signal. Furthermore, we compare Collimonas trait possession with sister genera like Herbaspirillum and Janthinobacterium.	[Ballhausen, Max-Bernhard; de Boer, Wietse] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Vandamme, Peter] Univ Ghent, Microbiol Lab, Ghent, Belgium; [de Boer, Wietse] Wageningen Univ, Dept Soil Qual, Wageningen, Netherlands; [Ballhausen, Max-Bernhard] Inst Vegetable & Ornamental Crops, Dept Plant Hlth, Grossbeeren Erfurt eV, Grossbeeren, Germany	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Ghent University; Wageningen University & Research; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	de Boer, W (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.; de Boer, W (corresponding author), Wageningen Univ, Dept Soil Qual, Wageningen, Netherlands.	w.deboer@nioo.knaw.nl	de Boer, Wietse/C-2737-2011; Vandamme, Peter AR/B-7967-2009; Vandamme, Peter/ABG-3431-2021; KNAW, NIOO-KNAW/A-4320-2012	de Boer, Wietse/0000-0002-5380-2993; Vandamme, Peter AR/0000-0002-5581-7937; Vandamme, Peter/0000-0002-5581-7937; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organization for Scientific Research, division Earth and Life Sciences (NWO-ALW) [819.01.016]	Netherlands Organization for Scientific Research, division Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	This research was supported by a grant from the Netherlands Organization for Scientific Research, division Earth and Life Sciences (NWO-ALW), grant number 819.01.016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2005, SOIL SCI PLANT NUTR, V51, P303, DOI 10.1111/j.1747-0765.2005.tb00034.x; Bai YN, 2016, ENVIRON MICROBIOL, V18, P38, DOI 10.1111/1462-2920.12545; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Cheng X, 2013, ENV MICROBIOL REP, V5, P608, DOI 10.1111/1758-2229.12061; de Boer W, 2004, INT J SYST EVOL MICR, V54, P857, DOI 10.1099/ijs.0.02920-0; De Boer W, 1998, SOIL BIOL BIOCHEM, V30, P193, DOI 10.1016/S0038-0717(97)00100-4; De Boer W, 2001, APPL ENVIRON MICROB, V67, P3358, DOI 10.1128/AEM.67.8.3358-3362.2001; DEROOIJVANDERGOES PCEM, 1995, EUR J PLANT PATHOL, V101, P149, DOI 10.1007/BF01874761; Deveau A, 2007, NEW PHYTOL, V175, P743, DOI 10.1111/j.1469-8137.2007.02148.x; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; Eydallin G, 2014, ENVIRON MICROBIOL, V16, P813, DOI 10.1111/1462-2920.12208; Folse HJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00338; Fritsche K, 2014, ENVIRON MICROBIOL, V16, P1334, DOI 10.1111/1462-2920.12440; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Hakvag S, 2009, MAR DRUGS, V7, P576, DOI 10.3390/md7040576; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hoppener-Ogawa S, 2008, INT J SYST EVOL MICR, V58, P414, DOI 10.1099/ijs.0.65375-0; Hoppener-Ogawa S, 2009, ISME J, V3, P190, DOI 10.1038/ismej.2008.97; Hoppener-Ogawa S, 2007, APPL ENVIRON MICROB, V73, P4191, DOI 10.1128/AEM.00387-07; Hoppener-Ogawa S, 2009, ENVIRON MICROBIOL, V11, P1444, DOI 10.1111/j.1462-2920.2009.01872.x; Hornung C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055045; Kielak AM, 2013, APPL ENVIRON MICROB, V79, P263, DOI 10.1128/AEM.02546-12; Krause S, 2014, J EVOLUTION BIOL, V27, P1240, DOI 10.1111/jeb.12401; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Leveau JHJ, 2010, ENVIRON MICROBIOL, V12, P281, DOI 10.1111/j.1462-2920.2009.02010.x; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Mannisto MK, 2006, SYST APPL MICROBIOL, V29, P229, DOI 10.1016/j.syapm.2005.09.001; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Martiny JBH, 2015, SCIENCE, V350, DOI 10.1126/science.aac9323; Mela F, 2012, ENV MICROBIOL REP, V4, P424, DOI 10.1111/j.1758-2229.2012.00336.x; Mela F, 2011, ISME J, V5, P1494, DOI 10.1038/ismej.2011.29; Moore E., 2004, MOL MICROBIAL ECOLOG; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Nissinen RM, 2012, FEMS MICROBIOL ECOL, V82, P510, DOI 10.1111/j.1574-6941.2012.01464.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Perez-Miranda S, 2007, J MICROBIOL METHODS; Rudnick MB, 2015, ENV MICROBIOL REP, V7, P709, DOI 10.1111/1758-2229.12290; Rudnick MB, 2015, SOIL BIOL BIOCHEM, V88, P73, DOI 10.1016/j.soilbio.2015.04.015; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharp CE, 2014, ISME J, V8, P1166, DOI 10.1038/ismej.2013.237; Sutherland IW, 1996, MICROBIOL-UK, V142, P867, DOI 10.1099/00221287-142-4-867; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587; Uroz S, 2007, APPL ENVIRON MICROB, V73, P3019, DOI 10.1128/AEM.00121-07; Uroz S, 2009, SOIL BIOL BIOCHEM, V41, P2178, DOI 10.1016/j.soilbio.2009.07.031; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wolf AB, 2015, EARLY COLONIZERS OF; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	51	8	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157552	10.1371/journal.pone.0157552	http://dx.doi.org/10.1371/journal.pone.0157552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309848	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800095
J	Bird, TG; Dimitropoulou, P; Turner, RM; Jenks, SJ; Cusack, P; Hey, SY; Blunsum, A; Kelly, S; Sturgeon, C; Hayes, PC; Bird, SM				Bird, Thomas G.; Dimitropoulou, Polyxeni; Turner, Rebecca M.; Jenks, Sara J.; Cusack, Pearce; Hey, Shiying; Blunsum, Andrew; Kelly, Sarah; Sturgeon, Catharine; Hayes, Peter C.; Bird, Sheila M.			Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; SURVEILLANCE TEST; PROGNOSTIC ROLE; MANAGEMENT; CIRRHOSIS; TRIAL; ASIA	Detection of hepatocellular carcinoma (HCC) through screening can improve outcomes. However, HCC surveillance remains costly, cumbersome and suboptimal. We tested whether and how serum Alpha-Fetoprotein (AFP) should be used in HCC surveillance. Record linkage, dedicated pathways for management and AFP data-storage identified i) consecutive highly characterised cases of HCC diagnosed in 2009-14 and ii) a cohort of ongoing HCC-free patients undergoing regular HCC surveillance from 2009. These two well-defined Scottish patient cohorts enabled us to test the utility of AFP surveillance. Of 304 cases of HCC diagnosed over 6 years, 42% (129) were identified by a dedicated HCC surveillance programme. Of these 129, 47% (61) had a detectable lesion first identified by screening ultrasound (US) but 38% (49) were prompted by elevated AFP. Despite pre-HCC diagnosis AFP >20kU/L being associated with poor outcome, 'AFP-detected' tumours were offered potentially curative management as frequently as 'US-detected' HCCs; and had comparable survival. Linearity of serial log10-transformed AFPs in HCC cases and in the screening 'HCC-free' cohort (n = 1509) provided indicators of high-risk AFP behaviour in HCC cases. An algorithm was devised in static mode, then tested dynamically. A case/control series in hepatitis C related disease demonstrated highly significant detection (p<1.72*10(-5)) of patients at high risk of developing HCC. These data support the use of AFP in HCC surveillance. We show proof-of-principle that an automated and further refineable algorithmic interpretation of AFP can identify patients at higher risk of HCC. This approach could provide a cost-effective, user-friendly and much needed addition to US surveillance.	[Bird, Thomas G.; Cusack, Pearce; Hey, Shiying; Blunsum, Andrew; Kelly, Sarah; Hayes, Peter C.] Royal Infirm Edinburgh NHS Trust, Ctr Liver & Digest Disorders, Edinburgh EH16 4SA, Midlothian, Scotland; [Bird, Thomas G.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Dimitropoulou, Polyxeni; Turner, Rebecca M.; Bird, Sheila M.] MRC Biostat Unit, Cambridge CB2 0SR, England; [Jenks, Sara J.; Sturgeon, Catharine] Royal Infirm Edinburgh NHS Trust, Dept Clin Biochem, Edinburgh EH16 4SA, Midlothian, Scotland; [Bird, Sheila M.] Univ Strathclyde, Dept Math & Stat, Glasgow G1 1XH, Lanark, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; Beatson Institute; MRC Biostatistics Unit; Royal Infirmary of Edinburgh; University of Edinburgh; University of Strathclyde	Bird, TG (corresponding author), Royal Infirm Edinburgh NHS Trust, Ctr Liver & Digest Disorders, Edinburgh EH16 4SA, Midlothian, Scotland.; Bird, TG (corresponding author), Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland.	t.bird@beatson.gla.ac.uk	Bird, Tom/H-3840-2019	Bird, Tom/0000-0002-6120-1581	Academy of Medical Science Starter Grant for Clinical Lecturers; Wellcome Trust [107492/z/15/z]; Medical Research Council (MRC) programme [MC_U105260794]; MRC programme [MC_U105260558]; Medical Research Council [MC_U105260558, MC_U105260794] Funding Source: researchfish; MRC [MC_U105260558, MC_U105260794] Funding Source: UKRI	Academy of Medical Science Starter Grant for Clinical Lecturers; Wellcome Trust(Wellcome Trust); Medical Research Council (MRC) programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TGB is supported by an Academy of Medical Science Starter Grant for Clinical Lecturers and a Wellcome Trust Intermediate Fellowship (107492/z/15/z). SMB and PD were supported by Medical Research Council (MRC) programme MC_U105260794, RT by MRC programme MC_U105260558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal EW, 2014, J SURG ONCOL, V110, P967, DOI 10.1002/jso.23765; Biselli M, 2015, BRIT J CANCER, V112, P69, DOI 10.1038/bjc.2014.536; Bruce MG, 2008, J VIRAL HEPATITIS, V15, P179, DOI 10.1111/j.1365-2893.2007.00928.x; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chang TS, 2015, AM J GASTROENTEROL, V110, P836, DOI 10.1038/ajg.2015.100; Chen TM, 2007, J GASTROEN HEPATOL, V22, P669, DOI 10.1111/j.1440-1746.2007.04898.x; Colli A, 2006, AM J GASTROENTEROL, V101, P513, DOI 10.1111/j.1572-0241.2006.00467.x; Dalton-Fitzgerald E, 2015, CLIN GASTROENTEROL H, V13, P791, DOI 10.1016/j.cgh.2014.06.031; Duvoux C, 2012, GASTROENTEROLOGY, V143, P986, DOI 10.1053/j.gastro.2012.05.052; El-Serag HB, 2013, CLIN GASTROENTEROL H, V11, P441, DOI 10.1016/j.cgh.2012.12.046; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Fong ZV, 2014, CANCER-AM CANCER SOC, V120, P2824, DOI 10.1002/cncr.28730; Giannini EG, 2012, HEPATOLOGY, V56, P1371, DOI 10.1002/hep.25814; Gupta S, 2003, ANN INTERN MED, V139, P46, DOI 10.7326/0003-4819-139-1-200307010-00012; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones AL, 1994, GRADUATE SCH MED PAP, P237; Joshi K, 2014, DIGEST DIS SCI, V59, P3073, DOI 10.1007/s10620-014-3256-6; Khalili M, 2011, DIGEST DIS SCI, V56, P1516, DOI 10.1007/s10620-010-1439-3; Kim GA, 2015, LIVER INT, V35, P232, DOI 10.1111/liv.12516; Lee E, 2013, CLIN GASTROENTEROL H, V11, P437, DOI 10.1016/j.cgh.2012.11.029; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Ma WJ, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-212; McGowan CE, 2015, CLIN GASTROENTEROL H, V13, P799, DOI 10.1016/j.cgh.2014.07.056; McMahon BJ, 2000, HEPATOLOGY, V32, P842, DOI 10.1053/jhep.2000.17914; Nguyen MH, 2002, HEPATOLOGY, V36, P410, DOI 10.1053/jhep.2002.34744; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Richardson P, 2012, CLIN GASTROENTEROL H, V10, P428, DOI 10.1016/j.cgh.2011.11.025; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Singal AG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001624; Singal AG, 2013, AM J GASTROENTEROL, V108, P425, DOI 10.1038/ajg.2012.449; Sinn DH, 2015, HEPATO-GASTROENTEROL, V62, P327, DOI 10.5754/hge11951; Tayob N, 2016, CLIN GASTROENTEROL H, V14, P469, DOI 10.1016/j.cgh.2015.07.049; Trevisani F, 2004, AM J GASTROENTEROL, V99, P1470, DOI 10.1111/j.1572-0241.2004.30137.x; van Meer S, 2015, J HEPATOL, V63, P1156, DOI 10.1016/j.jhep.2015.06.012; Wong GLH, 2014, HEPATOLOGY, V59, P986, DOI 10.1002/hep.26739; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0; Zhang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050919; Zhou L, 2012, HEPATO-GASTROENTEROL, V59, P840, DOI 10.5754/hge10404	42	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156801	10.1371/journal.pone.0156801	http://dx.doi.org/10.1371/journal.pone.0156801			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308823	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000378029800013
J	Nichols, JA; Bednar, MS; Murray, WM				Nichols, Jennifer A.; Bednar, Michael S.; Murray, Wendy M.			Surgical Simulations Based on Limited Quantitative Data: Understanding How Musculoskeletal Models Can Be Used to Predict Moment Arms and Guide Experimental Design	PLOS ONE			English	Article							PROXIMAL ROW CARPECTOMY; TOTAL SHOULDER ARTHROPLASTY; TIBIOFEMORAL CONTACT FORCES; TENDON TRANSFER; 4-CORNER ARTHRODESIS; EXTERNAL ROTATION; MOTOR TENDONS; MUSCLE; WRIST; KINEMATICS	The utility of biomechanical models and simulations to examine clinical problems is currently limited by the need for extensive amounts of experimental data describing how a given procedure or disease affects the musculoskeletal system. Methods capable of predicting how individual biomechanical parameters are altered by surgery are necessary for the efficient development of surgical simulations. In this study, we evaluate to what extent models based on limited amounts of quantitative data can be used to predict how surgery influences muscle moment arms, a critical parameter that defines how muscle force is transformed into joint torque. We specifically examine proximal row carpectomy and scaphoid-excision four-corner fusion, two common surgeries to treat wrist osteoarthritis. Using models of these surgeries, which are based on limited data and many assumptions, we perform simulations to formulate a hypothesis regarding how these wrist surgeries influence muscle moment arms. Importantly, the hypothesis is based on analysis of only the primary wrist muscles. We then test the simulation-based hypothesis using a cadaveric experiment that measures moment arms of both the primary wrist and extrinsic thumb muscles. The measured moment arms of the primary wrist muscles are used to verify the hypothesis, while those of the extrinsic thumb muscles are used as cross-validation to test whether the hypothesis is generalizable. The moment arms estimated by the models and measured in the cadaveric experiment both indicate that a critical difference between the surgeries is how they alter radial-ulnar deviation versus flexion-extension moment arms at the wrist. Thus, our results demonstrate that models based on limited quantitative data can provide novel insights. This work also highlights that synergistically utilizing simulation and experimental methods can aid the design of experiments and make it possible to test the predictive limits of current computer simulation techniques.	[Nichols, Jennifer A.; Murray, Wendy M.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Murray, Wendy M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Murray, Wendy M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Nichols, Jennifer A.; Murray, Wendy M.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Nichols, Jennifer A.; Bednar, Michael S.; Murray, Wendy M.] Edward Hines Jr VA Hosp, Hines, IL USA; [Bednar, Michael S.] Loyola Univ Chicago, Stritch Sch Med, Dept Orthopaed Surg & Rehabil, Maywood, IL USA; [Nichols, Jennifer A.] Univ Utah, Dept Orthopaed, Salt Lake City, UT USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Shirley Ryan AbilityLab; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago; Utah System of Higher Education; University of Utah	Murray, WM (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Murray, WM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.; Murray, WM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.; Murray, WM (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.; Murray, WM (corresponding author), Edward Hines Jr VA Hosp, Hines, IL USA.	w-murray@northwestern.edu	Murray, Wendy/AAD-6257-2022; Nichols, Jennifer A./T-3583-2019; Murray, Wendy/B-7629-2009; Murray, Wendy M./D-1520-2009; Nichols, Jennifer/O-8942-2015	Murray, Wendy/0000-0002-7547-621X; Murray, Wendy M./0000-0002-7547-621X; Nichols, Jennifer/0000-0001-5167-9197	National Institutes of Health (NIH) [F31 AG041627, T32 HD007418]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG041627] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institutes of Health (NIH) under the following award numbers: F31 AG041627 (funding awarded to JAN) and T32 HD007418 (predoctoral fellow and trainee: JAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland DC, 2012, J BONE JOINT SURG AM, V94A, P1886, DOI 10.2106/JBJS.J.01861; Ackland DC, 2010, J BONE JOINT SURG AM, V92A, P1221, DOI 10.2106/JBJS.I.00001; Afschrift M, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-111; AN KN, 1983, J BIOMECH, V16, P419, DOI 10.1016/0021-9290(83)90074-X; Arnold A S, 2000, Comput Aided Surg, V5, P108, DOI 10.3109/10929080009148877; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Asakawa DS, 2004, J BONE JOINT SURG AM, V86A, P348, DOI 10.2106/00004623-200402000-00019; Association AM, 2015, ICD 9 CM 2015 PROF E; Blankenhorn BD, 2007, J HAND SURG-AM, V32A, P37, DOI 10.1016/j.jhsa.2006.10.014; Brandon SCE, 2014, J BIOMECH, V47, P1409, DOI 10.1016/j.jbiomech.2014.01.038; Buffi JH, 2015, ANN BIOMED ENG, V43, P404, DOI 10.1007/s10439-014-1144-z; Cohen MS, 2001, J HAND SURG-AM, V26A, P94, DOI 10.1053/jhsu.2001.20160; Crossley KM, 2012, OSTEOARTHR CARTILAGE, V20, P1243, DOI 10.1016/j.joca.2012.07.011; Crouch DL, 2011, J HAND SURG-AM, V36A, P1644, DOI 10.1016/j.jhsa.2011.07.019; Dacho AK, 2008, J PLAST RECONSTR AES, V61, P1210, DOI 10.1016/j.bjps.2007.08.007; DELP SL, 1995, COMPUT BIOL MED, V25, P21, DOI 10.1016/0010-4825(95)98882-E; Donnelly CJ, 2012, J BIOMECH, V45, P1491, DOI 10.1016/j.jbiomech.2012.02.010; Favre P, 2008, J SHOULDER ELB SURG, V17, P650, DOI 10.1016/j.jse.2007.12.010; Gao F, 2011, AM J PHYS MED REHAB, V90, P364, DOI 10.1097/PHM.0b013e318214f699; Gerus P, 2013, J BIOMECH, V46, P2778, DOI 10.1016/j.jbiomech.2013.09.005; Hartzler RU, 2012, J SHOULDER ELB SURG, V21, P1370, DOI 10.1016/j.jse.2012.01.026; Hoenecke HR, 2014, J SHOULDER ELB SURG, V23, P1128, DOI 10.1016/j.jse.2013.11.025; Holzbaur KRS, 2005, ANN BIOMED ENG, V33, P829, DOI 10.1007/s10439-005-3320-7; Hui HEJ, 2007, FOOT ANKLE INT, V28, P441, DOI 10.3113/FAI.2007.0441; LaRoque ES, 2008, J BONE JOINT SURG AM, V90A, P1979, DOI 10.2106/JBJS.G.01015; Lenhart RL, 2014, MED SCI SPORT EXER, V46, P557, DOI 10.1249/MSS.0b013e3182a78c3a; Lieber RL, 2005, J HAND SURG-AM, V30A, P273, DOI 10.1016/j.jhsa.2004.10.003; Liu J, 1998, J BONE JOINT SURG AM, V80A, P853, DOI 10.2106/00004623-199806000-00009; Loren GJ, 1996, J BIOMECH, V29, P331, DOI 10.1016/0021-9290(95)00055-0; Magermans DJ, 2004, CLIN BIOMECH, V19, P116, DOI 10.1016/j.clinbiomech.2003.09.008; Mogk JPM, 2011, J BIOMECH, V44, P669, DOI 10.1016/j.jbiomech.2010.11.004; Mulford JS, 2009, J HAND SURG-EUR VOL, V34E, P256, DOI 10.1177/1753193408100954; Murray WM, 2006, J BONE JOINT SURG AM, V88A, P2009, DOI 10.2106/JBJS.E.00973; Nakajima T, 1999, CLIN BIOMECH, V14, P265, DOI 10.1016/S0268-0033(98)00075-8; Nakajima T., 2002, Journal of Musculoskeletal Research, V6, P147, DOI 10.1142/S0218957702000903; Neptune RR, 2000, CLIN BIOMECH, V15, P528, DOI 10.1016/S0268-0033(00)00005-X; Nichols JA, 2015, CLIN BIOMECH, V30, P424, DOI 10.1016/j.clinbiomech.2015.03.015; Nichols JA, 2013, J BIOMECH, V46, P192, DOI 10.1016/j.jbiomech.2012.10.035; Omokawa S, 2000, CLIN ORTHOP RELAT R, P262; Richards C, 2010, J BIOMECH, V43, P2595, DOI 10.1016/j.jbiomech.2010.05.006; Saul KR, 2015, COMPUT METHOD BIOMEC, V18, P1445, DOI 10.1080/10255842.2014.916698; Scheys L, 2008, GAIT POSTURE, V28, P640, DOI 10.1016/j.gaitpost.2008.04.010; Schmidt CC, 2010, J SHOULDER ELB SURG, V19, P1157, DOI 10.1016/j.jse.2010.05.027; Schuind F, 1994, J Shoulder Elbow Surg, V3, P191, DOI 10.1016/S1058-2746(09)80035-9; Shah MA, 2003, J HAND SURG-AM, V28A, P661, DOI 10.1016/S0363-5023(03)00180-1; Sheehan FT, 2012, CLIN BIOMECH, V27, P525, DOI 10.1016/j.clinbiomech.2011.12.012; Siston RA, 2006, J ORTHOP RES, V24, P1607, DOI 10.1002/jor.20163; Sobczak S, 2013, CLIN BIOMECH, V28, P187, DOI 10.1016/j.clinbiomech.2012.12.008; Sobczak S, 2011, CLIN BIOMECH, V26, P718, DOI 10.1016/j.clinbiomech.2011.03.002; Steele KM, 2012, J BIOMECH, V45, P2564, DOI 10.1016/j.jbiomech.2012.07.028; Tang CY, 2002, J BIOMECH, V35, P1143, DOI 10.1016/S0021-9290(02)00059-3; Tang JB, 1997, J ORTHOPAED RES, V15, P324, DOI 10.1002/jor.1100150303; Tang JB, 1999, J HAND SURG-AM, V24A, P121; Tang JB, 1997, J ORTHOPAED RES, V15, P69, DOI 10.1002/jor.1100150111; Vanhove W, 2008, J HAND SURG-EUR VOL, V33E, P118, DOI 10.1177/1753193408087116; Veeger HEJ, 2004, J HAND SURG-BRIT EUR, V29B, P259, DOI 10.1016/j.jhsb.2004.01.004; Ward SR, 2010, J ORTHOP SPORT PHYS, V40, P729, DOI 10.2519/jospt.2010.3279; Weiss APC, 2004, J HAND SURG-AM, V29A, P796, DOI 10.1016/j.jhsa.2004.04.023; Wohlman SJ, 2013, J BIOMECH, V46, P1014, DOI 10.1016/j.jbiomech.2012.10.044	60	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157346	10.1371/journal.pone.0157346	http://dx.doi.org/10.1371/journal.pone.0157346			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310013	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800057
J	Shackleford, GM; Shi, XH; Swanson, KS; Mahdi, MY; Gonzalez-Gomez, I; Asgharzadeh, S; D'Apuzzo, M; Erdreich-Epstein, A; Moats, RA				Shackleford, Gregory M.; Shi, Xiang-He; Swanson, Kimberly S.; Mahdi, Min Y.; Gonzalez-Gomez, Ignacio; Asgharzadeh, Shahab; D'Apuzzo, Massimo; Erdreich-Epstein, Anat; Moats, Rex A.			BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BARHL1 HOMEOBOX GENE; SUPER-ENHANCERS; SONIC HEDGEHOG; GROWTH-FACTOR; CELL-LINES; TRANSCRIPTION FACTORS; RETROVIRAL VECTORS; CURRENT CONSENSUS; BRAIN-TUMORS	Medulloblastomas are the most common malignant pediatric brain tumor and have been divided into four major molecular subgroups. Animal models that mimic the principal molecular aberrations of these subgroups will be important tools for preclinical studies and allow greater understanding of medulloblastoma biology. We report a new transgenic model of medulloblastoma that possesses a unique combination of desirable characteristics including, among others, the ability to incorporate multiple and variable genes of choice and to produce bioluminescent tumors from a limited number of somatic cells within a normal cellular environment. This model, termed BarTeL, utilizes a Barhl1 homeobox gene promoter to target expression of a bicistronic transgene encoding both the avian retroviral receptor TVA and an eGFP-Luciferase fusion protein to neonatal cerebellar granule neuron precursor (cGNP) cells, which are cells of origin for the sonic hedgehog (SHH) subgroup of human medulloblastomas. The Barhl1 promoter-driven transgene is expressed strongly in mammalian cGNPs and weakly or not at all in mature granule neurons. We efficiently induced bioluminescent medulloblastomas expressing eGFP-luciferase in BarTeL mice by infection of a limited number of somatic cGNPs with avian retroviral vectors encoding the active N-terminal fragment of SHH and a stabilized MYCN mutant. Detection and quantification of the increasing bioluminescence of growing tumors in young BarTeL mice was facilitated by the declining bioluminescence of their uninfected maturing cGNPs. Inclusion of eGFP in the transgene allowed enriched sorting of cGNPs from neonatal cerebella. Use of a single bicistronic avian vector simultaneously expressing both Shh and Mycn oncogenes increased the medulloblastoma incidence and aggressiveness compared to mixed virus infections. Bioluminescent tumors could also be produced by ex vivo transduction of neonatal BarTeL cerebellar cells by avian retroviruses and subsequent implantation into nontransgenic cerebella. Thus, BarTeL mice provide a versatile model with opportunities for use in medulloblastoma biology and therapeutics.	[Shackleford, Gregory M.; Shi, Xiang-He; Swanson, Kimberly S.; Asgharzadeh, Shahab; Erdreich-Epstein, Anat] Univ So Calif, Dept Pediat, Div Hematol Oncol & Blood & Marrow Transplantat, Saban Res Inst,Childrens Hosp Los Angeles, Los Angeles, CA 90089 USA; [Shackleford, Gregory M.; Shi, Xiang-He; Swanson, Kimberly S.; Asgharzadeh, Shahab; Erdreich-Epstein, Anat] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Shackleford, Gregory M.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Shackleford, Gregory M.; Swanson, Kimberly S.; Mahdi, Min Y.; Moats, Rex A.] Univ So Calif, Childrens Hosp Los Angeles, Dept Radiol, Saban Res Inst, Los Angeles, CA USA; [Shackleford, Gregory M.; Swanson, Kimberly S.; Mahdi, Min Y.; Moats, Rex A.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Gonzalez-Gomez, Ignacio; Erdreich-Epstein, Anat] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Moats, Rex A.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [D'Apuzzo, Massimo] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of Southern California; University of Southern California; City of Hope	Shackleford, GM (corresponding author), Univ So Calif, Dept Pediat, Div Hematol Oncol & Blood & Marrow Transplantat, Saban Res Inst,Childrens Hosp Los Angeles, Los Angeles, CA 90089 USA.; Shackleford, GM (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.; Shackleford, GM (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.; Shackleford, GM (corresponding author), Univ So Calif, Childrens Hosp Los Angeles, Dept Radiol, Saban Res Inst, Los Angeles, CA USA.; Shackleford, GM (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.	shacklef@usc.edu		Erdreich-Epstein, Anat/0000-0003-4269-4373; Asgharzadeh, Shahab/0000-0002-0510-3848	Jean Perkins Foundation; Pediatric Brain Tumor Foundation; Neil Bogart Memorial Fund; T.J. Martell Foundation for Leukemia, Cancer and AIDS Research; ThinkCure; Nautica Malibu Triathlon	Jean Perkins Foundation; Pediatric Brain Tumor Foundation; Neil Bogart Memorial Fund; T.J. Martell Foundation for Leukemia, Cancer and AIDS Research; ThinkCure; Nautica Malibu Triathlon	This work was supported in part by the Jean Perkins Foundation, the Pediatric Brain Tumor Foundation, the Neil Bogart Memorial Fund, the T.J. Martell Foundation for Leukemia, Cancer and AIDS Research, ThinkCure, and the Nautica Malibu Triathlon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVRAHAM H, 1989, MOL CELL BIOL, V9, P2058, DOI 10.1128/MCB.9.5.2058; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Binning MJ, 2008, CANCER RES, V68, P7838, DOI 10.1158/0008-5472.CAN-08-1899; Browd SR, 2006, CANCER RES, V66, P2666, DOI 10.1158/0008-5472.CAN-05-2198; Buhren J, 2000, J NEUROPATH EXP NEUR, V59, P229; Bulfone A, 2000, HUM MOL GENET, V9, P1443, DOI 10.1093/hmg/9.9.1443; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chellappa R, 2008, MOL CELL BIOL, V28, P1905, DOI 10.1128/MCB.01454-07; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Erdreich-Epstein A, 2006, GENE CHROMOSOME CANC, V45, P169, DOI 10.1002/gcc.20280; FEKETE DM, 1993, MOL CELL BIOL, V13, P2604, DOI 10.1128/MCB.13.4.2604; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; FRIEDMAN HS, 1985, J NEUROPATH EXP NEUR, V44, P592, DOI 10.1097/00005072-198511000-00005; FRIEDMAN HS, 1988, AM J PATHOL, V130, P472; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goslin, 1998, CULTURING NERVE CELL, P419; Gray PA, BARHL1 IN SITU HYBRI; Hare CB, 1997, CANCER CHEMOTH PHARM, V39, P187; HE XM, 1991, LAB INVEST, V64, P833; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Holland EC, 2000, TOXICOL PATHOL, V28, P171, DOI 10.1177/019262330002800122; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kahl CA, 2008, GENE THER, V15, P1079, DOI 10.1038/gt.2008.50; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Korshunov A, 2012, ACTA NEUROPATHOL, V123, P515, DOI 10.1007/s00401-011-0918-8; Koster J., R2 GENOMICS ANAL VIS; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; Li SG, 2002, DEVELOPMENT, V129, P3523; Li SG, 2006, DEV DYNAM, V235, P2260, DOI 10.1002/dvdy.20858; Lin CY, 2016, NATURE, V530, P57, DOI 10.1038/nature16546; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Margol AS, 2015, CLIN CANCER RES, V21, P1457, DOI 10.1158/1078-0432.CCR-14-1144; Markant SL, 2012, NEUROPATH APPL NEURO, V38, P228, DOI 10.1111/j.1365-2990.2011.01235.x; Martin P, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-4; Moxon-Emre I, 2014, J CLIN ONCOL, V32, P1760, DOI 10.1200/JCO.2013.52.3290; National Cancer Institute, CANC GEN AN PROJ SAG; NEBEL BR, 1961, SCIENCE, V134, P832, DOI 10.1126/science.134.3482.832; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Orsulic S, 2002, MAMM GENOME, V13, P543, DOI 10.1007/s00335-002-4003-4; Packer RJ, 2008, J CHILD NEUROL, V23, P1122, DOI 10.1177/0883073808320758; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; PETROPOULOS CJ, 1991, J VIROL, V65, P3728, DOI 10.1128/JVI.65.7.3728-3737.1991; Poschl J, 2011, ONCOGENE, V30, P4721, DOI 10.1038/onc.2011.173; Rachidi M, 2006, INT J DEV NEUROSCI, V24, P35, DOI 10.1016/j.ijdevneu.2005.11.015; Ramaswamy V, 2016, ACTA NEUROPATHOL, V131, P821, DOI 10.1007/s00401-016-1569-6; Reig G, 2007, DEV BIOL, V302, P367, DOI 10.1016/j.ydbio.2006.10.008; Rich JN, 1999, J BIOL CHEM, V274, P35053, DOI 10.1074/jbc.274.49.35053; Rutkowski S, 2010, J CLIN ONCOL, V28, P4961, DOI 10.1200/JCO.2010.30.2299; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Uziel T, 2006, CELL CYCLE, V5, P363, DOI 10.4161/cc.5.4.2475; von Werder A, 2012, NAT PROTOC, V7, P1167, DOI 10.1038/nprot.2012.060; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; WIKSTRAND CJ, 1977, CANCER RES, V37, P4267; Xu JY, 2012, J NEURO-ONCOL, V107, P269, DOI 10.1007/s11060-011-0756-5; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	68	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156907	10.1371/journal.pone.0156907	http://dx.doi.org/10.1371/journal.pone.0156907			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310018	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800018
J	Barbier, M; Jaensch, S; Cornelissen, F; Vidic, S; Gjerde, K; de Hoogt, R; Graeser, R; Gustin, E; Chong, YT				Barbier, Michael; Jaensch, Steffen; Cornelissen, Frans; Vidic, Suzana; Gjerde, Kjersti; de Hoogt, Ronald; Graeser, Ralph; Gustin, Emmanuel; Chong, Yolanda T.		IMI PREDECT Consortium	Ellipsoid Segmentation Model for Analyzing Light-Attenuated 3D Confocal Image Stacks of Fluorescent Multi-Cellular Spheroids	PLOS ONE			English	Article							CANCER; PLATFORM; DRUG	In oncology, two-dimensional in-vitro culture models are the standard test beds for the discovery and development of cancer treatments, but in the last decades, evidence emerged that such models have low predictive value for clinical efficacy. Therefore they are increasingly complemented by more physiologically relevant 3D models, such as spheroid microtumor cultures. If suitable fluorescent labels are applied, confocal 3D image stacks can characterize the structure of such volumetric cultures and, for example, cell proliferation. However, several issues hamper accurate analysis. In particular, signal attenuation within the tissue of the spheroids prevents the acquisition of a complete image for spheroids over 100 micrometers in diameter. And quantitative analysis of large 3D image data sets is challenging, creating a need for methods which can be applied to large-scale experiments and account for impeding factors. We present a robust, computationally inexpensive 2.5D method for the segmentation of spheroid cultures and for counting proliferating cells within them. The spheroids are assumed to be approximately ellipsoid in shape. They are identified from information present in the Maximum Intensity Projection (MIP) and the corresponding height view, also known as Z-buffer. It alerts the user when potential bias-introducing factors cannot be compensated for and includes a compensation for signal attenuation.	[Barbier, Michael; Jaensch, Steffen; Vidic, Suzana; Gjerde, Kjersti; de Hoogt, Ronald; Gustin, Emmanuel; Chong, Yolanda T.] Janssen Pharmaceut Co Johnson & Johnson, Discovery Sci, Beerse, Belgium; [Cornelissen, Frans] Janssen Pharmaceut Co Johnson & Johnson, Pharma R&D IT, Beerse, Belgium; [Vidic, Suzana; Gjerde, Kjersti] Erasmus MC, Dept Urol, Rotterdam, Netherlands; [Vidic, Suzana] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia; [Graeser, Ralph] Boehringer Ingelheim KG, Translat Med & Clin Pharmacol, Ingelheim, Germany	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Erasmus University Rotterdam; Erasmus MC; University of Primorska; Boehringer Ingelheim	Gustin, E; Chong, YT (corresponding author), Janssen Pharmaceut Co Johnson & Johnson, Discovery Sci, Beerse, Belgium.	egustin@its.jnj.com; ychong4@its.jnj.com	; Smalley, Matthew/M-7000-2015; Mauricio Brito Ataide Montes, Ana Catarina/A-2389-2009	Gustin, Emmanuel/0000-0002-7606-1075; Smalley, Matthew/0000-0001-9540-1146; Mauricio Brito Ataide Montes, Ana Catarina/0000-0002-8926-279X	Janssen Pharmaceutical Companies of Johnson Johnson; Innovative Medicines Initiative Joint Undertaking [115188]; European Union's Seventh Framework Programme (FP7)	Janssen Pharmaceutical Companies of Johnson Johnson; Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7)	Authors MB, SJ, FC, RH, RG, EG, and YTC were funded by Janssen Pharmaceutical Companies of Johnson & Johnson. Authors SV and KG were supported by Innovative Medicines Initiative Joint Undertaking under Grant agreement no 115188, the resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and contributions in kind from the European Federation of Pharmaceutical Industries and Associations. The funders provided support in the form of salaries for the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aljitawi OS, 2014, LEUKEMIA LYMPHOMA, V55, P378, DOI 10.3109/10428194.2013.793323; Chen WJ, 2014, JOVE-J VIS EXP, DOI 10.3791/51639; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Gue M, 2005, CYTOM PART A, V67A, P18, DOI 10.1002/cyto.a.20170; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Harma V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096426; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hickman JA, 2013, INT INNOV, P80; Hickman JA, 2014, BIOTECHNOL J, V9, P1115, DOI 10.1002/biot.201300492; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hodneland E, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-16; Jiglaire CJ, 2014, EXP CELL RES, V321, P99, DOI 10.1016/j.yexcr.2013.12.010; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Koshkin V, 2016, J CELL BIOCHEM, V117, P59, DOI 10.1002/jcb.25247; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Levinger I, 2014, ADV CANCER RES, V121, P383, DOI 10.1016/B978-0-12-800249-0.00009-3; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; Lou XH, 2014, STEM CELL REP, V2, P382, DOI 10.1016/j.stemcr.2014.01.010; Madar S, 2009, CARCINOGENESIS, V30, P20, DOI 10.1093/carcin/bgn232; Pampaloni F, 2013, CELL TISSUE RES, V352, P161, DOI 10.1007/s00441-013-1589-7; Parker DL, 2000, JMRI-J MAGN RESON IM, V11, P378, DOI 10.1002/(SICI)1522-2586(200004)11:4<378::AID-JMRI5>3.3.CO;2-R; Perche F, 2012, CANCER BIOL THER, V13, P1205, DOI 10.4161/cbt.21353; Piccinini F, 2015, COMPUT METH PROG BIO, V119, P43, DOI 10.1016/j.cmpb.2015.02.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Strasters K. C., 1994, Bioimaging, V2, P78, DOI 10.1002/1361-6374(199406)2:2<78::AID-BIO2>3.3.CO;2-4; Strasters KC, 1994, THESIS; Thoma CR, 2014, ADV DRUG DELIVER REV, V69, P29, DOI 10.1016/j.addr.2014.03.001; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Trinh A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0442-y; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wrzesinski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106973	33	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156942	10.1371/journal.pone.0156942	http://dx.doi.org/10.1371/journal.pone.0156942			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27303813	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000377824800030
J	Costion, CM; Kress, WJ; Crayn, DM				Costion, Craig M.; Kress, W. John; Crayn, Darren M.			DNA Barcodes Confirm the Taxonomic and Conservation Status of a Species of Tree on the Brink of Extinction in the Pacific	PLOS ONE			English	Article							PHYLOGENY; RUBIACEAE; EVOLUTION; FAMILY; SEQUENCE; SPACER; RBCL	The taxonomic status of a single island, narrow range endemic plant species from Palau, Micronesia (Timonius salsedoi) was assessed using DNA barcode markers, additional plastid loci, and morphology in order to verify its conservation status. DNA barcode loci distinguished T. salsedoi from all other Timonius species sampled from Palau, and were supported by sequence data from the atpB-rbcL intergenic spacer region. Timonius salsedoi was only known from two mature individual trees in 2012. Due to its extremely narrow range and population size, it had previously been recommended to be listed as Critically Endangered Status under three separate IUCN Criteria. In 2014 a second survey of the population following a typhoon revealed that the only two known trees had died suggesting that this species may now be extinct. Comprehensive follow up surveys of suitable habitat for this species are urgently required.	[Costion, Craig M.; Kress, W. John] Smithsonian Inst, MRC 166, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Costion, Craig M.; Crayn, Darren M.] James Cook Univ, Australian Trop Herbarium, Cairns Campus, Cairns, Qld, Australia; [Crayn, Darren M.] James Cook Univ, Ctr Trop Environm Sustainabil Sci, Cairns Campus, Cairns, Qld, Australia	Smithsonian Institution; Smithsonian National Museum of Natural History; James Cook University; James Cook University	Costion, CM (corresponding author), Smithsonian Inst, MRC 166, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA.; Costion, CM (corresponding author), James Cook Univ, Australian Trop Herbarium, Cairns Campus, Cairns, Qld, Australia.	costionc@si.edu	Crayn, Darren M/A-7386-2011	Crayn, Darren M/0000-0001-6614-4216	Critical Ecosystem Partnership Fund - Threatened Endemic Plants of Palau, University of Adelaide, EF-Critical Ecosystem Partnership Fund [56276]; Polynesia-Micronesia (Polynesia-Micronesia), Strategic Category: Safeguard and restore threatened species	Critical Ecosystem Partnership Fund - Threatened Endemic Plants of Palau, University of Adelaide, EF-Critical Ecosystem Partnership Fund; Polynesia-Micronesia (Polynesia-Micronesia), Strategic Category: Safeguard and restore threatened species	Funding was provided by Critical Ecosystem Partnership Fund: http://www.cepf.net/Pages/default.aspx - Threatened Endemic Plants of Palau, University of Adelaide, EF-Critical Ecosystem Partnership Fund, Grant #56276 (Status: Closed, CI Funds: $36,025.17, Period: May 1, 2010-Apr 30, 2012), Polynesia-Micronesia (Polynesia-Micronesia), Strategic Category: Safeguard and restore threatened species. CMC received funding. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achille F, 2006, ANN MO BOT GARD, V93, P103, DOI 10.3417/0026-6493(2006)93[103:PIGLRG]2.0.CO;2; Athens J. Stephen, 2002, Archaeology in Oceania, V37, P57; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; BAILLIE JEM, 2004, IUCN RED LIST THREAT; Bremer B, 1999, SYST BIOL, V48, P413, DOI 10.1080/106351599260085; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Buchanan GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029080; Costion CM, 2009, PLANT ENDEMISM RARIT, P131; Costion CM, 2012, BIOL CONSERV, V147, P153, DOI 10.1016/j.biocon.2011.12.026; Crayn DM, 2000, MOL PHYLOGENET EVOL, V16, P238, DOI 10.1006/mpev.2000.0794; Darwin SP, 2010, CANDOLLEA, V65, P217, DOI 10.15553/c2010v652a5; Duchene D, 2013, BMC EVOLUTIONARY BIO, V13, P11; FOSBERG F R, 1987, Micronesica, V20, P157; Fosberg FR, 1993, SMITHSONIAN CONTRIBU, V0, P1, DOI DOI 10.5479/SI.0081024X.81; Guo X, 2011, J SYST EVOL, V49, P203, DOI 10.1111/j.1759-6831.2011.00130.x; HOLDAWAY RN, 1989, NEW ZEAL J ECOL, V12, P11; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Lohne C, 2005, MOL BIOL EVOL, V22, P317, DOI 10.1093/molbev/msi019; Manns U, 2010, MOL PHYLOGENET EVOL, V56, P21, DOI 10.1016/j.ympev.2010.04.002; Miller SE, 2013, P ENTOMOL SOC WASH, V115, P107, DOI 10.4289/0013-8797.115.1.107; Moynihan J, 2001, INT J PLANT SCI, V162, P393, DOI 10.1086/319583; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nei M, 2000, MOL EVOLUTION PHYLOG, Vi-xiv, P1; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Popp M, 2001, MOL PHYLOGENET EVOL, V20, P474, DOI 10.1006/mpev.2001.0977; Porch N, 2007, QUATERNARY INT S, V328, P167; Porch N, 2007, QUATERNARY INT S, V327, P167; Prebble M, 2007, QUATERNARY INT S, V330, P167; Pregill GK, 2004, J HERPETOL, V38, P15, DOI 10.1670/73-03A; Rova JHE, 2002, AM J BOT, V89, P145, DOI 10.3732/ajb.89.1.145; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Smith CW, 1983, SOIL SURVEY ISLANDS; Steadman David W., 2006, P1; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JA, 2003, SYST BOT, V28, P723	38	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155118	10.1371/journal.pone.0155118	http://dx.doi.org/10.1371/journal.pone.0155118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304905	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000377824800004
J	Xu, WX; Yu, HY; Li, WH; Gao, W; Guo, LJ; Wang, GS				Xu, Weixian; Yu, Haiyi; Li, Weihong; Gao, Wei; Guo, Lijun; Wang, Guisong			Plasma Catestatin: A Useful Biomarker for Coronary Collateral Development with Chronic Myocardial Ischemia	PLOS ONE			English	Article							CHROMOGRANIN-A; CATECHOLAMINE RELEASE; EARLY DECLINE; GENETIC RISK; PEPTIDE; HYPERTENSION; INFARCTION; MIGRATION; HEART; ANGIOGENESIS	Backgrounds Catestatin is an endogenous multifunctional neuroendocrinepeptide. Recently, catestatin was discovered as a novel angiogenic cytokine. The study was to investigate the associations between endogenous catestatin and coronary collateral development among the patients with chronic myocardial ischemia. Methods Thirty-eight patients with coronary artery chronic total occlusions (CTO) (CTO group) and 38 patients with normal coronary arteries (normal group) were enrolled in the series. Among the patients with CTO, coronary collateral development was graded according to the Rentrop score method. Rentrop score 0-1 collateral development was regarded as poor collateral group and 2-3 collateral development was regarded as good collateral group. Plasma catestatin level and vascular endothelial growth factor (VEGF) were measured by ELISA kits. Results The plasma catestatin levels in CTO group were significantly higher than that in normal group (1.97 +/- 1.01 vs 1.36 +/- 0.97ng/ml, p = 0.009). In the CTO group, the patients with good collateral development had significantly higher catestatin and VEGF levels than those with poor collateral development (2.36 +/- 0.73 vs 1.61 +/- 1.12 ng/ml, p = 0.018; 425.23 +/- 140.10 vs 238.48 +/- 101.00pg/mL, p<0.001). There is a positive correlation between plasma catestatin levels and Rentrop scores (r = 0.40, p = 0.013) among the patients with CTO. However, there is no correlations between plasma catestatin levels and VEGF (r = -0.06, p = 0.744). In the multiple linear regression models, plasma catestatin level was one of the independent factors of coronary collateral development after adjustment for confounders. Conclusions Plasma catestatin was associated with coronary collateral developments. It may be a useful biomarker for coronary collateral development and potential target for therapeutic angiogenesis in patients with CTO.	[Xu, Weixian; Yu, Haiyi; Li, Weihong; Gao, Wei; Guo, Lijun; Wang, Guisong] Peking Univ, Hosp 3, Dept Cardiol,Minist Hlth,Minist Educ, Key Lab Mol Cardiovasc Sci,Key Lab Cardiovasc Mol, Beijing 100191, Peoples R China	Peking University	Xu, WX (corresponding author), Peking Univ, Hosp 3, Dept Cardiol,Minist Hlth,Minist Educ, Key Lab Mol Cardiovasc Sci,Key Lab Cardiovasc Mol, Beijing 100191, Peoples R China.	xwxbird05@163.com		Gao, Wei/0000-0003-3541-9568	Scientific Research Foundation for the Returned Overseas Scholars of Peking University Third Hospital [Y78504-1]; National Natural Science Foundation of China [NNSFC 81400319]	Scientific Research Foundation for the Returned Overseas Scholars of Peking University Third Hospital(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The Scientific Research Foundation for the Returned Overseas Scholars of Peking University Third Hospital (Xu WX. Y78504-1) and The National Natural Science Foundation of China(NNSFC 81400319, Xu WX).	Aung G, 2011, IMMUNOLOGY, V132, P527, DOI 10.1111/j.1365-2567.2010.03395.x; Avolio E, 2014, NEUROSCIENCE, V270, P48, DOI 10.1016/j.neuroscience.2014.04.001; Belloni D, 2007, FASEB J, V21, P3052, DOI 10.1096/fj.06-6829com; Biswas N, 2012, HYPERTENSION, V60, P1552, DOI 10.1161/HYPERTENSIONAHA.112.202127; Crippa L, 2013, BLOOD, V121, P392, DOI 10.1182/blood-2012-05-430314; Egger M, 2008, EUR J PHARMACOL, V598, P104, DOI 10.1016/j.ejphar.2008.09.016; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Gayen JR, 2009, ENDOCRINOLOGY, V150, P5027, DOI 10.1210/en.2009-0429; Goetze JP, 2014, BIOMARK MED, V8, P133, DOI 10.2217/bmm.13.102; Helle KB, 2014, CELL MOL LIFE SCI; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Liu L, 2013, PEPTIDES, V46, P20, DOI 10.1016/j.peptides.2013.05.003; Liu L, 2013, SCAND CARDIOVASC J, V47, P217, DOI 10.3109/14017431.2013.794951; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Mahata SK, 2010, REGUL PEPTIDES, V162, P33, DOI 10.1016/j.regpep.2010.01.006; Martin-Yuste V, 2012, REV ESP CARDIOL, V65, P334, DOI [10.1016/j.recesp.2011.11.009, 10.1016/j.rec.2011.11.008]; Mazza R, 2012, NITRIC OXIDE-BIOL CH, V27, P40, DOI 10.1016/j.niox.2012.04.003; Meng L, 2013, POSTGRAD MED J, V89, P193, DOI 10.1136/postgradmedj-2012-131060; O'Connor DT, 2002, ANN NY ACAD SCI, V971, P533, DOI 10.1111/j.1749-6632.2002.tb04520.x; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; Pei ZQ, 2014, PEPTIDES, V55, P131, DOI 10.1016/j.peptides.2014.02.016; Penna C, 2012, CURR MED CHEM, V19, P4074, DOI 10.2174/092986712802429966; Perrelli MG, 2013, PFLUG ARCH EUR J PHY, V465, P1031, DOI 10.1007/s00424-013-1217-0; Theurl M, 2010, CIRC RES, V107, P1326, DOI 10.1161/CIRCRESAHA.110.219493; Tota B, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00064; Wang XY, 2011, BIOMARKERS, V16, P372, DOI 10.3109/1354750X.2011.578260; Werner GS, 2003, CIRCULATION, V107, P1972, DOI 10.1161/01.CIR.0000061953.72662.3A; Xu WX, 2013, BIOMARKERS, V18, P343, DOI 10.3109/1354750X.2013.787459	28	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0149062	10.1371/journal.pone.0149062	http://dx.doi.org/10.1371/journal.pone.0149062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304618	gold, Green Submitted, Green Published			2022-12-27	WOS:000377824800001
J	Gelaye, B; Sumner, SJ; McRitchie, S; Carlson, JE; Ananth, CV; Enquobahrie, DA; Qiu, CF; Sorensen, TK; Williams, MA				Gelaye, Bizu; Sumner, Susan J.; McRitchie, Susan; Carlson, James E.; Ananth, Cande V.; Enquobahrie, Daniel A.; Qiu, Chunfang; Sorensen, Tanya K.; Williams, Michelle A.			Maternal Early Pregnancy Serum Metabolomics Profile and Abnormal Vaginal Bleeding as Predictors of Placental Abruption: A Prospective Study	PLOS ONE			English	Article							RISK-FACTORS; ALPHA-FETOPROTEIN; PRETERM DELIVERY; FATTY-ACID; PERFORMANCE; DEFICIENCY; METABOLISM; DIAGNOSIS; BIOMARKER; STORAGE	Background & Objective Placental abruption, an ischemic placental disorder, complicates about 1 in 100 pregnancies, and is an important cause of maternal and perinatal morbidity and mortality worldwide. Metabolomics holds promise for improving the phenotyping, prediction and understanding of pathophysiologic mechanisms of complex clinical disorders including abruption. We sought to evaluate maternal early pregnancy pre-diagnostic serum metabolic profiles and abnormal vaginal bleeding as predictors of abruption later in pregnancy. Methods Maternal serum was collected in early pregnancy (mean 16 weeks, range 15 to 22 weeks) from 51 abruption cases and 51 controls. Quantitative targeted metabolic profiles of serum were acquired using electrospray ionization liquid chromatography-mass spectrometry (ESI-LC-MS/MS) and the Absolute IDQ (R) p180 kit. Maternal sociodemographic characteristics and reproductive history were abstracted from medical records. Stepwise logistic regression models were developed to evaluate the extent to which metabolites aid in the prediction of abruption. We evaluated the predictive performance of the set of selected metabolites using a receiver operating characteristics (ROC) curve analysis and area under the curve (AUC). Results Early pregnancy vaginal bleeding, dodecanoylcarnitine/dodecenoylcarnitine (C12 / C12:1), and phosphatidylcholine acyl-alkyl C 38:1 (PC ae C38:1) strongly predict abruption risk.The AUC for these metabolites alone was 0.68, for early pregnancy vaginal bleeding alone was 0.65, and combined the AUC improved to 0.75 with the addition of quantitative metabolite data (P = 0.003). Conclusion Metabolomic profiles of early pregnancy maternal serum samples in addition to the clinical symptom, vaginal bleeding, may serve as important markers for the prediction of abruption. Larger studies are necessary to corroborate and validate these findings in other cohorts.	[Gelaye, Bizu; Williams, Michelle A.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Sumner, Susan J.; McRitchie, Susan; Carlson, James E.] RTI Int, Discovery Sci, Res Triangle Pk, NC USA; [Ananth, Cande V.] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA; [Ananth, Cande V.] Columbia Univ, Joseph L Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Enquobahrie, Daniel A.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Enquobahrie, Daniel A.; Qiu, Chunfang; Sorensen, Tanya K.] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA USA	Harvard University; Harvard T.H. Chan School of Public Health; Research Triangle Institute; Columbia University; Columbia University; University of Washington; University of Washington Seattle; Swedish Medical Center	Gelaye, B (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	bgelaye@hsph.harvard.edu		Gelaye, Bizu/0000-0001-7934-548X	National Institutes of Health [R01-HD059827, U24 DK097193]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by awards from the National Institutes of Health (R01-HD059827 and U24 DK097193). The NIH had no further role in study design; in the collection, analysis and interpretation of data; in drafting of the report; and in the decision to submit the paper for publication.; This research was supported by awards from the National Institutes of Health (R01-HD059827 and U24 DK097193). The NIH had no further role in study design; in the collection, analysis and interpretation of data; in drafting of the report; and in the decision to submit the paper for publication.	Ananth CV, 2004, OBSTET GYNECOL, V104, P71, DOI 10.1097/01.AOG.0000128172.71408.a0; Arnold DL, 2009, J OBSTET GYNAECOL RE, V35, P446, DOI 10.1111/j.1447-0756.2008.00980.x; Austdal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091923; Denis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116346; Enquobahrie DA, 2015, J CLIN ENDOCR METAB, V100, P4348, DOI 10.1210/jc.2015-2862; Hebels DGAJ, 2013, ENVIRON HEALTH PERSP, V121, P480, DOI 10.1289/ehp.1205657; Horgan RP, 2010, PLACENTA, V31, P893, DOI 10.1016/j.placenta.2010.07.002; Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008; Kistin N, 1996, PAEDIATR PERINAT EP, V10, P269, DOI 10.1111/j.1365-3016.1996.tb00050.x; Koster MPH, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/857108; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Kramer MS, 1997, OBSTET GYNECOL, V89, P221, DOI 10.1016/S0029-7844(96)00478-4; Lord R.S., 2008, LAB EVALUATIONS INTE; Magnusson M, 2013, EUR HEART J, V34, P1982, DOI 10.1093/eurheartj/ehs424; Nilsen RM, 2008, AM J EPIDEMIOL, V167, P867, DOI 10.1093/aje/kwm373; Onalan R, 2006, GYNECOL OBSTET INVES, V61, P142, DOI 10.1159/000090432; Oyelese Y, 2006, OBSTET GYNECOL, V108, P1005, DOI 10.1097/01.AOG.0000239439.04364.9a; Qiu Chunfang, 2015, BMC Res Notes, V8, P447, DOI 10.1186/s13104-015-1340-4; Qiu CF, 2014, DIABETES RES CLIN PR, V104, P393, DOI 10.1016/j.diabres.2014.03.001; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Sanchez SE, 2006, AM J OBSTET GYNECOL, V194, P225, DOI 10.1016/j.ajog.2005.05.013; Seibel BA, 2002, J EXP BIOL, V205, P297; Signore C, 2008, PRENATAL DIAG, V28, P852, DOI 10.1002/pd.2065; Signore C, 2006, OBSTET GYNECOL, V108, P338, DOI 10.1097/01.AOG.0000216014.72503.09; Tikkanen M, 2007, PRENATAL DIAG, V27, P240, DOI 10.1002/pd.1654; VANHOVE JLK, 1993, AM J HUM GENET, V52, P958; Vaswani K, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/850471; Wang TJ, 2013, J CLIN INVEST, V123, P4309, DOI 10.1172/JCI64801; Wikoff WR, 2015, J CLIN ONCOL, V33, P3880, DOI 10.1200/JCO.2015.61.7779; WILLIAMS MA, 1991, AM J EPIDEMIOL, V134, P965, DOI 10.1093/oxfordjournals.aje.a116181; WILLIAMS MA, 1992, AM J OBSTET GYNECOL, V167, P1032, DOI 10.1016/S0002-9378(12)80033-0; WILLIAMS MA, 1993, OBSTET GYNECOL, V82, P808; Williams MA, 2013, INT J MOL EPIDEMIOL, V4, P120; Workalemahu T, 2013, INT J MOL EPIDEMIOL, V4, P128; Xiao R, 2002, PAEDIATR PERINAT EP, V16, P297, DOI 10.1046/j.1365-3016.2002.00448.x; Yaron Y, 2002, PRENATAL DIAG, V22, P778, DOI 10.1002/pd.407; Zukunft S, 2013, CHROMATOGRAPHIA, V76, P1295, DOI 10.1007/s10337-013-2429-3	37	12	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156755	10.1371/journal.pone.0156755	http://dx.doi.org/10.1371/journal.pone.0156755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300725	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200013
J	Woolnough, JL; Atwood, BL; Liu, Z; Zhao, R; Giles, KE				Woolnough, Jessica L.; Atwood, Blake L.; Liu, Zhong; Zhao, Rui; Giles, Keith E.			The Regulation of rRNA Gene Transcription during Directed Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; CHROMATIN; PLURIPOTENCY; METHYLATION; EXPRESSION; RRN3; COMPLEX; BINDING	It has become increasingly clear that proper cellular control of pluripotency and differentiation is related to the regulation of rRNA synthesis. To further our understanding of the role that the regulation of rRNA synthesis has in pluripotency we monitored rRNA synthesis during the directed differentiation of human embryonic stem cells (hESCs). We discovered that the rRNA synthesis rate is reduced similar to 50% within 6 hours of ACTIVIN A treatment. This precedes reductions in expression of specific stem cell markers and increases in expression of specific germ layer markers. The reduction in rRNA synthesis is concomitant with dissociation of the Pol I transcription factor, UBTF, from the rRNA gene promoter and precedes any increase to heterochromatin throughout the rRNA gene. To directly investigate the role of rRNA synthesis in pluripotency, hESCs were treated with the Pol I inhibitor, CX-5461. The direct reduction of rRNA synthesis by CX-5461 induces the expression of markers for all three germ layers, reduces the expression of pluripotency markers, and is overall similar to the ACTIVIN A induced changes. This work indicates that the dissociation of UBTF from the rRNA gene, and corresponding reduction in transcription, represent early regulatory events during the directed differentiation of pluripotent stem cells.	[Woolnough, Jessica L.; Atwood, Blake L.; Liu, Zhong; Zhao, Rui; Giles, Keith E.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, UAB Stem Cell Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Giles, KE (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, UAB Stem Cell Inst, Birmingham, AL 35294 USA.	kegiles@uab.edu		Makofske, Jessica/0000-0002-6547-6451	State of Alabama; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	State of Alabama; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by start up funds, State of Alabama.	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; [Anonymous], 2014, Cancer Discov, V4, pOF5, DOI 10.1158/2159-8290.CD-NB2014-154; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Bhattacharya D, 2009, BIOPHYS J, V96, P3832, DOI 10.1016/j.bpj.2008.11.075; BIRD AP, 1981, J MOL BIOL, V152, P1, DOI 10.1016/0022-2836(81)90092-9; Boles NC, 2014, CELL REP, V6, P724, DOI 10.1016/j.celrep.2014.01.026; Cavanaugh AH, 2008, GENE EXPRESSION, V14, P131; CLOS J, 1986, P NATL ACAD SCI USA, V83, P604, DOI 10.1073/pnas.83.3.604; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Haddach M, 2012, ACS MED CHEM LETT, V3, P602, DOI 10.1021/ml300110s; Hamperl S, 2013, BBA-GENE REGUL MECH, V1829, P405, DOI 10.1016/j.bbagrm.2012.12.007; Hawkins PG, 2009, NUCLEIC ACIDS RES, V37, P2984, DOI 10.1093/nar/gkp127; Hayashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098586; Hou J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-92; Ikonomou L, 2015, J CELL PHYSIOL, V230, P246, DOI 10.1002/jcp.24771; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; LEARNED RM, 1985, MOL CELL BIOL, V5, P1358, DOI 10.1128/MCB.5.6.1358; Lee HJ, 2011, IMMUNOL LETT, V140, P92, DOI 10.1016/j.imlet.2011.07.001; Li FM, 2011, J CELL BIOCHEM, V112, P1022, DOI 10.1002/jcb.22962; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MCKNIGHT SL, 1976, CELL, V8, P305, DOI 10.1016/0092-8674(76)90014-3; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Moorefield B, 2000, P NATL ACAD SCI USA, V97, P4724, DOI 10.1073/pnas.080063997; MORGAN GT, 1983, P NATL ACAD SCI-BIOL, V80, P6490, DOI 10.1073/pnas.80.21.6490; Negi SS, 2015, ONCOTARGET; Noseda M, 2011, CIRC RES, V108, P129, DOI 10.1161/CIRCRESAHA.110.223792; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Panov KI, 2006, EMBO J, V25, P3310, DOI 10.1038/sj.emboj.7601221; Poortinga G, 2011, NUCLEIC ACIDS RES, V39, P3267, DOI 10.1093/nar/gkq1205; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanij E, 2009, EPIGENETICS-US, V4, P274, DOI 10.4161/epi.4.6.9449; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Santoro R, 2010, EMBO REP, V11, P52, DOI 10.1038/embor.2009.254; Savic N, 2014, CELL STEM CELL, V15, P720, DOI 10.1016/j.stem.2014.10.005; Schlesinger S, 2009, GENE DEV, V23, P2437, DOI 10.1101/gad.544509; Shaltouki A, 2013, STEM CELLS, V31, P941, DOI 10.1002/stem.1334; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Stefanovsky V, 2006, CELL CYCLE, V5, P735, DOI 10.4161/cc.5.7.2633; Strohner R, 2004, MOL CELL BIOL, V24, P1791, DOI 10.1128/MCB.24.4.1791-1798.2004; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; Watanabe-Susaki K, 2014, STEM CELLS, V32, P3099, DOI 10.1002/stem.1825; Woolnough JL, 2015, MOL CELL BIOL, V35, P2278, DOI 10.1128/MCB.00076-15; Yamamoto RT, 1996, EMBO J, V15, P3964, DOI 10.1002/j.1460-2075.1996.tb00770.x; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zentner GE, 2014, G3-GENES GENOM GENET, V4, P243, DOI 10.1534/g3.113.009290; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384	58	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157276	10.1371/journal.pone.0157276	http://dx.doi.org/10.1371/journal.pone.0157276			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299313	gold, Green Submitted, Green Published			2022-12-27	WOS:000377822200034
J	Bolsterlee, B; Gandevia, SC; Herbert, RD				Bolsterlee, Bart; Gandevia, Simon C.; Herbert, Robert D.			Effect of Transducer Orientation on Errors in Ultrasound Image-Based Measurements of Human Medial Gastrocnemius Muscle Fascicle Length and Pennation	PLOS ONE			English	Article							ARCHITECTURE; CURVATURE; CHILDREN; ANGLE	Ultrasound imaging is often used to measure muscle fascicle lengths and pennation angles in human muscles in vivo. Theoretically the most accurate measurements are made when the transducer is oriented so that the image plane aligns with muscle fascicles and, for measurements of pennation, when the image plane also intersects the aponeuroses perpendicularly. However this orientation is difficult to achieve and usually there is some degree of misalignment. Here, we used simulated ultrasound images based on three-dimensional models of the human medial gastrocnemius, derived from magnetic resonance and diffusion tensor images, to describe the relationship between transducer orientation and measurement errors. With the transducer oriented perpendicular to the surface of the leg, the error in measurement of fascicle lengths was about 0.4 mm per degree of misalignment of the ultrasound image with the muscle fascicles. If the transducer is then tipped by 20 degrees, the error increases to 1.1 mm per degree of misalignment. For a given degree of misalignment of muscle fascicles with the image plane, the smallest absolute error in fascicle length measurements occurs when the transducer is held perpendicular to the surface of the leg. Misalignment of the transducer with the fascicles may cause fascicle length measurements to be underestimated or overestimated. Contrary to widely held beliefs, it is shown that pennation angles are always overestimated if the image is not perpendicular to the aponeurosis, even when the image is perfectly aligned with the fascicles. An analytical explanation is provided for this finding.	[Bolsterlee, Bart; Gandevia, Simon C.; Herbert, Robert D.] Neurosci Res Australia, Sydney, NSW, Australia; [Bolsterlee, Bart; Gandevia, Simon C.; Herbert, Robert D.] Univ New S Wales, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Bolsterlee, B (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.; Bolsterlee, B (corresponding author), Univ New S Wales, Sydney, NSW, Australia.	b.bolsterlee@neura.edu.au	; Gandevia, Simon/D-5009-2011	Bolsterlee, Bart/0000-0001-8277-5026; Gandevia, Simon/0000-0002-1345-3821; Herbert, Rob/0000-0003-4188-9195	Australian NHMRC (National Health and Medical Research Council) [APP1055084]	Australian NHMRC (National Health and Medical Research Council)	The study was supported by the Australian NHMRC (National Health and Medical Research Council) (Program Grant APP1055084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SKEKETAL MUSCLE STRU; Benard MR, 2011, J ANAT, V219, P388, DOI 10.1111/j.1469-7580.2011.01402.x; Benard MR, 2009, MUSCLE NERVE, V39, P652, DOI 10.1002/mus.21287; Bolsterlee B, 2016, J BIOMECH, V49, P1002, DOI 10.1016/j.jbiomech.2016.02.014; Bolsterlee B, 2015, J BIOMECH, V48, P1133, DOI 10.1016/j.jbiomech.2015.01.012; Cronin NJ, 2013, GAIT POSTURE, V37, P305, DOI 10.1016/j.gaitpost.2012.07.024; Damon BM, 2002, MAGN RESON MED, V48, P97, DOI 10.1002/mrm.10198; Darby J, 2013, IEEE T BIO-MED ENG, V60, P1935, DOI 10.1109/TBME.2013.2245328; Diong JHL, 2012, MUSCLE NERVE, V46, P237, DOI 10.1002/mus.23356; Heemskerk AM, 2010, NMR BIOMED, V23, P294, DOI 10.1002/nbm.1463; Herbert RD, 2015, J PHYSIOL-LONDON, V593, P441, DOI 10.1113/jphysiol.2014.279166; HERBERT RD, 1995, J PHYSIOL-LONDON, V484, P523, DOI 10.1113/jphysiol.1995.sp020683; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; KAWAKAMI Y, 1993, J APPL PHYSIOL, V74, P2740, DOI 10.1152/jappl.1993.74.6.2740; Kellis E, 2009, J BIOMECH, V42, P2549, DOI 10.1016/j.jbiomech.2009.07.011; Klimstra M, 2007, J ELECTROMYOGR KINES, V17, P504, DOI 10.1016/j.jelekin.2006.04.011; Lee D, 2015, COMPUT METHOD BIOMEC, V18, P1474, DOI 10.1080/10255842.2014.917294; Muramatsu T, 2002, J APPL PHYSIOL, V92, P129, DOI 10.1152/jappl.2002.92.1.129; Narici MV, 1996, J PHYSIOL-LONDON, V496, P287, DOI 10.1113/jphysiol.1996.sp021685; Rana M, 2014, J APPL PHYSIOL, V117, P1388, DOI 10.1152/japplphysiol.00109.2013; Shortland AP, 2002, DEV MED CHILD NEUROL, V44, P158, DOI 10.1017/S0012162201001864; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zhong H, 2008, LECT NOTES COMPUT SC, V5242, P485, DOI 10.1007/978-3-540-85990-1_58	24	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157273	10.1371/journal.pone.0157273	http://dx.doi.org/10.1371/journal.pone.0157273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294280	gold, Green Published, Green Submitted			2022-12-27	WOS:000377821300031
J	ElNaggar, AC; Hays, JL; Chen, JL				ElNaggar, Adam C.; Hays, John L.; Chen, James L.			Addition of Everolimus Post VEGFR Inhibition Treatment Failure in Advanced Sarcoma Patients Who Previously Benefited from VEGFR Inhibition: A Case Series	PLOS ONE			English	Article							SOFT-TISSUE SARCOMA; HIGH-GRADE OSTEOSARCOMA; MULTICENTER PHASE-II; SORAFENIB; ANTHRACYCLINE; CHEMOTHERAPY; COMBINATION; DOXORUBICIN; PAZOPANIB; CRITERIA	Background Patients with metastatic sarcoma who progress on vascular endothelial growth factor receptor inhibitors (VEGFRi) have limited treatment options. Upregulation of the mTOR pathway has been demonstrated to be a means of resistance to targeted VEGFRi in metastatic sarcoma. Patients and methods Retrospective cohort study to evaluate the clinical benefit at four months of combining mTOR inhibition (mTORi) via everolimus with VEGFRi in patients who have derived benefit from single-agent VEGFRi but have progressed. Patients with recurrent, metastatic soft tissue or bone sarcomas who progressed after deriving clinical benefit to VEGFRi beyond 12 weeks were continued on VEGFRi with the addition of everolimus (5 mg daily). Progression free survival was measured from start of VEGFRi to disease progression on single agent VEGFRi as well as from the addition of everolimus therapy to disease progression or drug discontinuation due to toxicity. Clinical benefit was defined as stable disease or partial response at 4 months. Results Nine patients were evaluated. Two patients did not tolerate therapy due to GI toxicity and one elected to discontinue therapy. Of the remaining six patients, the clinical benefit rate at four months was 50%. Progression free survival (PFS) for these patients was 3.1 months ranging from 0.5 to 7.2 months with one patient remaining on combination therapy. Conclusion In this heavily pre-treated, advanced sarcoma population, the addition of mTOR inhibition to VEGFRi based therapy resulted in a clinical benefit for a subset of patients. Prospective studies will be needed to verify these results.	[ElNaggar, Adam C.; Hays, John L.] Ohio State Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Columbus, OH 43210 USA; [Hays, John L.; Chen, James L.] Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA; [Chen, James L.] Ohio State Univ, Div Bioinformat, Dept Biomed Informat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chen, JL (corresponding author), Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA.; Chen, JL (corresponding author), Ohio State Univ, Div Bioinformat, Dept Biomed Informat, Columbus, OH 43210 USA.	James.Chen@osumc.edu	ElNaggar, Adam/V-6999-2019	ElNaggar, Adam/0000-0003-3409-583X				Bramwell VH, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003293; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; George S, 2009, J CLIN ONCOL, V27, P3154, DOI 10.1200/JCO.2008.20.9890; Grignani G, 2012, ANN ONCOL, V23, P508, DOI 10.1093/annonc/mdr151; Grignani G, 2015, LANCET ONCOL, V16, P98, DOI 10.1016/S1470-2045(14)71136-2; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Judson I, 2014, LANCET ONCOL, V15, P415, DOI 10.1016/S1470-2045(14)70063-4; Katz D, 2013, J CLIN ONCOL, V31; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mir O, 2015, JOURNAL OF CLINICAL; Motzer R, 2015, JOURNAL OF CLINICAL; Pignochino Y, 2013, CLIN CANCER RES, V19, P2117, DOI 10.1158/1078-0432.CCR-12-2293; Richter S, 2010, 2010 ASCO ANNUAL MEE; Rodrigues HV, 2015, INVEST NEW DRUG, V33, P700, DOI 10.1007/s10637-015-0238-2; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Van Glabbeke M, 1999, J CLIN ONCOL, V17, P150, DOI 10.1200/JCO.1999.17.1.150; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang XR, 2009, EXPERT OPIN THER TAR, V13, P1193, DOI 10.1517/14728220903225008; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026343; Yoo C, 2013, INVEST NEW DRUG, V31, P1602, DOI 10.1007/s10637-013-0028-7	23	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156985	10.1371/journal.pone.0156985	http://dx.doi.org/10.1371/journal.pone.0156985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295141	Green Published, Green Submitted, gold			2022-12-27	WOS:000377821300016
J	Large, M; Kaneson, M; Myles, N; Myles, H; Gunaratne, P; Ryan, C				Large, Matthew; Kaneson, Muthusamy; Myles, Nicholas; Myles, Hannah; Gunaratne, Pramudie; Ryan, Christopher			Meta-Analysis of Longitudinal Cohort Studies of Suicide Risk Assessment among Psychiatric Patients: Heterogeneity in Results and Lack of Improvement over Time	PLOS ONE			English	Article							EVENTUAL SUICIDE; INPATIENT SUICIDE; CLINICAL PREDICTORS; SELF-HARM; INTENT; SCALE; HOPELESSNESS; IDEATION; 5-YEAR; SCHIZOPHRENIA	Objective It is widely assumed that the clinical care of psychiatric patients can be guided by estimates of suicide risk and by using patient characteristics to define a group of high-risk patients. However, the statistical strength and reliability of suicide risk categorization is unknown. Our objective was to investigate the odds of suicide in high-risk compared to lower-risk categories and the suicide rates in high-risk and lower-risk groups. Method We located longitudinal cohort studies where psychiatric patients or people who had made suicide attempts were stratified into high-risk and lower-risk groups for suicide with suicide mortality as the outcome by searching for peer reviewed publications indexed in PubMed or PsychINFO. Electronic searches were supplemented by hand searching of included studies and relevant review articles. Two authors independently extracted data regarding effect size, study population and study design from 53 samples of risk-assessed patients reported in 37 studies. Results The pooled odds of suicide among high-risk patients compared to lower-risk patients calculated by random effects meta-analysis was of 4.84 (95% Confidence Interval (CI) 3.79-6.20). Between-study heterogeneity was very high (I-2 = 93.3). There was no evidence that more recent studies had greater statistical strength than older studies. Over an average follow up period of 63 months the proportion of suicides among the high-risk patients was 5.5% and was 0.9% among lower-risk patients. The meta-analytically derived sensitivity and specificity of a high-risk categorization were 56% and 79% respectively. There was evidence of publication bias in favour of studies that inflated the pooled odds of suicide in high-risk patients. Conclusions The strength of suicide risk categorizations based on the presence of multiple risk factors does not greatly exceed the association between individual suicide risk factors and suicide. A statistically strong and reliable method to usefully distinguish patients with a high-risk of suicide remains elusive.	[Large, Matthew] Univ New S Wales, Sch Psychiat, Randwick, NSW, Australia; [Large, Matthew; Gunaratne, Pramudie] Prince Wales Hosp, Randwick, NSW 2031, Australia; [Kaneson, Muthusamy] Univ New S Wales, Fac Med, Randwick, NSW, Australia; [Myles, Nicholas] Queen Elizabeth Hosp, Woodville South, Australia; [Myles, Hannah] Univ Adelaide, Sch Med, Discipline Psychiat, Adelaide, SA 5005, Australia; [Myles, Hannah] Country Hlth SA Mental Hlth, Adelaide, SA, Australia; [Ryan, Christopher] Univ Sydney, Discipline Psychiat, Sydney, NSW 2006, Australia; [Ryan, Christopher] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia; [Ryan, Christopher] Westmead Hosp, Dept Psychiat, Westmead, NSW 2145, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Adelaide; University of Sydney; University of Sydney; University of Sydney	Large, M (corresponding author), Univ New S Wales, Sch Psychiat, Randwick, NSW, Australia.; Large, M (corresponding author), Prince Wales Hosp, Randwick, NSW 2031, Australia.	mmbl@bigpond.com		Myles, Hannah/0000-0003-3411-5693; Gunaratne, Pramudie/0000-0001-9796-6896				ALLGULANDER C, 1990, EUR ARCH PSY CLIN N, V239, P270, DOI 10.1007/BF01738583; BECK AT, 1989, J AFFECT DISORDERS, V17, P203, DOI 10.1016/0165-0327(89)90001-3; Beck AT, 1999, SUICIDE LIFE-THREAT, V29, P1; BECK AT, 1989, J CONSULT CLIN PSYCH, V57, P309, DOI 10.1037/0022-006X.57.2.309; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Beck AT, 1974, PREDICTION SUICIDE B; BECK RW, 1974, PSYCHOL REP, V34, P445, DOI 10.2466/pr0.1974.34.2.445; Berman AL, 2014, SUICIDE LIFE-THREAT, V44, P432, DOI 10.1111/sltb.12067; Boudreaux ED, 2014, AM J PREV MED, V47, pS163, DOI 10.1016/j.amepre.2014.06.005; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; BUGLASS D, 1974, BRIT J PSYCHIAT, V124, P573, DOI 10.1192/bjp.124.6.573; BUGLASS D, 1970, BRIT J PSYCHIAT, V116, P483, DOI 10.1192/bjp.116.534.483; Chapman CL, 2015, ACTA PSYCHIAT SCAND, V131, P162, DOI 10.1111/acps.12359; Chu C, 2015, J CLIN PSYCHOL, V71, P1186, DOI 10.1002/jclp.22210; CLARK DC, 1987, AM J PSYCHIAT, V144, P923; Cohen J, 1986, Ann N Y Acad Sci, V487, P34, DOI 10.1111/j.1749-6632.1986.tb27883.x; Department of Health, 2010, SUIC RISK ASS MAN SY; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Gaynes BN, 2004, ANN INTERN MED, V140, P822, DOI 10.7326/0003-4819-140-10-200405180-00015; GOLDSTEIN RB, 1991, ARCH GEN PSYCHIAT, V48, P418; Haney EM., 2012, SUICIDE RISK FACTORS; Harriss L, 2005, J AFFECT DISORDERS, V86, P225, DOI 10.1016/j.jad.2005.02.009; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Hawton K, 2005, J CLIN PSYCHIAT, V66, P693, DOI 10.4088/JCP.v66n0604; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Hjorthoj CR, 2014, SOC PSYCH PSYCH EPID, V49, P1357, DOI 10.1007/s00127-014-0860-x; Kessler RC, 2015, JAMA PSYCHIAT, V72, P49, DOI 10.1001/jamapsychiatry.2014.1754; Krupinski M, 2000, NERVENARZT, V71, P906, DOI 10.1007/s001150050682; Krupinski M, 1998, EUR ARCH PSY CLIN N, V248, P141, DOI 10.1007/s004060050031; Large M, 2011, ACTA PSYCHIAT SCAND, V124, P18, DOI 10.1111/j.1600-0447.2010.01672.x; Large M, 2011, AUST NZ J PSYCHIAT, V45, P619, DOI 10.3109/00048674.2011.590465; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Loas G, 2007, PSYCHOL REP, V100, P183, DOI 10.2466/PR0.100.1.183-190; Madsen T, 2012, J CLIN PSYCHIAT, V73, P1034, DOI 10.4088/JCP.12lr07795a; Madsen T, 2012, J CLIN PSYCHIAT, V73, P144, DOI 10.4088/JCP.10m06473; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; McCarthy JF, 2015, AM J PUBLIC HEALTH, V105, P1935, DOI 10.2105/AJPH.2015.302737; McMillan D, 2007, PSYCHOL MED, V37, P769, DOI 10.1017/S0033291706009664; Motto J A, 1990, Crisis, V11, P52; MOTTO JA, 1985, AM J PSYCHIAT, V142, P680; National Institute for Health and Care Excellence, 2012, SELF HARM LONG TERM; Neuner T, 2008, GEN HOSP PSYCHIAT, V30, P324, DOI 10.1016/j.genhosppsych.2008.03.003; Nimeus A, 1997, J AFFECT DISORDERS, V42, P137, DOI 10.1016/S0165-0327(96)01404-8; Nimeus A, 2000, EUR PSYCHIAT, V15, P416, DOI 10.1016/S0924-9338(00)00512-5; NIMEUS A., 2002, ARCH SUICIDE RES, V6, P211, DOI DOI 10.1080/13811110214142; NORDENTOFT M, 1993, BRIT MED J, V306, P1637, DOI 10.1136/bmj.306.6893.1637; NORDSTROM P, 1995, ACTA PSYCHIAT SCAND, V92, P345, DOI 10.1111/j.1600-0447.1995.tb09595.x; PALLIS DJ, 1984, BRIT J PSYCHIAT, V144, P139, DOI 10.1192/bjp.144.2.139; POKORNY AD, 1993, SUICIDE LIFE-THREAT, V23, P1; POKORNY AD, 1983, ARCH GEN PSYCHIAT, V40, P249; Rajalin M, 2013, J AFFECT DISORDERS, V148, P92, DOI 10.1016/j.jad.2012.11.055; Ribeiro JD, 2016, PSYCHOL MED, V46, P225, DOI 10.1017/S0033291715001804; ROSEN DH, 1976, JAMA-J AM MED ASSOC, V235, P2105, DOI 10.1001/jama.235.19.2105; Rosenthal JA, 1996, J SOC SERV RES, V21, P37, DOI 10.1300/J079v21n04_02; Runeson B, 2015, J CLIN PSYCHIAT; Schneider B, 2001, EUR PSYCHIAT, V16, P283, DOI 10.1016/S0924-9338(01)00579-X; Skogman K, 2004, SOC PSYCH PSYCH EPID, V39, P113, DOI 10.1007/s00127-004-0709-9; Steeg S, 2012, PSYCHOL MED, V42, P2012, DOI 10.1017/S0033291712001389; Stefansson J, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0607-6; Stefansson J, 2012, J AFFECT DISORDERS, V136, P167, DOI 10.1016/j.jad.2010.11.016; Stephens SH, 1999, J NERV MENT DIS, V187, P10, DOI 10.1097/00005053-199901000-00003; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suominen K, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-11; Tejedor MC, 1999, ACTA PSYCHIAT SCAND, V100, P205, DOI 10.1111/j.1600-0447.1999.tb10847.x; Walsh G, 2015, ACTA PSYCHIAT SCAND, V131, P174, DOI 10.1111/acps.12383; Wells G., 2013, OTTAWA HOSP RES I	66	123	123	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156322	10.1371/journal.pone.0156322	http://dx.doi.org/10.1371/journal.pone.0156322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1UG	27285387	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000011
J	Schiffer, JT; Swan, DA; Magaret, A; Schacker, TW; Wald, A; Corey, L				Schiffer, Joshua T.; Swan, David A.; Magaret, Amalia; Schacker, Timothy W.; Wald, Anna; Corey, Lawrence			Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital Mucosa	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CD8(+) T-CELLS; RAPIDLY CLEARED EPISODES; REACTIVATION; INFECTION; TYPE-2; SKIN; ACTIVATION; VACCINE; HIV	A signature feature of HIV infection is poor control of herpes virus infections, which reactivate from latency and cause opportunistic infections. While the general mechanism underlying this observation is deficient CD4+ T-cell function, it is unknown whether increased severity of herpes virus infections is due primarily to poor immune control in latent or lytic sites of infection, or whether CD4+ immunodeficiency leads to more critical downstream deficits in humoral or cell-mediated immunologic responses. Here we compare genital shedding patterns of herpes simplex virus-2 (HSV-2) in 98 HIV infected and 98 HIV uninfected men matched on length of infection, HSV-1 serostatus and nationality. We demonstrate that high copy HSV-2 shedding is more frequent in HIV positive men, particularly in participants with CD4+ T-cell count < 200/mu L. Genital shedding is more frequent due to higher rate of shedding episodes, as well as a higher proportion of prolonged shedding episodes. Peak episode viral load was not found to differ between HIV infected and uninfected participants regardless of CD4+ T-cell count. We simulate a mathematical model which recapitulates these findings and identifies that rate of HSV-2 release from neural tissue increases, duration of mucosal cytolytic immune protection decreases, and cell-free viral lifespan increases in HIV infected participants. These results suggest that increased HSV-2 shedding in HIV infected persons may be caused by impaired immune function in both latent and lytic tissue compartments, with deficits in clearance of HSV-2 infected cells and extracellular virus.	[Schiffer, Joshua T.; Swan, David A.; Magaret, Amalia; Wald, Anna; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Schiffer, Joshua T.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Schiffer, Joshua T.; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA USA; [Magaret, Amalia; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Magaret, Amalia] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Schacker, Timothy W.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle	Schiffer, JT (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Schiffer, JT (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.; Schiffer, JT (corresponding author), Univ Washington, Dept Med, Seattle, WA USA.	jschiffe@fredhutch.org	Corey, Lawrence/AAE-1796-2020; Wald, Anna/B-6272-2012	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438	National Institute of Allergy and Infectious Diseases [P01 AI030731, K23 AI087206]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042528, K24AI071113, P01AI030731] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases grant P01 AI030731 to JTS, AM, and AW and grant K23 AI087206 to JTS. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Chu T, 2013, CELL REP, V3, P701, DOI 10.1016/j.celrep.2013.02.020; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; Dhankani V, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003922; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gilbert PB, 2014, J INFECT DIS, V210, P1573, DOI 10.1093/infdis/jiu279; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Iversen MB, 2015, IMMUNOBIOLOGY, V220, P762, DOI 10.1016/j.imbio.2014.12.019; Johnson KE, 2009, AIDS, V23, P1807, DOI 10.1097/QAD.0b013e32832efdf1; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Lubinski JM, 2011, J VIROL, V85, P3239, DOI 10.1128/JVI.02509-10; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Majumder B, 2005, J VIROL, V79, P7990, DOI 10.1128/JVI.79.13.7990-8003.2005; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Mark KE, 2010, JAIDS-J ACQ IMM DEF, V54, P482, DOI 10.1097/QAI.0b013e3181d91322; Naranbhai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053251; NG VL, 1989, BLOOD, V74, P2471; Peng T, 2012, J VIROL, V86, P10587, DOI 10.1128/JVI.01237-12; Posavad CM, 1997, P NATL ACAD SCI USA, V94, P10289, DOI 10.1073/pnas.94.19.10289; Posavad CM, 2004, J INFECT DIS, V190, P693, DOI 10.1086/422755; SACKS SL, 1989, ANN INTERN MED, V111, P893, DOI 10.7326/0003-4819-111-11-893; SAFRIN S, 1991, NEW ENGL J MED, V325, P551, DOI 10.1056/NEJM199108223250805; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Schiffer JT, 2013, ANTIMICROB AGENTS CH, V57, P5820, DOI 10.1128/AAC.01114-13; Schiffer JT, 2013, ELIFE, V2, DOI 10.7554/eLife.00288; Schiffer JT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00209; Schiffer JT, 2011, J ANTIMICROB CHEMOTH, V66, P2593, DOI 10.1093/jac/dkr346; Schiffer Joshua T, 2010, Proc Natl Acad Sci U S A, V107, P18973, DOI 10.1073/pnas.1006614107; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Stock AT, 2011, IMMUNOL CELL BIOL, V89, P143, DOI 10.1038/icb.2010.66; Verjans GMGM, 2007, P NATL ACAD SCI USA, V104, P3496, DOI 10.1073/pnas.0610847104; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	40	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0155124	10.1371/journal.pone.0155124	http://dx.doi.org/10.1371/journal.pone.0155124			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285483	Green Published, Green Submitted, gold			2022-12-27	WOS:000377564000003
J	Nouwen, N; Fardoux, J; Giraud, E				Nouwen, Nico; Fardoux, Joel; Giraud, Eric			NodD1 and NodD2 Are Not Required for the Symbiotic Interaction of Bradyrhizobium ORS285 with Nod-Factor-Independent Aeschynomene Legumes	PLOS ONE			English	Article							NODULATION GENES; PHOTOSYNTHETIC BRADYRHIZOBIA; STRAIN ORS285; FLAVONOIDS; JAPONICUM; STEM; LIPOCHITOOLIGOSACCHARIDES; TRANSCRIPTION; UPSTREAM; REVEALS	Photosynthetic Bradyrhizobium strain ORS285 forms nitrogen-fixing nodules on the roots and stems of tropical aquatic legumes of the Aeschynomene genus. Depending on the Aeschynomene species, this symbiotic interaction does or does not rely on the synthesis of Nod-factors (NFs). However, whether during the interaction of Bradyrhizobium ORS285 with NF-independent Aeschynomene species the nod genes are expressed and if the general regulator NodD plays a symbiotic role is unknown. Expression studies showed that in contrast to the interaction with the NF-dependent Aeschynomene species, A. afraspera, the Bradyrhizobium ORS285 nod genes are not induced upon contact with the NF-independent host plant A. indica. Mutational analysis of the two nodD genes present in ORS285, showed that deletion of nodD1 and nodD2 did not affect the symbiotic interaction between Bradyrhizobium ORS285 and A. indica whereas the deletions had an effect on the symbiotic interaction with A. afraspera plants. In addition, when the expression of nod genes was artificially induced by adding naringenin to the plant growth medium, the nodulation of A. indica by Bradyrhizobium ORS285 is delayed and resulted in lower nodule numbers.	[Nouwen, Nico; Fardoux, Joel; Giraud, Eric] IRD, UMR IRD SupAgro INRA CIRAD UM2, Lab Symbioses Trop & Mediterraneennes, Montpellier, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Nouwen, N (corresponding author), IRD, UMR IRD SupAgro INRA CIRAD UM2, Lab Symbioses Trop & Mediterraneennes, Montpellier, France.	nico.nouwen@ird.fr			French national research agency [ANR-BugsInaCell-13-BSV7-0013]	French national research agency(French National Research Agency (ANR))	This work was supported by the French national research agency (ANR-BugsInaCell-13-BSV7- 0013).; This work was supported by a grant from the French national research agency (ANR-BugsInaCell-13-BSV7-0013). We thank the National BioResource Project (NIG, Japan): E.coli for providing plasmids pHRP308, pHRP315 and pHP45-Cm used in this study.	Abdel-Lateif K, 2013, NEW PHYTOL, V199, P1012, DOI 10.1111/nph.12326; ALAZARD D, 1987, PLANT SOIL, V101, P141, DOI 10.1007/BF02371043; ALAZARD D, 1985, APPL ENVIRON MICROB, V50, P732, DOI 10.1128/AEM.50.3.732-734.1985; Bonaldi K, 2011, MOL PLANT MICROBE IN, V24, P1359, DOI 10.1094/MPMI-04-11-0093; Bonaldi K, 2010, MOL PLANT MICROBE IN, V23, P760, DOI 10.1094/MPMI-23-6-0760; Broughton WJ, 2000, J BACTERIOL, V182, P5641, DOI 10.1128/JB.182.20.5641-5652.2000; Chaintreuil C, 2001, FEMS MICROBIOL LETT, V194, P83, DOI 10.1111/j.1574-6968.2001.tb09450.x; Eaglesham ARJ, 1990, 1 PHOTOSYNTHETIC N2F, P805; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; Feng J, 2003, NUCLEIC ACIDS RES, V31, P3143, DOI 10.1093/nar/gkg411; FISHER RF, 1988, GENE DEV, V2, P282, DOI 10.1101/gad.2.3.282; Garcia M, 1996, MOL PLANT MICROBE IN, V9, P625, DOI 10.1094/MPMI-9-0625; Giraud E, 2004, PHOTOSYNTH RES, V82, P115, DOI 10.1007/s11120-004-1768-1; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Gough C, 2013, TRENDS PLANT SCI, V18, P566, DOI 10.1016/j.tplants.2013.06.001; GYORGYPAL Z, 1991, MOL GEN GENET, V226, P337, DOI 10.1007/BF00273624; HUNGRIA M, 1992, MOL PLANT MICROBE IN, V5, P199, DOI 10.1094/MPMI-5-199; Kobayashi H, 2004, MOL MICROBIOL, V51, P335, DOI 10.1046/j.1365-2958.2003.03841.x; Krause A, 2002, MOL PLANT MICROBE IN, V15, P1228, DOI 10.1094/MPMI.2002.15.12.1228; Limpens E, 2015, ANNU REV PHYTOPATHOL, V53, P311, DOI 10.1146/annurev-phyto-080614-120149; Loh JT, 2001, MOL MICROBIOL, V42, P37, DOI 10.1046/j.1365-2958.2001.02625.x; Molouba F, 1999, APPL ENVIRON MICROB, V65, P3084; Okazaki S, 2016, ISME J, V10, P64, DOI 10.1038/ismej.2015.103; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Renier A, 2011, MOL PLANT MICROBE IN, V24, P1440, DOI 10.1094/MPMI-05-11-0104	26	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157888	10.1371/journal.pone.0157888	http://dx.doi.org/10.1371/journal.pone.0157888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315080	Green Published, gold			2022-12-27	WOS:000378030000064
J	Vervoort, G; Leunissen, I; Firbank, M; Heremans, E; Nackaerts, E; Vandenberghe, W; Nieuwboer, A				Vervoort, Griet; Leunissen, Inge; Firbank, Michael; Heremans, Elke; Nackaerts, Evelien; Vandenberghe, Wim; Nieuwboer, Alice			Structural Brain Alterations in Motor Subtypes of Parkinson's Disease: Evidence from Probabilistic Tractography and Shape Analysis	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; MILD COGNITIVE IMPAIRMENT; GRAY-MATTER ATROPHY; POSTURAL INSTABILITY; TREMOR-DOMINANT; GAIT DISORDER; WHITE; DEMENTIA; CIRCUITS; HIPPOCAMPAL	Background and Objectives The postural instability and gait disorder (PIGD) and tremor dominant (TD) subtypes of Parkinson's disease (PD) show different patterns of alterations in functional connectivity (FC) between specific brain regions. This study aimed to investigate the relation between symptomatic heterogeneity in PD and structural alterations underlying these FC changes. Methods 68 PD patients classified as PIGD (n = 41) or TD (n = 19) and 19 age-matched controls underwent Magnetic Resonance Imaging (MRI). Diffusion-weighted images were used to assess fractional anisotropy (FA) and mean diffusivity (MD) at the whole-brain level using tract-based spatial statistics (TBSS). In addition, structural connectivity was assessed between regions that previously showed altered FC using probabilistic tractography. Anatomical images were used to determine shape and volume of the putamen, caudate and pallidum. Results TBSS revealed widespread FA reductions in PIGD compared to controls involving the superior longitudinal fasciculi and corpus callosum. No such differences were found in TD. Both PD subgroups had increased MD compared to controls in tracts connecting the left caudate with the bilateral ventral putamen. TD patients additionally showed increased MD compared to PIGD and controls in tracts connecting the right inferior parietal lobule with the right pre-motor and primary motor cortex, which previously showed altered FC. We also found grey matter atrophy in the rostrodorsal head of the caudate in PIGD compared to controls. Conclusion Microstructural changes in white matter tracts, particularly in those connecting striatal subareas, partly underlie FC alterations in PD subtypes. Caudate shape alterations further implicate the striatum in PIGD pathophysiology.	[Vervoort, Griet; Heremans, Elke; Nackaerts, Evelien; Nieuwboer, Alice] Katholieke Univ Leuven, Dept Rehabil Sci, Tervuursevest 101-1501, B-3001 Leuven, Belgium; [Leunissen, Inge] Katholieke Univ Leuven, Dept Kinesiol, Tervuursevest 101-1501, B-3001 Leuven, Belgium; [Firbank, Michael] Newcastle Univ, Inst Neurosci, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Firbank, Michael] Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Vandenberghe, Wim] Univ Hosp Leuven, Dept Neurol, Herestr 49, B-3000 Leuven, Belgium; [Vandenberghe, Wim] Katholieke Univ Leuven, Dept Neurosci, Herestr 49, B-3000 Leuven, Belgium	KU Leuven; KU Leuven; Newcastle University - UK; Newcastle University - UK; KU Leuven; University Hospital Leuven; KU Leuven	Vervoort, G (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Tervuursevest 101-1501, B-3001 Leuven, Belgium.	griet.vervoort@faber.kuleuven.be	Firbank, Michael J/K-3335-2012; Nieuwboer, Alice/F-5643-2013	Firbank, Michael J/0000-0002-9536-0185; Nieuwboer, Alice/0000-0003-1193-6229; Leunissen, Inge/0000-0002-3977-3620; Nackaerts, Evelien/0000-0002-6580-4902	KU Leuven, Belgium [OT / 11/ 091]; King Baudouin foundation; Research Foundation Flanders [G.0906.11]	KU Leuven, Belgium(KU Leuven); King Baudouin foundation; Research Foundation Flanders(FWO)	Support for this study was provided through a grant from the Special Research Fund of KU Leuven, Belgium (contract OT / 11/ 091), Malou-Malou funds of the King Baudouin foundation and Research Foundation Flanders project G.0906.11.; We would like to thank all subjects for their motivated and enthusiastic participation in this study. Support for this study was provided through a grant from the Special Research Fund of KU Leuven, Belgium (contract OT / 11/ 091), Malou-Malou funds of the King Baudouin foundation and Research Foundation Flanders project G.0906.11. W.V. is a Senior Clinical Investigator of the Research Foundation Flanders. All authors report no conflict of interest.	Abe O, 2010, NEURORADIOLOGY, V52, P699, DOI 10.1007/s00234-010-0716-3; Agosta F, 2014, HUM BRAIN MAPP, V35, P1921, DOI 10.1002/hbm.22302; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; Apostolova LG, 2010, MOVEMENT DISORD, V25, P687, DOI 10.1002/mds.22799; Bartels AL, 2006, MOVEMENT DISORD, V21, P1326, DOI 10.1002/mds.20952; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bell PT, 2015, HUM BRAIN MAPP, V36, P1278, DOI 10.1002/hbm.22701; Bohnen NI, 2011, BRAIN, V134, P2358, DOI 10.1093/brain/awr139; Brooks DJ, 2006, BIOL PSYCHIAT, V59, P908, DOI 10.1016/j.biopsych.2005.12.017; Burn DJ, 2012, MOVEMENT DISORD, V27, P379, DOI 10.1002/mds.24041; Burn DJ, 2006, J NEUROL NEUROSUR PS, V77, P585, DOI 10.1136/jnnp.2005.081711; Canu E., 2015, HUM BRAIN MAPP; Caspers S, 2011, NEUROIMAGE, V58, P362, DOI 10.1016/j.neuroimage.2011.06.027; Chan LL, 2014, PARKINSONISM RELAT D, V20, P53, DOI 10.1016/j.parkreldis.2013.09.017; Choi EY, 2012, J NEUROPHYSIOL, V108, P2242, DOI 10.1152/jn.00270.2012; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Eggers C, 2011, MOVEMENT DISORD, V26, P416, DOI 10.1002/mds.23468; Factor SA, 2011, J NEUROL NEUROSUR PS, V82, P564, DOI 10.1136/jnnp.2010.222042; Fling BW, 2013, BRAIN, V136, P2405, DOI 10.1093/brain/awt172; Focke NK, 2008, NEUROIMAGE, V40, P728, DOI 10.1016/j.neuroimage.2007.12.031; Garces P, 2015, HUM BRAIN MAPP; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Gu QQ, 2014, CAN J NEUROL SCI, V41, P763, DOI 10.1017/cjn.2014.34; Helmich RC, 2012, BRAIN, V135, P3206, DOI 10.1093/brain/aws023; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Herman T, 2014, J NEUROLOGY; Herman T, 2014, MOVEMENT DISORD, V29, P134, DOI 10.1002/mds.25697; Herman T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055193; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Huang HQ, 2016, BRAIN CONNECT, V6, P99, DOI 10.1089/brain.2015.0382; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Lee E, 2014, PARKINSONISM RELAT D, V20, P1376, DOI 10.1016/j.parkreldis.2014.09.027; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lin CHJ, 2012, BRAIN CONNECT, V2, P56, DOI 10.1089/brain.2011.0059; Linder J, 2009, J NEUROL, V256, P1671, DOI 10.1007/s00415-009-5177-4; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Lord S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00249; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Martino J, 2014, CLIN ANAT, V27, P563, DOI 10.1002/ca.22321; Moccia M, 2014, J NEUROL, V261, P2112, DOI 10.1007/s00415-014-7459-8; Nyberg EM, 2015, PARKINSONISM RELAT D, V21, P536, DOI 10.1016/j.parkreldis.2015.03.008; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Prodoehl J, 2013, JAMA NEUROL, V70, P100, DOI 10.1001/jamaneurol.2013.582; Rosenberg-Katz K, 2013, NEUROLOGY, V80, P1476, DOI 10.1212/WNL.0b013e31828cfaa4; Rossi C, 2010, EUR J NEUROL, V17, P626, DOI 10.1111/j.1468-1331.2009.02898.x; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Schweder PM, 2010, NEUROREPORT, V21, P914, DOI 10.1097/WNR.0b013e32833ce5f1; Shine JM, 2013, BRAIN, V136, P1204, DOI 10.1093/brain/awt049; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song IU, 2014, ACTA RADIOL, V55, P366, DOI 10.1177/0284185113498075; Spiegel J, 2007, J NEURAL TRANSM, V114, P331, DOI 10.1007/s00702-006-0518-2; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Stam CJ, 2015, INT J PSYCHOPHYSIOL; Stebbins GT, 2013, MOVEMENT DISORD, V28, P668, DOI 10.1002/mds.25383; Sterling NW, 2013, NEUROBIOL AGING, V34, P2510, DOI 10.1016/j.neurobiolaging.2013.05.017; Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233; Vercruysse S, 2015, MOVEMENT DISORD, V30, P567, DOI 10.1002/mds.26130; Vervoort G, 2016, PARKINSONISM RELAT D, V24, P48, DOI 10.1016/j.parkreldis.2016.01.016; Vervoort G, 2015, BEHAV BRAIN RES, V287, P1, DOI 10.1016/j.bbr.2015.03.026; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wu T., 2014, CEREB CORTEX; Wu T, 2015, NEUROBIOL DIS, V82, P226, DOI 10.1016/j.nbd.2015.06.014; Wu T, 2012, NEUROSCI LETT, V524, P55, DOI 10.1016/j.neulet.2012.07.012; Zhang JQ, 2015, PARKINSONISM RELAT D, V21, P23, DOI 10.1016/j.parkreldis.2014.10.017	70	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157743	10.1371/journal.pone.0157743	http://dx.doi.org/10.1371/journal.pone.0157743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314952	Green Published, Green Submitted, gold			2022-12-27	WOS:000378030000049
J	Zhao, LQ; Wu, YR; Chen, S; Ren, YY; Chen, P; Niu, JM; Li, C; Sun, K				Zhao, Liqing; Wu, Yurong; Chen, Sun; Ren, Yunyun; Chen, Ping; Niu, Jianmei; Li, Cao; Sun, Kun			Feasibility Study on Prenatal Cardiac Screening Using Four-Dimensional Ultrasound with Spatiotemporal Image Correlation: A Multicenter Study	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; FETAL ECHOCARDIOGRAPHY; DIAGNOSIS; ACCURACY; TOOL	Objective This study aimed at investigating the feasibility of using the spatiotemporal image correlation (STIC) technology for prenatal cardiac screening, finding factors that influence the offline evaluation of reconstructed fetal heart, and establishing an optimal acquisition scheme. Methods The study included 452 gravidae presenting for routine screening at 3 maternity centers at 20-38 gestational weeks. The factors influencing the quality of STIC volume data were evaluated using t test, chi-square test, and logistic regression analysis. The predictive power was evaluated using the receiver operating characteristic (ROC) curve. Results Among the 452 fetuses enrolled, 353 (78.1%) were identified as successful and 99 (21.9%) as failure of evaluation of the reconstructed fetal heart. The total success rate of qualified STIC images was 78.1%. The display rates of reconstructed cardiac views were 86.5% (four-chamber view), 92.5% (left ventricular outflow tract view), 92.7% (right ventricular outflow tract view), 89.9% (three-vessel trachea view), 63.9% (aortic arch view), 81.4% (ductal arch view), 81% (short-axis view of great vessels), 80.1% (long-cava view), and 86.9% (abdominal view). A logistic regression analysis showed that more than 28 gestational weeks [OR = 0.39 (CI 95% 0.16, 0.19), P = 0.035], frequent fetal movements [OR = 0.37 (CI 95% 0.16, 0.87), P = 0.022], shadowing [OR = 0.36 (CI 95% 0.19, 0.72), P = 0.004], spine location at 10-2 o'clock [OR = 0.08 (CI 95% 0.02, 0.27), P = 0.0], and original cardiac view [OR = 0.51 (0.25, 0.89), P = 0.019] had a significant impact on the quality of STIC. The area under the ROC curve was 0.775. Conclusions Fetal cardiac-STIC seems a feasible tool for prenatal screening of congenital heart diseases. The influence factors on the quality of STIC images included the intensity of training, gestational age, fetal conditions and parameter settings. The optimal acquisition scheme may improve the application and widespread use of cardiac STIC.	[Zhao, Liqing; Wu, Yurong; Chen, Sun; Sun, Kun] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Div Pediat Cardiol, Shanghai 200030, Peoples R China; [Ren, Yunyun; Li, Cao] Fudan Univ, Obstet & Gynecol Hosp, Dept Med Ultrasound, Shanghai 200433, Peoples R China; [Chen, Ping] Shanghai First Matern & Infant Hosp, Dept Med Ultrasound, Shanghai, Peoples R China; [Niu, Jianmei] Int Peace Matern & Child Hlth Hosp, China Welf Inst, Dept Med Ultrasound, Shanghai, Peoples R China	Shanghai Jiao Tong University; Fudan University	Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Div Pediat Cardiol, Shanghai 200030, Peoples R China.	sunkun@xinhuamed.com.cn			National Basic Research Program of China [2010CB529501]; Shanghai health system important disease joint research project [2013ZYJB0016]	National Basic Research Program of China(National Basic Research Program of China); Shanghai health system important disease joint research project	The research was funded by a grant (2010CB529501) from the National Basic Research Program of China and supported by Shanghai health system important disease joint research project (No. 2013ZYJB0016) (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the patients for participating in this study. The research was funded by a grant (2010CB529501) from the National Basic Research Program of China and supported by Shanghai health system important disease joint research project (No. 2013ZYJB0016)(Sun Kun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed BI, 2014, J MATERN-FETAL NEO M, V27, P1163, DOI 10.3109/14767058.2013.847423; Araujo E, 2014, INT J WOMENS HEALTH, V6, P501, DOI 10.2147/IJWH.S47074; Bennasar M, 2010, ULTRASOUND OBST GYN, V36, P458, DOI 10.1002/uog.7720; Carvalho JS, 2013, ULTRASOUND OBST GYN, V41, P348, DOI 10.1002/uog.12403; DeVore GR, 2003, ULTRASOUND OBST GYN, V22, P380, DOI 10.1002/uog.217; Donofrio MT, 2014, CIRCULATION, V129, P2183, DOI 10.1161/01.cir.0000437597.44550.5d; Goncalves LF, 2006, ULTRASOUND OBST GYN, V27, P336, DOI 10.1002/uog.2724; Gupta N, 2014, EUR J PEDIATR, V173, P655, DOI 10.1007/s00431-013-2231-0; He YH, 2013, EXP THER MED, V5, P1637, DOI 10.3892/etm.2013.1060; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Ogge G, 2006, ULTRASOUND OBST GYN, V28, P779, DOI 10.1002/uog.3830; Paladini D, 2007, ULTRASOUND OBST GYN, V29, P605, DOI 10.1002/uog.4049; Randall P, 2005, BJOG-INT J OBSTET GY, V112, P24, DOI 10.1111/j.1471-0528.2004.00295.x; Tworetzky W, 2001, CIRCULATION, V103, P1269, DOI 10.1161/01.cir.103.9.1269; Uittenbogaard LB, 2008, ULTRASOUND OBST GYN, V31, P625, DOI 10.1002/uog.5351; Vinals F, 2005, ULTRASOUND OBST GYN, V25, P25, DOI 10.1002/uog.1796; Vinals F, 2003, ULTRASOUND OBST GYN, V22, P388, DOI 10.1002/uog.883; Yagel S, 2011, ULTRASOUND OBST GYN, V37, P432, DOI 10.1002/uog.8867; Yeu BK, 2008, FETAL DIAGN THER, V24, P241, DOI 10.1159/000151669	19	10	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157477	10.1371/journal.pone.0157477	http://dx.doi.org/10.1371/journal.pone.0157477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314236	gold, Green Submitted, Green Published			2022-12-27	WOS:000378030000031
J	Dikkers, MF; Westerman, MJ; Rubinstein, SM; van Tulder, MW; Anema, JR				Dikkers, Marije F.; Westerman, Marjan J.; Rubinstein, Sidney M.; van Tulder, Maurits W.; Anema, Johannes R.			Why Neck Pain Patients Are Not Referred to Manual Therapy: A Qualitative Study among Dutch Primary Care Stakeholders	PLOS ONE			English	Article							GENERAL-PRACTITIONER; CONSERVATIVE MANAGEMENT; PHYSICAL-THERAPY; CONTINUED CARE; LOW-BACK; COST; PHYSIOTHERAPY	Background Treatment of neck pain with manual therapy demonstrated to be more effective and cost-effective than general practitioner (GP) care or physiotherapy in a high quality RCT in the Netherlands in 2002. However, referral to manual therapy for neck pain is still relatively low. This study aims to explore the barriers and facilitators affecting the implementation of manual therapy in neck pain management in primary care. Methods An explorative study was conducted comprising semi-structured interviews with GPs (n = 13), physiotherapists (n = 10), manual therapists (n = 7) and their patients with neck pain (n = 27), and three focus groups with additional stakeholders (n = 10-12 per group). A thematic analysis approach was used. Results Different barriers and facilitators for referral were found for patients, GPs and physiotherapists on the individual level, but also in the interaction between stakeholders and their context. Individual perceptions such as knowledge and beliefs about manual therapy for neck pain either impeded or facilitated referral. Fear for complications associated with cervical manipulation was an important barrier for patients as well as GPs. For GPs and physiotherapists it was important whether they perceived it was part of their professional role to refer for manual therapy. Existing relations formed referral behavior, and the trust in a particular practitioner was a recurrent theme among GPs and physiotherapist as well as patients. The contextual factor availability of manual therapy played a role for all stakeholders. Conclusions Barriers and facilitators were found especially in individual perceptions on manual therapy for neck pain (e.g. knowledge and beliefs), the interaction between stakeholders (e.g. collaboration and trust) and the organizational context. Implementation strategies that focus on these different aspects seem to be likely to optimize referral rates and the use of manual therapy in primary care management of neck pain.	[Dikkers, Marije F.; Westerman, Marjan J.; Rubinstein, Sidney M.; van Tulder, Maurits W.] Vrije Univ Amsterdam, Dept Hlth Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands; [Dikkers, Marije F.; Westerman, Marjan J.; Rubinstein, Sidney M.; van Tulder, Maurits W.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands; [Anema, Johannes R.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands; [Anema, Johannes R.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Rubinstein, SM (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.; Rubinstein, SM (corresponding author), Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	s.m.rubinstein@vu.nl	van Tulder, Maurits/AAB-9785-2022	van Tulder, Maurits/0000-0002-7589-8471; Rubinstein, Sidney/0000-0002-4819-994X; Westerman, Marjan J./0000-0002-9827-6958	Netherlands Organization for Health Research and Development [171203011]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	This study is supported by a grant from the Netherlands Organization for Health Research and Development (project number 171203011) (www.zonmw.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker PD, 1996, BMJ-BRIT MED J, V313, P1291; [Anonymous], 2004, GEN M CAP TOWN MARCH; Bogduk N, 1999, BEST PRACT RES CL RH, V13, P261, DOI 10.1053/berh.1999.0020; Borghouts JAJ, 1999, PAIN, V80, P629, DOI 10.1016/S0304-3959(98)00268-1; Bot SDM, 2005, ANN RHEUM DIS, V64, P118, DOI 10.1136/ard.2003.019349; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Fleuren M, 2004, INT J QUAL HEALTH C, V16, P107, DOI 10.1093/intqhc/mzh030; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Gross A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004249.pub4; Gross AR, 2007, J RHEUMATOL, V34, P1083; Hoving JL, 2006, CLIN J PAIN, V22, P370, DOI 10.1097/01.ajp.0000180185.79382.3f; Hoving JL, 2002, ANN INTERN MED, V136, P713, DOI 10.7326/0003-4819-136-10-200205210-00006; Hurwitz EL, 1996, SPINE, V21, P1746, DOI 10.1097/00007632-199608010-00007; Hurwitz EL, 2008, SPINE, V33, pS123, DOI 10.1097/BRS.0b013e3181644b1d; Korthals-de Bos IBC, 2003, BRIT MED J, V326, P911; Ouwens M, 2012, DE ZACHTE KANTEN VAN; Paulussen, 2010, TSG, V88, P51, DOI [DOI 10.1007/BF03089541, 10.1007/BF03089541]; Perreault K, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-160; Scherer M, 2010, EUR SPINE J, V19, P963, DOI 10.1007/s00586-010-1297-x; Schers H, 2001, Spine (Phila Pa 1976), V26, pE348, DOI 10.1097/00007632-200108010-00013; Skargren EI, 1997, SPINE, V22, P2167, DOI 10.1097/00007632-199709150-00015; Stirbu-Wagner I, 2012, LANDELIJK INFORM HUI; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Verberne LDM, JAARCIJFERS 2011 TRE; Vos C, 2007, BRIT J GEN PRACT, V57, P23; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wermeling M, 2011, FAM PRACT, V28, P300, DOI 10.1093/fampra/cmq109	29	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157465	10.1371/journal.pone.0157465	http://dx.doi.org/10.1371/journal.pone.0157465			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311067	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800077
J	Lenzi, EK; Novatski, A; Farago, PV; Almeida, MA; Zawadzki, SF; Neto, RM				Lenzi, E. K.; Novatski, A.; Farago, P. V.; Almeida, M. A.; Zawadzki, S. F.; Neto, R. Menechini			Diffusion Processes and Drug Release: Capsaicinoids - Loaded Poly (epsilon-caprolactone) Microparticles	PLOS ONE			English	Article							FRACTIONAL DIFFUSION; EQUATION; MODELS	We present a generalmodel based on fractional diffusion equation coupled with a kinetic equation through the boundary condition. It covers several scenarios that may be characterized by usual or anomalous diffusion or present relaxation processes on the surface with non-Debye characteristics. A particular case of this model is used to investigate the experimental data obtained from the drug release of the capsaicinoids-loaded Poly (epsilon-caprolactone) microparticles. These considerations lead us to a good agreement with experimental data and to the conjecture that the burst effect, i.e., an initial large bolus of drug is released before the release rate reaches a stable profile, may be related to an anomalous diffusion manifested by the system.	[Lenzi, E. K.; Novatski, A.; Neto, R. Menechini] Univ Estadual Ponta Grossa, Dept Fis, BR-84030900 Ponta Grossa, Brazil; [Farago, P. V.] Univ Estadual Ponta Grossa, Dept Ciencias Farmaceut, BR-84030900 Ponta Grossa, Brazil; [Almeida, M. A.] Univ Fed Curitiba, Dept Quim, BR-81531980 Curitiba, Parana, Brazil	Universidade Estadual de Ponta Grossa; Universidade Estadual de Ponta Grossa; Universidade Federal do Parana	Lenzi, EK (corresponding author), Univ Estadual Ponta Grossa, Dept Fis, BR-84030900 Ponta Grossa, Brazil.	eklenzi@uepg.br	Lenzi, Ervin Kaminski/N-1767-2019; Novatski, Andressa/D-5366-2013; zawadzki, sonia f/T-1546-2017	Lenzi, Ervin Kaminski/0000-0003-3853-1790; Novatski, Andressa/0000-0002-8327-6285; 	CNPQ [303642/2014-9, 456403/2014-0, 401997/2014-6]; Fundacao Araucaria [613 / 2014, 822/13]	CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	The authors thank CNPQ (grant numbers, 303642/2014-9 (EKL), 456403/2014-0 (PVF), and 401997/2014-6 (RM)) and Fundacao Araucaria (grant numbers, 613 / 2014 (AN) and 822/13 (AN)) for the partial financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MA, 2014, MAT SCI ENG C-MATER, V40, P345, DOI 10.1016/j.msec.2014.03.049; Barkai E, 2012, PHYS TODAY, V65, P29, DOI 10.1063/PT.3.1677; Benichou O, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.038102; Berg, 2018, RANDOM WALKS BIOL; Bressloff P. C., 2014, STOCHASTIC PROCESSES; Bressloff PC, 2013, REV MOD PHYS, V85, P135, DOI 10.1103/RevModPhys.85.135; Bueno-Orovio A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0352; Chechkin AV, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3593198; Chechkin AV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.040105; Chechkin AV, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046129; Ciuchi F, 2012, J PHYS CHEM C, V116, P8773, DOI 10.1021/jp211097m; Condamin S, 2008, P NATL ACAD SCI USA, V105, P5675, DOI 10.1073/pnas.0712158105; Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1; Crank J., 1975, MATH DIFFUSION; Guimaraes VG, 2015, SOFT MATTER, V11, P1658, DOI 10.1039/c5sm00151j; Hayman M., 2008, CURR ANAESTH CRIT CA, V19, P338, DOI [10.1016/j.cacc.2008.07.003, DOI 10.1016/J.CACC.2008.07.003]; HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018; Hofling F, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046602; Iyiola OS, 2014, AIP ADV, V4, DOI 10.1063/1.4898331; Klafter J., 2012, FRACTIONAL DYNAMICS; KORSMEYER RW, 1981, J MEMBRANE SCI, V9, P211, DOI 10.1016/S0376-7388(00)80265-3; Langlands TAM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051102; Mathai AM, 2010, H-FUNCTION: THEORY AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-0916-9; Metzler R, 2014, PHYS CHEM CHEM PHYS, V16, P24128, DOI 10.1039/c4cp03465a; OSHAUGHNESSY B, 1985, PHYS REV LETT, V54, P455, DOI 10.1103/PhysRevLett.54.455; Peng HL, 2010, FOOD CHEM, V121, P23, DOI 10.1016/j.foodchem.2009.11.085; Podlubny I., 1999, FRACTIONAL DIFFERENT, VVolume 198; SCHNEIDER WR, 1989, J MATH PHYS, V30, P134, DOI 10.1063/1.528578; Schumer R, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002141; Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0; Siepmann J, 2013, INT J PHARMACEUT, V453, P12, DOI 10.1016/j.ijpharm.2013.04.044; Tateishi AA, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011147; WANG TT, 1969, J POLYM SCI A2, V7, P2019, DOI 10.1002/pol.1969.160071204; Wyld H. W., 1976, MATH METHODS PHYS; Yin C, 2011, INT J PHARMACEUT, V418, P78, DOI 10.1016/j.ijpharm.2010.12.009; Zola RS, 2007, CHEM PHYS LETT, V438, P144, DOI 10.1016/j.cplett.2007.02.068	36	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157662	10.1371/journal.pone.0157662	http://dx.doi.org/10.1371/journal.pone.0157662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309358	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800118
J	Smedley, J; Macalister, R; Wangari, S; Gathuka, M; Ahrens, J; Iwayama, N; May, D; Bratt, D; O'Connor, M; Munson, P; Koday, M; Lifson, J; Fuller, DH				Smedley, Jeremy; Macalister, Rhonda; Wangari, Solomon; Gathuka, Mercy; Ahrens, Joel; Iwayama, Naoto; May, Drew; Bratt, Debbie; O'Connor, Megan; Munson, Paul; Koday, Michael; Lifson, Jeff; Fuller, Deborah Heydenburg			Laparoscopic Technique for Serial Collection of Para-Colonic, Left Colic, and Inferior Mesenteric Lymph Nodes in Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; T-CELLS; IMMUNE RECONSTITUTION; SIV INFECTION; AIDS; RESERVOIR; ABSENCE; HIV-1; DEATH	Unlike peripheral lymph nodes (PLN), the mesenteric lymph nodes (MLN) draining the gastrointestinal (GI) tract are exposed to microbes and microbial products from the intestines and as such, are immunologically distinct. GI draining (MLN) have also been shown to be sites of early viral replication and likely impact early events that determine the course of HIV infection. They also are important reservoir sites that harbor latently-infected cells and from which the virus can emerge even after prolonged combination antiretroviral therapy (cART). Changes in the microbial flora and increased permeability of the GI epithelium associated with lentiviral infection can impact the gut associated lymphoid tissue (GALT) and induce changes to secondary lymphoid organs limiting immune reconstitution with cART. Nonhuman primate models for AIDS closely model HIV infection in humans and serial sampling of the GALT and associated secondary lymphoid organs in this model is crucial to gain a better understanding of the critical early events in infection, pathogenesis, and the role of immune responses or drugs in controlling virus at these sites. However, current techniques to sample GI draining (MLN) involve major surgery and/or necropsy, which have, to date, limited the ability to investigate mechanisms mediating the initiation, persistence and control of infection in this compartment. Here, we describe a minimally invasive laparoscopic technique for serial sampling of these sites that can be used with increased sampling frequency, yields greater cell numbers and immune cell subsets than current non-invasive techniques of the GALT and reduces the potential for surgical complications that could complicate interpretation of the results. This procedure has potential to facilitate studies of pathogenesis and evaluation of preventive and treatment interventions, reducing sampling variables that can influence experimental results, and improving animal welfare.	[Smedley, Jeremy; Wangari, Solomon; Ahrens, Joel; Iwayama, Naoto; May, Drew] Univ Washington, Div Primate Resources, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Macalister, Rhonda] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Gathuka, Mercy] Leidos Biomed Res Inc, Lab Anim Sci Program, Frederick Natl Lab, Frederick, MD USA; [Bratt, Debbie; O'Connor, Megan; Munson, Paul; Koday, Michael; Fuller, Deborah Heydenburg] Univ Washington, Div AIDS Res, Washington Natl Primate Res Ctr, Dept Microbiol, Seattle, WA 98195 USA; [Lifson, Jeff] Leidos Biomed Res Inc, AIDS & Canc Viruses Program, Frederick Natl Lab, Frederick, MD USA	University of Washington; University of Washington Seattle; Oregon Health & Science University; Oregon National Primate Research Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Smedley, J (corresponding author), Univ Washington, Div Primate Resources, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA.	jsmedley@uw.edu	Bratt, Debra/B-1106-2019	O'Connor, Megan/0000-0003-2127-5073; Fuller, Deborah/0000-0001-7315-2441; Smedley, Jeremy/0000-0003-3369-4662	NIH grants [P51 NIH P51 OD010425-54]; National Institute of Allergy and Infectious Disease [R01 AI104679-01]; National Cancer Institute [HHSN261200800001E]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the following NIH grants: P51 NIH P51 OD010425-54, National Institute of Allergy and Infectious Disease R01 AI104679-01 and in part with federal funds from the National Cancer Institute under contract [HHSN261200800001E]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CDC, 2013, HIV SURV REP, P25; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Cumont MC, 2007, CELL DEATH DIFFER, V14, P1747, DOI 10.1038/sj.cdd.4402192; ESTAQUIER J, 1994, P NATL ACAD SCI USA, V91, P9431, DOI 10.1073/pnas.91.20.9431; Estaquier J, 2008, M S-MED SCI, V24, P1055, DOI 10.1051/medsci/200824121055; Estes J, 2008, J INFECT DIS, V198, P456, DOI 10.1086/590112; Estes JD, 2007, J INFECT DIS, V195, P551, DOI 10.1086/510852; Estes JD, 2015, J INFECT DIS, V211, P744, DOI 10.1093/infdis/jiu519; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Hall HI, 2015, MMWR-MORBID MORTAL W, V64, P657; Hao XP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9020; Horiike M, 2012, VIROLOGY, V423, P107, DOI 10.1016/j.virol.2011.11.024; Klatt NR, 2012, MUCOSAL IMMUNOL, V5, P646, DOI 10.1038/mi.2012.38; Klatt NR, 2010, MUCOSAL IMMUNOL, V3, P387, DOI 10.1038/mi.2010.14; Macpherson AJ, 2006, J EXP MED, V203, P497, DOI 10.1084/jem.20060227; Miura Soichiro, 2012, Ann Vasc Dis, V5, P275, DOI 10.3400/avd.ra.12.00059; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Siliciano JM, 2015, J INFECT DIS, V212, P1345, DOI 10.1093/infdis/jiv219; Smedley J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092830	19	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157535	10.1371/journal.pone.0157535	http://dx.doi.org/10.1371/journal.pone.0157535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309717	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800094
J	Suetsugu, N; Higa, T; Gotoh, E; Wada, M				Suetsugu, Noriyuki; Higa, Takeshi; Gotoh, Eiji; Wada, Masamitsu			Light-Induced Movements of Chloroplasts and Nuclei Are Regulated in Both Cp-Actin-Filament-Dependent and -Independent Manners in Arabidopsis thaliana	PLOS ONE			English	Article							KINESIN-LIKE PROTEINS; ADIANTUM-CAPILLUS-VENERIS; BLUE-LIGHT; AVOIDANCE MOVEMENT; PLASTID MOVEMENT; PLASMA-MEMBRANE; PHOTORELOCATION MOVEMENT; PHYSCOMITRELLA-PATENS; OUTER-MEMBRANE; LEAF-CELLS	Light-induced chloroplast movement and attachment to the plasma membrane are dependent on actin filaments. In Arabidopsis thaliana, the short actin filaments on the chloroplast envelope, cp-actin filaments, are essential for chloroplast movement and positioning. Furthermore, cp-actin-filament-mediated chloroplast movement is necessary for the strong-light- induced nuclear avoidance response. The proteins CHLOROPLAST UNUSUAL POSITIONING 1 (CHUP1), KINESIN-LIKE PROTEIN FOR ACTIN-BASED CHLOROPLAST MOVEMENT 1 (KAC1) and KAC2 are required for the generation and/or maintenance of cp-actin filaments in Arabidopsis. In land plants, CHUP1 and KAC family proteins play pivotal roles in the proper movement of chloroplasts and their attachment to the plasma membrane. Here, we report similar but distinct phenotypes in chloroplast and nuclear photorelocation movements between chup1 and kac1kac2 mutants. Measurement of chloroplast photorelocation movement indicated that kac1kac2, but not chup1, exhibited a clear strong-light- induced increase in leaf transmittance changes. The chloroplast movement in kac1kac2 depended on phototropin 2, CHUP1 and two other regulators for cp-actin filaments, PLASTID MOVEMENT IMPAIRED 1 and THRUMIN 1. Furthermore, kac1kac2 retained a weak but significant nuclear avoidance response although chup1 displayed a severe defect in the nuclear avoidance response. The kac1kac2chup1 triple mutant was completely defective in both chloroplast and nuclear avoidance responses. These results indicate that CHUP1 and the KACs function somewhat independently, but interdependently mediate both chloroplast and nuclear photorelocation movements.	[Suetsugu, Noriyuki; Higa, Takeshi; Wada, Masamitsu] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Gotoh, Eiji] Kyushu Univ, Dept Agr, Fukuoka 812, Japan; [Suetsugu, Noriyuki] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Higa, Takeshi; Wada, Masamitsu] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Biol Sci, Tokyo 158, Japan	Kyushu University; Kyushu University; Kyoto University; Tokyo Metropolitan University	Wada, M (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.; Wada, M (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Biol Sci, Tokyo 158, Japan.	masamitsu.wada@gmail.com		Higa, Takeshi/0000-0002-3196-2160	Japan Society of Promotion of Science [20227001, 22657016, 23120523, 20870030]; Grants-in-Aid for Scientific Research [15K18713, 25251033] Funding Source: KAKEN	Japan Society of Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Society of Promotion of Science [20227001, 22657016 and 23120523 to M.W., 20870030 to N.S.] (https://www.jsps.go.jp/english/index.html). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sam-Geun Kong for the assistance in measurement of chloroplast photorelocation movement and critical reading of the manuscript. We appreciate Atsuko Tsutsumi for technical assistance. This work was supported in part by the Japan Society of Promotion of Science [20227001, 22657016 and 23120523 to M.W., 20870030 to N.S.].	Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; DeBlasio SL, 2005, PLANT PHYSIOL, V139, P101, DOI 10.1104/pp.105.061887; GABRYS H, 1980, ACTA PHYSIOL PLANT, V4, P281; Higa T, 2014, J EXP BOT, V65, P2873, DOI 10.1093/jxb/ert414; Higa T, 2014, P NATL ACAD SCI USA, V111, P4327, DOI 10.1073/pnas.1317902111; Ichikawa S, 2011, PLANT CELL PHYSIOL, V52, P1422, DOI 10.1093/pcp/pcr087; Iwabuchi K, 2007, PLANT CELL PHYSIOL, V48, P1291, DOI 10.1093/pcp/pcm095; Iwabuchi K, 2010, PLANT PHYSIOL, V152, P1309, DOI 10.1104/pp.109.149526; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Jonsson E, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.87, 10.1038/nplants.2015.87]; Kadota A, 2009, P NATL ACAD SCI USA, V106, P13106, DOI 10.1073/pnas.0906250106; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Kodama Y, 2010, P NATL ACAD SCI USA, V107, P19591, DOI 10.1073/pnas.1007836107; Kong SG, 2013, PLANT CELL, V25, P572, DOI 10.1105/tpc.113.109694; Kong SG, 2013, PLANT CELL PHYSIOL, V54, P80, DOI 10.1093/pcp/pcs151; Lehmann P, 2011, PLANT SCI, V180, P650, DOI 10.1016/j.plantsci.2011.01.006; Luesse DR, 2006, PLANT PHYSIOL, V141, P1328, DOI 10.1104/pp.106.080333; Luesse DR, 2010, J EXP BOT, V61, P4387, DOI 10.1093/jxb/erq242; Oikawa K, 2003, PLANT CELL, V15, P2805, DOI 10.1105/tpc.016428; Oikawa K, 2008, PLANT PHYSIOL, V148, P829, DOI 10.1104/pp.108.123075; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sato Y, 2001, J CELL SCI, V114, P269; Shen ZY, 2015, J INTEGR PLANT BIOL, V57, P106, DOI 10.1111/jipb.12303; Suetsugu N, 2005, PLANT PHYSIOL, V139, P151, DOI 10.1104/pp.105.067371; Suetsugu N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00561; Suetsugu N, 2015, PLANT PHYSIOL, V169, P1155, DOI 10.1104/pp.15.00214; Suetsugu N, 2013, AM J BOT, V100, P60, DOI 10.3732/ajb.1200308; Suetsugu N, 2012, ADVANCES IN PHOTOSYNTHESIS - FUNDAMENTAL ASPECTS, P215; Suetsugu N, 2012, PLANT CELL PHYSIOL, V53, P1854, DOI 10.1093/pcp/pcs133; Suetsugu N, 2010, PLANT SIGNAL BEHAV, V5, P1190, DOI 10.4161/psb.5.10.12802; Suetsugu N, 2010, P NATL ACAD SCI USA, V107, P8860, DOI 10.1073/pnas.0912773107; Tsuboi H, 2007, PLANT CELL PHYSIOL, V48, P892, DOI 10.1093/pcp/pcm057; Tsuboi H, 2012, J PLANT RES, V125, P417, DOI 10.1007/s10265-011-0444-8; Usami H, 2012, PLANTA, V236, P1889, DOI 10.1007/s00425-012-1735-6; Vanstraelen M, 2006, CURR BIOL, V16, P308, DOI 10.1016/j.cub.2005.12.035; Vanstraelen M, 2004, PLANT PHYSIOL, V135, P1417, DOI 10.1104/pp.104.044818; von Braun SS, 2008, PLANTA, V227, P1151, DOI 10.1007/s00425-007-0688-7; Wada M, 2004, CURR OPIN PLANT BIOL, V7, P626, DOI 10.1016/j.pbi.2004.09.005; Wada M, 2013, PLANT SCI CELL BIOL, DOI [10.1007/SpringerReference_3685532013-10-0107:42:21UTC, DOI 10.1007/SPRINGERREFERENCE_3685532013-10-0107:42:21UTC]; Wada M, 2011, METHODS MOL BIOL, V774, P87, DOI 10.1007/978-1-61779-234-2_6; Whippo CW, 2011, CURR BIOL, V21, P59, DOI 10.1016/j.cub.2010.11.059; WILLIAMSON RE, 1993, ANNU REV PLANT PHYS, V44, P181, DOI 10.1146/annurev.pp.44.060193.001145; Yamashita H, 2011, PLANTA, V233, P357, DOI 10.1007/s00425-010-1299-2	44	23	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157429	10.1371/journal.pone.0157429	http://dx.doi.org/10.1371/journal.pone.0157429			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310016	Green Published, gold			2022-12-27	WOS:000378029800070
J	Wang, HB; Han, XK; Gambhir, D; Becker, S; Kunz, E; Liu, AJ; Hartnett, ME				Wang, Haibo; Han, Xiaokun; Gambhir, Deeksha; Becker, Silke; Kunz, Eric; Liu, Angelina Jingtong; Hartnett, M. Elizabeth			Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; INTRAVITREAL NEOVASCULARIZATION; MULLER CELLS; RAT MODEL; VEGF; RETINOPATHY; MIGRATION; NEURONS	Inhibition of chemokine C-C motif receptor 3 (CCR3) signaling has been considered as treatment for neovascular age-related macular degeneration (AMD). However, CCR3 is expressed in neural retina from aged human donor eyes. Therefore, broad CCR3 inhibition may be harmful to the retina. We assessed the effects of CCR3 inhibition on retina and choroidal endothelial cells (CECs) that develop into choroidal neovascularization (CNV). In adult murine eyes, CCR3 colocalized with glutamine-synthetase labeled Muller cells. In a murine laser-induced CNV model, CCR3 immunolocalized not only to lectin-stained cells in CNV lesions but also to the retina. Compared to non-lasered controls, CCR3 mRNA was significantly increased in laser-treated retina. An intravitreal injection of a CCR3 inhibitor (CCR3i) significantly reduced CNV compared to DMSO or PBS controls. Both CCR3i and a neutralizing antibody to CCR3 increased TUNEL+ retinal cells overlying CNV, compared to controls. There was no difference in cleaved caspase-3 in laser-induced CNV lesions or in overlying retina between CCR3i-or control-treated eyes. Following CCR3i, apoptotic inducible factor (AIF) was significantly increased and anti-apoptotic factor BCL2 decreased in the retina; there were no differences in retinal vascular endothelial growth factor (VEGF). In cultured human Muller cells exposed to eotaxin (CCL11) and VEGF, CCR3i significantly increased TUNEL+ cells and AIF but decreased BCL2 and brain derived neurotrophic factor, without affecting caspase-3 activity or VEGF. CCR3i significantly decreased AIF in RPE/choroids and immunostaining of phosphorylated VEGF receptor 2 (p-VEGFR2) in CNV with a trend toward reduced VEGF. In cultured CECs treated with CCL11 and/or VEGF, CCR3i decreased p-VEGFR2 and increased BCL2 without increasing TUNEL+ cells and AIF. These findings suggest that inhibition of retinal CCR3 causes retinal cell death and that targeted inhibition of CCR3 in CECs may be a safer if CCR3 inhibition is considered as a therapy for neovascular AMD.	[Wang, Haibo; Han, Xiaokun; Gambhir, Deeksha; Becker, Silke; Kunz, Eric; Liu, Angelina Jingtong; Hartnett, M. Elizabeth] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT USA; [Han, Xiaokun] China Med Univ, Affiliated Hosp 4, Dept Ophthalmol, Shenyang 110001, Peoples R China	Utah System of Higher Education; University of Utah; China Medical University	Hartnett, ME (corresponding author), Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT USA.	ME.Hartnett@hsc.utah.edu	Chopra, Deeksha Gambhir/K-7148-2014	Chopra, Deeksha Gambhir/0000-0003-0835-4703	National Eye Institute [R01EY015130, R01EY017011]; March of Dimes [6-FY13-75]; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE [R01EY017011] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); March of Dimes(March of Dimes); Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, R01EY015130 and R01EY017011 (https://nei.nih.gov) to MEH, the March of Dimes, 6-FY13-75 (http://www.marchofdimes.org) to MEH and the Knights Templar Eye Foundation (http://www.knightstemplar.org/ktef) to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2011, INVEST OPHTH VIS SCI, V52, P2166, DOI 10.1167/iovs.11-7328; Bradley John, 2007, Angiogenesis, V10, P141, DOI 10.1007/s10456-007-9069-x; Chen Y, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-15029; Dias JRD, 2011, BRIT J OPHTHALMOL, V95, P1631, DOI 10.1136/bjo.2010.186361; Edwards MM, 2012, EXP EYE RES, V96, P147, DOI 10.1016/j.exer.2011.12.005; Edwards MM, 2015, EXP EYE RES; Falavarjani KG, 2013, EYE, V27, P787, DOI 10.1038/eye.2013.107; Fu SH, 2015, DIABETES, V64, P3554, DOI 10.2337/db15-0180; Geisen P, 2006, EXP EYE RES, V82, P608, DOI 10.1016/j.exer.2005.08.021; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Jiang YC, 2014, INVEST OPHTH VIS SCI, V55, P824, DOI 10.1167/iovs.13-13755; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Lorenc VE, 2015, INVEST OPHTH VIS SCI, V56, P6948, DOI 10.1167/iovs.15-17496; Maloney S. C., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P147, DOI 10.2174/187152507780363197; Mizutani T, 2013, INVEST OPHTH VIS SCI, V54, P1564, DOI 10.1167/iovs.11-9095; Monaghan-Benson E, 2010, AM J PATHOL, V177, P2091, DOI 10.2353/ajpath.2010.090878; Nagai N, 2015, AM J PATHOL, V185, P2534, DOI 10.1016/j.ajpath.2015.04.029; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Ren F, 2014, J HAZARD MATER, V271, P283, DOI 10.1016/j.jhazmat.2014.02.026; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Sharma NK, 2012, DNA CELL BIOL, V31, P1618, DOI 10.1089/dna.2012.1786; Sullivan R, 2003, INVEST OPHTH VIS SCI, V44, P856, DOI 10.1167/iovs.02-0416; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Wang HB, 2013, AM J PATHOL, V183, P964, DOI 10.1016/j.ajpath.2013.05.011; Wang HB, 2011, INVEST OPHTH VIS SCI, V52, P8271, DOI 10.1167/iovs.11-8230	28	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157748	10.1371/journal.pone.0157748	http://dx.doi.org/10.1371/journal.pone.0157748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309355	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800131
J	Wilf, M; Ramot, M; Furman-Haran, E; Arzi, A; Levkovitz, Y; Malach, R				Wilf, Meytal; Ramot, Michal; Furman-Haran, Edna; Arzi, Anat; Levkovitz, Yechiel; Malach, Rafael			Diminished Auditory Responses during NREM Sleep Correlate with the Hierarchy of Language Processing	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; EYE-MOVEMENT SLEEP; EVENT-RELATED POTENTIALS; DEFAULT-MODE NETWORK; BOLD SIGNAL; PERCEPTUAL AWARENESS; SPEECH-PERCEPTION; PRIMATE PRIMARY; VISUAL-CORTEX; BRAIN	Natural sleep provides a powerful model system for studying the neuronal correlates of awareness and state changes in the human brain. To quantitatively map the nature of sleep-induced modulations in sensory responses we presented participants with auditory stimuli possessing different levels of linguistic complexity. Ten participants were scanned using functional magnetic resonance imaging (fMRI) during the waking state and after falling asleep. Sleep staging was based on heart rate measures validated independently on 20 participants using concurrent EEG and heart rate measurements and the results were confirmed using permutation analysis. Participants were exposed to three types of auditory stimuli: scrambled sounds, meaningless word sentences and comprehensible sentences. During non-rapid eye movement (NREM) sleep, we found diminishing brain activation along the hierarchy of language processing, more pronounced in higher processing regions. Specifically, the auditory thalamus showed similar activation levels during sleep and waking states, primary auditory cortex remained activated but showed a significant reduction in auditory responses during sleep, and the high order language-related representation in inferior frontal gyrus (IFG) cortex showed a complete abolishment of responses during NREM sleep. In addition to an overall activation decrease in language processing regions in superior temporal gyrus and IFG, those areas manifested a loss of semantic selectivity during NREM sleep. Our results suggest that the decreased awareness to linguistic auditory stimuli during NREM sleep is linked to diminished activity in high order processing stations.	[Wilf, Meytal; Ramot, Michal; Arzi, Anat; Malach, Rafael] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Furman-Haran, Edna] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Levkovitz, Yechiel] Tel Aviv Univ, Sch Med, Shalvata Mental Hlth Care Ctr, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University	Wilf, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	meytalwilf@gmail.com		Arzi, Anat/0000-0003-1005-1752; Wilf, Meytal/0000-0002-4037-8505; Ramot, Michal/0000-0001-9716-6469	EU FP7 VERE, ICORE program [ISF 51/11]; EU-Flagship, Human Brain Project grants; Helen and Martin Kimmel award	EU FP7 VERE, ICORE program; EU-Flagship, Human Brain Project grants; Helen and Martin Kimmel award	This work was funded by the EU FP7 VERE, ICORE program (ISF 51/11), the EU-Flagship, Human Brain Project grants and the Helen and Martin Kimmel award to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzi A, 2010, CHEM SENSES, V35, P31, DOI 10.1093/chemse/bjp079; Bastuji H, 2002, INT J PSYCHOPHYSIOL, V46, P243, DOI 10.1016/S0167-8760(02)00116-2; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P133; Brualla J, 1998, EVOKED POTENTIAL, V108, P283, DOI 10.1016/S0168-5597(97)00102-0; Cappe C, 2009, CEREB CORTEX; CARSKADON MA, 2000, PRINCIPLES PRACTICE, P15; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Coenen AML, 2002, INT J PSYCHOPHYSIOL, V46, P163, DOI 10.1016/S0167-8760(02)00110-1; Czisch M, 2004, EUR J NEUROSCI, V20, P566, DOI 10.1111/j.1460-9568.2004.03518.x; Czisch M, 2002, NEUROIMAGE, V16, P251, DOI 10.1006/nimg.2002.1071; Czisch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006749; Daltrozzo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050997; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Ebrahimi F, 2013, COMPUT METH PROG BIO, V112, P47, DOI 10.1016/j.cmpb.2013.06.007; Fisch L, 2009, NEURON, V64, P562, DOI 10.1016/j.neuron.2009.11.001; Freedman NS, 2001, AM J RESP CRIT CARE, V163, P451, DOI 10.1164/ajrccm.163.2.9912128; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Gutschalk A, 2008, PLOS BIOL, V6, P1156, DOI 10.1371/journal.pbio.0060138; Harpaz Y, 2009, CORTEX, V45, P1097, DOI 10.1016/j.cortex.2009.01.002; Hennevin E, 2007, NEUROBIOL LEARN MEM, V87, P416, DOI 10.1016/j.nlm.2006.10.006; Hesselmann G, 2011, NEUROIMAGE, V56, P1608, DOI 10.1016/j.neuroimage.2011.03.017; Hilton B A, 1976, J Adv Nurs, V1, P453, DOI 10.1111/j.1365-2648.1976.tb00932.x; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Iacovella V, 2011, MAGN RESON IMAGING, V29, P1338, DOI 10.1016/j.mri.2011.03.006; Issa EB, 2011, J NEUROSCI, V31, P2965, DOI 10.1523/JNEUROSCI.4920-10.2011; Issa EB, 2008, J NEUROSCI, V28, P14467, DOI 10.1523/JNEUROSCI.3086-08.2008; Jancke L, 1999, NEUROSCI LETT, V266, P125, DOI 10.1016/S0304-3940(99)00288-8; Kouider S, 2014, CURR BIOL, V24, P2208, DOI 10.1016/j.cub.2014.08.016; Larson-Prior LJ, 2011, PROG BRAIN RES, V193, P277, DOI 10.1016/B978-0-444-53839-0.00018-1; Laureys S, 2002, ACTA NEUROL BELG, V102, P176; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Ma T, 2005, P ANN INT IEEE EMBS, P996, DOI 10.1109/IEMBS.2005.1616585; Magnin M, 2010, P NATL ACAD SCI USA, V107, P3829, DOI 10.1073/pnas.0909710107; Maquet P, 2000, J SLEEP RES, V9, P207; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2012, ARCH ITAL BIOL, V150, P44, DOI 10.4449/aib.v150i2.1361; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; Nir Y, 2013, CEREB CORTEX; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Pal D, 2011, SPR SER COMPUT NEURO, V15, P1, DOI 10.1007/978-1-4614-0173-5_1; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; Perrin F, 2002, NEUROREPORT; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Picchioni Dante, 2014, Sleep, V37, P387, DOI 10.5665/sleep.3422; Portas CM, 2000, NEURON, V28, P991, DOI 10.1016/S0896-6273(00)00169-0; Quiroga RQ, 2008, P NATL ACAD SCI USA, V105, P3599, DOI 10.1073/pnas.0707043105; Ramot M, 2013, J NEUROSCI, V33, P14715, DOI 10.1523/JNEUROSCI.0232-13.2013; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rodd JM, 2005, CEREB CORTEX, V15, P1261, DOI 10.1093/cercor/bhi009; Sabri M, 2008, NEUROIMAGE, V39, P1444, DOI 10.1016/j.neuroimage.2007.09.052; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Schabus M, 2012, FRONTIERS NEUROLOGY, V3; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; SNYDER F, 1964, J APPL PHYSIOL, V19, P417, DOI 10.1152/jappl.1964.19.3.417; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; STERIADE M, 1991, J NEUROSCI, V11, P3200; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; Strauss M, 2015, P NATL ACAD SCI USA, V112, pE1353, DOI 10.1073/pnas.1501026112; Dang-Vu TT, 2011, P NATL ACAD SCI USA, V108, P15438, DOI 10.1073/pnas.1112503108; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; Tononi G, 2008, ANN NY ACAD SCI, V1129, P330, DOI 10.1196/annals.1417.024; van Buuren M, 2009, HUM BRAIN MAPP, V30, P3031, DOI 10.1002/hbm.20729; Xiao M, 2013, BIOMED SIGNAL PROCES, V8, P624, DOI 10.1016/j.bspc.2013.06.001	70	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157143	10.1371/journal.pone.0157143	http://dx.doi.org/10.1371/journal.pone.0157143			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310812	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800036
J	Bellan, V; Wallwork, SB; Stanton, TR; Reverberi, C; Gallace, A; Moseley, GL				Bellan, Valeria; Wallwork, Sarah B.; Stanton, Tasha R.; Reverberi, Carlo; Gallace, Alberto; Moseley, G. Lorimer			No Telescoping Effect with Dual Tendon Vibration	PLOS ONE			English	Article							PROPRIOCEPTIVE ILLUSIONS; MUSCLE VIBRATION; LIMB POSITION; PHANTOM-LIMB; BODY SHAPE; ONE ARM; MOVEMENT; REPRESENTATION; CONTRACTION; PERCEPTION	The tendon vibration illusion has been extensively used to manipulate the perceived position of one's own body part. However, findings from previous research do not seem conclusive sregarding the perceptual effect of the concurrent stimulation of both agonist and antagonist tendons over one joint. On the basis of recent data, it has been suggested that this paired stimulation generates an inconsistent signal about the limb position, which leads to a perceived shrinkage of the limb. However, this interesting effect has never been replicated. The aim of the present study was to clarify the effect of a simultaneous and equal vibration of the biceps and triceps tendons on the perceived location of the hand. Experiment 1 replicated and extended the previous findings. We compared a dual tendon stimulation condition with single tendon stimulation conditions and with a control condition ( no vibration) on both 'upward-downward' and 'towards-away from the elbow' planes. Our results show a mislocalisation towards the elbow of the position of the vibrated arm during dual vibration, in line with previous results; however, this did not clarify whether the effect was due to arm representation contraction (i.e., a 'telescoping' effect). Therefore, in Experiment 2 we investigated explicitly and implicitly the perceived arm length during the same conditions. Our results clearly suggest that in all the vibration conditions there was a mislocalisation of the entire arm (including the elbow), but no evidence of a contraction of the perceived arm length.	[Bellan, Valeria; Wallwork, Sarah B.; Stanton, Tasha R.; Moseley, G. Lorimer] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Bellan, Valeria; Wallwork, Sarah B.; Stanton, Tasha R.; Moseley, G. Lorimer] PainAdelaide, Adelaide, SA, Australia; [Bellan, Valeria; Reverberi, Carlo; Gallace, Alberto] Univ Milano Bicocca, Dept Psychol, I-20126 Milan, Italy; [Bellan, Valeria; Reverberi, Carlo; Gallace, Alberto] NeuroMI Milan Ctr Neurosci, Milan, Italy; [Stanton, Tasha R.; Moseley, G. Lorimer] Neurosci Res Australia, Randwick, NSW 2031, Australia	University of South Australia; University of Milano-Bicocca; Neuroscience Research Australia	Moseley, GL (corresponding author), Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia.; Moseley, GL (corresponding author), PainAdelaide, Adelaide, SA, Australia.; Moseley, GL (corresponding author), Neurosci Res Australia, Randwick, NSW 2031, Australia.	Lorimer.Moseley@unisa.edu.au	Moseley, Lorimer/A-7095-2009; Bellan, Valeria/J-4490-2018; Stanton, Tasha/F-4038-2013; Wallwork, Sarah/CAJ-0955-2022	Moseley, Lorimer/0000-0002-3750-4945; Bellan, Valeria/0000-0002-8512-5288; Stanton, Tasha/0000-0001-7106-4456; Wallwork, Sarah/0000-0003-1170-6263; GALLACE, ALBERTO/0000-0002-4561-8926	National Health & Medical Research Council of Australia [1008017]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The work was funded by a project grant from the National Health & Medical Research Council of Australia (ID 1008017) (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo DE, 2012, NEUROSCI LETT, V516, P188, DOI 10.1016/j.neulet.2012.03.077; Bellan V, 2015, EXP BRAIN RES, V233, P1689, DOI 10.1007/s00221-015-4242-8; Calvin-Figuiere S, 1999, EXP BRAIN RES, V124, P342, DOI 10.1007/s002210050631; Cody FWJ, 2008, NEUROSCI LETT, V433, P103, DOI 10.1016/j.neulet.2007.12.054; CORDO P, 1993, ELECTROEN CLIN NEURO, V89, P45, DOI 10.1016/0168-5597(93)90084-3; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; EKLUND G, 1972, J NEUROL NEUROSUR PS, V35, P606, DOI 10.1136/jnnp.35.5.606; Flor H, 2002, LANCET NEUROL, V1, P182, DOI 10.1016/S1474-4422(02)00074-1; Fuentes CT, 2012, EUR J NEUROSCI, V36, P3709, DOI 10.1111/ejn.12004; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; GILHODES JC, 1986, EXP BRAIN RES, V61, P395; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Hakuta N, 2014, EXP BRAIN RES, V232, P2197, DOI 10.1007/s00221-014-3911-3; Izumizaki M, 2010, J PHYSIOL-LONDON, V588, P2789, DOI 10.1113/jphysiol.2010.192336; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Longo MR, 2009, CURR BIOL, V19, pR727, DOI 10.1016/j.cub.2009.07.024; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763, DOI 10.1152/physrev.1978.58.4.763; Moseley GL, 2009, P NATL ACAD SCI USA, V106, P18798, DOI 10.1073/pnas.0907151106; Newport R, 2011, CURR BIOL, V21, pR804, DOI 10.1016/j.cub.2011.08.044; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Schofield JS, 2015, TECHNOL HEALTH CARE, V23, P129, DOI 10.3233/THC-140879; Stanton TR, 2016, PHYS THER, V96, P876, DOI 10.2522/ptj.20150241; Tidoni E, 2015, EXP BRAIN RES, V233, P375, DOI 10.1007/s00221-014-4121-8; Tsuge M, 2012, EXP BRAIN RES, V223, P541, DOI 10.1007/s00221-012-3281-7; Winter JA, 2005, J PHYSIOL-LONDON, V568, P1035, DOI 10.1113/jphysiol.2005.092619	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157351	10.1371/journal.pone.0157351	http://dx.doi.org/10.1371/journal.pone.0157351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305112	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000377824800051
J	Mansouri, S; Lietzau, G; Lundberg, M; Nathanson, D; Nystrom, T; Patrone, C				Mansouri, Shiva; Lietzau, Grazyna; Lundberg, Mathias; Nathanson, David; Nystrom, Thomas; Patrone, Cesare			Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieu	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; COGNITIVE FUNCTION; NEURODEGENERATIVE DISEASES; VASCULAR-DISEASE; RECEPTOR AGONIST; GLYCEMIC CONTROL; NEURONAL DEATH; CYCLOSPORINE-A; IN-VITRO; NEUROGENESIS	Hypoglycaemia is a common side-effect of glucose-lowering therapies for type-2 diabetic patients, which may cause cognitive/neurological impairment. Although the effects of hypoglycaemia in the brain have been extensively studied in neurons, how hypoglycaemia impacts the viability of adult neural stem cells (NSCs) has been poorly investigated. In addition, the cellular and molecular mechanisms of how hypoglycaemia regulates NSCs survival have not been characterized. Recent work others and us have shown that the pituitary adenylate cyclase-activating polypeptide (PACAP) and the glucagon-like peptide-1 receptor (GLP-1R) agonist Exendin-4 stimulate NSCs survival against glucolipoapoptosis. The aim of this study was to establish an in vitro system where to study the effects of hypoglycaemia on NSC survival. Furthermore, we determine the potential role of PACAP and Exendin-4 in counteracting the effect of hypoglycaemia. A hypoglycaemic in vitro milieu was mimicked by exposing subventricular zone-derived NSC to low levels of glucose. Moreover, we studied the potential involvement of apoptosis and endoplasmic reticulum stress by quantifying protein levels of Bcl-2, cleaved caspase-3 and mRNA levels of CHOP. We show that PACAP via PAC-1 receptor and PKA activation counteracts impaired NSC viability induced by hypoglycaemia. The protective effect induced by PACAP correlated with endoplasmic reticulum stress, Exendin-4 was ineffective. The results show that hypoglycaemia decreases NSC viability and that this effect can be substantially counteracted by PACAP via PAC-1 receptor activation. The data supports a potential therapeutic role of PAC-1 receptor agonists for the treatment of neurological complications, based on neurogenesis impairment by hypoglycaemia.	[Mansouri, Shiva; Lietzau, Grazyna; Lundberg, Mathias; Nathanson, David; Nystrom, Thomas; Patrone, Cesare] Karolinska Inst, Dept Clin Sci & Educ, Internal Med, Sodersjukhuset, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital	Mansouri, S (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Internal Med, Sodersjukhuset, Stockholm, Sweden.	shiva.mansouri@ki.se		Lietzau, Grazyna/0000-0001-5119-3082	Novo Nordisk foundation [5421]; Diabetesfonden [DIA2013-010]; Swedish Heart and Lung Foundation [20130523]; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; foundations Magnus Bergvalls; Syskonen Svensson; Ahlen; STROKE Riksforbundet; Gamla Tjanarinnor	Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Diabetesfonden; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; foundations Magnus Bergvalls; Syskonen Svensson; Ahlen; STROKE Riksforbundet; Gamla Tjanarinnor	This work was supported by Novo Nordisk foundation [Grant number 5421], (http://www.novonordiskfonden.dk/en/grantrecipients?field_date_value%5Bvalue%5D&field_date_value_1%5Bvalue%5D&field_related_center_tid=All&keys=&page=1), Diabetesfonden [Grant number DIA2013-010], (http://www.diabetesfonden.se/Forskning/Beviljade-projekt/), The Swedish Heart and Lung Foundation [grant number: 20130523, (http://www.hjartlungfonden.se/Forskning/), The fighting stroke project (Uppdrag Besegra Stroke). This work has also been supported by grants from: Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, The foundations Magnus Bergvalls, Syskonen Svensson, Ahlen, STROKE Riksforbundet, Gamla Tjanarinnor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago Y, 2011, NEUROSCIENCE, V172, P554, DOI 10.1016/j.neuroscience.2010.10.044; Ahren B, 2013, VASC HEALTH RISK MAN, V9, P155, DOI 10.2147/VHRM.S33934; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; AUER RN, 1986, STROKE, V17, P699, DOI 10.1161/01.STR.17.4.699; AUER RN, 1993, BAILLIERE CLIN ENDOC, V7, P611, DOI 10.1016/S0950-351X(05)80210-1; Aung PP, 2012, DIABETIC MED, V29, P328, DOI 10.1111/j.1464-5491.2011.03505.x; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7921; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Buse JB, 2010, DIABETES CARE, V33, P1255, DOI 10.2337/dc09-1914; Cavaliere F, 2006, EXP NEUROL, V201, P66, DOI 10.1016/j.expneurol.2006.03.020; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Curtis MA, 2007, NAT REV NEUROSCI, V8, P712, DOI 10.1038/nrn2216; Darsalia V, 2014, REV ENDOCR METAB DIS, V15, P233, DOI 10.1007/s11154-014-9285-9; Darsalia V, 2012, CLIN SCI, V122, P473, DOI 10.1042/CS20110374; Dave KR, 2011, STROKE, V42, P1404, DOI 10.1161/STROKEAHA.110.594937; de Galan BE, 2009, DIABETOLOGIA, V52, P2328, DOI 10.1007/s00125-009-1484-7; Dey J, 1997, DIABETES CARE, V20, P32, DOI 10.2337/diacare.20.1.32; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Estrada FS, 2009, NEUROSCI LETT, V459, P109, DOI 10.1016/j.neulet.2009.05.016; Fanelli CG, 2004, DIABETES-METAB RES, V20, pS32, DOI 10.1002/dmrr.514; Ferrand-Drake M, 2003, J NEUROCHEM, V85, P1431, DOI 10.1046/j.1471-4159.2003.01794.x; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Frier BM, 2011, DIABETES CARE, V34, pS132, DOI 10.2337/dc11-s220; Fujioka M, 1997, STROKE, V28, P584, DOI 10.1161/01.STR.28.3.584; de la Cadena SC, 2014, APOPTOSIS, V19, P414, DOI 10.1007/s10495-013-0930-7; Hershey T, 2010, DIABETES, V59, P236, DOI 10.2337/db09-1117; Holt Paula, 2011, Br J Community Nurs, V16, P246; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Isacson R, 2011, EUR J PHARMACOL, V650, P249, DOI 10.1016/j.ejphar.2010.10.008; Jang BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076466; Jauch-Chara K, 2014, NEUROSCIENCE, V283, P202, DOI 10.1016/j.neuroscience.2014.04.059; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Lee CW, 2013, CURR ALZHEIMER RES, V10, P298, DOI 10.2174/1567205011310030009; Lee DA, 2012, INT J DEV NEUROSCI, V30, P615, DOI 10.1016/j.ijdevneu.2012.07.003; Leyton J, 1998, CANCER LETT, V125, P131, DOI 10.1016/S0304-3835(97)00525-9; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lindvall O, 2011, STROKE, V42, P2369, DOI 10.1161/STROKEAHA.110.599654; Mansouri S, 2013, J NEUROCHEM, V127, P209, DOI 10.1111/jnc.12396; Mansouri S, 2012, J NEUROSCI RES, V90, P759, DOI 10.1002/jnr.22803; Mansouri Shiva D V, 2014, J DIABETES METABOLIS, V5; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McNay EC, 2010, PHYSIOL BEHAV, V100, P234, DOI 10.1016/j.physbeh.2010.01.004; Mercer A, 2004, J NEUROSCI RES, V76, P205, DOI 10.1002/jnr.20038; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Monnier L, 2009, DIABETES-METAB RES, V25, P393, DOI 10.1002/dmrr.962; Ogata K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120526; Ohta S, 2006, J NEUROSCI RES, V84, P1177, DOI 10.1002/jnr.21026; Ortsater H, 2007, MOL CELL ENDOCRINOL, V277, P1, DOI 10.1016/j.mce.2007.06.006; Persson K, 2002, ACTA PHYSIOL SCAND, V175, P25, DOI 10.1046/j.1365-201X.2002.00977.x; Punthakee Z, 2012, DIABETES CARE, V35, P787, DOI 10.2337/dc11-1855; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Rosenstock J, 2014, DIABETES CARE, V37, P2317, DOI 10.2337/dc14-0001; Ruan LH, 2014, PROG NEUROBIOL, V115, P116, DOI 10.1016/j.pneurobio.2013.12.006; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sander D, 2009, J NEUROL, V256, P1603, DOI 10.1007/s00415-009-5143-1; Snell-Bergeon JK, 2012, DIABETES TECHNOL THE, V14, pS51, DOI 10.1089/dia.2012.0031; Soares MBP, 1998, J IMMUNOL, V160, P1811; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2005, DIABETES, V54, P500, DOI 10.2337/diabetes.54.2.500; Suh SW, 2003, J NEUROSCI, V23, P10681; Tong L, 1998, J NEURAL TRANSM, V105, P905, DOI 10.1007/s007020050101; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Watson GS, 2004, EUR J PHARMACOL, V490, P97, DOI 10.1016/j.ejphar.2004.02.048; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865; Xu YY, 2011, BRAIN RES, V1375, P49, DOI 10.1016/j.brainres.2010.12.029; Yamada KA, 2004, PEDIATR RES, V55, P372, DOI 10.1203/01.PDR.0000110523.07240.C1; Yang Y.J., 2013, ABSTR APPL ANAL, V2013, P7, DOI DOI 10.1016/J.NEUR0SCIENCE.2013.07.009	72	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156867	10.1371/journal.pone.0156867	http://dx.doi.org/10.1371/journal.pone.0156867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305000	Green Submitted, gold, Green Published			2022-12-27	WOS:000377824800028
J	Zhang, XS; Liu, SS; Li, YK; Wang, Y; Tian, MM; Liu, GQ				Zhang, Xuesong; Liu, Sisi; Li, Yukun; Wang, Yan; Tian, Meimei; Liu, Guoqiang			Long-Term Effectiveness and Cost-Effectiveness of Metformin Combined with Liraglutide or Exenatide for Type 2 Diabetes Mellitus Based on the CORE Diabetes Model Study	PLOS ONE			English	Article							BIPHASIC INSULIN ASPART; SOUTH-KOREA; CHINA; GLIMEPIRIDE; GLARGINE; GLUCOSE; TRIAL; INDIA	Background Type 2 diabetes mellitus (T2DM) is associated with beta cell impairment. Agonists of the glucagon-like peptide 1 (GLP-1) receptor (such as liraglutide and exenatide) can increase the number of pancreatic beta cells and improve cell function. These drugs contribute to the longterm control of T2DM. Objective To evaluate the cost-effectiveness of metformin combined with liraglutide or exenatide in Chinese patient with T2DM. Methods Patients with T2DM from the Third Hospital of Hebei Medical University were treated with oral metformin combined with liraglutide (0.6 mg/day, could be increased by 0.6 mg weekly until 1.2 or 1.8 mg) or exenatide (5 mu g bid for four weeks, increased to 10 mu g bid). The computer simulation model CORE was used to calculate the 30-year expected life expectancy, quality-adjusted life years (QALY), direct costs, HbA1c levels, body mass index (BMI), and the incidence of cardiovascular, renal, and ocular complications of T2DM. Patients were followed up for 52 weeks. Medication costs were calculated according to retail prices in China. A 3% annual discount was adopted in this study. Results The 30-year simulation showed that the total direct medical costs were lower using liraglutide compared to exenatide by 2130 RMB/QALY yearly, while the expected life expectancy and QALY were increased by 0.471 years and 0.388, respectively, using liraglutide with an incremental cost-effectiveness of -11,550 RMB/QALYs. Conclusion Liraglutide 1.2 mg/day was superior to exenatide 10 mu g bid with respect to cost-effectiveness in Chinese patients with T2DM.	[Zhang, Xuesong] Hebei Med Univ, Hosp 3, CT Dept, Shijiazhuang, Peoples R China; [Liu, Sisi; Liu, Guoqiang] Hebei Med Univ, Hosp 3, Dept Pharm, Shijiazhuang, Peoples R China; [Li, Yukun; Wang, Yan; Tian, Meimei] Hebei Med Univ, Hosp 3, Dept Endocrinol 2, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Liu, GQ (corresponding author), Hebei Med Univ, Hosp 3, Dept Pharm, Shijiazhuang, Peoples R China.	liugq15@163.com			Key Research Project of Hebei Province Health and Family Planning Commission [ZL20140178]	Key Research Project of Hebei Province Health and Family Planning Commission	The study was supported by Key Research Project of Hebei Province Health and Family Planning Commission (No. ZL20140178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by Key Research Project of Hebei Province Health and Family Planning Commission (No. ZL20140178). The authors appreciate all the investigators and their staff for participation in this study. The authors declare no conflict of interest.	American Diabetes Association, 2015, Clin Diabetes, V33, P97, DOI 10.2337/diaclin.33.2.97; [Anonymous], 2015, DIABETES CARE, V38, pS4, DOI 10.2337/dc15-S003; Bashier AMK, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0178-6; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; DeKoven M, 2014, ADV THER, V31, P202, DOI 10.1007/s12325-014-0098-8; Edwards CMB, 1999, DIABETES, V48, P86, DOI 10.2337/diabetes.48.1.86; Gao L, 2012, INT J TECHNOL ASSESS, V28, P436, DOI 10.1017/S0266462312000608; Gonzalez C, 2006, EXPERT OPIN INV DRUG, V15, P887, DOI 10.1517/13543784.15.8.887; Gupta V, 2015, J MED ECON, V18, P263, DOI 10.3111/13696998.2014.991791; Health. I, 2013, IMS CORE DIAB MOD US; Ingwersen SH, 2015, DIABETES RES CLIN PR, V108, P113, DOI 10.1016/j.diabres.2015.01.001; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Li HQ, 2015, J PHARMACOL SCI, V127, P170, DOI 10.1016/j.jphs.2014.12.004; McDonell AL, 2015, CLINICOECONOMIC OUTC, V7, P95, DOI 10.2147/CEOR.S69981; Palmer AJ, 2004, CURR MED RES OPIN, V20, pS5, DOI 10.1185/030079904X1980; Palmer AJ, 2004, CURR MED RES OPIN, V20, pS27, DOI 10.1185/030079904X2006; Palmer JL, 2008, ADV THER, V25, P752, DOI 10.1007/s12325-008-0080-4; Permsuwan U, 2016, APPL HEALTH ECON HEA, V14, P281, DOI 10.1007/s40258-016-0228-3; Qian L, 2009, DIABETES-METAB RES, V25, P144, DOI 10.1002/dmrr.922; Roussel R, 2015, J MED ECON, P1; Tzanetakos C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-419; Wang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121915; Wy Y., 2011, CHINESE J DIABETES C; Yang L, 2012, VALUE HEALTH, V15, pS56, DOI 10.1016/j.jval.2011.11.018; Yang W, 2011, DIABETES OBES METAB, V13, P81, DOI 10.1111/j.1463-1326.2010.01323.x; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zueger PM, 2014, PHARMACOECONOMICS, V32, P1079, DOI 10.1007/s40273-014-0192-4	28	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156393	10.1371/journal.pone.0156393	http://dx.doi.org/10.1371/journal.pone.0156393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304904	gold, Green Published			2022-12-27	WOS:000377824800015
J	Roberts, GC; Morris, PG; Moss, MA; Maltby, SL; Palmer, CA; Nash, CE; Smart, E; Holliday, DL; Speirs, V				Roberts, Grace C.; Morris, Paul G.; Moss, Marcus A.; Maltby, Sarah L.; Palmer, Chelsea A.; Nash, Claire E.; Smart, Emily; Holliday, Deborah L.; Speirs, Valerie			An Evaluation of Matrix-Containing and Humanised Matrix-Free 3-Dimensional Cell Culture Systems for Studying Breast Cancer	PLOS ONE			English	Article							IN-VITRO MODEL; FRAGMENTATION; MORPHOGENESIS; EXPRESSION; CASPASE-3; ADHESION; INVASION; INDUCE; TISSUE; ASSAYS	Background 3D cell cultures are emerging as more physiologically meaningful alternatives to monolayer cultures for many biological applications. They are attractive because they more closely mimic in vivo morphology, especially when co-cultured with stromal fibroblasts. Methodology/Principal Findings We compared the efficacy of 3 different 3D cell culture systems; collagen I, low attachment culture vessels and a modification of Fibrolife (R), a specialised humanised cell culture medium devoid of animal-derived components, using breast cancer cell lines representative of the different molecular subtypes of breast cancer, cultured alone or with human mammary fibroblasts with a view to developing matrix-free humanised systems. 3D collagen I culture supported the growth of a range of breast cancer cell lines. By modifying the composition of Fibrolife (R) to epiFL, matrix-free cell culture was possible. During sequential transfer to epiFL breast cancer cells gradually detached from the flask, growing progressively as spheroids. Phenotype was stable and reversible with cells remaining actively proliferating and easily accessible throughout culture. They could also be revived from frozen stocks. To achieve co-culture with fibroblasts in epiFL required use of low attachment culture vessels instead of standard plastic as fibroblasts remained adherent in epiFL. Here, cancer cell spheroids were allowed to form before adding fibroblasts. Immunohistochemical examination showed fibroblasts scattered throughout the epithelial spheroid, not dissimilar to the relationship of tumour stroma in human breast cancer. Conclusions Because of its ease of handling, matrix-free 3D cell culture may be a useful model to study the influence of fibroblasts on breast cancer epithelial cells with use of epiFL culture medium taking this a step further towards a fully humanised 3D model. This methodology could be applied to other types of cancer cell lines, making this a versatile technique for cancer researchers wishing to use in vitro systems that better reflect cancer in vivo.	[Roberts, Grace C.; Morris, Paul G.; Moss, Marcus A.; Maltby, Sarah L.; Palmer, Chelsea A.; Nash, Claire E.; Smart, Emily; Holliday, Deborah L.; Speirs, Valerie] Univ Leeds, Leeds Inst Canc & Pathol, Wellcome Trust Brenner Bldg, Leeds LS9 7TF, W Yorkshire, England	University of Leeds	Speirs, V (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Wellcome Trust Brenner Bldg, Leeds LS9 7TF, W Yorkshire, England.	v.speirs@leeds.ac.uk	Speirs, Valerie/ABE-7377-2021	Speirs, Valerie/0000-0002-0602-4666; Roberts, Grace Charlotte/0000-0003-4687-6940; Morris, Paul George/0000-0002-4554-2132	Breast Cancer Now [2008NovPr04]; Lord Dowding Fund; Pathological Society of Great Britain Ireland [PHD2011/13]; CRUK [C16708/A18080]; Dr Hadwen Trust	Breast Cancer Now; Lord Dowding Fund; Pathological Society of Great Britain Ireland; CRUK(Cancer Research UK); Dr Hadwen Trust	This work was supported by Breast Cancer Now (formerly Breast Cancer Campaign; http://breastcancernow.org/) Grant number 2008NovPr04; Lord Dowding Fund (http://www.ldf.org.uk/) No specific grant number; Pathological Society of Great Britain & Ireland (http://www.pathsoc.org/) Grant number PHD2011/13; CRUK (http://www.cancerresearchuk.org/) Grant number C16708/A18080; Dr Hadwen Trust (GB) (http://www.drhadwentrust.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, NATURE, V424, P861, DOI 10.1038/424861b; Bissell MJ, 2003, BREAST CANCER RES, V5, P117, DOI 10.1186/bcr579; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Guzman A, 2014, BIOMATERIALS, V35, P6954, DOI 10.1016/j.biomaterials.2014.04.086; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Holliday DL, 2010, ATLA-ALTERN LAB ANIM, V38, P41, DOI 10.1177/026119291003801S13; Holliday DL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2218; Ivascu A, 2007, INT J ONCOL, V31, P1403; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kagawa S, 2001, CLIN CANCER RES, V7, P1474; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; Kundu B, 2013, BIOMATERIALS, V34, P9462, DOI 10.1016/j.biomaterials.2013.08.047; Leeper AD, 2012, BIOMATERIALS, V33, P907, DOI 10.1016/j.biomaterials.2011.10.028; Li LY, 2011, J CANCER, V2, P458, DOI 10.7150/jca.2.458; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; Lovitt CJ, 2015, J CANCER RES CLIN, V141, P951, DOI 10.1007/s00432-015-1950-1; Mueller-Klieser W, 2000, CRIT REV ONCOL HEMAT, V36, P123, DOI 10.1016/S1040-8428(00)00082-2; Nash CE, 2015, DEV CHARACTERISATION; Nash CE, 2015, ONCOTARGET, V6, P13731, DOI 10.18632/oncotarget.3803; Offterdinger M, 2003, J CELL PHYSIOL, V195, P260, DOI 10.1002/jcp.10237; Olsen CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-444; Pervez Shahid, 2007, J Med Case Rep, V1, P83, DOI 10.1186/1752-1947-1-83; Pilling D, 2009, J IMMUNOL METHODS, V351, P62, DOI 10.1016/j.jim.2009.09.011; Pinto MP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-735; Russ A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047734; Simpkins SA, 2012, J PATHOL, V227, P490, DOI 10.1002/path.4034; Sommers CL, 1996, J MAMMARY GLAND BIOL, V1, P219, DOI 10.1007/BF02013645; Speirs V, 1998, BRIT J CANCER, V78, P1421, DOI 10.1038/bjc.1998.702; Stuelten CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060919; Tekkatte C, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/504723; Vaillant F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2851; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wang XL, 2010, BIOMATERIALS, V31, P3920, DOI 10.1016/j.biomaterials.2010.01.118; Weigelt B, 2014, ADV DRUG DELIVER REV, V69, P42, DOI 10.1016/j.addr.2014.01.001; Wu YH, 2011, BREAST CANCER RES TR, V127, P397, DOI 10.1007/s10549-010-1013-x	43	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157004	10.1371/journal.pone.0157004	http://dx.doi.org/10.1371/journal.pone.0157004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300768	Green Submitted, gold, Green Published			2022-12-27	WOS:000377822200023
J	Yang, SK; Yang, Q; Xu, XY; Lu, D; Li, DQ				Yang Shunkun; Yang Qian; Xu Xiaoyun; Lu Dan; Li Daqing			Observability Transitions in Networks with Betweenness Preference	PLOS ONE			English	Article							OPTIMAL PMU PLACEMENT; GENETIC ALGORITHM	A network is considered observable if its current state can be determined in finite time from knowledge of the observed states. The observability transitions in networks based on random or degree-correlated sensor placement have recently been studied. However, these placement strategies are predominantly based on local information regarding the network. In this paper, to understand the phase transition process of network observability, we analyze the network observability transition for a betweenness-based sensor placement strategy, in which sensors are placed on nodes according to their betweenness. Using numerical simulations, we compute the size of the network's largest observable component (LOC) and compare the observability transitions for different sensor placements. We find that betweenness-based sensor placement can generate a larger LOC in the observability transition than the random or degree-based placement strategy in both model and real networks. This finding may help to understand the relationship between network observability and the topological properties of the network.	[Yang Shunkun; Yang Qian; Xu Xiaoyun; Lu Dan; Li Daqing] Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China; [Xu Xiaoyun; Li Daqing] Sci & Technol Reliabil & Environm Engn Lab, Beijing, Peoples R China	Beihang University	Xu, XY; Li, DQ (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China.; Xu, XY; Li, DQ (corresponding author), Sci & Technol Reliabil & Environm Engn Lab, Beijing, Peoples R China.	xuxiaoyun0216@gmail.com; daqingl@buaa.edu.cn						Alinejad-Beromi Y, 2008, 2008 PROCEEDINGS OF THE 43RD INTERNATIONAL UNIVERSITIES POWER ENGINEERING CONFERENCE, VOLS 1-3, P589; BALDWIN TL, 1993, IEEE T POWER SYST, V8, P707, DOI 10.1109/59.260810; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V., 2006, PAJEK DATASETS; del Valle Y, 2008, IEEE T EVOLUT COMPUT, V12, P171, DOI 10.1109/TEVC.2007.896686; El-Zonkoly A, 2006, EXPERT SYST APPL, V31, P193, DOI 10.1016/j.eswa.2005.09.016; Hasegawa T, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042809; Havlin S, 2010, COMPLEX NETWORKS STR; Li DQ, 2015, P NATL ACAD SCI USA, V112, P669, DOI 10.1073/pnas.1419185112; Li DQ, 2014, NAT SCI REP, V4, P5381; Milosevic B, 2003, IEEE T POWER SYST, V18, P69, DOI 10.1109/TPWRS.2002.807064; MONTICELLI A, 1985, IEEE T POWER AP SYST, V104, P1035, DOI 10.1109/TPAS.1985.323453; Morone F, 2015, NATURE, V524, P65, DOI 10.1038/nature14604; Peng JN, 2006, INT J ELEC POWER, V28, P223, DOI 10.1016/j.ijepes.2005.05.005; Phadke AG, 2008, POWER ELECTRON POWER, P3, DOI 10.1007/978-0-387-76537-2_1; Rakpenthai C, 2007, IEEE T POWER DELIVER, V22, P101, DOI 10.1109/TPWRD.2006.881425; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.258701	18	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156764	10.1371/journal.pone.0156764	http://dx.doi.org/10.1371/journal.pone.0156764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299338	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200014
J	Gullberg, M; Lohse, L; Botner, A; McInerney, GM; Burman, A; Jackson, T; Polacek, C; Belsham, GJ				Gullberg, Maria; Lohse, Louise; Botner, Anette; McInerney, Gerald M.; Burman, Alison; Jackson, Terry; Polacek, Charlotta; Belsham, Graham J.			A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; EXPRESSION SYSTEM; IMPROVED VACCINES; MAMMALIAN-CELLS; FMD VACCINES; PROTEIN; RNA; REPLICATION; CHALLENGE; ALPHA-V-BETA-6	Foot-and-mouth disease (FMD) remains one of the most economically important infectious diseases of production animals globally. Vaccination can successfully control this disease, however, current vaccines are imperfect. They are made using chemically inactivated FMD virus (FMDV) that is produced in large-scale mammalian cell culture under high containment conditions. Here, we have expressed the FMDV capsid protein precursor (P1-2A) of strain O1 Manisa alone or with the FMDV 3C protease (3C(pro)) using a "single cycle" packaged alphavirus self-replicating RNA based on Semliki Forest virus (SFV). When the FMDV P1-2A was expressed with 3C(pro) then processing of the FMDV capsid precursor protein is observed within cells and the proteins assemble into empty capsid particles. The products interact with anti-FMDV antibodies in an ELISA and bind to the integrin alpha(v)beta(6) (a cellular receptor for FMDV). In cattle vaccinated with these rSFV-FMDV vectors alone, anti-FMDV antibodies were elicited but the immune response was insufficient to give protection against FMDV challenge. However, the prior vaccination with these vectors resulted in a much stronger immune response against FMDV post-challenge and the viremia observed was decreased in level and duration. In subsequent experiments, cattle were sequentially vaccinated with a rSFV-FMDV followed by recombinant FMDV empty capsid particles, or vice versa, prior to challenge. Animals given a primary vaccination with the rSFV-FMDV vector and then boosted with FMDV empty capsids showed a strong anti-FMDV antibody response prior to challenge, they were protected against disease and no FMDV RNA was detected in their sera post-challenge. Initial inoculation with empty capsids followed by the rSFV-FMDV was much less effective at combating the FMDV challenge and a large post-challenge boost to the level of anti-FMDV antibodies was observed. This prime-boost system, using reagents that can be generated outside of high-containment facilities, offers significant advantages to achieve control of FMD by vaccination.	[Gullberg, Maria; Lohse, Louise; Botner, Anette; Polacek, Charlotta; Belsham, Graham J.] Tech Univ Denmark, DTU Natl Vet Inst, Lindholm, Kalvehave, Denmark; [McInerney, Gerald M.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Burman, Alison; Jackson, Terry] Pirbright, Pirbright Inst, Woking, Surrey, England	Technical University of Denmark; Karolinska Institutet; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Belsham, GJ (corresponding author), Tech Univ Denmark, DTU Natl Vet Inst, Lindholm, Kalvehave, Denmark.	grbe@vet.dtu.dk	Belsham, Graham J./H-8589-2019; Belsham, Graham/J-3132-2019; McInerney, Gerald/G-5344-2012; Ibrahim, Essam Hassan/G-1960-2018	Belsham, Graham J./0000-0003-1187-4873; Belsham, Graham/0000-0003-1187-4873; McInerney, Gerald/0000-0003-2257-7241; Ibrahim, Essam Hassan/0000-0003-0130-2257; Polacek, Charlotta/0000-0003-0297-5672; Lohse, Louise/0000-0002-6769-5447	Danish Council for Independent Research \ Technology and Production Sciences (FTP grant) [09-070549]; plus Defra (UK) [SE1127]; DTU National Veterinary Institute	Danish Council for Independent Research \ Technology and Production Sciences (FTP grant); plus Defra (UK); DTU National Veterinary Institute	This work was supported by the Danish Council for Independent Research vertical bar Technology and Production Sciences (FTP grant 09-070549) to CP and GJB, plus Defra (UK) project number SE1127 to TJ and internal funding from DTU National Veterinary Institute to GJB.	ABRAMS CC, 1995, J GEN VIROL, V76, P3089, DOI 10.1099/0022-1317-76-12-3089; ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0; ANSARDI DC, 1992, J VIROL, V66, P4556, DOI 10.1128/JVI.66.7.4556-4563.1992; Balinda SN, 2009, TRANSBOUND EMERG DIS, V56, P362, DOI 10.1111/j.1865-1682.2009.01094.x; Barnett PV, 2002, VACCINE, V20, P1505, DOI 10.1016/S0264-410X(01)00503-5; Belsham GJ, 2005, CURR TOP MICROBIOL, V288, P43; Belsham GJ, 2000, J VIROL, V74, P272, DOI 10.1128/JVI.74.1.272-280.2000; Belsham GJ, 2015, VIRUS ADAPTATION TRE, V7, P1; Botner A, 2011, J GEN VIROL, V92, P1141, DOI 10.1099/vir.0.029710-0; Caridi F, 2015, J VIROL, V89, P5633, DOI 10.1128/JVI.03358-14; CHOW M, 1987, NATURE, V327, P482, DOI 10.1038/327482a0; Defra, 2004, AN HLTH WELF FMD DAT; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; DONALDSON AI, 1989, RES VET SCI, V46, P9, DOI 10.1016/S0034-5288(18)31109-3; Ellard FM, 1999, J GEN VIROL, V80, P1911, DOI 10.1099/0022-1317-80-8-1911; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gullberg M, 2013, J VIROL, V87, P11591, DOI 10.1128/JVI.01863-13; Gullberg M, 2013, J GEN VIROL, V94, P1769, DOI 10.1099/vir.0.054122-0; Jackson T, 2000, J VIROL, V74, P4949, DOI 10.1128/JVI.74.11.4949-4956.2000; Karlsson GB, 2003, METH MOLEC MED, V87, P69; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Kotecha A, 2015, NAT STRUCT MOL BIOL, V22, P788, DOI 10.1038/nsmb.3096; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Mateo R, 2008, J VIROL, V82, P12232, DOI 10.1128/JVI.01553-08; Mayr GA, 2001, VACCINE, V19, P2152, DOI 10.1016/S0264-410X(00)00384-4; Monaghan P, 2005, J GEN VIROL, V86, P2769, DOI 10.1099/vir.0.81172-0; Moraes MP, 2011, VACCINE, V29, P9431, DOI 10.1016/j.vaccine.2011.10.037; Moraes MP, 2002, VACCINE, V20, P1631, DOI 10.1016/S0264-410X(01)00483-2; Nayak A, 2006, J VIROL, V80, P9865, DOI 10.1128/JVI.00561-06; OIE, 2012, FOOT AND MOUTH DIS M; Polacek C, 2013, J GEN VIROL, V94, P1249, DOI 10.1099/vir.0.050492-0; Porta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003255; Porta C, 2013, J VIROL METHODS, V187, P406, DOI 10.1016/j.jviromet.2012.11.011; Reid SM, 2002, J VIROL METHODS, V105, P67, DOI 10.1016/S0166-0934(02)00081-2; Rincon V, 2014, STRUCTURE, V22, P1560, DOI 10.1016/j.str.2014.08.019; Rodriguez LL, 2009, VACCINE, V27, pD90, DOI 10.1016/j.vaccine.2009.08.039; ROEDER PL, 1987, RES VET SCI, V43, P225, DOI 10.1016/S0034-5288(18)30778-1; RWEYEMAMU MM, 1979, ARCH VIROL, V59, P69, DOI 10.1007/BF01317896; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Smerdou C, 1999, J VIROL, V73, P1092, DOI 10.1128/JVI.73.2.1092-1098.1999; Stenfeldt C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-66; Sweeney TR, 2007, J VIROL, V81, P115, DOI 10.1128/JVI.01587-06	42	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157435	10.1371/journal.pone.0157435	http://dx.doi.org/10.1371/journal.pone.0157435			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294397	Green Submitted, gold, Green Published			2022-12-27	WOS:000377821300045
J	Blaha, I; Recio, P; Martinez, MP; Lopez-Oliva, ME; Ribeiro, ASF; Agis-Torres, A; Martinez, AC; Benedito, S; Garcia-Sacristan, A; Fernandes, VS; Hernandez, M				Blaha, Igor; Recio, Paz; Pilar Martinez, Maria; Elvira Lopez-Oliva, Maria; Ribeiro, Ana S. F.; Agis-Torres, Angel; Cristina Martinez, Ana; Benedito, Sara; Garcia-Sacristan, Albino; Fernandes, Vitor S.; Hernandez, Medardo			Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors	PLOS ONE			English	Article							METABOLIC SYNDROME; OXIDATIVE STRESS; TRACT SYMPTOMS; DIABETIC-RATS; DYSFUNCTION; OVERACTIVITY; NERVE; MOUSE; EXPRESSION; AGONISTS	Metabolic syndrome (MS) is a known risk factor for lower urinary tract symptoms. This study investigates whether functional and expression changes of cannabinoid CB1 and CB2 receptors are involved in the bladder dysfunction in an obese rat model with insulin resistance. Bladder samples from obese Zucker rat (OZR) and their respective controls lean Zucker rat (LZR) were processed for immunohistochemistry and western blot for studying the cannabinoid receptors expression. Detrusor smooth muscle (DSM) strips from LZR and OZR were also mounted in myographs for isometric force recordings. Neuronal and smooth muscle CB1 and CB2 receptor expression and the nerve fiber density was diminished in the OZR bladder. Electrical field stimulation (EFS) and acetylcholine (ACh) induced frequency-and concentration-dependent contractions of LZR and OZR DSM. ACh contractile responses were similar in LZR and OZR. EFS-elicited contractions, however, were reduced in OZR bladder. Cannabinoid receptor agonists and antagonists failed to modify the DSM basal tension in LZR and OZR In LZR bladder, EFS responses were inhibited by ACEA and SER-601, CB1 and CB2 receptor agonists, respectively, these effects being reversed by ACEA plus the CB1 antagonist, AM-251 or SER-601 plus the CB2 antagonist, AM-630. In OZR bladder, the inhibitory action of ACEA on nerve-evoked contractions was diminished, whereas that SER-601 did not change EFS responses. These results suggest that a diminished function and expression of neuronal cannabinoid CB1 and CB2 receptors, as well as a lower nerve fiber density is involved in the impaired excitatory neurotransmission of the urinary bladder from the OZR.	[Blaha, Igor] Hosp Gen Univ Gregorio Maranon, Dept Urol, Madrid 28007, Spain; [Recio, Paz; Elvira Lopez-Oliva, Maria; Ribeiro, Ana S. F.; Agis-Torres, Angel; Cristina Martinez, Ana; Benedito, Sara; Garcia-Sacristan, Albino; Fernandes, Vitor S.; Hernandez, Medardo] Univ Complutense Madrid, Fac Farm, Dept Fisiol, E-28040 Madrid, Spain; [Pilar Martinez, Maria] Univ Complutense Madrid, Fac Vet, Dept Anat & Anat Patol Comparadas, E-28040 Madrid, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; Complutense University of Madrid	Hernandez, M (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Fisiol, E-28040 Madrid, Spain.	medardo@ucm.es	López-Oliva, Elvira ELO/L-1660-2014; Pilar Martinez, P Martinez/E-8591-2016; Ribeiro, Ana Sofia F/F-3428-2013; Martinez, Ana Cristina/H-9795-2015; Fernandes, Vitor Samuel/F-3437-2013; BENEDITO, SARA/H-9730-2015	López-Oliva, Elvira ELO/0000-0002-0615-9149; Pilar Martinez, P Martinez/0000-0001-9063-3191; Ribeiro, Ana Sofia F/0000-0003-3913-7859; Martinez, Ana Cristina/0000-0002-2829-0914; Fernandes, Vitor Samuel/0000-0001-6060-9035; AGIS TORRES, ANGEL/0000-0002-3548-7264; BENEDITO, SARA/0000-0001-9660-2409				Aizawa N, 2014, J UROLOGY, V192, P956, DOI 10.1016/j.juro.2014.04.008; Azadzoi KM, 2003, J UROLOGY, V169, P1885, DOI 10.1097/01.ju.0000048668.97821.f4; Bakali E, 2016, INT UROGYNECOL J, V27, P129, DOI 10.1007/s00192-015-2802-x; Bozkurt TE, 2016, EUR J PHARMACOL, V776, P132, DOI 10.1016/j.ejphar.2016.02.045; Changolkar AK, 2005, J UROLOGY, V173, P309, DOI 10.1097/01.ju.0000141583.31183.7a; Chung SD, 2013, EUR J NUTR, V52, P347, DOI 10.1007/s00394-012-0342-4; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fullhase C, 2014, BJU INT, V113, P144, DOI 10.1111/bju.12350; Gasbarro G, 2010, AM J PHYSIOL-RENAL, V298, pF72, DOI 10.1152/ajprenal.00309.2009; Gratzke C, 2010, EUR UROL, V57, P1093, DOI 10.1016/j.eururo.2010.02.027; Gratzke C, 2009, J UROLOGY, V181, P1939, DOI 10.1016/j.juro.2008.11.079; GuerreMillo M, 1997, BIOMED PHARMACOTHER, V51, P318, DOI 10.1016/S0753-3322(97)88048-1; Hedlund P, 2014, NEUROUROL URODYNAM, V33, P46, DOI 10.1002/nau.22442; Huang YC, 2010, J UROLOGY, V183, P1232, DOI 10.1016/j.juro.2009.11.012; Irwin DE, 2010, EUR UROL, V58, P532, DOI 10.1016/j.eururo.2010.06.007; Izzo AA, 2015, HANDB EXP PHARMACOL, V231, P423, DOI 10.1007/978-3-319-20825-1_15; Juan YS, 2009, INT UROL NEPHROL, V41, P513, DOI 10.1007/s11255-008-9492-y; Kendig DM, 2016, AM J PHYSIOL-RENAL, V310, pF909, DOI 10.1152/ajprenal.00511.2015; Kupelian V, 2009, J UROLOGY, V182, P616, DOI 10.1016/j.juro.2009.04.025; Lee WC, 2008, J UROLOGY, V179, P2470, DOI 10.1016/j.juro.2008.01.086; Lee WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045578; Lee WC, 2011, J UROLOGY, V186, P318, DOI 10.1016/j.juro.2011.03.037; Liu GM, 2008, NEUROUROL URODYNAM, V27, P429, DOI 10.1002/nau.20543; Marini P, 2013, BRIT J PHARMACOL, V169, P887, DOI 10.1111/bph.12191; Martin RS, 2000, BRIT J PHARMACOL, V129, P1707, DOI 10.1038/sj.bjp.0703229; Nobe K, 2008, J PHARMACOL EXP THER, V324, P631, DOI 10.1124/jpet.107.131334; Park HK, 2008, UROLOGY, V72, P556, DOI 10.1016/j.urology.2008.03.043; Pasquini S, 2008, J MED CHEM, V51, P5075, DOI 10.1021/jm800552f; Shen GX, 2010, CAN J PHYSIOL PHARM, V88, P241, DOI 10.1139/Y10-018; Shenfeld OZ, 2005, UROLOGY, V65, P181, DOI 10.1016/j.urology.2004.08.055; Tai HC, 2010, J CLIN ENDOCR METAB, V95, P1143, DOI 10.1210/jc.2009-1492; Tong YC, 2007, J UROLOGY, V178, P1537, DOI 10.1016/j.juro.2007.05.114; Torimoto K, 2004, J UROLOGY, V171, P1959, DOI 10.1097/01.ju.0000121283.92963.05; Tyagi V, 2009, J UROLOGY, V181, P1932, DOI 10.1016/j.juro.2008.11.078	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157424	10.1371/journal.pone.0157424	http://dx.doi.org/10.1371/journal.pone.0157424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285468	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000066
J	Ali, N; Bajwa, KB; Sablatnig, R; Chatzichristofis, SA; Iqbal, Z; Rashid, M; Habib, HA				Ali, Nouman; Bajwa, Khalid Bashir; Sablatnig, Robert; Chatzichristofis, Savvas A.; Iqbal, Zeshan; Rashid, Muhammad; Habib, Hafiz Adnan			A Novel Image Retrieval Based on Visual Words Integration of SIFT and SURF	PLOS ONE			English	Article							FEATURES; COLOR; REPRESENTATION; DETECTORS; SHAPE	With the recent evolution of technology, the number of image archives has increased exponentially. In Content-Based Image Retrieval (CBIR), high-level visual information is represented in the form of low-level features. The semantic gap between the low-level features and the high-level image concepts is an open research problem. In this paper, we present a novel visual words integration of Scale Invariant Feature Transform (SIFT) and Speeded-Up Robust Features (SURF). The two local features representations are selected for image retrieval because SIFT is more robust to the change in scale and rotation, while SURF is robust to changes in illumination. The visual words integration of SIFT and SURF adds the robustness of both features to image retrieval. The qualitative and quantitative comparisons conducted on Corel-1000, Corel-1500, Corel-2000, Oliva and Torralba and Ground Truth image benchmarks demonstrate the effectiveness of the proposed visual words integration.	[Ali, Nouman; Bajwa, Khalid Bashir; Iqbal, Zeshan; Habib, Hafiz Adnan] Univ Engn & Technol, Fac Telecommun & Informat Engn, Taxila, Pakistan; [Ali, Nouman; Sablatnig, Robert] Vienna Univ Technol, Comp Vis Lab, Inst Comp Aided Automat, A-1040 Vienna, Austria; [Chatzichristofis, Savvas A.] Democritus Univ Thrace, Dept Elect & Comp Engn, GR-67100 Xanthi, Greece; [Rashid, Muhammad] Umm Al Qura Univ, Dept Comp Engn, Mecca, Saudi Arabia	University of Engineering & Technology Taxila; Technische Universitat Wien; Democritus University of Thrace; Umm Al Qura University	Ali, N (corresponding author), Univ Engn & Technol, Fac Telecommun & Informat Engn, Taxila, Pakistan.; Ali, N (corresponding author), Vienna Univ Technol, Comp Vis Lab, Inst Comp Aided Automat, A-1040 Vienna, Austria.	nali@caa.tuwien.ac.at	Chatzichristofis, Savvas/AAA-2698-2020; Ali, Nouman/X-7462-2019; Iqbal, Zeshan/A-1166-2010; Rashid, Muhammad/H-3480-2018; Sablatnig, Robert/AAV-1518-2020	Chatzichristofis, Savvas/0000-0002-4657-4435; Ali, Nouman/0000-0002-0721-201X; Iqbal, Zeshan/0000-0003-4545-4092; Rashid, Muhammad/0000-0001-5852-1296; Sablatnig, Robert/0000-0003-4195-1593	Higher Education Commission (HEC) Pakistan [IRSIP 28 ENGG 03]	Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan)	The authors would like to thank Higher Education Commission (HEC) Pakistan for a fellowship grant (PIN No. IRSIP 28 ENGG 03 sanctioned in favor of Nouman Ali) for performing the research work at Institute of Computer Aided Automation, Computer Vision Lab, Technical University Vienna, Austria.	Ali N, 2016, COMPUTERS ELECTRICAL; Alzu'bi A, 2015, J VIS COMMUN IMAGE R, V32, P20, DOI 10.1016/j.jvcir.2015.07.012; Andrews S., 2002, ADV NEURAL INFORM PR, V15, P561; Anwar H, 2015, MACH VISION APPL, V26, P295, DOI 10.1007/s00138-015-0665-2; Anwar H, 2014, LECT NOTES COMPUT SC, V8753, P443, DOI 10.1007/978-3-319-11752-2_36; Arampatzis A, 2013, INFORM PROCESS MANAG, V49, P274, DOI 10.1016/j.ipm.2012.03.005; Bampis L, 2015, J SUPERCOMPUT, V71, P909, DOI 10.1007/s11227-014-1343-2; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Cardoso DNM, 2013, J CLERK MAXWELL A TR, V2, P68; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chatzichristofis SA, 2008, LECT NOTES COMPUT SC, V5008, P312; Chatzichristofis SA, 2013, IEEE T CYBERNETICS, V43, P192, DOI 10.1109/TSMCB.2012.2203300; Chuanqian W, 2013, INTEGRATED UNCERTAIN, P91, DOI DOI 10.1007/978-3-642-39515-4_8; Csurka G., 2004, WORKSHOP STAT LEARNI, P1, DOI DOI 10.1234/12345678; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Das R, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1515-4; Datta R, 2008, ACM COMPUT SURV, V40, DOI 10.1145/1348246.1348248; Gil A, 2010, MACH VISION APPL, V21, P905, DOI 10.1007/s00138-009-0195-x; Guo JM, 2015, IEEE T MULTIMEDIA, V17, P1576, DOI 10.1109/TMM.2015.2449234; Iakovidou C, 2015, EURASIP J ADV SIG PR, DOI 10.1186/s13634-015-0262-6; Iakovidou C, 2014, CBMI, P1, DOI DOI 10.1109/CBMI.2014.6849821; Irtaza A, 2014, MULTIMED TOOLS APPL, V72, P1911, DOI 10.1007/s11042-013-1489-6; Juan Luo, 2009, INT J IMAGE PROCESSI, V3, P143, DOI DOI 10.1007/S11270-006-2859-8; Karakasis EG, 2015, PATTERN RECOGN LETT, V55, P22, DOI 10.1016/j.patrec.2015.01.005; Khan N. Y., 2011, Proceedings of the 2011 International Conference on Digital Image Computing: Techniques and Applications (DICTA 2011), P501, DOI 10.1109/DICTA.2011.90; Krajnik T., 2015, P 2015 EUROPEAN C MO, P1; Krig S., 2014, COMPUTER VISION METR, P217, DOI [10.1007/978-1-4302-5930-5, DOI 10.1007/978-1-4302-5930-5, DOI 10.1007/978-1-4302-5930-5_6]; Lenc L, 2013, PROC SPIE, V9067, DOI 10.1117/12.2052804; Li J, 2008, IEEE T PATTERN ANAL, V30, P985, DOI 10.1109/TPAMI.2007.70847; Lin CH, 2009, IMAGE VISION COMPUT, V27, P658, DOI 10.1016/j.imavis.2008.07.004; Liu Y, 2007, PATTERN RECOGN, V40, P262, DOI 10.1016/j.patcog.2006.04.045; Liu Z, 2015, IEEE T MULTIMEDIA, V17, P538, DOI 10.1109/TMM.2015.2399851; Liu Z, 2014, IEEE T IMAGE PROCESS, V23, P1606, DOI 10.1109/TIP.2014.2305072; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Lux M, 2008, P 16 ACM INT C MULT, DOI [DOI 10.1145/1459359.1459577, 10.1145/1459359.1459577]; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; Mukherjee D, 2015, MACH VISION APPL, V26, P443, DOI 10.1007/s00138-015-0679-9; Nowak E, 2006, LECT NOTES COMPUT SC, V3954, P490; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Pang YW, 2012, NEUROCOMPUTING, V85, P6, DOI 10.1016/j.neucom.2011.12.006; Scaramuzza D, 2014, IEEE ROBOT AUTOM MAG, V21, P26, DOI 10.1109/MRA.2014.2322295; Shawe-Taylor J, 2004, KERNEL METHODS FOR P; Sivic J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1470, DOI 10.1109/iccv.2003.1238663; Tian XL, 2014, SIGNAL PROCESS-IMAGE, V29, P530, DOI 10.1016/j.image.2014.01.010; Tousch AM, 2012, PATTERN RECOGN, V45, P333, DOI 10.1016/j.patcog.2011.05.017; Valgren C, 2010, ROBOT AUTON SYST, V58, P149, DOI 10.1016/j.robot.2009.09.010; Vedaldi A, 2012, PROC CVPR IEEE, P2320, DOI 10.1109/CVPR.2012.6247943; Walia E, 2014, J VIS COMMUN IMAGE R, V25, P1335, DOI 10.1016/j.jvcir.2014.05.005; Wan J, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P157, DOI 10.1145/2647868.2654948; Wang JZ, 2001, IEEE T PATTERN ANAL, V23, P947, DOI 10.1109/34.955109; Yildizer E, 2012, KNOWL-BASED SYST, V31, P55, DOI 10.1016/j.knosys.2012.01.013; Yildizer E, 2012, EXPERT SYST APPL, V39, P2385, DOI 10.1016/j.eswa.2011.08.086; Yu J, 2013, NEUROCOMPUTING, V120, P355, DOI 10.1016/j.neucom.2012.08.061; Yuan X, 2011, IEEE INTERNATIONAL C; Zeng S, 2016, NEUROCOMPUTING, V171, P673, DOI 10.1016/j.neucom.2015.07.008; Zhang DS, 2012, PATTERN RECOGN, V45, P346, DOI 10.1016/j.patcog.2011.05.013; Zhang DS, 2004, PATTERN RECOGN, V37, P1, DOI 10.1016/j.patcog.2003.07.008; Zhou Z.-H., 2007, P 24 INT C MACHINE L, P1167	59	54	55	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157428	10.1371/journal.pone.0157428	http://dx.doi.org/10.1371/journal.pone.0157428			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315101	Green Published, Green Submitted, gold			2022-12-27	WOS:000378030000026
J	Cheng, E; Zhang, X; Wilson, KS; Wang, DH; Park, JY; Huo, XF; Yu, CH; Zhang, QY; Spechler, SJ; Souza, RF				Cheng, Edaire; Zhang, Xi; Wilson, Kathleen S.; Wang, David H.; Park, Jason Y.; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Spechler, Stuart J.; Souza, Rhonda F.			JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE	PLOS ONE			English	Article							SQUAMOUS-CELLS; GENE-EXPRESSION; FLUTICASONE; CHILDREN; INTERLEUKIN-13; CYTOKINES; DIAGNOSIS; MOTILITY; THERAPY; DISEASE	Background Although most studies on treatments for eosinophilic esophagitis (EoE) have focused on effects in the epithelium, EoE is a transmural disease. Eosinophils that infiltrate the subepithelial layers of the esophagus lead to fibrosis and the serious complications of EoE, and current therapies have shown minimal effects on this fibrosis. We aimed to elucidate T helper (Th) 2 cytokine effects on esophageal fibroblasts and to explore potential fibroblast-targeted therapies for EoE. Methods We established telomerase-immortalized fibroblasts from human esophageal biopsies. We stimulated these esophageal fibroblasts with Th2 cytokines, and examined effects of omeprazole and inhibitors of the Janus kinase (JAK)-signal transducer and activator of transcription (STAT6) pathway (AS1517499, leflunomide, and ruxolitinib) on STAT6 phosphorylation, STAT6 nuclear translocation, and eotaxin-3 expression. We also measured the effects of these inhibitors in esophageal epithelial cells stimulated with Th2 cytokines. Results As in esophageal epithelial cells, Th2 cytokines increased STAT6 phosphorylation, STAT6 nuclear translocation, eotaxin-3 transcription and protein secretion in esophageal fibroblasts. Unlike in epithelial cells, however, omeprazole did not inhibit cytokine-stimulated eotaxin-3 expression in fibroblasts. In contrast, JAK-STAT6 pathway inhibitors decreased cytokine-stimulated eotaxin-3 expression in both fibroblasts and epithelial cells. Conclusions Omeprazole does not inhibit Th2 cytokine-stimulated eotaxin-3 expression by esophageal fibroblasts, suggesting that PPIs will have limited impact on subepithelial EoE processes such as fibrosis. JAK-STAT6 pathway inhibitors block Th2 cytokine-stimulated eotaxin-3 expression both in fibroblasts and in epithelial cells, suggesting a potential role for JAK-STAT inhibitors in treating both epithelial inflammation and subepithelial fibrosis in EoE.	[Cheng, Edaire; Zhang, Xi; Wang, David H.; Park, Jason Y.; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Spechler, Stuart J.; Souza, Rhonda F.] Vet Affairs North Texas Hlth Care Syst, Esophageal Dis Ctr, Dallas, TX USA; [Cheng, Edaire; Zhang, Xi; Wang, David H.; Park, Jason Y.; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Spechler, Stuart J.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Cheng, Edaire] Childrens Hlth Childrens Med Ctr, Dept Pediat, Dallas, TX USA; [Cheng, Edaire] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Cheng, Edaire; Zhang, Xi; Wang, David H.; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Spechler, Stuart J.; Souza, Rhonda F.] Vet Affairs N Texas Hlth Care Syst, Med Serv, Dallas, TX USA; [Cheng, Edaire; Zhang, Xi; Wang, David H.; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Spechler, Stuart J.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Wilson, Kathleen S.; Park, Jason Y.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Wilson, Kathleen S.; Park, Jason Y.] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Wang, David H.; Spechler, Stuart J.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Park, Jason Y.] Childrens Hlth Childrens Med Ctr, Dept Pathol, Dallas, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cheng, E (corresponding author), Vet Affairs North Texas Hlth Care Syst, Esophageal Dis Ctr, Dallas, TX USA.; Cheng, E (corresponding author), Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.; Cheng, E (corresponding author), Childrens Hlth Childrens Med Ctr, Dept Pediat, Dallas, TX USA.; Cheng, E (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.; Cheng, E (corresponding author), Vet Affairs N Texas Hlth Care Syst, Med Serv, Dallas, TX USA.; Cheng, E (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	edaire.cheng@utsouthwestern.edu		Park, Jason/0000-0001-6797-4000	Office of Medical Research, Departments of Veterans Affairs; National Institutes of Health [K12-HD068369, K08-DK099383, R01-DK63621, R01-CA134571, R01-DK097340]; North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Foundation/AstraZeneca Award; American Gastroenterological Association Research Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097340, K08DK099383] Funding Source: NIH RePORTER	Office of Medical Research, Departments of Veterans Affairs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Foundation/AstraZeneca Award; American Gastroenterological Association Research Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Office of Medical Research, Departments of Veterans Affairs (RFS, SJS, DHW), the National Institutes of Health K12-HD068369 (EC), K08-DK099383 (EC), R01-DK63621 (RFS, SJS), R01-CA134571 (RFS, SJS), R01-DK097340 (DHW), the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Foundation/AstraZeneca Award (EC) www.naspghan.org, and American Gastroenterological Association Research Scholar Award (EC) www.gastro.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Sultaneh SMA, 2011, DIGEST DIS SCI, V56, P97, DOI 10.1007/s10620-010-1259-5; Aceves SS, 2010, ALLERGY, V65, P109, DOI 10.1111/j.1398-9995.2009.02142.x; Akiho H, 2005, AM J PHYSIOL-GASTR L, V288, pG609, DOI 10.1152/ajpgi.00273.2004; Barch MJ, 1997, AGT CYTOGENETICS LAB; Beppu L, 2015, J PEDIATR GASTR NUTR, V61, P194, DOI 10.1097/MPG.0000000000000668; Blanchard C, 2005, INT J BIOCHEM CELL B, V37, P2559, DOI 10.1016/j.biocel.2005.06.010; Caldwell JM, 2010, J ALLERGY CLIN IMMUN, V125, P879, DOI 10.1016/j.jaci.2010.01.038; Cheng E, 2013, GUT, V62, P824, DOI 10.1136/gutjnl-2012-302250; Cheng E, 2012, AM J PHYSIOL-GASTR L, V303, pG1175, DOI 10.1152/ajpgi.00313.2012; Chiba Y, 2009, AM J RESP CELL MOL, V41, P516, DOI 10.1165/rcmb.2008-0163OC; Dellon ES, 2014, CLIN GASTROENTEROL H, V12, P2015, DOI 10.1016/j.cgh.2014.06.019; Dellon ES, 2014, GASTROINTEST ENDOSC, V79, P577, DOI 10.1016/j.gie.2013.10.027; Dellon ES, 2013, AM J GASTROENTEROL, V108, P1854, DOI 10.1038/ajg.2013.363; Fontillon M, 2012, AM J GASTROENTEROL, V107, P1762, DOI 10.1038/ajg.2012.226; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hirano I, 2014, GASTROENTEROL CLIN N, V43, P297, DOI 10.1016/j.gtc.2014.02.015; Jaiswal KR, 2007, DIS ESOPHAGUS, V20, P256, DOI 10.1111/j.1442-2050.2007.00683.x; Kagami S, 2005, CLIN EXP IMMUNOL, V141, P459, DOI 10.1111/j.1365-2249.2005.02875.x; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; Levine J, 2012, ANN ALLERG ASTHMA IM, V108, P363, DOI 10.1016/j.anai.2012.02.024; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Lieberman JA, 2012, ALLERGY, V67, P1299, DOI 10.1111/j.1398-9995.2012.02881.x; Lipka S, 2016, J CLIN GASTROENTEROL, V50, P134, DOI 10.1097/MCG.0000000000000297; Lucendo AJ, 2011, J ALLERGY CLIN IMMUN, V128, P1037, DOI 10.1016/j.jaci.2011.08.007; Moawad FJ, 2013, AM J GASTROENTEROL, V108, P366, DOI 10.1038/ajg.2012.443; Molina-Infante J, 2014, ALIMENT PHARM THER, V40, P955, DOI 10.1111/apt.12914; Molina-Infante J, 2016, GUT, V65, P524, DOI 10.1136/gutjnl-2015-310991; Molina-Infante J, 2011, CLIN GASTROENTEROL H, V9, P110, DOI 10.1016/j.cgh.2010.09.019; Morales CP, 2003, GUT, V52, P327, DOI 10.1136/gut.52.3.327; Nagashima S, 2007, BIOORGAN MED CHEM, V15, P1044, DOI 10.1016/j.bmc.2006.10.015; NEWBOLD RF, 1982, NATURE, V299, P633, DOI 10.1038/299633a0; Punwani N, 2015, BRIT J DERMATOL, V173, P989, DOI 10.1111/bjd.13994; Rajan J, 2016, J ALLERGY CLIN IMMUN, V137, P147, DOI 10.1016/j.jaci.2015.05.045; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Rieder F, 2014, GASTROENTEROLOGY, V146, P1266, DOI 10.1053/j.gastro.2014.01.051; Schoepfer AM, 2013, GASTROENTEROLOGY, V145, P1230, DOI 10.1053/j.gastro.2013.08.015; Straumann A, 2011, CLIN GASTROENTEROL H, V9, P400, DOI 10.1016/j.cgh.2011.01.017; Straumann A, 2010, GASTROENTEROLOGY, V139, P1526, DOI 10.1053/j.gastro.2010.07.048; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043; Zhang HY, 2008, AM J PHYSIOL-GASTR L, V295, pG470, DOI 10.1152/ajpgi.90262.2008; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050037	41	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157376	10.1371/journal.pone.0157376	http://dx.doi.org/10.1371/journal.pone.0157376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310888	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800063
J	Peng, CN; Wang, XQ; Xian, ZC; Liu, X; Huang, WH; Xu, PC; Wang, JY				Peng, Changnong; Wang, Xiaoqing; Xian, Zhanchao; Liu, Xin; Huang, Wenhua; Xu, Pengcheng; Wang, Jinyang			The Impact of the Geometric Characteristics on the Hemodynamics in the Stenotic Coronary Artery	PLOS ONE			English	Article							FRACTIONAL FLOW RESERVE; OPTIMAL MEDICAL THERAPY; SHEAR-STRESS; BLOOD-FLOW; COMPUTED-TOMOGRAPHY; CT ANGIOGRAPHY; LESIONS; DISEASE; REVASCULARIZATION; INTERVENTION	The alterations of the hemodynamics in the coronary arteries, which result from patient-specific geometric significances are complex. The effect of the stenosis on the blood flow alteration had been wildly reported, but the combinational contribution from geometric factors required a comprehensive investigation to provide patient-specific information for diagnosis and assisting in the decision on the further treatment strategies. In the present study, we investigated the correlation between hemodynamic parameters and individual geometric factors in the patient-specific coronary arteries. Computational fluid dynamic simulations were performed on 22 patient-specific 3-dimensional coronary artery models that were reconstructed based on computed tomography angiography images. Our results showed that the increasing severity of the stenosis is associated with the increased maximum wall shear stress at the stenosis region (r = 0.752, P < 0.001). In contrast, the length of the recirculation zone has a moderate association with the curvature of the lesion segment (r = 0.505, P = 0.019) and the length of the lesions (r = 0.527, P = 0.064). Moreover, bifurcation in the coronary arteries is significantly correlated with the occurrence of recirculation, whereas the severity of distal stenosis demonstrated an effect on the alteration of the flow in the upstream bifurcation. These findings could serve as an indication for treatment planning and assist in prognosis evaluation.	[Peng, Changnong; Wang, Xiaoqing; Xian, Zhanchao] Shenzhen Sun Yat Sen Cardiovasc Hosp, Dept Cardiol, Shenzhen 518112, Peoples R China; [Liu, Xin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Ctr Biomed Informat Technol, Shenzhen 518055, Peoples R China; [Huang, Wenhua; Xu, Pengcheng; Wang, Jinyang] Southern Med Univ, Inst Clin Anat, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Southern Medical University - China	Liu, X (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Res Ctr Biomed Informat Technol, Shenzhen 518055, Peoples R China.; Huang, WH (corresponding author), Southern Med Univ, Inst Clin Anat, Guangzhou 510515, Guangdong, Peoples R China.	xingliu1024@sina.com; huangwenhua2009@139.com	huang, wenhua/AAO-5990-2020; Xu, Pengcheng/J-1429-2012; Wang, Jinyang/E-7780-2011	huang, wenhua/0000-0003-2382-9180; Xu, Pengcheng/0000-0001-8651-208X; Wang, Jinyang/0000-0003-0668-336X	Guangdong Image-guided Therapy Innovation Team [2011S013]; Shenzhen Innovation Funding [SGLH20150213143207911, JCYJ20140901003939025, SGLH20131010110119871, GJHZ20140415152115754, JCYJ20151030151431727, JCYJ20140414170821190, SGLH20150216172854731]; Shenzhen science and technology innovation Funding [CXZZ20140909004122087]; Science and Technology Project of Guangdong Province [2015B010125005]	Guangdong Image-guided Therapy Innovation Team; Shenzhen Innovation Funding; Shenzhen science and technology innovation Funding; Science and Technology Project of Guangdong Province	The work was supported by Guangdong Image-guided Therapy Innovation Team (2011S013), Shenzhen Innovation Funding (SGLH20150213143207911, JCYJ20140901003939025, SGLH20131010110119871, GJHZ20140415152115754, JCYJ20151030151431727, JCYJ20151030151431727, JCYJ20140414170821190, SGLH20150216172854731) and Shenzhen science and technology innovation Funding (CXZZ20140909004122087). It was also supported by the Science and Technology Project of Guangdong Province (2015B010125005).	Abbara Suhny, 2009, J Cardiovasc Comput Tomogr, V3, P190, DOI 10.1016/j.jcct.2009.03.004; Antoniadis AP, 2015, JACC-CARDIOVASC INTE, V8, P1281, DOI 10.1016/j.jcin.2015.06.015; Barlis Peter, 2015, EuroIntervention, V11, pe1, DOI 10.4244/EIJV11I5A111; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Choi G, 2014, JOURNAL OF THE AMERI, V64; Comsol Multiphysics User's Guide, 2014, 2014 COMSOL MULTIPHY; Einav S, 2004, ANN NY ACAD SCI, V1015, P351, DOI 10.1196/annals.1302.031; Fam JM, 2015, JACC CARDIOVASCULAR, V8, pS22; Frattolin J, 2015, COMPUT BIOL MED, V57, P130, DOI 10.1016/j.compbiomed.2014.11.014; Gaemperli O, 2007, EUR J NUCL MED MOL I, V34, P1162, DOI 10.1007/s00259-006-0307-z; Hacker M, 2007, EUR J NUCL MED MOL I, V34, P4, DOI 10.1007/s00259-006-0207-2; Hanson I., 2015, INTERVENTIONAL CARDI, P107; Iguchi T, 2013, CLIN CARDIOL, V36, P172, DOI 10.1002/clc.22076; Javadzadegan A, 2013, AM J PHYSIOL-HEART C, V304, pH559, DOI 10.1152/ajpheart.00428.2012; Johnston BM, 2006, J BIOMECH, V39, P1116, DOI 10.1016/j.jbiomech.2005.01.034; Kwon SS, 2014, PROG BIOPHYS MOL BIO, V116, P48, DOI 10.1016/j.pbiomolbio.2014.09.003; Li-Na P, 2012, QUANTITATIVE STUDY E, P245; Liu BY, 2007, MED ENG PHYS, V29, P868, DOI 10.1016/j.medengphy.2006.09.009; Min JK, 2015, JACC-CARDIOVASC IMAG, V8, P1209, DOI 10.1016/j.jcmg.2015.08.006; Morris PD, 2013, JACC-CARDIOVASC INTE, V6, P149, DOI 10.1016/j.jcin.2012.08.024; Muhlenbruch G, 2007, EUR RADIOL, V17, P603, DOI 10.1007/s00330-006-0429-5; Myers JG, 2001, ANN BIOMED ENG, V29, P109, DOI 10.1114/1.1349703; Naidu SS, 2012, CATHETER CARDIO INTE, V80, P456, DOI 10.1002/ccd.24311; Parodi O, 2012, IEEE T INF TECHNOL B, V16, P952, DOI 10.1109/TITB.2012.2201732; Rispler S, 2007, J AM COLL CARDIOL, V49, P1059, DOI 10.1016/j.jacc.2006.10.069; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Sankaran S, 2012, ANN BIOMED ENG, V40, P2228, DOI 10.1007/s10439-012-0579-3; Schuijf JD, 2006, J AM COLL CARDIOL, V48, P2508, DOI 10.1016/j.jacc.2006.05.080; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Siebert U, 2014, HEART LUNG CIRC, V23, P527, DOI 10.1016/j.hlc.2013.12.009; Tardy Y, 1997, ARTERIOSCL THROM VAS, V17, P3102, DOI 10.1161/01.ATV.17.11.3102; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Tian F.B., 2013, COMPUTERS BIOL MED; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Torii R, 2009, BRIT J RADIOL, V82, pS24, DOI 10.1259/bjr/62450556; Warboys CM, 2010, AM J PHYSIOL-HEART C, V298, pH1850, DOI 10.1152/ajpheart.00114.2010	37	15	15	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157490	10.1371/journal.pone.0157490	http://dx.doi.org/10.1371/journal.pone.0157490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310014	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800083
J	Schwingshackl, L; Hoffmann, G; Schwedhelm, C; Kalle-Uhlmann, T; Missbach, B; Knuppel, S; Boeing, H				Schwingshackl, Lukas; Hoffmann, Georg; Schwedhelm, Carolina; Kalle-Uhlmann, Tamara; Missbach, Benjamin; Knueppel, Sven; Boeing, Heiner			Consumption of Dairy Products in Relation to Changes in Anthropometric Variables in Adult Populations: A Systematic Review and Meta-Analysis of Cohort Studies	PLOS ONE			English	Review							TERM WEIGHT-GAIN; BODY-WEIGHT; METABOLIC SYNDROME; WAIST CIRCUMFERENCE; YOGURT CONSUMPTION; INTESTINAL MICROBIOTA; DIABETES-MELLITUS; FATTY-ACIDS; RISK; DIETARY	Background The current state of knowledge regarding the association of dairy products and weight gain, overweight, and obesity is based on studies reporting contradicting and inconclusive results. The aim of the present study was thus to clarify the link between dairy consumption in relation to changes in anthropometric measures/adiposity by a meta-analytical approach. Methods For the meta-analysis PubMed, EMBASE, Web of Sciences, and google scholar were searched by two independent authors up to May 2016 with no restriction to language or calendar date. Prospective cohort studies reporting about intake of dairy consumption (including milk, yogurt, cheese, butter) and changes in body weight or waist circumference, risk of overweight, obesity, or weight gain were eligible. Pooled effects were calculated using a random effects model, and also a fixed effect model for sensitivity analysis. Due to the heterogeneity of statistical analytical approaches of the studies the analysis were done separately for beta-coefficients of changes in body weight and/or waist circumference per serving of dairy, for differences in weight gain/gain in waist circumference when comparing extreme categories of dairy consumption, and for odds ratios in regard to weight gain, over-weight/obesity, or abdominal obesity. Findings 24 studies (27 reports) met the inclusion criteria for the systematic review, and 22 studies provided sufficient data for inclusion in the meta-analysis. The meta-analysis of the five studies on changes in body weight per serving of dairy no significant results could be found for whole fat dairy and low fat dairy. However, there was inverse association between changes in body weight for each serving's increase of yogurt (beta: -40.99 gram/year, 95% CI, -48.09 to -33.88), whereas each serving's increase of cheese was positively associated (beta: -10.97 gram/year, 95% CI, 2.86 to 19.07). Furthermore, the highest dairy intake category was associated with a reduced risk of abdominal obesity (OR: 0.85; 95% CI, 0.76 to 0.95), and risk of overweight (OR: 0.87; 95% CI, 0.76 to 1.00) compared to the lowest intake category. No significant association could be observed for risk of weight gain. Conclusion In summary the results of the meta-analysis still reflect that dairy consumption was not positively related to changes in body weight. Yogurt was the only dairy food that showed some evidence for a beneficial effect, where higher intakes were inversely associated a reduced risk of obesity, changes in body weight or waist circumference. Further research is needed, since the overall interpretation of the results is limited by heterogeneous risk estimates.	[Schwingshackl, Lukas; Schwedhelm, Carolina; Kalle-Uhlmann, Tamara; Knueppel, Sven; Boeing, Heiner] German Inst Human Nutr, Dept Epidemiol, Nuthetal, Germany; [Hoffmann, Georg; Missbach, Benjamin] Univ Vienna, Fac Life Sci, Dept Nutr Sci, Vienna, Austria	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Vienna	Schwingshackl, L (corresponding author), German Inst Human Nutr, Dept Epidemiol, Nuthetal, Germany.	lukas.schwingshackl@dife.de	Knüppel, Sven/AAI-7195-2020; Schwedhelm, Carolina/AAE-6756-2022; Schwingshackl, Lukas/AAC-4119-2019; Hoffmann, Georg/B-9201-2013; Missbach, Benjamin/B-3363-2017	Knüppel, Sven/0000-0001-9006-9906; Schwingshackl, Lukas/0000-0003-3407-7594; Missbach, Benjamin/0000-0002-8513-6382; Schwedhelm, Carolina/0000-0001-7617-6641	Open Access fund of the Leibniz Association	Open Access fund of the Leibniz Association	The publication of this article was funded by the Open Access fund of the Leibniz Association.	[Anonymous], 2013, TOP FOOD SOURC SAT F; Astrup A, 2010, PHYSIOL BEHAV, V100, P67, DOI 10.1016/j.physbeh.2010.01.039; Aune D, 2013, AM J CLIN NUTR, V98, P1066, DOI 10.3945/ajcn.113.059030; Babio N, 2015, J NUTR, V145, P2308, DOI 10.3945/jn.115.214593; Benatar JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076480; Booth AO, 2015, BRIT J NUTR, V114, P1013, DOI 10.1017/S0007114515001518; Chen M, 2012, AM J CLIN NUTR, V96, P735, DOI 10.3945/ajcn.112.037119; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drapeau V, 2004, AM J CLIN NUTR, V80, P29; Duffey KJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001050; Esfahani FH, 2014, INT J ENDOCRINOL MET, V12, DOI 10.5812/ijem.17236; Fumeron F, 2011, J AM COLL NUTR, V30, p454S, DOI 10.1080/07315724.2011.10719990; Funtikova AN, 2015, J NUTR, V145, P328, DOI 10.3945/jn.114.205229; Givens I, 2009, NUTRIENTS, V1, P71, DOI 10.3390/nu1010071; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Halkjer J, 2009, J AM DIET ASSOC, V109, P1356, DOI 10.1016/j.jada.2009.05.015; Heggie SJ, 2003, J NUTR, V133, p3837S, DOI 10.1093/jn/133.11.3837S; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hite AH, 2010, NUTRITION, V26, P915, DOI 10.1016/j.nut.2010.08.012; Holmberg S, 2013, SCAND J PRIM HEALTH, V31, P89, DOI 10.3109/02813432.2012.757070; Hu D, 2014, NUTR METAB CARDIOVAS, V24, P460, DOI 10.1016/j.numecd.2013.12.006; Kaikkonen JE, 2015, SCAND J CLIN LAB INV, V75, P133, DOI 10.3109/00365513.2014.992945; Kallus SJ, 2012, J CLIN GASTROENTEROL, V46, P16, DOI 10.1097/MCG.0b013e31823711fd; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Kirkpatrick SI, 2014, AM J PREV MED, V46, P94, DOI 10.1016/j.amepre.2013.08.015; Komar B, 2015, J NUTR HEALTH AGING, V19, P437, DOI 10.1007/s12603-014-0559-4; Kratz M, 2013, EUR J NUTR, V52, P1, DOI 10.1007/s00394-012-0418-1; Louie JCY, 2011, OBES REV, V12, pE582, DOI 10.1111/j.1467-789X.2011.00881.x; Martinez-Gonzalez MA, 2014, NUTR METAB CARDIOVAS, V24, P1189, DOI 10.1016/j.numecd.2014.05.015; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Newby PK, 2004, AM J CLIN NUTR, V80, P504, DOI 10.1093/ajcn/80.2.504; Nicklas TA, 2009, J AM COLL NUTR, V28, p73S, DOI 10.1080/07315724.2009.10719807; Nikolaou CK, 2015, INT J OBESITY, V39, P508, DOI 10.1038/ijo.2014.160; Noone EJ, 2002, BRIT J NUTR, V88, P243, DOI 10.1079/BJN2002615; Onakpoya IJ, 2011, NUTR REV, V69, P335, DOI 10.1111/j.1753-4887.2011.00397.x; Pal S, 2010, BRIT J NUTR, V104, P716, DOI 10.1017/S0007114510000991; Pan A, 2013, INT J OBESITY, V37, P1378, DOI 10.1038/ijo.2012.225; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Pfeuffer M, 2007, OBES REV, V8, P109, DOI 10.1111/j.1467-789X.2006.00265.x; Pihlanto-Leppala A, 2000, J DAIRY RES, V67, P53, DOI 10.1017/S0022029999003982; Poddar KH, 2009, J AM DIET ASSOC, V109, P1433, DOI 10.1016/j.jada.2009.05.005; Prentice AM, 2014, AM J CLIN NUTR, V99, p1212S, DOI 10.3945/ajcn.113.073437; Rajpathak SN, 2006, AM J CLIN NUTR, V83, P559, DOI 10.1093/ajcn.83.3.559; Ralston RA, 2012, J HUM HYPERTENS, V26, P3, DOI 10.1038/jhh.2011.3; Rautiainen S, 2016, AM J CLIN NUTR, V103, P979, DOI 10.3945/ajcn.115.118406; Romaguera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023384; Rosell M, 2006, AM J CLIN NUTR, V84, P1481, DOI 10.1093/ajcn/84.6.1481; Samara A, 2013, NUTRITION, V29, P519, DOI 10.1016/j.nut.2012.08.013; Sanchez-Villegas A, 2006, INT J OBESITY, V30, P350, DOI 10.1038/sj.ijo.0803118; Sayon-Orea C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1518-7; Schwingshackl L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140846; Shin H, 2013, J KOREAN MED SCI, V28, P1482, DOI 10.3346/jkms.2013.28.10.1482; Snijder MB, 2008, OBESITY, V16, P706, DOI 10.1038/oby.2007.93; Soedamah-Muthu SS, 2011, AM J CLIN NUTR, V93, P158, DOI 10.3945/ajcn.2010.29866; St-Pierre NR, 2001, J DAIRY SCI, V84, P741, DOI 10.3168/jds.S0022-0302(01)74530-4; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tong X, 2011, EUR J CLIN NUTR, V65, P1027, DOI 10.1038/ejcn.2011.62; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; U.S. Department of Agriculture and U.S. Department of Health and Human Services, 2010, DIET GUID AM; Vannice G, 2014, J ACAD NUTR DIET, V114, P136, DOI 10.1016/j.jand.2013.11.001; Vaskonen T, 2003, J NUTR BIOCHEM, V14, P492, DOI 10.1016/S0955-2863(03)00074-3; Veldhorst M, 2008, PHYSIOL BEHAV, V94, P300, DOI 10.1016/j.physbeh.2008.01.003; Vergnaud AC, 2008, AM J CLIN NUTR, V88, P1248, DOI 10.3945/ajcn.2007.25151; Wang H, 2014, INT J OBESITY, V38, P299, DOI 10.1038/ijo.2013.78; Wang HF, 2013, NUTR RES, V33, P18, DOI 10.1016/j.nutres.2012.11.009; Zemel MB, 2005, J AM COLL NUTR, V24, p537S, DOI 10.1080/07315724.2005.10719502; Zemel MB, 2005, OBES RES, V13, P1218, DOI 10.1038/oby.2005.144; Zong G, 2014, DIABETES CARE, V37, P56, DOI 10.2337/dc13-0975	75	70	73	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157461	10.1371/journal.pone.0157461	http://dx.doi.org/10.1371/journal.pone.0157461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310919	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800076
J	Lucon-Xiccato, T; Dadda, M				Lucon-Xiccato, Tyrone; Dadda, Marco			Guppies Show Behavioural but Not Cognitive Sex Differences in a Novel Object Recognition Test	PLOS ONE			English	Article							FEMALE MATE CHOICE; SPATIAL MEMORY; WATER MAZE; COLOR; SIZE; DISCRIMINATION; EXPLORATION; PERFORMANCE; MALES; RATS	The novel object recognition (NOR) test is a widely-used paradigm to study learning and memory in rodents. NOR performance is typically measured as the preference to interact with a novel object over a familiar object based on spontaneous exploratory behaviour. In rats and mice, females usually have greater NOR ability than males. The NOR test is now available for a large number of species, including fish, but sex differences have not been properly tested outside of rodents. We compared male and female guppies (Poecilia reticulata) in a NOR test to study whether sex differences exist also for fish. We focused on sex differences in both performance and behaviour of guppies during the test. In our experiment, adult guppies expressed a preference for the novel object as most rodents and other species do. When we looked at sex differences, we found the two sexes showed a similar preference for the novel object over the familiar object, suggesting that male and female guppies have similar NOR performances. Analysis of behaviour revealed that males were more inclined to swim in the proximity of the two objects than females. Further, males explored the novel object at the beginning of the experiment while females did so afterwards. These two behavioural differences are possibly due to sex differences in exploration. Even though NOR performance is not different between male and female guppies, the behavioural sex differences we found could affect the results of the experiments and should be carefully considered when assessing fish memory with the NOR test.	[Lucon-Xiccato, Tyrone; Dadda, Marco] Univ Padua, Dipartimento Psicol Gen, Padua, Italy	University of Padua	Lucon-Xiccato, T (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.	tyrone.luconxiccato@studenti.unipd.it	DADDA, Marco/ABI-7266-2020; Lucon-Xiccato, Tyrone/AAG-9221-2020	DADDA, Marco/0000-0001-7944-4058; Lucon-Xiccato, Tyrone/0000-0002-1017-9230	"Progetto di Ateneo" from University of Padova [CPDA 131092/13]	"Progetto di Ateneo" from University of Padova	Funding was provided by "Progetto di Ateneo" from University of Padova to MD (CPDA 131092/13).	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Barchard KA, 2015, ANAL SOC ISS PUB POL, V15, P418, DOI 10.1111/asap.12095; Barkley CL, 2007, ANIM BEHAV, V73, P321, DOI 10.1016/j.anbehav.2006.07.009; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; Beiko J, 2004, BEHAV BRAIN RES, V151, P239, DOI 10.1016/j.bbr.2003.08.019; Bettis T, 2012, BEHAV BRAIN RES, V233, P288, DOI 10.1016/j.bbr.2012.04.028; Bettis TJ, 2013, ANIM COGN, V16, P873, DOI 10.1007/s10071-013-0619-x; Bettis TJ, 2009, BEHAV PROCESS, V82, P249, DOI 10.1016/j.beproc.2009.07.004; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Blaser R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00183; Braida D, 2014, PROG NEURO-PSYCHOPH, V55, P80, DOI 10.1016/j.pnpbp.2014.03.010; Brown C, 2007, J FISH BIOL, V71, P1590, DOI 10.1111/j.1095-8649.2007.01627.x; Brown C., 2008, FISH COGNITION BEHAV, DOI DOI 10.1098/rsbl.2017.0002; Burns JG, 2008, J COMP PSYCHOL, V122, P344, DOI 10.1037/0735-7036.122.4.344; Callahan H, 2000, PROG NEURO-PSYCHOPH, V24, P693, DOI 10.1016/S0278-5846(00)00102-0; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; DUGATKIN LA, 1992, P ROY SOC B-BIOL SCI, V249, P179, DOI 10.1098/rspb.1992.0101; Eakley AL, 2004, P ROY SOC B-BIOL SCI, V271, pS299, DOI 10.1098/rsbl.2004.0165; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Gasparini C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3072; Ghi P, 1999, PHARMACOL BIOCHEM BE, V64, P761, DOI 10.1016/S0091-3057(99)00143-4; Gori S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06443; Harris S, 2010, OIKOS, V119, P1711, DOI 10.1111/j.1600-0706.2010.18028.x; Heyser CJ, 2012, BEHAV PROCESS, V89, P232, DOI 10.1016/j.beproc.2011.12.004; Hodgson ZG, 2005, ANIM COGN, V8, P211, DOI 10.1007/s10071-004-0249-4; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; Irving E, 2013, J FISH BIOL, V83, P311, DOI 10.1111/jfb.12165; Jacobs LF, 1996, TRENDS ECOL EVOL, V11, pA82; Jeffreys H., 1998, THEORY PROBABILITY; Kinzler KD, 2007, PROG BRAIN RES, V164, P257, DOI 10.1016/S0079-6123(07)64014-X; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; LONG KD, 1989, ETHOLOGY, V82, P316; Lucon-Xiccato T, 2016, ANIM COGN, V19, P733, DOI 10.1007/s10071-016-0969-2; Lucon-Xiccato T, 2016, ETHOLOGY, V122, P481, DOI 10.1111/eth.12498; Lucon-Xiccato T, 2015, ANIM BEHAV, V107, P183, DOI 10.1016/j.anbehav.2015.06.019; Lucon-Xiccato T, 2014, BEHAV PROCESS, V106, P1, DOI 10.1016/j.beproc.2014.03.010; Lucon-Xiccato T, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0206; Magurran AE, 2000, J FISH BIOL, V57, P839, DOI [10.1006/jfbi.2000.1391, 10.1111/j.1095-8649.2000.tb02196.x]; Malkova L, 2003, J NEUROSCI, V23, P1956; May Z, 2016, BEHAV BRAIN RES, V296, P199, DOI 10.1016/j.bbr.2015.09.016; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; Muller CA, 2011, BIOL LETTERS, V7, P689, DOI 10.1098/rsbl.2011.0287; O'Hara M, 2015, ANIM BEHAV, V101, P51, DOI 10.1016/j.anbehav.2014.12.022; Okujava V, 2005, ACTA NEUROBIOL EXP, V65, P205; Oliveira J, 2015, ZEBRAFISH, V12, P166, DOI 10.1089/zeb.2014.1019; Petrazzini MEM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15497; Petrazzini MEM, 2012, BEHAV BRAIN RES, V233, P443, DOI 10.1016/j.bbr.2012.05.044; Reader SM, 2000, ANIM BEHAV, V60, P175, DOI 10.1006/anbe.2000.1450; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Saucier DM, 2008, ANIM COGN, V11, P129, DOI 10.1007/s10071-007-0096-1; Sava S, 2005, HORM BEHAV, V48, P23, DOI 10.1016/j.yhbeh.2005.01.011; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Silverman I, 2007, ARCH SEX BEHAV, V36, P261, DOI 10.1007/s10508-006-9168-6; Sokal R.R., 2012, BIOMETRY; Sovrano VA, 2008, ANIM COGN, V11, P161, DOI 10.1007/s10071-007-0100-9; Sovrano VA, 2009, PERCEPTION, V38, P579, DOI 10.1068/p6121; Steckler T, 1998, PROG NEUROBIOL, V54, P289, DOI 10.1016/S0301-0082(97)00060-9; Stowe M, 2006, BEHAV PROCESS, V73, P68, DOI 10.1016/j.beproc.2006.03.015; Sutcliffe JS, 2007, BEHAV BRAIN RES, V177, P117, DOI 10.1016/j.bbr.2006.10.029; Tello-Ramos MC, 2014, ANIM BEHAV, V93, P129, DOI 10.1016/j.anbehav.2014.04.036; THINUSBLANC C, 1992, BEHAV PROCESS, V26, P43, DOI 10.1016/0376-6357(92)90031-8; Thornton A, 2012, PHILOS T R SOC B, V367, P2773, DOI 10.1098/rstb.2012.0214; Vallortigara G, 1996, BEHAV PROCESS, V36, P289, DOI 10.1016/0376-6357(95)00063-1; Visser EK, 2002, PHYSIOL BEHAV, V76, P289, DOI 10.1016/S0031-9384(02)00698-4; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; WARREN EW, 1976, BEHAV BIOL, V18, P499, DOI 10.1016/S0091-6773(76)92524-4; WARREN EW, 1975, J FISH BIOL, V7, P105, DOI 10.1111/j.1095-8649.1975.tb04580.x; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	69	30	30	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156589	10.1371/journal.pone.0156589	http://dx.doi.org/10.1371/journal.pone.0156589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305102	gold, Green Published, Green Submitted			2022-12-27	WOS:000377824800018
J	Okada, M; Ishikawa, T; Ikegaya, Y				Okada, Mami; Ishikawa, Tomoe; Ikegaya, Yuji			A Computationally Efficient Filter for Reducing Shot Noise in Low S/N Data	PLOS ONE			English	Article							ACTION-POTENTIALS; NEURONAL POPULATIONS; CALCIUM	Functional multineuron calcium imaging (fMCI) provides a useful experimental platform to simultaneously capture the spatiotemporal patterns of neuronal activity from a large cell population in situ. However, fMCI often suffers from low signal-to-noise ratios (S/N). The main factor that causes the low S/N is shot noise that arises from photon detectors. Here, we propose a new denoising procedure, termed the Okada filter, which is designed to reduce shot noise under low S/N conditions, such as fMCI. The core idea of the Okada filter is to replace the fluorescence intensity value of a given frame time with the average of two values at the preceding and following frames unless the focused value is the median among these three values. This process is iterated serially throughout a time-series vector. In fMCI data of hippocampal neurons, the Okada filter rapidly reduces background noise and significantly improves the S/N. The Okada filter is also applicable for reducing shot noise in electrophysiological data and photographs. Finally, the Okada filter can be described using a single continuous differentiable equation based on the logistic function and is thus mathematically tractable.	[Okada, Mami; Ishikawa, Tomoe; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Ikegaya, Yuji] Natl Inst Informat & Communicat Technol, Ctr Informat & Neural Networks, Suita, Osaka 5650871, Japan	University of Tokyo; National Institute of Information & Communications Technology (NICT) - Japan	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan.; Ikegaya, Y (corresponding author), Natl Inst Informat & Communicat Technol, Ctr Informat & Neural Networks, Suita, Osaka 5650871, Japan.	yuji@ikegaya.jp		Ikegaya, Yuji/0000-0003-2260-8191	 [22115003]		This work was supported by Grants-in-Aid for Science Research on Innovative Areas, "Mesoscopic Neurocircuitry" (22115003).	Arias-Castro E, 2009, ANN STAT, V37, P1172, DOI 10.1214/08-AOS604; Fiore L, 1996, J NEUROSCI METH, V70, P177, DOI 10.1016/S0165-0270(96)00116-1; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Ishikawa T, 2015, INT J PHARMACOL, V11, P318, DOI 10.3923/ijp.2015.318.326; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; Little MA, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0546; Mizunuma M, 2014, NAT NEUROSCI, V17, P503, DOI 10.1038/nn.3674; Namiki S, 2009, BIOL PHARM BULL, V32, P1, DOI 10.1248/bpb.32.1; Sasaki T, 2008, J NEUROPHYSIOL, V100, P1668, DOI 10.1152/jn.00084.2008; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sjulson L, 2007, PHYSIOLOGY, V22, P47, DOI 10.1152/physiol.00036.2006; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Szymanska AF, J NEUROSCI IN PRESS; Takahashi N, 2007, NEUROSCI RES, V58, P219, DOI 10.1016/j.neures.2007.03.001; Takahashi Naoya, 2011, Curr Protoc Neurosci, VChapter 2, DOI 10.1002/0471142301.ns0214s57; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	19	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157595	10.1371/journal.pone.0157595	http://dx.doi.org/10.1371/journal.pone.0157595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304217	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800076
J	Pagano, JJ; Chow, K; Khan, A; Michelakis, E; Paterson, I; Oudit, GY; Thompson, RB				Pagano, Joseph J.; Chow, Kelvin; Khan, Aneal; Michelakis, Evangelos; Paterson, Ian; Oudit, Gavin Y.; Thompson, Richard B.			Reduced Right Ventricular Native Myocardial T-1 in Anderson-Fabry Disease: Comparison to Pulmonary Hypertension and Healthy Controls	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; ENZYME REPLACEMENT THERAPY; CARDIOMYOPATHY; INVOLVEMENT; DIAGNOSIS; ECHOCARDIOGRAPHY; DIFFERENTIATION; HYPERTROPHY; ASSOCIATION; PREVALENCE	Aims Anderson-Fabry disease (AFD) is characterized by progressive multiorgan accumulation of intracellular sphingolipids due to a-galactosidase A enzyme deficiency, resulting in progressive ventricular hypertrophy, heart failure, arrhythmias, and death. Decreased native (non-contrast) left ventricular (LV) T-1 (longitudinal relaxation time) with MRI discriminates AFD from healthy controls or other presentations of concentric hypertrophy, but the right ventricle (RV) has not been studied. The aims of the current study were to evaluate native RV T-1 values in AFD, with a goal of better understanding the pathophysiology of RV involvement. Methods and Results Native T-1 values were measured in the inferior RV wall (RVI), interventricular septum (IVS), and inferior LV (LVI) in patients with AFD, patients with pulmonary hypertension, who provided an alternative RV pathological process for comparison, and healthy controls. A minimum wall thickness of 4 mm was selected to minimize partial volume errors in tissue T-1 analysis. T-1 analysis was performed in 6 subjects with AFD, 6 subjects with PH, and 21 controls. Native T-1 values were shorter (adjusted p<0.05 for all comparisons), independent of location, in subjects with AFD (RVI-T-1 = 1096 +/- 49 ms, IVS-T-1 = 1053 +/- 41 ms, LVI-T-1 = 1072 +/- 44 ms) compared to both PH (RVI-T-1 = 1239 +/- 41 ms, IVS-T-1 = 1280 +/- 123 ms, LVI-T-1 = 1274 +/- 57 ms) and HC (IVS-T-1 = 1180 +/- 60 ms, LVI-T-1 = 1183 +/- 45 ms). RVI measurements were not possible in controls due to insufficient wall thickness. Conclusion Native T-1 values appear similarly reduced in the left and right ventricles of individuals with AFD and RV wall thickening, suggesting a common pathology. In contrast, individuals with PH and thickened RVs showed increased native T-1 values in both ventricles, suggestive of fibrosis.	[Pagano, Joseph J.; Chow, Kelvin; Thompson, Richard B.] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Khan, Aneal] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Michelakis, Evangelos; Paterson, Ian; Oudit, Gavin Y.] Univ Alberta, Dept Med, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada	University of Alberta; University of Calgary; University of Alberta	Thompson, RB (corresponding author), Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.	richard.thompson@ualberta.ca	Khan, Aneal/W-2019-2018	Paterson, David Ian/0000-0003-4529-3102; Thompson, Richard/0000-0003-3319-4377	Alberta Innovates-Health Solutions Interdisciplinary Team Grant [AHFMR ITG 200801018]; University Hospital Foundation [RES0002513]; Genzyme Canada; Alberta Innovates-Health Solutions [201200120]; Women and Children's Health Research Institute; Natural Sciences and Engineering Research Council of Canada	Alberta Innovates-Health Solutions Interdisciplinary Team Grant; University Hospital Foundation; Genzyme Canada(Sanofi-AventisGenzyme Corporation); Alberta Innovates-Health Solutions; Women and Children's Health Research Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The research was partially funded by Alberta Innovates-Health Solutions Interdisciplinary Team Grant #AHFMR ITG 200801018 (http://www.aihealthsolutions.ca/), the University Hospital Foundation RES0002513 (http://www.universityhospitalfoundation.ab.ca/), and a research grant from Genzyme Canada. JJP received funding support from Alberta Innovates-Health Solutions 201200120 and the Women and Children's Health Research Institute (http://www.wchri.org/). KC received funding support from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng-Baron J, 2015, MAGN RESON MED, V73, P586, DOI 10.1002/mrm.25166; Chow K, 2014, MAGN RESON MED, V71, P2082, DOI 10.1002/mrm.24878; Clarke JTR, 2007, ANN INTERN MED, V146, P425, DOI 10.7326/0003-4819-146-6-200703200-00007; Dall'Armellina E, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-15; De Cobelli F, 2009, AM J ROENTGENOL, V192, pW97, DOI 10.2214/AJR.08.1201; Ezekowitz JA, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-91; Ferreira VM, 2013, JACC-CARDIOVASC IMAG, V6, P1048, DOI 10.1016/j.jcmg.2013.03.008; FOALE R, 1986, BRIT HEART J, V56, P33; Garcia-Alvarez A, 2015, JACC-CARDIOVASC IMAG, V8, P76, DOI 10.1016/j.jcmg.2014.08.012; Hughes DA, 2008, HEART, V94, P153, DOI 10.1136/hrt.2006.104026; Kampmann C, 2005, ACTA PAEDIATR, V94, P15, DOI 10.1080/08035320510028049; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Madonna R, 2014, EUR HEART J-CARD IMG, V15, P1094, DOI 10.1093/ehjci/jeu080; Mehta BB, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0209-y; Mehta BB, 2015, MAGN RESON MED, V73, P150, DOI 10.1002/mrm.25100; Moon JCC, 2003, EUR HEART J, V24, P2151, DOI 10.1016/j.ehj.2003.09.017; Morris DA, 2015, INT J CARDIOVAS IMAG, V31, P301, DOI 10.1007/s10554-014-0551-4; Nair V, 2010, J CLIN PATHOL, V63, P12, DOI 10.1136/jcp.2009.072462; Niemann M, 2011, JACC-CARDIOVASC IMAG, V4, P592, DOI 10.1016/j.jcmg.2011.01.020; Niemann M, 2010, HEART, V96, P1915, DOI 10.1136/hrt.2010.204586; Palecek T, 2008, J AM SOC ECHOCARDIOG, V21, P1265, DOI 10.1016/j.echo.2008.09.002; Petritsch B, 2012, ROFO-FORTSCHR RONTG, V184, P1020, DOI 10.1055/s-0032-1313059; Pica S, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0099-4; Puntmann VO, 2013, JACC-CARDIOVASC IMAG, V6, P475, DOI 10.1016/j.jcmg.2012.08.019; Putko BN, 2015, EUR HEART J-CARD IMG, V16, P1129, DOI 10.1093/ehjci/jev057; Putko BN, 2015, HEART FAIL REV, V20, P179, DOI 10.1007/s10741-014-9452-9; Sado DM, 2015, J MAGN RESON IMAGING, V41, P1505, DOI 10.1002/jmri.24727; Sado DM, 2013, CIRC-CARDIOVASC IMAG, V6, P392, DOI 10.1161/CIRCIMAGING.112.000070; Sanz J, 2007, AM J CARDIOL, V100, P731, DOI 10.1016/j.amjcard.2007.03.094; Shanks M, 2013, J AM SOC ECHOCARDIOG, V26, P1407, DOI 10.1016/j.echo.2013.09.005; Sheppard MN, 2010, CARDIOVASC PATHOL, V19, P293, DOI 10.1016/j.carpath.2009.05.003; Thompson RB, 2013, CIRC-CARDIOVASC IMAG, V6, P637, DOI 10.1161/CIRCIMAGING.113.000482; Wuest W, 2011, ROFO-FORTSCHR RONTG, V183, P1037, DOI 10.1055/s-0031-1281744; Yousef Z, 2013, EUR HEART J, V34, P802, DOI 10.1093/eurheartj/ehs166	35	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157565	10.1371/journal.pone.0157565	http://dx.doi.org/10.1371/journal.pone.0157565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305064	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800072
J	Chan, IH; Van Hoof, D; Abramova, M; Bilardello, M; Mar, E; Jorgensen, B; McCauley, S; Bal, H; Oft, M; Van Vlasselaer, P; Mumm, JB				Chan, Ivan H.; Van Hoof, Dennis; Abramova, Marina; Bilardello, Melissa; Mar, Elliot; Jorgensen, Brett; McCauley, Scott; Bal, Harminder; Oft, Martin; Van Vlasselaer, Peter; Mumm, John B.			PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; RECOMBINANT HUMAN INTERLEUKIN-10; REVERSE CHOLESTEROL TRANSPORT; ACUTE MYELOGENOUS LEUKEMIA; NECROSIS-FACTOR-ALPHA; NONALCOHOLIC STEATOHEPATITIS; NEGATIVE REGULATION; MESSENGER-RNA; GENE-TRANSFER; LIVER-CELLS	Interleukin-10 (IL-10) is a multifunctional cytokine that exerts potent context specific immunostimulatory and immunosuppressive effects. We have investigated the mechanism by which PEGylated rIL-10 regulates plasma cholesterol in mice and humans. In agreement with previous work on rIL-10, we report that PEGylated rIL-10 harnesses the myeloid immune system to control total plasma cholesterol levels. We have discovered that PEG-NrMuIL-10's dramatic lowering of plasma cholesterol is dependent on phagocytotic cells. In particular, PEG-rHuIL-10 enhances cholesterol uptake by Kupffer cells. In addition, removal of phagocytotic cells dramatically increases plasma cholesterol levels, suggesting for the first time that immunological cells are implicitly involved in regulating total cholesterol levels. These data suggest that treatment with PEG-rIL-10 potentiates endogenous cholesterol regulating cell populations not currently targeted by standard of care therapeutics. Furthermore, we show that IL-10's increase of Kupffer cell cholesterol phagocytosis is concomitant with decreases in liver cholesterol and triglycerides. This leads to the reversal of early periportal liver fibrosis and facilitates the restoration of liver health. These data recommend PEG-rIL-10 for evaluation in the treatment of fatty liver disease and preventing its progression to non-alcoholic steatohepatitis. In direct confirmation of our in vivo findings in the treatment of hypercholesterolemic mice with PEG-rMuIL-10, we report that treatment of hypercholesterolemic cancer patients with PEG-rHuIL-10 lowers total plasma cholesterol by up to 50%. Taken together these data suggest that PEG-rIL-10's cholesterol regulating biology is consistent between mice and humans.	[Chan, Ivan H.; Van Hoof, Dennis; Abramova, Marina; Bilardello, Melissa; Mar, Elliot; Jorgensen, Brett; McCauley, Scott; Bal, Harminder; Oft, Martin; Van Vlasselaer, Peter; Mumm, John B.] ARMO BioSci Inc, 575 Chesapeake Dr, Redwood City, CA 94063 USA; [Van Hoof, Dennis] Becton Dickinson Biosci, 2350 Qume Dr, San Jose, CA 95131 USA; [Abramova, Marina] Kaiser Permanente, 128 Locust Ave, Larkspur, CA 94939 USA; [Mar, Elliot] Soundninja, 415 Middlefield Rd, Belmont, CA 94002 USA	Becton Dickinson; Kaiser Permanente	Mumm, JB (corresponding author), ARMO BioSci Inc, 575 Chesapeake Dr, Redwood City, CA 94063 USA.	john.mumm@armobio.com	Abramova, Marina/AAA-8459-2020; Chan, Ivan/B-7922-2010	Chan, Ivan/0000-0003-2834-2574; McCauley, Scott/0000-0003-4549-5599	Kleiner Perkins Caufield Byers; Orbimed; ARMO BioSciences Inc.	Kleiner Perkins Caufield Byers; Orbimed; ARMO BioSciences Inc.	ARMO BioSciences is 100% financed by venture funding. At the time this work was conducted the following venture capital firms had provided funds: Kleiner Perkins Caufield Byers, http://www.kpcb.com/; Orbimed, http://www.orbimed.com/. ARMO BioSciences will not conduct clinical trials for the purposes of testing PEG-rHuIL-10's capacity to control cholesterol. ARMO BioSciences is developing PEG-rHuIL-10 only in immunoncology. The funders did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. ARMO BioSciences Inc. provided support in the form of salaries for authors [IHC, DVH, MA, MB, EM, BJ, SM, HB, MO, PVV, JBM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allister EM, 2005, DIABETES, V54, P1676, DOI 10.2337/diabetes.54.6.1676; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Asadullah K, 1999, ARCH DERMATOL, V135, P187, DOI 10.1001/archderm.135.2.187; Bell DA, 2011, EXPERT OPIN INV DRUG, V20, P265, DOI 10.1517/13543784.2011.547471; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; BUDD D, 1986, CANCER, V58, P1361, DOI 10.1002/1097-0142(19860915)58:6<1361::AID-CNCR2820580630>3.0.CO;2-S; Chan IH, 2015, J INTERF CYTOK RES, V35, P948, DOI 10.1089/jir.2014.0221; Chang J, 2009, P NATL ACAD SCI USA, V106, P18327, DOI 10.1073/pnas.0905815106; Cuchel M, 2013, LANCET, V381, P40, DOI 10.1016/S0140-6736(12)61731-0; Curtale G, 2013, P NATL ACAD SCI USA, V110, P11499, DOI 10.1073/pnas.1219852110; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; de Fost M, 2009, ATHEROSCLEROSIS, V204, P267, DOI 10.1016/j.atherosclerosis.2008.08.027; Denning TL, 2000, INT IMMUNOL, V12, P133, DOI 10.1093/intimm/12.2.133; Fedorak RN, 2000, GASTROENTEROLOGY, V119, P1473, DOI 10.1053/gast.2000.20229; GINSBERG H, 1984, CLIN GENET, V26, P109; Halvorsen B, 2005, J LIPID RES, V46, P211, DOI 10.1194/jlr.M400324-JLR200; Han XB, 2010, FASEB J, V24, P2869, DOI 10.1096/fj.09-148155; Han XB, 2009, J BIOL CHEM, V284, P32950, DOI 10.1074/jbc.M109.040899; HARKES L, 1984, BIOCHIM BIOPHYS ACTA, V794, P340, DOI 10.1016/0005-2760(84)90165-6; HARKES L, 1984, BIOCHEM J, V224, P21, DOI 10.1042/bj2240021; Herbert DR, 2008, J IMMUNOL, V181, P7214, DOI 10.4049/jimmunol.181.10.7214; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Ichimura M, 2015, HEPATOL RES, V45, P458, DOI 10.1111/hepr.12358; Infante JR, 2015, ASCO M S, V33, P3017; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; KAMPS JAAM, 1991, BIOCHEM J, V276, P135, DOI 10.1042/bj2760135; Kimball AB, 2002, ARCH DERMATOL, V138, P1341, DOI 10.1001/archderm.138.10.1341; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Lambert G, 2012, J LIPID RES, V53, P2515, DOI 10.1194/jlr.R026658; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Martel C, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0354-4; Martel C, 2013, J CLIN INVEST, V123, P1571, DOI 10.1172/JCI63685; MILLER GJ, 1975, LANCET, V1, P16; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P577, DOI 10.1016/j.intimp.2004.01.007; Nelson DR, 2003, HEPATOLOGY, V38, P859, DOI 10.1053/jhep.2003.50427; NENSETER MS, 1992, J LIPID RES, V33, P867; NIMER SD, 1988, JAMA-J AM MED ASSOC, V260, P3297, DOI 10.1001/jama.260.22.3297; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Peterson AS, 2008, J LIPID RES, V49, P1595, DOI 10.1194/jlr.CX00001-JLR200; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; Reich K, 2001, J INVEST DERMATOL, V116, P319, DOI 10.1046/j.1523-1747.2001.01248.x; REVERTER JC, 1988, EUR J HAEMATOL, V41, P317; Ritchlin C, 2001, J RHEUMATOL, V28, P698; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Rubic T, 2006, CARDIOVASC RES, V69, P527, DOI 10.1016/j.cardiores.2005.10.018; Santucci L, 1996, GASTROENTEROLOGY, V111, P736, DOI 10.1053/gast.1996.v111.pm8780580; Schreiber S, 2000, GASTROENTEROLOGY, V119, P1461, DOI 10.1053/gast.2000.20196; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; Steib CJ, 2011, GUT, V60, P1307, DOI 10.1136/gut.2011.242560; Tatidis L, 2001, CANCER LETT, V170, P169, DOI 10.1016/S0304-3835(01)00592-4; Thomas GS, 2013, J AM COLL CARDIOL, V62, P2178, DOI 10.1016/j.jacc.2013.07.081; Tilg H, 2002, GUT, V50, P191, DOI 10.1136/gut.50.2.191; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; von der Thusen JH, 2001, FASEB J, V15, P2730, DOI 10.1096/fj.01-0483fje; Wang XZ, 2004, WORLD J GASTROENTERO, V10, P2706, DOI 10.3748/wjg.v10.i18.2706; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; Yoshioka T, 2004, GENE THER, V11, P1772, DOI 10.1038/sj.gt.3302348; Zhang LJ, 2007, HEPATO-GASTROENTEROL, V54, P2092	65	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156229	10.1371/journal.pone.0156229	http://dx.doi.org/10.1371/journal.pone.0156229			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299860	Green Submitted, Green Published, gold			2022-12-27	WOS:000377822200007
J	Kaye, DR; Pinto, PA; Cecchi, F; Reilly, J; Semerjian, A; Rabe, DC; Gupta, G; Choyke, PL; Bottaro, DP				Kaye, Deborah R.; Pinto, Peter A.; Cecchi, Fabiola; Reilly, Joseph; Semerjian, Alice; Rabe, Daniel C.; Gupta, Gopal; Choyke, Peter L.; Bottaro, Donald P.			Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; C-MET; BONE METASTASES; ANTIGEN LEVEL; PROGRESSION; EXPRESSION; RECEPTOR; CABOZANTINIB; CARCINOMA; LOCATION	Objective To measure Met protein content in prostate biopsies guided by fused magnetic resonance and ultrasound imaging, and to measure soluble Met (sMet) protein concentration in plasma samples from patients presenting evidence of prostate cancer. Patients and Methods 345 patients had plasma samples drawn prior to image-guided biopsy of the prostate. Of these, 32% had benign biopsies. Of the 236 that were positive for prostate adenocarcinoma (PCa), 132 treated by total prostatectomy had Gleason scores of 6 (17%), 7, (55%), 8 (16%), or 9-10 (12%). 23% had evidence of local invasion. Plasma samples were also obtained from 80 healthy volunteers. Tissue Met and plasma sMet were measured by two-site immunoassay; values were compared among clinically defined groups using non-parametric statistical tests to determine significant differences or correlations. Results PCa tumor Met correlated significantly with plasma sMet, but median values were similar among benign and malignant groups. Median plasma sMet values were also similar among those groups, although both medians were significantly above normal. Median Met content in primary PCa tumors and sMet concentrations were independent of Gleason score, final pathologic stage and age. Conclusion Plasma sMet is not predictive of PCa or its severity in patients with organ-confined or locally invasive disease. Quantitative analysis of Met protein content and activation state in PCa tumor biopsy samples was highly feasible and may have value in follow-up to genomic and/or transcriptomic-based screens that show evidence of oncogenically relevant MET gene features that occur at relatively low frequency in non-metastatic PCa.	[Kaye, Deborah R.; Pinto, Peter A.; Cecchi, Fabiola; Reilly, Joseph; Semerjian, Alice; Rabe, Daniel C.; Gupta, Gopal; Bottaro, Donald P.] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Choyke, Peter L.] NCI, Mol Imaging Program, Ctr Canc Res, Bethesda, MD 20892 USA; [Kaye, Deborah R.] Johns Hopkins Univ, James Buchanan Brady Urol Inst, 600 N Wolfe St, Baltimore, MD 21287 USA; [Cecchi, Fabiola; Reilly, Joseph] NantOmics, 9600 Med Ctr Dr,Suite 300, Rockville, MD 20850 USA; [Semerjian, Alice] George Washington Univ Med Fac Associates, 2150 Penn Ave NW, Washington, DC 20037 USA; [Rabe, Daniel C.] Univ Chicago, Div Biol Sci, BSLC, 924 E 57th St,Suite 104, Chicago, IL 60637 USA; [Gupta, Gopal] Loyola Univ, Med Ctr, Dept Urol, 2160 S First Ave,Bldg 54,Room 237A, Maywood, IL 60153 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; University of Chicago; Loyola University Chicago	Bottaro, DP (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	dbottaro@helix.nih.gov	Bottaro, Donald P/AAF-3853-2020; Rabe, Daniel/F-2420-2018; Bottaro, Donald P/F-8550-2010	Bottaro, Donald P/0000-0002-5057-5334; Rabe, Daniel/0000-0001-6126-2280; Bottaro, Donald P/0000-0002-5057-5334	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; National Institutes of Health Intramural Research Program, National Cancer Institute, Center for Cancer Research [ZIA BC011124]; NATIONAL CANCER INSTITUTE [ZIABC011081, ZIABC011124] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Intramural Research Program, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Institutes of Health Intramural Research Program, National Cancer Institute, Center for Cancer Research, awarded to DPB, ZIA BC011124: http://fundedresearch.cancer.gov/nciportfolio/search/detailsaction=abstract&grantNum=ZIA%20BC%20011124&grantID=34045&grtSCDC=FY%202013&absID=34045&absSCDC=PUB2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. We thank Alessio Giubellino for contributions to Met measurements reported here.	AIHARA M, 1994, J UROLOGY, V151, P1558, DOI 10.1016/S0022-5347(17)35302-8; Athauda G, 2006, CLIN CANCER RES, V12, P4154, DOI 10.1158/1078-0432.CCR-06-0250; Basch E, 2015, EUR UROL, V67, P310, DOI 10.1016/j.eururo.2014.02.013; Bensalah K, 2008, PROSTATE CANCER P D, V11, P112, DOI 10.1038/sj.pcan.4501026; Cecchi F, 2012, CANCER CELL, V22, P250, DOI 10.1016/j.ccr.2012.06.029; Cecchi F, 2012, EXPERT OPIN THER TAR, V16, P553, DOI 10.1517/14728222.2012.680957; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Clyne Melanie, 2014, Nat Rev Urol, V11, P188, DOI 10.1038/nrurol.2014.57; Fall K, 2007, JNCI-J NATL CANCER I, V99, P526, DOI 10.1093/jnci/djk110; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gartrell BA, 2014, NAT REV CLIN ONCOL, V11, P335, DOI 10.1038/nrclinonc.2014.70; Graham TJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju033; Gupta A, 2008, CLIN CANCER RES, V14, P7385, DOI 10.1158/1078-0432.CCR-07-5110; HUMPHREY PA, 1995, AM J PATHOL, V147, P386; Humphrey PA, 2006, CLIN GENITOURIN CANC, V4, P269, DOI 10.3816/CGC.2006.n.006; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Knudsen BS, 2002, UROLOGY, V60, P1113, DOI 10.1016/S0090-4295(02)01954-4; Lee RJ, 2013, CLIN CANCER RES, V19, P3088, DOI 10.1158/1078-0432.CCR-13-0319; Leibovici D, 2007, CANCER, V109, P198, DOI 10.1002/cncr.22372; Naughton M, 2001, J UROLOGY, V165, P1325, DOI 10.1016/S0022-5347(01)69893-8; PISTERS LL, 1995, J UROLOGY, V154, P293, DOI 10.1016/S0022-5347(01)67297-5; Russo AL, 2009, CLIN CANCER RES, V15, P4292, DOI 10.1158/1078-0432.CCR-09-0599; Sandblom G, 2008, CANCER, V112, P813, DOI 10.1002/cncr.23235; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; Turkbey B, 2011, CANCER IMAGING, V11, P31, DOI 10.1102/1470-7330.2011.0007; Turkbey B, 2011, BJU INT, V107, P53, DOI 10.1111/j.1464-410X.2010.09483.x; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Watanabe M, 1999, CANCER LETT, V141, P173, DOI 10.1016/S0304-3835(99)00102-0	28	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157130	10.1371/journal.pone.0157130	http://dx.doi.org/10.1371/journal.pone.0157130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300295	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200030
J	Kelsey, TW; Ginbey, E; Chowdhury, MM; Bath, LE; Anderson, RA; Wallace, WHB				Kelsey, Thomas W.; Ginbey, Eleanor; Chowdhury, Moti M.; Bath, Louise E.; Anderson, Richard A.; Wallace, W. Hamish B.			A Validated Normative Model for Human Uterine Volume from Birth to Age 40 Years	PLOS ONE			English	Article							CENTRAL PRECOCIOUS PUBERTY; PELVIC ULTRASONOGRAPHY; HEALTHY GIRLS; EARLY DIFFERENTIATION; ULTRASOUND EVALUATION; POSTMENOPAUSAL WOMEN; PREMATURE THELARCHE; REPLACEMENT THERAPY; TURNER-SYNDROME; OVARIAN	Transabdominal pelvic ultrasound and/or pelvic Magnetic Resonance Imaging are safe, accurate and non-invasive means of determining the size and configuration of the internal female genitalia. The assessment of uterine size and volume is helpful in the assessment of many conditions including disorders of sex development, precocious or delayed puberty, infertility and menstrual disorders. Using our own data from the assessment of MRI scans in healthy young females and data extracted from four studies that assessed uterine volume using transabdominal ultrasound in healthy females we have derived and validated a normative model of uterine volume from birth to age 40 years. This shows that uterine volume increases across childhood, with a faster increase in adolescence reflecting the influence of puberty, followed by a slow but progressive rise during adult life. The model suggests that around 84% of the variation in uterine volumes in the healthy population up to age 40 is due to age alone. The derivation of a validated normative model for uterine volume from birth to age 40 years has important clinical applications by providing age-related reference values for uterine volume.	[Kelsey, Thomas W.] Univ St Andrews, Sch Comp Sci, St Andrews KY16 9SX, Fife, Scotland; [Ginbey, Eleanor] Univ Edinburgh, Sch Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [Chowdhury, Moti M.] Royal Hosp Sick Children, Dept Paediat Radiol, Edinburgh EH9 1LF, Midlothian, Scotland; [Bath, Louise E.] Royal Hosp Sick Children, Dept Endocrinol & Diabet, Edinburgh EH9 1LF, Midlothian, Scotland; [Anderson, Richard A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland; [Wallace, W. Hamish B.] Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland	University of St Andrews; University of Edinburgh; University of Edinburgh	Wallace, WHB (corresponding author), Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland.	hamish.wallace@nhs.net	Kelsey, Thomas W/H-3727-2019	Kelsey, Thomas W/0000-0002-8091-1458				Abbassi V, 1998, PEDIATRICS, V102, P507; Albertsson-Wikland K, 2014, HORM RES PAEDIAT, V82, P158, DOI 10.1159/000363106; Badouraki M, 2008, J CLIN ULTRASOUND, V36, P539, DOI 10.1002/jcu.20522; Bath LE, 1999, BRIT J OBSTET GYNAEC, V106, P1265, DOI 10.1111/j.1471-0528.1999.tb08180.x; Bridges NA, 1996, ARCH DIS CHILD, V75, P330, DOI 10.1136/adc.75.4.330; Buzi F, 1998, ACTA PAEDIATR, V87, P1138; Cagnacci A, 2000, MENOPAUSE, V7, P117, DOI 10.1097/00042192-200007020-00008; Christodoulacos G, 2002, MATURITAS, V42, P77, DOI 10.1016/S0378-5122(02)00027-0; Critchley Hilary O D, 2005, J Natl Cancer Inst Monogr, P64; Da Costa AG, 2004, ULTRASOUND MED BIOL, V30, P7, DOI 10.1016/j.ultrasmedbio.2003.09.009; de Vries L, 2006, EUR J ENDOCRINOL, V154, P891, DOI 10.1530/eje.1.02151; Elsedfy HH, 2012, J PEDIATR ENDOCR MET, V25, P441, DOI 10.1515/jpem-2012-0040; HABER HP, 1995, EUR J PEDIATR, V154, P182, DOI 10.1007/BF01954267; Haber HP, 1999, J ULTRAS MED, V18, P271; HABER HP, 1994, PEDIATR RADIOL, V24, P11, DOI 10.1007/BF02017650; Hagen CP, 2015, FERTIL STERIL, V104, P452, DOI 10.1016/j.fertnstert.2015.04.042; Hauth EAM, 2007, EUR RADIOL, V17, P734, DOI 10.1007/s00330-006-0313-3; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Herter LD, 2002, J ULTRAS MED, V21, P1237, DOI 10.7863/jum.2002.21.11.1237; HOLM K, 1995, ULTRASOUND OBST GYN, V6, P175, DOI 10.1046/j.1469-0705.1995.06030175.x; HRA, 2013, DOES MY PROJ REQ REV; Kelsey TW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153843; Kelsey TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109346; Kelsey TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071465; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; Larsen EC, 2004, ACTA OBSTET GYN SCAN, V83, P96, DOI 10.1111/j.1600-0412.2004.00332.x; Merz E, 1996, ULTRASOUND OBST GYN, V7, P38, DOI 10.1046/j.1469-0705.1996.07010038.x; Nella AA, 2014, J PEDIATR ENDOCR MET, V27, P821, DOI 10.1515/jpem-2013-0415; Razzaghy-Azar M, 2011, J CLIN ULTRASOUND, V39, P64, DOI 10.1002/jcu.20723; RIGSBY CK, 1994, J COMPUT ASSIST TOMO, V18, P72, DOI 10.1097/00004728-199401000-00016; Rohatgi A., 2015, WEBPLOTDIGITIZER; SALARDI S, 1988, J PEDIATR-US, V112, P880, DOI 10.1016/S0022-3476(88)80208-7; SALARDI S, 1985, ARCH DIS CHILD, V60, P120, DOI 10.1136/adc.60.2.120; SORNES T, 1989, ACTA OBSTET GYN SCAN, V68, P439, DOI 10.3109/00016348909021017; TSE WY, 1989, ACTA PAEDIATR SCAND, P38; Verguts J, 2013, ULTRASOUND OBST GYN, V42, P713, DOI 10.1002/uog.12538; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772	37	18	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157375	10.1371/journal.pone.0157375	http://dx.doi.org/10.1371/journal.pone.0157375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295032	Green Published, Green Submitted, gold			2022-12-27	WOS:000377821300038
J	Marmesat, E; Soriano, L; Mazzoni, CJ; Sommer, S; Godoy, JA				Marmesat, Elena; Soriano, Laura; Mazzoni, Camila J.; Sommer, Simone; Godoy, Jose A.			PCR Strategies for Complete Allele Calling in Multigene Families Using High-Throughput Sequencing Approaches	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TAQ DNA-POLYMERASE; MHC; MISMATCH; AMPLIFICATION; POLYMORPHISM; GENE; DISCRIMINATION; POPULATION; EXPRESSION	The characterization of multigene families with high copy number variation is often approached through PCR amplification with highly degenerate primers to account for all expected variants flanking the region of interest. Such an approach often introduces PCR biases that result in an unbalanced representation of targets in high-throughput sequencing libraries that eventually results in incomplete detection of the targeted alleles. Here we confirm this result and propose two different amplification strategies to alleviate this problem. The first strategy (called pooled-PCRs) targets different subsets of alleles in multiple independent PCRs using different moderately degenerate primer pairs, whereas the second approach (called pooled-primers) uses a custom-made pool of non-degenerate primers in a single PCR. We compare their performance to the common use of a single PCR with highly degenerate primers using the MHC class I of the Iberian lynx as a model. We found both novel approaches to work similarly well and better than the conventional approach. They significantly scored more alleles per individual (11.33 +/- 1.38 and 11.72 +/- 0.89 vs 7.94 +/- 1.95), yielded more complete allelic profiles (96.28 +/- 8.46 and 99.50 +/- 2.12 vs 63.76 +/- 15.43), and revealed more alleles at a population level (13 vs 12). Finally, we could link each allele's amplification efficiency with the primer-mismatches in its flanking sequences and show that ultra-deep coverage offered by high-throughput technologies does not fully compensate for such biases, especially as real alleles may reach lower coverage than artefacts. Adopting either of the proposed amplification methods provides the opportunity to attain more complete allelic profiles at lower coverages, improving confidence over the downstream analyses and subsequent applications.	[Marmesat, Elena; Soriano, Laura; Godoy, Jose A.] CSIC, Dept Integrat Ecol, Estn Biol Donana, E-41080 Seville, Spain; [Mazzoni, Camila J.] Berlin Ctr Genom Biodivers Res BeGenDiv, Berlin, Germany; [Mazzoni, Camila J.] Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany; [Sommer, Simone] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, D-89069 Ulm, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Leibniz Institut fur Zoo und Wildtierforschung; Ulm University	Godoy, JA (corresponding author), CSIC, Dept Integrat Ecol, Estn Biol Donana, E-41080 Seville, Spain.	godoy@ebd.csic.es	Mazzoni, Camila/AAJ-9702-2020; Marmesat, Elena/AAC-4300-2020; Godoy, José Antonio/B-9288-2008	Mazzoni, Camila/0000-0001-6758-5427; Marmesat, Elena/0000-0002-3007-4284; Godoy, José Antonio/0000-0001-7502-9471	Direccion General de Investigacion Cinetifica y Tecnica, Spanish Science and Innovation Ministry [CGL2010-21540/BOS, CGL2013-47755-P]; CSIC (Spanish National Research Council); CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI); Life project [LIFE10NAT/ES/570]; Spanish Direccion General de Investigacion Cientifica y Tecnica [CGL2013-47755-P, CCGL2010-21540/BOS]; ESF activity on 'Conservation Genomics: Amalgamation of Conservation Genetics and Ecological and Evolutionary Genomics'	Direccion General de Investigacion Cinetifica y Tecnica, Spanish Science and Innovation Ministry; CSIC (Spanish National Research Council); CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI); Life project; Spanish Direccion General de Investigacion Cientifica y Tecnica(Spanish Government); ESF activity on 'Conservation Genomics: Amalgamation of Conservation Genetics and Ecological and Evolutionary Genomics'	Funding for this project was provided by the Direccion General de Investigacion Cinetifica y Tecnica, Spanish Science and Innovation Ministry, through grants CGL2010-21540/BOS and CGL2013-47755-P. Elena Marmesat received a JAE predoctoral grant from CSIC (Spanish National Research Council) and a short stay grant within the framework of the ESF activity on 'Conservation Genomics: Amalgamation of Conservation Genetics and Ecological and Evolutionary Genomics'. The authors acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Ana Piriz and Maria Mendez for support with laboratory work and to P. James Macaluso for his proofreading services. Thanks to the Junta de Andalucia, the Iberian lynx Captive Breeding Program and the Life project LIFE10NAT/ES/570 for kindly providing the samples used in this study. Logistical support was provided by Laboratorio de Ecologia Molecular, Estacion Biologica de Donana, CSIC (LEM-EBD). This study was funded by the Spanish Direccion General de Investigacion Cientifica y Tecnica through projects CCGL2010-21540/BOS and CGL2013-47755-P. We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Ayyadevara S, 2000, ANAL BIOCHEM, V284, P11, DOI 10.1006/abio.2000.4635; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Babik W, 2009, MOL ECOL RESOUR, V9, P713, DOI 10.1111/j.1755-0998.2009.02622.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Burri R, 2014, MOL ECOL RESOUR, V14, P778, DOI 10.1111/1755-0998.12234; Casas-Marce M, 2013, MOL ECOL, V22, P5503, DOI 10.1111/mec.12498; Castro-Prieto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049129; Castro-Prieto A, 2011, MOL BIOL EVOL, V28, P1455, DOI 10.1093/molbev/msq330; Christopherson C, 1997, NUCLEIC ACIDS RES, V25, P654, DOI 10.1093/nar/25.3.654; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Day JP, 1999, NUCLEIC ACIDS RES, V27, P1810, DOI 10.1093/nar/27.8.1810; Denovo.cnag.cat, 2016, JBROWSE; DRESSLER GR, 1988, TRENDS GENET, V4, P214, DOI 10.1016/S0168-9525(88)80003-9; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Herdegen M, 2014, J EVOLUTION BIOL, V27, P2347, DOI 10.1111/jeb.12476; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim UK, 2004, J DENT RES, V83, P448, DOI 10.1177/154405910408300603; KLEIN J, 1986, NATURAL HIST MAJOR H; Lamaze FC, 2014, MOL ECOL, V23, P1730, DOI 10.1111/mec.12684; Larsen KB, 2010, J HISTOCHEM CYTOCHEM, V58, P669, DOI 10.1369/jhc.2010.955757; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lighten J, 2014, MOL ECOL, V23, P3957, DOI 10.1111/mec.12843; Lighten J, 2014, MOL ECOL RESOUR, V14, P753, DOI 10.1111/1755-0998.12225; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Oomen RA, 2013, MOL ECOL RESOUR, V13, P103, DOI 10.1111/1755-0998.12027; Parducci L, 2013, MOL ECOL, V22, P3511, DOI 10.1111/mec.12298; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; Pokorny I, 2010, IMMUNOGENETICS, V62, P667, DOI 10.1007/s00251-010-0475-7; R Core Team, 2008, LECT NOTE PHYS, V739, P2673, DOI [10.1007/978-3-540-74686-7, DOI 10.1007/978-3-540-74686-7]; R Development Core Team, 2014, R LANG ENV STAT COMP; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sachdev M, 2005, TISSUE ANTIGENS, V66, P9, DOI 10.1111/j.1399-0039.2005.00432.x; Sambrook J., 2001, MOL CLONING LAB MANU; SARKAR G, 1990, ANAL BIOCHEM, V186, P64, DOI 10.1016/0003-2697(90)90573-R; Sebastian A, 2016, MOL ECOL RESOUR, V16, P498, DOI 10.1111/1755-0998.12453; Sepil I, 2013, MOL ECOL, V22, P384, DOI 10.1111/mec.12123; Shum J, 2009, ANAL BIOCHEM, V388, P266, DOI 10.1016/j.ab.2009.02.033; Sommer S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-542; Stutz WE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100587; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wegner KM, 2009, MOL ECOL, V18, P1818, DOI 10.1111/j.1365-294X.2009.04173.x; Wu JH, 2009, J MICROBIOL METH, V77, P267, DOI 10.1016/j.mimet.2009.03.001; YANAGI S, 1975, LIFE SCI, V17, P1411, DOI 10.1016/0024-3205(75)90161-7; Yuhki N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002674; Zagalska-Neubauer M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-395	53	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157402	10.1371/journal.pone.0157402	http://dx.doi.org/10.1371/journal.pone.0157402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294261	Green Submitted, Green Published, gold			2022-12-27	WOS:000377821300043
J	Niendorf, S; Klemm, U; Marques, AM; Bock, CT; Hohne, M				Niendorf, Sandra; Klemm, Uwe; Marques, Andreas Mas; Bock, C. -Thomas; Hoehne, Marina			Infection with the Persistent Murine Norovirus Strain MNV-S99 Suppresses IFN-Beta Release and Activation of Stat1 In Vitro	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; HEPATITIS-C VIRUS; REGULATORY FACTOR-3; GAMMA-INTERFERON; REPLICATION; PROTEIN; CELLS; DEGRADATION; IRF-3; GASTROENTERITIS	Norovirus infection is the main cause of epidemic non-bacterial gastroenteritis in humans. Although human norovirus (HuNoV) infection is self-limiting, it can persist for extended periods of time in immune deficient patients. Due to the lack of robust cell culture and small animal systems, little is known about HuNoV pathogenicity. However, murine norovirus (MNV) can be propagated in cell culture and is used as a model to study norovirus infection. Several MNV are known to persist in mice. In this study, we show that the MNV strain MNV-S99 persists in wild type inbred (C57BL/6J) mice over a period of at least 5 weeks post infection. Viral RNA was detectable in the jejunum, ileum, cecum, and colon, with the highest titers in the colon and cecum. To characterize the effect of MNV-S99 on the innate immune response, Stat1 phosphorylation and IFN-beta production were analyzed and compared to the non-persistent strain MNV-1. CW3. While MNV-S99 and MNV-1. CW3 showed comparable growth characteristics in vitro, Stat1 phosphorylation and IFN-beta release is strongly decreased after infection with MNV-S99 compared to MNV-1. CW3. In conclusion, our results show that unlike MNV-1. CW3, MNV-S99 establishes a persistent infection in mice, possibly due to interfering with the innate immune response.	[Niendorf, Sandra; Marques, Andreas Mas; Bock, C. -Thomas; Hoehne, Marina] Robert Koch Inst, Dept Viral Gastroenteritis & Hepatitis Pathogens, Berlin, Germany; [Klemm, Uwe] Max Planck Inst Infect Biol, Berlin, Germany	Robert Koch Institute; Max Planck Society	Niendorf, S (corresponding author), Robert Koch Inst, Dept Viral Gastroenteritis & Hepatitis Pathogens, Berlin, Germany.	NiendorfS@rki.de	Bock, C.-Thomas/A-3518-2012	Bock, C.-Thomas/0000-0002-2773-486X; Mas Marques, Andreas/0000-0001-8112-8054				Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002; Arias A, 2012, J GEN VIROL, V93, P1432, DOI 10.1099/vir.0.042176-0; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Bellecave P, 2010, HEPATOLOGY, V51, P1127, DOI 10.1002/hep.23426; Capizzi T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-131; Chang KO, 2004, P NATL ACAD SCI USA, V101, P8733, DOI 10.1073/pnas.0401126101; Changotra H, 2009, J VIROL, V83, P5683, DOI 10.1128/JVI.00231-09; Graff JW, 2007, J GEN VIROL, V88, P613, DOI 10.1099/vir.0.82255-0; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Hsu CC, 2006, COMPARATIVE MED, V56, P247; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kim JR, 2011, J VET MED SCI, V73, P687, DOI 10.1292/jvms.10-0226; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Ludwig A, 2008, J MED VIROL, V80, P1461, DOI 10.1002/jmv.21217; Maloney NS, 2012, J VIROL, V86, P12655, DOI 10.1128/JVI.01564-12; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; McCartney SA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000108; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Muller B, 2007, ARCH VIROL, V152, P1709, DOI 10.1007/s00705-007-0989-y; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Perdue KA, 2007, J AM ASSOC LAB ANIM, V46, P39; Rodriguez MR, 2014, J VIROL, V88, P9277, DOI 10.1128/JVI.01422-14; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schorn R, 2010, CLIN INFECT DIS, V51, P307, DOI 10.1086/653939; Shortland A, 2014, J GEN VIROL, V95, P413, DOI 10.1099/vir.0.059188-0; Taube S, 2013, MBIO, V4, DOI 10.1128/mBio.00450-13; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Thackray LB, 2012, J VIROL, V86, P13515, DOI 10.1128/JVI.01824-12; Tian J, 2015, INFECT GENET EVOL, V34, P352, DOI 10.1016/j.meegid.2015.06.003; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Waugh E, 2014, VIRUS RES, V181, P27, DOI 10.1016/j.virusres.2013.12.025; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Xu RH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002475; Yumiketa Y, 2016, VET MICROBIOL, V185, P62, DOI 10.1016/j.vetmic.2016.02.005	42	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156898	10.1371/journal.pone.0156898	http://dx.doi.org/10.1371/journal.pone.0156898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294868	gold, Green Published, Green Submitted			2022-12-27	WOS:000377821300013
J	Robertson, J; Newby, DA; Walkom, EJ				Robertson, Jane; Newby, David A.; Walkom, Emily J.			Health Care Spending: Changes in the Perceptions of the Australian Public	PLOS ONE			English	Article							CANCER CARE; NONRESPONSE	Background Increasing demand for services and rising health care costs create pressures within the Australian health care system and result in higher health insurance premiums and out-of-pocket costs for consumers. Objective To measure changes in consumer views on the quality of the Australian health care system, contributors to rising costs and attitudes towards managing these costs. Methods Two computer-assisted telephone interviews were conducted in 2006 (533 respondents) and 2015 (1318 respondents) and results compared. Results More respondents in 2015 rated the Australian health care system 'very adequate' than in 2006 (22.3% vs 8.3%; Odds Ratio OR 3.2, 99% CI 2.1, 5.1) with fewer 'concerned' or 'fairly concerned' about the health care costs (69.0% vs 85.7%; OR 0.37, 99% CI 0.25, 0.53). The 2015 respondents were more likely to identify new treatments for cancer (77% vs 65.7%; OR 1.75, 99% CI 1.30, 2.35) and community expectations for access to the latest technologies (73.8% vs 67%; OR 1.39, 99% CI 1.04, 1.86) as contributors to rising health care costs. While more 2015 respondents agreed that patients should pay a greater part of the health care costs, this remained a minority view (37.9% vs 31.7%; OR 1.32, 99% CI 0.99, 1.76). They were less likely to agree that doctors should offer medical treatments regardless of the cost and chance of benefit (63.6% vs 82.9%; OR 0.36, 99% CI 0.25, 0.50). Conclusions Satisfaction with the Australian health care system has increased over time. Consumers recognise the cost pressures and have lower expectations that all services should be provided regardless of their costs and potential benefit. Public consultation on the allocation of health care resources and involvement in health care decision-making remains important. There should be community consultation about the principles and values that should guide resource allocation decisions.	[Robertson, Jane; Newby, David A.; Walkom, Emily J.] Univ Newcastle, Dept Clin Pharmacol, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia	University of Newcastle	Robertson, J (corresponding author), Univ Newcastle, Dept Clin Pharmacol, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia.	Jane.Robertson@newcastle.edu.au	Walkom, Emily/ABC-2159-2021; Newby, David/G-7225-2013; WALKOM, EMILY/G-7025-2013	Walkom, Emily/0000-0002-4458-5448; Newby, David/0000-0002-6818-6636; WALKOM, EMILY/0000-0002-4458-5448				[Anonymous], 2014, AUSTR HLTH SER; [Anonymous], 2009, CANBERRA TIMES 0514, P19; Attia J, 2015, CONVERSATION; Australian Commision on Safety and Quality in Health Care, 2012, NAT SAF QUAL HLTH SE; Australian Government Department of Health, PHARM BENEFITS SCHEM; Australian Government Department of Human Services, MED SERV; Bach PB, 2016, J CLIN ONCOL, V34, P889, DOI 10.1200/JCO.2015.63.7397; Bourke L., 2015, SYDNEY MORNING HERAL; Braithwaite J, 2016, SYDNEY MORN HERALD, P16; Carpenter A, 2015, HEALTH POLICY, V119, P907, DOI 10.1016/j.healthpol.2015.03.010; Chalkidou K, 2014, LANCET ONCOL, V15, pE119, DOI 10.1016/S1470-2045(13)70547-3; Commonwealth of Australia, 2015, AV NEW INN SPEC CANC; Commonwealth of Australia, 2014, REF FED WHIT PAP ROL; Conklin A, 2015, HEALTH EXPECT, V18, P153, DOI 10.1111/hex.12038; Cresswell A, 2011, RESULTS NATIONS HLTH; Cresswell A, 2011, AUSTRALIAN, P5; Cronin D., 2007, CANBERRA TIMES 0514, P5; Curtin R, 2005, PUBLIC OPIN QUART, V69, P87, DOI 10.1093/poq/nfi002; Del Mar CB, 2014, MED J AUSTRALIA, V200, P367, DOI 10.5694/mja14.00223; Doggett J., 2014, EMPTY POCKETS WHY CO; Duckett Stephen, 2015, CONVERSATION; Eagar K., 2008, OPTIONS REFORM COMMO; Ghinea N, 2015, CONVERSATION; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Hawkes N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4803; Heffernan M, 2012, AGE, P7; Kelly RJ, 2014, LANCET ONCOL, V15, pE112, DOI 10.1016/S1470-2045(13)70578-3; Kmietowicz Z, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4988; Knight A., 2013, AUSTR PRESCRIBER, V6, P199, DOI DOI 10.18773/austprescr.2013.078; Krinks R, 2016, HEALTH EXPECT, V19, P1015, DOI 10.1111/hex.12397; Laba TL, 2015, AUST HEALTH REV, V39, P33, DOI 10.1071/AH14087; Metherell M., 2010, AGE, P9; Nous Group, 2012, MENZ NOUS AUSTR HLTH; O'Rourke D, 1989, INT J PUBLIC OPINION, V1, P164, DOI DOI 10.1093/IJPOR/1.2.164; Pizzo E, 2015, HEALTH EXPECT, V18, P1918, DOI 10.1111/hex.12204; Productivity Commission, 2015, EFF HLTH; Queensland Government, WAIT LISTS; Richardson JR, 2014, MED J AUSTRALIA, V200, P629, DOI 10.5694/mja14.00564; Robertson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019222; Russell L, 2015, TACKLING OUT POCKET; Saltz LB, 2015, J CLIN ONCOL, V33, P1093, DOI 10.1200/JCO.2014.60.1401; Scheunemann LP, 2011, CHEST, V140, P1625, DOI 10.1378/chest.11-0622; Shih YCT, 2013, J CLIN ONCOL, V31, P4151, DOI 10.1200/JCO.2013.51.0651; Swan N, 2015, ABC NEWS; Swerissen H, 2015, MED J AUSTRALIA, V202, P10, DOI 10.5694/mja14.01580; The George Institute for Global Health Australia, 2004, HLTH LEAD AGR AUSTR; Wells L, 2015, STRONGER MEDICARE; Wells L, 2015, CANBERRA TIMES  1028, P5	48	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157312	10.1371/journal.pone.0157312	http://dx.doi.org/10.1371/journal.pone.0157312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KF	27294518	Green Published, Green Submitted, gold			2022-12-27	WOS:000377821300034
J	Ceccarelli, DM; Emslie, MJ; Richards, ZT				Ceccarelli, Daniela M.; Emslie, Michael J.; Richards, Zoe T.			Post-Disturbance Stability of Fish Assemblages Measured at Coarse Taxonomic Resolution Masks Change at Finer Scales	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MARINE PROTECTED AREAS; CORAL-REEFS; TROPICAL CYCLONE; TERRITORIAL DAMSELFISHES; COMMUNITY STRUCTURE; HABITAT; CLIMATE; RECOVERY; IMPACT	Quantifying changes to coral reef fish assemblages in the wake of cyclonic disturbances is challenging due to spatial variability of damage inherent in such events. Often, fish abundance appears stable at one spatial scale (e.g. reef-wide), but exhibits substantial change at finer scales (e.g. site-specific decline or increase). Taxonomic resolution also plays a role; overall stability at coarse taxonomic levels (e.g. family) may mask species-level turnover. Here we document changes to reef fish communities after severe Tropical Cyclone Ita crossed Lizard Island, Great Barrier Reef. Coral and reef fish surveys were conducted concurrently before and after the cyclone at four levels of exposure to the prevailing weather. Coral cover declined across all exposures except sheltered sites, with the largest decline at exposed sites. There was no significant overall reduction in the total density, biomass and species richness of reef fishes between 2011 and 2015, but individual fish taxa (families and species) changed in complex and unpredictable ways. For example, more families increased in density and biomass than decreased following Cyclone Ita, particularly at exposed sites whilst more fish families declined at lagoon sites even though coral cover did not decline. All sites lost biomass of several damselfish species, and at most sites there was an increase in macroinvertivores and grazers. Overall, these results suggest that the degree of change measured at coarse taxonomic levels masked high species-level turnover, although other potential explanations include that there was no impact of the storm, fish assemblages were impacted but underwent rapid recovery or that there is a time lag before the full impacts become apparent. This study confirms that in high-complexity, high diversity ecosystems such as coral reefs, species level analyses are essential to adequately capture the consequences of disturbance events.	[Ceccarelli, Daniela M.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Emslie, Michael J.] Australian Inst Marine Sci, TMC, PMB 3, Townsville, Qld 4810, Australia; [Richards, Zoe T.] Western Australian Museum, Dept Aquat Zool, 49 Kew St, Perth, WA 6016, Australia	James Cook University; Australian Institute of Marine Science; Western Australian Museum	Ceccarelli, DM (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	dmcecca@gmail.com	Ceccarelli, Daniela/AAN-3577-2020; Ceccarelli, Daniela/AGO-7628-2022		John and Laurie Proud Foundation; Hermon Slade Raiatea Foundation; Isobel Bennett Fellowships; Australian Museum	John and Laurie Proud Foundation; Hermon Slade Raiatea Foundation; Isobel Bennett Fellowships; Australian Museum	The 2015 study was undertaken with support from the John and Laurie Proud Foundation, the Hermon Slade Raiatea Foundation and Isobel Bennett Fellowships awarded to DMC and ZTR. The 2011 study was supported and funded from a research grant by the Australian Museum to ZTR. The funders provided support in the form of salaries for authors (Z. Richards in 2011, Z. Richards and D. Ceccarelli in 2015), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adam TC, 2014, OECOLOGIA, V176, P285, DOI 10.1007/s00442-014-3011-x; Alvarez-Filip L, 2011, ECOL APPL, V21, P2223, DOI 10.1890/10-1563.1; Arias-Gonzalez JE, 2006, MAR ECOL PROG SER, V320, P29, DOI 10.3354/meps320029; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Bellwood DR, 2012, OECOLOGIA, V170, P567, DOI 10.1007/s00442-012-2306-z; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Ceccarelli DM, 2001, OCEANOGR MAR BIOL, V39, P355; Cheal AJ, 2002, CORAL REEFS, V21, P131, DOI 10.1007/s00338-002-0227-8; Coker DJ, 2009, BEHAV ECOL, V20, P1204, DOI 10.1093/beheco/arp113; De'ath G, 2012, P NATL ACAD SCI US; DONE TJ, 1986, GREAT BARRIER REEF M, V7, P50; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Emslie MJ, 2011, CORAL REEFS, V30, P461, DOI 10.1007/s00338-011-0730-x; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Emslie MJ, 2015, CURR BIOL, V25, P983, DOI 10.1016/j.cub.2015.01.073; Emslie MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105384; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; FENNER DP, 1991, B MAR SCI, V48, P719; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Glynn PW, 1998, CORAL REEFS, V17, P368, DOI 10.1007/s003380050140; Gochfeld DJ, 2010, MAR ECOL PROG SER, V398, P137, DOI 10.3354/meps08302; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; Holbrook SJ, 2002, MAR FRESHWATER RES, V53, P1045, DOI 10.1071/MF02063; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Johansen JL, 2013, ECOL APPL, V23, P1504, DOI 10.1890/12-0704.1; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kaufman L.S., 1983, Coral Reefs, V2, P43, DOI 10.1007/BF00304731; KLUMPP DW, 1987, MAR ECOL PROG SER, V40, P41, DOI 10.3354/meps040041; KNOWLTON N, 1981, NATURE, V294, P251, DOI 10.1038/294251a0; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kulbicki M, 2005, CYBIUM, V29, P235; LASSIG BR, 1983, ENVIRON BIOL FISH, V9, P55, DOI 10.1007/BF00001058; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Madin JS, 2014, ECOL LETT, V17, P1008, DOI 10.1111/ele.12306; Messmer V, 2011, ECOLOGY, V92, P2285, DOI 10.1890/11-0037.1; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Oouchi K, 2006, J METEOROL SOC JPN, V84, P259, DOI 10.2151/jmsj.84.259; Perry CT, 2014, GEOMORPHOLOGY, V222, P92, DOI 10.1016/j.geomorph.2014.03.012; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Pratchett MS, 2006, J FISH BIOL, V69, P1269, DOI 10.1111/j.1095-8649.2006.01161.x; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; SANO M, 1984, PAC SCI, V38, P51; VANWOESIK R, 1991, J COASTAL RES, V7, P551; Wilson SK, 2009, CORAL REEFS, V28, P3, DOI 10.1007/s00338-008-0431-2; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wilson SK, 2012, CONSERV BIOL, V26, P995, DOI 10.1111/j.1523-1739.2012.01926.x; WOODLEY JD, 1981, SCIENCE, V214, P749, DOI 10.1126/science.214.4522.749; Wyatt ASJ, 2012, CORAL REEFS, V31, P1029, DOI 10.1007/s00338-012-0923-y	55	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156232	10.1371/journal.pone.0156232	http://dx.doi.org/10.1371/journal.pone.0156232			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285160	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000377564000010
J	Hanney, WJ; Masaracchio, M; Liu, XL; Kolber, MJ				Hanney, William J.; Masaracchio, Michael; Liu, Xinliang; Kolber, Morey J.			The Influence of Physical Therapy Guideline Adherence on Healthcare Utilization and Costs among Patients with Low Back Pain: A Systematic Review of the Literature	PLOS ONE			English	Review							CLINICAL GUIDELINES; MANAGEMENT; PHYSIOTHERAPISTS; KNOWLEDGE; ATTITUDES; QUALITY; EXPENDITURES; PREVALENCE; DISABILITY; EXERCISE	Background Low back pain (LBP) is common and associated healthcare costs are significant. While clinical practice guidelines have been established in an attempt to reduce costs and healthcare utilization, it is unclear if adherence to physical therapy guidelines for those with LBP is efficacious. Therefore, the purpose of this study was to assess current evidence and evaluate the impact of physical therapy guideline adherence on subsequent healthcare costs and utilization for patients with LBP. Methods An electronic search was conducted in PubMed, CINAHL (EBSCO Host), AMED (Ovid), and PEDro. Studies included in this review were published in peer reviewed journals and the primary mode of treatment was administered by a physical therapist. Also, the definition of adherence was clearly defined based on claims data and at least one measure of cost or utilization reported. Quality assessment was evaluated via a modified Downs and Black checklist. Due to the conceptual heterogeneity in variable measurements, data were qualitatively synthesized and stratified by reported utilization and cost measures. Results A total of 256 results were identified and after omitting duplicates, 4 articles were retained, which were all retrospective in nature. Quality scores ranged between 19 and 21 points out of a possible 26 on the modified Downs and Black checklist. All identified studies used the same definition of guideline adherence, which focused on billing active codes and minimizing use of passive codes. The results demonstrated trends that, with a few exceptions, suggested those patients with LBP that were treated with an adherent guideline program demonstrated decreased healthcare utilization and an overall healthcare savings. Conclusion Preliminary evidence suggests that adherence to established clinical practice guidelines may assist with decreasing healthcare utilization and costs. Additional research based on prospective randomized controlled trials are needed to provide high quality evidence regarding the impact of guideline adherence among patients with LBP.	[Hanney, William J.] Univ Cent Florida, Dept Hlth Profess, Orlando, FL 32816 USA; [Masaracchio, Michael] Long Isl Univ, Dept Phys Therapy, Brooklyn, NY USA; [Liu, Xinliang] Univ Cent Florida, Dept Hlth Management & Informat, Orlando, FL 32816 USA; [Kolber, Morey J.] Nova SE Univ, Dept Phys Therapy, Ft Lauderdale, FL 33314 USA	State University System of Florida; University of Central Florida; Long Island University-Brooklyn Campus; State University System of Florida; University of Central Florida; Nova Southeastern University	Hanney, WJ (corresponding author), Univ Cent Florida, Dept Hlth Profess, Orlando, FL 32816 USA.	William.Hanney@ucf.edu			New York Physical Therapy Association	New York Physical Therapy Association	This study was supported by a research grant from the New York Physical Therapy Association.	[Anonymous], 1987, SPINE, V12, pS1; [Anonymous], 2001, CROSSING QUALITY CHA; Arnau JM, 2006, EUR SPINE J, V15, P543, DOI 10.1007/s00586-005-1027-y; Bekkering GE, 2005, QUAL SAF HEALTH CARE, V14, P107, DOI 10.1136/qshc.2003.009357; Bekkering GE., 2003, PHYS THER, V89, P82, DOI DOI 10.1016/S0031-9406(05)60579-2; Burton AK, 1998, BAILLIERE CLIN RHEUM, V12, P17; Cassidy JD, 1998, SPINE, V23, P1860, DOI 10.1097/00007632-199809010-00012; Chenot JF, 2008, EUR J PAIN, V12, P275, DOI 10.1016/j.ejpain.2007.06.004; Childs JD, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0830-3; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Cote AM, 2009, J OCCUP REHABIL, V19, P94, DOI 10.1007/s10926-009-9167-2; Delitto A, 2012, J ORTHOP SPORT PHYS, V42, pA1, DOI 10.2519/jospt.2012.42.4.A1; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Fritz JM, 2008, SPINE, V33, P1800, DOI 10.1097/BRS.0b013e31817bd853; Fritz JM, 2007, MED CARE, V45, P973, DOI 10.1097/MLR.0b013e318070c6cd; Fritz JM, 2013, ARCH PHYS MED REHAB, V94, P808, DOI 10.1016/j.apmr.2013.01.008; Fritz JM, 2012, SPINE, V37, P2114, DOI 10.1097/BRS.0b013e31825d32f5; Gellhorn AC, 2012, SPINE, V37, P775, DOI 10.1097/BRS.0b013e3181d79a09; Graves JM, 2014, HEALTH SERV RES, V49, P645, DOI 10.1111/1475-6773.12098; Graves JM, 2012, SPINE, V37, P1617, DOI 10.1097/BRS.0b013e318251887b; Grimshaw J, 1995, J Eval Clin Pract, V1, P37, DOI 10.1111/j.1365-2753.1995.tb00006.x; Hanney WJ, 2010, PHYS THER REV, V15, P84, DOI 10.1179/174328810X12719009060308; Hanney WJ, 2010, AM J LIFESTYLE MED, V4, P166, DOI 10.1177/1559827609351134; Harstall C, 2011, J EVAL CLIN PRACT, V17, P693, DOI 10.1111/j.1365-2753.2010.01420.x; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Iles R, 2006, PHYSIOTHER RES INT, V11, P93, DOI 10.1002/pri.328; Jette DU, 2003, PHYS THER, V83, P786, DOI 10.1093/ptj/83.9.786; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Ladeira CE, 2015, J MAN MANIP THER, V23, P109, DOI 10.1179/2042618613Y.0000000065; Learman KE, 2014, PHYS THER, V94, P934, DOI 10.2522/ptj.20130567; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Nau E, 2008, STRENGTH COND J, V30, P43, DOI 10.1519/SSC.0b013e31816a6d0f; Ojha HA, 2014, PHYS THER, V94, P14, DOI 10.2522/ptj.20130096; Pabian Patrick, 2008, N Am J Sports Phys Ther, V3, P161; Savigny P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1805; Simmonds MJ, 2012, CLIN J PAIN, V28, P467, DOI 10.1097/AJP.0b013e31825bfe65; Smith M, 2013, J MANIP PHYSIOL THER, V36, P2, DOI 10.1016/j.jmpt.2012.12.001; Staal J.B., 2017, KNGF RICHTLIJN; Staal JB, 2003, OCCUP ENVIRON MED, V60, P618, DOI 10.1136/oem.60.9.618; Stevenson K, 2004, J EVAL CLIN PRACT, V10, P207, DOI 10.1111/j.1365-2753.2003.00479.x; Swinkels ICS, 2005, AUST J PHYSIOTHER, V51, P35, DOI 10.1016/S0004-9514(05)70051-9; van Tulder MW, 2004, SPINE, V29, pE357, DOI 10.1097/01.brs.0000137056.64166.51; Welsh Caitlyn, 2010, N Am J Sports Phys Ther, V5, P85; Williams CM, 2010, ARCH INTERN MED, V170, P271, DOI 10.1001/archinternmed.2009.507	47	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156799	10.1371/journal.pone.0156799	http://dx.doi.org/10.1371/journal.pone.0156799			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1UG	27285608	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000022
J	Xia, XR; Dai, CJ; Zhu, XC; Liao, QM; Luo, X; Fu, YY; Wang, LX				Xia, Xiaoru; Dai, Caijun; Zhu, Xiaochun; Liao, Qiumei; Luo, Xu; Fu, Yangyang; Wang, Liangxing			Identification of a Novel NLRP12 Nonsense Mutation (Trp408X) in the Extremely Rare Disease FCAS by Exome Sequencing	PLOS ONE			English	Article							UNDIAGNOSED PERIODIC FEVERS; AUTOINFLAMMATORY DISORDERS; HEALTHY CONTROLS; F402L VARIANT; CUTTING EDGE; IMMUNODEFICIENCY; FAMILY; CIAS1; GENE	Familial cold autoinflammatory syndrome (FCAS) is an extremely rare autosomal dominant inherited disease. Although there are four genes that have been linked with FCAS, its molecular diagnosis has been challenging in a relatively large proportion of cases. In this study, we aimed to investigate the genetic defect of a recruited FCAS family using exome sequencing followed by in-depth bioinformatics analysis. As a result, a novel heterozygous stop-gain mutation (Trp408X) in NLRP12 was identified in autosomal dominant inherited FCAS with clinical features of recurrent fever and skin urticaria due to cold conditions. When combined with previous studies, all of the reported mutations were found to have occurred in a highly conserved region in the NACHT domain coding sequence in NLRP12 exon 3, suggesting that a screening strategy for FCAS should focus on this area of the gene. In conclusion, this study demonstrates the importance of exome sequencing for clinical diagnosis of genetic disorders and provides molecular insight into FCAS treatment and diagnosis.	[Xia, Xiaoru; Zhu, Xiaochun; Liao, Qiumei] Wenzhou Med Univ, Affiliated Hosp 1, Dept Rheumatol, Wenzhou, Peoples R China; [Dai, Caijun; Fu, Yangyang; Wang, Liangxing] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pneumol, Wenzhou, Peoples R China; [Luo, Xu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Wounds & Burns, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wang, LX (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Pneumol, Wenzhou, Peoples R China.	wzyxywlx@163.com			Natural Science Foundation of Zhejiang province, China [LY16H110002]	Natural Science Foundation of Zhejiang province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from Natural Science Foundation of Zhejiang province, China (LY16H110002).	Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Borghini S, 2011, ARTHRITIS RHEUM-US, V63, P830, DOI 10.1002/art.30170; Borte S, 2014, CLIN IMMUNOL, V154, P105, DOI 10.1016/j.clim.2014.07.003; Cai T, 2015, P NATL ACAD SCI USA, V112, P8064, DOI 10.1073/pnas.1502454112; Cruceanu C, 2013, GENOME, V56, P634, DOI 10.1139/gen-2013-0081; Cuisset L, 2011, ANN RHEUM DIS, V70, P495, DOI 10.1136/ard.2010.138420; de Jesus AA, 2013, CLIN IMMUNOL, V147, P155, DOI 10.1016/j.clim.2013.03.016; De Pieri C, 2014, CLIN EXP RHEUMATOL, V32, P993; De Pieri C, 2015, PEDIATR RHEUMATOL, V13, DOI 10.1186/s12969-015-0006-z; Goh Gerald, 2012, Genomics & Informatics, V10, P214, DOI 10.5808/GI.2012.10.4.214; Hoffman HM, 2003, HUM GENET, V112, P209, DOI 10.1007/s00439-002-0860-x; Hoffman HM, 2001, J ALLERGY CLIN IMMUN, V108, P615, DOI 10.1067/mai.2001.118790; Ida Hiroaki, 2015, Rinsho Byori, V63, P1207; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jeru I, 2011, ARTHRITIS RHEUM-US, V63, P2142, DOI 10.1002/art.30378; Kapur Saloni, 2009, P T, V34, P138; Kitamura A, 2014, J EXP MED, V211, P2385, DOI 10.1084/jem.20141091; Li GX, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-25; Li JC, 2015, J MED GENET, V52, P275, DOI 10.1136/jmedgenet-2014-102656; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; MacDonald JA, 2013, IUBMB LIFE, V65, P851, DOI 10.1002/iub.1210; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Rabbani B, 2012, J HUM GENET, V57, P621, DOI 10.1038/jhg.2012.91; Rusmini M, 2016, ANN RHEUM DIS, V75, P1550, DOI 10.1136/annrheumdis-2015-207701; Shinar Y, 2012, ANN RHEUM DIS, V71, P1599, DOI 10.1136/annrheumdis-2011-201271; Tunca Mehmet, 2005, Current Drug Targets - Inflammation and Allergy, V4, P77, DOI 10.2174/1568010053622957; Vitale A, 2014, CLIN EXP RHEUMATOL, V32, P994; Vitale A, 2013, CLIN EXP RHEUMATOL, V31, pS155	30	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0156981	10.1371/journal.pone.0156981	http://dx.doi.org/10.1371/journal.pone.0156981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314497	Green Published, gold, Green Submitted			2022-12-27	WOS:000378030000006
J	Fahner, NA; Shokralla, S; Baird, DJ; Hajibabaei, M				Fahner, Nicole A.; Shokralla, Shadi; Baird, Donald J.; Hajibabaei, Mehrdad			Large-Scale Monitoring of Plants through Environmental DNA Metabarcoding of Soil: Recovery, Resolution, and Annotation of Four DNA Markers	PLOS ONE			English	Article							BARCODE; CHALLENGES; PATTERNS	In a rapidly changing world we need methods to efficiently assess biodiversity in order to monitor ecosystem trends. Ecological monitoring often uses plant community composition to infer quality of sites but conventional aboveground surveys only capture a snapshot of the actively growing plant diversity. Environmental DNA (eDNA) extracted from soil samples, however, can include taxa represented by both active and dormant tissues, seeds, pollen, and detritus. Analysis of this eDNA through DNA metabarcoding provides a more comprehensive view of plant diversity at a site from a single assessment but it is not clear which DNA markers are best used to capture this diversity. Sequence recovery, annotation, and sequence resolution among taxa were evaluated for four established DNA markers (matK, rbcL, ITS2, and the trnL P6 loop) in silico using database sequences and in situ using high throughput sequencing of 35 soil samples from a remote boreal wetland. Overall, ITS2 and rbcL are recommended for DNA metabarcoding of vascular plants from eDNA when not using customized or geographically restricted reference databases. We describe a new framework for evaluating DNA metabarcodes and, contrary to existing assumptions, we found that full length DNA barcode regions could outperform shorter markers for surveying plant diversity from soil samples. By using current DNA barcoding markers rbcL and ITS2 for plant metabarcoding, we can take advantage of existing resources such as the growing DNA barcode database. Our work establishes the value of standard DNA barcodes for soil plant eDNA analysis in ecological investigations and biomonitoring programs and supports the collaborative development of DNA barcoding and metabarcoding.	[Fahner, Nicole A.; Shokralla, Shadi; Hajibabaei, Mehrdad] Univ Guelph, Dept Integrat Biol & Biodivers, Inst Ontario, Guelph, ON N1G 2W1, Canada; [Baird, Donald J.] Environm Canada, Canadian Rivers Inst, Fredericton, NB, Canada; [Baird, Donald J.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada	University of Guelph; Environment & Climate Change Canada; University of New Brunswick	Hajibabaei, M (corresponding author), Univ Guelph, Dept Integrat Biol & Biodivers, Inst Ontario, Guelph, ON N1G 2W1, Canada.	mhajibab@uoguelph.ca			Ontario Genomics Institute; Genome Canada; NSERC; Environment Canada; Parks Canada	Ontario Genomics Institute; Genome Canada(Genome Canada); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Parks Canada	This work was supported by the Ontario Genomics Institute; Genome Canada, NSERC, Environment Canada, Parks Canada.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elliott TL, 2014, MOL ECOL RESOUR, V14, P883, DOI 10.1111/1755-0998.12277; Epp LS, 2012, MOL ECOL, V21, P1821, DOI 10.1111/j.1365-294X.2012.05537.x; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Ficetola GF, 2016, MOL ECOL RESOUR, V16, P604, DOI 10.1111/1755-0998.12508; Gibson JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138432; Hajibabaei M, 2012, TRENDS GENET, V28, P535, DOI 10.1016/j.tig.2012.08.001; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hiiesalu I, 2012, MOL ECOL, V21, P2004, DOI 10.1111/j.1365-294X.2011.05390.x; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Lamb EG, 2016, PLANT SOIL, P1; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McClenaghan B, 2015, ECOL EVOL, V5, P3046, DOI 10.1002/ece3.1585; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Oksanen J., 2020, VEGAN COMMUNITY ECOL; R Core Team, 2021, R LANGUAGE ENV STAT; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timoney K.P., 2013, PEACE ATHABASCA DELT, P15; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Wilson MJ, 2013, AQUAT ECOSYST HEALTH, V16, P288, DOI 10.1080/14634988.2013.825194; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Young JM, 2014, FORENSIC SCI INT-GEN, V13, P176, DOI 10.1016/j.fsigen.2014.07.014; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	44	80	88	3	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157505	10.1371/journal.pone.0157505	http://dx.doi.org/10.1371/journal.pone.0157505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310720	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800088
J	Switzer, WM; Tang, SH; Zheng, HQ; Shankar, A; Sprinkle, PS; Sullivan, V; Granade, TC; Heneine, W				Switzer, William M.; Tang, Shaohua; Zheng, HaoQiang; Shankar, Anupama; Sprinkle, Patrick S.; Sullivan, Vickie; Granade, Timothy C.; Heneine, Walid			Dual Simian Foamy Virus/Human Immunodeficiency Virus Type 1 Infections in Persons from Cote d'Ivoire	PLOS ONE			English	Article							CROSS-SPECIES TRANSMISSION; MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; TO-CHILD TRANSMISSION; HIGH PROVIRAL LOAD; NONHUMAN-PRIMATES; GENETIC DIVERSITY; IVORY-COAST; HIV-1; LEUKEMIA; HTLV-1	Zoonotic transmission of simian retroviruses in West-Central Africa occurring in primate hunters has resulted in pandemic spread of human immunodeficiency viruses (HIVs) and human T-lymphotropic viruses (HTLVs). While simian foamy virus (SFV) and simian T-lymphotropic virus (STLV)-like infection were reported in healthy persons exposed to nonhuman primates (NHPs) in West-Central Africa, less is known about the distribution of these viruses in Western Africa and in hospitalized populations. We serologically screened for SFV and STLV infection using 1,529 specimens collected between 1985 and 1997 from Cote d'Ivoire patients with high HIV prevalence. PCR amplification and analysis of SFV, STLV, and HIV/SIV sequences from PBMCs was used to investigate possible simian origin of infection. We confirmed SFV antibodies in three persons (0.2%), two of whom were HIV1- infected. SFV polymerase (pol) and LTR sequences were detected in PBMC DNA available for one HIV-infected person. Phylogenetic comparisons with new SFV sequences from African guenons showed infection likely originated from a Chlorocebus sabaeus monkey endemic to Cote d'Ivoire. 4.6% of persons were HTLV seropositive and PCR testing of PBMCs from 15 HTLV seroreactive persons identified nine with HTLV-1 and one with HTLV-2 LTR sequences. Phylogenetic analysis showed that two persons had STLV-1-like infections, seven were HTLV-1, and one was an HTLV-2 infection. 310/858 (53%), 8/858 (0.93%), and 18/858 (2.1%) were HIV-1, HIV-2, and HIV-positive but undifferentiated by serology, respectively. No SIV sequences were found in persons with HIV-2 antibodies (n = 1) or with undifferentiated HIV results (n = 7). We document SFV, STLV-1-like, and dual SFV/HIV infection in Cote d'Ivoire expanding the geographic range for zoonotic simian retrovirus transmission to West Africa. These findings highlight the need to define the public health consequences of these infections. Studying dual HIV-1/SFV infections in immunocompromised populations may provide a new opportunity to better understand SFV pathogenicity and transmissibility in humans.	[Switzer, William M.; Tang, Shaohua; Zheng, HaoQiang; Shankar, Anupama; Sprinkle, Patrick S.; Sullivan, Vickie; Granade, Timothy C.; Heneine, Walid] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Switzer, WM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA.	bis3@cdc.gov						Abouya L, 1998, AIDS, V12, P505, DOI 10.1097/00002030-199805000-00012; ADJORLOLOJOHNSON G, 1994, JAMA-J AM MED ASSOC, V272, P462, DOI 10.1001/jama.272.6.462; Ahuka-Mundeke S, 2012, AIDS RES HUM RETROV, V28, P628, DOI [10.1089/aid.2011.0211, 10.1089/AID.2011.0211]; Ayouba A, 2013, AIDS, V27, P2488, DOI 10.1097/01.aids.0000432443.22684.50; Besson G, 2009, J CLIN MICROBIOL, V47, P1129, DOI 10.1128/JCM.02006-08; Best I, 2006, CLIN EXP IMMUNOL, V146, P226, DOI 10.1111/j.1365-2249.2006.03208.x; Betsem E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002306; Bi SG, 2012, FOLIA PRIMATOL, V83, P11, DOI 10.1159/000338752; BONIS J, 1994, J INFECT DIS, V169, P225, DOI 10.1093/infdis/169.1.225; Calattini S, 2007, EMERG INFECT DIS, V13, P1314, DOI 10.3201/eid1309.061162; Calvignac-Spencer S, 2012, EMERG INFECT DIS, V18, P830, DOI 10.3201/eid1805.111663; Choudhary A, 2013, VIRUSES-BASEL, V5, P1414, DOI 10.3390/v5061414; Courgnaud V, 2001, J VIROL, V75, P857, DOI 10.1128/JVI.75.2.857-866.2001; DECOCK KM, 1990, AIDS, V4, P443, DOI 10.1097/00002030-199005000-00010; DECOCK KM, 1991, BMJ-BRIT MED J, V302, P496, DOI 10.1136/bmj.302.6775.496; DECOCK KM, 1989, LANCET, V2, P408; DJOMAND G, 1995, J ACQ IMMUN DEF SYND, V10, P358; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Enose-Akahata Y, 2015, RETROVIROLOGY SUPPL, V12, DOI [10.1186/1742-4690-12-S1-O30, DOI 10.1186/1742-4690-12-S1-O30]; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; Goldberg TL, 2009, J VIROL, V83, P11318, DOI 10.1128/JVI.02616-08; Haus T, 2013, AM J PRIMATOL, V75, P350, DOI 10.1002/ajp.22113; Heneine W, 2006, TRANSFUSION, V46, P1276, DOI 10.1111/j.1537-2995.2006.00925.x; HUGON J, 1990, J NEUROL NEUROSUR PS, V53, P269, DOI 10.1136/jnnp.53.3.269; Hussain AI, 2003, VIROLOGY, V309, P248, DOI 10.1016/S0042-6822(03)00070-9; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Jones-Engel L, 2008, EMERG INFECT DIS, V14, P1200, DOI 10.3201/eid1408.071430; Kaplan JE, 1996, J ACQ IMMUN DEF SYND, V12, P193, DOI 10.1097/00042560-199606010-00014; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200; Kwaan N, 2006, J INFECT DIS, V194, P1557, DOI 10.1086/508899; LeBreton M, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.7; Leendertz SAJ, 2010, J VIROL, V84, P7427, DOI 10.1128/JVI.00697-10; Lezin A, 2005, J INFECT DIS, V191, P1830, DOI 10.1086/429962; Liegeois F, 2008, VIROLOGY, V371, P405, DOI 10.1016/j.virol.2007.09.037; Locatelli S, 2012, AIDS, V26, P659, DOI 10.1097/QAD.0b013e328350fb68; MCCARTHY TJ, 1990, LAB ANIM SCI, V40, P79; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; Meertens L, 2001, VIROLOGY, V287, P275, DOI 10.1006/viro.2001.1018; Moens B, 2009, J CLIN MICROBIOL, V47, P3682, DOI 10.1128/JCM.00781-09; Mouinga-Ondeme A, 2012, J VIROL, V86, P1255, DOI 10.1128/JVI.06016-11; Murray SM, 2006, J MED PRIMATOL, V35, P225, DOI 10.1111/j.1600-0684.2006.00171.x; Murray SM, 2006, J VIROL, V80, P663, DOI 10.1128/JVI.80.2.663-670.2006; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; NKENGASONG JN, 1995, J MED VIROL, V47, P278, DOI 10.1002/jmv.1890470315; OUATTARA SA, 1989, J ACQ IMMUN DEF SYND, V2, P481; Peeters M, 2002, EMERG INFECT DIS, V8, P451, DOI 10.3201/eid0805.010522; Refisch J, 2005, BIOTROPICA, V37, P136, DOI 10.1111/j.1744-7429.2005.03174.x; Rua R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077072; Schiffer C, 2004, J VIROL, V78, P11405, DOI 10.1128/JVI.78.20.11405-11410.2004; Schweizer M, 1997, J VIROL, V71, P4821, DOI 10.1128/JVI.71.6.4821-4824.1997; Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318; Sharp Paul M, 2010, Philos Trans R Soc Lond B Biol Sci, V365, P2487, DOI 10.1098/rstb.2010.0031; Silva MTT, 2007, CLIN INFECT DIS, V44, P689, DOI 10.1086/510679; Sintasath DM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-97; Sintasath DM, 2009, EMERG INFECT DIS, V15, P175, DOI 10.3201/eid1502.080584; Smith KM, 2012, PLOS ONE, V7, P71, DOI 10.1371/journal.pone.0029505; Switzer W, 2011, RETROVIROLOGY, V8, pA233, DOI DOI 10.1186/1742-4690-8-S1-A233; Switzer W. M., 2011, MOL DETECTION HUMAN, V1, P131; Switzer WM, 2008, J INFECT DIS, V197, P1389, DOI 10.1086/587493; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Switzer WM, 2004, J VIROL, V78, P2780, DOI 10.1128/JVI.78.6.2780-2789.2004; SWITZER WM, 1995, J VIROL, V69, P621, DOI 10.1128/JVI.69.2.621-632.1995; Switzer WM, 2001, TRANSPLANTATION, V71, P959, DOI 10.1097/00007890-200104150-00022; Takenouchi N, 2003, J NEUROVIROL, V9, P29, DOI 10.1080/13550280390173418; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ureta-Vidal A, 1999, INT J CANCER, V82, P832, DOI 10.1002/(SICI)1097-0215(19990909)82:6&lt;832::AID-IJC11&gt;3.0.CO;2-P; VERDIER M, 1989, J INFECT DIS, V160, P363, DOI 10.1093/infdis/160.3.363; VERDIER M, 1990, J INFECT DIS, V161, P1309, DOI 10.1093/infdis/161.6.1309; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Wolfe ND, 2006, EMERG INFECT DIS, P139; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9; Yamano Y, 2002, BLOOD, V99, P88, DOI 10.1182/blood.V99.1.88	75	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157709	10.1371/journal.pone.0157709	http://dx.doi.org/10.1371/journal.pone.0157709			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310836	Green Published, gold			2022-12-27	WOS:000378029800128
J	Berg, JA; Merrill, BD; Crockett, JT; Esplin, KP; Evans, MR; Heaton, KE; Hilton, JA; Hyde, JR; McBride, MS; Schouten, JT; Simister, AR; Thurgood, TL; Ward, AT; Breakwell, DP; Hope, S; Grose, JH				Berg, Jordan A.; Merrill, Bryan D.; Crockett, Justin T.; Esplin, Kyle P.; Evans, Marlee R.; Heaton, Karli E.; Hilton, Jared A.; Hyde, Jonathan R.; McBride, Morgan S.; Schouten, Jordan T.; Simister, Austin R.; Thurgood, Trever L.; Ward, Andrew T.; Breakwell, Donald P.; Hope, Sandra; Grose, Julianne H.			Characterization of Five Novel Brevibacillus Bacteriophages and Genomic Comparison of Brevibacillus Phages	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; INSECTICIDAL ACTIVITY; PAENIBACILLUS-LARVAE; INSERTION-SEQUENCE; LATEROSPORUS; TOOL; VIRULENCE; ALIGNMENT; CLASSIFICATION; PATHOGENICITY	Brevibacillus laterosporus is a spore-forming bacterium that causes a secondary infection in beehives following European Foulbrood disease. To better understand the contributions of Brevibacillus bacteriophages to the evolution of their hosts, five novel phages (Jenst, Osiris, Powder, SecTim467, and Sundance) were isolated and characterized. When compared with the five Brevibacillus phages currently in NCBI, these phages were assigned to clusters based on whole genome and proteome synteny. Powder and Osiris, both myoviruses, were assigned to the previously described Jimmer-like cluster. SecTim467 and Jenst, both siphoviruses, formed a novel phage cluster. Sundance, a siphovirus, was assigned as a singleton phage along with the previously isolated singleton, Emery. In addition to characterizing the basic relationships between these phages, several genomic features were observed. A motif repeated throughout phages Jenst and SecTim467 was frequently upstream of genes predicted to function in DNA replication, nucleotide metabolism, and transcription, suggesting transcriptional co-regulation. In addition, paralogous gene pairs that encode a putative transcriptional regulator were identified in four Brevibacillus phages. These paralogs likely evolved to bind different DNA sequences due to variation at amino acid residues predicted to bind specific nucleotides. Finally, a putative transposable element was identified in Sec-Tim467 and Sundance that carries genes homologous to those found in Brevibacillus chromosomes. Remnants of this transposable element were also identified in phage Jenst. These discoveries provide a greater understanding of the diversity of phages, their behavior, and their evolutionary relationships to one another and to their host. In addition, they provide a foundation with which further Brevibacillus phages can be compared.	[Berg, Jordan A.; Merrill, Bryan D.; Crockett, Justin T.; Esplin, Kyle P.; Evans, Marlee R.; Heaton, Karli E.; Hilton, Jared A.; Hyde, Jonathan R.; McBride, Morgan S.; Schouten, Jordan T.; Simister, Austin R.; Thurgood, Trever L.; Ward, Andrew T.; Breakwell, Donald P.; Hope, Sandra; Grose, Julianne H.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Brigham Young University	Grose, JH (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	julianne_grose@byu.edu	Berg, Jordan/ADH-9043-2022; Merrill, Bryan/L-1235-2015; Berg, Jordan/AAG-1230-2019	Berg, Jordan/0000-0002-5096-0558; Merrill, Bryan/0000-0002-9967-5539; Berg, Jordan/0000-0002-5096-0558; Grose, Julianne/0000-0001-8816-6635	BYU Department of Microbiology and Molecular Biology	BYU Department of Microbiology and Molecular Biology	This work was supported by a private donation from BYU Philanthropies, and by the BYU Department of Microbiology and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bagyan I, 1996, J BACTERIOL, V178, P4500, DOI 10.1128/jb.178.15.4500-4507.1996; BAILEY L, 1963, J INSECT PATHOL, V5, P198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barber MF, 2014, SCIENCE, V346, P1362, DOI 10.1126/science.1259329; Berdygulova Z, 2011, J MOL BIOL, V405, P125, DOI 10.1016/j.jmb.2010.10.049; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; BLOT M, 1994, GENETICA, V93, P5, DOI 10.1007/BF01435235; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Casjens SR, 2011, VIROLOGY, V411, P393, DOI 10.1016/j.virol.2010.12.046; Chen J, 2009, SCIENCE, V323, P139, DOI 10.1126/science.1164783; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; de Graaf DC, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.11; de Oliveira EJ, 2004, APPL ENVIRON MICROB, V70, P6657, DOI 10.1128/AEM.70.11.6657-6664.2004; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; DUFFY JJ, 1977, NATURE, V270, P28, DOI 10.1038/270028a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAVRET ME, 1985, J INVERTEBR PATHOL, V45, P195, DOI 10.1016/0022-2011(85)90009-6; Forsgren E, 2008, VET MICROBIOL, V129, P342, DOI 10.1016/j.vetmic.2007.12.001; Forsgren E, 2010, J INVERTEBR PATHOL, V103, pS5, DOI 10.1016/j.jip.2009.06.016; FOULGER D, 1991, MOL MICROBIOL, V5, P1363, DOI 10.1111/j.1365-2958.1991.tb00783.x; FOX TD, 1976, J MOL BIOL, V101, P427, DOI 10.1016/0022-2836(76)90157-1; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Genersch E, 2006, INT J SYST EVOL MICR, V56, P501, DOI 10.1099/ijs.0.63928-0; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; GILLIAM M, 1976, J INVERTEBR PATHOL, V28, P275, DOI 10.1016/0022-2011(76)90137-3; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Gordon D, 2013, BIOINFORMATICS, V29, P2936, DOI 10.1093/bioinformatics/btt515; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grenha R, 2013, P NATL ACAD SCI USA, V110, P1047, DOI 10.1073/pnas.1213770110; Grose JH, 2014, VIROLOGY, V468, P421, DOI 10.1016/j.virol.2014.08.024; Grose JH, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01118-13; Grose JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-855; Grose JH, 2014, J VIROL, V88, P11846, DOI 10.1128/JVI.01364-14; Guzina J, 2015, BMC EVOL BIOL, V15, DOI 10.1186/1471-2148-15-S1-S1; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hayek N, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00041; Heo YJ, 2007, MICROBIOL-SGM, V153, P2885, DOI 10.1099/mic.0.2007/007260-0; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; KAISER AD, 1957, VIROLOGY, V3, P42, DOI 10.1016/0042-6822(57)90022-3; KLECKNER N, 1981, ANNU REV GENET, V15, P341, DOI 10.1146/annurev.ge.15.120181.002013; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lavigne R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-224; Lawrence J, 2012, DNA MASTER; LEVINE M, 1957, VIROLOGY, V3, P22, DOI 10.1016/0042-6822(57)90021-1; Li MR, 2003, APPL ENVIRON MICROB, V69, P1728, DOI 10.1128/AEM.69.3.1728-1738.2003; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Ludwig W, 2009, BERGEYS MANUAL SYSTE, V3, P1, DOI DOI 10.1007/978-0-387-68489-5_; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Ma JZ, 2013, BIOINFORMATICS, V29, P257, DOI 10.1093/bioinformatics/btt210; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Mahadevan Padmanabhan, 2009, International Journal of Computational Biology and Drug Design, V2, P100; Mahadevan Padmanabhan, 2009, BMC Res Notes, V2, P168, DOI 10.1186/1756-0500-2-168; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Merrill BD, 2014, BMC GENOMICS, V15; MORI H, 1986, J MOL BIOL, V192, P1, DOI 10.1016/0022-2836(86)90459-6; Orlova MV, 1998, APPL ENVIRON MICROB, V64, P2723; Peng J, 2011, PROTEINS, V79, P1930, DOI 10.1002/prot.23016; Pope WH, 2015, ELIFE, V4, DOI 10.7554/eLife.06416; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RIVERS DB, 1991, J INVERTEBR PATHOL, V58, P444, DOI 10.1016/0022-2011(91)90191-R; Ruiu L, 2014, POULTRY SCI, V93, P519, DOI 10.3382/ps.2013-03418; Ruiu Luca, 2013, Insects, V4, P476, DOI 10.3390/insects4030476; Ruiu L, 2012, J INVERTEBR PATHOL, V111, P211, DOI 10.1016/j.jip.2012.08.005; Sheflo MA, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00668-13; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith KC, 2013, BMC GENOMICS, V14; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; SOLINAS F, 1995, GENE, V155, P77, DOI 10.1016/0378-1119(94)00922-F; TALKINGTON C, 1978, P NATL ACAD SCI USA, V75, P1185, DOI 10.1073/pnas.75.3.1185; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson-Stewart D, 1994, P NATL ACAD SCI USA, V91; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f; Watkins D, 2010, J MOL BIOL, V396, P1145, DOI 10.1016/j.jmb.2009.12.050; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Xu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002672; Yan C, 2015, NUCL ACIDS RES; Yeo CC, 1997, FEMS MICROBIOL LETT, V149, P257, DOI 10.1111/j.1574-6968.1997.tb10338.x; Zafar N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-12; Zhao J, 2012, PEPTIDES, V33, P206, DOI 10.1016/j.peptides.2012.01.001	97	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156838	10.1371/journal.pone.0156838	http://dx.doi.org/10.1371/journal.pone.0156838			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304881	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800025
J	Zhang, XJ; Noor, R; Savalei, V				Zhang, Xijuan; Noor, Ramsha; Savalei, Victoria			Examining the Effect of Reverse Worded Items on the Factor Structure of the Need for Cognition Scale	PLOS ONE			English	Article							COVARIANCE STRUCTURE-ANALYSIS; GLOBAL SELF-ESTEEM; RESPONSE BIAS; FIT INDEXES; DIMENSIONALITY; PERSONALITY; MISRESPONSE; DECISIONS; MODEL	Reverse worded (RW) items are often used to reduce or eliminate acquiescence bias, but there is a rising concern about their harmful effects on the covariance structure of the scale. Therefore, results obtained via traditional covariance analyses may be distorted. This study examined the effect of the RW items on the factor structure of the abbreviated 18-item Need for Cognition (NFC) scale using confirmatory factor analysis. We modified the scale to create three revised versions, varying from no RW items to all RW items. We also manipulated the type of the RW items (polar opposite vs. negated). To each of the four scales, we fit four previously developed models. The four models included a 1-factor model, a 2-factor model distinguishing between positively worded (PW) items and RW items, and two 2-factor models, each with one substantive factor and one method factor. Results showed that the number and type of the RW items affected the factor structure of the NFC scale. Consistent with previous research findings, for the original NFC scale, which contains both PW and RW items, the 1-factor model did not have good fit. In contrast, for the revised scales that had no RW items or all RW items, the 1-factor model had reasonably good fit. In addition, for the scale with polar opposite and negated RW items, the factor model with a method factor among the polar opposite items had considerably better fit than the 1-factor model.	[Zhang, Xijuan; Noor, Ramsha; Savalei, Victoria] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Zhang, XJ (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	cathyxijuan@psych.ubc.ca						Baumgartner H, 2001, J MARKETING RES, V38, P143, DOI 10.1509/jmkr.38.2.143.18840; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bentler P.M., 2008, EQS 6 STRUCTURAL EQU; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bors DA, 2006, PERS INDIV DIFFER, V40, P819, DOI 10.1016/j.paid.2005.09.007; Brosseau-Liard PE, 2014, MULTIVAR BEHAV RES, V49, P460, DOI 10.1080/00273171.2014.933697; Brosseau-Liard PE, 2012, MULTIVAR BEHAV RES, V47, P904, DOI 10.1080/00273171.2012.715252; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Chalmers RP, 2012, J STAT SOFTW, V48, P1; DAVIS TL, 1993, J APPL SOC PSYCHOL, V23, P451, DOI 10.1111/j.1559-1816.1993.tb01098.x; DiStefano C, 2006, STRUCT EQU MODELING, V13, P440, DOI 10.1207/s15328007sem1303_6; Eid M, 2000, PSYCHOMETRIKA, V65, P241, DOI 10.1007/BF02294377; Forsterlee R, 1999, EDUC PSYCHOL MEAS, V59, P471, DOI 10.1177/00131649921969983; Furnham A, 2013, J INDIVID DIFFER, V34, P230, DOI 10.1027/1614-0001/a000119; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hevey D, 2012, INT J ED PSYCHOL ASS, V12, P20; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; John O. P., 1991, THE BIG FIVE INVENTO; Lewis CH, 1982, USING THE THINKING A; Lindwall M, 2012, J PERS ASSESS, V94, P196, DOI 10.1080/00223891.2011.645936; Lord KR, 2006, PSYCHOL MARKET, V23, P11, DOI 10.1002/mar.20108; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Marsh HW, 1996, J PERS SOC PSYCHOL, V70, P810, DOI 10.1037/0022-3514.70.4.810; MIROWSKY J, 1991, SOC PSYCHOL QUART, V54, P127, DOI 10.2307/2786931; PILOTTE WJ, 1990, EDUC PSYCHOL MEAS, V50, P603, DOI 10.1177/0013164490503016; Revelle W., 2015, PSYCH PROCEDURES FOR; Satorra A., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; Savalei V, 2014, MULTIVAR BEHAV RES, V49, P407, DOI 10.1080/00273171.2014.931800; SCHRIESHEIM CA, 1981, EDUC PSYCHOL MEAS, V41, P1101, DOI 10.1177/001316448104100420; Swain SD, 2008, J MARKETING RES, V45, P116, DOI 10.1509/jmkr.45.1.116; TAFARODI RW, 1995, J PERS ASSESS, V65, P322, DOI 10.1207/s15327752jpa6502_8; TANAKA JS, 1988, MULTIVAR BEHAV RES, V23, P35, DOI 10.1207/s15327906mbr2301_2; van Sonderen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068967; WATSON D, 1992, SOCIOL METHOD RES, V21, P52, DOI 10.1177/0049124192021001003; Weijters B, 2012, J MARKETING RES, V49, P737, DOI 10.1509/jmr.11.0368; Wu, 2008, J SOC PSYCHOL, V148, P535, DOI [10.3200/SOCP.148.5.535-552, DOI 10.3200/SOCP.148.5.535-552]; Yuan KH, 2004, EDUC PSYCHOL MEAS, V64, P737, DOI 10.1177/0013164404264853; Zhang XJ, 2016, EDUC PSYCHOL MEAS, V76, P357, DOI 10.1177/0013164415596421; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	42	70	70	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157795	10.1371/journal.pone.0157795	http://dx.doi.org/10.1371/journal.pone.0157795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5LO	27305001	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800083
J	Carrara, VI; Darakomon, MC; Thin, NWW; Paw, NTK; Wah, N; Wah, HG; Helen, N; Keereecharoen, S; Paw, NTM; Jittamala, P; Nosten, FH; Ricci, D; McGready, R				Carrara, Verena I.; Darakomon, Mue Chae; Thin, Nant War War; Paw, Naw Ta Kaw; Wah, Naw; Wah, Hser Gay; Helen, Naw; Keereecharoen, Suporn; Paw, Naw Ta Mlar; Jittamala, Podjanee; Nosten, Francois H.; Ricci, Daniela; McGready, Rose			Evaluation and Acceptability of a Simplified Test of Visual Function at Birth in a Limited-Resource Setting	PLOS ONE			English	Article							THIAMINE-DEFICIENCY; MATURATION; PREGNANCY; REFUGEES; MALARIA; BORDER; WOMEN	Neurological examination, including visual fixation and tracking of a target, is routinely performed in the Shoklo Malaria Research Unit postnatal care units on the Thailand-Myanmar border. We aimed to evaluate a simple visual newborn test developed in Italy and performed by non-specialized personnel working in neonatal care units. An intensive training of local health staff in Thailand was conducted prior to performing assessments at 24, 48 and 72 hours of life in healthy, low-risk term singletons. The 48 and 72 hours results were then compared to values obtained to those from Italy. Parents and staff administering the test reported on acceptability. One hundred and seventy nine newborns, between June 2011 and October 2012, participated in the study. The test was rapidly completed if the infant remained in an optimal behavioral stage (7 +/- 2 minutes) but the test duration increased significantly (12 +/- 4 minutes, p < 0.001) if its behavior changed. Infants were able to fix a target and to discriminate a colored face at 24 hours of life. Horizontal tracking of a target was achieved by 96% (152/159) of the infants at 48 hours. Circular tracking, stripe discrimination and attention to distance significantly improved between each 24-hour test period. The test was easily performed by non-specialized local staff and well accepted by the parents. Healthy term singletons in this limited-resource setting have a visual response similar to that obtained to gestational age matched newborns in Italy. It is possible to use these results as a reference set of values for the visual assessment in Karen and Burmese infants in the first 72 hours of life. The utility of the 24 hours test should be pursued.	[Carrara, Verena I.; Darakomon, Mue Chae; Thin, Nant War War; Paw, Naw Ta Kaw; Wah, Naw; Wah, Hser Gay; Helen, Naw; Keereecharoen, Suporn; Paw, Naw Ta Mlar] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Jittamala, Podjanee] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Nosten, Francois H.; McGready, Rose] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand; [Nosten, Francois H.; McGready, Rose] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Ricci, Daniela] Catholic Univ, Paediat Neurol Unit, Rome, Italy	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Carrara, VI (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand.	verena@shoklo-unit.com	McGready, Rose/A-3290-2014; Nosten, Francois/AAC-5509-2019; Carrara, Verena/R-6492-2019; Ricci, Daniela/AAC-3415-2022	McGready, Rose/0000-0003-1621-3257; Nosten, Francois/0000-0002-7951-0745; Carrara, Verena/0000-0002-2758-0872; ricci, daniela/0000-0002-3547-7592	Malaria in Pregnancy Consortium (MiPC), schedule 11, ASAP	Malaria in Pregnancy Consortium (MiPC), schedule 11, ASAP	The study was funded by the Malaria in Pregnancy Consortium (MiPC), schedule 11, ASAP. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The study was funded by the Malaria in Pregnancy Consortium (MiPC), schedule 11, ASAP.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Boel M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000887; BRONSON G, 1974, CHILD DEV, V45, P873, DOI 10.1111/j.1467-8624.1974.tb00683.x; Carrara VI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001398; Carrara VI, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-45; Dubowitz L, 1977, GESTATIONAL AGE NEWB; DUBOWITZ LMS, 1986, LANCET, V1, P1139, DOI 10.1016/S0140-6736(86)91847-7; Fowkes FJI, 2013, CLIN INFECT DIS, V56, P749, DOI 10.1093/cid/cis979; McGready R, 2003, ANN TROP PAEDIATR, V23, P193, DOI 10.1179/027249303322296510; McGready R, 2000, ANN TROP PAEDIATR, V20, P323, DOI 10.1080/02724936.2000.11748154; McGready R, 2001, AM J CLIN NUTR, V74, P808; McGready R, 2015, F1000RESEARCH, V3, P123, DOI 10.12688/f1000research.4190.2; McGready R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040244; Ricci D, 2008, EARLY HUM DEV, V84, P107, DOI 10.1016/j.earlhumdev.2007.03.010; Ricci D, 2008, EARLY HUM DEV, V84, P277, DOI 10.1016/j.earlhumdev.2007.10.002; Ricci D, 2010, EARLY HUM DEV, V86, P29, DOI 10.1016/j.earlhumdev.2009.11.004; Ricci D, 2008, PEDIATRICS, V122, pE1193, DOI 10.1542/peds.2008-1888; Rijken MJ, 2009, ULTRASOUND OBST GYN, V34, P395, DOI 10.1002/uog.7350; Russell-Eggitt I, 1998, DEV MED CHILD NEUROL, V40, P130; Stuetz W, 2006, SCI TOTAL ENVIRON, V363, P78, DOI 10.1016/j.scitotenv.2005.06.032; Stuetz W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036280; Stuetz W, 2012, EUR J NUTR, V51, P425, DOI 10.1007/s00394-011-0226-z; Teeyapant P, 2014, J TOXICOL SCI, V39, P121, DOI 10.2131/jts.39.121; Turner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072721; Turner C, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-93; White AL, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-19; YAGI N, 1979, J ENVIRON PATHOL TOX, V2, P1119	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157087	10.1371/journal.pone.0157087	http://dx.doi.org/10.1371/journal.pone.0157087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300137	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200029
J	Herrera, C; Klokk, TI; Cole, R; Sandvig, K; Mantis, NJ				Herrera, Cristina; Klokk, Tove Irene; Cole, Richard; Sandvig, Kirsten; Mantis, Nicholas J.			A Bispecific Antibody Promotes Aggregation of Ricin Toxin on Cell Surfaces and Alters Dynamics of Toxin Internalization and Trafficking	PLOS ONE			English	Article							PASSIVELY PROTECTS MICE; RETROGRADE TRANSPORT; ENDOPLASMIC-RETICULUM; NEUTRALIZING AGENT; BINDING; MACROPINOCYTOSIS; MECHANISM; CHAIN; RETROTRANSLOCATION; NANOPARTICLES	JJX12 is an engineered bispecific antibody against ricin, a member of the medically important A-B family of toxins that exploits retrograde transport as means to gain entry into the cytosol of target cells. JJX12 consists of RTA-D10, a camelid single variable domain (VHH) antibody directed against an epitope on ricin's enzymatic subunit (RTA), linked via a 15-mer peptide to RTB-B7, a VHH against ricin's bivalent galactose binding subunit (RTB). We previously reported that JJX12, but not an equimolar mixture of RTA-D10 and RTB-B7 monomers, was able to passively protect mice against a lethal dose ricin challenge, demonstrating that physically linking RTB-B7 and RTA-D10 is critical for toxin-neutralizing activity in vivo. We also reported that JJX12 promotes aggregation of ricin in solution, presumably through the formation of intermolecular crosslinking. In the current study, we now present evidence that JJX12 affects the dynamics of ricin uptake and trafficking in human epithelial cells. Confocal microscopy, as well as live cell imaging coupled with endocytosis pathway-specific inhibitors, revealed that JJX12-toxin complexes are formed on the surfaces of mammalian cells and internalized via a pathway sensitive to amiloride, a known inhibitor of macropinocytosis. Moreover, in the presence of JJX12, retrograde transport of ricin to the trans-Golgi network was significantly reduced, while accumulation of the toxin in late endosomes was significantly enhanced. In summary, we propose that JJX12, by virtue of its ability to crosslink ricin toxin, alters the route of toxin uptake and trafficking within cells.	[Herrera, Cristina; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY USA; [Herrera, Cristina; Cole, Richard; Mantis, Nicholas J.] Univ Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Klokk, Tove Irene; Sandvig, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Mol Cell Biol, N-0450 Oslo, Norway; [Klokk, Tove Irene; Sandvig, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Ctr Canc Biomed, N-0450 Oslo, Norway; [Klokk, Tove Irene; Sandvig, Kirsten] Univ Oslo, Dept Biosci, Oslo, Norway; [Cole, Richard] New York State Dept Hlth, Wadsworth Ctr, Div Translat Med, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Oslo; University of Oslo; University of Oslo; State University of New York (SUNY) System; Wadsworth Center	Mantis, NJ (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY USA.; Mantis, NJ (corresponding author), Univ Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA.	nicholas.mantis@health.ny.gov		Mantis, Nicholas/0000-0002-5083-8640	National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (USA) [HHSN272201400021C]; South-Eastern Norway Regional Health Authority; Norwegian Cancer Society; Norwegian Research Council through its Centers of Excellence funding scheme [179571]	National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (USA); South-Eastern Norway Regional Health Authority; Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council through its Centers of Excellence funding scheme	This work was supported by contract HHSN272201400021C (PI-Mantis) from the National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (USA): https://www.fbo.gov/index?s=opportunity&mode=form&tab=core&id=977f0135ae02cab0bdb4e84e35bf9b18. TIK and KS were supported by grants from the South-Eastern Norway Regional Health Authority, the Norwegian Cancer Society and the Norwegian Research Council through its Centers of Excellence funding scheme, project number 179571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrowicz P, 2011, J INFECT DIS, V204, pS957, DOI 10.1093/infdis/jir326; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Gage E, 2011, TOXINS, V3, P1131, DOI 10.3390/toxins3091131; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Gold S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011360; Herrera C, 2015, J BIOL CHEM, V290, P27880, DOI 10.1074/jbc.M115.658070; Herrera C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099788; Hu WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045595; Iversen TG, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-33; Klokk TI, 2016, CELL MOL LIFE SCI, V73, P1301, DOI 10.1007/s00018-015-2049-1; Klokk TI, 2011, TOXINS, V3, P1203, DOI 10.3390/toxins3091203; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Moayeri M, 2016, CLIN VACCINE IMMUNOL, V23, P213, DOI 10.1128/CVI.00611-15; Moayeri M, 2015, J BIOL CHEM, V290, P6584, DOI 10.1074/jbc.M114.627943; Mukherjee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106422; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Murase T, 2014, J BIOL CHEM, V289, P2331, DOI 10.1074/jbc.M113.505917; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; O'Hara JM, 2012, VACCINE, V30, P1239, DOI 10.1016/j.vaccine.2011.12.058; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Reisler Ronald B, 2012, Adv Prev Med, V2012, P149737, DOI 10.1155/2012/149737; Rudolph MJ, 2014, J MOL BIOL, V426, P3057, DOI 10.1016/j.jmb.2014.05.026; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; Sandvig K, 2013, HISTOCHEM CELL BIOL, V140, P317, DOI 10.1007/s00418-013-1111-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sheoran AS, 2015, INFECT IMMUN, V83, P286, DOI 10.1128/IAI.02360-14; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Sully EK, 2014, TOXICON, V92, P36, DOI 10.1016/j.toxicon.2014.09.006; Sully EK, 2014, CLIN VACCINE IMMUNOL, V21, P777, DOI 10.1128/CVI.00003-14; Tekle C, 2008, NANO LETT, V8, P1858, DOI 10.1021/nl0803848; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Unger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07850; Vance D, 2009, ADV DRUG DELIVER REV, V61, P931, DOI 10.1016/j.addr.2009.06.002; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; Wolfe DN, 2013, HUM VACC IMMUNOTHER, V9, P1591, DOI 10.4161/hv.24063; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196; Yermakova A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22721; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8	45	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156893	10.1371/journal.pone.0156893	http://dx.doi.org/10.1371/journal.pone.0156893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300140	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200019
J	Mikkelsen, S; Brauer, C; Pedersen, EB; Alkjaer, T; Koblauch, H; Simonsen, EB; Helweg-Larsen, K; Thygesen, LC				Mikkelsen, Sigurd; Brauer, Charlotte; Pedersen, Ellen Botker; Alkjaer, Tine; Koblauch, Henrik; Simonsen, Erik Bruun; Helweg-Larsen, Karin; Thygesen, Lau Caspar			A Cohort Study on Meniscal Lesions among Airport Baggage Handlers	PLOS ONE			English	Article							RISK-FACTORS; KNEE DISORDERS; FLOOR LAYERS; POPULATION; REGISTERS; PATHOLOGY; HEALTH; TEARS; MRI	Meniscal lesions are common and may contribute to the development of knee arthrosis. A few case-control and cross-sectional studies have identified knee-straining work as risk factors for meniscal lesions, but exposure-response relations and the role of specific exposures are uncertain, and previous results may be sensitive to reporting and selection bias. We examined the relation between meniscal lesions and cumulative exposure to heavy lifting in a prospective register-based study with complete follow-up and independent information on exposure and outcome. We established a cohort of unskilled men employed at Copenhagen Airport or in other companies in the metropolitan Copenhagen area from 1990 to 2012 (the Copenhagen Airport Cohort). The cohort at risk included 3,307 airport baggage handlers with heavy lifting and kneeling or squatting work tasks and 63,934 referents with a similar socioeconomic background and less knee-straining work. Baggage handlers lifted suitcases with an average weight of approximately 15 kg, in total approximately five tonnes during a 9-hour workday. The cohort was followed in the National Patient Register and Civil Registration System. The outcome was a first time hospital diagnosis or surgery of a meniscal lesion. Baggage handlers had a higher incidence of meniscal lesions than the referents. Within baggage handlers spline regression showed that the incidence rate ratio was 1.91 (95% confidence interval: 1.29-2.84) after five years as a baggage handler and then decreased slowly to reach unity after approximately 30 years, adjusted for effects of potential confounders. This relation between baggage handling and meniscal lesions was present for work on the apron which involves lifting in a kneeling or squatting position, but not in the baggage hall, which only involves lifting in standing positions. The results support that long-term heavy lifting in a kneeling or squatting position is a risk factor for the development of symptomatic meniscal lesions.	[Mikkelsen, Sigurd; Brauer, Charlotte; Pedersen, Ellen Botker] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Alkjaer, Tine; Koblauch, Henrik; Simonsen, Erik Bruun] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Helweg-Larsen, Karin; Thygesen, Lau Caspar] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	Aarhus University; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Southern Denmark	Mikkelsen, S (corresponding author), Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark.	sigurd.mikkelsen.01@regionh.dk	Thygesen, Lau/W-9096-2019	Thygesen, Lau/0000-0001-8375-5211; Alkjaer, Tine/0000-0002-9105-3882; Brauer, Charlotte/0000-0002-2109-3264; Simonsen, Erik Bruun/0000-0002-6378-6595	Danish Working Environment Research Fund [24-2011-03]; Danish Rheumatism Association [R101-A2003]	Danish Working Environment Research Fund; Danish Rheumatism Association	The study was funded by The Danish Working Environment Research Fund (grant number 24-2011-03) (( http://arbejdstilsynet.dk/da/om%20arbejdstilsynet/arbejdsmiljoforskningsfonden.aspx) and The Danish Rheumatism Association (grant number R101-A2003) (https://www.gigtforeningen.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; Baker P, 2003, OCCUP ENVIRON MED, V60, P794, DOI 10.1136/oem.60.10.794; Baker P, 2002, J RHEUMATOL, V29, P557; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Englund M, 2012, NAT REV RHEUMATOL, V8, P412, DOI 10.1038/nrrheum.2012.69; Englund M, 2011, ANN RHEUM DIS, V70, P1733, DOI 10.1136/ard.2011.150052; Englund M, 2009, J RHEUMATOL, V36, P1362, DOI 10.3899/jrheum.090335; Hardin G T, 1992, Orthop Rev, V21, P1311; Jensen LK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001109; Jensen LK, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-188; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Katz JN, 2009, ARTHRITIS RHEUM, V60, P633, DOI 10.1002/art.24363; KIVIMAKI J, 1992, SCAND J WORK ENV HEA, V18, P310, DOI 10.5271/sjweh.1571; Lass Preben, 2006, Ugeskr Laeger, V168, P4212; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Rytter Soren, 2009, J Occup Med Toxicol, V4, P19, DOI 10.1186/1745-6673-4-19; Rytter S, 2009, J RHEUMATOL, V36, P1512, DOI 10.3899/jrheum.081150; SHARRARD WJ, 1962, BRIT J IND MED, V19, P195; Snoeker BAM, 2013, J ORTHOP SPORT PHYS, V43, P352, DOI 10.2519/jospt.2013.4295; The Danish Data Protection Agency, 2008, STAND TERMS RES PROJ; The National Committee on Health Research Ethics (DNVK) Copenhagen, 2011, GUID NOT ETC BIOM RE; Thorlund JB, 2014, ACTA ORTHOP, V85, P287, DOI 10.3109/17453674.2014.919558; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157336	10.1371/journal.pone.0157336	http://dx.doi.org/10.1371/journal.pone.0157336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299861	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200037
J	Mollgaard, A; Zettler, I; Dammeyer, J; Jensen, MH; Lehmann, S; Mathiesen, J				Mollgaard, Anders; Zettler, Ingo; Dammeyer, Jesper; Jensen, Mogens H.; Lehmann, Sune; Mathiesen, Joachim			Measure of Node Similarity in Multilayer Networks	PLOS ONE			English	Article							ASSUMED SIMILARITY; FRIENDSHIP; PERCEPTIONS; RELIABILITY; AGREEMENT; VALIDITY; CHOICE; SCHOOL; SCALE	The weight of links in a network is often related to the similarity of the nodes. Here, we introduce a simple tunable measure for analysing the similarity of nodes across different link weights. In particular, we use the measure to analyze homophily in a group of 659 freshman students at a large university. Our analysis is based on data obtained using smartphones equipped with custom data collection software, complemented by questionnaire-based data. The network of social contacts is represented as a weighted multilayer network constructed from different channels of telecommunication as well as data on face-to-face contacts. We find that even strongly connected individuals are not more similar with respect to basic personality traits than randomly chosen pairs of individuals. In contrast, several socio-demographics variables have a significant degree of similarity. We further observe that similarity might be present in one layer of the multilayer network and simultaneously be absent in the other layers. For a variable such as gender, our measure reveals a transition from similarity between nodes connected with links of relatively low weight to dis-similarity for the nodes connected by the strongest links. We finally analyze the overlap between layers in the network for different levels of acquaintanceships.	[Mollgaard, Anders; Jensen, Mogens H.; Mathiesen, Joachim] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Zettler, Ingo; Dammeyer, Jesper] Univ Copenhagen, Dept Psychol, DK-1353 Copenhagen, Denmark; [Lehmann, Sune] Tech Univ Denmark, DK-2800 Lyngby, Denmark	University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Technical University of Denmark	Mathiesen, J (corresponding author), Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark.	mathies@nbi.dk	Jensen, Mogens H./U-5510-2017; Zettler, Ingo/O-1233-2014	Jensen, Mogens H./0000-0001-8104-4299; Mathiesen, Joachim/0000-0002-5621-5487; Zettler, Ingo/0000-0001-6140-7160; Lehmann, Sune/0000-0001-6099-2345; Dammeyer, Jesper/0000-0001-6753-8516	University of Copenhagen UCPH Excellence Programme for Interdisciplinary Research; Villum Fonden [00007192] Funding Source: researchfish	University of Copenhagen UCPH Excellence Programme for Interdisciplinary Research; Villum Fonden(Villum Fonden)	All authors received funding through the University of Copenhagen UCPH 2016 Excellence Programme for Interdisciplinary Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharony N, 2011, PERVASIVE MOB COMPUT, V7, P643, DOI 10.1016/j.pmcj.2011.09.004; Back MD, 2013, J PERS SOC PSYCHOL, V105, P1013, DOI 10.1037/a0034431; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen TR, 2013, J RES PERS, V47, P816, DOI 10.1016/j.jrp.2013.08.009; Crandall CS, 1997, GROUP DYN-THEOR RES, V1, P133, DOI [10.1037/1089-2699.1.2.133, DOI 10.1037/1089-2699.1.2.133]; Currarini S, 2010, P NATL ACAD SCI USA, V107, P4857, DOI 10.1073/pnas.0911793107; DeLay D, 2013, J RES ADOLESCENCE, V23, P464, DOI 10.1111/jora.12017; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; KANDEL DB, 1978, J PERS SOC PSYCHOL, V36, P306, DOI 10.1037/0022-3514.36.3.306; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Kurtz JE, 2003, J PERS, V71, P21, DOI 10.1111/1467-6494.t01-1-00005; Lee K, 2009, J PERS SOC PSYCHOL, V96, P460, DOI 10.1037/a0014059; Lund R, 2014, J AGING HEALTH, V26, P128, DOI 10.1177/0898264313510033; Mollgaard A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154442; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Nicosia V, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032805; Paunonen SV, 2013, J RES PERS, V47, P800, DOI 10.1016/j.jrp.2013.08.007; Rosenberg M, 1989, SOC ADOLESCENT SELF; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; Rushton JP, 2005, PSYCHOL SCI, V16, P555, DOI 10.1111/j.0956-7976.2005.01574.x; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Sekara V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100915; SHERER M, 1982, PSYCHOL REP, V51, P663, DOI 10.2466/pr0.1982.51.2.663; Stehle J, 2013, SOC NETWORKS, V35, P604, DOI 10.1016/j.socnet.2013.08.003; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	33	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157436	10.1371/journal.pone.0157436	http://dx.doi.org/10.1371/journal.pone.0157436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300084	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200049
J	Barzykowski, K; Niedzwienska, A				Barzykowski, Krystian; Niedzwienska, Agnieszka			The Effects of Instruction on the Frequency and Characteristics of Involuntary Autobiographical Memories	PLOS ONE			English	Article							NEURAL MECHANISMS; VOLUNTARY; SPECIFICITY; RECALL	The present study investigated the effects of experimental instruction on the retrieval of involuntary autobiographical memories (IAMs). In previous studies of IAMs, participants were either instructed to record only memories (henceforth, the restricted group) or any thoughts (henceforth, the unrestricted group). However, it is unknown whether these two different types of instructions influence the retrieval of IAMs. The most recent study by Vannucci and her colleagues directly addressed this question and demonstrated that the frequency and phenomenological characteristics of IAMs strongly depended on the type of instruction received. The goal of the present study was to replicate these results while addressing some limitations of the Vannucci et al. study and to test three possible mechanisms proposed to explain the effect of instructions on the retrieval of IAMs. Our results accord well with the data presented by Vannucci et al. When participants were instructed to record only IAMs (the restricted group), they reported more memories and rated them as being retrieved in a more goal-oriented fashion. Their memories also were less clear, vivid, detailed and were less frequently accompanied by physiological reactions, compared to memories reported by the participants in the unrestricted group. In addition, the events to which the memories referred were rated as more unusual and personal by the restricted group. These results are consistent with the assumption that retrieval of IAMs depends on the type of instructions used in a study. In addition, our results suggest that one of the main mechanisms underlying the higher frequency of IAMs in the restricted group may be participants' ability to monitor the stream of consciousness and to extract autobiographical content from this flow. Further implications of the effect of instructions for IAMs research are discussed.	[Barzykowski, Krystian; Niedzwienska, Agnieszka] Jagiellonian Univ, Appl Memory Res Lab, Inst Psychol, Krakow, Poland	Jagiellonian University	Barzykowski, K (corresponding author), Jagiellonian Univ, Appl Memory Res Lab, Inst Psychol, Krakow, Poland.	krystian.barzykowski@uj.edu.pl	Barzykowski, Krystian/AAJ-5797-2021; Niedzwienska, Agnieszka/AAF-1091-2019	Barzykowski, Krystian/0000-0003-4016-3966; Niedzwienska, Agnieszka/0000-0002-9252-3639	Polish National Science Centre [DEC-2011/01/N/HS6/02370, DEC-2013/08/T/HS6/00065]; Marie Curie Intra European Fellowship within 7th European Community Framework Programme	Polish National Science Centre; Marie Curie Intra European Fellowship within 7th European Community Framework Programme	The research was supported by a grant from the Polish National Science Centre (no.: DEC-2011/01/N/HS6/02370) for Krystian Barzykowski. The paper and doctoral dissertation preparation were supported by a doctoral scholarship from the Polish National Science Centre (no.: DEC-2013/08/T/HS6/00065) for Krystian Barzykowski. The funder's website: https://www.ncn.gov.pl/?language=en. Agnieszka Niedzwienska was supported by a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball C. T., 2007, INVOLUNTARY MEMORY, P127, DOI [DOI 10.1002/9780470774069.CH7, 10.1002/9780470774069.ch7]; Ball CT, 2006, APPL COGNITIVE PSYCH, V20, P1167, DOI 10.1002/acp.1264; Barzykowski K, 2016, BRIT J PSYCHOL, V107, P519, DOI 10.1111/bjop.12160; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berntsen D, 2009, INVOLUNTARY AUTOBIOGRAPHICAL MEMORIES: AN INTRODUCTION TO THE UNBIDDEN PAST, P1, DOI 10.1017/CBO9780511575921; Berntsen D, 2004, MEM COGNITION, V32, P789, DOI 10.3758/BF03195869; Berntsen D, 1998, MEMORY, V6, P113, DOI 10.1080/741942071; Berntsen D, 2002, PSYCHOL AGING, V17, P636, DOI 10.1037//0882-7974.17.4.636; Berntsen D, 1996, APPL COGNITIVE PSYCH, V10, P435, DOI 10.1002/(SICI)1099-0720(199610)10:5<435::AID-ACP408>3.0.CO;2-L; Berntsen D, 2015, CLINICAL PERSPECTIVES ON AUTOBIOGRAPHICAL MEMORY, P172; Berntsen D, 2013, J EXP PSYCHOL GEN, V142, P426, DOI 10.1037/a0029128; Berntsen D, 2010, CURR DIR PSYCHOL SCI, V19, P138, DOI 10.1177/0963721410370301; Botzung A, 2008, MEMORY, V16, P351, DOI 10.1080/09658210801931222; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2001, PHILOS T R SOC B, V356, P1375, DOI 10.1098/rstb.2001.0940; Gisquet-Verrier P, 2012, LEARN MEMORY, V19, P401, DOI 10.1101/lm.026054.112; Hall NM, 2008, MEMORY, V16, P48, DOI 10.1080/09658210701333271; Hall NM, 2008, BEHAV BRAIN RES, V186, P261, DOI 10.1016/j.bbr.2007.08.026; Haque S, 2001, EUR J COGN PSYCHOL, V13, P529, DOI 10.1080/09541440125757; Johannessen KB, 2010, CONSCIOUS COGN, V19, P847, DOI 10.1016/j.concog.2010.01.009; Karpicke JD, 2010, J MEM LANG, V62, P227, DOI 10.1016/j.jml.2009.11.010; Kvavilashvili L, 2011, MEMORY, V19, P331, DOI 10.1080/09658211.2011.568495; LePort AKR, 2012, NEUROBIOL LEARN MEM, V98, P78, DOI 10.1016/j.nlm.2012.05.002; Loveday C, 2010, ACT REMEMBERING UNDE, P56, DOI DOI 10.1002/9781444328202.CH4; Mace JH, 2009, APPL MEMORY, P199; Mace JH., 2010, ACT REMEMBERING UNDE, P43, DOI [10.1002/9781444328202, DOI 10.1002/9781444328202, DOI 10.1002/9781444328202.CH3]; Mace JH, 2006, MEMORY, V14, P917, DOI 10.1080/09658210600759766; McDonald DG, 2015, COMMUN RES, V42, P3, DOI 10.1177/0093650212464771; McEnery A, 2006, ROUTLEDGE APPL LINGU; Michael RB, 2012, CURR DIR PSYCHOL SCI, V21, P151, DOI 10.1177/0963721412446369; Moulds ML, 2015, Clinical Perspectives on Autobiographical Memory, P154; Parker ES, 2006, NEUROCASE, V12, P35, DOI 10.1080/13554790500473680; Parnowski T, 1977, Psychiatr Pol, V11, P417; Przepiorkowski A, 2009, CORPUS BASED GRAMMAR, P302; Rasmussen AS, 2009, APPL COGNITIVE PSYCH, V23, P1137, DOI 10.1002/acp.1615; Ritchie TD, 2006, MEMORY, V14, P471, DOI 10.1080/09658210500478434; Roediger HL, 1987, MEMORY COGNITIVE PRO, P349; Schlagman S, 2008, MEM COGNITION, V36, P920, DOI 10.3758/MC.36.5.920; Schlagman S, 2009, PSYCHOL AGING, V24, P397, DOI 10.1037/a0015785; Smieja M, 2007, STUDIA PSYCHOLOGICZN, V45, P19; Suresh Kp, 2011, J Hum Reprod Sci, V4, P8, DOI 10.4103/0974-1208.82352; TULVING E, 1984, BEHAV BRAIN SCI, V7, P223, DOI 10.1017/S0140525X0004440X; Vannucci M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089582; Watson LA, 2013, J BEHAV THER EXP PSY, V44, P7, DOI 10.1016/j.jbtep.2012.06.001; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122	47	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157121	10.1371/journal.pone.0157121	http://dx.doi.org/10.1371/journal.pone.0157121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KF	27294408	Green Submitted, Green Published, gold			2022-12-27	WOS:000377821300021
J	Benhalima, K; Jegers, K; Devlieger, R; Verhaeghe, J; Mathieu, C				Benhalima, Katrien; Jegers, Katleen; Devlieger, Roland; Verhaeghe, Johan; Mathieu, Chantal			Glucose Intolerance after a Recent History of Gestational Diabetes Based on the 2013 WHO Criteria	PLOS ONE			English	Article							BETA-CELL FUNCTION; INSULIN SENSITIVITY; PREGNANCY OUTCOMES; WOMEN; MELLITUS; POSTPARTUM; TOLERANCE; RESISTANCE; COHORT	Aims Uncertainty exists on the prevalence of glucose intolerance in women with a recent diagnosis of gestational diabetes (GDM) based on a two-step screening strategy and the 2013 World Health Organization (WHO) criteria. Our aim was to evaluate the uptake of postpartum screening, the prevalence and the risk factors for glucose intolerance in women with a recent history of GDM. Methods Retrospective analysis of the medical records of women with a recent history of GDM diagnosed in a universal two-step screening strategy with the 2013 WHO criteria. All women with a history of GDM are advised to undergo a 75g oral glucose tolerance test (OGTT) around 12 weeks postpartum. Indices of insulin sensitivity (the Matsuda index and the reciprocal of the homeostasis model assessment of insulin resistance, 1/HOMA-IR) and an index of beta-cell function, the Insulin Secretion-Sensitivity Index-2 (ISSI-2) were calculated based on the OGTT postpartum. Multivariable logistic regression was used to adjust for confounders such as age, BMI, ethnicity and breastfeeding. Results Of the 191 women with GDM, 29.3%(56) did not attend the scheduled postpartum OGTT. These women had a higher BMI (28.6 +/- 6.8 vs. 26.2 +/- 5.6, p = 0.015), were more often from an ethnic minority (EM) background (41.1% vs. 25.2%, p = 0.029) and smoked more often during pregnancy (14.3% vs. 2.2%, p = 0.001) than women who attended the OGTT postpartum. Of all women (135) who received an OGTT postpartum, 42.2% (57) had prediabetes (11.9% impaired fasting glucose, 24.4% impaired glucose tolerance and 5.9% both impaired fasting and impaired glucose tolerance) and 1.5% (2) had overt diabetes. Compared to women with a normal OGTT postpartum, women with glucose intolerance were older (32.5 +/- 4.3 vs. 30.8 +/- 4.8 years, p = 0.049), were more often obese (34.5% vs. 17.3%, p = 0.023), were more often from an EM background (33.9% vs. 18.4%, p = 0.040), less often breastfed (69.5% vs. 84.2%, p = 0.041) and had more often an abnormal fasting glycaemia at the time of the OGTT in pregnancy (55.6% vs. 37.3%, p = 0.040). In the multivariable logistic regression, an EM background [OR = 2.76 (1.15-6.62), p = 0.023] and the HbA1c level at the time of the OGTT in pregnancy [OR = 4.78 (1.19-19.20), p = 0.028] remained significant predictors for glucose intolerance postpartum. Women with glucose intolerance postpartum had a similar insulin sensitivity [Matsuda index 0.656 (0.386-1.224) vs. 0.778 (0.532-1.067), p = 0.709; 1/HOMA-IR 0.004 (0.002-0.009) vs. (0.004-0.003-0.007), p = 0.384] but a lower beta-cell function compared to women with a normal OGTT postpartum, remaining significant after adjustment for confounders [ISSI-2 1.6 (1.2-2.1) vs. 1.9 (1.7-2.4), p = 0.002]. Conclusions Glucose intolerance is very frequent in early postpartum in women with GDM based on the 2013 WHO criteria in a two-step screening strategy and these women have an impaired beta-cell function. Nearly one third of women did not attend the scheduled OGTT postpartum and these women have an adverse risk profile. More efforts are needed to engage and stimulate women with GDM to attend the postpartum OGTT.	[Benhalima, Katrien; Jegers, Katleen; Mathieu, Chantal] Katholieke Univ Leuven, UZ Gasthuisberg, Dept Endocrinol, Leuven, Belgium; [Devlieger, Roland; Verhaeghe, Johan] Katholieke Univ Leuven, Dept Obstet & Gynecol, UZ Gasthuisberg, Leuven, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Benhalima, K (corresponding author), Katholieke Univ Leuven, UZ Gasthuisberg, Dept Endocrinol, Leuven, Belgium.	katrien.benhalima@uzleuven.be	Devlieger, Roland/AAS-9181-2020; Benhalima, Katrien/K-5800-2017; mathieu, chantal/ABD-5505-2021	Devlieger, Roland/0000-0001-7837-4684; Benhalima, Katrien/0000-0002-3325-0263; mathieu, chantal/0000-0002-4055-5233				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2013, DIAGNOSTIC CRITERIA; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Benhalima K, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0706-x; Benhalima K, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/727652; Benhalima K, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-226; Benhalima K, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-66; Bihan H, 2014, DIABETES METAB, V40, P151, DOI 10.1016/j.diabet.2013.12.002; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Duran A, 2014, DIABETES CARE, V37, P2442, DOI 10.2337/dc14-0179; Gunderson EP, 2012, DIABETES CARE, V35, P50, DOI 10.2337/dc11-1409; International Diabetes Federation, 2013, DIABETES E ATLAS; Picon MJ, 2012, DIABETES CARE, V35, P1648, DOI 10.2337/dc11-2111; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kirwan JP, 2001, DIABETES CARE, V24, P1602, DOI 10.2337/diacare.24.9.1602; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Kramer CK, 2014, DIABETES CARE, V37, P3262, DOI 10.2337/dc14-1529; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Leuridan L, 2015, PRIM CARE DIABETES, V9, P244, DOI 10.1016/j.pcd.2015.03.007; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Noctor E, 2013, EUR J ENDOCRINOL, V169, P681, DOI 10.1530/EJE-13-0491; O'Reilly MW, 2011, EUR J ENDOCRINOL, V165, P953, DOI 10.1530/EJE-11-0663; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Retnakaran R, 2008, DIABETES CARE, V31, P2026, DOI 10.2337/dc08-0972; Sacks DA, 2012, DIABETES CARE, V35, P526, DOI 10.2337/dc11-1641; Shah BR, 2011, BJOG-INT J OBSTET GY, V118, P1484, DOI 10.1111/j.1471-0528.2011.03083.x; The National Institute for Health and Care Excellence (NICE), 2015, UPDATED GUIDELINES O	32	28	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157272	10.1371/journal.pone.0157272	http://dx.doi.org/10.1371/journal.pone.0157272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285104	Green Published, gold			2022-12-27	WOS:000377564000055
J	Bergler, T; Jung, B; Bourier, F; Kuhne, L; Banas, MC; Rummele, P; Wurm, S; Banas, B				Bergler, Tobias; Jung, Bettina; Bourier, Felix; Kuehne, Louisa; Banas, Miriam C.; Ruemmele, Petra; Wurm, Simone; Banas, Bernhard			Infiltration of Macrophages Correlates with Severity of Allograft Rejection and Outcome in Human Kidney Transplantation	PLOS ONE			English	Article							HUMAN RENAL-ALLOGRAFTS; PROGNOSTIC-SIGNIFICANCE; MONOCLONAL-ANTIBODIES; ADHESION MOLECULES; BIOPSIES; DYSFUNCTION; EXPRESSION; MONOCYTES; INJURY; C4D	Objective Despite substantial progress in recent years, graft survival beyond the first year still requires improvement. Since modern immunosuppression addresses mainly T-cell activation and proliferation, we studied macrophage infiltration into the allografts of 103 kidney transplant recipients during acute antibody and T-cell mediated rejection. Macrophage infiltration was correlated with both graft function and graft survival until month 36 after transplantation. Results Macrophage infiltration was significantly elevated in antibody-mediated and T-cell mediated rejection, but not in kidneys with established IFTA. Treatment of rejection with steroids was less successful in patients with more prominent macrophage infiltration into the allografts. Macrophage infiltration was accompanied by increased cell proliferation as well as antigen presentation. With regard to the compartmental distribution severity of T-cell-mediated rejection was correlated to the amount of CD68(+) cells especially in the peritubular and perivascular compartment, whereas biopsies with ABMR showed mainly peritubular CD68 infiltration. Furthermore, severity of macrophage infiltration was a valid predictor of resulting creatinine values two weeks as well as two and three years after renal transplantation as illustrated by multivariate analysis. Additionally performed ROC curve analysis showed that magnitude of macrophage infiltration (below vs. above the median) was a valid predictor for the necessity to restart dialysis. Having additionally stratified biopsies in accordance to the magnitude of macrophage infiltration, differential CD68+ cell infiltration was reflected by striking differences in overall graft survival. Conclusion The differences in acute allograft rejection have not only been reflected by different magnitudes of macrophage infiltration, but also by compartment-specific infiltration pattern and subsequent impact on resulting allograft function as well as need for dialysis initiation. There is a robust relationship between macrophage infiltration, accompanying antigen-presentation and resulting allograft function.	[Bergler, Tobias; Jung, Bettina; Bourier, Felix; Kuehne, Louisa; Banas, Miriam C.; Wurm, Simone; Banas, Bernhard] Univ Hosp Regensburg, Dept Nephrol, Regensburg, Germany; [Ruemmele, Petra] Univ Regensburg, Dept Pathol, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Bergler, T (corresponding author), Univ Hosp Regensburg, Dept Nephrol, Regensburg, Germany.	tobias.bergler@ukr.de	Steines, Louisa/AAD-3347-2022	Steines, Louisa/0000-0002-6027-2986; Bourier, Felix/0000-0003-4861-6595; Bergler, Tobias/0000-0002-3875-6730; Banas, Bernhard/0000-0003-2076-2195	Else Kroner-Fresenius-Stiftung	Else Kroner-Fresenius-Stiftung	This work was supported by the Else Kroner-Fresenius-Stiftung to BT.	AXELSEN RA, 1985, CLIN NEPHROL, V23, P1; Bajwa A, 2009, CURR DRUG TARGETS, V10, P1196, DOI 10.2174/138945009789753174; BISHOP GA, 1986, KIDNEY INT, V29, P708, DOI 10.1038/ki.1986.56; BURKHARDT K, 1995, TRANSPLANT P, V27, P890; Chadban SJ, 2010, SEMIN NEPHROL, V30, P278, DOI 10.1016/j.semnephrol.2010.03.009; Copin M C, 1995, Transpl Immunol, V3, P229, DOI 10.1016/0966-3274(95)80029-8; DIAMOND JR, 1992, TRANSPLANTATION, V54, P710, DOI 10.1097/00007890-199210000-00028; DOOPER IMM, 1994, TRANSPLANTATION, V58, P820, DOI 10.1097/00007890-199410150-00013; Girlanda R, 2008, AM J TRANSPLANT, V8, P600, DOI 10.1111/j.1600-6143.2007.02109.x; Guillen-Gomez E, 2014, CLIN EXP IMMUNOL, V175, P323, DOI 10.1111/cei.12228; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; HABIB R, 1993, KIDNEY INT, V44, pS104; HANCOCK WH, 1993, TRANSPLANTATION, V56, P643, DOI 10.1097/00007890-199309000-00028; HANCOCK WW, 1983, TRANSPLANTATION, V35, P458, DOI 10.1097/00007890-198305000-00013; HARRY TR, 1984, TRANSPLANTATION, V37, P70, DOI 10.1097/00007890-198401000-00019; HEEMANN UW, 1994, TRANSPLANT INT, V7, P349, DOI 10.1007/BF00336711; Hoffmann U, 2006, NEPHROL DIAL TRANSPL, V21, P1373, DOI 10.1093/ndt/gfk075; Hoffmann U, 2013, TRANSPL IMMUNOL, V28, P24, DOI 10.1016/j.trim.2012.12.001; Ikezumi Y, 2015, PEDIATR NEPHROL, V30, P1007, DOI 10.1007/s00467-014-3023-0; Kirk AD, 1999, TRANSPLANTATION, V68, P1578, DOI 10.1097/00007890-199911270-00024; Mannon RB, 2012, CURR OPIN ORGAN TRAN, V17, P20, DOI 10.1097/MOT.0b013e32834ee5b6; MATHEW TH, 1975, AM J MED, V59, P177, DOI 10.1016/0002-9343(75)90352-6; MATHEW TH, 1988, AM J KIDNEY DIS, V12, P85, DOI 10.1016/S0272-6386(88)80001-5; Matoza JRA, 2008, TRANSPL P, V40, P2303, DOI 10.1016/j.transproceed.2008.07.004; Mauiyyedi S, 2001, J AM SOC NEPHROL, V12, P574, DOI 10.1681/ASN.V123574; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Messias NC, 2001, TRANSPLANTATION, V72, P655, DOI 10.1097/00007890-200108270-00016; Nankivell BJ, 2006, AM J TRANSPLANT, V6, P2006, DOI 10.1111/j.1600-6143.2006.01436.x; Nankivell BJ, 2006, TRANSPLANTATION, V81, P643, DOI 10.1097/01.tp.0000190423.82154.01; OM A, 1987, TRANSPLANT P, V19, P1618; RAFTERY MJ, 1989, TRANSPLANTATION, V48, P238, DOI 10.1097/00007890-198908000-00011; RAMOS EL, 1995, TRANSPLANTATION, V59, P490; Regele H, 2002, J AM SOC NEPHROL, V13, P2371, DOI 10.1097/01.ASN.0000025780.03790.0F; RICHARDSON WP, 1981, NEW ENGL J MED, V305, P57, DOI 10.1056/NEJM198107093050201; Rowshani AT, 2012, TRANSPLANTATION, V94, P309, DOI 10.1097/TP.0b013e318250c10f; RUSH DN, 1994, TRANSPLANTATION, V57, P208, DOI 10.1097/00007890-199401001-00009; SERON D, 1989, TRANSPLANTATION, V47, P811, DOI 10.1097/00007890-198905000-00013; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Tinckam KJ, 2005, KIDNEY INT, V68, P1866, DOI 10.1111/j.1523-1755.2005.00606.x; Toki D, 2014, AM J TRANSPLANT, V14, P2126, DOI 10.1111/ajt.12803; Wyburn KR, 2005, TRANSPLANTATION, V80, P1641, DOI 10.1097/01.tp.0000173903.26886.20	41	47	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156900	10.1371/journal.pone.0156900	http://dx.doi.org/10.1371/journal.pone.0156900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285579	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000030
J	Muka, T; Oliver-Williams, C; Colpani, V; Kunutsor, S; Chowdhury, S; Chowdhury, R; Kavousi, M; Franco, OH				Muka, Taulant; Oliver-Williams, Clare; Colpani, Veronica; Kunutsor, Setor; Chowdhury, Susmita; Chowdhury, Rajiv; Kavousi, Maryam; Franco, Oscar H.			Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; POSTMENOPAUSAL WOMEN; HOT FLASHES; SLEEP DURATION; BLOOD-PRESSURE; PANIC-ATTACKS; DEPRESSION; MORTALITY; EVENTS; MEN	Importance Vasomotor symptoms (hot flushes and night sweats) and other symptoms, including depression, anxiety and panic attacks, are commonly experienced by menopausal women and have been associated with an unfavourable cardiovascular risk profile. Objective To investigate whether presence of menopausal symptoms is associated with the development of cardiovascular disease (CVD). Methods Five electronic databases (Medline, EMBASE and Web of Science) were search until February 17th, 2015 to identify relevant studies. Observational cohort studies or randomised intervention studies were eligible for inclusion if they followed participants prospectively (at least 1 year of follow-up), and reported relevant estimates on the association of any vasomotor symptoms, or other menopausal symptoms, with risk of CVD, coronary heart disease (CHD), or stroke in perimenopausal, menopausal, or postmenopausal women. Data were extracted by two independent reviewers using a pre-designed data collection form. Separate pooled relative risks (RRs) for age and non-established cardiovascular risk factors (e.g., education, ethnicity) adjusted data and for established cardiovascular risk factors and potential mediators-adjusted data (e.g., smoking, body mass index, and hypertension) were calculated. Results Out of 9,987 initially identified references, ten studies were selected, including 213,976 women with a total of 10,037 cardiovascular disease outcomes. The age and non-established cardiovascular risk factors adjusted RRs) [95% confidence intervals] for development of CHD, Stroke and CVD comparing women with and without any menopausal symptoms were 1.34 [1.13-1.58], 1.30 [0.99-1.70], 1.48 [1.21-1.80] respectively, and the corresponding RRs adjusted for cardiovascular risk factors and potential mediators were 1.18 [1.03-1.35], 1.08 [0.89-1.32], 1.29 [0.98-1.71]. However, these analyses were limited by potential unmeasured confounding and the small number of studies on this topic. Conclusion Presence of vasomotor symptoms and other menopausal symptoms are generally associated with an increased risk of cardiovascular disease, which is mainly explained by cardiovascular risk factors.	[Muka, Taulant; Colpani, Veronica; Kavousi, Maryam; Franco, Oscar H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Oliver-Williams, Clare; Kunutsor, Setor; Chowdhury, Susmita; Chowdhury, Rajiv] Univ Cambridge, Cardiovasc Epidemiol Unit, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Colpani, Veronica] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil	Erasmus University Rotterdam; Erasmus MC; University of Cambridge; Universidade Federal do Rio Grande do Sul	Muka, T (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	t.muka@erasmusmc.nl	Chowdhury, Rajiv/AHB-1253-2022; Franco, Óscar H/ABE-2305-2020; Colpani, Veronica/B-3964-2015; Colpani, Verônica/AAH-8439-2020; Kavousi, Maryam/F-1174-2018; Kunutsor, Setor K/H-9807-2019	Franco, Óscar H/0000-0002-4606-4929; Colpani, Verônica/0000-0002-7908-4213; Kavousi, Maryam/0000-0001-5976-6519; Kunutsor, Setor K/0000-0002-2625-0273	Metagenics Inc.; Nestle Nutrition (Nestec Ltd.); AXA; MRC [MR/L003120/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, RG/13/13/30194] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish	Metagenics Inc.; Nestle Nutrition (Nestec Ltd.)(Nestle SA); AXA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding/Support: This study was sponsored and funded by Metagenics Inc. Role of the Funder/Sponsor: Metagenics Inc. had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review or approval of the manuscript. The funder/sponsor did not have the ability to veto publication of study results. Disclosure statement: TM and OHF work in ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd.), Metagenics Inc. and AXA. MK is supported by the AXA Research Fund. Nestle Nutrition (Nestec Ltd.), Metagenics Inc. AXA had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review or approval of the manuscript.	Ahto M, 2007, INT J GERIATR PSYCH, V22, P757, DOI 10.1002/gps.1735; Breheny MS, 2000, NZ FAM PHYS, V34, P43; Brunner EJ, 2014, EUR J PREV CARDIOL, V21, P340, DOI 10.1177/2047487314520785; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Carney RM, 2005, PSYCHOSOM MED, V67, pS29, DOI 10.1097/01.psy.0000162254.61556.d5; Carr DB, 2006, DIABETES CARE, V29, P2078, DOI 10.2337/dc05-2482; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Cohen LS, 2005, AM J MED, V118, P1408, DOI 10.1016/j.amjmed.2005.10.018; Collins P, 2007, EUR HEART J, V28, P2028, DOI 10.1093/eurheartj/ehm296; de Leon CFM, 1998, ARCH INTERN MED, V158, P2341; de Wit LM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-14; Dennerstein L, 2000, OBSTET GYNECOL, V96, P351, DOI 10.1016/S0029-7844(00)00930-3; DiBonaventura MD, 2013, INT J WOMENS HEALTH, V5, P261, DOI 10.2147/IJWH.S39027; Esler M, 2004, ANN NY ACAD SCI, V1018, P505, DOI 10.1196/annals.1296.062; Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261; Franco OH, 2015, MATURITAS, V81, P353, DOI 10.1016/j.maturitas.2015.04.016; FREEDMAN RR, 1995, J CLIN ENDOCR METAB, V80, P2354, DOI 10.1210/jc.80.8.2354; Gast GCM, 2008, HYPERTENSION, V51, P1492, DOI 10.1161/HYPERTENSIONAHA.107.106526; Gast GCM, 2011, MENOPAUSE, V18, P146, DOI 10.1097/gme.0b013e3181f464fb; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kagitani H, 2014, AM J HYPERTENS, V27, P503, DOI 10.1093/ajh/hpt125; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Lallukka T, 2012, SLEEP MED, V13, P1271, DOI 10.1016/j.sleep.2012.06.020; Laugsand LE, 2014, EUR HEART J, V35, P1382, DOI 10.1093/eurheartj/eht019; Mannisto T, 2013, CIRCULATION, V127, P681, DOI 10.1161/CIRCULATIONAHA.112.128751; Mittleman MA, 2011, CIRCULATION, V124, P346, DOI 10.1161/CIRCULATIONAHA.110.968776; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Ohayon MM, 2006, ARCH INTERN MED, V166, P1262, DOI 10.1001/archinte.166.12.1262; Palacios S, 2010, CLIMACTERIC, V13, P419, DOI 10.3109/13697137.2010.507886; Panay Nick, 2013, Menopause Int, V19, P59, DOI 10.1177/1754045313489645; Pascual-Leone Pascual AM, 2015, AN R ACAD FARM, V80, P466; Penninx BWJH, 1998, AM J CARDIOL, V81, P988, DOI 10.1016/S0002-9149(98)00077-0; Player MS, 2011, INT J PSYCHIAT MED, V41, P365, DOI 10.2190/PM.41.4.f; Reed SD, 2013, MATURITAS, V75, P152, DOI 10.1016/j.maturitas.2013.03.003; Sands-Lincoln M, 2013, J WOMENS HEALTH, V22, P477, DOI 10.1089/jwh.2012.3918; Smoller JW, 2007, ARCH GEN PSYCHIAT, V64, P1153, DOI 10.1001/archpsyc.64.10.1153; Smoller JW, 2003, ARCH INTERN MED, V163, P2041, DOI 10.1001/archinte.163.17.2041; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Svartberg J, 2009, MENOPAUSE, V16, P888, DOI 10.1097/gme.0b013e3181a4866b; Szmuilowicz ED, 2011, MENOPAUSE, V18, P603, DOI 10.1097/gme.0b013e3182014849; Thurston RC, 2006, INT J BEHAV MED, V13, P163, DOI 10.1207/s15327558ijbm1302_8; Walters K, 2008, EUR HEART J, V29, P2981, DOI 10.1093/eurheartj/ehn477; Wassertheil-Smoller S, 2004, ARCH INTERN MED, V164, P289, DOI 10.1001/archinte.164.3.289; Whooley MA, 1998, ARCH INTERN MED, V158, P2129, DOI 10.1001/archinte.158.19.2129	46	56	65	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157417	10.1371/journal.pone.0157417	http://dx.doi.org/10.1371/journal.pone.0157417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315068	Green Published, Green Submitted, gold			2022-12-27	WOS:000378030000024
J	Goerg, SJ; Hennig-Schmidt, H; Walkowitz, G; Winter, E				Goerg, Sebastian J.; Hennig-Schmidt, Heike; Walkowitz, Gari; Winter, Eyal			In Wrong Anticipation - Miscalibrated Beliefs between Germans, Israelis, and Palestinians	PLOS ONE			English	Article							BEHAVIORAL-EXPERIMENTS; CULTURAL INTERACTION; SOCIAL-EXCHANGE; TRUST; RECIPROCITY; DISCRIMINATION; COOPERATION; IDENTITY	The reconcilability of actions and beliefs in inter-country relationships, either in business or politics, is of vital importance as incorrect beliefs on foreigners' behavior can have serious implications. We study a typical inter-country interaction by means of a controlled laboratory investment game experiment in Germany, Israel and Palestine involving 400 student participants in total. An investor has to take a risky decision in a foreign country that involves transferring money to an investee/allocator. We found a notable constellation of calibrated and un-calibrated beliefs. Within each country, transfer standards exist, which investees correctly anticipate within their country. However, across countries these standards differ. By attributing the standard of their own environment to the other countries investees are remarkably bad in predicting foreign investors' behavior. The tendency to ignore this potential difference can be a source of misinterpreting motives in cross-country interaction. Foreigners might perceive behavior as unfavorable or favorable differentiation, even thoughunknown to them-investors actually treat fellow-country people and foreigners alike.	[Goerg, Sebastian J.] Florida State Univ, Dept Econ, Tallahassee, FL 32306 USA; [Goerg, Sebastian J.] Max Planck Inst Res Collect Goods, Bonn, Germany; [Hennig-Schmidt, Heike] Univ Bonn, Lab Expt Econ, Bonn, Germany; [Hennig-Schmidt, Heike] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway; [Walkowitz, Gari] Univ Cologne, Corp Dev & Business Eth, D-50931 Cologne, Germany; [Winter, Eyal] Hebrew Univ Jerusalem, Ctr Study Rat, Jerusalem, Israel	State University System of Florida; Florida State University; Max Planck Society; University of Bonn; University of Oslo; University of Cologne; Hebrew University of Jerusalem	Hennig-Schmidt, H (corresponding author), Univ Bonn, Lab Expt Econ, Bonn, Germany.; Hennig-Schmidt, H (corresponding author), Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway.	hschmidt@uni-bonn.de	Walkowitz, Gari/L-6016-2017; Hennig-Schmidt, Heike/L-2924-2017; Goerg, Sebastian J./AAL-4475-2020	Goerg, Sebastian J./0000-0002-1740-6870; Winter, Eyal/0000-0002-4318-1759; Hennig-Schmidt, Heike/0000-0002-2841-4657	Deutsche Forschungsgemeinschaft [SE 137/3-1,2]; Kate Hamburger Kolleg / Centre for Global Cooperation Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kate Hamburger Kolleg / Centre for Global Cooperation Research	The authors gratefully acknowledge financial support from Deutsche Forschungsgemeinschaft, Grant number: SE 137/3-1,2, www.dfg.de/en/index.jsp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge Reinhard Selten's steady support of this research as well as his helpful and valuable comments and suggestions. Thanks go to Zeina Barakat, Julia Berndt, Emanuel Castillo, Alon Elkin, Ihab Dakkak, Christine Hottenrott, Shani Kuna, Liza Kozan, and Petra Muller for valuable research assistance. Instructions, decision sheets and computer screens were translated and cross-checked by Karim Daiz, Alon Elkin, Yossi Elsner, Talya Kittan, and Ibrahim Lashin. We are grateful to Manuel Hassassian for enabling us to run the sessions at Bethlehem University and to Mohammed Dajani for giving us the opportunity to run the experiment at Abu Dis University. We appreciate valuable comments and suggestions by participants at various conferences and seminars: Nankai University, Tianjin, P. R. China; Sozialwissenschaftlicher Ausschuss, Verein fur Socialpolitik, Munchen, Germany; IMEBE and SABE Meetings, Granada, Spain; Research Seminars at the Universities of Paderborn, Konstanz, and Nuremberg, Germany. Thanks go also to Jan-Erik Lonnqvist, Oliver Kirchkamp, Axel Ostmann, Bettina Rockenbach and Daniel Wiesen for helpful comments. We are grateful to the Editor of this journal and to two anonymous referees for their insightful comments and suggestions. Heike Hennig-Schmidt acknowledges a fellowship of Kate Hamburger Kolleg / Centre for Global Cooperation Research while working on the paper.	ADLER NJ, 1989, J INT BUS STUD, V20, P515, DOI 10.1057/palgrave.jibs.8490367; Akai K, 2012, J SOCIO-ECON, V41, P266, DOI 10.1016/j.socec.2011.08.028; Aumann RJ, 2008, 497 HEBR U JER CTR S; Aumann RJ, 2008, 3 LIND M EC SCI 2008; Balliet D, 2014, PSYCHOL BULL, V140, P1556, DOI 10.1037/a0037737; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Boarini R, 2009, THEOR DECIS, V67, P341, DOI 10.1007/s11238-009-9135-5; Bohnet I, 2008, AM ECON REV, V98, P294, DOI 10.1257/aer.98.1.294; Bohnet I, 2010, Q J ECON, V125, P811, DOI 10.1162/qjec.2010.125.2.811; Bornhorst F, 2010, EXP ECON, V13, P260, DOI 10.1007/s10683-010-9240-x; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Buchan N, 2004, J ECON BEHAV ORGAN, V55, P485, DOI 10.1016/j.jebo.2003.11.005; Buchan NR, 2011, PSYCHOL SCI, V22, P821, DOI 10.1177/0956797611409590; Buchan NR, 2009, P NATL ACAD SCI USA, V106, P4138, DOI 10.1073/pnas.0809522106; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cardenas JC, 2008, J DEV STUD, V44, P311, DOI 10.1080/00220380701848327; Chuah SH, 2007, J ECON BEHAV ORGAN, V64, P35, DOI 10.1016/j.jebo.2006.04.006; COHEN R, 1987, INT J INTERCULT REL, V11, P29, DOI 10.1016/0147-1767(87)90030-7; Cohen Raymond, 1990, CULTURE CONFLICT EGY; Costa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094842; Costa A, 2014, COGNITION, V130, P236, DOI 10.1016/j.cognition.2013.11.010; Dufwenberg M, 2011, GAME ECON BEHAV, V73, P459, DOI 10.1016/j.geb.2011.02.003; Engelmann D, 2012, GAME ECON BEHAV, V76, P678, DOI 10.1016/j.geb.2012.07.009; Fershtman C, 2005, J LEGAL STUD, V34, P371, DOI 10.1086/429846; Fershtman C, 2001, Q J ECON, V116, P351, DOI 10.1162/003355301556338; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; Goerg S. J., 2013, CGS WORKING PAPER, V4, P0; Goerg SJ, 2010, J ECON PSYCHOL, V31, P849, DOI 10.1016/j.joep.2010.06.001; Guiso L, 2006, J ECON PERSPECT, V20, P23, DOI 10.1257/jep.20.2.23; Hall E. T., 1976, CULTURE; Harbring C, 2010, J INST THEOR ECON, V166, P690, DOI 10.1628/093245610793524938; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Herrmann B, 2008, ANTISOCIAL PUNISHMEN; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Hofstede, 1991, ORG CULTURES SOFTWAR; Johnson ND, 2011, J ECON PSYCHOL, V32, P865, DOI 10.1016/j.joep.2011.05.007; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kuwabaaa K, 2007, SOC PSYCHOL QUART, V70, P461, DOI 10.1177/019027250707000412; Lane T, 2016, EUR ECON REV, V90, P375, DOI 10.1016/j.euroecorev.2015.11.011; Matsumoto D, 2011, INT J INTERCULT REL, V35, P677, DOI 10.1016/j.ijintrel.2011.02.017; Netzer RJ, 2009, U INNSBRUCK WORKING; Oberhammer C, 2006, PREPRINT; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Richerson PJ., 2005, NOT GENES ALONE CULT; Rosenboim M, 2012, EXP ECON, V15, P145, DOI 10.1007/s10683-011-9294-4; ROTH AE, 1991, AM ECON REV, V81, P1068; Ruffle BJ, 2006, J ECON BEHAV ORGAN, V60, P147, DOI 10.1016/j.jebo.2004.07.007; Sagie A, PROBLEMS PERSPECTIVE, V2, P148; Schubert M, 2014, J CONFLICT RESOLUT, V58, P539, DOI 10.1177/0022002713478792; Selten R., 1967, BEITRAGE EXPT WIRTSC, P136; Takahashi C, 2008, INT J INTERCULT REL, V32, P215, DOI 10.1016/j.ijintrel.2007.11.003; Willinger M, 2003, J ECON PSYCHOL, V24, P447, DOI 10.1016/S0167-4870(02)00165-4; Zaharna RS, 1991, HOWARD J COMMUNICATI, V3, P87	57	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156998	10.1371/journal.pone.0156998	http://dx.doi.org/10.1371/journal.pone.0156998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27311066	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800025
J	Marriott, AC; Dennis, M; Kane, JA; Gooch, KE; Hatch, G; Sharpe, S; Prevosto, C; Leeming, G; Zekeng, EG; Staples, KJ; Hall, G; Ryan, KA; Bate, S; Moyo, N; Whittaker, CJ; Hallis, B; Silman, NJ; Lalvani, A; Wilkinson, TM; Hiscox, JA; Stewart, JP; Carroll, MW				Marriott, Anthony C.; Dennis, Mike; Kane, Jennifer A.; Gooch, Karen E.; Hatch, Graham; Sharpe, Sally; Prevosto, Claudia; Leeming, Gail; Zekeng, Elsa-Gayle; Staples, Karl J.; Hall, Graham; Ryan, Kathryn A.; Bate, Simon; Moyo, Nathifa; Whittaker, Catherine J.; Hallis, Bassam; Silman, Nigel J.; Lalvani, Ajit; Wilkinson, Tom M.; Hiscox, Julian A.; Stewart, James P.; Carroll, Miles W.			Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of Infection	PLOS ONE			English	Article							RESPIRATORY-TRACT; NONHUMAN-PRIMATES; AVIAN INFLUENZA; RESPONSES; HUMANS; PROTECTION; VACCINE; CELL; PATHOGENICITY; TRANSMISSION	Non-human primates are the animals closest to humans for use in influenza A virus challenge studies, in terms of their phylogenetic relatedness, physiology and immune systems. Previous studies have shown that cynomolgus macaques (Macaca fascicularis) are permissive for infection with H1N1pdm influenza virus. These studies have typically used combined challenge routes, with the majority being intra-tracheal delivery, and high doses of virus (> 107 infectious units). This paper describes the outcome of novel challenge routes (inhaled aerosol, intra-nasal instillation) and low to moderate doses (103 to 106 plaque forming units) of H1N1pdm virus in cynomolgus macaques. Evidence of virus replication and sero-conversion were detected in all four challenge groups, although the disease was subclinical. Intra-nasal challenge led to an infection confined to the nasal cavity. A low dose (103 plaque forming units) did not lead to detectable infectious virus shedding, but a 1000-fold higher dose led to virus shedding in all intra-nasal challenged animals. In contrast, aerosol and intra-tracheal challenge routes led to infections throughout the respiratory tract, although shedding from the nasal cavity was less reproducible between animals compared to the high-dose intra-nasal challenge group. Intra-tracheal and aerosol challenges induced a transient lymphopaenia, similar to that observed in influenza-infected humans, and greater virus-specific cellular immune responses in the blood were observed in these groups in comparison to the intra-nasal challenge groups. Activation of lung macrophages and innate immune response genes was detected at days 5 to 7 post-challenge. The kinetics of infection, both virological and immunological, were broadly in line with human influenza A virus infections. These more authentic infection models will be valuable in the determination of anti-influenza efficacy of novel entities against less severe (and thus more common) influenza infections.	[Marriott, Anthony C.; Dennis, Mike; Kane, Jennifer A.; Gooch, Karen E.; Hatch, Graham; Sharpe, Sally; Prevosto, Claudia; Hall, Graham; Ryan, Kathryn A.; Bate, Simon; Whittaker, Catherine J.; Hallis, Bassam; Silman, Nigel J.; Carroll, Miles W.] Publ Hlth England, Natl Infect Serv, Porton Down, Wilts, England; [Leeming, Gail; Zekeng, Elsa-Gayle; Moyo, Nathifa; Hiscox, Julian A.; Stewart, James P.] Univ Liverpool, Inst Infect & Global Hlth, Dept Infect Biol, Liverpool L69 3BX, Merseyside, England; [Staples, Karl J.; Wilkinson, Tom M.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton, Hants, England; [Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Infect, London, England; [Prevosto, Claudia] Guys Hosp, Kings Coll London, Res Oncol Dept, London SE1 9RT, England; [Bate, Simon] Def Sci & Technol Lab, Porton Down, Wilts, England	Public Health England; University of Liverpool; University of Southampton; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Defence Science & Technology Laboratory	Marriott, AC (corresponding author), Publ Hlth England, Natl Infect Serv, Porton Down, Wilts, England.	Anthony.marriott@phe.gov.uk		Ryan, Kathryn Ann/0000-0001-8608-1144; Staples, Karl/0000-0003-3844-6457; Hiscox, Julian/0000-0002-6582-0275; Marriott, Anthony/0000-0002-8862-9852; Moyo, Nathifa Adaoha/0000-0003-3203-9463; Wilkinson, Tom/0000-0003-1771-3851; Lalvani, Ajit/0000-0002-2396-246X; Stewart, James/0000-0002-8928-2037	Department of Health; Biotechnology and Biological Sciences Research Council [BB/K009664/1]; BBSRC [BB/K009664/1] Funding Source: UKRI; MRC [G0801620] Funding Source: UKRI; Medical Research Council [G0801620] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10155] Funding Source: researchfish	Department of Health; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Department of Health, grant in aid (AM), https://www.gov.uk/government/organisations/department-of-health; Biotechnology and Biological Sciences Research Council, BB/K009664/1 (JS), http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Davis AS, 2015, ANTIVIR RES, V117, P75, DOI 10.1016/j.antiviral.2015.02.011; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Go JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-627; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Herfst S, 2010, VET PATHOL, V47, P1040, DOI 10.1177/0300985810374836; Huang KYA, 2014, J INFECT DIS, V209, P1354, DOI 10.1093/infdis/jit650; Huang YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002234; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Josset L, 2012, J VIROL, V86, P11115, DOI 10.1128/JVI.01571-12; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Killingley B, 2012, J INFECT DIS, V205, P35, DOI 10.1093/infdis/jir701; Kipar A, 2001, J COMP PATHOL, V125, P182, DOI 10.1053/jcpa.2001.0501; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Koopman G, 2016, J VIROL, V90, P1023, DOI 10.1128/JVI.02757-15; Kuiken T, 2003, VET PATHOL, V40, P304, DOI 10.1354/vp.40-3-304; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Marriott AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094090; McClain MT, 2013, J CLIN VIROL, V58, P689, DOI 10.1016/j.jcv.2013.09.015; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Memoli MJ, 2015, CLIN INFECT DIS, V60, P693, DOI 10.1093/cid/ciu924; Merekoulias G, 2010, PLOS CURR, V2, DOI [10.1371/currents.rrn1154, DOI 10.1371/CURRENTS.RRN1154]; Mooij P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126132; O'Donnell CD, 2011, MICROBES INFECT, V13, P502, DOI 10.1016/j.micinf.2011.01.014; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Scherliess R, 2014, VACCINE, V32, P2231, DOI 10.1016/j.vaccine.2014.01.077; Short SJ, 2010, BIOL PSYCHIAT, V67, P965, DOI 10.1016/j.biopsych.2009.11.026; Siegers JY, 2014, J VIROL, V88, P4595, DOI 10.1128/JVI.03190-13; Skinner JA, 2014, CLIN VACCINE IMMUNOL, V21, P1668, DOI 10.1128/CVI.00547-14; Sridhar S, 2012, EUR J IMMUNOL, V42, P2913, DOI 10.1002/eji.201242504; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Staples KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121527; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Stewart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001673; Teunis PFM, 2010, EPIDEMICS-NETH, V2, P215, DOI 10.1016/j.epidem.2010.10.001; Thompson KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056278; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Watson JM, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0240-5; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	46	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157887	10.1371/journal.pone.0157887	http://dx.doi.org/10.1371/journal.pone.0157887			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311020	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800142
J	Roy, M; Pompella, A; Kubacki, J; Szade, J; Roy, RA; Hedzelek, W				Roy, Marco; Pompella, Alfonso; Kubacki, Jerzy; Szade, Jacek; Roy, Robert A.; Hedzelek, Wieslaw			Photofunctionalization of Titanium: An Alternative Explanation of Its Chemical-Physical Mechanism	PLOS ONE			English	Article							SURFACE INTERACTION; IMPLANT SURFACES; AMINO-ACIDS; ADSORPTION; ANATASE; TIO2(110); DYNAMICS; GLYCINE; MOLECULES; CYSTEINE	Objectives To demonstrate that titanium implant surfaces as little as 4 weeks from production are contaminated by atmospheric hydrocarbons. This phenomenon, also known as biological ageing can be reversed by UVC irradiation technically known as photofunctionalization. To propose a new model from our experimental evidence to explain how the changes in chemical structure of the surface will affect the adsorption of amino acids on the titanium surface enhancing osteointegration. Methods In our study XPS and AES were used to analyze the effects of UVC irradiation (photofunctionalization) in reversing biological ageing of titanium. SEM was used to analyze any possible effects on the topography of the surface. Results UVC irradiation was able to reverse biological ageing of titanium by greatly reducing the amount of carbon contamination present on the implant surface by up to 4 times, while the topography of the surface was not affected. UVC photon energy reduces surface H2O and increases TiOH with many -OH groups being produced. These groups explain the superhydrophilic effect from photofunctionalization when these groups come into contact with water. Significance Photofunctionalization has proven to be a valid method to reduce the amount of hydrocarbon contamination on titanium dental implants and improve biological results. The chemisorption mechanisms of amino acids, in our study, are dictated by the chemical structure and electric state present on the surface, but only in the presence of an also favourable geometrical composition at the atomical level.	[Roy, Marco; Hedzelek, Wieslaw] Poznan Univ Med Sci, Dept Prosthodont, Poznan, Poland; [Pompella, Alfonso] Univ Pisa, Sch Med, Dept Translat Res & New Technol Med & Surg, I-56100 Pisa, Italy; [Kubacki, Jerzy; Szade, Jacek] Silesian Univ, A Chelkowski Inst Phys, Katowice, Poland; [Kubacki, Jerzy; Szade, Jacek] Silesian Ctr Educ & Interdisciplinary Res, Chorzow, Poland	Poznan University of Medical Sciences; University of Pisa; University of Silesia in Katowice	Roy, M (corresponding author), Poznan Univ Med Sci, Dept Prosthodont, Poznan, Poland.	metalmark@hotmail.it	Kubacki, Jerzy/B-4280-2019; Szade, Jacek/W-6169-2018	Kubacki, Jerzy/0000-0001-9596-4539; Roy, Marco/0000-0002-1842-0551; Szade, Jacek/0000-0003-2083-4275				Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; Att W, 2012, INT J ORAL MAX IMPL, V27, P753; Atta W, 2009, BIOMATERIALS, V30, P5352, DOI 10.1016/j.biomaterials.2009.06.040; Bengtsson N., 2011, APPL TITANIUM DIOXID, P5; Buddy Ratner AH, 2013, INTRO MAT MED; Carravetta V, 2006, J PHYS CHEM B, V110, P6160, DOI 10.1021/jp056760j; Carravetta V, 2009, THEOR CHEM ACC, V123, P299, DOI 10.1007/s00214-009-0513-4; Hayashi R, 2014, J DENT RES, V93, P698, DOI 10.1177/0022034514536578; Iwasa F, 2010, BIOMATERIALS, V31, P2717, DOI 10.1016/j.biomaterials.2009.12.024; Jackman MJ, 2015, J PHYS CHEM C, V119, P13682, DOI 10.1021/acs.jpcc.5b02732; John F., 1995, HDB XRAY PHOTOELECTR, P255; Kang BS, 2009, ACTA BIOMATER, V5, P2222, DOI 10.1016/j.actbio.2009.01.049; Kanie K, 2004, CHEM COMMUN, P1584, DOI 10.1039/b404220d; Kevin E., 1992, BIOMATERIALS, V13, P9; Koppen S, 2008, J PHYS CHEM C, V112, P13600, DOI 10.1021/jp803354z; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Li C, 2014, LANGMUIR, V30, P8819, DOI 10.1021/la5014973; Li C, 2012, J PHYS CHEM C, V116, P18318, DOI 10.1021/jp3060729; Monti S, 2008, LANGMUIR, V24, P3205, DOI 10.1021/la702956t; Monti S, 2015, J PHYS CHEM C, V119, P6703, DOI 10.1021/acs.jpcc.5b00932; Morra M, 2003, INT J ORAL MAX IMPL, V18, P40; Muir JMR, 2013, SURF SCI, V617, P60, DOI 10.1016/j.susc.2013.07.009; Pang CL, 2008, CHEM SOC REV, V37, P2328, DOI 10.1039/b719085a; Qiu TZ, 2006, J COLLOID INTERF SCI, V303, P229, DOI 10.1016/j.jcis.2006.07.053; Roy M., 2014, J STOMATOL CZAS STOM, V67, P682, DOI DOI 10.5604/00114553.1127421; Seah M. P., 1979, Surface and Interface Analysis, V1, P86, DOI 10.1002/sia.740010304; Steinemann SG, 1998, PERIODONTOL 2000, V17, P7, DOI 10.1111/j.1600-0757.1998.tb00119.x; Szieberth D, 2010, PHYS CHEM CHEM PHYS, V12, P11033, DOI 10.1039/c004155f; Thomas AG, 2012, CHEM SOC REV, V41, P4207, DOI 10.1039/c2cs35057b; Tonner R, 2010, CHEMPHYSCHEM, V11, P1053, DOI 10.1002/cphc.200900902; Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320	31	31	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157481	10.1371/journal.pone.0157481	http://dx.doi.org/10.1371/journal.pone.0157481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309723	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800081
J	Song, YJ; Kim, YK; Jeoung, JW; Park, KH				Song, Yong Ju; Kim, Young Kook; Jeoung, Jin Wook; Park, Ki Ho			Assessment of Open-Angle Glaucoma Peripapillary and Macular Choroidal Thickness Using Swept-Source Optical Coherence Tomography (SS-OCT)	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; NERVE HEAD; DAMAGE; HEMODYNAMICS; EYES	Objective To compare peripapillary and macular choroidal thickness (PCT and MCT) between open-angle glaucoma (OAG) and normal controls using swept-source optical coherence tomography (SS-OCT), and to evaluate global and localized relationships between choroidal thickness and various factors in OAG, also using SS-OCT. Methods In this cross-sectional comparative study, 134 OAG patients and 73 normal controls were examined. PCT (global, 12 clock-hour sectors), MCT (global, six sectors) were measured by SS-OCT. The difference in choroidal thickness between the OAG patients and the normal controls was analyzed. The relationships between choroidal thickness and various factors including age, sex, spherical equivalent (SE), axial length (AXL), central corneal thickness (CCT), intraocular pressure (IOP), peripapillary retinal nerve fiber layer thickness (pRNFLT), visual field mean deviation (MD), ganglion cell-inner plexiform layer thickness (GCIPLT), and disc area were analyzed by univariate and multivariate linear regression. Global and regional analyses were performed in 12 segments of the peripapillary circle and in six sectors of the macula. Results There were significant differences in global PCT and MCT between the OAG patients and the normal controls (115.22 +/- 41.17 vs. 138.89 +/- 44.70, P<0.001), (184.36 +/- 57.15 vs. 209.25 +/- 61.11, P = 0.004). The difference in global PCT remained, both after adjusting for age, AXL (117.08 +/- 3.45 vs. 135.47 +/- 4.70, P = 0.002) and also after adjusting for age, AXL, disc area (117.46 +/- 3.46 vs. 135.67 +/- 4.67, P = 0.002). But the difference in global MCT did not remain after adjusting for age, AXL, SE (188.18 +/- 4.46 vs. 202.25 +/- 6.08, P = 0.066). PCT showed significant differences between the groups in all of the 12 clock-hour sectors. These differences remained after adjusting for age, AXL and for age, AXL, disc area, with the exception of the 10 o'clock (o/c) sector. MCT in six sectors showed differences between the two groups, but they did not remain after adjusting for age, AXL, SE. In a multivariate regression analysis of the OAG patients, global PCT showed correlations with age (beta = -1.18, P = 0.001), AXL (beta = -14.01, P<0.001), and disc area (beta = -16.67, P = 0.026). Global MCT, meanwhile, showed a significant correlation with age (beta = -1.92, P<0.001), AXL. (beta = -21.97, P<0.001). Choroidal thickness did not show any global or localized relationship with glaucoma severity in the OAG patients. Conclusions The global and all 12 clock-hour PCT, with the exception of the 10 o/c sector, were thinner in OAG; however, they did not show any correlation with glaucoma severity. Possible roles of PCT in glaucoma pathogenesis should be investigated further.	[Song, Yong Ju; Kim, Young Kook; Jeoung, Jin Wook; Park, Ki Ho] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Seoul National University (SNU)	Park, KH (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	kihopark@snu.ac.kr		Kim, Young Kook/0000-0002-6037-8449				Cioffi GA, 2004, ARCH OPHTHALMOL-CHIC, V122, P1517, DOI 10.1001/archopht.122.10.1517; CRISTINI G, 1991, OPHTHALMOLOGICA, V202, P81, DOI 10.1159/000310179; Duijm HFA, 1997, BRIT J OPHTHALMOL, V81, P735, DOI 10.1136/bjo.81.9.735; Ehrlich JR, 2011, EXP EYE RES, V92, P189, DOI 10.1016/j.exer.2011.01.002; Galassi F, 2003, ARCH OPHTHALMOL-CHIC, V121, P1711, DOI 10.1001/archopht.121.12.1711; Grunwald JE, 1998, INVEST OPHTH VIS SCI, V39, P2329; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P563, DOI 10.1016/S1350-9462(01)00004-0; Hirooka K, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-29; Hirooka K, 2012, CLIN EXP OPHTHALMOL, V40, P576, DOI 10.1111/j.1442-9071.2012.02762.x; Hosseini Hamid, 2014, J Ophthalmic Vis Res, V9, P154; Li L, 2013, AM J OPHTHALMOL, V156, P1277, DOI 10.1016/j.ajo.2013.07.011; Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016; Mwanza JC, 2012, INVEST OPHTH VIS SCI, V53, P6695, DOI 10.1167/iovs.12-10388; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P3430, DOI 10.1167/iovs.10-6600; Nicolela MT, 1997, J GLAUCOMA, V6, P157; Park HYL, 2014, J GLAUCOMA, V23, P225, DOI 10.1097/IJG.0000000000000045; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Roberts KF, 2012, ARCH OPHTHALMOL-CHIC, V130, P980, DOI 10.1001/archophthalmol.2012.371; Suh W, 2014, JPN J OPHTHALMOL, V58, P62, DOI 10.1007/s10384-013-0290-4; Usui S, 2012, AM J OPHTHALMOL, V153, P10, DOI 10.1016/j.ajo.2011.05.037; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yin ZQ, 1997, J GLAUCOMA, V6, P23; Zhang CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109683; Zhang ZW, 2016, J GLAUCOMA, V25, pE446, DOI 10.1097/IJG.0000000000000275	24	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157333	10.1371/journal.pone.0157333	http://dx.doi.org/10.1371/journal.pone.0157333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309734	Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800055
J	Zhang, Y; Walter, R; Ng, P; Luong, PN; Dutt, S; Heuer, H; Rojas-Rodriguez, JC; Tsai, R; Litvan, I; Dickerson, BC; Tartaglia, MC; Rabinovici, G; Miller, BL; Rosen, HJ; Schuff, N; Boxer, AL				Zhang, Yu; Walter, Rudolph; Ng, Peter; Luong, Phi N.; Dutt, Shubir; Heuer, Hilary; Rojas-Rodriguez, Julio C.; Tsai, Richard; Litvan, Irene; Dickerson, Bradford C.; Tartaglia, Maria Carmela; Rabinovici, Gil; Miller, Bruce L.; Rosen, Howard J.; Schuff, Norbert; Boxer, Adam L.			Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study	PLOS ONE			English	Article							WHITE-MATTER; NEUROPATHOLOGIC CRITERIA; CEREBELLAR PEDUNCLE; CLINICAL-DIAGNOSIS; ALZHEIMERS-DISEASE; TASK-FORCE; MRI; ATROPHY; DISORDERS; RATES	Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are both 4 microtubule binding repeat tauopathy related disorders. Clinical trials need new biomarkers to assess the effectiveness of tau-directed therapies. This study investigated the regional distribution of longitudinal diffusion tensor imaging changes, measured by fractional anisotropy, radial and axial diffusivity over 6 months median interval, in 23 normal control subjects, 35 patients with PSP, and 25 patients with CBS. A mixed-effects framework was used to test longitudinal changes within and between groups. Correlations between changes in diffusion variables and clinical progression were also tested. The study found that over a 6 month period and compared to controls, the most prominent changes in PSP were up to 3 +/- 1% higher rates of FA reduction predominantly in superior cerebellar peduncles, and up to 18 +/- 6% higher rates of diffusivity increases in caudate nuclei. The most prominent changes in CBS compared to controls were up to 4 +/- 1% higher rates of anisotropy reduction and 18 +/- 6% higher rates of diffusivity increase in basal ganglia and widespread white matter regions. Compared to PSP, CBS was mainly associated with up to 3 +/- 1% greater rates of anisotropy reduction around the central sulci, and 11 +/- 3% greater rates of diffusivity increase in superior fronto-occipital fascicules. Rates of diffusivity increases in the superior cerebellar peduncle correlated with rates of ocular motor decline in PSP patients. This study demonstrated that longitudinal diffusion tensor imaging measurement is a promising surrogate marker of disease progression in PSP and CBS over a relatively short period.	[Zhang, Yu; Walter, Rudolph; Ng, Peter; Schuff, Norbert] VA Med Ctr San Francisco, Ctr Imaging Neurodegenerat Dis, San Francisco, CA USA; [Zhang, Yu; Walter, Rudolph; Ng, Peter; Schuff, Norbert] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Luong, Phi N.; Dutt, Shubir; Heuer, Hilary; Rojas-Rodriguez, Julio C.; Tsai, Richard; Tartaglia, Maria Carmela; Rabinovici, Gil; Miller, Bruce L.; Rosen, Howard J.; Boxer, Adam L.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Litvan, Irene] Univ Calif San Diego, Movement Disorder Ctr, Dept Neurosci, San Diego, CA 92103 USA; [Dickerson, Bradford C.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Tartaglia, Maria Carmela] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Tartaglia, Maria Carmela] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Zhang, Y (corresponding author), VA Med Ctr San Francisco, Ctr Imaging Neurodegenerat Dis, San Francisco, CA USA.; Zhang, Y (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	Yu.Zhang@ucsf.edu	Litvan, Irene/X-9319-2018; Rabinovici, Gil/AAA-2495-2020	Litvan, Irene/0000-0002-3485-3445; Zhang, Yu/0000-0001-8066-7275	National Institutes of Health [R01AG038791, R01AG032306]; Frontotemporal Lobar Degeneration Clinical Research Consortium [U54NS092089]; Tau Consortium; Veterans Affairs Medical Center, San Francisco, California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS092089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032306, K24AG045333, R01AG038791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frontotemporal Lobar Degeneration Clinical Research Consortium; Tau Consortium; Veterans Affairs Medical Center, San Francisco, California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by the National Institutes of Health grants (R01AG038791, R01AG032306); The Frontotemporal Lobar Degeneration Clinical Research Consortium (U54NS092089); Tau Consortium; and with resources of the Veterans Affairs Medical Center, San Francisco, California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MJ, 2013, NEUROLOGY, V80, P496, DOI 10.1212/WNL.0b013e31827f0fd1; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boeve BF, 2007, NEUROL CLIN, V25, P761, DOI 10.1016/j.ncl.2007.04.002; Borroni B, 2008, ARCH NEUROL-CHICAGO, V65, P796, DOI 10.1001/archneur.65.6.796; Adam L, 2013, ALZHEIMERS DEMENT, V9, P189, DOI 10.1016/j.jalz.2012.03.003; Canu E, 2011, MOVEMENT DISORD, V26, P1752, DOI 10.1002/mds.23739; Dickson Dennis W, 2008, Handb Clin Neurol, V89, P487, DOI 10.1016/S0072-9752(07)01245-6; Dickson DW, 2002, J NEUROPATH EXP NEUR, V61, P935, DOI 10.1093/jnen/61.11.935; Dutt S, 2015, NEUROLOGY, V84; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forman MS, 2002, AM J PATHOL, V160, P2045, DOI 10.1016/S0002-9440(10)61154-6; Golbe LI, 2007, BRAIN, V130, P1552, DOI 10.1093/brain/awm032; Ishizawa K, 2001, J NEUROPATH EXP NEUR, V60, P647, DOI 10.1093/jnen/60.6.647; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Josephs KA, 2013, MOVEMENT DISORD, V28, P1117, DOI 10.1002/mds.25437; Knake S, 2010, MOVEMENT DISORD, V25, P1232, DOI 10.1002/mds.23054; Lee SE, 2011, ANN NEUROL, V70, P327, DOI 10.1002/ana.22424; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Naylor MG, 2014, HUM BRAIN MAPP, V35, P831, DOI 10.1002/hbm.22217; OHTSUKA K, 1992, OPHTHALMOLOGICA, V204, P44, DOI 10.1159/000310265; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Padovani A, 2006, J NEUROL NEUROSUR PS, V77, P457, DOI 10.1136/jnnp.2005.075713; Paviour DC, 2006, BRAIN, V129, P1040, DOI 10.1093/brain/awl021; Paviour DC, 2007, J NEUROL, V254, P478, DOI 10.1007/s00415-006-0396-4; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Reginold W, 2014, PARKINSONISM RELAT D, V20, P222, DOI 10.1016/j.parkreldis.2013.10.002; Revesz T, 2003, MOVEMENT DISORD, V18, pS13, DOI 10.1002/mds.10558; Rizzo G, 2008, BRAIN, V131, P2690, DOI 10.1093/brain/awn195; Sajjadi SA, 2013, BRAIN, V136, P2253, DOI 10.1093/brain/awt118; Sakai K, 2006, ACTA NEUROPATHOL, V112, P341, DOI 10.1007/s00401-006-0093-5; Scaravilli T, 2005, MOVEMENT DISORD, V20, pS21, DOI 10.1002/mds.20536; Schuff N, 2015, MOVEMENT DISORD, V30, P1885, DOI 10.1002/mds.26325; Schwab R, 1969, 3 S PARK DIS RES; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sudmeyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041873; Tsuboi Y, 2003, NEUROLOGY, V60, P1766, DOI 10.1212/01.WNL.0000068011.21396.F4; Whitwell JL, 2007, BRAIN, V130, P1148, DOI 10.1093/brain/awm021; Whitwell JL, 2014, PARKINSONISM RELAT D, V20, P493, DOI 10.1016/j.parkreldis.2014.01.023; Whitwell JL, 2011, PARKINSONISM RELAT D, V17, P599, DOI 10.1016/j.parkreldis.2011.05.013; Williams DR, 2007, BRAIN, V130, P1566, DOI 10.1093/brain/awm104	50	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157218	10.1371/journal.pone.0157218	http://dx.doi.org/10.1371/journal.pone.0157218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310132	Green Published, gold			2022-12-27	WOS:000378029800045
J	Chou, PS; Hsu, CY; Wu, MN; Liou, LM; Lu, SR; Liu, CK; Lai, CL				Chou, Ping-Song; Hsu, Chung-Yao; Wu, Meng-Ni; Liou, Li-Min; Lu, Shinag-Ru; Liu, Ching-Kuan; Lai, Chiou-Lian			Action-Monitoring Dysfunction in Obstructive Sleep Apnea - A Pilot Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; NEUROCOGNITIVE FUNCTION; METABOLIC SYNDROME; DEPRIVATION; PERFORMANCE; TASK; IMPAIRMENT	Obstructive sleep apnea (OSA) is associated with a broad range of frontal lobe dysfunctions. However, no study has investigated action monitoring, a crucial domain of frontal cognitive functions, in patients with OSA. By using the modified Flanker task, we tested the hypothesis that patients with OSA have an impaired action monitoring function. We recruited 25 untreated patients with moderate-severe OSA and 12 control participants who were matched for age, sex, apolipoprotein E4, and education level. Every enrolled participant underwent a standard overnight laboratory-based polysomnography and completed a modified Flanker task. Compared with the controls, the patients with OSA presented a significantly lower correct response rate in all trials (78.9% vs 95.9%, P = .008), congruent trials (84.7% vs 98.3%, P = .016), and incongruent trials (77.4% vs 94.7%, P = .009). The post-error correction rate was significantly lower in the patients with OSA than in the controls (74.9% vs 93.8%, P = .005). Furthermore, strong significant correlations were observed between the arousal index and correct rate in all trials (r = -0.390, P < .05) and in the incongruent trials (r = -0.429, P < .01), as well as between the arousal index and rate of post-error correction (r = -0.435, P < .01). We concluded that the action monitoring function was impaired in the patients with OSA. Sleep fragmentation was a major determinant of impaired action monitoring in these patients.	[Chou, Ping-Song; Hsu, Chung-Yao; Wu, Meng-Ni; Liou, Li-Min; Lu, Shinag-Ru; Liu, Ching-Kuan; Lai, Chiou-Lian] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chou, Ping-Song] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hsu, Chung-Yao; Liou, Li-Min; Lu, Shinag-Ru; Liu, Ching-Kuan; Lai, Chiou-Lian] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Neurol, Kaohsiung, Taiwan; [Lai, Chiou-Lian] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Neurol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Lai, CL (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan.; Lai, CL (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Neurol, Kaohsiung, Taiwan.; Lai, CL (corresponding author), Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Neurol, Kaohsiung, Taiwan.	cllai@kmu.edu.tw		Chou, Ping-Song/0000-0003-3693-3323; Hsu, Chung-Yao/0000-0002-9880-5944	Ministry of Science and Technology, Taiwan [NSC-101-2314-B-037-067]; Kaohsiung Medical University Hospital [KMUH101-1R54]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital	This study was supported by grants from the Ministry of Science and Technology, Taiwan (NSC-101-2314-B-037-067) and Kaohsiung Medical University Hospital (KMUH101-1R54). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayalon L, 2009, SLEEP, V32, P373, DOI 10.1093/sleep/32.3.373; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Bucks RS, 2013, RESPIROLOGY, V18, P61, DOI 10.1111/j.1440-1843.2012.02255.x; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Castronovo V, 2014, SLEEP, V37, P1465, DOI 10.5665/sleep.3994; Chen NH, 2002, QUAL LIFE RES, V11, P817, DOI 10.1023/A:1020818417949; Grundy SM, 2006, CURR OPIN CARDIOL, V21, P1, DOI 10.1097/01.hco.0000200416.65370.a0; Henderson H, 2006, BRAIN COGNITION, V61, P96, DOI 10.1016/j.bandc.2005.12.009; Hsieh S, 2007, J SLEEP RES, V16, P137, DOI 10.1111/j.1365-2869.2007.00583.x; Hsieh S, 2009, J SLEEP RES, V18, P159, DOI 10.1111/j.1365-2869.2008.00730.x; Iber C., 2007, AASM MANUAL SCORING; Ko CH, 2015, BIOL PSYCHOL, V104, P163, DOI 10.1016/j.biopsycho.2014.12.008; Lal C, 2012, CHEST, V141, P1601, DOI 10.1378/chest.11-2214; Lam B, 2007, INT J TUBERC LUNG D, V11, P2; Li CSR, 2008, J COGNITIVE NEUROSCI, V20, P1021, DOI 10.1162/jocn.2008.20071; Lim DC, 2014, SLEEP MED REV, V18, P35, DOI 10.1016/j.smrv.2012.12.003; Liu HC, 2002, DEMENT GERIATR COGN, V13, P244, DOI 10.1159/000057703; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Mannarino MR, 2012, EUR J INTERN MED, V23, P586, DOI 10.1016/j.ejim.2012.05.013; Marshall NS, 2014, J CLIN SLEEP MED, V10, P355, DOI 10.5664/jcsm.3600; McCall WV, 2006, J CLIN SLEEP MED, V2, P424; Murphy TI, 2006, J SLEEP RES, V15, P15, DOI 10.1111/j.1365-2869.2006.00503.x; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Rabbitt, 1966, J EXP PSYCHOL, V71, P264; Renn RP, 2013, INT J PSYCHOPHYSIOL, V88, P64, DOI 10.1016/j.ijpsycho.2013.01.013; Rodgers Rabbitt, 1977, J EXP PSYCHOL, V29, P727; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Thomas RJ, 2005, J APPL PHYSIOL, V98, P2226, DOI 10.1152/japplphysiol.01225.2004; Tulek B, 2013, J SLEEP RES, V22, P422, DOI 10.1111/jsr.12038; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Zhang X, 2011, SLEEP MED, V12, P335, DOI 10.1016/j.sleep.2010.08.015	35	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157575	10.1371/journal.pone.0157575	http://dx.doi.org/10.1371/journal.pone.0157575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300504	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200061
J	Li, JJ; Liu, YR; Jiang, YZ; Shao, ZM				Li, Junjie; Liu, Yirong; Jiang, Yizhou; Shao, Zhimin			Breast Cancer-Specific Mortality Pattern and Its Changing Feature According to Estrogen Receptor Status in Two Time Periods	PLOS ONE			English	Article							OVARIAN SUPPRESSION; ADJUVANT TAMOXIFEN; RECURRENCE; DIAGNOSIS; SURVIVAL; THERAPY; CONSENSUS; EFFICACY; OUTCOMES; MODELS	Purpose To determine whether and how the patterns of breast cancer-specific mortality (BCSM) changed along with time periods. Methods We used the Surveillance, Epidemiology and End Results registry to identify 228209 female patients diagnosed with invasive breast cancer between 1990 and 2000 (cohort 1 [C1], 112981) and between 2001 and 2005 (cohort 2 [C2], 115228). BCSM was compared in two cohorts using Cox proportional hazard regression models. We analysed the relative hazard ratios (HRs) and absolute BCSM rates by flexible parametric survival modelling. Results The patterns of BCSM were similar between the two cohorts, with the peak of mortality presenting in the first 2-3 years after diagnosis, and mortality rate significantly decreased in C2 in all cases. In C2, the annual BCSM rate of all cases was 9.64 (per 1000 persons per year) in year 10 with a peak rate of 23.34 in year 2. In ER-negative and high-risk patients, marked survival improvements were achieved mostly in the first 5 years, while in ER-positive and low-risk patients, survival improvements were less but constant up to 10 years. Conclusion There has been a significant improvement of BCSM with substantially decreased mortality within 5 years. The current pattern of BCSM and its changing feature differs according to ER status. Our findings have some clinical implications both for treatment decisions and adjuvant treatment trial design.	[Li, Junjie; Liu, Yirong; Jiang, Yizhou; Shao, Zhimin] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China; [Li, Junjie; Liu, Yirong; Jiang, Yizhou; Shao, Zhimin] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Shao, ZM (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China.; Shao, ZM (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com		Liu, Yirong/0000-0003-4019-6901				Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Cardoso F, 2014, ANN ONCOL, V25, P1871, DOI 10.1093/annonc/mdu385; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Colzani E, 2011, J CLIN ONCOL, V29, P4014, DOI 10.1200/JCO.2010.32.6462; Cossetti RJD, 2015, J CLIN ONCOL, V33, P65, DOI 10.1200/JCO.2014.57.2461; Cuzick J, 2013, ONCOLOGY-NY, V27, P1224; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; International Agency for Research on Cancer (IARC), 2002, IARC HDB CANC PREV, V7; Jatoi I, 2011, J CLIN ONCOL, V29, P2301, DOI 10.1200/JCO.2010.32.3550; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Muss HB, 2008, J CLIN ONCOL, V26, P1956, DOI 10.1200/JCO.2007.12.6334; National Cancer Institute, CANC DRUGS APPR FOOD; Pagani O, 2014, NEW ENGL J MED, V371, P107, DOI 10.1056/NEJMoa1404037; Park JH, 2015, J CLIN ONCOL, V33, P2870, DOI 10.1200/JCO.2014.59.9191; Park S, 2012, BREAST, V21, P50, DOI 10.1016/j.breast.2011.07.008; Ribelles N, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3559; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Rutqvist LE, 1996, J NATL CANCER I, V88, P1543; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Savci-Heijink CD, 2015, BREAST CANCER RES TR, V150, P547, DOI 10.1007/s10549-015-3352-0; Surveillance Epidemiology and End Results (SEER) Program, 2014, SEER STAT DAT INC SE; Ufen MP, 2014, ANN ONCOL, V25, P95, DOI 10.1093/annonc/mdt429; Yu KD, 2012, J CLIN ENDOCR METAB, V97, pE2201, DOI 10.1210/jc.2012-2423	30	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157322	10.1371/journal.pone.0157322	http://dx.doi.org/10.1371/journal.pone.0157322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299729	Green Submitted, Green Published, gold			2022-12-27	WOS:000377822200036
J	Zhao, J; Xia, YF; Kaminski, J; Hao, ZL; Mott, F; Campbell, J; Sadek, R; Kong, FM				Zhao, Jing; Xia, Yingfeng; Kaminski, Joseph; Hao, Zhonglin; Mott, Frank; Campbell, Jeff; Sadek, Ramses; Kong, Feng-Ming (Spring)			Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies	PLOS ONE			English	Article							PHASE-III TRIAL; HYPERFRACTIONATED RADIATION-THERAPY; LOW-DOSE CARBOPLATIN; STAGE-III; THORACIC RADIOTHERAPY; INDUCTION CHEMOTHERAPY; SEQUENTIAL CHEMORADIOTHERAPY; ELDERLY-PATIENTS; CLINICAL-TRIAL; RISK-FACTORS	Treatment related death (TRD) is the worst adverse event in chemotherapy and radiotherapy for patients with cancer, the reports for TRDs were sporadically. We aimed to study TRDs in non-small cell lung cancer (NSCLC) patients treated with concurrent chemoradiotherapy (CCRT), and determine whether high radiation dose and newer chemotherapy regimens were associated with the risk of TRD. Data from randomized clinical trials for locally advanced/unresectable NSCLC patients were analyzed. Eligible studies had to have at least one arm with CCRT. The primary endpoint was TRD. Pooled odds ratios (ORs) for TRDs were calculated. In this study, a total of fifty-three trials (8940 patients) were eligible. The pooled TRD rate (accounting for heterogeneity) was 1.44% for all patients. In 20 trials in which comparison of TRDs between CCRT and non-CCRT was possible, the OR (95% CI) of TRDs was 1.08 (0.70-1.66) (P = 0.71). Patients treated with third-generation chemotherapy and concurrent radiotherapy had an increase of TRDs compared to those with other regimens in CCRT (2.70% vs. 1.37%, OR = 1.50, 95% CI: 1.09-2.07, P = 0.008). No significant difference was found in TRDs between high (>= 66 Gy) and low (< 66 Gy) radiation dose during CCRT (P = 0.605). Neither consolidation (P = 0.476) nor induction chemotherapy (P = 0.175) had significant effects with increased TRDs in this study. We concluded that CCRT is not significantly associated with the risk of TRD compared to non-CCRT. The third-generation chemotherapy regimens may be a risk factor with higher TRDs in CCRT, while high dose radiation is not significantly associated with more TRDs. This observation deserves further study.	[Zhao, Jing; Kaminski, Joseph; Campbell, Jeff; Kong, Feng-Ming (Spring)] Georgia Regents Univ, Med Coll Georgia, GRU Canc Ctr, Dept Radiat Oncol, Augusta, GA USA; [Zhao, Jing] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan 430074, Peoples R China; [Xia, Yingfeng] Three Gorges Univ, Peoples Hosp, Hosp Yichang 1, Yichang, Peoples R China; [Hao, Zhonglin; Mott, Frank] Georgia Regents Univ, Med Coll Georgia, GRU Canc Ctr, Dept Internal Med, Augusta, GA USA; [Sadek, Ramses] Georgia Regents Univ, Med Coll Georgia, GRU Canc Ctr, Dept Biostat & Epidemiol, Augusta, GA USA; [Kong, Feng-Ming (Spring)] Indiana Univ Sch Med, Dept Radiat Oncol, Simon Canc Ctr, Indianapolis, IN 46202 USA	University System of Georgia; Augusta University; Huazhong University of Science & Technology; China Three Gorges University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Indiana University System; Indiana University Bloomington	Kong, FM (corresponding author), Georgia Regents Univ, Med Coll Georgia, GRU Canc Ctr, Dept Radiat Oncol, Augusta, GA USA.; Kong, FM (corresponding author), Indiana Univ Sch Med, Dept Radiat Oncol, Simon Canc Ctr, Indianapolis, IN 46202 USA.	fkong@gru.edu	Kaminski, Joseph/AAB-6493-2020; Kong, Feng-Ming/Y-2825-2019	Kong, Feng-Ming/0000-0003-2652-098X; Kaminski, Joseph/0000-0002-7518-4962	National Institute of Health R01 grant [CA142840]; NATIONAL CANCER INSTITUTE [R01CA142840] Funding Source: NIH RePORTER	National Institute of Health R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institute of Health R01 grant CA142840 to Dr. Feng-Ming (Spring) Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NCCN CLIN PRACTICE G; Atagi S, 2005, JPN J CLIN ONCOL, V35, P195, DOI 10.1093/jjco/hyi060; Atagi S, 2012, LANCET ONCOL, V13, P671, DOI 10.1016/S1470-2045(12)70139-0; Ball D, 1999, RADIOTHER ONCOL, V52, P129, DOI 10.1016/S0167-8140(99)00093-6; Belani CP, 2005, J CLIN ONCOL, V23, P5883, DOI 10.1200/JCO.2005.55.405; Belderbos J, 2007, EUR J CANCER, V43, P114, DOI 10.1016/j.ejca.2006.09.005; Bradley J, 2005, SEMIN ONCOL, V32, pS111, DOI 10.1053/j.seminoncol.2005.03.020; Bradley J, 2011, 53 ANN M AM SOC RAD; Cakir S, 2004, LUNG CANCER-J IASLC, V43, P309, DOI 10.1016/j.lungcan.2003.09.009; Clamon G, 1999, J CLIN ONCOL, V17, P4, DOI 10.1200/JCO.1999.17.1.4; CLAMON G, 1994, CANCER INVEST, V12, P273, DOI 10.3109/07357909409023025; Crvenkova S, 2009, CONTRIBUTIONS MACEDO, V30, P197; Curran WJ, 2011, J NATL CANCER I, V103, P1452, DOI 10.1093/jnci/djr325; Dasgupta Anirban, 2006, J Cancer Res Ther, V2, P47; Fournel P, 2005, J CLIN ONCOL, V23, P5910, DOI 10.1200/JCO.2005.03.070; Fujiwara Y, 2011, ANN ONCOL, V22, P376, DOI 10.1093/annonc/mdq360; Goksel T, 2005, RESPIROLOGY, V10, P456, DOI 10.1111/j.1440-1843.2005.00739.x; Gouda Yousry S, 2006, J Egypt Natl Canc Inst, V18, P73; Groen HJM, 2004, ANN ONCOL, V15, P427, DOI 10.1093/annonc/mdh100; Hanna N, 2008, J CLIN ONCOL, V26, P5755, DOI 10.1200/JCO.2008.17.7840; Hara S, 2001, CALCIFIED TISSUE INT, V68, P23, DOI 10.1007/BF02684999; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; Huber RM, 2006, J CLIN ONCOL, V24, P4397, DOI 10.1200/JCO.2005.05.4163; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JEREMIC B, 1995, J CLIN ONCOL, V13, P452, DOI 10.1200/JCO.1995.13.2.452; Jeremic B, 1996, J CLIN ONCOL, V14, P1065, DOI 10.1200/JCO.1996.14.4.1065; Kong FM, 2014, J THORAC DIS, V6, P336, DOI 10.3978/j.issn.2072-1439.2014.01.23; Kong FM, 2005, INT J RADIAT ONCOL, V63, P324, DOI 10.1016/j.ijrobp.2005.02.010; Kong FM, SEMIN RAD O IN PRESS; Kubota K, 2000, ANN ONCOL, V11, P445, DOI 10.1023/A:1008328207137; Machtay M, 2012, INT J RADIAT ONCOL, V82, P425, DOI 10.1016/j.ijrobp.2010.09.004; Masters GA, 1998, J CLIN ONCOL, V16, P2157, DOI 10.1200/JCO.1998.16.6.2157; Minami-Shimmyo Y, 2012, J THORAC ONCOL, V7, P177, DOI 10.1097/JTO.0b013e31823c4c07; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mornex F, 2013, LUNG CANCER, V80, P68, DOI 10.1016/j.lungcan.2012.12.007; O'Rourke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002140.pub3; Ohe Y, 2001, EUR J CANCER, V37, P54, DOI 10.1016/S0959-8049(00)00350-6; Sarihan S, 2004, J INT MED RES, V32, P375, DOI 10.1177/147323000403200405; Scagliotti GV, 2006, BRIT J CANCER, V94, P1375, DOI 10.1038/sj.bjc.6603115; Schild SE, 2002, INT J RADIAT ONCOL, V54, P729, DOI 10.1016/S0360-3016(02)03018-3; Song CH, 2010, INT J RADIAT ONCOL, V78, P651, DOI 10.1016/j.ijrobp.2009.08.068; Takeda K, 2011, JPN J CLIN ONCOL, V41, P25, DOI 10.1093/jjco/hyq163; Vokes EE, 2007, J CLIN ONCOL, V25, P1698, DOI 10.1200/JCO.2006.07.3569; Vokes EE, 2009, CLIN LUNG CANCER, V10, P193, DOI 10.3816/CLC.2009.n.027; Zatloukal P, 2004, LUNG CANCER-J IASLC, V46, P87, DOI 10.1016/j.lungcan.2004.03.004	46	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157455	10.1371/journal.pone.0157455	http://dx.doi.org/10.1371/journal.pone.0157455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300551	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200052
J	Eden, A; Marcotte, TD; Heaton, RK; Nilsson, S; Zetterberg, H; Fuchs, D; Franklin, D; Price, RW; Grant, I; Letendre, SL; Gisslen, M				Eden, Arvid; Marcotte, Thomas D.; Heaton, Robert K.; Nilsson, Staffan; Zetterberg, Henrik; Fuchs, Dietmar; Franklin, Donald; Price, Richard W.; Grant, Igor; Letendre, Scott L.; Gisslen, Magnus			Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment	PLOS ONE			English	Article							CEREBROSPINAL-FLUID NEOPTERIN; CENTRAL-NERVOUS-SYSTEM; ANTIRETROVIRAL THERAPY; NEUROFILAMENT PROTEIN; HIV-1 INFECTION; DEFICIT SCORES; DISORDERS; CSF; PREVALENCE; BIOMARKERS	Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). Design and Methods We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Results Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). Conclusions Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies.	[Eden, Arvid; Gisslen, Magnus] Univ Gothenburg, Dept Infect Dis, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden; [Marcotte, Thomas D.; Heaton, Robert K.; Franklin, Donald; Grant, Igor; Letendre, Scott L.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Nilsson, Staffan] Chalmers, Math Sci, S-41296 Gothenburg, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, London, England; [Fuchs, Dietmar] Med Univ Innsbruck, Div Biol Chem, Bioctr, A-6020 Innsbruck, Austria; [Price, Richard W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of Gothenburg; University of California System; University of California San Diego; Chalmers University of Technology; University of Gothenburg; University of London; University College London; Medical University of Innsbruck; University of California System; University of California San Francisco	Eden, A (corresponding author), Univ Gothenburg, Dept Infect Dis, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.	arvid.eden@vgregion.se	Letendre, Scott L./GLU-6874-2022; Fuchs, Dietmar/AAL-8011-2021; Gisslen, Magnus/D-7454-2015	Fuchs, Dietmar/0000-0003-1627-9563; Gisslen, Magnus/0000-0002-2357-1020; Nilsson, Staffan/0000-0003-4748-0446	US National Institutes of Health [N01MH22005, P30MH62512, U24MH100928, P50DA026306, HHSN271201000036C, K24MH097673]; Swedish Research Council [K2011-58P-20931-01-4, K2010-63P-21562-01-4, K2011-61X-20401-05-6, 2013-2546, K2013-61X-14002-13-5]; Sahlgrenska University Hospital [ALFGBG-430271, ALFGBG-441051, ALFGBG-139671]; Knut and Alice Wallenberg Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107345, P30MH062512, K24MH097673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094067] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Sahlgrenska University Hospital; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health [awards N01MH22005 (IG), P30MH62512 (RKH), U24MH100928 (IG), P50DA026306 (IG), HHSN271201000036C (IG), K24MH097673 (SLL)]; The Swedish Research Council [K2011-58P-20931-01-4, K2010-63P-21562-01-4, K2011-61X-20401-05-6, 2013-2546, K2013-61X-14002-13-5] (MG); the Sahlgrenska University Hospital [ALFGBG-430271, ALFGBG-441051, ALFGBG-139671] (MG); and the Knut and Alice Wallenberg Foundation (HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulle S, 2007, J NEUROLOGY; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Blackstone K, 2012, CLIN NEUROPSYCHOL, V26, P894, DOI 10.1080/13854046.2012.694479; BOGNER JR, 1992, CLIN INVESTIGATOR, V70, P665; Brew BJ, 1996, J INFECT DIS, V174, P294, DOI 10.1093/infdis/174.2.294; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Cysique LA, 2011, J NEUROVIROL, V17, P176, DOI 10.1007/s13365-011-0021-x; Cysique LA, 2011, J CLIN EXP NEUROPSYC, V33, P505, DOI 10.1080/13803395.2010.535504; Dahl V, 2014, AIDS, V28, P2251, DOI 10.1097/QAD.0000000000000400; Eden A, 2007, J INFECT DIS, V196, P1779, DOI 10.1086/523648; Gelman BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046178; Gisslen M, 2007, J NEUROIMMUNE PHARM, V2, P112, DOI 10.1007/s11481-006-9035-1; Gisslen M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-356; Grant I, 2014, NEUROLOGY, V82, P2055, DOI 10.1212/WNL.0000000000000492; Hagberg L, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-15; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2014, NEUROCOGNITIVE CHANG, DOI [10.1093/cid/ciu862, DOI 10.1093/CID/CIU862]; Krut JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088591; Krut JJ, 2013, J NEUROL, V260, P620, DOI 10.1007/s00415-012-6688-y; Lescure FX, 2011, CLIN INFECT DIS, V52, P235, DOI 10.1093/cid/ciq041; Mellgren A, 2007, NEUROLOGY, V69, P1536, DOI 10.1212/01.wnl.0000277635.05973.55; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Peterson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116081; Price RW, 2007, NEUROLOGY, V69, P1781, DOI 10.1212/01.wnl.0000278457.55877.eb; Rosengren LE, 1999, NEUROLOGY, V52, P1090, DOI 10.1212/WNL.52.5.1090; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Sattler FR, 2015, JAIDS-J ACQ IMM DEF, V68, P281, DOI 10.1097/QAI.0000000000000458; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Torti C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-138; Yilmaz A, 2008, JAIDS-J ACQ IMM DEF, V47, P168, DOI 10.1097/QAI.0b013e31815ace97; Yilmaz A, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-62	31	72	72	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157160	10.1371/journal.pone.0157160	http://dx.doi.org/10.1371/journal.pone.0157160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295036	Green Published, gold			2022-12-27	WOS:000377821300026
J	Pani, G; Dessi, A; Dallocchio, R; Scherm, B; Azara, E; Delogu, G; Migheli, Q				Pani, Giovanna; Dessi, Alessandro; Dallocchio, Roberto; Scherm, Barbara; Azara, Emanuela; Delogu, Giovanna; Migheli, Quirico			Natural Phenolic Inhibitors of Trichothecene Biosynthesis by the Wheat Fungal Pathogen Fusarium culmorum: A Computational Insight into the Structure-Activity Relationship	PLOS ONE			English	Article							SWISS-MODEL REPOSITORY; GRAMINEARUM; MECHANISMS; RESISTANCE; MOLECULES; DERIVATIVES; SYSTEM; GENES; ACID; FOOD	A model of the trichodiene synthase (TRI5) of the wheat fungal pathogen and type-B trichothecene producer Fusarium culmorum was developed based on homology modelling with the crystallized protein of F. sporotrichioides. Eight phenolic molecules, namely ferulic acid 1, apocynin 2, propyl gallate 3, eugenol 4, Me-dehydrozingerone 5, eugenol dimer 6, magnolol 7, and ellagic acid 8, were selected for their ability to inhibit trichothecene production and/or fungal vegetative growth in F. culmorum. The chemical structures of phenols were constructed and partially optimised based on Molecular Mechanics (MM) studies and energy minimisation by Density Functional Theory (DFT). Docking analysis of the phenolic molecules was run on the 3D model of F. culmorum TRI5. Experimental biological activity, molecular descriptors and interacting-structures obtained from computational analysis were compared. Besides the catalytic domain, three privileged sites in the interaction with the inhibitory molecules were identified on the protein surface. The TRI5-ligand interactions highlighted in this study represent a powerful tool to the identification of new Fusarium-targeted molecules with potential as trichothecene inhibitors.	[Pani, Giovanna; Scherm, Barbara; Migheli, Quirico] Univ Sassari, Dipartimento Agr, Viale Italia 39, I-07100 Sassari, Italy; [Pani, Giovanna; Scherm, Barbara; Migheli, Quirico] Univ Sassari, Ist Nazl Biostrutture & Biosistemi, Unita Ric, Viale Italia 39, I-07100 Sassari, Italy; [Dessi, Alessandro; Dallocchio, Roberto; Azara, Emanuela; Delogu, Giovanna] Ist CNR Chim Biomol, Traversa La Crucca 3, I-07100 Sassari, Italy	University of Sassari; University of Sassari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR)	Migheli, Q (corresponding author), Univ Sassari, Dipartimento Agr, Viale Italia 39, I-07100 Sassari, Italy.; Migheli, Q (corresponding author), Univ Sassari, Ist Nazl Biostrutture & Biosistemi, Unita Ric, Viale Italia 39, I-07100 Sassari, Italy.; Delogu, G (corresponding author), Ist CNR Chim Biomol, Traversa La Crucca 3, I-07100 Sassari, Italy.	giovanna.delogu@icb.cnr.it; qmigheli@uniss.it	Migheli, Quirico/B-7203-2009; Migheli, Quirico/K-7065-2019; Dessì, Alessandro/B-8021-2015	Migheli, Quirico/0000-0002-2459-5833; Migheli, Quirico/0000-0002-2459-5833; Dessì, Alessandro/0000-0001-8258-7332; Azara, Emanuela/0000-0001-9199-9398; Dallocchio, Roberto Nico/0000-0003-4626-4792	Ministry of University and Research; P.O.R. SARDEGNA F.S.E. - Obiettivo competitivita regionale e occupazione, Asse IV Capitale umano, Linea di Attivita l. 3.1 (research project: "Ide	Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); P.O.R. SARDEGNA F.S.E. - Obiettivo competitivita regionale e occupazione, Asse IV Capitale umano, Linea di Attivita l. 3.1 (research project: "Ide	Research was funded by the Ministry of University and Research (PRIN 2011: "Cell wall determinants to improve durum wheat resistance to Fusarium diseases"). BS acknowledges support by P.O.R. SARDEGNA F.S.E. 2007-2013 - Obiettivo competitivita regionale e occupazione, Asse IV Capitale umano, Linea di Attivita l. 3.1 (research project: "Identification of natural and natural-like molecules inhibiting mycotoxin biosynthesis by Fusaria pathogenic on cereals"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NJ, 2009, TOXIN REV, V28, P198, DOI 10.1080/15569540903092142; Altomare C, 2004, J AGR FOOD CHEM, V52, P2997, DOI 10.1021/jf035233z; Arunachalam C, 2013, TOXICOL LETT, V217, P149, DOI 10.1016/j.toxlet.2012.12.003; Bakan B, 2003, J AGR FOOD CHEM, V51, P2826, DOI 10.1021/jf020957g; Baldwin TK, 2010, MOL PLANT MICROBE IN, V23, P566, DOI 10.1094/MPMI-23-5-0566; Becher R, 2010, PHYTOPATHOLOGY, V100, P444, DOI 10.1094/PHYTO-100-5-0444; Bhat R, 2010, COMPR REV FOOD SCI F, V9, P57, DOI 10.1111/j.1541-4337.2009.00094.x; Boutigny AL, 2008, EUR J PLANT PATHOL, V121, P411, DOI 10.1007/s10658-007-9266-x; Boutigny AL, 2010, EUR J PLANT PATHOL, V127, P275, DOI 10.1007/s10658-010-9592-2; Boutigny AL, 2009, MYCOL RES, V113, P746, DOI 10.1016/j.mycres.2009.02.010; Cardinali A., 2006, PHYTOCHEM ADV RES, V661, P23; CHANG G, 1989, J AM CHEM SOC, V111, P4379, DOI 10.1021/ja00194a035; da Silva JKR, 2014, MOLECULES, V19, P17926, DOI 10.3390/molecules191117926; Dambolena JS, 2012, FOOD CONTROL, V28, P163, DOI 10.1016/j.foodcont.2012.05.008; Dennington R., 2009, GAUSS VIEW VERSION 5; Desmond OJ, 2008, MOL PLANT PATHOL, V9, P435, DOI 10.1111/J.1364-3703.2008.00475.X; Dettori MA, 2015, LETT DRUG DES DISCOV, V12, P131; Eriksson ARB, 2002, EMBL GENBANK D UNPUB; Frisch G. W., 2013, GAUSSIAN 09; Fujisawa S, 2007, IN VIVO, V21, P181; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gunnaiah R, 2014, PLANT PHYSIOL BIOCH, V83, P40, DOI 10.1016/j.plaphy.2014.07.002; Hajduk PJ, 2000, J MED CHEM, V43, P3443, DOI 10.1021/jm000164q; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Lowe RGT, 2010, MOL PLANT MICROBE IN, V23, P1605, DOI 10.1094/MPMI-04-10-0092; Marchiani A, 2013, AMINO ACIDS, V45, P327, DOI 10.1007/s00726-013-1503-3; Maresca M, 2013, TOXINS, V5, P784, DOI 10.3390/toxins5040784; Menke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063077; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Ortega FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060871; Pan JZ, 2014, LETT DRUG DES DISCOV, V11, P27; Pani G, 2014, J AGR FOOD CHEM, V62, P4969, DOI 10.1021/jf500647h; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prandini A, 2009, FOOD CHEM TOXICOL, V47, P927, DOI 10.1016/j.fct.2008.06.010; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Sagrera G, 2011, BIOORGAN MED CHEM, V19, P3060, DOI 10.1016/j.bmc.2011.04.010; Sakuda S, 2016, BIOSCI BIOTECH BIOCH, V80, P43, DOI 10.1080/09168451.2015.1086261; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Scherm B, 2011, MOL PLANT PATHOL, V12, P759, DOI 10.1111/J.1364-3703.2011.00709.X; Shiina I, 2008, BIOCHEM PHARMACOL, V75, P1014, DOI 10.1016/j.bcp.2007.11.005; Vedula LS, 2007, ARCH BIOCHEM BIOPHYS, V466, P260, DOI 10.1016/j.abb.2007.06.016; Vedula LS, 2008, ARCH BIOCH BIOPHYS, V469; Vogel H.J., 1956, MICROB GENET B, V13, P42; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199; Wu HS, 2010, SCI HORTIC-AMSTERDAM, V124, P448, DOI 10.1016/j.scienta.2010.02.007	50	16	16	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157316	10.1371/journal.pone.0157316	http://dx.doi.org/10.1371/journal.pone.0157316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294666	Green Submitted, Green Published, gold			2022-12-27	WOS:000377821300035
J	Cheng, L; Zhang, S; Hu, Y				Cheng, Liang; Zhang, Shuo; Hu, Yang			BLAT2DOLite: An Online System for Identifying Significant Relationships between Genetic Sequences and Diseases	PLOS ONE			English	Article							ONTOLOGY; GENOME; BLAST; CORE	The significantly related diseases of sequences could play an important role in understanding the functions of these sequences. In this paper, we introduced BLAT2DOLite, an online system for annotating human genes and diseases and identifying the significant relationships between sequences and diseases. Currently, BLAT2DOLite integrates Entrez Gene database and Disease Ontology Lite (DOLite), which contain loci of gene and relationships between genes and diseases. It utilizes hypergeometric test to calculate P-values between genes and diseases of DOLite. The system can be accessed from: http://123.59.132.21:8080/BLAT2DOLite. The corresponding web service is described in: http://123.59.132.21:8080/BLAT2DOLite/BLAT2DOLiteIDMappingPort?wsdl.	[Cheng, Liang] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China; [Zhang, Shuo] Harbin Univ Commerce, Sch Management, Harbin 150028, Peoples R China; [Hu, Yang] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China	Harbin Medical University; Harbin University of Commerce; Harbin Institute of Technology	Cheng, L (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China.; Hu, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China.	liangcheng@hrbmu.edu.cn; huyang@hit.edu.cn	Cheng, Liang/ABY-7421-2022	Hu, Yang/0000-0002-4508-5365; Cheng, Liang/0000-0002-6665-6710	National Natural Science Foundation of China [61502125]; Heilongjiang Postdoctoral Fund [LBH-Z15179]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Postdoctoral Fund	This work was supported by the National Natural Science Foundation of China (Grant No. 61502125) and Heilongjiang Postdoctoral Fund (NO: LBH-Z15179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Bioinformatics UG, 2011, GRCH37 HG19 ASS; Cheng X, 2012, BMC GENOMICS, V13, P1; Danilov A, 2013, ONCOTARGET, V4, P1507, DOI 10.18632/oncotarget.1272; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Feng G, 2012, METHODS MOL BIOL, V802, P101, DOI 10.1007/978-1-61779-400-1_7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janjic V, 2012, MOL BIOSYST, V8, P2614, DOI 10.1039/c2mb25230a; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; Liu YS, 2017, IEEE ACM T COMPUT BI, V14, P905, DOI 10.1109/TCBB.2016.2550432; Lu ZY, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P269; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Meystre S, 2005, STUD HEALTH TECHNOL, V116, P823; Nair J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094328; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Sarajlic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071537; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shah NH, 2004, BIOINFORMATICS, V20, P1196, DOI 10.1093/bioinformatics/bth056; Shashni B, 2013, J DRUG TARGET, V21, P161, DOI 10.3109/1061186X.2012.736998; Sqalli MH, 2012, UCLOUD SIMULATED HYB, P170; Sullivan J, 2013, SCI REPORTS, V3; Vaughan-Nichols SJ, 2002, WEB SERVICES HYPE, P18; Vazquez-Naya JM, 2010, CURR PHARM DESIGN, V16, P2724; Xiang Y, 2012, IEEE ACM T COMPUT BI, V9, P294, DOI 10.1109/TCBB.2011.58; Yang JL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-18; Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zou Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/810514; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177	35	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157274	10.1371/journal.pone.0157274	http://dx.doi.org/10.1371/journal.pone.0157274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315278	Green Published, Green Submitted, gold			2022-12-27	WOS:000378030000016
J	Rost, K; Stahel, L; Frey, BS				Rost, Katja; Stahel, Lea; Frey, Bruno S.			Digital Social Norm Enforcement: Online Firestorms in Social Media	PLOS ONE			English	Article							COLLECTIVE ACTION; SELF-AWARENESS; INTERNET USE; LOW-COST; ANONYMITY; COMMUNICATION; DEINDIVIDUATION; IDENTIFICATION; PARTICIPATION; INSTIGATION	Actors of public interest today have to fear the adverse impact that stems from social media platforms. Any controversial behavior may promptly trigger temporal, but potentially devastating storms of emotional and aggressive outrage, so called online firestorms. Popular targets of online firestorms are companies, politicians, celebrities, media, academics and many more. This article introduces social norm theory to understand online aggression in a social-political online setting, challenging the popular assumption that online anonymity is one of the principle factors that promotes aggression. We underpin this social norm view by analyzing a major social media platform concerned with public affairs over a period of three years entailing 532,197 comments on 1,612 online petitions. Results show that in the context of online firestorms, non-anonymous individuals are more aggressive compared to anonymous individuals. This effect is reinforced if selective incentives are present and if aggressors are intrinsically motivated.	[Rost, Katja; Stahel, Lea] Univ Zurich, Inst Sociol, Zurich, Switzerland; [Frey, Bruno S.] Ctr Res Econ Management & Arts, Zurich, Switzerland	University of Zurich	Stahel, L (corresponding author), Univ Zurich, Inst Sociol, Zurich, Switzerland.	stahel@soziologie.uzh.ch	Frey, Bruno/AAW-9103-2021; Rost, Katja/N-3420-2013	Rost, Katja/0000-0002-7752-7818				Alonzo M, 2004, DECIS SUPPORT SYST, V36, P205, DOI 10.1016/S0167-9236(02)00190-2; Andreoni J, 2004, J PUBLIC ECON, V88, P1605, DOI 10.1016/S0047-2727(03)00040-9; [Anonymous], 2014, J MARK COMMUN, DOI DOI 10.1080/13527266.2013.797778; Bargh JA, 2002, J SOC ISSUES, V58, P33, DOI 10.1111/1540-4560.00247; Bendor J, 2001, AM J SOCIOL, V106, P1493, DOI 10.1086/321298; Best H, 2012, KOLNER Z SOZIOL SOZ, V64, P535, DOI 10.1007/s11577-012-0174-5; Bishop Jonathan, 2014, International Journal of Web Based Communities, V10, P7; Brauer M, 2005, J APPL SOC PSYCHOL, V35, P1519, DOI 10.1111/j.1559-1816.2005.tb02182.x; Buckels EE, 2014, PERS INDIV DIFFER, V67, P97, DOI 10.1016/j.paid.2014.01.016; Cammaerts B, 2005, POLIT COMMUN, V22, P179, DOI 10.1080/10584600590933188; Castells M., 2012, NETWORKS OUTRAGE HOP; Cho D, 2012, 45TH HAWAII INTERNAT; Connolly K, GERMAN TV PRESENTER; Cooper RB, 2008, EUR J INFORM SYST, V17, P631, DOI 10.1057/ejis.2008.51; David-Ferdon C, 2007, J ADOLESCENT HEALTH, V41, pS1, DOI 10.1016/j.jadohealth.2007.08.020; Dennis AR, 2003, MIS QUART, V27, P289; Dennis AR, 1996, MIS QUART, V20, P433, DOI 10.2307/249563; Dennis K, 2008, SOCIOL REV, V56, P347, DOI 10.1111/j.1467-954X.2008.00793.x; DESANCTIS G, 1987, MANAGE SCI, V33, P589, DOI 10.1287/mnsc.33.5.589; DIEKMANN A, 1992, KOLNER Z SOZIOL SOZ, V44, P226; Douglas KM, 2001, BRIT J SOC PSYCHOL, V40, P399, DOI 10.1348/014466601164894; Ellickson RC, 1999, SOCIAL SCI RES NETWO; ELSTER J, 1989, J ECON PERSPECT, V3, P99, DOI 10.1257/jep.3.4.99; FEATHER N T, 1982, Motivation and Emotion, V6, P217, DOI 10.1007/BF00992246; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Geller, 1985, HUMAN COMPUTER INTER, V1, P77, DOI [10.1207/s15327051hci0101_3, DOI 10.1207/S15327051HCI0101_3]; Ginges J, 2009, ANN NY ACAD SCI, V1167, P115, DOI 10.1111/j.1749-6632.2009.04543.x; Gopal A, 2000, MIS QUART, V24, P509, DOI 10.2307/3250972; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gunther AC, 2006, J COMMUN, V56, P52, DOI 10.1111/j.1460-2466.2006.00002.x; Guth W, 2006, ECON J, V116, P1037, DOI 10.1111/j.1468-0297.2006.01122.x; Gutwin C., 2002, Computer Supported Cooperative Work: The Journal of Collaborative Computing, V11, P411, DOI 10.1023/A:1021271517844; Haines R, 2014, GROUP DECIS NEGOT, V23, P765, DOI 10.1007/s10726-012-9318-2; Hale S.A., 2013, ANN C UK POL STUD AS; HARRINGTON CL, 1995, SOCIOL QUART, V36, P607, DOI 10.1111/j.1533-8525.1995.tb00456.x; Hayne SC, 2003, J MANAGE INFORM SYST, V20, P301; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Hollenbaugh EE, 2013, J COMPUT-MEDIAT COMM, V18, P283, DOI 10.1111/jcc4.12008; Homans G. C., 1950, HUMAN GROUP; Hughes M, 2013, S AFR J PSYCHOL, V43, P252, DOI 10.1177/0081246313482629; Hutcherson CA, 2011, J PERS SOC PSYCHOL, V100, P719, DOI 10.1037/a0022408; Joinson AN, 2007, PSYCHOL INTERNET 2, V2nd, P75; KIESLER S, 1984, AM PSYCHOL, V39, P1123, DOI 10.1037/0003-066X.39.10.1123; Klandermans B., 2003, OXFORD HDB POLITICAL, P670; Kokkinos CM, 2014, J APPL DEV PSYCHOL, V35, P204, DOI 10.1016/j.appdev.2014.04.001; Lee EJ, 2007, J COMMUN, V57, P385, DOI 10.1111/j.1460-2466.2007.00348.x; Lee SJ, 1996, AGGRESSIVE BEHAV, V22, P17; Li Q, 2007, COMPUT HUM BEHAV, V23, P1777, DOI 10.1016/j.chb.2005.10.005; Mann S, 2013, SURVEILL SOC, V11, P18; Mason KL, 2008, PSYCHOL SCHOOLS, V45, P323, DOI 10.1002/pits.20301; MCADAM D, 1986, AM J SOCIOL, V92, P64, DOI 10.1086/228463; MCADAM D, 1993, AM J SOCIOL, V99, P640, DOI 10.1086/230319; McLeod PL, 2000, RES MANAG GRP TEAM, V3, P175, DOI 10.1016/S1534-0856(00)03010-3; Mehari KR, 2014, PSYCHOL VIOLENCE, V4, P399, DOI 10.1037/a0037521; Mishna F, 2009, CHILD YOUTH SERV REV, V31, P1222, DOI 10.1016/j.childyouth.2009.05.004; Moore MJ, 2012, COMPUT HUM BEHAV, V28, P861, DOI 10.1016/j.chb.2011.12.005; Myers DJ, 2000, AM J SOCIOL, V106, P173, DOI 10.1086/303110; Nocentini A, 2010, AUST J GUID COUNS, V20, P129, DOI 10.1375/ajgc.20.2.129; O'Sullivan PB, 2003, NEW MEDIA SOC, V5, P69, DOI 10.1177/1461444803005001908; Oehmer F, 2011, SKANDALE STRUKTUREN; Olson M., 1965, LOGIC COLLECTIVE ACT; Opp KD, 2002, RATION SOC, V14, P131, DOI 10.1177/1043463102014002001; Opp KD, 2001, KYKLOS, V54, P355, DOI 10.1111/j.0023-5962.2001.00158.x; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Parsons T, 1964, SOCIAL SYSTEM; Patchin J. W., 2006, YOUTH VIOLENCE JUV J, V4, P148, DOI [10.1177/1541204006286288, DOI 10.1177/1541204006286288]; Pinsonneault A., 1997, Journal of Management Information Systems, V14, P89; Posner RA, 1999, INT REV LAW ECON, V19, P369, DOI 10.1016/S0144-8188(99)00013-7; PRENTICEDUNN S, 1982, J PERS SOC PSYCHOL, V43, P503, DOI 10.1037/0022-3514.43.3.503; PUTNAM RD, 1995, J DEMOCRACY, V0006; Rauhut H, 2008, Z SOZIOL, V37, P380; Reinig BA, 2004, SMALL GR RES, V35, P698, DOI 10.1177/1046496404266773; Reiss S, 2004, REV GEN PSYCHOL, V8, P179, DOI 10.1037/1089-2680.8.3.179; Rost K, 2013, CORP GOV-OXFORD, V21, P351, DOI 10.1111/corg.12018; Salmivalli C, 1996, AGGRESSIVE BEHAV, V22, P1, DOI 10.1002/(SICI)1098-2337(1996)22:1<1::AID-AB1>3.0.CO;2-T; Sassenberg K, 2002, BRIT J SOC PSYCHOL, V41, P463, DOI 10.1348/014466602760344313; Slonje R, 2008, SCAND J PSYCHOL, V49, P147, DOI 10.1111/j.1467-9450.2007.00611.x; Smith PK, 2008, J CHILD PSYCHOL PSYC, V49, P376, DOI 10.1111/j.1469-7610.2007.01846.x; Sontag LM, 2011, J YOUTH ADOLESCENCE, V40, P392, DOI 10.1007/s10964-010-9575-9; Stanley JW, 2004, ADMIN SOC, V36, P503, DOI 10.1177/0095399704268503; Suler J, 2004, CYBERPSYCHOL BEHAV, V7, P321, DOI 10.1089/1094931041291295; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tichy W, 2013, Z WIRSCHAFTSRECHT, V5, P396; Valacich JS, 1992, GROUP DECIS NEGOT, V1, P219, DOI DOI 10.1007/BF00126264; van Stekelenburg J, 2011, REV PSICOL SOC, V26, P91, DOI 10.1174/021347411794078426; van Zomeren M, 2004, J PERS SOC PSYCHOL, V87, P649, DOI 10.1037/0022-3514.87.5.649; Vandebosch H, 2008, CYBERPSYCHOL BEHAV, V11, P499, DOI 10.1089/cpb.2007.0042; Vandebosch H, 2009, NEW MEDIA SOC, V11, P1349, DOI 10.1177/1461444809341263; Wahrman R, 2010, SMALL GR RES, V41, P91, DOI 10.1177/1046496409359505; Weiss HM, 1999, J APPL PSYCHOL, V84, P786, DOI 10.1037/0021-9010.84.5.786; Wolak J, 2008, AM PSYCHOL, V63, P111, DOI 10.1037/0003-066X.63.2.111; Ybarra ML, 2007, J ADOLESCENT HEALTH, V41, P189, DOI 10.1016/j.jadohealth.2007.03.005; Ybarra ML, 2004, J CHILD PSYCHOL PSYC, V45, P1308, DOI 10.1111/j.1469-7610.2004.00328.x; Ybarra ML, 2004, J ADOLESCENCE, V27, P319, DOI 10.1016/j.adolescence.2004.03.007	97	64	64	7	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0155923	10.1371/journal.pone.0155923	http://dx.doi.org/10.1371/journal.pone.0155923			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JQ	27315071	Green Accepted, Green Published, gold			2022-12-27	WOS:000378030000001
J	Cantarino, SG; Pinto, JMD; Fabiao, JADAD; Garcia, AMC; Abellan, MV; Rodrigues, MA				Gomez Cantarino, Sagrario; de Matos Pinto, Jose Manuel; Amaro de Oliveira Fabiao, Joana Alice da Silva; Carrobles Garcia, Ana Maria; Velasco Abellan, Minerva; Rodrigues, Manuel Alves			The Importance of Religiosity/Spirituality in the Sexuality of Pregnant and Postpartum Women	PLOS ONE			English	Article							RELIGION; SPIRITUALITY; SEX	In this article, we decided to study the representation of the Spanish pregnant and postpartum women and the importance of religiosity/spirituality and the social context for them. We analyzed the influence of religion on the woman within her social context. Objective: to understand how pregnant and postpartum women experience their sexuality according to their religious beliefs and the opinion of others from a socially learned perspective. Method: qualitative study using ethnography. This study aims at understanding reality from the women's point of view, acknowledging that the points of view are constructed through interaction with others, through cultural and historical norms that influence the lives of individuals. Results: The findings indicate a difference in the religious beliefs and sexual behaviors of these women, which is more marked in urban than rural areas. Mothers have an influence on their daughters, conditioning their behavior. Conclusion We conclude that the process of change is underway. However, some paradoxes still persist concerning the sexual roles to be adopted, as well as some contradictions between sexual behaviors and the statements on religion. Within the scope of our study, we can confirm that pregnant and postpartum women are more or less pressured by the religious and social norms conveyed by their mothers, mainly in rural settings. From an external point of view, to be sexually free goes against the maternal and social expectations. However, the internal representation, marked by religion, that has been experienced over the years does not change the narratives of sexual experiences, assigning women to traditional role. This role brings conflict more or less assumed by women.	[Gomez Cantarino, Sagrario; Velasco Abellan, Minerva] Univ Castilla La Mancha, Escuela Enfermeria & Fisioterapia, Dept Enfermeria Fisioterapia & Terapia Ocupac, Campus Toledo, Toledo, Spain; [de Matos Pinto, Jose Manuel; Amaro de Oliveira Fabiao, Joana Alice da Silva; Rodrigues, Manuel Alves] Nursing Sch Coimbra, Hlth Sci Res Unit Nursing, Coimbra, Portugal; [Carrobles Garcia, Ana Maria] Univ Castilla La Mancha, Escuela Enfermeria & Fisioterapia, Dept Enfermeria Fisioterapia & Terapia Ocupac, Campus Talavera Reina, Toledo, Spain	Universidad de Castilla-La Mancha; Nursing School of Coimbra; Universidad de Castilla-La Mancha	Cantarino, SG (corresponding author), Univ Castilla La Mancha, Escuela Enfermeria & Fisioterapia, Dept Enfermeria Fisioterapia & Terapia Ocupac, Campus Toledo, Toledo, Spain.	sagrario.gomez@uclm.es	Cantarino, Sagrario Gómez/AAP-3845-2021	Cantarino, Sagrario Gómez/0000-0002-9640-0409	FISCAM (Foundation for Health Research in Castilla la Mancha) [PI-2009/73, 78]	FISCAM (Foundation for Health Research in Castilla la Mancha)	The study was funded by FISCAM (Foundation for Health Research in Castilla la Mancha) on the April 16th, 2009, Call (DOCM No. 78 of April 24th, 2009) File Number: PI-2009/73.	Barkan SE, 2006, J SCI STUD RELIG, V45, P407, DOI 10.1111/j.1468-5906.2006.00315.x; Baumeister RF, 2001, PERS SOC PSYCHOL REV, V5, P242, DOI 10.1207/S15327957PSPR0503_5; Bridges SK, 2007, J SEX MARITAL THER, V33, P41, DOI 10.1080/00926230600998466; Byers ES, 2005, J SEX RES, V42, P113, DOI 10.1080/00224490509552264; Carrillo Pineda Marcela, 2011, Index Enferm, V20, P96, DOI 10.4321/s1132-12962011000100020; Chozas J., 2006, REV FILOS, P81; Creswell J. W., 2007, QUALITATIVE INQUIRY; Di Virgilio M. M., 2007, REV ARGENTINA SOCIOL, V5, P90; Garnier G, 1975, SEXUALIDAD MUJER EMB, P13; Gomez S., 2012, THESIS; Guba EG., 1994, HDB QUALITATIVE RES, P105; Hardy SA, 2003, ADOLESCENT RELIG SEX, P97; Hernandez Collazo Y, 2010, HACIA PSICOLOGIA PUE, P174; Hill PC, 2000, J THEOR SOC BEHAV, V30, P51, DOI 10.1111/1468-5914.00119; Johnstone, 2015, RELIG SOC; Koenig HG, 2008, MED RELIG HLTH WHERE; Leininger M, 2005, ASUNTOS CRITICOS INV, P112; Leyva JM, 2010, THESIS; Lucca Irizarry N, 2003, INVESTIGACION CUALIT; Marks MJ, 2005, SEX ROLES, V52, P175, DOI 10.1007/s11199-005-1293-5; Medina J. L., 2005, DESEO CUIDAR VOLUNTA; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Moran JM, 2012, REFLEXIONES TORNO DE, P13; Murray SH, 2012, J SEX MARITAL THER, V38, P28, DOI 10.1080/0092623X.2011.569637; Murray SH., 2012, CANADIAN J HUMAN SEX, V21, P101; O'Sullivan L.F., 2008, CAN J HUM SEX, V17, P109; O'Sullivan LF, 2008, J ADOLESCENT HEALTH, V42, P207, DOI 10.1016/j.jadohealth.2008.01.002; Pargament KI, 2005, J SOC ISSUES, V61, P665, DOI 10.1111/j.1540-4560.2005.00426.x; Rodriguez T., 2007, REPRESENTACIONES SOC, P157; Ruiz J. I., 2009, METODOLOGIA INVESTIG, V5; Santos R.S., 2020, THESIS; Servicio de salud de Castilla La Mancha, 2010, SESCAM CIFRAS; Sofiati F, 2010, ANPUH, V8, P227; Sprecher S, 2002, J SEX RES, V39, P190, DOI 10.1080/00224490209552141; Strauss A, 2002, BASES INVESSTIGACION; Zinnbauer BJ, 1999, J PERS, V67, P889, DOI 10.1111/1467-6494.00077	36	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156809	10.1371/journal.pone.0156809	http://dx.doi.org/10.1371/journal.pone.0156809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309528	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800015
J	Hamidou, Z; Chibaudel, B; Hebbar, M; de Larauze, MH; Andre, T; Louvet, C; Brusquant, D; Garcia-Larnicol, ML; de Gramont, A; Bonnetain, F				Hamidou, Zeinab; Chibaudel, Benoist; Hebbar, Mohamed; de Larauze, Marine Hug; Andre, Thierry; Louvet, Christophe; Brusquant, David; Garcia-Larnicol, Marie-Line; de Gramont, Aimery; Bonnetain, Franck			Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial	PLOS ONE			English	Article							CLINICAL-TRIALS; 5-FLUOROURACIL; CHEMOTHERAPY; OUTCOMES	Purpose We previously showed that a sequential chemotherapy with dose-dense oxaliplatin (FOLFOX7) and irinotecan (FOLFIRI; irinotecan plus 5-fluorouracil/leucovorin) is not superior to FOLFOX4 in patients at advanced stage of colorectal cancer with liver metastases. Here we aimed to determine whether time to health-related quality of life (HRQoL) score definitive deterioration (TUDD) differs by study arm. Methods HRQoL was evaluated using the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 at baseline and every 4 cycles until the end of the study or death. Functional scale, symptom scale, global health status, and financial difficulties were analyzed. The TUDD was defined as the time interval between randomization and the first decrease in HRQoL score >= 5-point with no further improvement in HRQoL score >= 5 points or any further HRQoL data. TUDD was estimated using the Kaplan-Meier method and the long-rank test. Cox regression analyses were used to identify HRQoL items influencing TUDD. Sensitivity analyses were done using a multiple imputation method and different definitions of TUDD. Results Of the 284 patients, 171 (60.2%) completed HRQoL questionnaires. Cox multivariate analysis showed no statistically significant difference in TUDD for most of the QLQ-C30 scales between treatments. Patients with dyspnea and those without symptoms at baseline had a significantly longer TUDD when there was a delay > 12 months between diagnosis of the primary tumor and metastases (HR 0.48 [0.26-0.89]) and when there was diarrhea (HR 0.59 [0.36-0.96]), respectively. Conclusion This study shows that TUDD does not differ significantly according to type of treatment. The TUDD method produces meaningful longitudinal HRQoL results that may facilitate effective clinical decision making in patients with mCRC.	[Hamidou, Zeinab; Bonnetain, Franck] Natl Clin Res Platform Qual Life Oncol, Marseille, France; [Hamidou, Zeinab] Coll Med, Publ Hlth Lab, Marseille, France; [Chibaudel, Benoist; Andre, Thierry; Garcia-Larnicol, Marie-Line] St Antoine Hosp, Dept Med Oncol, Paris, France; [Hebbar, Mohamed; de Gramont, Aimery] Ctr Hosp Reg Univ, Claude Huriez Hosp, Med Oncol Serv, Lille, France; [de Larauze, Marine Hug; Brusquant, David] Grp Cooperateur Multidisciplinaire Oncol GERCOR, Paris, France; [Louvet, Christophe] Inst Mutualiste Montsouris, Dept Med Oncol, Paris, France; [Bonnetain, Franck] Univ Hosp Besancon, Methodol & Qual Life Unit Oncol EA3181, Besancon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; CHU Besancon	Hamidou, Z (corresponding author), Natl Clin Res Platform Qual Life Oncol, Marseille, France.; Hamidou, Z (corresponding author), Coll Med, Publ Hlth Lab, Marseille, France.	zeinab.hamidou@univ-amu.fr	André, Thierry P/N-8830-2017	André, Thierry P/0000-0002-5103-7095; Chibaudel, Benoist/0000-0003-1279-2044	Group Cooperateur Multidisciplinaire en Oncologie (GERCOR) (France); Ligue nationale contre le cancer; National clinical research Platform for Quality of life in Oncology; Sanofi-Aventis	Group Cooperateur Multidisciplinaire en Oncologie (GERCOR) (France); Ligue nationale contre le cancer(Ligue nationale contre le cancer); National clinical research Platform for Quality of life in Oncology; Sanofi-Aventis(Sanofi-Aventis)	This work was funded by the Group Cooperateur Multidisciplinaire en Oncologie (GERCOR) (France) and the Ligue nationale contre le cancer. This work was also supported by the National clinical research Platform for Quality of life in Oncology labelled by the National Cancer Ligue and the French National Cancer, Institute, and by Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Anota A, 2015, QUAL LIFE RES, V24, P5, DOI 10.1007/s11136-013-0583-6; BAUER P, 1991, STAT MED, V10, P871, DOI 10.1002/sim.4780100609; Bezjak A, 2006, J CLIN ONCOL, V24, P3831, DOI 10.1200/JCO.2006.05.8073; Bonnetain F, 2016, J CLIN ONCOL; Bonnetain F, 2010, EUR J CANCER, V46, P2753, DOI 10.1016/j.ejca.2010.07.023; Carsin AE, 2008, BRIT J CANCER, V99, P266, DOI 10.1038/sj.bjc.6604467; Curley SA, 2005, SEMIN ONCOL, V32, pS109, DOI 10.1053/j.seminoncol.2005.06.011; Donaldson GW, 2005, J CLIN ONCOL, V23, P7380, DOI 10.1200/JCO.2005.07.022; GODFREY K, 1985, NEW ENGL J MED, V313, P1450, DOI 10.1056/NEJM198512053132305; Gray NM, 2011, BRIT J CANCER, V104, P1697, DOI 10.1038/bjc.2011.155; Hamidou Z, 2011, ONCOLOGIST, V16, P1458, DOI 10.1634/theoncologist.2011-0085; Hebbar M, 2015, ANN ONCOL, V26, P340, DOI 10.1093/annonc/mdu539; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Kabbinavar FF, 2008, ONCOLOGIST, V13, P1021, DOI 10.1634/theoncologist.2008-0003; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LEVI F, 1992, CANCER, V69, P893, DOI 10.1002/1097-0142(19920215)69:4<893::AID-CNCR2820690410>3.0.CO;2-X; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Misiakos EP, 2011, WORLD J GASTROENTERO, V17, P4067, DOI 10.3748/wjg.v17.i36.4067; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Osoba D, 1999, INT J CANCER, P132; Ramsey SD, 2002, AM J GASTROENTEROL, V97, P1228, DOI 10.1111/j.1572-0241.2002.05694.x; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; StataCorp, 2009, STAT STAT SOFTW REL; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wei AC, 2006, ANN SURG ONCOL, V13, P668, DOI 10.1245/ASO.2006.05.039	27	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157067	10.1371/journal.pone.0157067	http://dx.doi.org/10.1371/journal.pone.0157067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310205	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800032
J	Lin, BR; Le, DJ; Chen, YB; Wang, QW; Chung, DD; Frausto, RF; Croasdale, C; Yee, RW; Hejtmancik, FJ; Aldave, AJ				Lin, Benjamin R.; Le, Derek J.; Chen, Yabin; Wang, Qiwei; Chung, D. Doug; Frausto, Ricardo F.; Croasdale, Christopher; Yee, Richard W.; Hejtmancik, Fielding J.; Aldave, Anthony J.			Whole Exome Sequencing and Segregation Analysis Confirms That a Mutation in COL17A1 Is the Cause of Epithelial Recurrent Erosion Dystrophy in a Large Dominant Pedigree Previously Mapped to Chromosome 10q23-q24	PLOS ONE			English	Article							BEHNKE CORNEAL-DYSTROPHY; INDIVIDUAL PHENOTYPIC VARIANCES; GENE; PREDICTION; EXCLUSION; COLLAGEN; FAMILY; CDB2; XVII	Purpose To report identification of a COL17A1 mutation in a family with a corneal dystrophy previously mapped to chromosome 10q23-q24. Methods Whole-exome sequencing was performed on DNA samples from five affected family members and two unrelated, unaffected individuals. Identified variants were filtered for those that were: located in the linked interval on chromosome 10q23-q24; novel or rare (minor allele frequency <= 0.01); heterozygous; present in all affected individuals and not in controls; and present in genes that encode proteins expressed in human corneal epithelial cells (reads per kilobase per million >= 1). Sanger sequencing of identified variants (SNVs) was performed in additional family members. In silico analysis was used to predict the functional impact of non-synonymous variants. Results Three SNVs located in two genes were identified that met the filtering criteria: one rare synonymous c.3156C>T variant in the collagen, type XVII, alpha I (COL17A1) gene; and two rare variants, one synonymous and one missense, in the dynamin binding protein (DNMBP) gene. Sanger sequencing of additional family members determined that only the COL17A1 variant segregates with the affected phenotype. In silico analysis predicts that the missense variant in DNMBP would be tolerated. Conclusions The corneal dystrophy mapped to chromosome 10q23-q24 is associated with the c.3156C>T variant in COL17A1. As this variant has recently been identified in five other families with early onset recurrent corneal erosions, and has been shown in vitro to introduce a cryptic splice donor site, this dystrophy is likely caused by aberrant splicing of COL17A1 and should be classified as epithelial recurrent erosion dystrophy.	[Lin, Benjamin R.; Le, Derek J.; Chung, D. Doug; Frausto, Ricardo F.; Aldave, Anthony J.] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA; [Chen, Yabin; Wang, Qiwei; Hejtmancik, Fielding J.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Croasdale, Christopher] Davis Duehr Dean Clin, Madison, WI USA; [Yee, Richard W.] Cross Ophthalmol Associates, Houston, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Aldave, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA.	aldave@jsei.ucla.edu	Chen, Yabin/N-3845-2015; Frausto, Ricardo/AAE-3146-2021	Frausto, Ricardo/0000-0003-3064-6745; Lin, Benjamin/0000-0002-6035-2468	National Eye Institute [R01EY022082, Z01EY000272]; National Institute of Health [P30 EY000331]; Research to Prevent Blindness (Stein Eye Institute); NATIONAL EYE INSTITUTE [R01EY022082] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (Stein Eye Institute)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by the following: National Eye Institute Grants R01EY022082 (A.J.A.) and Z01EY000272 (F.J.H.), https://nei.nih.gov/; National Institute of Health grant P30 EY000331 (core grant to Stein Eye Institute), http://www.nih.gov/; unrestricted grant from Research to Prevent Blindness (Stein Eye Institute), no grant #, https://www.rpbusa.org/rpb/?. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldave AJ, 2005, MOL VIS, V11, P713; Bucklers M, 1949, KLIN MONATSBL AUGENH, V114, P386; Dighiero P, 2000, OPHTHALMOLOGY, V107, P1353, DOI 10.1016/S0161-6420(00)00149-4; Evans CJ, 2015, ANN HUM GENET, V79, P1, DOI 10.1111/ahg.12090; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Jonsson F, 2015, HUM MUTAT, V36, P463, DOI 10.1002/humu.22764; Kodaganur SG, 2013, MOL VIS, V19, P1694; Lisch W, 2013, CORNEA, V32, pE192, DOI 10.1097/ICO.0b013e3182a73865; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; Nakamura H, 2012, CORNEA, V31, P1217, DOI 10.1097/ICO.0b013e3181c32efd; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Okada M, 1998, AM J OPHTHALMOL, V126, P535, DOI 10.1016/S0002-9394(98)00135-4; Oliver VF, 2016, OPHTHALMOLOGY, V123, P709, DOI 10.1016/j.ophtha.2015.12.008; Reis W, 1917, DEUT MED WOCHENSCHR, V43, P575; Ridgway AEA, 2000, INVEST OPHTH VIS SCI, V41, P3286; Sullivan LS, 2003, CURR EYE RES, V27, P223, DOI 10.1076/ceyr.27.4.223.16595; Thiel H J, 1967, Klin Monbl Augenheilkd, V150, P862; Vincent AL, 2009, MOL VIS, V15, P1700; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; Weiss JS, 2015, CORNEA, V34, P117, DOI 10.1097/ICO.0000000000000307; Yee RW, 1997, GENOMICS, V46, P152, DOI 10.1006/geno.1997.5028	24	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157418	10.1371/journal.pone.0157418	http://dx.doi.org/10.1371/journal.pone.0157418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309958	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800069
J	Natarajan, S; Kim, HT; Thamilarasan, SK; Veerappan, K; Park, JI; Nou, IS				Natarajan, Sathishkumar; Kim, Hoy-Taek; Thamilarasan, Senthil Kumar; Veerappan, Karpagam; Park, Jong-In; Nou, Ill-Sup			Whole Genome Re-Sequencing and Characterization of Powdery Mildew Disease-Associated Allelic Variation in Melon	PLOS ONE			English	Article							MOLECULAR MARKERS; VIRUS-RESISTANCE; CUCUMIS-SATIVUS; MOSAIC-VIRUS; RACE 2; GENE; INHERITANCE; L.; GENERATION; SINGLE	Powdery mildew is one of the most common fungal diseases in the world. This disease frequently affects melon (Cucumis melo L.) and other Cucurbitaceous family crops in both open field and greenhouse cultivation. One of the goals of genomics is to identify the polymorphic loci responsible for variation in phenotypic traits. In this study, powdery mildew disease assessment scores were calculated for four melon accessions, 'SCNU1154', 'Edisto47', 'MR-1', and 'PMR5'. To investigate the genetic variation of these accessions, whole genome re-sequencing using the Illumina HiSeq 2000 platform was performed. A total of 754,759,704 quality-filtered reads were generated, with an average of 82.64% coverage relative to the reference genome. Comparisons of the sequences for the melon accessions revealed around 7.4 million single nucleotide polymorphisms (SNPs), 1.9 million InDels, and 182,398 putative structural variations (SVs). Functional enrichment analysis of detected variations classified them into biological process, cellular component and molecular function categories. Further, a disease-associated QTL map was constructed for 390 SNPs and 45 InDels identified as related to defense-response genes. Among them 112 SNPs and 12 InDels were observed in powdery mildew responsive chromosomes. Accordingly, this whole genome re-sequencing study identified SNPs and InDels associated with defense genes that will serve as candidate polymorphisms in the search for sources of resistance against powdery mildew disease and could accelerate marker-assisted breeding in melon.	[Natarajan, Sathishkumar; Kim, Hoy-Taek; Thamilarasan, Senthil Kumar; Veerappan, Karpagam; Park, Jong-In; Nou, Ill-Sup] Sunchon Natl Univ, Dept Hort, Sunchon 540950, Jeonnam, South Korea	Sunchon National University	Nou, IS (corresponding author), Sunchon Natl Univ, Dept Hort, Sunchon 540950, Jeonnam, South Korea.	nis@sunchon.ac.kr	Thamilarasan, Senthil Kumar/AAX-5643-2021	Thamilarasan, Senthil Kumar/0000-0003-3691-5838; Natarajan, Sathishkumar/0000-0002-9001-8495; Veerappan, Karpagam/0000-0002-9910-6715	Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS) [213003-04-4-SB110]; Export Promotion Technology Development Program [312065-05-4-HD030]; Golden Seed Project (Center for Horticultural Seed Development); Ministry of Agriculture, Food and Rural Affairs (MAFRA)	Ministry of Oceans and Fisheries (MOF)(Ministry of Oceans & Fisheries (MOF), Republic of Korea); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS)(Korea Forest Service); Export Promotion Technology Development Program; Golden Seed Project (Center for Horticultural Seed Development); Ministry of Agriculture, Food and Rural Affairs (MAFRA)(Ministry of Agriculture, Food & Rural Affairs (MAFRA), Republic of Korea)	This research was supported by Golden Seed Project (Center for Horticultural Seed Development, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS): 213003-04-4-SB110. Export Promotion Technology Development Program (Grant No. 312065-05-4-HD030), Ministry of Agriculture, Food and Rural Affairs, Republic of Korea.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BaudraccoArnas S, 1996, THEOR APPL GENET, V93, P57, DOI 10.1007/BF00225727; BOHN GW, 1964, PHYTOPATHOLOGY, V54, P587; Brotman Y, 2005, THEOR APPL GENET, V110, P337, DOI 10.1007/s00122-004-1845-z; Causse M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-791; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clepet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-252; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Dogimont C, 1997, EUPHYTICA, V96, P391, DOI 10.1023/A:1003069703294; Dogimont C, 2011, GENE LIST FOR MELON; EPINAT C, 1993, EUPHYTICA, V65, P135, DOI 10.1007/BF00022575; Esteras C, 2013, THEOR APPL GENET, V126, P1285, DOI 10.1007/s00122-013-2053-5; Esteva J, 1988, RESISTANCE YELLOWING; Fukino N, 2004, BREEDING SCI, V54, P141, DOI 10.1270/jsbbs.54.141; Garcia-Mas J, 2000, THEOR APPL GENET, V101, P860, DOI 10.1007/s001220051553; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gonzalez VM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-246; Gonzalez VM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1131; Gonzalez VM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-782; Gonzalez VM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-339; Gumpf D, 1979, PHYTOPATHOLOGY; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; HARWOOD RR, 1968, J HERED, V59, P213, DOI 10.1093/oxfordjournals.jhered.a107695; HARWOOD RR, 1968, J HERED, V59, P126, DOI 10.1093/oxfordjournals.jhered.a107663; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Iovieno P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2325-3; Jagger I, 1938, PHYTOPATHOLOGY, V28, P761; Jahn M, 2002, POWDERY MILDEWS: A COMPREHENSIVE TREATISE, P239; JEFFREY C, 1980, BOT J LINN SOC, V81, P233, DOI 10.1111/j.1095-8339.1980.tb01676.x; Jewel H, EXPRESSION PROFILING; Joobeur T, 2004, PLANT J, V39, P283, DOI 10.1111/j.1365-313X.2004.02134.x; KENIGSBUCH D, 1989, PLANT DIS, V73, P206, DOI 10.1094/PD-73-0206; Kim Hoy-taek, 2016, Journal of Plant Biotechnology, V43, P58, DOI 10.5010/JPB.2016.43.1.58; Kong Q, 2014, SCREENING SUITABLE R; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lebeda A., 2006, Cucurbitaceae 2006, Asheville, North Carolina, USA, 17-21 September 2006, P444; Lebeda A, 2015, EUROPEAN J PLANT PAT, P1; Leida C, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0183-2; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu LZ, 2010, HORTSCIENCE, V45, P1407, DOI 10.21273/HORTSCI.45.9.1407; Nunes EWLP, 2015, CROP BREED APPL BIOT, V15, P181, DOI 10.1590/1984-70332015v15n3n31; Lopesz-Sese AI, 2000, HORTSCIENCE, V35, P110, DOI 10.21273/HORTSCI.35.1.110; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; McCreight JD, 2008, HORTSCIENCE, V43, P122, DOI 10.21273/HORTSCI.43.1.122; McCreight JD, 1991, POTENTIAL SOURCES RE, V14, P51; McGrath MT, 2001, PLANT DIS, V85, P236, DOI 10.1094/PDIS.2001.85.3.236; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Monforte AJ, 2003, PLANT BREEDING, V122, P153, DOI 10.1046/j.1439-0523.2003.00848.x; Morishita M, 2003, JARQ-JPN AGR RES Q, V37, P7, DOI 10.6090/jarq.37.7; Ning XF, 2014, EUPHYTICA, V195, P345, DOI 10.1007/s10681-013-1000-5; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pech JC, 2008, PLANT SCI, V175, P114, DOI 10.1016/j.plantsci.2008.01.003; PITRAT M, 1984, EUPHYTICA, V33, P57, DOI 10.1007/BF00022750; Pitrat M, 1991, J HEREDITY, V82; Pitrat Michel, 2008, V1, P283; Quiot-Douine L, 1988, EUCARPIA M CUC GEN B; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Salari M., 2012, African Journal of Biotechnology, V11, P15324; Sanseverino W, 2013, NUCLEIC ACIDS RES, V41, pD1167, DOI 10.1093/nar/gks1183; Saxena RK, 2014, BRIEF FUNCT GENOMICS, V13, P296, DOI 10.1093/bfgp/elu016; Sebastian P, 2010, P NATL ACAD SCI USA, V107, P14269, DOI 10.1073/pnas.1005338107; Silberstein L, 1999, SCI HORTIC-AMSTERDAM, V79, P101, DOI 10.1016/S0304-4238(98)00199-X; Sitterly WR, 1978, POWDERY MILDEWS, P359; Sugiyama M, 2007, J JPN SOC HORTIC SCI, V76, P316, DOI 10.2503/jjshs.76.316; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Webb R, 1979, HORTSCIENCE USA; Xu XY, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0240-6; Zhang BC, 2010, P NATL ACAD SCI USA, V107, P13532, DOI 10.1073/pnas.0910558107	73	22	24	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157524	10.1371/journal.pone.0157524	http://dx.doi.org/10.1371/journal.pone.0157524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311063	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800090
J	Schroder, M; Melum, GR; Landsverk, OJB; Bujko, A; Yaqub, S; Gran, E; Aamodt, H; Baekkevold, ES; Jahnsen, FL; Richter, L				Schroder, Martine; Melum, Guro Reinholt; Landsverk, Ole J. B.; Bujko, Anna; Yaqub, Sheraz; Gran, Einar; Aamodt, Henrik; Baekkevold, Espen S.; Jahnsen, Frode L.; Richter, Lisa			CD1c-Expression by Monocytes - Implications for the Use of Commercial CD1c(+) Dendritic Cell Isolation Kits	PLOS ONE			English	Article							HUMAN TISSUES; CUTTING EDGE; BLOOD; SUBSETS; DISTINCT; RESPONSES; MACROPHAGES; EXPRESSION; POLARIZATION; INDUCTION	Conventional dendritic cells (cDCs) comprise a heterogeneous population of cells that are important regulators of immunity and homeostasis. CD1c(+) cDCs are present in human blood and tissues, and found to efficiently activate naive CD4(+) T cells. While CD1c is thought to specifically identify this subset of human cDCs, we show here that also classical and intermediate monocytes express CD1c. Accordingly, the commercial CD1c (BDCA-1) Dendritic Cell Isolation Kit isolates two distinct cell populations from blood: CD1c(+) CD14 cDCs and CD1c(+) CD14(+) monocytes. CD1c(+) cDCs and CD1c(+) monocytes exhibited strikingly different properties, including their differential regulation of surface marker expression, their levels of cytokine production, and their ability to stimulate naive CD4(+) T cells. These results demonstrate that a commercial CD1c (BDCA-1) Dendritic Cell Isolation Kit isolates two functionally different cell populations, which has important implications for the interpretation of previously generated data using this kit to characterize CD1c(+) cDCs.	[Schroder, Martine; Melum, Guro Reinholt; Landsverk, Ole J. B.; Bujko, Anna; Baekkevold, Espen S.; Jahnsen, Frode L.; Richter, Lisa] Oslo Univ Hosp, Dept Pathol, N-0450 Oslo, Norway; [Schroder, Martine; Landsverk, Ole J. B.; Bujko, Anna; Baekkevold, Espen S.; Jahnsen, Frode L.; Richter, Lisa] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Yaqub, Sheraz] Oslo Univ Hosp, Dept Gastrointestinal Surg, N-0450 Oslo, Norway; [Gran, Einar] Lovisenberg Diakonale Hosp, Dept Otolaryngol, Oslo, Norway; [Aamodt, Henrik] Oslo Univ Hosp, Dept Cardiothorac Surg, N-0450 Oslo, Norway; [Aamodt, Henrik] Oslo Univ Hosp, Dept Pathol, Tumor Immunol Grp, N-0450 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Richter, L (corresponding author), Oslo Univ Hosp, Dept Pathol, N-0450 Oslo, Norway.; Richter, L (corresponding author), Univ Oslo, Ctr Immune Regulat, Oslo, Norway.	lisamgr@medisin.uio.no	Yaqub, Sheraz/AAC-3906-2019; Richter, Lisa/AAJ-8014-2021; Landsverk, Ole Jørgen Bjarnason/J-1975-2019	Yaqub, Sheraz/0000-0002-5696-2319; Richter, Lisa/0000-0002-0769-619X; Landsverk, Ole Jørgen Bjarnason/0000-0002-1367-2397; Bujko, Anna/0000-0001-8693-9227	Research Council of Norway through its Centres of Excellence funding scheme [179573/V40]; South Eastern Norway Regional Health Authority [1012105]	Research Council of Norway through its Centres of Excellence funding scheme; South Eastern Norway Regional Health Authority	This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179573/V40 (LR FLJ); and by a grant from the South Eastern Norway Regional Health Authority, project number 1012105 (LR GRM OJBL FLJ ESB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Kathrine Hagelsteen, Kjersti Thorvaldsen Hagen and Aaste Aursjo for excellent technical assistance, and the Flowcytometry Core Facility at Oslo University Hospital, Rikshopitalet. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179573/V40; and by grant from the South Eastern Norway Regional Health Authority, project number 1012105.	[Anonymous], 2008, CD1C BDCA 1 DENDR CE; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Beitnes ACR, 2011, SCAND J IMMUNOL, V74, P186, DOI 10.1111/j.1365-3083.2011.02549.x; Beitnes ACR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033556; Bigley V, 2015, J LEUKOCYTE BIOL, V97, P627, DOI 10.1189/jlb.1HI0714-351R; Bine S, 2012, CLIN EXP IMMUNOL, V169, P10, DOI 10.1111/j.1365-2249.2012.04586.x; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chow KV, 2016, J IMMUNOL, V196, P624, DOI 10.4049/jimmunol.1501202; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; DALE I, 1985, AM J CLIN PATHOL, V84, P24, DOI 10.1093/ajcp/84.1.24; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Faivre V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047209; Franks HA, 2014, INT J CANCER, V134, P575, DOI 10.1002/ijc.28398; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gingras MC, 2002, MOL IMMUNOL, V38, P817, DOI 10.1016/S0161-5890(02)00004-4; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Horlock C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r30; Jongbloed SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1864; Karlsson A, 2007, CLIN VACCINE IMMUNOL, V14, P328, DOI 10.1128/CVI.00349-06; Kassianos AJ, 2013, AM J PHYSIOL-RENAL, V305, pF1391, DOI 10.1152/ajprenal.00318.2013; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Mann ER, 2016, GUT, V65, P256, DOI 10.1136/gutjnl-2014-307916; Mann ER, 2012, INFLAMM BOWEL DIS, V18, P1275, DOI 10.1002/ibd.21893; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Melum GR, 2015, MUCOSAL DENDRITIC CE; Melum GR, 2014, J ALLERGY CLIN IMMUN, V134, P613, DOI 10.1016/j.jaci.2014.05.010; Milne P, 2015, BLOOD, V125, P470, DOI 10.1182/blood-2014-08-593582; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637, DOI 10.4049/jimmunol.170.7.3637; STASHENKO P, 1982, INFECT IMMUN, V38, P938, DOI 10.1128/IAI.38.3.938-947.1982; Vittorakis S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/231036; Watchmaker PB, 2014, NAT IMMUNOL, V15, P98, DOI 10.1038/ni.2768; Wilkinson R, 2006, PROSTATE, V66, P180, DOI 10.1002/pros.20333	46	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157387	10.1371/journal.pone.0157387	http://dx.doi.org/10.1371/journal.pone.0157387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311059	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800064
J	Velusamy, P; Su, CH; Kumar, GV; Adhikary, S; Pandian, K; Gopinath, SCB; Chen, Y; Anbu, P				Velusamy, Palaniyandi; Su, Chia-Hung; Kumar, Govindarajan Venkat; Adhikary, Shritama; Pandian, Kannaiyan; Gopinath, Subash C. B.; Chen, Yeng; Anbu, Periasamy			Biopolymers Regulate Silver Nanoparticle under Microwave Irradiation for Effective Antibacterial and Antibiofilm Activities	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; AG NANOPARTICLES; SODIUM ALGINATE; GREEN SYNTHESIS; PARTICLES; CELLULOSE; TOXICITY	In the current study, facile synthesis of carboxymethyl cellulose (CMC) and sodium alginate capped silver nanoparticles (AgNPs) was examined using microwave radiation and aniline as a reducing agent. The biopolymer matrix embedded nanoparticles were synthesized under various experimental conditions using different concentrations of biopolymer (0.5, 1, 1.5, 2%), volumes of reducing agent (50, 100, 150 mu L), and duration of heat treatment (30 s to 240 s). The synthesized nanoparticles were analyzed by scanning electron microscopy, UV-Vis spectroscopy, X-ray diffraction, and Fourier transform infrared spectroscopy for identification of AgNPs synthesis, crystal nature, shape, size, and type of capping action. In addition, the significant antibacterial efficacy and antibiofilm activity of biopolymer capped AgNPs were demonstrated against different bacterial strains, Staphylococcus aureus MTCC 740 and Escherichia coli MTCC 9492. These results confirmed the potential for production of biopolymer capped AgNPs grown under microwave irradiation, which can be used for industrial and biomedical applications.	[Velusamy, Palaniyandi; Kumar, Govindarajan Venkat; Adhikary, Shritama] SRM Univ, Dept Biotechnol, Sch Bioengn, Kancheepuram, Tamil Nadu, India; [Su, Chia-Hung] Ming Chi Univ Technol, Dept Chem Engn, Taipei, Taiwan; [Pandian, Kannaiyan] Univ Madras, Dept Inorgan Chem, Guindy Campus, Madras, Tamil Nadu, India; [Gopinath, Subash C. B.] Univ Malaysia, Inst Nano Elect Engn, Kangar, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn, Arau, Perlis, Malaysia; [Chen, Yeng] Univ Malaya, Fac Dent, Dept Oral Biol & Biomed Sci, Kuala Lumpur, Malaysia; [Anbu, Periasamy] Inha Univ, Coll Engn, Dept Biol Engn, Inchon, South Korea	SRM Institute of Science & Technology Chennai; Ming Chi University of Technology; University of Madras; Universiti Malaysia Perlis; Universiti Malaya; Inha University	Velusamy, P (corresponding author), SRM Univ, Dept Biotechnol, Sch Bioengn, Kancheepuram, Tamil Nadu, India.	velusamy.p@ktr.srmuniv.ac.in	Chen, Yeng -/A-6873-2011; Gopinath, Subash/D-2953-2015; Velusamy, Palaniyandi/AAA-6517-2022; pandian, Kannaiyan/AAZ-3539-2020; Kumar, G. Venkat/AAL-7001-2020; Govindarajan, Venkat Kumar/N-9424-2016; Su, Chia-Hung/C-2807-2008	Chen, Yeng -/0000-0002-0064-7678; Gopinath, Subash/0000-0002-8347-4687; Velusamy, Palaniyandi/0000-0002-6551-979X; Kumar, G. Venkat/0000-0001-6137-774X; Govindarajan, Venkat Kumar/0000-0001-6137-774X; Velusamy, Palaniyandi/0000-0002-9238-7390; Anbiu, Periasamy/0000-0003-4519-5254; Su, Chia-Hung/0000-0002-4203-5143	High Impact Research grant-"MoE Grant" [UM.C/625/1/HIR/MOE/DENT/09]; High Impact Research grant-"UM-MoHE HIR" [UM.C/625/1/HIR/MOHE/MED/16/5]; Inha University, Republic of Korea	High Impact Research grant-"MoE Grant"; High Impact Research grant-"UM-MoHE HIR"; Inha University, Republic of Korea	YC thanks the support from High Impact Research grants-"MoE Grant UM.C/625/1/HIR/MOE/DENT/09" and "UM-MoHE HIR UM.C/625/1/HIR/MOHE/MED/16/5". PA thanks Inha University, Republic of Korea, for providing a research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank the Nanotechnology Research Centre, Interdisciplinary School of Indian System of Medicine and Department of Physics and Nanotechnology of SRM University for performing SEM, FTIR, and XRD analysis, respectively. We also thank the School of Bioengineering, SRM University for providing the facilities for conduct of these studies. The author would like to thank Inha University Research grant for proof reading support.	Abdel-Halim ES, 2011, CARBOHYD POLYM, V86, P1615, DOI 10.1016/j.carbpol.2011.06.072; Ali K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131178; Avasthi DK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/12/125604; Bankura K, 2014, CARBOHYD POLYM, V107, P151, DOI 10.1016/j.carbpol.2014.02.047; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bhui DK, 2011, J MOL LIQ, V158, P170, DOI 10.1016/j.molliq.2010.11.014; Bonnemann H, 2001, EUR J INORG CHEM, P2455; Campi G, 2011, NANOSCALE, V3, P3774, DOI 10.1039/c1nr10474h; Carneiro-Da-Cunha MG, 2010, CARBOHYD POLYM, V82, P153, DOI 10.1016/j.carbpol.2010.04.043; Darroudi M, 2011, INT J NANOMED, V6, P569, DOI 10.2147/IJN.S16867; Deepika H, 2013, ACS SUSTAIN CHEM ENG, V1, P703; Dipak KB, 2012, CARBOHYD POLYM, V89, P830, DOI [10.1016/j.carbpol.2012.04.017, DOI 10.1016/J.CARBP0L.2012.04.017]; Dwivedi S, 2015, COLLOID SURFACE B, V132, P290, DOI 10.1016/j.colsurfb.2015.05.034; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Fard JK, 2015, ADV PHARM BULL, V5, P447, DOI 10.15171/apb.2015.061; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Gopinath SCS, 2009, ANAL CHEM, V81, P4963, DOI 10.1021/ac802757z; Guzman M, 2012, NANOMED-NANOTECHNOL, V8, P37, DOI 10.1016/j.nano.2011.05.007; Hebeish AA, 2010, CARBOHYD POLYM, V82, P933, DOI 10.1016/j.carbpol.2010.06.020; Hebeish A, 2013, CARBOHYD POLYM, V92, P407, DOI 10.1016/j.carbpol.2012.08.094; Hsueh YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144306; Kou JH, 2013, CHEM COMMUN, V49, P692, DOI 10.1039/c2cc37696b; Kumar M, 2016, PLASMONICS, V11, P261, DOI 10.1007/s11468-015-0044-x; Kumar M, 2014, PLASMONICS, V9, P129, DOI 10.1007/s11468-013-9605-z; Kumar M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3555593; Kumar M, 2010, PHYSICA E, V42, P1940, DOI 10.1016/j.physe.2010.03.002; Kumar M, 2009, PHYS STATUS SOLIDI B, V246, P2232, DOI 10.1002/pssb.200844464; Le Ouay B, 2015, NANO TODAY, V10, P339, DOI 10.1016/j.nantod.2015.04.002; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Li S, 2011, BIOMACROMOLECULES, V12, P2864, DOI 10.1021/bm2001439; Li SM, 2011, CARBOHYD POLYM, V86, P441, DOI 10.1016/j.carbpol.2011.04.060; Li SM, 2011, CARBOHYD POLYM, V83, P422, DOI 10.1016/j.carbpol.2010.08.003; Lin N, 2012, NANOSCALE, V4, P3274, DOI 10.1039/c2nr30260h; Liu K, 2013, J AGR FOOD CHEM, V61, P6562, DOI 10.1021/jf4010065; Lunhong A, 2013, BIORESOURCE TECHNOL, V132, P374, DOI [10.1016/j.biortech.2012.10.161, DOI 10.1016/J.BIORTECH.2012.10.161]; Mishra YK, 2007, SCRIPTA MATER, V56, P629, DOI 10.1016/j.scriptamat.2006.12.008; Mohan YM, 2007, J APPL POLYM SCI, P3375; Mohapatra S, 2008, J NANOSCI NANOTECHNO, V8, P4285, DOI 10.1166/jnn.2008.AN30; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Moulton MC, 2010, NANOSCALE, V2, P763, DOI 10.1039/c0nr00046a; Nadagouda MN, 2011, ACCOUNTS CHEM RES, V44, P469, DOI 10.1021/ar1001457; Pandey S, 2012, INT J BIOL MACROMOL, V51, P583, DOI 10.1016/j.ijbiomac.2012.06.033; Parlak O, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400136; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Rao YN, 2010, RADIAT PHYS CHEM, V79, P1240, DOI 10.1016/j.radphyschem.2010.07.004; Rastogi PK, 2012, MATER SCI ENG B-ADV, V177, P456, DOI 10.1016/j.mseb.2012.02.012; Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j; Sarmast MK, 2016, MOL BIOTECHNOL; Seo SY, 2012, CARBOHYD POLYM, V90, P109, DOI 10.1016/j.carbpol.2012.05.002; Shankar S, 2015, CARBOHYD POLYM, V130, P353, DOI 10.1016/j.carbpol.2015.05.018; Sharma S, 2012, RSC ADV, V2, P5837, DOI 10.1039/c2ra00006g; Son WK, 2006, CARBOHYD POLYM, V65, P430, DOI 10.1016/j.carbpol.2006.01.037; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Velusamy P, 2016, J TAIWAN INST CHEM E, V59, P450, DOI 10.1016/j.jtice.2015.07.018; Velusamy P, 2015, IND CROP PROD, V66, P103, DOI 10.1016/j.indcrop.2014.12.042; Vishvanath T, 2014, J NANOMED NANOTECHNO, V5, P6; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wei DW, 2009, CARBOHYD RES, V344, P2375, DOI 10.1016/j.carres.2009.09.001; Yang JS, 2012, ACTA MATER, V60, P4753, DOI 10.1016/j.actamat.2012.05.037; Yang LB, 2007, J PHYS CHEM C, V111, P5300, DOI 10.1021/jp067010s; Zhao XH, 2014, COLLOID SURFACE A, V444, P180, DOI 10.1016/j.colsurfa.2013.12.008	61	47	47	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157612	10.1371/journal.pone.0157612	http://dx.doi.org/10.1371/journal.pone.0157612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304672	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800078
J	Chen, YC; Liu, CS; Parker, WD; Chen, HY; Beach, TG; Liu, XH; Serrano, GE; Lu, YF; Huang, JJ; Yang, KF; Wang, CM				Chen, Yucai; Liu, Changsheng; Parker, William Davis; Chen, Hongyi; Beach, Thomas G.; Liu, Xinhua; Serrano, Geidy E.; Lu, Yanfen; Huang, Jianjun; Yang, Kunfang; Wang, Chunmei			Mitochondrial DNA Rearrangement Spectrum in Brain Tissue of Alzheimer's Disease: Analysis of 13 Cases	PLOS ONE			English	Article							KEARNS-SAYRE SYNDROME; DONATION PROGRAM; RIBOSOMAL-RNA; MUTATIONS; TRANSCRIPTION; PROTEIN; CELLS; DYSFUNCTION; DEFICIENCY; DELETIONS	Background Mitochondrial dysfunction may play a central role in the pathologic process of Alzheimer's disease (AD), but there is still a scarcity of data that directly links the pathology of AD with the alteration of mitochondrial DNA. This study aimed to provide a comprehensive assessment of mtDNA rearrangement events in AD brain tissue. Patients and Methods Postmortem frozen human brain cerebral cortex samples were obtained from the Banner Sun Health Research Institute Brain and Body Donation Program, Sun City, AZ. Mitochondria were isolated and direct sequence by using MiSeq (R), and analyzed by relative software. Results Three types of mitochondrial DNA (mtDNA) rearrangements have been seen in post mortem human brain tissue from patients with AD and age matched control. These observed rearrangements include a deletion, F-type rearrangement, and R-type rearrangement. We detected a high level of mtDNA rearrangement in brain tissue from cognitively normal subjects, as well as the patients with Alzheimer's disease (AD). The rate of rearrangements was calculated by dividing the number of positive rearrangements by the coverage depth. The rearrangement rate was significantly higher in AD brain tissue than in control brain tissue (17.9% versus 6.7%; p = 0.0052). Of specific types of rearrangement, deletions were markedly increased in AD (9.2% versus 2.3%; p = 0.0005). Conclusions Our data showed that failure of mitochondrial DNA in AD brain might be important etiology of AD pathology.	[Chen, Yucai; Lu, Yanfen; Huang, Jianjun; Yang, Kunfang; Wang, Chunmei] Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Childrens Hosp, Shanghai 200030, Peoples R China; [Chen, Yucai; Parker, William Davis; Chen, Hongyi] Univ Illinois, Dept Pediat, Peoria, IL USA; [Liu, Changsheng; Liu, Xinhua] SoftGenetics LLC, State Coll, PA USA; [Beach, Thomas G.; Serrano, Geidy E.] Banner Sun Hlth Res Inst, Sun City, AZ USA	Shanghai Jiao Tong University; University of Illinois System; University of Illinois Peoria; Banner Research; Banner Health; Banner Sun Health Research Institute	Chen, YC (corresponding author), Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Childrens Hosp, Shanghai 200030, Peoples R China.; Chen, YC (corresponding author), Univ Illinois, Dept Pediat, Peoria, IL USA.	chenyucaiphd@hotmail.com			Pediatrics Department, University of Illinois College of Medicine at Peoria; Shanghai Children's Hospital, Shanghai Jiao Tong University; National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-90, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG019610] Funding Source: NIH RePORTER	Pediatrics Department, University of Illinois College of Medicine at Peoria; Shanghai Children's Hospital, Shanghai Jiao Tong University; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported funding from Pediatrics Department, University of Illinois College of Medicine at Peoria, and funding from Shanghai Children's Hospital, Shanghai Jiao Tong University. The authors are grateful to the Banner Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona for the provision of human brain tissue. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011,05-90 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. Changsheng Liu and Xinhua Liu from SoftGenetics LLC played a role in sequence data analysis by using modified NextGENe software. Changsheng Liu also played a role in preparation of the manuscript.; We thank the individual brain donors and their families for their extremely generous gift. We thank the scientists of SoftGenetics LLC for modifying NextGENe software for this project. We thank Peggy Mankin for her assistance with the preparation of this manuscript. This work was supported funding from Pediatrics Department, University of Illinois College of Medicine at Peoria, and funding from Shanghai Children's Hospital, Shanghai Jiao Tong University. We are grateful to the Banner Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona for the provision of human brain tissue. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011,05-90and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. Changsheng Liu and Xinhua Liu from SoftGenetics LLC play a role in sequence data analysis by using modified NextGENe software. Changsheng Liu also plays a role in preparation of the manuscript.	Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Beach TG, 2015, NEUROPATHOLOGY, V35, P354, DOI 10.1111/neup.12189; Beckman KB, 1998, ANN NY ACAD SCI, V854, P118, DOI 10.1111/j.1749-6632.1998.tb09897.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; BROCKINGTON M, 1993, NAT GENET, V4, P67, DOI 10.1038/ng0593-67; Burzio VA, 2009, P NATL ACAD SCI USA, V106, P9430, DOI 10.1073/pnas.0903086106; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982; Damas J, 2014, HUM MUTAT, V35, P1, DOI 10.1002/humu.22452; Das A, 2011, J BIOL CHEM, V286, P43771, DOI 10.1074/jbc.M111.263574; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; Hyman B. T., 1997, EXP NEUROL, V56, P1095, DOI [10.1097/00005072-199710000-00002, DOI 10.1097/00005072-199710000-00002]; Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Landerer E, 2011, CELL ONCOL, V34, P297, DOI 10.1007/s13402-011-0018-8; Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021; Lightowlers RH, 1999, TRENDS GENET, V15, P91, DOI 10.1016/S0168-9525(98)01684-9; Maniataki E, 2005, RNA, V11, P849, DOI 10.1261/rna.2210805; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; NAKASE H, 1990, AM J HUM GENET, V46, P418; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pang CY, 2008, FRONT BIOSCI-LANDMRK, V13, P3661, DOI 10.2741/2957; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302; Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; Sulijoadikusumo I, 2001, BIOCHEMISTRY-US, V40, P11559, DOI 10.1021/bi015526q; WALLACE DC, 1990, PEDIATR RES, V28, P525, DOI 10.1203/00006450-199011000-00023	33	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0154582	10.1371/journal.pone.0154582	http://dx.doi.org/10.1371/journal.pone.0154582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299301	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200004
J	Heydarchi, B; Center, RJ; Gonelli, C; Muller, B; Mackenzie, C; Khoury, G; Lichtfuss, M; Rawlin, G; Purcell, DFJ				Heydarchi, Behnaz; Center, Rob J.; Gonelli, Christopher; Muller, Brian; Mackenzie, Charlene; Khoury, Georges; Lichtfuss, Marit; Rawlin, Grant; Purcell, Damian F. J.			Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response	PLOS ONE			English	Article							HYPERIMMUNE BOVINE COLOSTRUM; PREEXPOSURE PROPHYLAXIS; BROAD NEUTRALIZATION; ENVELOPE PROTEIN; VIRUS; TRIMERS; SITE; POTENT; GP120; TRANSMISSION	An important feature of a potential vaccine against HIV is the production of broadly neutralising antibodies (BrNAbs) capable of potentially blocking infectivity of a diverse array of HIV strains. BrNAbs naturally arise in some HIV infected individuals after several years of infection and their serum IgG can neutralise various HIV strains across different subtypes. We previously showed that vaccination of cows with HIV gp140 AD8 trimers resulted in a high titre of serum IgG against HIV envelope (Env) that had strong BrNAb activity. These polyclonal BrNAbs concentrated into the colostrum during the late stage of pregnancy and can be harvested in vast quantities immediately after calving. In this study, we investigated the effect of prolonged HIV gp140 vaccination on bovine colostrum IgG HIV Env-binding and BrNAb activity over subsequent pregnancies. Repeated immunisation led to a maintained high titre of HIV Env specific IgG in the colostrum batches, but this did not increase through repeated cycles. Colostrum IgG from all batches also strongly competed with sCD4 binding to gp140 Env trimer and with human-derived monoclonal VRC01 and b12 BrNAbs that bind the CD4 binding site (CD4bs). Furthermore, competition neutralisation assays using RSC3 Env gp120 protein core and a derivative CD4bs mutant, RSC3 Delta 371I/P363N, showed that CD4bs neutralising antibodies contribute to the neutralising activity of all batches of purified bovine colostrum IgG. This result indicates that the high IgG titre/avidity of anti-CD4bs antibodies with BrNAb activity was achieved during the first year of vaccination and was sustained throughout the years of repeated vaccinations in the cow tested. Although IgG of subsequent colostrum batches may have a higher avidity towards the CD4bs, the overall breadth in neutralisation was not enhanced. This implies that the boosting vaccinations over 4 years elicited a polyclonal antibody response that maintained the proportion of both neutralising and non-neutralising CD4bs antibodies.	[Heydarchi, Behnaz; Center, Rob J.; Gonelli, Christopher; Muller, Brian; Mackenzie, Charlene; Khoury, Georges; Lichtfuss, Marit; Rawlin, Grant; Purcell, Damian F. J.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Center, Rob J.] Burnet Inst, Ctr Biomed Res, Prahran, Vic, Australia	University of Melbourne; Burnet Institute	Purcell, DFJ (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.	dfjp@unimelb.edu.au	Purcell, Damian F/G-5068-2011; Khoury, Georges/AGZ-0672-2022; Khoury, Georges/AGY-8421-2022	Khoury, Georges/0000-0002-2136-2487; HEYDARCHI, BEHNAZ/0000-0003-3043-1322; Gonelli, Christopher/0000-0002-7521-8528	Immuron Ltd; AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH [12042, 12362]	Immuron Ltd; AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Immuron Ltd funded the animal husbandry and veterinarian support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ian Gill and Noel Russell for Veterinary care of the cows and Victor Wong and Gerhardt Rank for technical assistance. RSC3 (catalog no. 12042) and RSC3 Delta 371I/P363N (catalog no. 12362) were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH, from Zhi-Yong Yang, Peter Kwong, and Gary Nabel.	Beddows S, 1999, J VIROL, V73, P1740, DOI 10.1128/JVI.73.2.1740-1745.1999; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bower JF, 2004, J VIROL, V78, P4710, DOI 10.1128/JVI.78.9.4710-4719.2004; Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203; Bures R, 2000, AIDS RES HUM RETROV, V16, P2019, DOI 10.1089/088922200750054756; Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; Center RJ, 2009, VACCINE, V27, P6605, DOI 10.1016/j.vaccine.2009.08.016; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; EARL PL, 1989, AIDS RES HUM RETROV, V5, P23, DOI 10.1089/aid.1989.5.23; Goo L, 2012, J VIROL, V86, P9566, DOI 10.1128/JVI.00953-12; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; HAIGWOOD NL, 1990, AIDS RES HUM RETROV, V6, P855, DOI 10.1089/aid.1990.6.855; Hammonds J, 2005, J VIROL, V79, P14804, DOI 10.1128/JVI.79.23.14804-14814.2005; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kaushik AK, 2009, VET IMMUNOL IMMUNOP, V127, P106, DOI 10.1016/j.vetimm.2008.09.024; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kramski M, 2012, EUR J IMMUNOL, V42, P2771, DOI 10.1002/eji.201242469; Kramski M, 2012, ANTIMICROB AGENTS CH, V56, P4310, DOI 10.1128/AAC.00453-12; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mayer KH, 2001, CLIN INFECT DIS, V32, P476, DOI 10.1086/318496; McCoy LE, 2012, J EXP MED, V209, P1091, DOI 10.1084/jem.20112655; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Rademeyer C, 2007, VIROLOGY, V368, P172, DOI 10.1016/j.virol.2007.06.013; Ramjee G, 2010, AIDS, V24, pS40, DOI 10.1097/01.aids.0000390706.81383.f3; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Sinclair MC, 1997, J IMMUNOL, V159, P3883; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhao YF, 2006, DEV COMP IMMUNOL, V30, P175, DOI 10.1016/j.dci.2005.06.012; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157353	10.1371/journal.pone.0157353	http://dx.doi.org/10.1371/journal.pone.0157353			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300145	Green Published, gold			2022-12-27	WOS:000377822200039
J	Wei, JW; Lee, BPYH; Wen, LB				Wei, James Wang; Lee, Benjamin P. Y-H.; Wen, Low Bing			Citizen Science and the Urban Ecology of Birds and Butterflies-A Systematic Review	PLOS ONE			English	Review							SPECIES-AREA RELATIONSHIP; GARDEN PLANTS; HABITAT; CONSERVATION; DIVERSITY; LANDSCAPE; URBANIZATION; MANAGEMENT; SUBURBAN; TOOL	Citizen science has gained widespread currency as a tool for ecological research over the past decade. However, in the discipline of urban ecology, the existing contributions and future potential of citizen science engagement, specifically in terms of knowledge gain, have not yet been comprehensively explored. Here, we present a systematic review of published work on the urban ecology of birds and butterflies in relation to their use of citizen science data between 2005 and 2014. We compared the number of studies that used citizen science data to the number of studies that could potentially have employed data derived fromcitizen science. The take-up rates of citizen science data were 21% and 26% for birds and butterflies respectively. Most studies that employed citizen science used volunteer-derived data as primary data, and adopted Collegial, Collaborative and Contributional engagement modes to the exclusion of Contractual and Co-created arrangements. There was no evidence that citizen science studies investigated a different organismal scale (community vs. species) compared to the urban ecology literature. For both taxa, citizen science contributions were lower than expected compared to their representation in the urban ecology literature for studies on species-environment relationships at landscape and micro-environment scales, as well as behavioural ecology in general. Other research topics that could benefit from further citizen science involvement include breeding studies and guild analyses for birds, and multi-taxa studies for butterflies. Promising models of citizen science engagement for urban ecology are highlighted in relation to their thematic foci and methodological detail, and a number of research questions that could be productively addressed using citizen science are identified. The dynamics of contemporary engagement between citizen science and urban ecology described by this review could inform the design and refinement of urban ecology-citizen science programmes in order to optimise their scientific contributions.	[Wei, James Wang; Lee, Benjamin P. Y-H.; Wen, Low Bing] Natl Pk Board, Singapore, Singapore; [Wei, James Wang] Natl Univ Singapore, Dept Geog, Singapore 117548, Singapore; [Lee, Benjamin P. Y-H.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England	National University of Singapore; University of Kent	Wei, JW (corresponding author), Natl Pk Board, Singapore, Singapore.; Wei, JW (corresponding author), Natl Univ Singapore, Dept Geog, Singapore 117548, Singapore.	james.wang@u.nus.edu	LEE, BENJAMIN/A-7944-2013					Alberti M., 2009, ADV URBAN ECOLOGY IN; [Anonymous], 2014, R LANG ENV STAT COMP; Balogh AL, 2011, J ORNITHOL, V152, P717, DOI 10.1007/s10336-011-0648-7; Bergerot B, 2011, LANDSCAPE ECOL, V26, P83, DOI 10.1007/s10980-010-9537-3; Bergerot B, 2010, LANDSCAPE URBAN PLAN, V96, P98, DOI 10.1016/j.landurbplan.2010.02.007; Bird TJ, 2014, BIOL CONSERV, V173, P144, DOI 10.1016/j.biocon.2013.07.037; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Braschler B, 2009, BIOSCIENCE, V59, P103, DOI 10.1525/bio.2009.59.2.2; Breeden JB, 2008, WILSON J ORNITHOL, V120, P384, DOI 10.1676/07-082.1; Campbell MO, 2011, URBAN FOR URBAN GREE, V10, P47, DOI 10.1016/j.ufug.2010.10.001; CATLINGROVES CL, 2012, INT J ZOOL, V2012, DOI DOI 10.1155/2012/349630; Charre GM, 2013, ORNITOL NEOTROP, V24, P279; Chong KY, 2014, BIOL CONSERV, V171, P299, DOI 10.1016/j.biocon.2014.01.037; Clark Peter J., 2007, Urban Ecosystems, V10, P321, DOI 10.1007/s11252-007-0029-4; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; Cooper CB, 2007, ECOL SOC, V12; Cooper CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106508; Coulson JC, 2009, WATERBIRDS, V32, P1, DOI 10.1675/063.032.0101; Couvet D, 2008, INTERDISCIPL SCI REV, V33, P95, DOI 10.1179/030801808X260031; Crall AW, 2011, CONSERV LETT, V4, P433, DOI 10.1111/j.1755-263X.2011.00196.x; Dallimer M, 2012, DIVERS DISTRIB, V18, P742, DOI 10.1111/j.1472-4642.2012.00891.x; Davis RA, 2013, URBAN ECOSYST, V16, P427, DOI 10.1007/s11252-012-0275-y; DeCandido R, 2006, WILSON J ORNITHOL, V118, P53, DOI 10.1676/1559-4491(2006)118[0053:NHBPFA]2.0.CO;2; Deguines N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045822; Dennis RLH, 2013, BIODIVERS CONSERV, V22, P2709, DOI 10.1007/s10531-013-0540-2; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dowling JL, 2012, BEHAV ECOL, V23, P201, DOI 10.1093/beheco/arr176; Drinnan IN, 2005, BIOL CONSERV, V124, P339, DOI 10.1016/j.biocon.2005.01.040; Dunn AM, 2008, EMU, V108, P42, DOI 10.1071/MU07034; Elliott KH, 2006, WILSON J ORNITHOL, V118, P380, DOI 10.1676/04-126.1; Evans D.M., 2013, TRENDS ECOL EVOL, V28, P451, DOI [DOI 10.1016/J.TREE.2013.05.003, 10.1016/j.tree.2013.05.003]; Fischer JD, 2015, CONSERV BIOL, V29, P1246, DOI 10.1111/cobi.12451; Follett R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143687; Fontana CS, 2011, URBAN ECOSYST, V14, P341, DOI 10.1007/s11252-011-0156-9; French K, 2005, BIOL CONSERV, V121, P545, DOI 10.1016/j.biocon.2004.06.004; Gagne SA, 2011, ECOL APPL, V21, P2297, DOI 10.1890/09-1905.1; Garbuzov M, 2014, FUNCT ECOL, V28, P364, DOI 10.1111/1365-2435.12178; Gaston K. J, 2010, URBAN ECOLOGY; Geslin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063421; Gibbons DW, 2007, BIRD STUDY, V54, P324, DOI 10.1080/00063650709461492; Gravetter F., 2012, STAT BEHAV SCI; Hager SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053371; Hernandez-Brito D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100593; Hunter M, 2016, ECOL INDIC, V63, P121, DOI 10.1016/j.ecolind.2015.11.049; Ikin K, 2013, LANDSCAPE ECOL, V28, P45, DOI 10.1007/s10980-012-9811-7; LaPoint S, 2015, FUNCT ECOL, V29, P868, DOI 10.1111/1365-2435.12489; Legagneux P, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0417; Lepczyk CA, 2009, B ECOL SOC AM, V90, P308, DOI DOI 10.1890/0012-9623-90.3.308; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Lizee MH, 2012, LANDSCAPE ECOL, V27, P159, DOI 10.1007/s10980-011-9651-x; Loss SR, 2009, BIOL CONSERV, V142, P2578, DOI 10.1016/j.biocon.2009.06.004; MacGregor-Fors I, 2010, ECOL RES, V25, P883, DOI 10.1007/s11284-010-0717-z; MacIvor JS, 2016, ISR J ECOL EVOL, V62, P88, DOI 10.1080/15659801.2015.1052635; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Mason J, 2007, LANDSCAPE URBAN PLAN, V80, P153, DOI 10.1016/j.landurbplan.2006.07.002; Matteson KC, 2012, CONSERV BIOL, V26, P557, DOI 10.1111/j.1523-1739.2012.01825.x; McDonnell MJ, 2013, URBAN ECOSYST, V16, P397, DOI 10.1007/s11252-013-0315-2; McDonnell MJ, 2009, ECOLOGY OF CITIES AND TOWNS: A COMPARATIVE APPROACH, P1, DOI 10.1017/CBO9780511609763; Meehan TD, 2013, J INSECT CONSERV, V17, P411, DOI 10.1007/s10841-012-9523-y; Melles Stephanie J., 2005, Urban Habitats, V3, P25; Murgui E, 2007, GLOBAL ECOL BIOGEOGR, V16, P319, DOI 10.1111/j.1466-8238.2006.00304.x; Murgui Enrique, 2009, Urban Ecosystems, V12, P249, DOI 10.1007/s11252-009-0092-0; Newhouse MJ, 2008, WILSON J ORNITHOL, V120, P99, DOI 10.1676/06-156.1; Newman G, 2011, ECOL INFORM, V6, P217, DOI 10.1016/j.ecoinf.2011.03.002; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Ockinger E, 2009, LANDSCAPE URBAN PLAN, V93, P31, DOI 10.1016/j.landurbplan.2009.05.021; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Oliver AJ, 2011, LANDSCAPE URBAN PLAN, V102, P215, DOI 10.1016/j.landurbplan.2011.04.007; Pandya RE, 2012, FRONT ECOL ENVIRON, V10, P314, DOI 10.1890/120007; Paton D, 2012, LANDSCAPE URBAN PLAN, V104, P1, DOI 10.1016/j.landurbplan.2011.09.002; Pauw A, 2012, ECOL SOC, V17, DOI 10.5751/ES-04758-170227; Peris S, 2014, TURK J ZOOL, V38, P316, DOI 10.3906/zoo-1305-20; Phillimore AB, 2012, AM NAT, V180, P655, DOI 10.1086/667893; Pickett S.T.A., 2008, URBAN ECOLOGY INT PE, P99, DOI 10.1007/978-0-387-73412-5_7; Platt Andrew, 2006, Urban Ecosystems, V9, P83, DOI 10.1007/s11252-006-7900-6; Polgar CA, 2013, BIOL CONSERV, V160, P25, DOI 10.1016/j.biocon.2012.12.024; REBELE F, 1994, GLOBAL ECOL BIOGEOGR, V4, P173, DOI 10.2307/2997649; Robertson B, 2010, ACTA ZOOL ACAD SCI H, V56, P283; Robertson MP, 2010, DIVERS DISTRIB, V16, P363, DOI 10.1111/j.1472-4642.2010.00639.x; Robinson N, 2014, ECOL MODEL, V281, P15, DOI 10.1016/j.ecolmodel.2014.01.022; Rouquette JR, 2013, DIVERS DISTRIB, V19, P1429, DOI 10.1111/ddi.12120; Rutz C, 2008, J ANIM ECOL, V77, P1008, DOI 10.1111/j.1365-2656.2008.01420.x; Santos CD, 2010, ACTA OECOL, V36, P166, DOI 10.1016/j.actao.2009.11.008; Sekercioglu CH, 2012, BIOL CONSERV, V151, P69, DOI 10.1016/j.biocon.2011.10.024; Severns PM, 2008, ANIM CONSERV, V11, P476, DOI 10.1111/j.1469-1795.2008.00203.x; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Shwartz A, 2008, LANDSCAPE URBAN PLAN, V84, P219, DOI 10.1016/j.landurbplan.2007.08.003; Shwartz A, 2014, GLOBAL ENVIRON CHANG, V28, P39, DOI 10.1016/j.gloenvcha.2014.06.002; Shwartz A, 2013, BIOL CONSERV, V157, P285, DOI 10.1016/j.biocon.2012.09.009; Silvertown J., 2013, KEY TOPICS CONSERVAT, V2, P127, DOI [10.1002/9781118520178.CH8, DOI 10.1002/9781118520178.CH8]; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Smith AC, 2014, URBAN ECOSYST, V17, P27, DOI 10.1007/s11252-013-0301-8; Soga M, 2014, BIODIVERS CONSERV, V23, P649, DOI 10.1007/s10531-014-0622-9; Soga M, 2012, ECOL RES, V27, P265, DOI 10.1007/s11284-011-0896-2; Sorace A, 2010, BIODIVERS CONSERV, V19, P205, DOI 10.1007/s10531-009-9716-1; Strohbach MW, 2013, LANDSCAPE URBAN PLAN, V114, P69, DOI 10.1016/j.landurbplan.2013.02.007; Suhonen J, 2009, ECOSCIENCE, V16, P502, DOI 10.2980/16-4-3280; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Sumasgutner P, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-48; Tennekes M., 2015, TREEMAP TREEMAP VISU; Theobald EJ, 2015, BIOL CONSERV, V181, P236, DOI 10.1016/j.biocon.2014.10.021; Trulio LA, 2008, J WILDLIFE MANAGE, V72, P1775, DOI 10.2193/2007-014; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; Tulloch AIT, 2012, EMU, V112, P313, DOI 10.1071/MU12009; Turner WR, 2006, ECOL SOC, V11; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; van Swaay CAM, 2008, BIODIVERS CONSERV, V17, P3455, DOI 10.1007/s10531-008-9491-4; Williams MR, 2011, J INSECT CONSERV, V15, P37, DOI 10.1007/s10841-010-9307-1; Yaukey PH, 2010, GEOGR REV, V100, P263, DOI 10.1111/j.1931-0846.2010.00026.x; Zipperer WC, 2000, ECOL APPL, V10, P685, DOI 10.2307/2641038	114	20	23	6	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156425	10.1371/journal.pone.0156425	http://dx.doi.org/10.1371/journal.pone.0156425			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285581	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000012
J	Dbara, S; Haworth, M; Emiliani, G; Ben Mimoun, M; Gomez-Cadenas, A; Centritto, M				Dbara, Soumaya; Haworth, Matthew; Emiliani, Giovani; Ben Mimoun, Mehdi; Gomez-Cadenas, Aurelio; Centritto, Mauro			Partial Root-Zone Drying of Olive (Olea europaea var. 'Chetoui') Induces Reduced Yield under Field Conditions	PLOS ONE			English	Article							REGULATED DEFICIT IRRIGATION; LEAF GAS-EXCHANGE; WATER-USE; ABSCISIC-ACID; STOMATAL CONTROL; PROLINE ACCUMULATION; DIFFUSIONAL LIMITATIONS; PHOTOSYNTHETIC CAPACITY; MESOPHYLL CONDUCTANCE; HYDRAULIC CONTROL	The productivity of olive trees in arid and semi-arid environments is closely linked to irrigation. It is necessary to improve the efficiency of irrigation techniques to optimise the amount of olive fruit produced in relation to the volume of water used. Partial root-zone drying (PRD) is a water saving irrigation technique that theoretically allows the production of a root-to shoot signal that modifies the physiology of the above-ground parts of the plant; specifically reducing stomatal conductance (g(s)) and improving water use efficiency (WUE). Partial root zone drying has been successfully applied under field conditions to woody and non-woody crops; yet the few previous trials with olive trees have produced contrasting results. Thirty year-old olive trees (Olea europaea 'var. Chetoui') in a Tunisian grove were exposed to four treatments from May to October for three-years: 'control' plants received 100% of the potential evapotranspirative demand (ETc) applied to the whole root-zone; 'PRD100' were supplied with an identical volume of water to the control plants alternated between halves of the root-zone every ten-days; 'PRD50' were given 50% of ETc to half of the root-system, and; 'rain-fed' plants received no supplementary irrigation. Allowing part of the root-zone to dry resulted in reduced vegetative growth and lower yield: PRD100 decreased yield by similar to 47% during productive years. During the less productive years of the alternate bearing cycle, irrigation had no effect on yield; this suggests that withholding of water during 'off-years' may enhance the effectiveness of irrigation over a two-year cycle. The amount and quality of oil within the olive fruit was unaffected by the irrigation treatment. Photosynthesis declined in the PRD50 and rain-fed trees due to greater diffusive limitations and reduced biochemical uptake of CO2. Stomatal conductance and the foliar concentration of abscisic acid (ABA) were not altered by PRD100 irrigation, which may indicate the absence of a hormonal root to-shoot signal. Rain-fed and PRD50 treatments induced increased stem water potential and increased foliar concentrations of ABA, proline and soluble sugars. The stomata of the olive trees were relatively insensitive to super-ambient increases in [CO2] and higher [ABA]. These characteristics of 'hydro-passive' stomatal behaviour indicate that the 'Chetoui' variety of olive tree used in this study lacks the physiological responses required for the successful exploitation of PRD techniques to increase yield and water productivity. Alternative irrigation techniques such as partial deficit irrigation may be more suitable for 'Chetour' olive production.	[Dbara, Soumaya] Ctr Reg Rech Hort & Agr Biol, BP57, Chott Mariem 4042, Tunisia; [Haworth, Matthew; Emiliani, Giovani; Centritto, Mauro] CNR, IVALSA, Natl Res Council, Trees & Timber Inst, Via Madonna Piano 10, I-50019 Sesto Fiorentino, FI, Italy; [Ben Mimoun, Mehdi] Inst Natl Agron Tunisie, 43 Ave Charles Nicolle, Tunis 1082, Tunisia; [Gomez-Cadenas, Aurelio] Univ Jaume 1, Dept Ciencias Agr & Medio Nat, Campus Riu Sec, E-12071 Castellon de La Plana, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR); Universite de Carthage; Universitat Jaume I	Centritto, M (corresponding author), CNR, IVALSA, Natl Res Council, Trees & Timber Inst, Via Madonna Piano 10, I-50019 Sesto Fiorentino, FI, Italy.	mauro.centritto@cnr.it	Haworth, Matthew/B-7817-2013; Gomez-Cadenas, Aurelio/K-6084-2012; Mimoun, Mehdi Ben/AAI-9156-2020; Emiliani, Giovanni/G-5023-2016	Gomez-Cadenas, Aurelio/0000-0002-4598-2664; Mimoun, Mehdi Ben/0000-0002-3379-8229; Emiliani, Giovanni/0000-0002-1264-8002; Haworth, Matthew/0000-0002-3225-6620	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN "PRO-ROOT"; Progetto Premiale "Aqua"; Marie Curie IEF [2010-275626]	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN "PRO-ROOT"; Progetto Premiale "Aqua"; Marie Curie IEF(European Commission)	MC acknowledges funding from the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN 2010-2011 "PRO-ROOT" and Progetto Premiale 2012 "Aqua". MH acknowledges funding from a Marie Curie IEF (2010-275626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN 2010-2011 "PRO-ROOT" and Progetto Premiale 2012 "Aqua". MH acknowledges funding from a Marie Curie IEF (2010-275626). We are grateful to Dr Mohamed Ghrab (Olive Tree Institute) for technical assistance and scientific discussion. The comments of Georgios Koubouris (Hellenic Agricultural Organization) and two anonymous reviewers significantly improved this manuscript.	Aganchich B, 2008, GRASAS ACEITES, V59, P225; Aganchich B, 2007, PLANT BIOSYST, V141, P252, DOI 10.1080/11263500701401893; Aganchich B., 2013, Journal of Agricultural Science and Technology, B, V3, P344; Aganchich B, 2009, TREE PHYSIOL, V29, P685, DOI 10.1093/treephys/tpp012; Allen RG, 2006, AGR WATER MANAGE, V81, P1, DOI 10.1016/j.agwat.2005.03.007; Antolin MC, 2006, AUST J GRAPE WINE R, V12, P13, DOI 10.1111/j.1755-0238.2006.tb00039.x; Aparicio R., 2013, HDB OLIVE OIL ANAL P, P590; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BLUM A, 1976, CROP SCI, V16, P428, DOI 10.2135/cropsci1976.0011183X001600030030x; BOYER JS, 1970, PLANT PHYSIOL, V46, P233, DOI 10.1104/pp.46.2.233; Brodribb TJ, 2011, SCIENCE, V331, P582, DOI 10.1126/science.1197985; Centritto M, 2005, AGR ECOSYST ENVIRON, V106, P303, DOI 10.1016/j.agee.2004.10.016; Centritto M, 2003, PLANT CELL ENVIRON, V26, P585, DOI 10.1046/j.1365-3040.2003.00993.x; Centritto M, 2009, J EXP BOT, V60, P2325, DOI 10.1093/jxb/erp123; Connor DJ, 2005, AUST J AGR RES, V56, P1181, DOI 10.1071/AR05169; Cowan I. R., 1977, Advances in Botanical Research, V4, P117, DOI 10.1016/S0065-2296(08)60370-5; Davies WJ, 2002, NEW PHYTOL, V153, P449, DOI 10.1046/j.0028-646X.2001.00345.x; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; Diaz-Espejo A, 2007, PLANT CELL ENVIRON, V30, P922, DOI 10.1111/j.1365-3040.2007.001686.x; dos Santos MR, 2014, REV BRAS ENG AGR AMB, V18, P899, DOI 10.1590/1807-1929/agriambi.v18n09p899-907; Dry P, 1999, 3 INT S IRR HORT CRO, P537; Dry P. R., 1998, Australian Journal of Grape and Wine Research, V4, P140, DOI 10.1111/j.1755-0238.1998.tb00143.x; Duarte F, 2008, J ENVIRON MANAGE, V89, P86, DOI 10.1016/j.jenvman.2007.05.024; EC. European Commission, 2012, DIR GEN AGR RUR DEV; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fernandez JE, 2006, PLANT SOIL, V284, P273, DOI 10.1007/s11104-006-0045-9; Fernandez JE, 1997, PLANT SOIL, V190, P179, DOI 10.1023/A:1004293026973; Fernandez JE, 2003, AGRONOMIE, V23, P545, DOI 10.1051/agro:2003031; Fernandez-Escobar R, 1999, SCI HORTIC-AMSTERDAM, V82, P25, DOI 10.1016/S0304-4238(99)00045-X; Flexas J, 2013, PHOTOSYNTH RES, V117, P45, DOI 10.1007/s11120-013-9844-z; Fuchs EE, 1996, PLANT CELL ENVIRON, V19, P1091, DOI 10.1111/j.1365-3040.1996.tb00216.x; Galan C, 2008, AGRON J, V100, P98, DOI 10.2134/agronj2006.0345; Ghrab M, 2013, AGR WATER MANAGE, V123, P1, DOI 10.1016/j.agwat.2013.03.007; Giday H, 2014, J EXP BOT, V65, P4361, DOI 10.1093/jxb/eru216; Gomez-Cadenas A, 2002, PHYTOCHEM ANALYSIS, V13, P228, DOI 10.1002/pca.640; Greven M, 2009, AGR WATER MANAGE, V96, P1525, DOI 10.1016/j.agwat.2009.06.002; Grierson CS, 2011, NEW PHYTOL, V192, P6, DOI 10.1111/j.1469-8137.2011.03859.x; Gucci R, 2007, J HORTIC SCI BIOTECH, V82, P648, DOI 10.1080/14620316.2007.11512286; Guerfel M, 2009, SCI HORTIC-AMSTERDAM, V119, P257, DOI 10.1016/j.scienta.2008.08.006; Gutierrez F, 2001, J SCI FOOD AGR, V81, P1463, DOI 10.1002/jsfa.958; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Haworth M, 2015, AM J BOT, V102, P677, DOI 10.3732/ajb.1400508; Haworth M, 2013, OECOLOGIA, V171, P71, DOI 10.1007/s00442-012-2406-9; Holbrook NM, 2002, J EXP BOT, V53, P1503, DOI 10.1093/jexbot/53.373.1503; Hutton R., 2000, Farmers' Newsletter, Horticulture, P47; Hutton RJ, 2007, AUST J EXP AGR, V47, P71, DOI 10.1071/EA05233; Iniesta F, 2009, EUR J AGRON, V30, P258, DOI 10.1016/j.eja.2008.12.004; Kalua CM, 2007, FOOD CHEM, V100, P273, DOI 10.1016/j.foodchem.2005.09.059; Killi D, 2014, INT BIODETER BIODEGR, V94, P48, DOI 10.1016/j.ibiod.2014.06.019; Koyama K, 2009, AM NAT, V173, P640, DOI 10.1086/597604; Laisk A.K., 1977, KINETICS PHOTOSYNTHE; Lauteri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109054; Lavee S, 2007, SCI HORTIC-AMSTERDAM, V112, P156, DOI 10.1016/j.scienta.2006.12.017; Leib BG, 2006, IRRIGATION SCI, V24, P85, DOI 10.1007/s00271-005-0013-9; Liu FL, 2005, AUST J AGR RES, V56, P1245, DOI 10.1071/AR05062; Liu FL, 2006, J EXP BOT, V57, P3727, DOI 10.1093/jxb/erl131; LONG SP, 1991, PLANT CELL ENVIRON, V14, P729, DOI 10.1111/j.1365-3040.1991.tb01439.x; Mailer RJ, 2005, OLIVE HARVEST HARVES; Marino G, 2014, ENVIRON EXP BOT, V99, P43, DOI 10.1016/j.envexpbot.2013.10.008; McAdam SAM, 2011, J EXP BOT, V62, P195, DOI 10.1093/jxb/erq260; Mizokami Y, 2015, PLANT CELL ENVIRON, V38, P388, DOI 10.1111/pce.12394; Morales-Sillero A, 2013, AGR WATER MANAGE, V123, P79, DOI 10.1016/j.agwat.2013.03.008; Moriana A, 2003, J AM SOC HORTIC SCI, V128, P425, DOI 10.21273/JASHS.128.3.0425; Morison JIL, 2008, PHILOS T R SOC B, V363, P639, DOI 10.1098/rstb.2007.2175; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Panigrahi P, 2013, IRRIG DRAIN, V62, P67, DOI 10.1002/ird.1719; Panigrahi P, 2013, INT J PLANT PROD, V7, P33; Parvizi H, 2014, AGR WATER MANAGE, V146, P45, DOI 10.1016/j.agwat.2014.07.005; Patakas A, 2002, PLANT SCI, V163, P361, DOI 10.1016/S0168-9452(02)00140-1; Quiroga S, 2009, AGR SYST, V101, P91, DOI 10.1016/j.agsy.2009.03.006; References IOC, 2014, INT OL COUNC WORLD O; Reuveni J, 1997, ANN BOT-LONDON, V80, P539, DOI 10.1006/anbo.1997.0489; Robyt JF, 1987, BIOCH TECHNIQUES THE, p[xvi, 407]; Ruehr NK, 2009, NEW PHYTOL, V184, P950, DOI 10.1111/j.1469-8137.2009.03044.x; Sahin U, 2014, CHIL J AGR RES, V74, P302, DOI 10.4067/S0718-58392014000300008; Salvador MD, 2001, FOOD CHEM, V73, P45, DOI 10.1016/S0308-8146(00)00276-4; Sampathkumar T, 2014, EXP AGR, V50, P407, DOI 10.1017/S0014479713000598; Schofield P, 2001, ANIM FEED SCI TECH, V91, P21, DOI 10.1016/S0377-8401(01)00228-0; Sezen SM, 2011, IRRIG DRAIN, V60, P499, DOI 10.1002/ird.607; SIDDIQUE KHM, 1989, FIELD CROP RES, V21, P59, DOI 10.1016/0378-4290(89)90041-5; Sofo A, 2004, PHYSIOL PLANTARUM, V121, P58, DOI 10.1111/j.0031-9317.2004.00294.x; Sun PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105165; Talluto G, 2008, AUST J AGR RES, V59, P785, DOI 10.1071/AR07458; TARDIEU F, 1992, PLANT PHYSIOL, V98, P540, DOI 10.1104/pp.98.2.540; Tattini M, 1997, PLANT SOIL, V197, P87, DOI 10.1023/A:1004241628878; Tazoe Y, 2015, PLANT CELL ENVIRON, V38, P385, DOI 10.1111/pce.12437; Tomimatsu H, 2012, OECOLOGIA, V169, P869, DOI 10.1007/s00442-012-2256-5; TREJO CL, 1991, J EXP BOT, V42, P1507, DOI 10.1093/jxb/42.12.1507; TSIMIDOU M, 1992, FOOD CHEM, V45, P141, DOI 10.1016/0308-8146(92)90025-W; Uceda M, 1975, EPOCAS RECOLECCION E; VERNON LP, 1960, ANAL CHEM, V32, P1144, DOI 10.1021/ac60165a029; Wahbi S, 2005, AGR ECOSYST ENVIRON, V106, P289, DOI 10.1016/j.agee.2004.10.015; Wilkinson S, 1997, PLANT PHYSIOL, V113, P559, DOI 10.1104/pp.113.2.559; Wolf JP, 1968, MANUAL ANAL CORPS GR; WWAP U, 2012, WORLD WAT ASS PROGR; Yao C, 2001, PLANT CELL ENVIRON, V24, P227, DOI 10.1111/j.1365-3040.2001.00667.x; Yin XY, 2011, J EXP BOT, V62, P3489, DOI 10.1093/jxb/err038	98	26	26	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157089	10.1371/journal.pone.0157089	http://dx.doi.org/10.1371/journal.pone.0157089			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315081	Green Published, gold, Green Submitted			2022-12-27	WOS:000378030000012
J	Selvey, LA; Slimings, C; Joske, DJL; Riley, TV				Selvey, Linda A.; Slimings, Claudia; Joske, David J. L.; Riley, Thomas V.			Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study	PLOS ONE			English	Article							CELL TRANSPLANT RECIPIENTS; PCR RIBOTYPE 027; RISK-FACTORS; DISEASE; OUTCOMES; AUSTRALIA; DIARRHEA; EPIDEMIOLOGY; VANCOMYCIN; MORBIDITY	Objectives Identify risk factors for Clostridium difficile infection (CDI) and assess CDI outcomes among Australian patients with a haematological malignancy. Methods A retrospective cohort study involving all patients admitted to hospitals in Western Australia with a haematological malignancy from July 2011 to June 2012. Hospital admission data were linked with all hospital investigated CDI case data. Potential risk factors were assessed by logistic regression. The risk of death within 60 and 90 days of CDI was assessed by Cox Proportional Hazards regression. Results There were 2085 patients of whom 65 had at least one CDI. Twenty percent of CDI cases were either community-acquired, indeterminate source or had only single-day admissions in the 28 days prior to CDI. Using logistic regression, having acute lymphocytic leukaemia, neutropenia and having had bacterial pneumonia or another bacterial infection were associated with CDI. CDI was associated with an increased risk of death within 60 and 90 days post CDI, but only two deaths had CDI recorded as an antecedent factor. Ribotyping information was available for 33 of the 65 CDIs. There were 19 different ribotypes identified. Conclusions Neutropenia was strongly associated with CDI. While having CDI is a risk factor for death, in many cases it may not be a direct contributor to death but may reflect patients having higher morbidity. A wide variety of C. difficile ribotypes were found and community-acquired infection may be under-estimated in these patients.	[Selvey, Linda A.] Curtin Univ, Sch Publ Hlth, GPO Box U1987, Perth, WA 6845, Australia; [Slimings, Claudia; Riley, Thomas V.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Joske, David J. L.] Sir Charles Gairdner Hosp, Dept Haematol, Nedlands, WA 6009, Australia; [Joske, David J. L.] Univ Western Australia, Sch Med, Perth, WA 6009, Australia; [Riley, Thomas V.] PathWest Lab Med, Dept Microbiol, Nedlands, WA, Australia	Curtin University; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Selvey, LA (corresponding author), Curtin Univ, Sch Publ Hlth, GPO Box U1987, Perth, WA 6845, Australia.	linda.selvey@curtin.edu.au	Selvey, Linda/B-8473-2017; Slimings, Claudia/AAE-6550-2019	Selvey, Linda/0000-0001-8493-0974; Slimings, Claudia/0000-0001-7988-1186	Sanofi Pasteur	Sanofi Pasteur	Sanofi Pasteur funded the data linkage component of the study. The funders had no role in the study design, data collection and analysis or decision to publish. The funders did review the manuscript prior to publication. www.sanofipasteur.us.	Alonso CD, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0414-0; Apostolopoulou E, 2011, EUR J ONCOL NURS, V15, P404, DOI 10.1016/j.ejon.2010.11.002; Arango JI, 2006, BONE MARROW TRANSPL, V37, P517, DOI 10.1038/sj.bmt.1705269; Arthur C, 2012, 54TH AMERICAN SOCIET; Australian Commission on Safety and Quality in Healthcare, 2013, IMPL GUID SURV CLOST; Australian Institute of Health and Welfare, 2016, METEOR MET ONL REG; Bradstock KF, 2005, BLOOD, V105, P481, DOI 10.1182/blood-2004-01-0326; Callejas-Diaz A, 2014, CURR HEMATOL MALIG R, V9, P85, DOI 10.1007/s11899-013-0193-y; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chopra T, 2010, EXPERT REV ANTI-INFE, V8, P1113, DOI [10.1586/eri.10.95, 10.1586/ERI.10.95]; Clements ACA, 2010, LANCET INFECT DIS, V10, P395, DOI 10.1016/S1473-3099(10)70080-3; Dial S, 2006, CAN MED ASSOC J, V175, P745, DOI 10.1503/cmaj.060284; Gifford AH, 2006, EUR J CLIN MICROBIOL, V25, P751, DOI 10.1007/s10096-006-0220-1; Gorschluter M, 2001, CLIN INFECT DIS, V33, P786, DOI 10.1086/322616; Gu SL, 2015, J MED MICROBIOL, V64, P209, DOI 10.1099/jmm.0.000028; Guddati AK, 2014, INT J HEMATOL, V99, P758, DOI 10.1007/s12185-014-1577-z; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Kamboj M, 2014, BIOL BLOOD MARROW TR, V20, P1626, DOI 10.1016/j.bbmt.2014.06.025; Kuijper E.J., 2008, EUROSURVEILLANCE, V13, P1; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Luo RH, 2015, INFECT CONT HOSP EP, V36, P794, DOI 10.1017/ice.2015.54; McCann R, 2014, HEALTHCARE INFECT SU; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; Moorin RE, 2010, EMERG INFECT DIS, V16, P1440, DOI 10.3201/eid1609.081665; ONeill GL, 1996, ANAEROBE, V2, P205, DOI 10.1006/anae.1996.0028; Parmar SR, 2014, J ONCOL PHARM PRACT, V20, P172, DOI 10.1177/1078155213490004; Peterson A, 2014, HEALTHCARE INFECT SU; RAMPLING A, 1985, J CLIN PATHOL, V38, P445, DOI 10.1136/jcp.38.4.445; Richards M, 2011, MED J AUSTRALIA, V194, P369, DOI 10.5694/j.1326-5377.2011.tb03012.x; Riley TV, 2009, MED J AUSTRALIA, V190, P706, DOI 10.5694/j.1326-5377.2009.tb02644.x; Schalk E, 2010, ANN HEMATOL, V89, P9, DOI 10.1007/s00277-009-0772-0; Slimings C, 2014, MED J AUSTRALIA, V200, P272, DOI 10.5694/mja13.11153; Stagg V, 2006, CHARLSON STATA MODUL; Trifilio SM, 2013, BIOL BLOOD MARROW TR, V19, P405, DOI 10.1016/j.bbmt.2012.10.030; Vehreschild MJ, 2014, BIOL BLOOD MARROW TR; Yoon YK, 2014, SUPPORT CARE CANCER, V22, P2039, DOI 10.1007/s00520-014-2174-7; Zacharioudakis Ioannis M, 2014, Biol Blood Marrow Transplant, V20, P1650, DOI 10.1016/j.bbmt.2014.06.001	37	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157839	10.1371/journal.pone.0157839	http://dx.doi.org/10.1371/journal.pone.0157839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314498	Green Published, gold, Green Submitted			2022-12-27	WOS:000378030000058
J	Veluchamy, JP; Spanholtz, J; Tordoir, M; Thijssen, VL; Heideman, DAM; Verheul, HMW; de Gruijl, TD; van der Vliet, HJ				Veluchamy, John Pradeep; Spanholtz, Jan; Tordoir, Marleen; Thijssen, Victor L.; Heideman, Danielle A. M.; Verheul, Henk M. W.; de Gruijl, Tanja D.; van der Vliet, Hans J.			Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DEPENDENT CELLULAR CYTOTOXICITY; GROWTH-FACTOR RECEPTOR; ANTI-EGFR THERAPY; MONOCLONAL-ANTIBODY; KRAS MUTATIONS; COLON-CANCER; LUNG-CANCER; HLA-E; POLYMORPHISMS	The ability of Natural Killer (NK) cells to kill tumor targets has been extensively studied in various hematological malignancies. However, NK cell therapy directed against solid tumors is still in early development. Epidermal Growth Factor Receptor (EGFR) targeted therapies using monoclonal antibodies (mAbs) such as cetuximab and panitumumab are widely used for the treatment of metastatic colorectal cancer (mCRC). Still, the clinical efficacy of this treatment is hampered by mutations in RAS gene, allowing tumors to escape from anti-EGFR mAb therapy. It is well established that NK cells kill tumor cells by natural cytotoxicity and can in addition be activated upon binding of IgG(1) mAbs through Fc receptors (CD16/Fc gamma RIIIa) on their surface, thereby mediating antibody dependent cellular cytotoxicity (ADCC). In the current study, activated Peripheral Blood NK cells (PBNK) were combined with anti-EGFR mAbs to study their effect on the killing of EGFR(+/-) cancer cell lines, including those with RAS mutations. In vitro cytotoxicity experiments using colon cancer primary tumors and cell lines COLO320, Caco-2, SW620, SW480 and HT-29, demonstrated that PBNK cells are cytotoxic for a range of tumor cells, regardless of EGFR, RAS or BRAF status and at low E:T ratios. Cetuximab enhanced the cytotoxic activity of NK cells on EGFR(+) tumor cells (either RAS(wt), RAS(mut) or BRAF(mut)) in a CD16 dependent manner, whereas it could not increase the killing of EGFR(-) COLO320. Our study provides a rationale to strengthen NK cell immunotherapy through a combination with cetuximab for RAS and BRAF mutant mCRC patients.	[Veluchamy, John Pradeep; Thijssen, Victor L.; Verheul, Henk M. W.; de Gruijl, Tanja D.; van der Vliet, Hans J.] Vrije Univ Amsterdam, Ctr Canc, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Heideman, Danielle A. M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Veluchamy, John Pradeep; Spanholtz, Jan; Tordoir, Marleen] Glycostem Therapeut, Oss, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van der Vliet, HJ (corresponding author), Vrije Univ Amsterdam, Ctr Canc, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.	jj.vandervliet@vumc.nl	Verheul, Henk/V-6462-2019; Verheul, Henk M.W./J-9775-2013; Thijssen, Victor LJL/B-2792-2009	Verheul, Henk/0000-0001-5981-922X; Thijssen, Victor LJL/0000-0002-6146-1842; Veluchamy, John/0000-0002-5681-1860; Spanholtz, Jan/0000-0001-7152-6956; van der Vliet, Hans/0000-0001-7846-8613	Marie Curie FP7 NATURIMMUN Network; Glycostem; Marie Curie FP7 ITN NATURIMMUN network	Marie Curie FP7 NATURIMMUN Network; Glycostem; Marie Curie FP7 ITN NATURIMMUN network	This work was supported by the Marie Curie FP7 NATURIMMUN Network (http://www.naturimmun.eu/) to JV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Glycostem) provided support in the form of salaries for authors: JS, JV, MT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contribution' section.; The authors thank all voluntary blood donors, Charlotte Huijts and Roeland Lameris of VUmc Cancer Center Amsterdam for their help in collecting blood and Martijn Bogaarts for technical assistance. This work was financially supported by Marie Curie FP7 ITN NATURIMMUN network.	Abdullah N, 1999, CANCER IMMUNOL IMMUN, V48, P517, DOI 10.1007/s002620050600; Arai S, 2008, CYTOTHERAPY, V10, P625, DOI 10.1080/14653240802301872; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Binyamin L, 2008, J IMMUNOL, V180, P6392, DOI 10.4049/jimmunol.180.9.6392; Calemma R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-232; Capdevila J, 2009, CANCER TREAT REV, V35, P354, DOI 10.1016/j.ctrv.2009.02.001; Carrega P, 2008, CANCER-AM CANCER SOC, V112, P863, DOI 10.1002/cncr.23239; Cheng M, 2013, CELL MOL IMMUNOL, V10, P230, DOI 10.1038/cmi.2013.10; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Er TK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/591867; Geller MA, 2011, IMMUNOTHERAPY-UK, V3, P1445, DOI [10.2217/IMT.11.131, 10.2217/imt.11.131]; Gulubova M, 2009, APMIS, V117, P870, DOI 10.1111/j.1600-0463.2009.02547.x; Heideman DAM, 2009, CELL ONCOL, V31, P329, DOI 10.3233/CLO-2009-0489; Heideman DAM, 2012, J MOL DIAGN, V14, P247, DOI 10.1016/j.jmoldx.2012.01.011; Jeong WJ, 2014, WORLD J GASTROENTERO, V20, P9862, DOI 10.3748/wjg.v20.i29.9862; Kjersem JB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-340; Koehl U, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00118; Kurai J, 2007, CLIN CANCER RES, V13, P1552, DOI 10.1158/1078-0432.CCR-06-1726; Kuss I, 2004, CLIN CANCER RES, V10, P3755, DOI 10.1158/1078-0432.CCR-04-0054; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Levy EM, 2008, INT J ONCOL, V32, P633, DOI 10.3892/ijo.32.3.633; Lindenberg JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070237; Lo Monaco E, 2011, NEOPLASIA, V13, P822, DOI 10.1593/neo.101684; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Levy EM, 2009, INNATE IMMUN-LONDON, V15, P91, DOI 10.1177/1753425908101404; Mellor JD, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-1; Menon AG, 2002, LAB INVEST, V82, P1725, DOI 10.1097/01.LAB.0000043124.75633.ED; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Paz-Ares LG, 2011, J CLIN ONCOL, V29, P3783, DOI 10.1200/JCO.2011.34.8888; Pietra G, 2009, INT IMMUNOL, V21, P793, DOI 10.1093/intimm/dxp047; Roberti MP, 2012, BREAST CANCER RES TR, V136, P659, DOI 10.1007/s10549-012-2287-y; Sconocchia G, 2009, NEOPLASIA, V11, P662, DOI 10.1593/neo.09296; Seidel UJE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00076; Shaib W, 2013, J GASTROINTEST ONCOL, V4, P308, DOI 10.3978/j.issn.2078-6891.2013.029; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; VANDENINGH HF, 1987, BRIT J CANCER, V55, P125, DOI 10.1038/bjc.1987.26; Vermorken JB, 1999, LANCET, V353, P345, DOI 10.1016/S0140-6736(98)07186-4; Vincent MD, 2012, CURR ONCOL, V19, pS33, DOI 10.3747/co.19.1149	47	59	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157830	10.1371/journal.pone.0157830	http://dx.doi.org/10.1371/journal.pone.0157830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314237	Green Submitted, Green Published, gold			2022-12-27	WOS:000378030000057
J	Brzoska, AJ; Jensen, SO; Barton, DA; Davies, DS; Overall, RL; Skurray, RA; Firth, N				Brzoska, Anthony J.; Jensen, Slade O.; Barton, Deborah A.; Davies, Danielle S.; Overall, Robyn L.; Skurray, Ronald A.; Firth, Neville			Dynamic Filament Formation by a Divergent Bacterial Actin-Like ParM Protein	PLOS ONE			English	Article							PLASMID-DNA-SEGREGATION; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; IN-VITRO; PSK41; EXPRESSION; SYSTEM; CYTOSKELETON; INSTABILITY	Actin-like proteins (Alps) are a diverse family of proteins whose genes are abundant in the chromosomes and mobile genetic elements of many bacteria. The low-copy-number staphylococcal multiresistance plasmid pSK41 encodes ParM, an Alp involved in efficient plasmid partitioning. pSK41 ParM has previously been shown to form filaments in vitro that are structurally dissimilar to those formed by other bacterial Alps. The mechanistic implications of these differences are not known. In order to gain insights into the properties and behavior of the pSK41 ParM Alp in vivo, we reconstituted the parMRC system in the ectopic rodshaped host, E. coli, which is larger and more genetically amenable than the native host, Staphylococcus aureus. Fluorescence microscopy showed a functional fusion protein, ParM-YFP, formed straight filaments in vivo when expressed in isolation. Strikingly, however, in the presence of ParR and parC, ParM-YFP adopted a dramatically different structure, instead forming axial curved filaments. Time-lapse imaging and selective photobleaching experiments revealed that, in the presence of all components of the parMRC system, ParM-YFP filaments were dynamic in nature. Finally, molecular dissection of the parMRC operon revealed that all components of the system are essential for the generation of dynamic filaments.	[Brzoska, Anthony J.; Jensen, Slade O.; Barton, Deborah A.; Davies, Danielle S.; Overall, Robyn L.; Skurray, Ronald A.; Firth, Neville] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia; [Jensen, Slade O.] Univ Western Sydney, Ingham Inst Appl Med Res, Sch Med, Sydney, NSW 1871, Australia	University of Sydney; Ingham Institute for Applied Medical Research; Western Sydney University	Brzoska, AJ (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.	anthony.brzoska@sydney.edu.au	Barton, Deborah/C-8124-2013	Firth, Neville/0000-0002-5791-7691; Jensen, Slade/0000-0003-4489-589X	National Health and Medical Research Council of Australia [307620, APP1030003]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia Project grants 307620 and APP1030003 to NF and RS (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Health and Medical Research Council of Australia Project grants 307620 and APP1030003.	Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Berg T, 1998, J BACTERIOL, V180, P4350, DOI 10.1128/JB.180.17.4350-4359.1998; Brzoska AJ, 2013, APPL ENVIRON MICROB, V79, P3133, DOI 10.1128/AEM.00144-13; CHANG ACY, 1978, NATURE, V275, P617, DOI 10.1038/275617a0; Derman AI, 2012, J BACTERIOL, V194, P2715, DOI 10.1128/JB.06550-11; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gayathri P, 2012, SCIENCE, V338, P1334, DOI 10.1126/science.1229091; Godfrin-Estevenon AM, 2002, MOL MICROBIOL, V43, P39, DOI 10.1046/j.1365-2958.2002.02735.x; Ingerson-Mahar M, 2012, FEMS MICROBIOL REV, V36, P256, DOI 10.1111/j.1574-6976.2011.00316.x; Kwong SM, 2010, MICROBIOL-SGM, V156, P975, DOI 10.1099/mic.0.038323-0; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; LeBard RJ, 2008, FEMS MICROBIOL LETT, V284, P58, DOI 10.1111/j.1574-6968.2008.01190.x; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Ni L, 2009, NUCLEIC ACIDS RES, V37, P6970, DOI 10.1093/nar/gkp756; Pilhofer M, 2013, CURR OPIN CELL BIOL, V25, P125, DOI 10.1016/j.ceb.2012.10.019; Polka JK, 2014, P NATL ACAD SCI USA, V111, P2176, DOI 10.1073/pnas.1304127111; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; Popp D, 2012, J BIOL CHEM, V287, P21121, DOI 10.1074/jbc.M112.341016; Popp D, 2011, MOL MICROBIOL, V80, P300, DOI 10.1111/j.1365-2958.2011.07599.x; Popp D, 2010, J BIOL CHEM, V285, P10130, DOI 10.1074/jbc.M109.071613; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; Sambrook J., 2001, MOL CLONING LAB MANU; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Weaver KE, 2009, PLASMID, V61, P94, DOI 10.1016/j.plasmid.2008.11.004; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656; Zhu WM, 2013, ANTIMICROB AGENTS CH, V57, P212, DOI 10.1128/AAC.01587-12	36	2	2	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156944	10.1371/journal.pone.0156944	http://dx.doi.org/10.1371/journal.pone.0156944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310470	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800021
J	Orton, S; Coleman, T; Lewis, S; Cooper, S; Jones, LL				Orton, Sophie; Coleman, Tim; Lewis, Sarah; Cooper, Sue; Jones, Laura L.			"I Was a Full Time Proper Smoker": A Qualitative Exploration of Smoking in the Home after Childbirth among Women Who Relapse Postpartum	PLOS ONE			English	Article							PREGNANCY; CHILDREN; CESSATION; BEHAVIOR; MAINTENANCE; PREDICTORS; COTININE; MOTHERS; TRENDS; RISK	Background Many women stop smoking during pregnancy but relapse shortly afterwards, potentially putting their infants at risk of secondhand smoke (SHS) exposure. Women who were able to stop during pregnancy may be a motivated group, receptive to making behaviour changes postpartum to protect their infant from SHS exposure. Understanding more about their experiences of relapse, and if this influences home smoking behaviours and children's exposure to SHS in the home may help to inform intervention development to prevent infant SHS exposure. Methods Guided by interpretative phenomenological methodology we conducted and analysed nine semi-structured interviews with women who quit smoking during pregnancy, but relapsed <= 3 months postpartum. Findings Central to mothers' accounts of their smoking behaviours during pregnancy and postpartum was their desire to be a 'responsible mother'. Mothers described using strategies to protect their infant from SHS exposure, and held strong negative attitudes towards other smoking parents. After relapsing, mothers appeared to reposition themselves as 'social' or 'occasional' smokers rather than 'regular' smokers. Conclusions Findings suggest that interventions to prevent/reduce infants' home SHS exposure should build on mothers' intentions to be responsible parents. As mothers who relapse principally view themselves as 'social' or 'occasional' smokers, interventions that are highlighted as relevant for women with these types of smoking patterns may be more likely to be responded to, and, ultimately, be effective.	[Orton, Sophie; Coleman, Tim; Lewis, Sarah; Cooper, Sue; Jones, Laura L.] Univ Nottingham, UK Ctr Tobacco & Alcohol Studies, Nottingham NG7 2RD, England; [Orton, Sophie; Coleman, Tim; Cooper, Sue] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Lewis, Sarah] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Jones, Laura L.] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Birmingham	Orton, S (corresponding author), Univ Nottingham, UK Ctr Tobacco & Alcohol Studies, Nottingham NG7 2RD, England.; Orton, S (corresponding author), Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England.	Sophie.orton@nottingham.ac.uk	Jones, Laura/AAY-6159-2020; Cooper, Sue/A-7471-2011	Jones, Laura/0000-0002-4018-3855; Orton, Sophie/0000-0002-8577-216X; Cooper, Sue/0000-0002-1994-6395; Coleman, Tim/0000-0002-7303-4805	National Institute for Health Research (NIHR) School for Primary Care Research (NIHR SPCR); NIHR under the Programme Grants for Applied Research programme [RP-PG-0109-10020]; Medical Research Council [MR/K023195/1] Funding Source: researchfish; National Institute for Health Research [SPCR-041, RP-PG-0109-10020] Funding Source: researchfish	National Institute for Health Research (NIHR) School for Primary Care Research (NIHR SPCR)(National Institute for Health Research (NIHR)); NIHR under the Programme Grants for Applied Research programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	SO is funded by the National Institute for Health Research (NIHR) School for Primary Care Research (NIHR SPCR). The NIHR SPCR is a partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham, Oxford, Southampton and University College London. This article presents independent research funded by the NIHR under the Programme Grants for Applied Research programme (RP-PG-0109-10020). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Abrahamsson A, 2005, HEALTH EDUC RES, V20, P367, DOI 10.1093/her/cyg127; Ashford KB, 2009, PUBLIC HEALTH REP, V124, P515, DOI 10.1177/003335490912400408; Baldwin AS, 2006, HEALTH PSYCHOL, V25, P626, DOI 10.1037/0278-6133.25.5.626; Baxter S, 2011, HEALTH EDUC RES, V26, P265, DOI 10.1093/her/cyq092; Brocki JM, 2006, PSYCHOL HEALTH, V21, P87, DOI 10.1080/14768320500230185; Bull L, 2007, J NEONATAL NURS, V13, P100, DOI DOI 10.1016/J.JNN.2007.01.002; Businelle MS, 2013, ANN BEHAV MED, V45, P180, DOI 10.1007/s12160-012-9434-x; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Colman GJ, 2003, AM J PREV MED, V24, P29, DOI 10.1016/S0749-3797(02)00574-3; Coxhead L, 2006, SOCIOL HEALTH ILL, V28, P98, DOI 10.1111/j.1467-9566.2005.00484.x; Dwyer SC., 2009, INT J QUAL METHODS, V8, P54, DOI 10.1177/160940690900800105; FINGERHUT LA, 1990, AM J PUBLIC HEALTH, V80, P541, DOI 10.2105/AJPH.80.5.541; Flemming K, 2013, J ADV NURS, V69, P1023, DOI 10.1111/jan.12066; Godin G, 2005, BRIT J SOC PSYCHOL, V44, P497, DOI 10.1348/014466604X17452; Hajek P, 2001, ADDICTION, V96, P485, DOI 10.1046/j.1360-0443.2001.96348511.x; Harmer C, 2013, NICOTINE TOB RES, V15, P904, DOI 10.1093/ntr/nts221; Haslam C, 2004, HEALTH PSYCHOL, V23, P486, DOI 10.1037/0278-6133.23.5.486; Heppner WL, 2011, HEALTH PSYCHOL, V30, P736, DOI 10.1037/a0025132; Hill L, 2003, HEALTH PROMOT J AUST, V14, P196; Holdsworth C, 2008, SOCIOL HEALTH ILL, V30, P1086, DOI 10.1111/j.1467-9566.2008.01102.x; Holdsworth C, 2007, SOCIOLOGY, V41, P401, DOI 10.1177/0038038507076614; Kahn RS, 2002, AM J PUBLIC HEALTH, V92, P1801, DOI 10.2105/AJPH.92.11.1801; Leas EC, 2014, SMOKERS WHO REPORT S; McBride CM, 2003, HEALTH EDUC RES, V18, P156, DOI 10.1093/her/18.2.156; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, 2012, PREV TOB UYOUTH YO; Nichter M, 2008, QUAL HEALTH RES, V18, P1184, DOI 10.1177/1049732308321738; Notley C, 2015, ADDICTION, V110, P1712, DOI 10.1111/add.13062; Office for National Statistics, 2014, AD SMOK HAB GREAT BR, V2013; Orton S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004915; Pickett KE, 2009, J EPIDEMIOL COMMUN H, V63, P474, DOI 10.1136/jech.2008.082594; Poland B., 2009, Critical Public Health, V19, P203, DOI 10.1080/09581590802395416; Polanska K, 2011, MATERN CHILD HLTH J, V15, P579, DOI 10.1007/s10995-010-0639-y; Prady SL, 2012, MATERN CHILD HLTH J, V16, P1364, DOI 10.1007/s10995-011-0899-1; Reid K, 2005, PSYCHOLOGIST, V18, P20; Robinson J, 2008, INT REV QUAL RES, V1, P173; Robinson J, 2009, HEALTH EDUC RES, V24, P11, DOI 10.1093/her/cym080; Robinson J, 2007, HEALTH PLACE, V13, P894, DOI 10.1016/j.healthplace.2007.03.001; Robinson Jude, 2013, Contemp Drug Probl, V40, P47; Robinson J, 2011, SOCIOL HEALTH ILL, V33, P66, DOI 10.1111/j.1467-9566.2010.01273.x; Sims M, 2010, ADDICTION, V105, P543, DOI 10.1111/j.1360-0443.2009.02805.x; Smith J., 2008, DOING SOCIAL PSYCHOL, P229; Smith JA, 2009, QUAL RES PSYCHOL; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wakefield M, 2000, AM J PREV MED, V19, P188, DOI 10.1016/S0749-3797(00)00197-5; Wilson IS, 2013, HEALTH EDUC RES, V28, P165, DOI 10.1093/her/cys082; Woodby LL, 1999, ADDICTION, V94, P283, DOI 10.1046/j.1360-0443.1999.94228311.x	46	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157525	10.1371/journal.pone.0157525	http://dx.doi.org/10.1371/journal.pone.0157525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27308829	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000378029800091
J	Savage, JR; Pulsipher, A; Rao, NV; Kennedy, TP; Prestwich, GD; Ryan, ME; Lee, WY				Savage, Justin R.; Pulsipher, Abigail; Rao, Narayanam V.; Kennedy, Thomas P.; Prestwich, Glenn D.; Ryan, Maria E.; Lee, Won Yong			A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; PORPHYROMONAS-GINGIVALIS; ANTIBIOTIC-RESISTANCE; INFLAMMATORY RESPONSE; OSTEOCLAST FORMATION; TREPONEMA-DENTICOLA; BONE-RESORPTION; HYALURONIC-ACID; DECOY RECEPTOR	Background Periodontitis is characterized by microbial infection, inflammation, tissue breakdown, and accelerated loss of alveolar bone matrix. Treatment targeting these multiple stages of the disease provides ways to treat or prevent periodontitis. Certain glycosaminoglycans (GAGs) block multiple inflammatory mediators as well as suppress bacterial growth, suggesting that these GAGs may be exploited as a therapeutic for periodontitis. Methods We investigated the effects of a synthetic GAG, GM-0111, on various molecular events associated with periodontitis: growth of Porphyromonas gingivalis (P. gingivalis) and Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans) pathogenic bacteria associated with periodontitis; activation of pro-inflammatory signaling through TLR2 and TLR4 in mouse macrophage RAW 264.7 cells and heterologously expressed HEK 293 cells; osteoclast formation and bone matrix resorption in cultured mouse pre-osteoclasts. Results (1) GM-0111 suppressed the growth of P. gingivalis and A. actinomycetemcomitans even at 1% (w/v) solution. The antibacterial effects of GM-0111 were stronger than hyaluronic acid (HA) or xylitol in P. gingivalis at all concentrations and comparable to xylitol in A. actinomycetemcomitans at >= 2% (w/v) solution. We also observed that GM-0111 suppressed biofilm formation of P. gingivalis and these effects were much stronger than HA. (2) GM-0111 inhibited TLR-mediated pro-inflammatory cellular signaling both in macrophage and HEK 293 cells with higher selectivity for TLR2 than TLR4 (IC50 of 1-10 ng/mL vs. > 100 mu g/mL, respectively). (3) GM-0111 blocked RANKL-induced osteoclast formation (as low as 300 ng/mL) and bone matrix resorption. While GM-0111 showed high affinity binding to RANKL, it did not interfere with RANKL/RANK/NF-kappa B signaling, suggesting that GM-0111 inhibits osteoclast formation by a RANKL-RANK-independent mechanism. Conclusions We report that GM-0111 inhibits multiple molecular events involved in periodontitis, spanning from the early pro-inflammatory TLR signaling, to pathways activated at the later stage component of bone loss.	[Savage, Justin R.; Pulsipher, Abigail; Rao, Narayanam V.; Kennedy, Thomas P.; Prestwich, Glenn D.; Lee, Won Yong] GlycoMira Therapeut Inc, Salt Lake City, UT 84108 USA; [Kennedy, Thomas P.] Tulane Univ, Sch Med, Pulm Dis Crit Care & Environm Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA; [Prestwich, Glenn D.] Univ Utah, Ctr Therapeut Biomat, Salt Lake City, UT 84108 USA; [Ryan, Maria E.] SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA	Tulane University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lee, WY (corresponding author), GlycoMira Therapeut Inc, Salt Lake City, UT 84108 USA.	lee.wonyong@glycomira.com		Lee, Won Yong/0000-0001-7915-1829	National Institute of Dental and Craniofacial Research [5R44DE022216, 1R43DE024024]; GlycoMira Therapeutics, Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R43DE024024, R44DE022216, R44DE024024] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); GlycoMira Therapeutics, Inc.; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant numbers 5R44DE022216 (WYL, GDP, MER) and 1R43DE024024 (WYL) from the National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GlycoMira Therapeutics, Inc. provided support in the form of salaries for authors [JRS, AP, WYL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acharya A, 2013, AM J EPIDEMIOL, V177, P700, DOI 10.1093/aje/kws293; Alatalo SL, 2000, CLIN CHEM, V46, P1751; Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502; [Anonymous], 2015, STATSREF STAT ANAL H; Applequist SE, 2002, INT IMMUNOL, V14, P1065, DOI 10.1093/intimm/dxf069; Ardila CM, 2010, J PERIODONTAL RES, V45, P557, DOI 10.1111/j.1600-0765.2010.01274.x; Ardizzoni A, 2011, J MATER SCI-MATER M, V22, P2329, DOI 10.1007/s10856-011-4408-2; Ariyoshi W, 2005, J BIOL CHEM, V280, P18967, DOI 10.1074/jbc.M412740200; Ariyoshi W, 2008, J CELL BIOCHEM, V103, P1707, DOI 10.1002/jcb.21559; Bodet C, 2007, PATHOL BIOL, V55, P154, DOI 10.1016/j.patbio.2006.07.045; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Campo GM, 2012, BIOFACTORS, V38, P69, DOI 10.1002/biof.202; Campo GM, 2009, ARCH BIOCHEM BIOPHYS, V491, P7, DOI 10.1016/j.abb.2009.09.017; Chen B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/731039; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chhina Shivjot, 2015, J Contemp Dent Pract, V16, P474; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Crotti T, 2003, J PERIODONTAL RES, V38, P380, DOI 10.1034/j.1600-0765.2003.00615.x; Deo Vikas, 2010, Dent Today, V29, P60; Di Paola R, 2007, J CLIN PERIODONTOL, V34, P95, DOI 10.1111/j.1600-051X.2006.01016.x; Ebid Rainer, 2014, ISRN Nephrol, V2014, P714081, DOI 10.1155/2014/714081; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Endo Y, 2010, J PERIODONTOL, V81, P520, DOI 10.1902/jop.2009.090574; Enersen M, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20265; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Giannopoulou C, 2012, ACTA ODONTOL SCAND, V70, P629, DOI 10.3109/00016357.2011.645064; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Gunasekera TS, 2000, APPL ENVIRON MICROB, V66, P1228, DOI 10.1128/AEM.66.3.1228-1232.2000; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hasan M, 1999, J IMMUNOL, V162, P1064; Hirabara S, 2013, BIOCHEM BIOPH RES CO, V430, P519, DOI 10.1016/j.bbrc.2012.12.003; Iwamoto K, 2004, BIOCHEM BIOPH RES CO, V325, P229, DOI 10.1016/j.bbrc.2004.10.024; Jeganathan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104498; Jung SM, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/137468; Jungermann GB, 2011, J ENDODONT, V37, P1337, DOI 10.1016/j.joen.2011.06.028; Kelk P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.6; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; Khan G, 2016, AAPS PHARMSCITECH, V17, P1312, DOI 10.1208/s12249-015-0466-y; Kim KW, 2007, IMMUNOL LETT, V110, P54, DOI 10.1016/j.imlet.2007.03.004; Krajewski AC, 2009, APMIS, V117, P746, DOI 10.1111/j.1600-0463.2009.02532.x; KREMER M, 1995, J CELL BIOCHEM, V57, P271, DOI 10.1002/jcb.240570211; Kumar PS, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00035; Lee WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077854; Ling L, 2010, J CELL BIOCHEM, V109, P1222, DOI 10.1002/jcb.22506; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Maezono H, 2011, ANTIMICROB AGENTS CH, V55, P5887, DOI 10.1128/AAC.05169-11; Makimura Y, 2006, CLIN EXP IMMUNOL, V146, P159, DOI 10.1111/j.1365-2249.2006.03182.x; Mombelli A, 2016, J PERIODONTOL, V87, P539, DOI 10.1902/jop.2015.150494; Mori Y, 2003, ORAL MICROBIOL IMMUN, V18, P54, DOI 10.1034/j.1399-302X.2003.180109.x; Muia C, 2006, EUR J PHARMACOL, V539, P205, DOI 10.1016/j.ejphar.2006.03.072; Mummery RS, 2000, J IMMUNOL, V165, P5671, DOI 10.4049/jimmunol.165.10.5671; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; Myneni SR, 2013, IMMUNOL INVEST, V42, P519, DOI 10.3109/08820139.2013.822761; Mysak J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/476068; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nibali L, 2013, J DENT RES, V92, P868, DOI 10.1177/0022034513501878; Noguchi N, 2005, APPL ENVIRON MICROB, V71, P8738, DOI 10.1128/AEM.71.12.8738-8743.2005; Nussbaum G, 2009, INFECT IMMUN, V77, P3939, DOI 10.1128/IAI.00488-09; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Page RC, 2007, ORAL MICROBIOL IMMUN, V22, P162, DOI 10.1111/j.1399-302X.2007.00337.x; Paquette DW, 2000, PERIODONTOL 2000, V24, P239, DOI 10.1034/j.1600-0757.2000.2240112.x; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Pirnazar P, 1999, J PERIODONTOL, V70, P370, DOI 10.1902/jop.1999.70.4.370; Pollari S, 2012, MOL CANCER RES, V10, P597, DOI 10.1158/1541-7786.MCR-11-0482; Prestwich GD, 2012, Alkylated semi synthetic glycosaminoglycosan ethers, and methods for making and using thereof, Patent No. [US 8329673 B2, 8329673]; Priyanka N, 2015, J Int Acad Periodontol, V17, P42; Raja M, 2014, J CLIN DIAGN RES, V8, pZE13, DOI 10.7860/JCDR/2014/9845.4766; ROSETT W, 1980, J CLIN MICROBIOL, V11, P30, DOI 10.1128/JCM.11.1.30-34.1980; Salbach J, 2012, BIOMATERIALS, V33, P8418, DOI 10.1016/j.biomaterials.2012.08.028; Scapoli Luca, 2012, Dent Res J (Isfahan), V9, pS202, DOI 10.4103/1735-3327.109755; Scheres N, 2011, MICROB PATHOGENESIS, V51, P149, DOI 10.1016/j.micpath.2011.04.006; Serrano Carlos, 2009, Acta odontol. latinoam., V22, P99; Siddiqui H, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00947-14; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Ukai T, 2008, INFECT IMMUN, V76, P812, DOI 10.1128/IAI.01241-07; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Yoshimura A, 2002, INFECT IMMUN, V70, P218, DOI 10.1128/IAI.70.1.218-225.2002; Zhang JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016658; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085; Zhang WJ, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-89; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	91	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157310	10.1371/journal.pone.0157310	http://dx.doi.org/10.1371/journal.pone.0157310			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308827	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800052
J	D'Ambrosio, R; Degasperi, E; Aghemo, A; Fraquelli, M; Lampertico, P; Rumi, MG; Facchetti, F; Grassi, E; Casazza, G; Rosenberg, W; Bedossa, P; Colombo, M				D'Ambrosio, Roberta; Degasperi, Elisabetta; Aghemo, Alessio; Fraquelli, Mirella; Lampertico, Pietro; Rumi, Maria Grazia; Facchetti, Floriana; Grassi, Eleonora; Casazza, Giovanni; Rosenberg, William; Bedossa, Pierre; Colombo, Massimo			Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon	PLOS ONE			English	Article							SERUM MARKER PANELS; LIVER FIBROSIS; FOLLOW-UP; LONG-TERM; TRANSIENT ELASTOGRAPHY; ESOPHAGEAL-VARICES; ACCURATE MARKER; ELF SCORE; CIRRHOSIS; THERAPY	Background and Aim Liver biopsy (LB) has lost popularity to stage liver fibrosis in the era of highly effective anti-hepatitis C virus (HCV) therapy, yet diagnosis of persistent cirrhosis may have important implications following HCV eradication. As performance of serological non-invasive tests (NITs) to predict residual fibrosis in non-viremic HCV patients is unknown, we investigated accuracy of NITs to predict residual fibrosis in cirrhotics after a sustained virological response (SVR) to interferon (IFN). Methods Thirty-eight patients with a pre-treatment histological diagnosis of cirrhosis and a 48-104 months post-SVR LB were tested with APRI, CDS, FIB-4, FibroQ, Forns Score, GUCI Index, King Score, Lok Index, PLF, ELF. In 23 (61%) patients, cirrhosis had histologically regressed. Results All NITs values declined after SVR without any significant difference between regressors and non-regressors (AUROC 0.52-0.75). Using viremic cut-offs, PPV ranged from 34% to 100%, with lower NPV (63% - 68%). NITs performance did not improve using derived cutoffs (PPV: 40% - 80%; NPV: 66% - 100%). PLF, which combines several NITs with transient elastography, had the best diagnostic performance (AUROC 0.75, Sn 61%, Sp 90%, PPV 80%, NPV 78%). After treatment, none of the NITs resulted significantly associated with any of the histological features (activity grade, fibrosis stage, area of fibrosis). Conclusions The diagnostic estimates obtained using both viremic and derived cut-off values of NITs were suboptimal, indicating that none of these tests helps predicting residual fibrosis and that LB remains the gold standard for this purpose.	[D'Ambrosio, Roberta; Degasperi, Elisabetta; Aghemo, Alessio; Lampertico, Pietro; Facchetti, Floriana; Grassi, Eleonora; Colombo, Massimo] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Div Gastroenterol & Hepatol, Milan, Italy; [Fraquelli, Mirella] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Div Gastroenterol & Endoscopy, Milan, Italy; [Rumi, Maria Grazia] Univ Milan, Osped San Giuseppe, Div Hepatol, Milan, Italy; [Casazza, Giovanni] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy; [Rosenberg, William] UCL, Ctr Hepatol, Div Med, London, England; [Bedossa, Pierre] Univ Paris Diderot, Hop Beaujon, Dept Pathol, Clichy, France; [Bedossa, Pierre] Univ Paris Diderot, Hop Beaujon, INSERM U773, Clichy, France	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	D'Ambrosio, R (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Div Gastroenterol & Hepatol, Milan, Italy.	roberta.dambrosio@unimi.it	Aghemo, Alessio/ABE-5976-2021; Rosenberg, William/ABA-1071-2021; Lampertico, Pietro/J-8463-2018; D'Ambrosio, Roberta/K-3078-2016; Casazza, Giovanni/G-3661-2012	Aghemo, Alessio/0000-0003-0941-3226; Rosenberg, William/0000-0002-2732-2304; Lampertico, Pietro/0000-0002-1026-7476; D'Ambrosio, Roberta/0000-0003-0019-1153; Casazza, Giovanni/0000-0003-3718-1784; RUMI, MARIAGRAZIA/0000-0002-5876-8528; Bedossa, Pierre/0000-0002-8487-7322	Siemens	Siemens(Siemens AG)	Prof. William Rosenberg has been paid by Siemens for providing lectures on ELF marker. He is named inventor on a patent wholly owned by Siemens. He has no financial or non-financial competing relevant interests to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Arif A, 2003, DIGEST DIS SCI, V48, P1425, DOI 10.1023/A:1024196201684; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bonacini M, 1997, AM J GASTROENTEROL, V92, P1302; Bota S, 2011, HEPAT MON, V11, P548; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Bruno S, 2010, HEPATOLOGY, V51, P2069, DOI 10.1002/hep.23528; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Colli A, 2005, WORLD J GASTROENTERO, V11, P7318, DOI 10.3748/wjg.v11.i46.7318; Cross TJS, 2009, EUR J GASTROEN HEPAT, V21, P730, DOI 10.1097/MEG.0b013e32830dfcb3; D'Ambrosio R, 2013, J HEPATOL, V59, P251, DOI 10.1016/j.jhep.2013.03.013; D'Ambrosio R, 2012, HEPATOLOGY, V56, P532, DOI 10.1002/hep.25606; D'Ambrosio R, 2011, ANTIVIR THER, V16, P677, DOI 10.3851/IMP1807; Everson GT, 2008, ALIMENT PHARM THERAP, V27, P542, DOI 10.1111/j.1365-2036.2008.03620.x; Fontana RJ, 2009, CLIN GASTROENTEROL H, V7, P219, DOI 10.1016/j.cgh.2008.10.034; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Guechot J, 2012, CLIN CHEM LAB MED, V50, P693, DOI 10.1515/cclm-2011-0858; Hsieh YY, 2012, WORLD J GASTROENTERO, V18, P746, DOI 10.3748/wjg.v18.i8.746; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Islam S, 2005, SCAND J GASTROENTERO, V40, P867, DOI 10.1080/00365520510015674; Lichtinghagen R, 2013, J HEPATOL, V59, P236, DOI 10.1016/j.jhep.2013.03.016; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; MAHARAJ B, 1986, LANCET, V1, P523; Mallet V, 2008, ANN INTERN MED, V149, P399, DOI 10.7326/0003-4819-149-6-200809160-00006; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; Parkes J, 2006, J HEPATOL, V44, P462, DOI 10.1016/j.jhep.2005.10.019; Pol S, 2004, HUM PATHOL, V35, P107, DOI 10.1016/j.humpath.2003.08.012; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Reichard O, 1999, J HEPATOL, V30, P783, DOI 10.1016/S0168-8278(99)80129-9; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schiff ER, 2011, CLIN GASTROENTEROL H, V9, P274, DOI 10.1016/j.cgh.2010.11.040; Sebastian G, 2008, J VIRAL HEPATITIS, V15, P212, DOI 10.1111/j.1365-2893.2007.00932.x; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Tachi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133515; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346	50	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155967	10.1371/journal.pone.0155967	http://dx.doi.org/10.1371/journal.pone.0155967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304619	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800012
J	Cerman, E; Akkoc, T; Eraslan, M; Sahin, O; Ozkara, S; Aker, FV; Subasi, C; Karaoz, E; Akkoc, T				Cerman, Eren; Akkoc, Tolga; Eraslan, Muhsin; Sahin, Ozlem; Ozkara, Selvinaz; Aker, Fugen Vardar; Subasi, Cansu; Karaoz, Erdal; Akkoc, Tunc			Retinal Electrophysiological Effects of Intravitreal Bone Marrow Derived Mesenchymal Stem Cells in Streptozotocin Induced Diabetic Rats	PLOS ONE			English	Article							ELECTRORETINOGRAPHIC OSCILLATORY POTENTIALS; MULLER CELL; DYSFUNCTION; RETINOPATHY; MODEL; TRANSPLANTATION; REGENERATION; PROGENITORS; NEUROPROTECTION; DIFFERENTIATION	Diabetic retinopathy is the most common cause of legal blindness in developed countries at middle age adults. In this study diabetes was induced by streptozotocin (STZ) in male Wistar albino rats. After 3 months of diabetes, rights eye were injected intravitreally with green fluorescein protein (GFP) labelled bone marrow derived stem cells (BMSC) and left eyes with balanced salt solution (Sham). Animals were grouped as Baseline (n = 51), Diabetic (n = 45), Diabetic+BMSC (n = 45 eyes), Diabetic+Sham (n = 45 eyes), Healthy+BMSC (n = 6 eyes), Healthy+Sham (n = 6 eyes). Immunohistology analysis showed an increased retinal gliosis in the Diabetic group, compared to Baseline group, which was assessed with GFAP and vimentin expression. In the immunofluorescence analysis BMSC were observed to integrate mostly into the inner retina and expressing GFP. Diabetic group had prominently lower oscillatory potential wave amplitudes than the Baseline group. Three weeks after intravitreal injection Diabetic+BMSC group had significantly better amplitudes than the Diabetic+Sham group. Taken together intravitreal BMSC were thought to improve visual function.	[Cerman, Eren; Eraslan, Muhsin; Sahin, Ozlem] Marmara Univ, Sch Med, Dept Ophthalmol, Istanbul, Turkey; [Akkoc, Tolga] Sci & Technol Res Council Turkey, Genet Engn & Biotechnol Inst, Kocaeli, Turkey; [Ozkara, Selvinaz; Aker, Fugen Vardar] Haydarpasa Numune Educ & Res Hosp, Dept Pathol, Istanbul, Turkey; [Subasi, Cansu; Karaoz, Erdal] Kocaeli Univ, Ctr Stem Cell & Gene Therapies, Kocaeli, Turkey; [Akkoc, Tunc] Marmara Univ, Sch Med, Dept Pediat Allergy & Immunol, Istanbul, Turkey	Marmara University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Istanbul Haydarpasa Numune Training & Research Hospital; Kocaeli University; Marmara University	Cerman, E (corresponding author), Marmara Univ, Sch Med, Dept Ophthalmol, Istanbul, Turkey.	erencerman@yahoo.com	Karaoz, Erdal/AAO-1470-2020; Cerman, Eren/S-7203-2016	Cerman, Eren/0000-0002-8681-9214	Marmara University, BAPKO (Scientific Research Project Commission) [SAG-A-090512-0126, SAG-B-131113-0421, SAG-D-100615-0265]	Marmara University, BAPKO (Scientific Research Project Commission)	The study was granted by Marmara University, BAPKO (Scientific Research Project Commission) with the project numbers SAG-A-090512-0126, SAG-B-131113-0421 and SAG-D-100615-0265.	Akbarzadeh A, 2007, INDIAN J CLIN BIOCHE, V22, P60, DOI 10.1007/BF02913315; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Baydas G, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1001, DOI 10.1023/B:BIRY.0000043542.39691.95; Bogdanov P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097302; BRESNICK GH, 1987, ARCH OPHTHALMOL-CHIC, V105, P929, DOI 10.1001/archopht.1987.01060070065030; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Bui Bang Viet, 2002, Documenta Ophthalmologica, V104, P17, DOI 10.1023/A:1014401502915; Bunce C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-58; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Chang HM, 2015, J CHIN MED ASSOC, V78, P169, DOI 10.1016/j.jcma.2014.08.017; Chung K H, 1994, Korean J Ophthalmol, V8, P1; Coorey NJ, 2012, CLIN EXP OPTOM, V95, P266, DOI 10.1111/j.1444-0938.2012.00741.x; Cronk SM, 2015, STEM CELL TRANSL MED, V4, P459, DOI 10.5966/sctm.2014-0108; Das AV, 2006, DEV BIOL, V299, P283, DOI 10.1016/j.ydbio.2006.07.029; Deliyanti D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134392; DiCicco RM, 2014, INVEST OPHTH VIS SCI, V55, P6281, DOI 10.1167/iovs.14-14724; Feenstra Derrick J, 2013, J Clin Exp Ophthalmol, V4, P298; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Forte JD, 2008, J NEUROSCI METH, V169, P191, DOI 10.1016/j.jneumeth.2007.12.007; Friedlander Martin, 2007, Angiogenesis, V10, P89, DOI 10.1007/s10456-007-9070-4; Gajdosik A, 1999, GEN PHYSIOL BIOPHYS, V18, P54; Hamilton R, 2007, VISION RES, V47, P2968, DOI 10.1016/j.visres.2007.04.020; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; JUEN S, 1990, ARCH OPHTHALMOL-CHIC, V108, P372, DOI 10.1001/archopht.1990.01070050070033; Katsman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050417; Kicic A, 2003, J NEUROSCI, V23, P7742; Kizawa J, 2006, JPN J OPHTHALMOL, V50, P367, DOI 10.1007/s10384-006-0326-0; Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Kong JH, 2015, INT J OPHTHALMOL-CHI, V8, P257, DOI 10.3980/j.issn.2222-3959.2015.02.08; Lai AKW, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/106594; Li Q, 2002, INVEST OPHTH VIS SCI, V43, P3109; Li TQ, 2013, CELL RES, V23, P788, DOI 10.1038/cr.2013.48; LI XX, 1992, DOC OPHTHALMOL, V81, P173, DOI 10.1007/BF00156006; Ly A, 2011, INVEST OPHTH VIS SCI, V52, P9316, DOI 10.1167/iovs.11-7879; Marchetti V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00076; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Mead B, 2015, STEM CELL RES, V14, P243, DOI 10.1016/j.scr.2015.02.003; Mead B, 2015, NEURAL REGEN RES, V10, P371, DOI 10.4103/1673-5374.153681; Mendel TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065691; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Pardue MT, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.3.6; Park SS, 2015, INVEST OPHTH VIS SCI, V56, P81, DOI 10.1167/iovs.14-15415; Park TS, 2014, CIRCULATION, V129, P359, DOI 10.1161/CIRCULATIONAHA.113.003000; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Phipps JA, 2004, INVEST OPHTH VIS SCI, V45, P4592, DOI 10.1167/iovs.04-0842; Rajashekhar G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00059; Rajashekhar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084671; Ramsden CM, 2013, DEVELOPMENT, V140, P2576, DOI 10.1242/dev.092270; Ramsey DJ, 2006, INVEST OPHTH VIS SCI, V47, P5116, DOI 10.1167/iovs.06-0364; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Ritter MR, 2006, J CLIN INVEST, V116, P3266, DOI 10.1172/JCI29683; Scalinci SZ, 2011, CLIN OPHTHALMOL, V5, P691, DOI 10.2147/OPTH.S21161; Schraermeyer U, 2001, CELL TRANSPLANT, V10, P673, DOI 10.3727/000000001783986215; Scuteri A, 2011, CURR STEM CELL RES T, V6, P82, DOI 10.2174/157488811795495486; SEVERNS ML, 1993, DOC OPHTHALMOL, V85, P135, DOI 10.1007/BF01371129; Tan SM, 2015, EXP EYE RES, V136, P1, DOI 10.1016/j.exer.2015.04.015; Tian B, 2010, CHINESE MED J-PEKING, V123, P2265, DOI 10.3760/cma.j.issn.0366-6999.2010.16.020; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Tucker BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125947; Vadala M, 2002, ACTA OPHTHALMOL SCAN, V80, P305, DOI 10.1034/j.1600-0420.2002.800314.x; Vujosevic S, 2015, INVEST OPHTH VIS SCI, V56, P3913, DOI 10.1167/iovs.15-16554; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Weerasekera LY, 2015, INVEST OPHTH VIS SCI, V56, P3721, DOI 10.1167/iovs.14-16289; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Wong Vickie H Y, 2011, J Ocul Biol Dis Infor, V4, P42, DOI 10.1007/s12177-011-9069-3; Yang ZK, 2010, GRAEF ARCH CLIN EXP, V248, P1415, DOI 10.1007/s00417-010-1384-z; YOSHIDA A, 1991, OPHTHALMOLOGY, V98, P1266; Yoshii C, 2007, DEV BIOL, V303, P45, DOI 10.1016/j.ydbio.2006.11.024; Yu S, 2006, BIOCHEM BIOPH RES CO, V344, P1071, DOI 10.1016/j.bbrc.2006.03.231; Zhang Y, 2010, INVEST OPHTH VIS SCI, V51, P3742, DOI 10.1167/iovs.08-3314; Zhao XJ, 2015, INVEST OPHTH VIS SCI, V56, P2773, DOI 10.1167/iovs.14-16104; Zou H, 2010, BIOCHEM BIOPH RES CO, V391, P1268, DOI 10.1016/j.bbrc.2009.12.057	74	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156495	10.1371/journal.pone.0156495	http://dx.doi.org/10.1371/journal.pone.0156495			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300133	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200009
J	Dores, MR; Grimsey, NJ; Mendez, F; Trejo, J				Dores, Michael R.; Grimsey, Neil J.; Mendez, Francisco; Trejo, JoAnn			ALIX Regulates the Ubiquitin-Independent Lysosomal Sorting of the P2Y(1) Purinergic Receptor via a YPX3L Motif	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ESCRT-III; GROWTH-FACTOR; MULTIVESICULAR ENDOSOMES; MEDIATES UBIQUITINATION; ENDOCYTIC TRAFFICKING; DOWN-REGULATION; COMPLEX; HRS; CELLS	Endocytic sorting and lysosomal degradation are integral to the regulation of G protein-coupled receptor (GPCR) function. Upon ligand binding, classical GPCRs are activated, internalized and recycled or sorted to lysosomes for degradation, a process that requires receptor ubiquitination. However, recent studies have demonstrated that numerous GPCRs are sorted to lysosomes independent of receptor ubiquitination. Here, we describe an ubiquitin-independent lysosomal sorting pathway for the purinergic GPCR P2Y(1). After activation, P2Y(1) sorts to lysosomes for degradation independent of direct ubiquitination that is mediated by a YPX3L motif within the second intracellular loop that serves as a binding site for the adaptor protein ALIX. Depletion of ALIX or site-directedmutation of the YPX3L motif inhibits P2Y(1) sorting into the lumen of multivesicular endosomes/lysosomes and degradation. These findings confirm the function of YPX3L motifs as lysosomal targeting sequences for GPCRs and demonstrate that ALIX mediates the ubiquitin-independent degradation of certain GPCRs.	[Dores, Michael R.; Grimsey, Neil J.; Mendez, Francisco; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Dores, Michael R.] Hofstra Univ, Dept Biol, Hempstead, NY 11549 USA	University of California System; University of California San Diego; Hofstra University	Trejo, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu	Grimsey, Neil/AAB-9153-2020	Grimsey, Neil/0000-0002-0481-4920; TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health/National Institute of General Medical Sciences [R01 GM090689]; National Institutes of Health [K12 GM06852]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689, K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 GM090689 (to JT): National Institutes of Health/National Institute of General Medical Sciences: https://www.nigms.nih.gov/Pages/default.aspx. K12 GM06852 (MRD): National Institutes of Health: https://www.nigms.nih.gov/Training/CareerDev/Pages/TWDInstRes.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009; Bissig C, 2013, DEV CELL, V25, P364, DOI 10.1016/j.devcel.2013.04.003; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Dores MR, 2015, METHOD CELL BIOL, V130, P319, DOI 10.1016/bs.mcb.2015.05.006; Dores MR, 2015, MOL BIOL CE IN PRESS; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Freeman CL, 2014, J CELL SCI, V127, P2053, DOI 10.1242/jcs.144659; Govindan S, 2010, BRIT J PHARMACOL, V160, P1953, DOI 10.1111/j.1476-5381.2010.00763.x; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Hardy AR, 2004, BLOOD, V104, P1745, DOI 10.1182/blood-2004-02-0534; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Keren-Kaplan T, 2013, EMBO J, V32, P538, DOI 10.1038/emboj.2013.4; Ko T, 2012, PANCREAS, V41, P797, DOI 10.1097/MPA.0b013e31823ba3b3; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lu Q, 2003, P NATL ACAD SCI US; Malerod L, 2007, TRAFFIC, V8, P1617, DOI 10.1111/j.1600-0854.2007.00630.x; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Nisar S, 2010, TRAFFIC, V11, P508, DOI 10.1111/j.1600-0854.2010.01035.x; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; Pashkova N, 2013, DEV CELL, V25, P520, DOI 10.1016/j.devcel.2013.04.007; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Reiner S, 2009, MOL PHARMACOL, V76, P1162, DOI 10.1124/mol.109.060467; Sachse M, 2004, J CELL SCI, V117, P1699, DOI 10.1242/jcs.00998; Scheuring S, 2001, J MOL BIOL, V312, P469, DOI 10.1006/jmbi.2001.4917; Shen JZ, 2008, CIRC RES, V102, P448, DOI 10.1161/CIRCRESAHA.107.165795; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shinozaki Y, 2006, GLIA, V54, P606, DOI 10.1002/glia.20408; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; van Weering JRT, 2012, EMBO J, V31, P4466, DOI 10.1038/emboj.2012.283; Wei Q, 2011, BIOCHEM PHARMACOL, V82, P418, DOI 10.1016/j.bcp.2011.05.013; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao KH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203091; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319	56	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157587	10.1371/journal.pone.0157587	http://dx.doi.org/10.1371/journal.pone.0157587			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27301021	Green Published, gold			2022-12-27	WOS:000377822200063
J	Tago, D; Hammitt, JK; Thomas, A; Raboisson, D				Tago, Damian; Hammitt, James K.; Thomas, Alban; Raboisson, Didier			The Impact of Farmers' Strategic Behavior on the Spread of Animal Infectious Diseases	PLOS ONE			English	Article							CATTLE; EPIDEMIC; NETWORKS; FRANCE; POLICY; VIRUS	One of the main strategies to control the spread of infectious animal diseases is the implementation of movement restrictions. This paper shows a loss in efficiency of the movement restriction policy (MRP) when behavioral responses of farmers are taken into account. Incorporating the strategic behavior of farmers in an epidemiologic model reveals that the MRP can trigger premature animal sales by farms at high risk of becoming infected that significantly reduce the efficacy of the policy. The results are validated in a parameterized network via Monte Carlo simulations and measures to mitigate the loss of efficiency of the MRP are discussed. Financial aid to farmers can be justified by public health concerns, not only for equity. This paper contributes to developing an interdisciplinary analytical framework regarding the expansion of infectious diseases combining economic and epidemiologic dimensions.	[Tago, Damian] CMAEE, CIRAD, UMR, Petit Bourg, Guadeloupe, France; [Tago, Damian] CMAEE, INRA, UMR1309, F-34398 Montpellier, France; [Hammitt, James K.; Thomas, Alban] Univ Toulouse, INRA, Toulouse Sch Econ Rech, F-31000 Toulouse, France; [Hammitt, James K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02215 USA; [Hammitt, James K.] Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Boston, MA 02215 USA; [Raboisson, Didier] Univ Toulouse, INRA, ENVT, IHAP, Toulouse, France	CIRAD; INRAE; INRAE; Universite de Toulouse; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Tago, D (corresponding author), CMAEE, CIRAD, UMR, Petit Bourg, Guadeloupe, France.; Tago, D (corresponding author), CMAEE, INRA, UMR1309, F-34398 Montpellier, France.	damian.tago_pacheco@cirad.fr	Raboisson, Didier/AAL-4025-2020; THOMAS, Alban/X-8092-2019; THOMAS, Alban/AAW-7849-2020	Raboisson, Didier/0000-0003-1630-6218; THOMAS, Alban/0000-0002-8730-2487; Tago Pacheco, Damian/0000-0001-7251-9408	INRA Scientific Package; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant [609642]; INRA Scientific Package; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant [609642]	INRA Scientific Package; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant; INRA Scientific Package; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant	This work was partially sponsored by an INRA Scientific Package and by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement number 609642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was partially sponsored by an INRA Scientific Package and by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement number 609642.	ANDERSON R M, 1991; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178701; Bosman KJ, 2013, TRANSBOUND EMERG DIS, V60, P303, DOI 10.1111/j.1865-1682.2012.01348.x; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Ellis-Iversen J, 2010, PREV VET MED, V93, P276, DOI 10.1016/j.prevetmed.2009.11.005; Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; GLOSTER J, 1981, VET REC, V108, P370, DOI 10.1136/vr.108.17.370; Hennessy DA, 2007, AM J AGR ECON, V89, P1226, DOI 10.1111/j.1467-8276.2007.01088.x; Hennessy DA, 2007, AM J AGR ECON, V89, P698, DOI 10.1111/j.1467-8276.2007.01001.x; Jin H.J., 2004, EFFECTS BSE OUTBREAK; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Muchnik L., 2013, COMPLEX NETWORKS PAC; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pioz M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085444; Pioz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043360; Rautureau S, 2011, TRANSBOUND EMERG DIS, V58, P110, DOI 10.1111/j.1865-1682.2010.01187.x; Sahneh FD, 2012, SCI REP, P2; Shirley MDF, 2005, EPIDEMIOL INFECT, V133, P1023, DOI 10.1017/S095026880500453X; Sinn HW, 2008, INT TAX PUBLIC FINAN, V15, P360, DOI 10.1007/s10797-008-9082-z; Tago D, 2014, PREV VET MED, V117, P577, DOI 10.1016/j.prevetmed.2014.10.010; Turner J, 2012, SCI REP, P2; Volchenkov D, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046137; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Wismans WMG, 1999, COMPUT ELECTRON AGR, V24, P99, DOI 10.1016/S0168-1699(99)00040-X; Yupiana Y, 2010, INT J INFECT DIS, V14, pE800, DOI 10.1016/j.ijid.2010.03.014; Zar JH, 1998, ENCY BIOSTATISTICS, P4191	31	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157450	10.1371/journal.pone.0157450	http://dx.doi.org/10.1371/journal.pone.0157450			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300368	Green Published, gold			2022-12-27	WOS:000377822200051
J	Hong, JY; Sunwoo, MK; Oh, JS; Kim, JS; Sohn, YH; Lee, PH				Hong, Jin Yong; Sunwoo, Mun Kyung; Oh, Jungsu S.; Kim, Jae Seung; Sohn, Young H.; Lee, Phil Hyu			Persistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter Imaging	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CLINICAL-FEATURES; TYROSINE-HYDROXYLASE; I-123-FP-CIT SPECT; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; HALOPERIDOL; DYSKINESIA; PET; ACCURACY	Functional neuroimaging for the dopamine transporter (DAT) is used to distinguish drug-induced parkinsonism (DIP) from subclinical Parkinson's disease (PD). Although DIP patients who show a normal DAT image are expected to recover completely, some do not. We investigated whether these patients showed changes in striatal DAT activity using semi-quantitative analysis of F-18-FP-CIT PET data. DIP patients with visually normal DAT images were selected from medical records. The subjects were classified as patients who recovered partially (PR) or completely within 12 months (CR). The F-18-FP-CIT uptake in each striatal subregion was compared between the CR and the PR groups. In total, 41 and 9 patients of the CR and PR groups were assessed, respectively. The two patient groups were comparable in terms of clinical characteristics including age, sex, and severity of parkinsonism. From semi-quantitative analysis of the PET image, the PR patients showed a relatively lower ligand uptake in the ventral striatum, the anterior putamen and the posterior putamen compared with the CR patients. This result suggests that persistent DIP in patients with visually normal DAT imaging may be associated with subtle decrement of DAT activity.	[Hong, Jin Yong] Yonsei Univ Wonju, Coll Med, Dept Neurol, Wonju, South Korea; [Sunwoo, Mun Kyung] Bundang Jesaeng Gen Hosp, Dept Neurol, Songnam, South Korea; [Oh, Jungsu S.; Kim, Jae Seung] Univ Ulsan, Coll Med, Dept Nucl Med, Asan Med Ctr, Seoul, South Korea; [Sohn, Young H.; Lee, Phil Hyu] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Sohn, Young H.; Lee, Phil Hyu] Yonsei Univ, Coll Med, Brain Res Inst, Seoul, South Korea; [Lee, Phil Hyu] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; University of Ulsan; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Hong, JY (corresponding author), Yonsei Univ Wonju, Coll Med, Dept Neurol, Wonju, South Korea.	mlunoilu@hanmail.net		Lee, Phil Hyu/0000-0001-9931-8462; Sohn, Young H./0000-0001-6533-2610	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) - Korean government (MSIP) [2014M3C7A1064752]	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) - Korean government (MSIP)	This research was supported by the Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (no. 2014M3C7A1064752). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa MT, 2006, MOVEMENT DISORD, V21, P800, DOI 10.1002/mds.20806; Benito-Leon J, 2003, MOVEMENT DISORD, V18, P267, DOI 10.1002/mds.10362; Bishnoi M, 2007, PHARMACOLOGY, V79, P171, DOI 10.1159/000100924; BURN DJ, 1993, NEUROLOGY, V43, P552, DOI 10.1212/WNL.43.3_Part_1.552; Chiba S, 2012, NEUROBIOL AGING, V33, P2491, DOI 10.1016/j.neurobiolaging.2011.11.002; Cuberas-Borros G, 2011, CLIN NUCL MED, V36, P991, DOI 10.1097/RLU.0b013e3182291a7b; Diaz-Corrales FJ, 2010, EUR J NUCL MED MOL I, V37, P556, DOI 10.1007/s00259-009-1289-4; Eerola J, 2005, J NEUROL NEUROSUR PS, V76, P1211, DOI 10.1136/jnnp.2004.045237; Erro R, 2015, MOVEMENT DISORD, V30, P780, DOI 10.1002/mds.26209; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Foubert-Samier A, 2012, NEUROLOGY, V79, P1615, DOI 10.1212/WNL.0b013e31826e25ce; GOETZ CG, 1983, ARCH NEUROL-CHICAGO, V40, P325, DOI 10.1001/archneur.1983.04050050093019; HARDIE RJ, 1988, J NEUROL NEUROSUR PS, V51, P850, DOI 10.1136/jnnp.51.6.850; Hong JY, 2014, NEUROLOGY, V82, P1597, DOI 10.1212/WNL.0000000000000385; Horvath J, 2014, J ALZHEIMERS DIS, V39, P115, DOI 10.3233/JAD-131289; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jimenez-Jimenez F J, 1996, Parkinsonism Relat Disord, V2, P145, DOI 10.1016/1353-8020(96)00013-2; Kim JS, 2013, ARCH GERONTOL GERIAT, V56, P124, DOI 10.1016/j.archger.2012.05.001; Levinson AJ, 1998, NEUROSCIENCE, V84, P201, DOI 10.1016/S0306-4522(97)00447-8; Lorberboym M, 2006, MOVEMENT DISORD, V21, P510, DOI 10.1002/mds.20748; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; Meredith GE, 2004, BRAIN RES, V995, P14, DOI 10.1016/j.brainres.2003.09.040; Oh JS, 2014, NEUROREPORT, V25, P1198, DOI 10.1097/WNR.0000000000000247; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; Romero JO, 2013, NEUROLOGIA, V28, P276, DOI 10.1016/j.nrl.2012.05.005; RAJPUT AH, 1982, ARCH NEUROL-CHICAGO, V39, P644, DOI 10.1001/archneur.1982.00510220042009; Rinne JO, 2002, NEUROLOGY, V58, P1489, DOI 10.1212/WNL.58.10.1489; Rinne JO, 1998, NEUROLOGY, V50, P152, DOI 10.1212/WNL.50.1.152; ROLLEMA H, 1994, J PHARMACOL EXP THER, V268, P380; Shin HW, 2015, NEUROL SCI, V36, P269, DOI 10.1007/s10072-014-1945-8; Shin HW, 2012, J CLIN NEUROL, V8, P15, DOI 10.3988/jcn.2012.8.1.15; Shuaib UA, 2016, MOVEMENT DISORD, V31, P360, DOI 10.1002/mds.26467; STEPHEN PJ, 1984, LANCET, V2, P1082; Tinazzi M, 2008, MOVEMENT DISORD, V23, P1825, DOI 10.1002/mds.22098; Tinazzi M, 2012, SCHIZOPHR RES, V139, P40, DOI 10.1016/j.schres.2012.06.003; Tsai GC, 1998, AM J PSYCHIAT, V155, P1207, DOI 10.1176/ajp.155.9.1207; Vlaar AMM, 2008, EUR NEUROL, V59, P258, DOI 10.1159/000115640	37	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157410	10.1371/journal.pone.0157410	http://dx.doi.org/10.1371/journal.pone.0157410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294367	Green Submitted, Green Published, gold			2022-12-27	WOS:000377821300044
J	Zein, JG; Udeh, BL; Teague, WG; Koroukian, SM; Schlitz, NK; Bleecker, ER; Busse, WB; Calhoun, WJ; Castro, M; Comhair, SA; Fitzpatrick, AM; Israel, E; Wenzel, SE; Holguin, F; Gaston, BM; Erzurum, SC				Zein, Joe G.; Udeh, Belinda L.; Teague, W. Gerald; Koroukian, Siran M.; Schlitz, Nicholas K.; Bleecker, Eugene R.; Busse, William B.; Calhoun, William J.; Castro, Mario; Comhair, Suzy A.; Fitzpatrick, Anne M.; Israel, Elliot; Wenzel, Sally E.; Holguin, Fernando; Gaston, Benjamin M.; Erzurum, Serpil C.		Severe Asthma Res Program	Impact of Age and Sex on Outcomes and Hospital Cost of Acute Asthma in the United States, 2011-2012	PLOS ONE			English	Article							SECONDARY DATABASES; NATIONAL HEART; EXACERBATIONS; PREVALENCE; CHILDHOOD; SEVERITY; SYMPTOMS; LUNG; BIAS	Background Worldwide, asthma is a leading cause of morbidity, mortality and economic burden, with significant gender and racial disparities. However, little attention has been given to the independent role of age on lifetime asthma severity and hospitalization. We aimed to assess the effect of age, gender, race and ethnicity on indicators of asthma severity including asthma related hospitalization, mortality, hospital cost, and the rate of respiratory failure. Methods We analyzed the 2011 and 2012 Healthcare Cost and Utilization Project-National Inpatient Sample (NIS). We validated and extended those results using the National Heart, Lung, and Blood Institute-Severe Asthma Research Program (SARP; 2002-2011) database. Severe asthma was prospectively defined using the stringent American Thoracic Society (ATS) definition. Results Hospitalization for asthma was reported in 372,685 encounters in 2012 and 368,528 in 2011. The yearly aggregate cost exceeded $2 billion. There were distinct bimodal distributions for hospitalization age, with an initial peak at 5 years and a second at 50 years. Likewise, this bimodal age distribution of patients with severe asthma was identified using SARP. Males comprised the majority of individuals in the first peak, but women in the second. Aggregate hospital cost mirrored the bimodal peak distribution. The probability of respiratory failure increased with age until the age of 60, after which it continued to increase in men, but not in women. Conclusions Severe asthma is primarily a disease of young boys and middle age women. Greater understanding of the biology of lung aging and influence of sex hormones will allow us to plan for targeted interventions during these times in order to reduce the personal and societal burdens of asthma.	[Zein, Joe G.; Comhair, Suzy A.; Erzurum, Serpil C.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA; [Zein, Joe G.; Comhair, Suzy A.; Erzurum, Serpil C.] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA; [Udeh, Belinda L.] Cleveland Clin, Inst Anesthesiol, Dept Outcomes Res, Cleveland, OH 44106 USA; [Teague, W. Gerald] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA; [Koroukian, Siran M.; Schlitz, Nicholas K.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Bleecker, Eugene R.] Wake Forest Univ, Sch Med, Ctr Genom & Personalized Med, Winston Salem, NC 27109 USA; [Busse, William B.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Calhoun, William J.] Univ Texas Med Branch, Dept Med, Galveston, TX 77555 USA; [Castro, Mario] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Fitzpatrick, Anne M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Israel, Elliot] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm, Boston, MA 02115 USA; [Wenzel, Sally E.; Holguin, Fernando] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA USA; [Gaston, Benjamin M.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Virginia; Case Western Reserve University; Wake Forest University; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Medical Branch Galveston; Washington University (WUSTL); Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Zein, JG (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA.; Zein, JG (corresponding author), Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA.	zeinj@ccf.org	Koroukian, Siran/S-9127-2019	Koroukian, Siran/0000-0002-8106-9581; Fitzpatrick, Anne/0000-0002-2933-5926; Wenzel, Sally/0000-0002-4242-0164; Calhoun, William/0000-0001-7075-712X	National Institute of Health-National Heart, Lung, and Blood Institute [HL109250, HL081064, HL69170, HL103453, U10 HL109250, UL1TR000439]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453, P01HL081064, U10HL109250] Funding Source: NIH RePORTER	National Institute of Health-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SCE received funding from the National Institute of Health-National Heart, Lung, and Blood Institute: HL109250, HL081064, HL69170, HL103453, U10 HL109250, and UL1TR000439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami Lara J, 2012, NCHS Data Brief, P1; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; *CDC, NAT HLTH INT SURV; Ciccone G, 1997, EUR RESPIR J, V10, P1780; Cisternas MG, 2003, J ALLERGY CLIN IMMUN, V111, P1212, DOI 10.1067/mai.2003.1449; Department of Health and Human Services, INT CLASS DIS, V1; DODGE RR, 1980, AM REV RESPIR DIS, V122, P567; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Godard P, 2002, EUR RESPIR J, V19, P61, DOI 10.1183/09031936.02.00232001; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; HLATKY MA, 1984, AM J MED, V77, P64, DOI 10.1016/0002-9343(84)90437-6; Jarjour NN, 2012, AM J RESP CRIT CARE, V185, P356, DOI 10.1164/rccm.201107-1317PP; Jenkins MA, 2006, CLIN EXP ALLERGY, V36, P609, DOI 10.1111/j.1365-2222.2006.02475.x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Krishnan V, 2006, AM J RESP CRIT CARE, V174, P633, DOI 10.1164/rccm.200601-007OC; Mandhane PJ, 2005, AM J RESP CRIT CARE, V172, P45, DOI 10.1164/rccm.200412-1738OC; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Moorman JE, 2012, VITAL HLTH STAT, V35, P1; NORMAN GR, 1985, J MED EDUC, V60, P925; Pfuntner A, 2011, MOST FREQUENT CONDIT MOST FREQUENT CONDIT; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Rao CK, 2013, CHEST, V143, P984, DOI 10.1378/chest.12-0973; RETHANS JJ, 1994, BRIT J GEN PRACT, V44, P153; Schneeweiss S, 2004, J CLIN PSYCHOPHARM, V24, P632, DOI 10.1097/01.jcp.0000145344.76288.39; Schneeweiss S, 2007, J CLIN EPIDEMIOL, V60, P648, DOI 10.1016/j.jclinepi.2006.10.019; SENNHAUSER FH, 1995, PEDIATR PULM, V19, P161, DOI 10.1002/ppul.1950190304; Serra-Batlles J, 1998, EUR RESPIR J, V12, P1322, DOI 10.1183/09031936.98.12061322; ten Brinke A, 2005, EUR RESPIR J, V26, P812, DOI 10.1183/09031936.05.00037905; Terris DD, 2007, J CLIN EPIDEMIOL, V60, P734, DOI 10.1016/j.jclinepi.2006.08.012; Tsai CL, 2012, J ALLERGY CLIN IMMUN, V129, P1252, DOI 10.1016/j.jaci.2012.01.061; United Nations, 2 WORLD ASS AG; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Wilchesky M, 2004, J CLIN EPIDEMIOL, V57, P131, DOI 10.1016/S0895-4356(03)00246-4; Zein J, 2016, AM THOR SOC INT C AM, pA1436; Zein JG, 2015, PLOS ONE IN PRESS	36	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157301	10.1371/journal.pone.0157301	http://dx.doi.org/10.1371/journal.pone.0157301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294365	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000377821300032
J	Cabinian, A; Sinsimer, D; Tang, M; Zumba, O; Mehta, H; Toma, A; Sant'Angelo, D; Laouar, Y; Laouar, A				Cabinian, Allison; Sinsimer, Daniel; Tang, May; Zumba, Osvaldo; Mehta, Hetali; Toma, Annmarie; Sant'Angelo, Derek; Laouar, Yasmina; Laouar, Amale			Transfer of Maternal Immune Cells by Breastfeeding: Maternal Cytotoxic T Lymphocytes Present in Breast Milk Localize in the Peyer's Patches of the Nursed Infant	PLOS ONE			English	Article							INTESTINAL-ABSORPTION; GASTROINTESTINAL-TRACT; MEDIATED-IMMUNITY; THYMIC EMIGRANTS; MAMMARY-GLAND; PLASMA-CELLS; ANTIBODY; ANTIGEN; CYTOKINE; PROTECTION	Despite our knowledge of the protective role of antibodies passed to infants through breast milk, our understanding of immunity transfer via maternal leukocytes is still limited. To emulate the immunological interface between the mother and her infant while breast-feeding, we used murine pups fostered after birth onto MHC-matched and MHC-mismatched dams. Overall, data revealed that: 1) Survival of breast milk leukocytes in suckling infants is possible, but not significant after the foster-nursing ceases; 2) Most breast milk lymphocytes establish themselves in specific areas of the intestine termed Peyer's patches (PPs); 3) While most leukocytes in the milk bolus were myeloid cells, the majority of breast milk leukocytes localized to PPs were T lymphocytes, and cytotoxic T cells (CTLs) in particular; 4) These CTLs exhibit high levels of the gut-homing molecules alpha 4 beta 7 and CCR9, but a reduced expression of the systemic homing marker CD62L; 5) Under the same activation conditions, transferred CD8 T cells through breast milk have a superior capacity to produce potent cytolytic and inflammatory mediators when compared to those generated by the breastfed infant. It is therefore possible that maternal CTLs found in breast milk are directed to the PPs to compensate for the immature adaptive immune system of the infant in order to protect it against constant oral infectious risks during the postnatal phase.	[Cabinian, Allison; Sinsimer, Daniel; Tang, May; Zumba, Osvaldo; Mehta, Hetali; Toma, Annmarie; Sant'Angelo, Derek; Laouar, Amale] Rutgers State Univ, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08903 USA; [Laouar, Yasmina] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Michigan System; University of Michigan	Laouar, A (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08903 USA.; Laouar, Y (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	ylaouar@umich.edu; laouaram@rwjms.rutgers.edu	Laouar, Amale/AAO-2903-2020	Laouar, Amale/0000-0002-3714-4628	Robert Wood Johnson Foundation [67038, 581534]; NIH NIAID [R01 AI083988, R01AI083642]; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge the support of the Robert Wood Johnson Foundation (grant # 67038) for the Child Health Institute of New Jersey, NIH NIAID R01 AI083988 to DSA, NIH NIAID R01AI083642 to YL, and Robert Wood Johnson Foundation (grant # 581534) to AL.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Arnardottir H, 2015, MUCOSAL IMMUNOLOGY; Arvola M, 2000, BIOL REPROD, V63, P1817, DOI 10.1095/biolreprod63.6.1817; Autengruber A, 2012, EUR J MICROBIOL IMMU, V2, P112, DOI 10.1556/EuJMI.2.2012.2.3; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Beyer K, 2002, J ALLERGY CLIN IMMUN, V109, P707, DOI 10.1067/mai.2002.122503; Alves JGB, 2012, BREASTFEED MED, V7, P25, DOI 10.1089/bfm.2011.0009; BOASS A, 1963, AM J PHYSIOL, V204, P101, DOI 10.1152/ajplegacy.1963.204.1.101; BOORMAN KE, 1958, ARCH DIS CHILD, V33, P24, DOI 10.1136/adc.33.167.24; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; CRUZ JR, 1988, ACTA PAEDIATR SCAND, V77, P658, DOI 10.1111/j.1651-2227.1988.tb10726.x; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; DAHLGREN UIH, 1987, J IMMUNOL, V138, P1397; Ebsen H, 2015, MOL IMMUNOL, V65, P416, DOI 10.1016/j.molimm.2015.02.008; EGLINTON BA, 1994, IMMUNOL CELL BIOL, V72, P306, DOI 10.1038/icb.1994.46; Eidelman AI, 2012, BREASTFEED MED, V7, P323, DOI 10.1089/bfm.2012.0067; Faucher JL, 2007, CYTOM PART A, V71A, P934, DOI 10.1002/cyto.a.20457; Gasparoni A, 2003, BIOL NEONATE, V84, P297, DOI 10.1159/000073638; Ghose P, 2011, J IMMUNOL, V187, P1333, DOI 10.4049/jimmunol.1100092; GLASS RI, 1983, NEW ENGL J MED, V308, P1389, DOI 10.1056/NEJM198306093082304; GOLD E, 1964, PEDIATRICS, V33, P541; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Hanson L A, 1978, Adv Exp Med Biol, V107, P165; Hanson LA, 1998, ANN ALLERG ASTHMA IM, V81, P523, DOI 10.1016/S1081-1206(10)62704-4; HANSON LA, 1961, INT ARCH ALLER A IMM, V18, P241, DOI 10.1159/000229177; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; HEAD JR, 1977, TRANSPLANT P, V9, P1465; HIRANO S, 1986, ARCH HISTOL CYTOL, V49, P333, DOI 10.1679/aohc.49.333; Houston EG, 2011, P NATL ACAD SCI USA, V108, P5366, DOI 10.1073/pnas.1015286108; HUGHES A, 1988, IMMUNOLOGY, V64, P213; Ichikawa M, 2003, IMMUNOLOGY, V108, P189, DOI 10.1046/j.1365-2567.2003.01572.x; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; JAIN L, 1989, ARCH DIS CHILD-FETAL, V64, P930, DOI 10.1136/adc.64.7_Spec_No.930; Jakaitis BM, 2014, CLIN PERINATOL, V41, P423, DOI 10.1016/j.clp.2014.02.011; Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710; Kim SH, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.165; Laouar A, 2005, NAT IMMUNOL, V6, P698, DOI 10.1038/ni1212; Laouar A, 2007, J IMMUNOL, V178, P652, DOI 10.4049/jimmunol.178.2.652; Laouar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004089; Li XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105314; Li XY, 2004, IMMUNOLOGY, V113, P44, DOI 10.1111/j.1365-2567.2004.01928.x; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Lohman-Payne B, 2012, AIDS, V26, P2007, DOI 10.1097/QAD.0b013e328359b7e0; Lonnerdal B, 2000, NUTRITION, V16, P509, DOI 10.1016/S0899-9007(00)00363-4; Losonsky G A, 1981, Prog Clin Biol Res, V70, P171; M'Rabet L, 2008, J NUTR, V138, p1782S, DOI 10.1093/jn/138.9.1782S; Ma L, 2008, FIFTH INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY, VOL 3, PROCEEDINGS, P3, DOI 10.1109/FSKD.2008.17; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; MANDALAPU P, 1995, CELL IMMUNOL, V162, P178, DOI 10.1006/cimm.1995.1067; MANNING LS, 1980, J IMMUNOL, V125, P2508; Marild S, 2004, ACTA PAEDIATR, V93, P164, DOI 10.1080/08035250310007402; MILLER SC, 1981, J REPROD IMMUNOL, V3, P187, DOI 10.1016/0165-0378(81)90060-7; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ouellette AJ, 1996, FASEB J, V10, P1280, DOI 10.1096/fasebj.10.11.8836041; PALACIOS R, 1986, EUR J IMMUNOL, V16, P12, DOI 10.1002/eji.1830160104; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; PARMELY MJ, 1977, J DAIRY SCI, V60, P655, DOI 10.3168/jds.S0022-0302(77)83915-5; Pearson T, 2008, CURRENT PROTOCOLS IM; Persson LA, 2002, ADV EXP MED BIOL, V503, P115; RIVAS RA, 1994, BIOL NEONATE, V66, P195, DOI 10.1159/000244108; Roederer M, 1997, J CLIN INVEST, V99, P1555, DOI 10.1172/JCI119318; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; ROUX ME, 1981, CELL IMMUNOL, V61, P141, DOI 10.1016/0008-8749(81)90361-0; RUDLOFF HE, 1992, PEDIATR RES, V31, P29, DOI 10.1203/00006450-199201000-00005; RUIZPALACIOS GM, 1990, J PEDIATR-US, V116, P707, DOI 10.1016/S0022-3476(05)82652-6; Sabbaj S, 2005, J IMMUNOL, V174, P2951, DOI 10.4049/jimmunol.174.5.2951; Sabbaj S, 2002, J VIROL, V76, P7365, DOI 10.1128/JVI.76.15.7365-7373.2002; Salmon H, 2000, ADV EXP MED BIOL, V480, P279; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schnell FJ, 2005, J IMMUNOL, V175, P2270, DOI 10.4049/jimmunol.175.4.2270; SCHNORR KL, 1984, J REPROD IMMUNOL, V6, P329, DOI 10.1016/0165-0378(84)90031-7; SEELIG LL, 1981, TRANSPLANT P, V13, P1245; SHELDRAKE RF, 1985, RES VET SCI, V39, P10, DOI 10.1016/S0034-5288(18)31762-4; Shiou SR, 2013, J BIOL CHEM, V288, P34757, DOI 10.1074/jbc.M113.503946; SILVERS WK, 1975, J IMMUNOL, V115, P1117; Slavica L, 2013, J LEUKOCYTE BIOL, V94, P1003, DOI 10.1189/jlb.1212617; Stifter SA, 2015, J IMMUNOL, V194, P2455, DOI 10.4049/jimmunol.1402794; STOLIAR OA, 1976, LANCET, V1, P1258; Strand TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036436; Tanneau GM, 1999, J HISTOCHEM CYTOCHEM, V47, P1581, DOI 10.1177/002215549904701210; TATEMATSU M, 1975, CELL DIFFER DEV, V4, P285, DOI 10.1016/0045-6039(75)90013-5; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; THORPE LW, 1986, PEDIATR RES, V20, P373, DOI 10.1203/00006450-198604000-00023; Tobin NH, 2013, IMMUNOL REV, V254, P143, DOI 10.1111/imr.12074; Torow N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8725; Tourneur E, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/270301; Tuboly S, 2002, ADV EXP MED BIOL, V503, P107; TUBOLY S, 1995, ACTA VET HUNG, V43, P105; Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Walch M, 2014, CELL, V157, P1309, DOI 10.1016/j.cell.2014.03.062; WARREN RJ, 1964, PEDIATRICS, V34, P4; WEILER IJ, 1983, AM J REPROD IMMUNOL, V4, P95, DOI 10.1111/j.1600-0897.1983.tb00261.x; WEISZCARRINGTON P, 1979, J IMMUNOL, V123, P1705; WOLF JL, 1984, ANNU REV MED, V35, P95, DOI 10.1146/annurev.med.35.1.95; Xu RJ, 1996, REPROD FERT DEVELOP, V8, P35, DOI 10.1071/RD9960035; Zhou L, 2000, IMMUNOLOGY, V101, P570, DOI 10.1046/j.1365-2567.2000.00144.x	99	73	78	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156762	10.1371/journal.pone.0156762	http://dx.doi.org/10.1371/journal.pone.0156762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285085	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000019
J	Wolf, L; Eertmans, F; Wolf, D; Rossel, B; Adriaens, E				Wolf, Luise; Eertmans, Frank; Wolf, Doerte; Rossel, Bart; Adriaens, Els			Efficacy and Safety of a Mineral Oil-Based Head Lice Shampoo: A Randomized, Controlled, Investigator-Blinded, Comparative Study	PLOS ONE			English	Article							RESISTANCE	Background Due to increased resistance and safety concerns with insecticide-based pediculicides, there is growing demand for head lice treatments with a physical mode of action. Certain mineral oils kill lice by blocking spiracles or by disrupting the epicuticular wax layer. The present study was performed to evaluate efficacy and safety of a mineral oil-based shampoo. Methods This randomized, controlled, investigator-blinded, monocentric study (EudraCT registration no. 2014-002918-23) was performed from October 2014-June 2015 in Germany. A mineral oil shampoo (Mosquito (R) Med Lause Shampoo 10 in Germany, Paranix or Silcap shampoo elsewhere), registered as medical device, was compared to a conventional, locally reimbursed, pyrethroid-based pediculicide (Goldgeist (R) Forte solution). In total, 107 patients (>1 year) with confirmed head lice infestation were included (test arm: n = 53; control arm: n = 54). All subjects received two applications of either test or control product at day 0 and day 7, according to the instructions for use. Efficacy and safety was evaluated directly, 1h and 24h after first application, before and after second treatment, and at day 10. The main objective was demonstrating a cure rate for the test product, being superior to 70% at day 10. Results Cure rates at day 10 (corrected for re-infestation) for the test product (96.1%) and control (94%) significantly exceeded the pre-defined target (70%) (p < 0.001, 2-sided, 1-sample, chi-square test) with confirmed non-inferiority for the test product. Over all visits, cure rates were consistently higher for the test product, whereas more initially-cured subjects remained lice-free until end of study (78%; control: 60%). Both products were safe and well tolerated, offering good esthetical effects. Conclusion This study showed that substance-based medical devices (including the tested mineral oil shampoo) can be safe and effective alternatives for insecticide-based pediculicides, with less risk for development of resistance because of the physical mode of action.	[Wolf, Luise; Wolf, Doerte] Cardiosec Clin Res GmbH, Dalbergsweg 21, D-99084 Erfurt, Germany; [Eertmans, Frank; Rossel, Bart] Oystershell Labs, Booiebos 24, B-9031 Drongen, Ovl, Belgium; [Adriaens, Els] Adriaens Consulting, Bellemdorpweg 95, B-9881 Bellem, Ovl, Belgium		Rossel, B (corresponding author), Oystershell Labs, Booiebos 24, B-9031 Drongen, Ovl, Belgium.	research@oystershell.com	Eertmans, Frank/H-6419-2013	Eertmans, Frank/0000-0002-2820-7658				Agnello A. M., 2002, SPRAY OILS 2000 SUST, P2; [Anonymous], 1998, FED REGISTER, V63, P49583; Barker SC, 2010, BMC DERMATOL, V10, DOI 10.1186/1471-5945-10-6; Burgess IF, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-43; Burgess IF, 2011, MED DEVICES-EVID RES, V4, P35, DOI 10.2147/MDER.S17551; Burgess IF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035419; Burgess Ian F., 2009, BMC Pharmacology, V9, P3, DOI 10.1186/1471-2210-9-3; Buteler M, 2011, REV MODE ACTION CURR, DOI [10.5772/20394.2011, DOI 10.5772/20394]; Toloza AC, 2014, J MED ENTOMOL, V51, P139, DOI 10.1603/ME13138; Durand R, 2012, CLIN MICROBIOL INFEC, V18, P338, DOI 10.1111/j.1469-0691.2012.03806.x; Falagas ME, 2008, EMERG INFECT DIS, V14, P1493, DOI 10.3201/eid1409.080368; Feldmeier H, 2012, EUR J CLIN MICROBIOL, V31, P2105, DOI 10.1007/s10096-012-1575-0; Frankowski BL, 2010, PEDIATRICS, V126, P392, DOI 10.1542/peds.2010-1308; Gallardo A, 2012, PARASITOL RES, V110, P1601, DOI 10.1007/s00436-011-2668-x; Grieve K., 2007, AUST PHARM, V26, P738; Heukelbach J, 2009, BMC DERMATOL, V9, DOI 10.1186/1471-5945-9-12; Heukelbach J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-115; International Conference on Harmonization (ICH), 2009, POINTS CONS SWITCH S; Kurt O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-441; Mougabure CG, 2006, J MED ENTOMOL, V43, P634; Mumcuoglu Kosta Y, 2007, J Drugs Dermatol, V6, P409; Robert Koch-Institut (RKI), 2008, RKI RAT ARZT KOPFL; Saillenfait AM, 2015, INT J HYG ENVIR HEAL, V218, P281, DOI 10.1016/j.ijheh.2015.01.002; Taverner P, 2002, SPRAY OILS 2000 SUST, P78	24	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156853	10.1371/journal.pone.0156853	http://dx.doi.org/10.1371/journal.pone.0156853			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286033	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000024
J	Hora, B; Keating, SM; Chen, Y; Sanchez, AM; Sabino, E; Hunt, G; Ledwaba, J; Hackett, J; Swanson, P; Hewlett, I; Ragupathy, V; Vemula, SV; Zeng, PB; Tee, KK; Chow, WZ; Ji, HZ; Sandstrom, P; Denny, TN; Busch, MP; Gao, F				Hora, Bhavna; Keating, Sheila M.; Chen, Yue; Sanchez, Ana M.; Sabino, Ester; Hunt, Gillian; Ledwaba, Johanna; Hackett, John, Jr.; Swanson, Priscilla; Hewlett, Indira; Ragupathy, Viswanath; Vemula, Sai Vikram; Zeng, Peibin; Tee, Kok-Keng; Chow, Wei Zhen; Ji, Hezhao; Sandstrom, Paul; Denny, Thomas N.; Busch, Michael P.; Gao, Feng		REDS-iii; EQAPOL Programs	Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NON-B SUBTYPES; DRUG-RESISTANCE; IMMUNOLOGICAL RESPONSE; ANTIRETROVIRAL THERAPY; RECOMBINANT FORMS; APTIMA HIV-1; VIRAL LOAD; IDENTIFICATION; QUANTIFICATION	HIV-1 subtypes and drug resistance are routinely tested by many international surveillance groups. However, results from different sites often vary. A systematic comparison of results from multiple sites is needed to determine whether a standardized protocol is required for consistent and accurate data analysis. A panel of well-characterized HIV-1 isolates (N = 50) from the External Quality Assurance Program Oversight Laboratory (EQAPOL) was assembled for evaluation at seven international sites. This virus panel included seven subtypes, six circulating recombinant forms (CRFs), nine unique recombinant forms (URFs) and three group O viruses. Seven viruses contained 10 major drug resistance mutations (DRMs). HIV-1 isolates were prepared at a concentration of 10(7) copies/ml and compiled into blinded panels. Subtypes and DRMs were determined with partial or full pol gene sequences by conventional Sanger sequencing and/or Next Generation Sequencing (NGS). Subtype and DRM results were reported and decoded for comparison with full-length genome sequences generated by EQAPOL. The partial pol gene was amplified by RT-PCR and sequenced for 89.4%-100% of group M viruses at six sites. Subtyping results of majority of the viruses (83%-97.9%) were correctly determined for the partial pol sequences. All 10 major DRMs in seven isolates were detected at these six sites. The complete pol gene sequence was also obtained by NGS at one site. However, this method missed six group M viruses and sequences contained host chromosome fragments. Three group O viruses were only characterized with additional group O-specific RT-PCR primers employed by one site. These results indicate that PCR protocols and subtyping tools should be standardized to efficiently amplify diverse viruses and more consistently assign virus genotypes, which is critical for accurate global subtype and drug resistance surveillance. Targeted NGS analysis of partial pol sequences can serve as an alternative approach, especially for detection of low-abundance DRMs.	[Hora, Bhavna; Chen, Yue; Sanchez, Ana M.; Denny, Thomas N.; Gao, Feng] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Hora, Bhavna; Chen, Yue; Sanchez, Ana M.; Denny, Thomas N.; Gao, Feng] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Keating, Sheila M.; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Keating, Sheila M.; Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Sabino, Ester] Inst Trop Med, Sao Paulo, Brazil; [Hunt, Gillian; Ledwaba, Johanna] Natl Inst Communicable Dis, Johannesburg, South Africa; [Hackett, John, Jr.; Swanson, Priscilla] Abbott Labs, Infect Dis Res, Abbott Pk, IL 60064 USA; [Hewlett, Indira; Ragupathy, Viswanath; Vemula, Sai Vikram] Food & Drug Adm, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Zeng, Peibin] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China; [Tee, Kok-Keng; Chow, Wei Zhen] Univ Malaya, Fac Med, Dept Med Microbiol, Ctr Excellence Res AIDS, Kuala Lumpur, Malaysia; [Ji, Hezhao; Sandstrom, Paul] Publ Hlth Agcy Canada, JC Wilt Infect Dis Res Ctr, Natl HIV & Retrovirol Labs, Winnipeg, MB, Canada	Duke University; Duke University; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; National Institute for Communicable Diseases (NICD); Abbott Laboratories; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Universiti Malaya; Public Health Agency of Canada	Gao, F (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA.; Gao, F (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Busch, MP (corresponding author), Blood Syst Res Inst, San Francisco, CA USA.; Busch, MP (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	mbusch@bloodsystems.org; fgao@duke.edu	Tee, Kok Keng/A-8148-2008; Ragupathy, Viswanath/ABA-3444-2021; Sabino, Ester C/F-7750-2010	Tee, Kok Keng/0000-0002-7923-5448; Sabino, Ester C/0000-0003-2623-5126; Keating, Sheila/0000-0002-8324-3694; Ji, Hezhao/0000-0002-5451-6294; Ledwaba, Johanna/0000-0003-4727-1601	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for External Quality Assurance Program Oversight Laboratory (EQAPOL) [HHSN272201000045C, HHSN272200800014C]; National Heart, Lung, and Blood Institute (NHLBI), NIH [HHSN268201100001I, HHSN268201100007I, HSN268201100008I, HHSN268201100009I]; Global HIV panel project [DAIDS IAA - Y1-HB-5026-01];  [UM.C/625/1/HIR/MOE/CHAN/02/02]	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for External Quality Assurance Program Oversight Laboratory (EQAPOL); National Heart, Lung, and Blood Institute (NHLBI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Global HIV panel project; 	This study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for External Quality Assurance Program Oversight Laboratory (EQAPOL) (HHSN272201000045C and HHSN272200800014C), the National Heart, Lung, and Blood Institute (NHLBI), NIH for funding for the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) (HHSN268201100001I, HHSN268201100007I, HSN268201100008I and HHSN268201100009I), Global HIV panel project (DAIDS IAA - Y1-HB-5026-01) and the High Impact Research grant for KKT (UM.C/625/1/HIR/MOE/CHAN/02/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Abbott Laboratories did not play a role in the study design, decision to publish or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials.	Aldrich C, 2012, TRENDS MOL MED, V18, P691, DOI 10.1016/j.molmed.2012.06.004; Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Berg Michael G, 2016, J Clin Microbiol, V54, P868, DOI 10.1128/JCM.02479-15; Bourlet T, 2011, J CLIN MICROBIOL, V49, P292, DOI 10.1128/JCM.01688-10; Chudy M, 2012, TRANSFUSION, V52, P431, DOI 10.1111/j.1537-2995.2011.03281.x; Delwart E, 2012, J INFECT DIS, V205, P875, DOI 10.1093/infdis/jir862; Fernandez-Garcia A, 2010, AIDS RES HUM RETROV, V26, P827, DOI 10.1089/aid.2009.0311; Foley B., 2013, HIV SEQUENCE COMPEND; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Geretti AM, 2009, CLIN INFECT DIS, V48, P1296, DOI 10.1086/598502; Hemelaar J, 2013, J INFECTION, V66, P391, DOI 10.1016/j.jinf.2012.10.026; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Ji H., 2015, 8 INT AIDS SOC C HIV; Kantor R, 2006, CURR OPIN INFECT DIS, V19, P594, DOI 10.1097/QCO.0b013e3280109122; Klein Marina B, 2014, CMAJ Open, V2, pE318, DOI 10.9778/cmajo.20140017; Kleinman S, 2014, TRANSFUSION, V54, P942, DOI 10.1111/trf.12468; Luk KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141723; Martinez-Cajas JL, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-11; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; Mor O, 2015, J CLIN MICROBIOL, V53, P3458, DOI 10.1128/JCM.01806-15; Muller B, 2013, TRANSFUSION, V53, P2422, DOI 10.1111/trf.12298; Nair SV, 2016, J CLIN VIROL, V77, P46, DOI 10.1016/j.jcv.2016.02.002; Paraskevis D, 2013, AIDS RES HUM RETROV, V29, P461, DOI [10.1089/aid.2012.0143, 10.1089/AID.2012.0143]; Pasquier C, 2001, J VIROL METHODS, V94, P45, DOI 10.1016/S0166-0934(01)00272-5; Peeters M, 2010, CLIN MICROBIOL INFEC, V16, P1525, DOI 10.1111/j.1469-0691.2010.03300.x; Perez L, 2006, AIDS RES HUM RETROV, V22, P724, DOI 10.1089/aid.2006.22.724; Pessoa R, 2015, TRANSFUSION, V55, P980, DOI 10.1111/trf.12936; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Sanchez AM, 2014, J IMMUNOL METHODS, V409, P117, DOI 10.1016/j.jim.2014.01.004; Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Shapland EB, 2015, ACS SYNTH BIOL, V4, P860, DOI 10.1021/sb500362n; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Sierra M, 2007, JAIDS-J ACQ IMM DEF, V45, P151, DOI 10.1097/QAI.0b013e318046ea47; Singh K, 2014, VIRUSES-BASEL, V6, P3535, DOI 10.3390/v6093535; Sutherland KA, 2015, J ANTIMICROB CHEMOTH, V70, P243, DOI 10.1093/jac/dku365; Tatem AJ, 2012, AIDS, V26, P2351, DOI 10.1097/QAD.0b013e328359a904; Touloumi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071174; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; Vidal N, 2006, AIDS RES HUM RETROV, V22, P182, DOI 10.1089/aid.2006.22.182	43	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157340	10.1371/journal.pone.0157340	http://dx.doi.org/10.1371/journal.pone.0157340			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314585	gold, Green Published, Green Submitted			2022-12-27	WOS:000378030000020
J	Laspas, P; Culmann, PD; Grus, FH; Prokosch-Willing, V; Poplawksi, A; Pfeiffer, N; Hoffmann, EM				Laspas, Panagiotis; Culmann, Philipp David; Grus, Franz Hermann; Prokosch-Willing, Verena; Poplawksi, Alicia; Pfeiffer, Norbert; Hoffmann, Esther Maria			A New Method for Revision of Encapsulated Blebs after Trabeculectomy: Combination of Standard Bleb Needling with Transconjunctival Scleral Flap Sutures Prevents Early Postoperative Hypotony	PLOS ONE			English	Article							LONG-TERM OUTCOMES; MITOMYCIN-C; MACULOPATHY; MORPHOLOGY; INJECTION; EFFICACY; SAFETY	Purpose A simple needling procedure is the standard method for restoring the function of an encapsulated bleb after trabeculectomy. However, postoperative hypotony represents a possible hazard. This study describes a new surgical approach for treating encapsulated blebs with reduced risk of early postoperative hypotony: bleb needling combined with transconjunctival sutures tightening the scleral flap directly. Methods The study included two groups of 23 patients with failing bleb following trabeculectomy: "Group 1" underwent simple needling revision of the filtering bleb and served as a control group, while "Group 2" received needling revision with additional transconjunctival scleral flap sutures, if intraoperatively the intraocular pressure was estimated to be very low. Intraocular pressure (IOP), postoperative management and complications were analyzed over a follow-up period of 4 weeks postoperatively. Results were compared using t-test or Mann-Whitney U-tests. Results Adverse effects occurred with a higher frequency after sole needling of the bleb (5 cases of choroidal effusion and 1 case of choroidal hemorrhage) than after the combined method with additional scleral sutures (1 case of choroidal effusion). The IOP on the first postoperative day was significantly lower in group 1, with 9.43 +/- 9.01 mm Hg vs. 16.43 +/- 8.35 mm Hg in group 2 (P = 0.01). Ten patients with ocular hypotony (IOD of 5 mmHg or lower) were found in group 1 and only two in group 2. One week and one month after surgery the intraocular pressure was similar in both groups (P>0.05). Conclusions This new needling technique with additional transconjunctival scleral flap sutures appears to reduce postoperative hypotony, and may thus protect from further complications, such as subchoroidal hemorrhage.	[Laspas, Panagiotis; Culmann, Philipp David; Grus, Franz Hermann; Prokosch-Willing, Verena; Poplawksi, Alicia; Pfeiffer, Norbert; Hoffmann, Esther Maria] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Laspas, P (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany.	panoslaspas@gmail.com	Hoffmann, Esther/AAY-3575-2020; Hoffmann, Esther/AAO-5968-2021; Pfeiffer, Norbert/AAO-7586-2020; Poplawski, Alicia/U-4910-2019	Hoffmann, Esther/0000-0002-0949-4268; Schulze, Alicia/0000-0003-2527-0763				Anand N, 2009, J GLAUCOMA, V18, P513, DOI 10.1097/IJG.0b013e3181911271; Azuara-Blanco A, 1998, SURV OPHTHALMOL, V43, P93, DOI 10.1016/S0039-6257(98)00025-3; Cohen SM, 1995, OPHTHALMIC SURG LAS, V26, P435; De Fendi LI, 2013, CLIN EXP OPHTHALMOL, V41, P798, DOI 10.1111/ceo.12097; Dinah C, 2010, BRIT J OPHTHALMOL, V94, P392, DOI 10.1136/bjo.2009.164160; Eha J, 2013, AM J OPHTHALMOL, V155, P864, DOI 10.1016/j.ajo.2012.12.004; Errico D, 2011, CLIN OPHTHALMOL, V5, P1679, DOI 10.2147/OPTH.S25611; Green E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001132.pub2; Kawai M, 2014, CASE REP OPHTHALM, V5, P297, DOI 10.1159/000368159; Koukkoulli A, 2015, GRAEF ARCH CLIN EXP, V253, P99, DOI 10.1007/s00417-014-2810-4; Letartre L, 2009, CAN J OPHTHALMOL, V44, P567, DOI 10.3129/i09-123; Maestrini HA, 2011, OPHTHALMOLOGY, V118, P755, DOI 10.1016/j.ophtha.2010.08.020; NUYTS RMMA, 1994, AM J OPHTHALMOL, V118, P322, DOI 10.1016/S0002-9394(14)72956-3; Occleston NL, 1997, INVEST OPHTH VIS SCI, V38, P1998; Radhakrishnan S, 2009, OPHTHALMOLOGY, V116, P1713, DOI 10.1016/j.ophtha.2009.04.003; Rotchford AP, 2008, OPHTHALMOLOGY, V115, P1148, DOI 10.1016/j.ophtha.2007.10.023; Rulli E, 2013, JAMA OPHTHALMOL, V131, P1573, DOI 10.1001/jamaophthalmol.2013.5059; Schwenn O, 2001, J GLAUCOMA, V10, P85, DOI 10.1097/00061198-200104000-00003; Shafi F, 2011, CAN J OPHTHALMOL, V46, P537, DOI 10.1016/j.jcjo.2011.09.005; SHERWOOD MB, 1987, ARCH OPHTHALMOL-CHIC, V105, P1517, DOI 10.1001/archopht.1987.01060110063032	20	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157320	10.1371/journal.pone.0157320	http://dx.doi.org/10.1371/journal.pone.0157320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314495	Green Published, Green Submitted, gold			2022-12-27	WOS:000378030000019
J	Recha-Sancho, L; Semino, CE				Recha-Sancho, Lourdes; Semino, Carlos E.			Chondroitin Sulfate- and Decorin-Based Self-Assembling Scaffolds for Cartilage Tissue Engineering	PLOS ONE			English	Article							MOUSE EMBRYONIC FIBROBLASTS; MESENCHYMAL STEM-CELLS; IN-VITRO; CHONDROCYTES; HYDROGEL; MATRIX; REPAIR; DEFECTS; BONE; DIFFERENTIATION	Cartilage injury and degenerative tissue progression remain poorly understood by the medical community. Therefore, various tissue engineering strategies aim to recover areas of damaged cartilage by using non-traditional approaches. To this end, the use of biomimetic scaffolds for recreating the complex in vivo cartilage microenvironment has become of increasing interest in the field. In the present study, we report the development of two novel biomaterials for cartilage tissue engineering (CTE) with bioactive motifs, aiming to emulate the native cartilage extracellular matrix (ECM). We employed a simple mixture of the self-assembling peptide RAD16-I with either Chondroitin Sulfate (CS) or Decorin molecules, taking advantage of the versatility of RAD16-I. After evaluating the structural stability of the bi-component scaffolds at a physiological pH, we characterized these materials using two different in vitro assessments: re-differentiation of human articular chondrocytes (AC) and induction of human adipose derived stem cells (ADSC) to a chondrogenic commitment. Interestingly, differences in cellular morphology and viability were observed between cell types and culture conditions (control and chondrogenic). In addition, both cell types underwent a chondrogenic commitment under inductive media conditions, and this did not occur under control conditions. Remarkably, the synthesis of important ECM constituents of mature cartilage, such as type II collagen and proteoglycans, was confirmed by gene and protein expression analyses and toluidine blue staining. Furthermore, the viscoelastic behavior of ADSC constructs after 4 weeks of culture was more similar to that of native articular cartilage than to that of AC constructs. Altogether, this comparative study between two cell types demonstrates the versatility of our novel biomaterials and suggests a potential 3D culture system suitable for promoting chondrogenic differentiation.	[Recha-Sancho, Lourdes; Semino, Carlos E.] Ramon Llull Univ, IQS Sch Engn, Dept Bioengn, Tissue Engn Lab, Barcelona, Spain	Universitat Ramon Llull; Institut Quimic de Sarria	Semino, CE (corresponding author), Ramon Llull Univ, IQS Sch Engn, Dept Bioengn, Tissue Engn Lab, Barcelona, Spain.	carlos.semino@iqs.url.edu	Semino, Carlos/AAF-2298-2019		AO Foundation in Acute Cartilage Injury Collaborative Research Program (ACI CRP) under the project "Bioactive and biomimetic scaffolds for cartilage regeneration" (BIOCART); "Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement" of Catalan Government; Fons Socials Europeus [2015FI_B2 00109]	AO Foundation in Acute Cartilage Injury Collaborative Research Program (ACI CRP) under the project "Bioactive and biomimetic scaffolds for cartilage regeneration" (BIOCART); "Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement" of Catalan Government; Fons Socials Europeus	This research was supported by funding from the AO Foundation in Acute Cartilage Injury Collaborative Research Program (ACI CRP) under the project "Bioactive and biomimetic scaffolds for cartilage regeneration" (BIOCART). The authors thank "Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement" of Catalan Government and "Fons Socials Europeus" for the pre-doctoral fellowship 2015FI_B2 00109 to Lourdes Recha Sancho.; This research was supported by funding from the AO Foundation in Acute Cartilage Injury Collaborative Research Program(ACI CRP) under the project "Bioactive and biomimetic scaffolds for cartilage regeneration" (BIOCART). We thank "Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement" of Catalan Government and "Fons Socials Europeus" for the pre-doctoral fellowship 2015FI_B2 00109 to Lourdes Recha Sancho. We also thank the Materials Science Laboratory of the IQS-School of Engineering for kindly helping us with the DMA analysis and Scientific and Technological Centers of Barcelona University for SEM services. Additionally, we thank Maria Pilar Armengol from the Genomic Unit of the IGTP for her help with quantitative PCR.	Alemany-Ribes M, 2014, ADV DRUG DELIVER REV, V79-80, P40, DOI 10.1016/j.addr.2014.06.004; Alemany-Ribes M, 2013, TISSUE ENG PT A, V19, P1665, DOI [10.1089/ten.TEA.2012.0661, 10.1089/ten.tea.2012.0661]; Baghaban Eslaminejad Mohamadreza, 2014, World J Stem Cells, V6, P344, DOI 10.4252/wjsc.v6.i3.344; Bauge C, 2014, AGING DIS, V5, P394, DOI 10.14336/AD.2014.0500394; Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Bussmann B.M., 2013, J TISSUE ENG REGEN M; Cals FLJ, 2012, J TISSUE ENG REGEN M, V6, P68, DOI 10.1002/term.399; Castells-Sala C, 2012, IEEE ENG MED BIO, P5658, DOI 10.1109/EMBC.2012.6347278; Castells-sala C, 2013, BIOCHIPS TISSUE CHIP, DOI [10.4172/2153-0777.S2-004, DOI 10.4172/2153-0777.S2-004]; Chen WC, 2011, J BIOSCI BIOENG, V111, P226, DOI 10.1016/j.jbiosc.2010.10.002; Chiang HS, 2009, J FORMOS MED ASSOC, V108, P87, DOI 10.1016/S0929-6646(09)60039-5; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; Fernandez-Muinos T, 2015, ACTA BIOMATER, V16, P35, DOI 10.1016/j.actbio.2015.01.008; Fernandez-Muinos T, 2014, TISSUE ENG PT A, V20, P1145, DOI 10.1089/ten.tea.2013.0369; Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215; Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012; Genove E, 2009, J CELL MOL MED, V13, P3387, DOI 10.1111/j.1582-4934.2009.00970.x; Girotto D, 2003, BIOMATERIALS, V24, P3265, DOI 10.1016/S0142-9612(03)00160-1; Grad S, 2006, EFFECTS SIMPLE COMPL, P12; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hubka KM, 2014, TISSUE ENG PART B-RE, V20, P641, DOI [10.1089/ten.teb.2014.0034, 10.1089/ten.TEB.2014.0034]; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Jeng L, 2011, PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION, P761, DOI 10.1016/B978-0-12-381422-7.10042-2; Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18; Keeney M, 2011, CURR OPIN BIOTECH, V22, P734, DOI 10.1016/j.copbio.2011.04.003; Kim M, 2011, BIOMATERIALS, V32, P7883, DOI 10.1016/j.biomaterials.2011.07.015; Kopesky PW, 2010, SELF ASSEMBLING PEPT, P16; LaPorta TF, 2012, ORTHOP CLIN N AM, V43, P245, DOI 10.1016/j.ocl.2012.02.002; Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016; LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1051, P266, DOI 10.1016/0167-4889(90)90132-W; Mari-Buye N, 2013, TISSUE ENG PT A, V19, P870, DOI [10.1089/ten.tea.2012.0077, 10.1089/ten.TEA.2012.0077]; Merceron C, 2008, JOINT BONE SPINE, V75, P672, DOI 10.1016/j.jbspin.2008.07.007; Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048; Mullen LM, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5325-y; Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quinatana L, 2009, TISSUE ENG PT A, V15, P45, DOI 10.1089/ten.tea.2007.0296; Recha-Sancho L, 2016, J BIOMED MATER RES P; Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#; Seidler DG, 2008, IUBMB LIFE, V60, P729, DOI 10.1002/iub.115; Semino CE, 2008, J DENT RES, V87, P606, DOI 10.1177/154405910808700710; Semino CE, 2003, J BIOMED BIOTECHNOL, P164, DOI 10.1155/S1110724303208019; Semino CE, 2004, TISSUE ENG PART, V10; Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1; Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241; Tiedemann K, 2005, GLYCOBIOLOGY, V15, P1277, DOI 10.1093/glycob/cwj027; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806; Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002; Vater C, 2011, ACTA BIOMATER, V7, P463, DOI 10.1016/j.actbio.2010.07.037; Wu Jonathan, 2010, Journal of Nanobiotechnology, V8, P29, DOI 10.1186/1477-3155-8-29	53	25	26	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157603	10.1371/journal.pone.0157603	http://dx.doi.org/10.1371/journal.pone.0157603			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315119	Green Published, Green Submitted, gold			2022-12-27	WOS:000378030000040
J	Custodio, IDD; Marinho, ED; Gontijo, CA; Pereira, TSS; Paiva, CE; Maia, YCD				Dias Custodio, Isis Danyelle; Marinho, Eduarda da Costa; Gontijo, Cristiana Araujo; Silva Pereira, Taisa Sabrina; Paiva, Carlos Eduardo; de Paiva Maia, Yara Cristina			Impact of Chemotherapy on Diet and Nutritional Status of Women with Breast Cancer: A Prospective Study	PLOS ONE			English	Article							HEALTHY EATING INDEX; PHYSICAL-ACTIVITY; ENERGY-INTAKE; WEIGHT CHANGE; QUALITY; INFLAMMATION; OBESITY; SURVIVORS; RISK; GAIN	Certain food groups are often rejected during chemotherapy (CT) due to the side effects of treatment, which may interfere with adequate diet and nutritional status. The aim of this study was to evaluate the treatment impact on the diet and nutritional status of women with breast cancer (BC). In this prospective longitudinal study, conducted in 2014-2015, 55 women diagnosed with BC, with a mean age 51.5 +/- 10.1 years, were followed and data were collected at three different times. Anthropometric and dietary assessments were performed, the latter by applying nine 24h dietary recalls, by using the Brazilian Healthy Eating Index Revised (BHEI-R), and calculating the prevalence of inadequacy by the EAR cut-off point method. Regarding the BHEI-R analysis, the majority of women had a "diet requires modification', both at the beginning (T0, 58.2%, n = 32) and during treatment (T1, 54.5%, n = 30). However, after the end of the CT, the greater percentage of patients (T2, 49.1%, n = 27) were classified as having an "inadequate diet", since the Total Fruit consumption as well as the Dark Green and Orange Vegetable and Legume consumption decreased significantly during treatment (p = 0.043 and p = 0.026, respectively). There was a significant reduction in the intake of macro and micronutrients, with a high prevalence of inadequacy, of up to 100%, for calcium, iron, phosphorus, magnesium, niacin, riboflavin, thiamin, vitamin B6, vitamin C and zinc. Assessment of the nutritional status indicated that 56% (n = 31) of patients were overweight at these three different times. Weight, BMI and Waist Circumference increased significantly, indicating a worse nutritional status, and there was a correlation between poor diet quality and higher values for BMI, Waist-Hip Ratio and Waist-to-Height Ratio. Chemotherapy interferes in the patients' diet generating a negative impact on the quality and intake of micro and macronutrients, as well as an impact on their nutritional status, with an increase in anthropometric measurements.	[Dias Custodio, Isis Danyelle; Marinho, Eduarda da Costa; Gontijo, Cristiana Araujo; de Paiva Maia, Yara Cristina] Univ Fed Uberlandia, Grad Program Hlth Sci, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil; [Silva Pereira, Taisa Sabrina] Univ Fed Espirito Santo, Grad Program Publ Hlth, Vitoria, ES, Brazil; [Paiva, Carlos Eduardo] Barretos Canc Hosp, Dept Clin Oncol, Grad Program Oncol, Palliat Care & Qual Life Res Grp GPQual,Pio Fdn 1, Barretos, SP, Brazil	Universidade Federal de Uberlandia; Universidade Federal do Espirito Santo; Hospital de Cancer de Barretos	Maia, YCD (corresponding author), Univ Fed Uberlandia, Grad Program Hlth Sci, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	yara.maia@ufu.br	Maia, Yara/AAT-8314-2020; Pereira, Taísa Sabrina Silva/AAB-3715-2021; Gontijo, Cristiana Araújo/AAP-8315-2020; Paiva, Carlos E/F-4810-2012; Gontijo, Cristiana/AAI-2118-2019	Pereira, Taísa Sabrina Silva/0000-0002-5922-7424; Gontijo, Cristiana Araújo/0000-0002-0957-273X; Paiva Maia, Yara Cristina de/0000-0001-9169-5028; Paiva, Carlos Eduardo/0000-0002-7934-1451; Custodio, Isis Danyelle Dias/0000-0003-2741-5110	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq) [449938/2014-0]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Fundacao PIO XII	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao PIO XII	This study received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil (CNPq Grant number: 449938/2014-0), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and to Fundacao PIO XII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches MV, 2011, EUR J CANCER PREV, V20, P403, DOI 10.1097/CEJ.0b013e328347618e; Ahmed Syed Danish Haseen, 2015, Asian Pac J Cancer Prev, V16, P4945; Ambrosi C, 2011, REV BRAS GINECOL OBS, V33, P207, DOI 10.1590/S0100-72032011000800007; [Anonymous], 1995, PHYS STAT US INT ANT; [Anonymous], 2011, TAB BRAS COMP AL; Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Aune D, 2012, BREAST CANCER RES TR, V134, P479, DOI 10.1007/s10549-012-2118-1; Azim HA, 2011, ANN ONCOL, V22, P1939, DOI 10.1093/annonc/mdq683; Beasley JM, 2011, BREAST CANCER RES TR, V128, P229, DOI 10.1007/s10549-010-1323-z; BEATON GH, 1994, AM J CLIN NUTR, V59, p253S, DOI 10.1093/ajcn/59.1.253S; Bell KE, 2014, CLIN NUTR, V33, P550, DOI 10.1016/j.clnu.2013.08.001; Boltong A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103512; Brasil. Ministerio da Saude (MS), 2015, VIG BRAS 2014 VIG FA; Brasil. Ministerio da Saude. Secretaria de Atsencao a Saude. Coordenacao-Geral da Politica de Alimentacao e Nutricao, 2006, GUIA AL POP BRAS PRO; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Ceccatto V, 2014, NUTR HOSP, V30, P1101, DOI 10.3305/nh.2014.30.5.7439; Chen XL, 2011, NUTR CANCER, V63, P538, DOI 10.1080/01635581.2011.539316; de Andrade SC, 2013, REV SAUDE PUBL, V47, P675, DOI 10.1590/S0034-8910.2013047004267; Eilat-Adar S, 2013, NUTRIENTS, V5, P3646, DOI 10.3390/nu5093646; Fabian CJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0571-6; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fisberg Regina Mara, 2004, Rev. Nutr., V17, P301, DOI 10.1590/S1415-52732004000300003; Food and Agriculture Organization [FAO], 2010, FAO FOOD NUTR PAPER; George SM, 2014, CANCER EPIDEM BIOMAR, V23, P575, DOI 10.1158/1055-9965.EPI-13-1162; George SM, 2011, CANCER CAUSE CONTROL, V22, P589, DOI 10.1007/s10552-011-9732-9; George SM, 2010, CANCER EPIDEM BIOMAR, V19, P2220, DOI 10.1158/1055-9965.EPI-10-0464; Guenther PM, 2007, DEV EVALUATION HLTH, P1; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; INCA, 2015, EST 2016 INC CANC BR; IOM, 1997, DIET REF INT TABL AP; Irwin ML, 2004, MED SCI SPORT EXER, V36, P1484, DOI 10.1249/01.MSS.0000074670.03001.98; Izano MA, 2013, NUTR CANCER, V65, P820, DOI 10.1080/01635581.2013.804939; Karimi Z, 2014, PUBLIC HEALTH NUTR, V17, P1098, DOI 10.1017/S1368980013001018; KENNEDY ET, 1995, J AM DIET ASSOC, V95, P1103, DOI 10.1016/S0002-8223(95)00300-2; Kim EHJ, 2011, NUTR CANCER, V63, P381, DOI 10.1080/01635581.2011.535963; Kottschade L, 2016, SUPPORT CARE CANCER, V24, P2661, DOI 10.1007/s00520-016-3080-y; Kwan ML, 2009, J CLIN ONCOL, V27, P919, DOI 10.1200/JCO.2008.19.4035; Kwok A, 2015, SUPPORT CARE CANCER, V23, P1561, DOI 10.1007/s00520-014-2496-5; LIPSCHITZ DA, 1994, PRIMARY CARE, V21, P55; Milliron BJ, 2014, J ACAD NUTR DIET, V114, P932, DOI 10.1016/j.jand.2013.08.015; Mourouti N, 2015, INT J FOOD SCI NUTR, V66, P1, DOI 10.3109/09637486.2014.950207; Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570; Nusser SM, 1995, 6 IOW STAT U CTR AGR, P1; Patnaik JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2901; Patterson RE, 2011, J NUTR, V141, P201, DOI 10.3945/jn.110.128777; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Previdelli AN, 2011, REV SAUDE PUBL, V45, P794, DOI 10.1590/S0034-89102011005000035; Qiu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036497; Rockenbach G, 2011, NUTR HOSP, V26, P737, DOI [10.1590/S0212-16112011000400011, 10.3305/nh.2011.26.4.5067]; San Felipe MJR, 2013, NUTR HOSP, V28, P1829, DOI [10.3305/nh.2013.28.6.6981, 10.3305/nutr hosp.v28in06.6981]; Shivappa N, 2015, BRIT J CANCER, V113, P1099, DOI 10.1038/bjc.2015.304; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115; Tredan O, 2010, CLIN NUTR, V29, P187, DOI 10.1016/j.clnu.2009.08.003; *USDA, 2005, DIET GUID AM; Vance V, 2011, OBES REV, V12, P282, DOI 10.1111/j.1467-789X.2010.00805.x; Vance V, 2014, APPL PHYSIOL NUTR ME, V39, P707, DOI 10.1139/apnm-2013-0400; Velentzis LS, 2011, BREAST CANCER RES TR, V128, P473, DOI 10.1007/s10549-010-1238-8; Wayne SJ, 2006, BREAST CANCER RES TR, V96, P227, DOI 10.1007/s10549-005-9018-6; WCRF World Cancer Research Fund, 2014, DIET NUTR PHYS ACT B; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Yaw YH, 2014, ASIAN PAC J CANCER P, V15, P39, DOI 10.7314/APJCP.2014.15.1.39; Zuniga K. E., 2015, EUR J NUTR, P1	66	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157113	10.1371/journal.pone.0157113	http://dx.doi.org/10.1371/journal.pone.0157113			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310615	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800035
J	Guest, SK; Ribas, R; Pancholi, S; Nikitorowicz-Buniak, J; Simigdala, N; Dowsett, M; Johnston, SR; Martin, LA				Guest, Stephanie K.; Ribas, Ricardo; Pancholi, Sunil; Nikitorowicz-Buniak, Joanna; Simigdala, Nikiana; Dowsett, Mitch; Johnston, Stephen R.; Martin, Lesley-Ann			Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation	PLOS ONE			English	Article							ER-ALPHA PHOSPHORYLATION; TAMOXIFEN-RESISTANT; ANTITUMOR-ACTIVITY; MOLECULAR MARKERS; DASATINIB THERAPY; PATIENT SELECTION; KINASE INHIBITOR; GENE-EXPRESSION; MCF-7 CELLS; PATHWAYS	Despite the effectiveness of endocrine therapies in estrogen receptor positive (ER+) breast cancer, approximately 40% of patients relapse. Previously, we identified the Focal-adhesion kinase canonical pathway as a major contributor of resistance to estrogen deprivation and cellular-sarcoma kinase (c-src) as a dominant gene in this pathway. Dasatinib, a pansrc inhibitor, has recently been used in clinical trials to treat ER+ patients but has shown mixed success. In the following study, using isogenic cell line models, we provide a potential explanation for these findings and suggest a sub-group that may benefit. A panel of isogenic cell lines modelling resistance to aromatase inhibitors (LTED) and tamoxifen (TAMR) were assessed for response to dasatinib +/- endocrine therapy. Dasatinib caused a dose-dependent decrease in proliferation in MCF7-TAMR cells and resensitized them to tamoxifen and fulvestrant but not in HCC1428-TAMR. In contrast, in estrogen-deprived conditions, dasatinib increased the proliferation rate of parental-MCF7 cells and had no effect on MCF7-LTED or HCC1428-LTED. Treatment with dasatinib caused a decrease in src-phosphorylation and inhibition of downstream pathways, including AKT and ERK1/2 in all cell lines tested, but only the MCF7-TAMR showed a concomitant decrease in markers of cell cycle progression. Inhibition of src also caused a significant decrease in cell migration in both MCF7-LTED and MCF7-TAMR cells. Finally, we showed that, in MCF7-TAMR cells, in contrast to tamoxifen sensitive cell lines, ER is expressed throughout the cell rather than being restricted to the nucleus and that treatment with dasatinib resulted in nuclear shuttling of ER, which was associated with an increase in ER-mediated transcription. These data suggest that src has differential effects in endocrine-resistant cell lines, particularly in tamoxifen resistant models, with low ER genomic activity, providing further evidence of the importance of patient selection for clinical trials testing dasatinib utility in ER+ breast cancer.	[Guest, Stephanie K.; Ribas, Ricardo; Pancholi, Sunil; Nikitorowicz-Buniak, Joanna; Simigdala, Nikiana; Dowsett, Mitch; Martin, Lesley-Ann] Inst Canc Res, Breast Canc Now & Toby Robins Res Ctr, London SW3 6JB, England; [Dowsett, Mitch; Johnston, Stephen R.] Royal Marsden Hosp, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Martin, LA (corresponding author), Inst Canc Res, Breast Canc Now & Toby Robins Res Ctr, London SW3 6JB, England.	lesley-ann.martin@icr.ac.uk	Martin, Lesley-Ann/AAA-1841-2020	Ribas, Ricardo/0000-0002-8134-0036; Dowsett, Mitch/0000-0003-4122-744X; Pancholi, Sunil/0000-0002-0880-1588; Nikitorowicz-Buniak, Joanna/0000-0002-7510-3843	Breast Cancer Now; NHS funding to the Royal Marsden Hospital's NIHR Biomedical Research Centre; National Institute for Health Research [NF-SI-0512-10122] Funding Source: researchfish	Breast Cancer Now; NHS funding to the Royal Marsden Hospital's NIHR Biomedical Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge Breast Cancer Now and NHS funding to the Royal Marsden Hospital's NIHR Biomedical Research Centre for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; [Anonymous], 2014, CANC DISCOV, V4, P138; Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Beliakoff J, 2003, CLIN CANCER RES, V9, P4961; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Brann DW, 2008, MOL CELL ENDOCRINOL, V290, P2, DOI 10.1016/j.mce.2008.04.019; Caccia D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-278; Castoria G, 2012, ONCOGENE, V31, P4868, DOI 10.1038/onc.2011.642; Ceppi P, 2009, MOL CANCER THER, V8, P3066, DOI 10.1158/1535-7163.MCT-09-0151; Chakravarty D, 2010, IUBMB LIFE, V62, P163, DOI 10.1002/iub.287; Cheskis BJ, 2008, STEROIDS, V73, P901, DOI 10.1016/j.steroids.2007.12.028; Eastman BM, 2012, CELL SIGNAL, V24, P1847, DOI 10.1016/j.cellsig.2012.05.011; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Finn RS, 2011, CLIN CANCER RES, V17, P6905, DOI 10.1158/1078-0432.CCR-11-0288; Herold CI, 2011, CLIN CANCER RES, V17, P6061, DOI 10.1158/1078-0432.CCR-11-1071; Hiscox S, 2006, BREAST CANCER RES TR, V97, P263, DOI 10.1007/s10549-005-9120-9; Huang F, 2007, CANCER RES, V67, P2226, DOI 10.1158/0008-5472.CAN-06-3633; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Konecny GE, 2009, BRIT J CANCER, V101, P1699, DOI 10.1038/sj.bjc.6605381; Llombart A, 2012, CANC RES S, V71; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; LYKKESFELDT AE, 1994, CANCER RES, V54, P1587; Martin LA, 2003, J BIOL CHEM, V278, P30458, DOI 10.1074/jbc.M305226200; Mayer EL, 2011, CLIN CANCER RES, V17, P6897, DOI 10.1158/1078-0432.CCR-11-0070; Moulder S, 2010, MOL CANCER THER, V9, P1120, DOI 10.1158/1535-7163.MCT-09-1117; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Pancholi S, 2008, ENDOCR-RELAT CANCER, V15, P985, DOI 10.1677/ERC-07-0240; Patani N, 2012, BREAST CANCER RES TR, V131, P1, DOI 10.1007/s10549-011-1751-4; Paul D, 2014, CANC RES S, V73; Pusztai L, 2014, CLIN CANCER RES, V20, P5265, DOI 10.1158/1078-0432.CCR-14-0800; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Sarwar N, 2006, ENDOCR-RELAT CANCER, V13, P851, DOI 10.1677/erc.1.01123; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Sun J, 2012, MOL ENDOCRINOL, V26, P1567, DOI 10.1210/me.2012-1140; Thomas NBP, 2010, BREAST CANCER RES TR, V119, P575, DOI 10.1007/s10549-009-0355-8; Tryfonopoulos D, 2011, ANN ONCOL, V22, P2234, DOI 10.1093/annonc/mdq757; Wang XD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r255; Weigel MT, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3191; Wright G, 2012, CANC RES, V71	42	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157397	10.1371/journal.pone.0157397	http://dx.doi.org/10.1371/journal.pone.0157397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308830	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800065
J	Hwang, SD; Kim, SH; Kim, YO; Jin, DC; Song, HC; Choi, EJ; Kim, YL; Kim, YS; Kang, SW; Kim, NH; Yang, CW; Kim, YK				Hwang, Seun Deuk; Kim, Su-Hyun; Kim, Young Ok; Jin, Dong Chan; Song, Ho Chul; Choi, Euy Jin; Kim, Yong-Lim; Kim, Yon-Su; Kang, Shin-Wook; Kim, Nam-Ho; Yang, Chul Woo; Kim, Yong Kyun			Serum Alkaline Phosphatase Levels Predict Infection-Related Mortality and Hospitalization in Peritoneal Dialysis Patients	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; CALCIFICATION; INFLAMMATION	Background Serum alkaline phosphatase (ALP) levels have been reported to be associated with all-cause and cardiovascular mortality in peritoneal dialysis (PD) patients. However, it is unclear whether serum ALP levels predict infection-related clinical outcomes in PD patients. The aim of this study was to determine the relationships between serum ALP levels, infection-related mortality and hospitalization in PD patients. Methods PD patients from the Clinical Research Center registry for end-stage renal disease, a multicenter prospective observational cohort study in Korea, were included in the present study. Patients were categorized into three groups by serum ALP tertiles as follows: Tertile 1, ALP <78 U/L; Tertile 2, ALP = 78-155 U/L; Tertile 3, ALP >155 U/L. Tertile 1 was used as the reference category. The primary outcomes were infection-related mortality and hospitalization. Results A total of 1,455 PD patients were included. The median follow-up period was 32 months. The most common cause of infection-related mortality and hospitalization was PD-related peritonitis. Multivariate Cox regression analyses showed that patients in the highest tertiles of serum ALP levels were at higher risk of infection-related mortality (HR 2.29, 95% CI, 1.42-5.21, P = 0.008) after adjustment for clinical variables. Higher tertiles of serum ALP levels were associated with higher risk of infection-related hospitalization (Tertile 2: HR 1.56, 95% CI, 1.18-2.19, P = 0.009, tertile 3: HR 1.34, 95% CI, 1.03-2.62, P = 0.031). Conclusions Our data showed that elevated serum ALP levels were independently associated with a higher risk of infection-related mortality and hospitalization in PD patients.	[Hwang, Seun Deuk; Kim, Young Ok; Jin, Dong Chan; Song, Ho Chul; Choi, Euy Jin; Yang, Chul Woo; Kim, Yong Kyun] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Su-Hyun] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Kim, Yon-Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea; [Kim, Yong Kyun] Catholic Univ Korea, Cell Death Dis Res Ctr, Seoul, South Korea	Catholic University of Korea; Chung Ang University; Chung Ang University Hospital; Kyungpook National University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Chonnam National University; Catholic University of Korea	Kim, YK (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, YK (corresponding author), Catholic Univ Korea, Cell Death Dis Res Ctr, Seoul, South Korea.	drkimyk@catholic.ac.kr			Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azechi T, 2013, J ATHEROSCLER THROMB, V20, P538, DOI 10.5551/jat.15826; Blayney MJ, 2008, KIDNEY INT, V74, P655, DOI 10.1038/ki.2008.248; Campbell EL, 2010, P NATL ACAD SCI USA, V107, P14298, DOI 10.1073/pnas.0914730107; Chuang SH, 2015, SINGAPORE MED J; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; Collins AJ, 1999, AM J KIDNEY DIS, V34, P1065, DOI 10.1016/S0272-6386(99)70012-0; Horowitz MC, 2005, IMMUNOL REV, V208, P141, DOI 10.1111/j.0105-2896.2005.00328.x; Huang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071636; Inoshita H, 2008, CLIN NEPHROL, V69, P58; Johnson DW, 2009, CLIN J AM SOC NEPHRO, V4, P1620, DOI 10.2215/CJN.01750309; Kerner A, 2005, ARTERIOSCL THROM VAS, V25, P193, DOI 10.1161/01.ATV.0000148324.63685.6a; Kim H, 2014, KIDNEY INT, V86, P991, DOI 10.1038/ki.2014.163; Lammers WJ, 2014, GASTROENTEROLOGY, V147, P1338, DOI 10.1053/j.gastro.2014.08.029; Liu XH, 2014, CLIN J AM SOC NEPHRO, V9, P771, DOI 10.2215/CJN.08280813; Pelletier S, 2012, KIDNEY INT, V82, P581, DOI 10.1038/ki.2012.166; Peters E, 2014, AM J KIDNEY DIS, V63, P1038, DOI 10.1053/j.ajkd.2013.11.027; Regidor DL, 2008, J AM SOC NEPHROL, V19, P2193, DOI 10.1681/ASN.2008010014; Rhee CM, 2014, PERITON DIALYSIS INT, V34, P732, DOI 10.3747/pdi.2013.00110; TIETZ NW, 1983, CLIN CHEM, V29, P751; Vanholder R, 2002, BLOOD PURIFICAT, V20, P477, DOI 10.1159/000063556; Ye HJ, 2015, CLIN CHEM LAB MED, V53, pE110, DOI 10.1515/cclm-2014-0770	21	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157361	10.1371/journal.pone.0157361	http://dx.doi.org/10.1371/journal.pone.0157361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310428	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800060
J	Jazi, MM; Khorzoghi, EG; Botanga, C; Seyedi, SM				Jazi, Maryam Moazzam; Khorzoghi, Effat Ghadirzadeh; Botanga, Christopher; Seyedi, Seyed Mahdi			Identification of Reference Genes for Quantitative Gene Expression Studies in a Non-Model Tree Pistachio (Pistacia vera L.)	PLOS ONE			English	Article							REAL-TIME PCR; RT-PCR; HOUSEKEEPING GENES; NORMALIZATION; VALIDATION; SELECTION; QPCR; RNA; STRESS	The tree species, Pistacia vera (P. vera) is an important commercial product that is salt-tolerant and long-lived, with a possible lifespan of over one thousand years. Gene expression analysis is an efficient method to explore the possible regulatory mechanisms underlying these characteristics. Therefore, having the most suitable set of reference genes is required for transcript level normalization under different conditions in P. vera. In the present study, we selected eight widely used reference genes, ACT, EF1 alpha, alpha-TUB, beta-TUB, GAPDH, CYP2, UBQ10, and 18S rRNA. Using qRT-PCR their expression was assessed in 54 different samples of three cultivars of P. vera. The samples were collected from different organs under various abiotic treatments (cold, drought, and salt) across three time points. Several statistical programs (geNorm, NormFinder, and BestKeeper) were applied to estimate the expression stability of candidate reference genes. Results obtained from the statistical analysis were then exposed to Rank aggregation package to generate a consensus gene rank. Based on our results, EF1 alpha was found to be the superior reference gene in all samples under all abiotic treatments. In addition to EF1 alpha, ACT and beta-TUB were the second best reference genes for gene expression analysis in leaf and root. We recommended beta-TUB as the second most stable gene for samples under the cold and drought treatments, while ACT holds the same position in samples analyzed under salt treatment. This report will benefit future research on the expression profiling of P. vera and other members of the Anacardiaceae family.	[Jazi, Maryam Moazzam; Khorzoghi, Effat Ghadirzadeh; Seyedi, Seyed Mahdi] Natl Inst Genet Engn & Biotechnol, Dept Plant Biotechnol, Tehran, Iran; [Botanga, Christopher] Chicago State Univ, Dept Biol Sci, Chicago, IL USA	Chicago State University	Seyedi, SM (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Plant Biotechnol, Tehran, Iran.	Seyedi@nigeb.ac.ir			Iran National Science Foundation (INSF); Iran National Science Foundation (INSF), Tehran, Iran	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); Iran National Science Foundation (INSF), Tehran, Iran(Iran National Science Foundation (INSF))	This work was supported by the Iran National Science Foundation (INSF).; The authors appreciate the financial support for this work provided by the Iran National Science Foundation (INSF), Tehran, Iran.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arabnezhad H, 2011, SCI HORTIC-AMSTERDAM, V128, P249, DOI 10.1016/j.scienta.2011.01.028; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dubrovina AS, 2013, J PLANT PHYSIOL, V170, P1491, DOI 10.1016/j.jplph.2013.06.014; Faccioli P, 2007, PLANT MOL BIOL, V63, P679, DOI 10.1007/s11103-006-9116-9; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Faostat F., 2009, STAT DATABASES; Gantasala Nagavara Prasad, 2013, BMC Res Notes, V6, P312, DOI 10.1186/1756-0500-6-312; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; HABIBI G, 2014, PROG BIOL SCI, V4, P189; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ishitani R, 1996, J NEUROCHEM, V66, P928; Jazi MM, 2015, PHYSIOL MOL BIOL PLA, V21, P597, DOI 10.1007/s12298-015-0319-x; Jiang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092262; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087197; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Kumar V, 2011, AUST J CROP SCI, V5, P1455; Lim FH, 2014, J OIL PALM RES, V26, P170; Ma SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075271; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Marchal Elisabeth, 2013, BMC Res Notes, V6, P237, DOI 10.1186/1756-0500-6-237; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Morgante Carolina V, 2011, BMC Res Notes, V4, P339, DOI 10.1186/1756-0500-4-339; Najafpanah MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083041; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Niu X, 2015, FRONT PLANT SCI, P6; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Robledo D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-648; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Sun M, 2015, PLOS ONE, P10; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang H., 2015, SCI REP, P5; Yoo WG, 2009, PARASITOL RES, V104, P321, DOI 10.1007/s00436-008-1195-x; Zhang LJ, 2014, INT J MOL SCI, V15, P21825, DOI 10.3390/ijms151221825; Zhao WJ, 2011, J IND MICROBIOL BIOT, V38, P1279, DOI 10.1007/s10295-010-0906-3	51	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157467	10.1371/journal.pone.0157467	http://dx.doi.org/10.1371/journal.pone.0157467			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308855	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800078
J	Karamitros, T; Harrison, I; Piorkowska, R; Katzourakis, A; Magiorkinis, G; Mbisa, JL				Karamitros, Timokratis; Harrison, Ian; Piorkowska, Renata; Katzourakis, Aris; Magiorkinis, Gkikas; Mbisa, Jean Lutamyo			De Novo Assembly of Human Herpes Virus Type 1 (HHV-1) Genome, Mining of Non-Canonical Structures and Detection of Novel Drug-Resistance Mutations Using Short- and Long-Read Next Generation Sequencing Technologies	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; COMPLETE DNA-SEQUENCE; SIMPLEX-VIRUS; THYMIDINE KINASE; GENITAL HERPES; VARIABILITY; ALIGNMENT; REPEAT; EVOLUTION; MUTANTS	Human herpesvirus type 1 (HHV-1) has a large double-stranded DNA genome of approximately 152 kbp that is structurally complex and GC-rich. This makes the assembly of HHV-1 whole genomes from short-read sequencing data technically challenging. To improve the assembly of HHV-1 genomes we have employed a hybrid genome assembly protocol using data from two sequencing technologies: the short-read Roche 454 and the long-read Oxford Nanopore MinlON sequencers. We sequenced 18 HHV-1 cell culture-isolated clinical specimens collected from immunocompromised patients undergoing antiviral therapy. The susceptibility of the samples to several antivirals was determined by plaque reduction assay. Hybrid genome assembly resulted in a decrease in the number of contigs in 6 out of 7 samples and an increase in N(G) 50 and N(G) 75 of all 7 samples sequenced by both technologies. The approach also enhanced the detection of non-canonical contigs including a rearrangement between the unique (UL) and repeat (T/IRL) sequence regions of one sample that was not detectable by assembly of 454 reads alone. We detected several known and novel resistance-associated mutations in UL23 and UL30 genes. Genome-wide genetic variability ranged from <1% to 53% of amino acids in each gene exhibiting at least one substitution within the pool of samples. The UL23 gene had one of the highest genetic variabilities at 35.2% in keeping with its role in development of drug resistance. The assembly of accurate, full-length HHV-1 genomes will be useful in determining genetic determinants of drug resistance, virulence, pathogenesis and viral evolution. The numerous, complex repeat regions of the HHV-1 genome currently remain a barrier towards this goal.	[Karamitros, Timokratis; Katzourakis, Aris; Magiorkinis, Gkikas] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England; [Harrison, Ian; Piorkowska, Renata; Magiorkinis, Gkikas; Mbisa, Jean Lutamyo] Publ Hlth England, Natl Infect Serv, Virus Reference Dept, London, England	University of Oxford; Public Health England	Magiorkinis, G (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.; Magiorkinis, G; Mbisa, JL (corresponding author), Publ Hlth England, Natl Infect Serv, Virus Reference Dept, London, England.	gkikas.magiorkinis@zoo.ox.ac.uk; tamyo.mbisa@phe.gov.uk	Karamitros, Timokratis/ABE-3880-2021	Karamitros, Timokratis/0000-0003-0841-9159; Katzourakis, Aris/0000-0003-3328-6204; Mbisa, Jean/0000-0002-0348-9679	Public Health England (PHE) Pump-Priming & Small Initiatives Fund; Medical Research Council (MRC) grant [MR/K010565/1]; MRC [MR/K010565/1] Funding Source: UKRI; Medical Research Council [MR/K010565/1] Funding Source: researchfish	Public Health England (PHE) Pump-Priming & Small Initiatives Fund; Medical Research Council (MRC) grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was partly supported by a Public Health England (PHE) Pump-Priming & Small Initiatives Fund to JLM and by a Medical Research Council (MRC) grant [MR/K010565/1] to GM. The views expressed are those of the authors and not necessarily those of PHE, the Department of Health or MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei G, 2013, CURR OPIN INFECT DIS, V26, P551, DOI 10.1097/QCO.0000000000000015; Andrei G, 2013, J INFECT DIS, V207, P1295, DOI 10.1093/infdis/jit019; Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chayavichitsilp P, 2009, PEDIATR REV, V30, P119, DOI 10.1542/pir.30-4-119; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; CHOU J, 1985, CELL, V41, P803, DOI 10.1016/S0092-8674(85)80061-1; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Colgrove RC, 2016, VIROLOGY, V487, P215, DOI 10.1016/j.virol.2015.09.026; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Garceau R, 2012, CAN J INFECT DIS MED, V23; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Harmenberg J, 2010, ACTA DERM-VENEREOL, V90, P122, DOI 10.2340/00015555-0806; JENKINS FJ, 1986, J VIROL, V59, P494, DOI 10.1128/JVI.59.2.494-499.1986; JENKINS FJ, 1990, INTERVIROLOGY, V31, P129, DOI 10.1159/000150147; Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148; Kolb AW, 2011, INVEST OPHTH VIS SCI, V52, P9061, DOI 10.1167/iovs.11-7812; Kortekangas-Savolainen O, 2014, SEX TRANSM DIS, V41, P268, DOI 10.1097/OLQ.0000000000000101; Labetoulle M, 2005, OPHTHALMOLOGY, V112, P888, DOI 10.1016/j.ophtha.2004.11.052; LARDER BA, 1985, VIROLOGY, V146, P262, DOI 10.1016/0042-6822(85)90009-1; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Macdonald SJ, 2012, J VIROL, V86, P9540, DOI 10.1128/JVI.01469-12; Macdonald SJ, 2012, J VIROL, V86, P6371, DOI 10.1128/JVI.00646-12; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Mahiet C, 2012, J VIROL, V86, P8592, DOI 10.1128/JVI.00223-12; Mbisa J.L., 2013, ANTIVIRAL RESISTANCE; MCGEOCH DJ, 1986, NUCLEIC ACIDS RES, V14, P1727, DOI 10.1093/nar/14.4.1727; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; Morfin F, 2003, J CLIN VIROL, V26, P29, DOI 10.1016/S1386-6532(02)00263-9; Norberg P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022527; Pielberg Gerli, 2007, V373, P147; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; Quick J, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-22; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; SAKAOKA H, 1987, J GEN VIROL, V68, P749, DOI 10.1099/0022-1317-68-3-749; SAKAOKA H, 1995, J MED VIROL, V46, P387, DOI 10.1002/jmv.1890460416; Samra Z, 2003, SEX TRANSM DIS, V30, P794, DOI 10.1097/01.OLQ.0000079517.04451.79; Sauerbrei Andreas, 2010, Virulence, V1, P555, DOI 10.4161/viru.1.6.13806; Schubert A, 2014, ANTIVIR RES, V107, P16, DOI 10.1016/j.antiviral.2014.03.015; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; SMILEY JR, 1990, J VIROL, V64, P5036, DOI 10.1128/JVI.64.10.5036-5050.1990; Szpara ML, 2014, J VIROL, V88, P1209, DOI 10.1128/JVI.01987-13; Szpara ML, 2010, J VIROL, V84, P5303, DOI 10.1128/JVI.00312-10; Takahashi G, 2013, J GEN VIROL, V94, P726, DOI 10.1099/vir.0.044834-0; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Ushijima Y, 2007, MICROBES INFECT, V9, P142, DOI 10.1016/j.micinf.2006.10.019; Warren RL, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0076-3; Watson G, 2012, VIROLOGY, V433, P528, DOI 10.1016/j.virol.2012.08.043; Watson M, 2015, BIOINFORMATICS, V31, P114, DOI 10.1093/bioinformatics/btu590; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Wyles DL, 2005, CLIN INFECT DIS, V41, P676, DOI 10.1086/432477	58	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157600	10.1371/journal.pone.0157600	http://dx.doi.org/10.1371/journal.pone.0157600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309375	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800105
J	Velez, AM; Khajuria, C; Wang, H; Narva, KE; Siegfried, BD				Velez, Ana Maria; Khajuria, Chitvan; Wang, Haichuan; Narva, Kenneth E.; Siegfried, Blair D.			Knockdown of RNA Interference Pathway Genes in Western Corn Rootworms (Diabrotica virgifera virgifera Le Conte) Demonstrates a Possible Mechanism of Resistance to Lethal dsRNA	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DISTINCT ROLES; ARGONAUTE; INSECTS; DICER-2; GENOME	RNA interference (RNAi) is being developed as a potential tool for insect pest management. Increased understanding of the RNAi pathway in target insect pests will provide information to use this technology effectively and to inform decisions related to resistant management strategies for RNAi based traits. Dicer 2 (Dcr2), an endonuclease responsible for formation of small interfering RNA's and Argonaute 2 (Ago2), an essential catalytic component of the RNA-induced silencing complex (RISC) have both been associated with the RNAi pathway in a number of different insect species including the western corn rootworm, Diabrotica virgifera virgifera (Coleoptera: Chrysomelidae). We identified both genes from a transcriptome library generated from different tissues and developmental stages of the western corn rootworm, an important target pest for transgenic plants expressing dsRNA targeting essential genes. The expression of these genes was suppressed by more than 90% after injecting gene specific dsRNA into adult rootworms. The injected beetles were then fed vATPase A dsRNA which has previously been demonstrated to cause mortality in western corn rootworm adults. The suppression of both RNAi pathway genes resulted in reduced mortality after subsequent exposure to lethal concentrations of vATPase A dsRNA as well as increased vATPase A expression relative to control treatments. Injections with dsRNA for a non-lethal target sequence (Laccase 2) did not affect mortality or expression caused by vATPase A dsRNA indicating that the results observed with Argo and Dicer dsRNA were not caused by simple competition among different dsRNA's. These results confirm that both genes play an important role in the RNAi pathway for western corn rootworms and indicate that selection pressures that potentially affect the expression of these genes may provide a basis for future studies to understand potential mechanisms of resistance.	[Velez, Ana Maria; Khajuria, Chitvan; Wang, Haichuan] Univ Nebraska, Dept Entomol, 103 Entomology Hall, Lincoln, NE 68583 USA; [Narva, Kenneth E.] Dow AgroSci, 9330 Zionsville Rd, Indianapolis, IN 46268 USA; [Siegfried, Blair D.] Univ Florida, Dept Entomol & Nematol, POB 110260, Gainesville, FL 32611 USA	University of Nebraska System; University of Nebraska Lincoln; Dow Chemical Company; State University System of Florida; University of Florida	Siegfried, BD (corresponding author), Univ Florida, Dept Entomol & Nematol, POB 110260, Gainesville, FL 32611 USA.	bsiegfried1@ufl.edu		Velez, Ana Maria/0000-0002-8329-6243; Narva, Kenneth/0000-0001-8094-6418	University of Nebraska; Dow AgroSciences	University of Nebraska; Dow AgroSciences	This study was funded through an Industry Partnership Grant between University of Nebraska and Dow AgroSciences. Dow Agrosciences provided the salary for author KN who participated in study design and manuscript preparation. Dow AgroSciences had no role in the data collection and analysis or in the decision to publish.	Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Eyun SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094052; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gassmann AJ, 2012, J INVERTEBR PATHOL, V110, P287, DOI 10.1016/j.jip.2012.04.006; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Miller SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047431; Miyata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101661; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; SAS-Institute, 2011, SAS US MAN VERS 9 3; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Siegfried BD., 2012, GENE CONTAINMENT; Song JJ, 2006, CURR OPIN STRUC BIOL, V16, P5, DOI 10.1016/j.sbi.2006.01.010; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R; Zhang XY, 2013, INSECT SCI, V20, P61, DOI 10.1111/j.1744-7917.2012.01539.x	28	27	28	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157520	10.1371/journal.pone.0157520	http://dx.doi.org/10.1371/journal.pone.0157520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310918	Green Published, gold			2022-12-27	WOS:000378029800089
J	Verloigne, M; Cardon, G; De Craemer, M; D'Haese, S; De Bourdeaudhuij, I				Verloigne, Maite; Cardon, Greet; De Craemer, Marieke; D'Haese, Sara; De Bourdeaudhuij, Ilse			Mediating Effects of Self-Efficacy, Benefits and Barriers on the Association between Peer and Parental Factors and Physical Activity among Adolescent Girls with a Lower Educational Level	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; SOCIAL SUPPORT; FEMALE ADOLESCENTS; PERCEIVED BARRIERS; HEALTH; BEHAVIORS; YOUTH; PARTICIPATION; PERCEPTIONS; FITNESS	Background The prevalence of physical activity among lower educated adolescent girls is low, suggesting it is important to have insights into the complex processes that may underlie their physical activity levels. Therefore, this study aimed to examine the mediating effects of self-efficacy, perceived benefits and barriers on the associations between peer and parental variables and physical activity among lower educated adolescent girls. Methods In total, 226 girls (mean age 16.0 +/- 1.0 years; 53% technical education; 47% vocational education) from a convenience sample of 6 secondary schools in Flanders, Belgium, completed a questionnaire on their total physical activity level and related peer and parental variables (i.e. modeling of physical activity, co-participation in physical activities and encouragement to be active) and personal variables (i.e. self-efficacy to be active, and specific perceived benefits of physical activity and specific barriers to be active). Mediating effects were tested using MacKinnon's product-of-coefficients test based on multilevel linear regression analyses. Results Higher peer and parental modeling, co-participation and encouragement were significantly related to a higher physical activity level among adolescent girls (p<0.05). Self-efficacy, the perceived benefits of having fun, being around friends or meeting new people, and not being bored and the perceived barrier of not liking physical activity mediated several associations between peer and parental variables and girls' physical activity, with some of the mediated proportions exceeding 60%. Conclusions This study contributed to a better understanding of the complexity of how parental and peer factors work together with personal factors to influence the physical activity levels of adolescent girls with a lower educational level. Interventions should involve both peers and parents, as they may influence girls' physical activity both directly and indirectly through the internalisation of several personal variables, such as self-efficacy to be active and the perceived benefit of having fun.	[Verloigne, Maite; Cardon, Greet; De Craemer, Marieke; D'Haese, Sara; De Bourdeaudhuij, Ilse] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Verloigne, Maite; D'Haese, Sara] Res Fdn FWO, Brussels, Belgium	Ghent University	Verloigne, M (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sports Sci, B-9000 Ghent, Belgium.; Verloigne, M (corresponding author), Res Fdn FWO, Brussels, Belgium.	maite.verloigne@ugent.be	De Craemer, Marieke/P-6072-2016; De+Bourdeaudhuij, Ilse/AAC-5528-2019; De Craemer, Marieke/Z-3050-2019	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; De Craemer, Marieke/0000-0002-5220-7850; Cardon, Greet/0000-0003-4983-6557	Fund for Scientific Research Flanders (FWO) [FWO13/PDO/191, FWO12/ASP/102]	Fund for Scientific Research Flanders (FWO)(FWO)	MV and SDH are supported by a grant from the Fund for Scientific Research Flanders (FWO) (grant numbers: MV: FWO13/PDO/191; SDH: FWO12/ASP/102; www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio M, 2002, BRIT J SPORT MED, V36, P360, DOI 10.1136/bjsm.36.5.360; Arredondo EM, 2014, FAM COMMUNITY HEALTH, V37, P6, DOI 10.1097/FCH.0000000000000015; Beets MW, 2010, HEALTH EDUC BEHAV, V37, P621, DOI 10.1177/1090198110363884; Beets MW, 2006, AM J HEALTH BEHAV, V30, P278, DOI 10.5993/AJHB.30.3.6; Biddle SJH, 2005, J PHYS ACT HEALTH, V2, P423, DOI [DOI 10.1123/JPAH.2.4.423, 10.1123/jpah.2.4.423]; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Camacho-Minano MJ, 2011, HEALTH EDUC RES, V26, P1025, DOI 10.1093/her/cyr040; Cheng KY, 2003, J SPORT MED PHYS FIT, V43, P523; Craggs C, 2011, AM J PREV MED, V40, P645, DOI 10.1016/j.amepre.2011.02.025; De Bourdeaudhuij I, 2002, PREV MED, V34, P279, DOI 10.1006/pmed.2001.0979; De Meester F, 2013, SOC SCI MED, V81, P1, DOI 10.1016/j.socscimed.2013.01.013; Deforche B, 2004, PATIENT EDUC COUNS, V55, P407, DOI 10.1016/j.pec.2003.07.012; Deforche B, 2010, PREV MED, V50, pS24, DOI 10.1016/j.ypmed.2009.08.017; Dishman RK, 2010, J PEDIATR PSYCHOL, V35, P188, DOI 10.1093/jpepsy/jsp042; Dwyer JJM, 2006, ADOLESCENCE, V41, P75; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-50; Elstad JI, 2010, SOC THEOR HEALTH, V8, P134, DOI 10.1057/sth.2009.26; Fortier MS, 2007, PSYCHOL SPORT EXERC, V8, P741, DOI 10.1016/j.psychsport.2006.10.006; Franzini L, 2009, AM J PUBLIC HEALTH, V99, P271, DOI 10.2105/AJPH.2007.128702; Graham DJ, 2014, J PHYS ACT HEALTH, V11, P51, DOI 10.1123/jpah.2011-0239; Haerens L, 2008, EUR J CLIN NUTR, V62, P51, DOI 10.1038/sj.ejcn.1602681; Haug E, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-47; Hsu YW, 2011, J PHYS ACT HEALTH, V8, P210, DOI 10.1123/jpah.8.2.210; Jago R, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-83; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kargarfard M, 2012, PREV MED, V54, P219, DOI 10.1016/j.ypmed.2012.01.010; Kirby J, 2011, J PHYS ACT HEALTH, V8, P785, DOI 10.1123/jpah.8.6.785; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Kremers SPJ, 2010, PATIENT EDUC COUNS, V79, P291, DOI 10.1016/j.pec.2010.03.002; Lubans DR, 2012, ARCH PEDIAT ADOL MED, V166, P821, DOI 10.1001/archpediatrics.2012.41; Lytle LA, 2009, ANN BEHAV MED, V38, P124, DOI 10.1007/s12160-009-9127-2; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Madsen KA, 2009, J PEDIATR-US, V154, P278, DOI 10.1016/j.jpeds.2008.07.044; Mommerency G., 1994, RES REPORT; Morgan A, 2012, HLTH BEHAV SCH AGED; Motl RW, 2007, J PEDIATR PSYCHOL, V32, P6, DOI 10.1093/jpepsy/jsl001; Pender N.J., 1996, HLTH PROMOTION NURSI; Peterson MS, 2013, HEALTH PSYCHOL, V32, P666, DOI 10.1037/a0029129; Philippaerts RM, 2006, INT J SPORTS MED, V27, P131, DOI 10.1055/s-2005-837619; Ransdell LB, 2003, MED SCI SPORT EXER, V35, P286, DOI 10.1249/01.MSS.0000048836.67270.1F; Robbins LB, 2003, J MIDWIFERY WOM HEAL, V48, P206, DOI 10.1016/S1526-9523(03)00054-0; Ruiz-Canela M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-2; Sallis JF, 2008, HLTH BEHAV HLTH ED T, P464; Sebire SJ, 2014, J PHYS ACT HEALTH, V11, P734, DOI 10.1123/jpah.2012-0034; Sharma SV, 2009, J PHYS ACT HEALTH, V6, P606, DOI 10.1123/jpah.6.5.606; Shaw C., 2011, GUIDELINES RES CHILD; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Spittaels H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-149; Springer AE, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-8; Srof BJ, 2006, NURS SCI QUART, V19, P366, DOI 10.1177/0894318406292831; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Vereecken CA, 2004, J ADOLESCENT HEALTH, V34, P330, DOI 10.1016/j.jadohealth.2003.07.011; Vissers D, 2008, J NUTR EDUC BEHAV, V40, P65, DOI 10.1016/j.jneb.2007.06.010; Voorhees CC, 2005, AM J HEALTH BEHAV, V29, P183, DOI 10.5993/AJHB.29.2.9; Whitehead S, 2008, EUR PHYS EDUC REV, V14, P243, DOI 10.1177/1356336X08090708; Zaragoza J, 2011, J SPORT MED PHYS FIT, V51, P128	57	17	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157216	10.1371/journal.pone.0157216	http://dx.doi.org/10.1371/journal.pone.0157216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27309847	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800043
J	Calabrese, SK; Magnus, M; Mayer, KH; Krakower, DS; Eldahan, AI; Hawkins, LAG; Hansen, NB; Kershaw, TS; Underhill, K; Betancourt, JR; Dovidio, JF				Calabrese, Sarah K.; Magnus, Manya; Mayer, Kenneth H.; Krakower, Douglas S.; Eldahan, Adam I.; Hawkins, Lauren A. Gaston; Hansen, Nathan B.; Kershaw, Trace S.; Underhill, Kristen; Betancourt, Joseph R.; Dovidio, John F.			Putting PrEP into Practice: Lessons Learned from Early-Adopting US Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care	PLOS ONE			English	Article							UNITED-STATES; ATTITUDES; KNOWLEDGE; WILLINGNESS; ADULTS; RISK; SEX	Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource, requires expanding healthcare providers' adoption of PrEP into clinical practice. This qualitative study explored PrEP providers' firsthand experiences relative to six commonly-cited barriers to prescription-financial coverage, implementation logistics, eligibility determination, adherence concerns, side effects, and anticipated behavior change (risk compensation)-as well as their recommendations for training PrEP-inexperienced providers. U.S.-based PrEP providers were recruited via direct outreach and referral from colleagues and other participants (2014-2015). One-on-one interviews were conducted in person or by phone, transcribed, and analyzed. The sample (n = 18) primarily practiced in the Northeastern (67%) or Southern (22%) U.S. Nearly all (94%) were medical doctors (MDs), most of whom self-identified as infectious disease specialists. Prior experience prescribing PrEP ranged from 2 to 325 patients. Overall, providers reported favorable experiences with PrEP implementation and indicated that commonly anticipated problems were minimal or manageable. PrEP was covered via insurance or other programs for most patients; however, pre-authorization requirements, laboratory/service provision costs, and high deductibles sometimes presented challenges. Various models of PrEP care and coordination with other providers were utilized, with several providers highlighting the value of clinical staff support. Eligibility was determined through joint decision-making with patients; CDC guidelines were commonly referenced but not considered absolute. Patient adherence was variable, with particularly strong adherence noted among patients who had actively sought PrEP (self-referred). Providers observed minimal adverse effects or increases in risk behavior. However, they identified several barriers with respect to accessing and engaging PrEP candidates. Providers offered a wide range of suggestions regarding content, strategy, and logistics surrounding PrEP training, highlighting sexual history-taking and sexual minority competence as areas to prioritize. These insights from early-adopting PrEP providers may facilitate adoption of PrEP into clinical practice by PrEP-inexperienced providers, thereby improving access for individuals at risk for HIV.	[Calabrese, Sarah K.; Eldahan, Adam I.; Hawkins, Lauren A. Gaston; Kershaw, Trace S.; Dovidio, John F.] Yale Univ, Dept Chron Dis Epidemiol, Sch Publ Hlth, New Haven, CT USA; [Calabrese, Sarah K.; Hansen, Nathan B.; Kershaw, Trace S.; Underhill, Kristen; Dovidio, John F.] Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT USA; [Magnus, Manya] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA; [Mayer, Kenneth H.; Krakower, Douglas S.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.; Krakower, Douglas S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Hansen, Nathan B.] Univ Georgia, Dept Hlth Promot & Behav, Coll Publ Hlth, Athens, GA 30602 USA; [Underhill, Kristen] Yale Univ, Sch Law, New Haven, CT 06520 USA; [Betancourt, Joseph R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dispar Solut Ctr, Boston, MA USA; [Dovidio, John F.] Yale Univ, Dept Psychol, New Haven, CT USA	Yale University; Yale University; George Washington University; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Georgia; University of Georgia; Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Yale University	Calabrese, SK (corresponding author), Yale Univ, Dept Chron Dis Epidemiol, Sch Publ Hlth, New Haven, CT USA.; Calabrese, SK (corresponding author), Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT USA.	sarah.calabrese@yale.edu		Dovidio, John/0000-0002-6110-8344; Gaston-Hawkins, Lauren/0000-0003-0786-8892	National Institute of Mental Health (NIMH) [K01-MH103080, K01-MH093273, K23-MH098795]; Yale University Center for Interdisciplinary Research on AIDS [P30-MH062294]; Harvard University Center for AIDS Research [P30-AI060354]; National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH098795, K01MH103080] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Yale University Center for Interdisciplinary Research on AIDS; Harvard University Center for AIDS Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding and resources for this research were provided by the National Institute of Mental Health (NIMH; www.nimh.nih.gov) via Award Number K01-MH103080 (SKC) and the Yale University Center for Interdisciplinary Research on AIDS (P30-MH062294). The efforts of SKC, KU, and DSK were supported by the NIMH via Award Numbers K01-MH103080 (SKC), K01-MH093273 (KU), and K23-MH098795 (DSK). Additional support was provided through the Harvard University Center for AIDS Research (P30-AI060354), funded by the National Institutes of Health (http://www.nih.gov). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIMH or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LM, 2015, HIV SPECIALIST, V7, P18; Arnold EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040603; Auerbach JD, 2015, AIDS PATIENT CARE ST, V29, P102, DOI 10.1089/apc.2014.0142; Cohen SE, 2015, JAIDS-J ACQ IMM DEF, V68, P439, DOI 10.1097/QAI.0000000000000479; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Grant RM, 2016, CURR OPIN HIV AIDS, V11, P3, DOI 10.1097/COH.0000000000000216; Karris MY, 2014, CLIN INFECT DIS, V58, P704, DOI 10.1093/cid/cit796; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Krakower DS, 2016, CLIN INFECT DIS, V62, P99, DOI 10.1093/cid/civ736; Krakower DS, 2016, CURR OPIN HIV AIDS, V11, P41, DOI 10.1097/COH.0000000000000206; Mayer KH, 2015, CURR OPIN HIV AIDS, V10, P226, DOI 10.1097/COH.0000000000000170; Mullins TLK, 2015, AIDS PATIENT CARE ST, V29, P193, DOI 10.1089/apc.2014.0273; Schneider J, 2015, ANN M AM PUBL HLTH A; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Spector AY, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/1747-597X-10-1; Stein M, 2014, AIDS BEHAV, V18, P1694, DOI 10.1007/s10461-014-0778-z; Tripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1b; U. S. Centers for Disease Control and Prevention, 2014, HIV SURV REP DIAGN H, P26; Underhill K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112425; US Public Health Service, 2014, PREEXP PROPH PREV HI; White House Office of National AIDS Policy, 2015, NAT HIV AIDS STRAT U; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030	23	81	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157324	10.1371/journal.pone.0157324	http://dx.doi.org/10.1371/journal.pone.0157324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5LO	27304883	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800047
J	Carr, D; Sanchez-Alvarez, L; Imai, JH; Slatculescu, C; Noblett, N; Mao, L; Beese, L; Colavita, A				Carr, David; Sanchez-Alvarez, Leticia; Imai, Janice H.; Slatculescu, Cristina; Noblett, Nathaniel; Mao, Lei; Beese, Lorena; Colavita, Antonio			A Farnesyltransferase Acts to Inhibit Ectopic Neurite Formation in C. elegans	PLOS ONE			English	Article							PLANAR CELL POLARITY; PRICKLE; PROTEIN; FARNESYLATION; LOCALIZATION; STRABISMUS; MIGRATION	Genetic pathways that regulate nascent neurite formation play a critical role in neuronal morphogenesis. The core planar cell polarity components VANG-1/Van Gogh and PRKL-1/Prickle are involved in blocking inappropriate neurite formation in a subset of motor neurons in C. elegans. A genetic screen for mutants that display supernumerary neurites was performed to identify additional factors involved in this process. This screen identified mutations in fntb-1, the beta subunit of farnesyltransferase. We show that fntb-1 is expressed in neurons and acts cell-autonomously to regulate neurite formation. Prickle proteins are known to be post-translationally modified by farnesylation at their C-terminal CAAX motifs. We show that PRKL-1 can be recruited to the plasma membrane in both a CAAX-dependent and CAAX-independent manner but that PRKL-1 can only inhibit neurite formation in a CAAX-dependent manner.	[Carr, David; Sanchez-Alvarez, Leticia; Imai, Janice H.; Slatculescu, Cristina; Noblett, Nathaniel; Colavita, Antonio] Ottawa Hosp, Res Inst, Neurosci Program, Ottawa, ON, Canada; [Carr, David; Sanchez-Alvarez, Leticia; Noblett, Nathaniel; Colavita, Antonio] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Mao, Lei; Beese, Lorena] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Colavita, Antonio] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Duke University; University of Ottawa	Colavita, A (corresponding author), Ottawa Hosp, Res Inst, Neurosci Program, Ottawa, ON, Canada.; Colavita, A (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.; Colavita, A (corresponding author), Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada.	colavita@uottawa.ca		Colavita, Antonio/0000-0001-9391-5282	Canadian Institutes of Health Research [123513]; Natural Sciences and Engineering Research Council of Canada [312460-2012]; National Institutes of Health [GM052362]; CIHR [123513]; NSERC [312460-2012]; NIH Office of Research Infrastructure Programs [P40 OD010440]; C. elegans Gene Knockout Consortium (University of British Columbia and the University of Oklahoma); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); C. elegans Gene Knockout Consortium (University of British Columbia and the University of Oklahoma); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Canadian Institutes of Health Research Grant 123513 and Natural Sciences and Engineering Research Council of Canada Discovery Grant 312460-2012 to AC and by National Institutes of Health Grant GM052362 to LB (http://www.cihr-irsc.gc.ca/e/193.html; http://www.nserc-crsng.gc.ca/index_eng.asp; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by CIHR Grant 123513 and NSERC Discovery Grant 312460-2012 to A.C. Some strains were provided by the Caenorhabditis Genetics Center (University of Minnesota), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), Shohei Mitani (National Bioresource Project, Japan) and the C. elegans Gene Knockout Consortium (University of British Columbia and the University of Oklahoma). We thank Wormbase.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BRENNER S, 1974, GENETICS, V77, P71; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Colavita A, 2003, SCIENCE, V302, P293, DOI 10.1126/science.1089163; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lin YY, 2009, DEV BIOL, V325, P386, DOI 10.1016/j.ydbio.2008.10.042; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Mapp OM, 2011, DEVELOPMENT, V138, P2121, DOI 10.1242/dev.060442; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; Randlett O, 2011, NEURON, V70, P266, DOI 10.1016/j.neuron.2011.03.013; Saengsawang W, 2012, CURR BIOL, V22, P494, DOI 10.1016/j.cub.2012.01.038; Sanchez-Alvarez L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002257; Sebti SM, 2005, CANCER CELL, V7, P297, DOI 10.1016/j.ccr.2005.04.005; Shen MY, 2015, DRUG DISCOV TODAY, V20, P267, DOI 10.1016/j.drudis.2014.10.002; Strutt DI, 2002, SEMIN CELL DEV BIOL, V13, P225, DOI 10.1016/S1084-9521(02)00041-1; Strutt H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003654; Tank EMH, 2011, J NEUROSCI, V31, P9279, DOI 10.1523/JNEUROSCI.6606-10.2011; Tao H, 2012, DEV BIOL, V364, P138, DOI 10.1016/j.ydbio.2012.01.025; Tissir F, 2013, NAT REV NEUROSCI, V14, P525, DOI 10.1038/nrn3525; van Beuningen SFB, 2015, NEURON, V88, P1208, DOI 10.1016/j.neuron.2015.11.012; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157537	10.1371/journal.pone.0157537	http://dx.doi.org/10.1371/journal.pone.0157537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300162	gold, Green Published, Green Submitted			2022-12-27	WOS:000377822200059
J	Castro, R; Ribeiro-Alves, M; Correa, RG; Derrico, M; Lemos, K; Grangeiro, JR; de Jesus, B; Pires, D; Veloso, VG; Grinsztejn, B				Castro, Rodolfo; Ribeiro-Alves, Marcelo; Correa, Renato Girade; Derrico, Monica; Lemos, Katia; Grangeiro, Jose Roberto; de Jesus, Beto; Pires, Denise; Veloso, Valdilea G.; Grinsztejn, Beatriz			The Men Who Have Sex with Men HIV Care Cascade in Rio de Janeiro, Brazil	PLOS ONE			English	Article							MEDICAL-CARE; INFECTION; STIGMA; EPIDEMIOLOGY; RETENTION; HEALTH; MSM; TRANSMISSION; ENGAGEMENT; CONTINUUM	Brazil has a concentrated HIV epidemic and men who have sex with men (MSM) are disproportionately affected. Yet, no data is available on the HIV care cascade for this population. This study aimed to assess the HIV care cascade among MSM newly diagnosed through innovative testing strategies in Rio de Janeiro. Data from 793 MSM and travestites/transgender women (transwomen) tested for HIV at a non-governmental LGBT organization and a mobile testing unit located at a gay friendly venue were analyzed. A 12-month-after-HIV-diagnosis- censored cohort was established using CD4, viral load and combination antiretro-viral therapy (cART) longitudinal data from those diagnosed with HIV. A cross-sectional HIV care cascade was built using this data. The relative risks of achieving each cascade-stage were estimated using generalized linear models according to age, self-declared skin-color, education, history of sexually transmitted diseases (STD), drug use and prior HIV testing. From Jan-2013 to Jan-2014, 793 MSM and transwomen were tested, 131 (16.5%) were HIV-infected. As of January 2015, 95 (72.5%) were linked to HIV care, 90 (68.7%) were retained in HIV care, 80 (61.1%) were on cART, and 50 (38.2%) were virally suppressed one year after HIV diagnosis. Being non-white (Relative risk [lower bound; upper bound of 95% confidence interval] = 1.709 [1.145; 2.549]) and having a prior HIV-test (1.954 [1.278; 2.986]) were associated with an HIV-positive diagnosis. A higher linkage (2.603 [1.091; 6.211]) and retention in care (4.510 [1.880; 10.822]) were observed among those who were older than 30 years of age. Using community-based testing strategies, we were able to access a high-risk MSM population and a small sample of transwomen. Despite universal care coverage and the test-and-treat policy adopted in Brazil, the MSM cascade of care indicates that strategies to increase linkage to care and prompt cART initiation targeted to these populations are critically needed. Interventions targeting non-white and young MSM should be prioritized.	[Castro, Rodolfo; Ribeiro-Alves, Marcelo; Derrico, Monica; Lemos, Katia; Grangeiro, Jose Roberto; Veloso, Valdilea G.; Grinsztejn, Beatriz] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil; [Castro, Rodolfo] Univ Fed Estado Rio de Janeiro, Inst Saude Colet, Rio De Janeiro, RJ, Brazil; [Correa, Renato Girade] Minist Saude, Dept DST Aids & Hepatites Virais, Brasilia, DF, Brazil; [Lemos, Katia; Pires, Denise] Secretaria Estado Saude Sao Paulo, Gerrncia DST Aids Sangue & Hemoderivados, Rio De Janeiro, RJ, Brazil; [Grangeiro, Jose Roberto] Grp Arco Iris, Rio De Janeiro, RJ, Brazil; [de Jesus, Beto] Assoc Int Lesbicas Gays Bissexuais Transexuais &, Buenos Aires, DF, Argentina	Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro	Castro, R (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil.	rodolfo.castro@ini.fiocruz.br	Castro, Rodolfo/D-4231-2013	Castro, Rodolfo/0000-0002-0701-2528; Ribeiro-Alves, Marcelo/0000-0002-8663-3364	NIAID NIH HHS [UM1 AI069476] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069476] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agwu AL, 2015, J ADOLESCENT HEALTH, V56, P345, DOI 10.1016/j.jadohealth.2014.11.009; Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; [Anonymous], 2014, R LANG ENV STAT COMP; Ayala G., 2014, Journal of AIDS and Clinical Research, V5, P331; Baral SD, 2014, CURR OPIN HIV AIDS, V9, P156, DOI 10.1097/COH.0000000000000037; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Blashill AJ, 2013, ANN BEHAV MED, V46, P149, DOI [10.1007/s12160-013-9527-1, 10.1007/s12160-013-9489-3]; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2014, B EP AIDS DST ANO 3; Brito AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130445; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; De Boni R, 2014, CURR OPIN HIV AIDS, V9, P192, DOI 10.1097/COH.0000000000000031; Veras MADM, 2015, AIDS BEHAV, V19, P1589, DOI 10.1007/s10461-014-0944-3; Dickson NP, 2012, HIV MED, V13, P182, DOI 10.1111/j.1468-1293.2011.00959.x; Dowshen N, 2009, AIDS PATIENT CARE ST, V23, P371, DOI 10.1089/apc.2008.0256; Gardner EM, 2014, LANCET INFECT DIS, V14, P5, DOI 10.1016/S1473-3099(13)70272-X; Giordano TR, 2009, HIV CLIN TRIALS, V10, P299, DOI 10.1310/hct1005-299; Grangeiro A, 2009, REV SAUDE PUBL, V43, DOI 10.1590/S0034-89102009000300006; Grangeiro A, 2009, CAD SAUDE PUBLICA, V25, P2053, DOI 10.1590/S0102-311X2009000900019; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Hallett TB, 2013, JAIDS-J ACQ IMM DEF, V63, pS228, DOI 10.1097/QAI.0b013e318298721b; Hoenigl M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0458-5; Instituto Nacional de Estudos e Pesquisas Educacionais Anisio Teixeira, 2014, SIN EST ED SUP GRAD; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; Leaity S, 2000, AIDS, V14, P547, DOI 10.1097/00002030-200003310-00010; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; Lorente N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061225; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; MacCarthy S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1313; Magidson JF, 2016, AIDS BEHAV, V20, P699, DOI 10.1007/s10461-015-1142-7; Mello A, 2008, ASSESSMENT RISK FACT; Mimiaga MJ, 2009, AIDS PATIENT CARE ST, V23, P825, DOI 10.1089/apc.2009.0086; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2011, CLIN INFECT DIS, V52, pS238, DOI 10.1093/cid/ciq048; Nachega JB, 2014, CLIN INFECT DIS, V59, pS21, DOI 10.1093/cid/ciu299; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; Pachankis JE, 2015, AIDS, V29, P1239, DOI 10.1097/QAD.0000000000000724; Peretti-Watel P, 2006, AIDS CARE, V18, P254, DOI 10.1080/09540120500456193; Peretti-Watel P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000411; Pines HA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010388; Puljic VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093734; Rodger ABT., 2014, C RETR OPP INF 2014; Mota RMS, 2011, JAIDS-J ACQ IMM DEF, V57, pS153, DOI 10.1097/QAI.0b013e31821e9c10; Shivaji T, 2014, J INT AIDS SOC, V17, P129, DOI 10.7448/IAS.17.4.19690; Silva DS, 2016, AIDS BEHAV, V20, P1039, DOI 10.1007/s10461-015-1235-3; Tripathi A, 2011, AIDS RES HUM RETROV, V27, P751, DOI [10.1089/aid.2010.0268, 10.1089/AID.2010.0268]; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; UNAIDS, 2014, GLOB AIDS RESP PROGR; WHO, 2015, CONSOLIDATED GUIDELI	49	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157309	10.1371/journal.pone.0157309	http://dx.doi.org/10.1371/journal.pone.0157309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KO	27299524	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200035
J	Subburaj, S; Cao, SH; Xia, XC; He, ZH				Subburaj, Saminathan; Cao, Shuanghe; Xia, Xianchun; He, Zhonghu			Phylogenetic Analysis, Lineage-Specific Expansion and Functional Divergence of seed dormancy 4-Like Genes in Plants	PLOS ONE			English	Article							CODON-SUBSTITUTION MODELS; POSITIVE SELECTION; GENOME; EXPRESSION; DUPLICATION; ARABIDOPSIS; MECHANISMS; CLONING; FAMILY; SUBFUNCTIONALIZATION	The rice gene seed dormancy 4 (OsSdr4) functions in seed dormancy and is a major factor associated with pre-harvest sprouting (PHS). Although previous studies of this protein family were reported for rice and other species, knowledge of the evolution of genes homologous to OsSdr4 in plants remains inadequate. Fifty four Sdr4-like (hereafter designated Sdr4L) genes were identified in nine plant lineages including 36 species. Phylogenetic analysis placed these genes in eight subfamilies (I-VIII). Genes from the same lineage clustered together, supported by analysis of conserved motifs and exon-intron patterns. Segmental duplications were present in both dicot and monocot clusters, while tandemly duplicated genes occurred only in monocot clusters indicating that both tandem and segmental duplications contributed to expansion of the grass I and II subfamilies. Estimation of the approximate ages of the duplication events indicated that ancestral Sdr4 genes evolved from a common angiosperm ancestor, about 160 million years ago (MYA). Moreover, diversification of Sdr4L genes in mono and dicot plants was mainly associated with genome-wide duplication and speciation events. Functional divergence was observed in all subfamily pairs, except IV/VIIIa. Further analysis indicated that functional constraints between subfamily pairs I/II, I/VIIIb, II/VI, II/VIIIb, II/IV, and VI/VIIIb were statistically significant. Site and branch-site model analyses of positive selection suggested that these genes were under strong adaptive selection pressure. Critical amino acids detected for both functional divergence and positive selection were mostly located in the loops, pointing to functional importance of these regions in this protein family. In addition, differential expression studies by transcriptome atlas of 11 Sdr4L genes showed that the duplicated genes may have undergone divergence in expression between plant species. Our findings showed that Sdr4L genes are functionally divergent and positively selected. These may contribute to further functional analysis and molecular evolution of Sdr4L gene families in land plants.	[Subburaj, Saminathan; Cao, Shuanghe; Xia, Xianchun; He, Zhonghu] Chinese Acad Agr Sci, Inst Crop Sci, Natl Wheat Improvement Ctr, 12 Zhongguancun South St, Beijing 100081, Peoples R China; [He, Zhonghu] Int Maize & Wheat Improvement Ctr CIMMYT China Of, 12 Zhongguancun South St, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	He, ZH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Wheat Improvement Ctr, 12 Zhongguancun South St, Beijing 100081, Peoples R China.; He, ZH (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT China Of, 12 Zhongguancun South St, Beijing, Peoples R China.	zhhecaas@163.com	He, Zhonghu/E-1625-2015	CAO, SHUANGHE/0000-0002-2905-0728; He, Zhonghu/0000-0003-1384-3712; SUBBURAJ, SAMINATHAN/0000-0002-9660-7661	International Science & Technology Cooperation Programs of China [2012DFA32290, 2013DFG30530, 2014DFG31690]; China Agriculture Research System [CARS-3-1-3]	International Science & Technology Cooperation Programs of China; China Agriculture Research System	This work was supported by International Science & Technology Cooperation Programs of China, grant numbers 2012DFA32290, 2013DFG30530, and 2014DFG31690 (Zhonghu He); and China Agriculture Research System, grant number CARS-3-1-3 (Zhonghu He).; The authors are grateful to Prof. R. A. McIntosh, Plant Breeding Institute, University of Sydney, for review of this manuscript. This study was supported by the International Science & Technology Cooperation Programs of China (2012DFA32290, 2013DFG30530, 2014DFG31690), and China Agriculture Research System (CARS-3-1-3).	Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Ashikawa I, 2013, PLANT SCI, V208, P1, DOI 10.1016/j.plantsci.2013.03.011; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Cheng J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030088, 10.1371/journal.pone.0042436]; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ermolaeva MD, 2003, PLANT MOL BIOL, V51, P859, DOI 10.1023/A:1023001130337; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Frugoli JA, 1998, GENETICS, V149, P355; Graeber K, 2012, PLANT CELL ENVIRON, V35, P1769, DOI 10.1111/j.1365-3040.2012.02542.x; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gubler F, 2005, CURR OPIN PLANT BIOL, V8, P183, DOI 10.1016/j.pbi.2005.01.011; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Ha M, 2009, P NATL ACAD SCI USA, V106, P2295, DOI 10.1073/pnas.0807350106; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lecharny Alain, 2003, Journal of Structural and Functional Genomics, V3, P111, DOI 10.1023/A:1022614001371; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liu QP, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-256; Liu QP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-313; Lynch M, 2000, GENETICS, V154, P459; Lynch M, 2001, GENETICS, V159, P1789; Monke G, 2012, NUCLEIC ACIDS RES, V40, P8240, DOI 10.1093/nar/gks594; Moon HD, 2016, BIOL PLANTARUM, V60, P105, DOI 10.1007/s10535-015-0567-1; Muhlhausen S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-202; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Nonogaki H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00233; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlueter JA, 2004, GENOME, V47, P868, DOI [10.1139/g04-047, 10.1139/G04-047]; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Song WL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-124; Sugimoto K, 2010, P NATL ACAD SCI USA, V107, P5792, DOI 10.1073/pnas.0911965107; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Suzuki M, 2005, PLANT PHYSIOL, V139, P437, DOI 10.1104/pp.104.058412; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wagner A, 1998, BIOESSAYS, V20, P785, DOI 10.1002/(SICI)1521-1878(199810)20:10<785::AID-BIES2>3.3.CO;2-D; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wu NN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0373-5; Yang ZF, 2008, GENOMICS, V92, P246, DOI 10.1016/j.ygeno.2008.06.001; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang YJ, 2014, THEOR APPL GENET, V127, P855, DOI 10.1007/s00122-014-2262-6; Zheng Y, 2007, J EXP ZOOL PART B, V308B, P85, DOI 10.1002/jez.b.21140	68	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0153717	10.1371/journal.pone.0153717	http://dx.doi.org/10.1371/journal.pone.0153717			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300553	Green Submitted, Green Published, gold			2022-12-27	WOS:000377822200002
J	Campagna, G; Zampetti, S; Gallozzi, A; Giansanti, S; Chiesa, C; Pacifico, L; Buzzetti, R				Campagna, Giuseppe; Zampetti, Simona; Gallozzi, Alessia; Giansanti, Sara; Chiesa, Claudio; Pacifico, Lucia; Buzzetti, Raffaella			Excellent Intra and Inter-Observer Reproducibility of Wrist Circumference Measurements in Obese Children and Adolescents	PLOS ONE			English	Article							WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; NECK CIRCUMFERENCE; RATIO; VARIABILITY; RELIABILITY; HEIGHT; INDEX; TOOLS; FAT	In a previous study, we found that wrist circumference, in particular its bone component, was associated with insulin resistance in a population of overweight/obese children. The aim of the present study was to evaluate the intra- and inter-operator variability in wrist circumference measurement in a population of obese children and adolescents. One hundred and two (54 male and 48 female) obese children and adolescents were consecutively enrolled. In all subjects wrist circumferences were measured by two different operators two times to assess intra- and inter-operator variability. Statistical analysis was performed using SAS v. 9.4 and JMP v. 12. Measurements of wrist circumference showed excellent inter-operator reliability with Intra class Correlation Coefficients (ICC) of 0.96 and ICC of 0.97 for the first and the second measurement, respectively. The intra- operator reliability was, also, very strong with a Concordance Correlation Coefficient (CCC) of 0.98 for both operators. The high reproducibility demonstrated in our results suggests that wrist circumference measurement, being safe, non-invasive and repeatable can be easily used in out-patient settings to identify youths with increased risk of insulin-resistance. This can avoid testing the entire population of overweight/obese children for insulin resistance parameters.	[Campagna, Giuseppe; Zampetti, Simona; Buzzetti, Raffaella] Univ Roma La Sapienza, Dept Expt Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Gallozzi, Alessia; Giansanti, Sara; Pacifico, Lucia] Univ Roma La Sapienza, Policlin Umberto Hosp 1, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Chiesa, Claudio] CNR, Inst Translat Pharmacol, Rome, Italy	Sapienza University Rome; Sapienza University Rome; University Hospital Sapienza Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Buzzetti, R (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	raffaella.buuzzetti@uniroma1.it	CAMPAGNA, GIUSEPPE/AAT-2796-2020; Pacifico, Lucia/S-4662-2019; Buzzetti, Raffaella/K-3090-2016	CAMPAGNA, GIUSEPPE/0000-0002-1884-9171; Buzzetti, Raffaella/0000-0003-1490-6041				Ashwell M, 1996, BRIT MED J, V312, P377; Ben-Noun Liubov Louba, 2006, Exp Clin Cardiol, V11, P14; Berg RL, 1992, P 17 ANN SAS US GROU, P1521; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bosy-Westphal A, 2010, J NUTR, V140, P954, DOI 10.3945/jn.109.118737; Bridger T, 2009, PAED CHILD HEALT-CAN, V14, P177, DOI 10.1093/pch/14.3.177; Capizzi M, 2011, CIRCULATION, V123, P1757, DOI 10.1161/CIRCULATIONAHA.110.012898; Chiarelli F, 2008, EUR J ENDOCRINOL, V159, pS67, DOI 10.1530/EJE-08-0245; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Silva Cleliani de Cassia da, 2014, Rev. paul. pediatr., V32, P221, DOI 10.1590/0103-0582201432210713; Ferrante E, 1993, Minerva Pediatr, V45, P289; GRANT JP, 1981, SURG CLIN N AM, V61, P437; Hazani Ron, 2008, Eplasty, V8, pe53; Hirschler V, 2005, ARCH PEDIAT ADOL MED, V159, P740, DOI 10.1001/archpedi.159.8.740; Kahn HS, 2005, J PEDIATR-US, V146, P482, DOI 10.1016/j.jpeds.2004.12.028; LaBerge RC, 2009, PEDIATR PULM, V44, P64, DOI 10.1002/ppul.20944; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; LINDNER P, 1973, ASSESS DEGREES FATNE; Magalhães Elma Izze da Silva, 2014, Rev. paul. pediatr., V32, P273, DOI 10.1590/0103-0582201432320; MILLER JZ, 1991, BONE MINER, V14, P137, DOI 10.1016/0169-6009(91)90091-D; Mitrea A, 2013, ROM J DIABETES NUTR, V20, P323; Mueller NT, 2013, AM J HUM BIOL, V25, P581, DOI 10.1002/ajhb.22416; Nadas J, 2008, MED SCI MONITOR, V14, pCR15; Noudeh YJ, 2013, J CLIN ENDOCR METAB, V98, P777, DOI 10.1210/jc.2012-2416; Nyland J, 2006, CLIN IMAG, V30, P335, DOI 10.1016/j.clinimag.2006.02.004; Panoulas VF, 2008, POSTGRAD MED J, V84, P344, DOI 10.1136/pgmj.2008.068825; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Reddy RS, 2005, CURR ORTHOPAED, V19, P171, DOI 10.1016/j.cuor.2005.02.008; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stabe C, 2013, CLIN ENDOCRINOL, V78, P874, DOI 10.1111/j.1365-2265.2012.04487.x; Strobel MJ, 2002, MANUAL ARTHROSCOPIC, P97, DOI [10.1007/978-3-540-87410-2_2, DOI 10.1007/978-3-540-87410-2_2]; Sung RYT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-324; Taylor RW, 2000, AM J CLIN NUTR, V72, P490	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156646	10.1371/journal.pone.0156646	http://dx.doi.org/10.1371/journal.pone.0156646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294398	Green Submitted, Green Published, gold			2022-12-27	WOS:000377821300009
J	Saad, A; Hegde, S; Kechichian, T; Gamble, P; Rahman, M; Stutz, SJ; Anastasio, NC; Alshehri, W; Lei, J; Mori, S; Kajs, B; Cunningham, KA; Saade, G; Burd, I; Costantine, M				Saad, Antonio; Hegde, Shruti; Kechichian, Talar; Gamble, Phyllis; Rahman, Mahbubur; Stutz, Sonja J.; Anastasio, Noelle C.; Alshehri, Wael; Lei, Jun; Mori, Susumu; Kajs, Bridget; Cunningham, Kathryn A.; Saade, George; Burd, Irina; Costantine, Maged			Is There a Causal Relation between Maternal Acetaminophen Administration and ADHD?	PLOS ONE			English	Article							PREGNANCY; HYPERACTIVITY; TOXICITY	Objective Recent epidemiological studies reported an association between maternal intake of acetaminophen (APAP) and attention deficit hyperactivity disorder (ADHD) in their children. However, none of these studies demonstrated causality. Our objective was to determine whether exposure to APAP during pregnancy result in hyperkinetic dysfunctions in offspring, using a murine model. Material and Methods Pregnant CD1 mice (N = 8/group) were allocated to receive by gavage either APAP (150 mg/kg/day, equivalent to the FDA-approved maximum human clinical dose), or 0.5% carboxymethylcellulose (control group), starting on embryonic day 7 until delivery. Maternal serum APAP and alanine transaminase (ALT) concentrations were determined by ELISA and kinetic colorimetric assays, respectively. Open field locomotor activity (LMA) in the 30-day old mouse offspring was quantified using Photobeam Activity System. Mouse offspring were then sacrificed, whole brains processed for magnetic resonance imaging (MRI; 11.7 Tesla magnet) and for neuronal quantification using Nissl stain. The association between APAP exposure and LMA in mouse offspring was analyzed using a mixed effects Poisson regression model that accounted for mouse offspring weight, gender, random selection, and testing time and day. We corrected for multiple comparisons and considered P<0.008 as statistically significant. Results Maternal serum APAP concentration peaked 30 minutes after gavage, reaching the expected mean of 117 mu g/ml. Serum ALT concentrations were not different between groups. There were no significant differences in vertical (rearing), horizontal, or total locomotor activity between the two rodent offspring groups at the P level fixed to adjust for multiple testing. In addition, no differences were found in volumes of 29 brain areas of interest on MRI or in neuronal quantifications between the two groups. Conclusion This study refutes that hypothesis that prenatal exposure to APAP causes hyperkinetic dysfunction in mouse offspring. Due to lack of accurate assessment of ADHD in murine models, our results should be taken with caution when compared to the reported clinical data.	[Saad, Antonio; Hegde, Shruti; Kechichian, Talar; Gamble, Phyllis; Rahman, Mahbubur; Stutz, Sonja J.; Anastasio, Noelle C.; Cunningham, Kathryn A.; Saade, George; Costantine, Maged] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, Galveston, TX 77555 USA; [Lei, Jun; Kajs, Bridget; Burd, Irina] Johns Hopkins Univ, Dept Gynecol & Obstet, Div Maternal Fetal Med, Integrated Res Ctr Fetal Med, Baltimore, MD USA; [Alshehri, Wael; Mori, Susumu] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA	University of Texas System; University of Texas Medical Branch Galveston; Johns Hopkins University; Johns Hopkins University	Saad, A (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, Galveston, TX 77555 USA.	afsaad@utmb.edu		Cunningham, Kathryn A./0000-0002-4257-1739; Saad, Antonio/0000-0003-0034-3567; Alshehri, Wael/0000-0002-6347-7848	NIDA NIH HHS [K05 DA020087] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA020087] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BOYD EM, 1966, BRIT J PHARM CHEMOTH, V26, P606, DOI 10.1111/j.1476-5381.1966.tb01841.x; Brust V, 2015, FRONT ZOOL, V12, DOI 10.1186/1742-9994-12-S1-S17; Carver AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100873; Chau V, 2013, NEUROLOGY, V81, P2082, DOI 10.1212/01.wnl.0000437298.43688.b9; Colborn T, 2004, ENVIRON HEALTH PERSP, V112, P944, DOI 10.1289/ehp.6601; HYND GW, 1993, J CHILD NEUROL, V8, P339, DOI 10.1177/088307389300800409; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; LARREY D, 1986, J PHARMACOL EXP THER, V237, P283; Liew Z, 2014, JAMA PEDIATR, V168, P313, DOI 10.1001/jamapediatrics.2013.4914; Nagaraju K, 2010, TREAT NMD SOP; Pastor Patricia N, 2008, Vital Health Stat 10, P1; REEL JR, 1992, FUND APPL TOXICOL, V18, P233, DOI 10.1016/0272-0590(92)90051-I; Schug TT, 2015, ENDOCRINOLOGY; Thiele K, 2013, J REPROD IMMUNOL, V97, P128, DOI 10.1016/j.jri.2012.10.014; Thompson JMD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108210; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Werler MM, 2005, AM J OBSTET GYNECOL, V193, P771, DOI 10.1016/j.ajog.2005.02.100; WHITEHOUSE LW, 1977, J PHARM SCI, V66, P1399, DOI 10.1002/jps.2600661012; Yang X, 2013, J PHARMACOL EXP THER, V344, P286, DOI 10.1124/jpet.112.199067; Zhu JM, 2012, J NEUROSCI, V32, P9410, DOI 10.1523/JNEUROSCI.1041-12.2012	20	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157380	10.1371/journal.pone.0157380	http://dx.doi.org/10.1371/journal.pone.0157380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295086	gold, Green Submitted, Green Published			2022-12-27	WOS:000377821300039
J	Wulaningsih, W; Holmberg, L; Abeler-Doner, L; Ng, T; Rohrmann, S; Van Hemelrijck, M				Wulaningsih, Wahyu; Holmberg, Lars; Abeler-Doner, Lucie; Ng, Tony; Rohrmann, Sabine; Van Hemelrijck, Mieke			Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women	PLOS ONE			English	Article							COLORECTAL-CANCER; PROGNOSTIC ROLE; RISK; SURVIVAL; CELLS; METAANALYSIS; INTERLEUKIN-6; RECRUITMENT; NEUTROPHIL; BIOMARKERS	Inflammation may play a role in breast cancer, but evidence in the general population is lacking. We investigated the association between serum inflammatory markers (C-reactive protein (CRP), absolute granulocyte count (AGC) and granulocyte-to-lymphocyte (G/L) ratio) and breast cancer (BCa) mortality in American women while accounting for adiposity. From the Third National Health and Nutrition Examination Survey (NHANES III) we selected all women aged 20+ without any known history of cancer (n = 7,780). Multivariable Cox regression models were used to assess CRP, AGC and G/L ratio in relation to mortality from BCa, all cancer, cardiovascular disease and all causes. Stratification analyses by body mass index (BMI) and waist circumference were performed to investigate the effect of adiposity on this association. During a mean follow-up of 167 months, 44 women died from BCa. After adjustments for BMI and waist circumference, only G/L ratio was associated to risk of BCa death (e.g. HR: 2.35, 95% CI: 1.36-4.06 for the 3rd compared to the 1st tertile, P-trend = 0.01). Except for a borderline interaction between CRP categories and obesity by BMI, no statistically significant interaction between markers and categories of BMI or waist circumference was observed. All three markers were associated with mortality from cardiovascular disease and all causes. Our findings support a role of inflammation in BCa mortality which may involve mechanisms apart from obesity, and potential usefulness of GLR as a marker in assessing inflammation and cancer.	[Wulaningsih, Wahyu; Holmberg, Lars; Van Hemelrijck, Mieke] Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England; [Wulaningsih, Wahyu] Univ Gadjah Mada, Div Haematol Oncol, Yogyakarta, Indonesia; [Holmberg, Lars] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Holmberg, Lars] Uppsala Univ, Reg Canc Ctr, Uppsala, Sweden; [Abeler-Doner, Lucie] Kings Coll London, Dept Immunobiol, London WC2R 2LS, England; [Ng, Tony] Kings Coll London, Richard Dimbleby Dept Canc Res, Randall Div, London WC2R 2LS, England; [Ng, Tony] Kings Coll London, Div Canc Studies, London WC2R 2LS, England; [Ng, Tony] UCL, Dept Med Oncol, Inst Canc, London, England; [Rohrmann, Sabine] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland	University of London; King's College London; Gadjah Mada University; Uppsala University; Uppsala University; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; University College London; University of Zurich	Wulaningsih, W (corresponding author), Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England.; Wulaningsih, W (corresponding author), Univ Gadjah Mada, Div Haematol Oncol, Yogyakarta, Indonesia.	wahyu.wulaningsih@kcl.ac.uk	Wulaningsih, Wahyu/AAW-4307-2020; Rohrmann, Sabine/D-2113-2012	Rohrmann, Sabine/0000-0002-2215-1200; Van Hemelrijck, Mieke/0000-0002-7317-0858; Ng, Tony/0000-0003-3894-5619	Cancer Research UK (CRUK); National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London	Cancer Research UK (CRUK)(Cancer Research UK); National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London	The research was funded/supported by Cancer Research UK (CRUK) and the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the CRUK, the NHS, the NIHR or the Department of Health.	Allavena P, 2000, IMMUNOL REV, V177, P141, DOI 10.1034/j.1600-065X.2000.17714.x; Allin KH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2891; Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; Andre F, 2013, CLIN CANCER RES, V19, P28, DOI 10.1158/1078-0432.CCR-11-2701; [Anonymous], 1994, Vital Health Stat 1, P1; [Anonymous], 1994, J CLIN ONCOL, V12, P2471; [Anonymous], 2010, NHANES 3 LINK MORT F; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bronte V, 1999, J IMMUNOL, V162, P5728; Chen ML, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-539; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; de la Cruz-Merino L, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/785317; Dossus L, 2014, CANCER CAUSE CONTROL, V25, P533, DOI 10.1007/s10552-014-0355-9; Eklund CM, 2009, ADV CLIN CHEM, V48, P111, DOI 10.1016/S0065-2423(09)48005-3; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gunter EW, 1996, LAB PROCEDURES USED; Guo YZ, 2013, ASIAN PAC J CANCER P, V14, P243, DOI 10.7314/APJCP.2013.14.1.243; Gwilliam B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4920; Han YJ, 2011, INT J BIOL MARKER, V26, P209, DOI 10.5301/JBM.2011.8872; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Handin RI, 2003, BLOOD PRINCIPLES PRA; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; Hu Q., 2014, UROL ONCOL, V32, pe51, DOI DOI 10.1016/J.UR0L0NC.2013.07.016; Jenkins P, 2009, ANN ONCOL, V20, P34, DOI 10.1093/annonc/mdn560; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; PETRIE HT, 1985, J IMMUNOL, V134, P230; Prizment AE, 2013, CANCER CAUSE CONTROL, V24, P2077, DOI 10.1007/s10552-013-0285-y; Rao SR, 2007, CIRCULATION, V115, P109, DOI 10.1161/CIRCULATIONAHA.106.614859; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Saxena NK, 2007, J BIOL CHEM, V282, P13316, DOI 10.1074/jbc.M609798200; Shimazaki J, 2013, ONCOLOGY-BASEL, V84, P356, DOI 10.1159/000350836; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wulaningsih W, 2015, CARCINOGENESIS, V36, P1121, DOI 10.1093/carcin/bgv096; Xiong H, 2013, INT J CANC; Zhou BY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038827, 10.1371/journal.pone.0038241]	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157482	10.1371/journal.pone.0157482	http://dx.doi.org/10.1371/journal.pone.0157482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294662	Green Published, gold, Green Submitted			2022-12-27	WOS:000377821300047
J	Fan, B; Guan, J; Wang, XM; Cong, YL				Fan, Bing; Guan, Jie; Wang, Xiumei; Cong, Yulong			Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model	PLOS ONE			English	Article							GALLERIA-MELLONELLA MODEL; IN-VIVO EFFICACY; FIELD GEL-ELECTROPHORESIS; TRACT-INFECTION; VITRO SYNERGY; MOUSE MODEL; CARBAPENEM; THERAPY; PNEUMONIA; METAANALYSIS	Few effective therapeutic options are available for treating severe infections caused by extensively drug-resistant Acinetobacter baumannii (XDR-AB). Using a murine thigh-infection model, we examined the in vivo efficacy of colistin in combination with meropenem, tige-cycline, fosfomycin, fusidic acid, rifampin, or sulbactam against 12 XDR-AB strains. Colistin, tigecycline, rifampin, and sulbactam monotherapy significantly decreased bacterial counts in murine thigh infections compared with those observed in control mice receiving no treatment. Colistin was the most effective agent tested, displaying bactericidal activity against 91.7% of strains at 48 h post-treatment. With strains showing a relatively low minimum inhibitory concentration (MIC) for meropenem (MIC <= 32 mg/L), combination therapy with colistin plus meropenem caused synergistic inhibition at both 24 h and 48 h post-treatment. However, when the meropenem MIC was >= 64 mg/L, meropenem did not significantly alter the efficacy of colistin. The addition of rifampin and fusidic acid significantly improved the efficacy of colistin, showing a synergistic effect in 100% and 58.3% of strains after 24 h of treatment, respectively, while the addition of tigecycline, fosfomycin, or sulbactam did not show obvious synergistic activity. No clear differences in activities were observed between colistin-rifampin and colistin-fusidic acid combination therapy with most strains. Overall, our in vivo study showed that administering colistin in combination with rifampin or fusidic acid is more efficacious in treating XDR-AB infections than other combinations. The colistin-meropenem combination may be another appropriate option if the MIC is <= 32 mg/L. Further clinical studies are urgently needed to confirm the relevance of these findings.	[Fan, Bing; Cong, Yulong] Chinese Peoples Liberat Army Gen Hosp, Clin Lab South Bldg, Beijing 100853, Peoples R China; [Fan, Bing] Gen Hosp Chinese Peoples Armed Police Forces, Clin Lab Clin Dist 2, Beijing 100039, Peoples R China; [Guan, Jie] Peking Univ, Hosp 1, Dept Clin Lab, Beijing 100034, Peoples R China; [Wang, Xiumei] Gen Hosp Chinese Peoples Armed Police Forces, Dept Clin Lab, Beijing 100039, Peoples R China	Chinese People's Liberation Army General Hospital; Peking University	Cong, YL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Clin Lab South Bldg, Beijing 100853, Peoples R China.	congyulongpla301@163.com						Barthold SW, 2010, ANTIMICROB AGENTS CH, V54, P643, DOI 10.1128/AAC.00788-09; BELLAHSENE A, 1980, INFECT IMMUN, V29, P873; Biswas S, 2012, EXPERT REV ANTI-INFE, V10, P917, DOI [10.1586/eri.12.78, 10.1586/ERI.12.78]; Cheng A, 2015, CRIT CARE MED, V43, P1194, DOI 10.1097/CCM.0000000000000933; Chuang YC, 2011, CLIN INFECT DIS, V52, P352, DOI 10.1093/cid/ciq154; Clinical and Laboratory Standards Institute, 2014, CLSI DOCUMENT M100 S; Clinical and Laboratory Standards Institute, 2012, CLSI DOCUMENT M07 A9; Dinc G, 2013, CHEMOTHERAPY, V59, P325, DOI 10.1159/000356755; Durante-Mangoni E, 2013, CLIN INFECT DIS, V57, P349, DOI 10.1093/cid/cit253; Galani I, 2014, INT J ANTIMICROB AG, V43, P370, DOI 10.1016/j.ijantimicag.2013.12.010; Gordon NC, 2010, ANTIMICROB AGENTS CH, V54, P5316, DOI 10.1128/AAC.00922-10; GOUBY A, 1992, J CLIN MICROBIOL, V30, P1588, DOI 10.1128/JCM.30.6.1588-1591.1992; Hornsey M, 2011, ANTIMICROB AGENTS CH, V55, P3534, DOI 10.1128/AAC.00230-11; Hornsey M, 2013, INT J ANTIMICROB AG, V41, P285, DOI 10.1016/j.ijantimicag.2012.11.013; Lee HJ, 2013, ANTIMICROB AGENTS CH, V57, P3738, DOI 10.1128/AAC.00703-13; Lefort A, 2014, INT J ANTIMICROB AG, V43, P366, DOI 10.1016/j.ijantimicag.2013.12.001; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Michail G, 2013, ANTIMICROB AGENTS CH, V57, P6028, DOI 10.1128/AAC.00891-13; Montero A, 2002, ANTIMICROB AGENTS CH, V46, P1946, DOI 10.1128/AAC.46.6.1946-1952.2002; Morinaga Y, 2008, J ANTIMICROB CHEMOTH, V62, P1326, DOI 10.1093/jac/dkn411; Ni WT, 2015, INT J ANTIMICROB AG, V45, P8, DOI 10.1016/j.ijantimicag.2014.10.002; Pachon-Ibanez ME, 2010, ANTIMICROB AGENTS CH, V54, P1165, DOI 10.1128/AAC.00367-09; Paul M, 2014, J ANTIMICROB CHEMOTH, V69, P2305, DOI 10.1093/jac/dku168; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Phee LM, 2015, ANTIMICROB AGENTS CH, V59, P4544, DOI 10.1128/AAC.00753-15; Pogue JM, 2013, EXPERT REV ANTI-INFE, V11, P881, DOI 10.1586/14787210.2013.827881; Song JY, 2007, J ANTIMICROB CHEMOTH, V60, P317, DOI 10.1093/jac/dkm136; Song JY, 2009, INT J ANTIMICROB AG, V33, P33, DOI 10.1016/j.ijantimicag.2008.07.008; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Vila J, 2012, EXPERT OPIN PHARMACO, V13, P2319, DOI 10.1517/14656566.2012.729820; Wareham DW, 2011, J ANTIMICROB CHEMOTH, V66, P1047, DOI 10.1093/jac/dkr069; Yang HF, 2015, INT J ANTIMICROB AG, V45, P188, DOI 10.1016/j.ijantimicag.2014.10.012; Yilmaz EM, 2012, INT J ANTIMICROB AG, V40, P332, DOI 10.1016/j.ijantimicag.2012.06.003; Zusman O, 2013, ANTIMICROB AGENTS CH, V57, P5104, DOI 10.1128/AAC.01230-13	36	47	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157757	10.1371/journal.pone.0157757	http://dx.doi.org/10.1371/journal.pone.0157757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315107	Green Submitted, gold, Green Published			2022-12-27	WOS:000378030000051
J	Gonzalez-Pena, D; Nixon, SE; Southey, BR; Lawson, MA; McCusker, RH; Hernandez, AG; Dantzer, R; Kelley, KW; Rodriguez-Zas, SL				Gonzalez-Pena, Dianelys; Nixon, Scott E.; Southey, Bruce R.; Lawson, Marcus A.; McCusker, Robert H.; Hernandez, Alvaro G.; Dantzer, Robert; Kelley, Keith W.; Rodriguez-Zas, Sandra L.			Differential Transcriptome Networks between IDO1-Knockout and Wild-Type Mice in Brain Microglia and Macrophages	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; INDOLEAMINE 2,3-DIOXYGENASE; ANALYSIS REVEALS; MYELOID CELLS; MOUSE MODEL; T-CELLS; PROTEIN; IDENTIFICATION; RNA	Microglia in the brain and macrophages in peripheral organs are cell types responsible for immune response to challenges. Indoleamine 2,3-dioxygenase 1 (IDO1) is an immunomodulatory enzyme of the tryptophan pathway that is expressed in the brain. The higher activity of IDO1 in response to immune challenge has been implicated in behavioral disorders. The impact of IDO1 depletion on the microglia transcriptome has not been studied. An investigation of the transcript networks in the brain microglia from IDO1-knockout (IDO1-KO) mice was undertaken, relative to peripheral macrophages and to wild-type (WT) mice under unchallenged conditions. Over 105 transcript isoforms were differentially expressed between WT and IDO1-KO within cell type. Within microglia, Saa3 and Irg1 were over-expressed in IDO1-KO relative to WT. Within macrophages, Csf3 and Sele were over-expressed in IDO1-KO relative to WT. Among the genes differentially expressed between strains, enriched biological processes included ion homeostasis and ensheathment of neurons within microglia, and cytokine and chemokine expression within macrophages. Over 11,110 transcript isoforms were differentially expressed between microglia and macrophages and of these, over 10,800 transcripts overlapped between strains. Enriched biological processes among the genes over- and under-expressed in microglia relative to macrophages included cell adhesion and apoptosis, respectively. Detected only in microglia or macrophages were 421 and 43 transcript isoforms, respectively. Alternative splicing between cell types based on differential transcript isoform abundance was detected in 210 genes including Phf11d, H2afy, and Abr. Across strains, networks depicted a predominance of genes under-expressed in microglia relative to macrophages that may be a precursor for the different response of both cell types to challenges. The detected transcriptome differences enhance the understanding of the role of IDO1 in the microglia transcriptome under unchallenged conditions.	[Gonzalez-Pena, Dianelys; Nixon, Scott E.; Southey, Bruce R.; Lawson, Marcus A.; McCusker, Robert H.; Kelley, Keith W.; Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Hernandez, Alvaro G.] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA; [Dantzer, Robert] Univ Illinois, Roy J Carver Biotechnol Ctr, High Throughput Sequencing & Genotyping Unit, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Stat, Champaign, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Carle Woese Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; UTMD Anderson Cancer Center; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL USA.; Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Stat, Champaign, IL USA.; Rodriguez-Zas, SL (corresponding author), Univ Illinois, Carle Woese Inst Genom Biol, Urbana, IL USA.	rodrgzzs@illinois.edu	Peña, Dianelys Gonzalez/AAF-4021-2019	Peña, Dianelys Gonzalez/0000-0003-4846-7569; Southey, Bruce/0000-0002-8959-7709; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Dantzer, Robert/0000-0001-9399-6107	NIH [R21 MH 096030, R01 MH 090127, R01 SUB UT 00000712, R01 MH083767]; USDA NIFA grant [ILLU-538-632, ILLU-538-909]; NIH National Institute of Drug Abuse [5P30DA018310]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA NIFA grant; NIH National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The support of NIH grant numbers: R21 MH 096030 to SRZ, R01 MH 090127 to RHM, R01 SUB UT 00000712 to KWK, R01 MH083767 to MAL, USDA NIFA grant numbers ILLU-538-632 to SRZ and ILLU-538-909 to SRZ, and 5P30DA018310 NIH National Institute of Drug Abuse to Bruce Southey to BRS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Akhtar MN, 2012, J PROTEOME RES, V11; Balch SG, 2002, EUR J IMMUNOGENET, V29, P61, DOI 10.1046/j.1365-2370.2002.00266.x; Ball HJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00485; Beardsley DI, 2003, EXP CELL RES, V290, P402, DOI 10.1016/S0014-4827(03)00353-7; Bell-Temin H, 2012, PROTEOMICS, V12, P246, DOI 10.1002/pmic.201100398; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bsibsi M, 2010, J IMMUNOL, V184, P6929, DOI 10.4049/jimmunol.0902419; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Caetano-Anolles K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116828; Chang MY, 2014, CANCER BIOL THER, V12, P1050; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; Cunnick JM, 2009, MOL CELL BIOL, V29, P5742, DOI 10.1128/MCB.00357-09; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Das A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121117; Delfino KR, 2011, CANCER GENOM PROTEOM, V8, P173; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dobos N, 2012, J ALZHEIMERS DIS, V28, P905, DOI 10.3233/JAD-2011-111097; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Finelli D, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.08.001; FORD AL, 1995, J IMMUNOL, V154, P4309; Foulkes T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000086; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goldmann O, 2007, INFECT IMMUN, V75, P4148, DOI 10.1128/IAI.00181-07; Gomes-Leal W, 2012, BRAIN BEHAV, V2, P345, DOI 10.1002/brb3.51; Gonzalez-Pena D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150858; Gow DJ, 2014, MOL THER, V22, P1580, DOI 10.1038/mt.2014.112; He JQ, 2008, EUR RESPIR J, V32, P25, DOI 10.1183/09031936.00040307; HEISTERKAMP N, 1989, NUCLEIC ACIDS RES, V17, P8821, DOI 10.1093/nar/17.21.8821; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hobson GM, 2002, ANN NEUROL, V52, P477, DOI 10.1002/ana.10320; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066546; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Jiang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059229; Karlstetter M, 2010, J IMMUNOL, V185, P3379, DOI 10.4049/jimmunol.0903300; Keum S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003807; Kim H, 2012, J CLIN INVEST, V122, P2940, DOI 10.1172/JCI61884; Kim JM, 2006, DNA RES, V13, P275, DOI 10.1093/dnares/dsl016; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Kolodziej L, 2013, TRANSGENIC RES, V22, P1049, DOI 10.1007/s11248-013-9696-5; KONIG G, 1992, J BIOL CHEM, V267, P10804; Kota RS, 2006, BIOCHEM BIOPH RES CO, V342, P1137, DOI 10.1016/j.bbrc.2006.02.087; Krappa R, 1999, P NATL ACAD SCI USA, V96, P4633, DOI 10.1073/pnas.96.8.4633; Kuhn H, 1996, PROG LIPID RES, V35, P203, DOI 10.1016/S0163-7827(96)00008-2; Lauridsen JB, 2011, NEUROSCI RES, V70, P269, DOI 10.1016/j.neures.2011.03.011; Linnartz B, 2012, CELL TISSUE RES, V349, P215, DOI 10.1007/s00441-012-1342-7; Linnartz-Gerlach B, 2014, NEUROSCIENCE, V275, P113, DOI 10.1016/j.neuroscience.2014.05.061; Liu J, 2007, J PROTEOME RES, V6, P3614, DOI 10.1021/pr0701512; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Loniewski KJ, 2007, MOL IMMUNOL, V44, P3715, DOI 10.1016/j.molimm.2007.04.002; Madeddu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127336; Magee DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032034; Markart P, 2004, BIOCHEM J, V380, P385, DOI 10.1042/BJ20031810; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; McDonald JG, 2010, J LEUKOCYTE BIOL, V88, P1071, DOI 10.1189/jlb.0710418; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; Mellor AL, 2003, J IMMUNOL, V171, P1652, DOI 10.4049/jimmunol.171.4.1652; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Moog U, 2011, J MED GENET, V48, P741, DOI 10.1136/jmedgenet-2011-100218; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; Nikodemova M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-147; Nixon SE, 2015, J BIOINF COMPUT BIOL, V13, DOI 10.1142/S0219720015500109; Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594; Otto EA, 2009, J MED GENET, V46, P663, DOI 10.1136/jmg.2009.066613; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Prendergast GC, 2008, ONCOGENE, V27, P3889, DOI 10.1038/onc.2008.35; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16; Rodriguez-Zas SL, 2015, BRAIN BEHAV IMMUN, V44, P176, DOI 10.1016/j.bbi.2014.09.018; Sadasivan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124047; Sadeque A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-59; Serao NVL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078530; Serao NVL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-94; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siddiqui S, 2013, CELL IMMUNOL, V281, P159, DOI 10.1016/j.cellimm.2013.03.001; Smith ME, 1998, J NEUROSCI RES, V54, P68, DOI 10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F; Solga AC, 2015, GLIA, V63, P531, DOI 10.1002/glia.22754; Sosa RA, 2013, J IMMUNOL, V191, P5848, DOI 10.4049/jimmunol.1300771; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Stamova B, 2012, INTERNATIONAL MEETIN; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swearingen KE, 2010, J PROTEOME RES, V9, P2412, DOI 10.1021/pr901124u; Szulzewsky F., 2015, THESIS; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Taylor JMW, 2010, CARDIOVASC RES, V86, P526, DOI 10.1093/cvr/cvq015; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Weisser SB, 2011, EUR J IMMUNOL, V41, P1742, DOI 10.1002/eji.201041105; Williams WM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-127; Winter J, 2004, HUM GENET, V114, P541, DOI 10.1007/s00439-004-1114-x; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Yool D, 2002, GLIA, V39, P256, DOI 10.1002/glia.10103; Yutsudo N, 2013, NEUROPSYCHOPHARMACOL, V38, P895, DOI 10.1038/npp.2012.260; Zavala C, 2014, PROCEEDINGS OF THE 6, P93; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang Y., 2014, MEDIAT INFLAMM, V2014, P11, DOI DOI 10.3171/2014.11.JNS14770; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao PS, 2013, INFECT GENET EVOL, V20, P257, DOI 10.1016/j.meegid.2013.09.016; Zhu XL, 2014, NAT NEUROSCI, V17, P773, DOI 10.1038/nn.3713	113	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157727	10.1371/journal.pone.0157727	http://dx.doi.org/10.1371/journal.pone.0157727			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314674	Green Submitted, Green Published, gold			2022-12-27	WOS:000378030000047
J	Johnson, FA; Fackler, PL; Boomer, GS; Zimmerman, GS; Williams, BK; Nichols, JD; Dorazio, RM				Johnson, Fred A.; Fackler, Paul L.; Boomer, G. Scott; Zimmerman, Guthrie S.; Williams, Byron K.; Nichols, James D.; Dorazio, Robert M.			State-Dependent Resource Harvesting with Lagged Information about System States	PLOS ONE			English	Article							ADAPTIVE-MANAGEMENT FRAMEWORK; OPTIMAL FIRE MANAGEMENT; ENVIRONMENTAL-MANAGEMENT; UNCERTAINTY; OPTIMIZATION; CONSERVATION; PERSISTENCE; POPULATION; STRATEGIES; HABITAT	Markov decision processes (MDPs), which involve a temporal sequence of actions conditioned on the state of the managed system, are increasingly being applied in natural resource management. This study focuses on the modification of a traditional MDP to account for those cases in which an action must be chosen after a significant time lag in observing system state, but just prior to a new observation. In order to calculate an optimal decision policy under these conditions, possible actions must be conditioned on the previous observed system state and action taken. We show how to solve these problems when the state transition structure is known and when it is uncertain. Our focus is on the latter case, and we show how actions must be conditioned not only on the previous system state and action, but on the probabilities associated with alternative models of system dynamics. To demonstrate this framework, we calculated and simulated optimal, adaptive policies for MDPs with lagged states for the problem of deciding annual harvest regulations for mallards (Anas platyrhynchos) in the United States. In this particular example, changes in harvest policy induced by the use of lagged information about system state were sufficient to maintain expected management performance (e.g. population size, harvest) even in the face of an uncertain system state at the time of a decision.	[Johnson, Fred A.; Dorazio, Robert M.] US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL USA; [Fackler, Paul L.] N Carolina State Univ, Dept Agr & Resource Econ, Raleigh, NC 27695 USA; [Boomer, G. Scott] US Fish & Wildlife Serv, Div Migratory Bird Management, Laurel, MD USA; [Zimmerman, Guthrie S.] US Fish & Wildlife Serv, Div Migratory Bird Management, Sacramento, CA USA; [Williams, Byron K.] Wildlife Soc, Bethesda, MD USA; [Nichols, James D.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA	United States Department of the Interior; United States Geological Survey; University of North Carolina; North Carolina State University; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey	Johnson, FA (corresponding author), US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL USA.	fjohnson@usgs.gov	Johnson, Fred/GLU-6494-2022; Nichols, James/AAF-7336-2020; Nichols, James/AAG-1500-2019		U.S. Fish and Wildlife Service	U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	Funding for this study was provided by the U.S. Fish and Wildlife Service (through an interagency agreement). URL:http://www.fws.gov/birds/index.php. The funder (Ken Richkus) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR, 2011, J ENVIRON MANAGE, V92, P1339, DOI 10.1016/j.jenvman.2010.11.019; Anderson D. R., 1976, FISH WILDLIFE SERVIC, V128; ANDERSON DR, 1975, ECOLOGY, V56, P1281, DOI 10.2307/1934697; Bogich T, 2008, ECOL APPL, V18, P748, DOI 10.1890/07-0642.1; Breininger D, 2014, LAND, V3, P874, DOI 10.3390/land3030874; Chades I., 2014, P AAAI C ART INT, V26, DOI [10.1609/aaai.v26i1.8171, DOI 10.1609/AAAI.V26I1.8171]; Chades I, 2008, P NATL ACAD SCI USA, V105, P13936, DOI 10.1073/pnas.0805265105; Chades I, 2011, P NATL ACAD SCI USA, V108, P8323, DOI 10.1073/pnas.1016846108; Convertino M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02922; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Dujardin Y, 2015, P 24 INT JOINT C ART; Fackler P, 2014, J ENVIRON MANAGE, V133, P27, DOI 10.1016/j.jenvman.2013.11.004; Fackler PL, 2013, INT REV ENVIRON RESO, V7, P109, DOI 10.1561/101.00000058; Fackler PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102434; Fackler PL, 2014, RESOUR ENERGY ECON, V37, P226, DOI 10.1016/j.reseneeco.2013.12.005; Gregory R, 2006, ECOL APPL, V16, P2411, DOI 10.1890/1051-0761(2006)016[2411:DAMCFA]2.0.CO;2; Johnson F.A., 2015, ADAPTIVE MANAGEMENT, P61; Johnson FA, 2010, ANAL MANAGEMENT MIGR; Johnson FA, 2015, WILDLIFE SOC B, V39, P9, DOI 10.1002/wsb.518; Johnson FA, 2014, ECOL MODEL, V273, P186, DOI 10.1016/j.ecolmodel.2013.10.031; Johnson FA, 2011, J FISH WILDL MANAG, V2, P234, DOI 10.3996/012011-JFWM-003; Johnson FA, 2011, J ENVIRON MANAGE, V92, P1385, DOI 10.1016/j.jenvman.2010.10.064; Linkov I, 2006, ENVIRON INT, V32, P1072, DOI 10.1016/j.envint.2006.06.013; Linkov I, 2006, INTEGR ENVIRON ASSES, V2, P92, DOI 10.1002/ieam.5630020116; Loh WY, 2011, WIRES DATA MIN KNOWL, V1, P14, DOI 10.1002/widm.8; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Marescot L, 2013, METHODS ECOL EVOL, V4, P872, DOI 10.1111/2041-210X.12082; Martin J, 2011, CONSERV BIOL, V25, P316, DOI 10.1111/j.1523-1739.2010.01644.x; McCarthy MA, 2001, J APPL ECOL, V38, P585, DOI 10.1046/j.1365-2664.2001.00617.x; McCarthy MA, 2007, CONSERV BIOL, V21, P956, DOI 10.1111/j.1523-1739.2007.00677.x; McDonald-Madden E, 2008, ECOL LETT, V11, P1169, DOI 10.1111/j.1461-0248.2008.01226.x; McDonald-Madden E, 2011, NAT CLIM CHANGE, V1, P261, DOI 10.1038/NCLIMATE1170; McDonald-Madden E, 2011, ECOL APPL, V21, P844, DOI 10.1890/09-2075.1; McFadden JE, 2011, J ENVIRON MANAGE, V92, P1354, DOI 10.1016/j.jenvman.2010.10.038; McGowan CP, 2015, BIOL CONSERV, V191, P759, DOI 10.1016/j.biocon.2015.08.038; Miranda M. J., 2002, APPL COMPUTATIONAL E; Moilanen A, 2007, BIOL CONSERV, V136, P470, DOI 10.1016/j.biocon.2006.12.019; Moore CT, 2006, FOREST SCI, V52, P155; Nicol S, 2013, IJCAI 23 INT JOINT C; Nicol S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2984; Nicol S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028993; Possingham H., 1997, ECOLOGICAL BASIS CON, P298; Puterman ML., 2014, MARKOV DECISION PROC; Regan TJ, 2011, J APPL ECOL, V48, P76, DOI 10.1111/j.1365-2664.2010.01915.x; Richards SA, 1999, ECOL APPL, V9, P880, DOI 10.1890/1051-0761(1999)009[0880:OFMFMC]2.0.CO;2; Rist L, 2013, ENVIRON CONSERV, V40, P5, DOI 10.1017/S0376892912000240; Ross S.M., 1983, INTRO STOCHASTIC DYN; Rout TM, 2014, J APPL ECOL, V51, P804, DOI 10.1111/1365-2664.12234; Schreiber E.S.G., 2004, ECOL MANAG RESTOR, V5, P177, DOI [DOI 10.1111/J.1442-8903.2004.00206.X, 10.1111/j.1442-8903.2004.00206.x]; Southwell DM, 2016, ECOL APPL, V26, P279, DOI 10.1890/14-2430; Tenhumberg B, 2004, CONSERV BIOL, V18, P1304, DOI 10.1111/j.1523-1739.2004.00246.x; U.S. Fish and Wildlife Service, 2010, ISS ANN REG PERM HUN, P296; Walters C., 1986, ADAPTIVE MANAGEMENT; WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620; WALTERS CJ, 1978, ANNU REV ECOL SYST, V9, P157, DOI 10.1146/annurev.es.09.110178.001105; Westgate MJ, 2013, BIOL CONSERV, V158, P128, DOI 10.1016/j.biocon.2012.08.016; Williams B. K., 2009, ADAPTIVE MANAGEMENT; Williams B.K., 1989, NAT RESOUR MODEL, V3, P137, DOI DOI 10.1111/j.1939-7445.1989.tb00074.x; Williams BK, 1996, ECOL MODEL, V93, P101, DOI 10.1016/0304-3800(95)00217-0; Williams BK, 2001, ENVIRON ECOL STAT, V8, P269, DOI 10.1023/A:1011395725123; Williams BK, 1996, J WILDLIFE MANAGE, V60, P223, DOI 10.2307/3802220; Williams BK, 2015, ECOL EVOL, V5, P466, DOI 10.1002/ece3.1363; Williams BK, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025004; Williams BK, 2011, ECOL MODEL, V222, P1092, DOI 10.1016/j.ecolmodel.2010.12.015; Williams BK, 2011, J ENVIRON MANAGE, V92, P1346, DOI 10.1016/j.jenvman.2010.10.041; Williams BK, 2009, ECOL MODEL, V220, P830, DOI 10.1016/j.ecolmodel.2008.12.023	66	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157373	10.1371/journal.pone.0157373	http://dx.doi.org/10.1371/journal.pone.0157373			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314852	gold, Green Submitted, Green Published			2022-12-27	WOS:000378030000022
J	Asad, AA; Seah, S; Baumgartner, R; Feng, D; Jensen, A; Manigbas, E; Henry, B; Houghton, A; Evelhoch, JL; Derbyshire, SWG; Chin, CL				Asad, Abu Bakar Ali; Seah, Stephanie; Baumgartner, Richard; Feng, Dai; Jensen, Andres; Manigbas, Elaine; Henry, Brian; Houghton, Andrea; Evelhoch, Jeffrey L.; Derbyshire, Stuart W. G.; Chin, Chih-Liang			Distinct BOLD fMRI Responses of Capsaicin-Induced Thermal Sensation Reveal Pain-Related Brain Activation in Nonhuman Primates	PLOS ONE			English	Article							LOW-BACK-PAIN; SECONDARY HYPERALGESIA; CENTRAL SENSITIZATION; CORTICAL REPRESENTATION; THERAPEUTIC-EFFICACY; MECHANICAL ALLODYNIA; ANESTHETIZED RATS; OPIOID RECEPTORS; RHESUS-MONKEYS; NOXIOUS HEAT	Background Approximately 20% of the adult population suffer from chronic pain that is not adequately treated by current therapies, highlighting a great need for improved treatment options. To develop effective analgesics, experimental human and animal models of pain are critical. Topically/intra-dermally applied capsaicin induces hyperalgesia and allodynia to thermal and tactile stimuli that mimics chronic pain and is a useful translation from preclinical research to clinical investigation. Many behavioral and self-report studies of pain have exploited the use of the capsaicin pain model, but objective biomarker correlates of the capsaicin augmented nociceptive response in nonhuman primates remains to be explored. Methodology Here we establish an aversive capsaicin-induced fMRI model using non-noxious heat stimuli in Cynomolgus monkeys (n = 8). BOLD fMRI data were collected during thermal challenge (ON: 20 s/42 degrees C; OFF: 40 s/35 degrees C, 4-cycle) at baseline and 30 min post-capsaicin (0.1 mg, topical, forearm) application. Tail withdrawal behavioral studies were also conducted in the same animals using 42 degrees C or 48 degrees C water bath pre-and post-capsaicin application (0.1 mg, subcutaneous, tail). Principal Findings Group comparisons between pre-and post-capsaicin application revealed significant BOLD signal increases in brain regions associated with the 'pain matrix', including somatosensory, frontal, and cingulate cortices, as well as the cerebellum (paired t-test, p<0.02, n = 8), while no significant change was found after the vehicle application. The tail withdrawal behavioral study demonstrated a significant main effect of temperature and a trend towards capsaicin induced reduction of latency at both temperatures. Conclusions These findings provide insights into the specific brain regions involved with aversive, 'painlike', responses in a nonhuman primate model. Future studies may employ both behavioral and fMRI measures as translational biomarkers to gain deeper understanding of pain processing and evaluate the preclinical efficacy of novel analgesics.	[Asad, Abu Bakar Ali; Seah, Stephanie; Chin, Chih-Liang] MSD, Merck Res Labs, Translat Biomarkers, Singapore, Singapore; [Baumgartner, Richard; Feng, Dai] Merck & Co Inc, Merck Res Labs, Biometr Res Biostat & Res Decis Sci, Rahway, NJ USA; [Jensen, Andres; Henry, Brian] MSD, Merck Res Labs, Early Discovery Pharmacol, Singapore, Singapore; [Manigbas, Elaine] Maccine Pte Ltd, Imaging, Singapore, Singapore; [Houghton, Andrea] Merck & Co Inc, Merck Res Labs, Early Discovery Pharmacol, West Point, PA USA; [Evelhoch, Jeffrey L.] Merck & Co Inc, Merck Res Labs, Translat Biomarkers, West Point, PA USA; [Derbyshire, Stuart W. G.] Natl Univ Singapore, Dept Psychol, Singapore 117570, Singapore; [Derbyshire, Stuart W. G.] A STAR NUS Clin Imaging Res Ctr, Singapore, Singapore; [Manigbas, Elaine] Natl Univ Singapore, Comparat Med Imaging Facil, Singapore 117570, Singapore	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; National University of Singapore; National University of Singapore	Asad, AA (corresponding author), MSD, Merck Res Labs, Translat Biomarkers, Singapore, Singapore.	asad.abu.bakar.ali@merck.com	Evelhoch, Jeffrey/R-2619-2019	Derbyshire, Stuart/0000-0002-2766-3424	Merck Co.	Merck Co.(Merck & Company)	This research was funded by Merck & Co. The authors would like to declare that the following individuals are current or former employees of the funder: Abu Bakar Ali Asad, Stephanie Seah, Richard Baumgartner, Dai Feng, Andres Jensen, Brian Henry, Andrea Houghton, Jeffrey L. Evelhoch and Chih-Liang Chin. The funder provided support in the form of salaries for authors ABAA, SS, RB, DF, AJ, BH, AH, JLE and CLC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson JLR, 1997, EXP BRAIN RES, V117, P192, DOI 10.1007/s002210050215; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Banks ML, 2010, J PHARMACOL EXP THER, V335, P497, DOI 10.1124/jpet.110.169276; Baron R, 1999, NEUROLOGY, V53, P548, DOI 10.1212/WNL.53.3.548; Baron R, 2000, LANCET, V356, P785, DOI 10.1016/S0140-6736(00)02649-0; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Becerra L, 2013, J NEUROPHYSIOL, V110, P1221, DOI 10.1152/jn.00284.2013; Becerra L, 2011, NEUROIMAGE, V54, P1355, DOI 10.1016/j.neuroimage.2010.08.056; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Becerra L, 2006, J NEUROSCI, V26, P10646, DOI 10.1523/JNEUROSCI.2305-06.2006; Becerra LR, 1999, MAGN RESON MED, V41, P1044, DOI 10.1002/(SICI)1522-2594(199905)41:5<1044::AID-MRM25>3.0.CO;2-M; Berge OG, 2011, BRIT J PHARMACOL, V164, P1195, DOI 10.1111/j.1476-5381.2011.01300.x; Bingel U, 2007, CURR OPIN NEUROL, V20, P424, DOI 10.1097/WCO.0b013e328259c34d; Borsook D, 2008, CEREBELLUM, V7, P252, DOI 10.1007/s12311-008-0011-6; Borsook D, 2006, NAT REV DRUG DISCOV, V5, P411, DOI 10.1038/nrd2027; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Brooks JC, 2005, NEUROIMAGE, P27; Brooks JCW, 2002, NEUROIMAGE, V15, P293, DOI 10.1006/nimg.2001.0974; Burns David, 2006, BMC Anesthesiol, V6, P3, DOI 10.1186/1471-2253-6-3; Butelman ER, 2003, J PHARMACOL EXP THER, V306, P1106, DOI 10.1124/jpet.103.052381; Casey KL, 2003, EXP NEUROL, V184, pS80, DOI 10.1016/j.expneurol.2003.07.006; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen LM, 2012, PAIN, V153, P158, DOI 10.1016/j.pain.2011.10.006; Chizh BA, 2009, NEUROTHERAPEUTICS, V6, P749, DOI 10.1016/j.nurt.2009.08.005; Chizh BA, 2009, BRAIN RES REV, V60, P243, DOI 10.1016/j.brainresrev.2008.12.016; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Costigan M, 2012, CURR OPIN PHARMACOL, V12, P92, DOI 10.1016/j.coph.2011.10.019; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dirks J, 2000, ANESTH ANALG, V91, P967, DOI 10.1097/00000539-200010000-00037; Dirks J, 2002, ANESTHESIOLOGY, V97, P102, DOI 10.1097/00000542-200207000-00015; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; DYKSTRA LA, 1986, J PHARMACOL METHOD, V15, P263, DOI 10.1016/0160-5402(86)90056-2; England S, 2009, BRIT J PHARMACOL, V158, P1413, DOI 10.1111/j.1476-5381.2009.00437.x; Field CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003928; Flor H, 1995, NATURE; Frey S, 2011, NEUROIMAGE, V55, P1435, DOI 10.1016/j.neuroimage.2011.01.040; Gear RW, 1999, J NEUROSCI, V19, P7175, DOI 10.1523/JNEUROSCI.19-16-07175.1999; Governo RJM, 2006, PAIN, V126, P35, DOI 10.1016/j.pain.2006.06.012; Green BG, 2004, J NEUROBIOL, V61, P13, DOI 10.1002/neu.20081; Gyulai Ferenc E, 2004, Curr Opin Anaesthesiol, V17, P397, DOI 10.1097/00001503-200410000-00008; Harrison C, 2011, NAT REV DRUG DISCOV, V10, DOI 10.1038/nrd3396; Hood DD, 2003, ANESTH ANALG, V97, P810, DOI 10.1213/01.ANE.0000078811.80093.88; HSIEH JC, 1995, PAIN, V63, P225, DOI 10.1016/0304-3959(95)00048-W; Hu E, 2010, PAIN, V148, P107, DOI 10.1016/j.pain.2009.10.026; IADAROLA MJ, 1995, PAIN, V63, P55, DOI 10.1016/0304-3959(95)00015-K; Iadarola MJ, 1998, BRAIN, V121, P931, DOI 10.1093/brain/121.5.931; Iannetti GD, 2005, P NATL ACAD SCI USA, V102, P18195, DOI 10.1073/pnas.0506624102; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones Anthony K P, 2002, Curr Rheumatol Rep, V4, P329, DOI 10.1007/s11926-002-0042-9; Joshi SK, 2006, NEUROSCIENCE, V143, P587, DOI 10.1016/j.neuroscience.2006.08.005; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P1540; KARNI A, 1995, NATURE, V377, P155; KEEFE FJ, 1990, PAIN, V40, P153, DOI 10.1016/0304-3959(90)90066-M; Kissin I, 2010, ANESTH ANALG, V110, P780, DOI 10.1213/ANE.0b013e3181cde882; Klein T, 2005, PAIN, V115, P227, DOI 10.1016/j.pain.2005.03.021; Ko MC, 1999, J PHARMACOL EXP THER, V289, P378; Ko MC, 1998, J PHARMACOL EXP THER, V286, P150; Ko MC, 1999, PSYCHOPHARMACOLOGY, V143, P322, DOI 10.1007/s002130050955; Ko MC, 2009, NEUROPSYCHOPHARMACOL, V34, P2088, DOI 10.1038/npp.2009.33; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; Lawrence J, 2008, DRUGS R&D, V9, P323, DOI 10.2165/00126839-200809050-00003; Lloyd D, 2008, SPINE, V33, P1372, DOI 10.1097/BRS.0b013e3181734a8a; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Maihofner C, 2005, NEUROIMAGE, V28, P996, DOI 10.1016/j.neuroimage.2005.06.049; Mainero C, 2007, NEUROIMAGE, V35, P1201, DOI 10.1016/j.neuroimage.2007.01.024; Malisza KL, 2003, MAGN RESON IMAGING, V21, P489, DOI 10.1016/S0730-725X(03)00074-2; Malisza KL, 2001, J MAGN RESON IMAGING, V14, P341, DOI 10.1002/jmri.1192; Mao JR, 2012, TRENDS PHARMACOL SCI, V33, P568, DOI 10.1016/j.tips.2012.08.001; Mathiesen O, 2006, J PAIN, V7, P565, DOI 10.1016/j.jpain.2006.02.004; May A, 1998, PAIN, V74, P61, DOI 10.1016/S0304-3959(97)00144-9; Mogil JS, 2010, PAIN, V151, P12, DOI 10.1016/j.pain.2010.07.015; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mohr C, 2008, PAIN, V139, P416, DOI 10.1016/j.pain.2008.05.020; Mohr C, 2008, EUR J NEUROSCI, V27, P739, DOI 10.1111/j.1460-9568.2008.06036.x; Moisset X, 2007, NEUROIMAGE, V37, pS80, DOI 10.1016/j.neuroimage.2007.03.054; Moulton EA, 2005, J NEUROPHYSIOL, V93, P2183, DOI 10.1152/jn.01025.2004; Moulton EA, 2007, NEUROIMAGE, V35, P1586, DOI 10.1016/j.neuroimage.2007.02.001; Moulton EA, 2012, J NEUROSCI, V32, P6024, DOI 10.1523/JNEUROSCI.0006-12.2012; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Murphy KL, 2012, AM COLL LAB, P403, DOI 10.1016/B978-0-12-381365-7.00017-0; Negus SS, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/867067; Neubert JK, 2006, BEHAV BRAIN RES, V170, P308, DOI 10.1016/j.bbr.2006.03.008; O'Neill J, 2012, PHARMACOL REV, V64, P939, DOI 10.1124/pr.112.006163; Olesen AE, 2012, PHARMACOL REV, V64, P722, DOI 10.1124/pr.111.005447; Petersen KL, 1999, NEUROREPORT, V10, P1511, DOI 10.1097/00001756-199905140-00022; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Peyron R, 2004, NEUROLOGY, V63, P1838, DOI 10.1212/01.WNL.0000144177.61125.85; Popilskis SJ, 2008, AM COLL LAB, P335; Rempe T, 2014, J MAGN RESON IMAGING; Rempe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112325; SADATO N, 1995, ANN NEUROL, V37, P74, DOI 10.1002/ana.410370114; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Schenk LA, 2014, PAIN, V155, P150, DOI 10.1016/j.pain.2013.09.024; Schweinhardt P, 2006, NEUROIMAGE, V32, P256, DOI 10.1016/j.neuroimage.2006.03.024; Scrivani S, 2010, PAIN MED, V11, P920, DOI 10.1111/j.1526-4637.2010.00859.x; Shenoy Ravikiran, 2011, J Pain Res, V4, P365, DOI 10.2147/JPR.S24810; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Svensson P, 1997, EVOKED POTENTIAL, V104, P343, DOI 10.1016/S0168-5597(97)00026-9; Symons KT, 2011, J PHARMACOL EXP THER, V336, P468, DOI 10.1124/jpet.110.172817; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tracey I, 2008, BRIT J ANAESTH, V101, P32, DOI 10.1093/bja/aen102; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tuor UI, 2000, PAIN, V87, P315, DOI 10.1016/S0304-3959(00)00293-1; Upadhyay J, 2011, NEUROPSYCHOPHARMACOL, V36, P2659, DOI 10.1038/npp.2011.156; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wang HS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001269; Watkinson P, 2013, PAIN, V154, P743, DOI 10.1016/j.pain.2013.01.016; Wey HY, 2010, NEUROIMAGE, V52, P1420, DOI 10.1016/j.neuroimage.2010.05.014; Wiech K, 2005, NEUROIMAGE, V27, P59, DOI 10.1016/j.neuroimage.2005.03.044; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Young SS, 1999, LAB ANIM, V33, P162, DOI 10.1258/002367799780578363; Zhao FQ, 2015, NEUROIMAGE, V106, P364, DOI 10.1016/j.neuroimage.2014.12.001; Zhao FQ, 2014, NEUROIMAGE, V84, P724, DOI 10.1016/j.neuroimage.2013.09.036	118	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156805	10.1371/journal.pone.0156805	http://dx.doi.org/10.1371/journal.pone.0156805			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309348	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800014
J	Marrone, G; Mellgren, A; Eriksson, LE; Svedhem, V				Marrone, Gaetano; Mellgren, Asa; Eriksson, Lars E.; Svedhem, Veronica			High Concordance between Self-Reported Adherence, Treatment Outcome and Satisfaction with Care Using a Nine-Item Health Questionnaire in InfCareHIV	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; QUALITY-OF-LIFE; HIV-INFECTED PATIENTS; MEDICATION ADHERENCE; PEOPLE; ART; NONADHERENCE; METAANALYSIS; PROGRESSION; MORTALITY	Background In this cross-sectional study we present an integrated analysis of a self-reported Health Questionnaire and socio-demographic and treatment outcome data from the national Swedish HIV cohort, InfCareHIV. Objectives To evaluate the Health Questionnaire and identify the main determinants of adherence. Methods A total of 2,846 patients answered a nine-item disease-specific Health Questionnaire between 2012 and 2014, corresponding to 44% of all active patients in the national InfCareHIV cohort. The questionnaire assessed patient related outcome measures (PROMs) regarding health and antiretroviral treatment (ART) and patient related experience measures (PREMs) regarding involvement in care and satisfaction with the care provider. Result We found the Health Questionnaire to be valid and reliable when used in ordinary clinical practice. There was a high concordance between self-reported adherence to ART in the past seven days and treatment outcome, with 94% of patients who reported optimal adherence having a viral load <50 copies/ml. The main determinants of optimal adherence were heterosexual transmission path, being born in Sweden, being male, not reporting experience of ART side effects and being fully satisfied with care. Conclusion The nine-item Health Questionnaire can identify patients at risk of treatment failure, those in need of clinical assessment of adverse events and those with impaired physical health.	[Marrone, Gaetano] Karolinska Univ Hosp, Dept Infect Dis & Clin Virol, Stockholm, Sweden; [Marrone, Gaetano] Karolinska Inst, Dept Publ Hlth Sci, Solna, Sweden; [Mellgren, Asa] South Alvsborg Hosp, Clin Infect Dis, Boras, Sweden; [Eriksson, Lars E.] Karolinska Inst, Dept Learning Informat Management & Eth, Solna, Sweden; [Eriksson, Lars E.; Svedhem, Veronica] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Eriksson, Lars E.] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Svedhem, Veronica] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; City University London; Karolinska Institutet	Svedhem, V (corresponding author), Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden.; Svedhem, V (corresponding author), Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden.	veronica.svedhem-johansson@karolinska.se		Marrone, Gaetano/0000-0002-2991-1663; Mellgren, Asa/0000-0002-1202-3504	Stockholm County Council; Gilead Nordic Fellow program; Swedish Association of Local Authorities and Regions	Stockholm County Council(Stockholm County Council); Gilead Nordic Fellow program; Swedish Association of Local Authorities and Regions	This work was supported by the Stockholm County Council (www.sll.se), Gilead Nordic Fellow program (www.Gilead.com), and the Swedish Association of Local Authorities and Regions (www.kvalitetsregister.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; Andrade ASA, 2013, JAIDS-J ACQ IMM DEF, V62, P282, DOI 10.1097/QAI.0b013e31827ed678; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Brannstrom J, 2015, HIV MED; Bulgiba A, 2013, PREV MED, V57, pS34, DOI 10.1016/j.ypmed.2013.01.002; Silva ACDE, 2014, REV LAT-AM ENFERM, V22, P994, DOI 10.1590/0104-1169.3534.2508; Degroote S, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18643; Eriksson LE, 2000, J ADV NURS, V32, P1213, DOI 10.1046/j.1365-2648.2000.01592.x; Ettenhofer ML, 2010, NEUROLOGY, V74, P1217, DOI 10.1212/WNL.0b013e3181d8c1ca; Fayers Peter MD, 2007, ASSESSMENT ANAL INTE; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Gisslen M, 2016, SWEDISH HIV TREATMEN; Haggblom A, 2016, THE LANCET IN PRESS; Haubrich RH, 1999, AIDS, V13, P1099, DOI 10.1097/00002030-199906180-00014; Hill A, 2013, J INFECT DIS, V207, pS78, DOI 10.1093/infdis/jit112; Langebeek N, 2014, BMC MED, V12, DOI [10.1186/s12916-014-0142-1, 10.1186/PREACCEPT-1453408941291432]; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Miners A, 2014, LANCET HIV, V1, pE32, DOI 10.1016/S2352-3018(14)70018-9; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Nieuwkerk PT, 2005, JAIDS-J ACQ IMM DEF, V38, P445, DOI 10.1097/01.qai.0000147522.34369.12; Protopopescu C, 2009, J ANTIMICROB CHEMOTH, V64, P599, DOI 10.1093/jac/dkp232; Rydstrom LL, 2016, AIDS CARE, V28, P665, DOI 10.1080/09540121.2015.1120267; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Sodergard B, 2006, J CLIN PHARM THER, V31, P605, DOI 10.1111/j.1365-2710.2006.00782.x; Tadesse WT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-32; Villes V, 2007, ANTIVIR THER, V12, P1067; Wagner GJ, 2000, AIDS CARE, V12, P405, DOI 10.1080/09540120050123800	28	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156916	10.1371/journal.pone.0156916	http://dx.doi.org/10.1371/journal.pone.0156916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310201	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000378029800019
J	Montero-Marin, J; Zubiaga, F; Cereceda, M; Demarzo, MMP; Trenc, P; Garcia-Campayo, J				Montero-Marin, Jesus; Zubiaga, Fernando; Cereceda, Maria; Piva Demarzo, Marcelo Marcos; Trenc, Patricia; Garcia-Campayo, Javier			Burnout Subtypes and Absence of Self-Compassion in Primary Healthcare Professionals: A Cross-Sectional Study	PLOS ONE			English	Article							LEAST-SQUARES ESTIMATION; WORK ENGAGEMENT; PHYSICIAN BURNOUT; NEGATIVE AFFECT; PANAS SCALES; RISK-FACTORS; JOB DEMANDS; SATISFACTION; VALIDATION; WORKAHOLISM	Background Primary healthcare professionals report high levels of distress and burnout. A new model of burnout has been developed to differentiate three clinical subtypes: 'frenetic', 'underchallenged' and 'worn-out'. The aim of this study was to confirm the validity and reliability of the burnout subtype model in Spanish primary healthcare professionals, and to assess the explanatory power of the self-compassion construct as a possible protective factor. Method The study employed a cross-sectional design. A sample of n = 440 Spanish primary healthcare professionals (214 general practitioners, 184 nurses, 42 medical residents) completed the Burnout Clinical Subtype Questionnaire (BCSQ-36), the Maslach Burnout Inventory General Survey (MBI-GS), the Self-Compassion Scale (SCS), the Utrecht Work Engagement Scale (UWES) and the Positive and Negative Affect Schedule (PANAS). The factor structure of the BCSQ-36 was estimated using confirmatory factor analysis (CFA) by the unweighted least squares method from polychoric correlations. Internal consistency (R) was assessed by squaring the correlation between the latent true variable and the observed variables. The relationships between the BCSQ-36 and the other constructs were analysed using Spearman's r and multiple linear regression models. Results The structure of the BCSQ-36 fit the data well, with adequate CFA indices for all the burnout subtypes. Reliability was adequate for all the scales and sub-scales (R >= 0.75). Self-judgement was the self-compassion factor that explained the frenetic subtype (Beta = 0.36; p<0.001); isolation explained the underchallenged (Beta = 0.16; p = 0.010); and over-identification the worn-out (Beta = 0.25; p = 0.001). Other significant associations were observed between the different burnout subtypes and the dimensions of the MBI-GS, UWES and PANAS. Conclusions The typological definition of burnout through the BCSQ-36 showed good structure and appropriate internal consistence in Spanish primary healthcare professionals. The negative self-compassion dimensions seem to play a relevant role in explaining the burnout profiles in this population, and they should be considered when designing specific treatments and interventions tailored to the specific vulnerability of each subtype.	[Montero-Marin, Jesus] Univ Zaragoza, Fac Hlth & Sport Sci, Zaragoza, Spain; [Montero-Marin, Jesus; Zubiaga, Fernando; Cereceda, Maria; Trenc, Patricia; Garcia-Campayo, Javier] Primary Care Prevent & Hlth Promot Res Network Re, Zaragoza, Spain; [Montero-Marin, Jesus; Zubiaga, Fernando; Cereceda, Maria; Trenc, Patricia; Garcia-Campayo, Javier] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Oviedo, Spain; [Piva Demarzo, Marcelo Marcos] Univ Fed Sao Paulo, UNIFESP, Dept Prevent Med, Mente Aberta Brazilian Ctr Mindfulness & Hlth Pr, Sao Paulo, Brazil; [Garcia-Campayo, Javier] Miguel Servet Hosp, Zaragoza, Spain; [Garcia-Campayo, Javier] Univ Zaragoza, Zaragoza, Spain	University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universidade Federal de Sao Paulo (UNIFESP); Miguel Servet University Hospital; University of Zaragoza	Garcia-Campayo, J (corresponding author), Primary Care Prevent & Hlth Promot Res Network Re, Zaragoza, Spain.; Garcia-Campayo, J (corresponding author), CIBERSAM, Ctr Invest Biomed Red Salud Mental, Oviedo, Spain.; Garcia-Campayo, J (corresponding author), Miguel Servet Hosp, Zaragoza, Spain.; Garcia-Campayo, J (corresponding author), Univ Zaragoza, Zaragoza, Spain.	jgarcamp@gmail.com	Demarzo, Marcelo/A-7021-2010; Montero-Marin, Jesus/ABG-8919-2020	Demarzo, Marcelo/0000-0002-7447-1839; Montero-Marin, Jesus/0000-0001-5677-1662; Garcia-Campayo, Javier/0000-0002-3797-4218	Research Network on Preventative Activities and Health Promotion (REDIAPP); Aragon Health Sciences Institute, Zaragoza, Spain	Research Network on Preventative Activities and Health Promotion (REDIAPP); Aragon Health Sciences Institute, Zaragoza, Spain	This study was supported by the Research Network on Preventative Activities and Health Promotion (REDIAPP) and the Aragon Health Sciences Institute, Zaragoza, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2010, J PSYCHOSOM RES, V69, P51, DOI 10.1016/j.jpsychores.2010.01.002; Al-Sareai NS, 2013, E MEDITERR HEALTH J, V19, P426, DOI 10.26719/2013.19.5.426; Andreassen CS, 2011, STRESS HEALTH, V27, pE209, DOI 10.1002/smi.1366; [Anonymous], 1998, THE; Atanes ACM, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0823-0; Bakker AB, 2005, J OCCUP HEALTH PSYCH, V10, P170, DOI 10.1037/1076-8998.10.2.170; Boellinghaus I, 2014, MINDFULNESS, V5, P129, DOI 10.1007/s12671-012-0158-6; BOLLEN KA, 1986, PSYCHOMETRIKA, V51, P375, DOI 10.1007/BF02294061; Breso E., 2007, SINDROME ESTAR QUEMA; Briggs NE, 2003, MULTIVAR BEHAV RES, V38, P25, DOI 10.1207/S15327906MBR3801_2; Byrne B, 2001, STUCTURAL EQUATION M; DECKARD GJ, 1992, J INFECT DIS, V165, P224, DOI 10.1093/infdis/165.2.224; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demerouti E, 2001, SCAND J WORK ENV HEA, V27, P279, DOI 10.5271/sjweh.615; Demerouti E, 2010, J OCCUP HEALTH PSYCH, V15, P209, DOI 10.1037/a0019408; Dolan ED, 2015, J GEN INTERN MED, V30, P582, DOI 10.1007/s11606-014-3112-6; Farber B.A, 1990, PSYCHOTHERAPY PRIVAT, V8, P35, DOI [DOI 10.1300/J294V08N01_07, 10.1300/J294v08n01_07]; Farber BA, 2000, J CLIN PSYCHOL, V56, P589, DOI 10.1002/(SICI)1097-4679(200005)56:5<589::AID-JCLP1>3.0.CO;2-S; Fortney L, 2013, ANN FAM MED, V11, P412, DOI 10.1370/afm.1511; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Gabbe SG, 2002, AM J OBSTET GYNECOL, V186, P601, DOI 10.1067/mob.2002.122391; Garcia-Campayo J, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-4; Gazelle G, 2015, J GEN INTERN MED, V30, P508, DOI 10.1007/s11606-014-3144-y; Girón Manuel, 2002, Rev. Esp. Salud Publica, V76, P561, DOI 10.1590/s1135-57272002000500016; Goetz JL, 2010, PSYCHOL BULL, V136, P351, DOI 10.1037/a0018807; Goldberg R, 1996, ACAD EMERG MED, V3, P1156, DOI 10.1111/j.1553-2712.1996.tb03379.x; Graham JM, 2006, EDUC PSYCHOL MEAS, V66, P930, DOI 10.1177/0013164406288165; Heffernan M, 2010, INT J NURS PRACT, V16, P366, DOI 10.1111/j.1440-172X.2010.01853.x; Heras-Mosteiro J, 2016, INT J HEALTH SERV, V46, P283, DOI 10.1177/0020731415625251; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyman SA, 2011, ANESTHESIOLOGY, V114, P194, DOI 10.1097/ALN.0b013e318201ce9a; Kemper KJ, 2015, J ALTERN COMPLEM MED, V21, P496, DOI 10.1089/acm.2014.0281; King G, 2003, INT STUDIES PERSPECT, V4, P100, DOI DOI 10.1111/1528-3577.04105; KNOL DL, 1991, MULTIVAR BEHAV RES, V26, P457, DOI 10.1207/s15327906mbr2603_5; Krasner MS, 2009, JAMA-J AM MED ASSOC, V302, P1284, DOI 10.1001/jama.2009.1384; Kubota K, 2010, IND HEALTH, V48, P864, DOI 10.2486/indhealth.MS1139; Lama D., 2001, OPEN HEART PRACTICIN; Lamothe M, 2016, COMPLEMENT THER MED, V24, P19, DOI 10.1016/j.ctim.2015.11.001; Lee CT, 2012, MULTIVAR BEHAV RES, V47, P314, DOI 10.1080/00273171.2012.658340; Levy J, 2006, MODELIZACION CON EST, P21; Linzer M, 2001, AM J MED, V111, P170, DOI 10.1016/S0002-9343(01)00814-2; MARDIA KV, 1974, SANKHYA SER B, V36, P115; Martinez-Gonzalez M, 2006, BIOESTADISTICA AMIGA, P851; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C., 1996, MASLACH BURNOUT INVE; Mazzetti G, 2016, EUR JPSYCHOL ASSESS; Montero-Marin J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01895; Montero-Marin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089090; Montero-Marin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087071; Montero-Marin J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-922; Montero-Marin J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-74; Montero-Marin J, 2011, BMC MED EDUC, V11, DOI [10.1186/1472-6920-11-103, 10.1186/1471-244X-11-49]; Montero-Marin J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-302; Montero-Marin Jesus, 2009, J Occup Med Toxicol, V4, P31, DOI 10.1186/1745-6673-4-31; Muris P., 2016, CLIN PSYCHOL PSYCHOT; MUTHEN B, 1992, BRIT J MATH STAT PSY, V45, P19, DOI 10.1111/j.2044-8317.1992.tb00975.x; Navarro-Gonzalez D, 2015, Semergen, V41, P191, DOI 10.1016/j.semerg.2014.03.008; Neff K, 2003, SELF IDENTITY, V2, P85, DOI 10.1080/15298860390129863; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Ng TWH, 2007, J ORGAN BEHAV, V28, P111, DOI 10.1002/job.424; PARRY CDH, 1991, APPL PSYCH MEAS, V15, P35, DOI 10.1177/014662169101500105; Raab K, 2014, J HEALTH CARE CHAPL, V20, P95, DOI 10.1080/08854726.2014.913876; Rabatin J, 2015, J PRIM CARE COMMUNIT; Rao N, 2016, J EVID BASED COMPLEM; Raykov T, 1997, APPL PSYCH MEAS, V21, P173, DOI 10.1177/01466216970212006; Reijseger G., 2016, J BUS PSYCHOL; Richter A, 2015, INT ARCH OCC ENV HEA, V88, P103, DOI 10.1007/s00420-014-0941-x; Russett B, 2003, INT STUDIES PERSPECT, V4, P88; Sandin B, 1999, PSICOTHEMA, V11, P37; Schaufeli W.B., 2002, J HAPPINESS STUD, V3, P72, DOI [10.1023/A:1015630930326, DOI 10.1023/A:1015630930326]; Schaufeli WB, 2008, APPL PSYCHOL-INT REV, V57, P173, DOI 10.1111/j.1464-0597.2007.00285.x; Schaufeli WB, 2009, CAREER DEV INT, V14, P204, DOI 10.1108/13620430910966406; Schutte N, 2000, J OCCUP ORGAN PSYCH, V73, P53, DOI 10.1348/096317900166877; Shanafelt TD, 2014, J CLIN ONCOL, V32, P678, DOI 10.1200/JCO.2013.51.8480; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; Shimazu A, 2015, INT J BEHAV MED, V22, P18, DOI 10.1007/s12529-014-9410-x; Slocum-Gori S, 2013, PALLIATIVE MED, V27, P172, DOI 10.1177/0269216311431311; Thomas MR, 2007, J GEN INTERN MED, V22, P177, DOI 10.1007/s11606-006-0039-6; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Williams ES, 2007, HEALTH CARE MANAGE R, V32, P203, DOI 10.1097/01.HMR.0000281626.28363.59	82	49	49	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157499	10.1371/journal.pone.0157499	http://dx.doi.org/10.1371/journal.pone.0157499			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310426	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800086
J	Monti, DA; Zabrecky, G; Kremens, D; Liang, TW; Wintering, NA; Cai, JL; Wei, XT; Bazzan, AJ; Zhong, L; Bowen, B; Intenzo, CM; Iacovitti, L; Newberg, AB				Monti, Daniel A.; Zabrecky, George; Kremens, Daniel; Liang, Tsao-Wei; Wintering, Nancy A.; Cai, Jingli; Wei, Xiatao; Bazzan, Anthony J.; Zhong, Li; Bowen, Brendan; Intenzo, Charles M.; Iacovitti, Lorraine; Newberg, Andrew B.			N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data	PLOS ONE			English	Article							OXIDATIVE STRESS; ALPHA-SYNUCLEIN; TRANSPORTER BINDING; HEALTHY CONTROLS; FOLLOW-UP; BRAIN; ACETYLCYSTEINE; SPECT; ANTIOXIDANTS; GLUTATHIONE	Backgound The purpose of this study was to assess the biological and clinical effects of n-acetyl-cysteine (NAC) in Parkinson's disease (PD). Methods The overarching goal of this pilot study was to generate additional data about potentially protective properties of NAC in PD, using an in vitro and in vivo approach. In preparation for the clinical study we performed a cell tissue culture study with human embryonic stem cell (hESC)-derived midbrain dopamine (mDA) neurons that were treated with rotenone as a model for PD. The primary outcome in the cell tissue cultures was the number of cells that survived the insult with the neurotoxin rotenone. In the clinical study, patients continued their standard of care and were randomized to receive either daily NAC or were a waitlist control. Patients were evaluated before and after 3 months of receiving the NAC with DaTscan to measure dopamine transporter (DAT) binding and the Unified Parkinson's Disease Rating Scale (UPDRS) to measure clinical symptoms. Results The cell line study showed that NAC exposure resulted in significantly more mDA neurons surviving after exposure to rotenone compared to no NAC, consistent with the protective effects of NAC previously observed. The clinical study showed significantly increased DAT binding in the caudate and putamen (mean increase ranging from 4.4% to 7.8%; p<0.05 for all values) in the PD group treated with NAC, and no measurable changes in the control group. UPDRS scores were also significantly improved in the NAC group (mean improvement of 12.9%, p = 0.01). Conclusions The results of this preliminary study demonstrate for the first time a potential direct effect of NAC on the dopamine system in PD patients, and this observation may be associated with positive clinical effects. A large-scale clinical trial to test the therapeutic efficacy of NAC in this population and to better elucidate the mechanism of action is warranted.	[Monti, Daniel A.; Zabrecky, George; Wintering, Nancy A.; Bazzan, Anthony J.; Zhong, Li; Bowen, Brendan; Newberg, Andrew B.] Thomas Jefferson Univ, Myrna Brind Ctr Integrat Med, Philadelphia, PA 19107 USA; [Kremens, Daniel; Liang, Tsao-Wei] Thomas Jefferson Univ, Dept Neurol, Movement Disorders Ctr, Philadelphia, PA 19107 USA; [Cai, Jingli; Wei, Xiatao; Iacovitti, Lorraine; Newberg, Andrew B.] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA; [Intenzo, Charles M.] Thomas Jefferson Univ, Dept Radiol, Div Nucl Med, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University	Newberg, AB (corresponding author), Thomas Jefferson Univ, Myrna Brind Ctr Integrat Med, Philadelphia, PA 19107 USA.; Newberg, AB (corresponding author), Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA.	Andrew.newberg@jefferson.edu			Marcus Foundation	Marcus Foundation	The Marcus Foundation supported this research study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2002, JAMA-J AM MED ASSOC, V288, P311, DOI 10.1001/jama.288.3.311; Aoki E, 2009, EXP MOL PATHOL, V86, P57, DOI 10.1016/j.yexmp.2008.10.004; Bagh MB, 2008, FREE RADICAL RES, V42, P574, DOI 10.1080/10715760802158430; Banaclocha MM, 2000, BRAIN RES, V859, P173, DOI 10.1016/S0006-8993(00)02005-9; Banaclocha MM, 1997, BRAIN RES, V762, P256, DOI 10.1016/S0006-8993(97)00493-9; Booij J, 1997, J NEUROL NEUROSUR PS, V62, P133, DOI 10.1136/jnnp.62.2.133; BORGSTROM L, 1986, EUR J CLIN PHARMACOL, V31, P217, DOI 10.1007/BF00606662; Braak H, 2000, J NEUROL, V247, P3; Brunswick DJ, 2003, AM J PSYCHIAT, V160, P1836, DOI 10.1176/appi.ajp.160.10.1836; Cai JL, 2013, DEV BIOL, V376, P62, DOI 10.1016/j.ydbio.2013.01.012; Chao JF, 2012, NUTR REV, V70, P373, DOI 10.1111/j.1753-4887.2012.00484.x; Chinta SJ, 2008, BBA-GEN SUBJECTS, V1780, P1362, DOI 10.1016/j.bbagen.2008.02.005; Clark J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012333; Eshuis SA, 2009, EUR J NUCL MED MOL I, V36, P454, DOI 10.1007/s00259-008-0989-5; FROST JJ, 1993, ANN NEUROL, V34, P423, DOI 10.1002/ana.410340331; Garcia-Gomez FJ, 2013, REV ESP MED NUCL IMA, V32, P350, DOI 10.1016/j.remn.2013.02.009; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goetz CG, 2008, MOVEMENT DISORD, V23, P690, DOI 10.1002/mds.21894; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Hauser RA, 2009, MOVEMENT DISORD, V24, P979, DOI 10.1002/mds.22401; Hesse S, 2008, J NEUROL, V255, P1059, DOI 10.1007/s00415-008-0849-z; Holmay MJ, 2013, CLIN NEUROPHARMACOL, V36, P103, DOI 10.1097/WNF.0b013e31829ae713; INNIS RB, 1993, P NATL ACAD SCI USA, V90, P11965, DOI 10.1073/pnas.90.24.11965; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Jaber M, 1997, MOVEMENT DISORD, V12, P629, DOI 10.1002/mds.870120502; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; JENNER P, 1993, J NEURAL TRANSM-GEN, P23; Jiang Y, 2013, NEUROSCIENCE, V255, P19, DOI 10.1016/j.neuroscience.2013.09.049; Koch W, 2014, EUR J NUCL MED MOL I, V41, P1938, DOI 10.1007/s00259-014-2785-8; Korell M, 2005, PARKINSONS DIS, P39; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lehto SM, 2008, NEUROSCI LETT, V441, P291, DOI 10.1016/j.neulet.2008.06.042; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Marek K, 2002, JAMA-J AM MED ASSOC, V287, P1653; Martinez M, 1999, LIFE SCI, V64, P1253, DOI 10.1016/S0024-3205(98)00472-X; Medina S, 2002, FREE RADICAL RES, V36, P1179, DOI 10.1080/107157602100006445; Newberg AB, 2012, PSYCHIAT RES-NEUROIM, V202, P161, DOI 10.1016/j.pscychresns.2011.12.015; Offen D, 1996, EXP NEUROL, V141, P32, DOI 10.1006/exnr.1996.0136; OLSSON B, 1988, EUR J CLIN PHARMACOL, V34, P77, DOI 10.1007/BF01061422; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; PERRY TL, 1985, NEUROSCI LETT, V60, P109, DOI 10.1016/0304-3940(85)90229-0; RATAN RR, 1994, J NEUROSCI, V14, P4385; SCHERMAN D, 1989, ANN NEUROL, V26, P551, DOI 10.1002/ana.410260409; SCHOEMAKER H, 1985, N-S ARCH PHARMACOL, V329, P227, DOI 10.1007/BF00501873; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Seibyl JP, 1998, J NUCL MED, V39, P1500; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Sharma A, 2007, CELL MOL BIOL, V53, P48, DOI 10.1170/T774; Shivalingappa PC, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/424285; SIES H, 1985, PHILOS T ROY SOC B, V311, P617, DOI 10.1098/rstb.1985.0168; Sumec R, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/620674; Thomas MP, 2007, J NEUROCHEM, V100, P503, DOI 10.1111/j.1471-4159.2006.04315.x; Unnithan AS, 2014, NEUROSCI LETT, V560, P71, DOI 10.1016/j.neulet.2013.12.023; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; VINA J, 1983, EXPERIENTIA, V39, P164; Wang J, 2007, J NEUROL, V254, P185, DOI 10.1007/s00415-006-0322-9; Weber CA, 2006, ANN PHARMACOTHER, V40, P935, DOI 10.1345/aph.1G551; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609; Zigmond Michael J, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS123, DOI 10.1016/S1353-8020(13)70030-0	59	85	90	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157602	10.1371/journal.pone.0157602	http://dx.doi.org/10.1371/journal.pone.0157602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309537	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800106
J	Nam, VT; van Kuijk, M; Anten, NPR				Vu Thanh Nam; van Kuijk, Marijke; Anten, Niels P. R.			Allometric Equations for Aboveground and Belowground Biomass Estimations in an Evergreen Forest in Vietnam	PLOS ONE			English	Article							LIFE-HISTORY VARIATION; WOOD SPECIFIC-GRAVITY; SECONDARY FORESTS; TREE ALLOMETRY; DENSITY	Allometric regression models are widely used to estimate tropical forest biomass, but balancing model accuracy with efficiency of implementation remains a major challenge. In addition, while numerous models exist for aboveground mass, very few exist for roots. We developed allometric equations for aboveground biomass (AGB) and root biomass (RB) based on 300 (of 45 species) and 40 (of 25 species) sample trees respectively, in an evergreen forest in Vietnam. The biomass estimations from these local models were compared to regional and pan-tropical models. For AGB we also compared local models that distinguish functional types to an aggregated model, to assess the degree of specificity needed in local models. Besides diameter at breast height (DBH) and tree height (H), wood density (WD) was found to be an important parameter in AGB models. Existing pan-tropical models resulted in up to 27% higher estimates of AGB, and overestimated RB by nearly 150%, indicating the greater accuracy of local models at the plot level. Our functional group aggregated local model which combined data for all species, was as accurate in estimating AGB as functional type specific models, indicating that a local aggregated model is the best choice for predicting plot level AGB in tropical forests. Finally our study presents the first allometric biomass models for aboveground and root biomass in forests in Vietnam.	[Vu Thanh Nam; van Kuijk, Marijke] Univ Utrecht, Dept Biol, Utrecht, Netherlands; [Vu Thanh Nam] Vietnam Adm Forestry, Hanoi, Vietnam; [Anten, Niels P. R.] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands; [Vu Thanh Nam] Bach Ma Natl Pk, Phu Loc Dist, Thua Thien Hue, Vietnam	Utrecht University; Wageningen University & Research	Nam, VT (corresponding author), Univ Utrecht, Dept Biol, Utrecht, Netherlands.; Nam, VT (corresponding author), Vietnam Adm Forestry, Hanoi, Vietnam.; Nam, VT (corresponding author), Bach Ma Natl Pk, Phu Loc Dist, Thua Thien Hue, Vietnam.	Nam@vnforest.gov.vn			Tropenbos International	Tropenbos International	This work was supported by Tropenbos International. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Anten NPR, 2010, AM NAT, V175, P250, DOI 10.1086/649581; Ban DV, 2010, J FOREST SCI RES I V, V1, P7; Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; BROWN S, 1989, FOREST SCI, V35, P881; Brown S, 1997, ESTIMATING BIOMASS B, V134, P55; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J., 2005, MEASURING WOOD DENSI; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Djomo AN, 2010, FOREST ECOL MANAG, V260, P1873, DOI 10.1016/j.foreco.2010.08.034; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; Fayolle A, 2013, FOREST ECOL MANAG, V305, P29, DOI 10.1016/j.foreco.2013.05.036; Feldpausch TR, 2011, BIOGEOSCIENCES, V8, P1081, DOI 10.5194/bg-8-1081-2011; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Henry M, 2010, FOREST ECOL MANAG, V260, P375, DOI [10.1016/j.foreco.2010.1007.1040, DOI 10.1016/J.FORECO.2010.1007.1040]; Iida Y, 2012, FUNCT ECOL, V26, P274, DOI 10.1111/j.1365-2435.2011.01921.x; IPCC, 2003, GOOD PRACTICE GUIDAN; Ishihara MI, 2015, ECOL APPL, V25, P1433, DOI 10.1890/14-0175.1; Kenzo T, 2009, J FOREST RES-JPN, V14, P365, DOI 10.1007/s10310-009-0149-1; Kenzo T, 2009, J TROP ECOL, V25, P371, DOI 10.1017/S0266467409006129; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; Lung NN, 2011, FINAL REPORT FOREST; MARD, 2000, NAM FOR PLANTS VIETN; Ministry of Agriculture and Rural Development (MARD), 2004, 102004QDBNN MARD; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; Nelson BW, 1999, FOREST ECOL MANAG, V117, P149, DOI 10.1016/S0378-1127(98)00475-7; Niiyama K, 2010, J TROP ECOL, V26, P271, DOI 10.1017/S0266467410000040; Lima AJN, 2012, FOREST ECOL MANAG, V277, P163, DOI 10.1016/j.foreco.2012.04.028; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; van Breugel M, 2011, FOREST ECOL MANAG, V262, P1648, DOI 10.1016/j.foreco.2011.07.018; van Gelder HA, 2006, NEW PHYTOL, V171, P367, DOI 10.1111/j.1469-8137.2006.01757.x; Vieilledent G, 2012, ECOL APPL, V22, P572, DOI 10.1890/11-0039.1; Wiemann MC, 2002, WOOD FIBER SCI, V34, P96	38	33	34	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156827	10.1371/journal.pone.0156827	http://dx.doi.org/10.1371/journal.pone.0156827			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309718	Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800016
J	Wenger, DS; Kawut, SM; Ding, JZ; Bluemke, DA; Hough, CL; Kronmal, RA; Lima, JA; Leary, PJ				Wenger, David S.; Kawut, Steven M.; Ding, Jingzhong; Bluemke, David A.; Hough, Catherine L.; Kronmal, Richard A.; Lima, Joao A.; Leary, Peter J.			Pericardial Fat and Right Ventricular Morphology: The Multi-Ethnic Study of Atherosclerosis-Right Ventricle Study (MESA-RV)	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; RIGHT-HEART-FAILURE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; MOLECULAR-MECHANISMS; RISK-FACTORS; ADULTS; ASSOCIATION; VOLUME; PLAQUE	Background Pericardial fat has been implicated in the pathogenesis of obesity-related cardiovascular disease. Proposed mechanisms may be relevant in right heart failure, but relationships between pericardial fat and right ventricular (RV) morphology have not been explored. Methods The Multi-Ethnic Study of Atherosclerosis is a prospective cohort that enrolled participants without clinical cardiovascular disease. Pericardial fat was measured using computed tomography and RV parameters using cardiac MRI. Linear regression estimated associations of pericardial fat with RV mass, RV end diastolic volume (RV-EDV), RV end systolic volume (RV-ESV), RV stroke volume (RV-SV), and RV ejection fraction (RV-EF). Limited models adjusted for age, gender, race, height, and study site with and without weight. Fully adjusted models also accounted for socioeconomic parameters and health behaviors. Adjustment for left ventricular morphology, metabolic syndrome, and systemic inflammation was also performed. Results The study sample included 3988 participants with complete assessment of RV morphology, pericardial fat and all covariates. Greater pericardial fat volume was associated with reduced RV mass (-0.3g per 40 cm(3) increase in pericardial fat, p<0.001), smaller RV-EDV (-3.7ml per 40 cm(3) increase in pericardial fat, p<0.001), smaller RV-ESV (-1.0ml per 40cm(3) increase in pericardial fat, p<0.001), and smaller RV-SV (-2.7mL per 40 cm(3) increase in pericardial fat, p<0.001) in participants after adjustment for weight. Associations were unchanged when accounting for health behaviors, markers of systemic inflammation, and the metabolic syndrome. Conclusions Greater pericardial fat was associated with reduced RV mass, smaller RV-EDV, smaller RV-ESV, and smaller RV-SV in participants after adjustment for weight. Relationships between pericardial fat and RV morphology could be relevant to diseases of right heart failure.	[Wenger, David S.] Univ Washington, Dept Gen Internal Med, Seattle, WA 98195 USA; [Kawut, Steven M.] Univ Penn, Perelman Sch Med, Div Pulm & Crit Care Med, Dept Med & Epidemiol, Philadelphia, PA 19104 USA; [Ding, Jingzhong] Wake Forest Univ, Dept Gen Internal Med, Winston Salem, NC 27109 USA; [Bluemke, David A.] NIH, Dept Radiol, Div Radiol & Imaging Sci, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Hough, Catherine L.; Leary, Peter J.] Univ Washington, Dept Gen Internal Med, Div Pulm & Crit Care, Seattle, WA 98195 USA; [Kronmal, Richard A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Lima, Joao A.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA	University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Wake Forest University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University	Leary, PJ (corresponding author), Univ Washington, Dept Gen Internal Med, Div Pulm & Crit Care, Seattle, WA 98195 USA.	learyp@uw.edu	Leary, Peter/ABF-6210-2021; Bluemke, David/GYU-8169-2022	Bluemke, David/0000-0002-8323-8086; Leary, Peter/0000-0001-5716-248X	National Heart, Lung, and Blood Institute [N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169]; NCRR [UL1-TR-000040, UL1-TR-001079]; National Center for Advancing Translational Sciences [KL2TR000421]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002317, KL2TR000421] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL103844] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute and by grants UL1-TR-000040 and UL1-TR-001079 from NCRR, and KL2TR000421 from the National Center for Advancing Translational Sciences.	Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; Bertoni AG, 2006, DIABETES CARE, V29, P588, DOI 10.2337/diacare.29.03.06.dc05-1501; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Chahal H, 2012, CHEST, V141, P388, DOI 10.1378/chest.11-0172; Chahal H, 2010, AM J CARDIOL, V106, P110, DOI 10.1016/j.amjcard.2010.02.022; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; Ding JZ, 2008, OBESITY, V16, P1914, DOI 10.1038/oby.2008.278; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Fox CS, 2009, CIRCULATION, V119, P1586, DOI 10.1161/CIRCULATIONAHA.108.828970; Gopal DM, 2012, AM HEART J, V164, P236, DOI 10.1016/j.ahj.2012.05.013; Harhay MO, 2013, INT J CARDIOL, V168, P3818, DOI 10.1016/j.ijcard.2013.06.028; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Hickson D, 2011, CHEST, V140, p731A; Kawut SM, 2010, BIOMARKERS, V15, P731, DOI 10.3109/1354750X.2010.516455; Khawaja T, 2011, AM J CARDIOL, V108, P397, DOI 10.1016/j.amjcard.2011.03.058; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Miao CL, 2011, RADIOLOGY, V261, P109, DOI 10.1148/radiol.11110346; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Natori S, 2006, AM J ROENTGENOL, V186, pS357, DOI 10.2214/AJR.04.1868; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Sheehan F, 2008, HEART, V94, P1510, DOI 10.1136/hrt.2007.132779; Tadic M, 2013, EUR J INTERN MED, V24, P608, DOI 10.1016/j.ejim.2013.08.007; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Vogel-Claussen J, 2006, J COMPUT ASSIST TOMO, V30, P426, DOI 10.1097/00004728-200605000-00013; Yorgun H, 2013, INT J CARDIOL, V165, P308, DOI 10.1016/j.ijcard.2011.08.067	30	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157654	10.1371/journal.pone.0157654	http://dx.doi.org/10.1371/journal.pone.0157654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27311062	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800116
J	Zhai, Q; Huang, B; Dong, H; Zhao, QP; Zhu, SH; Liang, ST; Li, S; Yang, SH; Han, HY				Zhai, Qi; Huang, Bing; Dong, Hui; Zhao, Qiping; Zhu, Shunhai; Liang, Siting; Li, Sha; Yang, Sihan; Han, Hongyu			Molecular Characterization and Immune Protection of a New Conserved Hypothetical Protein of Eimeria tenella	PLOS ONE			English	Article							APICAL ORGANELLES; HOST-CELL; COCCIDIOSIS; CD8; IDENTIFICATION; RESISTANCE; INVASION; BIOLOGY; MAXIMA; SERUM	The genome sequences of Eimeria tenella have been sequenced, but >70% of these genes are currently categorized as having an unknown function or annotated as conserved hypothetical proteins, and few of them have been studied. In the present study, a conserved hypothetical protein gene of E. tenella, designated EtCHP559, was cloned using rapid amplification of cDNA 5'-ends (5'RACE) based on the expressed sequence tag (EST). The 1746-bp full-length cDNA of EtCHP559 contained a 1224-bp open reading frame (ORF) that encoded a 407-amino acid polypeptide with the predicted molecular weight of 46.04 kDa. Real-time quantitative PCR analysis revealed that EtCHP559 was expressed at higher levels in sporozoites than in the other developmental stages (unsporulated oocysts, sporulated oocysts and second generation merozoites). The ORF was inserted into pCold-TF to produce recombinant EtCHP559. Using western blotting, the recombinant protein was successfully recognized by rabbit serum against E. tenella sporozoites. Immunolocalization by using EtCHP559 antibody showed that EtCHP559 was mainly distributed on the parasite surface in free sporozoites and became concentrated in the anterior region after sporozoites were incubated in complete medium. The EtCHP559 became uniformly dispersed in immature and mature schizonts. Inhibition of EtCHP559 function using anti-rEtCHP559 polyclonal antibody reduced the ability of E. tenella sporozoites to invade host cells by >70%. Animal challenge experiments demonstrated that the recombinant EtCHP559 significantly increased the average body weight gain, reduced the oocyst outputs, alleviated cecal lesions of the infected chickens, and resulted in anticoccidial index >160 against E. tenella. These results suggest that EtCHP559 plays an important role in sporozoite invasion and could be an effective candidate for the development of a new vaccine against E. tenella.	[Zhai, Qi; Huang, Bing; Dong, Hui; Zhao, Qiping; Zhu, Shunhai; Liang, Siting; Li, Sha; Yang, Sihan; Han, Hongyu] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China; [Huang, Bing] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Han, HY (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China.	hhysh@shvri.ac.cn			National Science Foundation of China [31201699, 31572266, 31272557]; Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses [2015JB10]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses	This work was supported by grants from National Science Foundation of China (No. 31201699, No. 31572266, No. 31272557) and Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses (No. 2015JB10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; Blake DP, 2015, VET PARASITOL, V212, P68, DOI 10.1016/j.vetpar.2015.05.007; Chapman HD, 2013, ADV PARASIT, V83, P93, DOI 10.1016/B978-0-12-407705-8.00002-1; Chen PP, 2015, EXP PARASITOL, V155, P1, DOI 10.1016/j.exppara.2015.04.020; del Cacho E, 2007, J PARASITOL, V93, P328, DOI 10.1645/GE-992R.1; del Cacho E, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-25; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; Han HY, 2013, PARASITOLOGY, V140, P746, DOI 10.1017/S0031182012002107; Han HY, 2010, J PARASITOL, V96, P95, DOI 10.1645/GE-2221.1; Han HY, 2015, EXP PARASITOL, V154, P118, DOI 10.1016/j.exppara.2015.04.002; Han HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099914; HARPAZ R, 1992, J CLIN INVEST, V90, P515, DOI 10.1172/JCI115889; HUANG B, 1993, SHANGHAI J ANIM HUSB, V3, P18; Huang JW, 2015, AVIAN PATHOL, V44, P392, DOI 10.1080/03079457.2015.1071780; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jahn D, 2009, PARASITOL RES, V105, P655, DOI 10.1007/s00436-009-1437-6; Jiang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041115; Jiang LL, 2012, PARASITOL RES, V110, P865, DOI 10.1007/s00436-011-2568-0; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Lal K, 2009, PROTEOMICS, V9, P4566, DOI 10.1002/pmic.200900305; Li GQ, 2004, VET PARASITOL, V119, P261, DOI 10.1016/j.vetpar.2003.12.009; Lillehoj HS, 2005, AVIAN DIS, V49, P112, DOI 10.1637/7249-073004R; Lillehoj HS, 2004, POULTRY SCI, V83, P611, DOI 10.1093/ps/83.4.611; Ltd MSDC, 1998, CONTR COCC MSD TECHN, P2; MCMANUS EC, 1968, J PARASITOL, V54, P1190, DOI 10.2307/3276989; Nam HW, 2009, KOREAN J PARASITOL, V47, pS29, DOI 10.3347/kjp.2009.47.S.S29; Orditura M, 1998, INT J MOL MED, V2, P75; Peroval M, 2006, INT J PARASITOL, V36, P1205, DOI 10.1016/j.ijpara.2006.04.006; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Reid AJ, 2014, GENOME RES, V24, P1676, DOI 10.1101/gr.168955.113; Rodriguez P, 2012, MED MICROBIOL IMMUN, V201, P157, DOI 10.1007/s00430-011-0217-y; ROSE ME, 1983, PARASITE IMMUNOL, V5, P479, DOI 10.1111/j.1365-3024.1983.tb00762.x; Rothwell L, 2004, J IMMUNOL, V173, P2675, DOI 10.4049/jimmunol.173.4.2675; Saini P, 2014, PROTEIN EXPRES PURIF, V104, P71, DOI 10.1016/j.pep.2014.09.004; Sharma Sourabh, 2015, J Parasit Dis, V39, P147, DOI 10.1007/s12639-013-0302-9; Shirley MW, 2007, VACCINE, V25, P5540, DOI 10.1016/j.vaccine.2006.12.030; Shirley MW, 2005, ADV PARASIT, V60, P285, DOI 10.1016/S0065-308X(05)60005-X; Tabares E, 2004, MOL BIOCHEM PARASIT, V135, P123, DOI 10.1016/j.molbiopara.2004.01.013; Talebi A, 2005, EXP PARASITOL, V110, P342, DOI 10.1016/j.exppara.2005.03.026; Tomley F, 1997, METHODS, V13, P171, DOI 10.1006/meth.1997.0509; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Wang CC, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-29; Willsie SK, 1996, J LEUKOCYTE BIOL, V59, P813, DOI 10.1002/jlb.59.6.813; Zajkowska J, 2001, INFECTION, V29, P71, DOI 10.1007/s15010-001-1078-x; Zhang J, 2014, VET PARASITOL, V205, P62, DOI 10.1016/j.vetpar.2014.06.029; Zhang L, 2013, EXP PARASITOL, V133, P121, DOI 10.1016/j.exppara.2012.11.009; Zhang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115411; Zhou BH, 2010, EXP PARASITOL, V125, P264, DOI 10.1016/j.exppara.2010.01.022	49	15	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157678	10.1371/journal.pone.0157678	http://dx.doi.org/10.1371/journal.pone.0157678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309852	Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800121
J	Murrison, LB; Ananthakrishnan, R; Sukumar, S; Augustine, S; Krishnan, N; Pai, M; Dowdy, DW				Murrison, Liza Bronner; Ananthakrishnan, Ramya; Sukumar, Sumanya; Augustine, Sheela; Krishnan, Nalini; Pai, Madhukar; Dowdy, David W.			Use of Rapid, Point-of-Care Assays by Private Practitioners in Chennai, India: Priorities for Tuberculosis Diagnostic Testing	PLOS ONE			English	Article							XPERT MTB/RIF; PULMONARY TUBERCULOSIS; SECTOR; PROVIDERS; ACCURACY; TANZANIA; IMPACT; DELAYS	Setting Private practitioners are frequently the first point of healthcare contact for patients with tuberculosis (TB) in India. As new molecular tests are developed for point-of-care (POC) diagnosis of TB, it is imperative to understand these individuals' practices and preferences for POC testing. Objective To evaluate rapid testing practices and identify priorities for novel POC TB tests among private practitioners in Chennai. Design We conducted a cross-sectional survey of 228 practitioners practicing in the private sector from January 2014 to February 2015 who saw at least one TB patient in the previous year. Practitioners were randomly selected from both the general community and a list of practitioners who referred patients to a public-private mix program for TB treatment. We used standardized questionnaires to collect data on current practices related to point-of-care diagnosis and interest in hypothetical POC tests. We used multivariable Poisson regression with robust estimates of standard error to calculate measures of association. Results Among 228 private practitioners, about half (48%) utilized any rapid testing in their current practice, most commonly for glucose (43%), pregnancy (21%), and malaria (5%). Providers using POC tests were more likely to work in hospitals (56% vs. 43%, P = 0.05) and less likely to be chest specialists (21% vs. 54%, P < 0.001). Only half (51%) of providers would use a hypothetical POC test for TB that was accurate, equipment-free, and took 20 minutes to complete. Chest specialists were half as likely to express interest in performing the hypothetical POC TB test in-house as other practitioners (aPR 0.5, 95% CI: 0.2-0.9). Key challenges to performing POC testing for TB in this study included time constraints, easy access to local private labs and lack of an attached lab facility. Conclusion As novel POC tests for TB are developed and scaled up, attention must be paid to integrating these diagnostics into healthcare providers' routine practice and addressing barriers for POC testing.	[Murrison, Liza Bronner; Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Murrison, Liza Bronner; Dowdy, David W.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Ananthakrishnan, Ramya; Sukumar, Sumanya; Augustine, Sheela; Krishnan, Nalini] REACH, Madras, Tamil Nadu, India; [Pai, Madhukar] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; McGill University; McGill University	Dowdy, DW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.; Dowdy, DW (corresponding author), Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA.	ddowdy1@jhmi.edu	Murrison, Liza/AAE-7682-2019; PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Bronner Murrison, Liza/0000-0002-8668-3898	Bill & Melinda Gates Foundation [OPP1061487]; Tier 1 Canada Research Chair from the Canadian Institutes of Health Research; B. Frank and Kathleen Polk Assistant Professorship in Epidemiology at the Johns Hopkins Bloomberg School of Public Health	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Tier 1 Canada Research Chair from the Canadian Institutes of Health Research; B. Frank and Kathleen Polk Assistant Professorship in Epidemiology at the Johns Hopkins Bloomberg School of Public Health	This study was supported in part by a grant by the Bill & Melinda Gates Foundation (grant OPP1061487). MP is a recipient of a Tier 1 Canada Research Chair from the Canadian Institutes of Health Research. DD is supported in part by the B. Frank and Kathleen Polk Assistant Professorship in Epidemiology at the Johns Hopkins Bloomberg School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Das J, 2015, LANCET INFECT DIS; Denkinger CM, 2012, LANCET INFECT DIS, V12, P169, DOI 10.1016/S1473-3099(11)70257-2; Dhanaraj B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124260; Diggle E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-502; Engel N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135112; Government of India Ministry of Home Affairs Office of the Registrar General and Census Commissioner, 2011, PRIM CENS ABSTR CHEN; Jani IV, 2013, NEW ENGL J MED, V368, P2319, DOI 10.1056/NEJMsb1214197; Jaroslawski S, 2012, J EPIDEMIOL GLOB HEA, V2, P39, DOI 10.1016/j.jegh.2011.12.001; Kapoor SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042458; Krishnan N, 2009, INT J TUBERC LUNG D, V13, P112; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lin HH, 2012, B WORLD HEALTH ORGAN, V90, P739, DOI 10.2471/BLT.11.101436; Murrison LB, 2016, INT J TUBERC LUNG D, V20, P544, DOI 10.5588/ijtld.15.0423; Murrison LB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149862; Pai M, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001805; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Qin ZZ, 2015, EUR RESPIR J, V45, P549, DOI 10.1183/09031936.00147714; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089301; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126065; Salje H, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001674; Satyanarayana S, 2015, INT J TUBERC LUNG D, V19, P751, DOI 10.5588/ijtld.15.0186; Satyanarayana S, 2014, PUBLIC HEALTH ACTION, V4, P249, DOI 10.5588/pha.14.0061; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Williams HA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-239; World Health Organization, 2014, WHOHTMTB201408; World Health Organization, HIGH PRIOR TARG PROD; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243	31	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155775	10.1371/journal.pone.0155775	http://dx.doi.org/10.1371/journal.pone.0155775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304061	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800009
J	Navarrete, E; Ortega-Bernal, JR; Trejo-Munoz, L; Diaz, G; Montufar-Chaveznava, R; Caldelas, I				Navarrete, Erika; Roberto Ortega-Bernal, Juan; Trejo-Munoz, Lucero; Diaz, Georgina; Montufar-Chaveznava, Rodrigo; Caldelas, Ivette			Participation of the Olfactory Bulb in Circadian Organization during Early Postnatal Life in Rabbits	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; MAMMARY PHEROMONE; LOCOMOTOR-ACTIVITY; BODY-TEMPERATURE; NEWBORN RABBITS; BULBECTOMIZED RATS; ACTIVITY RHYTHMS; YOUNG-RABBITS; PUPS	Experimental evidence indicates that during pre-visual stages of development in mammals, circadian regulation is still not under the control of the light-entrainable hypothalamic pacemaker, raising the possibility that the circadian rhythmicity that occurs during postnatal development is under the control of peripheral oscillators, such as the main olfactory bulb (MOB). We evaluated the outcome of olfactory bulbectomy on the temporal pattern of core body temperature and gross locomotor activity in newborn rabbits. From postnatal day 1 (P1), pups were randomly assigned to one of the following conditions: intact pups (INT), intact pups fed by enteral gavage (INT+ENT), sham operated pups (SHAM), pups with unilateral lesions of the olfactory bulb (OBx-UNI), and pups with bilateral lesions of the olfactory bulb (OBx-BI). At the beginning of the experiment, from P1-8, the animals in all groups were fed at 11:00, from P9-13 the feeding schedule was delayed 6 h (17:00), and finally, from P14-15 the animals were subjected to fasting conditions. The rabbit pups of the INT, INT+ENT, SHAM and OBx-UNI groups exhibited a clear circadian rhythmicity in body temperature and locomotor activity, with a conspicuous anticipatory rise hours prior to the nursing or feeding schedule, which persisted even during fasting conditions. In addition, phase delays in the nursing or feeding schedule induced a clear phase shift in both parameters. In contrast, the OBx-BI group exhibited atypical rhythmicity in both parameters under entrained conditions that altered the anticipatory component, as well as deficient phase control of both rhythms. The present results demonstrate that the expression of circadian rhythmicity at behavioral and physiological levels during early stages of rabbit development largely depends on the integrity of the main olfactory bulb.	[Navarrete, Erika; Roberto Ortega-Bernal, Juan; Trejo-Munoz, Lucero; Diaz, Georgina; Caldelas, Ivette] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Ciudad De Mexico, Mexico; [Montufar-Chaveznava, Rodrigo] Univ Nacl Autonoma Mexico, Fac Ingn, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Caldelas, I (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Ciudad De Mexico, Mexico.	caldelas@biomedicas.unam.mx			Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica from the Universidad Nacional Autonoma de Mexico [IN208513-3]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica from the Universidad Nacional Autonoma de Mexico	The grant IN208513-3 was provided by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica from the Universidad Nacional Autonoma de Mexico. http://dgapa.unam.mx/html/papiit/papit.html.	Albrecht U, 2004, FRONT BIOSCI-LANDMRK, V9, P48, DOI 10.2741/1196; Caldelas I, 2007, NEUROSCIENCE, V144, P395, DOI 10.1016/j.neuroscience.2006.09.020; Caldelas I, 2005, BIOL RHYTHM RES, V36, P23, DOI 10.1080/09291010400028500; Caldelas I., 2008, COMP ASPECTS CIRCADI, P143; Caldellas I, 2009, DEV NEUROBIOL, V69, P47, DOI 10.1002/dneu.20687; Coureaud G, 2004, CHEM SENSES, V29, P341, DOI 10.1093/chemse/bjh037; Coureaud G, 2008, CHEMOECOLOGY, V18, P53, DOI 10.1007/s00049-007-0392-x; Deutsch J. A., 1957, British Journal of Animal Behaviour, V5, P53, DOI 10.1016/S0950-5601(57)80026-4; Escobar C, 2000, J COMP PHYSIOL A, V186, P33, DOI 10.1007/s003590050004; Gilbert C, 2007, AM J PHYSIOL-REG I, V293, pR867, DOI 10.1152/ajpregu.00081.2007; Goel N, 1998, BRAIN RES, V792, P229, DOI 10.1016/S0006-8993(98)00134-6; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Granados-Fuentes D, 2011, J BIOL RHYTHM, V26, P552, DOI 10.1177/0748730411420247; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Hernandez-Campos O, 2013, THESIS; HUDSON R, 1982, BEHAVIOUR, V79, P255, DOI 10.1163/156853982X00292; HUDSON R, 1987, BRAIN RES, V421, P85, DOI 10.1016/0006-8993(87)91278-9; Jilge B, 2000, J BIOL RHYTHM, V15, P329, DOI 10.1177/074873000129001431; JILGE B, 1993, J BIOL RHYTHM, V8, P247, DOI 10.1177/074873049300800307; Jilge B, 2001, LAB ANIM-UK, V35, P364, DOI 10.1258/0023677011911831; Jilge B, 2001, CHRONOBIOL INT, V18, P1, DOI 10.1081/CBI-100001275; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Marcilhac A, 1997, ARCH PHYSIOL BIOCHEM, V105, P552, DOI 10.1076/apab.105.6.552.3273; Marcilhac A, 1999, PHARMACOL BIOCHEM BE, V63, P599, DOI 10.1016/S0091-3057(99)00024-6; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Montufar-Chaveznava R, 2012, NEUROSCIENCE, V207, P198, DOI 10.1016/j.neuroscience.2012.01.025; Montufar-Chaveznava R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074048; NUESSLEINHILDESHEIM B, 1995, J COMP PHYSIOL B, V165, P13, DOI 10.1007/BF00264681; Okamura H, 2004, J BIOL RHYTHM, V19, P388, DOI 10.1177/0748730404269169; ONODA N, 1984, JPN J PHYSIOL, V34, P933, DOI 10.2170/jjphysiol.34.933; Perret M, 2003, J BIOL RHYTHM, V18, P392, DOI 10.1177/0748730403254248; PIEPER DR, 1990, J NEUROENDOCRINOL, V2, P707, DOI 10.1111/j.1365-2826.1990.tb00468.x; PIEPER DR, 1991, AM J PHYSIOL, V261, pR973, DOI 10.1152/ajpregu.1991.261.4.R973; Possidente B, 1996, BRAIN RES, V713, P108, DOI 10.1016/0006-8993(95)01490-X; POSSIDENTE B, 1990, BRAIN RES, V513, P325, DOI 10.1016/0006-8993(90)90475-Q; RAPISARDI SC, 1975, EXP BRAIN RES, V22, P295; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rivkees SA, 2000, SEMIN PERINATOL, V24, P232, DOI 10.1053/sper.2000.8598; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; Schley P, 1980, MUTTERLOSE AUFZUCHT; Silver R, 2005, METHOD ENZYMOL, V393, P451, DOI 10.1016/S0076-6879(05)93022-X; Tanida M, 2005, BRAIN RES, V1058, P44, DOI 10.1016/j.brainres.2005.07.048; Tanida M, 2008, NEUROSCI LETT, V439, P192, DOI 10.1016/j.neulet.2008.05.021; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Trejo-Munoz L, 2014, NEUROSCIENCE, V275, P170, DOI 10.1016/j.neuroscience.2014.06.007; Trejo-Munoz L, 2012, PHYSIOL BEHAV, V106, P587, DOI 10.1016/j.physbeh.2012.04.005; TUCKER GS, 1982, EXP BRAIN RES, V48, P263; VANRIEZEN H, 1990, PHARMACOL THERAPEUT, V47, P21, DOI 10.1016/0163-7258(90)90043-2; Vinkers CH, 2009, NEUROSCIENCE, V159, P39, DOI 10.1016/j.neuroscience.2008.12.009; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405; ZARROW MX, 1965, SCIENCE, V150, P1835, DOI 10.1126/science.150.3705.1835	55	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156539	10.1371/journal.pone.0156539	http://dx.doi.org/10.1371/journal.pone.0156539			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305041	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800017
J	Khoroshko, VA; Levitsky, VG; Zykova, TY; Antonenko, OV; Belyaeva, ES; Zhimulev, IF				Khoroshko, Varvara A.; Levitsky, Viktor G.; Zykova, Tatyana Yu.; Antonenko, Oksana V.; Belyaeva, Elena S.; Zhimulev, Igor F.			Chromatin Heterogeneity and Distribution of Regulatory Elements in the Late-Replicating Intercalary Heterochromatin Domains of Drosophila melanogaster Chromosomes	PLOS ONE			English	Article							POLYTENE CHROMOSOMES; GENUS DROSOPHILA; DNA-REPLICATION; GENOME; REVEALS; REGIONS; UNDERREPLICATION; IDENTIFICATION; CONSERVATION; ORGANIZATION	Late-replicating domains (intercalary heterochromatin) in the Drosophila genome display a number of features suggesting their organization is quite unique. Typically, they are quite large and encompass clusters of functionally unrelated tissue-specific genes. They correspond to the topologically associating domains and conserved microsynteny blocks. Our study aims at exploring further details of molecular organization of intercalary heterochromatin and has uncovered surprising heterogeneity of chromatin composition in these regions. Using the 4HMM model developed in our group earlier, intercalary heterochromatin regions were found to host chromatin fragments with a particular epigenetic profile. Aquamarine chromatin fragments (spanning 0.67% of late-replicating regions) are characterized as a class of sequences that appear heterogeneous in terms of their decompactization. These fragments are enriched with enhancer sequences and binding sites for insulator proteins. They likely mark the chromatin state that is related to the binding of cis-regulatory proteins. Malachite chromatin fragments (11% of late-replicating regions) appear to function as universal transitional regions between two contrasting chromatin states. Namely, they invariably delimit intercalary heterochromatin regions from the adjacent active chromatin of interbands. Malachite fragments also flank aquamarine fragments embedded in the repressed chromatin of latereplicating regions. Significant enrichment of insulator proteins CP190, SU(HW), and MOD2.2 was observed inmalachite chromatin. Neither aquamarine nor malachite chromatin types appear to correlate with the positions of highly conserved non-coding elements (HCNE) that are typically replete in intercalary heterochromatin. Malachite chromatin found on the flanks of intercalary heterochromatin regions tends to replicate earlier than the malachite chromatin embedded in intercalary heterochromatin. In other words, there exists a gradient of replication progressing from the flanks of intercalary heterochromatin regions center-wise. The peculiar organization and features of replication in large late-replicating regions are discussed as possible factors shaping the evolutionary stability of intercalary heterochromatin.	[Khoroshko, Varvara A.; Zykova, Tatyana Yu.; Antonenko, Oksana V.; Belyaeva, Elena S.; Zhimulev, Igor F.] SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Levitsky, Viktor G.; Zhimulev, Igor F.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Levitsky, Viktor G.] RAS, Inst Cytol & Genet SB, Novosibirsk, Russia	Russian Academy of Sciences; Novosibirsk State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Khoroshko, VA (corresponding author), SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia.	vicerna@mcb.nsc.ru	Antonenko, Oksana/N-7471-2015; Khoroshko, Varvara A/N-5496-2015; Levitsky, Victor G/R-5696-2016; Zhimulev, Igor F/N-7978-2015; Zykova (Vatolina), Tatyana/I-3897-2014; Belyaeva, Elena S/N-8066-2015	Levitsky, Victor/0000-0002-4905-3088; Zhimulev, Igor/0000-0002-6220-3028	Russian Science Foundation [14-04-00934]; Federal Agency of Scientific Organizations of Russian Federation [0310-2014-0002]; Russian Science Foundation [14-14-00934] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Federal Agency of Scientific Organizations of Russian Federation; Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the grant 14-04-00934 from the Russian Science Foundation and the project 0310-2014-0002 from Federal Agency of Scientific Organizations of the Russian Federation.; The authors are grateful to Dr. Igor V. Makunin for stimulating discussions and help with the replication profiling analysis. This work was supported by the grant 14-04-00934 from the Russian Science Foundation and the project 0310-2014-0002 from the Federal Agency for Scientific Organizations of the Russian Federation.	Ahanger SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep03917; Andreyenkova NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083319; Belyaeva ES, 2008, CHROMOSOMA, V117, P411, DOI 10.1007/s00412-008-0163-7; Belyaeva ES, 2006, CHROMOSOMA, V115, P355, DOI 10.1007/s00412-006-0063-7; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Belyakin SN, 2005, P NATL ACAD SCI USA, V102, P8269, DOI 10.1073/pnas.0502702102; Belyakin SN, 2010, CHROMOSOMA, V119, P589, DOI 10.1007/s00412-010-0280-y; Boldyreva LV, 2017, CURR GENOMICS, V18, P214, DOI 10.2174/1389202917666160512164913; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Diaz-Castillo C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002475; Eagen KP, 2015, CELL, V163, P934, DOI 10.1016/j.cell.2015.10.026; Eggert H, 2004, J CELL SCI, V117, P4253, DOI 10.1242/jcs.01292; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; HAGELE K, 1971, CHROMOSOMA, V33, P297; Heitz E, 1932, PLANTA; Hiratani I, 2009, EPIGENETICS-US, V4, P93, DOI 10.4161/epi.4.2.7772; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Kaufmann BP, 1939, P NATL ACAD SCI USA, V25, P571, DOI 10.1073/pnas.25.11.571; KEYL HG, 1958, CHROMOSOMA, V9, P441; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; LAMB MM, 1987, CHROMOSOMA, V95, P227, DOI 10.1007/BF00294779; Leach TJ, 2000, MOL CELL BIOL, V20, P6308, DOI 10.1128/MCB.20.17.6308-6316.2000; MacAlpine D, 2005, CHROMOSOME RES, V13, P309, DOI 10.1007/s10577-005-1508-1; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Makunin IV, 2014, GENOME BIOL EVOL, V6, P2050, DOI 10.1093/gbe/evu156; Makunin IV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082362; Milon B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-988; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sahagun V, 2012, GENOME BIOL EVOL, V4, P1054, DOI 10.1093/gbe/evs089; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sher N, 2012, GENOME RES, V22, P64, DOI 10.1101/gr.126003.111; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; von Grotthuss M, 2010, GENOME RES, V20, P1084, DOI 10.1101/gr.103713.109; Weber CC, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r23; White R, 2012, BRIEF FUNCT GENOMICS, V11, P347, DOI 10.1093/bfgp/els020; Yang JP, 2012, CURR OPIN GENET DEV, V22, P86, DOI 10.1016/j.gde.2011.12.007; Yarosh W, 2014, GENE DEV, V28, P1840, DOI 10.1101/gad.245811.114; ZHIMULEV IF, 1982, CHROMOSOMA, V87, P197, DOI 10.1007/BF00338489; Zhimulev IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101631	56	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157147	10.1371/journal.pone.0157147	http://dx.doi.org/10.1371/journal.pone.0157147			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300486	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200031
J	Shi, YQ; Dong, YW; Huang, WH; Zhu, DC; Mao, H; Su, PZ				Shi, Yanqiang; Dong, Yiwei; Huang, Wenhui; Zhu, Decong; Mao, Hua; Su, Peizhu			Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							INFLAMMATORY-BOWEL-DISEASE; RANDOMIZED CLINICAL-TRIAL; MANAGEMENT; REMISSION; CHILDREN; FECES; ENEMA	Background Fecal microbiota transplantation (FMT) has been recognized as a novel treatment for ulcerative colitis (UC). However, its efficacy and safety remain unclear. Objective We conducted this systematic review to assess the efficacy and safety of FMT in UC. Data Sources PubMed, EMBASE, Cochrane Central, Web of Science Core Collection, and three other Chinese databases were searched for reports of FMT in UC with clear outcomes. Data Extraction and Synthesis We estimated pooled rates [with 95% confidence interval (CI)] of clinical remission among 15 cohort studies and clinical response among 16 cohort studies. Results Twenty five studies (2 randomized controlled trials, 15 cohort studies, and 8 case studies) with 234 UC patients were included. Overall, 41.58% (84/202) patients achieved clinical remission (CR) and 65.28% (126/193) achieved clinical response. Among the cohort studies, the pooled estimate of patients who achieved CR and clinical response were 40.5% (95% CI 24.7%-58.7%), and 66.1% (95% CI 43.7%-83.0%). Most adverse events were slight and self-resolving. The analyses of gut microbiota in 7 studies showed that FMT could increase microbiota diversity and richness, similarity, and certain change of bacterial composition. Conclusion FMT provides a promising effect for UC with few adverse events. Successful FMT may be associated with an increase in microbiota diversity and richness, similarity, and certain change of bacterial composition.	[Shi, Yanqiang; Dong, Yiwei; Huang, Wenhui; Zhu, Decong] Southern Med Univ, Clin Med Sch 2, Guangzhou 510280, Guangdong, Peoples R China; [Mao, Hua; Su, Peizhu] Southern Med Univ, Zhujiang Hosp, Dept Gastroenterol, Guangzhou 510280, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Su, PZ (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Gastroenterol, Guangzhou 510280, Guangdong, Peoples R China.	supeizhu1986@163.com		Shi, Yanqiang/0000-0003-0814-6322				Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; Angelberger S, 2013, AM J GASTROENTEROL, V108, P1620, DOI 10.1038/ajg.2013.257; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; BENNET JD, 1989, LANCET, V1, P164; Berg D, 2015, EXPERT REV GASTROENT, V9, P781, DOI 10.1586/17474124.2015.1013031; Borody T, 2012, AM J GASTROENTEROL, V107, pS665, DOI 10.14309/00000434-201210001-01644; Borody T, 2011, AM J GASTROENTEROL, V106, pS352; BORODY TJ, 1989, MED J AUSTRALIA, V150, P604, DOI 10.5694/j.1326-5377.1989.tb136704.x; Borody TJ, 2003, J CLIN GASTROENTEROL, V37, P42, DOI 10.1097/00004836-200307000-00012; Bringiotti Roberto, 2014, World J Gastrointest Pathophysiol, V5, P550, DOI 10.4291/wjgp.v5.i4.550; Cammarota G, 2015, ALIMENT PHARM THER, V41, P835, DOI 10.1111/apt.13144; Cammarota G, 2015, PHARMACOL THERAPEUT, V149, P191, DOI 10.1016/j.pharmthera.2014.12.006; Cammarota G, 2014, J CLIN GASTROENTEROL, V48, P693, DOI 10.1097/MCG.0000000000000046; Colman RJ, 2014, J CROHNS COLITIS, V8, P1569, DOI 10.1016/j.crohns.2014.08.006; Cui BT, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0646-2; Damman CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133925; Damman CJ, 2012, AM J GASTROENTEROL, V107, P1452, DOI 10.1038/ajg.2012.93; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Dekkers OM, 2012, ANN INTERN MED, V156, P37, DOI 10.7326/0003-4819-156-1-201201030-00006; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EISEMAN B, 1958, SURGERY, V44, P854; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hohmann EL, 2014, NEW ENGL J MED, V371, P668, DOI 10.1056/NEJMcpc1400842; Hold GL, 2014, WORLD J GASTROENTERO, V20, P1192, DOI 10.3748/wjg.v20.i5.1192; Karolewska-Bochenek K, 2015, J CROHNS COLITIS, V9, pS294; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kellermayer R, 2015, AM J GASTROENTEROL, V110, P604, DOI 10.1038/ajg.2015.19; Kelly CR, 2015, GASTROENTEROLOGY, V149, P223, DOI 10.1053/j.gastro.2015.05.008; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Kunde S, 2013, J PEDIATR GASTR NUTR, V56, P597, DOI 10.1097/MPG.0b013e318292fa0d; Landy J, 2013, GASTROENTEROLOGY, V144, pS897; Liu Chang-qin WW, 2013, CHINESE J DIGESTION; Macfarlane S, 2004, ADV APPL MICROBIOL, V54, P261, DOI 10.1016/S0065-2164(04)54010-8; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Negroni A, 2012, INFLAMM BOWEL DIS, V18, P913, DOI 10.1002/ibd.21899; Ni XD, 2015, CPEN CHINESE, V22, P29; Oliva S, 2012, ALIMENT PHARM THER, V35, P327, DOI 10.1111/j.1365-2036.2011.04939.x; Petritsch W., 2013, OP187 PRELIMINARY CL; RAO SSC, 1988, GUT, V29, P342, DOI 10.1136/gut.29.3.342; Ren Rongrong, 2015, Zhonghua Nei Ke Za Zhi, V54, P411; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Scaldaferri F, 2015, GASTROENTEROLOGY, V148, pS870; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sood A, 2009, CLIN GASTROENTEROL H, V7, P1202, DOI 10.1016/j.cgh.2009.07.016; Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001; Suskind DL, 2015, J PEDIATR GASTR NUTR, V60, P27, DOI 10.1097/MPG.0000000000000544; Tursi A, 2010, AM J GASTROENTEROL, V105, P2218, DOI 10.1038/ajg.2010.218; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vandenplas Y, 2015, J PEDIATR GASTR NUTR, V61, pE12, DOI 10.1097/MPG.0000000000000281; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Wei Y, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/517597; Wells G.A., NEWCASTLE OTTAWA SCA; WK-y Wang Mei, 2014, CHINESE J DIGESTIVE; Zhang FM, 2012, AM J GASTROENTEROL, V107, P1755, DOI 10.1038/ajg.2012.251	57	50	54	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157259	10.1371/journal.pone.0157259	http://dx.doi.org/10.1371/journal.pone.0157259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295210	Green Submitted, Green Published, gold			2022-12-27	WOS:000377821300029
J	Ahmed, MN; Abdullah, AH; Kaiwartya, O				Ahmed, Malik N.; Abdullah, Abdul Hanan; Kaiwartya, Omprakash			FSM-F: Finite State Machine Based Framework for Denial of Service and Intrusion Detection in MANET	PLOS ONE			English	Article							IDS	Due to the continuous advancements in wireless communication in terms of quality of communication and affordability of the technology, the application area of Mobile Adhoc Networks (MANETs) significantly growing particularly in military and disaster management. Considering the sensitivity of the application areas, security in terms of detection of Denial of Service (DoS) and intrusion has become prime concern in research and development in the area. The security systems suggested in the past has state recognition problem where the system is not able to accurately identify the actual state of the network nodes due to the absence of clear definition of states of the nodes. In this context, this paper proposes a framework based on Finite State Machine (FSM) for denial of service and intrusion detection in MANETs. In particular, an Interruption Detection system for Adhoc On-demand Distance Vector (ID-AODV) protocol is presented based on finite state machine. The packet dropping and sequence number attacks are closely investigated and detection systems for both types of attacks are designed. The major functional modules of ID-AODV includes network monitoring system, finite state machine and attack detection model. Simulations are carried out in network simulator NS-2 to evaluate the performance of the proposed framework. A comparative evaluation of the performance is also performed with the state-of-the-art techniques: RIDAN and AODV. The performance evaluations attest the benefits of proposed framework in terms of providing better security for denial of service and intrusion detection attacks.	[Ahmed, Malik N.; Abdullah, Abdul Hanan; Kaiwartya, Omprakash] Univ Teknol Malaysia, Fac Comp, Johor Baharu 81310, Malaysia	Universiti Teknologi Malaysia	Ahmed, MN (corresponding author), Univ Teknol Malaysia, Fac Comp, Johor Baharu 81310, Malaysia.	mali7k@gmail.com	Kaiwartya, Omprakash/H-4782-2016; ABDULLAH, ABDUL HANAN/P-9181-2018	Kaiwartya, Omprakash/0000-0001-9669-8244; 				Ahmed A., 2011, Proceedings of the 2011 5th International Conference on Network and System Security (NSS 2011), P1, DOI 10.1109/ICNSS.2011.6059953; Damopoulos D, 2012, SECUR COMMUN NETW, V5, P3, DOI 10.1002/sec.341; Djahel S, 2011, IEEE COMMUN SURV TUT, V13, P658, DOI 10.1109/SURV.2011.072210.00026; ILGUN K, 1995, IEEE T SOFTWARE ENG, V21, P181, DOI 10.1109/32.372146; Jain AK, P INT C COMP INT COM, V1, P256; Joseph JFC, 2011, IEEE T DEPEND SECURE, V8, P233, DOI 10.1109/TDSC.2009.48; Kheyri D, 2012, COMPUTER INFORM SCI, V5, P132; Li W., 2004, P US DEP ENERGY CYBE, V1, P1; Mamatha G.S., 2010, INT J COMPUTER SCI S, V4, P275; Mutlu S, 2011, PROCEEDINGS OF ICNS 2011: THE SEVENTH INTERNATIONAL CONFERENCE ON NETWORKING AND SERVICES, P292; Nadeem A, 2009, INT C WIR COMM MOB C, P926, DOI DOI 10.1145/1582379; Nadeem A, 2013, IEEE COMMUN SURV TUT, V15, P2027, DOI 10.1109/SURV.2013.030713.00201; Panaousis EA, 2012, INFORM SYST FRONT, V14, P541, DOI 10.1007/s10796-010-9259-8; Perkins C, 2003, 3561 IETF RFC; Rafsanjani MK, 2009, INT C COMP ELEC ENG, P625, DOI 10.1109/ICCEE.2009.74; Stakhanova N, 2010, COMPUT SECUR, V29, P253, DOI 10.1016/j.cose.2009.08.007; Stamouli I, 2005, I S WORLD WIREL MOBI, P374, DOI 10.1109/WOWMOM.2005.85; Tamilselvan Latha, 2006, 2006 International Symposium on Ad Hoc and Ubiquitous Computing, P42, DOI 10.1109/ISAHUC.2006.4290645; Tseng CY, 2003, P WORKSH SEC AD HOC, V1, P125, DOI DOI 10.1145/986858.986876; Visumathi J, 2012, PROCEDIA ENGINEER, V38, P2816, DOI 10.1016/j.proeng.2012.06.330; Wu B, 2007, SIGNALS COMMUN TECHN, P103, DOI 10.1007/978-0-387-33112-6_5; Xenakis C, 2011, COMPUT SECUR, V30, P63, DOI 10.1016/j.cose.2010.10.008	22	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156885	10.1371/journal.pone.0156885	http://dx.doi.org/10.1371/journal.pone.0156885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285146	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000028
J	Song, N; Zhang, H; Li, H; Cai, WZ				Song, Nan; Zhang, Hao; Li, Hu; Cai, Wanzhi			All 37 Mitochondrial Genes of Aphid Aphis craccivora Obtained from Transcriptome Sequencing: Implications for the Evolution of Aphids	PLOS ONE			English	Article							INSECTA HEMIPTERA APHIDIDAE; GENOME SEQUENCE; SOFTWARE PACKAGE; PHYLOGENY; HOMOPTERA; DNA; AUCHENORRHYNCHA; SYSTEMATICS; SELECTION	The availability of mitochondrial genome data for Aphididae, one of the economically important insect pest families, in public databases is limited. The advent of next generation sequencing technology provides the potential to generate mitochondrial genome data for many species timely and cost-effectively. In this report, we used transcriptome sequencing technology to determine all the 37 mitochondrial genes of the cowpea aphid, Aphis craccivora. This method avoids the necessity of finding suitable primers for long PCRs or primer-walking amplicons, and is proved to be effective in obtaining the whole set of mitochondrial gene data for insects with difficulty in sequencing mitochondrial genome by PCR-based strategies. Phylogenetic analyses of aphid mitochondrial genome data show clustering based on tribe level, and strongly support the monophyly of the family Aphididae. Within the monophyletic Aphidini, three samples from Aphis grouped together. In another major clade of Aphididae, Pterocomma pilosum was recovered as a potential sister-group of Cavariella salicicola, as part of Macrosiphini.	[Song, Nan] Henan Agr Univ, Coll Plant Protect, Zhengzhou, Peoples R China; [Zhang, Hao] Henan Vocat & Technol Coll Commun, Zhengzhou, Peoples R China; [Li, Hu; Cai, Wanzhi] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China	Henan Agricultural University; China Agricultural University	Song, N (corresponding author), Henan Agr Univ, Coll Plant Protect, Zhengzhou, Peoples R China.	songnan@henau.edu.cn		Li, Hu/0000-0001-8590-1753	National Natural Science Foundation of China [31402002]; Key scientific research projects of Henan Province, China [14B210036, 16A210029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key scientific research projects of Henan Province, China	This research is supported by grants from the National Natural Science Foundation of China (No. 31402002), and Key scientific research projects of Henan Province, China (No. 14B210036, No. 16A210029).	Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Blackman R.L., 2000, APHIDS WORLDS CROPS, V2nd; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cameron SL, 2014, SYST ENTOMOL, V39, P400, DOI 10.1111/syen.12071; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; CAMPBELL BC, 1995, SYST ENTOMOL, V20, P175, DOI 10.1111/j.1365-3113.1995.tb00090.x; Chen K, 1998, CHINESE J OIL CROP S, V21, P64; Chen K, 1998, CHINESE J OIL CROP S, V21, P55; Coceano P. G., 1998, Phytopathologia Mediterranea, V37, P111; Cryan JR, 2012, SYST ENTOMOL, V37, P7, DOI 10.1111/j.1365-3113.2011.00611.x; Dixon AF G, 1998, APHID ECOLOGY; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Forero D, 2008, REV COLOMB ENTOMOL, V34, P1; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heie O.E., 1987, World Crop Pests, V2A, P367; HEIE OE, 1990, ACTA PHYTOPATHOL HUN, V25, P253; Holland BR, 2003, SYST BIOL, V52, P229, DOI 10.1080/10635150390192771; Ilharco F.A., 1987, World Crop Pests, V2A, P51; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109140; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-156; Mc Gavin GC, 1993, BUGS OF THE WORLD; Miller M.A., 2010, P GAT COMP ENV WORKS; MORAN NA, 1988, AM NAT, V132, P681, DOI 10.1086/284882; Moretti S, 2008, NUCLEIC ACIDS RES, V36, pW10, DOI 10.1093/nar/gkn278; Nabholz B, 2010, MOL PHYLOGENET EVOL, V57, P466, DOI 10.1016/j.ympev.2010.06.009; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; Novakova E, 2013, MOL PHYLOGENET EVOL, V68, P42, DOI 10.1016/j.ympev.2013.03.016; Ortiz-Rivas B, 2004, MOL PHYLOGENET EVOL, V30, P24, DOI 10.1016/S1055-7903(03)00155-6; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Remaudiere G., 1997, CATALOGUE APHIDIDAE; Rufener L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001091; Sano M, 2011, SYST ENTOMOL, V36, P607, DOI 10.1111/j.1365-3113.2011.00589.x; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Shaposhnikov G., 1998, P481; Simon S, 2013, MOL PHYLOGENET EVOL, V69, P393, DOI 10.1016/j.ympev.2013.03.033; SMITH AB, 1994, BIOL J LINN SOC, V51, P279, DOI 10.1111/j.1095-8312.1994.tb00962.x; Smith DR, 2013, BRIEF FUNCT GENOMICS, V12, P454, DOI 10.1093/bfgp/els066; Song N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048778; Song N, 2009, ACTA BIOCH BIOPH SIN, V41, P206, DOI 10.1093/abbs/gmp003; STACKEBRANDT E, 1994, SYST APPL MICROBIOL, V17, P39, DOI 10.1016/S0723-2020(11)80029-9; Stewart JB, 2005, GENOME, V48, P46, DOI 10.1139/G04-090; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; TZAGOLOFF A, 1986, ANNU REV BIOCHEM, V55, P249, DOI 10.1146/annurev.bi.55.070186.001341; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; Von Dohlen CD, 2000, BIOL J LINN SOC, V71, P689, DOI 10.1006/bijl.2000.0470; VONDOHLEN CD, 1995, J MOL EVOL, V41, P211, DOI 10.1007/BF00170675; Wang Y, 2015, INT J MOL SCI, V16, P30091, DOI 10.3390/ijms161226219; Wang Y, 2014, INSECT SCI, V21, P278, DOI 10.1111/1744-7917.12112; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077511; Ware JL, 2008, SYST ENTOMOL, V33, P429, DOI 10.1111/j.1365-3113.2008.00424.x; WHEELER WC, 1990, CLADISTICS, V6, P363, DOI 10.1111/j.1096-0031.1990.tb00550.x; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang B, 2016, MITOCHONDRIAL DNA A, V27, P945, DOI 10.3109/19401736.2014.926498; Zhang B, 2014, GENE, V533, P253, DOI 10.1016/j.gene.2013.09.064; Zhang KJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-417; Zhang S, 2016, MITOCHONDRIAL DNA A, V27, P854, DOI 10.3109/19401736.2014.919474	72	13	13	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157857	10.1371/journal.pone.0157857	http://dx.doi.org/10.1371/journal.pone.0157857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314587	Green Published, gold, Green Submitted			2022-12-27	WOS:000378030000059
J	Wallach, J; Kang, H; Colestock, T; Morris, H; Bortolotto, ZA; Collingridge, GL; Lodge, D; Halberstadt, AL; Brandt, SD; Adejare, A				Wallach, Jason; Kang, Heather; Colestock, Tristan; Morris, Hamilton; Bortolotto, Zuner A.; Collingridge, Graham L.; Lodge, David; Halberstadt, Adam L.; Brandt, Simon D.; Adejare, Adeboye			Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues	PLOS ONE			English	Article							METHYL-D-ASPARTATE; PREPULSE INHIBITION; ACOUSTIC STARTLE; CHANNEL COMPLEX; SIGMA-RECEPTORS; PHENCYCLIDINE; MK-801; ANTAGONISTS; KETAMINE; MODULATE	1,2-Diarylethylamines including lanicemine, lefetamine, and remacemide have clinical relevance in a range of therapeutic areas including pain management, epilepsy, neurodegenerative disease and depression. More recently 1,2-diarylethylamines have been sold as 'legal highs' in a number of different forms including powders and tablets. These compounds are sold to circumvent governmental legislation regulating psychoactive drugs. Examples include the opioid MT-45 and the dissociative agents diphenidine (DPH) and 2-methoxydiphenidine (2-MXP). A number of fatal and non-fatal overdoses have been linked to abuse of these compounds. As with many 'legal highs', little is known about their pharmacology. To obtain a better understanding, the effects of DPH, 2-MXP and its 3-and 4-MeO-isomers, and 2-Cl-diphenidine (2-Cl-DPH) were investigated using binding studies at 46 central nervous system receptors including the N-methyl-D-aspartate receptor (NMDAR), serotonin, dopamine, norepinephrine, histamine, and sigma receptors as well as the reuptake transporters for serotonin, dopamine and norepinephrine. Reuptake inhibition potencies were measured at serotonin, norepinephrine and dopamine transporters. NMDAR antagonism was established in vitro using NMDAR-induced field excitatory postsynaptic potential (fEPSP) experiments. Finally, DPH and 2-MXP were investigated using tests of pre-pulse inhibition of startle (PPI) in rats to determine whether they reduce sensorimotor gating, an effect observed with known dissociative drugs such as phencyclidine (PCP) and ketamine. The results suggest that these 1,2-diarylethylamines are relatively selective NMDAR antagonists with weak off-target inhibitory effects on dopamine and norepinephrine reuptake. DPH and 2-MXP significantly inhibited PPI. DPH showed greater potency than 2-MXP, acting with a median effective dose (ED50) of 9.5 mg/kg, which is less potent than values reported for other commonly abused dissociative drugs such as PCP and ketamine.	[Wallach, Jason; Colestock, Tristan; Morris, Hamilton; Adejare, Adeboye] Univ Sci, Pharmaceut Sci, Philadelphia Coll Pharm, Philadelphia, PA USA; [Kang, Heather] Univ Bristol, Ctr Synapt Plast, Sch Clin Sci, Bristol, Avon, England; [Bortolotto, Zuner A.; Collingridge, Graham L.; Lodge, David] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Ctr Synapt Plast, Bristol, Avon, England; [Collingridge, Graham L.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Collingridge, Graham L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Halberstadt, Adam L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Brandt, Simon D.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Byrom St, Liverpool L3 5UX, Merseyside, England	University of Bristol; University of Bristol; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of California System; University of California San Diego; Liverpool John Moores University	Wallach, J (corresponding author), Univ Sci, Pharmaceut Sci, Philadelphia Coll Pharm, Philadelphia, PA USA.	jwallach@mail.usciences.edu	collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015; Wallach, Jason/AAK-3776-2020; Halberstadt, Adam L/J-9328-2015	Collingridge, Graham L/0000-0002-9572-5359; Brandt, Simon D./0000-0001-8632-5372; Wallach, Jason/0000-0002-2467-5761	USA NIH NIMH Psychoactive Drug Screening Program; NIMH [MH100644]; NIDA [DA002925]; MRC [MR/K023098/1] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH100644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002925] Funding Source: NIH RePORTER; Medical Research Council [MR/K023098/1] Funding Source: researchfish	USA NIH NIMH Psychoactive Drug Screening Program; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge support of the USA NIH NIMH Psychoactive Drug Screening Program for the screening of the compounds in receptors and the monoamine transporter assays. Dr. Halberstadt was supported by NIMH (MH100644) and NIDA (DA002925).	Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; [Anonymous], 2012, ACMD REP METH; Berger ML, 2009, BIOORGAN MED CHEM, V17, P3456, DOI 10.1016/j.bmc.2009.03.025; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Ceolin L, 2012, NEUROCHEM INT, V61, P517, DOI 10.1016/j.neuint.2012.02.035; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DEMONTIS MG, 1985, PHARMACOL RES COMMUN, V17, P471, DOI 10.1016/0031-6989(85)90082-7; Elliott SP, 2015, J ANAL TOXICOL, V39, P287, DOI 10.1093/jat/bkv006; Fray MJ, 2006, BIOORG MED CHEM LETT, V16, P4345, DOI 10.1016/j.bmcl.2006.05.051; Fray MJ, 2010, BIOORG MED CHEM LETT, V20, P3788, DOI 10.1016/j.bmcl.2010.04.052; Geyer M A, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0807s03; Gray NM, 1989, Patent, Patent No. [EP346791A1, 346791]; Guitart X, 2004, PSYCHOPHARMACOLOGY, V174, P301, DOI 10.1007/s00213-004-1920-9; Halberstadt AL, 2016, PSYCHOPHARM IN PRESS; Helander A, 2014, CLIN TOXICOL, V52, P901, DOI 10.3109/15563650.2014.943908; Helander A, 2015, CLIN TOXICO IN PRESS; JANIRI L, 1994, DRUG ALCOHOL DEPEN, V36, P139, DOI 10.1016/0376-8716(94)90096-5; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lodge D, 2015, BRIT J PHARMACOL, V172, P4254, DOI 10.1111/bph.13222; MANSBACH RS, 1991, PSYCHOPHARMACOLOGY, V105, P162, DOI 10.1007/BF02244303; MANSBACH RS, 1989, NEUROPSYCHOPHARMACOL, V2, P299, DOI 10.1016/0893-133X(89)90035-3; McLaughlin G, 2016, DRUG TEST ANAL, V8, P99, DOI 10.1002/dta.1800; MONNET FP, 1995, P NATL ACAD SCI USA, V92, P3774, DOI 10.1073/pnas.92.9.3774; Morris H, 2014, DRUG TEST ANAL, V6, P614, DOI 10.1002/dta.1620; NATSUKA K, 1987, J MED CHEM, V30, P1779, DOI 10.1021/jm00393a017; NOZAKI M, 1983, LIFE SCI, V33, P431, DOI 10.1016/0024-3205(83)90534-9; Palmer GC, 1997, EXCITATORY AMINO ACI, P109; Pochwat B, 2014, EXPERT OPIN INV DRUG, V23, P1181, DOI 10.1517/13543784.2014.918951; Reynolds I J, 2001, Curr Protoc Pharmacol, VChapter 1, DOI 10.1002/0471141755.ph0120s11; Reynolds LJ, 1999, METH MOL B, V128, P93; Roth B, 2013, PSYCHOACTIVE DRUG SC; Roth BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059334; Sanacora G, 2014, MOL PSYCHIATR, V19, P978, DOI 10.1038/mp.2013.130; TRICKLEBANK MD, 1989, EUR J PHARMACOL, V167, P127, DOI 10.1016/0014-2999(89)90754-1; Uchiyama N, 2014, FORENSIC TOXICOL, V32, P9, DOI 10.1007/s11419-013-0194-5; Vilner BJ, 2000, J PHARMACOL EXP THER, V292, P900; Volianskis A, 2013, J PHYSIOL-LONDON, V591, P955, DOI 10.1113/jphysiol.2012.247296; Vollenweider FX, 2001, BRAIN RES BULL, V56, P495, DOI 10.1016/S0361-9230(01)00646-3; Wallach J. V., 2014, THESIS; Wallach J, 2015, DRUG TEST ANAL, V7, P358, DOI 10.1002/dta.1689; Wiley JL, 2003, PSYCHOPHARMACOLOGY, V165, P378, DOI 10.1007/s00213-002-1297-6; Wink CSD, 2016, DRUG TEST ANAL, V8, P1005, DOI 10.1002/dta.1946; WONG EHF, 1988, J NEUROCHEM, V50, P274, DOI 10.1111/j.1471-4159.1988.tb13260.x; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; WOODRUFF GN, 1987, NEUROPHARMACOLOGY, V26, P903, DOI 10.1016/0028-3908(87)90068-2; YAMAMOTO H, 1995, J NEUROSCI, V15, P731	49	48	48	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157021	10.1371/journal.pone.0157021	http://dx.doi.org/10.1371/journal.pone.0157021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314670	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000378030000008
J	Gaume, X; Place, C; Delage, H; Mongelard, F; Monier, K; Bouvet, P				Gaume, Xavier; Place, Christophe; Delage, Helene; Mongelard, Fabien; Monier, Karine; Bouvet, Philippe			Expression of Nucleolin Affects Microtubule Dynamics	PLOS ONE			English	Article							BINDING-PROTEIN; LIPID-RAFT; NUCLEOPHOSMIN/B23; CENTROSOME; GROWTH; CYCLE; INSTABILITY; INTERPLAY; TARGET; LEADS	Nucleolin is present in diverse cellular compartments and is involved in a variety of cellular processes from nucleolar structure and function to intracellular trafficking, cell adhesion and migration. Recently, nucleolin has been localized at the mature centriole where it is involved in microtubule nucleation and anchoring. Although this new function of nucleolin linked to microtubule regulation has been identified, the global effects of nucleolin on microtubule dynamics have not been addressed yet. In the present study, we analyzed the roles of nucleolin protein levels on global microtubule dynamics by tracking the EB3 microtubule plus end binding protein in live cells. We have found that during microtubule growth phases, nucleolin affects both the speed and life time of polymerization and by analyzing catastrophe events, we showed that nucleolin reduces catastrophe frequency. This new property of nucleolin was then confirmed in a cold induced microtubule depolymerization experiment in which we have found that cold resistant microtubules were totally destabilized in nucleolin depleted cells. Altogether, our data demonstrate a new function of nucleolin on microtubule stabilization, thus bringing novel insights into understanding the multifunctional properties of nucleolin in healthy and cancer cells.	[Gaume, Xavier; Delage, Helene; Mongelard, Fabien; Monier, Karine; Bouvet, Philippe] Univ Lyon, Ecole Normale Super Lyon, UMR INSERM CNRS 5286 1052,Ctr Leon Berard, Canc Cell Plast Dept,Ctr Rech Cancerol Lyon, Lyon, France; [Place, Christophe] Univ Lyon, Ecole Normale Super Lyon, Univ Claude Bernard, CNRS,Lab Phys, F-69342 Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Monier, K; Bouvet, P (corresponding author), Univ Lyon, Ecole Normale Super Lyon, UMR INSERM CNRS 5286 1052,Ctr Leon Berard, Canc Cell Plast Dept,Ctr Rech Cancerol Lyon, Lyon, France.	Karine.monier@ens-lyon.fr; pbouvet@ens-lyon.fr	Monier, Karine/AAP-4806-2021; , Bouvet/AAC-8779-2020	Bouvet, Philippe/0000-0003-4524-2233; Mongelard, Fabien/0000-0002-5929-6120	Agence Nationale de la Recherche [ANR-07-BLAN-0062-01]; Association pour la Recherche sur le Cancer [ECL2010R01122]; Ligue contre le Cancer (Rhone); FINOVI; CNRS; Ecole Normale Superieure de Lyon	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue contre le Cancer (Rhone); FINOVI; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic)	This project was funded thanks to the Agence Nationale de la Recherche [ANR-07-BLAN-0062-01], the Association pour la Recherche sur le Cancer n_ECL2010R01122, Ligue contre le Cancer (Rhone), FINOVI, the CNRS and Ecole Normale Superieure de Lyon.	Akhmanova A, 2013, CURR OPIN CELL BIOL, V25, P3, DOI 10.1016/j.ceb.2012.12.003; Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Berger CM, 2015, BIOCHIMIE        APR; Bi JJ, 2013, MOL CELLS, V36, P507, DOI 10.1007/s10059-013-0149-z; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Chen XG, 2011, MOL THER, V19, P93, DOI 10.1038/mt.2010.214; Cheung YK, 1997, STAT SINICA, V7, P805; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; DERENZINI M, 1995, LAB INVEST, V73, P497; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Gaume X, 2015, CELL CYCLE, V14, P902, DOI 10.1080/15384101.2014.1000197; Gaume X, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/187624; Giannakakou P, 2000, J NATL CANCER I, V92, P182, DOI 10.1093/jnci/92.3.182; Greco A, 2012, J VIROL, V86, P1449, DOI 10.1128/JVI.06194-11; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hollander BA, 1999, CELL MOTIL CYTOSKEL, V43, P114, DOI 10.1002/(SICI)1097-0169(1999)43:2<114::AID-CM3>3.3.CO;2-D; Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; Koutsioumpa M, 2014, RECENT PAT ANTI-CANC, V9, DOI 10.2174/1574892808666131119095953; Koutsioumpa M, 2013, J BIOL CHEM, V288, P343, DOI 10.1074/jbc.M112.387076; Larrucea S, 1998, J BIOL CHEM, V273, P31718, DOI 10.1074/jbc.273.48.31718; Larrucea S, 1999, BIOCHEM BIOPH RES CO, V266, P51, DOI 10.1006/bbrc.1999.1766; Li N, 2009, BIOCHEM BIOPH RES CO, V384, P76, DOI 10.1016/j.bbrc.2009.04.077; Li YP, 1996, EUR J BIOCHEM, V237, P153, DOI 10.1111/j.1432-1033.1996.0153n.x; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Neukirchen D, 2011, SEMIN CELL DEV BIOL, V22, P825, DOI 10.1016/j.semcdb.2011.08.007; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Reyes-Reyes EM, 2008, EXP CELL RES, V314, P2212, DOI 10.1016/j.yexcr.2008.03.016; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Shinmura K, 2005, FEBS LETT, V579, P6621, DOI 10.1016/j.febslet.2005.10.057; Smole Z, 2014, CANCER RES, V74, P353, DOI 10.1158/0008-5472.CAN-13-1334; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Stepanova T, 2003, J NEUROSCI, V23, P2655; Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455; Syred HM, 2013, MOL CELL PROTEOMICS, V12, P3135, DOI 10.1074/mcp.M113.028563; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Wang GX, 2010, J BIOL CHEM, V285, P19060, DOI 10.1074/jbc.M110.100396	45	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157534	10.1371/journal.pone.0157534	http://dx.doi.org/10.1371/journal.pone.0157534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309529	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800093
J	Kootker, LM; Mbeki, L; Morris, AG; Kars, H; Davies, GR				Kootker, Lisette M.; Mbeki, Linda; Morris, Alan G.; Kars, Henk; Davies, Gareth R.			Dynamics of Indian Ocean Slavery Revealed through Isotopic Data from the Colonial Era Cobern Street Burial Site, Cape Town, South Africa (1750-1827)	PLOS ONE			English	Article							BIOLOGICALLY AVAILABLE STRONTIUM; STABLE CARBON; WESTERN CAPE; RATIOS; BONE; SR-87/SR-86; RECONSTRUCTION; DIAGENESIS; MIGRATION; MOBILITY	The Dutch East India Company (VOC) intended the Cape of Good Hope to be a refreshment stop for ships travelling between the Netherlands and its eastern colonies. The indigenous Khoisan, however, did not constitute an adequate workforce, therefore the VOC imported slaves from East Africa, Madagascar and Asia to expand the workforce. Cape Town became a cosmopolitan settlement with different categories of people, amongst them a non-European underclass that consisted of slaves, exiles, convicts and free-blacks. This study integrated new strontium isotope data with carbon and nitrogen isotope results from an 18th-19th century burial ground at Cobern Street, Cape Town, to identify non-European forced migrants to the Cape. The aim of the study was to elucidate individual mobility patterns, the age at which the forced migration took place and, if possible, geographical provenance. Using three proxies, Sr-87/Sr-86, delta C-13(dentine) and the presence of dental modifications, a majority (54.5%) of the individuals were found to be born non-locally. In addition, the Sr-87/Sr-86 data suggested that the non-locally born men came from more diverse geographic origins than the migrant women. Possible provenances were suggested for two individuals. These results contribute to an improved understanding of the dynamics of slave trading in the Indian Ocean world.	[Kootker, Lisette M.; Davies, Gareth R.] Vrije Univ Amsterdam, Geol & Geochem Cluster, Amsterdam, Netherlands; [Kootker, Lisette M.; Mbeki, Linda; Kars, Henk] Vrije Univ Amsterdam, Res Inst Culture, Hist & Heritage CLUE, Amsterdam, Netherlands; [Morris, Alan G.] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, ZA-7925 Cape Town, South Africa	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Cape Town	Kootker, LM (corresponding author), Vrije Univ Amsterdam, Geol & Geochem Cluster, Amsterdam, Netherlands.; Kootker, LM; Mbeki, L (corresponding author), Vrije Univ Amsterdam, Res Inst Culture, Hist & Heritage CLUE, Amsterdam, Netherlands.	lisette.kootker@vu.nl; l.mbeki@vu.nl	Mbeki, Linda/Q-1194-2019; Morris, Alan G/V-7363-2019; Kootker, Lisette/Q-7715-2019	Mbeki, Linda/0000-0003-2537-2022; Kootker, Lisette/0000-0002-3551-2730; Davies, Gareth Rees/0000-0002-6136-9202	National Research Foundation (South Africa) [74691]; Oppenheimer Memorial Trust (OMT) [19671/02]; Institute for Geo- and Bioarchaeology of the Vrije Universiteit Amsterdam; Centre for International Cooperation (CIS) of the Vrije Universiteit Amsterdam; European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC [319209]	National Research Foundation (South Africa)(National Research Foundation - South Africa); Oppenheimer Memorial Trust (OMT); Institute for Geo- and Bioarchaeology of the Vrije Universiteit Amsterdam; Centre for International Cooperation (CIS) of the Vrije Universiteit Amsterdam; European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC(European Research Council (ERC))	This research benefitted from funding from the National Research Foundation (South Africa: grant no. 74691), the Oppenheimer Memorial Trust (OMT ref. 19671/02), the former Institute for Geo- and Bioarchaeology of the Vrije Universiteit Amsterdam and the Centre for International Cooperation (CIS) of the Vrije Universiteit Amsterdam (Ref: Mbeki). GRD is funded by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC Synergy grant agreement no 319209.	ABERG G, 1995, WATER AIR SOIL POLL, V79, P309, DOI 10.1007/BF01100444; Adams TS, 2000, LIMNOL OCEANOGR, V45, P601, DOI 10.4319/lo.2000.45.3.0601; Allen R.B., 2015, EUROPEAN SLAVE TRADI; Alpers Edward, 2014, INDIAN OCEAN WORLD H; [Anonymous], 1981, HDB STABLE STRONTIUM, DOI DOI 10.1007/978-1-4684-3698-3_5; Apollonio Heather, 1998, IDENTIFYING DEAD 18; Babraj J, 2002, BIOCHEM SOC T, V30, P61, DOI 10.1042/bst0300061; Balasse M, 2002, J ARCHAEOL SCI, V29, P917, DOI 10.1006/jasc.2001.0787; Batavia Raben R., 1996, BATAVIA COLOMBO ETHN; Bentley R.A., 2009, ASIAN PERSPECT, V48, P79, DOI [10.1353/asi.0.0017, DOI 10.1353/ASI.0.0017]; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2005, ARCHAEOMETRY, V47, P629, DOI 10.1111/j.1475-4754.2005.00223.x; Beyers J, 2016, HTS TEOL STUD-THEOL, V72, DOI [10.4102/hts.v72i1.3117, 10.4102/hts.v72i4.3449, 10.4102/hts.v72i4.3450]; Bogaard A, 2007, J ARCHAEOL SCI, V34, P335, DOI 10.1016/j.jas.2006.04.009; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Budd P, 2000, APPL GEOCHEM, V15, P687, DOI 10.1016/S0883-2927(99)00069-4; Burton JH, 1999, J ARCHAEOL SCI, V26, P609, DOI 10.1006/jasc.1998.0378; Capo RC, 1998, GEODERMA, V82, P197, DOI 10.1016/S0016-7061(97)00102-X; Clarence-Smith William., 2013, SLAVERY ABOLIT, P209, DOI [DOI 10.1080/01440398808574970, 10.1080/01440398808574970]; Compton JS, 2003, CHEM GEOL, V201, P239, DOI 10.1016/S0009-2541(03)00239-0; Copeland SR, STRONTIUM ISOTOPE IN; Cox G, 2001, WORLD ARCHAEOL, V33, P73, DOI 10.1080/00438240120047645; Cox G., 1999, THESIS; Cox G, 1995, HIST BACKGROUND ISOT; Cox G., 1997, S AFRICA INT J HIST, V1, P207, DOI DOI 10.1023/A:1027349115474; De Kock V, 1950, THOSE BONDAGE; Degryse P, 2012, ANAL METHODS-UK, V4, P2674, DOI 10.1039/c2ay25035g; Dijkstra FA, 2003, BIOGEOCHEMISTRY, V62, P253, DOI 10.1023/A:1021132132199; Elphick R, 1979, SHAPING S AFRICAN SO, P116; ERICSON JE, 1985, J HUM EVOL, V14, P503, DOI 10.1016/S0047-2484(85)80029-4; Evans JA, 2010, J GEOL SOC LONDON, V167, P1, DOI 10.1144/0016-76492009-090; Evans JA, 2009, J GEOL SOC LONDON, V166, P617, DOI 10.1144/0016-76492008-043; Faure G., 1986, PRINCIPLES ISOTOPE G, V2nd; Font L, 2007, J ANAL ATOM SPECTROM, V22, P513, DOI 10.1039/b616328a; Font L, 2015, SCI JUSTICE, V55, P34, DOI 10.1016/j.scijus.2014.06.011; Frei KM, 2011, APPL GEOCHEM, V26, P325, DOI 10.1016/j.apgeochem.2010.12.006; Goodman Alan H., 2009, SKELETAL BIOL NEW 1, P95; Groenewald G, 2010, HISTORY COMPASS, V8, P964, DOI 10.1111/j.1478-0542.2010.00724.x; Hakenbeck S, 2010, AM J PHYS ANTHROPOL, V143, P235, DOI 10.1002/ajpa.21309; HANDLER JS, 1982, J HUM EVOL, V11, P297, DOI 10.1016/S0047-2484(82)80021-3; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Hedman KM, 2009, J ARCHAEOL SCI, V36, P64, DOI 10.1016/j.jas.2008.07.009; Hobson KA, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P273, DOI 10.1007/978-90-481-3354-3_13; Hoppe KA, 2003, INT J OSTEOARCHAEOL, V13, P20, DOI 10.1002/oa.663; International Commission on Radiological Protection, 1973, ALKALINE EARTH METAB; Kajiyama S., 1965, NIHON U DENT J, V39, P77; Kinaston RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064580; Klaver M, 2016, J ANAL ATOM SPECTROM, V31, P171, DOI 10.1039/c5ja00130g; Kootker LM, 2016, J ARCHAEOL SCI-REP, V6, P1, DOI 10.1016/j.jasrep.2016.01.015; Laffoon JE, 2012, J ARCHAEOL SCI, V39, P2371, DOI 10.1016/j.jas.2012.02.002; Leatherdale A. J., 2013, TOTEM U W ONTARIO J, V21, P40; Liversidge HM., 2008, DENT AGE REVISITED T; Manyaapelo T, 2007, THESIS; Maurer AF, 2012, SCI TOTAL ENVIRON, V433, P216, DOI 10.1016/j.scitotenv.2012.06.046; Mbeki L, 2017, SLAVERY ABOLIT, V38, P95, DOI 10.1080/0144039X.2016.1159004; MILLER EK, 1993, NATURE, V362, P438, DOI 10.1038/362438a0; Montgomery J, 2010, ANN HUM BIOL, V37, P325, DOI 10.3109/03014461003649297; Moorrees CF, 1963, J DENT RES, V42, P490; Morris A. G, 1997, 27 ANN C AN SOC SO A; Nafplioti A, 2011, J ARCHAEOL SCI, V38, P1560, DOI 10.1016/j.jas.2011.02.021; Nelson S.J., 2010, WHEELERS DENT ANATOM, V9th; Nielsen-Marsh CM, 2000, J ARCHAEOL SCI, V27, P1139, DOI 10.1006/jasc.1999.0537; Nielson FH, 1986, TRACE ELEMENTS HUMAN, V2; Nystrom KC, 2011, J ARCHAEOL SCI, V38, P3505, DOI 10.1016/j.jas.2011.08.013; Oelze VM, 2012, AM J PHYS ANTHROPOL, V148, P406, DOI 10.1002/ajpa.22063; Pate F. D., 1998, QUATERNARY AUSTRALAS, V16, P43; Price T., 2003, FUNDBERICHTE BADEN W, P23; Price TD, 2006, AM J PHYS ANTHROPOL, V130, P485, DOI 10.1002/ajpa.20390; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Pye K, 2004, GEOL SOC SPEC PUBL, V232, P215, DOI [10.1144/GSL.SP.2004.232.01.20, DOI 10.1144/GSL.SP.2004.232.01.20]; Reid DJ, 2006, J HUM EVOL, V50, P329, DOI 10.1016/j.jhevol.2005.09.003; Richards MP, 2002, AM J PHYS ANTHROPOL, V119, P205, DOI 10.1002/ajpa.10124; Schroeder H, 2009, AM J PHYS ANTHROPOL, V139, P547, DOI 10.1002/ajpa.21019; Schumm DE, 1995, ESSENTIALS BIOCH; Schwarcz HP, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P335, DOI 10.1007/978-90-481-3354-3_16; Schwarcz HP, 1999, J ARCHAEOL SCI, V26, P629, DOI 10.1006/jasc.1998.0380; SEALY JC, 1991, J ARCHAEOL SCI, V18, P399, DOI 10.1016/0305-4403(91)90074-Y; Sharp Z., 2007, PRINCIPLES STABLE IS; Shea MK, 2015, YOUNGSCIENTIST, V5, P42; Shell Robert, 1994, CHILDREN BONDAGE SOC; Slovak NM, 2011, ADV ISOTOP GEOCHEM, P743, DOI 10.1007/978-3-642-10637-8_35; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Szczepanek A., 2011, MINERALOGIA, V42, P93, DOI [10.2478/v10002-011-0009-4, DOI 10.2478/V10002-011-0009-4]; Trincherini PR, 2014, FOOD CHEM, V145, P349, DOI 10.1016/j.foodchem.2013.08.030; van Rossum Matthias, 2015, KLEURRIJKE TRAGIEK G; VANDERMERWE NJ, 1982, AM SCI, V70, P596; VEIZER J, 1989, ANNU REV EARTH PL SC, V17, P141, DOI 10.1146/annurev.earth.17.1.141; Vink M, 2003, J WORLD HIST, V14, P131, DOI 10.1353/jwh.2003.0026; Voerkelius S, 2010, FOOD CHEM, V118, P933, DOI 10.1016/j.foodchem.2009.04.125; Waterlow JC, 2006, PROTEIN TURNOVER, P1, DOI 10.1079/9780851996134.0000; Whipkey CE, 2000, CHEM GEOL, V168, P37, DOI 10.1016/S0009-2541(00)00187-X; Willmes M, 2014, EARTH SYST SCI DATA, V6, P117, DOI 10.5194/essd-6-117-2014; WOELFEL JB, 2002, DENT ANATOMY ITS REL; Worden N, 2007, CONTINGENT LIVES SOC; Worden Nigel, 1985, SLAVERY DUTCH S AFRI; Worden Nigel., 2005, ABOLITION ITS AFTERM, P29; Wright LE, 2005, J ARCHAEOL SCI, V32, P555, DOI 10.1016/j.jas.2004.11.011	98	24	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157750	10.1371/journal.pone.0157750	http://dx.doi.org/10.1371/journal.pone.0157750			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DO8JO	27309532	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800132
J	Cazarim, MD; de Freitas, O; Penaforte, TR; Achcar, A; Pereira, LRL				Cazarim, Maurilio de Souza; de Freitas, Osvaldo; Penaforte, Thais Rodrigues; Achcar, Angela; Leira Pereira, Leonardo Regis			Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge	PLOS ONE			English	Article							PHARMACIST INTERVENTIONS; BLOOD-PRESSURE; PROGRAM; ENALAPRIL; OUTCOMES; DISEASE; BRAZIL	Introduction Almost 50% of the 17.5 million deaths worldwide from cardiovascular disease have been associated with systemic arterial hypertension (SAH). Into this scenario, Pharmaceutical Care (PC) has been inserted in order to improve the management of SAH and reduce its risks. Objective To evaluate the outcomes and healthcare assistance achieved after discharge of hypertension patients from the PC program. Methods This is a quasi-experimental study with historical controls. Retrospective data collection from 2006 to 2012 was begun in 2013 and included a PC program performed over one year. PC was performed in two basic units of the public health systemin Ribeirao Preto-SP, Brazil, where the pharmacist followed up 104 hypertensive patients. The clinical indicators of systolic (SBP) and diastolic blood pressure (DBP), triglycerides, total-cholesterol, high and low density lipoprotein cholesterol were collected, as well as care indicators related to the number of consultations (basic, specialized and emergency care) and antihypertensive drugs used. The coronary risk of patients by the Framingham risk score was also calculated. For the analysis, the data were divided into three periods, 2006-2008 as pre-PC, 2009 as PC and 2010-2012 as post-PC. Results In the pre-PC period, 54.4%, 79.0% and 27.3% of patients presented satisfactory levels of SBP, DBP and total-cholesterol, respectively. In the post-PC period, the percentages were 93.0% for SBP and DBP [p < 0.001] and 60.6% for total-cholesterol [p < 0.001]. The average number of consultations per patient/year in primary care was 1.66 +/- 1.43 and 2.36 +/- 1.73, [p = 0.012]; and for emergency care was 1.70 +/- 1.43 and 1.06 +/- 0.81, [p = 0.002] in the pre-PC and post-PC periods, respectively. The pre-PC Framingham risk in the last year was 14.3% +/- 10.6 and the average post-PC was 10.9% +/- 7.9. Conclusion PC was effective in the control of blood pressure and total-cholesterolafter discharge of the hypertensive patients from PC program.	[Cazarim, Maurilio de Souza; de Freitas, Osvaldo; Leira Pereira, Leonardo Regis] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, BR-14049 Ribeirao Preto, SP, Brazil; [Penaforte, Thais Rodrigues] Univ Fed Bahia, Sch Pharm, Dept Med, Salvador, BA, Brazil; [Achcar, Angela] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Social Med, BR-14049 Ribeirao Preto, SP, Brazil; [Leira Pereira, Leonardo Regis] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Ctr Pesquisa Assistencia Farmaceut & Farm Clin CP, 23 Blc S,Av Cafe S-N, BR-14040903 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Federal da Bahia; Universidade de Sao Paulo; Universidade de Sao Paulo	Cazarim, MD (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, BR-14049 Ribeirao Preto, SP, Brazil.	maurilio.jf@gmail.com	de Freitas, Osvaldo/AAK-2913-2020; Freitas, Osvaldo/C-1440-2012; Pereira, Leonardo R L/J-9322-2012	de Freitas, Osvaldo/0000-0001-7055-2028; Pereira, Leonardo R L/0000-0002-8609-1390; Cazarim, Maurilio de Souza/0000-0002-2826-5903	Sao Paulo Research Foundation (FAPESP);  [2014/020879];  [07/06514-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ; 	This work was supported by funding of Sao Paulo Research Foundation (FAPESP). This organization helped with scholarships for authors Maurilio Souza Cazarim [grant number 2014/020879], URL (http://bvs.fapesp.br/en/pesquisador/673633/maurilio-de-souza-cazarim/) and Thais Rodrigues Penaforte [grant number 07/06514-5], URL (http://www.bv.fapesp.br/en/pesquisador/77829/thaisrodrigues-penaforte/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions, assumptions and conclusions or recommendations expressed in this article are responsibility of the authors and do not necessarily reflect the viewpoint of FAPESP.	Aguwa CN, 2008, PHARM WORLD SCI, V30, P107, DOI 10.1007/s11096-007-9151-x; Mazroui NR, 2009, BRIT J CLIN PHARMACO, V67, P547, DOI 10.1111/j.1365-2125.2009.03391.x; Almeida CM, 1995, CAD SAUDE PUBLICA, V11, P639, DOI [10.1590/S0102-311X1995000400020, DOI 10.1590/S0102-311X1995000400020]; Araujo A. L. A., 2005, Revista de Ciencias Farmaceuticas Basica e Aplicada, V26, P87; Borges APS, 2008, THESIS; Brazilian Institute of Geography and Statistics-IBGE, CONS EXP SURV BRAZ; Bruckert E, 2008, CARDIOVASC DRUG THER, V22, P495, DOI 10.1007/s10557-008-6137-4; Carter BL, 2009, ARCH INTERN MED, V169, P1748, DOI 10.1001/archinternmed.2009.316; Chinwong S, 2004, PHARM WORLD SCI, V26, P96, DOI 10.1023/B:PHAR.0000018599.47002.e7; Ciconelli RM, 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Cipolle RJ, 1998, PHARM CARE PRACTICE; Coelho Eduardo Barbosa, 2005, Arq. Bras. Cardiol., V85, P157, DOI 10.1590/S0066-782X2005001600002; DAWBER T. R., 1957, AMER JOUR PUBL HEALTH, V47, P4, DOI 10.2105/AJPH.47.4_Pt_2.4; de Castro MS, 2007, ANN PHARMACOTHER, V41, P1486, DOI 10.1345/aph.1K080; Borges APD, 2011, ARQ BRAS ENDOCRINOL, V55, P686, DOI 10.1590/S0004-27302011000900003; De Souza WA, 2007, AM J HEALTH-SYST PH, V64, P1955, DOI 10.2146/ajhp060547; ELMANGOUSH M, 1990, POSTGRAD MED J, V66, P446, DOI 10.1136/pgmj.66.776.446; Fleury S, 2011, LANCET, V377, P1724, DOI 10.1016/S0140-6736(11)60318-8; Gale CR, 2014, AGE, V36, DOI 10.1007/s11357-014-9692-6; HEPLER CD, 1990, AM J HOSP PHARM, V47, P533, DOI 10.1093/ajhp/47.3.533; Ivama AM, 2002, CONSENSO BRASILEIRO; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1; Pereira LRL, 2008, REV BRAS CIENC FARM, V44, P601, DOI 10.1590/S1516-93322008000400006; Lynch RL, 2009, FINANCIAL TIMES; Lyra Júnior Divaldo Pereira de, 2008, Rev. Bras. Cienc. Farm., V44, P451, DOI 10.1590/S1516-93322008000300015; Machado M, 2007, ANN PHARMACOTHER, V41, P1770, DOI 10.1345/aph.1K311; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Murabito J M, 1995, J Am Med Womens Assoc (1972), V50, P35; Obreli-Neto PR, 2011, INT J CLIN PHARM-NET, V33, P642, DOI 10.1007/s11096-011-9518-x; Paulos CP, 2005, ANN PHARMACOTHER, V39, P939, DOI 10.1345/aph.1E347; Penaforte TR, 2011, THESIS; Polgreen LA, 2015, HYPERTENSION, V66, P1145, DOI 10.1161/HYPERTENSIONAHA.115.06023; Pontes-Neto OM, 2008, STROKE, V39, P292, DOI 10.1161/STROKEAHA.107.493908; Roush G, 2014, J AM SOC HYPERTENS, V8, pe59, DOI DOI 10.1016/J.JASH.2014.03.132; Santschi V, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000718; Silva-Castro M M, 2010, Farm Hosp, V34, P106, DOI 10.1016/j.farma.2009.09.007; [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001; Tikkanen MJ, 1998, DIABETES CARE, V21, P477, DOI 10.2337/diacare.21.4.477; Von Muenster SJ, 2008, PHARM WORLD SCI, V30, P128, DOI 10.1007/s11096-007-9155-6; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2010, GLOB STAT REP NONC D; World Health Organization, 2017, CARD DIS CVDS; Zanchetti A, 2001, AM J HYPERTENS, V14, P129, DOI 10.1016/S0895-7061(00)01240-1; Zubioli A, 2013, BRAZ J PHARM SCI, V49, P85, DOI 10.1590/S1984-82502013000100010	45	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155204	10.1371/journal.pone.0155204	http://dx.doi.org/10.1371/journal.pone.0155204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304922	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800005
J	Jiang, TA; Tian, G; Zhao, QY; Kong, DX; Cheng, C; Zhong, LY; Li, LJ				Jiang, Tian'an; Tian, Guo; Zhao, Qiyu; Kong, Dexing; Cheng, Chao; Zhong, Liyun; Li, Lanjuan			Diagnostic Accuracy of 2D-Shear Wave Elastography for Liver Fibrosis Severity: A Meta-Analysis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; NONINVASIVE ASSESSMENT; SHEAR; STIFFNESS; DISEASE; ELASTICITY; BIOPSY	Purpose To evaluate the accuracy of shear wave elastography (SWE) in the quantitative diagnosis of liver fibrosis severity. Methods The published literatures were systematically retrieved from PubMed, Embase, Web of science and Scopus up to May 13th, 2016. Included studies reported the pooled sensitivity, specificity, positive and negative predictive values, as well as the diagnostic odds ratio of SWE in populations with liver fibrosis. A bivariate mixed-effects regression model was used, which was estimated by the I-2 statistics. The quality of articles was evaluated by quality assessment of diagnostic accuracy studies (QUADAS). Results Thirteen articles including 2303 patients were qualified for the study. The pooled sensitivity and specificity of SWE for the diagnosis of liver fibrosis are as follows: >= F10.76 (p<0.001, 95% CI, 0.71-0.81, I-2 = 75.33%), 0.92 (p<0.001, 95% CI, 0.80-0.97, I-2 = 79.36%); >= F2 0.84 (p = 0.35, 95% CI, 0.81-0.86, I-2 = 9.55%), 0.83 (p<0.001, 95% CI, 0.77-0.88, I-2 = 86.56%); >= F30.89 (p = 0.56, 95% CI, 0.86-0.92, I-2 = 0%), 0.86 (p<0.001, 95% CI, 0.82-0.90, I-2 = 75.73%); F40.89 (p = 0.24, 95% CI, 0.84-0.92, I-2 = 20.56%), 0.88 (p<0.001, 95% CI, 0.84-0.92, I-2 = 82.75%), respectively. Sensitivity analysis showed no significant changes if any one of the studies was excluded. Publication bias was not detected in this meta-analysis. Conclusions Our study suggests that SWE is a helpful method to appraise liver fibrosis severity. Future studies that validate these findings would be appropriate.	[Jiang, Tian'an; Zhong, Liyun] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Ultrasonog, Hangzhou 310003, Zhejiang, Peoples R China; [Tian, Guo; Li, Lanjuan] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis, Sch Med,Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Qiyu; Cheng, Chao] Zhejiang Univ, Affiliated Hosp 1, Dept Hepatobiliary Pancreat Surg, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Kong, Dexing] Zhejiang Univ, Dept Math, Hangzhou 310027, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis, Sch Med,Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn			opening foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases; First Affiliated Hospital of Medical College, Zhejiang University [2015KF06]	opening foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases; First Affiliated Hospital of Medical College, Zhejiang University	This study was supported by the opening foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Medical College, Zhejiang University, grant NO. 2015KF06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the opening foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Medical College, Zhejiang University, grant NO. 2015KF06.	Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Beland MD, 2014, AM J ROENTGENOL, V203, pW267, DOI 10.2214/AJR.13.11718; Cassinotto C, 2014, J HEPATOL, V61, P550, DOI 10.1016/j.jhep.2014.04.044; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chu HT, 2006, J CLIN EPIDEMIOL, V59, P1331, DOI 10.1016/j.jclinepi.2006.06.011; Cleophas TJ, 2009, CLIN CHEM LAB MED, V47, P1351, DOI 10.1515/CCLM.2009.317; Cosgrove D, 2013, ULTRASCHALL MED, V34, P238, DOI 10.1055/s-0033-1335375; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Deffieux T, 2015, J HEPATOL, V62, P317, DOI 10.1016/j.jhep.2014.09.020; El-Serag HB, 2002, HEPATOLOGY, V36, pS74, DOI 10.1053/jhep.2002.36807; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gerber L, 2015, ULTRASOUND MED BIOL, P41; Guibal A, 2016, DIAGN INTERV IMAG, V97, P91, DOI 10.1016/j.diii.2015.11.001; Hagan M, 2015, EXPERT REV GASTROENT, V9, P1251, DOI 10.1586/17474124.2015.1075391; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang ZP, 2014, ULTRASOUND MED BIOL, V40, P2549, DOI 10.1016/j.ultrasmedbio.2014.05.008; Leung VYF, 2013, RADIOLOGY, V269, P910, DOI 10.1148/radiol.13130128; Li Y, 2016, ALIMENT PHARM THER, V43, P458, DOI 10.1111/apt.13488; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127782; Lu YP, 2014, J HUAZHONG U SCI-MED, V34, P921, DOI 10.1007/s11596-014-1375-0; Mariani A, 2014, J SURG RES, V188, P37, DOI 10.1016/j.jss.2013.12.024; Samir AE, 2015, RADIOLOGY, V274, P888, DOI 10.1148/radiol.14140839; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Sporea I, 2012, ULTRASCHALL MED, V33, P550, DOI 10.1055/s-0032-1313011; Suh CH, 2014, RADIOLOGY, V271, P895, DOI 10.1148/radiol.14131251; Tada T, 2015, HEPATOL RES, V45, pE122, DOI 10.1111/hepr.12476; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Verlinden W, 2016, J ULTRAS MED, V35, P1299, DOI 10.7863/ultra.15.08066; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Yoneda M, 2015, CLIN GASTROENTEROL H, V13, P1502, DOI 10.1016/j.cgh.2015.03.014; Zeng J, 2014, EUR RADIOL, V24, P2572, DOI 10.1007/s00330-014-3292-9; Zheng J, 2015, RADIOLOGY, V275, P290, DOI 10.1148/radiol.14140828	35	35	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157219	10.1371/journal.pone.0157219	http://dx.doi.org/10.1371/journal.pone.0157219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300569	Green Submitted, gold, Green Published			2022-12-27	WOS:000377822200032
J	Jurado-Garcia, J; Garcia-Borruel, MM; Rodriguez-Peralvarez, ML; Ruiz-Cuesta, P; Poyato-Gonzalez, A; Barrera-Baena, P; Fraga-Rivas, E; Costan-Rodero, G; Briceno-Delgado, J; Montero-Alvarez, JL; de la Mata-Garcia, M				Jurado-Garcia, Juan; Munoz Garcia-Borruel, Maria; Luis Rodriguez-Peralvarez, Manuel; Ruiz-Cuesta, Patricia; Poyato-Gonzalez, Antonio; Barrera-Baena, Pilar; Fraga-Rivas, Enrique; Costan-Rodero, Guadalupe; Briceno-Delgado, Javier; Luis Montero-Alvarez, Jose; de la Mata-Garcia, Manuel			Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SERUM SODIUM; NATURAL-HISTORY; MODEL; CIRRHOSIS; SURVIVAL; SCORE; CANDIDATES; PREDICTION; RATES	Background and aims MELD allocation system has changed the clinical consequences on waiting list (WL) for LT, but its impact on mortality has been seldom studied. We aimed to assess the ability of MELD and other prognostic scores to predict mortality after LT. Methods 301 consecutive patients enlisted for LT were included, and prioritized within WL by using the MELD-score according to: hepatic insufficiency (HI), refractory ascites (RA) and hepatocellular carcinoma (HCC). The analysis was performed to predict early mortality after LT (8 weeks). Results Patients were enlisted as HI (44.9%), RA (19.3%) and HCC (35.9%). The major aetiologies of liver disease were HCV (45.5%). Ninety-four patients (31.3%) were excluded from WL, with no differences among the three groups (p = 0.23). The remaining 207 patients (68.7%) underwent LT, being HI the most frequent indication (42.5%). HI patients had the shortest length within WL (113.6 days vs 215.8 and 308.9 respectively; p<0.001), but the highest early post-LT mortality rates (18.2% vs 6.8% and 6.7% respectively; p<0.001). The independent predictors of early post-LT mortality in the HI group were higher bilirubin (OR = 1.08; p = 0.038), increased iMELD (OR = 1.06; p = 0.046) and non-alcoholic cirrhosis (OR = 4.13; p = 0.017). Among the prognostic scores the iMELD had the best predictive accuracy (AUC = 0.66), which was strengthened in non-alcoholic cirrhosis (AUC = 0.77). Conclusion Patients enlisted due to HI had the highest early post-LT mortality rates despite of the shortest length within WL. The iMELD had the best accuracy to predict early post-LT mortality in patients with HI, and thus it may benefit the WL management.	[Jurado-Garcia, Juan; Munoz Garcia-Borruel, Maria; Luis Rodriguez-Peralvarez, Manuel; Ruiz-Cuesta, Patricia; Poyato-Gonzalez, Antonio; Barrera-Baena, Pilar; Fraga-Rivas, Enrique; Costan-Rodero, Guadalupe; Luis Montero-Alvarez, Jose; de la Mata-Garcia, Manuel] Reina Sofia Univ Hosp, Dept Hepatol & Liver Transplantation, Cordoba, Spain; [Jurado-Garcia, Juan; Munoz Garcia-Borruel, Maria; Luis Rodriguez-Peralvarez, Manuel; Ruiz-Cuesta, Patricia; Poyato-Gonzalez, Antonio; Barrera-Baena, Pilar; Fraga-Rivas, Enrique; Costan-Rodero, Guadalupe; Briceno-Delgado, Javier; Luis Montero-Alvarez, Jose; de la Mata-Garcia, Manuel] Maimonides Biomed Res Inst, IMIBIC, Cordoba, Spain; [Luis Rodriguez-Peralvarez, Manuel; Poyato-Gonzalez, Antonio; Barrera-Baena, Pilar; Fraga-Rivas, Enrique; Costan-Rodero, Guadalupe; Luis Montero-Alvarez, Jose; de la Mata-Garcia, Manuel] CIBERehd Networked Biomed Res Ctr Hepat & Digest, Cordoba, Spain; [Briceno-Delgado, Javier] Reina Sofia Univ Hosp, Dept Hepatobiliary Surg & Liver Transplantation, Cordoba, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Jurado-Garcia, J (corresponding author), Reina Sofia Univ Hosp, Dept Hepatol & Liver Transplantation, Cordoba, Spain.; Jurado-Garcia, J (corresponding author), Maimonides Biomed Res Inst, IMIBIC, Cordoba, Spain.	juanjg.24j@gmail.com	Rodríguez-Perálvarez, Manuel/AAO-8616-2021; Rodríguez-perálvarez, Manuel/AGR-2409-2022	Rodríguez-perálvarez, Manuel/0000-0002-1795-2919				Barber K, 2011, TRANSPLANTATION, V92, P469, DOI 10.1097/TP.0b013e318225db4d; Benckert C, 2011, SCAND J GASTROENTERO, V46, P941, DOI 10.3109/00365521.2011.568521; Bernardi M, 2011, J HEPATOL, V54, P1297, DOI 10.1016/j.jhep.2010.11.008; Biggins SW, 2005, HEPATOLOGY, V41, P32, DOI 10.1002/hep.20517; Biselli M, 2010, LIVER TRANSPLANT, V16, P964, DOI 10.1002/lt.22093; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; de la Mata M, 2006, TRANSPLANTATION, V82, P1429, DOI 10.1097/01.tp.0000244559.60989.5a; Freeman RB, 2004, AM J TRANSPLANT, V4, P1735, DOI 10.1111/j.1600-6143.2004.00644.x; GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124; Goldberg D, 2012, LIVER TRANSPLANT, V18, P434, DOI 10.1002/lt.23394; Heuman DM, 2004, HEPATOLOGY, V40, P802, DOI 10.1002/hep.20405; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Klein KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080661; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Londono MC, 2007, GUT, V56, P1283, DOI 10.1136/gut.2006.102764; Luca A, 2007, LIVER TRANSPLANT, V13, P1174, DOI 10.1002/lt.21197; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Massie AB, 2011, AM J TRANSPLANT, V11, P2362, DOI 10.1111/j.1600-6143.2011.03735.x; Northup PG, EXCESS MORTALITY LIV; Pomfret EA, 2010, LIVER TRANSPLANT, V16, P262, DOI 10.1002/lt.21999; Quante M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/264015; Schlansky B, 2014, LIVER TRANSPLANT, V20, P1045, DOI 10.1002/lt.23917; Sharma P, 2008, GASTROENTEROLOGY, V135, P1575, DOI 10.1053/j.gastro.2008.08.004; Toso C, 2012, HEPATOLOGY, V56, P149, DOI 10.1002/hep.25603; Vitale A, 2014, J HEPATOL, V60, P290, DOI 10.1016/j.jhep.2014.02.018; Washburn K, 2010, AM J TRANSPLANT, V10, P1643, DOI 10.1111/j.1600-6143.2010.03127.x; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0155822	10.1371/journal.pone.0155822	http://dx.doi.org/10.1371/journal.pone.0155822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299728	gold, Green Published, Green Submitted			2022-12-27	WOS:000377822200006
J	Medina-Mirapeix, F; Bernabeu-Mora, R; Garcia-Guillamon, G; Novella, EV; Gacto-Sanchez, M; Garcia-Vidal, JA				Medina-Mirapeix, Francesc; Bernabeu-Mora, Roberto; Garcia-Guillamon, Gloria; Valera Novella, Elisa; Gacto-Sanchez, Mariano; Antonio Garcia-Vidal, Jose			Patterns, Trajectories, and Predictors of Functional Decline after Hospitalization for Acute Exacerbations in Men with Moderate to Severe Chronic Obstructive Pulmonary Disease: A Longitudinal Study	PLOS ONE			English	Article							OLDER-ADULTS; DISABILITY; FRAILTY; HEALTH	Background Hospitalization for acute exacerbations (AE) of chronic obstructive pulmonary disease (COPD) is common, but little is known about the impact of hospitalization on the development of disability. The purpose of this study was to determine the rate and time course of functional changes 3 months after hospital discharge for AE-COPD compared with baseline levels 2 weeks before admission, and to identify predictors of functional decline. Methods This was a prospective study including 103 patients (age mean, 71 years; standard deviation, 9.1 years) who were hospitalized with AE-COPD. Number of dependencies in Activities of Daily Living (ADLs) was measured at the preadmission baseline and at weeks 6 and 12 after discharge. Patterns of improvement, no change, and decline were defined over 3 consecutive intervals (baseline and weeks 6 and 12). Trajectories grouped patients with similar time courses of disability. Recovery was defined as returning to baseline function after functional decline. Univariate and multivariate multiple logistic regression was used to determine predictors of functional decline after week 12. Results Six trajectories of functional changes were found. From baseline to 12 weeks, 50% of patients continued to have the same function whereas 31% experienced functional decline after 6 weeks; 16.7% recovered over subsequent weeks. At week 12, as a consequence of all trajectories, 38% of patients showed functional declines compared with baseline function, 57% had not declined, and 6 improved. Length of stay (odds ratio [OR] = 1.12; 95% [confidence interval] CI 1.03-1.22), dyspnea ( OR = 1.85; 95% CI 1.05-3.26), and frailty ( OR = 3.97; 95% CI 1.13-13.92) were independent predictors of functional decline after 12 weeks. Conclusions Hospitalization for AE-COPD is a risk factor for the progression of disability. More than one third of patients hospitalized for AE-COPD declined during the 12 weeks following discharge, with most of this decline occurring by week 6.	[Medina-Mirapeix, Francesc; Garcia-Guillamon, Gloria; Valera Novella, Elisa; Antonio Garcia-Vidal, Jose] Univ Murcia, Dept Phys Therapy, Murcia, Spain; [Bernabeu-Mora, Roberto] Hosp Morales Meseguer, Div Pneumol, Murcia, Spain; [Gacto-Sanchez, Mariano] EUSES Univ Girona, Dept Phys Therapy, Girona, Spain	University of Murcia	Bernabeu-Mora, R (corresponding author), Hosp Morales Meseguer, Div Pneumol, Murcia, Spain.	rbernabeumora@hotmail.com	VIDAL, JOSE ANTONIO JAGV GARCIA/M-6944-2018	Garcia Vidal, Jose Antonio/0000-0003-3063-2693; Gacto-Sanchez, Mariano/0000-0003-0256-331X	AstraZeneca; Menarini; Pfizer	AstraZeneca(AstraZeneca); Menarini(Menarini Group); Pfizer(Pfizer)	The corresponding author hereby declares that the study was supported by AstraZeneca, Menarini and Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd CM, 2009, J AM GERIATR SOC, V57, P1757, DOI 10.1111/j.1532-5415.2009.02455.x; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Covinsky KE, 2000, J AM GERIATR SOC, V48, P164, DOI 10.1111/j.1532-5415.2000.tb03907.x; Eisner MD, 2011, THORAX, V66, P108, DOI 10.1136/thx.2010.137661; Eisner MD, 2002, AM J PUBLIC HEALTH, V92, P1506, DOI 10.2105/AJPH.92.9.1506; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Gill TM, 1999, J GERONTOL A-BIOL, V54, pM377, DOI 10.1093/gerona/54.7.M377; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2015, GLOB STRAT DIAGN MAN; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; Hardy SE, 2005, AM J EPIDEMIOL, V161, P575, DOI 10.1093/aje/kwi083; Hilmer SN, 2009, AUSTRALAS J AGEING, V28, P182, DOI 10.1111/j.1741-6612.2009.00367.x; HOSMER DW, 1989, APPL LOGISTIC REGRES; Inouye SK, 2000, J AM GERIATR SOC, V48, P1697; Jeppesen E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003573.pub2; Jette AM, 2007, J REHABIL MED, V39, P585, DOI 10.2340/16501977-0119; Ram FSF, 2004, BMJ-BRIT MED J, V329, P315, DOI 10.1136/bmj.38159.650347.55; Sager MA, 1998, CLIN GERIATR MED, V14, P669; Schunemann Holger J, 2005, COPD, V2, P81; Tabachnick B. G., 2013, USING MULTIVARIATE S; Turner D, 2010, J CLIN EPIDEMIOL, V63, P28, DOI 10.1016/j.jclinepi.2009.01.024	21	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157377	10.1371/journal.pone.0157377	http://dx.doi.org/10.1371/journal.pone.0157377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KO	27300577	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200042
J	Whittemore, K; Johnston, SA; Sykes, K; Shen, LH				Whittemore, Kurt; Johnston, Stephen Albert; Sykes, Kathryn; Shen, Luhui			A General Method to Discover Epitopes from Sera	PLOS ONE			English	Article							PHAGE-DISPLAY LIBRARIES; ANTIBODY EPITOPES; IDENTIFICATION; MIMOTOPES; IDENTIFY; ANTIGEN; LIGANDS	Antigen-antibody complexes are central players in an effective immune response. However, finding those interactions relevant to a particular disease state can be arduous. Nonetheless many paths to discovery have been explored since deciphering these interactions can greatly facilitate the development of new diagnostics, therapeutics, and vaccines. In silico B cell epitope mapping approaches have been widely pursued, though success has not been consistent. Antibody mixtures in immune sera have been used as handles for biologically relevant antigens, but these and other experimental approaches have proven resource intensive and time consuming. In addition, these methods are often tailored to individual diseases or a specific proteome, rather than providing a universal platform. Most of these methods are not able to identify the specific antibody's epitopes from unknown antigens, such as un-annotated neo antigens in cancer. Alternatively, a peptide library comprised of sequences unrestricted by naturally-found protein space provides for a universal search for mimotopes of an antibody's epitope. Here we present the utility of such a non-natural random sequence library of 10,000 peptides physically addressed on a microarray for mimotope discovery without sequence information of the specific antigen. The peptide arrays were probed with serum from an antigen-immunized rabbit, or alternatively probed with serum pre-absorbed with the same immunizing antigen. With this positive and negative screening scheme, we identified the library-peptides as the mimotopes of the antigen. The unique library peptides were successfully used to isolate antigen-specific antibodies from complete immune serum. Sequence analysis of these peptides revealed the epitopes in the immunized antigen. We present this method as an inexpensive, efficient method for identifying mimotopes of any antibody's targets. These mimotopes should be useful in defining both components of the antigen-antibody complex.	[Whittemore, Kurt; Johnston, Stephen Albert; Sykes, Kathryn; Shen, Luhui] Arizona State Univ, Biodesign Inst, Ctr Innovat Med, 1001 South McAllister Ave, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Shen, LH (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Innovat Med, 1001 South McAllister Ave, Tempe, AZ 85287 USA.	Luhui.Shen@asu.edu			Calviri, LLC	Calviri, LLC	This project was funded by unrestricted funds from Calviri, LLC to Center for Innovations in Medicine.	BILLINGS PB, 1983, P NATL ACAD SCI-BIOL, V80, P7104, DOI 10.1073/pnas.80.23.7104; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Coomber David W J, 2002, Methods Mol Biol, V178, P133; FOLGORI A, 1994, EMBO J, V13, P2236, DOI 10.1002/j.1460-2075.1994.tb06501.x; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Gao XL, 2004, MOL DIVERS, V8, P177, DOI 10.1023/B:MODI.0000036233.58271.25; Halperin RF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000786; Halperin RF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-1; Hueber W, 2005, ARTHRITIS RHEUM-US, V52, P2645, DOI 10.1002/art.21269; Hughes AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040201; Kukreja M, 2013, J PROTEOMICS BIOINFO; Lam Kit S., 1996, Methods (Orlando), V9, P482, DOI 10.1006/meth.1996.0056; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Legutki JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5785; Legutki JB, 2013, P NATL ACAD SCI USA, V110, P18614, DOI 10.1073/pnas.1309390110; Lim HS, 2009, BIOORG MED CHEM LETT, V19, P3866, DOI 10.1016/j.bmcl.2009.03.153; Reineke U, 2002, J IMMUNOL METHODS, V267, P37, DOI 10.1016/S0022-1759(02)00139-4; Restrepo L, 2013, J NEUROIMMUNOL, V254, P154, DOI 10.1016/j.jneuroim.2012.09.014; Richer J, 2015, MOL CELL PROTEOMICS, V14, P136, DOI 10.1074/mcp.M114.043513; Schimmele B, 2005, J MOL BIOL, V352, P229, DOI 10.1016/j.jmb.2005.06.073; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Sykes KF, 2013, TRENDS BIOTECHNOL, V31, P45, DOI 10.1016/j.tibtech.2012.10.012; Usuda S, 1999, J VIROL METHODS, V80, P97, DOI 10.1016/S0166-0934(99)00039-7; Wang LF, 2004, CURR DRUG TARGETS, V5, P1, DOI 10.2174/1389450043490668	24	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157462	10.1371/journal.pone.0157462	http://dx.doi.org/10.1371/journal.pone.0157462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300760	gold, Green Published, Green Submitted			2022-12-27	WOS:000377822200053
J	Yang, AW; Johnson, JD; Fronczak, CM; LaGrange, CA				Yang, Andy W.; Johnson, Justin D.; Fronczak, Carolyn M.; LaGrange, Chad A.			Lunar Phases and Emergency Department Visits for Renal Colic Due to Ureteral Calculus	PLOS ONE			English	Article								Background Urolithiasis affects an estimated 5% of the population and the lifetime risk of passing a stone in the urinary tract is estimated to be 8-10%. Urinary calculus formation is highly variable and while certain risk factors such as age, gender, seasonality, anatomic abnormality, and metabolic diseases have been identified, not much is known regarding the association of environmental factors such as lunar phases on renal colic. We conducted a retrospective study to test the hypothesis that full moon phase is an environmental factor associated for increased emergency department (ED) visits for renal colic due to ureteral calculus. Methods We analyzed 559 renal colic diagnoses by the ED at the University of Nebraska Medical Center in a 24-month period and compared them with corresponding lunar phases as well as supermoon events. The lunar phases were defined as full moon +/- two days, new moon +/- two days, and the days in-between as normal days according to the lunar calendar. Supermoon event dates were obtained from NASA. Results 90 cases (16.1%) were diagnosed during full moon phase, 89 cases (15.9%) were diagnosed during new moon phase, and 380 cases (68.0%) were diagnosed during normal days. The incidence of renal colic showed no statistically significant association with lunar phases or supermoon events. Conclusion In this retrospective longitudinal study with adequate power, neither full moon phase nor supermoon event exhibited an association with increased renal colic diagnoses due to ureteral calculus by the ED at the University of Nebraska Medical Center.	[Yang, Andy W.; Johnson, Justin D.; Fronczak, Carolyn M.; LaGrange, Chad A.] Univ Nebraska Med Ctr, Dept Surg, Div Urol Surg, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Yang, AW (corresponding author), Univ Nebraska Med Ctr, Dept Surg, Div Urol Surg, Omaha, NE USA.	ayang@unmc.edu			University of Nebraska Medical Center Department of Surgery's Summer Research Program	University of Nebraska Medical Center Department of Surgery's Summer Research Program	This study was supported in part by the University of Nebraska Medical Center Department of Surgery's Summer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arampatzis S, 2011, EMERG MED INT, V2011, DOI 10.1155/2011/813460; Asplin JR, 1996, BRENNER RECTORS KIDN; Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200; Barr W, 2000, J Psychosoc Nurs Ment Health Serv, V38, P28; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Chauhan V, 2004, AM J EMERG MED, V22, P560, DOI 10.1016/j.ajem.2004.08.016; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Ghiandoni G, 1998, EUR J OBSTET GYN R B, V77, P47, DOI 10.1016/S0301-2115(97)00226-1; Hermida Perez Jose A., 2010, Archivos Espanoles de Urologia, V63, P173; Kazemi-Bajestani SMR, 2011, ASIAN J PSYCHIATR, V4, P45, DOI 10.1016/j.ajp.2010.12.002; LAW SP, 1986, ACTA OBSTET GYN SCAN, V65, P45, DOI 10.3109/00016348609158228; Molaee Govarchin Ghalae H, 2009, UROLOGY J, V8, P137; NASA, 2014, SOL SYST EXPL; Pamporaki C, 2014, EUR J ENDOCRINOL, V170, P349, DOI 10.1530/EJE-13-0673; Parmar MS, 2004, BMJ-BRIT MED J, V328, P1420, DOI 10.1136/bmj.328.7453.1420; Polychronopoulos P, 2006, NEUROLOGY, V66, P1442, DOI 10.1212/01.wnl.0000210482.75864.e8; Refinetti R, 2015, ANN MED, V47, P530, DOI 10.3109/07853890.2015.1085125; ROBERTSON WG, 1975, CLIN SCI MOL MED, V49, P597, DOI 10.1042/cs0490597; Torricelli FCM, 2014, UROLOGY, V84, P544, DOI 10.1016/j.urology.2014.02.074; Wake R, 2008, ENVIRON HEALTH INSIG, V1, P63	20	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157589	10.1371/journal.pone.0157589	http://dx.doi.org/10.1371/journal.pone.0157589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299307	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200064
J	Jain, V; Srivastava, I; Palchaudhuri, S; Goel, M; Sinha-Mahapatra, SK; Dhingra, NK				Jain, Varsha; Srivastava, Ipsit; Palchaudhuri, Shriya; Goel, Manvi; Sinha-Mahapatra, Sumit K.; Dhingra, Narender K.			Classical Photoreceptors Are Primarily Responsible for the Pupillary Light Reflex in Mouse	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; METHYL-N-NITROSOUREA; ROD-CONE INPUT; MORPHOLOGIC CHARACTERISTICS; SODIUM IODATE; RAT RETINA; MELANOPSIN; MICE; DEGENERATION; VISION	Pupillary light reflex (PLR) is an important clinical tool to assess the integrity of visual pathways. The available evidence suggests that melanopsin-expressing retinal ganglion cells (mRGCs) mediate PLR-driven by the classical photoreceptors (rods and cones) at low irradiances and by melanopsin activation at high irradiances. However, genetic or pharmacological elimination of melanopsin does not completely abolish PLR at high irradiances, raising the possibility that classical photoreceptors may have a role even at high irradiances. Using an inducible mouse model of photoreceptor degeneration, we asked whether classical photoreceptors are responsible for PLR at all irradiances, and found that the PLR was severely attenuated at all irradiances. Using multiple approaches, we show that the residual PLR at high irradiances in this mouse was primarily from the remnant rods and cones, with a minor contribution from melanopsin activation. In contrast, in rd1 mouse where classical photoreceptor degeneration occurs during development, the PLR was absent at low irradiances but intact at high irradiances, as reported previously. Since mRGCs receive inputs from classical photoreceptors, we also asked whether developmental loss of classical photoreceptors as in rd1 mouse leads to compensatory takeover of the high-irradiance PLR by mRGCs. Specifically, we looked at a distinct subpopulation of mRGCs that express Brn3b transcription factor, which has been shown to mediate PLR. We found that rd1 mouse had a significantly higher proportion of Brn3b-expressing M1 type of mRGCs than in the inducible model. Interestingly, inducing classical photoreceptor degeneration during development also resulted in a higher proportion of Brn3b-expressing M1 cells and partially rescued PLR at high irradiances. These results suggest that classical photoreceptors are primarily responsible for PLR at all irradiances, while melanopsin activation makes a minor contribution at very high irradiances.	[Jain, Varsha; Srivastava, Ipsit; Palchaudhuri, Shriya; Goel, Manvi; Sinha-Mahapatra, Sumit K.; Dhingra, Narender K.] Natl Brain Res Ctr, Gurgaon 122051, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Dhingra, NK (corresponding author), Natl Brain Res Ctr, Gurgaon 122051, Haryana, India.	narender.dhingra@gmail.com	Goel, Manvi/T-3148-2019	Goel, Manvi/0000-0003-2049-5605; Palchaudhuri, Shriya/0000-0002-1537-0886; jain, varsha/0000-0002-1620-4177	National Brain Research Centre; Department of Biotechnology, Government of India [BT/PR6410/Med/14/801/2005]	National Brain Research Centre; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by National Brain Research Centre and a grant (BT/PR6410/Med/14/801/2005) from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Brain Research Centre and a grant (BT/PR6410/Med/14/801/2005) from the Department of Biotechnology, Government of India. The authors thank Noga Vardi and Michael Freed for their valuable comments on the manuscript; Kaushik Deka for his assistance in statistical analyses; and Ethiraj Ravindran and Sushma Dagar for their technical assistance.	Aleman TS, 2004, INVEST OPHTH VIS SCI, V45, P1259, DOI 10.1167/iovs.03-1230; Allen AE, 2011, J NEUROSCI, V31, P16833, DOI 10.1523/JNEUROSCI.2505-11.2011; Allen AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015063; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Boudard DL, 2009, EUR J NEUROSCI, V30, P1527, DOI 10.1111/j.1460-9568.2009.06935.x; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Dagar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090250; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Do MTH, 2013, P NATL ACAD SCI USA, V110, P7470, DOI 10.1073/pnas.1304039110; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Enzmann V, 2006, EXP EYE RES, V82, P441, DOI 10.1016/j.exer.2005.08.002; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gerlai R, 2001, BEHAV BRAIN RES, V125, P13, DOI 10.1016/S0166-4328(01)00282-0; Goel M, 2012, NEUROSCIENCE, V225, P152, DOI 10.1016/j.neuroscience.2012.08.066; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; HERROLD KM, 1967, ARCH OPHTHALMOL-CHIC, V78, P650, DOI 10.1001/archopht.1967.00980030652017; Homma K, 2009, J NEUROSCI RES, V87, P2175, DOI 10.1002/jnr.22024; Jain V, 2012, J COMP NEUROL, V520, P742, DOI 10.1002/cne.22765; Jones KA, 2013, NAT CHEM BIOL, V9, P630, DOI [10.1038/NCHEMBIO.1333, 10.1038/nchembio.1333]; Karnas D, 2013, J COMP NEUROL, V521, P912, DOI 10.1002/cne.23210; Kiuchi K, 2003, CURR EYE RES, V26, P355, DOI 10.1076/ceyr.26.5.355.15435; Kiuchi K, 2002, CURR EYE RES, V25, P373, DOI 10.1076/ceyr.25.6.373.14227; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Machalinska A, 2010, NEUROCHEM RES, V35, P1819, DOI 10.1007/s11064-010-0248-6; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; McNeill DS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-8; Nagar S, 2009, NEUROSCIENCE, V160, P517, DOI 10.1016/j.neuroscience.2009.02.056; Nambu H, 1997, PATHOL INT, V47, P377, DOI 10.1111/j.1440-1827.1997.tb04511.x; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P3812, DOI 10.1167/iovs.06-1322; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; Picciotto MR, 1998, PHYSIOL REV, V78, P1131, DOI 10.1152/physrev.1998.78.4.1131; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Ruggiero L, 2009, EUR J NEUROSCI, V29, P359, DOI 10.1111/j.1460-9568.2008.06589.x; Sakamoto K, 2004, J NEUROSCI, V24, P9693, DOI 10.1523/JNEUROSCI.2556-04.2004; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2010, J NEUROSCI, V30, P16262, DOI 10.1523/JNEUROSCI.3656-10.2010; Semo M, 2003, EUR J NEUROSCI, V18, P3007, DOI 10.1111/j.1460-9568.2003.03061.x; Semo M, 2016, INVEST OPHTH VIS SCI, V57, P115, DOI 10.1167/iovs.15-17609; SMITH SB, 1986, EXP EYE RES, V43, P791, DOI 10.1016/S0014-4835(86)80010-0; Szikra T, 2014, NAT NEUROSCI, V17, P1728, DOI 10.1038/nn.3852; Thompson S, 2008, INVEST OPHTH VIS SCI, V49, P2737, DOI 10.1167/iovs.07-1546; Thompson S, 2011, INVEST OPHTH VIS SCI, V52, P618, DOI 10.1167/iovs.10-6146; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Vugler A, 2015, NEUROSCIENCE, V286, P60, DOI 10.1016/j.neuroscience.2014.11.044; Wan J, 2006, NEUROSCI LETT, V400, P48, DOI 10.1016/j.neulet.2006.02.084; Weng SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066480; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Zhao XW, 2014, J PHYSIOL-LONDON, V592, P1619, DOI 10.1113/jphysiol.2013.262782	60	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157226	10.1371/journal.pone.0157226	http://dx.doi.org/10.1371/journal.pone.0157226			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295136	gold, Green Published, Green Submitted			2022-12-27	WOS:000377821300028
J	Lopez-Villamizar, I; Cabezas, A; Pinto, RM; Canales, J; Ribeiro, JM; Cameselle, JC; Costas, MJ				Lopez-Villamizar, Iralis; Cabezas, Alicia; Maria Pinto, Rosa; Canales, Jose; Meireles Ribeiro, Joao; Carlos Cameselle, Jose; Jesus Costas, Maria			The Characterization of Escherichia coli CpdB as a Recombinant Protein Reveals that, besides Having the Expected 3 '-Nucleotidase and 2 ',3 '-Cyclic Mononucleotide Phosphodiesterase Activities, It Is Also Active as Cyclic Dinucleotide Phosphodiesterase	PLOS ONE			English	Article							C-DI-AMP; GMP-SPECIFIC PHOSPHODIESTERASE; DIPHOSPHATE-SUGAR HYDROLASE; ENTERICA SEROVAR PULLORUM; AFFECT BACTERIAL-GROWTH; MYCOBACTERIUM-TUBERCULOSIS; 3-NUCLEOTIDASE ACTIVITY; ACETOBACTER-XYLINUM; CELLULOSE SYNTHESIS; BACILLUS-SUBTILIS	Endogenous cyclic diadenylate phosphodiesterase activity was accidentally detected in lysates of Escherichia coli BL21. Since this kind of activity is uncommon in Gram-negative bacteria, its identification was undertaken. After partial purification and analysis by denaturing gel electrophoresis, renatured activity correlated with a protein identified by fingerprinting as CpdB (cpdB gene product), which is annotated as 3'-nucleotidase / 2',3'-cyclic-mononucleotide phosphodiesterase, and it is synthesized as a precursor protein with a signal sequence removable upon export to the periplasm. It has never been studied as a recombinant protein. The coding sequence of mature CpdB was cloned and expressed as a GST fusion protein. The study of the purified recombinant protein, separated from GST, confirmed CpdB annotation. The assay of catalytic efficiencies (kcat/Km) for a large substrate set revealed novel CpdB features, including very high efficiencies for 3'-AMP and 2',3'-cyclic mononucleotides, and previously unknown activities on cyclic and linear dinucleotides. The catalytic efficiencies of the latter activities, though low in relative terms when compared to the major ones, are far from negligible. Actually, they are perfectly comparable to those of the 'average' enzyme and the known, bona fide cyclic dinucleotide phosphodiesterases. On the other hand, CpdB differs from these enzymes in its extracytoplasmic location and in the absence of EAL, HD and DHH domains. Instead, it contains the domains of the 5'-nucleotidase family pertaining to the metallophosphoesterase superfamily, although CpdB lacks 5'-nucleotidase activity. The possibility that the extracytoplasmic activity of CpdB on cyclic dinucleotides could have physiological meaning is discussed.	[Lopez-Villamizar, Iralis; Cabezas, Alicia; Maria Pinto, Rosa; Canales, Jose; Meireles Ribeiro, Joao; Carlos Cameselle, Jose; Jesus Costas, Maria] Univ Extremadura, Grp Enzimol, Dept Bioquim & Biol Mol & Genet, Fac Med, Badajoz, Spain	Universidad de Extremadura	Costas, MJ (corresponding author), Univ Extremadura, Grp Enzimol, Dept Bioquim & Biol Mol & Genet, Fac Med, Badajoz, Spain.	macostas@unex.es	Costas, Maria Jesus/K-7394-2014; Ribeiro, João Meireles/K-6555-2014; Cameselle, Jose Carlos/K-6421-2014; Canales, Jose/K-8793-2014; Pinto, Rosa M/K-6560-2014; Cabezas, Alicia/K-6564-2014	Costas, Maria Jesus/0000-0001-8815-1839; Ribeiro, João Meireles/0000-0002-6548-1402; Cameselle, Jose Carlos/0000-0003-0005-081X; Canales, Jose/0000-0002-7897-9832; Pinto, Rosa M/0000-0003-4594-8113; Cabezas, Alicia/0000-0002-2908-9147	Gobierno de Extremadura or Junta de Extremadura - Fondo Europeo de Desarrollo Regional [GR10133, GR15143];  [2015/00481/001]	Gobierno de Extremadura or Junta de Extremadura - Fondo Europeo de Desarrollo Regional; 	Research in the authors' laboratory is supported by grants from the Gobierno de Extremadura or Junta de Extremadura cofinanced by Fondo Europeo de Desarrollo Regional (GR10133 and GR15143), and by a private donation from MJC (contract 2015/00481/001). The institutional funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, while the private donor is one of the authors.	Alves-Pereira I, 2008, J BACTERIOL, V190, P6153, DOI 10.1128/JB.00658-08; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Anantharaman V, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-34; ANDERSON BM, 1985, J GEN MICROBIOL, V131, P2041; ANRAKU Y, 1964, J BIOL CHEM, V239, P3412; ANRAKU Y, 1964, J BIOL CHEM, V239, P3420; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Bar-Even A, 2015, BIOCHEMISTRY-US, V54, P4969, DOI 10.1021/acs.biochem.5b00621; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; BEACHAM IR, 1980, J GEN MICROBIOL, V119, P31; BEACHAM IR, 1973, J BACTERIOL, V116, P957, DOI 10.1128/JB.116.2.957-964.1973; Bellini D, 2014, MOL MICROBIOL, V91, P26, DOI 10.1111/mmi.12447; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; CENTER MS, 1968, J BIOL CHEM, V243, P138; Chambert R, 2003, J BIOCHEM, V134, P655, DOI 10.1093/jb/mvg189; Chao L, 2013, J BACTERIOL, V195, P3827, DOI 10.1128/JB.00498-13; Cho KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069425; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Commichau FM, 2015, MOL MICROBIOL, V97, P189, DOI 10.1111/mmi.13026; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Dey B, 2014, SEMIN IMMUNOL, V26, P486, DOI 10.1016/j.smim.2014.09.002; Fehrst A, 1998, A GUIDE TO ENZYME CA; Galan JE, 1996, MOL MICROBIOL, V20, P263, DOI 10.1111/j.1365-2958.1996.tb02615.x; Gandara C, 2015, DNA REPAIR, V27, P1, DOI 10.1016/j.dnarep.2014.12.007; GLASER L, 1967, J BIOL CHEM, V242, P1944; Gomelsky M, 2010, THE SECOND MESSENGER, P37; Hames BD., 1990, GEL ELECTROPHORESIS, P1; Hengge R, 2016, J BACTERIOL, V198, P15, DOI 10.1128/JB.00331-15; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Huynh TN, 2015, P NATL ACAD SCI USA, V112, pE747, DOI 10.1073/pnas.1416485112; Kakehi M, 2007, J MOL MICROB BIOTECH, V13, P96, DOI 10.1159/000103601; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Lee HS, 2010, INFECT IMMUN, V78, P1832, DOI 10.1128/IAI.00446-09; Liu HF, 2015, MICROB PATHOGENESIS, V80, P21, DOI 10.1016/j.micpath.2015.01.002; LIU J, 1986, J BACTERIOL, V165, P1002, DOI 10.1128/jb.165.3.1002-1010.1986; Lovering AL, 2011, MBIO, V2, DOI 10.1128/mBio.00163-11; Luo YP, 2012, J FISH BIOL, V80, P842, DOI 10.1111/j.1095-8649.2012.03229.x; Manikandan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086096; McDonough E, 2016, MOL MICROBIOL, V99, P453, DOI 10.1111/mmi.13128; Miner KD, 2013, BIOCHEMISTRY-US, V52, P5329, DOI 10.1021/bi4009215; NEU HC, 1968, BIOCHEMISTRY-US, V7, P3774, DOI 10.1021/bi00850a060; NEU HC, 1968, J BACTERIOL, V95, P1732, DOI 10.1128/JB.95.5.1732-1737.1968; NEU HC, 1967, J BIOL CHEM, V242, P3896; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Peng X, 2016, MOL MICROBIOL, V99, P945, DOI 10.1111/mmi.13277; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2010, BIOCHEM BIOPH RES CO, V398, P500, DOI 10.1016/j.bbrc.2010.06.107; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; RODDEN JL, 1972, ARCH BIOCHEM BIOPHYS, V153, P837, DOI 10.1016/0003-9861(72)90406-7; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; ROSS P, 1990, J BIOL CHEM, V265, P18933; RUIZ A, 1989, J BACTERIOL, V171, P6703, DOI 10.1128/jb.171.12.6703-6709.1989; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Savage CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125440; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; SHIMADA K, 1969, BIOCHIM BIOPHYS ACTA, V185, P367, DOI 10.1016/0005-2744(69)90430-6; Stelitano V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074920; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sundriyal A, 2014, J BIOL CHEM, V289, P6978, DOI 10.1074/jbc.M113.516195; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tang Q, 2015, INT J BIOL SCI, V11, P813, DOI 10.7150/ijbs.11797; Trulzsch K, 2001, MICROBIOL-UK, V147, P203; Tschowri N, 2016, J BACTERIOL, V198, P47, DOI 10.1128/JB.00423-15; Huynh TN, 2016, CURR OPIN MICROBIOL, V30, P22, DOI 10.1016/j.mib.2015.12.007; UNEMOTO T, 1969, BIOCHIM BIOPHYS ACTA, V171, P89, DOI 10.1016/0005-2744(69)90108-9; Wigley P, 2001, INFECT IMMUN, V69, P7873, DOI 10.1128/IAI.69.12.7873-7879.2001; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; YAGIL E, 1975, J BACTERIOL, V121, P401, DOI 10.1128/JB.121.2.401-405.1975; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14	86	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157308	10.1371/journal.pone.0157308	http://dx.doi.org/10.1371/journal.pone.0157308			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294396	gold, Green Submitted, Green Published			2022-12-27	WOS:000377821300033
J	Ries, AJ; Touryan, J; Ahrens, B; Connolly, P				Ries, Anthony J.; Touryan, Jon; Ahrens, Barry; Connolly, Patrick			The Impact of Task Demands on Fixation-Related Brain Potentials during Guided Search	PLOS ONE			English	Article							EEG; ONSET; COMPONENT; ERPS; LOAD	Recording synchronous data from EEG and eye-tracking provides a unique methodological approach for measuring the sensory and cognitive processes of overt visual search. Using this approach we obtained fixation related potentials (FRPs) during a guided visual search task specifically focusing on the lambda and P3 components. An outstanding question is whether the lambda and P3 FRP components are influenced by concurrent task demands. We addressed this question by obtaining simultaneous eye-movement and electroencephalographic (EEG) measures during a guided visual search task while parametrically modulating working memory load using an auditory N-back task. Participants performed the guided search task alone, while ignoring binaurally presented digits, or while using the auditory information in a 0, 1, or 2-back task. The results showed increased reaction time and decreased accuracy in both the visual search and N-back tasks as a function of auditory load. Moreover, high auditory task demands increased the P3 but not the lambda latency while the amplitude of both lambda and P3 was reduced during high auditory task demands. The results show that both early and late stages of visual processing indexed by FRPs are significantly affected by concurrent task demands imposed by auditory working memory.	[Ries, Anthony J.; Touryan, Jon] US Army Res Lab, Human Res & Engn Directorate, Aberdeen Proving Ground, MD USA; [Ahrens, Barry] Nova SE Univ, Coll Engn & Comp, Ft Lauderdale, FL 33314 USA; [Connolly, Patrick] Teledyne Sci Co, Durham, NC USA	United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); Nova Southeastern University	Ries, AJ (corresponding author), US Army Res Lab, Human Res & Engn Directorate, Aberdeen Proving Ground, MD USA.	anthony.j.ries2.civ@mail.mil	Touryan, Jonathan/AAA-7108-2019	Touryan, Jonathan/0000-0001-7343-7869	U.S. Army Prime [W911NF-09-D-0001]	U.S. Army Prime	U.S. Army Prime Contract No. W911NF-09-D-0001. The funder provided support in the form of salaries for authors [BA and PC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors would like to thank Steve Simons and David Kowachek for their valuable feedback on the manuscript. This research was supported by U.S. Army Prime Contract No. W911NF-09-D-0001.	ARMINGTON JC, 1974, J OPT SOC AM, V64, P1263, DOI 10.1364/JOSA.64.001263; BARLOW JS, 1969, ELECTROEN CLIN NEURO, V26, P183, DOI 10.1016/0013-4694(69)90209-0; BILLINGS RJ, 1989, ELECTROEN CLIN NEURO, V72, P95, DOI 10.1016/0013-4694(89)90170-3; Brouwer AM, 2013, J VISION, V13, DOI 10.1167/13.3.17; Dandekar S, 2012, J NEUROPHYSIOL, V107, P1776, DOI 10.1152/jn.00237.2011; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Devillez H, 2015, J VISION, V15, DOI 10.1167/15.13.20; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Dimigen O, 2011, J EXP PSYCHOL GEN, V140, P552, DOI 10.1037/a0023885; Dimigen O, 2009, J NEUROSCI, V29, P12321, DOI 10.1523/JNEUROSCI.0911-09.2009; Drews FA, 2008, J EXP PSYCHOL-APPL, V14, P392, DOI 10.1037/a0013119; Eckstein MP, 2011, J VISION, V11, DOI 10.1167/11.5.14; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; GAARDER K, 1964, SCIENCE, V146, P1481, DOI 10.1126/science.146.3650.1481; Gherri E, 2011, J COGNITIVE NEUROSCI, V23, P832, DOI 10.1162/jocn.2010.21468; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Handy TC, 2001, PSYCHOL SCI, V12, P213, DOI 10.1111/1467-9280.00338; HANSEN JC, 1980, ELECTROEN CLIN NEURO, V49, P277, DOI 10.1016/0013-4694(80)90222-9; Hickey C, 2009, J COGNITIVE NEUROSCI, V21, P760, DOI 10.1162/jocn.2009.21039; Kahneman D., 1973, ATTENTION EFFORT; Kasper RW, 2014, J COGNITIVE NEUROSCI, V26, P476, DOI 10.1162/jocn_a_00480; Kaunitz LN, 2014, NEUROIMAGE, V89, P297, DOI 10.1016/j.neuroimage.2013.12.006; Kazai K, 2005, INT CONGR SER, V1278, P61, DOI 10.1016/j.ics.2004.11.053; Kazai K, 1999, INT J PSYCHOPHYSIOL, V32, P193, DOI 10.1016/S0167-8760(99)00010-0; Kazai K, 2003, COGN AFFECT BEHAV NE, V3, P46, DOI 10.3758/CABN.3.1.46; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P1013, DOI 10.1111/j.1469-8986.2008.00700.x; Klemen J, 2010, J COGNITIVE NEUROSCI, V22, P437, DOI 10.1162/jocn.2009.21204; Li FL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15129; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Luck S.J., 2005, INTRO EVENT RELATED; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Marathe AR, 2014, IEEE T NEUR SYS REH, V22, P201, DOI 10.1109/TNSRE.2014.2304884; MARTON M, 1982, STUD PSYCHOL, V24, P165; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; Morimoto CH, 2005, COMPUT VIS IMAGE UND, V98, P4, DOI 10.1016/j.cviu.2004.07.010; Nikolaev AR, 2011, NEUROIMAGE, V56, P1598, DOI 10.1016/j.neuroimage.2011.03.021; Plochl M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00278; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pratt N, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00057; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Rajkai C, 2008, CEREB CORTEX, V18, P200, DOI 10.1093/cercor/bhm046; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Simola J, 2015, NEUROIMAGE, V106, P21, DOI 10.1016/j.neuroimage.2014.11.030; Sorqvist P, 2012, J COGNITIVE NEUROSCI, V24, P2147; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Takeda Y., 2012, KANSEI ENG INT J, V11, P121, DOI DOI 10.5057/KEI.11.121; THICKBROOM GW, 1991, BRAIN RES, V551, P150, DOI 10.1016/0006-8993(91)90927-N; Tian Y, 2013, PSYCHOPHYSIOLOGY, V50, P1282, DOI 10.1111/psyp.12130; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Wickens C. D., 2002, THEORETICAL ISSUES E, V3, P159, DOI [10.1080/14639220210123806, DOI 10.1080/14639220210123806]; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x; YAGI A, 1981, ELECTROEN CLIN NEURO, V52, P604, DOI 10.1016/0013-4694(81)91434-6; YAGI A, 1979, PHYSIOL PSYCHOL, V7, P370; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	55	17	17	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157260	10.1371/journal.pone.0157260	http://dx.doi.org/10.1371/journal.pone.0157260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286248	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000051
J	Apostolov, A; Litim-Mecheri, I; Oravecz, A; Goepp, M; Kirstetter, P; Marchal, P; Ittel, A; Mauvieux, L; Chan, S; Kastner, P				Apostolov, Apostol; Litim-Mecheri, Isma; Oravecz, Attila; Goepp, Marie; Kirstetter, Peggy; Marchal, Patricia; Ittel, Antoine; Mauvieux, Laurent; Chan, Susan; Kastner, Philippe			Sumoylation Inhibits the Growth Suppressive Properties of Ikaros	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DNA-BINDING PROTEINS; SUMO-1 MODIFICATION; TRANSCRIPTIONAL ACTIVITY; CELL-LINE; T-CELLS; ACTIVATION; PHOSPHORYLATION; LOCALIZATION; TRANSITION	The Ikaros transcription factor is a tumor suppressor that is also important for lymphocyte development. How post-translational modifications influence Ikaros function remains partially understood. We show that Ikaros undergoes sumoylation in developing T cells that correspond to mono-, bi- or poly-sumoylation by SUMO1 and/or SUMO2/3 on three lysine residues (K58, K240 and K425). Sumoylation occurs in the nucleus and requires DNA binding by Ikaros. Sumoylated Ikaros is less effective than unsumoylated forms at inhibiting the expansion of murine leukemic cells, and Ikaros sumoylation is abundant in human B-cell acute lymphoblastic leukemic cells, but not in healthy peripheral blood leukocytes. Our results suggest that sumoylation may be important in modulating the tumor suppressor function of Ikaros.	[Apostolov, Apostol; Litim-Mecheri, Isma; Oravecz, Attila; Goepp, Marie; Kirstetter, Peggy; Marchal, Patricia; Chan, Susan; Kastner, Philippe] Univ Strasbourg, CNRS UMR 7104, INSERM U964, IGBMC, F-67404 Illkirch Graffenstaden, France; [Ittel, Antoine; Mauvieux, Laurent] Hop Univ Strasbourg, Hematol Lab, Strasbourg, France; [Ittel, Antoine; Mauvieux, Laurent] Univ Strasbourg, Fac Med Strasbourg, Federat Med Translat Strasbourg, Inst Hematol & Immunol,Lab Hematol Cellulaire,EA, Strasbourg, France; [Kastner, Philippe] Univ Strasbourg, Fac Med, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kastner, P (corresponding author), Univ Strasbourg, CNRS UMR 7104, INSERM U964, IGBMC, F-67404 Illkirch Graffenstaden, France.; Kastner, P (corresponding author), Univ Strasbourg, Fac Med, Strasbourg, France.	scpk@igbmc.fr	Kirstetter, Peggy/I-9582-2016	Kirstetter, Peggy/0000-0001-7592-8004; APOSTOLOV, Apostol/0000-0002-8825-582X; Goepp, Marie/0000-0003-1659-5689; ITTEL, Antoine/0000-0001-5067-575X; Mauvieux, Laurent/0000-0002-9043-1845	Agence Nationale de la Recherche [ANR-11-BSV3-018]; Ligue Nationale contre le Cancer (equipe labellisee); Conference de Coordination Inter-Regionale du Grand-Est of the Ligue contre le Cancer [173AC.2012]; INSERM, CNRS, University of Strasbourg; Ministry of Research and Technology; Fondation ARC; Institut National du Cancer; Fondation pour la Recherche Medicale;  [ANR-10-LABX-0030-INRT]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Nationale contre le Cancer (equipe labellisee)(Ligue nationale contre le cancer); Conference de Coordination Inter-Regionale du Grand-Est of the Ligue contre le Cancer; INSERM, CNRS, University of Strasbourg; Ministry of Research and Technology(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Fondation ARC; Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); 	This work was supported by the Agence Nationale de la Recherche (ANR-11-BSV3-018), the Ligue Nationale contre le Cancer (equipe labellisee 2006-2012 and 2015-2017), the Conference de Coordination Inter-Regionale du Grand-Est of the Ligue contre le Cancer (#173AC.2012 to PK) and institutional funds from INSERM, CNRS, University of Strasbourg and the ANR-10-LABX-0030-INRT grant. A.A. received a pre-doctoral fellowship from the Ministry of Research and Technology. I.L-M. received a post-doctoral fellowship from the Fondation ARC. A.O. received post-doctoral fellowships from the Institut National du Cancer and the Fondation pour la Recherche Medicale.	Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Druker J, 2013, MOL CELL BIOL, V33, P2116, DOI 10.1128/MCB.01470-12; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; FINDLEY HW, 1982, BLOOD, V60, P1305; Geimer Le Lay AS, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004545; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; GRAMATZKI M, 1985, CANCER, V55, P77, DOI 10.1002/1097-0142(19850101)55:1<77::AID-CNCR2820550113>3.0.CO;2-A; Gurel Z, 2008, J BIOL CHEM, V283, P8291, DOI 10.1074/jbc.M707906200; Kastner P, 2013, AM J BLOOD RES, V3, P1; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Ke QD, 2008, TOXICOL APPL PHARM, V228, P190, DOI 10.1016/j.taap.2007.12.015; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim KI, 2002, J CELL PHYSIOL, V191, P257, DOI 10.1002/jcp.10100; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Myatt SS, 2014, ONCOGENE, V33, P4316, DOI 10.1038/onc.2013.546; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; OKABE M, 1987, BLOOD, V69, P990; Oravecz A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9823; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rosonina E, 2012, GENE DEV, V26, P350, DOI 10.1101/gad.184689.111; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Uckun FM, 2012, P NATL ACAD SCI USA, V109, P18072, DOI 10.1073/pnas.1209828109; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204	30	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157767	10.1371/journal.pone.0157767	http://dx.doi.org/10.1371/journal.pone.0157767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315244	Green Published, Green Submitted, gold			2022-12-27	WOS:000378030000053
J	Schubring-Giese, M; Leemburg, S; Luft, AR; Hosp, JA				Schubring-Giese, Maximilian; Leemburg, Susan; Luft, Andreas Rudiger; Hosp, Jonas Aurel			Protein Synthesis Inhibition in the Peri-Infarct Cortex Slows Motor Recovery in Rats	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; STROKE; PLASTICITY; REORGANIZATION; STIMULATION; MAINTENANCE; MECHANISMS; ANISOMYCIN; DEPENDS; MODELS	Neuroplasticity and reorganization of brain motor networks are thought to enable recovery of motor function after ischemic stroke. Especially in the cortex surrounding the ischemic scar (i.e., peri-infarct cortex), evidence for lasting reorganization has been found at the level of neurons and networks. This reorganization depends on expression of specific genes and subsequent protein synthesis. To test the functional relevance of the peri-infarct cortex for recovery we assessed the effect of protein synthesis inhibition within this region after experimental stroke. Long-Evans rats were trained to perform a skilled-reaching task (SRT) until they reached plateau performance. A photothrombotic stroke was induced in the forelimb representation of the primary motor cortex (M1) contralateral to the trained paw. The SRT was re-trained after stroke while the protein synthesis inhibitor anisomycin (ANI) or saline were injected into the peri-infarct cortex through implanted cannulas. ANI injections reduced protein synthesis within the peri-infarct cortex by 69% and significantly impaired recovery of reaching performance through re-training. Improvement of motor performance within a single training session remained intact, while improvement between training sessions was impaired. ANI injections did not affect infarct size. Thus, protein synthesis inhibition within the peri-infarct cortex impairs recovery of motor deficits after ischemic stroke by interfering with consolidation of motor memory between training sessions but not short-term improvements within one session.	[Schubring-Giese, Maximilian; Leemburg, Susan; Luft, Andreas Rudiger; Hosp, Jonas Aurel] Univ & Univ Hosp Zurich, Dept Neurol, Div Vasc Neurol & Rehabil, Zurich, Switzerland; [Luft, Andreas Rudiger] Cereneo Ctr Neurol & Rehabil, Vitznau, Switzerland; [Luft, Andreas Rudiger] Johns Hopkins Univ, Dept Neurol, 1550 Orleans St, Baltimore, MD 21231 USA	University of Zurich; University Zurich Hospital; Johns Hopkins University	Luft, AR (corresponding author), Univ & Univ Hosp Zurich, Dept Neurol, Div Vasc Neurol & Rehabil, Zurich, Switzerland.; Luft, AR (corresponding author), Cereneo Ctr Neurol & Rehabil, Vitznau, Switzerland.; Luft, AR (corresponding author), Johns Hopkins Univ, Dept Neurol, 1550 Orleans St, Baltimore, MD 21231 USA.	andreas.luft@uzh.ch		/0000-0002-7949-4044	Swiss National Science Foundation (SNF, NCCR Neuro); P & K Puhringer Foundation	Swiss National Science Foundation (SNF, NCCR Neuro)(Swiss National Science Foundation (SNSF)); P & K Puhringer Foundation	Funding came from the Swiss National Science Foundation (SNF, NCCR Neuro) and the P & K Puhringer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; BISBY MA, 1992, MOL NEUROBIOL, V6, P107, DOI 10.1007/BF02780547; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Brown CE, 2010, J CEREBR BLOOD F MET, V30, P783, DOI 10.1038/jcbfm.2009.241; Buitrago MM, 2004, BEHAV BRAIN RES, V155, P249, DOI 10.1016/j.bbr.2004.04.025; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Carr J., 1987, A MOTOR RELEARNING P; Cramer SC, 2006, STROKE, V37, P111, DOI 10.1161/01.STR.0000195135.70379.1f; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Eisner-Janowicz I, 2008, J NEUROPHYSIOL, V100, P1498, DOI 10.1152/jn.90447.2008; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Hagemann G, 1998, ANN NEUROL, V44, P255, DOI 10.1002/ana.410440217; Hong SS, 2007, BRAIN RES, V1149, P76, DOI 10.1016/j.brainres.2007.02.062; Hosp JA, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/871296; Kawai R, 2015, NEURON, V86, P800, DOI 10.1016/j.neuron.2015.03.024; Lehane C, 2013, J PHARMACOL EXP THER, V347, P781, DOI 10.1124/jpet.113.205989; Luft AR, 2004, LEARN MEMORY, V11, P379, DOI 10.1101/lm.72604; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Molina-Luna K, 2007, J NEUROSCI METH, V161, P118, DOI 10.1016/j.jneumeth.2006.10.025; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schubring-Giese M, 2007, EXP BRAIN RES, V181, P359, DOI 10.1007/s00221-007-0930-3; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Smith JB, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00004; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; Zeiler SR, 2013, CURR OPIN NEUROL, V26, P609, DOI 10.1097/WCO.0000000000000025; Zeiler SR, 2013, STROKE, V44, P483, DOI 10.1161/STROKEAHA.112.676940; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157859	10.1371/journal.pone.0157859	http://dx.doi.org/10.1371/journal.pone.0157859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314672	Green Accepted, gold, Green Published			2022-12-27	WOS:000378030000060
J	Alwan, N; Esmaeili, HR; Krupp, F				Alwan, Nisreen; Esmaeili, Hamid-Reza; Krupp, Friedhelm			Molecular Phylogeny and Zoogeography of the Capoeta damascina Species Complex (Pisces: Teleostei: Cyprinidae)	PLOS ONE			English	Article							RIVER; FISH; SEQUENCE; CARP; DNA	Capoeta damascina was earlier considered by many authors as one of the most common freshwater fish species found throughout the Levant, Mesopotamia, Turkey, and Iran. However, owing to a high variation in morphological characters among and within its various populations, 17 nominal species were described, several of which were regarded as valid by subsequent revising authors. Capoeta damascina proved to be a complex of closely related species, which had been poorly studied. The current study aims at defining C. damascina and the C. damascina species complex. It investigates phylogenetic relationships among the various members of the C. damascina complex, based on mitochondrial and nuclear DNA sequences. Phylogenetic relationships were projected against paleogeographical events to interpret the geographic distribution of the taxa under consideration in relation to the area's geological history. Samples were obtained from throughout the geographic range and were subjected to genetic analyses, using two molecular markers targeting the mitochondrial cytochrome oxidase I (n = 103) and the two adjacent divergence regions (D1-D2) of the nuclear 28S rRNA genes (n = 65). Six closely related species were recognized within the C. damascina complex, constituting two main lineages: A western lineage represented by C. caelestis, C. damascina, and C. umbla and an eastern lineage represented by C. buhsei, C. coadi, and C. saadii. The results indicate that speciation of these taxa is rather a recent event. Dispersal occurred during the Pleistocene, resulting in present-day distribution patterns. A coherent picture of the phylogenetic relationships and evolutionary history of the C. damascina species complex is drawn, explaining the current patterns of distribution as a result of paleogeographic events and ecological adaptations.	[Alwan, Nisreen; Krupp, Friedhelm] Senckenberg Res Inst, D-60325 Frankfurt, Germany; [Alwan, Nisreen; Krupp, Friedhelm] Museum Nat, D-60325 Frankfurt, Germany; [Alwan, Nisreen] Modern Univ Business & Sci, Sch Hlth Sci, POB 113-7501, Beirut, Lebanon; [Esmaeili, Hamid-Reza] Shiraz Univ, Dept Biol, Coll Sci, Shiraz 71454, Iran; [Krupp, Friedhelm] Qatar Museums Author, Qatar Nat Hist Museum, POB 2777, Doha, Qatar	Senckenberg Gesellschaft fur Naturforschung (SGN); Shiraz University; Qatar Museums	Alwan, N (corresponding author), Senckenberg Res Inst, D-60325 Frankfurt, Germany.; Alwan, N (corresponding author), Museum Nat, D-60325 Frankfurt, Germany.; Alwan, N (corresponding author), Modern Univ Business & Sci, Sch Hlth Sci, POB 113-7501, Beirut, Lebanon.	alwan.nisreen@gmail.com	Esmaeili, Hamid Reza/AAT-7368-2020	Esmaeili, Hamid Reza/0000-0002-9736-397X; Alwan, Nisreen/0000-0002-3307-4730	Shiraz University [SU-909789]; German Academic Exchange Service (DAAD)	Shiraz University; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The research work in Iran was funded by Shiraz University (SU-909789) and by the German Academic Exchange Service (DAAD) and was approved by the Ethics Committee of Biology Department (SU-909789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the German Academic Exchange Service (DAAD) for supporting all field research in the Levant and Iran carried out for this study in the framework of the project "Establishment of a Middle Eastern Biodiversity Network". Many thanks are also due to our colleagues at the Grunelius-Mollgaard Laboratory for Molecular Evolution Research and the LOEWE Biodiversity and Climate Research Centre (BiK-F), Germany for support and granting access to their facilities. We would like to thank Kai Borkenhagen, Florian Wicker, Nadia Manasfi, Mehdi Ghanbari Fardi, Abbas Kazemi, Mohammed Abdel Sater, Masoumeh Malek, Alireza Sari, Michel Bariche, Zuhair Amr, and Adwan Shehab for vital support during field research. The first author wishes to thank Michel Bariche and Jorg Freyhof for providing samples, and the latter as well as Kai Borkenhagen, Tilman Alpermann and Florian Wicker for stimulating valuable discussions throughout the course of this work.	Abdoli A, 2000, INLAND WATER FISHES; Alwan N, 2011, THESIS; Alwan NH, 2016, ZOOKEYS, P155, DOI 10.3897/zookeys.572.7377; AMERY HA, 1993, GEOGR REV, V83, P229, DOI 10.2307/215726; Banarescu P. M, 1999, FRESHWATER FISHES 1; Banister K.K., 1980, Monographiae Biologicae, V38, P95; Barrois T., 1894, Revue Biologique du Nord de la France, Vvi, P224; Berberian M, 1999, B SEISMOL SOC AM, V89, P120; BIANCO P G, 1982, Cybium, V6, P75; Bobek H., 1963, CHANGES CLIMATE, P403; Bobek H., 1959, FEATURES FORMATION G; BUTZER KW, 1961, HISTORY LAND USE ARI, P31; CHANG YS, 1994, J MOL EVOL, V38, P138, DOI 10.1007/BF00166161; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coad B.W., 1987, Beihefte zum Tuebinger Atlas des Vorderen Orients Reihe A Naturwissenschaften, P213; Coad B.W., 1991, Syllogeus, P1; Coad B.W., 1996, Publicaciones Especiales Instituto Espanol de Oceanografia, V21, P63; Coad B.W., 2010, FRESHWATER FISHES IR; Coad B. W., 2008, FISHES TEHRAN PROVIN; Coad Brian W., 1995, Acta Scientiarum Naturalium Academiae Scientiarum Bohemicae Brno, V29, P1; Cuvier G, 1842, HIST NATURELLE POISS, V16, P1; Cuvier G, 1844, HIST NATURELLE POISO, V17, P1; de Vaumas E., 1957, B SOC GEOGR EGYPT, V30, P97; Durand JD, 2002, MOL PHYLOGENET EVOL, V22, P91, DOI 10.1006/mpev.2001.1040; Esmaeili H. R., 2010, ZOOSYSTEMATICA ROSSICA, V19, P361; Esmaeili Hamid Reza, 2016, FishTaxa-Journal of Fish Taxonomy, V1, P35, DOI 10.7508/jft.2016.01.005; Gruvel A., 1931, ETATS SYRIE RICHESSE; Hanko B., 1924, Annales Historico Naturales Musei Nationalis Hungarici, V21, P137; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heckel J.J., 1849, REISEN EUROPA ASIEN, V2, P255; Heckel JJ., 1843, ABBILDUNGEN BESCHREI; Horowitz A, 1979, QUATERNARY ISRAEL, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KARAMAN M S, 1969, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V66, P17; Kassler P, 1973, PERSIAN GULF, P11, DOI DOI 10.1007/978-3-642-65545-6_2; KESSLER KF, 1877, T ARALO KASPIISKOI E, V4, P1; Kinzelbach R., 1987, P S FAUN ZOOG MIDDL, P41; Kinzelbach R, 1980, NAT MUS, V110, P9; Krinsley DB, 1970, GEOMORPHOLOGICAL PAL, P1; Krupp F., 1987, Beihefte zum Tuebinger Atlas des Vorderen Orients Reihe A Naturwissenschaften, P229; Krupp F., 1985, THESIS; Kucuk F, 2009, ZOOL MIDDLE EAST, V47, P71; Levin BA, 2012, MOL PHYLOGENET EVOL, V62, P542, DOI 10.1016/j.ympev.2011.09.004; MIR S, 1988, J FISH BIOL, V32, P931, DOI 10.1111/j.1095-8649.1988.tb05436.x; Mitchell R. C., 1959, GEOL RUNDSCH, V46, P476; Nylander JAA, 2004, MRMODELTEST V2 2 PRO, P1; Ozulug M, 2008, ICHTHYOL EXPLOR FRES, V19, P289; PIETSCHMANN VIKTOR, 1933, AKAD WISS WIEN MATH NAT KL ANZ, V70, P21; Por F.D, 1989, LEGACY TETHYS AQUATI, P1; Rozen S, 2000, Methods Mol Biol, V132, P365; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Schoter C, 2009, ICHTHYOL EXPLOR FRES, V20, P229; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; STEINITZ H., 1957, BULL RES COUNC ISRAEL SECT B BIOL AND MED, V6, P176; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAKIN M, 1972, NATURE, V235, P147, DOI 10.1038/235147a0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsigenopoulos CS, 2003, BIOL J LINN SOC, V80, P207, DOI 10.1046/j.1095-8312.2003.00237.x; Turan Cemal, 2008, Acta Zoologica Cracoviensia Ser. A - Vertebrata, V51A, P1, DOI 10.3409/azc.51a_1-2.1-14; Turan D, 2006, ICHTHYOL EXPLOR FRES, V17, P147; Turan D, 2008, ICHTHYOL EXPLOR FRES, V19, P263; Vera MI, 1997, COMP BIOCHEM PHYS B, V118, P777, DOI 10.1016/S0305-0491(97)00271-X; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weulersse J., 1940, ORONTE ETUDE FLEUVE, P1; Wolfart R., 1967, GEOLOGIE SYRIEN LIBA, P1; Wolfart R, 1987, P S  FAUN ZOOG MIDDL, P9	68	12	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156434	10.1371/journal.pone.0156434	http://dx.doi.org/10.1371/journal.pone.0156434			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309854	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800004
J	Liu, BZ; Tao, L; Chen, YZ; Li, XZ; Dong, YL; Ma, YJ; Li, SG; Li, F; Zhang, WJ				Liu, Bin Zheng; Tao, Lin; Chen, Yun Zhao; Li, Xu Zhe; Dong, Yu Ling; Ma, Ya Jing; Li, Shu Gang; Li, Feng; Zhang, Wen Jie			Preoperative Body Mass Index, Blood Albumin and Triglycerides Predict Survival for Patients with Gastric Cancer	PLOS ONE			English	Article							LONG-TERM SURVIVAL; METABOLIC SYNDROME; PROSPECTIVE COHORT; OBESITY PARADOX; SERUM-ALBUMIN; OUTCOMES; RISK; MORTALITY; RATIO	Background Gastric cancer (GC) is common and its prognosis is often poor due to difficulties in early diagnosis and optimal treatment strategies. TNM staging system is useful in predicting prognosis but only possible after surgery. Therefore, it is desirable to investigate prognostic factors/markers that may predict prognosis before surgery by which helps appropriate management decisions preoperatively. Methods A total of 320 GC patients were consecutively recruited from 2004 to 2013 and followed up for 127 months (10.6 years) after surgery. These patients' were examined for body mass index (BMI) and blood levels of albumin, triglyceride, total cholesterol, low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol (HDL-C). Kaplan-Meier method and log rank test were used to analyze long-term survival using the above potential risk markers. We first employed medians of these variables to reveal maximal potentials of the above prognostic predictors. Results Three major findings were obtained: (1) Preoperative BMI was positively correlated with albumin (r = 0.144, P<0.05) and triglyceride (r = 0.365, P<0.01), but negatively correlated with TNM staging (r = -0.265, P<0.05). Preoperative albumin levels were positively correlated with triglyceride (r = 0.173, P<0.05) but again, negatively correlated with TNM staging (r = -0.137, P<0.05); (2) Poor survival was observed in GC patients with lower levels of BMI (P = 0.028), albumin (P = 0.004), and triglyceride (P = 0.043), respectively. Receiver operating characteristic (ROC) curve analyses suggested BMI, albumin and triglyceride to have survival-predictor powers similar to TNM system; and (3) Cox multi-factorial analyses demonstrated that age (P = 0.049), BMI (P = 0.016), cell differentiation (P = 0.001), and TNM staging (P = 0.011) were independent overall survival-predictors for GC patients. Conclusions Preoperative BMI, albumin, and triglyceride levels are capable of predicting survival for GC patients superior to postoperative TNM system in terms of timing for management. As potential survival-predictors, preoperative tests of BMI, albumin and triglyceride, combined with clinical imaging, may help personalized management for GC patients including planning surgical strategy, optimal radio-chemotherapy and appropriate follow-up intervals after surgery.	[Liu, Bin Zheng; Tao, Lin; Chen, Yun Zhao; Li, Xu Zhe; Dong, Yu Ling; Li, Feng; Zhang, Wen Jie] Shihezi Univ, Sch Med, Affiliated Univ Hosp 1, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Liu, Bin Zheng; Tao, Lin; Chen, Yun Zhao; Li, Xu Zhe; Dong, Yu Ling; Zhang, Wen Jie] Shihezi Univ, Sch Med, Key Labs Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [Ma, Ya Jing] Shihezi Univ, Sch Med, Affiliated Univ Hosp 1, Clin Lab, Shihezi, Xinjiang, Peoples R China; [Li, Shu Gang] Shihezi Univ, Sch Med, Dept Prevent Med, Shihezi, Xinjiang, Peoples R China; [Li, Shu Gang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Pathol, Beijing, Peoples R China; [Liu, Bin Zheng] Jiande First Peoples Hosp, Dept Pathol, Hangzhou, Jiangsu, Peoples R China	Shihezi University; Shihezi University; Shihezi University; Shihezi University; Capital Medical University	Zhang, WJ (corresponding author), Shihezi Univ, Sch Med, Affiliated Univ Hosp 1, Dept Pathol, Shihezi, Xinjiang, Peoples R China.; Zhang, WJ (corresponding author), Shihezi Univ, Sch Med, Key Labs Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China.	zhangwj82@yahoo.com			Xinjiang Uyghur Autonomous Region [XJGRI2015056]; Oasis Scholar Fund of Shihezi University [LZXZ201023]; National Natural Science Foundation of China [81360358, 81460362]	Xinjiang Uyghur Autonomous Region; Oasis Scholar Fund of Shihezi University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from Xinjiang Uyghur Autonomous Region (Xinjiang Graduate Student Innovation Program (No. XJGRI2015056), the Oasis Scholar Fund of Shihezi University (No. LZXZ201023), and the National Natural Science Foundation of China (Nos. 81360358, 81460362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4; Arques S, 2011, J CARD FAIL, V17, P451, DOI 10.1016/j.cardfail.2011.02.010; Azab B, 2013, INT J COLORECTAL DIS, V28, P1629, DOI 10.1007/s00384-013-1748-z; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Bickenbach KA, 2013, ANN SURG ONCOL, V20, P780, DOI 10.1245/s10434-012-2653-3; Chen HN, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001769; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen Wen, 2016, Computer Aided Engineering, V25, P1, DOI 10.13340/j.cae.2016.03.001; Cong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090262; Crumley ABC, 2010, WORLD J SURG, V34, P2393, DOI 10.1007/s00268-010-0641-y; Cui Jingli, 2014, Zhonghua Wai Ke Za Zhi, V52, P409; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Dawood S, 2008, CLIN CANCER RES, V14, P1718, DOI 10.1158/1078-0432.CCR-07-1479; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; HANLEY JA, 1988, RADIOLOGY, V168, P568, DOI 10.1148/radiology.168.2.3393683; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Kawut SM, 2005, AM J CARDIOL, V95, P199, DOI 10.1016/j.amjcard.2004.09.006; Lianos GD, 2014, FUTURE ONCOL, V10, P249, DOI [10.2217/FON.13.188, 10.2217/fon.13.188]; Lindkvist B, 2013, CANCER CAUSE CONTROL, V24, P107, DOI 10.1007/s10552-012-0096-6; Martin RM, 2009, CANCER CAUSE CONTROL, V20, P1181, DOI 10.1007/s10552-009-9319-x; Medical Administration Department of Ministry of Health P.R.C, 2006, PRC NAT GUID CLIN LA; Mullen JT, 2009, ANN SURG, V250, P166, DOI 10.1097/SLA.0b013e3181ad8935; O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC; Okamura T, 2004, J CLIN EPIDEMIOL, V57, P1188, DOI 10.1016/j.jclinepi.2004.02.019; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pasini F, 2011, ANTICANCER RES, V31, P3543; Schindl M, 2005, ARCH SURG-CHICAGO, V140, P183, DOI 10.1001/archsurg.140.2.183; Sinicrope FA, 2010, CLIN CANCER RES, V16, P1884, DOI 10.1158/1078-0432.CCR-09-2636; Tateishi R, 2005, GUT, V54, P419, DOI 10.1136/gut.2003.035055; Thrumurthy SG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6367; Tokunaga M, 2009, ANN SURG ONCOL, V16, P3245, DOI 10.1245/s10434-009-0645-8; Ulmer H, 2009, BRIT J CANCER, V101, P1202, DOI 10.1038/sj.bjc.6605264; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wu N, 2015, NUTR CANCER, V67, P481, DOI 10.1080/01635581.2015.1004726; Yasunaga H, 2013, BRIT J SURG, V100, P1335, DOI 10.1002/bjs.9221; Zhao DQ, 2014, HEPATO-GASTROENTEROL, V61, P1154, DOI 10.5754/hge13576; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	40	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157401	10.1371/journal.pone.0157401	http://dx.doi.org/10.1371/journal.pone.0157401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309531	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800067
J	Haslacher, H; Nistler, S; Batmyagmar, D; Ponocny-Seliger, E; Perkmann, T; Scherzer, TM; Kundi, M; Endler, G; Ratzinger, F; Pilger, A; Wagner, OF; Winker, R				Haslacher, Helmuth; Nistler, Sonja; Batmyagmar, Delgerdalai; Ponocny-Seliger, Elisabeth; Perkmann, Thomas; Scherzer, Thomas M.; Kundi, Michael; Endler, Georg; Ratzinger, Franz; Pilger, Alexander; Wagner, Oswald F.; Winker, Robert			Low Vitamin D Levels Do Not Predict Hyperglycemia in Elderly Endurance Athletes (but in Controls)	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; BIOMARKERS; DIAGNOSIS; EXERCISE; OBESITY; RISK	Background and Aim Recent studies revealed a link between hypovitaminosis D-3 and the risk for hyperglycemia. Further mechanistic and interventional investigations suggested a common reason for both conditions rather than a causal relationship. Exposure to sunlight is the most relevant source of vitamin D-3(25(OH)D), whereas adipose tissue is able to store relevant amounts of the lipophilic vitamin. Since running/bicycling leads to increased out-door time and alters physiological response mechanisms, it can be hypothesized that the correlation between hypovitaminosis D-3 and hyperglycemia might be disturbed in outdoor athletes. Methods 47 elderly marathoners/bicyclists and 47 age/sex matched controls were studied in a longitudinal setting at baseline and after three years. HbA1c as a surrogate for (pre-)diabetic states was quantified via HPLC, 25(OH)D levels were measured by means of chemiluminescent assays. Physical performance was assessed by ergometry. Results When adjusted for seasonal variations, 25(OH)D was significantly higher in athletes than in controls. 25(OH)D levels inversely correlated with triglycerides in both groups, whereas only in controls an association between high BMI or low physical performance with hypovitaminosis D-3 had been found. Likewise, the presence of hypovitaminosis D-3 at baseline successfully predicted hyperglycemia at the follow up examinations within the control group (AUC = 0.85, 95% CI [0.74, 0.96], p < .001, statistically independent from BMI), but not in athletes. Conclusion Our data suggest that mechanisms of HbA(1c) elevation might differ between athletes and controls. Thus, intense physical activity must be taken into account as a potential pre-analytic confounder when it is aimed to predict metabolic risk by vitamin D-3 levels.	[Haslacher, Helmuth; Perkmann, Thomas; Ratzinger, Franz; Wagner, Oswald F.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Scherzer, Thomas M.; Winker, Robert] Sanat Hera, Hlth & Prevent Ctr, Vienna, Austria; [Batmyagmar, Delgerdalai; Kundi, Michael] Med Univ Vienna, Dept Publ Hlth, Vienna, Austria; [Endler, Georg] Gruppenpraxis Lab At, Vienna, Austria; [Pilger, Alexander] Med Univ Vienna, Div Occupat Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Haslacher, H (corresponding author), Med Univ Vienna, Dept Lab Med, Vienna, Austria.	helmuth.haslacher@meduniwien.ac.at	Haslacher, Helmuth/D-4233-2013; Perkmann, Thomas/F-3074-2012	Haslacher, Helmuth/0000-0003-4605-2503; Perkmann, Thomas/0000-0002-7976-0285; Ratzinger, Franz/0000-0002-1910-1018	Austrian National Bank [14511, 12979]	Austrian National Bank	This trial was supported by the Anniversary Fund of the Austrian National Bank (No. 14511, No. 12979), https://www.oenb.at/en/About-Us/Research-Promotion/The-OeNBAnniversary-Fund.html. Moreover, authors EP and GE are currently affiliated with commercial companies. However, neither these companies nor the funder (Austrian National Bank), who inter alia provided support in the form of salaries for authors (EP, DB), did have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Agawa H, 2008, INT J SPORTS MED, V29, P867, DOI 10.1055/s-2008-1038490; Al-Shoumer KAS, 2015, WORLD J DIABETES, V6, P1057, DOI 10.4239/wjd.v6.i8.1057; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohm H, 1978, OST ARZTEZTG, V33, P333; Clemente-Postigo M, 2015, J CLIN ENDOCR METAB, V100, pE591, DOI 10.1210/jc.2014-3016; George PS, 2012, DIABETIC MED, V29, pE142, DOI 10.1111/j.1464-5491.2012.03672.x; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; Hamstra-Wright KL, 2013, J STRENGTH COND RES, V27, P2828, DOI 10.1519/JSC.0b013e31828a4733; Haslacher H, 2012, INT J SPORTS MED, V33, P1034, DOI 10.1055/s-0032-1304637; Haslacher H, 2015, J SPORT EXERCISE PSY, V37, P637, DOI 10.1123/jsep.2015-0111; Haslacher H, 2015, NEUROPSYCHOBIOLOGY, V71, P168, DOI 10.1159/000381350; Heidari B, 2015, AM HEART J, V170, P573, DOI 10.1016/j.ahj.2015.06.017; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Kabadi SM, 2012, DIABETES CARE, V35, P2048, DOI 10.2337/dc12-0235; Kratz A, 2002, AM J CLIN PATHOL, V118, P856, DOI 10.1092/BTWQ5YMYVQ67QK9L; Lupton JR, 2016, J CLIN LIPIDOL, V10, P72, DOI 10.1016/j.jacl.2015.09.006; Marliss EB, 2002, DIABETES, V51, pS271, DOI 10.2337/diabetes.51.2007.S271; Morgan WP, 1996, INT J SPORTS MED, V17, P305, DOI 10.1055/s-2007-972852; Nathan DM, 2015, JAMA-J AM MED ASSOC, V314, P1052, DOI 10.1001/jama.2015.9536; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Peeling P, 2013, INT J SPORTS MED, V34, P248, DOI 10.1055/s-0032-1321894; Poolsup N, 2015, EFFECT VITAMIN D SUP; Sanchis-Gomar F, 2014, BIOCHEM MEDICA, V24, P68, DOI 10.11613/BM.2014.009; Saraff V, 2015, ARCH DIS CHILD; Sattar N, 2012, DIABETIC MED, V29, P5, DOI 10.1111/j.1464-5491.2011.03480.x; Song YQ, 2013, DIABETES CARE, V36, P1422, DOI 10.2337/dc12-0962; Wamberg L, 2015, CAUSES VITAMIN D DEF; Winker R, 2010, WIEN KLIN WOCHENSCHR, V122, P704, DOI 10.1007/s00508-010-1485-z; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Zilinski JL, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002487	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157695	10.1371/journal.pone.0157695	http://dx.doi.org/10.1371/journal.pone.0157695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304888	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800080
J	Michl, C; Vivarelli, F; Weigl, J; De Nicola, GR; Canistro, D; Paolini, M; Iori, R; Rascle, A				Michl, Carina; Vivarelli, Fabio; Weigl, Julia; De Nicola, Gina Rosalinda; Canistro, Donatella; Paolini, Moreno; Iori, Renato; Rascle, Anne			The Chemopreventive Phytochemical Moringin Isolated from Moringa oleifera Seeds Inhibits JAK/STAT Signaling	PLOS ONE			English	Article							NF-KAPPA-B; JAK-STAT PATHWAY; TRANSCRIPTION 3; GLUCOMORINGIN ISOTHIOCYANATE; DEACETYLASE INHIBITORS; ENDOTHELIAL-CELLS; CANCER PREVENTION; MONOCYTE ADHESION; MAMMARY-GLAND; SULFORAPHANE	Sulforaphane (SFN) and moringin (GMG-ITC) are edible isothiocyanates present as glucosinolate precursors in cruciferous vegetables and in the plant Moringa oleifera respectively, and recognized for their chemopreventive and medicinal properties. In contrast to the well-studied SFN, little is known about the molecular pathways targeted by GMG-ITC. We investigated the ability of GMG-ITC to inhibit essential signaling pathways that are frequently upregulated in cancer and immune disorders, such as JAK/STAT and NF-kappa B. We report for the first time that, similarly to SFN, GMG-ITC in the nanomolar range suppresses IL-3-induced expression of STAT5 target genes. GMG-ITC, like SFN, does not inhibit STAT5 phosphorylation, suggesting a downstream inhibitory event. Interestingly, treatment with GMG-ITC or SFN had a limited inhibitory effect on IFN alpha-induced STAT1 and STAT2 activity, indicating that both isothiocyanates differentially target JAK/STAT signaling pathways. Furthermore, we showed that GMG-ITC in the micromolar range is a more potent inhibitor of TNF-induced NF-kappa B activity than SFN. Finally, using a cellular system mimicking constitutive active STAT5-induced cell transformation, we demonstrated that SFN can reverse the survival and growth advantage mediated by oncogenic STAT5 and triggers cell death, therefore providing experimental evidence of a cancer chemopreventive activity of SFN. This work thus identified STAT5, and to a lesser extent STAT1/STAT2, as novel targets of moringin. It also contributes to a better understanding of the biological activities of the dietary isothiocyanates GMG-ITC and SFN and further supports their apparent beneficial role in the prevention of chronic illnesses such as cancer, inflammatory diseases and immune disorders.	[Michl, Carina; Vivarelli, Fabio; Weigl, Julia; Rascle, Anne] Univ Regensburg, Inst Immunol, Signaling Res Grp Stat5, D-93053 Regensburg, Germany; [Vivarelli, Fabio; Canistro, Donatella; Paolini, Moreno] Univ Bologna, Dept Pharm & Biotechnol, Mol Toxicol Unit, Bologna, Italy; [De Nicola, Gina Rosalinda; Iori, Renato] Ctr Ric Colture Ind CREA CIN, Consiglio Ric Agr & Anal Econ Agr, Bologna, Italy; [Weigl, Julia] GeneArt AG Thermo Fisher Sci, BioPk 11, D-93053 Regensburg, Germany	University of Regensburg; University of Bologna; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Thermo Fisher Scientific	Rascle, A (corresponding author), Univ Regensburg, Inst Immunol, Signaling Res Grp Stat5, D-93053 Regensburg, Germany.	anne.rascle@klinik.uni-regensburg.de	De Nicola, Gina Rosalinda/AAC-9218-2021; Rascle, Anne/AAC-1904-2019	De Nicola, Gina Rosalinda/0000-0002-2916-8662; Rascle, Anne/0000-0001-7464-8545; CANISTRO, DONATELLA/0000-0002-6378-1698; Vivarelli, Fabio/0000-0002-8734-0985	Deutsche Forschungsgemeinschaft [RA 2010/2-1]; Deutsche Krebshilfe [109750]; German Research Foundation (DFG) [INST 89/318-3]; institutional research funds (Foerderlinie C)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); German Research Foundation (DFG)(German Research Foundation (DFG)); institutional research funds (Foerderlinie C)	This work was supported by the Deutsche Forschungsgemeinschaft (Grant No. RA 2010/2-1 to AR), the Deutsche Krebshilfe (Grant No. 109750 to AR), and institutional research funds (Foerderlinie C to AR). Open access charges were covered by the funding programme "Open Access Publishing" of the German Research Foundation (DFG) (INST 89/318-3 to the University of Regensburg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; Barash I, 2006, J CELL PHYSIOL, V209, P305, DOI 10.1002/jcp.20771; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brunelli D, 2010, BIOCHEM PHARMACOL, V79, P1141, DOI 10.1016/j.bcp.2009.12.008; Butturini E, 2013, FREE RADICAL BIO MED, V65, P1322, DOI 10.1016/j.freeradbiomed.2013.09.015; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Cheenpracha S, 2010, BIOORGAN MED CHEM, V18, P6598, DOI 10.1016/j.bmc.2010.03.057; Chen CY, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0139-x; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; DiSanto JP, 1997, CURR BIOL, V7, pR424, DOI 10.1016/S0960-9822(06)00208-9; Esatbeyoglu T, 2012, ANGEW CHEM INT EDIT, V51, P5308, DOI 10.1002/anie.201107724; Galuppo M, 2015, J BIOL REG HOMEOS AG, V29, P343; Galuppo M, 2014, FITOTERAPIA, V95, P160, DOI 10.1016/j.fitote.2014.03.018; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Geymayer S, 2000, FASEB J, V14, P1159, DOI 10.1096/fasebj.14.9.1159; Go VLW, 2004, J NUTR, V134, p3513S, DOI 10.1093/jn/134.12.3513S; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Guthridge MA, 1998, STEM CELLS, V16, P301, DOI 10.1002/stem.160301; Hahm ER, 2010, CANCER PREV RES, V3, P484, DOI 10.1158/1940-6207.CAPR-09-0250; Hanan EJ, 2012, J MED CHEM, V55, P10090, DOI 10.1021/jm3012239; Hayakawa F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.63; Heiss E, 2005, ANTIOXID REDOX SIGN, V7, P1601, DOI 10.1089/ars.2005.7.1601; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; Ho E, 2009, J NUTR, V139, P2393, DOI 10.3945/jn.109.113332; Holst B, 2004, NAT PROD REP, V21, P425, DOI 10.1039/b204039p; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Huang CS, 2013, MOL NUTR FOOD RES, V57, P1918, DOI 10.1002/mnfr.201300063; Hung CN, 2014, J MED FOOD, V17, P1095, DOI 10.1089/jmf.2013.2901; Hutzen B, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-24; Ioannidis S, 2011, J MED CHEM, V54, P262, DOI 10.1021/jm1011319; Jatiani Shashidhar S, 2010, Genes Cancer, V1, P331, DOI 10.1177/1947601910371337; Jeong SI, 2010, ARCH PHARM RES, V33, P1867, DOI 10.1007/s12272-010-1120-6; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Keum YS, 2011, ANN NY ACAD SCI, V1229, P184, DOI 10.1111/j.1749-6632.2011.06092.x; Kim BH, 2013, BIOCHEM PHARMACOL, V86, P950, DOI 10.1016/j.bcp.2013.08.009; Kivela AM, 2010, ATHEROSCLEROSIS, V213, P122, DOI 10.1016/j.atherosclerosis.2010.07.015; Kraus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037207; Lampronti I, 2005, MED CHEM, V1, P327, DOI 10.2174/1573406054368684; Leone A, 2015, INT J MOL SCI, V16, P12791, DOI 10.3390/ijms160612791; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Liu YC, 2008, VASC PHARMACOL, V48, P54, DOI 10.1016/j.vph.2007.11.006; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Luo C, 2004, DRUG DISCOV TODAY, V9, P268, DOI 10.1016/S1359-6446(03)03014-9; Ma L, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.6; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Muller C, 2015, PHYTOCHEMISTRY, V118, P139, DOI 10.1016/j.phytochem.2015.08.007; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Muller J, 2008, ANAL BIOCHEM, V375, P249, DOI 10.1016/j.ab.2008.01.017; Nakamura Y, 2010, BIOSCI BIOTECH BIOCH, V74, P242, DOI 10.1271/bbb.90731; Nallasamy P, 2014, J NUTR BIOCHEM, V25, P824, DOI 10.1016/j.jnutbio.2014.03.011; Nelson Erik A, 2012, Genes Cancer, V3, P503, DOI 10.1177/1947601912466555; Nelson EA, 2011, ONCOTARGET, V2, P518; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Pinz S, 2015, NUCLEIC ACIDS RES, V43, P3524, DOI 10.1093/nar/gkv188; Pinz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099391; Pinz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090275; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Rajan TS, 2016, FITOTERAPIA, V110, P1, DOI 10.1016/j.fitote.2016.02.007; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Rascle A, 2009, EXP CELL RES, V315, P76, DOI 10.1016/j.yexcr.2008.10.012; Santos FPS, 2011, BLOOD REV, V25, P53, DOI 10.1016/j.blre.2010.10.004; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun CC, 2015, J BIOL CHEM, V290, P17784, DOI 10.1074/jbc.M115.655019; Ullrich A, 2004, ANN ONCOL, V15, P249, DOI 10.1093/annonc/mdh935; Valentino L, 2006, BIOCHEM PHARMACOL, V71, P713, DOI 10.1016/j.bcp.2005.12.017; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Ward AC, 2000, BLOOD, V95, P19; Warsch W, 2013, BLOOD, V122, P2167, DOI 10.1182/blood-2013-02-485573; Weber A, 2013, PHARMACEUTICALS, V6, P960, DOI 10.3390/ph6080960; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Yadav VR, 2011, INT IMMUNOPHARMACOL, V11, P295, DOI 10.1016/j.intimp.2010.12.006; Yang J, 2010, MOL CANCER THER, V9, P3386, DOI 10.1158/1535-7163.MCT-10-0416; Youn HS, 2010, J IMMUNOL, V184, P411, DOI 10.4049/jimmunol.0803988; Zhang YS, 2001, CARCINOGENESIS, V22, P425, DOI 10.1093/carcin/22.3.425; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	86	36	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157430	10.1371/journal.pone.0157430	http://dx.doi.org/10.1371/journal.pone.0157430			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304884	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800058
J	Sonoda, S; Sakamoto, T; Kuroiwa, N; Arimura, N; Kawano, H; Yoshihara, N; Yamashita, T; Uchino, E; Kinoshita, T; Mitamura, Y				Sonoda, Shozo; Sakamoto, Taiji; Kuroiwa, Nobuhiro; Arimura, Noboru; Kawano, Hiroki; Yoshihara, Naoya; Yamashita, Takehiro; Uchino, Eisuke; Kinoshita, Takamasa; Mitamura, Yoshinori			Structural Changes of Inner and Outer Choroid in Central Serous Chorioretinopathy Determined by Optical Coherence Tomography	PLOS ONE			English	Article							INDOCYANINE GREEN VIDEOANGIOGRAPHY; HEALTHY EYES; THICKNESS; BINARIZATION; FEATURES; IMAGES	Purpose To determine the structural changes of the choroid in eyes with central serous chorioretinopathy (CSC) by enhanced depth imaging optical coherence tomography (EDI-OCT). Methods A retrospective comparative study was performed at two academic institutions. Forty eyes with CSC, their fellow eyes, and 40 eyes of age-matched controls were studied. Subfoveal cross sectional EDI-OCT images were recorded, and the hypo reflective and hyperreflective areas of the inner and outer choroid in the EDI-OCT images were separately measured. The images were analyzed by a binarization method to determine the sizes of the hyporeflective and hyperreflective areas. Results In the inner choroid, the hyperreflective area was significantly larger in the CSC eyes (35,640 +/- 10,229 mu m(2)) than the fellow eyes (22,908 +/- 8,522 mu m(2)) and the control eyes (20,630 +/- 8,128 mu m(2); P< 0.01 vs control for both, Wilcoxon signed-rank test). In the outer choroid, the hyporeflective area was significantly larger in the CSC eyes (446,549 +/- 121,214 mu m(2)) than the control eyes (235,680 +/- 97,352 mu m(2), P< 0.01). The average ratio of the hyporeflective area to the total choroidal area was smaller in the CSC eyes (67.0%) than the fellow eyes (76.5%) and the control eyes (76.7%) in the inner choroid (P<0.01, both). However, the ratio was larger in the CSC eyes (75.2%) and fellow eyes (71.7%) than in the control eyes (64.7%) in the outer choroid (P<0.01, both). Conclusions The larger hyperreflective area in the inner choroid is related to the inflammation and edema of the stroma of the choroid in the acute stage of CSC. The larger hyporeflective areas in the outer choroid is due to a dilatation of the vascular lumens of the larger blood vessels. These are the essential characteristics of eyes with CSC regardless of the onset.	[Sonoda, Shozo; Sakamoto, Taiji; Kuroiwa, Nobuhiro; Arimura, Noboru; Kawano, Hiroki; Yoshihara, Naoya; Yamashita, Takehiro; Uchino, Eisuke] Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Kinoshita, Takamasa; Mitamura, Yoshinori] Univ Tokushima, Dept Ophthalmol, Grad Sch Med, Tokushima 770, Japan	Kagoshima University; Tokushima University	Sakamoto, T (corresponding author), Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp	Kinoshita, Takamasa/S-9174-2019	Kinoshita, Takamasa/0000-0002-0465-2140				Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Fujimoto H, 2008, OPHTHALMOLOGY, V115, P1494, DOI 10.1016/j.ophtha.2008.01.021; GUYER DR, 1994, ARCH OPHTHALMOL-CHIC, V112, P1057, DOI 10.1001/archopht.1994.01090200063023; Iida T, 1999, RETINA-J RET VIT DIS, V19, P508, DOI 10.1097/00006982-199911000-00005; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Jirarattanasopa P, 2012, OPHTHALMOLOGY, V119, P1666, DOI 10.1016/j.ophtha.2012.02.021; Kim SW, 2011, RETINA-J RET VIT DIS, V31, P1904, DOI 10.1097/IAE.0b013e31821801c5; Kitaya N, 2003, BRIT J OPHTHALMOL, V87, P709, DOI 10.1136/bjo.87.6.709; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P1603, DOI 10.1097/IAE.0b013e31820f4b39; Maruko I, 2010, OPHTHALMOLOGY, V117, P1792, DOI 10.1016/j.ophtha.2010.01.023; Nicholson B, 2013, SURV OPHTHALMOL, V58, P103, DOI 10.1016/j.survophthal.2012.07.004; Oh JH, 2014, INVEST OPHTH VIS SCI, V55, P1502, DOI 10.1167/iovs.13-13183; Prunte C, 1996, AM J OPHTHALMOL, V121, P26; Saito M, 2013, BRIT J OPHTHALMOL, V97, P775, DOI 10.1136/bjophthalmol-2012-302349; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3893, DOI 10.1167/iovs.14-14447; Spaide RF, 1996, RETINA-J RET VIT DIS, V16, P203, DOI 10.1097/00006982-199616030-00004; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spaide RF, 2015, AM J OPHTHALMOL, V160, P1211, DOI 10.1016/j.ajo.2015.08.018; Spaide RF, 2009, AM J OPHTHALMOL, V147, P644, DOI 10.1016/j.ajo.2008.10.005; Tittl M, 2005, INVEST OPHTH VIS SCI, V46, P4717, DOI 10.1167/iovs.05-0268; Yang LH, 2013, ACTA OPHTHALMOL, V91, pE358, DOI 10.1111/aos.12059; YOSHIOKA H, 1982, OPHTHALMOLOGICA, V185, P168, DOI 10.1159/000309239	24	43	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157190	10.1371/journal.pone.0157190	http://dx.doi.org/10.1371/journal.pone.0157190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27305042	Green Submitted, Green Published, gold			2022-12-27	WOS:000377824800038
J	Wu, Y; Adi, D; Long, M; Wang, J; Liu, F; Gai, MT; Aierken, A; Li, MY; Li, Q; Wu, LQ; Ma, YT; Hujiaaihemaiti, M				Wu, Yun; Adi, Dilare; Long, Mei; Wang, Jie; Liu, Fen; Gai, Min-Tao; Aierken, Alidan; Li, Ming-Yuan; Li, Qian; Wu, Lei-Qi; Ma, Yi-Tong; Hujiaaihemaiti, Minawaer			4-Phenylbutyric Acid Induces Protection against Pulmonary Arterial Hypertension in Rats	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ENDOTHELIAL-CELLS; ER-STRESS; OXIDATIVE STRESS; APOPTOSIS; PREVENTS; PATHWAY; PROLIFERATION; INHIBITION	Background Endoplasmic reticulum (ER) stress has been implicated in the pathophysiology of various pulmonary diseases via the activation of the unfolded protein response. However, the role of ER stress in pulmonary arterial hypertension (PAH) remains unclear. The well-known chemical chaperone 4-phenylbutyric acid (4-PBA) inhibits ER stress signaling. We hypothesized that known chemical chaperones, including 4-PBA, would inhibit the activation of ER stress and prevent and/or reverse PAH. Methods and Results Male Wistar rats were randomly divided into four groups: a normal control group (NORMAL group), a PAH group, and two PAH model plus 4-PBA treatment groups. The latter two groups included rats receiving 4-PBA by gavage each day as a preventive measure (the PRE group, with PBA starting on the day of PAH induction and continuing for 4 weeks) or as a reversal measure (the REV group, with PBA starting on the third week of PAH induction and continuing for 2 weeks). The PAH model was induced by intraperitoneally administering monocrotaline. The mean pulmonary artery pressure and mean right ventricular pressure were lower in the REV and PRE groups than in the NORMAL group. Furthermore, 4-PBA improved pulmonary arterial remodeling and suppressed the expression of ER stress indicators. Conclusion Our findings indicate that PAH induces ER stress and provokes pulmonary arterial and right ventricular remodeling. Additionally, we show that attenuation of ER stress has the potential to be an effective therapeutic strategy for protecting pulmonary arteries.	[Wu, Yun; Aierken, Alidan; Li, Ming-Yuan; Li, Qian; Wu, Lei-Qi; Hujiaaihemaiti, Minawaer] Xinjiang Med Univ, Affiliated Hosp 1, Dept Gen Practice, Urumqi 830011, Peoples R China; [Liu, Fen; Gai, Min-Tao; Ma, Yi-Tong] Xinjiang Med Univ, Affiliated Hosp 1, Xinjiang Key Lab Cardiovasc Dis Res, Urumqi 830011, Peoples R China; [Wu, Yun; Adi, Dilare; Ma, Yi-Tong] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi 830011, Peoples R China; [Long, Mei] Xinjiang Med Univ, Dept Mech & Funct, Urumqi 830011, Peoples R China; [Wang, Jie] Xinjiang Med Univ, Affiliated Hosp 1, Dept Pharm, Urumqi 830011, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Hujiaaihemaiti, M (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Gen Practice, Urumqi 830011, Peoples R China.; Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Xinjiang Key Lab Cardiovasc Dis Res, Urumqi 830011, Peoples R China.; Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi 830011, Peoples R China.	myt_xj@sina.com; 247477874@qq.com		Wu, Yun/0000-0002-2692-9067; Wang, Jie/0000-0002-1200-1196; Wang, Jie/0000-0001-7905-034X	Natural Science Foundation of Xinjiang Province [2014211C071]	Natural Science Foundation of Xinjiang Province	This work was supported by the Natural Science Foundation of Xinjiang Province (CN) (grant#: 2014211C071). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Natural Science Foundation of Xinjiang Province (CN) (grant# 2014211C071).	Asmarinah, 2014, INT J ONCOL, V45, P1489, DOI 10.3892/ijo.2014.2576; Ayala P, 2012, EXP MOL PATHOL, V92, P97, DOI 10.1016/j.yexmp.2011.10.012; Benoist D, 2011, AM J PHYSIOL-HEART C, V300, pH2230, DOI 10.1152/ajpheart.01226.2010; Bourdier G., 2015, AM J PHYSL HEART CIR; Bruchmann A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-96; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Cheng X, 2014, INT J MOL MED, V34, P772, DOI 10.3892/ijmm.2014.1822; Chin KM, 2008, J AM COLL CARDIOL, V51, P1527, DOI 10.1016/j.jacc.2008.01.024; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Dromparis P, 2013, CIRCULATION, V127, P115, DOI 10.1161/CIRCULATIONAHA.112.133413; Dror V, 2008, J BIOL CHEM, V283, P9909, DOI 10.1074/jbc.M710601200; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Feng JY, 2014, OPHTHALMIC RES, V52, P224, DOI 10.1159/000363387; Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832; Frump AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080319; Galie N, 2015, EUR HEART J; Handoko ML, 2009, CIRCULATION, V120, P42, DOI 10.1161/CIRCULATIONAHA.108.829713; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Knowlton AA, 2007, CARDIOVASC RES, V73, P1, DOI 10.1016/j.cardiores.2006.11.002; Kolb PS, 2015, INT J BIOCHEM CELL B, V61, P45, DOI 10.1016/j.biocel.2015.01.015; Koyama M, 2014, AM J PHYSIOL-HEART C, V306, pH1314, DOI 10.1152/ajpheart.00869.2013; Krajewska M, 1996, AM J PATHOL, V148, P1567; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Levy M, 2007, J AM COLL CARDIOL, V49, P803, DOI 10.1016/j.jacc.2006.09.049; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sakao S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-95; Sanderson TH, 2010, NEUROSCIENCE, V169, P1307, DOI 10.1016/j.neuroscience.2010.05.076; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Sutendra G, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002194; Tang CHA, 2014, J CLIN INVEST, V124, P2585, DOI 10.1172/JCI73448; Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107; Toth Ambrus, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P205, DOI 10.2174/187152907781745260; Voelkel NF, 2004, CARDIOL CLIN, V22, P343, DOI 10.1016/j.ccl.2004.04.010; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yeager Michael E, 2012, Pulm Circ, V2, P229, DOI 10.4103/2045-8932.97613; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhu M, 2014, ENDOCRINE, V47, P129, DOI 10.1007/s12020-013-0132-7	42	27	27	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157538	10.1371/journal.pone.0157538	http://dx.doi.org/10.1371/journal.pone.0157538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304885	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800069
J	van Dijke, A; van 't Wout, M; Ford, JD; Aleman, A				van Dijke, Annemiek; van 't Wout, Mascha; Ford, Julian D.; Aleman, Andre			Deficits in Degraded Facial Affect Labeling in Schizophrenia and Borderline Personality Disorder	PLOS ONE			English	Article							EMOTION RECOGNITION; SOMATOFORM DISORDERS; AFFECT DYSREGULATION; FACES; PERCEPTION; AMYGDALA; METAANALYSIS; MEDIATOR; DISCRIMINATION; NEUROCOGNITION	Although deficits in facial affect processing have been reported in schizophrenia as well as in borderline personality disorder (BPD), these disorders have not yet been directly compared on facial affect labeling. Using degraded stimuli portraying neutral, angry, fearful and angry facial expressions, we hypothesized more errors in labeling negative facial expressions in patients with schizophrenia compared to healthy controls. Patients with BPD were expected to have difficulty in labeling neutral expressions and to display a bias towards a negative attribution when wrongly labeling neutral faces. Patients with schizophrenia (N = 57) and patients with BPD (N = 30) were compared to patients with somatoform disorder (SoD, a psychiatric control group; N = 25) and healthy control participants (N = 41) on facial affect labeling accuracy and type of misattributions. Patients with schizophrenia showed deficits in labeling angry and fearful expressions compared to the healthy control group and patients with BPD showed deficits in labeling neutral expressions compared to the healthy control group. Schizophrenia and BPD patients did not differ significantly from each other when labeling any of the facial expressions. Compared to SoD patients, schizophrenia patients showed deficits on fearful expressions, but BPD did not significantly differ from SoD patients on any of the facial expressions. With respect to the type of misattributions, BPD patients mistook neutral expressions more often for fearful expressions compared to schizophrenia patients and healthy controls, and less often for happy compared to schizophrenia patients. These findings suggest that although schizophrenia and BPD patients demonstrate different as well as similar facial affect labeling deficits, BPD may be associated with a tendency to detect negative affect in neutral expressions.	[van Dijke, Annemiek] Vrije Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Yulius Acad,Yulius COLK,Rotterdam Dordrecht Area, Amsterdam, Netherlands; [van Dijke, Annemiek] Vrije Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Dept Clin Psychol, Amsterdam, Netherlands; [van 't Wout, Mascha] Brown Univ, Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Ford, Julian D.] Univ Connecticut, Ctr Hlth, Dept Psychiat, Farmington, CT 06032 USA; [Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Aleman, Andre] Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Brown University; University of Connecticut; University of Groningen; University of Groningen	van Dijke, A (corresponding author), Vrije Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Yulius Acad,Yulius COLK,Rotterdam Dordrecht Area, Amsterdam, Netherlands.; van Dijke, A (corresponding author), Vrije Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Dept Clin Psychol, Amsterdam, Netherlands.	a.vandijke@umc.uva.nl	van 't Wout, Mascha/AAO-5710-2021	van 't Wout, Mascha/0000-0002-1497-1989; van Dijke, Annemiek/0000-0003-3879-9359				Addington J, 2006, SCHIZOPHR RES, V85, P142, DOI 10.1016/j.schres.2006.03.028; Agrawal HR, 2004, HARVARD REV PSYCHIAT, V12, P94, DOI 10.1080/10673220490447218; Aleman A, 2005, PROG NEUROBIOL, V77, P283, DOI 10.1016/j.pneurobio.2005.11.005; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; [Anonymous], 2015, PERSONALITY DISORDER; ARCHER J, 1992, BRIT J CLIN PSYCHOL, V31, P45, DOI 10.1111/j.2044-8260.1992.tb00967.x; Arntz A, 2003, J PERS DISORD, V17, P45, DOI 10.1521/pedi.17.1.45.24053; Arntz A, 1999, BPDSI BORDERLINE PER; Baer RA, 2012, CLIN PSYCHOL REV, V32, P359, DOI 10.1016/j.cpr.2012.03.002; Bankier B, 2001, PSYCHOSOMATICS, V42, P235, DOI 10.1176/appi.psy.42.3.235; Barkl SJ, 2014, SCHIZOPHR RES, V160, P150, DOI 10.1016/j.schres.2014.10.035; Barnow S, 2009, BEHAV RES THER, V47, P359, DOI 10.1016/j.brat.2009.02.003; Bateman A, 2004, PSYCHOTHERAPY BORDER, DOI 10.1093/med:psych/9780198527664.001.0001; Beck A, 1979, COGNITIVE THERAPY DE; Bland Ann R, 2004, Issues Ment Health Nurs, V25, P655, DOI 10.1080/01612840490486692; Brune M, 2005, PSYCHIAT RES, V133, P135, DOI 10.1016/j.psychres.2004.10.007; Burba B, 2006, CAN J PSYCHIAT, V51, P468, DOI 10.1177/070674370605100709; Chan RCK, 2010, PSYCHIAT RES, V178, P381, DOI 10.1016/j.psychres.2009.03.035; Cloitre M, 2002, J CONSULT CLIN PSYCH, V70, P1067, DOI 10.1037//0022-006X.70.5.1067; Daros AR, 2013, PSYCHOL MED, V43, P1953, DOI 10.1017/S0033291712002607; Daros AR, 2014, PERSONAL DISORD, V5, P79, DOI 10.1037/per0000056; Davis MC, 2014, NEUROPSYCHOPHARMACOL, V39, P2070, DOI 10.1038/npp.2014.68; Diamond Adele, ANNU REV PSYCHOL, V64, P135, DOI [DOI 10.1146/annurev-clinpsy-032813-153724, 10.1146/annurev-psych-113011-143750, DOI 10.1146/ANNUREV-PSYCH-113011-143750]; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Domes G, 2008, J PERS DISORD, V22, P135, DOI 10.1521/pedi.2008.22.2.135; Domes G, 2009, J PERS DISORD, V23, P6, DOI 10.1521/pedi.2009.23.1.6; Donegan NH, 2003, BIOL PSYCHIAT, V54, P1284, DOI 10.1016/S0006-3223(03)00636-X; Dyck M, 2009, PSYCHOL MED, V39, P855, DOI 10.1017/S0033291708004273; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Ford J, 2014, COMPLEX PTSD AFFECT, V1, P7; Frigerio E, 2002, PSYCHIAT RES, V113, P161, DOI 10.1016/S0165-1781(02)00244-5; Frith C., 2015, COGNITIVE NEUROPSYCH; Gur R. E, 2014, AM J PSYCHIAT; Hall J, 2008, BIOL PSYCHIAT, V64, P70, DOI 10.1016/j.biopsych.2007.12.014; Herpertz SC, 2001, BIOL PSYCHIAT, V50, P292, DOI 10.1016/S0006-3223(01)01075-7; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Ibanez A, 2012, PSYCHIAT RES, V195, P18, DOI 10.1016/j.psychres.2011.07.027; Irani F, 2012, SCHIZOPHR RES, V137, P203, DOI 10.1016/j.schres.2012.01.023; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Koenigsberg HW, 2002, AM J PSYCHIAT, V159, P784, DOI 10.1176/appi.ajp.159.5.784; Kohler C. G, 2009, SCHIZOPHRENIA B, V192; Kohler CG, 2003, AM J PSYCHIAT, V160, P1768, DOI 10.1176/appi.ajp.160.10.1768; Krabbendam L, 2003, PSYCHOPHARMACOLOGY, V169, P376, DOI 10.1007/s00213-002-1326-5; LANE RD, 1987, AM J PSYCHIAT, V144, P133; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; LEVIN HS, 1975, J PSYCHOL, V91, P223, DOI 10.1080/00223980.1975.9923946; Levine D, 1997, J NERV MENT DIS, V185, P240, DOI 10.1097/00005053-199704000-00004; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Linehan MM, 2006, ARCH GEN PSYCHIAT, V63, P757, DOI 10.1001/archpsyc.63.7.757; Loth E, 2010, NEUROPSYCHOLOGIA, V48, P1227, DOI 10.1016/j.neuropsychologia.2009.12.023; Lynch TR, 2006, EMOTION, V6, P647, DOI 10.1037/1528-3542.6.4.647; Lysaker PH, 2010, ACTA PSYCHIAT SCAND, V122, P405, DOI 10.1111/j.1600-0447.2010.01554.x; Minzenberg MJ, 2007, PSYCHIAT RES-NEUROIM, V155, P231, DOI 10.1016/j.pscychresns.2007.03.006; Mitchell AE, 2014, NEUROPSYCHOL REV, V24, P166, DOI 10.1007/s11065-014-9254-9; Norusis M. J., 2002, SPSS 11 0 GUIDE DATA; Nyklicek I, 2009, PSYCHOL ASSESSMENT, V21, P32, DOI 10.1037/a0014418; Pedrosa Gil Francisco, 2009, Depress Anxiety, V26, pE26, DOI 10.1002/da.20456; Pinkham AE, 2006, PSYCHIAT RES, V143, P167, DOI 10.1016/j.psychres.2005.09.005; Ruocco AC, 2012, PSYCHIAT RES-NEUROIM, V201, P245, DOI 10.1016/j.pscychresns.2012.02.012; Schmahl C, 2006, J PSYCHIATR RES, V40, P419, DOI 10.1016/j.jpsychires.2005.08.011; Schmidt SJ, 2011, SCHIZOPHRENIA BULL, V37, pS41, DOI 10.1093/schbul/sbr079; Schulze L, 2011, PSYCHONEUROENDOCRINO, V36, P1378, DOI 10.1016/j.psyneuen.2011.03.011; Scott LN, 2011, PERSONAL DISORD, V2, P98, DOI 10.1037/a0020011; Shamay-Tsoory SG, 2007, SCHIZOPHR RES, V90, P274, DOI 10.1016/j.schres.2006.09.020; Silver H, 2006, SCHIZOPHR RES, V85, P151, DOI 10.1016/j.schres.2006.02.027; Subic-Wrana C, 2010, PSYCHOSOM MED, V72, P404, DOI 10.1097/PSY.0b013e3181d35e83; Taylor SF, 2012, BIOL PSYCHIAT, V71, P136, DOI 10.1016/j.biopsych.2011.09.007; TERSMITTEN M, 1998, COMPOSITE INT DIAGNO; Unoka Z, 2011, PSYCHIAT RES, V189, P419, DOI 10.1016/j.psychres.2011.02.010; Van Dijke A., 2008, AFFECT REGULATION CO, P150; van Dijke A, 2013, PSYCHOPATHOLOGY, V46, P153, DOI 10.1159/000338832; van Dijke A, 2012, PSYCHOL TRAUMA-US, V4, P162, DOI 10.1037/a0025732; van Dijke A, 2010, J TRAUMA DISSOCIATIO, V11, P424, DOI 10.1080/15299732.2010.496140; van Dijke A, 2010, J PERS DISORD, V24, P296, DOI 10.1521/pedi.2010.24.3.296; van't Wout M, 2004, SCHIZOPHR RES, V68, P271, DOI 10.1016/j.schres.2003.09.006; van't Wout M, 2007, J NERV MENT DIS, V195, P758, DOI 10.1097/NMD.0b013e318142cc31; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wagner AW, 1999, J PERS DISORD, V13, P329, DOI 10.1521/pedi.1999.13.4.329; Waller E, 2006, INT REV PSYCHIATR, V18, P13, DOI 10.1080/09540260500466774; Waller E, 2004, J PSYCHOSOM RES, V57, P239, DOI 10.1016/S0022-3999(03)00613-5; WEAVER TL, 1993, J CONSULT CLIN PSYCH, V61, P1068, DOI 10.1037/0022-006X.61.6.1068; Williams LM, 1999, SCHIZOPHR RES, V40, P189, DOI 10.1016/S0920-9964(99)00056-0; Wood Stephen J., 2009, NEUROPSYCHOLOGY MENT; World Health Organization, 1990, COMP INT DIAGN INT C; van t'wout M, 2007, PSYCHIAT RES, V150, P227, DOI 10.1016/j.psychres.2006.03.010; 2002, PSYCHOL SOFTWARE TOO	86	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0154145	10.1371/journal.pone.0154145	http://dx.doi.org/10.1371/journal.pone.0154145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KO	27300727	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200003
J	Wang, Y; Chen, YJ; Ding, LP; Zhang, JW; Wei, JH; Wang, HZ				Wang, Ying; Chen, Yajuan; Ding, Liping; Zhang, Jiewei; Wei, Jianhua; Wang, Hongzhi			Validation of Reference Genes for Gene Expression by Quantitative Real-Time RT-PCR in Stem Segments Spanning Primary to Secondary Growth in Populus tomentosa	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RELIABLE REFERENCE GENES; ACCURATE NORMALIZATION; HOUSEKEEPING GENES; SELECTION; IDENTIFICATION; BIOSYNTHESIS; TRICHOCARPA; SOFTWARE; STRESSES	The vertical segments of Populus stems are an ideal experimental system for analyzing the gene expression patterns involved in primary and secondary growth during wood formation. Suitable internal control genes are indispensable to quantitative real time PCR (qRT-PCR) assays of gene expression. In this study, the expression stability of eight candidate reference genes was evaluated in a series of vertical stem segments of Populus tomentosa. Analysis through software packages geNorm, NormFinder and BestKeeper showed that genes ribosomal protein (RP) and tubulin beta (TUBB) were the most unstable across the developmental stages of P. tomentosa stems, and the combination of the three reference genes, eukaryotic translation initiation factor 5A (eIF5A), Actin (ACT6) and elongation factor 1-beta (EF1-beta) can provide accurate and reliable normalization of qRT-PCR analysis for target gene expression in stem segments undergoing primary and secondary growth in P. tomentosa. These results provide crucial information for transcriptional analysis in the P. tomentosa stem, which may help to improve the quality of gene expression data in these vertical stemsegments, which constitute an excellent plant system for the study of wood formation.	[Wang, Ying; Chen, Yajuan; Ding, Liping; Zhang, Jiewei; Wei, Jianhua; Wang, Hongzhi] Beijing Acad Agr & Forestry Sci, Beijing Key Lab Agr Gene Resource & Biotechnol, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Wei, JH; Wang, HZ (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Key Lab Agr Gene Resource & Biotechnol, Beijing, Peoples R China.	weijianhua@baafs.net.cn; wanghongzhi@baafs.net.cn			National Natural Science Foundation of China [31270593]; State 863 High-Tech Program of China [2013AA102702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State 863 High-Tech Program of China(National High Technology Research and Development Program of China)	This work was funded by National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to HW (31270593) as a principal investigator and by the State 863 High-Tech Program of China (http://www.most.gov.cn/bszn/new/863/bslc/) to JW as one of the co-principal investigators (2013AA102702).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brentner LB, 2008, CHEMOSPHERE, V73, P657, DOI 10.1016/j.chemosphere.2008.07.059; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Duval I, 2009, PLANT CELL REP, V28, P811, DOI 10.1007/s00299-009-0670-x; Galeano Esteban, 2014, BMC Res Notes, V7, P464, DOI 10.1186/1756-0500-7-464; Galli V, 2015, GENE, V554, P205, DOI 10.1016/j.gene.2014.10.049; Groover A, 2006, CURR OPIN PLANT BIOL, V9, P55, DOI 10.1016/j.pbi.2005.11.013; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Han KH, 2007, BIOFUEL BIOPROD BIOR, V1, P135, DOI 10.1002/bbb.14; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; LARSON P R, 1971, Canadian Journal of Forest Research, V1, P1, DOI 10.1139/x71-001; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Lu SF, 2001, ACTA BOT SIN, V43, P435; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Pettengill Emily A, 2012, BMC Res Notes, V5, P366, DOI 10.1186/1756-0500-5-366; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Prassinos C, 2005, PLANT CELL PHYSIOL, V46, P1213, DOI 10.1093/pcp/pci130; Ray Debashree L, 2014, BMC Res Notes, V7, P304, DOI 10.1186/1756-0500-7-304; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Simon Bindu, 2013, BMC Res Notes, V6, P397, DOI 10.1186/1756-0500-6-397; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; van Raemdonck D, 2005, J EXP BOT, V56, P2211, DOI 10.1093/jxb/eri221; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HL, 2014, PHYSIOL PLANTARUM, V152, P529, DOI 10.1111/ppl.12206; Wang HZ, 2012, MOL PLANT, V5, P297, DOI 10.1093/mp/ssr098; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Yang XH, 2014, GENET MOL RES, V13, P9489, DOI 10.4238/2014.November.11.14; Zhang DQ, 2010, MOL GENET GENOMICS, V284, P105, DOI 10.1007/s00438-010-0552-5; Zhang L, 2013, INT J MOL SCI, V14, P24338, DOI 10.3390/ijms141224338; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005	39	17	17	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157370	10.1371/journal.pone.0157370	http://dx.doi.org/10.1371/journal.pone.0157370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300480	Green Published, Green Submitted, gold			2022-12-27	WOS:000377822200041
J	Zhang, J; Qiao, CZ; Chang, L; Guo, YH; Fan, YB; Villacorta, L; Chen, YE; Zhang, JF				Zhang, Ji; Qiao, Congzhen; Chang, Lin; Guo, Yanhong; Fan, Yanbo; Villacorta, Luis; Chen, Y. Eugene; Zhang, Jifeng			Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy	PLOS ONE			English	Article							ACID-BINDING PROTEIN; ACTIVATED RECEPTOR-GAMMA; CARDIAC-HYPERTROPHY; DIASTOLIC DYSFUNCTION; SIGNALING PATHWAY; ADIPOSE-TISSUE; IN-VIVO; ADIPOCYTE; EXPRESSION; DISEASE	Fatty acid binding protein 4 (FABP4) is a member of the intracellular lipid-binding protein family, responsible for the transportation of fatty acids. It is considered to express mainly in adipose tissues, and be strongly associated with inflammation, obesity, diabetes and cardiovasculardiseases. Here we report that FABP4 is also expressed in cardiomyocytes and plays an important role in regulating heart function under pressure overload. We generated heart-specific transgenic FABP4 (FABP4-TG) mice using a myosin-heavy chain (alpha-MHC) promoter and human FABP4 sequence, resulting in over-expression of FABP4 in cardiomyocytes. The FABP4-TG mice displayed normal cardiac morphology and contractile function. When they were subjected to the transverse aorta constriction (TAC) procedure, the FABP4-TG mice developed more cardiac hypertrophy correlated with significantly increased ERK phosphorylation, compared with wild type controls. FABP4 over-expression in cardiomyocytes activated phosphor-ERK signal and up-regulate the expression of cardiac hypertrophic marker genes. Conversely, FABP4 induced phosphor-ERK signal and hypertrophic gene expressions can be markedly inhibited by an ERK inhibitor PD098059 as well as the FABP4 inhibitor BMS309403. These results suggest that FABP4 over-expression in cardiomyocytes can aggravate the development of cardiac hypertrophy through the activation of ERK signal pathway.	[Zhang, Ji; Qiao, Congzhen; Chang, Lin; Guo, Yanhong; Fan, Yanbo; Villacorta, Luis; Chen, Y. Eugene; Zhang, Jifeng] Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Zhang, J; Chen, YE (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA.	jifengz@umich.edu; echenum@umich.edu	Villacorta, Luis/E-8937-2011; Fan, Yanbo/C-6360-2013; Guo, Yanhong/D-9764-2012; Fan, Yanbo/AAD-4710-2020	Villacorta, Luis/0000-0001-7824-7028; Fan, Yanbo/0000-0002-3845-7562; Fan, Yanbo/0000-0002-3845-7562	National Institute of Health [HL068878, HL105114, HL088391]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088391, R01HL105114, R01HL068878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported wholly by National Institute of Health Grants HL068878, HL105114, and HL088391 (to YEC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported, in whole or in part, by National Institute of Health Grants HL068878, HL105114, and HL088391 (to Y.E.C.). Special thanks are extended to Dr. Aimin Xu from the University of Hong Kong for the FABP4 knockout mouse tissue samples and other reagents.	Allard MF, 2004, CURR HYPERTENS REP, V6, P430, DOI 10.1007/s11906-004-0036-2; Baessler A, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.3; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Carvajal K, 2003, ARCH MED RES, V34, P89, DOI 10.1016/S0188-4409(03)00004-3; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chang L, 2009, CIRCULATION, V119, P2161, DOI 10.1161/CIRCULATIONAHA.108.815803; Chow WS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004176; DEVEREUX RB, 1987, J CLIN HYPERTENS, V3, P87; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Kabaeva Z, 2008, AM J PHYSIOL-HEART C, V294, pH1667, DOI 10.1152/ajpheart.01144.2007; Kannel WB, 1997, CARDIOVASC DRUG THER, V11, P199, DOI 10.1023/A:1007792820944; Korner P I, 1995, Blood Press Suppl, V2, P6; Kostis JB, 2003, AM J HYPERTENS, V16, p18S, DOI 10.1016/S0895-7061(03)00966-X; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Lan H, 2011, J LIPID RES, V52, P646, DOI 10.1194/jlr.M012757; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Liu MY, 2013, CLIN SCI, V124, P115, DOI 10.1042/CS20120004; Liu QY, 2007, MOL CELL BIOCHEM, V302, P203, DOI 10.1007/s11010-007-9442-5; Agra R, 2014, INFLAMMATION, V37, P1504, DOI 10.1007/s10753-014-9876-3; Meng RS, 2011, ARCH BIOCHEM BIOPHYS, V511, P1, DOI 10.1016/j.abb.2011.04.010; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P2604, DOI 10.1001/jama.2013.284788; Nishikimi T, 1996, HYPERTENSION, V28, P22, DOI 10.1161/01.HYP.28.1.22; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; PASSMAN RS, 1994, J CLIN INVEST, V94, P2421, DOI 10.1172/JCI117609; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Ritchie RH, 2006, CLIN EXP PHARMACOL P, V33, P159, DOI 10.1111/j.1440-1681.2006.04342.x; Salgado-Somoza A, 2012, ATHEROSCLEROSIS, V224, P492, DOI 10.1016/j.atherosclerosis.2012.07.014; Schlottmann I, 2014, INT J OBESITY, V38, P1221, DOI 10.1038/ijo.2013.241; Shin J, 2009, J ANIM SCI, V87, P3923, DOI 10.2527/jas.2009-2124; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Thumser AE, 2014, CURR OPIN CLIN NUTR, V17, P124, DOI 10.1097/MCO.0000000000000031; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tso AWK, 2011, NEUROLOGY, V76, P1968, DOI 10.1212/WNL.0b013e31821e54b3; Usui S, 2006, J MOL CELL CARDIOL, V41, P219, DOI 10.1016/j.yjmcc.2006.05.006; van Bilsen M, 2004, CARDIOVASC RES, V61, P218, DOI 10.1016/j.cardiores.2003.11.014; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu HL, 2015, MOL CELL BIOL, V35, P1055, DOI 10.1128/MCB.01122-14; Yap LB, 2004, CLIN BIOCHEM, V37, P847, DOI 10.1016/j.clinbiochem.2004.06.002; Yeung DCY, 2009, DIABETES CARE, V32, P132, DOI 10.2337/dc08-1333; Zhang J, 2011, CARDIOVASC RES, V91, P90, DOI 10.1093/cvr/cvr068; Zhou M, 2015, CLIN SCI, V129, P547, DOI 10.1042/CS20150073	52	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157372	10.1371/journal.pone.0157372	http://dx.doi.org/10.1371/journal.pone.0157372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294862	Green Submitted, Green Published, gold			2022-12-27	WOS:000377821300037
J	Chen, DQ; Kluz, T; Fang, L; Zhang, XR; Sun, H; Jin, CY; Costa, M				Chen, Danqi; Kluz, Thomas; Fang, Lei; Zhang, Xiaoru; Sun, Hong; Jin, Chunyuan; Costa, Max			Hexavalent Chromium (Cr(VI)) Down-Regulates Acetylation of Histone H4 at Lysine 16 through Induction of Stressor Protein Nupr1	PLOS ONE			English	Article							CELL LUNG-CANCER; MISMATCH REPAIR; IN-VITRO; H4K16 ACETYLATION; MAMMALIAN-CELLS; GENE-EXPRESSION; DNA-DAMAGE; P8; CHROMATE; MOF	The environmental and occupational carcinogen Hexavalent Chromium (Cr(VI)) has been shown to cause lung cancer in humans when inhaled. In spite of a considerable research effort, the mechanisms of Cr(VI)-induced carcinogenesis remain largely unknown. Nupr1 (nuclear protein 1) is a small, highly basic, and unfolded protein with molecular weight of 8,800 daltons and is induced by a variety of stressors. Studies in animal models have suggested that Nupr1 is a key factor in the development of lung and pancreatic cancers, with little known about the underlying molecular mechanisms. Here we report that the level of Nupr1 is significantly increased in human bronchial epithelial BEAS2B cells following exposure to Cr(VI) through epigenetic mechanisms. Interestingly, Cr(VI) exposure also results in the loss of acetylation at histone H4K16, which is considered a 'hallmark' of human cancer. Cr(VI)-induced reduction of H4K16 acetylation appears to be caused by the induction of Nupr1, since (a) overexpression of Nupr1 decreased the levels of both H4K16 acetylation and the histone acetyltransferase MOF (male absent on the first; also known as Kat8, Myst 1), which specifically acetylates H4K16; (b) the loss of acetylation of H4K16 upon Cr(VI) exposure is greatly compromised by knockdown of Nupr1. Moreover, Nupr1-induced reduction of H4K16 acetylation correlates with the transcriptional down-regulation at several genomic loci. Notably, overexpression of Nupr1 induces anchorage-independent cell growth and knockdown of Nupr1 expression prevents Cr(VI)-induced cell transformation. We propose that Cr(VI) induces Nupr1 and rapidly perturbs gene expression by downregulating H4K16 acetylation, thereby contributing to Cr(VI)-induced carcinogenesis.	[Chen, Danqi; Kluz, Thomas; Fang, Lei; Zhang, Xiaoru; Sun, Hong; Jin, Chunyuan; Costa, Max] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA; [Jin, Chunyuan; Costa, Max] NYU, Sch Med, Dept Mol Pharmacol & Biochem, New York, NY USA	New York University; New York University	Jin, CY; Costa, M (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA.; Jin, CY; Costa, M (corresponding author), NYU, Sch Med, Dept Mol Pharmacol & Biochem, New York, NY USA.	Chunyuan.jin@nyumc.org; Max.costa@nyumc.org	Jin, Chunyuan/GRX-9623-2022; Chen, Danqi/AAP-1269-2020	Fang, Lei/0000-0002-2582-4845	National Institutes of Health, National Institute of Environmental Health Sciences [R01ES023174, P30ES000260, R01ES022935, 1R01ES026138-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022935, R01ES023174, R01ES026138] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health, National Institute of Environmental Health Sciences grants R01ES023174, P30ES000260, R01ES022935 (to MC), and 1R01ES026138-01 (to MC and CJ).	Aldrich MV, 2003, ENVIRON SCI TECHNOL, V37, P1859, DOI 10.1021/es0208916; [Anonymous], 2008, NATL TOXICOL PROGRAM, V546, P1; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Cheng RYS, 2004, MOL CARCINOGEN, V40, P1, DOI 10.1002/mc.20022; Chowdhury U, 2009, CANCER METAST REV, V28, P225, DOI 10.1007/s10555-009-9183-x; Chun SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119379; Clark DW, 2008, CURR CANCER DRUG TAR, V8, P421, DOI 10.2174/156800908785133196; Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gibb HJ, 2000, AM J IND MED, V38, P115, DOI 10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.3.CO;2-P; Gironella M, 2009, J CELL PHYSIOL, V221, P594, DOI 10.1002/jcp.21889; Goruppi S, 2007, MOL CELL BIOL, V27, P993, DOI 10.1128/MCB.00996-06; Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887; Guo XT, 2012, ANAT REC, V295, P2114, DOI 10.1002/ar.22571; Gupta A, 2008, MOL CELL BIOL, V28, P397, DOI 10.1128/MCB.01045-07; Hamidi T, 2012, J CLIN INVEST, V122, P2092, DOI 10.1172/JCI60144; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Horikoshi Nobuo, 2013, Genome Integr, V4, P3, DOI 10.1186/2041-9414-4-3; Ito Y, 2005, ANTICANCER RES, V25, P3419; Jiang YF, 1999, BIOCHEM BIOPH RES CO, V260, P686, DOI 10.1006/bbrc.1999.0953; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Katoh H, 2011, MOL CELL, V44, P770, DOI 10.1016/j.molcel.2011.10.012; Kondo K, 2006, LUNG CANCER, V53, P295, DOI 10.1016/j.lungcan.2006.05.022; LeRoy G, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-20; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Lou JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071031; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Nickens KP, 2010, CHEM-BIOL INTERACT, V188, P276, DOI 10.1016/j.cbi.2010.04.018; Ovesen JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097849; Peterson-Roth E, 2005, MOL CELL BIOL, V25, P3596, DOI 10.1128/MCB.25.9.3596-3607.2005; Proctor DM, 2014, TOXICOLOGY, V325, P160, DOI 10.1016/j.tox.2014.08.009; Ree AH, 1999, CANCER RES, V59, P4675; Reynolds M, 2007, CARCINOGENESIS, V28, P1613, DOI 10.1093/carcin/bgm031; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Song JS, 2012, PATHOL INT, V62, P182, DOI 10.1111/j.1440-1827.2011.02776.x; Sun H, 2009, TOXICOL APPL PHARM, V237, P258, DOI 10.1016/j.taap.2009.04.008; Taieb D, 2005, HEPATOLOGY, V42, P176, DOI 10.1002/hep.20759; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Taylor GCA, 2013, GENOME RES, V23, P2053, DOI 10.1101/gr.155028.113; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Vasseur S, 2002, EMBO REP, V3, P165, DOI 10.1093/embo-reports/kvf023; Veerla S, 2008, GENE CHROMOSOME CANC, V47, P368, DOI 10.1002/gcc.20542; Wei YD, 2004, J BIOL CHEM, V279, P4110, DOI 10.1074/jbc.M310800200; Zhitkovich A, 1996, BIOCHEMISTRY-US, V35, P7275, DOI 10.1021/bi960147w; ZHITKOVICH A, 1995, CARCINOGENESIS, V16, P907, DOI 10.1093/carcin/16.4.907; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	51	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157317	10.1371/journal.pone.0157317	http://dx.doi.org/10.1371/journal.pone.0157317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285315	gold, Green Submitted, Green Published			2022-12-27	WOS:000377564000056
J	Klein-Theyer, A; Horwath-Winter, J; Rabensteiner, DF; Schwantzer, G; Wultsch, G; Aminfar, H; Heidinger, A; Boldin, I				Klein-Theyer, Angelika; Horwath-Winter, Jutta; Rabensteiner, Dieter Franz; Schwantzer, Gerold; Wultsch, Georg; Aminfar, Haleh; Heidinger, Andrea; Boldin, Ingrid			The Impact of Visual Guided Order Picking on Ocular Comfort, Ocular Surface and Tear Function	PLOS ONE			English	Article							COMPUTER VISION SYNDROME; BLINK RATE; DRY EYE; DISPLAY; SYMPTOMS	Purpose We investigated the effects of a visual picking system on ocular comfort, the ocular surface and tear function compared to those of a voice guided picking solution. Design Prospective, observational, cohort study. Method Setting: Institutional. Study Population: A total of 25 young asymptomatic volunteers performed commissioning over 10 hours on two consecutive days. Main Outcome Measures: The operators were guided in the picking process by two different picking solutions, either visually or by voice while their subjective symptoms and ocular surface and tear function parameters were recorded. Results The visual analogue scale (VAS) values, according to subjective dry eye symptoms, in the visual condition were significantly higher at the end of the commissioning than the baseline measurements. In the voice condition, the VAS values remained stable during the commissioning. The tear break-up time (BUT) values declined significantly in the visual condition (pre-task: 16.6 sec and post-task: 9.6 sec) in the right eyes, that were exposed to the displays, the left eyes in the visual condition showed only a minor decline, whereas the BUT values in the voice condition remained constant (right eyes) or even increased (left eyes) over the time. No significant differences in the tear meniscus height values before and after the commissioning were observed in either condition. Conclusion In our study, the use of visually guided picking solutions was correlated with post-task subjective symptoms and tear film instability.	[Klein-Theyer, Angelika; Horwath-Winter, Jutta; Rabensteiner, Dieter Franz; Aminfar, Haleh; Heidinger, Andrea; Boldin, Ingrid] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Schwantzer, Gerold] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Wultsch, Georg] Med Univ Graz, AMEZ Graz Occupat Hlth Ctr, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Klein-Theyer, A (corresponding author), Med Univ Graz, Dept Ophthalmol, Graz, Austria.	angelika.klein@medunigraz.at	Schwantzer, Gerold/A-3209-2012	Schwantzer, Gerold/0000-0003-3349-1101				Abelson MB, 2010, REV OPHTHALMOL, V17, P92; Acosta MC, 1999, EXP EYE RES, V68, P663, DOI 10.1006/exer.1998.0656; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; Cardona G, 2011, CURR EYE RES, V36, P190, DOI 10.3109/02713683.2010.544442; Cole BL, 1996, OPTOMETRY VISION SCI, V73, P512, DOI 10.1097/00006324-199608000-00001; Goto E, 2001, CORNEA, V20, P807, DOI 10.1097/00003226-200111000-00006; Himebaugh NL, 2009, OPTOMETRY VISION SCI, V86, P106, DOI 10.1097/OPX.0b013e318194e962; Iwakiri Kazuyuki, 2004, Sangyo Eiseigaku Zasshi, V46, P201, DOI 10.1539/sangyoeisei.46.201; Miyake-Kashima M, 2005, CORNEA, V24, P567, DOI 10.1097/01.ico.0000151564.24989.38; Mocci F, 2001, OCCUP ENVIRON MED, V58, P267, DOI 10.1136/oem.58.4.267; OCULUS Inc, KERATOGRAPH 5M; PATEL S, 1991, OPTOMETRY VISION SCI, V68, P888, DOI 10.1097/00006324-199111000-00010; Portello JK, 2012, OPHTHAL PHYSL OPT, V32, P375, DOI 10.1111/j.1475-1313.2012.00925.x; Rosenfield M, 2011, OPHTHAL PHYSL OPT, V31, P502, DOI 10.1111/j.1475-1313.2011.00834.x; Salibello C, 1995, J Am Optom Assoc, V66, P479; Schlote T, 2004, GRAEF ARCH CLIN EXP, V242, P306, DOI 10.1007/s00417-003-0845-z; Shima M, 1993, Nihon Eiseigaku Zasshi, V47, P1032; Studeli T, 2001, BERICHT ZUM 47 ARBEI, P111; Taino G, 2006, G Ital Med Lav Ergon, V28, P487; Teoh SC, 2012, J OPTOMET, V5, P56; Tsubota K, 1999, BRIT J OPHTHALMOL, V83, P390, DOI 10.1136/bjo.83.4.390; Uchino M, 2013, AM J OPHTHALMOL, V156, P759, DOI 10.1016/j.ajo.2013.05.040; Vincent SJ, 2015, OPHTHAL PHYSL OPT, V35, P552, DOI 10.1111/opo.12225	23	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157564	10.1371/journal.pone.0157564	http://dx.doi.org/10.1371/journal.pone.0157564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314855	gold, Green Published, Green Submitted			2022-12-27	WOS:000378030000035
J	Lee, SY; Kim, JH; Seo, TK; No, JS; Kim, H; Kim, WK; Choi, HG; Kang, SH; Song, JW				Lee, Sook-Young; Kim, Jeong-Hoon; Seo, Tae-Kun; No, Jin Sun; Kim, Hankyeom; Kim, Won-Keun; Choi, Han-Gu; Kang, Sung-Ho; Song, Jin-Won			Genetic and Molecular Epidemiological Characterization of a Novel Adenovirus in Antarctic Penguins Collected between 2008 and 2013	PLOS ONE			English	Article							COMPLETE DNA-SEQUENCE; AVIAN ADENOVIRUS; GENOME ANALYSIS; CHINSTRAP PENGUINS; ORGANIZATION; ADELIE; IDENTIFICATION; COMPLETION; INFECTION; LINEAGE	Antarctica is considered a relatively uncontaminated region with regard to the infectious diseases because of its extreme environment, and isolated geography. For the genetic characterization and molecular epidemiology of the newly found penguin adenovirus in Antarctica, entire genome sequencing and annual survey of penguin adenovirus were conducted. The entire genome sequences of penguin adenoviruses were completed for two Chinstrap penguins (Pygoscelis antarctica) and two Gentoo penguins (Pygoscelis papua). The whole genome lengths and G+ C content of penguin adenoviruses were found to be 24,63024,662 bp and 35.5-35.6%, respectively. Notably, the presence of putative sialidase gene was not identified in penguin adenoviruses by Rapid Amplification of cDNA Ends (RACEPCR) as well as consensus specific PCR. The penguin adenoviruses were demonstrated to be a new species within the genus Siadenovirus, with a distance of 29.9-39.3%(amino acid, 32.1-47.9%) in DNA polymerase gene, and showed the closest relationship with turkey adenovirus 3 (TAdV-3) in phylogenetic analysis. During the 2008-2013 study period, the penguin adenoviruses were annually detected in 22 of 78 penguins (28.2%), and the molecular epidemiological study of the penguin adenovirus indicates a predominant infection in Chinstrap penguin population (12/30, 40%). Interestingly, the genome of penguin adenovirus could be detected in several internal samples, except the lymph node and brain. In conclusion, an analysis of the entire adenoviral genomes from Antarctic penguins was conducted, and the penguin adenoviruses, containing unique genetic character, were identified as a new species within the genus Siadenovirus. Moreover, it was annually detected in Antarctic penguins, suggesting its circulation within the penguin population.	[Lee, Sook-Young; No, Jin Sun; Kim, Won-Keun; Song, Jin-Won] Korea Univ, Coll Med, Dept Microbiol, Seoul 136705, South Korea; [Kim, Jeong-Hoon; Seo, Tae-Kun; Choi, Han-Gu] Korea Polar Res Inst, Div Life Sci, Inchon, South Korea; [Kim, Hankyeom] Korea Univ, Guro Hosp, Coll Med, Dept Pathol, Seoul, South Korea; [Kang, Sung-Ho] Korea Polar Res Inst, Div Polar Ocean Environm, Inchon, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Korea University; Korea University Medicine (KU Medicine); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Song, JW (corresponding author), Korea Univ, Coll Med, Dept Microbiol, Seoul 136705, South Korea.	jwsong@korea.ac.kr	Song, Jin/HHS-8731-2022		Korea Polar Research Institute, Korea [PC12010, PE15020]; Polar Academic Program	Korea Polar Research Institute, Korea(Korea Polar Research Institute of Marine Research Placement (KOPRI)); Polar Academic Program	This work was supported by grants PC12010 (Polar Academic Program) and PE15020 provided by the Korea Polar Research Institute, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jin Woo Jung, Min-Goo Lee, Kyeong Hoon Cho, and Yeong Woong Kim for assistance in sample collection. This work was supported by Polar Academic Program and Korea Polar Research Institute, Korea.	Aggarwal N, 2000, INTERVIROLOGY, V43, P6, DOI 10.1159/000025016; Beach NM, 2009, J GEN VIROL, V90, P1978, DOI 10.1099/vir.0.010090-0; Benko M, 2014, ICTV OFFICIAL TAXONO; Berk AJ, 2007, FIELDS VIROLOGY, P2355; Chiocca S, 1996, J VIROL, V70, P2939, DOI 10.1128/JVI.70.5.2939-2949.1996; Chown SL, 2012, SCIENCE, V337, P158, DOI 10.1126/science.1222821; Dan A, 1998, J GEN VIROL, V79, P1453; DAVISON AJ, 1993, J MOL BIOL, V234, P1308, DOI 10.1006/jmbi.1993.1687; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Davison AJ, 2000, J GEN VIROL, V81, P2431, DOI 10.1099/0022-1317-81-10-2431; Farkas SL, 2008, VIRUS RES, V132, P132, DOI 10.1016/j.virusres.2007.11.009; Grimaldi WW, 2015, POLAR BIOL, V38, P591, DOI 10.1007/s00300-014-1632-5; Harrach B, 1995, VIRUS TAXONOMY, V9, P125; Hess M, 1997, VIROLOGY, V238, P145, DOI 10.1006/viro.1997.8815; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Hurt AC, 2014, MBIO, V5, DOI 10.1128/mBio.01098-14; Joseph HM, 2014, VET MICROBIOL, V172, P35, DOI 10.1016/j.vetmic.2014.04.006; Katoh H, 2009, VIRUS RES, V144, P294, DOI 10.1016/j.virusres.2009.04.012; Kerry K., 1998, DIS ANTARCTIC WILDLI, V18, P89; Kohl C, 2012, J VIROL, V86, P1888, DOI 10.1128/JVI.05974-11; Kovacs ER, 2011, INFECT GENET EVOL, V11, P1058, DOI 10.1016/j.meegid.2011.03.021; Kovacs ER, 2010, J VIROL METHODS, V163, P262, DOI 10.1016/j.jviromet.2009.10.007; Kovacs GM, 2004, J GEN VIROL, V85, P2799, DOI 10.1099/vir.0.80225-0; Kovacs GM, 2003, VIRUS RES, V98, P27, DOI 10.1016/j.virusres.2003.08.010; Lee SY, 2014, VIRUSES-BASEL, V6, P2052, DOI 10.3390/v6052052; Meissner JD, 1997, VIRUS RES, V51, P53, DOI 10.1016/S0168-1702(97)00079-8; Miller AK, 2010, CONDOR, V112, P683, DOI 10.1525/cond.2010.090221; Morrison MD, 1997, J GEN VIROL, V78, P873, DOI 10.1099/0022-1317-78-4-873; Park YM, 2012, VIROLOGY, V422, P144, DOI 10.1016/j.virol.2011.10.008; Pitcovski J, 1998, VIROLOGY, V249, P307, DOI 10.1006/viro.1998.9336; Rivera S, 2009, J VET DIAGN INVEST, V21, P415, DOI 10.1177/104063870902100402; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rusvai M, 2000, VIRUS RES, V70, P25, DOI 10.1016/S0168-1702(00)00201-X; Singh AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139339; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TRIVELPIECE WZ, 1987, ECOLOGY, V68, P351, DOI 10.2307/1939266; Varsani A, 2015, J GEN VIROL, V96, P851, DOI 10.1099/vir.0.000038; Varsani A, 2014, J GEN VIROL, V95, P1352, DOI 10.1099/vir.0.064436-0; Wellehan JFX, 2009, AVIAN PATHOL, V38, P413, DOI 10.1080/03079450903183660	39	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157032	10.1371/journal.pone.0157032	http://dx.doi.org/10.1371/journal.pone.0157032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309961	Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800030
J	Orang'o, EO; Wachira, J; Asirwa, FC; Busakhala, N; Naanyu, V; Kisuya, J; Otieno, G; Keter, A; Mwangi, A; Inui, T				Orang'o, Elkanah Omenge; Wachira, Juddy; Asirwa, Fredrick Chite; Busakhala, Naftali; Naanyu, Violet; Kisuya, Job; Otieno, Grieven; Keter, Alfred; Mwangi, Ann; Inui, Thomas			Factors Associated with Uptake of Visual Inspection with Acetic Acid (VIA) for Cervical Cancer Screening in Western Kenya	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INFECTED WOMEN; SINGLE-VISIT; PREVENTION; ACCEPTABILITY; INDIA; FEASIBILITY; VACCINATION; THAILAND; LESIONS	Purpose Cervical cancer screening has been successful in reducing the rates of cervical cancer in developed countries, but this disease remains the leading cause of cancer deaths among women in sub-Saharan Africa. We sought to understand factors associated with limited uptake of screening services in our cervical cancer-screening program in Western Kenya. Participants and Methods Using items from a previously validated cancer awareness questionnaire repurposed for use in cervical cancer and culturally adapted for use in Kenya, we interviewed 2,505 women aged 18-55 years receiving care in gynecology clinics or seeking other services in 4 health facilities in Western Kenya between April 2014 and September 2014. We used logistic regression modeling to assess factors associated with uptake (or non-uptake), associated odds ratios (ORs) and the 95% confidence intervals (95% CI). Results Only two hundred and seventy-three women out of 2505 (11%) accepted VIA cervical cancer screening. Knowledge of just how women are screened for cervical cancer was significantly associated with reduced uptake of cervical cancer screening (OR: 0.53; CI 0.380.73) as was fear that screening would reveal a cancer (OR 0.70; CI 0.63-0.77), and reliance on prayer with the onset of illness (OR 0.43; CI 0.26-0.71). Participants who thought that one should get cervical cancer screening even if there were no symptoms were more than twice as likely to accept cervical cancer screening (OR 2.21; 95% CI 1.24-3.93). Older patients, patients living with HIV and women who do not know if bleeding immediately after sex might be a sign of cervical cancer were also more likely to accept screening (OR 1.03, CI 1.02-1.04; OR 1.78, CI 1.01-3.14; OR 2.39, CI 1.31-4.39, respectively). Conclusions In our population, a high percent of women knew that it is appropriate for all women to get cervical cancer screening, but only a small proportion of women actually got screening. There may be an opportunity to design educational materials for this population that will not only encourage participation in cervical cancer screening but also remediate misconceptions. The discussion illustrates how our findings could be used in such an effort.	[Orang'o, Elkanah Omenge; Wachira, Juddy; Asirwa, Fredrick Chite; Busakhala, Naftali; Naanyu, Violet; Kisuya, Job; Otieno, Grieven; Keter, Alfred; Mwangi, Ann; Inui, Thomas] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Orang'o, Elkanah Omenge] Moi Univ, Coll Hlth Sci, Sch Med, Dept Reprod Hlth, Eldoret, Kenya; [Busakhala, Naftali] Moi Univ, Coll Hlth Sci, Sch Med, Dept Pharmacol Oncol, Eldoret, Kenya; [Naanyu, Violet; Mwangi, Ann] Moi Univ, Coll Hlth Sci, Sch Med, Dept Behav Sci, Eldoret, Kenya; [Asirwa, Fredrick Chite; Inui, Thomas] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46204 USA; [Asirwa, Fredrick Chite; Inui, Thomas] Regenstrief Inst Inc, Indianapolis, IN USA	Moi University; Moi University; Moi University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Orang'o, EO (corresponding author), Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya.; Orang'o, EO (corresponding author), Moi Univ, Coll Hlth Sci, Sch Med, Dept Reprod Hlth, Eldoret, Kenya.	bworango@mu.ac.ke	Naanyu, Violet/AAL-6106-2020; Asirwa, Fredrick Chite/AAS-3461-2021; Naanyu, Violet/GNM-8783-2022	Naanyu, Violet/0000-0003-0182-1719; Naanyu, Violet/0000-0003-0182-1719; Orango, Elkanah Omenge/0000-0003-1551-244X; Otieno, Grieven/0000-0002-3053-1369; Kisuya, Job/0000-0003-4988-7266	Walther Cancer Foundation, Inc. [IU 0110.01]	Walther Cancer Foundation, Inc.	This study was supported by a grant (IU 0110.01) from the Walther Cancer Foundation, Inc. (http://www.walther.org/) to Indiana University. Their respective universities supported all authors in the Walther Cancer research team, and no individuals employed or contracted by the Walther Cancer Foundation played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, OBSTET GYNECOL, V127, pe1, DOI [10.1097/AOG.0000000000001263, DOI 10.1097/AOG.0000000000001263]; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Brewster WR, 2005, JAMA-J AM MED ASSOC, V294, P2182, DOI 10.1001/jama.294.17.2182; Cox DS, 2010, HEALTH PSYCHOL, V29, P29, DOI 10.1037/a0016942; De Vuyst H, 2005, INT J GYNECOL OBSTET, V89, P120, DOI 10.1016/j.ijgo.2005.01.035; Delmas MC, 2000, AIDS, V14, P1775, DOI 10.1097/00002030-200008180-00013; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Gorin SNS, 2011, ADV THER, V28, P615, DOI 10.1007/s12325-011-0045-x; Huh WK, 2009, OBSTET GYNECOL, V114, P139, DOI 10.1097/AOG.0b013e3181ab6878; Jia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067005; Katharine W, 1997, SOC SCI MED, V45, P283; Kavanagh AM, 1997, BRIT MED J, V314, P1388; Leung SSK, 2010, INT J WOMENS HEALTH, V2, P221; Mabeya H, 2012, J LOW GENIT TRACT DI, V16, P92, DOI 10.1097/LGT.0b013e3182320f0c; Mangoma J F, 2006, Afr J Reprod Health, V10, P91; Moreira Edson Duarte Jr, 2006, J Pediatr Adolesc Gynecol, V19, P81, DOI 10.1016/j.jpag.2006.01.003; Mutyaba T, 2007, INFLUENCES UPTAKE RE; Mwanahamuntu MH, 2009, AIDS, V23, pN1, DOI 10.1097/QAD.0b013e3283236e11; Rositch AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040766; Sanghvi H, 2008, REPROD HEALTH MATTER, V16, P67, DOI 10.1016/S0968-8080(08)32401-X; Sankaranarayanan R, 2007, BRIT J CANCER, V96, P738, DOI 10.1038/sj.bjc.6603633; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Urasa M, 2011, AFR HEALTH SCI, V11, P48; Vetter KM, 2007, J WOMENS HEALTH, V16, P1258, DOI 10.1089/jwh.2007.0493; WHO, 2008, EP FACT SHEET HIV AI; Wong LP, 2011, INT J BEHAV MED, V18, P105, DOI 10.1007/s12529-010-9104-y; World Health Organization, 2009, HPV VACC POS PAP; World Health Organization, 2004, GLOB BURD DIS REP KE	30	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157217	10.1371/journal.pone.0157217	http://dx.doi.org/10.1371/journal.pone.0157217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310005	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800044
J	Stranak, Z; Saliba, E; Kosma, P; Posfay-Barbe, K; Yunis, K; Farstad, T; Unnebrink, K; van Wyk, J; Wegzyn, C; Notario, G; Kalus, S; Campbell, FJ				Stranak, Zbynek; Saliba, Elie; Kosma, Paraskevi; Posfay-Barbe, Klara; Yunis, Khalid; Farstad, Teresa; Unnebrink, Kristina; van Wyk, Jean; Wegzyn, Colleen; Notario, Gerard; Kalus, Stefanie; Campbell, Fiona J.			Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI)	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; RISK-FACTORS; PREMATURE-INFANTS; PRETERM INFANTS; INFECTION; CHILDREN; BRONCHIOLITIS; PALIVIZUMAB; PROPHYLAXIS; PREVENTION	Background Preterm infants are at high risk of developing respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI). This observational epidemiologic study evaluated RSV disease burden and risk factors for RSV-associated LRTI hospitalization in preterm infants 33 weeks+0 days to 35 weeks+6 days gestational age not receiving RSV prophylaxis. Methods Preterm infants <= 6 months of age during RSV season (1 October 2013-30 April 2014) were followed at 72 sites across 23 countries from September 2013-July 2014 (study period). RSV testing was performed according to local clinical practice. Factors related to RSV-associated hospitalization for LRTI were identified using multivariable logistic regression with backward selection. Results Of the 2390 evaluable infants, 204 and 127 were hospitalized for LRTI during the study period and RSV season, respectively. Among these subjects, 64/204 and 46/127, respectively, were hospitalized for confirmed RSV LRTI. Study period and RSV season normalized RSV hospitalization rates (per 100 infant years) were 4.1 and 6.1, respectively. Factors associated with an increased risk of RSV-related LRTI hospitalization in multivariable analyses were smoking of family members (P < 0.0001), non-hemodynamically significant congenital heart disease diagnosis (P = 0.0077), maternal age of <= 25 years at delivery (P = 0.0009), low maternal educational level (P = 0.0426), household presence of children aged 4 to 5 years (P = 0.0038), age on 1 October <= 3 months (P = 0.0422), and presence of paternal atopy (P < 0.0001). Conclusions During the 2013-2014 RSV season across 23 countries, for preterm infants 33-35 weeks gestation <= 6 months old on 1 October not receiving RSV prophylaxis, confirmed RSV LRTI hospitalization incidence was 4.1 per 100 infant years during the study period and 6.1 per 100 infant years during the RSV season. This study enhances the findings of single-country studies of common risk factors for severe RSV infection in preterm infants and suggests that combinations of 4-6 risk factors may be used to accurately predict risk of RSV hospitalization. These findings may be useful in the identification of infants most at risk of severe RSV infection.	[Stranak, Zbynek] Charles Univ Prague, Fac Med 3, Inst Care Mother & Child, Prague, Czech Republic; [Saliba, Elie] Univ Tours, Inserm U930, Tours, France; [Saliba, Elie] Univ Hosp Clocheville, Dept Neonatol, Tours, France; [Kosma, Paraskevi] Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden; [Posfay-Barbe, Klara] Geneva Sch Med, Dept Pediat, Geneva, Switzerland; [Posfay-Barbe, Klara] Univ Hosp Geneva, Geneva, Switzerland; [Yunis, Khalid] Amer Univ Beirut, Dept Pediat & Adolescent Med, Beirut, Lebanon; [Farstad, Teresa] Akershus Univ Hosp, Dept Pediat, Lorenskog, Norway; [Unnebrink, Kristina] AbbVie Deutschland GmbH & Co KG, Data & Stat Sci, Ludwigshafen, Germany; [van Wyk, Jean; Notario, Gerard] AbbVie Inc, Virol, N Chicago, IL USA; [Wegzyn, Colleen] AbbVie Inc, Neonatol, N Chicago, IL USA; [Kalus, Stefanie] GKM Gesell Therapieforsch MbH, Biostat, Munich, Germany; [Campbell, Fiona J.] AbbVie Ltd, Neonatol & HIV, Dublin, Ireland	Charles University Prague; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Karolinska Institutet; University of Geneva; University of Geneva; American University of Beirut; University of Oslo; AbbVie; AbbVie; AbbVie; AbbVie	Stranak, Z (corresponding author), Charles Univ Prague, Fac Med 3, Inst Care Mother & Child, Prague, Czech Republic.	z.stranak@seznam.cz	Posfay-Barbe, Klara M./AAV-2515-2021; Posfay-Barbe, Klara M/E-9131-2013	Posfay-Barbe, Klara M./0000-0001-9464-5704; Posfay-Barbe, Klara M/0000-0001-9464-5704; Stranak, Zbynek/0000-0001-7095-3198; Yunis, Khalid/0000-0002-6384-2745	AbbVie Inc.; AbbVie	AbbVie Inc.(AbbVie); AbbVie(AbbVie)	Financial support for the epidemiologic study was provided by AbbVie Inc. The funder played a direct role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript through the participation of the coauthors. Medical writing support was provided by John E. Fincke, PhD, and Lisa M. Havran, PhD, at Complete Publication Solutions, LLC; this support was funded by AbbVie.	ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Ambrose CS, 2014, PEDIATR INFECT DIS J, V33, P576, DOI 10.1097/INF.0000000000000219; American Academy of Pediatrics (AAP) Committee on Fetus and Newborn and American College of Obstetricians and Gynecologists ACOG Committee on Obstetric Practice, 2012, STAND TERM REP REPR, P497; Blanken MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059161; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Carbonell-Estrany X, 2008, EUR J CLIN MICROBIOL, V27, P891, DOI 10.1007/s10096-008-0520-8; Cilla G, 2006, EPIDEMIOL INFECT, V134, P506, DOI 10.1017/S0950268805005571; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Feltes TF, 2011, PEDIATR RES, V70, P186, DOI 10.1203/PDR.0b013e318220a553; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Figueras Aloy J, 2010, AN PEDIAT BARC, V73; Figueras-Aloy J, 2008, PEDIATR INFECT DIS J, V27, P788, DOI 10.1097/INF.0b013e3181710990; Garcia CG, 2010, PEDIATRICS, V126, pE1453, DOI 10.1542/peds.2010-0507; German Society for Paediatric Infectious Diseases (DGPI) German Society of Pediatric Cardiology (DGPK) Society of Pediatric Pneumology (GPP) Society of Neonatology and Pediatric Intensive Care Medicine (GNPI) Professional Association of Child and Adolescent Physicians (BVKJ), 2012, GUID PREV SER ILLN R; Gijtenbeek RGP, 2015, EUR J PEDIATR, V174, P435, DOI 10.1007/s00431-014-2415-2; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HOLBERG CJ, 1991, AM J EPIDEMIOL, V133, P1135, DOI 10.1093/oxfordjournals.aje.a115826; Holman RC, 2003, PEDIATR INFECT DIS J, V22, P483, DOI 10.1097/00006454-200306000-00001; Law BJ, 2004, PEDIATR INFECT DIS J, V23, P806, DOI 10.1097/01.inf.0000137568.71589.bd; Liese JG, 2003, EUR J PEDIATR, V162, P230, DOI 10.1007/s00431-002-1105-7; MEERT K, 1990, CRIT CARE MED, V18, P1357, DOI 10.1097/00003246-199012000-00009; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Pickerling LK., 2012, RED BOOK 2012 REPORT, V29th ed, P609; Resch B, 2002, INFECTION, V30, P193, DOI 10.1007/s15010-002-2122-1; Resch B, 2008, MONATSSCHR KINDERH, V156, P381, DOI DOI 10.1007/S00112-008-1722-Y; Robinson JL, 2011, PAED CHILD HEALT-CAN, V16, P487, DOI 10.1093/pch/16.8.487; Samson L, 2009, PAED CHILD HEALT-CAN, V14, P521, DOI 10.1093/pch/14.8.521; Simoes EAF, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-78; Sommer Constanze, 2011, Open Microbiol J, V5, P144, DOI 10.2174/1874285801105010144; Steyerberg E., 2009, CLIN PREDICTION MODE; Weisman LE, 2003, PEDIATR INFECT DIS J, V22, pS33, DOI 10.1097/00006454-200302001-00005; WHO, 2010, ICD10, V10; Zhang XB, 2014, WORLD J PEDIATR, V10, P360, DOI 10.1007/s12519-014-0513-x	33	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157446	10.1371/journal.pone.0157446	http://dx.doi.org/10.1371/journal.pone.0157446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310438	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800073
J	Veinovic, G; Ruzic-Sabljic, E; Strle, F; Cerar, T				Veinovic, Gorana; Ruzic-Sabljic, Eva; Strle, Franc; Cerar, Tjasa			Comparison of Growth of Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi Sensu Stricto at Five Different Temperatures	PLOS ONE			English	Article							BSK-II MEDIUM; LYME-DISEASE; ERYTHEMA MIGRANS; LATO STRAINS; CULTIVATION; MEDIA; BLOOD; MKP	Lyme borreliosis is caused by the spirochete Borrelia burgdorferi sensu lato, a fastidious bacterium that replicates slowly and requires special conditions to grow in the laboratory. Borrelia isolation from clinical material is a golden standard for microbiological diagnosis of borrelial infection. Important factors that affect in vitro borrelia growth are temperature of incubation and number of borrelia cells in the sample. The aimof the study was to assess the influence of temperature on borrelia growth and survival by evaluation and comparison of growth of 31 different borrelia strains at five different temperatures and to determine the influence of different inoculums on borrelia growth at different temperatures. Borreliae were cultured in the MKP medium; the initial and final number of spirochetes was determined by dark field microscopy using Neubauer counting chamber. The growth of borrelia was defined as final number of cells/mL after three days of incubation. For all three Borrelia species, the best growth was found at 33 degrees C, followed by 37, 28, and 23 degrees C, while no growth was detected at 4 degrees C (P<0.05). The growth of B. afzelii species was weaker in comparison to the other two species at 23, 28, 33 and 37 degrees C (P<0.05), respectively. There was no statistically significant difference between the growth of B. garinii and B. burgdorferi sensu stricto at 28, 33, and 37 degrees C (P>0.05), respectively. Inoculum had statistically significant influence on growth of all three Borrelia species at all tested temperatures except at 4 degrees C.	[Veinovic, Gorana] Univ Belgrade, Dept Microbiol & Immunol, Fac Pharm, Belgrade, Serbia; [Veinovic, Gorana; Ruzic-Sabljic, Eva; Cerar, Tjasa] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Ljubljana, Slovenia; [Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia	University of Belgrade; University of Ljubljana; University Medical Centre Ljubljana	Cerar, T (corresponding author), Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Ljubljana, Slovenia.	tjasa.cerar@mf.uni-lj.si		Cerar Kisek, Tjasa/0000-0002-4053-5590	Ministry of Higher Education, Science and Sport of Slovenia [P3-0083]	Ministry of Higher Education, Science and Sport of Slovenia	This study was supported by the Ministry of Higher Education, Science and Sport of Slovenia (grant no. P3-0083).	Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986; BERGER BW, 1992, J CLIN MICROBIOL, V30, P359, DOI 10.1128/JCM.30.2.359-361.1992; Bergstrom S NL, 2002, LYME BORRELIOSIS BIO, P47; CAMPBELL GL, 1994, AM J CLIN PATHOL, V101, P154, DOI 10.1093/ajcp/101.2.154; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Heroldova M, 1998, ZBL BAKT-INT J MED M, V288, P451, DOI 10.1016/S0934-8840(98)80058-3; Hubalek Z, 1998, J MED MICROBIOL, V47, P929, DOI 10.1099/00222615-47-10-929; JOBE DA, 1993, J CLIN MICROBIOL, V31, P1896, DOI 10.1128/JCM.31.7.1896-1898.1993; LORIAN V, 1989, J CLIN MICROBIOL, V27, P2403, DOI 10.1128/JCM.27.11.2403-2406.1989; NADELMAN RB, 1990, AM J MED, V88, P21, DOI 10.1016/0002-9343(90)90122-T; O'Rourke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063968; POLLACK RJ, 1993, J CLIN MICROBIOL, V31, P1251, DOI 10.1128/JCM.31.5.1251-1255.1993; Preac-Mursic V., 1993, P44; PREACMURSIC V, 1986, ZBL BAKT-INT J MED M, V263, P112; Reisinger E, 1996, SCAND J INFECT DIS, V28, P155, DOI 10.3109/00365549609049067; Ruzic-Sabljic E, 2002, WIEN KLIN WOCHENSCHR, V114, P544; Ruzic-Sabljic ER, 2004, INT J MED MICROBIOL, V294, P407, DOI 10.1016/j.ijmm.2004.08.002; Ruzic-Sabljic E, 2006, INT J MED MICROBIOL, V296, P267, DOI 10.1016/j.ijmm.2006.01.005; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Strle F, 1996, CLIN INFECT DIS, V23, P61, DOI 10.1093/clinids/23.1.61; Wilske B., 1993, ASPECTS LYME BORRELI, P268; Wormser GP, 2000, J CLIN MICROBIOL, V38, P1648, DOI 10.1128/JCM.38.4.1648-1650.2000; Yang XF, 2001, INFECT IMMUN, V69, P4159, DOI 10.1128/IAI.69.6.4159-4163.2001	27	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157706	10.1371/journal.pone.0157706	http://dx.doi.org/10.1371/journal.pone.0157706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310556	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800126
J	Goldsztein, GH				Goldsztein, Guillermo H.			Reactions of Standing Bipeds on Moving Platforms to Keep Their Balance May Increase the Amplitude of Oscillations of Platforms Satisfying Hooke's Law	PLOS ONE			English	Article							CENTER-OF-MASS; LATERAL PERTURBATIONS; INTERMITTENT CONTROL; QUIET STANCE; POSTURE; RESPONSES; ANKLE; FOOTBRIDGES; STABILITY; DYNAMICS	Consider a person standing on a platform that oscillates laterally, i.e. to the right and left of the person. Assume the platform satisfies Hooke's law. As the platform moves, the person reacts and moves its body attempting to keep its balance. We develop a simple model to study this phenomenon and show that the person, while attempting to keep its balance, may do positive work on the platform and increase the amplitude of its oscillations. The studies in this article are motivated by the oscillations in pedestrian bridges that are sometimes observed when large crowds cross them.	[Goldsztein, Guillermo H.] Georgia Inst Technol, Sch Math, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Goldsztein, GH (corresponding author), Georgia Inst Technol, Sch Math, Atlanta, GA 30332 USA.	ggold@math.gatech.edu						Balasubramaniam R, 2002, TRENDS COGN SCI, V6, P531, DOI 10.1016/S1364-6613(02)02021-1; Bardy BG, 2002, J EXP PSYCHOL HUMAN, V28, P499, DOI 10.1037//0096-1523.28.3.499; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Bender C.M., 1999, ADVANCED MATHEMATICA; Bennett M, 2002, P ROY SOC A-MATH PHY, V458, P563, DOI 10.1098/rspa.2001.0888; BLACK FO, 1982, AM J OTOLARYNG, V3, P309, DOI 10.1016/S0196-0709(82)80002-1; Bocian M, 2012, J SOUND VIB, V331, P3914, DOI 10.1016/j.jsv.2012.03.023; Bodgi J, 2007, KEY ENG MATER, V347, P685, DOI 10.4028/www.scientific.net/KEM.347.685; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Bruno L, 2012, ENG STRUCT, V36, P228, DOI 10.1016/j.engstruct.2011.12.012; BRUNT D, 1992, MED SCI SPORT EXER, V24, P171; Carpenter MG, 2010, NEUROSCIENCE, V171, P196, DOI 10.1016/j.neuroscience.2010.08.030; Carpenter MG, 2001, EXP BRAIN RES, V138, P210, DOI 10.1007/s002210100681; Carver SG, 2009, CHAOS, V19, DOI 10.1063/1.3127577; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; DALLARD P., 2001, J BRIDGE ENG, V6, P412, DOI [10.1061/(ASCE)1084-0702(2001)6:6(412), DOI 10.1061/(ASCE)1084-0702(2001)6:6(412)]; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Gage WH, 2004, GAIT POSTURE, V19, P124, DOI 10.1016/S0966-6362(03)00037-7; Gatev P, 1999, J PHYSIOL-LONDON, V514, P915, DOI 10.1111/j.1469-7793.1999.915ad.x; Henry SM, 2001, J NEUROPHYSIOL, V85, P559, DOI 10.1152/jn.2001.85.2.559; Hof AL, 2010, J EXP BIOL, V213, P2655, DOI 10.1242/jeb.042572; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2007, J BIOMECH, V40, P451, DOI 10.1016/j.jbiomech.2005.12.016; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Huygens C., 1986, GEOMETRICAL DEMONSTR; Ingolfsson ET, 2012, ENG STRUCT, V45, P21, DOI 10.1016/j.engstruct.2012.05.038; Ko JH, 2013, EXP BRAIN RES, V226, P183, DOI 10.1007/s00221-013-3424-5; Ko YG, 2001, HUM MOVEMENT SCI, V20, P737, DOI 10.1016/S0167-9457(01)00052-5; Ko YG, 2003, HUM MOVEMENT SCI, V22, P47, DOI 10.1016/S0167-9457(02)00177-X; Koluda P, 2014, COMMUN NONLINEAR SCI, V19, P977, DOI 10.1016/j.cnsns.2013.08.008; Kuo A.D., 1993, PROG BRAIN RES, V97, P349, DOI 10.1016/s0079-6123(08)62294-3; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; KUO AD, 1993, J BIOMECH, V26, P137, DOI 10.1016/0021-9290(93)90085-S; Kuo AD, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S07; Macdonald JH, 2008, PROCEEDINGS OF THE R; MACKINNON CD, 1993, J BIOMECH, V26, P633, DOI 10.1016/0021-9290(93)90027-C; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; MCCOLLUM G, 1989, J MOTOR BEHAV, V21, P225; Nawayseh N, 2006, J SOUND VIB, V298, P725, DOI 10.1016/j.jsv.2006.06.027; O'Connor SM, 2009, J NEUROPHYSIOL, V102, P1411, DOI 10.1152/jn.00131.2009; Otten E, 1999, PHILOS T ROY SOC B, V354, P869, DOI 10.1098/rstb.1999.0439; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Pai YC, 2000, J BIOMECH, V33, P387, DOI 10.1016/S0021-9290(99)00199-2; Pantaleone J, 2002, AM J PHYS, V70, P992, DOI 10.1119/1.1501118; Park S, 2004, EXP BRAIN RES, V154, P417, DOI 10.1007/s00221-003-1674-3; Rietdyk S, 1999, J BIOMECH, V32, P1149, DOI 10.1016/S0021-9290(99)00116-5; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Ulrichs H, 2009, CHAOS, V19, DOI 10.1063/1.3266924; Venuti F, 2009, PHYS LIFE REV, V6, P176, DOI 10.1016/j.plrev.2009.07.001; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085414; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Winter DA, 2003, J ELECTROMYOGR KINES, V13, P49, DOI 10.1016/S1050-6411(02)00085-8; WINTER DA, 1993, NEUROSCI RES COMMUN, V12, P141; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	60	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157675	10.1371/journal.pone.0157675	http://dx.doi.org/10.1371/journal.pone.0157675			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304857	Green Published, gold, Green Submitted			2022-12-27	WOS:000377824800079
J	Hayat, T; Bibi, S; Alsaadi, F; Rafiq, M				Hayat, Tasawar; Bibi, Shahida; Alsaadi, Fuad; Rafiq, Maimona			Peristaltic Transport of Prandtl-Eyring Liquid in a Convectively Heated Curved Channel	PLOS ONE			English	Article							NON-NEWTONIAN FLUID; MASS-TRANSFER; HEAT/MASS TRANSFER; COMPLIANT WALLS; MAGNETIC-FIELD; FLOW; VISCOSITY; ANNULUS; MOTION; MHD	Here peristaltic activity for flow of a Prandtl-Eyring material is modeled and analyzed for curved geometry. Heat transfer analysis is studied using more generalized convective conditions. The channel walls satisfy complaint walls properties. Viscous dissipation in the thermal equation accounted. Unlike the previous studies is for uniform magnetic field on this topic, the radial applied magnetic field has been utilized in the problems development. Solutions for stream function (psi), velocity (u), and temperature (theta) for small parameter beta have been derived. The salient features of heat transfer coefficient Z and trapping are also discussed for various parameters of interest including magnetic field, curvature, material parameters of fluid, Brinkman, Biot and compliant wall properties. Main observations of present communication have been included in the conclusion section.	[Hayat, Tasawar; Bibi, Shahida; Rafiq, Maimona] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaadi, Fuad] King Abdulaziz Univ, Dept Elect & Comp Engn, Fac Engn, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Rafiq, M (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan.	maimona_88@hotmail.com	Rafiq, Maimona/AAM-7714-2020; Alsaadi, Fuad E/Q-6022-2018; Hayat, Tasawar/Y-2524-2019	Alsaadi, Fuad E/0000-0001-6420-3948; 				Abbasi FM, 2015, J MAGN MAGN MATER, V382, P104, DOI 10.1016/j.jmmm.2015.01.040; Abd Elmaboud Y, 2011, APPL MATH MODEL, V35, P2695, DOI 10.1016/j.apm.2010.11.031; Abd-Alla AM, 2015, J MAGN MAGN MATER, V374, P680, DOI 10.1016/j.jmmm.2014.08.091; Abd-Alla AM, 2014, J MAGN MAGN MATER, V363, P166, DOI 10.1016/j.jmmm.2014.03.023; Ali N, 2010, EUR J MECH B-FLUID, V29, P387, DOI 10.1016/j.euromechflu.2010.04.002; Ali N, 2010, Z NATURFORSCH A, V65, P191, DOI 10.1515/zna-2010-0306; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Gad NS, 2014, APPL MATH COMPUT, V235, P546, DOI 10.1016/j.amc.2014.02.081; Gul T., 2015, UNSTEADY MHD THIN FI, V10; Gul T., 2014, HEAT TRANSFER ANAL M, V9; Gul T., 2014, THIN FILM FLOW MHD 3, V9; Hayat T, 2014, J MOL LIQ, V193, P74, DOI 10.1016/j.molliq.2013.12.036; Hayat T, 2013, J MECH, V29, P599, DOI 10.1017/jmech.2013.28; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P5126, DOI 10.1016/j.ijheatmasstransfer.2011.07.036; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P1615, DOI 10.1016/j.ijheatmasstransfer.2010.11.022; Hina S, 2015, APPL MATH COMPUT, V263, P378, DOI 10.1016/j.amc.2015.04.068; Hina S, 2012, INT J HEAT MASS TRAN, V55, P3386, DOI 10.1016/j.ijheatmasstransfer.2012.02.074; Hina S, 2012, INT J HEAT MASS TRAN, V55, P3511, DOI 10.1016/j.ijheatmasstransfer.2012.03.014; Hussain Q, 2015, J CENT SOUTH UNIV, V22, P392, DOI 10.1007/s11771-015-2534-6; Hussain Q, 2014, J BRAZ SOC MECH SCI, V36, P681, DOI 10.1007/s40430-013-0104-0; Javed M, 2014, APPL MATH COMPUT, V244, P654, DOI 10.1016/j.amc.2014.07.009; Kothandapani M, 2015, J MAGN MAGN MATER, V378, P152, DOI 10.1016/j.jmmm.2014.11.031; Lachiheb M, 2014, APPL MATH COMPUT, V244, P761, DOI 10.1016/j.amc.2014.07.062; Latham TW., 1996, FLUID MOTION PERISTA; Mekheimer K., 2014, J EGYPT MATH SOC, V22, P143, DOI [10.1016/j.joems.2013.05.003, DOI 10.1016/J.JOEMS.2013.05.003]; Nadeem S, 2009, INT J HEAT MASS TRAN, V52, P4722, DOI 10.1016/j.ijheatmasstransfer.2009.04.037; Saleem M, 2014, INT J HEAT MASS TRAN, V68, P514, DOI 10.1016/j.ijheatmasstransfer.2013.09.053; Sato H., 2000, T JAPAN SOC MECH ENG, V66, P679; SHAPIRO AH, 1969, J FLUID MECH, V37, P799, DOI 10.1017/S0022112069000899; Sinha A, 2015, ALEX ENG J, V54, P691, DOI 10.1016/j.aej.2015.03.030; Srinivas S, 2009, COMPUT PHYS COMMUN, V180, P2115, DOI 10.1016/j.cpc.2009.06.015; Tripathi D, 2013, MATH COMPUT MODEL, V57, P1270, DOI 10.1016/j.mcm.2012.10.030; Vajravelu K, 2007, INT J NONLIN MECH, V42, P754, DOI 10.1016/j.ijnonlinmec.2007.02.014	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156995	10.1371/journal.pone.0156995	http://dx.doi.org/10.1371/journal.pone.0156995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304458	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800033
J	Viera, JT; El-Merahbi, R; Nieswandt, B; Stegner, D; Sumara, G				Viera, Jonathan Trujillo; El-Merahbi, Rabih; Nieswandt, Bernhard; Stegner, David; Sumara, Grzegorz			Phospholipases D1 and D2 Suppress Appetite and Protect against Overweight	PLOS ONE			English	Article							SIGNALING PATHWAYS; HUMAN PLATELETS; PPAR-GAMMA; MTOR; INHIBITION; CANCER	Obesity is a major risk factor predisposing to the development of peripheral insulin resistance and type 2 diabetes (T2D). Elevated food intake and/or decreased energy expenditure promotes body weight gain and acquisition of adipose tissue. Number of studies implicated phospholipase D (PLD) enzymes and their product, phosphatidic acid (PA), in regulation of signaling cascades controlling energy intake, energy dissipation and metabolic homeostasis. However, the impact of PLD enzymes on regulation of metabolism has not been directly determined so far. In this study we utilized mice deficient for two major PLD isoforms, PLD1 and PLD2, to assess the impact of these enzymes on regulation of metabolic homeostasis. We showed that mice lacking PLD1 or PLD2 consume more food than corresponding control animals. Moreover, mice deficient for PLD2, but not PLD1, present reduced energy expenditure. In addition, deletion of either of the PLD enzymes resulted in development of elevated body weight and increased adipose tissue content in aged animals. Consistent with the fact that elevated content of adipose tissue predisposes to the development of hyperlipidemia and insulin resistance, characteristic for the pre-diabetic state, we observed that Pld1(-/-) and Pld2(-/-) mice present elevated free fatty acids (FFA) levels and are insulin as well as glucose intolerant. In conclusion, our data suggest that deficiency of PLD1 or PLD2 activity promotes development of overweight and diabetes.	[Viera, Jonathan Trujillo; El-Merahbi, Rabih; Nieswandt, Bernhard; Stegner, David; Sumara, Grzegorz] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2,Haus D15, D-97080 Wurzburg, Germany; [Nieswandt, Bernhard; Stegner, David] Univ Hosp Wurzburg, Inst Expt Biomed, Josef Schneider Str 2,Haus D15, D-97080 Wurzburg, Germany	University of Wurzburg	Sumara, G (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2,Haus D15, D-97080 Wurzburg, Germany.	grzegorz.sumara@uni-wuerzburg.de	Stegner, David/AAA-4948-2019	Stegner, David/0000-0003-1059-9865; Trujillo-Viera, Jonathan/0000-0003-0566-4589; Sumara, Grzegorz/0000-0003-1502-6265	German Research Foundation (DFG) [Su 820/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by Emmy Noether grant (Number Su 820/1-1) from German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The authors disclose no financial or competing interests.	Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Bruntz RC, 2014, PHARMACOL REV, V66, P1033, DOI 10.1124/pr.114.009217; Burkhardt U, 2014, NEUROSCI LETT, V572, P48, DOI 10.1016/j.neulet.2014.04.052; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; COORSSEN JR, 1993, FEBS LETT, V316, P170, DOI 10.1016/0014-5793(93)81209-I; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; Elia M, 1992, ENERGY EXPENDITURE F; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Frohman MA, 2015, TRENDS PHARMACOL SCI, V36, P137, DOI 10.1016/j.tips.2015.01.001; Ghim J, 2014, ARTERIOSCL THROM VAS, V34, P1697, DOI 10.1161/ATVBAHA.114.303416; Han JB, 2015, NATURE, V524, P243, DOI 10.1038/nature14557; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Joy JM, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-29; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Peng X, 2012, ACTA PHYSIOL, V204, P219, DOI 10.1111/j.1748-1716.2011.02298.x; Provost JJ, 1996, BIOCHEM J, V319, P285, DOI 10.1042/bj3190285; Riebeling C, 2009, BBA-MOL CELL BIOL L, V1791, P876, DOI 10.1016/j.bbalip.2009.04.003; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Stegner D, 2013, ARTERIOSCL THROM VAS, V33, P2212, DOI 10.1161/ATVBAHA.113.302030; Teng SZ, 2015, MOL BIOL CELL, V26, P506, DOI 10.1091/mbc.E14-03-0802; Thielmann I, 2012, J THROMB HAEMOST, V10, P2361, DOI 10.1111/j.1538-7836.2012.04924.x; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Vorland M, 2008, PLATELETS, V19, P211, DOI 10.1080/09537100701777329; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	33	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157607	10.1371/journal.pone.0157607	http://dx.doi.org/10.1371/journal.pone.0157607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299737	gold, Green Published, Green Submitted			2022-12-27	WOS:000377822200066
J	Li, FL; Zan, QJ; Hu, ZY; Shin, PKS; Cheung, SG; Wong, YS; Tam, NFY; Lei, AP				Li, Feng-Lan; Zan, Qi-Jie; Hu, Zheng-Yu; Shin, Paul-K. S.; Cheung, Siu-Gin; Wong, Yuk-Shan; Tam, Nora Fung-Yee; Lei, An-Ping			Are Photosynthetic Characteristics and Energetic Cost Important Invasive Traits for Alien Sonneratia Species in South China?	PLOS ONE			English	Article							LEAF CONSTRUCTION COST; GAS-EXCHANGE CHARACTERISTICS; NITROGEN-USE EFFICIENCY; MIKANIA-MICRANTHA; LITTER PRODUCTION; CELL-WALLS; ALLOCATION; AREA; ASSIMILATION; COMMUNITY	A higher photosynthesis and lower energetic cost are recognized as important characteristics for invasive species, but whether these traits are also important for the ability of alien mangrove species to become invasive has seldom been reported. A microcosm study was conducted to compare the photosynthetic characteristics, energetic cost indices and other growth traits between two alien species (Sonneratia apetala and S. caseolaris) and four native mangrove species over four seasons in a subtropical mangrove nature reserve in Shenzhen, South China. The aim of the study was to evaluate the invasive potential of Sonneratia based on these physiological responses. The annual average net photosynthetic rate (P-n), stomatal conductance (G(s)) and total carbon assimilation per unit leaf area (A(total)) of the two alien Sonneratia species were significantly higher than the values of the native mangroves. In contrast, the opposite results were obtained for the leaf construction cost (CC) per unit dry mass (CCM) and CC per unit area (CCA) values. The higher A(total) and lower CC values resulted in a 72% higher photosynthetic energy-use efficiency (PEUE) for Sonneratia compared to native mangroves, leading to a higher relative growth rate (RGR) of the biomass and height of Sonneratia with the respective values being 51% and 119% higher than those of the native species. Higher photosynthetic indices for Sonneratia compared to native species were found in all seasons except winter, whereas lower CC values were found in all four seasons. The present findings reveal that alien Sonneratia species may adapt well and become invasive in subtropical mangrove wetlands in Shenzhen due to their higher photosynthetic characteristics coupled with lower costs in energy use, leading to a higher PEUE. The comparison of these physiological responses between S. apetala and S. caseolaris reveal that the former species is more invasive than the latter one, thus requiring more attention in future.	[Li, Feng-Lan; Lei, An-Ping] Shenzhen Univ, Coll Life Sci, Shenzhen, Peoples R China; [Li, Feng-Lan; Shin, Paul-K. S.; Cheung, Siu-Gin; Wong, Yuk-Shan; Tam, Nora Fung-Yee] City Univ Hong Kong, Futian CityU Mangrove Res & Dev Ctr, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China; [Zan, Qi-Jie] Guangdong Neilingding Futian Natl Nat Reserve, Shenzhen, Peoples R China; [Hu, Zheng-Yu] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Shin, Paul-K. S.; Cheung, Siu-Gin; Tam, Nora Fung-Yee] City Univ Hong Kong, Dept Biol & Chem, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China; [Wong, Yuk-Shan] Open Univ Hong Kong, Sch Sci & Technol, Kowloon, Hong Kong, Peoples R China	Shenzhen University; City University of Hong Kong; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; City University of Hong Kong; Hong Kong Metropolitan University	Lei, AP (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen, Peoples R China.; Tam, NFY (corresponding author), City Univ Hong Kong, Futian CityU Mangrove Res & Dev Ctr, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.; Tam, NFY (corresponding author), City Univ Hong Kong, Dept Biol & Chem, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.	bhntam@cityu.edu.hk; bioaplei@szu.edu.cn		CHEUNG, Siu Gin/0000-0001-8091-7385	National Natural Science Foundation of China [31170491, 30770393, 31470513, 41576086, 41306084]; Innovation Team Project from Shenzhen University [T201203]; Innovation of Science, Technology Commission of Shenzhen Municipality [JCYJ20150416163041307]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Project from Shenzhen University; Innovation of Science, Technology Commission of Shenzhen Municipality	This research was supported by the National Natural Science Foundation of China (URL: http://isisn.nsfc.gov.cn/egrantweb), no. 31170491, 30770393 (An-Ping Lei's funding), no. 31470513 (Qi-Jie Zan's funding), and no. 41576086, 41306084 (Nora Fung-Yee Tam's funding); Innovation Team Project from Shenzhen University (URL: http://www.szu.edu.cn), no. T201203 (An-Ping Lei's funding); and the Innovation of Science, Technology Commission of Shenzhen Municipality (URL: http://www.szsti.gov.cn/), no. JCYJ20150416163041307 (Nora Fung-Yee Tam's funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; Chen LZ, 2008, ESTUAR COAST SHELF S, V79, P644, DOI 10.1016/j.ecss.2008.06.003; Deng X, 2004, BOT BULL ACAD SINICA, V45, P213; Ding J., 1996, CONSERVING CHINAS BI, P125; Drake J. A., 1989, BIOL INVASIONS GLOBA, P525; Durand LZ, 2001, OECOLOGIA, V126, P345, DOI 10.1007/s004420000535; Eamus D, 1998, TREE PHYSIOL, V18, P537; Ewe SML, 2003, FOREST ECOL MANAG, V179, P27, DOI 10.1016/S0378-1127(02)00531-5; Feng YL, 2008, PLANTA, V228, P383, DOI 10.1007/s00425-008-0732-2; Feng YL, 2008, PHYSIOL PLANTARUM, V133, P318, DOI 10.1111/j.1399-3054.2008.01072.x; Feng YL, 2008, PHYSIOL PLANTARUM, V132, P350, DOI 10.1111/j.1399-3054.2007.01019.x; Feng YL, 2011, J ECOL, V99, P1116, DOI 10.1111/j.1365-2745.2011.01843.x; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Funk JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064502; Han WD, 2004, GUANGXI SCI, V11, P243; Huang Min-shen, 2012, Shengtaixue Zazhi, V31, P2996; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Li FL, 2011, MAR POLLUT BULL, V62, P1957, DOI 10.1016/j.marpolbul.2011.06.032; Li Shichuan, 2014, Journal of Plant Resources and Environment, V23, P15, DOI 10.3969/j.issn.1674-7895.2014.03.03; Li Yun, 1998, Forest Research, V11, P39; [廖宝文 Liao Baowen], 2004, [生态学杂志, Chinese Journal of Ecology], V23, P10; [林初夏 Lin Chuxia], 2004, [生态科学, Ecologic Science], V23, P118; Liu LN, 2014, MAR POLLUT BULL, V85, P747, DOI 10.1016/j.marpolbul.2014.04.047; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lu WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091238; Nagel JM, 2005, NEW PHYTOL, V166, P513, DOI 10.1111/j.1469-8137.2005.01341.x; Nagel JM, 2004, ECOLOGY, V85, P100, DOI 10.1890/02-3005; Onoda Y, 2004, FUNCT ECOL, V18, P419, DOI 10.1111/j.0269-8463.2004.00847.x; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pattison RR, 1998, OECOLOGIA, V117, P449, DOI 10.1007/s004420050680; PENNINGDEVRIES FW, 1974, J THEOR BIOL, V45, P339; Poorter H, 1998, OECOLOGIA, V116, P26, DOI 10.1007/s004420050560; Poorter Hendrik, 1997, P39, DOI 10.1016/B978-012083490-7/50003-7; Schieving F, 1999, NEW PHYTOL, V143, P201, DOI 10.1046/j.1469-8137.1999.00431.x; Shipley B, 2006, FUNCT ECOL, V20, P565, DOI 10.1111/j.1365-2435.2006.01135.x; Simberloff D, 2004, AM NAT, V163, P787, DOI 10.1086/420777; Song LY, 2007, BOT STUD, V48, P331; Song LY, 2009, ACTA OECOL, V35, P128, DOI 10.1016/j.actao.2008.09.002; Tam NFY, 1998, J EXP MAR BIOL ECOL, V226, P1, DOI 10.1016/S0022-0981(97)00233-5; Wang BS, 2002, MANGROVE FOREST ECOS, P133; Weltzin JF, 2003, FRONT ECOL ENVIRON, V1, P146, DOI 10.1890/1540-9295(2003)001[0146:BIIAGW]2.0.CO;2; WILLIAMS K, 1987, PLANT CELL ENVIRON, V10, P725; Yuk CL, 2006, THESIS CITY U HONG K; Zan Q.J., 2001, J WUHAN BOT RES, V19, P391; [昝启杰 Zan Qijie], 2002, [广西植物, Guihaia], V22, P331; Zan QJ, 2003, ACTA BOT SIN, V45, P544; [曾群英 Zeng Qunying], 2015, [西北林学院学报, Journal of Northwest Forestry University], V30, P28; Zeng XK, 2015, THESIS SHENZHEN U; Zeng XueQin, 2008, Biodiversity Science, V16, P236, DOI 10.3724/SP.J.1003.2008.07326; Zhang HD, 1998, STUDIES FUTIAN MANGR, P14	51	4	4	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157169	10.1371/journal.pone.0157169	http://dx.doi.org/10.1371/journal.pone.0157169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286250	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000042
J	Mannan, M; Mamun, A; Doi, S; Clavarino, A				Mannan, Munim; Mamun, Abdullah; Doi, Suhail; Clavarino, Alexandra			Prospective Associations between Depression and Obesity for Adolescent Males and Females- A Systematic Review and Meta-Analysis of Longitudinal Studies	PLOS ONE			English	Review							BODY-MASS INDEX; RISK-FACTORS; PHYSICAL-ACTIVITY; EFFECTS MODEL; CHILDHOOD; GIRLS; OVERWEIGHT; SYMPTOMS; DISORDER; EPIDEMIOLOGY	Adolescent obesity and depression are increasingly prevalent and are currently recognised as major public health concerns worldwide. The aim of this study is to evaluate the bi-directional associations between obesity and depression in adolescents using longitudinal studies. A systematic literature search was conducted using Pubmed (including Medline), PsycINFO, Embase, CINAHL, BIOSIS Preview and the Cochrane Library databases. According to the inclusion criteria, 13 studies were found where seven studies evaluated depression leading to obesity and six other studies examined obesity leading to depression. Using a bias-adjusted quality effects model for the meta-analysis, we found that adolescents who were depressed had a 70% (RR 1.70, 95% CI: 1.40, 2.07) increased risk of being obese, conversely obese adolescents had an increased risk of 40% (RR 1.40, 95% CI: 1.16, 1.70) of being depressed. The risk difference (RD) of early adolescent depression leading to obesity is 3% higher risk than it is for obesity leading to depression. In sensitivity analysis, the association between depression leading to obesity was greater than that of obesity leading to depression for females in early adulthood compared with females in late adolescence. Overall, the findings of this study suggest a bi-directional association between depression and obesity that was stronger for female adolescents. However, this finding also underscores the importance of early detection and treatment strategies to inhibit the development of reciprocal disorders.	[Mannan, Munim; Clavarino, Alexandra] Univ Queensland, Sch Pharm, 20 Cornwall St, Woolloongabba, Qld 4102, Australia; [Mamun, Abdullah] Univ Queensland, Sch Populat Hlth, Herston Rd, Herston, Qld 4006, Australia; [Doi, Suhail] Australian Natl Univ, ANU Coll Med Biol & Environm, Res Sch Populat Hlth, Acton, ACT 2601, Australia	University of Queensland; University of Queensland; Australian National University	Mannan, M (corresponding author), Univ Queensland, Sch Pharm, 20 Cornwall St, Woolloongabba, Qld 4102, Australia.	mannan.munim@uq.net.au	Clavarino, Alexandra M/F-1411-2010; Mamun, Abdullah A/A-4673-2011; Mamun, Abdullah/HHM-9898-2022	Clavarino, Alexandra M/0000-0002-1145-5946; Mamun, Abdullah A/0000-0002-1535-8086; Doi, Suhail/0000-0002-2630-2125				Al Khalaf MM, 2011, J CLIN EPIDEMIOL, V64, P119, DOI 10.1016/j.jclinepi.2010.01.009; Anderson SE, 2007, PSYCHOSOM MED, V69, P740, DOI 10.1097/PSY.0b013e31815580b4; Anderson SE, 2010, INT J PEDIAT OBES; Angold A, 1999, PSYCHOL MED, V29, P1043, DOI 10.1017/S0033291799008946; Bayer O, 2011, OBESITY, V19, P1069, DOI 10.1038/oby.2010.250; Blaine B, 2008, J HEALTH PSYCHOL, V13, P1190, DOI 10.1177/1359105308095977; Bornstein SR, 2006, MOL PSYCHIATR, V11, P892, DOI 10.1038/sj.mp.4001873; Boutelle KN, 2010, HEALTH PSYCHOL, V29, P293, DOI 10.1037/a0018645; Brennan M, 2010, PSI CHI J UNDERGRAD, V15, P130, DOI [DOI 10.24839/1089-4136.JN15.3.130, 10.24839/1089-4136.JN15.3.130]; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Cohen GJ, 2002, PEDIATRICS, V110, P1019, DOI 10.1542/peds.110.5.1019; Conley CS, 2009, DEV PSYCHOPATHOL, V21, P593, DOI 10.1017/S0954579409000327; DERSIMONIAN R, 1990, ANESTH ANALG, V70, P475; Di Pietrantonj C, 2006, STAT MED, V25, P2299, DOI 10.1002/sim.2287; Doi SAR, 2008, EPIDEMIOLOGY, V19, P94, DOI 10.1097/EDE.0b013e31815c24e7; Doi SAR, 2013, J EVAL CLIN PRACT, V19, P653, DOI 10.1111/j.1365-2753.2012.01890.x; Doi SAR, 2011, CONTEMP CLIN TRIALS, V32, P288, DOI 10.1016/j.cct.2010.12.006; Ernst M, 2006, PSYCHOL MED, V36, P299, DOI 10.1017/S0033291705005891; Fetherman D. L., 1993, J RES ADOLESCENCE, V3, P217, DOI DOI 10.1207/S15327795JRA0303_; Franko DL, 2005, PSYCHOL MED, V35, P1505, DOI 10.1017/S0033291705005386; Frisco ML, 2013, AM J EPIDEMIOL, V178, P22, DOI 10.1093/aje/kws462; Furuya-Kanamori L, 2014, J CLIN EPIDEMIOL, V67, P364, DOI 10.1016/j.jclinepi.2013.10.010; Ge XJ, 2006, DEV PSYCHOPATHOL, V18, P253, DOI 10.1017/S0954579406060147; Gilbody SM, 2000, ACTA PSYCHIAT SCAND, V102, P241, DOI 10.1034/j.1600-0447.2000.102004241.x; Goldfield G, 2010, PAED CHILD HEALT-CAN, V15, P283, DOI 10.1093/pch/15.5.283; Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.497; Goran MI, 2006, HANDBOOK OF PDEATRIC; Gray L, 2008, EUR J PUBLIC HEALTH, V18, P616, DOI 10.1093/eurpub/ckn044; Guo S S, 1999, Am J Clin Nutr, V70, p145S, DOI 10.1093/ajcn/70.1.145s; Harbron J, 2014, NUTRIENTS, V6, P3130, DOI 10.3390/nu6083130; Hardy LL, 2007, J ADOLESCENT HEALTH, V40, P158, DOI 10.1016/j.jadohealth.2006.09.009; Harrington R, 2001, BRIT MED BULL, V57, P47, DOI 10.1093/bmb/57.1.47; Herva A, 2006, INT J OBESITY, V30, P520, DOI 10.1038/sj.ijo.0803174; Hung CF, 2014, BRIT J PSYCHIAT, V205, P24, DOI 10.1192/bjp.bp.113.130419; Incledon E, 2011, INT J PEDIATR OBES, V6, pE1, DOI 10.3109/17477166.2010.549491; Jordan Amy B, 2008, Adolesc Med State Art Rev, V19, P431; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Kivimaki M, 2014, MOL PSYCHIATR, V19, P149, DOI 10.1038/mp.2013.35; Kivimaki M, 2009, DIABETES CARE, V32, P1867, DOI 10.2337/dc09-0716; Korczak DJ, 2013, DEV MED CHILD NEUROL; Kubzansky LD, 2012, ANN BEHAV MED, V43, P219, DOI 10.1007/s12160-011-9323-8; Landhuis CE, 2008, PEDIATRICS, V122, P955, DOI 10.1542/peds.2007-3521; Liem ET, 2008, ARCH PEDIAT ADOL MED, V162, P981, DOI 10.1001/archpedi.162.10.981; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Malina RM, 2004, GROWTH MATURATION PH, P535; Marmorstein NR, 2014, INT J OBESITY, V38, P906, DOI 10.1038/ijo.2014.19; Moher D, 2015, SYST REV, V4, DOI [10.1186/s13643-015-0087-2, 10.1186/2046-4053-4-1]; Muhlig Y, 2016, OBES REV, V17, P235, DOI 10.1111/obr.12357; Nierenberg AA, 1998, J CLIN PSYCHIAT, V59, P5; Noma H, 2011, STAT MED, V30, P3304, DOI 10.1002/sim.4350; Overton RC, 1998, PSYCHOL METHODS, V3, P354, DOI 10.1037/1082-989X.3.3.354; Pine DS, 2001, PEDIATRICS, V107, P1049, DOI 10.1542/peds.107.5.1049; Pine DS, 1997, AM J PUBLIC HEALTH, V87, P1303, DOI 10.2105/AJPH.87.8.1303; Presnell K, 2007, PREVENTION RES, V14, P3; Privitera G. J., 2008, PSYCHOL DIETER ITS N; Privitera GJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00873; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Raison CL, 2013, MOL PSYCHIATR, V18, P15, DOI 10.1038/mp.2012.2; Richardson LP, 2003, ARCH PEDIAT ADOL MED, V157, P739, DOI 10.1001/archpedi.157.8.739; Roberts RE, 2016, ANN BEHAV MED; Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8; Russell-Mayhew S, 2012, J OBES, V2012, DOI 10.1155/2012/281801; Schwartz T L, 2004, Obes Rev, V5, P115, DOI 10.1111/j.1467-789X.2004.00139.x; Shamliyan T, 2010, J CLIN EPIDEMIOL, V63, P1061, DOI 10.1016/j.jclinepi.2010.04.014; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Slyper AH, 2006, CLIN ENDOCRINOL, V65, P1, DOI 10.1111/j.1365-2265.2006.02539.x; Soares CN, 2008, J PSYCHIATR NEUROSCI, V33, P331; Spoor STP, 2006, INT J EAT DISORDER, V39, P700, DOI 10.1002/eat.20283; Stice E, 2005, J CONSULT CLIN PSYCH, V73, P195, DOI 10.1037/0022-006X.73.2.195; Stice E, 2002, HEALTH PSYCHOL, V21, P131, DOI 10.1037//0278-6133.21.2.131; Su SC, 2011, INT J PSYCHIAT MED, V42, P211, DOI 10.2190/PM.42.3.a; Suissa D, 2012, J CLIN EPIDEMIOL, V65, P42, DOI 10.1016/j.jclinepi.2011.04.009; Sweeting Helen, 2005, J Adolesc Health, V37, P409, DOI 10.1016/j.jadohealth.2005.01.008; Takkouche B, 1999, AM J EPIDEMIOL, V150, P206; van Houwelingen H, 1999, STAT MED, V18, P110, DOI 10.1002/(SICI)1097-0258(19990115)18:1<110::AID-SIM14>3.3.CO;2-3; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; WHO Global InfoBase Team, 2009, 2 SURF WHO GLOB INFO; Witherspoon D, 2013, J PEDIATR PSYCHOL, V38, P1112, DOI 10.1093/jpepsy/jst055	81	178	179	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157240	10.1371/journal.pone.0157240	http://dx.doi.org/10.1371/journal.pone.0157240			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1UG	27285386	Green Published, Green Submitted, gold			2022-12-27	WOS:000377564000047
J	Pang, JX; Lindblom, A; Tolfvenstam, T; Thein, TL; Naim, ANM; Ling, L; Chow, A; Chen, MIC; Ooi, EE; Leo, YS; Hibberd, ML				Pang, Junxiong; Lindblom, Anna; Tolfvenstam, Thomas; Thein, Tun-Linn; Naim, Ahmad Nazri Mohamed; Ling, Ling; Chow, Angelia; Chen, Mark I-Cheng; Ooi, Eng Eong; Leo, Yee Sin; Hibberd, Martin L.			Discovery and Validation of Prognostic Biomarker Models to Guide Triage among Adult Dengue Patients at Early Infection	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HEMORRHAGIC-FEVER; SHOCK SYNDROME; DISEASE SEVERITY; VIRUS-INFECTION; DIAGNOSIS; EXPRESSION; HOSPITALIZATION; CLASSIFICATION; TUBERCULOSIS	Background Dengue results in a significant public health burden in endemic regions. The World Health Organization (WHO) recommended the use of warning signs (WS) to stratify patients at risk of severe dengue disease in 2009. However, WS is limited in stratifying adult dengue patients at early infection (Day 1-3 post fever), who require close monitoring in hospitals to prevent severe dengue. The aim of this study is to identify and validate prognostic models, built with differentially expressed biomarkers, that enable the early identification of those with early dengue infection that require close clinical monitoring. Methods RNA microarray and protein assays were performed to identify differentially expressed biomarkers of severity among 92 adult dengue patients recruited at early infection from years 2005-2008. This comprised 47 cases who developed WS after first presentation and required hospitalization (WS+Hosp), as well as 45 controls who did not develop WS after first presentation and did not require hospitalization (Non-WS+Non-Hosp). Independent validation was conducted with 80 adult dengue patients recruited from years 2009-2012. Prognostic models were developed based on forward stepwise and backward elimination estimation, using multiple logistic regressions. Prognostic power was estimated by the area under the receiver operating characteristic curve (AUC). Results The WS+Hosp group had significantly higher viral load (P<0.001), lower platelet (P<0.001) and lymphocytes counts (P = 0.004) at early infection compared to the Non-WS+Non-Hosp group. From the RNA microarray and protein assays, the top single RNA and protein prognostic models at early infection were CCL8 RNA (AUC:0.73) and IP-10 protein (AUC:0.74), respectively. The model with CCL8, VPS13C RNA, uPAR protein, and with CCL8, VPS13C RNA and platelets were the best biomarker models for stratifying adult dengue patients at early infection, with sensitivity and specificity up to 83% and 84%, respectively. These results were tested in the independent validation group, showing sensitivity and specificity up to 96% and 54.6%, respectively. Conclusions At early infection, adult dengue patients who later presented WS and require hospitalization have significantly different pathophysiology compared with patients who consistently presented no WS and/or require no hospitalization. The molecular prognostic models developed and validated here based on these pathophysiology differences, could offer earlier and complementary indicators to the clinical WHO 2009 WS guide, in order to triage adult dengue patients at early infection.	[Pang, Junxiong; Lindblom, Anna; Tolfvenstam, Thomas; Naim, Ahmad Nazri Mohamed; Ling, Ling; Hibberd, Martin L.] Genome Inst Singapore, Infect Dis, Singapore, Singapore; [Pang, Junxiong; Chen, Mark I-Cheng; Leo, Yee Sin; Hibberd, Martin L.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Pang, Junxiong; Thein, Tun-Linn; Chen, Mark I-Cheng; Leo, Yee Sin] Tan Tock Seng Hosp, Communicable Dis Ctr, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Lindblom, Anna; Tolfvenstam, Thomas] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Dept Med Solna,Unit Infect Dis, Stockholm, Sweden; [Tolfvenstam, Thomas] Publ Hlth Agcy Sweden, Unit Highly Pathogen Viruses, Stockholm, Sweden; [Chow, Angelia; Ooi, Eng Eong] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Ooi, Eng Eong] DSO Natl Labs, Singapore, Singapore; [Leo, Yee Sin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Hibberd, Martin L.] London Sch Hyg & Trop Med, London WC1, England	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Tan Tock Seng Hospital; Karolinska Institutet; Karolinska University Hospital; Public Health Agency of Sweden; National University of Singapore; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine	Lindblom, A (corresponding author), Genome Inst Singapore, Infect Dis, Singapore, Singapore.; Lindblom, A (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Dept Med Solna,Unit Infect Dis, Stockholm, Sweden.	anna.lindblom@ki.se	Thein, Tun-Linn/Y-9520-2018; Chen, Mark/CAG-2949-2022; Chen, Mark/AGC-5338-2022; Pang, Junxiong/AAI-5115-2021; Thein, Tun-Linn/K-5281-2019	Thein, Tun-Linn/0000-0002-5254-032X; Chen, Mark/0000-0001-9369-5830; Chen, Mark/0000-0001-9369-5830; Thein, Tun-Linn/0000-0002-5254-032X; Ooi, Eng Eong/0000-0002-0520-1544; Tolfvenstam, Thomas/0000-0003-3549-8083; Pang, Junxiong, Vincent/0000-0002-9788-701X; Berggren, Anna/0000-0002-4012-699X; Hibberd, Martin/0000-0001-8587-1849	STOP Dengue grant from the National Medical Research Council, Singapore [NMRC/TCR/05/008]; Singapore agency for science, technology and research (A*STAR)	STOP Dengue grant from the National Medical Research Council, Singapore(National Medical Research Council, Singapore); Singapore agency for science, technology and research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This study is supported by the STOP Dengue grant (NMRC/TCR/05/008; http://www.nmrc.gov.sg/content/nmrc_internet/home.html) awarded to YSL from the National Medical Research Council, Singapore and by Singapore agency for science, technology and research (A*STAR) awarded to MLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x; Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476; Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106; Becquart P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-356; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072; Hellier S, 2003, HEPATOLOGY, V38, P1468, DOI [10.1016/j.hep.2003.09.027, 10.1053/jhep.2003.09027]; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; Huang HL, 2014, CLIN INFECT DIS, V58, P1707, DOI 10.1093/cid/ciu202; Huang J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-81; Ito M, 2004, J CLIN MICROBIOL, V42, P5935, DOI 10.1128/JCM.42.12.5935-5937.2004; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06; Lee LK, 2013, T ROY SOC TROP MED H, V107, P37, DOI 10.1093/trstmh/trs009; Lee VJ, 2009, TROP MED INT HEALTH, V14, P1154, DOI 10.1111/j.1365-3156.2009.02337.x; Lee VJ, 2008, J CLIN VIROL, V42, P34, DOI 10.1016/j.jcv.2007.12.017; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Leo YS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-498; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Long TH, 2010, J VIROL, V84, P12982, DOI 10.1128/JVI.01224-10; Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397; Nguyen NM, J INFECT DIS; Ooi Eng Eong, 2003, Int J Infect Dis, V7, P231, DOI 10.1016/S1201-9712(03)90057-9; Pang JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001641; Pham TB, 2009, J CLIN VIROL, V45, P276, DOI 10.1016/j.jcv.2009.04.004; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Sidenius N, 2000, BLOOD, V96, P4091; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Srikiatkhachorn A, 2011, CLIN INFECT DIS, V53, P563, DOI 10.1093/cid/cir451; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Tanner L, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000196; Thein TL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002023; Tolfvenstam T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-209; Tsai CY, 2013, J MICROBIOL IMMUNOL, V46, P271, DOI 10.1016/j.jmii.2012.07.005; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; World Health Organization, 2009, DENGUE GUIDELINES DI; Yacoub S, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0147-9	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0155993	10.1371/journal.pone.0155993	http://dx.doi.org/10.1371/journal.pone.0155993			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286230	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000377564000006
J	Rivera, AR; Castillo-Pichardo, L; Gerena, Y; Dharmawardhane, S				Rivera, Amilcar Rivera; Castillo-Pichardo, Linette; Gerena, Yamil; Dharmawardhane, Suranganie			Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade	PLOS ONE			English	Article							GRAPE SEED EXTRACT; RED WINE POLYPHENOLS; MAMMARY-TUMOR GROWTH; FLAVONOID QUERCETIN; CELL-PROLIFERATION; PI3K PATHWAY; INHIBITION; AMPK; BIOAVAILABILITY; RESVERATROL	The Akt/adenosine monophosphate protein kinase (AMPK)/mammalian target of rapamycin (mTOR) pathway has emerged as a critical signaling nexus for regulating cellular metabolism, energy homeostasis, and cell growth. Thus, dysregulation of this pathway contributes to the development of metabolic disorders such as obesity, type 2diabetes, and cancer. We previously reported that a combination of grape polyphenols (resveratrol, quercetin and catechin: RQC), at equimolar concentrations, reduces breast cancer (BC) growth and metastasis in nude mice, and inhibits Akt and mTOR activities and activates AMPK, an endogenous inhibitor of mTOR, in metastatic BC cells. The objective of the present study was to determine the contribution of individual polyphenols to the effect of combined RQC on mTOR signaling. Metastatic BC cells were treated with RQC individually or in combination, at various concentrations, and the activities (phosphorylation) of AMPK, Akt, and the mTOR downstream effectors, p70S6 kinase (p70S6K) and 4E binding protein (4EBP1), were determined by Western blot. Results show that quercetin was the most effective compound for Akt/mTOR inhibition. Treatment with quercetin at 15 mu M had a similar effect as the RQC combination in the inhibition of BC cell proliferation, apoptosis, and migration. However, cell cycle analysis showed that the RQC treatment arrested BC cells in the G1 phase, while quercetin arrested the cell cycle in G2/M. In vivo experiments, using SCID mice with implanted tumors from metastatic BC cells, demonstrated that administration of quercetin at 15mg/kg body weight resulted in a similar to 70% reduction in tumor growth. In conclusion, quercetin appears to be a viable grape polyphenol for future development as an anti BC therapeutic.	[Rivera, Amilcar Rivera; Castillo-Pichardo, Linette; Dharmawardhane, Suranganie] Univ Puerto Rico Med Sci Campus, Sch Med, Dept Biochem, San Juan, PR USA; [Castillo-Pichardo, Linette] Univ Cent Caribe, Dept Pathol & Lab Med, Bayamon, PR USA; [Gerena, Yamil] Univ Puerto Rico Med Sci Campus, Dept Pharmacol & Toxicol, San Juan, PR USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Dharmawardhane, S (corresponding author), Univ Puerto Rico Med Sci Campus, Sch Med, Dept Biochem, San Juan, PR USA.	su.d@upr.edu		Gerena, Yamil/0000-0002-5324-109X	National Institutes of Health (NIH)/National Institute of General Medicine (NIGMS) [SC3GM084824]; UPR RCM NIH/NIMHHD [G12MD007600, R25GM061838, U54CA096297]; NIH/NIMHHD [G12MD007583]; U.S. Department of Education [P031M10505, P031S130068]; NATIONAL CANCER INSTITUTE [U54CA096297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, SC3GM084824, P20GM103475] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583, G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of General Medicine (NIGMS); UPR RCM NIH/NIMHHD; NIH/NIMHHD; U.S. Department of Education(US Department of Education); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by National Institutes of Health (NIH)/National Institute of General Medicine (NIGMS) Grant SC3GM084824 (to S.D.); UPR RCM NIH/NIMHHD grants G12MD007600, R25GM061838 (to A.R.R.), and U54CA096297 (to A.R.R.); NIH/NIMHHD G12MD007583, and Title V PPOHA P031M10505 and Title V Cooperative P031S130068 from U.S. Department of Education to UCC.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Boly R, 2011, INT J ONCOL, V38, P833, DOI 10.3892/ijo.2010.890; Bonofiglio D, 2016, MINI-REV MED CHEM, V16, P596, DOI 10.2174/1389557515666150709110959; Bouvet Michael, 2015, Methods Mol Biol, V1267, P321, DOI 10.1007/978-1-4939-2297-0_16; Cao HH, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0367-4; Castillo-Pichardo L, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-6; Castillo-Pichardo L, 2012, NUTR CANCER, V64, P1058, DOI 10.1080/01635581.2012.716898; Castillo-Pichardo L, 2009, CLIN EXP METASTAS, V26, P505, DOI 10.1007/s10585-009-9250-2; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Damianaki A, 2000, J CELL BIOCHEM, V78, P429, DOI 10.1002/1097-4644(20000901)78:3<429::AID-JCB8>3.0.CO;2-M; Deng XH, 2013, EXP THER MED, V6, P1155, DOI 10.3892/etm.2013.1285; Faustino RS, 2003, MOL CELL BIOCHEM, V249, P11, DOI 10.1023/A:1024745513314; Ferry DR, 1996, CLIN CANCER RES, V2, P659; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hollman PCH, 1997, FEBS LETT, V418, P152, DOI 10.1016/S0014-5793(97)01367-7; Kim H, 2004, J NUTR, V134, p3445S, DOI 10.1093/jn/134.12.3445S; Kolker I I, 1979, Klin Med (Mosk), V57, P77; Lai WW, 2013, ANTICANCER RES, V33, P1941; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Larson AJ, 2012, ADV NUTR, V3, P39, DOI 10.3945/an.111.001271; Casella ML, 2014, MOL NUTR FOOD RES, V58, P289, DOI 10.1002/mnfr.201300362; Levi F, 2005, EUR J CANCER PREV, V14, P139, DOI 10.1097/00008469-200504000-00009; Li WD, 2015, ONCOTARGET, V6, P7365, DOI 10.18632/oncotarget.3629; Lin CW, 2008, CARCINOGENESIS, V29, P1807, DOI 10.1093/carcin/bgn162; Lu JM, 2009, CARCINOGENESIS, V30, P636, DOI 10.1093/carcin/bgp009; Lu Jing, 2009, Cancer Res, V69, P4951, DOI 10.1158/0008-5472.CAN-09-0099; Martinez C, 2005, HISTOL HISTOPATHOL, V20, P1121, DOI 10.14670/HH-20.1121; Maurya AK, 2015, TUMOR BIOL, V36, P8913, DOI 10.1007/s13277-015-3634-5; Maurya AK, 2015, MOL BIOL REP, V42, P1419, DOI 10.1007/s11033-015-3921-7; Michaud-Levesque J, 2012, EXP CELL RES, V318, P925, DOI 10.1016/j.yexcr.2012.02.017; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mojsin M, 2014, FOOD FUNCT, V5, P2564, DOI [10.1039/c4fo00484a, 10.1039/C4FO00484A]; Morre DM, 2005, CANC LETT; Nigdikar SV, 1998, AM J CLIN NUTR, V68, P258, DOI 10.1093/ajcn/68.2.258; Perez-Vizcaino F, 2012, J SCI FOOD AGR, V92, P1822, DOI 10.1002/jsfa.5697; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047516, 10.1371/journal.pone.0052279]; Ramos S, 2008, MOL NUTR FOOD RES, V52, P507, DOI 10.1002/mnfr.200700326; Ranganathan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141370; Rein MJ, 2013, BRIT J CLIN PHARMACO, V75, P588, DOI 10.1111/j.1365-2125.2012.04425.x; Sak K, 2014, NUTR CANCER, V66, P177, DOI 10.1080/01635581.2014.864418; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Schlachterman A, 2008, TRANSL ONCOL, V1, P19, DOI 10.1593/tlo.07100; Singh RP, 2004, INT J CANCER, V108, P733, DOI 10.1002/ijc.11620; Singletary KW, 2003, J AGR FOOD CHEM, V51, P7280, DOI 10.1021/jf030278l; TOMATIS L, 1993, ENVIRON HEALTH PERSP, V101, P149, DOI 10.2307/3431859; Trung LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055183; van der Heijden MS, 2010, CLIN CANCER RES, V16, P3094, DOI 10.1158/1078-0432.CCR-09-3004; Vidya Priyadarsini R, 2010, Eur J Pharmacol, V649, P84, DOI 10.1016/j.ejphar.2010.09.020; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Weixel KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078019; Zhou HY, 2010, CRIT REV EUKAR GENE, V20, P1	54	62	62	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157251	10.1371/journal.pone.0157251	http://dx.doi.org/10.1371/journal.pone.0157251			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285995	Green Submitted, gold, Green Published			2022-12-27	WOS:000377564000050
J	Konrat, K; Schwebke, I; Laue, M; Dittmann, C; Levin, K; Andrich, R; Arvand, M; Schaudinn, C				Konrat, Katharina; Schwebke, Ingeborg; Laue, Michael; Dittmann, Christin; Levin, Katja; Andrich, Ricarda; Arvand, Mardjan; Schaudinn, Christoph			The Bead Assay for Biofilms: A Quick, Easy and Robust Method for Testing Disinfectants	PLOS ONE			English	Article							MICROBIAL BIOFILMS; RESISTANCE	Bacteria live primarily in microbial communities (biofilms), where they exhibit considerably higher biocide tolerance than their planktonic counterparts. Current standardized efficacy testing protocols of disinfectants, however, employ predominantly planktonic bacteria. In order to test the efficacy of biocides on biofilms in a standardized manner, a new assay was developed and optimized for easy-handling, quickness, low running costs, and above allrepeatability. In this assay, 5 mm glass-or polytetrafluoroethylene beads in 24 well microtiter plates served as substrate for Pseudomonas aeruginosa biofilms. After optimizing result-relevant steps, the actual performance of the assay was explored by treating P. aeruginosa biofilms with glutaraldehyde, isopropanol, or peracetic acid in predefined concentrations. The aspired 5 log(10) reduction in CFU counts was achieved by glutaraldehyde at 5% (30 min), and by peracetic acid at 0.3% (10 min). In contrast, 80% isopropanol (30 min) failed to meet the reduction goal. However, the main accomplishment of this study was to unveil the potential of the array itself; most noteworthy here, a reliable repeatability of the results. The new bead assay for biofilms is a robust, quick and cost-effective method for assessing the efficacy of biocides against biofilms.	[Konrat, Katharina; Schwebke, Ingeborg; Levin, Katja; Andrich, Ricarda; Arvand, Mardjan] Div Appl Infect Control, Berlin, Germany; [Konrat, Katharina; Schwebke, Ingeborg; Levin, Katja; Andrich, Ricarda; Arvand, Mardjan] Hosp Hyg, Robert Koch Inst, Berlin, Germany; [Konrat, Katharina; Laue, Michael; Dittmann, Christin; Schaudinn, Christoph] Robert Koch Inst, Adv Light & Electron Microscopy, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Schaudinn, C (corresponding author), Robert Koch Inst, Adv Light & Electron Microscopy, Berlin, Germany.	schaudinnc@rki.de						Allan N, 2011, SCI MICROBIAL PATHOG, P864; Angeloni S, 2004, AM J GASTROENTEROL, V99, P280, DOI 10.1111/j.1572-0241.2004.04056.x; [Anonymous], 2006, DIN EN 14561 2006 08; [Anonymous], 2014, DIN EN 13727 2014 03; ASTM, 2012, E2799 12; Bardouniotis E, 2001, FEMS MICROBIOL LETT, V203, P263, DOI 10.1111/j.1574-6968.2001.tb10851.x; BARMAN AA, 1981, CARDIOVASC DIS, V8, P555; Buckingham-Meyer K, 2007, J MICROBIOL METH, V70, P236, DOI 10.1016/j.mimet.2007.04.010; Carson L, 2009, GREEN CHEM, V11, P492, DOI 10.1039/b821842k; Cholodny N, 1924, BER DEUT BOT GES, VXLII, P35; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; FRASER VJ, 1993, INFECT CONT HOSP EP, V14, P383, DOI 10.2307/30148320; Harrison JJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-53; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; International A, 2007, STAND TEST METH EV D, P1444; Krankenhaushygiene DGf, 1994, HYGMED, V19, P477; Liu Y, 2002, WATER RES, V36, P1653, DOI 10.1016/S0043-1354(01)00379-7; LOH A, 1993, EUR J VASCULAR SURG, V7, P26, DOI 10.1016/S0950-821X(05)80539-0; Parker AE, 2014, J MICROBIOL METH, V102, P55, DOI 10.1016/j.mimet.2014.04.013; Schulte S, 2006, CHEM-ING-TECH, V78, P1683, DOI 10.1002/cite.200600088; Tote K, 2010, APPL ENVIRON MICROB, V76, P3135, DOI 10.1128/AEM.02095-09; Vikram A, 2015, ANTIMICROB AGENTS CH, V59, P3433, DOI 10.1128/AAC.05152-14; Webster P, 2006, J HISTOCHEM CYTOCHEM, V54, P829, DOI 10.1369/jhc.6A6922.2006	23	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157663	10.1371/journal.pone.0157663	http://dx.doi.org/10.1371/journal.pone.0157663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315246	Green Published, gold, Green Submitted			2022-12-27	WOS:000378030000042
J	Lindemann, U; Mohr, C; Machann, J; Blatzonis, K; Rapp, K; Becker, C				Lindemann, Ulrich; Mohr, Christian; Machann, Juergen; Blatzonis, Konstantinos; Rapp, Kilian; Becker, Clemens			Association between Thigh Muscle Volume and Leg Muscle Power in Older Women	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; FUNCTIONAL-CAPACITY; SARCOPENIA; ADULTS; STRENGTH; VALIDITY; MASS; RELIABILITY; PREVALENCE; MYOSTATIN	The construct of sarcopenia is still discussed with regard to best appropriate measures of muscle volume and muscle function. The aim of this post-hoc analysis of a cross-sectional experimental study was to investigate and describe the hierarchy of the association between thigh muscle volume and measurements of functional performance in older women. Thigh muscle volume of 68 independently living older women (mean age 77.6 years) was measured via magnetic resonance imaging. Isometric strength was assessed for leg extension in a movement laboratory in sitting position with the knee flexed at 90 degrees and for hand grip. Maximum and habitual gait speed was measured on an electronic walk way. Leg muscle power was measured during single leg push and during sit-to-stand performance. Thigh muscle volume was associated with sit-to-stand performance power (r = 0.628), leg push power (r = 0.550), isometric quadriceps strength (r = 0.442), hand grip strength (r = 0.367), fast gait speed (r = 0.291), habitual gait speed (r = 0.256), body mass index (r = 0.411) and age (r = -0.392). Muscle power showed the highest association with thigh muscle volume in healthy older women. Sit-to-stand performance power showed an even higher association with thigh muscle volume compared to single leg push power.	[Lindemann, Ulrich; Mohr, Christian; Rapp, Kilian; Becker, Clemens] Robert Bosch Krankenhaus, Dept Clin Gerontol & Rehabil, Stuttgart, Germany; [Machann, Juergen] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis IDM, Tubingen, Germany; [Machann, Juergen] Univ Tubingen, Dept Diagnost & Intervent Radiol, Sect Expt Radiol, Tubingen, Germany; [Blatzonis, Konstantinos] Robert Bosch Krankenhaus, Dept Radiol & Nucl Med, Stuttgart, Germany	Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Bosch; Robert Bosch Krankenhaus	Lindemann, U (corresponding author), Robert Bosch Krankenhaus, Dept Clin Gerontol & Rehabil, Stuttgart, Germany.	ulrich.lindemann@rbk.de	Rapp, Kilian/AAJ-3370-2020; Becker, Clemens/ABI-5405-2020	Rapp, Kilian/0000-0003-1625-2571; 	German Research Council [BE 2338/2-1]	German Research Council(German Research Foundation (DFG))	This work was supported by the German Research Council (www.dfg.de) [BE 2338/2-1]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSEY EJ, 1990, EUR J APPL PHYSIOL, V60, P385, DOI 10.1007/BF00713504; Bean JF, 2003, J GERONTOL A-BIOL, V58, P728; Becker C, 2015, LANCET DIABETES ENDO, V3, P948, DOI 10.1016/S2213-8587(15)00298-3; Bernabei R, 2014, CLIN CASES MINER BON, V11, P201, DOI 10.11138/ccmbm/2014.11.3.201; Bowen TS, 2015, J CACHEXIA SARCOPENI, V6, P197, DOI 10.1002/jcsm.12043; Cawthon PM, 2015, J CLIN DENSITOM, V18, P467, DOI 10.1016/j.jocd.2015.05.063; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Cutlip RG, 2000, GAIT POSTURE, V12, P134, DOI 10.1016/S0966-6362(00)00062-X; Delmonico MJ, 2008, EUR J CLIN NUTR, V62, P1372, DOI 10.1038/sj.ejcn.1602880; Gray M, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-145; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; Harridge S, 2000, OXFORD TXB GERIATRIC; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Leenders M, 2013, J AM MED DIR ASSOC, V14, P585, DOI 10.1016/j.jamda.2013.02.006; Lindemann U, 2008, GAIT POSTURE, V27, P91, DOI 10.1016/j.gaitpost.2007.02.005; Lindemann U, 2015, PHYSIOTHERAPY, V101, P298, DOI 10.1016/j.physio.2014.12.005; Lindemann U, 2014, AGE AGEING, V43, P571, DOI 10.1093/ageing/afu057; Maden-Wilkinson TM, 2013, J MUSCULOSKEL NEURON, V13, P320; Morley JE, 2014, J CACHEXIA SARCOPENI, V5, P253, DOI 10.1007/s13539-014-0161-y; Morley JE, 2012, FAM PRACT, V29, pi44, DOI 10.1093/fampra/cmr063; Nayak S, 2015, OSTEOPOROSIS INT, V26, P1543, DOI 10.1007/s00198-015-3025-1; O'Brien TD, 2009, EXP PHYSIOL, V94, P731, DOI 10.1113/expphysiol.2008.045062; Scherbakov N, 2013, INT J CARDIOL, V170, P89, DOI 10.1016/j.ijcard.2013.10.031; Villani AM, 2013, J CACHEXIA SARCOPENI, V4, P209, DOI 10.1007/s13539-013-0108-8; White TA, 2014, GERONTOLOGY, V60, P289, DOI 10.1159/000356740; Wilhelm EN, 2014, AGE, V36, P1113, DOI 10.1007/s11357-014-9625-4; Zhang W, 2014, SENSORS-BASEL, V14, P8705, DOI 10.3390/s140508705; Zijlstra W, 2010, GAIT POSTURE, V31, P272, DOI 10.1016/j.gaitpost.2009.11.003	30	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157885	10.1371/journal.pone.0157885	http://dx.doi.org/10.1371/journal.pone.0157885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315060	Green Submitted, Green Published, gold			2022-12-27	WOS:000378030000063
J	Music, N; Reber, AJ; Kim, JH; York, IA				Music, Nedzad; Reber, Adrian J.; Kim, Jin Hyang; York, Ian A.			Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus	PLOS ONE			English	Article							CD8(+) T-CELLS; PANDEMIC INFLUENZA; MOUSE MODEL; INFLAMMATION; PATHOGENESIS; CD4(+); TRANSMISSION; IMMUNITY; RECEPTOR; DEATH	In order to better understand inflammation associated with influenza virus infection, we measured cell trafficking, via flow cytometry, to various tissues in the ferret model following infection with an A(H3N2) human seasonal influenza virus (A/Perth/16/2009). Changes in immune cells were observed in the blood, bronchoalveolar lavage fluid, and spleen, as well as lymph nodes associated with the site of infection or distant from the respiratory system. Nevertheless clinical symptoms were mild, with circulating leukocytes exhibiting rapid, dynamic, and profound changes in response to infection. Each of the biological compartments examined responded differently to influenza infection. Two days after infection, when infected ferrets showed peak fever, a marked, transient lymphopenia and granulocytosis were apparent in all infected animals. Both draining and distal lymph nodes demonstrated significant accumulation of T cells, B cells, and granulocytes at days 2 and 5 post-infection. CD8+ T cells significantly increased in spleen at days 2 and 5 post-infection; CD4+ T cells, B cells and granulocytes significantly increased at day 5. We interpret our findings as showing that lymphocytes exit the peripheral blood and differentially home to lymph nodes and tissues based on cell type and proximity to the site of infection. Monitoring leukocyte homing and trafficking will aid in providing a more detailed view of the inflammatory impact of influenza virus infection.	[Music, Nedzad; Reber, Adrian J.; Kim, Jin Hyang; York, Ian A.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Music, Nedzad] Battelle Mem Inst, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	York, IA (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.	ite1@cdc.gov	York, Ian/X-9351-2019	York, Ian/0000-0002-3478-3344	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The source of funding for this work was the Centers for Disease Control and Prevention. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belser JA, 2013, VIROLOGY, V438, P56, DOI 10.1016/j.virol.2013.01.012; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Brown C, 2006, LAB ANIMAL, V35, P23, DOI 10.1038/laban0206-23; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Chaussee MS, 2011, VACCINE, V29, P3773, DOI 10.1016/j.vaccine.2011.03.031; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Dondi E, 2004, J IMMUNOL, V173, P3740, DOI 10.4049/jimmunol.173.6.3740; Feng YL, 2015, J CLIN PATHOL, V68, P57, DOI 10.1136/jclinpath-2014-202441; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Houser KV, 2013, J VIROL, V87, P13480, DOI 10.1128/JVI.02434-13; Huang SSH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027512; Hufford MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046581; Ibrahim HM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/148725; Kreijtz JHCM, 2011, VIRUS RES, V162, P19, DOI 10.1016/j.virusres.2011.09.022; Kuiken T, 2012, CURR OPIN VIROL, V2, P276, DOI 10.1016/j.coviro.2012.02.013; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107966; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Music N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100926; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Okamba FR, 2010, VACCINE, V28, P4802, DOI 10.1016/j.vaccine.2010.04.089; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; REED L. J., 1938, AMER JOUR HYG, V27, P493; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Russell S M, 1977, Dev Biol Stand, V39, P397; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shrestha S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0233; Shrestha S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005982; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132; Sun J, 2011, NAT IMMUNOL, V12, P327, DOI 10.1038/ni.1996; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; van Domselaar R, 2011, REV MED VIROL, V21, P301, DOI 10.1002/rmv.697; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Wu HL, 2011, J IMMUNOL, V187, P4474, DOI 10.4049/jimmunol.1101443; Ye SY, 2015, J VIROL, V89, P2672, DOI 10.1128/JVI.03529-14	57	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157903	10.1371/journal.pone.0157903	http://dx.doi.org/10.1371/journal.pone.0157903			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315117	gold, Green Submitted, Green Published			2022-12-27	WOS:000378030000065
J	Thomson, FJ; Auld, TD; Ramp, D; Kingsford, RT				Thomson, Fiona J.; Auld, Tony D.; Ramp, Daniel; Kingsford, Richard T.			A Switch in Keystone Seed-Dispersing Ant Genera between Two Elevations for a Myrmecochorous Plant, Acacia terminalis	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; SOIL TEMPERATURES; FUNCTIONAL-GROUPS; REMOVAL; VEGETATION; AUSTRALIA; PREDATION; COMMUNITIES; DISTURBANCE; MUTUALISM	The dispersal capacity of plant species that rely on animals to disperse their seeds (biotic dispersal) can alter with changes to the populations of their keystone dispersal vectors. Knowledge on how biotic dispersal systems vary across landscapes allows better understanding of factors driving plant persistence. Myrmecochory, seed dispersal by ants, is a common method of biotic dispersal for many plant species throughout the world. We tested if the seed dispersal system of Acacia terminalis (Fabaceae), a known myrmecochore, differed between two elevations in the Greater Blue Mountains World Heritage Area, in southeastern Australia. We compared ant assemblages, seed removal rates of ants and other vertebrates (bird and mammal) and the dominant seed-dispersing ant genera. At low elevations (c.200 ma.s.l) seed removal was predominantly by ants, however, at high elevation sites (c.700 ma.s.l) vertebrate seed dispersers or seed predators were present, removing over 60% of seeds from experimental depots when ants were excluded. We found a switch in the keystone seed-dispersing ant genera from Rhytidoponera at low elevations sites to Aphaenogaster at high elevation sites. This resulted in more seeds being removed faster at low elevation sites compared to high elevation sites, however long-term seed removal rates were equal between elevations. Differences in the keystone seed removalist, and the addition of an alternate dispersal vector or seed predator at high elevations, will result in different dispersal and establishment patterns for A. terminalis at different elevations. These differences in dispersal concur with other global studies that report myrmecochorous dispersal systems alter with elevation.	[Thomson, Fiona J.] Landcare Res Manaaki Whenua, Lincoln, New Zealand; [Thomson, Fiona J.; Ramp, Daniel; Kingsford, Richard T.] Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia; [Thomson, Fiona J.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Auld, Tony D.] Off Environm & Heritage, Sydney, NSW, Australia; [Ramp, Daniel] Univ Technol Sydney, Sch Life Sci, Ctr Compassionate Conservat, Sydney, NSW 2007, Australia	Landcare Research - New Zealand; University of New South Wales Sydney; University of New South Wales Sydney; Office of Environment & Heritage - New South Wales; University of Technology Sydney	Thomson, FJ (corresponding author), Landcare Res Manaaki Whenua, Lincoln, New Zealand.; Thomson, FJ (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia.; Thomson, FJ (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	ThomsonF@landcareresearch.co.nz	Ramp, Daniel/C-3692-2008	Ramp, Daniel/0000-0003-3202-9898; Auld, Tony/0000-0002-8766-2829; Kingsford, Richard/0000-0001-6565-4134	Australian Research Council [LP0774833]; Landcare Research from the Ministry of Business, Innovation and Employment, New Zealand; ARC [LP0774833]; Landcare Research	Australian Research Council(Australian Research Council); Landcare Research from the Ministry of Business, Innovation and Employment, New Zealand; ARC(Australian Research Council); Landcare Research	Fiona J. Thomson received funding from the Australian Research Council (http://www.arc.gov.au/) Linkage project, (LP0774833) Managing for Ecosystem Change in the Greater Blue Mountains World Heritage Area project for this work. Fiona J. Thomson also received core funding to rewrite this manuscript from Landcare Research (http://www.landcareresearch.co.nz) from the Ministry of Business, Innovation and Employment (http://www.mbie.govt.nz/), New Zealand.; Thanks to our field assistants, including Tom Mullaney. Also thanks to David J. Eldridge, Terry B. Koen and Sarah Richardson for statistical advice, and Peter Bellingham and the anonymous reviewers for comments on the manuscript. This work was part of the ARC Linkage project, (LP0774833) Managing for Ecosystem Change in the Greater Blue Mountains World Heritage Area project. We thank the industry partners: Office of Environment and Heritage NSW, Hawkesbury Nepean Catchment Management Authority, Blue Mountains City Council and New South Wales Department of Primary Industry. We also thank our research collaborators on this project; the University of Wollongong, the University of Western Sydney and the Greater Blue Mountains World Heritage Institute. Lastly, we thank Landcare Research for providing funding and time to rewrite the manuscript.	ANDERSEN AN, 1988, AUST J ECOL, V13, P285, DOI 10.1111/j.1442-9993.1988.tb00976.x; Andersen AN, 1997, J BIOGEOGR, V24, P433, DOI 10.1111/j.1365-2699.1997.00137.x; ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; Andersen AN, 1998, AUST J ECOL, V23, P483, DOI 10.1111/j.1442-9993.1998.tb00756.x; ANDERSEN AN, 1988, AUST J ECOL, V13, P469, DOI 10.1111/j.1442-9993.1988.tb00995.x; Auld TD, 1999, PLANT ECOL, V144, P201, DOI 10.1023/A:1009817132378; Auld TD, 1996, AUST J ECOL, V21, P106, DOI 10.1111/j.1442-9993.1996.tb00589.x; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Beaumont KP, 2013, OECOLOGIA, V172, P791, DOI 10.1007/s00442-012-2534-2; Benson D. H., 1992, Cunninghamia, V2, P541; BERG RY, 1975, AUST J BOT, V23, P475, DOI 10.1071/BT9750475; Botes A, 2006, J BIOGEOGR, V33, P71, DOI 10.1111/j.1365-2699.2005.01336.x; BRIESE DT, 1981, AUST J ECOL, V6, P1, DOI 10.1111/j.1442-9993.1981.tb01269.x; Calvino-Cancela M, 2008, DIVERS DISTRIB, V14, P11, DOI 10.1111/j.1472-4642.2007.00402.x; Christian CE, 2001, NATURE, V413, P635, DOI 10.1038/35098093; Clarke K. R, 2006, PRIMER V5 USER MANUA; DRAKE WE, 1981, AUST J BOT, V29, P293, DOI 10.1071/BT9810293; Edwards W, 2006, J ECOL, V94, P687, DOI 10.1111/j.1365-2745.2006.01116.x; Fenner M, 1985, SEED ECOLOGY; Gibb H, 2003, OIKOS, V103, P469, DOI 10.1034/j.1600-0706.2003.12652.x; Gomez C, 2013, ECOGRAPHY, V36, P1193, DOI 10.1111/j.1600-0587.2013.00289.x; Gove AD, 2007, OECOLOGIA, V153, P687, DOI 10.1007/s00442-007-0756-5; Hammil K, 2010, VEGETATION FIRE CLIM; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HUGHES L, 1992, ECOLOGY, V73, P1285, DOI 10.2307/1940676; HUGHES L, 1990, ECOLOGY, V71, P138, DOI 10.2307/1940254; HUGHES L, 1992, ECOLOGY, V73, P1300, DOI 10.2307/1940677; Lengyel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005480; Lomov B, 2009, AUSTRAL ECOL, V34, P751, DOI 10.1111/j.1442-9993.2009.01981.x; Lubertazzi D, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14118; MAJER JD, 1985, AUST J BOT, V33, P611, DOI 10.1071/BT9850611; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; Menke SB, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00234.1; MOSSOP MK, 1989, AUST J ECOL, V14, P367, DOI 10.1111/j.1442-9993.1989.tb01445.x; Munoz AA, 2002, ARCT ANTARCT ALP RES, V34, P178, DOI 10.2307/1552469; Ness JH, 2009, OIKOS, V118, P1793, DOI 10.1111/j.1600-0706.2009.17430.x; Ness JH, 2004, ECOLOGY, V85, P1244, DOI 10.1890/03-0364; Ness JH, 2004, BIOL INVASIONS, V6, P445, DOI 10.1023/B:BINV.0000041556.88920.dd; New South Wales National Parks and Wildlife Service, 1998, GREAT BLUE MOUNT AR; Ooi MKJ, 2009, GLOBAL CHANGE BIOL, V15, P2375, DOI 10.1111/j.1365-2486.2009.01887.x; Reymond A, 2013, ECOL ENTOMOL, V38, P364, DOI 10.1111/een.12027; RICE B, 1986, ECOLOGY, V67, P1270, DOI 10.2307/1938682; RICE B, 1981, AUST J ECOL, V6, P291, DOI 10.1111/j.1442-9993.1981.tb01579.x; Robinson L., 2003, FIELD GUIDE NATIVE P; Shattuck S. O., 1999, AUSTR ANTS THEIR BIO; Stuble KL, 2014, PEERJ, V2, DOI 10.7717/peerj.286; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Warren RJ, 2010, J ECOL, V98, P1178, DOI 10.1111/j.1365-2745.2010.01694.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Zelikova TJ, 2008, ACTA OECOL, V34, P155, DOI 10.1016/j.actao.2008.05.002	53	10	10	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157632	10.1371/journal.pone.0157632	http://dx.doi.org/10.1371/journal.pone.0157632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310262	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800111
J	Werner, A; Herzog, B; Frey, S; Poggeler, S				Werner, Antonia; Herzog, Britta; Frey, Stefan; Poeggeler, Stefanie			Autophagy-Associated Protein SmATG12 Is Required for Fruiting-Body Formation in the Filamentous Ascomycete Sordaria macrospora	PLOS ONE			English	Article							ATG12-ATG5 CONJUGATE; ASCOSPORE GERMINATION; SEXUAL DEVELOPMENT; VEGETATIVE GROWTH; LC3 LIPIDATION; GENES SMATG8; YEAST; MEMBRANE; MUTANTS; MECHANISM	In filamentous fungi, autophagy functions as a catabolic mechanism to overcome starvation and to control diverse developmental processes under normal nutritional conditions. Autophagy involves the formation of double-membrane vesicles, termed autophagosomes that engulf cellular components and bring about their degradation via fusion with vacuoles. Two ubiquitin-like (UBL) conjugation systems are essential for the expansion of the autophagosomal membrane: the UBL protein ATG8 is conjugated to the lipid phosphatidylethanolamine and the UBL protein ATG12 is coupled to ATG5. We recently showed that in the homothallic ascomycete Sordaria macrospora autophagy-related genes encoding components of the conjugation systems are required for fruiting-body development and/or are essential for viability. In the present work, we cloned and characterized the S. macrospora (Sm)atg12 gene. Two-hybrid analysis revealed that SmATG12 can interact with SmATG7 and SmATG3. To examine its role in S. macrospora, we replaced the open reading frame of Smatg12 with a hygromycin resistance cassette and generated a homokaryotic Delta Smatg12 knockout strain, which displayed slower vegetative growth under nutrient starvation conditions and was unable to form fruiting bodies. In the hyphae of S. macrospora EGFP-labeled SmATG12 was detected in the cytoplasm and as punctate structures presumed to be phagophores or phagophore assembly sites. Delivery of EGFP-labelled SmATG8 to the vacuole was entirely dependent on SmATG12.	[Werner, Antonia; Herzog, Britta; Frey, Stefan; Poeggeler, Stefanie] Univ Gottingen, Inst Microbiol & Genet, Dept Genet Eukaryot Microorganisms, D-37073 Gottingen, Germany; [Poeggeler, Stefanie] Univ Gottingen, Gottingen Ctr Mol Biosci GZMB, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Poggeler, S (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Genet Eukaryot Microorganisms, D-37073 Gottingen, Germany.; Poggeler, S (corresponding author), Univ Gottingen, Gottingen Ctr Mol Biosci GZMB, D-37073 Gottingen, Germany.	spoegge@gwdg.de			Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (Deutsche Forschungsgemeinschaft) [GSC 226/1, GSC 226/2]; Open Access Publication Funds of the Gottingen University	Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (Deutsche Forschungsgemeinschaft); Open Access Publication Funds of the Gottingen University	AW and SF were partly supported by the Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (Deutsche Forschungsgemeinschaft Grants GSC 226/1, GSC 226/2). The authors acknowledge support by the Open Access Publication Funds of the Gottingen University.; We thank Gertrud Stahlhut for excellent technical assistance. We are very grateful to Prof. Dr. Michael Thumm (Department of Cellular Biochemistry, UMG, Georg-August University Gottingen) for kindly providing the API antibody and plasmid pRS315-GFP-ATG8. AW and SF were partly supported by the Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (DFG Grants GSC 226/1, GSC 226/2). The authors acknowledge support by the Open Access Publication Funds of the Gottingen University.	Amberg DC., 2005, METHODS YEAST GENETI; Avin-Wittenberg T, 2012, PROTOPLASMA, V249, P285, DOI 10.1007/s00709-011-0296-z; Becker D M, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1307s27; Bloemendal S, 2012, MOL MICROBIOL, V84, P310, DOI 10.1111/j.1365-2958.2012.08024.x; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Chinnici JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110603; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chung T, 2010, PLANT J, V62, P483, DOI 10.1111/j.1365-313X.2010.04166.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Elleuche S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005177; Engh I, 2010, EUR J CELL BIOL, V89, P864, DOI 10.1016/j.ejcb.2010.07.002; Esser K, 1992, CRYPTOGAMS CYANAOBAC; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; James P, 1996, GENETICS, V144, P1425; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Josefsen L, 2012, AUTOPHAGY, V8, P326, DOI 10.4161/auto.18705; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Kim SH, 2015, EXP PARASITOL, V159, P46, DOI 10.1016/j.exppara.2015.08.013; Kitamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042977; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Li FQ, 2015, PLANT CELL, V27, P1389, DOI 10.1105/tpc.15.00158; Lord KM, 2011, FUNGAL GENET BIOL, V48, P388, DOI 10.1016/j.fgb.2010.11.009; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Metlagel Z, 2013, P NATL ACAD SCI USA, V110, P18844, DOI 10.1073/pnas.1314755110; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Mukaiyama H, 2009, MICROBIOL-SGM, V155, P3816, DOI 10.1099/mic.0.034389-0; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Murrow L, 2015, NAT CELL BIOL, V17, P300, DOI 10.1038/ncb3112; Nakatogawa H, 2013, ESSAYS BIOCHEM, V55, P39, DOI [10.1042/bse0550039, 10.1042/BSE0550039]; Noda NN, 2013, EMBO REP, V14, P206, DOI 10.1038/embor.2012.208; Nolting N, 2009, FUNGAL GENET BIOL, V46, P531, DOI 10.1016/j.fgb.2009.03.008; Nowrousian M, 1999, MOL CELL BIOL, V19, P450; Nowrousian M, 2012, G3-GENES GENOM GENET, V2, P261, DOI 10.1534/g3.111.001479; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Poggeler S, 2006, MOL GENET GENOMICS, V275, P492, DOI 10.1007/s00438-006-0107-y; Poggeler S, 2006, GENE, V378, P1, DOI 10.1016/j.gene.2006.03.020; Poggeler S, 1997, J MICROBIOL METH, V29, P49, DOI 10.1016/S0167-7012(97)00018-3; Poggeler S, 2003, CURR GENET, V43, P54, DOI 10.1007/s00294-003-0370-y; Poggeler S., 2008, FUNGAL GENET REP, V55, P8, DOI [10.4148/1941-4765.1083, DOI 10.4148/1941-4765.1083]; Poggeler S., 2018, PHYSL GENETICS, V15, P325, DOI [10.1007/978-3-319-71740-1_1, DOI 10.1007/978-3-319-71740-1_1, DOI 10.1007/3-540-28135-5_16]; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Sambrook J., 2001, MOL CLONING LAB MANU; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; Shoji JY, 2014, CURR OPIN MICROBIOL, V20, P1, DOI 10.1016/j.mib.2014.03.002; Shoji Jun-ya, 2011, Fungal Biology Reviews, V25, P79, DOI 10.1016/j.fbr.2011.04.001; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2013, J CELL SCI, V126, P2534, DOI 10.1242/jcs.122960; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Teichert I., 2014, ADV GENET, V87, P201; Teichert I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-511; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Tucker CL, 2009, GENETICS, V182, P1377, DOI 10.1534/genetics.109.103069; Voigt O, 2014, MICROBIOL RES, V169, P128, DOI 10.1016/j.micres.2013.07.012; Voigt O, 2013, FUNGAL GENET BIOL, V61, P50, DOI 10.1016/j.fgb.2013.09.006; Voigt O, 2013, APPL MICROBIOL BIOT, V97, P9277, DOI 10.1007/s00253-013-5221-2; Voigt O, 2013, AUTOPHAGY, V9, P33, DOI 10.4161/auto.22398; Yamazaki-Sato H, 2003, FEBS LETT, V551, P71, DOI 10.1016/S0014-5793(03)00899-8	88	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157960	10.1371/journal.pone.0157960	http://dx.doi.org/10.1371/journal.pone.0157960			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309377	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800144
J	Witso, IL; Rukke, HV; Benneche, T; Scheie, AA				Witso, Ingun Lund; Rukke, Hakon Valen; Benneche, Tore; Scheie, Anne Aamdal			Thiophenone Attenuates Enteropathogenic Escherichia coli O103:H2 Virulence by Interfering with AI-2 Signaling	PLOS ONE			English	Article							BIOFILM FORMATION; SALMONELLA-TYPHIMURIUM; HOST COMMUNICATION; VIBRIO-HARVEYI; SENSOR KINASE; EPINEPHRINE; EXPRESSION; SYSTEM; NOREPINEPHRINE; AUTOINDUCER-2	Interference with bacterial quorum sensing communication provides an anti-virulence strategy to control pathogenic bacteria. Here, using the Enteropathogenic E. coli (EPEC) O103:H2, we showed for the first time that thiophenone TF101 reduced expression of lsrB; the gene encoding the AI-2 receptor. Combined results of transcriptional and phenotypic analyses suggested that TF101 interfere with AI-2 signalling, possibly by competing with AI-2 for binding to LsrB. This is supported by in silico docking prediction of thiophenone TF101 in the LsrB pocket. Transcriptional analyses furthermore showed that thiophenone TF101 interfered with expression of the virulence genes eae and fimH. In addition, TF101 reduced AI-2 induced E. coli adhesion to colorectal adenocarcinoma cells. TF101, on the other hand, did not affect epinephrine or norepinephrine enhanced E. coli adhesion. Overall, our results showed that thiophenone TF101 interfered with virulence expression in E. coli O103:H2, suggestedly by interfering with AI-2 mediated quorum sensing. We thus conclude that thiophenone TF101 might represent a promising future anti-virulence agent in the fight against pathogenic E. coli.	[Witso, Ingun Lund; Scheie, Anne Aamdal] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway; [Rukke, Hakon Valen] Nord Inst Dent Mat NIOM, Oslo, Norway; [Benneche, Tore] Univ Oslo, Fac Math & Nat Sci, Dept Chem, Oslo, Norway	University of Oslo; University of Oslo	Witso, IL (corresponding author), Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway.	ingunwitso@gmail.com		Valen, Hakon/0000-0002-9038-4153	Faculty of Dentistry, University of Oslo	Faculty of Dentistry, University of Oslo	This work was funded by the Faculty of Dentistry, University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON P, 1991, INFECT IMMUN, V59, P2915, DOI 10.1128/IAI.59.9.2915-2921.1991; Bansal T, 2008, APPL MICROBIOL BIOT, V78, P811, DOI 10.1007/s00253-008-1359-8; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Benneche T, 2011, RSC ADV, V1, P323, DOI 10.1039/c1ra00254f; Brito PH, 2013, GENOME BIOL EVOL, V5, P16, DOI 10.1093/gbe/evs122; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Defoirdt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041788; Elhadidy M, 2014, FOODBORNE PATHOG DIS, V11, P874, DOI 10.1089/fpd.2014.1780; Freestone PP, 2002, SHOCK, V18, P465, DOI 10.1097/00024382-200211000-00014; Freestone PPE, 1999, FEMS MICROBIOL LETT, V172, P53, DOI 10.1111/j.1574-6968.1999.tb13449.x; Freestone PPE, 2008, TRENDS MICROBIOL, V16, P55, DOI 10.1016/j.tim.2007.11.005; Hancock V, 2007, FEMS MICROBIOL LETT, V267, P30, DOI 10.1111/j.1574-6968.2006.00507.x; Hernandes RT, 2009, FEMS MICROBIOL LETT, V297, P137, DOI 10.1111/j.1574-6968.2009.01664.x; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karavolos MH, 2013, MOL MICROBIOL, V87, P455, DOI 10.1111/mmi.12110; Kendall MM, 2007, INFECT IMMUN, V75, P4875, DOI 10.1128/IAI.00550-07; Kjelleberg S., 2001, MICROBIOL TODAY, V28, P134; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Lee KM, 2011, FEMS MICROBIOL LETT, V321, P67, DOI 10.1111/j.1574-6968.2011.02311.x; Lonn-Stensrud J, 2007, ORAL MICROBIOL IMMUN, V22, P340, DOI 10.1111/j.1399-302X.2007.00367.x; Lonn-Stensrud J, 2010, SCI TECHNOLOGY MICRO, P155; Lonn-Stensrud J, 2012, FEMS IMMUNOL MED MIC, V65, P326, DOI 10.1111/j.1574-695X.2012.00964.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Nesse LL, 2014, APPL ENVIRON MICROB, V80, P2042, DOI 10.1128/AEM.03331-13; Pacheco AR, 2009, CURR OPIN MICROBIOL, V12, P192, DOI 10.1016/j.mib.2009.01.006; Pereira CS, 2012, MOL MICROBIOL, V84, P93, DOI 10.1111/j.1365-2958.2012.08010.x; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Ren DC, 2004, BIOTECHNOL BIOENG, V88, P630, DOI 10.1002/bit.20259; Ren DC, 2001, ENVIRON MICROBIOL, V3, P731, DOI 10.1046/j.1462-2920.2001.00249.x; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Sekse C, 2013, APPL ENVIRON MICROB, V79, P7502, DOI 10.1128/AEM.01825-13; Sircili MP, 2004, INFECT IMMUN, V72, P2329, DOI 10.1128/IAI.72.4.2329-2337.2004; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Stevens MP, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0007-2013; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Vattem DA, 2007, FITOTERAPIA, V78, P302, DOI 10.1016/j.fitote.2007.03.009; Vestby LK, 2014, J APPL MICROBIOL, V116, P258, DOI 10.1111/jam.12355; Vieira MAM, 2001, J INFECT DIS, V183, P762, DOI 10.1086/318821; Witso IL, 2014, PATHOG DIS, V70, P297, DOI 10.1111/2049-632X.12128; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; Xue T, 2009, CELL RES, V19, P1258, DOI 10.1038/cr.2009.91; Yang K, 2014, CELL BIOCHEM BIOPHYS, V70, P391, DOI 10.1007/s12013-014-9924-5	51	4	4	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157334	10.1371/journal.pone.0157334	http://dx.doi.org/10.1371/journal.pone.0157334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309855	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800056
J	Yuan, HW; Niu, SH; El-Kassaby, YA; Li, Y; Li, W				Yuan, Huwei; Niu, Shihui; El-Kassaby, Yousry A.; Li, Yue; Li, Wei			Simple Genetic Distance-Optimized Field Deployments for Clonal Seed Orchards Based on Microsatellite Markers: As a Case of Chinese Pine Seed Orchard	PLOS ONE			English	Article							NATURAL-POPULATIONS; UNEQUAL DEPLOYMENT; PARENTAGE ANALYSIS; PATERNITY ANALYSIS; SELECTION; TABULIFORMIS; PARAMETERS; DESIGN	Chinese pine seed orchards are in a period of transition from first-generation to advanced-generations. How to effectively select populations for second-generation seed orchards and significantly increase genetic gain through rational deployment have become major issues. In this study, we examined open-and control-pollinated progeny of the first-generation Chinese pine seed orchards in Zhengning (Gansu Province, China) and Xixian (Shanxi Province, China) to address issues related to phenotypic selection for high volume growth, genetic diversity analysis and genetic distance-based phylogenetic analysis of the selections by simple sequence repeats (SSRs), and phylogenetic relationship-based field deployment for advanced-generation orchards. In total, 40, 28, 20, and 13 superior individuals were selected from the large-scale no-pedigree open-pollinated progeny of Zhengning (ZN-NP), open-pollinated families of Zhengning (ZN-OP), open-pollinated families of Xixian (XX-OP), and control-pollinated families of Xixian, with mean volume dominance ratios of 0.83, 0.15, 0.25, and 0.20, respectively. Phylogenetic relationship analysis of the ZN-NP and XX-OP populations showed that the 40 superior individuals in the ZN-NP selected population belonged to 23 families and could be further divided into five phylogenetic groups, and that families in the same group were closely related. Similarly, 20 families in the XX-OP population were related to varying degrees. Based on these results, we found that second-generation Chinese pine seed orchards in Zhengning and Xixian should adopt a grouped, unbalanced, complete, fixed block design and an unbalanced, incomplete, fixed block design, respectively. This study will provide practical references for applying molecular markers to establishing advanced-generation seed orchards.	[Yuan, Huwei; Niu, Shihui; Li, Yue; Li, Wei] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Forest Tree Breeding,Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China; [El-Kassaby, Yousry A.] Univ British Columbia, Fac Forestry, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada	Beijing Forestry University; University of British Columbia	Li, Y (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Forest Tree Breeding,Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China.	liyue@bjfu.edu.cn; bjfuliwei@bjfu.edu.cn	El-Kassaby, Yousry A/K-9856-2016; Niu, Shihui/HCH-9336-2022	El-Kassaby, Yousry A/0000-0002-4887-8977; Niu, Shihui/0000-0002-6296-9373	Fundamental Research Funds for the Central Universities [2015ZCQ-SW-02]; Special Fund for Forestry Scientific Research in the Public Interest [201104022]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Forestry Scientific Research in the Public Interest	This work was supported by "the Fundamental Research Funds for the Central Universities (No. 2015ZCQ-SW-02)" and "Special Fund for Forestry Scientific Research in the Public Interest (No. 201104022)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlinder J, 2014, TREE GENET GENOMES, V10, P27, DOI 10.1007/s11295-013-0659-z; BELL GD, 1978, SILVAE GENET, V27, P223; Burczyk J, 1997, ANN SCI FOREST, V54, P129, DOI 10.1051/forest:19970201; CHEN B. W, 1992, J BEIJING FORESTRY U, V14, P7; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; El-Kassaby YA, 2014, TREE GENET GENOMES, V10, P555, DOI 10.1007/s11295-014-0703-7; El-Kassaby YA, 2012, NEW FOREST, V43, P631, DOI 10.1007/s11056-012-9338-4; El-Kassaby YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025737; El-Kassaby YA, 2009, GENET RES, V91, P111, DOI 10.1017/S001667230900007X; Fang P, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300057; Gomes F, 2016, J FOR RES, V24, P227; Grattapaglia D, 2004, THEOR APPL GENET, V109, P192, DOI 10.1007/s00122-004-1617-9; GRIFFIN AR, 1985, THEOR APPL GENET, V71, P334, DOI 10.1007/BF00252077; Hodge GR, 1993, NEW FOREST, V7, P213; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Kang KyuSuk, 1999, Forest Genetics, V6, P191; Klapste J, 2014, TREE GENET GENOMES, V10, P241, DOI 10.1007/s11295-013-0673-1; Korecky J, 2013, TREE GENET GENOMES, V9, P1227, DOI 10.1007/s11295-013-0630-z; Li W, 2012, SILVAE GENET, V61, P133, DOI 10.1515/sg-2012-0017; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; Lindgren D, 2009, FORESTRY, V82, P17, DOI 10.1093/forestry/cpn033; Lu YQ, 2015, J FORESTRY RES, V26, P963, DOI 10.1007/s11676-015-0093-1; Luikart G, 1999, TRENDS ECOL EVOL, V14, P253, DOI 10.1016/S0169-5347(99)01632-8; Massah N, 2010, J HERED, V101, P154, DOI 10.1093/jhered/esp102; Moriguchi Y, 2011, TREE GENET GENOMES, V7, P1089, DOI 10.1007/s11295-011-0397-z; NAMKOONG G, 1966, FOREST SCI, V12, P8; Ndez JSF, 2009, CONSERV GENET, V10, P45; Neff BD, 2000, MOL ECOL, V9, P515, DOI 10.1046/j.1365-294x.2000.00889.x; Ng CH, 2012, J FOREST RES-JPN, V17, P479, DOI 10.1007/s10310-011-0318-x; Nielsen R, 2001, GENETICS, V157, P1673; PENA SDJ, 1994, TRENDS GENET, V10, P204, DOI 10.1016/0168-9525(94)90257-7; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Shimono A, 2011, TREE GENET GENOMES, V7, P499, DOI 10.1007/s11295-010-0351-5; Wang JL, 2012, MOL ECOL, V21, P100, DOI 10.1111/j.1365-294X.2011.05373.x; Wang SS, 1985, J BEIJING FOR U, V7, P72; Wang XR, 2010, TREE GENET GENOMES, V6, P227, DOI 10.1007/s11295-009-0243-8; WANG XR, 1989, J BEIJING FORESTRY U, V11, P60; Weng YH, 2012, TREE GENET GENOMES, V8, P77, DOI 10.1007/s11295-011-0422-2; Weng YH, 2010, TREE GENET GENOMES, V6, P367, DOI 10.1007/s11295-009-0255-4; Wu C.Y., 1995, VEGETATION CHINA; Xu H., 1993, CHINESE PINE; Yuan HW, 2016, J FORESTRY RES, V27, P1003, DOI 10.1007/s11676-016-0238-x; Yuan HW, 2014, SILVAE GENET, V63, P41, DOI 10.1515/sg-2014-0007; Zhang DongMei, 2007, Journal of Beijing Forestry University, V29, P13; Zhang HuaXin, 2002, Scientia Silvae Sinicae, V38, P129; Zhao P, 2013, NEW FOREST, V44, P357, DOI 10.1007/s11056-012-9343-7	46	2	5	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157646	10.1371/journal.pone.0157646	http://dx.doi.org/10.1371/journal.pone.0157646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310437	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800112
J	Abraham, N; Paul, B; Ragnarsson, L; Lewis, RJ				Abraham, Nikita; Paul, Blessy; Ragnarsson, Lotten; Lewis, Richard J.			Escherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs)	PLOS ONE			English	Article							NEURONAL NICOTINIC RECEPTORS; CRYSTAL-STRUCTURES; LIGAND RECOGNITION; REVEALS; PURIFICATION; DESIGN; COMPLEX; FUSION	Nicotinic acetylcholine receptors (nAChR) are ligand gated ion channels, identified as therapeutic targets for a range of human diseases. Drug design for nAChR related disorders is increasingly using structure-based approaches. Many of these structural insights for therapeutic lead development have been obtained from co-crystal structures of nAChR agonists and antagonists with the acetylcholine binding protein (AChBP). AChBP is a water soluble, structural and functional homolog of the extracellular, ligand-binding domain of nAChRs. Currently, AChBPs are recombinantly expressed in eukaryotic expression systems for structural and biophysical studies. Here, we report the establishment of an Escherichia coli (E. coli) expression system that significantly reduces the cost and time of production compared to the existing expression systems. E. coli can efficiently express unglycosylated AChBP for crystallography and makes the expression of isotopically labelled forms feasible for NMR. We used a pHUE vector containing an N-terminal His-tagged ubiquitin fusion protein to facilitate AChBP expression in the soluble fractions, and thus avoid the need to recover protein from inclusion bodies. The purified protein yield obtained from the E. coli expression system is comparable to that obtained from existing AChBP expression systems. E. coli expressed AChBP bound nAChR agonists and antagonists with affinities matching those previously reported. Thus, the E. coli expression system significantly simplifies the expression and purification of functional AChBP for structural and biophysical studies.	[Abraham, Nikita; Ragnarsson, Lotten; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, Ctr Pain Res, Brisbane, Qld, Australia; [Paul, Blessy] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, Ctr Pain Res, Brisbane, Qld, Australia.	r.lewis@imb.uq.edu.au	Abraham, Nikita/R-1691-2018; Lewis, Richard/T-8763-2019; Ragnarsson, Lotten/A-8632-2012	Abraham, Nikita/0000-0003-1790-6012; Lewis, Richard/0000-0003-3470-923X; Ragnarsson, Lotten/0000-0002-7137-1656; Paul, Blessy/0000-0001-6097-119X	NHMRC (National Health and Medical Research Council) Program Grant [APP1072113]	NHMRC (National Health and Medical Research Council) Program Grant	Funded by NHMRC (National Health and Medical Research Council) Program Grant APP1072113.	Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Arneric SP, 2007, BIOCHEM PHARMACOL, V74, P1092, DOI 10.1016/j.bcp.2007.06.033; Baker RT, 1996, CURR OPIN BIOTECH, V7, P541, DOI 10.1016/S0958-1669(96)80059-0; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cassels BK, 2005, DRUG DISCOV TODAY, V10, P1657, DOI 10.1016/S1359-6446(05)03665-2; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Changeux JP, 2012, J BIOL CHEM, V287, P40207, DOI 10.1074/jbc.R112.407668; Chasapis CT, 2011, BIOCHEMISTRY-US, V50, P9681, DOI 10.1021/bi201223u; Chen R, 2012, BIOTECHNOL ADV, V30, P1102, DOI 10.1016/j.biotechadv.2011.09.013; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Dyson MR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-32; Gao F, 2006, MOL PHARMACOL, V70, P1230, DOI 10.1124/mol.106.027185; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Ihara Makoto, 2008, Invertebrate Neuroscience, V8, P71, DOI 10.1007/s10158-008-0069-3; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; Kesters D, 2013, EMBO REP, V14, P49, DOI 10.1038/embor.2012.189; Lloyd GK, 2000, J PHARMACOL EXP THER, V292, P461; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; McCormack T, 2010, BIOCHEMISTRY-US, V49, P2279, DOI 10.1021/bi902023y; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Moon WJ, 2007, PROTEIN EXPRES PURIF, V51, P141, DOI 10.1016/j.pep.2006.07.010; Mowrey DD, 2015, BBA-BIOMEMBRANES, V1848, P307, DOI 10.1016/j.bbamem.2014.03.014; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Rosano GL, 2014, FRONT MICROBIOL, P5; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; San-Miguel T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-89; Sekiguchi H, 2014, SCI REPORTS, P4; Shahsavar A, 2015, MOL PHARMACOL, V88, P697, DOI 10.1124/mol.115.098061; Shahsavar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040757; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Stevens RC, 2000, STRUCTURE, V8, pR177, DOI 10.1016/S0969-2126(00)00193-3; Talley TT, 2006, J BIOL CHEM, V281, P24678, DOI 10.1074/jbc.M602969200; Taylor P, 2007, BIOCHEM PHARMACOL, V74, P1164, DOI 10.1016/j.bcp.2007.07.038; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Weidner Maria, 2010, J Vis Exp, DOI 10.3791/1862; Wells GB, 2008, FRONT BIOSCI-LANDMRK, V13, P5479, DOI 10.2741/3094; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	55	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157363	10.1371/journal.pone.0157363	http://dx.doi.org/10.1371/journal.pone.0157363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304486	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800055
J	Lind, KR; Lee, N; Sizmur, T; Siemianowski, O; Van Bruggen, S; Ganapathysubramaniam, B; Cademartiri, L				Lind, Kara R.; Lee, Nigel; Sizmur, Tom; Siemianowski, Oskar; Van Bruggen, Shawn; Ganapathysubramaniam, Baskar; Cademartiri, Ludovico			Plant Growth Environments with Programmable Relative Humidity and Homogeneous Nutrient Availability	PLOS ONE			English	Article							PHENOMICS; RESPONSES; FUTURE; LIFE	We describe the design, characterization, and use of "programmable", sterile growth environments for individual (or small sets of) plants. The specific relative humidities and nutrient availability experienced by the plant is established (RH between 15% and 95%; nutrient concentration as desired) during the setup of the growth environment, which takes about 5 minutes and < 1$ in disposable cost. These systems maintain these environmental parameters constant for at least 14 days with minimal intervention (one minute every two days). The design is composed entirely of off-the-shelf components (e.g., LEGO1 bricks) and is characterized by (i) a separation of root and shoot environment (which is physiologically relevant and facilitates imposing specific conditions on the root system, e.g., darkness), (ii) the development of the root system on a flat surface, where the root enjoys constant contact with nutrient solution and air, (iii) a compatibility with root phenotyping. We demonstrate phenotyping by characterizing root systems of Brassica rapa plants growing in different relative humidities (55%, 75%, and 95%). While most phenotypes were found to be sensitive to these environmental changes, a phenotype tightly associated with root system topology-the size distribution of the areas encircled by roots-appeared to be remarkably and counter-intuitively insensitive to humidity changes. These setups combine many of the advantages of hydroponics conditions (e.g., root phenotyping, complete control over nutrient composition, scalability) and soil conditions (e.g., aeration of roots, shading of roots), while being comparable in cost and setup time to Magenta (R) boxes.	[Lind, Kara R.; Sizmur, Tom; Siemianowski, Oskar; Cademartiri, Ludovico] Iowa State Univ Sci & Technol, Dept Mat Sci & Engn, Ames, IA 50011 USA; [Lee, Nigel; Ganapathysubramaniam, Baskar] Iowa State Univ Sci & Technol, Dept Mech Engn, Ames, IA 50011 USA; [Sizmur, Tom] Univ Reading, Dept Geog & Environm Sci, Reading, Berks, England; [Van Bruggen, Shawn; Cademartiri, Ludovico] Iowa State Univ Sci & Technol, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Sizmur, Tom; Cademartiri, Ludovico] US DOE, Ames Lab, Ames, IA 50011 USA	Iowa State University; Iowa State University; University of Reading; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory	Cademartiri, L (corresponding author), Iowa State Univ Sci & Technol, Dept Mat Sci & Engn, Ames, IA 50011 USA.; Cademartiri, L (corresponding author), Iowa State Univ Sci & Technol, Dept Chem & Biol Engn, Ames, IA 50011 USA.; Cademartiri, L (corresponding author), US DOE, Ames Lab, Ames, IA 50011 USA.	lcademar@iastate.edu	Siemianowski, Oskar/A-9904-2018; Cademartiri, Ludovico/A-4142-2008	Cademartiri, Ludovico/0000-0001-8805-9434; Siemianowski, Oskar/0000-0002-7842-8977	Arnold and Mabel Beckman Foundation; Plant Science Institute at Iowa State University	Arnold and Mabel Beckman Foundation; Plant Science Institute at Iowa State University	The work was funded by the Arnold and Mabel Beckman Foundation through a Young Investigator Award to LC. Root phenotyping work was separately funded by the Plant Science Institute at Iowa State University through a Faculty Scholar Award to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Automation and environmental control in plant tissue culture, 1995, AUTOMATION AND ENVIR; Chen CC, 2004, BIOSYST ENG, V88, P231, DOI 10.1016/j.biosystemseng.2004.02.007; Coyle Walter J, 2008, Curr Gastroenterol Rep, V10, P393, DOI 10.1007/s11894-008-0074-z; Dhondt S, 2013, TRENDS PLANT SCI, V18, P433, DOI 10.1016/j.tplants.2013.04.008; Fang FC, 2011, INFECT IMMUN, V79, P1401, DOI 10.1128/IAI.01343-10; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Garcia-Palacios P, 2012, J ECOL, V100, P1303, DOI 10.1111/j.1365-2745.2012.02014.x; Glass DJ, 2008, CELL, V134, P378, DOI 10.1016/j.cell.2008.07.033; GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011; Hartmann A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-148; Haynes W.M., 2014, CRC HDB CHEM PHYS, V95th ed.; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Kozai T, 1997, PLANT CELL TISS ORG, V51, P49, DOI 10.1023/A:1005809518371; Lind KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100867; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Massonnet C, 2010, PLANT PHYSIOL, V152, P2142, DOI 10.1104/pp.109.148338; Mishra Y, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-6; Poorter H, 2012, FUNCT PLANT BIOL, V39, P821, DOI 10.1071/FP12028; Raoult D, 2010, FUTURE MICROBIOL, V5, P135, DOI 10.2217/FMB.09.119; ROLFE BG, 1980, PLANT SCI LETT, V19, P277, DOI 10.1016/0304-4211(80)90082-6; Saint Pierre C, 2012, J EXP BOT, V63, P1799, DOI 10.1093/jxb/err385; Shillito R D, 1983, Plant Cell Rep, V2, P244, DOI 10.1007/BF00269151; Sizmur T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096730; Spellman F., 2012, HDB NATURE; Spomer LA, 1997, HUMIDITY; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; White JW, 2012, FIELD CROP RES, V133, P101, DOI 10.1016/j.fcr.2012.04.003; WILLIAMS RR, 1993, AUST J BOT, V41, P237, DOI 10.1071/BT9930237; Yang WN, 2013, CURR OPIN PLANT BIOL, V16, P180, DOI 10.1016/j.pbi.2013.03.005; Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151	32	4	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0155960	10.1371/journal.pone.0155960	http://dx.doi.org/10.1371/journal.pone.0155960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304431	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000377824800011
J	Siskind, DJ; Leung, J; Russell, AW; Wysoczanski, D; Kisely, S				Siskind, Dan J.; Leung, Janni; Russell, Anthony W.; Wysoczanski, Daniel; Kisely, Steve			Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							LIFE-STYLE INTERVENTION; DOUBLE-BLIND; WEIGHT-GAIN; SCHIZOPHRENIA; 1ST-EPISODE; REDUCTION; DATABASES	Background Although clozapine is the gold-standard for treatment refractory schizophrenia, it has the worst metabolic profile of all antipsychotics. This is partly mediated by clozapine's impact on glucagon-like peptide (GLP-1). There is an absence of robust evidence for effective treatments for clozapine associated weight gain and metabolic syndrome. Metformin, with its role in increasing GLP-1 may aid weight loss among people on clozapine. Methods We conducted a systematic-review and meta-analysis of metformin versus placebo for change in weight and metabolic syndrome for people on clozapine without diabetes mellitus. We searched the Cochrane Schizophrenia Group's trial register, Pubmed and Embase, as well as the following Chinese databases: the Chinese Biomedical Literature Service System and China Knowledge Resource Integrated Database. This was supplemented by hand searches of key papers. Results Eight studies, of which three were from Chinese databases, with 478 participants were included. We found that metformin was superior to placebo in terms of weight loss (-3.12kg, 95% CI -4.88kg to -1.37kg) and BMI (-1.18kg/m(2), 95% CI -1.76kg/m(2) to -0.61kg/m(2)). Metformin significantly improved three of the five components of metabolic syndrome; waist circumference, fasting glucose and triglycerides. Sensitivity analysis on study quality and duration did not greatly impact results. Conclusions Metformin led to clinically meaningful weight loss among people on clozapine, and may reduce the rates of metabolic syndrome. Inclusion of metformin into the treatment protocols of people on clozapine, as tolerated, should be considered.	[Siskind, Dan J.; Russell, Anthony W.; Wysoczanski, Daniel; Kisely, Steve] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Siskind, Dan J.; Wysoczanski, Daniel; Kisely, Steve] Metro South Addict & Mental Hlth Serv, Brisbane, Qld, Australia; [Siskind, Dan J.; Leung, Janni] Univ Queensland, Sch Publ Hlth, QCMHR, Brisbane, Qld, Australia; [Leung, Janni] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Russell, Anthony W.] Princess Alexandra Hosp, Dept Endocrinol, Brisbane, Qld 4102, Australia; [Kisely, Steve] Griffith Univ, Griffith Inst Hlth, Brisbane, Qld 4111, Australia; [Kisely, Steve] Dalhousie Univ, Dept Psychiat, Dept Community Hlth, Halifax, NS, Canada; [Kisely, Steve] Dalhousie Univ, Dept Epidemiol, Halifax, NS, Canada	University of Queensland; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Griffith University; Dalhousie University; Dalhousie University	Siskind, DJ (corresponding author), Univ Queensland, Sch Med, Brisbane, Qld, Australia.; Siskind, DJ (corresponding author), Metro South Addict & Mental Hlth Serv, Brisbane, Qld, Australia.; Siskind, DJ (corresponding author), Univ Queensland, Sch Publ Hlth, QCMHR, Brisbane, Qld, Australia.	d.siskind@uq.edu.au	Siskind, Dan/A-9812-2014; Leung, Janni/H-1003-2012; Russell, Anthony/AGE-0557-2022; Russell, Anthony/A-8807-2011; Kisely, Steve/B-4680-2012	Siskind, Dan/0000-0002-2072-9216; Leung, Janni/0000-0001-5816-2959; Russell, Anthony/0000-0001-7886-8844; Kisely, Steve/0000-0003-4021-2924; Russell, Anthony/0000-0003-4902-6693	University of Queensland School of Medicine; NHMRC ECF [APP1111136]	University of Queensland School of Medicine(University of Queensland); NHMRC ECF(National Health and Medical Research Council (NHMRC) of Australia)	The authors received an Intra-Faculty Collaborative Workshop grant from the University of Queensland School of Medicine which covered the open access publication costs of this manuscript. DS is funded in part through an NHMRC ECF (APP1111136).	Agid O, 2011, J CLIN PSYCHIAT, V72, P1439, DOI 10.4088/JCP.09m05785yel; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bjorkhem-Bergman L, 2011, J PSYCHOPHARMACOL, V25, P299, DOI 10.1177/0269881109353461; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Carrizo E, 2009, SCHIZOPHR RES, V113, P19, DOI 10.1016/j.schres.2009.05.007; Chen CH, 2013, J CLIN PSYCHIAT, V74, pE424, DOI 10.4088/JCP.12m08186; Choi Yun-Jung, 2015, ScientificWorldJournal, V2015, P970730, DOI 10.1155/2015/970730; Cohen JF, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0017-3; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Hebrani P, 2015, J RES MED SCI, V20, P364; Henderson DC, 2005, J CLIN PSYCHIAT, V66, P1116, DOI 10.4088/JCP.v66n0905; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lawrence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2539; Liu HP, 2012, LINCHUANG XINSHEN JI, V18, P97; Mannucci E, 2001, DIABETES CARE, V24, P489, DOI 10.2337/diacare.24.3.489; Mayfield K, 2015, J PSYCHOPHA IN PRESS; Mayfield K, 2015, BJPSYCH OPEN, V1, P67, DOI 10.1192/bjpo.bp.115.001073; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; National Institute for Health and Care Excellence, 2014, PSYCH SCHIZ AD TREAT; Rosenbaum S, 2014, J CLIN PSYCHIAT, V75, P964, DOI 10.4088/JCP.13r08765; Ryan MCM, 2003, AM J PSYCHIAT, V160, P284, DOI 10.1176/appi.ajp.160.2.284; Salpeter SR, 2008, AM J MED, V121, P149, DOI 10.1016/j.amjmed.2007.09.016; StJeor ST, 1997, J AM DIET ASSOC, V97, P481, DOI 10.1016/S0002-8223(97)00126-0; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; [王相立 WANG Xiang-li], 2009, [中国全科医学, Chinese General Practice], V12, P840; Whitney Z, 2015, EUR J CLIN PHARM; Wu RR, 2008, JAMA-J AM MED ASSOC, V299, P185, DOI 10.1001/jama.2007.56-b; Wu RR, 2012, AM J PSYCHIAT, V169, P813, DOI 10.1176/appi.ajp.2012.11091432; Wu W, 2014, CHINESE PEOPLES HLTH, V26, P68; Xia J, 2008, HEALTH INFO LIBR J, V25, P55, DOI 10.1111/j.1471-1842.2007.00734.x; Zheng W, 2015, J CLIN PSYCHOPHARM, V35, P499, DOI 10.1097/JCP.0000000000000392	34	60	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0156208	10.1371/journal.pone.0156208	http://dx.doi.org/10.1371/journal.pone.0156208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304831	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800013
J	Ramya, P; Singh, GP; Jain, N; Singh, PK; Pandey, MK; Sharma, K; Kumar, A; Harikrishna; Prabhu, KV				Ramya, P.; Singh, Gyanendra Pratap; Jain, Neelu; Singh, Pradeep Kumar; Pandey, Manoj Kumar; Sharma, Kavita; Kumar, Arun; Harikrishna; Prabhu, Kumble Vinod			Effect of Recurrent Selection on Drought Tolerance and Related Morpho-Physiological Traits in Bread Wheat	PLOS ONE			English	Article							LOWLAND TROPICAL MAIZE; CARBON-ISOTOPE DISCRIMINATION; GRAIN-YIELD; 8 CYCLES; PHYSIOLOGICAL TRAITS; DWARFING GENES; KERNEL WEIGHT; EARLY VIGOR; POPULATION; RESPONSES	Drought is one of the major abiotic stresses affecting wheat yield. A recurrent selection program was conducted to improve the drought tolerance and yield of bread wheat using drought tolerant advanced breeding lines from a drought tolerant x susceptible cross (HI 1500 x HUW 510). The parental lines were evaluated for yield, biomass and harvest index (HI) in addition to the drought adaptive traits like Canopy Temperature (CT), chlorophyll content and Normalized Difference Vegetative Index (NDVI). After three rounds of recurrent selection, the half sib progenies exhibited a marked reduction in CT, chlorophyll content and biomass; whereas improvement was noted for yield, HI and NDVI. Drought tolerance of the half-sib population appeared enhanced as indicated by drought indices and grain yield. Compared to base population, half-sibs showed better HI, grain filling and a significant (17.1%) increase in grain yield under water stress conditions. Cooler canopies and increased early vigour might have contributed to drought tolerance. A favourable combination of gibberellin sensitive and insensitive Rhtalleles was observed in the recombinant progenies. However, increased yield under water stress had a negative trade off in reduction of biomass. The study also identified potential lines with high yield and drought tolerance for subsequent varietal development for water limited areas.	[Ramya, P.; Singh, Gyanendra Pratap; Jain, Neelu; Singh, Pradeep Kumar; Pandey, Manoj Kumar; Sharma, Kavita; Kumar, Arun; Harikrishna; Prabhu, Kumble Vinod] ICAR Indian Agr Res Inst, Div Genet, Delhi, India; [Ramya, P.] ICAR Indian Inst Hort Res, Div Vegetable Crops, Bangalore, Karnataka, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Horticultural Research	Ramya, P (corresponding author), ICAR Indian Agr Res Inst, Div Genet, Delhi, India.; Ramya, P (corresponding author), ICAR Indian Inst Hort Res, Div Vegetable Crops, Bangalore, Karnataka, India.	ramyakurian@gmail.com			Generation Challenge Project (GCP)	Generation Challenge Project (GCP)	The authors acknowledge the financial assistance from Generation Challenge Project (GCP) in conducting the study.	Allard R., 1960, PRINCIPLES PLANT BRE, P485; Araus JL, 2003, CROP SCI, V43, P170, DOI 10.2135/cropsci2003.0170; ARAUS JL, 1987, PLANT PHYSIOL, V85, P667, DOI 10.1104/pp.85.3.667; BAILEY TB, 1976, CROP SCI, V16, P363, DOI 10.2135/cropsci1976.0011183X001600030012x; Barreto HJ, 1997, DEV DROUGHT LOW N TO, P544; BLUM A, 1989, FIELD CROP RES, V22, P289, DOI 10.1016/0378-4290(89)90028-2; Blum A., 1988, Plant breeding for stress environments.; BOLANOS J, 1993, FIELD CROP RES, V31, P233, DOI 10.1016/0378-4290(93)90064-T; BOLANOS J, 1993, FIELD CROP RES, V31, P253, DOI 10.1016/0378-4290(93)90065-U; BOLANOS J, 1993, FIELD CROP RES, V31, P269, DOI 10.1016/0378-4290(93)90066-V; Borrell AK, 2000, CROP SCI, V40, P1037, DOI 10.2135/cropsci2000.4041037x; Borrell AK, 2014, J EXP BOT, V65, P6251, DOI 10.1093/jxb/eru232; Boyer JS, 1996, ADV AGRON, V56, P187, DOI 10.1016/S0065-2113(08)60182-0; BUSCH RH, 1982, CROP SCI, V22, P568, DOI 10.2135/cropsci1982.0011183X002200030032x; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; DELZER BW, 1995, CROP SCI, V35, P730, DOI 10.2135/cropsci1995.0011183X003500030014x; DONALD CM, 1976, ADV AGRON, V28, P361, DOI 10.1016/S0065-2113(08)60559-3; Edmeades G. O., 1999, DROUGHT RESISTANCE C; Fernandez GCJ, 1992, ADAPTATION FOOD CROP, P257, DOI DOI 10.22001/WVC.72511; FOROUGHIWEHR B, 1990, THEOR APPL GENET, V80, P564, DOI 10.1007/BF00226761; HOSSAIN ABS, 1990, CROP SCI, V30, P622, DOI 10.2135/cropsci1990.0011183X003000030030x; Hu HH, 2014, ANNU REV PLANT BIOL, V65, P715, DOI 10.1146/annurev-arplant-050213-040000; HULL FH, 1945, J AM SOC AGRON, V37, P134; JENKINS MERLE T., 1940, JOUR AMER SOC AGRON, V32, P55; Joshi AK, 2007, EUPHYTICA, V157, P431, DOI 10.1007/s10681-007-9385-7; Khanna-Chopra R, 2013, INDIAN J PLANT GENET, V26, P25; Kountche BA, 2013, FIELD CROP RES, V154, P82, DOI 10.1016/j.fcr.2013.07.008; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; LOFFLER CM, 1983, CROP SCI, V23, P1097, DOI 10.2135/cropsci1983.0011183X002300060018x; Lopes MS, 2012, FIELD CROP RES, V128, P129, DOI 10.1016/j.fcr.2011.12.017; Lopes MS, 2010, FUNCT PLANT BIOL, V37, P147, DOI 10.1071/FP09121; Ludlow M. M., 1990, ADV AGRONOMY, V43, P107; Mir RR, 2012, MOL BREEDING, V29, P963, DOI 10.1007/s11032-011-9693-4; Mullan DJ, 2010, FUNCT PLANT BIOL, V37, P703, DOI 10.1071/FP09277; Olivares-Villegas JJ, 2007, FUNCT PLANT BIOL, V34, P189, DOI 10.1071/FP06148; OLMEDOARCEGA OB, 1995, CROP SCI, V35, P714, DOI 10.2135/cropsci1995.0011183X003500030011x; PARLEVLIET JE, 1988, EUPHYTICA, V37, P261, DOI 10.1007/BF00015122; Pask A, 2014, FIELD CROP RES, V168, P156, DOI 10.1016/j.fcr.2014.07.004; Piepho HP, 2007, GENETICS, V177, P1881, DOI 10.1534/genetics.107.074229; Posadas LG, 2014, CROP SCI, V54, P2536, DOI 10.2135/cropsci2014.01.0090; Ramirez-Vallejo P, 1998, EUPHYTICA, V99, P127, DOI 10.1023/A:1018353200015; Ramya R, 2015, INDIAN J GENET PL BR, V75, P250, DOI 10.5958/0975-6906.2015.00038.3; Rebetzke GJ, 2012, FIELD CROP RES, V127, P17, DOI 10.1016/j.fcr.2011.11.003; Rebetzke GJ, 1999, AUST J AGR RES, V50, P291, DOI 10.1071/A98125; Rebetzke GJ, 2002, CROP SCI, V42, P739, DOI 10.2135/cropsci2002.0739; Reynolds M.P., 2001, APPL PHYSL WHEAT BRE, P88; Reynolds M, 2007, J EXP BOT, V58, P177, DOI 10.1093/jxb/erl250; ROSIELLE AA, 1981, CROP SCI, V21, P943, DOI 10.2135/cropsci1981.0011183X002100060033x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sheoran S, 2013, INDIAN J AGR SCI, V83, P820; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Tehripour F, 2015, 2015 AAEA WAEA JOINT; Veillet S, 1996, THEOR APPL GENET, V92, P644, DOI 10.1007/BF00226084; Venuprasad R, 2007, CROP SCI, V47, P285, DOI 10.2135/cropsci2006.03.0181; Wiersma JJ, 2001, CROP SCI, V41, P999, DOI 10.2135/cropsci2001.414999x; Wilson PB, 2015, FIELD CROP RES, V183, P102, DOI 10.1016/j.fcr.2015.07.002; Zhang JJ, 2013, MOL BREEDING, V32, P771, DOI 10.1007/s11032-013-9905-1; Zhang L, 2015, J EXP BOT, V66, P1215, DOI 10.1093/jxb/eru468	59	26	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156869	10.1371/journal.pone.0156869	http://dx.doi.org/10.1371/journal.pone.0156869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300000	gold, Green Published, Green Submitted			2022-12-27	WOS:000377822200018
J	Valente, TS; Baldi, F; Sant'Anna, AC; Albuquerque, LG; da Costa, MJRP				Valente, Tiago Silva; Baldi, Fernando; Sant'Anna, Aline Cristina; Albuquerque, Lucia Galvao; Rodrigues Paranhos da Costa, Mateus Jose			Genome-Wide Association Study between Single Nucleotide Polymorphisms and Flight Speed in Nellore Cattle	PLOS ONE			English	Article							SOLUBLE GUANYLYL CYCLASE; MAPPING INCLUDING PHENOTYPES; HUMAN CARBOXYPEPTIDASE-E; MEAT QUALITY TRAITS; BEEF-CATTLE; NITRIC-OXIDE; ANTHRAX TOXIN; AFFECTING TEMPERAMENT; GENETIC ASSOCIATIONS; FEEDING-BEHAVIOR	Introduction Cattle temperament is an important factor that affects the profitability of beef cattle enterprises, due to its relationship with productivity traits, animal welfare and labor safety. Temperament is a complex phenotype often assessed by measuring a series of behavioral traits, which result from the effects of multiple environmental and genetic factors, and their interactions. The aims of this study were to perform a genome-wide association study and detect genomic regions, potential candidate genes and their biological mechanisms underlying temperament, measured by flight speed (FS) test in Nellore cattle. Materials and Methods The genome-wide association study (GWAS) was performed using a single-step procedure (ssGBLUP) which combined simultaneously all 16,600 phenotypes from genotyped and non-genotyped animals, full pedigree information of 162,645 animals and 1,384 genotyped animals in one step. The animals were genotyped with High Density Bovine SNP BeadChip which contains 777,962 SNP markers. After quality control (QC) a total of 455,374 SNPs remained. Results Heritability estimated for FS was 0.21 +/- 0.02. Consecutive SNPs explaining 1% or more of the total additive genetic variance were considered as windows associated with FS. Nine candidate regions located on eight different Bos taurus chromosomes (BTA) (1 at 73 Mb, 2 at 65 Mb, 5 at 22 Mb and 119 Mb, 9 at 98 Mb, 11 at 67 Mb, 15 at 16 Mb, 17 at 63 Kb, and 26 at 47 Mb) were identified. The candidate genes identified in these regions were NCKAP5 (BTA2), PARK2 (BTA9), ANTXR1 (BTA11), GUCY1A2 (BTA15), CPE (BTA17) and DOCK1 (BTA26). Among these genes PARK2, GUCY1A2, CPE and DOCK1 are related to dopaminergic system, memory formation, biosynthesis of peptide hormone and neurotransmitter and brain development, respectively. Conclusions Our findings allowed us to identify nine genomic regions (SNP windows) associated with beef cattle temperament, measured by FS test. Within these windows, six promising candidate genes and their biological functions were identified. These results may contribute to a better comprehension into the genetic control of temperament expression in Nellore cattle.	[Valente, Tiago Silva; Baldi, Fernando; Albuquerque, Lucia Galvao; Rodrigues Paranhos da Costa, Mateus Jose] Univ Estadual Paulista, UNESP, Fac Ciencias Agr & Vet, Dept Zootecnia, Via Acesso Prof Paulo Donato Castellane, BR-14884900 Jaboticabal, SP, Brazil; [Sant'Anna, Aline Cristina] Univ Fed Juiz de Fora, Inst Ciencias Biol, Dept Zool, Rua Jose Lourenco Kelmer, BR-36036900 Juiz de Fora, MG, Brazil	Universidade Estadual Paulista; Universidade Federal de Juiz de Fora	da Costa, MJRP (corresponding author), Univ Estadual Paulista, UNESP, Fac Ciencias Agr & Vet, Dept Zootecnia, Via Acesso Prof Paulo Donato Castellane, BR-14884900 Jaboticabal, SP, Brazil.	mpcosta@fcav.unesp.br	Sant'Anna, Aline C/J-7529-2013; da Costa, Mateus J.R. Paranhos/C-5993-2012; da Costa, Mateus Paranhos/V-4750-2019; Baldi, Fernando/E-5492-2012; Albuquerque, Lucia/A-7402-2013	Sant'Anna, Aline C/0000-0002-5431-7199; da Costa, Mateus J.R. Paranhos/0000-0002-0088-4008; da Costa, Mateus Paranhos/0000-0002-0088-4008; Baldi, Fernando/0000-0003-4094-2011; Albuquerque, Lucia/0000-0002-2030-7590	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil [2009/53609-7, 2009/16118-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This project was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil (Grant numbers: 2009/53609-7 and 2009/16118-5). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil (Grant numbers: 2009/53609-7 and 2009/16118-5). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank Agropecuaria Jacarezinho Ltda for allowing access to the animals and records. We would like to acknowledge Dr. Graham Plastow for the useful contributions to this paper.	Adamczyk K, 2013, LIVEST SCI, V154, P1, DOI 10.1016/j.livsci.2013.01.016; Aguilar I, 2011, J ANIM BREED GENET, V128, P422, DOI 10.1111/j.1439-0388.2010.00912.x; Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Ambroziak W, 2015, J APPL GENET; [Anonymous], 2002, P 7 WORLD C GEN APPL; Bauer ME, 2001, PHYSIOL BEHAV, V73, P525, DOI 10.1016/S0031-9384(01)00503-0; Bayram Y, 2014, AM J MED GENET A, V164, P2328, DOI 10.1002/ajmg.a.36678; Besschetnova TY, 2015, MATRIX BIOL, V42, P56, DOI 10.1016/j.matbio.2014.12.002; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Budworth J, 1999, BIOCHEM BIOPH RES CO, V263, P696, DOI 10.1006/bbrc.1999.1444; Burdick N. C., 2011, International Journal of Zoology, V2011, P373197, DOI 10.1155/2011/373197; Burdick NC, 2010, LIVEST SCI, V129, P166, DOI 10.1016/j.livsci.2010.01.020; Burrow H. M., 1997, Animal Breeding Abstracts, V65, P477; Burrow H.M., 1988, P AUST SOC ANIM PROD, V17, P154; Burrow HM, 2000, AUST J AGR RES, V51, P155, DOI 10.1071/AR99053; Burrow HM, 2001, LIVEST PROD SCI, V70, P213, DOI 10.1016/S0301-6226(01)00178-6; Capitanio JP, 2011, BRAIN BEHAV IMMUN, V25, P151, DOI 10.1016/j.bbi.2010.09.008; Cargill EJ, 1998, J ANIM SCI, V76, P2211; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Cavigelli SA, 2008, BRAIN BEHAV IMMUN, V22, P727, DOI 10.1016/j.bbi.2007.10.014; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Chen DH, 2013, CANCER RES, V73, P5821, DOI 10.1158/0008-5472.CAN-13-1080; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Curley KO, 2006, J ANIM SCI, V84, P3100, DOI 10.2527/jas.2006-055; de Mena L, 2013, J MOL NEUROSCI, V50, P264, DOI 10.1007/s12031-012-9942-y; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; Dikmen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069202; Esmailizadeh AK, 2008, J ANIM SCI, V86, P1038, DOI 10.2527/jas.2007-0589; FORDYCE G, 1982, PROC AUST SOC ANIM P, V14, P329; Franke K, 2012, EMBO J, V31, P2908, DOI 10.1038/emboj.2012.130; Fricker LD, 1986, NATURE, V3, P666; Fukae J, 2009, FEBS LETT, V583, P521, DOI 10.1016/j.febslet.2008.12.055; Gerozissis K, 2004, EUR J PHARMACOL, V490, P59, DOI 10.1016/j.ejphar.2004.02.044; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; GIANOLA D, 1986, J ANIM SCI, V63, P217, DOI 10.2527/jas1986.631217x; Gibb BJ, 2001, EUR J NEUROSCI, V13, P539, DOI 10.1046/j.1460-9568.2001.01421.x; Glenske K, 2011, ANIMAL, V5, P195, DOI 10.1017/S1751731110001801; Glenske K, 2010, ARCH TIERZUCHT, V53, P388, DOI 10.5194/aab-53-388-2010; Grady DL, 2013, J NEUROSCI, V33, P286, DOI 10.1523/JNEUROSCI.3515-12.2013; GRANDIN T, 1993, APPL ANIM BEHAV SCI, V36, P1, DOI 10.1016/0168-1591(93)90094-6; Gupta G, 1997, J CLIN INVEST, V100, P1488, DOI 10.1172/JCI119670; Gutierrez-Gil B, 2008, J HERED, V99, P629, DOI 10.1093/jhered/esn060; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Haegeman A, 2003, ANIM GENET, V34, P349, DOI 10.1046/j.1365-2052.2003.01008.x; Hanna LLH, 2014, LIVEST SCI, V161, P17, DOI 10.1016/j.livsci.2013.12.012; HARTENECK C, 1991, FEBS LETT, V292, P217, DOI 10.1016/0014-5793(91)80871-Y; HARTENECK C, 1990, FEBS LETT, V272, P221, DOI 10.1016/0014-5793(90)80489-6; Hase A, 2002, BRAIN RES, V930, P143, DOI 10.1016/S0006-8993(02)02241-2; Haskell MJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00368; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Hejjas K, 2009, GENES BRAIN BEHAV, V8, P330, DOI 10.1111/j.1601-183X.2008.00475.x; Herrmann D, 2010, DEV DYNAM, V239, P680, DOI 10.1002/dvdy.22194; Hiendleder S, 2003, J HERED, V94, P496, DOI 10.1093/jhered/esg090; Hoppe S, 2010, J ANIM SCI, V88, P1982, DOI 10.2527/jas.2008-1557; Hori Yusuke, 2013, Journal of Equine Science, V24, P31, DOI 10.1294/jes.24.31; Hu ZL, 2013, NUCLEIC ACIDS RES, P41; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Ingram RJ, 2013, CLIN EXP IMMUNOL, V173, P84, DOI 10.1111/cei.12090; Jaber M, 1996, NEUROPHARMACOLOGY, V35, P1503, DOI 10.1016/S0028-3908(96)00100-1; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Jensen P, 2008, APPL ANIM BEHAV SCI, V113, P383, DOI 10.1016/j.applanim.2008.01.012; Kadel MJ, 2006, AUST J AGR RES, V57, P1029, DOI 10.1071/AR05082; Keltikangas-Jarvinen L, 2003, PSYCHOSOM MED, V65, P471, DOI 10.1097/01.PSY.0000041547.31072.25; Khor SS, 2013, PEERJ, V1, DOI 10.7717/peerj.66; Kilgour RJ, 2006, APPL ANIM BEHAV SCI, V99, P21, DOI 10.1016/j.applanim.2005.09.012; Kim JY, 2011, J BIOL CHEM, V286, P37615, DOI 10.1074/jbc.M111.268029; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Koesling D, 2004, NEUROCHEM INT, V45, P813, DOI 10.1016/j.neuint.2004.03.011; Koglin M, 2000, BBA-GENE STRUCT EXPR, V1494, P286, DOI 10.1016/S0167-4781(00)00211-6; Koshimizu H, 2009, J MOL NEUROSCI, V39, P1, DOI 10.1007/s12031-008-9164-5; Kuroda Y, 2006, BIOCHEM BIOPH RES CO, V348, P787, DOI 10.1016/j.bbrc.2006.06.201; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Lindholm-Perry AK, 2015, ANIM GENET, V46, P60, DOI 10.1111/age.12244; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; MacKay JRD, 2013, J ANIM SCI, V91, P4917, DOI 10.2527/jas.2012-5473; Makino Y, 2006, J CELL SCI, V119, P923, DOI 10.1242/jcs.02797; MANSER E, 1990, BIOCHEM J, V267, P517, DOI 10.1042/bj2670517; Matuoka K, 1997, BIOCHEM BIOPH RES CO, V239, P488, DOI 10.1006/bbrc.1997.7492; McDonald L J, 1995, Adv Pharmacol, V34, P263; Mergia E, 2003, CELL SIGNAL, V15, P189, DOI 10.1016/S0898-6568(02)00078-5; Meyerhoff JL, 1985, PERSPECTIVES BEHAV M, P250; Mizuno Y, 2001, CURR OPIN NEUROL, V14, P477, DOI 10.1097/00019052-200108000-00008; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Momozawa Y, 2005, MAMM GENOME, V16, P538, DOI 10.1007/s00335-005-0021-3; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; Nkrumah JD, 2007, J ANIM SCI, V85, P2382, DOI 10.2527/jas.2006-657; Osman W, 2012, HUM MOL GENET, V21, P2836, DOI 10.1093/hmg/dds103; Petherick JC, 2002, AUST J EXP AGR, V42, P389, DOI 10.1071/EA01084; Pezeshkpour Gholam H, 2013, Genes Cancer, V4, P315, DOI 10.1177/1947601913497573; Potter LR, 2011, CELL SIGNAL, V23, P1921, DOI 10.1016/j.cellsig.2011.09.001; Prayaga KC, 2009, ANIM PROD SCI, V49, P413, DOI 10.1071/EA08247; Ptacek R, 2011, MED SCI MONITOR, V17, pRA215, DOI 10.12659/MSM.881925; Pugh KA, 2011, CAN J ANIM SCI, V91, P567, DOI [10.4141/CJAS2011-046, 10.4141/cjas2011-046]; Raftery AE., 1992, BAYESIAN STAT, V4, P763; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Robinson DL, 2001, PERS INDIV DIFFER, V31, P1233, DOI 10.1016/S0191-8869(00)00211-7; Rolfe KM, 2011, J ANIM SCI, V89, P3452, DOI 10.2527/jas.2011-3961; Russwurm M, 1998, BIOCHEM J, V335, P125, DOI 10.1042/bj3350125; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; SANDERS KM, 1992, JPN J PHARMACOL, V58, pP220; Sant'Anna AC, 2015, J ANIM BREED GENET, V132, P42, DOI 10.1111/jbg.12117; Sant'Anna AC, 2012, J ANIM SCI, V90, P3427, DOI 10.2527/jas.2011-5044; Santana MHA, 2014, J ANIM BREED GENET, V131, P210, DOI 10.1111/jbg.12084; Schaker K, 2015, J BIOL CHEM, V290, P6408, DOI 10.1074/jbc.M114.633701; Schmidt LA, 2009, PSYCHOL SCI, V20, P831, DOI 10.1111/j.1467-9280.2009.02374.x; Schmutz SM, 2001, J HERED, V92, P290, DOI 10.1093/jhered/92.3.290; Shi L, 2013, COMMUN INTEGR BIOL, P6; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shin SC, 2007, ASIAN AUSTRAL J ANIM, V20, P1; Shiraishi JI, 2008, DOMEST ANIM ENDOCRIN, V34, P223, DOI 10.1016/j.domaniend.2007.05.002; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Spelman RJ, 1999, J DAIRY SCI, V82, P2514, DOI 10.3168/jds.S0022-0302(99)75503-7; St Croix B, 2000, SCIENCE, V289, P1197; Stranecky V, 2013, AM J HUM GENET, V92, P792, DOI 10.1016/j.ajhg.2013.03.023; STRITTMATTER SM, 1984, J BIOL CHEM, V259, P1812; Sun X., 2011, J ANIM SCI S2, V89, P28; Tiezzi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114919; TIPTON RE, 1984, AM J MED GENET, V19, P209, DOI 10.1002/ajmg.1320190202; Tuominen L, 2013, PSYCHOL MED, V43, P881, DOI 10.1017/S003329171200164X; Valente TS, 2015, J APPL GENET, V56, P349, DOI 10.1007/s13353-014-0259-0; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vargas M, 2012, PLOS ONE, P8; Vetters MDD, 2013, J ANIM SCI, V91, P374, DOI 10.2527/jas.2012-5122; Vitezica ZG, 2011, GENET RES, V93, P357, DOI 10.1017/S001667231100022X; Wan M, 2013, ANIM GENET, V44, P717, DOI 10.1111/age.12058; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wang HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00134; Wang J, 2008, ACTA PHARMACOL SIN, V29, P736, DOI 10.1111/j.1745-7254.2008.00798.x; Wang J, 2014, INT J GYNECOL CANCER, V24, P844, DOI 10.1097/IGC.0000000000000137; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Warner T D, 1994, Adv Pharmacol, V26, P171, DOI 10.1016/S1054-3589(08)60054-X; Webb LE, 2015, APPL ANIM BEHAV SCI, V165, P33, DOI 10.1016/j.applanim.2015.01.013; WEDEL B, 1995, J BIOL CHEM, V270, P24871, DOI 10.1074/jbc.270.42.24871; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661; Woronowicz A, 2008, HIPPOCAMPUS, V18, P1051, DOI 10.1002/hipo.20462; Yang MY, 2011, BBA-MOL CELL RES, V1813, P39, DOI 10.1016/j.bbamcr.2010.11.013; Yoshino A, 2005, BIOL PSYCHIAT, V57, P1, DOI 10.1016/j.biopsych.2004.09.027; YUEN PST, 1990, BIOCHEMISTRY-US, V29, P10872, DOI 10.1021/bi00501a002; Zhang CY, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0192-1; Zhao F, 2011, HISTOPATHOLOGY, V59, P1163, DOI 10.1111/j.1365-2559.2011.04045.x	152	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156956	10.1371/journal.pone.0156956	http://dx.doi.org/10.1371/journal.pone.0156956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300296	Green Submitted, gold, Green Published			2022-12-27	WOS:000377822200020
J	Pijls, BG; Meessen, JMTA; Schoones, JW; Fiocco, M; van der Heide, HJL; Sedrakyan, A; Nelissen, RGHH				Pijls, B. G.; Meessen, J. M. T. A.; Schoones, J. W.; Fiocco, M.; van der Heide, H. J. L.; Sedrakyan, A.; Nelissen, R. G. H. H.			Increased Mortality in Metal-on-Metal versus Non-Metal-on-Metal Primary Total Hip Arthroplasty at 10 Years and Longer Follow-Up: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; BONE-MINERAL DENSITY; SERUM-COBALT LEVELS; BEARING SURFACES; ION LEVELS; CANCER-RISK; POLYETHYLENE; REPLACEMENT; HEAD; TOXICITY	Importance There are concerns about increased mortality in patients with metal-on-metal bearings in total hip arthroplasty (THA). Objective To determine the mortality and the morbidity in patients with metal-on-metal articulations (MOM THA) compared to patients with non-metal-on-metal articulations (non-MOM THA) after primary total hip arthroplasty. Data Sources Search of PubMed, MEDLINE, EMBASE, Web of Science, Cochrane, CINAHL, Academic-SearchPremier, ScienceDirect, Wiley and clinical trial registers through March 2015, augmented by a hand search of references from the included articles. No language restrictions were applied. Study Selection Two reviewers screened and identified randomised controlled trials and observational studies of primary total hip arthroplasty comparing MOM THA with non-MOM THA. Data Extraction and Synthesis Two reviewers independently extracted study data and assessed risk of bias. Risk differences (RD) were calculated with random effect models. Meta-regression was used to explore modifying factors. Main Outcomes and Measures Difference in mortality and difference in morbidity expressed as revisions and medical complications between patients with MOM THA and non-MOM THA. Results Forty-seven studies were included, comprising 4,000 THA in randomised trials and over 500,000 THA in observational studies. For mortality, random effects analysis revealed a higher pooled RD of 0.7%, 95%, confidence interval (CI) [0.0%, 2.3%], I-square 42%; the heterogeneity was explained by differences in follow-up. When restricted to studies with long term follow-up (i.e. 10 years or more), the RD for mortality was 8.5%, 95%, CI [5.8%, 11.2%]; number needed to treat was 12. Further subgroup analyses and meta-regression random effects models revealed no evidence for other moderator variables (study level covariates, e.g. resurfacing vs. non-resurfacing MOM) than follow-up duration. The quality of the evidence presented in this meta-analysis was characterized as moderate according to the CLEAR-NPT (for non-pharmacological trials) and Cochrane risk of bias Table. Conclusions and Relevance Meta-analysis suggests there may be an increased long-term risk of mortality and revision surgery for patients with MOM THA compared to patients with non-MOM THA.	[Pijls, B. G.; Meessen, J. M. T. A.; van der Heide, H. J. L.; Nelissen, R. G. H. H.] Leiden Univ, Med Ctr, Dept Orthopaed, Leiden, Netherlands; [Fiocco, M.] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands; [Fiocco, M.] Leiden Univ, Inst Math, NL-2300 RA Leiden, Netherlands; [Schoones, J. W.] Leiden Univ, Med Ctr, Walaeus Lib, Leiden, Netherlands; [Sedrakyan, A.] US FDA, FDA Med Device Epidemiol MDEpiNet Sci & Infrastru, Silver Spring, MD USA; [Sedrakyan, A.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; US Food & Drug Administration (FDA); Cornell University	Pijls, BG (corresponding author), Leiden Univ, Med Ctr, Dept Orthopaed, Leiden, Netherlands.	b.g.c.w.pijls@lumc.nl	Dijkstra, Sander/F-2513-2017; Meessen, Jennifer/AAB-9648-2019; Nelissen, Rob/AAD-8134-2020; Schoones, Johannes Wilhelmus/B-2837-2008	Dijkstra, Sander/0000-0001-5368-757X; Meessen, Jennifer/0000-0002-1744-6899; Nelissen, Rob/0000-0003-1228-4162; Schoones, Johannes Wilhelmus/0000-0003-1120-4781; Pijls, Bart/0000-0001-5351-5057	Dutch Arthritis Foundation (LRR grant)	Dutch Arthritis Foundation (LRR grant)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available upon request from the corresponding author). RN is a President of the Netherlands Orthopaedic Association. The Leiden University Medical Center (LUMC) Department of Orthopaedics has received grants from the Dutch Arthritis Foundation (LRR grant) and ZonMW during 36 months prior to submittal of the manuscript. All other authors declare that they have no other conflicts of interest.	[Anonymous], 2016, 12 ANN REP NAT JOINT; Beaumont JJ, 2008, EPIDEMIOLOGY, V19, P12, DOI 10.1097/EDE.0b013e31815cea4c; Binazzi A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1042-2; Bjorgul K, 2013, BONE JOINT J, V95B, P881, DOI 10.1302/0301-620X.95B7.31067; Boutron I, 2005, J CLIN EPIDEMIOL, V58, P1233, DOI 10.1016/j.jclinepi.2005.05.004; Bradberry SM, 2014, CLIN TOXICOL, V52, P837, DOI 10.3109/15563650.2014.944977; Briggs TWR, 2015, BONE JOINT J, V97B, P1183, DOI 10.1302/0301-620X.97B9.34824; Brodner W, 2003, J BONE JOINT SURG AM, V85A, P2168, DOI 10.2106/00004623-200311000-00017; Clark MJ, 2014, AM J NEURORADIOL; CONVERY FR, 1975, J BONE JOINT SURG AM, VA 57, P57, DOI 10.2106/00004623-197557010-00010; Dahlstrand H, 2009, J ARTHROPLASTY, V24, P837, DOI 10.1016/j.arth.2008.07.019; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desmarchelier R, 2013, J ARTHROPLASTY, V28, P296, DOI 10.1016/j.arth.2012.05.028; Devlin JJ, 2013, J MED TOXICOL, V9, P405, DOI 10.1007/s13181-013-0320-0; Dorr LD, 2004, CLIN ORTHOP RELAT R, P80, DOI 10.1097/01.blo.0000150343.66755.79; Engh CA, 2014, J BONE JOINT SURG AM, V96A, P448, DOI 10.2106/JBJS.M.00164; Gauthier L, 2013, BONE JOINT RES, V2, P140, DOI 10.1302/2046-3758.28.2000173; Grubl A, 2006, J BONE JOINT SURG BR, V88B, P1003, DOI 10.1302/0301-620X.88B8; Gustafson K, 2014, ACTA ORTHOP, V85, P348, DOI 10.3109/17453674.2014.922730; Hailer NP, 2011, ACTA ORTHOP, V82, P6, DOI 10.3109/17453674.2010.548028; Hanna SA, 2012, HIP INT, V22, P592, DOI 10.5301/HIP.2012.10360; Hartmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070359; Howie DW, 2005, ORTHOP CLIN N AM, V36, P195, DOI 10.1016/j.ocl.2004.12.001; Ishida T, 2009, J BIOMED MATER RES B, V91B, P887, DOI 10.1002/jbm.b.31471; Jacobs M, 2004, J ARTHROPLASTY, V19, P48, DOI 10.1016/j.arth.2004.06.021; Jensen C, 2011, OSTEOARTHR CARTILAGE, V19, P1108, DOI 10.1016/j.joca.2011.06.011; Kandala NB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1506; Kendal AR, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6549; Ladon D, 2004, J ARTHROPLASTY, V19, P78, DOI 10.1016/j.arth.2004.09.010; Lalmohamed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065891; Lombardi AV, 2001, J ARTHROPLASTY, V16, P122, DOI 10.1054/arth.2001.29307; Lubbeke A, 2014, BONE JOINT J, V96B, P868, DOI 10.1302/0301-620X.96B7.32369; MacDonald SJ, 2003, CLIN ORTHOP RELAT R, P282, DOI 10.1097/01.blo.0000043066.62337.9d; MacDonald SJ, 2005, J BONE JOINT SURG BR, V87- B, P321; MacDonald SJ, 2005, J BONE JOINT SURG BR, V87-B, P495; Makela KT, 2014, ACTA ORTHOP, V85, P32, DOI 10.3109/17453674.2013.878830; Makela KT, 2012, BRIT MED J, V345, P445; Malviya A, 2011, J BONE JOINT SURG BR, V93B, P1602, DOI 10.1302/0301-620X.93B12.27533; Mao XZ, 2011, MED J AUSTRALIA, V194, P649, DOI 10.5694/j.1326-5377.2011.tb03151.x; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moulin JJ, 1998, AM J EPIDEMIOL, V148, P241; Pabinger C, 2003, CLIN ORTHOP RELAT R, P103, DOI 10.1097/01.blo.0000068766.86536.d3; Penny JO, 2012, J BONE JOINT SURG BR, V94B, P1036, DOI 10.1302/0301-620X.94B8.28222; Penny JO, 2013, ACTA ORTHOP, V84, P246, DOI 10.3109/17453674.2013.788435; Schouten R, 2012, J BONE JOINT SURG BR, V94B, P1462, DOI 10.1302/0301-620X.94B11.29343; Smith AJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2383; Smith AH, 2009, ANNU REV PUBL HEALTH, V30, P107, DOI 10.1146/annurev.publhealth.031308.100143; Straif K, 2009, LANCET ONCOL, V10, P453, DOI 10.1016/S1470-2045(09)70134-2; Suda AJ, 2009, EXPERT REV MED DEVIC, V6, P21, DOI 10.1586/17434440.6.1.21; Tiusanen H, 2013, SCAND J SURG, V102, P197, DOI 10.1177/1457496913491874; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Visuri T, 1996, CLIN ORTHOP RELAT R, pS280; Visuri T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-78; Wang Q, 2012, J BONE JOINT SURG BR, V94B, P768, DOI 10.1302/0301-620X.94B6.28522; Weissinger M, 2011, ACTA CHIR ORTHOP TR, V78, P410; Zagra L, 2013, CLIN ORTHOP RELAT R, V471, P3830, DOI 10.1007/s11999-013-2926-6; Zerahn B, 2011, HIP INT, V21, P176, DOI 10.5301/HIP.2011.6527; Zhang J D, 1987, Zhonghua Yu Fang Yi Xue Za Zhi, V21, P262; Zijlstra WP, 2011, INT ORTHOP, V35, P1771, DOI 10.1007/s00264-011-1233-7; Zijlstra WP, 2010, ORTHOPEDICS, V33, P77; Zijlstra WP, 2013, ACETABULAR BONE DENS, P05	62	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156051	10.1371/journal.pone.0156051	http://dx.doi.org/10.1371/journal.pone.0156051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295038	gold, Green Submitted, Green Published			2022-12-27	WOS:000377821300002
J	Prati, G; Zani, B; Pietrantoni, L; Scudiero, D; Perone, P; Cosmaro, L; Cerioli, A; Oldrini, M				Prati, Gabriele; Zani, Bruna; Pietrantoni, Luca; Scudiero, Diego; Perone, Patrizia; Cosmaro, Lella; Cerioli, Alessandra; Oldrini, Massimo			PEP and TasP Awareness among Italian MSM, PLWHA, and High-Risk Heterosexuals and Demographic, Behavioral, and Social Correlates	PLOS ONE			English	Article							HIV PREVENTION; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; SEXUAL-BEHAVIOR; GAY MEN; LIMITED KNOWLEDGE; ACCEPTABILITY; PEOPLE; MEDIA; POSTEXPOSURE	Post-exposure prophylaxis (PEP) has been proposed as a strategy to prevent the acquisition of HIV infection after certain high-risk exposures, and treatment as prevention (TasP) is also being advocated as a means to reduce sexual transmission of HIV. The aim of this study was to investigate the prevalence of PEP and TasP awareness and their demographic, behavioral, and social correlates in Italy. We conducted a cross-sectional survey of 1,028 high-risk heterosexual men and women, 1,874 non-HIV positive MSM (men who have sex with men), and 694 people living with HIV/AIDS (PLWHA). The majority of the participants was aware of PEP and unaware of TasP. MSM were less knowledgeable about PEP and TasP than were PLWHA and more knowledgeable about PEP and TasP than were high-risk heterosexual participants. The variables most consistently associated with PEP and TasP awareness were contact with HIV/ AIDS organizations, HIV testing, and HIV stigma. A positive relationship between unprotected sexual intercourse and PEP and TasP awareness was found among high risk heterosexual participants, while this association was not significant among MSM and PLWHA. Because PEP and TasP are currently recommended, effective educational and dissemination strategies are needed to increase the level of knowledge about PEP and TasP.	[Prati, Gabriele; Zani, Bruna; Pietrantoni, Luca] Univ Bologna, Dept Psychol, Bologna, Italy; [Scudiero, Diego; Perone, Patrizia; Cosmaro, Lella; Cerioli, Alessandra; Oldrini, Massimo] Italian League Fight AIDS, Como, Italy	University of Bologna	Prati, G (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	gabriele.prati@unibo.it	Prati, Gabriele/K-8426-2014; PIETRANTONI, LUCA/AAX-2518-2020	Prati, Gabriele/0000-0002-0749-183X; PIETRANTONI, LUCA/0000-0002-3966-3800; ZANI, BRUNA/0000-0001-7358-5001	Italian League for the Fight against AIDS (LILA)	Italian League for the Fight against AIDS (LILA)	This research was supported by a grant from the Italian League for the Fight against AIDS (LILA) that commissioned the research from the Department of Psychology of the University of Bologna. The funder participated in study design and data collection.	[Anonymous], 1974, Health Education Monograph, V2, P324; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2013, CURR HIV-AIDS REP, V10, P142, DOI 10.1007/s11904-013-0157-9; Camoni L., 2015, NOT IST SUPER SANITA, V28, P3; Camoni L, 2014, ANN I SUPER SANITA, V50, P291, DOI 10.4415/ANN_14_03_12; Camoni L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/209619; Chen YY, 2013, CURR HIV-AIDS REP, V10, P79, DOI 10.1007/s11904-012-0144-6; Cohen J, 2011, SCIENCE, V334, P1628, DOI 10.1126/science.334.6063.1628; Courtenay-Quirk C, 2006, AIDS EDUC PREV, V18, P56, DOI 10.1521/aeap.2006.18.1.56; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Delgado HM, 2007, CURR OPIN PEDIATR, V19, P405, DOI 10.1097/MOP.0b013e32823ed008; Dombrowski JC, 2010, AIDS PATIENT CARE ST, V24, P747, DOI 10.1089/apc.2010.0198; Doyle JS, 2014, CLIN INFECT DIS, V59, P1483, DOI 10.1093/cid/ciu602; Elford J, 2006, CURR OPIN INFECT DIS, V19, P26, DOI 10.1097/01.qco.0000199018.50451.e1; Elford J, 2004, AIDS, V18, P2216, DOI 10.1097/00002030-200411050-00021; European Centre for Disease Prevention and Control WHO Regional Office for Europe, 2015, HIV AIDS SURV EUR 20; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Golub Sarit A, 2010, Curr HIV/AIDS Rep, V7, P201, DOI 10.1007/s11904-010-0057-1; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guse K, 2012, J ADOLESCENT HEALTH, V51, P535, DOI 10.1016/j.jadohealth.2012.03.014; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Hintze J., 2011, PASS 11; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Holt M, 2013, AIDS BEHAV, V17, P2156, DOI 10.1007/s10461-012-0313-z; Istat, 2012, RAPP ANN 2012; Jones K, 2014, SEX TRANSM DIS, V41, P413, DOI 10.1097/OLQ.0000000000000146; Kalichman SC, 2010, HIV MED, V11, P502, DOI 10.1111/j.1468-1293.2009.00818.x; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Lauby JL, 2008, ARCH SEX BEHAV, V37, P708, DOI 10.1007/s10508-008-9365-6; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Mammone Alessia, 2016, AIDS, V30, P1131, DOI 10.1097/QAD.0000000000001034; McDonald K, 2011, CULT HEALTH SEX, V13, P1119, DOI 10.1080/13691058.2011.607242; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Nodin N, 2008, AIDS CARE, V20, P106, DOI 10.1080/09540120701449096; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Persson A, 2010, AIDS CARE, V22, P1487, DOI 10.1080/09540121.2010.482122; Poynten IM, 2010, HIV MED, V11, P282, DOI 10.1111/j.1468-1293.2009.00777.x; Prati G., 2013, PRATICHE POSITIVE IN; Prati G, 2016, INT J SEX HEALTH, V28, P1, DOI 10.1080/19317611.2015.1068903; Prati G, 2016, QUAL QUANT, V50, P637, DOI 10.1007/s11135-015-0168-2; Prati G, 2016, SOC WORK PUBLIC HLTH, V31, P30, DOI 10.1080/19371918.2015.1087911; Prati G, 2015, J AGING HEALTH, V27, P123, DOI 10.1177/0898264314538664; Prati G, 2014, INT J STD AIDS, V25, P496, DOI 10.1177/0956462413515193; Rosenstock IM, 1960, AM J PUBLIC HEALTH, V50, DOI [10.2105/AJPH.50.3_Pt_1.295, DOI 10.2105/AJPH.50.3_PT1.295]; Swanton R, 2015, SEX TRANSM INFECT, V91, P14, DOI 10.1136/sextrans-2014-051743; Tapscott D., 2008, GROWING DIGITAL RISE; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Young I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064038; Zablotska IB, 2011, JAIDS-J ACQ IMM DEF, V58, P424, DOI 10.1097/QAI.0b013e318230e885	54	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157339	10.1371/journal.pone.0157339	http://dx.doi.org/10.1371/journal.pone.0157339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KF	27294777	Green Submitted, Green Published, gold			2022-12-27	WOS:000377821300036
J	Biswal, DK; Debnath, M; Kharumnuid, G; Thongnibah, W; Tandon, V				Biswal, Devendra Kumar; Debnath, Manish; Kharumnuid, Graciously; Thongnibah, Welfrank; Tandon, Veena			Northeast India Helminth Parasite Information Database (NEIHPID): Knowledge Base for Helminth Parasites	PLOS ONE			English	Article							METACERCARIAE; GENOME	Most metazoan parasites that invade vertebrate hosts belong to three phyla: Platyhelminthes, Nematoda and Acanthocephala. Many of the parasitic members of these phyla are collectively known as helminths and are causative agents of many debilitating, deforming and lethal diseases of humans and animals. The North-East India Helminth Parasite Information Database (NEIHPID) project aimed to document and characterise the spectrum of helminth parasites in the north-eastern region of India, providing host, geographical distribution, diagnostic characters and image data. The morphology-based taxonomic data are supplemented with information on DNA sequences of nuclear, ribosomal and mitochondrial gene marker regions that aid in parasite identification. In addition, the database contains raw next generation sequencing (NGS) data for 3 foodborne trematode parasites, with more to follow. The database will also provide study material for students interested in parasite biology. Users can search the database at various taxonomic levels (phylum, class, order, superfamily, family, genus, and species), or by host, habitat and geographical location. Specimen collection locations are noted as co-ordinates in a MySQL database and can be viewed on Google maps, using Google Maps JavaScript API v3. The NEIHPID database has been made freely available at http://nepiac.nehu.ac.in/index.php	[Biswal, Devendra Kumar; Debnath, Manish; Kharumnuid, Graciously; Thongnibah, Welfrank] NE Hill Univ, Bioinformat Ctr, Shillong 793014, Meghalaya, India; [Tandon, Veena] NE Hill Univ, Dept Zool, Shillong 793014, Meghalaya, India; [Tandon, Veena] Biotech Pk, Lucknow, Uttar Pradesh, India	North Eastern Hill University; North Eastern Hill University	Tandon, V (corresponding author), NE Hill Univ, Dept Zool, Shillong 793014, Meghalaya, India.; Tandon, V (corresponding author), Biotech Pk, Lucknow, Uttar Pradesh, India.	tandonveena@gmail.com		Tandon, Veena/0000-0003-4315-2082; DEBNATH, MANISH/0000-0001-8631-9028; Biswal, Devendra/0000-0003-1093-7166	DIT, GOI in Bioinformatics Centre (BIC) at NEHU, Shillong [DIT/R&D/BIO/15(13)/2008]; Department of Biotechnology, GOI, under DBT-NER Twinning program [BT/48/NE/TBP/2010]; Indian Council of Medical Research Project	DIT, GOI in Bioinformatics Centre (BIC) at NEHU, Shillong; Department of Biotechnology, GOI, under DBT-NER Twinning program; Indian Council of Medical Research Project	This study was carried out under the project 'North East Parasite Information and Analysis Centre (NEPIAC): an in silico approach' sanctioned to Veena Tandon and Devendra Kumar Biswal by DIT, GOI (grant number: DIT/R&D/BIO/15(13)/2008 dated 29.09.2008) in the Bioinformatics Centre (BIC) at NEHU, Shillong. The NGS work was supported by the Department of Biotechnology, GOI, under the DBT-NER Twinning program (grant number BT/48/NE/TBP/2010 dated March 14, 2011) sanctioned to Veena Tandon and Devendra Kumar Biswal and partly by the Indian Council of Medical Research Project on worm zoonoses sanctioned to Veena Tandon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Diaz H, 2006, PARASITOL INT, V55, pS127, DOI 10.1016/j.parint.2005.11.020; BAVERSTOCK PR, 1991, INT J PARASITOL, V21, P329, DOI 10.1016/0020-7519(91)90035-6; Biswal DK, 2014, PEERJ, V2, DOI 10.7717/peerj.484; Biswal DK, 2013, PEERJ, V1, DOI 10.7717/peerj.207; BLAIR D, 1993, INT J PARASITOL, V23, P169, DOI 10.1016/0020-7519(93)90138-O; CHAUHAN B. S., 1953, REC INDIAN MUS, V51, P113; Cwiklinski K, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0632-2; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hunt P, 2006, T ROY SOC TROP MED H, V100, P603, DOI 10.1016/j.trstmh.2006.03.001; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Khalil LF, 1994, KEYS CESTODE PARASIT; MARIAUX J, 2001, INTERRELATIONSHIPS P, P127; Martin J, 2015, NUCLEIC ACIDS RES, V43, pD698, DOI 10.1093/nar/gku1128; Olson PD, 2005, ADV PARASIT, V60, P165, DOI 10.1016/S0065-308X(05)60003-6; Pandey K. C., 2008, ENCY INDIAN MONOGENO, P522; ROHDE K, 1993, INT J PARASITOL, V23, P705, DOI 10.1016/0020-7519(93)90067-9; SACHS R, 1990, ANN TROP MED PARASIT, V84, P277, DOI 10.1080/00034983.1990.11812467; Schmidt GD., 1986, HDB TAPEWORM IDENTIF; Shin Myeong-Heon, 1999, Korean Journal of Parasitology, V37, P55, DOI 10.3347/kjp.1999.37.1.55; Sugiyama H., 2007, SE ASIAN J TROPICAL, V38, P87; Nguyen TC, 2012, J VET MED SCI, V74, P1367, DOI 10.1292/jvms.12-0025; YAMAGUTI S, 1963, SYSTEMA HELMINTHUM, V4; Yamaguti S., 1959, SYSTEMA HELMINTHUM C, VII; Yamaguti S, 1975, SYNOPTICAL REV LIFE; Yu SenHai, 1994, Tropical Diseases Bulletin, V91, pR125	25	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157459	10.1371/journal.pone.0157459	http://dx.doi.org/10.1371/journal.pone.0157459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285615	Green Submitted, gold, Green Published			2022-12-27	WOS:000377564000067
J	Mousa, OY; Dhamoon, MS; Lander, S; Dhamoon, AS				Mousa, Omar Y.; Dhamoon, Mandip S.; Lander, Sarah; Dhamoon, Amit S.			The MD Blues: Under-Recognized Depression and Anxiety in Medical Trainees	PLOS ONE			English	Article							SUICIDAL-IDEATION; STUDENTS; DISTRESS; DISORDER	Background Mental health disease is under recognized in medical professionals. Objective To screen medical students (MS), residents and fellows for major depressive disorder (MDD) and generalized anxiety disorder (GAD) under the new era of work hour reform with age-matched controls from a large representative cross-sectional survey. Methods We conducted an anonymous online survey at a medical university in 2013-2014. We incorporated the Patient Health Questionnaire 2 (PHQ-2) to screen for MDD and the generalized anxiety disorder scale (GAD-7) to screen for GAD, along with additional questions on life stressors and academic performance. We compared these results to age-matched controls from the National Health and Nutrition Examination Survey (NHANES) database. Results 126 residents/fellows and 336 medical students participated voluntarily. 15.1% and 15.9% of postgraduates as well as 16.4% and 20.3% of MS screened positive for MDD and GAD, respectively. When compared to national estimates, the prevalence of a positive screen for MDD was over five-fold higher in medical trainees compared to age-matched controls (16% vs. 2.8%, p<0.0001). Similarly, the prevalence of a positive screen for GAD was over eightfold higher in medical trainees (19% vs. 2.3%, p<0.0001). The prevalence was consistently higher within age strata. 33.3% of postgraduates and 32% of MS believe there is a significant impact of depression or anxiety on their academic performance. For stress relief, one fifth of residents/fellows as well as MS reported alcohol use. Conclusions The stresses of medical education and practice may predispose trainees to psychopathological consequences that can affect their academic performance and patient care. The current study showed a significantly higher rate of MDD and GAD positive screens in medical trainees than the prevalence in an age-matched U.S. population, despite significant work hour reform for medical trainees. Increased awareness and support services are required at all levels of medical training. We propose that the ACGME and the Institute of Medicine may consider these findings when implementing future changes to work hour regulations.	[Mousa, Omar Y.; Lander, Sarah; Dhamoon, Amit S.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Dhamoon, Mandip S.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Icahn School of Medicine at Mount Sinai	Mousa, OY (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.	omar.mousa@hotmail.com	Mousa, Omar Y/AAE-6113-2020	Mousa, Omar Y/0000-0002-8411-3859				Drolet BC, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1011413; Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Greenberg PE, 2015, J CLIN PSYCHIAT, V76, P155, DOI 10.4088/JCP.14m09298; Guille Constance, 2010, J Grad Med Educ, V2, P210, DOI 10.4300/JGME-D-09-00086.1; Gulliver A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-157; Joules N, 2014, OPEN J DEPRESSION, V3; Joules NWDTA, 2014, OPEN J DEPRESSION, P89, DOI DOI 10.4236/OJD.2014.33013; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lindeman S, 1996, BRIT J PSYCHIAT, V168, P274, DOI 10.1192/bjp.168.3.274; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Roh MS, 2010, ACAD MED, V85, P1384, DOI 10.1097/ACM.0b013e3181df5e43; Rosal MC, 1997, ACAD MED, V72, P542, DOI 10.1097/00001888-199706000-00022; Rose M, 2008, BEHAV SLEEP MED, V6, P75, DOI 10.1080/15402000801952914; Saipanish R, 2003, MED TEACH, V25, P502, DOI 10.1080/0142159031000136716; Schwenk TL, 2010, JAMA-J AM MED ASSOC, V304, P1181, DOI 10.1001/jama.2010.1300; Shanafelt TD, 2011, ARCH SURG-CHICAGO, V146, P54, DOI 10.1001/archsurg.2010.292; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; West CP, 2009, JAMA-J AM MED ASSOC, V302, P1294, DOI 10.1001/jama.2009.1389	20	47	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156554	10.1371/journal.pone.0156554	http://dx.doi.org/10.1371/journal.pone.0156554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27286249	gold, Green Published, Green Submitted			2022-12-27	WOS:000377564000015
J	Fall, A; Dia, N; Cisse, EHAK; Kiori, DE; Sarr, FD; Sy, S; Goudiaby, D; Richard, V; Niang, MN				Fall, Amary; Dia, Ndongo; Cisse, El Hadj Abdel Kader; Kiori, Davy E.; Sarr, Fatoumata Diene; Sy, Sara; Goudiaby, Debora; Richard, Vincent; Niang, Mbayame Ndiaye			Epidemiology and Molecular Characterization of Human Respiratory Syncytial Virus in Senegal after Four Consecutive Years of Surveillance, 2012-2015	PLOS ONE			English	Article							INFLUENZA-LIKE ILLNESS; GENETIC DIVERSITY; VIRAL ETIOLOGY; SUBGROUP-A; INFECTION	Background The burden of respiratory syncytial virus (RSV) infection remains poorly defined in Africa. To address this, we carried out a descriptive and retrospective pilot study, with a focus on the epidemiology of RSV in Senegal after 4 years of surveillance. Methodology and Results From January 2012 to October 2015 swabs were collected from consenting ILI outpatients. Viral detection was performed using RV16 kit enabling direct subtyping of RSV-A and B. For the molecular characterization of HRSV, the second hypervariable region of the Glycoprotein (G) gene was targeted for sequencing. We enrolled 5338 patients with 2803 children younger than five years of age (52.5%). 610 (11.4%) were positive for RSV infection: 276 (45.2%) were group A infections, 334 (54.8%) were group B infections and 21 (3.4%) were A/B co-infections. RSV detection rate is significantly higher (P < 0.0001) in children below 5 years. We noted that the annual distribution of RSV varied substantially by season and for the predominant subtype. Globally, results show a clear circulation pattern in the second half of each year; between June and September and possibly extended into November. The majority of RSV-A strains from Senegal clustered with strains that were previously assigned NA1 and novel ON1 genotype sequences. RSV-B sequences from Senegal clustered with the BA9 genotype. At the amino acid level, RSV-A strains from Senegal show proximity with the genotype ON1 characterized by a 72 nt insertion in G, resulting in 24 extra amino acids of which 23 are duplications of as 261-283. Conclusion Globally our results show a clear circulation pattern of RSV in the second half of each year, between June and September and possibly extending into November, with children under 5 being more susceptible. Molecular studies identified the novel strains ON1 and BA9 as the major genotypes circulating in Senegal between 2012 and 2015.	[Fall, Amary; Dia, Ndongo; Cisse, El Hadj Abdel Kader; Kiori, Davy E.; Sy, Sara; Goudiaby, Debora; Niang, Mbayame Ndiaye] Inst Pasteur, Unite Virol Med, Dakar, Senegal; [Sarr, Fatoumata Diene; Richard, Vincent] Inst Pasteur, Unite Epidemiol Malad Infect, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Dia, N; Niang, MN (corresponding author), Inst Pasteur, Unite Virol Med, Dakar, Senegal.	ndia@pasteur.sn; niang@pasteur.sn	Fall, Amary/AAR-8776-2021	Fall, Amary/0000-0002-6890-7915; Vincent, RICHARD/0000-0002-6961-1753	Department of Health and Human Service (DHSS) via International Network of Pasteur Institutes; Pasteur Institute of Dakar	Department of Health and Human Service (DHSS) via International Network of Pasteur Institutes; Pasteur Institute of Dakar	This work was supported by the Department of Health and Human Service (DHSS) via the International Network of Pasteur Institutes and the Pasteur Institute of Dakar.	Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Ramirez JB, 2014, REV PANAM SALUD PUBL, V36, P101; Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Dia N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093227; Duvvuri VR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14268; Emukule GO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105543; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Fowlkes A, 2014, J INFECT DIS, V209, P1715, DOI 10.1093/infdis/jit806; Goto-Sugai K, 2010, JPN J INFECT DIS, V63, P393; Gupta R., 2004, RESEARCHGATE; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Homaira N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147982; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Lekana-Douki SE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-373; McIntosh K, 1990, VIROLOGY, V1, P1045; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Noh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064295; Otomaru H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123755; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Saha S, 2015, J GLOB HEALTH, V5, P233, DOI 10.7189/jogh.05.020419; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Uduman S. A., 1996, Journal of Communicable Diseases, V28, P245; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	33	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157163	10.1371/journal.pone.0157163	http://dx.doi.org/10.1371/journal.pone.0157163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315120	Green Published, Green Submitted, gold			2022-12-27	WOS:000378030000013
J	Faverial, J; Cornet, D; Paul, J; Sierra, J				Faverial, Julie; Cornet, Denis; Paul, Jacky; Sierra, Jorge			Multivariate Analysis of the Determinants of the End-Product Quality of Manure-Based Composts and Vermicomposts Using Bayesian Network Modelling	PLOS ONE			English	Article							STRUCTURE DISCOVERY; WASTES; BIODEGRADATION; PHOSPHORUS; CARBON; SOIL	Previous studies indicated that the quality of tropical composts is poorer than that of composts produced in temperate regions. The aim of this study was to test the type of manure, the use of co-composting with green waste, and the stabilization method for their ability to improve compost quality in the tropics. We produced 68 composts and vermicomposts that were analysed for their C, lignin and NPK contents throughout the composting process. Bayesian networks were used to assess the mechanisms controlling compost quality. The concentration effect, for C and lignin, and the initial blend quality, for NPK content, were the main factors affecting compost quality. Cattle manure composts presented the highest C and lignin contents, and poultry litter composts exhibited the highest NPK content. Co-composting improved quality by enhancing the concentration effect, which reduced the impact of C and nutrient losses. Vermicomposting did not improve compost quality; co-composting without earthworms thus appears to be a suitable stabilization method under the conditions of this study because it produced high quality composts and is easier to implement.	[Faverial, Julie; Paul, Jacky; Sierra, Jorge] INRA, ASTRO UR1321, Agrosyst Tropicaux, Petit Bourg, Guadeloupe, France; [Cornet, Denis] CIRAD, UMR AGAP, Montpellier, France	INRAE; CIRAD; Universite de Montpellier	Sierra, J (corresponding author), INRA, ASTRO UR1321, Agrosyst Tropicaux, Petit Bourg, Guadeloupe, France.	jorge.sierra@antilles.inra.fr	Cornet, Denis/N-3589-2019; Denis, Cornet JM/L-7477-2015	Cornet, Denis/0000-0001-9297-2680; Denis, Cornet JM/0000-0001-9297-2680; Sierra, Jorge/0000-0001-6973-7148	Regional Council of Guadeloupe; Animal Genetics Division of the French National Institute for Agricultural Research (INRA); Environment and Agronomy Division of the French National Institute for Agricultural Research (INRA); European Regional Development Fund (FEDER); Departmental Council of Guadeloupe	Regional Council of Guadeloupe; Animal Genetics Division of the French National Institute for Agricultural Research (INRA); Environment and Agronomy Division of the French National Institute for Agricultural Research (INRA); European Regional Development Fund (FEDER)(European Commission); Departmental Council of Guadeloupe	The contribution of the first author benefited from a Ph.D. fellowship co-financed by the Regional Council of Guadeloupe and the Animal Genetics and Environment and Agronomy Divisions of the French National Institute for Agricultural Research (INRA). This study was financed by the European Regional Development Fund (FEDER), the Departmental Council of Guadeloupe and the Regional Council of Guadeloupe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFNOR, 2005, 44162 AFNOR XPU; [Anonymous], 2011, BIOAUGMENTATION BIOS, V28, P107; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Castillo LE, 2006, SCI TOTAL ENVIRON, V367, P418, DOI 10.1016/j.scitotenv.2006.02.052; Cornet D, 2016, EUR J AGRON, V75, P80, DOI 10.1016/j.eja.2016.01.009; de Nijs PJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06682; Eckelman MJ, 2014, J IND ECOL, V18, P306, DOI 10.1111/jiec.12113; Evanylo G, 2008, AGR ECOSYST ENVIRON, V127, P50, DOI 10.1016/j.agee.2008.02.014; Francou C, 2008, BIORESOURCE TECHNOL, V99, P8926, DOI 10.1016/j.biortech.2008.04.071; Friedman N, 2003, MACH LEARN, V50, P95, DOI 10.1023/A:1020249912095; Gagnon B, 2012, CAN J SOIL SCI, V92, P711, DOI [10.4141/CJSS2012-032, 10.4141/cjss2012-032]; GARG VK, 2008, CURRENT DEV SOLID ST, P468, DOI DOI 10.1007/978-0-387-75213-6_20; Jensen FV, 2007, BAYESIAN NETWORKS DE; Jouquet P, 2010, APPL SOIL ECOL, V46, P125, DOI 10.1016/j.apsoil.2010.07.002; Kabore TWT, 2010, BIORESOURCE TECHNOL, V101, P1002, DOI 10.1016/j.biortech.2009.08.101; Kumar PR, 2009, CLEAN TECHNOL ENVIR, V11, P473, DOI 10.1007/s10098-009-0204-9; Larney FJ, 2007, BIORESOURCE TECHNOL, V98, P3221, DOI 10.1016/j.biortech.2006.07.005; Leconte MC, 2009, WASTE MANAGE, V29, P2446, DOI 10.1016/j.wasman.2009.04.006; Lewis FI, 2011, PREV VET MED, V100, P109, DOI 10.1016/j.prevetmed.2011.02.003; Lewis FI, 2012, AM J EPIDEMIOL, V176, P1051, DOI 10.1093/aje/kws183; Lobell DB, 2013, AGR FOREST METEOROL, V170, P58, DOI 10.1016/j.agrformet.2012.05.013; Mandonnet N, 2012, ANIMAL, V6, P705, DOI 10.1017/S1751731112000523; Neher DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079512; Parkinson R, 2004, BIORESOURCE TECHNOL, V91, P171, DOI 10.1016/S0960-8524(03)00174-3; Plummer M., 2003, P 3 INT WORKSH DISTR; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Regional Council of Guadeloupe, 2010, VAL EN BIOM GUAD ET; Sierra J, 2015, AGR ECOSYST ENVIRON, V213, P252, DOI 10.1016/j.agee.2015.08.015; Sierra J, 2013, SOIL RES, V51, P142, DOI 10.1071/SR13031; Sim EYS, 2010, J SCI FOOD AGR, V90, P2153, DOI 10.1002/jsfa.4127; Singh YK, 2009, RESOUR CONSERV RECY, V53, P386, DOI 10.1016/j.resconrec.2009.02.004; Stloukal P, 2015, WASTE MANAGE, V42, P31, DOI 10.1016/j.wasman.2015.04.006; Tuomela M, 2000, BIORESOURCE TECHNOL, V72, P169, DOI 10.1016/S0960-8524(99)00104-2; Wang K, 2015, J HAZARD MATER, V300, P745, DOI 10.1016/j.jhazmat.2015.08.016	35	4	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157884	10.1371/journal.pone.0157884	http://dx.doi.org/10.1371/journal.pone.0157884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314950	Green Published, Green Submitted, gold			2022-12-27	WOS:000378030000062
J	Bernal, ICPD; Lillebaek, T; Pedersen, MK; Martinez-Martinez, L; Folkvardsen, DB; Aguero, J; Rasmussen, EM				Perez del Molino Bernal, Inmaculada C.; Lillebaek, Troels; Pedersen, Mathias K.; Martinez-Martinez, Luis; Folkvardsen, Dorte B.; Agueero, Jesus; Michael Rasmussen, E.			Genomic Diversity of Mycobacterium tuberculosis Complex Strains in Cantabria (Spain), a Moderate TB Incidence Setting	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PULMONARY TUBERCULOSIS; CLUSTERED TUBERCULOSIS; MIRU-VNTRPLUS; TRANSMISSION; DATABASE; COUNTRY; 4-YEAR; RISK	Background Tuberculosis (TB) control strategies are focused mainly on prevention, early diagnosis, compliance to treatment and contact tracing. The objectives of this study were to explore the frequency and risk factors of recent transmission of clinical isolates of Mycobacterium tuberculosis complex (MTBC) in Cantabria in Northern Spain from 2012 through 2013 and to analyze their clonal complexity for better understanding of the transmission dynamics in a moderate TB incidence setting. Methods DNA from 85 out of 87 isolates from bacteriologically confirmed cases of MTBC infection were extracted directly from frozen stocks and genotyped using the mycobacterial interspersed repetitive units-variable number tandem repeat (MIRU-VNTR) method. The MIRU-VNTRpIus database tool was used to identify clusters and lineages and to build a neighbor joining (NJ) phylogenetic tree. In addition, data were compared to the SITVIT2 database at the Pasteur Institute of Guadeloupe. Results The rate of recent transmission was calculated to 24%. Clustering was associated with being Spanish-born. A high prevalence of isolates of the Euro-American lineage was found. In addition, MIRU-VNTR profiles of the studied isolates corresponded to previously found MIRU-VNTR types in other countries, including Spain, Belgium, Great Britain, USA, Croatia, South Africa and The Netherlands. Six of the strains analyzed represented clonal variants. Conclusion Transmission of MTBC is well controlled in Cantabria. The majority of TB patients were born in Spain. The population structure of MTBC in Cantabria has a low diversity of major clonal lineages with the Euro-American lineage predominating.	[Perez del Molino Bernal, Inmaculada C.; Martinez-Martinez, Luis; Agueero, Jesus] Univ Hosp Marques Valdecilla, Microbiol Serv, Santander, Spain; [Perez del Molino Bernal, Inmaculada C.; Lillebaek, Troels; Pedersen, Mathias K.; Folkvardsen, Dorte B.; Michael Rasmussen, E.] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark; [Perez del Molino Bernal, Inmaculada C.; Martinez-Martinez, Luis; Agueero, Jesus] Valdecilla Biomed Res Inst IDIVAL, Santander, Spain; [Martinez-Martinez, Luis; Agueero, Jesus] Univ Cantabria, Sch Med, Dept Mol Biol, E-39005 Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Statens Serum Institut; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Bernal, ICPD (corresponding author), Univ Hosp Marques Valdecilla, Microbiol Serv, Santander, Spain.; Bernal, ICPD (corresponding author), Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark.; Bernal, ICPD (corresponding author), Valdecilla Biomed Res Inst IDIVAL, Santander, Spain.	inmperez@humv.es	Martínez, Luis Martínez/U-1801-2017	Martínez, Luis Martínez/0000-0002-6091-4045; , Inmaculada/0000-0001-5315-3690; Lillebaek, Troels/0000-0002-2601-2718	Valdecilla Biomedical Research Institut (IDIVAL), Santander, Spain [CVE-2013-7667]	Valdecilla Biomedical Research Institut (IDIVAL), Santander, Spain	This study was supported by a grant from Valdecilla Biomedical Research Institut (IDIVAL), Santander, Spain (grant: CVE-2013-7667). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Lucerna MA, 2011, ENFERM INFEC MICR CL, V29, P174, DOI 10.1016/j.eimc.2010.06.010; [Anonymous], 2007, HIST CANT, VI, P213; [Anonymous], 2013, INFORME EPIDEMIOLOGI; [Anonymous], 2008, TUBERCULOSIS GENOTYP; Borgdorff MW, 2011, AM J EPIDEMIOL, V174, P243, DOI 10.1093/aje/kwr061; Braden CR, 2001, CLIN INFECT DIS, V33, pE42, DOI 10.1086/322635; Chaoui I, 2014, INFECT GENET EVOL, V21, P463, DOI 10.1016/j.meegid.2013.05.023; Cohen T, 2011, J CLIN MICROBIOL, V49, P385, DOI 10.1128/JCM.01378-10; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Dahle UR, 2001, J CLIN MICROBIOL, V39, P1802, DOI 10.1128/JCM.39.5.1802-1807.2001; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Fallico L, 2014, INFECT GENET EVOL, V26, P58, DOI 10.1016/j.meegid.2014.05.004; Fitzgibbon MM, 2013, EURO SURVEILL, V18; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Garcia de Viedma D, 2005, J CLIN MICROBIOL, V43, P5660, DOI 10.1128/JCM.43.11.5660-5664.2005; Garcia de Viedma D, 2005, J CLIN MICROBIOL, V43, P1797, DOI 10.1128/JCM.43.4.1797-1806.2005; Kamper-Jorgensen Z, 2012, J CLIN MICROBIOL, V50, P2660, DOI 10.1128/JCM.06358-11; Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI 10.2217/FMB.10.165; Lillebaek T, 2001, J CLIN MICROBIOL, V39, P855, DOI 10.1128/JCM.39.3.855-861.2001; Lopez Calleja AI, 2007, INT J TUBERC LUNG D, V11, P1080; Lopez Calleja AI, 2009, BMC PULM MED, V9, P3, DOI [10.1186/1471-2466-9-3, DOI 10.1186/1471-2466-9-3]; Navarro Y, 2011, J CLIN MICROBIOL, V49, P4131, DOI 10.1128/JCM.05203-11; Pena MJ, 2003, THORAX, V58, P618, DOI 10.1136/thorax.58.7.618; Perez-Lago L, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.015; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Perez-Lago L, 2011, J CLIN MICROBIOL, V49, P3771, DOI 10.1128/JCM.01285-11; Pfyffer GE, 1998, EUR RESPIR J, V11, P804, DOI 10.1183/09031936.98.11040804; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Roetzer A, 2011, J CLIN MICROBIOL, V49, P4173, DOI 10.1128/JCM.05293-11; Sanchez-Castanon M, 2009, INT J TUBERC LUNG D, V13, P480; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; van Deutekom H, 2004, AM J RESP CRIT CARE, V169, P806, DOI 10.1164/rccm.200306-856OC; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157266	10.1371/journal.pone.0157266	http://dx.doi.org/10.1371/journal.pone.0157266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27315243	Green Published, gold			2022-12-27	WOS:000378030000015
J	Carpino, G; Nobili, V; Renzi, A; De Stefanis, C; Stronati, L; Franchitto, A; Alisi, A; Onori, P; De Vito, R; Alpini, G; Gaudio, E				Carpino, Guido; Nobili, Valerio; Renzi, Anastasia; De Stefanis, Cristiano; Stronati, Laura; Franchitto, Antonio; Alisi, Anna; Onori, Paolo; De Vito, Rita; Alpini, Gianfranco; Gaudio, Eugenio			Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway	PLOS ONE			English	Article							DOCOSAHEXAENOIC ACID; DUCTULAR REACTION; BILIARY TREE; REGENERATION; FIBROSIS; CHILDREN; MOUSE; OMEGA-3-FATTY-ACIDS; POLARIZATION; NOMENCLATURE	Non-alcoholic fatty liver disease is one of the most important causes of liver-related morbidity in children. In non-alcoholic fatty liver disease, the activation of liver resident macrophage pool is a central event in the progression of liver injury. The aims of the present study were to evaluate the polarization of liver macrophages and the possible role of Wnt3a production by macrophages in hepatic progenitor cell response in the progression of pediatric nonalcoholic fatty liver disease. 32 children with biopsy-proven non-alcoholic fatty liver disease were included. 20 out of 32 patients were treated with docosahexaenoic acid for 18 months and biopsies at the baseline and after 18 months were included. Hepatic progenitor cell activation, macrophage subsets and Wnt/beta-catenin pathway were evaluated by immunohistochemistry and immunofluorescence. Our results indicated that in pediatric non-alcoholic fatty liver disease, pro-inflammatory macrophages were the predominant subset. Macrophage polarization was correlated with Non-alcoholic fatty liver disease Activity Score, ductular reaction, and portal fibrosis; docosahexaenoic acid treatment determined a macrophage polarization towards an anti-inflammatory phenotype in correlation with the reduction of serum inflammatory cytokines, with increased macrophage apoptosis, and with the up-regulation of macrophage Wnt3a expression; macrophage Wnt3a expression was correlated with beta-catenin phosphorylation in hepatic progenitor cells and signs of commitment towards hepatocyte fate. In conclusion, macrophage polarization seems to have a key role in the progression of pediatric non-alcoholic fatty liver disease; the modulation of macrophage polarization could drive hepatic progenitor cell response by Wnt3a production.	[Carpino, Guido] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Nobili, Valerio; De Stefanis, Cristiano; Alisi, Anna] Bambino Gesu Pediat Hosp, Unit Liver Res, Rome, Italy; [Renzi, Anastasia; Franchitto, Antonio; Onori, Paolo; Gaudio, Eugenio] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped Sci, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Stronati, Laura] ENEA, Dept Radiobiol & Human Hlth, Rome, Italy; [De Vito, Rita] Bambino Gesu Pediat Hosp, Unit Pathol, Rome, Italy; [Alpini, Gianfranco] Scott & White Mem Hosp & Clin, Dept Med, Scott & White Digest Dis Res Ctr, Res,Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Alpini, Gianfranco] Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX USA	Foro Italico University of Rome; IRCCS Bambino Gesu; Sapienza University Rome; Italian National Agency New Technical Energy & Sustainable Economics Development; IRCCS Bambino Gesu; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Gaudio, E (corresponding author), Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped Sci, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	eugenio.gaudio@uniroma1.it	De Stefanis, Cristiano/AAA-1524-2020; Alisi, Anna/A-6469-2010; Carpino, Guido/AAB-9692-2019; Franchitto, Antonio/C-8095-2009; Onori, Paolo/J-9394-2013; Nobili, Valerio/K-8670-2018; De Stefanis, Cristiano/K-8592-2018	De Stefanis, Cristiano/0000-0001-5898-9518; Alisi, Anna/0000-0001-7241-6329; Onori, Paolo/0000-0002-7195-3760; De Stefanis, Cristiano/0000-0001-5898-9518; De Vito, rita/0000-0002-7450-8398; Stronati, Laura/0000-0001-5222-9497	University "Sapienza" of Rome; FIRB [RBAP10Z7FS_001]; PRIN [2009X84L84_001]; Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from Scott White Hospital; NIH [DK07698]; Veterans Affairs [I01BX000574] Funding Source: NIH RePORTER	University "Sapienza" of Rome; FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from Scott White Hospital; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	E. Gaudio was supported by research project grant from the University "Sapienza" of Rome, FIRB grant# RBAP10Z7FS_001 and by PRIN grant# 2009X84L84_001 and the Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from Scott & White Hospital and the NIH grant DK07698 to Dr. Alpini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2012, NAT REV GASTRO HEPAT, V9, P152, DOI 10.1038/nrgastro.2011.273; Alkhouri N, 2015, J PEDIATR-US, V166, P1335, DOI 10.1016/j.jpeds.2015.03.003; Bartneck M, 2016, HEPATOLOGY, V63, P1310, DOI 10.1002/hep.28418; Bhatia L, 2016, ATHEROSCLEROSIS, V246, P13, DOI 10.1016/j.atherosclerosis.2015.12.028; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Carpino G, 2014, J HEPATOL, V60, P1194, DOI 10.1016/j.jhep.2014.01.026; Carpino G, 2013, INT J MOL SCI, V14, P20112, DOI 10.3390/ijms141020112; Conwell LS, 2004, DIABETES CARE, V27, P314, DOI 10.2337/diacare.27.2.314; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh T, 2014, HEPATOLOGY, V59, P1617, DOI 10.1002/hep.26753; Katoonizadeh A, 2006, LIVER INT, V26, P1225, DOI 10.1111/j.1478-3231.2006.01377.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lanzoni G, 2015, HEPATOLOGY IN PRESS; Masterton GS, 2010, ALIMENT PHARM THER, V31, P679, DOI 10.1111/j.1365-2036.2010.04230.x; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nobili V, 2013, NUTR METAB CARDIOVAS, V23, P1066, DOI 10.1016/j.numecd.2012.10.010; Nobili V, 2008, HEPATOLOGY, V48, P119, DOI 10.1002/hep.22336; Nobili V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088005; Nobili V, 2012, HEPATOLOGY, V56, P2142, DOI 10.1002/hep.25742; Nobili V, 2011, ARCH DIS CHILD, V96, P350, DOI 10.1136/adc.2010.192401; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Onori P, 2007, J HISTOCHEM CYTOCHEM, V55, P327, DOI 10.1369/jhc.6R7125.2006; Parker HM, 2012, J HEPATOL, V56, P944, DOI 10.1016/j.jhep.2011.08.018; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Sakaguchi S, 2011, DRUG METAB PHARMACOK, V26, P30, DOI 10.2133/dmpk.DMPK-10-RV-087; Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754; Sookoian S, 2011, ATHEROSCLEROSIS, V218, P378, DOI 10.1016/j.atherosclerosis.2011.05.014; Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367; Stueck AE, 2015, HEPATOLOGY, V61, P1696, DOI 10.1002/hep.27706; Vajro P, 2012, J PEDIATR GASTR NUTR, V54, P700, DOI 10.1097/MPG.0b013e318252a13f; Van Hul N, 2011, AM J PATHOL, V179, P1839, DOI 10.1016/j.ajpath.2011.06.042; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607; Wang XD, 2014, GUT, V63, P1805, DOI 10.1136/gutjnl-2013-306373; Wang YF, 2013, STEM CELLS, V31, P1966, DOI 10.1002/stem.1460; Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034; Yoon SM, 2011, HEPATOLOGY, V53, P964, DOI 10.1002/hep.24122	45	38	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157246	10.1371/journal.pone.0157246	http://dx.doi.org/10.1371/journal.pone.0157246			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310371	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800047
J	Comstock, SS; Maleki, SJ; Teuber, SS				Comstock, Sarah S.; Maleki, Soheila J.; Teuber, Suzanne S.			Boiling and Frying Peanuts Decreases Soluble Peanut (Arachis Hypogaea) Allergens Ara h 1 and Ara h 2 But Does Not Generate Hypoallergenic Peanuts	PLOS ONE			English	Article							CROSS-REACTIVITY; ATOPIC-DERMATITIS; COOKING METHODS; PHAGE DISPLAY; IGE-BINDING; CASHEW NUT; IDENTIFICATION; PROTEINS; CHALLENGE; TOLERANCE	Peanut allergy continues to be a problem in most developed countries of the world. We sought a processing method that would alter allergenic peanut proteins, such that allergen recognition by IgE from allergic individuals would be significantly reduced or eliminated. Such a method would render accidental exposures to trace amounts of peanuts safer. A combination of boiling and frying decreased recovery of Ara h 1 and Ara h 2 at their expected MWs. In contrast, treatment with high pressures under varying temperatures had no effect on protein extraction profiles. Antibodies specific for Ara h 1, Ara h 2, and Ara h 6 bound proteins extracted from raw samples but not in boiled/fried samples. However, pre-incubation of serum with boiled/fried extract removed most raw peanut-reactive IgE from solution, including IgE directed to Ara h 1 and 2. Thus, this method of processing is unlikely to generate a peanut product tolerated by peanut allergic patients. Importantly, variability in individual patients' IgE repertoires may mean that some patients' IgE would bind fewer polypeptides in the sequentially processed seed.	[Comstock, Sarah S.; Teuber, Suzanne S.] Univ Calif Davis, Dept Internal Med, Div Rheumatol Allergy & Clin Immunol, Sch Med, Davis, CA 95616 USA; [Maleki, Soheila J.] USDA ARS SRRC, New Orleans, LA USA; [Comstock, Sarah S.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA	University of California System; University of California Davis; United States Department of Agriculture (USDA); Michigan State University	Comstock, SS (corresponding author), Univ Calif Davis, Dept Internal Med, Div Rheumatol Allergy & Clin Immunol, Sch Med, Davis, CA 95616 USA.; Comstock, SS (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	comsto37@msu.edu			Masterfoods Inc.; University of California, Davis	Masterfoods Inc.; University of California, Davis(University of California System)	This research was partially supported by Masterfoods Inc. (SST). The remaining funding was provided by the University of California, Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asarnoj A, 2012, J ALLERGY CLIN IMMUN, V130, P468, DOI 10.1016/j.jaci.2012.05.019; Astier C, 2006, J ALLERGY CLIN IMMUN, V118, P250, DOI 10.1016/j.jaci.2006.04.053; Beyer KB, 2001, J ALLERGY CLIN IMMUN, V107, P1077, DOI 10.1067/mai.2001.115480; Blom WM, 2013, J ALLERGY CLIN IMMUN, V131, P172, DOI 10.1016/j.jaci.2012.10.034; Bublin M, 2013, J ALLERGY CLIN IMMUN, V132, P118, DOI 10.1016/j.jaci.2013.01.022; Burbank AJ, 2016, IMMUNOL ALLERGY CLIN, V36, P55, DOI 10.1016/j.iac.2015.08.007; BURKS AW, 1992, J ALLERGY CLIN IMMUN, V90, P962, DOI 10.1016/0091-6749(92)90469-I; BURKS AW, 1991, J ALLERGY CLIN IMMUN, V88, P172, DOI 10.1016/0091-6749(91)90325-I; Chung SY, 2001, J AGR FOOD CHEM, V49, P3911, DOI 10.1021/jf001186o; Chung SY, 1999, J AGR FOOD CHEM, V47, P5227, DOI 10.1021/jf9904416; Comstock SS, 2004, CLIN EXP ALLERGY, V34, P1583, DOI 10.1111/j.1365-2222.2004.02049.x; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Flinterman AE, 2006, J ALLERGY CLIN IMMUN, V117, P448, DOI 10.1016/j.jaci.2005.11.035; Hildebrandt S, 2010, J ALLERGY CAIRO 2010, V2010; Hourihane JO, 1997, BRIT MED J, V314, P1084, DOI 10.1136/bmj.314.7087.1084; Hu CQ, 2011, J SCI FOOD AGR, V91, P1304, DOI 10.1002/jsfa.4318; Kim J, 2013, ANN ALLERG ASTHMA IM, V110, P34, DOI 10.1016/j.anai.2012.10.011; Kleber-Janke T, 1999, INT ARCH ALLERGY IMM, V119, P265, DOI 10.1159/000024203; Kleber-Janke T, 2001, J CHROMATOGR B, V756, P295, DOI 10.1016/S0378-4347(01)00088-3; Kobayashi S, 2012, BIOSCI BIOTECH BIOCH, V76, P1182, DOI 10.1271/bbb.120063; Koppelman SJ, 1999, J BIOL CHEM, V274, P4770, DOI 10.1074/jbc.274.8.4770; Koppelman SJ, 2005, CLIN EXP ALLERGY, V35, P490, DOI 10.1111/j.1365-2222.2005.02204.x; Koppelman SJ, 2004, CLIN EXP ALLERGY, V34, P583, DOI 10.1111/j.1365-2222.2004.1923.x; Koppelman SJ, 2003, ALLERGY, V58, P1144, DOI 10.1034/j.1398-9995.2003.00259.x; Koppelman SJ, 2001, ALLERGY, V56, P132, DOI 10.1034/j.1398-9995.2001.056002132.x; Kopper RA, 2005, INT ARCH ALLERGY IMM, V136, P16, DOI 10.1159/000082580; Krause S, 2009, J ALLERGY CLIN IMMUN, V124, P771, DOI 10.1016/j.jaci.2009.06.008; Lauer I, 2009, CLIN EXP ALLERGY, V39, P1427, DOI 10.1111/j.1365-2222.2009.03312.x; Maleki SJ, 2000, J ALLERGY CLIN IMMUN, V106, P763, DOI 10.1067/mai.2000.109620; Maleki SJ, 2010, ANN ALLERG ASTHMA IM, V105, P451, DOI 10.1016/j.anai.2010.09.025; Mittag D, 2004, J ALLERGY CLIN IMMUN, V114, P1410, DOI 10.1016/j.jaci.2004.09.014; Mondoulet L, 2005, J AGR FOOD CHEM, V53, P4547, DOI 10.1021/jf050091p; Nesbit JB, 2012, MOL NUTR FOOD RES, V56, P1739, DOI 10.1002/mnfr.201100815; Petersen A, 2015, J ALLERGY CLIN IMMUN, V136, P1295, DOI 10.1016/j.jaci.2015.04.010; Poms RE, 2004, MOL NUTR FOOD RES, V48, P459, DOI 10.1002/mnfr.200400052; Pons L, 2002, ALLERGY, V57, P88, DOI 10.1034/j.1398-9995.57.s72.16.x; Santos AF, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0098-7; Schmitt D. A., 2004, Journal of Allergy and Clinical Immunology, V113, pS155, DOI 10.1016/j.jaci.2003.12.566; Schmitt DA, 2010, J AGR FOOD CHEM, V58, P1138, DOI 10.1021/jf902694j; Schwager C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123419; Su M, 2004, J SCI FOOD AGR, V84, P1119, DOI 10.1002/jsfa.1748; Taylor SL, 2014, FOOD CHEM TOXICOL, V63, P9, DOI 10.1016/j.fct.2013.10.032; Teuber SS, 2002, J AGR FOOD CHEM, V50, P6543, DOI 10.1021/jf025757j; Turner PJ, 2014, J ALLERGY CLIN IMMUN, V134, P751, DOI 10.1016/j.jaci.2014.06.016; Vissers YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023998; Wensing M, 2002, J ALLERGY CLIN IMMUN, V110, P915, DOI 10.1067/mai.2002.129235; Yu JM, 2011, FOOD CHEM, V127, P1014, DOI 10.1016/j.foodchem.2011.01.074	47	18	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157849	10.1371/journal.pone.0157849	http://dx.doi.org/10.1371/journal.pone.0157849			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310538	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800139
J	Guo, J; Hirasaki, N; Miyata, Y; Tanaka, K; Tanaka, T; Wu, X; Tahara, Y; Toko, K; Matsui, T				Guo, Jian; Hirasaki, Naoto; Miyata, Yuji; Tanaka, Kazunari; Tanaka, Takashi; Wu, Xiao; Tahara, Yusuke; Toko, Kiyoshi; Matsui, Toshiro			Evaluating the Reduced Hydrophobic Taste Sensor Response of Dipeptides by Theasinensin A by Using NMR and Quantum Mechanical Analyses	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; SPRAGUE-DAWLEY RATS; AMINO-ACIDS; PROTEIN HYDROLYSATE; FERMENTED TEA; CYCLODEXTRIN; ABSORPTION; PEPTIDES; PHOSPHOLIPIDS; INHIBITION	The current study demonstrated that theasinensin A (TSA) had a potential to form the complex with hydrophobic Trp-containing dipeptides, and to reduce their membrane potential by artificial-lipid membrane taste sensor. At a 1: 3 molar ratio of the 6 Trp-containing dipeptides together with TSA, we observed a significant chemical shift of the protons of the dipeptides (Delta delta) to a high magnetic field, when analyzed using H-1-nuclear-magnetic resonance (NMR) spectroscopy. The Delta delta values were correlated with the hydrophobicity (log P) of the dipeptides and significant correlations were obtained (P = 0.022, R-2 = 0.77); e.g., Trp-Leu with the highest log P value of 1.623 among the tested dipeptides showed the highest Delta delta value of 0.105 ppm for the H7 proton of Trp-Leu, while less chemical shifts were observed in theasinensin B and epigallocatechin-3-O-gallate. Diffusion-ordered NMR spectroscopy revealed that the diffusion coefficient of 3 mM of Trp-Leu (7.6 x 10(-11) m(2)/s) at a pulse field gradient in the range 0.05-0.3 T/m decreased in the presence of 3 mM TSA (6.6 x 10(-11) m(2)/s), suggesting that Trp-Leu forms a complex with TSA. Quantum mechanical calculations and rotating frame nuclear Overhauser effect-NMR spectroscopy provided configuration information on the geometry of the complex that Trp-Leu formed with TSA (1:1 complex) with a Delta G energy of -8.7 kJ/mol. A sensor analysis using artificial-lipid membranes demonstrated that the changes in membrane potential of 1 mM Trp-Leu (21.8 +/- 1.3 mV) and Leu-Trp (5.3 +/- 0.9 mV) were significantly (P < 0.001) reduced by 1 mM TSA (Trp-Leu, 13.1 +/- 2.4 mV; Leu-Trp, 3.5 +/- 0.5 mV; TSA alone, 0.2 +/- 0.01 mV), indicating the effective suppression of hydrophobicity of dipeptides by TSA-formed complex.	[Guo, Jian; Hirasaki, Naoto; Matsui, Toshiro] Kyushu Univ, Graduated Sch, Fac Agr, Dept Biosci & Biotechnol,Div Bioresource & Bioenv, 6-10-1 Hakozaki, Fukuoka 8128581, Japan; [Miyata, Yuji] Higashisonogi Tea Res Stn, Nagasaki Agr & Forestry Tech Dev Ctr, 1414 Nakano Go, Nagasaki 8593801, Japan; [Tanaka, Kazunari] Nagasaki Univ, Dept Nutr, 1-1-1 Manabino, Nagasaki 8512195, Japan; [Tanaka, Takashi] Nagasaki Univ, Grad Sch Biochem Sci, 1-14 Bukyo Machi, Nagasaki 8528521, Japan; [Wu, Xiao; Tahara, Yusuke; Toko, Kiyoshi] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan; [Toko, Kiyoshi; Matsui, Toshiro] Kyushu Univ, Res & Dev Ctr Taste & Odor Sensing, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan	Kyushu University; Nagasaki University; Nagasaki University; Kyushu University; Kyushu University	Matsui, T (corresponding author), Kyushu Univ, Graduated Sch, Fac Agr, Dept Biosci & Biotechnol,Div Bioresource & Bioenv, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.; Matsui, T (corresponding author), Kyushu Univ, Res & Dev Ctr Taste & Odor Sensing, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	tmatsui@agr.kyushu-u.ac.jp	Yusuke, Tahara/AAR-4156-2020; Tahara, Yusuke/H-3865-2011	Yusuke, Tahara/0000-0003-1216-4419; 	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry in Japan	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry in Japan	This work was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry in Japan.	Akitomi H, 2013, SENSOR ACTUAT B-CHEM, V179, P276, DOI 10.1016/j.snb.2012.09.014; Binello A, 2004, FLAVOUR FRAG J, V19, P394, DOI 10.1002/ffj.1434; Calton GJ, 2002, Modifying undesirable tastes, Patent No. [US 2002/0187180, 20020187180]; Cameron KS, 2001, J ORG CHEM, V66, P6891, DOI 10.1021/jo010081x; Cao RG, 2015, PHARM RES-DORDR, V32, P2301, DOI 10.1007/s11095-015-1621-6; Cao R, 2015, FOOD CHEM, V171, P8, DOI 10.1016/j.foodchem.2014.08.105; Cao R, 2014, ANAL SCI, V30, P383, DOI 10.2116/analsci.30.383; Cho SJ, 2007, J AGR FOOD CHEM, V55, P10599, DOI 10.1021/jf071903f; Durand J, 2008, MAGN RESON CHEM, V46, P739, DOI 10.1002/mrc.2244; Eckert M, 2007, FOOD TECHNOL-CHICAGO, V61, P20; Figueiras A, 2007, PHARM RES-DORDR, V24, P377, DOI 10.1007/s11095-006-9161-8; Hara D., 2014, SENSOR LETT, V12, P1172, DOI [10. 1166/sl. 2014. 3182, DOI 10.1166/SL.2014.3182]; HARA H, 1984, J NUTR, V114, P1122, DOI 10.1093/jn/114.6.1122; He Q, 2006, FOOD CHEM, V95, P250, DOI 10.1016/j.foodchem.2004.11.055; Jullian C, 2007, BIOORGAN MED CHEM, V15, P3217, DOI 10.1016/j.bmc.2007.02.035; Kato H, 1986, DEV FOOD FLAVOURS, P158; Katsuragi Y, 1997, PHARMACEUT RES, V14, P720, DOI 10.1023/A:1012138103223; Kobayashi Y, 2010, SENSORS-BASEL, V10, P3411, DOI 10.3390/s100403411; Kohl S, 2013, J AGR FOOD CHEM, V61, P53, DOI 10.1021/jf303146h; Kumrungsee T, 2014, BBA-GEN SUBJECTS, V1840, P3073, DOI 10.1016/j.bbagen.2014.07.020; Ley JP, 2008, CHEMOSENS PERCEPT, V1, P58, DOI 10.1007/s12078-008-9008-2; LINDE GA, 2009, FOOD RES INT, V42, P814, DOI DOI 10.1016/j.foodres.2009.03.016; Linde GA, 2010, FOOD RES INT, V43, P187, DOI 10.1016/j.foodres.2009.09.025; Maehashi K, 2009, CELL MOL LIFE SCI, V66, P1661, DOI 10.1007/s00018-009-8755-9; Maehashi K, 2008, BIOCHEM BIOPH RES CO, V365, P851, DOI 10.1016/j.bbrc.2007.11.070; Matsui T, 2010, BRIT J NUTR, V103, P309, DOI 10.1017/S0007114509991814; Miyata Y, 2013, J AGR FOOD CHEM, V61, P9366, DOI 10.1021/jf400123y; Miyata Y, 2011, FOOD SCI TECHNOL RES, V17, P585, DOI 10.3136/fstr.17.585; Murase K, 2000, JP patent, Patent No. [0021390, WO0021390]; Pszczola DE, 2004, FOOD TECHNOL-CHICAGO, V58, P56; Qiu J, 2012, J AGR FOOD CHEM, V60, P8036, DOI 10.1021/jf302242n; Roberts PR, 1999, DIGESTION, V60, P332, DOI 10.1159/000007679; Shii T, 2011, CHEM PHARM BULL, V59, P1183, DOI 10.1248/cpb.59.1183; Shii T, 2011, J AGR FOOD CHEM, V59, P7253, DOI 10.1021/jf201499n; Sohi H, 2004, DRUG DEV IND PHARM, V30, P429, DOI 10.1081/DDC-120037477; Tahara Y, 2013, IEEE SENS J, V13, P3001, DOI 10.1109/JSEN.2013.2263125; Toko K, 1997, SENSOR MATER, V9, P171; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Wroblewski K, 2001, EUR J BIOCHEM, V268, P4384, DOI 10.1046/j.1432-1327.2001.02350.x; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011	40	2	2	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157315	10.1371/journal.pone.0157315	http://dx.doi.org/10.1371/journal.pone.0157315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309380	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800053
J	Hsu, A; Griffiths, TL				Hsu, Anne; Griffiths, Thomas L.			Sampling Assumptions Affect Use of Indirect Negative Evidence in Language Learning	PLOS ONE			English	Article							ACQUISITION	A classic debate in cognitive science revolves around understanding how children learn complex linguistic patterns, such as restrictions on verb alternations and contractions, without negative evidence. Recently, probabilistic models of language learning have been applied to this problem, framing it as a statistical inference from a random sample of sentences. These probabilistic models predict that learners should be sensitive to the way in which sentences are sampled. There are two main types of sampling assumptions that can operate in language learning: strong and weak sampling. Strong sampling, as assumed by probabilistic models, assumes the learning input is drawn from a distribution of grammatical samples from the underlying language and aims to learn this distribution. Thus, under strong sampling, the absence of a sentence construction from the input provides evidence that it has low or zero probability of grammaticality. Weak sampling does not make assumptions about the distribution from which the input is drawn, and thus the absence of a construction from the input as not used as evidence of its ungrammaticality. We demonstrate in a series of artificial language learning experiments that adults can produce behavior consistent with both sets of sampling assumptions, depending on how the learning problem is presented. These results suggest that people use information about the way in which linguistic input is sampled to guide their learning.	[Hsu, Anne] Univ London, Sch Elect Engn, London, England; [Griffiths, Thomas L.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA	University of London; University of California System; University of California Berkeley	Hsu, A (corresponding author), Univ London, Sch Elect Engn, London, England.	anne.hsu@qmul.ac.uk		Griffiths, Thomas/0000-0002-5138-7255	Economics and Social Research Council [RES-000-22-3275]; National Science Foundation [SES-0631518]	Economics and Social Research Council; National Science Foundation(National Science Foundation (NSF))	This work was supported by grant number RES-000-22-3275 from the Economics and Social Research Council awarded to AH and grant number SES-0631518 from the National Science Foundation awarded to TG. http://www.esrc.ac.uk/. http://www.nsf.gov/. The funders were not involved in the study in any way.; Preliminary results of Experiment 1 were presented at the 22nd Neural Information Processing Systems conference [27]. The authors thank Ky Merritt for assistance in data collection for the experiments. This work was supported by grant number RES-000-22-3275 from the Economics and Social Research Council and grant number SES-0631518 from the National Science Foundation.	Bowerman Melissa., 1988, EXPLAINING LANGUAGE, P73; Boyd JK, 2011, LANGUAGE, V87, P55, DOI 10.1353/lan.2011.0012; Braine M. D., 1971, ONTOGENESIS GRAMMAR, P153; Briscoe E. J., 2002, LINGUISTIC EVOLUTION; Brown R, 1970, DERIVATIONAL COMPLEX; Chater N, 2006, TRENDS COGN SCI, V10, P287, DOI 10.1016/j.tics.2006.05.007; Chomsky N., 1965, ASPECTS THEORY SYNTA, DOI Cambridge, MA; Crain Stephen, 1999, INTRO LINGUISTIC THE; Dowman M, 2000, PROCEEDINGS OF THE TWENTY-SECOND ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P107; FORAKER S, 2007, P 29 ANN C COGN SCI; GOLD EM, 1967, INFORM CONTROL, V10, P447, DOI 10.1016/S0019-9958(67)91165-5; Hsu A., 2009, ADV NEURAL INFORM PR, V22; Langley P, 2000, LECT NOTES ARTIF INT, V1810, P220; MARCUS GF, 1993, COGNITION, V46, P53, DOI 10.1016/0010-0277(93)90022-N; Navarro DJ, 2012, COGNITIVE SCI, V36, P187, DOI 10.1111/j.1551-6709.2011.01212.x; Onnis L., 2002, P 24 ANN C COGN SCI, P720; PERFORS A, 2006, P 28 ANN C COGN SCI, P663; Perfors A, 2010, J CHILD LANG, V37, P607, DOI 10.1017/S0305000910000012; Pinker Steven., 1989, LEARNABILITY COGNITI; Redington M, 1998, COGNITIVE SCI, V22, P425, DOI 10.1016/S0364-0213(99)80046-9; Rohde DLT, 1999, COGNITION, V72, P67, DOI 10.1016/S0010-0277(99)00031-1; Stolcke A., 1994, THESIS; Tenebaum JB, 2001, BEHAV BRAIN SCI, V24, P629, DOI 10.1017/S0140525X01000061; Voorspoels W, 2015, COGNITIVE PSYCHOL, V81, P1, DOI 10.1016/j.cogpsych.2015.07.001; Wonnacott E, 2008, COGNITIVE PSYCHOL, V56, P165, DOI 10.1016/j.cogpsych.2007.04.002; Wonnacott E, 2011, J MEM LANG, V65, P1, DOI 10.1016/j.jml.2011.03.001; Xu F, 2007, DEVELOPMENTAL SCI, V10, P288, DOI 10.1111/j.1467-7687.2007.00590.x	27	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156597	10.1371/journal.pone.0156597	http://dx.doi.org/10.1371/journal.pone.0156597			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310576	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800009
J	Huls, A; Kramer, U; Stolz, S; Hennig, F; Hoffmann, B; Ickstadt, K; Vierkotter, A; Schikowski, T				Huels, Anke; Kraemer, Ursula; Stolz, Sabine; Hennig, Frauke; Hoffmann, Barbara; Ickstadt, Katja; Vierkoetter, Andrea; Schikowski, Tamara			Applicability of the Global Lung Initiative 2012 Reference Values for Spirometry for Longitudinal Data of Elderly Women	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; DECLINE; AGE; EQUATIONS; SAMPLE; ADULTS	Background and Objectives Lung function depends nonlinearly on age and height, so that the use of age and height specific reference values is required. The widely used age and height specific GLI (Global Lung Initiative) z-scores derived from cross-sectional data, however, have not been proven for validity in an elderly population or for longitudinal data. Therefore, we aimed to test their validity in a population of elderly women followed prospectively for more than 20 years. Methods We used spirometric data (forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) and FEV1/FVC) from the SALIA cohort of German women (baseline: 1985-1994 (aged 55 years), follow-up: 2008/2009 and 2012/2013). We calculated GLI-z-scores for baseline and follow-up examination separately (cross-sectional evaluation) and individual differences in z-scores between baseline and follow-up (longitudinal evaluation) for healthy never-smoking women. Results GLI reference values for FEV1, FVC and FEV1/FVC were cross-sectionally and longitudinally equivalent with our SALIA data. The mean change in z-scores between baseline and follow-up was 0.33 for FEV1, 0.38 for FVC and -0.10 for FEV1/FVC. Conclusions In conclusion, GLI z-scores fit cross-sectionally and longitudinally with FEV1, FVC and FEV1/FVC measured in women from Germany which indicates that they can be used in longitudinal association analyses.	[Huels, Anke; Kraemer, Ursula; Stolz, Sabine; Hennig, Frauke; Hoffmann, Barbara; Vierkoetter, Andrea; Schikowski, Tamara] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Hoffmann, Barbara] Univ Dusseldorf, Fac Med, Deanery Med, Dusseldorf, Germany; [Ickstadt, Katja] TU Dortmund Univ, Fac Stat, Dortmund, Germany	Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Dortmund University of Technology	Huls, A (corresponding author), IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.	Anke.Huels@IUF-Duesseldorf.de	Huels, Anke/J-8743-2019	Huels, Anke/0000-0002-6005-417X	Deutsche Forschungsgemeinschaft (DFG) [HE-4510/2-1, KR 1938/3-1, LU 691/4-1]; Ministry of the Environment of the state North Rhine-Westphalia (Dusseldorf, Germany); Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance) [VT 266.1]; European Community [211250]; German Federal Ministry of Education and Research (BMBF); Research Commission of the Medical Faculty of the Heinrich-Heine University of Dusseldorf [12/2011]; Open Access fund of the Leibniz Association	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of the Environment of the state North Rhine-Westphalia (Dusseldorf, Germany); Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance); European Community(European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Research Commission of the Medical Faculty of the Heinrich-Heine University of Dusseldorf; Open Access fund of the Leibniz Association	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; HE-4510/2-1, KR 1938/3-1, LU 691/4-1), by the Ministry of the Environment of the state North Rhine-Westphalia, (Dusseldorf, Germany), by the Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance) VT 266.1, by the European Community's Seventh Framework Program (FP7/2007-2011) under grant agreement number 211250, by the German Federal Ministry of Education and Research (BMBF) and by the Research Commission of the Medical Faculty of the Heinrich-Heine University of Dusseldorf (12/2011). The publication of this article was funded by the Open Access fund of the Leibniz Association.; This work was supported by the Deutsche Forschungsgemeinschaft (DFG; HE-4510/2-1, KR 1938/3-1, LU 691/4-1), by the Ministry of the Environment of the state North Rhine-Westphalia (Dusseldorf Germany), by the Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance) VT 266.1, by the European Community's Seventh Framework Program (FP7/2007-2011) under grant agreement number 211250, by the German Federal Ministry of Education and Research (BMBF) and by the Research Commission of the Medical Faculty of the Heinrich-Heine University of Dusseldorf (12/2011). The publication of this article was funded by the Open Access fund of the Leibniz Association.	Adam M, 2015, EUR RESPIR J, V45, P38, DOI 10.1183/09031936.00130014; [Anonymous], 1979, AM REV RESPIR DIS, V119, P831; [Anonymous], 2010, TESTING STAT HYPOTHE, DOI DOI 10.1201/EBK1439808184; Backman H, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0022-2; Ben Saad H, 2013, RESP MED, V107, P2000, DOI 10.1016/j.rmed.2013.10.015; BURROWS B, 1986, AM REV RESPIR DIS, V133, P974; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Hall GL, 2012, RESPIROLOGY, V17, P1150, DOI 10.1111/j.1440-1843.2012.02232.x; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Kainu A, 2016, CLIN PHYSIOL FUNCT I, V36, P346, DOI 10.1111/cpf.12237; Kerstjens HAM, 1997, THORAX, V52, P820, DOI 10.1136/thx.52.9.820; Koch B, 2011, RESP MED, V105, P352, DOI 10.1016/j.rmed.2010.10.014; LOUIS TA, 1986, J CHRON DIS, V39, P831, DOI 10.1016/0021-9681(86)90085-8; Marsh S, 2007, RESPIROLOGY, V12, P367, DOI 10.1111/j.1440-1843.2007.01071.x; Miller MR, 2014, EUR RESPIR J, V43, P1338, DOI 10.1183/09031936.00100313; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Muller-Brandes C, 2014, EUR RESPIR J, V43, P1347, DOI 10.1183/09031936.00058813; Quanjer PH, 2011, EUR RESPIR J, V37, P658, DOI 10.1183/09031936.00110010; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Quanjer PH, 2008, AM J RESP CRIT CARE, V178, P1262, DOI 10.1164/rccm.200805-700OC; R Development Core Team, 2014, R LANG ENV STAT COMP; Robinson AP, 2004, ECOL MODEL, V176, P349, DOI 10.1016/j.ecolmodel.2004.01.013; Schikowski T, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-152; Schikowski T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-113; Schikowski T, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-20; SCHUIRMANN DL, 1981, BIOMETRICS, V37, P617; Thompson BR, 2011, RESPIROLOGY, V16, P912, DOI 10.1111/j.1440-1843.2011.01970.x; Vossoughi M, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-5; WARE JH, 1990, AM J EPIDEMIOL, V132, P685, DOI 10.1093/oxfordjournals.aje.a115710; WESTLAKE WJ, 1981, BIOMETRICS, V37, P591	31	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157569	10.1371/journal.pone.0157569	http://dx.doi.org/10.1371/journal.pone.0157569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310365	gold, Green Submitted, Green Published			2022-12-27	WOS:000378029800099
J	Knepper, R; Borner, K				Knepper, Richard; Borner, Katy			Comparing the Consumption of CPU Hours with Scientific Output for the Extreme Science and Engineering Discovery Environment (XSEDE)	PLOS ONE			English	Article								This paper presents the results of a study that compares resource usage with publication output using data about the consumption of CPU cycles from the Extreme Science and Engineering Discovery Environment (XSEDE) and resulting scientific publications for 2,691 institutions/teams. Specifically, the datasets comprise a total of 5,374,032,696 central processing unit (CPU) hours run in XSEDE during July 1, 2011 to August 18, 2015 and 2,882 publications that cite the XSEDE resource. Three types of studies were conducted: a geospatial analysis of XSEDE providers and consumers, co-authorship network analysis of XSEDE publications, and bi-modal network analysis of how XSEDE resources are used by different research fields. Resulting visualizations show that a diverse set of consumers make use of XSEDE resources, that users of XSEDE publish together frequently, and that the users of XSEDE with the highest resource usage tend to be "traditional" high-performance computing (HPC) community members from astronomy, atmospheric science, physics, chemistry, and biology.	[Knepper, Richard] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [Borner, Katy] Indiana Univ, Sch Informat & Comp, Dept Informat & Lib Sci, Bloomington, IN USA; [Borner, Katy] Indiana Univ, Indiana Network Sci Inst, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Knepper, R (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN USA.	rich@iu.edu		Knepper, Richard/0000-0002-4296-9421	National Science Foundation under NCN CP Supplement [1553044]; National Institutes of Health [P01AG039347, U01CA198934]; Office of Advanced Cyberinfrastructure (OAC) [1566393] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U01CA198934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG039347] Funding Source: NIH RePORTER	National Science Foundation under NCN CP Supplement; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially funded by the National Science Foundation under NCN CP Supplement 1553044 and the National Institutes of Health under awards P01AG039347 and U01CA198934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Tom Furlani and Robert DeLeon of the University of Buffalo and Dave Hart of National Center for Atmospheric Research for providing XDMoD and publication data, as well as expert comments on an earlier version of this paper. Bob DeLeon and Amy Schuele of the National Center for Supercomputing Applications provided data for this project. Comments on the visualizations were provided by Guy Almes, Resa Alvord, Linda Akli, Scott Lathrop, Ken Hackworth, J Ray Scott, and Tom Maiden. Sara Bouchard provided design expertise for optimizing the figures. This work was partially funded by the National Science Foundation under NCN CP Supplement 1553044 and the National Institutes of Health under awards P01AG039347 and U01CA198934. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.	Furlani Thomas, 2013, ACM INT C PROCEEDING, DOI [10.1145/2484762.2484763, DOI 10.1145/2484762.2484763]; Hart DL, 2011, INT J HIGH PERFORM C, V25, P451, DOI 10.1177/1094342010394382; Knepper R, 2011, P 2011 TERAGRID C EX, DOI [10.1145/2016741.2016799, DOI 10.1145/2016741.2016799]; Mazloumian A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01167; National Science Foundation, CYB SUP TERAGRID; Palmer JT, 2015, COMPUT SCI ENG, V17, P52, DOI 10.1109/MCSE.2015.68; Sheddon M, MEASURING TERAGRID I; Wang F. Q., 2014, J APPL MATH, V2014, P1, DOI DOI 10.1080/10042857.2014.886802; XSEDE SP Forum, 2014, SERV PROV FOR CHART	9	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157628	10.1371/journal.pone.0157628	http://dx.doi.org/10.1371/journal.pone.0157628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310174	gold, Green Published, Green Submitted			2022-12-27	WOS:000378029800110
J	Lee, WJ; Chen, LK; Liang, CK; Peng, LN; Chiou, ST; Chou, P				Lee, Wei-Ju; Chen, Liang-Kung; Liang, Chih-Kuang; Peng, Li-Ning; Chiou, Shu-Ti; Chou, Pesus			Soluble ICAM-1, Independent of IL-6, Is Associated with Prevalent Frailty in Community-Dwelling Elderly Taiwanese People	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; INFLAMMATORY MARKERS; PHYSICAL PERFORMANCE; INTERLEUKIN-6; PREDICTORS; HEALTH; ADULTS; MASS	Background Activation of inflammatory pathway with elevation of inflammatory biomarkers such as Interleukin 6 (IL-6) has been considered a pathophysiological feature of frailty. In recent years, the association between Intercellular adhesive molecule -1 (ICAM-1) and vascular inflammatory was established. Provocation of inflammatory cascades from ICAM-1 is potential IL-6 related, although the association between the inflammatory process and frailty is little to known. The study was intended to evaluate the relationship between serum ICAM-1, IL-6 and frailty. Materials and Methods Data was derived from a representative national sampling cohort in Taiwan. The cross-sectional study included nine-hundred-forty-six community-dwelling people aged 53 and older. Frailty was defined as having three or more components (including, muscle shrinkage, slowness, weakness, exhaustion, and low activity) Serum IL-6 and ICAM-1 levels were measured using standard enzyme-linked immunosorbent assays. Results Soluble ICAM-1 (sICAM-1) levels were stepwise increased in non-frail, pre-frail and frail elderly people (the median levels were 255 vs. 265 vs. 285 ng/ml, respectively p<0.001). A multivariate multinomial logistic regression, which was adjusted for age, sex, smoking, education, BMI, and chronic disease number, was utilized to determine that the probability of being frail due to increased log (ICAM-1) and log (IL-6) standard deviation levels were 1.44 (95% CI 1.09-1.91) and 1.54 (95% CI 1.07-2.20), respectively. Conclusion sICAM-1 was significantly associated with frailty, independent of IL-6. This implied that leukocyte migration and inflammation cascade activation might contribute to frailty, in addition to monocyte/macrophage-mediated immuno-inflammation.	[Lee, Wei-Ju; Chen, Liang-Kung; Liang, Chih-Kuang; Peng, Li-Ning] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan; [Lee, Wei-Ju; Peng, Li-Ning; Chiou, Shu-Ti; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Wei-Ju] Taipei Vet Gen Hosp, Yuanshan Branch, Dept Family Med, Yilan, Taiwan; [Chen, Liang-Kung; Peng, Li-Ning] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan; [Liang, Chih-Kuang] Kaohsiung Vet Gen Hosp, Ctr Geriatr & Gerontol, Kaoshiung City, Taiwan; [Chiou, Shu-Ti] Minist Hlth & Welf, Hlth Promot Adm, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Kaohsiung Veterans General Hospital	Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	pschou@ym.edu.tw	Liang, Chih-Kuang/AAJ-5235-2020; Lee, Wei-Ju/AAK-1549-2021	Liang, Chih-Kuang/0000-0003-1604-1600; Lee, Wei-Ju/0000-0003-4326-333X; Chen, Liang-Kung/0000-0002-2387-8508	Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital; Ministry of Science and Technology of Taiwan [MOST 103-2633-B-400-002, MOST 105-3011-B-010-001]	Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, as well as the Ministry of Science and Technology of Taiwan (MOST 103-2633-B-400-002 and MOST 105-3011-B-010-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors express their gratitude to the Health Promotion Administration staff, the Ministry of Health and Welfare, Taiwan for data collection and to all of the participants for their assistance. This study was supported by the Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, as well as the Ministry of Science and Technology of Taiwan (MOST 103-2633-B-400-002 and MOST 105-3011-B-010-001).	Afilalo J, 2014, J AM COLL CARDIOL, V63, P747, DOI 10.1016/j.jacc.2013.09.070; Barron E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127550; Boey KW, 1999, INT J GERIATR PSYCH, V14, P608, DOI 10.1002/(SICI)1099-1166(199908)14:8<608::AID-GPS991>3.0.CO;2-Z; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Chen CY, 2010, ARCH GERONTOL GERIAT, V50, pS43, DOI 10.1016/S0167-4943(10)70012-1; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Hasegawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088150; Hofer S, 2009, CRIT CARE, V13, DOI 10.1186/cc7923; Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186; Joyce BT, 2015, CANC EPIDEMIOL BIOMA; Kim JC, 2013, J AM SOC NEPHROL, V24, P337, DOI 10.1681/ASN.2012010047; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; Leng S, 2002, J AM GERIATR SOC, V50, P1268, DOI 10.1046/j.1532-5415.2002.50315.x; Leng SX, 2007, J AM GERIATR SOC, V55, P864, DOI 10.1111/j.1532-5415.2007.01186.x; MCCABE SM, 1993, CELL IMMUNOL, V150, P364, DOI 10.1006/cimm.1993.1204; Nguyen QM, 2010, ANN EPIDEMIOL, V20, P53, DOI 10.1016/j.annepidem.2009.10.001; Puts MTE, 2005, CLIN ENDOCRINOL, V63, P403, DOI 10.1111/j.1365-2265.2005.02355.x; Qu Ning-ning, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P265; Qu T, 2009, CYTOKINE, V46, P319, DOI 10.1016/j.cyto.2009.02.015; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Rouhl RPW, 2012, NEUROBIOL AGING, V33, P1800, DOI 10.1016/j.neurobiolaging.2011.04.008; Santos MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044668; Schmal H, 1998, J IMMUNOL, V161, P3685; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; Taguchi O, 1997, INTERNAL MED, V36, P14, DOI 10.2169/internalmedicine.36.14; Theou O, 2015, AGEING RES REV, V21, P78, DOI 10.1016/j.arr.2015.04.001; Theou O, 2013, J AM GERIATR SOC, V61, P1537, DOI 10.1111/jgs.12420; Tiainen K, 2012, EXP GERONTOL, V47, P109, DOI 10.1016/j.exger.2011.11.002; Vemuganti R, 2004, STROKE, V35, P179, DOI 10.1161/01.STR.0000106479.53235.3E; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Wallet MA, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0106-z; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; Weinstein M., 2014, SOCIAL ENV BIOMARKER	34	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157877	10.1371/journal.pone.0157877	http://dx.doi.org/10.1371/journal.pone.0157877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JO	27310835	Green Published, Green Submitted, gold			2022-12-27	WOS:000378029800141
J	Liebick, M; Schlager, C; Oppermann, M				Liebick, Marcel; Schlaeger, Christian; Oppermann, Martin			Analysis of Chemokine Receptor Trafficking by Site-Specific Biotinylation	PLOS ONE			English	Article							5 CCR5 PHOSPHORYLATION; CELL-SURFACE PROTEINS; CONSTITUTIVE INTERNALIZATION; ENDOCYTIC PATHWAY; CANCER; CXCR4; GPCR; MECHANISMS; EXPRESSION; AGONIST	Chemokine receptors undergo internalization and desensitization in response to ligand activation. Internalized receptors are either preferentially directed towards recycling pathways (e.g. CCR5) or sorted for proteasomal degradation (e.g. CXCR4). Here we describe a method for the analysis of receptor internalization and recycling based on specific Bir A-mediated biotinylation of an acceptor peptide coupled to the receptor, which allows a more detailed analysis of receptor trafficking compared to classical antibody-based detection methods. Studies on constitutive internalization of the chemokine receptors CXCR4 (12.1% +/- 0.99% receptor internalization/h) and CCR5 (13.7% +/- 0.68%/h) reveals modulation of these processes by inverse (TAK779; 10.9% +/- 0.95%/h) or partial agonists (Met-CCL5; 15.6% +/- 0.5%/h). These results suggest an actively driven internalization process. We also demonstrate the advantages of specific biotinylation compared to classical antibody detection during agonist-induced receptor internalization, which may be used for immunofluorescence analysis as well. Site-specific biotinylation may be applicable to studies on trafficking of transmembrane proteins, in general.	[Liebick, Marcel; Schlaeger, Christian; Oppermann, Martin] Univ Gottingen, Dept Cellular & Mol Immunol, D-37073 Gottingen, Germany	University of Gottingen	Liebick, M (corresponding author), Univ Gottingen, Dept Cellular & Mol Immunol, D-37073 Gottingen, Germany.	marcel.liebick@med.uni-goettingen.de			Deutsche Forschungsgemeinschaft [DFG Op42-10]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (DFG Op42-10) (http://www.dfg.de/) (recipient: MO).	Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Alvarez-Curto E, 2011, MOL PHARMACOL, V80, P1033, DOI 10.1124/mol.111.074674; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Anselmo A, 2014, CYTOM PART A, V85, P292, DOI 10.1002/cyto.a.22439; Arancibia-Carcamo I. L., 2006, DYNAMIC SYNAPSE MOL; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Carrodus NL, 2014, JOVE-J VIS EXP, DOI 10.3791/51139; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Cull MG, 2000, METHOD ENZYMOL, V326, P430; Duffy S, 1998, ANAL BIOCHEM, V262, P122, DOI 10.1006/abio.1998.2770; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Ferain T, 2011, J PHARMACOL EXP THER, V337, P655, DOI 10.1124/jpet.111.179622; Fisher GW, 2010, J BIOMOL SCREEN, V15, P703, DOI 10.1177/1087057110370892; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Garcia-Perez J, 2011, J BIOL CHEM, V286, P4978, DOI 10.1074/jbc.M110.168955; Garippa RT, 2006, METHOD ENZYMOL, V414, P99, DOI 10.1016/S0076-6879(06)14007-0; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gilliland CT, 2013, J BIOL CHEM, V288, P32194, DOI 10.1074/jbc.M113.503797; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GRADY EF, 1995, MOL BIOL CELL, V6, P509, DOI 10.1091/mbc.6.5.509; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hammer MM, 2007, FASEB J, V21, P3827, DOI 10.1096/fj.07-8777com; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hoffmann C, 2008, BRIT J PHARMACOL, V153, pS358, DOI 10.1038/sj.bjp.0707615; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Kakinuma T, 2006, J LEUKOCYTE BIOL, V79, P639, DOI 10.1189/jlb.1105633; Kershaw T, 2009, METHOD ENZYMOL, V460, P357, DOI 10.1016/S0076-6879(09)05218-5; Kiss DL, 2009, CELL MOL BIOL LETT, V14, P537, DOI 10.2478/s11658-009-0017-1; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Lam VM, 2013, TRAFFIC, V14, P778, DOI 10.1111/tra.12073; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Levoye A, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00167; Li YF, 2012, PROTEIN EXPRES PURIF, V82, P162, DOI 10.1016/j.pep.2011.12.008; Longden J, 2008, BRIT J PHARMACOL, V153, P1513, DOI 10.1038/sj.bjp.0707691; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2014, CURR OPIN CELL BIOL, V27, P72, DOI 10.1016/j.ceb.2013.11.011; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; MOORE RH, 1995, J CELL SCI, V108, P2983; Mueller A, 2004, EUR J BIOCHEM, V271, P243, DOI 10.1046/j.1432-1033.2003.03918.x; Mueller A, 2002, BLOOD, V99, P785, DOI 10.1182/blood.V99.3.785; Murdoch C, 2000, BLOOD, V95, P3032; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; Robers MB, 2015, ANAL BIOCHEM, V489, P1, DOI 10.1016/j.ab.2015.08.005; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sarvaiya PJ, 2013, ONCOTARGET, V4, P2171, DOI 10.18632/oncotarget.1426; Signoret N, 2004, TRAFFIC, V5, P529, DOI 10.1111/j.1600-0854.2004.00200.x; Signoret N, 2000, METH MOL B, V138, P197; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Sorkin A, 2010, CURR PROTOC CELL BIO, V15, P1; Steel E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093646; Tamamis P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05447; Tamamis P, 2014, J CHEM INF MODEL, V54, P1174, DOI 10.1021/ci500069y; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Trivedi RR, 2012, BIOCHEM BIOPH RES CO, V427, P185, DOI 10.1016/j.bbrc.2012.09.040; Weitzenfeld P, 2014, CANCER LETT, V352, P36, DOI 10.1016/j.canlet.2013.10.006; Woehler Andrew, 2009, Curr Mol Pharmacol, V2, P237; Yokoyama Wayne M, 2013, Curr Protoc Immunol, V102, DOI 10.1002/0471142735.im0205s102; Zhang R, 2012, ACTA PHARMACOL SIN, V33, P372, DOI 10.1038/aps.2011.173; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015	86	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157502	10.1371/journal.pone.0157502	http://dx.doi.org/10.1371/journal.pone.0157502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310579	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800087
J	Ilori, TO; Enofe, N; Oommen, A; Cobb, J; Navarrete, J; Adedinsewo, DA; Oshikoya, O; Fevrier, H; Farris, AB; Plantinga, L; Ojo, AO				Ilori, Titilayo O.; Enofe, Nosayaba; Oommen, Anju; Cobb, Jason; Navarrete, Jose; Adedinsewo, Demilade A.; Oshikoya, Oluwatobiloba; Fevrier, Helene; Farris, Alton B.; Plantinga, Laura; Ojo, Akinlolu O.			Comparison of Outcomes between Individuals with Pure and Mixed Lupus Nephritis: A Retrospective Study	PLOS ONE			English	Article							MEMBRANOUS GLOMERULONEPHRITIS; HISTOLOGIC PATTERNS; RENAL INVOLVEMENT; CLINICAL-COURSE; ERYTHEMATOSUS; CLASSIFICATION; FEATURES; PROGNOSIS; DISCRETE; REGISTRY	Introduction Lupus nephritis (LN) is a serious organ manifestation of systemic lupus erythematosus. Histologic overlap is relatively common in the six pathologic classes (I to VI) of LN. For example, mixed proliferative LN (MPLN) often includes features of classes III & V or classes IV & V combined. We performed a comparative evaluation of renal outcomes in patients with MPLN to patients with pure proliferative LN (PPLN) against pre-specified renal outcomes, and we also identified predictor of clinical outcomes among those with PPLN and MPLN. Hypothesis Individuals with MPLN will have worse short-term renal outcomes compared to those with PPLN. Methods We retrospectively reviewed 278 adult LN patients (>= 18 years old) identified from an Emory University Hospital registry of native renal biopsies performed between January 2000 and December 2011. The final analytic sample consisted of individuals with a diagnosis of PPLN (n = 60) and MPLN (n = 96). We analyzed differences in clinical and laboratory characteristics at baseline. We also assessed associations between LN category and renal outcomes (complete remission and time to ESRD) with logistic and Cox proportional hazards models within two years of baseline. Results The study population was predominantly female (83.97%) and African American (71.8%) with a mean age of 33.4 years at baseline. Over a median follow up of 1.02 years, we did not find any statistically significant associations between MPLN and the development of ESRD or remission when compared to patients with PPLN (adjusted HR = 0.30, 95% CI = 0.07, 1.26). Conclusion There was no association between mixed or pure histopathologic features of LN at presentation and rate of complete or partial remission but higher baseline eGFR was associated with a lower probability of complete remission among patients with lupus nephritis.	[Ilori, Titilayo O.; Enofe, Nosayaba; Oommen, Anju; Cobb, Jason; Navarrete, Jose; Plantinga, Laura] Emory Univ, Sch Med, Dept Med, Div Nephrol, Atlanta, GA USA; [Adedinsewo, Demilade A.] Morehouse Sch Med, Dept Med, Atlanta, GA 30310 USA; [Oshikoya, Oluwatobiloba] Univ N Texas, Hlth Sci Ctr, Inst Cardiovasc & Metab Dis, Ft Worth, TX USA; [Fevrier, Helene] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Farris, Alton B.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Plantinga, Laura] Emory Univ, Dept Surg, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Ojo, Akinlolu O.] Univ Michigan, Div Nephrol, Ann Arbor, MI 48109 USA	Emory University; Morehouse School of Medicine; University of North Texas System; University of North Texas Health Science Center; Emory University; Rollins School Public Health; Emory University; Emory University; University of Michigan System; University of Michigan	Ilori, TO (corresponding author), Emory Univ, Sch Med, Dept Med, Div Nephrol, Atlanta, GA USA.	tilori@emory.edu	Farris, Alton Brad/S-6041-2017; Adedinsewo, Demilade/AAJ-7199-2021	Farris, Alton Brad/0000-0001-5534-7763; Osikoya, Oluwatobiloba A./0000-0002-7927-9002; Adedinsewo, Demilade/0000-0002-8629-2029; Ilori, Titilayo/0000-0002-7457-0618	Renal Division, Emory University School of Medicine; Department of Medicine Data Analytics and Biostatistics Core	Renal Division, Emory University School of Medicine; Department of Medicine Data Analytics and Biostatistics Core	We would like to thank the Renal Division, Emory University School of Medicine and Department of Medicine Data Analytics and Biostatistics Core for the support of this project and Shailesh Nair for his invaluable contribution to this project.	ADLER SG, 1990, MODERN PATHOL, V3, P186; [Anonymous], 1982, REN DIS CLASS ATL GL; APPEL GB, 1978, MEDICINE, V57, P371, DOI 10.1097/00005792-197809000-00001; APPEL GB, 1987, AM J MED, V83, P877, DOI 10.1016/0002-9343(87)90645-0; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; BALDWIN DS, 1970, ANN INTERN MED, V73, P929, DOI 10.7326/0003-4819-73-6-929; BALDWIN DS, 1977, AM J MED, V62, P12, DOI 10.1016/0002-9343(77)90345-X; Boneparth A, 2014, LUPUS, V23, P898, DOI 10.1177/0961203314531841; Contreras G, 2005, LUPUS, V14, P890, DOI 10.1191/0961203305lu2238oa; Emre S, 2001, NEPHRON, V87, P118, DOI 10.1159/000045899; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; Huong DLT, 1999, MEDICINE, V78, P148; Kasitanon N, 2006, MEDICINE, V85, P147, DOI 10.1097/01.md.0000224709.70133.f7; LEAKER B, 1987, Q J MED, V62, P163; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; LEWIS EJ, 1987, AM J KIDNEY DIS, V10, P192, DOI 10.1016/S0272-6386(87)80174-9; Liang MH, 2006, ARTHRITIS RHEUM-US, V54, P421, DOI 10.1002/art.21625; MUEHRCKE RC, 1957, MEDICINE, V36, P1; Najafi CC, 2001, KIDNEY INT, V59, P2156, DOI 10.1046/j.1523-1755.2001.0590062156.x; Navaneethan SD, 2011, CLIN J AM SOC NEPHRO, V6, P40, DOI 10.2215/CJN.04230510; Plantinga L, 2015, INCIDENCE END STAGE, DOI [10.1002/acr.22685, DOI 10.1002/ACR.22685]; Pollak VE, 1997, J AM SOC NEPHROL, V8, P1189; SCHWARTZ MM, 1989, AM J KIDNEY DIS, V13, P273, DOI 10.1016/S0272-6386(89)80033-2; SCHWARTZ MM, 1984, AM J NEPHROL, V4, P301, DOI 10.1159/000166828; Sloan RP, 1996, J AM SOC NEPHROL, V7, P299; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; WANG F, 1984, Q J MED, V53, P209; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D	28	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157485	10.1371/journal.pone.0157485	http://dx.doi.org/10.1371/journal.pone.0157485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304068	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800064
J	Eerola, T; Peltola, HR				Eerola, Tuomas; Peltola, Henna-Riikka			Memorable Experiences with Sad Music-Reasons, Reactions and Mechanisms of Three Types of Experiences	PLOS ONE			English	Article							EMOTIONAL RESPONSES; SEX-DIFFERENCES; GENDER; BRAIN; CLASSIFICATION; METAANALYSIS; PERSONALITY; COMPONENTS; PLEASURE; VALENCE	Reactions to memorable experiences of sad music were studied by means of a survey administered to a convenience (N = 1577), representative (N = 445), and quota sample (N = 414). The survey explored the reasons, mechanisms, and emotions of such experiences. Memorable experiences linked with sad music typically occurred in relation to extremely familiar music, caused intense and pleasurable experiences, which were accompanied by physiological reactions and positive mood changes in about a third of the participants. A consistent structure of reasons and emotions for these experiences was identified through exploratory and confirmatory factor analyses across the samples. Three types of sadness experiences were established, one that was genuinely negative (Grief-Stricken Sorrow) and two that were positive (Comforting Sorrow and Sweet Sorrow). Each type of emotion exhibited certain individual differences and had distinct profiles in terms of the underlying reasons, mechanisms, and elicited reactions. The prevalence of these broad types of emotional experiences suggested that positive experiences are the most frequent, but negative experiences were not uncommon in any of the samples. The findings have implications for measuring emotions induced by music and fiction in general, and call attention to the non-pleasurable aspects of these experiences.	[Eerola, Tuomas; Peltola, Henna-Riikka] Univ Jyvaskyla, Dept Mus, Jyvaskyla, Finland; [Eerola, Tuomas] Univ Durham, Dept Mus, Durham, England	University of Jyvaskyla; Durham University	Eerola, T (corresponding author), Univ Jyvaskyla, Dept Mus, Jyvaskyla, Finland.; Eerola, T (corresponding author), Univ Durham, Dept Mus, Durham, England.	tuomas.eerola@durham.ac.uk	Peltola, Henna-Riikka/GRS-2315-2022; Eerola, Tuomas/K-7596-2019	Eerola, Tuomas/0000-0002-2896-929X; Peltola, Henna-Riikka/0000-0002-9372-1805	Academy of Finland [270220]	Academy of Finland(Academy of Finland)	This work was financially supported by the Academy of Finland Grant 270220 to TE (Surun Suloisuus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jonna Vuoskoski for her invaluable insights in the planning phase. This work was financially supported by the Academy of Finland Grant 270220 (Surun Suloisuus).	AGAWU VK, 1988, ETHNOMUSICOLOGY, V32, P75, DOI 10.2307/852226; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Barrett FS, 2010, EMOTION, V10, P390, DOI 10.1037/a0019006; Bigand E, 2005, COGNITION EMOTION, V19, P1113, DOI 10.1080/02699930500204250; Bodner E, 2013, PSYCHOL MUSIC, V41, P329, DOI 10.1177/0305735611425905; Bonanno G.A., 2008, HDB EMOTIONS, P797; Brattico E, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00676; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; BRIGGS CL, 1993, AM ANTHROPOL, V95, P929, DOI 10.1525/aa.1993.95.4.02a00080; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Christov-Moore L, 2014, NEUROSCI BIOBEHAV R, V46, P604, DOI 10.1016/j.neubiorev.2014.09.001; Drake JE, 2013, COGNITION EMOTION, V27, P512, DOI 10.1080/02699931.2012.720567; Edmund B, 1757, PHILOS ENQUIRY ORIGI; Eerola T., 2015, PSYCHOMUSICOLOGY MUS, V25, P116, DOI [DOI 10.1037/PMU0000096, 10.1037/pmu0000096]; Eerola T, FRONTIERS HUMA UNPUB; Eerola T, 2011, PSYCHOL MUSIC, V39, P18, DOI 10.1177/0305735610362821; Fan XT, 2007, MULTIVAR BEHAV RES, V42, P509, DOI 10.1080/00273170701382864; Gabrielsson Alf, 2011, STRONG EXPERIENCES M; Gabrielsson Alf, 2010, HDB MUSIC EMOTION TH, P367, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0014; Garrido S, 2011, EMPIRICAL MUSICOLOGY, V6; Garrido S, 2015, PSYCHOL MUSIC, V43, P244, DOI 10.1177/0305735613501938; Garrido S, 2011, MUSIC PERCEPT, V28, P279, DOI 10.1525/MP.2011.28.3.279; Goldstein J. H, 1999, MEDIA PSYCHOL, V1, P271, DOI [10.1207/s1532785xmep0103_5, DOI 10.1207/S1532785XMEP0103_5]; Goldstein TR, 2009, PSYCHOL AESTHET CREA, V3, P232, DOI 10.1037/a0015343; Guba EG., 1994, HDB QUALITATIVE RES, P105; Hanich J, 2014, PSYCHOL AESTHET CREA, V8, P130, DOI 10.1037/a0035690; Hume D, 1757, OF TRAGEDY A MILLAR; Huron D, 2011, MUSIC SCI, V15, P146, DOI 10.1177/1029864911401171; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2008, EMOTION, V8, P668, DOI 10.1037/a0013505; Juslin PN, 2014, PSYCHOL MUSIC, V42, P599, DOI 10.1177/0305735613484548; Juslin PN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00596; Juslin PN, 2013, PHYS LIFE REV, V10, P235, DOI 10.1016/j.plrev.2013.05.008; Juslin PN, 2011, MUSIC SCI, V15, P174, DOI 10.1177/1029864911401169; Kant I., 1790, CRITIQUE POWER JUDGM, DOI 10.1017/CBO9780511804656; Kawakami A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00311; Kivy Peter., 1990, MUSIC ALONE PHILOS R, P202; Knobloch-Westerwick S, 2013, COMMUN RES, V40, P747, DOI 10.1177/0093650212437758; Koelsch S, 2013, NEUROIMAGE, V81, P49, DOI 10.1016/j.neuroimage.2013.05.008; Kotthoff Helga, 2001, VERBAL ART CULTURES, P167; Landgrebe TCW, 2007, PATTERN RECOGN LETT, V28, P1747, DOI 10.1016/j.patrec.2007.05.001; Mar RA, 2008, PERSPECT PSYCHOL SCI, V3, P173, DOI 10.1111/j.1745-6924.2008.00073.x; Mcrae K, 2008, GROUP PROCESS INTERG, V11, P143, DOI 10.1177/1368430207088035; Meerwijk EL, 2013, BRAIN IMAGING BEHAV, V7, P1, DOI 10.1007/s11682-012-9179-y; Meyer RK, 1998, MUSIC PERCEPT, V16, P135; Mills S., 2012, MORTALITY, V17, P145, DOI [10.1080/13576275.2012.675231, DOI 10.1080/13576275.2012.675231]; Peltola HR, 2016, MUSIC SCI, V20, P84, DOI 10.1177/1029864915611206; Peter M, 2001, EUR J PERSONALITY, V15, P19, DOI 10.1002/per.386; R Core Team, 2013, R LANG ENV STAT COMP; Randall WM, 2014, MUSIC SCI, V18, P275, DOI 10.1177/1029864914536430; Robinson MD, 2002, J PERS SOC PSYCHOL, V83, P198, DOI 10.1037//0022-3514.83.1.198; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Saarikallio SH, 2008, MUSIC SCI, V12, P291, DOI 10.1177/102986490801200206; Sachs ME, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00404; Schiller F., 1792, AESTHETICAL PHILOS E, V2, P86; Schonfelder S, 2014, SOC COGN AFFECT NEUR, V9, P1310, DOI 10.1093/scan/nst116; Smith A, 2006, PSYCHOL REC, V56, P3, DOI 10.1007/BF03395534; Smith JM, 2009, CLIN PSYCHOL REV, V29, P116, DOI 10.1016/j.cpr.2008.10.003; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; TAMBORINI R, 1987, COMMUN RES, V14, P415, DOI 10.1177/009365087014004003; Taruffi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110490; Thompson AE, 2014, COGNITION EMOTION, V28, P1164, DOI 10.1080/02699931.2013.875889; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trost W, 2012, CEREB CORTEX, V22, P2769, DOI 10.1093/cercor/bhr353; Turner RA, 2002, STRESS, V5, P269, DOI 10.1080/1025389021000037586-1; Van den Tol AJM, 2015, PSYCHOL MUSIC, V43, P473, DOI 10.1177/0305735613517410; Van den Tol AJM, 2013, PSYCHOL MUSIC, V41, P440, DOI 10.1177/0305735611430433; van der Eijk C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118900; van Hemert DA, 2011, CROSS-CULT RES, V45, P399, DOI 10.1177/1069397111404519; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; Vingerhoets A.J.J.M., 2001, ADULT CRYING BIOPSYC, P303; Vuoskoski JK, 2012, PSYCHOL AESTHET CREA, V6, P204, DOI 10.1037/a0026937; Vuoskoski JK, 2012, MUSIC PERCEPT, V29, P311, DOI 10.1525/MP.2012.29.3.311; Vuoskoski JK, 2011, MUSIC SCI, V15, P159, DOI 10.1177/1029864911403367; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Wagner V, 2014, PSYCHOL AESTHET CREA, V8, P120, DOI 10.1037/a0036126; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x; Zentner M., 2010, HDB MUSIC EMOTION TH, P187, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0008; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	81	25	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157444	10.1371/journal.pone.0157444	http://dx.doi.org/10.1371/journal.pone.0157444			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DO5KO	27300268	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000377822200050
J	Isla, RAT; Ameh, OI; Mapiye, D; Swanepoel, CR; Bello, AK; Ratsela, AR; Okpechi, IG				Isla, Ramon A. Tamayo; Ameh, Oluwatoyin I.; Mapiye, Darlington; Swanepoel, Charles R.; Bello, Aminu K.; Ratsela, Andrew R.; Okpechi, Ikechi G.			Baseline Predictors of Mortality among Predominantly Rural-Dwelling End-Stage Renal Disease Patients on Chronic Dialysis Therapies in Limpopo, South Africa	PLOS ONE			English	Article							AMBULATORY PERITONEAL-DIALYSIS; HEMODIALYSIS-PATIENTS; SURVIVAL; MODALITY; IMPACT; RISK	Background Dialysis therapy for end-stage renal disease (ESRD) continues to be the readily available renal replacement option in developing countries. While the impact of rural/remote dwelling on mortality among dialysis patients in developed countries is known, it remains to be defined in sub-Saharan Africa. Methods A single-center database of end-stage renal disease patients on chronic dialysis therapies treated between 2007 and 2014 at the Polokwane Kidney and Dialysis Centre (PKDC) of the Pietersburg Provincial Hospital, Limpopo South Africa, was retrospectively reviewed. All-cause, cardiovascular, and infection-related mortalities were assessed and associated baseline predictors determined. Results Of the 340 patients reviewed, 52.1% were male, 92.9% were black Africans, 1.8% were positive for the human immunodeficiency virus (HIV), and 87.5% were rural dwellers. The average distance travelled to the dialysis centre was 112.3 +/- 73.4 Km while 67.6% of patients lived in formal housing. Estimated glomerular filtration rate (eGFR) at dialysis initiation was 7.1 +/- 3.7 mls/min while hemodialysis (HD) was the predominant modality offered (57.1%). Ninety-two (92) deaths were recorded over the duration of follow-up with the majority (34.8%) of deaths arising from infection-related causes. Continuous ambulatory peritoneal dialysis(CAPD) was a significant predictor of all-cause mortality (HR: 1.62, CI: 1.07-2.46) and infection-related mortality (HR: 2.27, CI: 1.13-4.60). On multivariable cox regression, CAPD remained a significant predictor of all-cause mortality (HR: 2.00, CI: 1.29-3.10) while the risk of death among CAPD patients was also significantly modified by diabetes mellitus(DM) status (HR: 4.99, CI: 2.13-11.71). Conclusion CAPD among predominantly rural dwelling patients in the Limpopo province of South Africa is associated with an increased risk of death from all-causes and infection-related causes.	[Isla, Ramon A. Tamayo; Ratsela, Andrew R.] Pietersburg Prov Hosp, Polokwane Kidney & Dialysis Ctr, Polokwane, South Africa; [Isla, Ramon A. Tamayo; Ratsela, Andrew R.] Univ Limpopo, Polokwane, South Africa; [Ameh, Oluwatoyin I.; Swanepoel, Charles R.; Okpechi, Ikechi G.] Univ Cape Town, Div Nephrol & Hypertens, ZA-7925 Cape Town, South Africa; [Mapiye, Darlington] Univ Western Cape, South African Natl Bioinformat Inst, South Africa Bioinformat Unit, MRC, Cape Town, South Africa; [Bello, Aminu K.] Univ Alberta, Dept Med, Div Nephrol, Edmonton, AB, Canada	University of Limpopo; University of Cape Town; University of the Western Cape; University of Alberta	Ameh, OI (corresponding author), Univ Cape Town, Div Nephrol & Hypertens, ZA-7925 Cape Town, South Africa.	amethystpj2@yahoo.co.uk	Bello, Aminu K/D-2213-2013	Bello, Aminu K/0000-0002-6905-5937				Barsoum RS, 2002, ARTIF ORGANS, V26, P737, DOI 10.1046/j.1525-1594.2002.07061.x; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; Collins AJ, 2013, AM J KIDNEY DIS, V61, pE1, DOI 10.1053/j.ajkd.2012.11.031; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; GAMBA G, 1993, NEPHRON, V65, P23, DOI 10.1159/000187435; Heaf JG, 2002, NEPHROL DIAL TRANSPL, V17, P112, DOI 10.1093/ndt/17.1.112; Isla RAT, 2014, PERITON DIALYSIS INT, V34, P518, DOI 10.3747/pdi.2013.00334; Johnson DW, 2009, AM J KIDNEY DIS, V53, P290, DOI 10.1053/j.ajkd.2008.06.032; MAILLOUX LU, 1991, AM J KIDNEY DIS, V18, P326, DOI 10.1016/S0272-6386(12)80091-6; Obiagwu PN, 2015, TROP MED INT HEALTH, V20, P2, DOI 10.1111/tmi.12409; Okpechi IG, 2012, J NEPHROL, V25, P551, DOI 10.5301/jn.5000032; Okpechi IG, 2012, PERITON DIALYSIS INT, V32, P254, DOI 10.3747/pdi.2011.00100; Pei YPC, 2000, KIDNEY INT, V58, P1293, DOI 10.1046/j.1523-1755.2000.00285.x; Piraino B, 2010, BLOOD PURIFICAT, V29, P145, DOI 10.1159/000245641; Rizvi S Adibul Hasan, 2003, Kidney Int Suppl, pS96; Robson NZMH, 2010, ASIA-PAC J PUBLIC HE, V22, P271, DOI 10.1177/1010539509357446; Schroijen MA, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-69; Stack AG, 2003, KIDNEY INT, V64, P1071, DOI 10.1046/j.1523-1755.2003.00165.x; Swanepoel CR, 2013, NAT REV NEPHROL, V9, P610, DOI 10.1038/nrneph.2013.168; Thompson S, 2012, KIDNEY INT, V82, P352, DOI 10.1038/ki.2012.167; Verduijn M, 2011, NEPHROL DIAL TRANSPL, V26, P56, DOI 10.1093/ndt/gfq661; Vonesh EF, 2004, KIDNEY INT, V66, P2389, DOI 10.1111/j.1523-1755.2004.66028.x; Xu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050766; Yu XQ, 2015, AM J KIDNEY DIS, V65, P147, DOI 10.1053/j.ajkd.2014.08.023; ZENT R, 1994, PERITON DIALYSIS INT, V14, P48	26	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0156642	10.1371/journal.pone.0156642	http://dx.doi.org/10.1371/journal.pone.0156642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27300372	Green Published, gold, Green Submitted			2022-12-27	WOS:000377822200011
J	Muhlebner, A; van Scheppingen, J; Hulshof, HM; Scholl, T; Iyer, AM; Anink, JJ; van den Ouweland, AMW; Nellist, MD; Jansen, FE; Spliet, WGM; Krsek, P; Benova, B; Zamecnik, J; Crino, PB; Prayer, D; Czech, T; Wohrer, A; Rahimi, J; Hoftberger, R; Hainfellner, JA; Feucht, M; Aronica, E				Muehlebner, Angelika; van Scheppingen, Jackelien; Hulshof, Hanna M.; Scholl, Theresa; Iyer, Anand M.; Anink, Jasper J.; van den Ouweland, Ans M. W.; Nellist, Mark D.; Jansen, Floor E.; Spliet, Wim G. M.; Krsek, Pavel; Benova, Barbora; Zamecnik, Josef; Crino, Peter B.; Prayer, Daniela; Czech, Thomas; Woehrer, Adelheid; Rahimi, Jasmin; Hoeftberger, Romana; Hainfellner, Johannes A.; Feucht, Martha; Aronica, Eleonora			Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex	PLOS ONE			English	Article							CONSENSUS CLASSIFICATION; HIPPOCAMPAL SCLEROSIS; ILAE CLASSIFICATION; MRI FEATURES; MALFORMATIONS; DYSPLASIA; INTEROBSERVER; EXPRESSION; CHILDREN; LESIONS	Tuberous Sclerosis Complex (TSC) is a genetic hamartoma syndrome frequently associated with severe intractable epilepsy. In some TSC patients epilepsy surgery is a promising treatment option provided that the epileptogenic zone can be precisely delineated. TSC brain lesions (cortical tubers) contain dysmorphic neurons, brightly eosinophilic giant cells and white matter alterations in various proportions. However, a histological classification system has not been established for tubers. Therefore, the aim of this study was to define distinct histological patterns within tubers based on semi-automated histological quantification and to find clinically significant correlations. In total, we studied 28 cortical tubers and seven samples of perituberal cortex from 28 TSC patients who had undergone epilepsy surgery. We assessed mammalian target of rapamycin complex 1 (mTORC1) activation, the numbers of giant cells, dysmorphic neurons, neurons, and oligodendrocytes, and calcification, gliosis, angiogenesis, inflammation, and myelin content. Three distinct histological profiles emerged based on the proportion of calcifications, dysmorphic neurons and giant cells designated types A, B, and C. In the latter two types we were able to subsequently associate them with specific features on presurgical MRI. Therefore, these histopathological patterns provide consistent criteria for improved definition of the clinico-pathological features of cortical tubers identified by MRI and provide a basis for further exploration of the functional and molecular features of cortical tubers in TSC.	[Muehlebner, Angelika; Scholl, Theresa; Feucht, Martha] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Muehlebner, Angelika; van Scheppingen, Jackelien; Iyer, Anand M.; Anink, Jasper J.; Aronica, Eleonora] Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Hulshof, Hanna M.; Jansen, Floor E.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Pediat Neurol, Utrecht, Netherlands; [van den Ouweland, Ans M. W.; Nellist, Mark D.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Spliet, Wim G. M.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Krsek, Pavel; Benova, Barbora] Charles Univ Prague, Dept Pediat Neurol, Sch Med 2, Motol Univ Hosp, Prague, Czech Republic; [Zamecnik, Josef] Charles Univ Prague, Dept Pathol & Mol Med, Sch Med 2, Motol Univ Hosp, Prague, Czech Republic; [Crino, Peter B.] Temple Univ, Shriners Hosp Pediat Res Ctr, Philadelphia, PA 19122 USA; [Crino, Peter B.] Temple Univ, Dept Neurol, Philadelphia, PA 19122 USA; [Prayer, Daniela] Med Univ Vienna, Dept Radiol, Vienna, Austria; [Czech, Thomas] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Woehrer, Adelheid; Rahimi, Jasmin; Hoeftberger, Romana; Hainfellner, Johannes A.] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Aronica, Eleonora] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands; [Aronica, Eleonora] Stichting Epilepsie Nederland, Hemstede, Netherlands	Medical University of Vienna; University of Amsterdam; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Charles University Prague; Motol University Hospital; Charles University Prague; Motol University Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Amsterdam	Aronica, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Aronica, E (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands.; Aronica, E (corresponding author), Stichting Epilepsie Nederland, Hemstede, Netherlands.	e.aronica@amc.uva.nl	Mühlebner, Angelika/L-3734-2019; Benova, Barbora/AAB-3423-2019; Mühlebner, Angelika/ABC-9873-2021	Mühlebner, Angelika/0000-0001-9102-7353; Benova, Barbora/0000-0001-8448-2833; Mühlebner, Angelika/0000-0001-9102-7353; Krsek, Pavel/0000-0002-5740-3690; Feucht, Martha/0000-0001-7691-8158; Woehrer, Adelheid/0000-0001-8435-8189; Aronica, Eleonora/0000-0002-3542-3770; Iyer, Anand/0000-0001-6821-1048; Scholl, Theresa/0000-0002-9835-7328	Austrian Science Fund (FWF) [J3499]; Czech Ministry of Health [IGA NT/11443-5]; Framework Programme FP7 under the project acronym EPISTOP [602391]; MH CZ - DRO [00064203]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Czech Ministry of Health(Ministry of Health, Czech Republic); Framework Programme FP7 under the project acronym EPISTOP; MH CZ - DRO	This work was supported by the Austrian Science Fund (FWF): project no. J3499 (AM), Czech Ministry of Health grant: IGA NT/11443-5 (PK), MH CZ - DRO nr. 00064203 (JZ) and by the Framework Programme FP7/2007-2013 under the project acronym EPISTOP (grant agreement no. 602391; JvS, AI, HH, TS, EA, FJ, MF, BB, PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2014, NEUROTHERAPEUTICS, V11, P251, DOI 10.1007/s13311-013-0251-0; Blumcke I, 2011, CLIN NEUROPATHOL, V30, P164, DOI 10.5414/NP300398; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Blumcke I, 2013, LANCET NEUROL, V12, P844, DOI 10.1016/S1474-4422(13)70175-3; Boer K, 2008, EPILEPSY RES, V78, P7, DOI 10.1016/j.eplepsyres.2007.10.002; Boer K, 2008, NEUROPATHOLOGY, V28, P577, DOI 10.1111/j.1440-1789.2008.00920.x; Boer K, 2009, EPILEPSIA, V50, P2629, DOI 10.1111/j.1528-1167.2009.02191.x; Chamberlain WA, 2009, EPILEPSIA, V50, P2593, DOI 10.1111/j.1528-1167.2009.02344.x; Chu-Shore CJ, 2010, EPILEPSIA, V51, P1236, DOI 10.1111/j.1528-1167.2009.02474.x; Coras R, 2014, EPILEPSIA, V55, P2003, DOI 10.1111/epi.12828; Coras R, 2012, EPILEPSIA, V53, P1341, DOI 10.1111/j.1528-1167.2012.03508.x; Crino PB, 2004, J CHILD NEUROL, V19, P716, DOI 10.1177/08830738040190091301; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Curatolo P, 2008, HAND CLINIC, V87, P129, DOI 10.1016/S0072-9752(07)87009-6; Engel J Jr, 1996, NEW ENGL J MED, V334, P647, DOI DOI 10.1056/NEJM199603073341008; Fauser S, 2015, EPILEPSIA, V56, P66, DOI 10.1111/epi.12876; Gallagher A, 2010, J NEUROL, V257, P1373, DOI 10.1007/s00415-010-5535-2; Hong SJ, 2014, NEUROLOGY, V83, P48, DOI 10.1212/WNL.0000000000000543; Jahodova A, 2014, EUR J RADIOL, V83, P703, DOI 10.1016/j.ejrad.2013.12.024; Jansen FE, 2007, EPILEPSIA, V48, P1477, DOI 10.1111/j.1528-1167.2007.01117.x; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; LAGOS JC, 1967, MAYO CLIN PROC, V42, P26; Li S, 2012, BRAIN RES, V1453, P46, DOI 10.1016/j.brainres.2012.03.009; Liu JYW, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-72; Luders H, 2006, CURR OPIN NEUROL, V19, P169; Muhlebner A, 2014, EPILEPSY RES, V108, P1652, DOI 10.1016/j.eplepsyres.2014.08.012; Muhlebner A, 2012, ACTA NEUROPATHOL, V123, P259, DOI 10.1007/s00401-011-0920-1; Prabowo AS, 2013, BRAIN PATHOL, V23, P45, DOI 10.1111/j.1750-3639.2012.00616.x; Qin W, 2010, BRAIN PATHOL, V20, P1096, DOI 10.1111/j.1750-3639.2010.00416.x; Ruppe V, 2014, EPILEPSIA, V55, P539, DOI 10.1111/epi.12545; Schurr J, 2017, BRAIN PATHOL, V27, P26, DOI 10.1111/bpa.12347; Shepherd C, 2013, EPILEPSIA, V54, P898, DOI 10.1111/epi.12143; Shu HF, 2013, BRAIN DEV-JPN, V35, P252, DOI 10.1016/j.braindev.2012.04.007; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Surbeck W, 2011, EPILEPSIA, V52, P458, DOI 10.1111/j.1528-1167.2010.02910.x; Talos DM, 2012, ANN NEUROL, V71, P539, DOI 10.1002/ana.22696; Tsai V, 2014, CEREB CORTEX, V24, P315, DOI 10.1093/cercor/bhs310; Wong M, 2008, EPILEPSIA, V49, P8, DOI 10.1111/j.1528-1167.2007.01270.x	39	51	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157396	10.1371/journal.pone.0157396	http://dx.doi.org/10.1371/journal.pone.0157396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27295297	Green Published, Green Submitted, gold			2022-12-27	WOS:000377821300042
J	Yasar, I; Kahveci, R; Artantas, AB; Baser, DA; Cihan, FG; Sencan, I; Koc, EM; Ozkara, A				Yasar, Ilknur; Kahveci, Rabia; Artantas, Aylin Baydar; Baser, Duygu Ayhan; Cihan, Fatma Goksin; Sencan, Irfan; Koc, Esra Meltem; Ozkara, Adem			Quality Assessment of Clinical Practice Guidelines Developed by Professional Societies in Turkey	PLOS ONE			English	Article							APPRAISAL; RECOMMENDATIONS; MANAGEMENT; CARE	Background Clinical practice guidelines (CPGs) are systematically developed statements to assist practitioner and patient decisions about appropriate healthcare for specific clinical circumstances. There is a limited number of studies on guidelines in Turkey. The quality of Ministry of Health guidelines have formerly been assessed whereas there is no information on the other guidelines developed in the country. Aim This study aims to assess the quality of CPGs that are developed by professional societies that work for the health sector in Turkey, and compare the findings with international guidelines. Methodology Professional societies that work for the health sector were determined by using the data obtained from the Ministry of Internal Affairs. Inclusion and exclusion criteria were defined for selecting the CPGs. Guidelines containing recommendations about disease management to the doctors, accessible online, developed within the past 5 years, citing references for recommendations, about the diseases over 1% prevalence according to the "Statistical Yearbook of Turkey 2012" were included in the study. The quality of CPGs were assessed with the AGREE II instrument, which is an internationally recognized tool for this purpose. Four independent reviewers, who did not participate in the development of the selected guidelines and were trained in CPG appraisal, used the AGREE instrument for assessment of the selected guidelines. Findings 47 professional societies were defined which provided access to CPGs in their websites; 3 of them were only open to members so these could not be reached. 8 CPGs from 7 societies were selected from a total of 401 CPGs from 44 societies. The mean scores of the domains of the guidelines which were assessed by the AGREE II tool were; Scope and purpose: 64%, stakeholder involvement: 37.9%, rigour of development: 35.3%, clarity and presentation: 77.9%, applicability: 49.0% and editorial independence: 46.0%. Conclusion This is the first study in Turkey regarding quality appraisal of guidelines developed by the local professional societies. It adds to the limited amount of information in the literature that comes from Turkey as well as other developing countries.	[Yasar, Ilknur] Ankara Yenimahalle Publ Hlth Ctr, Dept Family Med, Ankara, Turkey; [Kahveci, Rabia; Sencan, Irfan; Ozkara, Adem] Ankara Numune Training & Res Hosp, Dept Family Med, Ankara, Turkey; [Artantas, Aylin Baydar] Ankara Numune Training & Res Hosp, Dept Family Med, Ankara, Turkey; [Baser, Duygu Ayhan] Dept Kocaeli Peliubl, Adollesence, Hlth Child, Hlth Directorate,Woman Reprod, Koc, Turkey; [Cihan, Fatma Goksin] Konya Necmettin Erbakan Univ, Dept Family Med, Konya, Turkey; [Koc, Esra Meltem] Ankara Mamak Publ Hlth Ctr, Dept Family Med, Ankara, Turkey	Ankara Yenimahalle Training & Research Hospital; Ankara Numune Training & Research Hospital; Ankara Numune Training & Research Hospital; Necmettin Erbakan University	Baser, DA (corresponding author), Dept Kocaeli Peliubl, Adollesence, Hlth Child, Hlth Directorate,Woman Reprod, Koc, Turkey.	duyguayhan@outlook.com	AYHAN BAŞER, DUYGU/A-3668-2019; Artantas, Aylin Baydar/Q-1558-2019; Şencan, İrfan/AAG-5653-2019; Özkara, Adem/AAP-5416-2020; Cihan, Fatma Goksin/AAF-9503-2020; Koç, Esra Meltem/AAB-7724-2021; ayhanbaser, duygu/E-6084-2015	AYHAN BAŞER, DUYGU/0000-0002-5153-2184; Şencan, İrfan/0000-0003-2008-8700; Cihan, Fatma Goksin/0000-0001-7393-6860; 				Alonso-Coello P., 2010, QUAL SAF HEALTH CARE, V19, P1, DOI DOI 10.1136/QSHC.2010.042077; Artantas AB, 2011, HEALTHMED, V5, P1565; Burgers JS, 2003, INT J TECHNOL ASSESS, V19, P148, DOI 10.1017/S026646230300014X; Burgers JS, 2003, INT J QUAL HEALTH C, V15, P31, DOI 10.1093/intqhc/15.1.31; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Fortin M, 2011, BMC FAMILY PRACTICE, V12, P4; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hill S, 2007, LANCET, V369, P1842, DOI 10.1016/S0140-6736(07)60676-X; IOM, 1990, CLIN PRACTICE GUIDEL; IOM (Institute of Medicine), 1995, SETT PRIOR CLIN PRAC; IOM (Institute of Medicine), 2011, CLIN PRACTICE GUIDEL; Klein WW, 2002, HEART, V87, P497, DOI 10.1136/heart.87.6.497; Minhas R, 2007, INT J CLIN PRACT, V61, P1137, DOI 10.1111/j.1742-1241.2007.01310.x; Oxman AD, 2007, LANCET, V369, P1883, DOI 10.1016/S0140-6736(07)60675-8; Poitras S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2339; Satman I, 2012, DIABETES RES CLIN PR, V98, P75, DOI 10.1016/j.diabres.2012.05.003; Saturno PJ, 2003, INT J QUAL HEALTH C, V15, P487, DOI 10.1093/intqhc/mzg077; Siering U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082915; Sinclair D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063715; Vlayen J, 2005, INT J QUAL HEALTH C, V17, P235, DOI 10.1093/intqhc/mzi027	20	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0156483	10.1371/journal.pone.0156483	http://dx.doi.org/10.1371/journal.pone.0156483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO5KF	27295303	gold, Green Submitted, Green Published			2022-12-27	WOS:000377821300006
J	Sankari, S; O'Brian, MR				Sankari, Siva; O'Brian, Mark R.			Synthetic Lethality of the bfr and mbfA Genes Reveals a Functional Relationship between Iron Storage and Iron Export in Managing Stress Responses in Bradyrhizobium japonicum	PLOS ONE			English	Article							HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; OXIDATIVE STRESS; IRR PROTEIN; BACTERIOFERRITIN; RESISTANCE; REGULATOR; INVOLVEMENT; HOMEOSTASIS; METABOLISM	An mbfA mutant of Bradyrhizobium japonicum defective in iron export is sensitive to short term exposure to high levels iron or H2O2. Here, we found that the mbfA strain grown in elevated iron media (100 mu M) became resistant to those treatments, suggesting a stress response adaptation. The bfr gene encodes the iron storage protein bacterioferritin, and its expression is derepressed by iron. An mbfA bfr double mutant showed a loss of stress adaptation, and had a severe growth phenotype in high iron media. Moreover, a bfr(up) allele in which bfr is constitutively derepressed conferred stress tolerance on an mbfA mutant without elevating the iron content in the growth media. The intracellular iron content of the mbfA bfr double mutant was substantially higher than that found in the wild type, even when grown in relatively low iron media (5 mu M). Under that condition, iron-responsive gene expression was aberrant in the mbfA bfr strain. Moreover, the double mutant was sensitive to the iron-activated antibiotic streptonigrin. We conclude that MbfA and Bfr work in concert to manage iron and oxidative stresses. In addition, the need for iron detoxification is not limited to extreme environments, but is also required for normal cellular function.	[Sankari, Siva; O'Brian, Mark R.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	O'Brian, MR (corresponding author), SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA.	mrobrian@buffalo.edu	sankaran, Siva Sankari iyer mani/AAB-5222-2020		National Institutes of Health [R01 GM099667]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health, R01 GM099667.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Bhubhanil S, 2014, MICROBIOL-SGM, V160, P863, DOI 10.1099/mic.0.076802-0; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chen CY, 1999, MICROBIOL-SGM, V145, P2967, DOI 10.1099/00221287-145-10-2967; Expert D, 2008, J BIOL CHEM, V283, P36564, DOI 10.1074/jbc.M807749200; Frawley ER, 2013, P NATL ACAD SCI USA, V110, P12054, DOI 10.1073/pnas.1218274110; FRUSTACI JM, 1991, J BACTERIOL, V173, P1145, DOI 10.1128/jb.173.3.1145-1150.1991; Guan GH, 2015, MOL MICROBIOL, V98, P787, DOI 10.1111/mmi.13158; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Jaggavarapu S, 2014, MOL MICROBIOL, V92, P609, DOI 10.1111/mmi.12584; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Nicolaou SA, 2013, APPL ENVIRON MICROB, V79, P7210, DOI 10.1128/AEM.02322-13; O'Brian MR, 2015, ANNU REV MICROBIOL, V69, P229, DOI 10.1146/annurev-micro-091014-104432; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Ruangkiattikul N, 2012, FEMS MICROBIOL LETT, V329, P87, DOI 10.1111/j.1574-6968.2012.02509.x; Sankari S, 2014, J BIOL CHEM, V289, P16498, DOI 10.1074/jbc.M114.571562; Small SK, 2011, J BACTERIOL, V193, P4088, DOI 10.1128/JB.05064-11; Wittenberg JB, 1996, PLANT SOIL, V178, P161, DOI 10.1007/BF00011579; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x; YEOWELL HN, 1982, ANTIMICROB AGENTS CH, V22, P961, DOI 10.1128/AAC.22.6.961; ZUBAY G, 1972, P NATL ACAD SCI USA, V69, P1100, DOI 10.1073/pnas.69.5.1100	22	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157250	10.1371/journal.pone.0157250	http://dx.doi.org/10.1371/journal.pone.0157250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285822	Green Submitted, gold, Green Published			2022-12-27	WOS:000377564000049
J	Spiegelhalder, K; Regen, W; Nissen, C; Feige, B; Baglioni, C; Riemann, D; Hennig, J; Lange, T				Spiegelhalder, Kai; Regen, Wolfram; Nissen, Christoph; Feige, Bernd; Baglioni, Chiara; Riemann, Dieter; Hennig, Juergen; Lange, Thomas			Magnetic Resonance Spectroscopy in Patients with Insomnia: A Repeated Measurement Study	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; CORTICAL GABA LEVELS; IN-VIVO; HUMAN BRAIN; SLEEP; REPRODUCIBILITY; ASSOCIATIONS; METABOLITES; VALIDATION; DISORDER	Chronic insomnia is one of the most prevalent central nervous system disorders. It is characterized by increased arousal levels, however, the neurobiological causes and correlates of hyperarousal in insomnia remain to be further determined. In the current study, magnetic resonance spectroscopy was used in the morning and evening in a well-characterized sample of 20 primary insomnia patients (12 females; 8 males; 42.7 +/- 13.4 years) and 20 healthy good sleepers (12 females; 8 males; 44.1 +/- 10.6 years). The most important inhibitory and excitatory neurotransmitters of the central nervous system, gamma-aminobutyric acid (GABA) and glutamate/glutamine (Glx), were assessed in the anterior cingulate cortex (ACC) and dorsolateral prefrontal cortex (DLPFC). The primary hypothesis, a diurnal effect on GABA levels in patients with insomnia, could not be confirmed. Moreover, the current results did not support previous findings of altered GABA levels in individuals with insomnia. Exploratory analyses, however, suggested that GABA levels in the ACC may be positively associated with habitual sleep duration, and, thus, reduced GABA levels may be a trait marker of objective sleep disturbances. Moreover, there was a significant GROUP x MEASUREMENT TIME interaction effect on Glx in the DLPFC with increasing Glx levels across the day in the patients but not in the control group. Therefore, Glx levels may reflect hyperarousal at bedtime in those with insomnia. Future confirmatory studies should include larger sample sizes to investigate brain metabolites in different subgroups of insomnia.	[Spiegelhalder, Kai; Regen, Wolfram; Nissen, Christoph; Feige, Bernd; Baglioni, Chiara; Riemann, Dieter] Univ Med Ctr Freiburg, Dept Clin Psychol & Psychophysiol, Ctr Mental Disorders, Freiburg, Germany; [Spiegelhalder, Kai; Lange, Thomas] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, Hugstetter Str 55, D-79106 Freiburg, Germany; [Hennig, Juergen] Univ Med Ctr Freiburg, Med Phys, Dept Radiol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Spiegelhalder, K (corresponding author), Univ Med Ctr Freiburg, Dept Clin Psychol & Psychophysiol, Ctr Mental Disorders, Freiburg, Germany.; Spiegelhalder, K (corresponding author), Univ Freiburg, Freiburg Inst Adv Studies FRIAS, Hugstetter Str 55, D-79106 Freiburg, Germany.	Kai.Spiegelhalder@uniklinik-freiburg.de	Spiegelhalder, Kai/B-7861-2019; Feige, Bernd/C-6690-2012; Lange, Thomas/P-5582-2018; Hennig, Jürgen/F-2424-2010; Riemann, Dieter/R-4013-2019; Nissen, Christoph/C-7642-2015; Baglioni, Chiara/ABC-3423-2020; Baglioni, Chiara/AAC-2605-2019	Feige, Bernd/0000-0002-9436-1258; Lange, Thomas/0000-0002-7467-8143; Hennig, Jürgen/0000-0002-2273-3497; Nissen, Christoph/0000-0001-9809-0275; Riemann, Dieter/0000-0002-1968-6220	Freiburg Institute for Advanced Studies (FRIAS); Helmholtz Alliance; "Deutsche Forschungsgemeinschaft" (DFG); German Research Foundation (DFG); University of Freiburg	Freiburg Institute for Advanced Studies (FRIAS)(Fonds de la Recherche Scientifique - FNRS); Helmholtz Alliance; "Deutsche Forschungsgemeinschaft" (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	The Freiburg Institute for Advanced Studies (FRIAS) provided grant support for KS and TL. The Helmholtz Alliance, and the "Deutsche Forschungsgemeinschaft" (DFG) provided grant support for TL. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2007, AASM MANUAL SCORING; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baglioni C, 2014, SLEEP, V37, P1907, DOI 10.5665/sleep.4240; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beck A.T., 1987, BECK DEPRESSION INVE; Bertisch SM, 2014, SLEEP, V37, P343, DOI 10.5665/sleep.3410; Bhattacharyya PK, 2014, NEUROIMAGE, V84, P1111, DOI 10.1016/j.neuroimage.2013.08.050; Bogner W, 2010, EUR J RADIOL, V73, P526, DOI 10.1016/j.ejrad.2009.01.014; Broomfield NM, 2005, J SLEEP RES, V14, P401, DOI 10.1111/j.1365-2869.2005.00481.x; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cavassila S, 2001, NMR BIOMED, V14, P278, DOI 10.1002/nbm.701; De Bondt T, 2015, BRAIN RES, V1597, P129, DOI 10.1016/j.brainres.2014.11.051; Edden RAE, 2012, J MAGN RESON IMAGING, V35, P229, DOI 10.1002/jmri.22865; Evans CJ, 2010, J MAGN RESON IMAGING, V31, P204, DOI 10.1002/jmri.21996; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Ganji SK, 2012, NMR BIOMED, V25, P523, DOI 10.1002/nbm.1767; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Huedo-Medina TB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8343; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Johann A, 2015, SOMNOLOGIE, V19, P88; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kucharczyk Erica R, 2012, Sleep Med Rev, V16, P547, DOI 10.1016/j.smrv.2012.01.005; Kyle SD, 2010, SLEEP MED REV, V14, P69, DOI 10.1016/j.smrv.2009.07.004; Lanfranchi PA, 2009, SLEEP, V32, P760, DOI 10.1093/sleep/32.6.760; Laugsand LE, 2014, EUR HEART J, V35, P1382, DOI 10.1093/eurheartj/eht019; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Leger D, 2010, SLEEP MED REV, V14, P379, DOI 10.1016/j.smrv.2010.01.003; Long ZY, 2015, NMR BIOMED, V28, P1315, DOI 10.1002/nbm.3381; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Meyerhoff DJ, 2014, SLEEP, V37, P893, DOI 10.5665/sleep.3654; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; Morgan PT, 2012, SLEEP, V35, P807, DOI 10.5665/sleep.1880; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; Morin CM, NAT REV DIS IN PRESS; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Near J, 2014, NEUROIMAGE, V99, P191, DOI 10.1016/j.neuroimage.2014.05.059; Near J, 2013, NMR BIOMED, V26, P1353, DOI 10.1002/nbm.2960; Near J, 2011, NMR BIOMED, V24, P1277, DOI 10.1002/nbm.1688; NICASSIO PM, 1985, BEHAV RES THER, V23, P263, DOI 10.1016/0005-7967(85)90004-X; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Plante DT, 2012, SLEEP, V35, P741, DOI 10.5665/sleep.1854; Plante DT, 2012, NEUROPSYCHOPHARMACOL, V37, P1548, DOI 10.1038/npp.2012.4; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Puts NAJ, 2013, J MAGN RESON IMAGING, V37, P999, DOI 10.1002/jmri.23817; Regen W, J PSYCHIAT IN PRESS; Reinhard MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109336; Riemann D, 2015, LANCET NEUROL, V14, P547, DOI 10.1016/S1474-4422(15)00021-6; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Shahly V, 2012, ARCH GEN PSYCHIAT, V69, P1054, DOI 10.1001/archgenpsychiatry.2011.2188; Sofi F, 2014, EUR J PREV CARDIOL, V21, P57, DOI 10.1177/2047487312460020; Spiegelhalder K, 2015, SOMNOLOGIE, V19, P93; Spiegelhalder K, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0527-3; Spiegelhalder K, 2014, HUM BRAIN MAPP, V35, P3431, DOI 10.1002/hbm.22412; Spiegelhalder K, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0364-5; Spiegelhalder K, 2013, SLEEP, V36, P731, DOI 10.5665/sleep.2638; Spiegelhalder K, 2011, J SLEEP RES, V20, P137, DOI 10.1111/j.1365-2869.2010.00863.x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Vgontzas AN, 2013, SLEEP MED REV, V17, P241, DOI 10.1016/j.smrv.2012.09.005; Winkelman JW, 2008, SLEEP, V31, P1499, DOI 10.1093/sleep/31.11.1499	64	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156771	10.1371/journal.pone.0156771	http://dx.doi.org/10.1371/journal.pone.0156771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285311	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000020
J	Wessler, I; Gartner, HA; Michel-Schmidt, R; Brochhausen, C; Schmitz, L; Anspach, L; Grunewald, B; Kirkpatrick, CJ				Wessler, Ignaz; Gaertner, Hedwig-Annabel; Michel-Schmidt, Rosmarie; Brochhausen, Christoph; Schmitz, Luise; Anspach, Laura; Gruenewald, Bernd; Kirkpatrick, Charles James			Honeybees Produce Millimolar Concentrations of Non-Neuronal Acetylcholine for Breeding: Possible Adverse Effects of Neonicotinoids	PLOS ONE			English	Article							CHOLINERGIC SYSTEM; BIOLOGICAL-SYSTEMS; HUMANS; BEES; MOLECULE; EXPRESSION; RECEPTORS; NICOTINE; TISSUES; GROWTH	The worldwide use of neonicotinoid pesticides has caused concern on account of their involvement in the decline of bee populations, which are key pollinators in most ecosystems. Here we describe a role of non-neuronal acetylcholine (ACh) for breeding of Apis mellifera carnica and a so far unknown effect of neonicotinoids on non-target insects. Royal jelly or larval food are produced by the hypopharyngeal gland of nursing bees and contain unusually high ACh concentrations (4-8 mM). ACh is extremely well conserved in royal jelly or brood food because of the acidic pH of 4.0. This condition protects ACh from degradation thus ensuring delivery of intact ACh to larvae. Raising the pH to >= 5.5 and applying cholinesterase reduced the content of ACh substantially (by 75-90%) in larval food. When this manipulated brood was tested in artificial larval breeding experiments, the survival rate was higher with food supplemented by 100% with ACh (6 mM) than with food not supplemented with ACh. ACh release from the hypopharyngeal gland and its content in brood food declined by 80%, when honeybee colonies were exposed for 4 weeks to high concentrations of the neonicotinoids clothianidin (100 parts per billion [ppb]) or thiacloprid (8,800 ppb). Under these conditions the secretory cells of the gland were markedly damaged and brood development was severely compromised. Even field-relevant low concentrations of thiacloprid (200 ppb) or clothianidin (1 and 10 ppb) reduced ACh level in the brood food and showed initial adverse effects on brood development. Our findings indicate a hitherto unknown target of neonicotinoids to induce adverse effects on non-neuronal ACh which should be considered when re-assessing the environmental risks of these compounds. To our knowledge this is a new biological mechanism, and we suggest that, in addition to their well documented neurotoxic effects, neonicotinoids may contribute to honeybee colony losses consecutive to a reduction of the ACh content in the brood food.	[Wessler, Ignaz; Michel-Schmidt, Rosmarie; Schmitz, Luise; Anspach, Laura; Kirkpatrick, Charles James] Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, Langenbeckstr 1, D-55122 Mainz, Germany; [Gaertner, Hedwig-Annabel; Gruenewald, Bernd] Goethe Univ Frankfurt, Inst Bienenkunde, Polytech Gesell Frankfurt Main, Fachbereich Biowissensch, Karl von Frisch Weg 2, D-61440 Oberursel, Germany; [Brochhausen, Christoph] Univ Regensburg, Inst Pathol, Franz Josef Str Allee 11, D-93053 Regensburg, Germany	Johannes Gutenberg University of Mainz; Goethe University Frankfurt; University of Regensburg	Wessler, I (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, Langenbeckstr 1, D-55122 Mainz, Germany.	wessler@uni-mainz.de	Grünewald, Bernd/G-2060-2012	Kirkpatrick, Charles James/0000-0002-0088-418X	Deutsche Forschungsgemeinschaft [Ki 601/8-02]; German Federal Ministry of Food and Agriculture (FitBee)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Food and Agriculture (FitBee)	This work was supported by: 1) Deutsche Forschungsgemeinschaft (grant Ki 601/8-02) to CJK, and 2) German Federal Ministry of Food and Agriculture (FitBee) to BG.	Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; Catone C, 2003, J NEUROSCI RES, V72, P46, DOI 10.1002/jnr.10550; COLHOUN EH, 1960, NATURE, V188, P854, DOI 10.1038/188854a0; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Ewins AJ, 1914, BIOCHEM J, V8, P44, DOI 10.1042/bj0080044; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; Genersch E, 2005, APPL ENVIRON MICROB, V71, P7551, DOI 10.1128/AEM.71.11.7551-7555.2005; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Grando SA, 2015, INT IMMUNOPHARMACOL, V29, P1, DOI 10.1016/j.intimp.2015.08.023; Grando SA, 2014, NAT REV CANCER, V14, P419, DOI 10.1038/nrc3725; Hatjina F, 2013, APIDOLOGIE, V44, P467, DOI 10.1007/s13592-013-0199-4; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Horiuchi Y, 2003, LIFE SCI, V72, P1745, DOI 10.1016/S0024-3205(02)02478-5; Kheyri H, 2012, CYTOSKELETON, V69, P1032, DOI 10.1002/cm.21059; KILBINGER H, 1980, N-S ARCH PHARMACOL, V314, P259, DOI 10.1007/BF00498547; Klapproth H, 1997, N-S ARCH PHARMACOL, V355, P515, DOI 10.1007/PL00004977; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; SASTRY BVR, 1978, PHARMACOL REV, V30, P65; SCHULLER HM, 1990, LIFE SCI, V47, P571, DOI 10.1016/0024-3205(90)90618-2; Smodis-Skerl MI, 2010, APIDOLOGIE, V41, P467; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Wang Y, 2008, J PHARMACEUT BIOMED, V47, P870, DOI 10.1016/j.jpba.2008.02.022; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Wessler I, 1999, CLIN EXP PHARMACOL P, V26, P198, DOI 10.1046/j.1440-1681.1999.03016.x; Wessler I, 2001, JPN J PHARMACOL, V85, P2, DOI 10.1254/jjp.85.2; Wessler I, 1998, PHARMACOL THERAPEUT, V77, P59, DOI 10.1016/S0163-7258(97)00085-5; Wessler I, 2013, NEUROSCI LETT, V547, P32, DOI 10.1016/j.neulet.2013.04.052; Wessler IK, 2012, HDB EXP PHARM, V208, P469; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	36	27	27	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156886	10.1371/journal.pone.0156886	http://dx.doi.org/10.1371/journal.pone.0156886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285384	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000029
J	Zheng, W; Cao, XL; Ungvari, GS; Xiang, YQ; Guo, T; Liu, ZR; Wang, YY; Forester, BP; Seiner, SJ; Xiang, YT				Zheng, Wei; Cao, Xiao-Lan; Ungvari, Gabor S.; Xiang, Ying-Qiang; Guo, Tong; Liu, Zheng-Rong; Wang, Yuan-Yuan; Forester, Brent P.; Seiner, Stephen J.; Xiang, Yu-Tao			Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; AUGMENTATION; QUALITY; BIAS; ECT	This meta-analysis of randomized controlled trials (RCTs) examined the efficacy and safety of the combination of electroconvulsive therapy (ECT) and antipsychotic medication (except for clozapine) versus the same antipsychotic monotherapy for treatment-resistant schizophrenia (TRS). Two independent investigators extracted data for a random effects meta-analysis and pre-specified subgroup and meta-regression analyses. Weighted and standard mean difference (WMD/SMD), risk ratio (RR) +/- 95% confidence intervals (CIs), number needed to treat (NNT), and number needed to harm (NNH) were calculated. Eleven studies (n = 818, duration = 10.2 +/- 5.5 weeks) were identified for meta-analysis. Adjunctive ECT was superior to antipsychoticmonotherapy regarding (1) symptomatic improvement at last-observation endpoint with an SMD of -0.67 (p<0.00001; I-2 = 62%), separating the two groups as early as weeks 1-2with anSMDof -0.58 (p<0.00001; I-2 = 0%); (2) study-defined response (RR = 1.48, p<0.0001) with an NNT of 6 (CI = 4-9) and remission rate (RR = 2.18, p = 0.0002) with an NNT of 8 (CI = 6-16); (3) PANSS positive and general symptom sub-scores at endpoint with a WMDbetween -3.48 to -1.32 (P = 0.01 to 0.009). Subgroup analyses were conducted comparing double blind/rater-masked vs. open RCTs, those with and without randomization details, and high quality (Jadad >= adadup analyses were Jadad<3) studies. The ECT-antipsychotic combination causedmore headache (p = 0.02) with anNNHof 6 (CI = 4-11) and memory impairment (p = 0.001) with an NNH of 3 (CI = 2-5). The use of ECT to augment antipsychotic treatment (clozapine excepted) can be an effective treatment option for TRS, with increased frequency of self-reportedmemory impairment and headache.	[Zheng, Wei] Guangzhou Med Univ, Guangzhou Huiai Hosp, Affiliated Brain Hosp, Guangzhou, Guangdong, Peoples R China; [Cao, Xiao-Lan] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Cao, Xiao-Lan] Shenzhen Kangning Hosp, Shenzhen Key Lab Psychol Healthcare, Shenzhen, Peoples R China; [Cao, Xiao-Lan] Shenzhen Kangning Hosp, Shenzhen Inst Mental Hlth, Shenzhen, Peoples R China; [Cao, Xiao-Lan] Shenzhen Mental Hlth Ctr, Shenzhen, Peoples R China; [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia; [Xiang, Ying-Qiang; Guo, Tong] Capital Med Univ, Natl Clin Res Ctr Mental Disorders, Beijing, Peoples R China; [Xiang, Ying-Qiang; Guo, Tong] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Liu, Zheng-Rong] Mental Hosp Guangzhou Civil Adm, Guangzhou 510430, Guangdong, Peoples R China; [Wang, Yuan-Yuan] Wuhan Univ, Fac Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430072, Hubei Province, Peoples R China; [Forester, Brent P.; Seiner, Stephen J.] McLean Hosp Belmont, Boston, MA USA; [Forester, Brent P.; Seiner, Stephen J.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Xiang, Yu-Tao] Univ Macau, Fac Hlth Sci, Unit Psychiat, Zhuhai, Macao Sar, Peoples R China	Guangzhou Medical University; Chinese University of Hong Kong; University of Western Australia; University of Notre Dame Australia; Capital Medical University; Capital Medical University; Wuhan University; Harvard University; McLean Hospital; Harvard University; Harvard Medical School; University of Macau	Zheng, W (corresponding author), Guangzhou Med Univ, Guangzhou Huiai Hosp, Affiliated Brain Hosp, Guangzhou, Guangdong, Peoples R China.; Xiang, YT (corresponding author), Univ Macau, Fac Hlth Sci, Unit Psychiat, Zhuhai, Macao Sar, Peoples R China.	zhengwei0702@163.com; xyutly@gmail.com	Cao, Xiao-Lan/X-4670-2019; Wang, Yuan/HHC-1520-2022; Lv, Yuanjie/AER-0767-2022		McLean Hospital-Chinese Psychiatric Society Initiative in Psychiatry (MCIP); University of Macau [SRG2014-00019-FHS, MYRG2015-00230-FHS]	McLean Hospital-Chinese Psychiatric Society Initiative in Psychiatry (MCIP); University of Macau	The study was supported by the McLean Hospital-Chinese Psychiatric Society Initiative in Psychiatry (MCIP), the Start-up Research Grant (SRG2014-00019-FHS) and the Multi-Year Research Grant (MYRG2015-00230-FHS) from the University of Macau. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Chanpattana W, 1999, J ECT, V15, P178; Chanpattana W, 1999, J ECT, V15, P129; Cohen J.E., 1988, STAT POWER ANAL BEHA; Correll CU, 2009, SCHIZOPHRENIA BULL, V35, P443, DOI 10.1093/schbul/sbn018; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Englisch Susanne, 2012, Mens Sana Monogr, V10, P20, DOI 10.4103/0973-1229.91588; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Goswami Utpal, 2003, Indian J Psychiatry, V45, P26; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Iqbal Mohammad Masud, 2003, Ann Clin Psychiatry, V15, P33, DOI 10.3109/10401230309085668; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; [姜小琴 JIANG Xiaoqin], 2009, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V35, P79; Kay SR, 1987, SCHIZOPHR B, V13, P463; Kendell RE, 1981, BRIT J PSYCHIAT, P139; Kho KH, 2004, EUR ARCH PSY CLIN N, V254, P372, DOI 10.1007/s00406-004-0517-y; Lally J, 2016, SCHIZOPHR RES, V171, P215, DOI 10.1016/j.schres.2016.01.024; Li N, 2015, MED INFORM, V28, P194; Li Q, 2015, SCHIZOPHR RES, V168, P523, DOI 10.1016/j.schres.2015.07.048; Liu W, 2012, ZHONGGUO YAOWU YU LI, V12, P115, DOI 10.3969/j.issn.1671-2560.2012.01.058; MELTZER HY, 1992, BRIT J PSYCHIAT, V160, P46, DOI 10.1192/S000712500029692X; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Petrides G, 2015, AM J PSYCHIAT, V172, P52, DOI 10.1176/appi.ajp.2014.13060787; Porcelli S, 2012, EUR NEUROPSYCHOPHARM, V22, P165, DOI 10.1016/j.euroneuro.2011.08.005; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; Shen YF, 2009, ELECTROCONVULSIVE TH; Tang WK, 2003, PROG NEURO-PSYCHOPH, V27, P373, DOI 10.1016/S0278-5846(02)00354-8; Tharyan P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000076; Vayisoglu S, 2014, TURK PSIKIYATR DERG, V25, P201, DOI 10.5080/u7455; Wang F, 2013, CHINESE J CLIN RATIO, V6, P99; Wang GK, 2015, MED INFORM, V28, P43; Wang Wenzheng, 2015, Shanghai Arch Psychiatry, V27, P206, DOI 10.11919/j.issn.1002-0829.215093; Weiner RD, 2008, PRACTICE ELECTROCONV; Young CR, 1998, SCHIZOPHRENIA BULL, V24, P381, DOI 10.1093/oxfordjournals.schbul.a033333; Zhang JY, 2014, YANBIAN YIXUE, V9, p[35, 7]; Zhang SR, 2012, RENMIN JUNYI, V55, P141; Zhang ZP, 2012, J CLIN PSYCHOSOMATIC, V18, P77, DOI 10.3969/j.issn.1672-187X.2012.01.031-0077-02; Zhou HJ, 2009, J NEUROSCIENCE MENTA, V9, P328, DOI 10.3969/j.issn.1009-6574.2009.04.017	43	34	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156510	10.1371/journal.pone.0156510	http://dx.doi.org/10.1371/journal.pone.0156510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285996	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000014
J	Kirkham, JJ; Dwan, KM; Blumle, A; von Elm, E; Williamson, PR				Kirkham, Jamie J.; Dwan, Kerry M.; Bluemle, Anette; von Elm, Erik; Williamson, Paula R.			How Much Participant Outcome Data Is Missing from Sight: Findings from a Cohort of Trials Submitted to a German Research Ethics Committee	PLOS ONE			English	Article							RANDOMIZED-TRIALS; REPORTING BIAS; CLINICAL-RESEARCH; FOLLOW-UP; PROTOCOLS	Background Study publication bias and outcome reporting bias have been recognised as two threats to the validity of systematic reviews. The purpose of this research was to estimate the proportion of missing participant outcome data from randomised controlled trials (RCTs) due to lack of publication of whole studies and due to outcome data missing within study publications. Methods and Findings Data were extracted from protocols of clinical research projects submitted to the research ethics committee of the University of Freiburg (Germany) between 2000 and 2002 and associated fully published articles. The total amount of published and unpublished outcome data from all trial participants was calculated for each trial and the overall proportion of missing data from both unpublished and published trials computed. Full and partially reported outcome data was also taken into consideration. The impact of funding source on missingness was also considered at the trial level. From 308 parallel group trials in the study cohort, 167 were published and 141 were unpublished. Overall, 260,563 participants contributed to a total of 2,618,116 participant outcome data across all trials. About half (47%) of the participant outcome data from the 308 trials was reported in full but at least 81% were partially reported. Of the 19% of participant data that were missing, 4% was attributable to missing data from published trials and 15% from unpublished trials. Commercially funded trials had a higher probability of publication (relative risk 1.20, 95% confidence interval 0.86, 1.67; p = 0.27) but were less likely to fully report all outcomes than non-commercially funded trials (relative risk 0.64, 95% confidence interval 0.30, 1.38; p = 0.26). Conclusions Missing participant outcome data from both published and unpublished trials is frequent. Clinical trial registration including outcome information not only identifies that clinical trials exist but the systematic examination and monitoring of trial information within a registry can help detect selective reporting of entire studies and of outcome data within studies and possibly prevent it.	[Kirkham, Jamie J.; Williamson, Paula R.] Univ Liverpool, MRC North West Hub Trials Methodol Res, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Dwan, Kerry M.] Cochrane Editorial Unit, London, England; [Bluemle, Anette] Univ Freiburg, Fac Med, Cochrane Germany, Hugstetter Str 55, D-79106 Freiburg, Germany; [von Elm, Erik] Inst Univ Med Sociale & Prevent, Cochrane Switzerland, Lausanne, Switzerland	University of Liverpool; University of Freiburg	Kirkham, JJ (corresponding author), Univ Liverpool, MRC North West Hub Trials Methodol Res, Dept Biostat, Liverpool L69 3BX, Merseyside, England.	jjk@liv.ac.uk	Kirkham, Jamie/AAD-4490-2019; Dwan, Kerry/AAG-4726-2022; Williamson, Paula R/B-6425-2016; Dwan, Kerry/AFK-6469-2022	Kirkham, Jamie/0000-0003-2579-9325; Dwan, Kerry/0000-0001-6918-1215; Williamson, Paula R/0000-0001-9802-6636; Dwan, Kerry/0000-0001-6918-1215; von Elm, Erik/0000-0002-7412-0406; Blumle, Anette/0000-0003-2877-1029	German Research Foundation (DFG) [EL 544/1-1]; University of Liverpool; MRC North West Hub for Trials Methodology Research [MR/K025635/1]; MRC [MR/K025635/1] Funding Source: UKRI; Medical Research Council [MR/K025635/1] Funding Source: researchfish	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Liverpool; MRC North West Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The original work was supported by the German Research Foundation (DFG), grant number: EL 544/1-1. JJK is funded by the University of Liverpool. PRW is funded by the MRC North West Hub for Trials Methodology Research (Grant Reference Number: MR/K025635/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumle A, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2008.024521; Blumle A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087184; Blumle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1828; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Ghersi D, 2006, ISSUES DESIGN CONDUC; Hahn S, 2002, J EVAL CLIN PRACT, V8, P353, DOI 10.1046/j.1365-2753.2002.00314.x; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Saini P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6501; Schmucker C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114023; Schroll JB, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2231; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251	14	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157883	10.1371/journal.pone.0157883	http://dx.doi.org/10.1371/journal.pone.0157883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JQ	27314853	gold, Green Published, Green Submitted			2022-12-27	WOS:000378030000061
J	Mahani, MAN; Haghgoo, HA; Azizi, S; Ahmadabadi, MN				Mahani, Mohammad-Ali Nikouei; Haghgoo, Hojjat Allah; Azizi, Solmaz; Ahmadabadi, Majid Nili			Attention Cueing and Activity Equally Reduce False Alarm Rate in Visual-Auditory Associative Learning through Improving Memory	PLOS ONE			English	Article							CONTINUOUS PERFORMANCE-TEST; OBJECT; RECOGNITION; INTEGRATION	In our daily life, we continually exploit already learned multisensory associations and form new ones when facing novel situations. Improving our associative learning results in higher cognitive capabilities. We experimentally and computationally studied the learning performance of healthy subjects in a visual-auditory sensory associative learning task across active learning, attention cueing learning, and passive learning modes. According to our results, the learning mode had no significant effect on learning association of congruent pairs. In addition, subjects' performance in learning congruent samples was not correlated with their vigilance score. Nevertheless, vigilance score was significantly correlated with the learning performance of the non-congruent pairs. Moreover, in the last block of the passive learning mode, subjects significantly made more mistakes in taking non-congruent pairs as associated and consciously reported lower confidence. These results indicate that attention and activity equally enhanced visual-auditory associative learning for non-congruent pairs, while false alarm rate in the passive learning mode did not decrease after the second block. We investigated the cause of higher false alarm rate in the passive learning mode by using a computational model, composed of a reinforcement learning module and a memory-decay module. The results suggest that the higher rate of memory decay is the source of making more mistakes and reporting lower confidence in non-congruent pairs in the passive learning mode.	[Mahani, Mohammad-Ali Nikouei; Ahmadabadi, Majid Nili] Univ Tehran, Sch Elect & Comp Engn, Cognit Robot Lab, Tehran, Iran; [Mahani, Mohammad-Ali Nikouei; Ahmadabadi, Majid Nili] Inst Res Fundamental Sci, Sch Cognit Sci, Tehran, Iran; [Mahani, Mohammad-Ali Nikouei] Univ Tubingen, Dept Psychol, Cognit & Percept, Tubingen, Germany; [Haghgoo, Hojjat Allah; Azizi, Solmaz] Univ Social Welf & Rehabil Sci, Occupat Therapy Dept, Tehran, Iran	University of Tehran; Eberhard Karls University of Tubingen	Mahani, MAN (corresponding author), Univ Tehran, Sch Elect & Comp Engn, Cognit Robot Lab, Tehran, Iran.; Mahani, MAN (corresponding author), Inst Res Fundamental Sci, Sch Cognit Sci, Tehran, Iran.; Mahani, MAN (corresponding author), Univ Tubingen, Dept Psychol, Cognit & Percept, Tubingen, Germany.	ma@mahani.info	Haghgoo, Hojjat/AAD-7124-2021; Haghgoo, Hojjat Allah/J-5327-2017; Haghgoo, Hojjat/P-8698-2018	Haghgoo, Hojjat/0000-0001-6136-2417; Nikouei Mahani, Mohammad-Ali/0000-0002-6718-3361				[Anonymous], 2014, COMMUN; [Anonymous], 2014, FRONT PSYCHOL, V5, P1, DOI [10.3389/fpsyg.2014.01095, DOI 10.3389/FPSYG.2014.01095]; Arble E, 2014, ARCH CLIN NEUROPSYCH, V29, P300, DOI 10.1093/arclin/acu006; Beets IAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037687; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; Butler AJ, 2012, J COGNITIVE NEUROSCI, V25, P1, DOI [10.1162/jo00284, DOI 10.1162/JO00284]; Butler AJ, 2011, J COGNITIVE NEUROSCI, V23, P3515, DOI 10.1162/jocn_a_00015; Chen TW, 2015, EUR J NEUROSCI, V41, P264, DOI 10.1111/ejn.12764; Cohen RA, NEUROPSYCHOLOGY ATTE; Ebbinghaus H, 1913, CONTRIBUTION EXPT PS; Gohil K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09485; James KH, 2001, CAN J EXP PSYCHOL, V55, P111, DOI 10.1037/h0087358; James KH, 2002, BEHAV RES METH INS C, V34, P383, DOI 10.3758/BF03195466; Kafaligonul H, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00026; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Parks CM, 2009, P NATL ACAD SCI USA, V106, P11515, DOI 10.1073/pnas.0905505106; Richard S., REINFORCEMENT LEARNI; Sasaoka T, 2010, PERCEPTION, V39, P289, DOI 10.1068/p5721; Schomaker J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00918; Spiegel DP, 2015, SCI REP-UK, V5, DOI 10.1038/srep10802; Talsma D, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00019; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Tinius TP, 2003, ARCH CLIN NEUROPSYCH, V18, P439, DOI 10.1016/S0887-6177(02)00144-0; Trewartha KM, 2015, BEHAV BRAIN RES, V279, P234, DOI 10.1016/j.bbr.2014.11.043; Voss JL, 2011, NAT NEUROSCI, V14, P115, DOI 10.1038/nn.2693	25	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2016	11	6							e0157680	10.1371/journal.pone.0157680	http://dx.doi.org/10.1371/journal.pone.0157680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO8JQ	27314235	Green Submitted, gold, Green Published			2022-12-27	WOS:000378030000044
J	Gusella, GL; Teixeira, A; Aberg, J; Uversky, VN; Mosoian, A				Gusella, G. Luca; Teixeira, Avelino; Aberg, Judith; Uversky, Vladimir N.; Mosoian, Arevik			Prothymosin-alpha Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways	PLOS ONE			English	Article							INTRINSIC DISORDER; TUMOR-CELLS; WEB SERVER; PROTEIN; SEQUENCE; GENE; DIFFERENTIATION; EXPRESSION; PREDICTION; INHIBITOR	Background Prothymosin a (ProT alpha) (isoform 2: iso2) is a widely distributed, small acidic protein with intracellular and extracellular-associated functions. Recently, we identified two new ProT alpha variants with potent anti-HIV activity from CD8(+) T cells and cervicovaginal lavage. The first is a splice variant of the ProT alpha gene known as isoB and the second is the product of ProT alpha pseudogene 7 (p7). Similarly to iso2, the anti-HIV activity of both variants is mediated by type I IFN. Here we tested whether the immunomodulatory activity of isoB and p7 are also TLR4 dependent and determined their kinetic of release in response to HIV-1 infection. Methods Type I, type III, TNF-alpha and IL-6 mRNA inducing activity was determined in macrophages from wild type and TLR4 knockout mice treated with recombinant ProT alpha variants. Supernatants from mock and HIV infected cells were analyzed by mass spectrometry in positive and negative modes for the presence of ProT alpha variants. In silico structural and functional analysis of ProT alpha variants were performed. Results We show that both isoB and p7 upregulate IFN-beta, IFN-lambda 1, IL-6, TNF-alpha and RANTES mRNAs in primary human macrophages. The potent stimulation of IFN-beta by the recombinant ProT alpha variants in human macrophages is dependent on the TLR4 pathway, whereas the induction of TNF-alpha and IL-6 may also occur independently of TLR4, suggesting the interaction of ProT alpha variants with other signaling molecules/receptors. In silico analyses confirmed that the novel isoB and p7 variants are intrinsically disordered proteins, which lack the NLS and mass spectrometry showed release of ProT alpha variants within minutes post HIV-1 infection. These features are consistent with the function of ProT alpha variants as damage associate molecular patterns (DAMPs). Conclusions Our findings indicate that ProTa variants strongly inhibit viral replication mainly, but not exclusively, through TLR4 signaling and that they are released within minutes of viral infection suggesting that they may function as DAMPs.	[Gusella, G. Luca; Teixeira, Avelino; Aberg, Judith; Mosoian, Arevik] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL USA; [Uversky, Vladimir N.] Univ S Florida, USF Hlth Byrd Alzheimers Res Inst, Morsani Coll Med, Tampa, FL USA; [Uversky, Vladimir N.] King Abdulaziz Univ, Fac Sci, Dept Biol, POB 80203, Jeddah 21589, Saudi Arabia; [Uversky, Vladimir N.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 194064, Russia	Icahn School of Medicine at Mount Sinai; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; King Abdulaziz University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Mosoian, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.	arevik.mosoian@mssm.edu	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857	Campbell Foundation; Lehman Brother Foundation; Dorothy Rodbell Cohen Cancer Research Program	Campbell Foundation; Lehman Brother Foundation; Dorothy Rodbell Cohen Cancer Research Program	This work was supported by grants from the Campbell Foundation, Lehman Brother Foundation, and Dorothy Rodbell Cohen Cancer Research Program (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos SM, 2011, CANCER IMMUNOL IMMUN, V60, P671, DOI 10.1007/s00262-011-0984-8; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bowick GC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956823; Chang TLY, 2003, J VIROL, V77, P6777, DOI 10.1128/JVI.77.12.6777-6784.2003; CORDERO OJ, 1992, BIOCHEM INT, V28, P1117; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; ESCHENFELDT WH, 1986, P NATL ACAD SCI USA, V83, P9403, DOI 10.1073/pnas.83.24.9403; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Nunez NG, 2012, CANCER RES, V72, P592, DOI 10.1158/0008-5472.CAN-11-0534; GOODALL GJ, 1986, P NATL ACAD SCI USA, V83, P8926, DOI 10.1073/pnas.83.23.8926; Halder SK, 2012, J NEUROCHEM, V123, P262, DOI 10.1111/j.1471-4159.2012.07897.x; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1008, DOI 10.1073/pnas.81.4.1008; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Ioannou K, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-43; Karachaliou CE, 2015, INT J PHARMACEUT, V486, P1, DOI 10.1016/j.ijpharm.2015.03.031; Kusmartsev S, 2006, CANCER METAST REV, V25, P323, DOI 10.1007/s10555-006-9002-6; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; MANROW RE, 1993, J MOL BIOL, V234, P281, DOI 10.1006/jmbi.1993.1583; MANROW RE, 1992, GENOMICS, V13, P319, DOI 10.1016/0888-7543(92)90248-Q; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Mosoian A, 2006, J VIROL, V80, P9200, DOI 10.1128/JVI.00589-06; Mosoian A, 2011, FUTURE MED CHEM, V3, P1199, DOI [10.4155/fmc.11.72, 10.4155/FMC.11.72]; Mosoian A, 2010, P NATL ACAD SCI USA, V107, P10178, DOI 10.1073/pnas.0914870107; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Omotuyi O, 2015, EXPERT OPIN BIOL TH, V15, pS223, DOI 10.1517/14712598.2015.1005597; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Romani L, 2004, BLOOD, V103, P4232, DOI 10.1182/blood-2003-11-4036; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rubtsov Iu P, 1995, Mol Biol (Mosk), V29, P1320; Rubtsov Y, 1996, FEBS LETT, V397, P215, DOI 10.1016/S0014-5793(96)01171-4; Rubtsov YP, 1997, FEBS LETT, V413, P135, DOI 10.1016/S0014-5793(97)00824-7; Salaun B, 2007, CLIN CANCER RES, V13, P4565, DOI 10.1158/1078-0432.CCR-07-0274; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Skopeliti M, 2007, PROTEOMICS, V7, P1814, DOI 10.1002/pmic.200600870; Song SX, 2009, VACCINE, V27, P1111, DOI 10.1016/j.vaccine.2008.11.095; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Teixeira A, 2014, J INFECT DIS, DOI [10.1093/infdis/jiu643PMID:25404520, DOI 10.1093/INFDIS/JIU643PMID:25404520]; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; Uversky VN, 2013, CURR PHARM DESIGN, V19, P4191, DOI 10.2174/1381612811319230005; Uversky VN, 1999, BIOCHEMISTRY-US, V38, P15009, DOI 10.1021/bi990752+; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Xie, 1998, Genome Inform Ser Workshop Genome Inform, V9, P193; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Yi SL, 2008, PROTEIN EXPRES PURIF, V57, P1, DOI 10.1016/j.pep.2007.09.005	54	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0156486	10.1371/journal.pone.0156486	http://dx.doi.org/10.1371/journal.pone.0156486			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310139	Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800006
J	Prins, MR; van der Wurff, P; Meijer, OG; Bruijn, SM; van Dieen, JH				Prins, Maarten R.; van der Wurff, Peter; Meijer, Onno G.; Bruijn, Sjoerd M.; van Dieen, Jaap H.			Mechanical Perturbations of the Walking Surface Reveal Unaltered Axial Trunk Stiffness in Chronic Low Back Pain Patients	PLOS ONE			English	Article							PELVIS-THORAX COORDINATION; TRANSVERSE PLANE; GAIT; ROTATIONS; PEOPLE; SPEED	Introduction Patients with chronic low back pain (CLBP) often demonstrate altered timing of thorax rotations in the transverse plane during gait. Increased axial trunk stiffness has been claimed to cause this movement pattern. Objectives The objective of this study was to assess whether axial trunk stiffness is increased in gait in CLBP patients. Methods 15 CLBP patients and 15 healthy controls walked on a treadmill that imposed rotational perturbations in the transverse plane. The effect of these perturbations on transverse pelvis, thorax and trunk (thorax relative to pelvis) rotations was evaluated in terms of residual rotations, i.e., the deviation of these movements from the unperturbed patterns. In view of the heterogeneity of the CLBP group, we additionally performed a subgroup comparison between seven patients and seven controls with maximal between-group contrast for timing of thorax rotations. Results Rotations of the walking surface had a clear effect on transverse pelvis, thorax and trunk rotations in all groups. No significant between-group differences on residual transverse pelvis, thorax and trunk rotations were observed. Conclusion Axial trunk stiffness in gait does not appear to be increased in CLBP. Altered timing of thorax rotations in CLBP does not seem to be a result of increased axial trunk stiffness.	[Prins, Maarten R.; van der Wurff, Peter] Mil Rehabil Ctr Aardenburg, Res & Dev, Doorn, Netherlands; [Prins, Maarten R.; Meijer, Onno G.; Bruijn, Sjoerd M.; van Dieen, Jaap H.] Vrije Univ Amsterdam, Fac Behav & Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Prins, Maarten R.; van der Wurff, Peter] HU Univ Appl Sci Utrecht, Dept Phys Therapy, Utrecht, Netherlands; [Meijer, Onno G.; Bruijn, Sjoerd M.] Fujian Med Univ, Orthopaed Biomech Lab, Quanzhou, Fujian, Peoples R China	Vrije Universiteit Amsterdam; Fujian Medical University	Prins, MR (corresponding author), Mil Rehabil Ctr Aardenburg, Res & Dev, Doorn, Netherlands.; Prins, MR (corresponding author), Vrije Univ Amsterdam, Fac Behav & Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.; Prins, MR (corresponding author), HU Univ Appl Sci Utrecht, Dept Phys Therapy, Utrecht, Netherlands.	MR.Prins@MRCDoorn.nl	Bruijn, S.M./AAE-7446-2019; van Dieen, Jaap/B-3937-2013; Prins, Maarten/E-7963-2018	Bruijn, S.M./0000-0003-0290-2131; van Dieen, Jaap/0000-0002-7719-5585; Prins, Maarten/0000-0003-3593-202X	Netherlands Organization for Scientific Research (NWO) [451-12-041]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Sjoerd M. Bruijn was supported by a grant from the Netherlands Organization for Scientific Research (NWO #451-12-041).	Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Brown SH, 2007, EXPLORING GEOMETRIC; Bruening DA, 2015, GAIT POSTURE, V41, P540, DOI 10.1016/j.gaitpost.2014.12.011; Bruijn SM, 2008, GAIT POSTURE, V27, P455, DOI 10.1016/j.gaitpost.2007.05.017; Freddolini M, 2014, J ELECTROMYOGR KINES, V24, P947, DOI 10.1016/j.jelekin.2014.09.009; Ghamkhar L, 2015, PM&R, V7, P519, DOI 10.1016/j.pmrj.2015.01.013; Huang YP, 2011, EUR SPINE J, V20, P491, DOI 10.1007/s00586-010-1639-8; Kubo M, 2006, J BIOMECH, V39, P750, DOI 10.1016/j.jbiomech.2004.12.024; Lamoth CJC, 2006, EUR SPINE J, V15, P23, DOI 10.1007/s00586-004-0825-y; Lamoth CJC, 2006, GAIT POSTURE, V23, P230, DOI 10.1016/j.gaitpost.2005.02.006; Lamoth CJC, 2002, GAIT POSTURE, V16, P101, DOI 10.1016/S0966-6362(01)00146-1; Lamoth CJC, 2002, SPINE, V27, pE92, DOI 10.1097/00007632-200202150-00016; Lamoth CJC, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-13; Lee PJ, 2006, J ELECTROMYOGR KINES, V16, P51, DOI 10.1016/j.jelekin.2005.06.006; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Seay JF, 2011, SPINE, V36, pE1070, DOI 10.1097/BRS.0b013e3182015f7c; Selles RW, 2001, CLIN BIOMECH, V16, P175, DOI 10.1016/S0268-0033(00)00080-2; van den Hoorn W, 2012, J BIOMECH, V45, P342, DOI 10.1016/j.jbiomech.2011.10.024; van der Hulst M, 2010, J ELECTROMYOGR KINES, V20, P31, DOI 10.1016/j.jelekin.2009.03.009; Weerdesteyn V, 2004, HUM MOVEMENT SCI, V23, P351, DOI 10.1016/j.humov.2004.08.011; Wu WH, 2014, HUM MOVEMENT SCI, V33, P194, DOI 10.1016/j.humov.2013.09.002; Wu WH, 2002, CLIN BIOMECH, V17, P678, DOI 10.1016/S0268-0033(02)00109-2	22	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157253	10.1371/journal.pone.0157253	http://dx.doi.org/10.1371/journal.pone.0157253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310528	Green Published, gold, Green Submitted			2022-12-27	WOS:000378029800048
J	Rossing, K; Bosselmann, HS; Gustafsson, F; Zhang, ZY; Gu, YM; Kuznetsova, T; Nkuipou-Kenfack, E; Mischak, H; Staessen, JA; Koeck, T; Schou, M				Rossing, Kasper; Bosselmann, Helle Skovmand; Gustafsson, Finn; Zhang, Zhen-Yu; Gu, Yu-Mei; Kuznetsova, Tatiana; Nkuipou-Kenfack, Esther; Mischak, Harald; Staessen, Jan A.; Koeck, Thomas; Schou, Morten			Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MASS-SPECTROMETRY; PROGNOSTIC-SIGNIFICANCE; CLINICAL PROTEOMICS; DIASTOLIC FUNCTION; BLOOD-PRESSURE; FOLLOW-UP; MS; OUTPATIENTS; DYSFUNCTION	Background Biomarker discovery and new insights into the pathophysiology of heart failure with reduced ejection fraction (HFrEF) may emerge from recent advances in high-throughput urinary proteomics. This could lead to improved diagnosis, risk stratification and management of HFrEF. Methods and Results Urine samples were analyzed by on-line capillary electrophoresis coupled to electrospray ionization micro time-of-flight mass spectrometry (CE-MS) to generate individual urinary proteome profiles. In an initial biomarker discovery cohort, analysis of urinary proteome profiles from 33 HFrEF patients and 29 age- and sex-matched individuals without HFrEF resulted in identification of 103 peptides that were significantly differentially excreted in HFrEF. These 103 peptides were used to establish the support vector machine-based HFrEF classifier HFrEF103. In a subsequent validation cohort, HFrEF103 very accurately (area under the curve, AUC = 0.972) discriminated between HFrEF patients (N = 94, sensitivity = 93.6%) and control individuals with and without impaired renal function and hypertension ( N = 552, specificity = 92.9%). Interestingly, HFrEF103 showed low sensitivity (12.6%) in individuals with diastolic left ventricular dysfunction (N = 176). The HFrEF-related peptide biomarkers mainly included fragments of fibrillar type I and III collagen but also, e.g., of fibrinogen beta and alpha-1-antitrypsin. Conclusion CE-MS based urine proteome analysis served as a sensitive tool to determine a vast array of HFrEF-related urinary peptide biomarkers which might help improving our understanding and diagnosis of heart failure.	[Rossing, Kasper; Gustafsson, Finn] Univ Copenhagen Hosp, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Bosselmann, Helle Skovmand] Univ Copenhagen, North Zealand Hosp, Dept Cardio Nephro & Endocrinol, Copenhagen, Denmark; [Zhang, Zhen-Yu; Gu, Yu-Mei; Kuznetsova, Tatiana; Staessen, Jan A.] Katholieke Univ Leuven, KU Leuven Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, Leuven, Belgium; [Nkuipou-Kenfack, Esther; Mischak, Harald; Koeck, Thomas] Mosa Diagnost & Therapeut AG, Hannover, Germany; [Mischak, Harald] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Schou, Morten] Herlev Hosp, Inst Clin Med, DK-2730 Herlev, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; KU Leuven; University of Glasgow; University of Copenhagen; Herlev & Gentofte Hospital	Rossing, K (corresponding author), Univ Copenhagen Hosp, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark.	kasper.rossing@regionh.dk	Staessen, Jan A/A-1065-2011; Kuznetsova, Tatiana/ABI-5662-2020; Zhang, Zhenyu/GZL-8479-2022	Staessen, Jan A/0000-0002-3026-1637; Kuznetsova, Tatiana/0000-0003-4293-4576; Zhang, Zhenyu/0000-0002-3785-7417; Mischak, Harald/0000-0003-0323-0306; Gustafsson, Finn/0000-0003-2144-341X	European Union grant EU-MASCARA [HEALTH-2011.2.4.2-2]; Muremester Laurits P Christensens Fund; Kaptajnlojtnant Harald Jensen og Hustrus Fund; Mosaiques Diagnostics GmbH; European Union grant HOMAGE [HEALTH-F7-305507 HOMAGE]	European Union grant EU-MASCARA; Muremester Laurits P Christensens Fund; Kaptajnlojtnant Harald Jensen og Hustrus Fund; Mosaiques Diagnostics GmbH; European Union grant HOMAGE	The funding organization (European Union; grants EU-MASCARA [HEALTH-2011.2.4.2-2] and HOMAGE [HEALTH-F7- 305507 HOMAGE] as well as the Muremester Laurits P Christensens Fund and the Kaptajnlojtnant Harald Jensen og Hustrus Fund had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support. Harald Mischak, Thomas Koeck and Esther Nkuipou-Kenfack were employed by and received salary from Mosaiques Diagnostics GmbH. Being employed by Mosaiques Diagnostics GmbH did not influence study design, decision to publish or preparation of the manuscript. Urinary proteomic data collection and analysis was performed at Mosaiques Diagnostics GmbH following established standard operating procedures.; The project was partly funded by the European Union grants EU-MASCARA (HEALTH-2011.2.4.2-2) and HOMAGE (HEALTH-F7-305507 HOMAGE) as well as the Murermester Laurits P Christensens Fund and the Kaptajnlojtnant Harald Jensen og Hustrus Fund. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barasch E, 2011, CIRC-HEART FAIL, V4, P733, DOI 10.1161/CIRCHEARTFAILURE.111.962027; Barasch E, 2009, CIRC-HEART FAIL, V2, P303, DOI 10.1161/CIRCHEARTFAILURE.108.828343; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosselmann H, 2014, INT J CARDIOL, V177, P942, DOI 10.1016/j.ijcard.2014.09.202; Bosselmann H, 2013, INT J CARDIOL, V170, P202, DOI 10.1016/j.ijcard.2013.10.064; Braam B, 2014, NAT REV NEPHROL, V10, P48, DOI 10.1038/nrneph.2013.250; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; BRILLA CG, 1995, AM J CARDIOL, V76, pD8, DOI 10.1016/S0002-9149(99)80485-8; Brouwers FP, 2013, EUR HEART J, V34, P1424, DOI 10.1093/eurheartj/eht066; Coon JJ, 2008, PROTEOM CLIN APPL, V2, P964, DOI 10.1002/prca.200800024; Dakna M, 2009, J CHROMATOGR B, V877, P1250, DOI 10.1016/j.jchromb.2008.10.048; Decramer S, 2006, NAT MED, V12, P398, DOI 10.1038/nm1384; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Felker GM, 2002, J AM COLL CARDIOL, V39, P210, DOI 10.1016/S0735-1097(01)01738-7; Girolami Mark, 2006, Drug Discov Today Technol, V3, P13, DOI 10.1016/j.ddtec.2006.03.010; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Kuznetsova T, 2002, BLOOD PRESS MONIT, V7, P215, DOI 10.1097/00126097-200208000-00003; Kuznetsova T, 2012, EUR HEART J, V33, P2342, DOI 10.1093/eurheartj/ehs185; Lemesle G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119265; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lofsjogard J, 2014, J CARDIOVASC MED, V15, P463, DOI 10.2459/01.JCM.0000435617.86180.0b; Lubrano V, 2017, J CARDIOVASC MED, V18, P774, DOI 10.2459/JCM.0000000000000016; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mentz RJ, 2014, J AM COLL CARDIOL, V64, P2281, DOI 10.1016/j.jacc.2014.08.036; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Passino C, 2015, CLIN CHIM ACTA, V443, P29, DOI 10.1016/j.cca.2014.09.006; Pejchinovski M, 2015, PROTEOM CLIN APPL, V9, P453, DOI 10.1002/prca.201400113; Pouleur AC, 2015, CLIN CHIM ACTA, V443, P9, DOI 10.1016/j.cca.2014.10.046; R Core Team, 2018, R LANG ENV STAT COMP; Rossing K, 2008, J AM SOC NEPHROL, V19, P1283, DOI 10.1681/ASN.2007091025; STAESSEN J, 1985, J CHRON DIS, V38, P397, DOI 10.1016/0021-9681(85)90135-3; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Theodorescu D, 2005, ELECTROPHORESIS, V26, P2797, DOI 10.1002/elps.200400208; Toprak G, 2013, EUR REV MED PHARMACO, V17, P2302; Valente MAE, 2014, EUR HEART J, V35, P1284, DOI 10.1093/eurheartj/ehu065; Weber KT, 1997, CIRCULATION, V96, P4065; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4; Wittke S, 2005, ELECTROPHORESIS, V26, P1476, DOI 10.1002/elps.200410140; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328; Zhang ZY, 2014, INT J CARDIOL, V176, P158, DOI 10.1016/j.ijcard.2014.07.014	43	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157167	10.1371/journal.pone.0157167	http://dx.doi.org/10.1371/journal.pone.0157167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27308822	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000378029800039
J	Tashiro, H; Takahashi, K; Hayashi, S; Kato, G; Kurata, K; Kimura, S; Sueoka-Aragane, N				Tashiro, Hiroki; Takahashi, Koichiro; Hayashi, Shinichiro; Kato, Go; Kurata, Keigo; Kimura, Shinya; Sueoka-Aragane, Naoko			Interleukin-33 from Monocytes Recruited to the Lung Contributes to House Dust Mite-Induced Airway Inflammation in a Mouse Model	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; DENDRITIC CELLS; LYMPHOID-CELLS; SEVERE ASTHMA; IL-33; CYTOKINES; IMMUNITY; DISEASE; HETEROGENEITY; PHAGOCYTOSIS	Background Interleukin-33 (IL-33) activates group 2 innate lymphoid cells (ILC2), resulting in T-helper-2 inflammation in bronchial asthma. Airway epithelial cells were reported as sources of IL-33 during apoptosis and necrosis. However, IL-33 is known to be from sources other than airway epithelial cells such as leukocytes, and the mechanisms of IL-33 production and release are not fully understood. The aim of this study was to clarify the role of IL-33 production by monocytes in airway inflammation. Methods BALB/c mice were sensitized and challenged with a house dust mite (HDM) preparation. Airway inflammation was assessed by quantifying inflammatory cells in bronchoalveolar lavage (BAL) fluid, and IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) levels in lung. Immunohistochemistry for IL-33 in lung sections was also performed. Ly6c, CD11b, and CD11c expression was examined by flow cytometry. Clodronate liposomes were used in the HDM-airway inflammation model to deplete circulating monocytes. Results The IL-33, but not IL-25 or TSLP, level in lung homogenates was markedly increased in HDM mice compared to control mice. IL-33-positive cells in the lungs were identified using immunohistochemistry and were increased in areas surrounding bronchi and vasculature. Furthermore, IL- 33 levels were increased in mononuclear cells derived from lungs of HDM mice compared to controls. The expression of Ly6c in mononuclear cells was significantly higher in HDM mice than in controls. Treatment with clodronate liposomes led to inhibition of not only inflammatory cells in BAL fluid, airway hyper reactivity and Th2 cytokines in lung, but also IL-33 in lung. Conclusion IL-33 from monocytes recruited to the lung may contribute to the pathogenesis of HDM-induced airway inflammation.	[Tashiro, Hiroki; Takahashi, Koichiro; Hayashi, Shinichiro; Kato, Go; Kimura, Shinya; Sueoka-Aragane, Naoko] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 840, Japan; [Kurata, Keigo] Inst Tokyo Environm Allergy, Tokyo, Japan	Saga University	Takahashi, K (corresponding author), Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 840, Japan.	takahak@cc.saga-u.ac.jp						Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chen LL, 2013, AM J PHYSIOL-LUNG C, V305, pL702, DOI 10.1152/ajplung.00194.2013; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guo Z, 2014, J ASTHMA, V51, P863, DOI 10.3109/02770903.2014.921196; Hsu CL, 2012, J IMMUNOL, V189, P3421, DOI 10.4049/jimmunol.1201224; Huynh MLN, 2005, AM J RESP CRIT CARE, V172, P972, DOI 10.1164/rccm.200501-035OC; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Kato G, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0039-y; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Li JJ, 2010, J IMMUNOL, V185, P4401, DOI 10.4049/jimmunol.1001039; Llop-Guevara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088714; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Martinez-Martinez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079176; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Pappas K, 2013, CYTOKINE, V64, P613, DOI 10.1016/j.cyto.2013.09.010; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Saglani S, 2013, J ALLERGY CLIN IMMUN, V132, P676, DOI 10.1016/j.jaci.2013.04.012; Sasaki O, 2013, J IMMUNOL, V191, P2879, DOI 10.4049/jimmunol.1300460; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Takahashi K, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-33; Tattersfield AE, 2002, LANCET, V360, P1313, DOI 10.1016/S0140-6736(02)11312-2; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yanagawa Y, 2011, BRAIN BEHAV IMMUN, V25, P1427, DOI 10.1016/j.bbi.2011.04.012; Yang M, 2012, J LEUKOCYTE BIOL, V91, P557, DOI 10.1189/jlb.0711357; Zaslona Z, 2014, J IMMUNOL, V193, P4245, DOI 10.4049/jimmunol.1400580	44	28	29	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157571	10.1371/journal.pone.0157571	http://dx.doi.org/10.1371/journal.pone.0157571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27310495	Green Submitted, Green Published, gold			2022-12-27	WOS:000378029800100
J	Gentile, AM; Lhamyani, S; Coin-Araguez, L; Oliva-Olivera, W; Zayed, H; Vega-Rioja, A; Monteseirin, J; Romero-Zerbo, SY; Tinahones, FJ; Bermudez-Silva, FJ; El Bekay, R				Gentile, Adriana-Mariel; Lhamyani, Said; Coin-Araguez, Leticia; Oliva-Olivera, Wilfredo; Zayed, Hatem; Vega-Rioja, Antonio; Monteseirin, Javier; Romero-Zerbo, Silvana-Yanina; Tinahones, Francisco-Jose; Bermudez-Silva, Francisco-Javier; El Bekay, Rajaa			RPL13A and EEF1A1 Are Suitable Reference Genes for qPCR during Adipocyte Differentiation of Vascular Stromal Cells from Patients with Different BMI and HOMA-IR	PLOS ONE			English	Article							REAL-TIME PCR; HUMAN ADIPOSE-TISSUE; INSULIN-RESISTANCE; STEM-CELLS; HOUSEKEEPING GENES; DATA NORMALIZATION; METABOLIC SYNDROME; LINKING OBESITY; QUANTIFICATION; INFLAMMATION	Real-time or quantitative PCR (qPCR) is a useful technique that requires reliable reference genes for data normalization in gene expression analysis. Adipogenesis is among the biological processes suitable for this technique. The selection of adequate reference genes is essential for qPCR gene expression analysis of human Vascular Stromal Cells (hVSCs) during their differentiation into adipocytes. To the best of our knowledge, there are no studies validating reference genes for the analyses of visceral and subcutaneous adipose tissue hVSCs from subjects with different Body Mass Index (BMI) and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) index. The present study was undertaken to analyze this question. We first analyzed the stability of expression of five potential reference genes: CYC, GAPDH, RPL13A, EEF1A1, and 18S ribosomal RNA, during in vitro adipogenic differentiation, in samples from these types of patients. The expression of RPL13A and EEF1A1 was not affected by differentiation, thus being these genes the most stable candidates, while CYC, GAPDH, and 18S were not suitable for this sort of analysis. This work highlights that RPL13A and EEF1A1 are good candidates as reference genes for qPCR analysis of hVSCs differentiation into adipocytes from subjects with different BMI and HOMA-IR.	[Gentile, Adriana-Mariel; Lhamyani, Said] Univ Malaga, IBIMA, Campus Teatinos S-N, Malaga 29010, Spain; [Coin-Araguez, Leticia; Oliva-Olivera, Wilfredo; Tinahones, Francisco-Jose; El Bekay, Rajaa] Carlos III Hlth Inst, CIBER Pathophysiol Obes & Nutr CB06 03, Malaga 29010, Spain; [Coin-Araguez, Leticia; Oliva-Olivera, Wilfredo; Tinahones, Francisco-Jose; El Bekay, Rajaa] Virgen de la Victoria Clin Univ Hosp, Biomed Res Lab, Malaga 29010, Spain; [Zayed, Hatem] Qatar Univ, Program Biomed Sci, Dept Hlth Sci, Coll Arts & Sci, POB 2713, Doha, Qatar; [Vega-Rioja, Antonio; Monteseirin, Javier] Hosp Univ Virgen Macarena, Unidad Gest Clin Alergia Interctr, Seville, Spain; [Romero-Zerbo, Silvana-Yanina; Bermudez-Silva, Francisco-Javier] Univ Malaga, Unidad Gest Clin Interctr Endocrinol & Nutr, Inst Invest Biomed Malaga IBIMA, Hosp Reg Univ Malaga, Malaga 29009, Spain; [Romero-Zerbo, Silvana-Yanina; Bermudez-Silva, Francisco-Javier] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Malaga, Spain; [Tinahones, Francisco-Jose] Virgen de la Victoria Clin Univ Hosp, Serv Endocrinol, Malaga 29010, Spain	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Qatar University; Hospital Universitario Virgen Macarena; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	El Bekay, R (corresponding author), Carlos III Hlth Inst, CIBER Pathophysiol Obes & Nutr CB06 03, Malaga 29010, Spain.; El Bekay, R (corresponding author), Virgen de la Victoria Clin Univ Hosp, Biomed Res Lab, Malaga 29010, Spain.; Vega-Rioja, A (corresponding author), Hosp Univ Virgen Macarena, Unidad Gest Clin Alergia Interctr, Seville, Spain.; Bermudez-Silva, FJ (corresponding author), Univ Malaga, Unidad Gest Clin Interctr Endocrinol & Nutr, Inst Invest Biomed Malaga IBIMA, Hosp Reg Univ Malaga, Malaga 29009, Spain.; Bermudez-Silva, FJ (corresponding author), Ctr Invest Biomed Red Diabet & Enfermedades Metab, Malaga, Spain.	macrofago@us.es; javier.bermudez@ibima.eu; elbekay@gmail.com	Bekay, Rajaa El/AAZ-3959-2020; Zayed, Hatem/R-1800-2019; GENTILE, Adriana Mariel/AAB-3350-2020; Bermudez-Silva, Francisco-Javier/Q-6920-2016; LHAMYANI, said/AAQ-1973-2020; Tinahones, Francisco José/AAB-2882-2020; El Bekay, RAJAA/AGN-6069-2022	Zayed, Hatem/0000-0001-8838-6638; GENTILE, Adriana Mariel/0000-0002-2296-9117; Bermudez-Silva, Francisco-Javier/0000-0003-3133-9691; LHAMYANI, said/0000-0002-9830-9772; El Bekay, RAJAA/0000-0003-3332-3431; Oliva Olivera, Wilfredo/0000-0003-3473-7898; Romero-Zerbo, Silvana-Yanina/0000-0002-6737-992X; Vega Rioja, Antonio/0000-0003-4698-9697; Tinahones, Francisco J/0000-0001-6871-4403	Instituto de Salud Carlos III [PI10/01947, PI13/02628, CPII13/00041]; Fondos FEDER; Consejeria de Economia e Innovacion, Ciencia y Empleo, Junta de Andalucia [CTS-7895]; "Miguel Servet II" research contract [CPII13/00042]; Consejeria de Salud [C-0070-2012]; FIS-Thematic Networks and Co-Operative Research Centres RIRAAF [RD07-0064]; Consejeria de Salud de la Junta de Andalucia [RH-0070-2013]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondos FEDER(European Commission); Consejeria de Economia e Innovacion, Ciencia y Empleo, Junta de Andalucia(Junta de Andalucia); "Miguel Servet II" research contract; Consejeria de Salud; FIS-Thematic Networks and Co-Operative Research Centres RIRAAF; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia)	This work was supported by grants from the Instituto de Salud Carlos III (PI10/01947, PI13/02628) with Fondos FEDER and the Consejeria de Economia e Innovacion, Ciencia y Empleo, Junta de Andalucia (CTS-7895) with Fondos FEDER. R. El Bekay is under a contract Miguel Servet type II (CPII13/00041) from the Instituto de Salud Carlos III. F-JB-S is a recipient of a "Miguel Servet II" research contract (CPII13/00042) and also belongs to the regional "Nicolas Monardes" research program of the Consejeria de Salud (C-0070-2012; Junta de Andalucia, Spain). This work was supported by the FIS-Thematic Networks and Co-Operative Research Centres RIRAAF (RD07-0064). JM is under the Programa de Intensificacion de la Actividad Investigadora del Sistema Nacional de Salud. AV-R is under a contract Proyectos de I+D+i para jovenes investigadores from the Ministerio de Economia y Competitividad (SAF2014-60649-JIN). S-YR-Z is recipient of a post-doctoral contract from Consejeria de Salud de la Junta de Andalucia (RH-0070-2013).	Amable PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073792; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Chechi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032265; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Farrokhi A, 2012, CELL MOL BIOL, V58, P1660, DOI 10.1170/193; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fu LY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-49; Quiroz FG, 2010, CYTOTECHNOLOGY, V62, P109, DOI 10.1007/s10616-010-9265-1; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Kollmer Melanie, 2013, J Dev Biol Tissue Eng, V5, P18; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Roca-Rodriguez MM, 2015, J CLIN ENDOCR METAB, V100, pE826, DOI 10.1210/jc.2014-4132; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; Oliva-Olivera W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144401; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Seo KW, 2013, CELL TRANSPLANT, V22, P29, DOI 10.3727/096368912X654948; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Studer D, 2012, TISSUE ENG PART C-ME, V18, P761, DOI 10.1089/ten.tec.2012.0081; Tratwal J, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-11; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Xie F., 2012, PLANT MOL BIOL; Yin RF, 2011, BIOCHEM BIOPH RES CO, V413, P537, DOI 10.1016/j.bbrc.2011.08.131; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	35	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2016	11	6							e0157002	10.1371/journal.pone.0157002	http://dx.doi.org/10.1371/journal.pone.0157002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5LO	27304673	Green Published, Green Submitted, gold			2022-12-27	WOS:000377824800034
J	Soto, C; Ofek, G; Joyce, MG; Zhang, BS; Mckee, K; Longo, NS; Yang, YP; Huang, JH; Parks, R; Eudailey, J; Lloyd, KE; Alam, SM; Haynes, BF; Mullikin, JC; Connors, M; Mascola, JR; Shapiro, L; Kwong, PD				Soto, Cinque; Ofek, Gilad; Joyce, M. Gordon; Zhang, Baoshan; Mckee, Krisha; Longo, Nancy S.; Yang, Yongping; Huang, Jinghe; Parks, Robert; Eudailey, Joshua; Lloyd, Krissey E.; Alam, S. Munir; Haynes, Barton F.; Mullikin, James C.; Connors, Mark; Mascola, John R.; Shapiro, Lawrence; Kwong, Peter D.		NISC Comparative Sequencing	Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8	PLOS ONE			English	Article							POTENT NEUTRALIZATION; HIV-1 NEUTRALIZATION; IMMUNOGEN DESIGN; STRUCTURAL BASIS; EPITOPE; BROAD; GP41; AUTOREACTIVITY; MATURATION; GERMLINE	Antibody 10E8 targets the membrane-proximal external region (MPER) of HIV-1 gp41, neutralizes >97% of HIV-1 isolates, and lacks the auto-reactivity often associated with MPER-directed antibodies. The developmental pathway of 10E8 might therefore serve as a promising template for vaccine design, but samples from time-of-infection-often used to infer the B cell record-are unavailable. In this study, we used crystallography, next-generation sequencing (NGS), and functional assessments to infer the 10E8 developmental pathway from a single time point. Mutational analysis indicated somatic hypermutation of the 2nd-heavy chain-complementarity determining region (CDR H2) to be critical for neutralization, and structures of 10E8 variants with V-gene regions reverted to genomic origin for heavy- nd-light chains or heavy chain-only showed structural differences > 2 angstrom relative to mature 10E8 in the CDR H2 and H3. To understand these developmental changes, we used bioinformatic sieving, maximum likelihood, and parsimony analyses of immunoglobulin transcripts to identify 10E8-lineage members, to infer the 10E8-unmutated common ancestor (UCA), and to calculate 10E8-developmental intermediates. We were assisted in this analysis by the preservation of a critical D-gene segment, which was unmutated in most 10E8-lineage sequences. UCA and early intermediates weakly bound a 26-residue-MPER peptide, whereas HIV-1 neutralization and epitope recognition in liposomes were only observed with late intermediates. Antibody 10E8 thus develops from a UCA with weak MPER affinity and substantial differences in CDR H2 and H3 from the mature 10E8; only after extensive somatic hypermutation do 10E8-lineage members gain recognition in the context of membrane and HIV-1 neutralization.	[Soto, Cinque; Ofek, Gilad; Joyce, M. Gordon; Zhang, Baoshan; Mckee, Krisha; Longo, Nancy S.; Yang, Yongping; Mascola, John R.; Shapiro, Lawrence; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Huang, Jinghe; Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Parks, Robert; Eudailey, Joshua; Lloyd, Krissey E.; Alam, S. Munir; Haynes, Barton F.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Mullikin, James C.; NISC Comparative Sequencing] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Columbia University	Mascola, JR; Shapiro, L; Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Shapiro, L (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA.	jmascola@nih.gov; shapiro@convex.hhmi.columbia.edu; pdkwong@nih.gov	Alam, S. Munir/AAC-6711-2019; Mascola, John/AAI-7193-2021; Shapiro, Lawrence/AAE-7172-2019; Huang, Jinghe/P-8068-2019	Huang, Jinghe/0000-0002-1968-871X	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Human Genome Research Institute, National Institutes of Health; Center for HIV/AIDS Vaccine Immunology-Immunogen Design grant from the Division of AIDS National Institutes of Infectious Disease, NIH [UM1 AI100645]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090, ZIAAI005022, ZICAI005111, UM1AI100645] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Center for HIV/AIDS Vaccine Immunology-Immunogen Design grant from the Division of AIDS National Institutes of Infectious Disease, NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases and the National Human Genome Research Institute, National Institutes of Health, and by the Center for HIV/AIDS Vaccine Immunology-Immunogen Design grant UM1 AI100645 to BFH from the Division of AIDS National Institutes of Infectious Disease, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aouinti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142353; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kabat EA, 1991, SEQUENCES PROTEINS I; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2007, ARCH VIROL, V152, P1799, DOI 10.1007/s00705-007-1019-9; Majeed S, 2003, STRUCTURE, V11, P1061, DOI 10.1016/S0969-2126(03)00185-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2014, J VIROL, V88, P2426, DOI 10.1128/JVI.02837-13; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	38	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157409	10.1371/journal.pone.0157409	http://dx.doi.org/10.1371/journal.pone.0157409			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299673	Green Submitted, Green Published, gold			2022-12-27	WOS:000377822200046
J	Zainabadi, K				Zainabadi, Kayvan			Malaria Parasite CLAG3, a Protein Linked to Nutrient Channels, Participates in High Molecular Weight Membrane-Associated Complexes in the Infected Erythrocyte	PLOS ONE			English	Article							SURFACE ANION CHANNEL; RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; PERMEATION PATHWAYS; MULTIGENE FAMILY; PERMEABILITY; RESISTANCE; INVASION; REVEALS	Malaria infected erythrocytes show increased permeability to a number of solutes important for parasite growth as mediated by the Plasmodial Surface Anion Channel (PSAC). The P. falciparum clag3 genes have recently been identified as key determinants of PSAC, though exactly how they contribute to channel function and whether additional host/ parasite proteins are required remain unknown. To begin to answer these questions, I have taken a biochemical approach. Here I have used an epitope-tagged CLAG3 parasite to perform coimmunoprecipitation experiments using membrane fractions of infected erythrocytes. Native PAGE and mass spectrometry studies reveal that CLAG3 participate in at least three different high molecular weight complexes: a similar to 720kDa complex consisting of CLAG3, RHOPH2 and RHOPH3; a similar to 620kDa complex consisting of CLAG3 and RHOPH2; and a similar to 480kDa complex composed solely of CLAG3. Importantly, these complexes can be found throughout the parasite lifecycle but are absent in untransfected controls. Extracellular biotin labeling and protease susceptibility studies localize the 480kDa complex to the erythrocyte membrane. This complex, likely composed of a homo-oligomer of 160kDa CLAG3, may represent a functional subunit, possibly the pore, of PSAC.	[Zainabadi, Kayvan] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Zainabadi, Kayvan] Univ Maryland, Sch Med, Inst Global Hlth, Div Malaria Res, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore	Zainabadi, K (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.; Zainabadi, K (corresponding author), Univ Maryland, Sch Med, Inst Global Hlth, Div Malaria Res, Baltimore, MD 21201 USA.	kzainabadi@medicine.umaryland.edu			Malaria Infection Biology Research Fellowship (NIAID); Intramural Research Program of NIAID, National Institutes of Health	Malaria Infection Biology Research Fellowship (NIAID); Intramural Research Program of NIAID, National Institutes of Health	This research was supported by a Malaria Infection Biology Research Fellowship (NIAID) and by the Intramural Research Program of NIAID, National Institutes of Health.; I would like to thank Susan Pierce for her encouragement, Louis Miller and Tom Wellems for their support and critical reading of the manuscript, Sanjay Desai for helpful discussions and feedback on experiments, and the Research Technologies Branch of the National Institutes of Allergy and Infectious Diseases (NIAD), particularly Renee Olano, for their help with mass spectrometry experiments. This research was supported by a Malaria Infection Biology Research Fellowship (NIAID) and by the Intramural Research Program of NIAID, National Institutes of Health.	Alkhalil A, 2004, BLOOD, V104, P4279, DOI 10.1182/blood-2004-05-2047; Alkhalil A, 2012, BBA-BIOMEMBRANES, V1818, P367, DOI 10.1016/j.bbamem.2011.11.010; Baumeister S, 2003, MOL BIOCHEM PARASIT, V132, P35, DOI 10.1016/j.molbiopara.2003.08.003; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Cohn JV, 2003, MOL BIOCHEM PARASIT, V132, P27, DOI 10.1016/j.molbiopara.2003.08.001; Comeaux CA, 2011, MOL MICROBIOL, V80, P378, DOI 10.1111/j.1365-2958.2011.07572.x; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crichton PG, 2013, J BIOL CHEM, V288, P22163, DOI 10.1074/jbc.M113.484329; Decherf G, 2004, BLOOD CELL MOL DIS, V32, P366, DOI 10.1016/j.bcmd.2004.01.008; Desai SA, 2000, NATURE, V406, P1001, DOI 10.1038/35023000; Desai SA, 2012, CELL MICROBIOL, V14, P1003, DOI 10.1111/j.1462-5822.2012.01790.x; GINSBURG H, 1986, BIOCHIM BIOPHYS ACTA, V861, P194, DOI 10.1016/0005-2736(86)90418-9; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Gupta A, 2015, DRUG RESIST UPDATE, V18, P47, DOI 10.1016/j.drup.2014.10.004; Heinz C, 2003, J BIOL CHEM, V278, P8678, DOI 10.1074/jbc.M212280200; HOMEWOOD CA, 1974, NATURE, V252, P718, DOI 10.1038/252718a0; Huber SM, 2004, J BIOL CHEM, V279, P41444, DOI 10.1074/jbc.M407618200; Kaneko O, 2005, MOL BIOCHEM PARASIT, V143, P20, DOI 10.1016/j.molbiopara.2005.05.003; Kaneko O, 2001, MOL BIOCHEM PARASIT, V118, P223, DOI 10.1016/S0166-6851(01)00391-7; Mira-Martinez S, 2013, CELL MICROBIOL, V15, P1913, DOI 10.1111/cmi.12162; Nguitragool W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093759; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224; Reisinger V, 2008, J PROTEOMICS, V71, P277, DOI 10.1016/j.jprot.2008.05.004; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Sharma P, 2015, INFECT IMMUN, V83, P2566, DOI 10.1128/IAI.02966-14; Sharma P, 2013, J BIOL CHEM, V288, P19429, DOI 10.1074/jbc.M113.468371; Staines HM, 2007, INT J PARASITOL, V37, P475, DOI 10.1016/j.ijpara.2006.12.013; Staines HM, 2000, BBA-BIOMEMBRANES, V1463, P88, DOI 10.1016/S0005-2736(99)00187-X; Thevenin D, 2008, PROTEIN SCI, V17, P1188, DOI 10.1110/ps.034843.108; Verloo P, 2004, J BIOL CHEM, V279, P10316, DOI 10.1074/jbc.M311540200; Vincensini L, 2008, MOL BIOCHEM PARASIT, V160, P81, DOI 10.1016/j.molbiopara.2008.04.002	35	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2016	11	6							e0157390	10.1371/journal.pone.0157390	http://dx.doi.org/10.1371/journal.pone.0157390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KO	27299521	Green Submitted, Green Published, gold			2022-12-27	WOS:000377822200045
J	Leithner, K; Hirschmugl, B; Li, YJ; Tang, B; Papp, R; Nagaraj, C; Stacher, E; Stiegler, P; Lindenmann, J; Olschewski, A; Olschewski, H; Hrzenjak, A				Leithner, Katharina; Hirschmugl, Birgit; Li, Yingji; Tang, Bi; Papp, Rita; Nagaraj, Chandran; Stacher, Elvira; Stiegler, Philipp; Lindenmann, Joerg; Olschewski, Andrea; Olschewski, Horst; Hrzenjak, Andelko			TASK-1 Regulates Apoptosis and Proliferation in a Subset of Non-Small Cell Lung Cancers	PLOS ONE			English	Article							DEPENDENT MULTIVITAMIN TRANSPORTER; POTASSIUM CHANNELS; K+ CHANNELS; FUNCTIONAL EXPRESSION; EPITHELIAL-CELLS; GENE-EXPRESSION; N2A CELLS; KCNK9; HYPOXIA; CULTURE	Lung cancer is the leading cause of cancer deaths worldwide; survival times are poor despite therapy. The role of the two-pore domain K+ (K2P) channel TASK-1 (KCNK3) in lung cancer is at present unknown. We found that TASK-1 is expressed in non-small cell lung cancer (NSCLC) cell lines at variable levels. In a highly TASK-1 expressing NSCLC cell line, A549, a characteristic pH-and hypoxia-sensitive non-inactivating K+ current was measured, indicating the presence of functional TASK-1 channels. Inhibition of TASK-1 led to significant depolarization in these cells. Knockdown of TASK-1 by siRNA significantly enhanced apoptosis and reduced proliferation in A549 cells, but not in weakly TASK-1 expressing NCI-H358 cells. Na+ -coupled nutrient transport across the cell membrane is functionally coupled to the efflux of K+ via K+ channels, thus TASK-1 may potentially influence Na+-coupled nutrient transport. In contrast to TASK-1, which was not differentially expressed in lung cancer vs. normal lung tissue, we found the Na+-coupled nutrient transporters, SLC5A3, SLC5A6, and SLC38A1, transporters for myo-inositol, biotin and glutamine, respectively, to be significantly overexpressed in lung adenocarcinomas. In summary, we show for the first time that the TASK-1 channel regulates apoptosis and proliferation in a subset of NSCLC.	[Leithner, Katharina; Li, Yingji; Tang, Bi; Olschewski, Horst; Hrzenjak, Andelko] Med Univ Graz, Dept Internal Med, Div Pulmonol, Graz, Austria; [Hirschmugl, Birgit] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Papp, Rita; Nagaraj, Chandran; Olschewski, Andrea; Hrzenjak, Andelko] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria; [Nagaraj, Chandran] Med Univ Graz, Univ Clin Anesthesiol & Intens Care Med, Expt Anesthesiol, Graz, Austria; [Stacher, Elvira] Med Univ Graz, Inst Pathol, Graz, Austria; [Stiegler, Philipp] Med Univ Graz, Dept Surg, Div Transplant Surg, Graz, Austria; [Lindenmann, Joerg] Med Univ Graz, Dept Surg, Div Thorac & Hyperbar Surg, Graz, Austria; [Olschewski, Andrea] Med Univ Graz, Inst Physiol, Graz, Austria	Medical University of Graz; Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Hrzenjak, A (corresponding author), Med Univ Graz, Dept Internal Med, Div Pulmonol, Graz, Austria.; Hrzenjak, A (corresponding author), Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria.	andelko.hrzenjak@medunigraz.at	Chandran, Nagaraj/AAP-2007-2020; Olschewski, Horst/L-3547-2019; Leithner, Katharina, MD, PhD/E-7662-2011	Chandran, Nagaraj/0000-0003-3825-8587; Olschewski, Horst/0000-0002-2834-7466; Leithner, Katharina, MD, PhD/0000-0002-8252-9279; Olschewski, Andrea/0000-0002-8189-3634; Stiegler, Philipp/0000-0002-0952-3030	Oesterreichische Nationalbank (Anniversary Fund) [12713]	Oesterreichische Nationalbank (Anniversary Fund)	The study was supported by funds of the Oesterreichische Nationalbank (Anniversary Fund, project number 12713 to HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005025; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Bittner S, 2012, EXP NEUROL, V238, P149, DOI 10.1016/j.expneurol.2012.08.021; Bittner S, 2009, BRAIN, V132, P2501, DOI 10.1093/brain/awp163; Brenner T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1480, DOI 10.1152/ajpendo.90652.2008; Burg ED, 2008, BRIT J PHARMACOL, V153, pS99, DOI 10.1038/sj.bjp.0707635; Chen LH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010043; Czirjak G, 2003, MOL PHARMACOL, V63, P646, DOI 10.1124/mol.63.3.646; Deranieh RM, 2009, BIOCHEM SOC T, V37, P1099, DOI 10.1042/BST0371099; Durlacher CT, 2015, CLIN EXP PHARMACOL P, V42, P427, DOI 10.1111/1440-1681.12385; Ernest NJ, 2010, J MEMBRANE BIOL, V237, P59, DOI 10.1007/s00232-010-9306-x; Garnett JP, 2012, EUR RESPIR J, V40, P1269, DOI 10.1183/09031936.00052612; Hamilton KL, 2012, AM J PHYSIOL-RENAL, V302, pF1069, DOI 10.1152/ajprenal.00646.2011; Hao XR, 2015, J MOL NEUROSCI, V55, P314, DOI 10.1007/s12031-014-0323-6; Hao XR, 2014, J MEMBRANE BIOL, V247, P273, DOI 10.1007/s00232-014-9632-5; Hougaard C, 2001, PFLUG ARCH EUR J PHY, V442, P622, DOI 10.1007/s004240100585; Innamaa A, 2013, ANTICANCER RES, V33, P1401; Jehle J, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.77; Kilisch M, 2015, PFLUG ARCH EUR J PHY, V467, P1105, DOI 10.1007/s00424-014-1672-2; Kim CJ, 2004, APMIS, V112, P588, DOI 10.1111/j.1600-0463.2004.apm1120905.x; Kondratskyi A, 2015, BBA-BIOMEMBRANES, V1848, P2532, DOI 10.1016/j.bbamem.2014.10.030; Kosztka L, 2011, MELANOMA RES, V21, P308, DOI 10.1097/CMR.0b013e3283462713; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lang F, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0108; Lee GW, 2012, ACTA PHYSIOL, V204, P513, DOI 10.1111/j.1748-1716.2011.02359.x; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Li XT, 2013, ONCOL LETT, V5, P865, DOI 10.3892/ol.2012.1088; Maingret F, 2001, EMBO J, V20, P47, DOI 10.1093/emboj/20.1.47; Manegold Christian, 2007, Lung Cancer, V57 Suppl 2, pS3, DOI 10.1016/S0169-5002(07)70420-8; Mant A, 2013, J BIOL CHEM, V288, P3251, DOI 10.1074/jbc.M112.405167; Meuth SG, 2008, J BIOL CHEM, V283, P14559, DOI 10.1074/jbc.M800637200; Meuth SG, 2008, J NEURO-ONCOL, V87, P263, DOI 10.1007/s11060-008-9517-5; Mounier C, 2014, INT J ONCOL, V45, P485, DOI 10.3892/ijo.2014.2441; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Nagaraj C, 2013, EUR RESPIR J, V41, P85, DOI 10.1183/09031936.00211811; O'Kelly I, 2015, PFLUG ARCH EUR J PHY, V467, P1133, DOI 10.1007/s00424-014-1641-9; Olschewski A, 2010, ADV EXP MED BIOL, V661, P459, DOI 10.1007/978-1-60761-500-2_30; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Patel AJ, 2001, EUR RESPIR J, V18, P221, DOI 10.1183/09031936.01.00204001; Patel M, 2012, INT J PHARMACEUT, V436, P324, DOI 10.1016/j.ijpharm.2012.06.011; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pei L, 2003, P NATL ACAD SCI USA, V100, P7803, DOI 10.1073/pnas.1232448100; Pochini L, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00061; Pocsai K, 2006, CELL MOL LIFE SCI, V63, P2364, DOI 10.1007/s00018-006-6166-8; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Rusznak Z, 2008, VIRCHOWS ARCH, V452, P415, DOI 10.1007/s00428-007-0545-x; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Svensson PA, 2011, INT J MOL MED, V27, P227, DOI 10.3892/ijmm.2010.566; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Vadlapudi AD, 2013, INT J PHARMACEUT, V441, P535, DOI 10.1016/j.ijpharm.2012.10.047; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wohlkoenig C, 2011, CANCER LETT, V308, P134, DOI 10.1016/j.canlet.2011.03.014; Zempleni J, 2009, J NUTR, V139, P163, DOI 10.3945/jn.108.091967	55	32	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2016	11	6							e0157453	10.1371/journal.pone.0157453	http://dx.doi.org/10.1371/journal.pone.0157453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO5KF	27294516	Green Published, gold, Green Submitted			2022-12-27	WOS:000377821300046
J	Ge, YJ; Xu, B				Ge, Yujia; Xu, Bin			Dynamic Staffing and Rescheduling in Software Project Management: A Hybrid Approach	PLOS ONE			English	Article							MODEL; SYSTEM	Resource allocation could be influenced by various dynamic elements, such as the skills of engineers and the growth of skills, which requires managers to find an effective and efficient tool to support their staffing decision-making processes. Rescheduling happens commonly and frequently during the project execution. Control options have to be made when new resources are added or tasks are changed. In this paper we propose a software project staffing model considering dynamic elements of staff productivity with a Genetic Algorithm (GA) and Hill Climbing (HC) based optimizer. Since a newly generated reschedule dramatically different from the initial schedule could cause an obvious shifting cost increase, our rescheduling strategies consider both efficiency and stability. The results of real world case studies and extensive simulation experiments show that our proposed method is effective and could achieve comparable performance to other heuristic algorithms in most cases.	[Ge, Yujia; Xu, Bin] Zhejiang Gongshang Univ, Coll Comp & Informat Engn, Hangzhou, Zhejiang, Peoples R China; [Ge, Yujia] Zhejiang Univ Technol, Coll Informat Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang Gongshang University; Zhejiang University of Technology	Ge, YJ (corresponding author), Zhejiang Gongshang Univ, Coll Comp & Informat Engn, Hangzhou, Zhejiang, Peoples R China.; Ge, YJ (corresponding author), Zhejiang Univ Technol, Coll Informat Engn, Hangzhou, Zhejiang, Peoples R China.	yge@mail.zjgsu.edu.cn			Scientific Research Fund of Zhejiang Provincial Education Department [Y201223642]; Zhejiang Provincial Natural Science Foundation [LY12F01018]	Scientific Research Fund of Zhejiang Provincial Education Department; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by Scientific Research Fund of Zhejiang Provincial Education Department (No. Y201223642) (Yujia Ge, PI), and Zhejiang Provincial Natural Science Foundation (No. LY12F01018) (Yujia Ge, co-PI).r This work was partly supported by Scientific Research Fund of Zhejiang Provincial Education Department (No. Y201223642) and Zhejiang Provincial Natural Science Foundation (No. LY12F01018). We also thank Dr. Carl K. Chang and Dr. Hsin-yi Jiang for their valuable comments of revising and editing the paper.	Abdel-Hamid T. K., 1991, SOFTWARE PROJECT DYN; Alba E, 2007, INFORM SCIENCES, V177, P2380, DOI 10.1016/j.ins.2006.12.020; Azzeh M, 2011, J SYST SOFTWARE, V84, P270, DOI 10.1016/j.jss.2010.09.028; Barros M, 2003, P 2003 SOFTW PROC SI; Boehm B., 1981, SOFTWARE ENG EC; Boehm B. W., 2000, SOFTWARE COST ESTIMA; Chang CK, 2008, INFORM SOFTWARE TECH, V50, P1142, DOI 10.1016/j.infsof.2008.03.002; Chang CK, 2001, ANN SOFTW ENG, V11, P107, DOI 10.1023/A:1012543203763; Chao C., 1994, THESIS U ILLINOIS CH; Chavoya A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050531; Chiu NH, 2007, J SYST SOFTWARE, V80, P628, DOI 10.1016/j.jss.2006.06.006; Contreras-Bolton C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137724; Cowling P, 2002, EUR J OPER RES, V139, P230, DOI 10.1016/S0377-2217(01)00355-1; Di Penta Massimiliano, 2007, 2007 IEEE International Conference on Software Maintenance, P315, DOI 10.1109/ICSM.2007.4362644; Di Y., 2001, THESIS U ILLINOIS CH; Donzelli P, 2006, IEEE SOFTWARE, V23, P67, DOI 10.1109/MS.2006.90; Ferrucci F, 2013, PROCEEDINGS OF THE 35TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE 2013), P462, DOI 10.1109/ICSE.2013.6606592; Ge YJ, 2009, 2009 INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND COMPUTATIONAL INTELLIGENCE, VOL I, PROCEEDINGS, P439, DOI 10.1109/AICI.2009.434; Gen M., 1999, GENETIC ALGORITHMS E; Gueorguiev Stefan, 2009, P 11 ANN C GEN EV CO, P1673, DOI DOI 10.1145/1569901.1570125; Hansen GA, 1996, COMPUTER, V29, P73, DOI 10.1109/2.481468; Harman M, 2012, ACM COMPUT SURV, V45, DOI 10.1145/2379776.2379787; Hartmann S, 2000, EUR J OPER RES, V127, P394, DOI 10.1016/S0377-2217(99)00485-3; Herroelen W, 2005, EUR J OPER RES, V165, P289, DOI 10.1016/j.ejor.2004.04.002; Holland J.H., 1975, ADAPTATION NATURAL A; Katragjini K, 2013, INT J PROD RES, V51, P780, DOI 10.1080/00207543.2012.666856; Kouskouras KG, 2007, EUR J OPER RES, V181, P374, DOI 10.1016/j.ejor.2006.05.031; Lakey PB, 2003, P 2003 SOFTW PROC SI; LEDERER AL, 1995, J SYST SOFTWARE, V31, P125, DOI 10.1016/0164-1212(94)00092-2; Martin R. H., 2000, Software Process Improvement and Practice, V5, P147, DOI 10.1002/1099-1670(200006/09)5:2/3<147::AID-SPIP122>3.0.CO;2-T; Mitchell M., 1994, ADV NEURAL INFORM PR, V6, P51; Pendharkar PC, 2005, IEEE T SOFTWARE ENG, V31, P615, DOI 10.1109/TSE.2005.75; Pfahl D, 1999, J SYST SOFTWARE, V46, P135, DOI 10.1016/S0164-1212(99)00007-2; Pfeiffer A., 2006, P 39 CIRP ISMS, P173; Plekhanova V, 1998, LECT NOTES COMPUT SC, V1487, P116; Ren J, 2011, LECT NOTES COMPUT SC, V6956, P127, DOI 10.1007/978-3-642-23716-4_14; Stylianou C, 2012, PROC INT C TOOLS ART, P277, DOI 10.1109/ICTAI.2012.45; Sukhodolsky J., 2001, Software Engineering Notes, V26, P59, DOI 10.1145/505776.505791; Ventana Systems Inc, 2015, VENS SOFTW TOOL	39	7	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157104	10.1371/journal.pone.0157104	http://dx.doi.org/10.1371/journal.pone.0157104			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27285420	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000038
J	Neves, JV; Caldas, C; Ramos, MF; Rodrigues, PNS				Neves, Joao V.; Caldas, Carolina; Ramos, Miguel F.; Rodrigues, Pedro N. S.			Hepcidin-Dependent Regulation of Erythropoiesis during Anemia in a Teleost Fish, Dicentrarchus labrax	PLOS ONE			English	Article							IRON-METABOLISM; TRANSCRIPTION FACTORS; MITOCHONDRIAL HEME; PEPTIDE HEPCIDIN; EXPRESSION; GENE; OVERLOAD; LIVER; BMP6; INFLAMMATION	Anemia is a common disorder, characterized by abnormally low levels of red blood cells or hemoglobin. The mechanisms of anemia development and response have been thoroughly studied in mammals, but little is known in other vertebrates, particularly teleost fish. In this study, different degrees of anemia were induced in healthy European sea bass specimens (Dicentrarchus labrax) and at pre-determined time points hematological parameters, liver iron content and the expression of genes involved in iron homeostasis and hematopoiesis, with particular attention on hepcidins, were evaluated. The experimental anemia prompted a decrease in hamp1 expression in all tested organs, in accordance to an increased need for iron absorption and mobilization, with slight increases in hamp2 in the kidney and intestine. The liver was clearly the major organ involved in iron homeostasis, decreasing its iron content and showing a gene expression profile consistent with an increased iron release and mobilization. Although both the spleen and head kidney are involved in erythropoiesis, the spleen was found to assume a more preponderant role in the recovery of erythrocyte levels. The intestine was also involved in the response to anemia, through the increase of iron transporting genes. Administration of Hamp1 or Hamp2 mature peptides showed that only Hamp1 affects hematological parameters and liver iron content. In conclusion, the molecular mechanisms of response to anemia present in sea bass are similar to the ones described for mammals, with these results indicating that the two hepcidin types from teleosts assume different roles during anemia.	[Neves, Joao V.; Caldas, Carolina; Ramos, Miguel F.; Rodrigues, Pedro N. S.] Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Neves, Joao V.; Caldas, Carolina; Ramos, Miguel F.; Rodrigues, Pedro N. S.] Univ Porto, IBMC, Iron & Innate Immun, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Rodrigues, Pedro N. S.] Univ Porto, ICBAS, Rua Campo Alegre 823, P-4100 Porto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto	Neves, JV (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Porto, Portugal.; Neves, JV (corresponding author), Univ Porto, IBMC, Iron & Innate Immun, Rua Campo Alegre 823, P-4100 Porto, Portugal.	jneves@ibmc.up.pt	Neves, Jessika M. M./F-9215-2017; Mott, Tamí/I-5317-2012; Caldas, Carlos/U-7250-2019; Rodrigues, Pedro/B-3228-2008; Pereira, Ricardo J/K-7451-2017	Neves, Jessika M. M./0000-0003-3983-5171; Mott, Tamí/0000-0002-5896-4780; Caldas, Carlos/0000-0003-3547-1489; Rodrigues, Pedro/0000-0002-3799-1544; Pereira, Ricardo J/0000-0002-8076-4822; Caldas, Carolina/0000-0003-3967-6211; Lima, Sergio Maia Queiroz/0000-0001-9365-4879; Neves, Joao/0000-0003-1993-0999	FEDER-Fundo Europeu de Desenvolvimento Regional funds through COMPETE - Operational Programme for Competitiveness and Internationalization (POCI), Portugal; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao [POCI-01-0145-FEDER-007274, FCOMP-01-0124-FEDER-029339 (PTDC/MAR-BIO/3204/2012)]; FCT [SFRH/BPD/86380/2012]	FEDER-Fundo Europeu de Desenvolvimento Regional funds through COMPETE - Operational Programme for Competitiveness and Internationalization (POCI), Portugal; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the projects "Institute for Research and Innovation in Health Sciences" (POCI-01-0145-FEDER-007274) and FCOMP-01-0124-FEDER-029339 (PTDC/MAR-BIO/3204/2012). JVN is supported by FCT under the grant SFRH/BPD/86380/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen P, 1999, CURR OPIN CHEM BIOL, V3, P200, DOI 10.1016/S1367-5931(99)80033-7; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arndt S, 2010, GASTROENTEROLOGY, V138, P372, DOI 10.1053/j.gastro.2009.09.048; Barnes AC, 2011, FISH SHELLFISH IMMUN, V31, P350, DOI 10.1016/j.fsi.2011.05.027; Boldt DH, 1999, AM J MED SCI, V318, P207, DOI 10.1097/00000441-199910000-00001; Bury N, 2003, COMP BIOCHEM PHYS C, V135, P97, DOI 10.1016/S1532-0456(03)00021-8; Bury NR, 2001, J EXP BIOL, V204, P3779; CATTON WT, 1951, BLOOD, V6, P39, DOI 10.1182/blood.V6.1.39.39; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Cho YS, 2009, DEV COMP IMMUNOL, V33, P46, DOI 10.1016/j.dci.2008.07.009; Clark SF, 2008, NUTR CLIN PRACT, V23, P128, DOI 10.1177/0884533608314536; Conrad ME, 1999, AM J MED SCI, V318, P213, DOI 10.1097/00000441-199910000-00002; Darshan D, 2009, BIOMETALS, V22, P77, DOI 10.1007/s10534-008-9187-y; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; ESTEBAN MA, 1989, ARCH HISTOL CYTOL, V52, P407, DOI 10.1679/aohc.52.407; Fleming MD, 2012, J CLIN INVEST, V122, P4328, DOI 10.1172/JCI66607; Ganz T, 2005, BEST PRACT RES CL HA, V18, P171, DOI 10.1016/j.beha.2004.08.020; Ganz T, 2004, CURR OPIN HEMATOL, V11, P251, DOI 10.1097/00062752-200407000-00004; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hilton KB, 2008, GENE, V415, P40, DOI 10.1016/j.gene.2008.02.016; Hu XY, 2007, COMP IMMUNOL MICROB, V30, P55, DOI 10.1016/j.cimid.2006.10.004; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Imagawa S, 1997, BLOOD, V89, P1430, DOI 10.1182/blood.V89.4.1430; Ingley E, 2004, IUBMB LIFE, V56, P177, DOI 10.1080/15216540410001703956; Kautz L, 2011, HAEMATOL-HEMATOL J, V96, P199, DOI 10.3324/haematol.2010.031963; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nam YK, 2011, FISH SHELLFISH IMMUN, V31, P1251, DOI 10.1016/j.fsi.2011.09.007; Neves JV, 2011, FISH SHELLFISH IMMUN, V31, P1154, DOI 10.1016/j.fsi.2011.10.006; Neves JV, 2015, J IMMUNOL, V195, P2696, DOI 10.4049/jimmunol.1501153; Neves JV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-106; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pereiro R, 2012, FISH SHELLFISH IMMUN, V32, P879, DOI 10.1016/j.fsi.2012.02.016; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Rodrigues PNS, 2006, DEV COMP IMMUNOL, V30, P1156, DOI 10.1016/j.dci.2006.02.005; Saboor Muhammad, 2011, J Ayub Med Coll Abbottabad, V23, P115; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Torrance J.D., 1980, METHODS HEMATOLOGY, P104; Viatte L, 2009, BIOCHIMIE, V91, P1223, DOI 10.1016/j.biochi.2009.06.012; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Wessling-Resnick M, 1999, CRIT REV BIOCHEM MOL, V34, P285, DOI 10.1080/10409239991209318; Worthen CA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00034; Zhou JG, 2011, FISH SHELLFISH IMMUN, V30, P559, DOI 10.1016/j.fsi.2010.11.021	50	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153940	10.1371/journal.pone.0153940	http://dx.doi.org/10.1371/journal.pone.0153940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27309356	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500102
J	Neves, JMM; Lima, SMQ; Mendes, LF; Torres, RA; Pereira, RJ; Mott, T				Neves, Jessika M. M.; Lima, Sergio M. Q.; Mendes, Liana F.; Torres, Rodrigo A.; Pereira, Ricardo J.; Mott, Tami			Population Structure of the Rockpool Blenny Entomacrodus vomerinus Shows Source-Sink Dynamics among Ecoregions in the Tropical Southwestern Atlantic	PLOS ONE			English	Article							REEF FISH; LARVAL DISPERSAL; PHYLOGEOGRAPHY; BIOGEOGRAPHY; NEUTRALITY; TELEOSTEI; MIGRATION; PATTERNS; GENETICS; COASTAL	The Tropical Southwestern Atlantic is characterized by prominent ecosystems with large-scale oceanographic complexity. Yet, the evolutionary processes underlying genetic differentiation and connectivity in this region remain largely unknown. Entomacrodus vomerinus (Valenciennes, 1836) is a demersal fish with planktonic larvae endemic to this marine province, inhabiting shallow tidal pools in continental and oceanic reef environments. We evaluated the population structure, genetic diversity and gene flow of E. vomerinus using mitochondrial data (CYTB and COI) and nuclear (rhodopsin, RHO) DNA sequences. We sampled a total of 85 individuals, comprising 46 from three oceanic archipelagos with varying distance from the coast (Sao Pedro and Sao Paulo-SS, Fernando de Noronha-FE and Rocas Atoll-RA) and 39 from two localities in northeastern Brazilian coast (Rio Grande do Norte-RN and Bahia-BA). Multilocus analysis revealed the presence of three Evolutionarily Significant Units-ESUs (SS, FE+RA, and RN+BA), which are in accordance with distinct marine ecoregions. Coalescent analyses showed that the central ESU has a larger effective population size than the other two, suggesting strong asymmetries in the genetic diversity across the species range. Moreover, they showed that gene flow is highly asymmetric, suggesting a source-sink dynamics from the central ESU into the remaining ones, in agreement with oceanic currents. Together, these results provide insights in the evolutionary mechanisms facilitating diversification in this marine province.	[Neves, Jessika M. M.; Mott, Tami] Univ Fed Alagoas, Setor Biodiversidade, Lab Diversidade Mol, Maceio, Alagoas, Brazil; [Lima, Sergio M. Q.] Univ Fed Rio Grande do Norte, Dept Bot & Zool, Lab Ictiol Sistemat & Evolut, BR-59072970 Natal, RN, Brazil; [Mendes, Liana F.] Univ Fed Rio Grande do Norte, Dept Ecol, Lab Oceano, BR-59072970 Natal, RN, Brazil; [Torres, Rodrigo A.] Univ Fed Pernambuco, Dept Zool, Lab Genom Evolutiva & Ambiental, Recife, PE, Brazil; [Pereira, Ricardo J.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	Universidade Federal de Alagoas; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal de Pernambuco; University of Copenhagen	Neves, JMM (corresponding author), Univ Fed Alagoas, Setor Biodiversidade, Lab Diversidade Mol, Maceio, Alagoas, Brazil.	neves.jmm@gmail.com	Neves, Jessika M. M./F-9215-2017; Mott, Tamí/I-5317-2012; Caldas, Carlos/U-7250-2019; Rodrigues, Pedro/B-3228-2008; Pereira, Ricardo J/K-7451-2017	Neves, Jessika M. M./0000-0003-3983-5171; Mott, Tamí/0000-0002-5896-4780; Caldas, Carlos/0000-0003-3547-1489; Rodrigues, Pedro/0000-0002-3799-1544; Pereira, Ricardo J/0000-0002-8076-4822; Caldas, Carolina/0000-0003-3967-6211; Lima, Sergio Maia Queiroz/0000-0001-9365-4879; Neves, Joao/0000-0003-1993-0999	Fundacao Universitaria de Desenvolvimento de Extensao e Pesquisa (Fundepes); Financiadora de Estudos e Projetos (FINEP) [1312/10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301208/2012-3]; European Union's Horizon research and innovation program under the Marie Sklodowska-Curie (MSCA) [658706]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Universitaria de Desenvolvimento de Extensao e Pesquisa (Fundepes); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Union's Horizon research and innovation program under the Marie Sklodowska-Curie (MSCA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by Fundacao Universitaria de Desenvolvimento de Extensao e Pesquisa (Fundepes - http://www.fundepes.br/) and Financiadora de Estudos e Projetos (FINEP - http://www.finep.gov.br/) grant #1312/10 (TM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - http://www.cnpq.br/) grant #301208/2012-3 (RAT); and the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie (MSCA - http://ec.europa.eu/research/mariecurieactions/index_en.htm) grant #658706 (RJP). Scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - http://www.capes.gov.br/) (JMMN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Baldwin CC, 2009, ZOOTAXA, P1; Barroso R, 2010, MAR BIOL, V157, P69, DOI 10.1007/s00227-009-1296-9; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cruzan MB, 2000, TRENDS ECOL EVOL, V15, P491, DOI 10.1016/S0169-5347(00)01998-4; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EDWARDS A, 1983, J BIOGEOGR, V10, P65, DOI 10.2307/2844583; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feitoza Bertran M., 2003, Aqua (Miradolo Terme), V7, P61; Fitzpatrick BM, 2009, MOL ECOL, V18, P3961, DOI 10.1111/j.1365-294X.2009.04314.x; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Francisco SM, 2011, J EXP MAR BIOL ECOL, V403, P14, DOI 10.1016/j.jembe.2011.03.020; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2015, MOL ECOL, V24, P1543, DOI 10.1111/mec.13129; Gama-Maia DJ, 2016, J MAR BIOL ASSOC UK, V96, P1677, DOI 10.1017/S0025315415002052; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Jacobina UP, 2014, HELGOLAND MAR RES, V68, P17, DOI 10.1007/s10152-013-0365-0; Joyeux JC, 2001, J BIOGEOGR, V28, P831, DOI 10.1046/j.1365-2699.2001.00602.x; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Leao Zelinda M. A. N., 2000, Marine Pollution Bulletin, V41, P112, DOI 10.1016/S0025-326X(00)00105-3; Leao ZMAN, 2005, MAR POLLUT BULL, V51, P599, DOI 10.1016/j.marpolbul.2005.04.024; Leigh JW, POPART POPULATION AN; Macedo-Soares LCP, 2012, MAR ECOL PROG SER, V444, P207, DOI 10.3354/meps09436; Macieira RM, 2015, ENVIRON BIOL FISH, V98, P385, DOI 10.1007/s10641-014-0269-0; Mai ACG, 2014, ESTUAR COAST SHELF S, V149, P80, DOI 10.1016/j.ecss.2014.07.013; Medeiros Paulo R., 2007, Pan-American Journal of Aquatic Sciences, V2, P288; Mendes LF, 2000, THESIS; Mendes LD, 2006, REV BRAS ZOOL, V23, P817, DOI 10.1590/S0101-81752006000300029; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Motoki A, 2009, REM-REV ESC MINAS, V62, P331, DOI 10.1590/S0370-44672009000300011; Muss A, 2001, EVOLUTION, V55, P561, DOI 10.1554/0014-3820(2001)055[0561:POOTRO]2.0.CO;2; Nanninga GB, 2014, MOL ECOL, V23, P591, DOI 10.1111/mec.12623; Nielsen R, 2001, GENETICS, V158, P885; Paiva Maria Isabel G., 2015, Pan-American Journal of Aquatic Sciences, V10, P19; Pinheiro HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118180; Pringle JM, 2001, P NATL ACAD SCI USA, V108, P15288; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rangel Carlos A., 2010, Revista Brasileira de Zoociencias, V12, P17; Rangel CA, 2009, ZOOTAXA, P51, DOI 10.11646/zootaxa.2006.1.4; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Rodriguez-Rey GT, 2016, J EXP MAR BIOL ECOL, V474, P204, DOI 10.1016/j.jembe.2015.10.016; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Sacramento LA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/264270; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; SMITH MF, 1993, BIOL J LINN SOC, V50, P149, DOI 10.1111/j.1095-8312.1993.tb00924.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stephens M, 2004, DOCUMENTATION PHASE, P35; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Ward Robert D, 2012, Methods Mol Biol, V858, P423, DOI 10.1007/978-1-61779-591-6_21; Wares JP, 2001, EVOLUTION, V55, P295; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Williams JT, 2014, ENTOMACRODUS VOMERIN, DOI [10.2305/IUCN.UK.2014-3.RLTS.T185176A1776911.en, DOI 10.2305/IUCN.UK.2014-3.RLTS.T185176A1776911.EN]	65	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2016	11	6							e0157472	10.1371/journal.pone.0157472	http://dx.doi.org/10.1371/journal.pone.0157472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO8JO	27309356	Green Submitted, gold, Green Published			2022-12-27	WOS:000378029800079
